PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ganesh, VK; Barbu, EM; Deivanayagam, CCS; Le, B; Anderson, AS; Matsuka, YV; Lin, SL; Foster, TJ; Narayana, SVL; Hook, M				Ganesh, Vannakambadi K.; Barbu, E. Magda; Deivanayagam, Champion C. S.; Binh Le; Anderson, Analiesa S.; Matsuka, Yury V.; Lin, Shuo L.; Foster, Timothy J.; Narayana, Sthanam V. L.; Hoeoek, Magnus			Structural and Biochemical Characterization of Staphylococcus aureus Clumping Factor B/Ligand Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B CLFB; FIBRONECTIN-BINDING-PROTEINS; NASAL CARRIAGE; MOLECULAR CHARACTERIZATION; SURFACE-PROTEINS; MSCRAMM; ADHESIN; ADHERENCE; PROMOTE; MODEL	Clumping factor B (ClfB) from Staphylococcus aureus is a bifunctional protein that binds to human cytokeratin 10 (K10) and fibrinogen (Fg). ClfB has been implicated in S. aureus colonization of nasal epithelium and is therefore a key virulence factor. People colonized with S. aureus are at an increased risk for invasive staphylococcal disease. In this study, we have determined the crystal structures of the ligand-binding region of ClfB in an apo-form and in complex with human K10 and Fg alpha-chain-derived peptides, respectively. We have determined the structures of MSCRAMM binding to two ligands with different sequences in the same site showing the versatile nature of the ligand recognition mode of microbial surface components recognizing adhesive matrix molecules. Both ligands bind ClfB by parallel beta-sheet complementation as observed for the clumping factor A.gamma-chain peptide complex. The beta-sheet complementation is shorter in the ClfB.Fg alpha-chain peptide complex. The structures show that several residues in ClfB are important for binding to both ligands, whereas others only make contact with one of the ligands. A common motif GSSGXG found in both ligands is part of the ClfB-binding site. This motif is found in many human proteins thus raising the possibility that ClfB recognizes additional ligands.	[Ganesh, Vannakambadi K.; Barbu, E. Magda; Binh Le; Hoeoek, Magnus] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Deivanayagam, Champion C. S.; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35205 USA; [Anderson, Analiesa S.; Matsuka, Yury V.; Lin, Shuo L.] Pfizer Vaccine Res, Pearl River, NY 10965 USA; [Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Alabama System; University of Alabama Birmingham; Pfizer; Trinity College Dublin	Ganesh, VK (corresponding author), Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	vganesh@ibt.tamhsc.edu		Deivanayagam, Champion/0000-0003-2972-1824	Pfizer Vaccine Research; Science Foundation of Ireland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073521] Funding Source: NIH RePORTER	Pfizer Vaccine Research; Science Foundation of Ireland(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from Pfizer Vaccine Research (to V. K. G. and M. H.) and by Science Foundation of Ireland (to T. J. F.). A. S. A., Y. V. M., and S. L. L. are employees of Pfizer. M. H. and T. J. F. are inventors on a United States patent claiming the use of ClfB as an S. aureus vaccine component and licensed to Pfizer through Inhibitex Inc.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chambers HF, 2009, J INFECT DIS, V199, P291, DOI 10.1086/595983; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murphy E, 2011, HUM VACCINES, V7, P51, DOI 10.4161/hv.7.0.14562; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; TALON D, 1995, J HOSP INFECT, V30, P39, DOI 10.1016/0195-6701(95)90247-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	42	57	60	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25963	25972		10.1074/jbc.M110.217414	http://dx.doi.org/10.1074/jbc.M110.217414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21543319	hybrid, Green Published			2022-12-27	WOS:000293073000055
J	Nolde, SB; Vassilevski, AA; Rogozhin, EA; Barinov, NA; Balashova, TA; Samsonova, OV; Baranov, YV; Feofanov, AV; Egorov, TA; Arseniev, AS; Grishin, EV				Nolde, Svetlana B.; Vassilevski, Alexander A.; Rogozhin, Eugene A.; Barinov, Nikolay A.; Balashova, Tamara A.; Samsonova, Olga V.; Baranov, Yuri V.; Feofanov, Alexey V.; Egorov, Tsezi A.; Arseniev, Alexander S.; Grishin, Eugene V.			Disulfide-stabilized Helical Hairpin Structure and Activity of a Novel Antifungal Peptide EcAMP1 from Seeds of Barnyard Grass (Echinochloa crus-galli)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NMR-SPECTROSCOPY; LIPOPOLYSACCHARIDE MICELLES; HOST-DEFENSE; PLANT; PROTEINS; MOTIF; PURIFICATION; INHIBITORS; ASSIGNMENT	This study presents purification, activity characterization, and H-1 NMR study of the novel antifungal peptide EcAMP1 from kernels of barnyard grass Echinochloa crus-galli. The peptide adopts a disulfide-stabilized alpha-helical hairpin structure in aqueous solution and thus represents a novel fold among naturally occurring antimicrobial peptides. Micromolar concentrations of EcAMP1 were shown to inhibit growth of several fungal phytopathogens. Confocal microscopy revealed intensive EcAMP1 binding to the surface of fungal conidia followed by internalization and accumulation in the cytoplasm without disturbance of membrane integrity. Close spatial structure similarity between EcAMP1, the trypsin inhibitor VhTI from seeds of Veronica hederifolia, and some scorpion and cone snail toxins suggests natural elaboration of different functions on a common fold.	[Nolde, Svetlana B.; Vassilevski, Alexander A.; Rogozhin, Eugene A.; Barinov, Nikolay A.; Balashova, Tamara A.; Samsonova, Olga V.; Baranov, Yuri V.; Feofanov, Alexey V.; Egorov, Tsezi A.; Arseniev, Alexander S.; Grishin, Eugene V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Arseniev, AS (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Miklukho Maklaya 16-10, Moscow 117997, Russia.	aars@nmr.ru; grev@mx.ibch.ru	Nolde, Svetlana B/AGQ-4485-2022; Rogozhin, Eugene/E-5333-2014; Rogozhin, Eugene A/Y-9273-2019; Vassilevski, Alexander/S-3824-2016; Barinov, Nikolay/L-9357-2016; Feofanov, Alexey V/K-3082-2012	Rogozhin, Eugene/0000-0003-0659-9547; Rogozhin, Eugene A/0000-0003-0659-9547; Vassilevski, Alexander/0000-0002-1359-0076; Barinov, Nikolay/0000-0002-0512-2547; Feofanov, Alexey V/0000-0002-1596-9506; Nolde, Svetlana/0000-0001-6866-4936	Russian Foundation for Basic Research [08-04-00783, 11-04-00190]; Ministry of Education and Science of Russian Federation [16.740.11.0424]; Russian scientific schools [4821.2008.4]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian scientific schools; Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Foundation for Basic Research (Grants 08-04-00783 and 11-04-00190), the Ministry of Education and Science of Russian Federation (State Contract 16.740.11.0424), the Russian scientific schools Grant 4821.2008.4, and the Program of Cell and Molecular Biology of the Russian Academy of Sciences.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Barnham KJ, 1997, J MOL BIOL, V268, P886, DOI 10.1006/jmbi.1997.0980; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Barthe P, 2000, PROTEIN SCI, V9, P942, DOI 10.1110/ps.9.5.942; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Conners R, 2007, J BIOL CHEM, V282, P27760, DOI 10.1074/jbc.M703871200; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; DUVICK JP, 1992, J BIOL CHEM, V267, P18814; Egorov TA, 2005, PEPTIDES, V26, P2064, DOI 10.1016/j.peptides.2005.03.007; Egorov TA, 1997, SPRING LAB MAN, P259; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Li F, 2003, PEPTIDES, V24, P799, DOI 10.1016/S0196-9781(03)00173-6; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; MARCHANT R, 1966, ANN BOT-LONDON, V30, P441, DOI 10.1093/oxfordjournals.aob.a084087; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Nicastro G, 2009, PROTEIN SCI, V18, P1786, DOI 10.1002/pro.168; Odintsova TI, 2009, FEBS J, V276, P4266, DOI 10.1111/j.1742-4658.2009.07135.x; Odintsova TI, 2008, BIOCHIMIE, V90, P1667, DOI 10.1016/j.biochi.2008.06.007; Park SS, 1997, FEBS LETT, V400, P103, DOI 10.1016/S0014-5793(96)01367-1; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rogozhin E A, 2009, Prikl Biokhim Mikrobiol, V45, P403; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; SZYPERSKI T, 1992, J MAGN RESON, V99, P552, DOI 10.1016/0022-2364(92)90209-P; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Vila-Perello M, 2005, J BIOL CHEM, V280, P1661, DOI 10.1074/jbc.M410577200; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	57	66	73	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25145	25153		10.1074/jbc.M110.200378	http://dx.doi.org/10.1074/jbc.M110.200378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561864	Green Published, hybrid			2022-12-27	WOS:000292547900062
J	Vishnivetskiy, SA; Gimenez, LE; Francis, DJ; Hanson, SM; Hubbell, WL; Klug, CS; Gurevich, VV				Vishnivetskiy, Sergey A.; Gimenez, Luis E.; Francis, Derek J.; Hanson, Susan M.; Hubbell, Wayne L.; Klug, Candice S.; Gurevich, Vsevolod V.			Few Residues within an Extensive Binding Interface Drive Receptor Interaction and Determine the Specificity of Arrestin Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; 3RD INTRACELLULAR LOOP; VISUAL ARRESTIN; BETA-ARRESTIN; CRYSTAL-STRUCTURE; COUPLED RECEPTORS; PHOSPHORYLATION-RECOGNITION; FLUORESCENT PROTEIN; CLATHRIN ADAPTER; 48-KDA PROTEIN	Arrestins bind active phosphorylated forms of Gprotein-coupled receptors, terminating G protein activation, orchestrating receptor trafficking, and redirecting signaling to alternative pathways. Visual arrestin-1 preferentially binds rhodopsin, whereas the two non-visual arrestins interact with hundreds of G protein-coupled receptor subtypes. Here we show that an extensive surface on the concave side of both arrestin-2 domains is involved in receptor binding. We also identified a small number of residues on the receptor binding surface of the N- and C-domains that largely determine the receptor specificity of arrestins. We show that alanine substitution of these residues blocks the binding of arrestin-1 to rhodopsin in vitro and of arrestin-2 and -3 to beta 2-adrenergic, M2 muscarinic cholinergic, and D2 dopamine receptors in intact cells, suggesting that these elements critically contribute to the energy of the interaction. Thus, in contrast to arrestin-1, where direct phosphate binding is crucial, the interaction of non-visual arrestins with their cognate receptors depends to a lesser extent on phosphate binding and more on the binding to non-phosphorylated receptor elements.	[Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Francis, Derek J.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Vishnivetskiy, Sergey A.; Gimenez, Luis E.; Hanson, Susan M.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Medical College of Wisconsin; Vanderbilt University	Hubbell, WL (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	hubbellw@jsei.ucla.edu; candice@mcw.edu; vsevolod.gurevich@vanderbilt.edu	Gimenez, Luis E Diaz/D-9291-2011; Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, GM070642, EY005216]; Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE [P30EY000331, R01EY011500, R37EY005216, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070642, R01GM077561, R56GM070642, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, EY011500 (to V. V. G.), GM070642 (to C. S. K.), and EY005216 (to W. L. H.). This work was also supported by the Jules Stein Professorship Endowment (to W. L. H.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Crane JM, 2005, J MOL BIOL, V353, P295, DOI 10.1016/j.jmb.2005.08.022; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; Gurevich Vsevolod V., 2008, P55; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kishi H, 2002, J BIOL CHEM, V277, P21939, DOI 10.1074/jbc.M110894200; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	93	75	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24288	24299		10.1074/jbc.M110.213835	http://dx.doi.org/10.1074/jbc.M110.213835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21471193	Green Published, hybrid			2022-12-27	WOS:000292294900070
J	Han, WN; Ming, M; He, YY				Han, Weinong; Ming, Mei; He, Yu-Ying			Caffeine Promotes Ultraviolet B-induced Apoptosis in Human Keratinocytes without Complete DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UVB-INDUCED APOPTOSIS; HUMAN-SKIN FIBROBLASTS; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; CYCLOOXYGENASE-2 EXPRESSION; XERODERMA-PIGMENTOSUM; IONIZING-RADIATION; CELL-PROLIFERATION; GENOME MAINTENANCE	In response to ultraviolet B damage, keratinocytes undergo apoptosis to eliminate damaged cells, thereby preventing tumorigenic transformation. Caffeine, the most widely consumed psychoactive substance, produces complex pharmacological actions; it has been shown to be chemopreventive in non-melamona skin cancer in mice through increasing apoptosis. Here we have investigated the molecular and cellular mechanisms in the pro-apoptotic effect of caffeine on UVB-irradiated human HaCaT keratinocytes. Pretreatment with caffeine increased UVB-induced apoptosis in HaCaT cells. Caffeine blocked UVB-induced Chk1 phosphorylation. In addition, similar to the effect of the PI3K inhibitor LY294002, caffeine also inhibited phosphorylation of AKT and up-regulation of COX-2, two critical oncogenic pathways in skin tumorigenesis. However, phosphorylation of EGFR or ERK was unaffected. Inhibiting ATR pathways by siRNA targeting ATR had little effect on UVB-induced apoptosis or AKT activation, indicating that the inhibitory effect of caffeine on apoptosis and the AKT pathway does not require the ATR pathway. Inhibiting AKT by caffeine blocked UVB-induced COX-2 up-regulation. Expression of constitutively active AKT that was not inhibited by caffeine was found to protect cells from caffeine-promoted apoptosis post-UVB irradiation, indicating that AKT is an essential inhibitory target for caffeine to promote apoptosis. Caffeine specifically sensitized cells with unrepaired DNA damage to UVB-induced apoptosis. These findings indicate that in HaCaT keratinocytes, inhibiting the AKT/COX-2 pathways through an ATR-independent pathway is a critical molecular mechanism by which caffeine promotes UVB-induced apoptosis of unrepaired keratinocytes for elimination.	[Han, Weinong; Ming, Mei; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA	University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu			National Institutes of Health [ES016936]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES016936 (to Y.-Y. H.). Further support was provided by UC Friends of Dermatology Research Funds.	Ahn JY, 2000, CANCER RES, V60, P5934; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; BODE AM, 2003, SCI STKE, pRE2; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; de Gruijl FR, 2008, PHOTOCHEM PHOTOBIOL, V84, P382, DOI 10.1111/j.1751-1097.2007.00275.x; Fiebich BL, 2000, NEUROPHARMACOLOGY, V39, P2205, DOI 10.1016/S0028-3908(00)00045-9; Fischer SM, 2007, MOL CARCINOGEN, V46, P363, DOI 10.1002/mc.20284; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Hannan MA, 2002, CARCINOGENESIS, V23, P1617, DOI 10.1093/carcin/23.10.1617; Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453; He YY, 2006, ONCOGENE, V25, P3680, DOI 10.1038/sj.onc.1209384; He ZW, 2003, CANCER RES, V63, P4396; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Johnson TM, 1998, J AM ACAD DERMATOL, V38, P681, DOI 10.1016/S0190-9622(98)70196-3; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lawlor MA, 2001, J CELL SCI, V114, P2903; Ling G, 2001, AM J PATHOL, V159, P1247, DOI 10.1016/S0002-9440(10)62511-4; Liu QH, 2000, GENE DEV, V14, P1448; Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955; Lu YP, 2007, CARCINOGENESIS, V28, P199, DOI 10.1093/carcin/bgl112; Lu YP, 2004, CANCER RES, V64, P5020, DOI 10.1158/0008-5472.CAN-04-0760; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Menoyo A, 2001, CANCER RES, V61, P7727; Ming M, 2010, ONCOGENE, V29, P492, DOI 10.1038/onc.2009.357; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nakagawa A, 1998, J INVEST DERMATOL, V110, P143, DOI 10.1046/j.1523-1747.1998.00100.x; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; NIGGLI HJ, 1988, J INVEST DERMATOL, V91, P579, DOI 10.1111/1523-1747.ep12477095; Nomura M, 2005, MOL CARCINOGEN, V44, P67, DOI 10.1002/mc.20120; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SELBY CP, 1990, P NATL ACAD SCI USA, V87, P3522, DOI 10.1073/pnas.87.9.3522; Sinn B, 2010, MOL CANCER THER, V9, P480, DOI 10.1158/1535-7163.MCT-09-0498; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Tang QB, 2001, CANCER RES, V61, P4329; Tiano HF, 2002, CANCER RES, V62, P3395; VINK AA, 1991, CARCINOGENESIS, V12, P861, DOI 10.1093/carcin/12.5.861; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	59	45	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22825	22832		10.1074/jbc.M111.222349	http://dx.doi.org/10.1074/jbc.M111.222349			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561856	Green Published, hybrid			2022-12-27	WOS:000292025000017
J	Keshwani, MM; von Daake, S; Newton, AC; Harris, TK; Taylor, SS				Keshwani, Malik M.; von Daake, Sventja; Newton, Alexandra C.; Harris, Thomas K.; Taylor, Susan S.			Hydrophobic Motif Phosphorylation Is Not Required for Activation Loop Phosphorylation of p70 Ribosomal Protein S6 Kinase 1 (S6K1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGC KINASES; IN-VIVO; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; BINDING POCKET; PDK1; DOMAIN; P70(S6K); SITE; MECHANISM	p70 ribosomal protein S6 kinase 1 (S6K1) is regulated by multiple phosphorylation events. Three of these sites are highly conserved among AGC kinases (cAMP dependent Protein Kinase, cGMP dependent Protein Kinase, and Protein Kinase C subfamily): the activation loop in the kinase domain, and two C-terminal sites, the turn motif and the hydrophobic motif. The common dogma has been that phosphorylation of the hydrophobic motif primes S6K1 for the phosphorylation at the activation loop by phosphoinositide-dependent protein kinase 1 (PDK1). Here, we show that the turn motif is, in fact, phosphorylated first, the activation loop second, and the hydrophobic motif is third. Specifically, biochemical analyses of a construct of S6K1 lacking the C-terminal autoinhibitory domain as well as full-length S6K1, reveals that S6K1 is constitutively phosphorylated at the turn motif when expressed in insect cells and becomes phosphorylated in vitro by purified PDK1 at the activation loop. Only the species phosphorylated at the activation loop by PDK1 gets phosphorylated at the hydrophobic motif by mammalian target of rapamycin (mTOR) in vitro. These data are consistent with a previous model in which constitutive phosphorylation of the turn motif provides the key priming step in the phosphorylation of S6K1. The data provide evidence for regulation of S6K1, where hydrophobic motif phosphorylation is not required for PDK1 to phosphorylate S6K1 at the activation loop, but instead activation loop phosphorylation of S6K1 is required for mTOR to phosphorylate the hydrophobic motif of S6K1.	[von Daake, Sventja; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Newton, Alexandra C.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Miami	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health through the NIDDK [19301, DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grants 19301 (to S. S. T.) and DK054441 through the NIDDK (to S. S. T. and A. C. N.).	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Keshwani MM, 2009, J BIOL CHEM, V284, P22611, DOI 10.1074/jbc.M109.032177; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	37	34	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23552	23558		10.1074/jbc.M111.258004	http://dx.doi.org/10.1074/jbc.M111.258004			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561857	hybrid, Green Published			2022-12-27	WOS:000292025000085
J	Nowak, AJ; Alfieri, C; Stirnimann, CU; Rybin, V; Baudin, F; Ly-Hartig, N; Lindner, D; Muller, CW				Nowak, Agnieszka J.; Alfieri, Claudio; Stirnimann, Christian U.; Rybin, Vladimir; Baudin, Florence; Ly-Hartig, Nga; Lindner, Doris; Mueller, Christoph W.			Chromatin-modifying Complex Component Nurf55/p55 Associates with Histones H3 and H4 and Polycomb Repressive Complex 2 Subunit Su(z) 12 through Partially Overlapping Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE ACTIVITY; STRUCTURAL BASIS; RECOGNITION; PROTEIN; MECHANISMS; ENHANCER; ESC	Drosophila Nurf55 is a component of different chromatin-modifying complexes, including the PRC2(Polycomb repressive complex 2). Based on the 1.75-angstrom crystal structure of Nurf55 bound to histone H4 helix 1, we analyzed interactions of Nurf55 (Nurf55 or p55 in fly and RbAp48/46 in human) with the N-terminal tail of histone H3, the first helix of histone H4, and an N-terminal fragment of the PRC2 subunit Su(z) 12 using isothermal calorimetry and pulldown experiments. Site-directed mutagenesis identified the binding site of histone H3 at the top of the Nurf55 WD40 propeller. Unmodified or K9me3- or K27me3-containing H3 peptides were bound with similar affinities, whereas the affinity for K4me3-containing H3 peptides was reduced. Helix 1 of histone H4 and Su(z) 12 bound to the edge of the beta-propeller using overlapping binding sites. Our results show similarities in the recognition of histone H4 and Su(z) 12 and identify Nurf55 as a versatile interactor that simultaneously contacts multiple partners.	[Nowak, Agnieszka J.; Alfieri, Claudio; Stirnimann, Christian U.; Rybin, Vladimir; Baudin, Florence; Ly-Hartig, Nga; Lindner, Doris; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Baudin, Florence] UJF EMBL CNRS UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Muller, CW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cmueller@embl.de	Müller, Christian/AAB-4783-2022; Müller, Christoph W/I-7420-2012	Müller, Christian/0000-0002-1120-6405; Müller, Christoph W/0000-0003-2176-8337; Stirnimann, Christian/0000-0002-1030-8864; Baudin, Florence/0000-0003-0816-0861; Alfieri, Claudio/0000-0003-3215-1607	Marie Curie Framework Program; European Molecular Biology Organization; European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group	Marie Curie Framework Program; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group	Supported by Marie Curie Framework Program 7 and the European Molecular Biology Organization Long-Term Fellowship Program.; We thank J. Muller for expression constructs and advice, M. Agez for recombinant histone H3/H4 heterodimers, the Proteomics and the Protein Expression and Purification Core Facilities at EMBL Heidelberg for support, and the European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group for access and support at the European Synchrotron Radiation Facility beamlines.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tie F, 2001, DEVELOPMENT, V128, P275; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5	27	52	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23388	23396		10.1074/jbc.M110.207407	http://dx.doi.org/10.1074/jbc.M110.207407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550984	Green Published, hybrid			2022-12-27	WOS:000292025000070
J	Serebryakova, MV; Demina, IA; Galyamina, MA; Kondratov, IG; Ladygina, VG; Govorun, VM				Serebryakova, Marina V.; Demina, Irina A.; Galyamina, Maria A.; Kondratov, Ilya G.; Ladygina, Valentina G.; Govorun, Vadim M.			The Acylation State of Surface Lipoproteins of Mollicute Acholeplasma laidlawii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEINS; SELECTIVE ACYLATION; ESCHERICHIA-COLI; CHEMICAL-ANALYSIS; LIPID-COMPOSITION; CHAINS; AGENT; ACID	Acylation of the N-terminal Cys residue is an essential, ubiquitous, and uniquely bacterial posttranslational modification that allows anchoring of proteins to the lipid membrane. In Gram-negative bacteria, acylation proceeds through three sequential steps requiring lipoprotein diacylglyceryltransferase, lipoprotein signal peptidase, and finally lipoprotein N-acyltransferase. The apparent lack of genes coding for recognizable homologs of lipoproteinN-acyltransferase in Gram-positive bacteria and Mollicutes suggests that the final step of the protein acylation process may be absent in these organisms. In this work, we monitored the acylation state of eight major lipoproteins of the mollicute Acholeplasma laidlawii using a combination of standard two-dimensional gel electrophoresis protein separation, blotting to nitrocellulose membranes, and MALDI-MS identification of modified N-terminal tryptic peptides. We show that for each A. laidlawii lipoprotein studied a third fatty acid in an amide linkage on the N-terminal Cys residue is present, whereas diacylated species were not detected. The result thus proves that A. laidlawii encodes a lipoprotein N-acyltransferase activity. We hypothesize that N-acyltransferases encoded by genes non-homologous to N-acyltransferases of Gram-negative bacteria are also present in other mollicutes and Gram-positive bacteria.	[Serebryakova, Marina V.; Demina, Irina A.; Galyamina, Maria A.; Kondratov, Ilya G.; Ladygina, Valentina G.; Govorun, Vadim M.] Fed Medicobiol Agcy, Inst Physicochem Med, Moscow 119992, Russia; [Serebryakova, Marina V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Serebryakova, MV (corresponding author), Fed Medicobiol Agcy, Inst Physicochem Med, Malaya Pirogovskaya 1A, Moscow 119992, Russia.	mserebr@mail.ru	Kondratov, Ilya/I-5859-2016; Irina, Demina/A-7876-2014; Serebryakova, Marina/E-2986-2012; Govorun, Vadim M/A-9043-2018	Irina, Demina/0000-0002-4317-2094; Serebryakova, Marina/0000-0002-5402-8215; 	Ministry of Education and Science of the Russian Federation [14.740.11.0763, 16.740.11.0371]; Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by Ministry of Education and Science of the Russian Federation State Contracts 14.740.11.0763 and 16.740.11.0371 (to V. M. G.) and Molecular and Cellular Biology program grant from the Russian Academy of Sciences (to Konstantin Severinov).	Andersson AS, 1998, BIOPHYS J, V75, P2877, DOI 10.1016/S0006-3495(98)77730-6; Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Golovina AY, 2009, RNA, V15, P1134, DOI 10.1261/rna.1494409; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jan G, 1996, CURR MICROBIOL, V32, P38, DOI 10.1007/s002849900007; Jan G, 1995, RES MICROBIOL, V146, P739, DOI 10.1016/0923-2508(96)81070-9; Jan G, 2001, ARCH MICROBIOL, V177, P81, DOI 10.1007/s00203-001-0364-4; Le Henaff M, 2000, CURR MICROBIOL, V40, P23, DOI 10.1007/s002849910005; Le Henaff M, 2000, ARCH MICROBIOL, V173, P339, DOI 10.1007/s002030000145; Le Henaff M, 2001, CURR MICROBIOL, V43, P424, DOI 10.1007/s002840010332; Lindblom G, 2002, BIOCHEMISTRY-US, V41, P11512, DOI 10.1021/bi0263098; LISKA B, 1974, FOLIA MICROBIOL, V19, P107, DOI 10.1007/BF02872843; Muhlradt PF, 1998, INFECT IMMUN, V66, P4804; NIEMI AR, 1995, BBA-BIOMEMBRANES, V1239, P186, DOI 10.1016/0005-2736(95)00132-M; NYSTROM S, 1992, EUR J BIOCHEM, V204, P231, DOI 10.1111/j.1432-1033.1992.tb16629.x; NYSTROM S, 1986, EUR J BIOCHEM, V156, P85, DOI 10.1111/j.1432-1033.1986.tb09552.x; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; SAITO Y, 1978, J BACTERIOL, V133, P66, DOI 10.1128/JB.133.1.66-74.1978; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; Serebryakova MV, 2006, EUR J MASS SPECTROM, V12, P51, DOI 10.1255/ejms.792; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; WIESLANDER A, 1982, REV INFECT DIS, V4, pS43	27	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22769	22776		10.1074/jbc.M111.231316	http://dx.doi.org/10.1074/jbc.M111.231316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540185	Green Published, hybrid			2022-12-27	WOS:000292025000011
J	Bradley, AS; Baharoglu, Z; Niewiarowski, A; Michel, B; Tsaneva, IR				Bradley, Alison S.; Baharoglu, Zeynep; Niewiarowski, Andrew; Michel, Benedicte; Tsaneva, Irina R.			Formation of a Stable RuvA Protein Double Tetramer Is Required for Efficient Branch Migration in Vitro and for Replication Fork Reversal in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DNA-REPAIR; SCHIZOSACCHAROMYCES-POMBE; OCTAMERIC RUVA; COMPLEX; RECOMBINATION; RESOLUTION; ENDONUCLEASE	In bacteria, RuvABC is required for the resolution of Holliday junctions (HJ) made during homologous recombination. The RuvAB complex catalyzes HJ branch migration and replication fork reversal (RFR). During RFR, a stalled fork is reversed to form a HJ adjacent to a DNA double strand end, a reaction that requires RuvAB in certain Escherichia coli replication mutants. The exact structure of active RuvAB complexes remains elusive as it is still unknown whether one or two tetramers of RuvA support RuvB during branch migration and during RFR. We designed an E. coli RuvA mutant, RuvA2(KaP), specifically impaired for RuvA tetramer-tetramer interactions. As expected, the mutant protein is impaired for complex II (two tetramers) formation on HJs, although the binding efficiency of complex I (a single tetramer) is as wild type. We show that although RuvA complex II formation is required for efficient HJ branch migration in vitro, RuvA2(KaP) is fully active for homologous recombination in vivo. RuvA2(KaP) is also deficient at forming complex II on synthetic replication forks, and the binding affinity of RuvA2(KaP) for forks is decreased compared with wildtype. Accordingly, RuvA2(KaP) is inefficient at processing forks in vitro and in vivo. These data indicate that RuvA2(KaP) is a separation-of-function mutant, capable of homologous recombination but impaired for RFR. RuvA2(KaP) is defective for stimulation of RuvB activity and stability of HJ.RuvA.RuvB tripartite complexes. This work demonstrates that the need for RuvA tetramer-tetramer interactions for full RuvAB activity in vitro causes specifically an RFR defect in vivo.	[Baharoglu, Zeynep; Michel, Benedicte] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Baharoglu, Zeynep; Michel, Benedicte] Univ Paris 11, F-91405 Orsay, France; [Bradley, Alison S.; Niewiarowski, Andrew; Tsaneva, Irina R.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	Michel, B (corresponding author), CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France.	benedicte.michel@cgm.cnrs-gif.fr; i.tsaneva@biochem.ucl.ac.uk	Zeynep, Baharoglu/O-3135-2013	Zeynep, Baharoglu/0000-0003-3477-2685	Biotechnology and Biological Sciences Research Council; Department of Structural Molecular Biology, University College London [ANR-05-BLAN-0204-01, ANR-BLAN08-3_309268]; Bettencourt-Shueller Foundation; Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale" [04 5 481]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Structural Molecular Biology, University College London; Bettencourt-Shueller Foundation; Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale"	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Department of Structural Molecular Biology, University College London, by Grants ANR-05-BLAN-0204-01 and ANR-BLAN08-3_309268, and by a "Prix Coup d'Elan" from the Bettencourt-Shueller Foundation (to the B. M. laboratory).; Supported by the Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale" Grant 04 5 481. Present address: Institut Pasteur, Unite Plasticite du Genome Bacterien, Departement Genomes et Genetique, Paris, France.	Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Chamberlain D, 1998, J MOL BIOL, V284, P385, DOI 10.1006/jmbi.1998.2177; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Dickman MJ, 2002, EUR J BIOCHEM, V269, P5492, DOI 10.1046/j.1432-1033.2002.03250.x; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Fujiwara Y, 2008, BIOCHEM BIOPH RES CO, V366, P426, DOI 10.1016/j.bbrc.2007.11.149; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; IWASAKI H, 1989, J BACTERIOL, V171, P5276, DOI 10.1128/jb.171.10.5276-5280.1989; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Mayanagi K, 2008, BIOCHEM BIOPH RES CO, V365, P273, DOI 10.1016/j.bbrc.2007.10.165; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Oram M, 1998, NUCLEIC ACIDS RES, V26, P594, DOI 10.1093/nar/26.2.594; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X; Yu X, 1997, J MOL BIOL, V266, P217, DOI 10.1006/jmbi.1996.0799	35	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22372	22383		10.1074/jbc.M111.233908	http://dx.doi.org/10.1074/jbc.M111.233908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531731	hybrid, Green Published			2022-12-27	WOS:000291719900047
J	Liu, SF; Chu, J; Yucer, N; Leng, M; Wang, SY; Chen, BPC; Hittelman, WN; Wang, Y				Liu, Shangfeng; Chu, Jessica; Yucer, Nur; Leng, Mei; Wang, Shih-Ya; Chen, Benjamin P. C.; Hittelman, Walter N.; Wang, Yi			RING Finger and WD Repeat Domain 3 (RFWD3) Associates with Replication Protein A (RPA) and Facilitates RPA-mediated DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; IONIZING-RADIATION; BINDING PROTEIN; P34 SUBUNIT; HOMOLOGOUS RECOMBINATION; INDUCED PHOSPHORYLATION; GENOME INTEGRITY; NUCLEAR-BODIES; 32-KDA SUBUNIT; BREAK REPAIR	DNA damage response is crucial for maintaining genomic integrity and preventing cancer by coordinating the activation of checkpoints and the repair of damaged DNA. Central to DNA damage response are the two checkpoint kinases ATM and ATR that phosphorylate a wide range of substrates. RING finger and WD repeat domain 3 (RFWD3) was initially identified as a substrate of ATM/ATR from a proteomic screen. Subsequent studies showed that RFWD3 is an E3 ubiquitin ligase that ubiquitinates p53 in vitro and positively regulates p53 levels in response to DNA damage. We report here that RFWD3 associates with replication protein A (RPA), a single-stranded DNA-binding protein that plays essential roles in DNA replication, recombination, and repair. Binding of RPA to single-stranded DNA (ssDNA), which is generated by DNA damage and repair, is essential for the recruitment of DNA repair factors to damaged sites and the activation of checkpoint signaling. We show that RFWD3 is physically associated with RPA and rapidly localizes to sites of DNA damage in a RPA-dependent manner. In vitro experiments suggest that the C terminus of RFWD3, which encompass the coiled-coil domain and the WD40 domain, is necessary for binding to RPA. Furthermore, DNA damage-induced phosphorylation of RPA and RFWD3 is dependent upon each other. Consequently, loss of RFWD3 results in the persistent foci of DNA damage marker gamma H2AX and the repair protein Rad51 in damaged cells. These findings suggest that RFWD3 is recruited to sites of DNA damage and facilitates RPA-mediated DNA damage signaling and repair.	[Liu, Shangfeng; Chu, Jessica; Yucer, Nur; Wang, Yi] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leng, Mei; Wang, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wang, Shih-Ya; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Hittelman, Walter N.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Wang, Y (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	yiw@bcm.edu			National Institutes of Health [GM080703]; McLean Foundation at Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McLean Foundation at Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080703 (to Y. W.). This work was also supported by McLean Foundation at Baylor College of Medicine (to Y. W.).	Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Feng JJ, 2009, MOL CELL BIOL, V29, P5696, DOI 10.1128/MCB.00191-09; Fu XY, 2010, P NATL ACAD SCI USA, V107, P4579, DOI 10.1073/pnas.0912094107; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sleeth KM, 2007, J MOL BIOL, V373, P38, DOI 10.1016/j.jmb.2007.07.068; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yuan SSF, 1999, CANCER RES, V59, P3547; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	54	47	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22314	22322		10.1074/jbc.M111.222802	http://dx.doi.org/10.1074/jbc.M111.222802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21558276	Green Published, hybrid			2022-12-27	WOS:000291719900040
J	Matsuura, T; Hosoda, K; Ichihashi, N; Kazuta, Y; Yomo, T				Matsuura, Tomoaki; Hosoda, Kazufumi; Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya			Kinetic Analysis of beta-Galactosidase and beta-Glucuronidase Tetramerization Coupled with Protein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXPRESSION SYSTEMS; FUSION PROTEINS; IN-VIVO; RIBOSOME; CELL; COMPONENTS; PROMOTERS; EVOLUTION; PLATFORM	Both beta-galactosidase (GAL) and beta-glucuronidase (GUS) are tetrameric enzymes used widely as reporter proteins. However, little is known about the folding and assembly of these enzymes. Although the refolding kinetics of GAL from a denatured enzyme have been reported, it is not known how the kinetics differ when coupled with a protein translation reaction. Elucidating the assembly kinetics of GAL and GUS when coupled with protein translation will illustrate the differences between these two reporter proteins and also the assembly process under conditions more relevant to those in vivo. In this study, we used an in vitro translation/transcription system to synthesize GAL and GUS, measured the time development of the activity and oligomerization state of these enzymes, and determined the rate constants of the monomer to tetramer assembly process. We found that at similar concentrations, GAL assembles into tetramers faster than GUS. The rate constant of monomer to dimer assembly of GAL was 50-fold faster when coupled with protein translation than that of refolding from the denatured state. Furthermore, GAL synthesis was found to lack the rate-limiting step in the assembly process, whereas GUS has two rate-limiting steps: monomer to dimer assembly and dimer to tetramer assembly. The consequence of these differences when used as reporter proteins is discussed.	[Matsuura, Tomoaki; Hosoda, Kazufumi; Ichihashi, Norikazu; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki; Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Matsuura, Tomoaki/W-6086-2019; Ichihashi, Norikazu/AAY-6897-2020; matsuura, tomoaki/O-7368-2018	Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781	Global Centers of Excellence Program; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Centers of Excellence Program and the Special Coordination Funds for Promoting Science and Technology: Yuragi Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	BLANCO C, 1987, BIOCHIMIE, V69, P157, DOI 10.1016/0300-9084(87)90248-3; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; COWIE DB, 1961, P NATL ACAD SCI USA, V47, P114, DOI 10.1073/pnas.47.1.114; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Fedorov AN, 1999, J MOL BIOL, V294, P579, DOI 10.1006/jmbi.1999.3281; Gronemeyer T, 2005, CURR OPIN BIOTECH, V16, P453, DOI 10.1016/j.copbio.2005.06.001; HAMLIN J, 1972, P NATL ACAD SCI USA, V69, P412, DOI 10.1073/pnas.69.2.412; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hosoda K, 2008, LANGMUIR, V24, P13540, DOI 10.1021/la802432f; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Jain VK, 1996, METHOD ENZYMOL, V273, P319; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Kazuta Y, 2008, MOL CELL PROTEOMICS, V7, P1530, DOI 10.1074/mcp.M800051-MCP200; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kiernan JA, 2007, BIOTECH HISTOCHEM, V82, P73, DOI 10.1080/10520290701375278; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; Kolb VA, 2000, J BIOL CHEM, V275, P16597, DOI 10.1074/jbc.M002030200; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kuthan H, 2001, PROG BIOPHYS MOL BIO, V75, P1, DOI 10.1016/S0079-6107(00)00023-7; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Matsuura T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.50; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Naleway JJ, 1992, GUS PROTOCOLS USING, P61; Nichtl A, 1998, J MOL BIOL, V282, P1083, DOI 10.1006/jmbi.1998.2075; Olsen SN, 2007, COMP BIOCHEM PHYS A, V148, P339, DOI 10.1016/j.cbpa.2007.05.009; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	33	26	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22028	22034		10.1074/jbc.M111.240168	http://dx.doi.org/10.1074/jbc.M111.240168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531724	Green Published, hybrid			2022-12-27	WOS:000291719900009
J	Nissim, I; Horyn, O; Nissim, I; Daikhin, Y; Caldovic, L; Barcelona, B; Cervera, J; Tuchman, M; Yudkoff, M				Nissim, Itzhak; Horyn, Oksana; Nissim, Ilana; Daikhin, Yevgeny; Caldovic, Ljubica; Barcelona, Belen; Cervera, Javier; Tuchman, Mendel; Yudkoff, Marc			Down-regulation of Hepatic Urea Synthesis by Oxypurines XANTHINE AND URIC ACID INHIBIT N-ACETYLGLUTAMATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; RAT-LIVER MITOCHONDRIA; ACETYL-L-GLUTAMATE; CITRULLINE SYNTHESIS; AMMONIA; UREAGENESIS; MECHANISM; ARGININE; BINDING; CARBAMYLGLUTAMATE	We previously reported that isobutylmethylxanthine (IBMX), a derivative of oxypurine, inhibits citrulline synthesis by an as yet unknown mechanism. Here, we demonstrate that IBMX and other oxypurines containing a 2,6-dione group interfere with the binding of glutamate to the active site of N-acetylglutamate synthetase (NAGS), thereby decreasing synthesis of N-acetylglutamate, the obligatory activator of carbamoyl phosphate synthase-1 (CPS1). The result is reduction of citrulline and urea synthesis. Experiments were performed with N-15-labeled substrates, purified hepatic CPS1, and recombinant mouse NAGS as well as isolated mitochondria. We also used isolated hepatocytes to examine the action of various oxypurines on ureagenesis and to assess the ameliorating affect of N-carbamylglutamate and/or L-arginine on NAGS inhibition. Among various oxypurines tested, only IBMX, xanthine, or uric acid significantly increased the apparent K-m for glutamate and decreased velocity of NAGS, with little effect on CPS1. The inhibition of NAGS is time-and dose-dependent and leads to decreased formation of the CPS1-N-acetylglutamate complex and consequent inhibition of citrulline and urea synthesis. However, such inhibition was reversed by supplementation with N-carbamylglutamate. The data demonstrate that xanthine and uric acid, both physiologically occurring oxypurines, inhibit the hepatic synthesis of N-acetylglutamate. An important and novel concept emerging from this study is that xanthine and/or uric acid may have a role in the regulation of ureagenesis and, thus, nitrogen homeostasis in normal and disease states.	[Nissim, Itzhak; Horyn, Oksana; Nissim, Ilana; Daikhin, Yevgeny; Yudkoff, Marc] Childrens Hosp Philadelphia, Div Child Dev Rehabil Med & Metab Dis, Philadelphia, PA 19104 USA; [Caldovic, Ljubica; Tuchman, Mendel] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Barcelona, Belen; Cervera, Javier] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Nissim, Itzhak; Yudkoff, Marc] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System; George Washington University; Prince Felipe Research Center; University of Pennsylvania; University of Pennsylvania	Nissim, I (corresponding author), Abramson Pediat Res Ctr, Rm 510D,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nissim@email.chop.edu	Barcelona, Belén/K-6409-2014	Barcelona, Belén/0000-0002-9818-2329; Caldovic, Ljubica/0000-0002-9140-5585	National Institutes of Health [DK-053761, DK-R56-053761, R01DK064913, R01DK047870, PO1HD26979, U54RR019453, HD058567]; Spanish Ministry for Science [SAF2010-17993]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979, R01HD058567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761, R01DK047870, R01DK064913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry for Science(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-053761 and DK-R56-053761 (to Itzhak Nissim) and Grants R01DK064913, R01DK047870, PO1HD26979, U54RR019453, and HD058567. This work was also supported in part by Spanish Ministry for Science Grant SAF2010-17993.	Ahuja V, 2008, J INHERIT METAB DIS, V31, P481, DOI 10.1007/s10545-008-0913-y; ALONSO E, 1992, J BIOL CHEM, V267, P4524; ALONSO E, 1983, EUR J BIOCHEM, V135, P331, DOI 10.1111/j.1432-1033.1983.tb07658.x; AOYAGI K, 1979, BIOCHIM BIOPHYS ACTA, V587, P515; BRITTON HG, 1988, EUR J BIOCHEM, V171, P615, DOI 10.1111/j.1432-1033.1988.tb13832.x; Caldovic L, 2006, MOL GENET METAB, V87, P226, DOI 10.1016/j.ymgme.2005.10.003; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; CLARKE S, 1976, J BIOL CHEM, V251, P950; COHEN NS, 1984, ARCH BIOCHEM BIOPHYS, V234, P31, DOI 10.1016/0003-9861(84)90321-7; COHEN NS, 1992, BIOCHEM J, V282, P173, DOI 10.1042/bj2820173; COHEN NS, 1982, J BIOL CHEM, V257, P6898; Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007; COUDE FX, 1979, J CLIN INVEST, V64, P1544, DOI 10.1172/JCI109614; COUDE FX, 1983, BIOCHEM J, V216, P233, DOI 10.1042/bj2160233; Gropman AL, 2007, J INHERIT METAB DIS, V30, P865, DOI 10.1007/s10545-007-0709-5; GUTHOHRL.G, 1968, EUR J BIOCHEM, V7, P119, DOI 10.1111/j.1432-1033.1968.tb19582.x; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; Jaing TH, 2009, J PEDIAT HEMATOL ONC, V31, P955, DOI 10.1097/MPH.0b013e3181b8beb1; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KAWAMOTO S, 1985, BIOCHEM J, V232, P329, DOI 10.1042/bj2320329; KIM S, 1972, P NATL ACAD SCI USA, V69, P3530, DOI 10.1073/pnas.69.12.3530; LUND P, 1987, BIOCHEM J, V243, P273, DOI 10.1042/bj2430273; LUSTY CJ, 1978, EUR J BIOCHEM, V85, P373, DOI 10.1111/j.1432-1033.1978.tb12249.x; McCudden CR, 1996, J BIOL CHEM, V271, P18285, DOI 10.1074/jbc.271.30.18285; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Mew NA, 2009, MOL GENET METAB, V98, P325, DOI 10.1016/j.ymgme.2009.07.010; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; MORIMOTO BH, 1990, BIOCHEM J, V272, P671, DOI 10.1042/bj2720671; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Nissim I, 2006, J BIOL CHEM, V281, P8486, DOI 10.1074/jbc.M506984200; Nissim I, 2005, J BIOL CHEM, V280, P17715, DOI 10.1074/jbc.M500607200; Nissim I, 1996, J BIOL CHEM, V271, P31234, DOI 10.1074/jbc.271.49.31234; Nissim I, 2008, J BIOL CHEM, V283, P15063, DOI 10.1074/jbc.M800163200; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; RAIJMAN L, 1976, ARCH BIOCHEM BIOPHYS, V175, P270, DOI 10.1016/0003-9861(76)90508-7; RUBIO V, 1983, EUR J BIOCHEM, V134, P337, DOI 10.1111/j.1432-1033.1983.tb07572.x; Rus DA, 2007, FRONT BIOSCI, V12, P1184, DOI 10.2741/2136; Sancho-Vaello E, 2009, FEBS LETT, V583, P202, DOI 10.1016/j.febslet.2008.12.001; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Treberg JR, 2010, ADV ENZYME REGUL, V50, P34, DOI 10.1016/j.advenzreg.2009.10.029; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b	46	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22055	22068		10.1074/jbc.M110.209023	http://dx.doi.org/10.1074/jbc.M110.209023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540182	hybrid, Green Published			2022-12-27	WOS:000291719900012
J	Whicher, JR; Florova, G; Sydor, PK; Singh, R; Alhamadsheh, M; Challis, GL; Reynolds, KA; Smith, JL				Whicher, Jonathan R.; Florova, Galina; Sydor, Paulina K.; Singh, Renu; Alhamadsheh, Mamoun; Challis, Gregory L.; Reynolds, Kevin A.; Smith, Janet L.			Structure and Function of the RedJ Protein, a Thioesterase from the Prodiginine Biosynthetic Pathway in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; COMBINATORIAL MUTAGENESIS; II THIOESTERASE; SYNTHASE; ENZYME; DOMAIN; UNDECYLPRODIGIOSIN; IDENTIFICATION; INTERMEDIATE; PRODIGIOSIN	Prodiginines are a class of red-pigmented natural products with immunosuppressant, anticancer, and antimalarial activities. Recent studies on prodiginine biosynthesis in Streptomyces coelicolor have elucidated the function of many enzymes within the pathway. However, the function of RedJ, which was predicted to be an editing thioesterase based on sequence similarity, is unknown. We report here the genetic, biochemical, and structural characterization of the redJ gene product. Deletion of redJ in S. coelicolor leads to a 75% decrease in prodiginine production, demonstrating its importance for prodiginine biosynthesis. RedJ exhibits thioesterase activity with selectivity for substrates having long acyl chains and lacking a beta-carboxyl substituent. The thioesterase has 1000-fold greater catalytic efficiency with substrates linked to an acyl carrier protein (ACP) than with the corresponding CoA thioester substrates. Also, RedJ strongly discriminates against the streptomycete ACP of fatty acid biosynthesis in preference to RedQ, an ACP of the prodiginine pathway. The 2.12 angstrom resolution crystal structure of RedJ provides insights into the molecular basis for the observed substrate selectivity. A hydrophobic pocket in the active site chamber is positioned to bind long acyl chains, as suggested by a long-chain ligand from the crystallization solution bound in this pocket. The accessibility of the active site is controlled by the position of a highly flexible entrance flap. These data combined with previous studies of prodiginine biosynthesis in S. coelicolor support a novel role for RedJ in facilitating transfer of a dodecanoyl chain from one acyl carrier protein to another en route to the key biosynthetic intermediate 2-undecylpyrrole.	[Whicher, Jonathan R.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Florova, Galina; Singh, Renu; Alhamadsheh, Mamoun; Reynolds, Kevin A.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Sydor, Paulina K.; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Portland State University; University of Warwick	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu	Singh, Renu/AAD-5532-2020	Challis, Gregory/0000-0001-5976-3545; Reynolds, Kevin/0000-0003-0270-9809	National Institutes of Health [GM77147]; Warwick Postgraduate Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warwick Postgraduate Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM77147 (to K. A. R. and G. L. C.) and DK42303 (to J. L. S.).; Recipient of the Warwick Postgraduate Research Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Cerdeno AM, 2001, CHEM BIOL, V8, P817, DOI 10.1016/S1074-5521(01)00054-0; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Gust B., 2002, REDIRECT TECHNOLOGY; Haynes SW, 2008, CHEM COMMUN, P1865, DOI 10.1039/b801677a; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Kieser T., 2000, PRACTICAL STREPTOMYC, P43; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo S, 2005, CHEM BIOL, V12, P191, DOI 10.1016/j.chembiol.2004.11.006; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Mortellaro A, 1999, J IMMUNOL, V162, P7102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Russell D.W, 2001, MOL CLONING; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Smirnova N, 2001, J BACTERIOL, V183, P2335, DOI 10.1128/JB.183.7.2335-2342.2001; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Zelyas N, 2009, GENE, V443, P48, DOI 10.1016/j.gene.2009.03.022; Zhou Z, 2006, CHEM BIOL, V13, P869, DOI 10.1016/j.chembiol.2006.06.011	45	35	38	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22558	22569		10.1074/jbc.M110.213512	http://dx.doi.org/10.1074/jbc.M110.213512			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543318	hybrid, Green Published			2022-12-27	WOS:000291719900063
J	Geng, HQ; Xu, GF; Ran, YL; Lopez, JA; Peng, YD				Geng, Hongquan; Xu, Guofeng; Ran, Yali; Lopez, Jose A.; Peng, Yuandong			Platelet Glycoprotein Ib beta/IX Mediates Glycoprotein Ib alpha Localization to Membrane Lipid Domain Critical for von Willebrand Factor Interaction at High Shear	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IX-V COMPLEX; PROTEIN-DISULFIDE-ISOMERASE; BERNARD-SOULIER-SYNDROME; GPIB-ALPHA; INTEGRIN ALPHA(IIB)BETA(3); TRANSMEMBRANE DOMAIN; MONOCLONAL-ANTIBODY; PHYSICAL PROXIMITY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE	The localization of the platelet glycoprotein GP Ib-IX complex (GP Ib alpha, GP Ib beta, and GP IX) to membrane lipid domain, also known as glycosphingolipid-enriched membranes (GEMs or raft) lipid domain, is essential for the GP Ib-IX complex mediated platelet adhesion to von Willebrand factor (vWf) and subsequent platelet activation. To date, the mechanism for the complex association with the GEMs remains unclear. Although the palmitate modifications of GP Ib beta and GP IX were thought to be critical for the complex presence in the GEMs, we found that the removal of the putative palmitoylation sites of GP Ib beta and GP IX had no effects on the localization of the GP Ib-IX complex to the GEMs. Instead, the disruption of GP Ib alpha disulfide linkage with GP Ib beta markedly decreased the amount of the GEM-associated GP Ib alpha without altering the GEM association of GP Ib beta and GP IX. Furthermore, partial dissociation with the GEMs greatly inhibited GP Ib alpha interaction with vWf at high shear instead of in static condition or under low shear stress. Thus, for the first time, we demonstrated that GP Ib beta/GP IX mediates the disulfide-linked GP Ib alpha localization to the GEMs, which is critical for vWf interaction at high shear.	[Geng, Hongquan; Xu, Guofeng] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200092, Peoples R China; [Lopez, Jose A.] Univ Washington, Puget Sound Blood Ctr, Div Hematol, Dept Med, Seattle, WA 98104 USA; [Peng, Yuandong] Baylor Coll Med, Thrombosis Div, Cardiovasc Sci Res Sect, Dept Med, Houston, TX 77030 USA	Shanghai Jiao Tong University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Baylor College of Medicine	Peng, YD (corresponding author), 1 Baylor Plaza,Alkek N1317-06, Houston, TX 77030 USA.	yuandong@bcm.tmc.edu			National Institutes of Health [HL095676]; American Heart Association [0635155N]; Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095676 (to Y.P.). This work was also supported by the American Heart Association Scientist Development Grant 0635155N (to Y.P.), the Alkek Endowment Fund (to Y.P.), and the Fondren Foundation.	Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bodnar RJ, 2002, J BIOL CHEM, V277, P47080, DOI 10.1074/jbc.M208329200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Cranmer SL, 1999, J BIOL CHEM, V274, P6097, DOI 10.1074/jbc.274.10.6097; DU XP, 1987, BLOOD, V69, P1524; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Essex DW, 2004, ANTIOXID REDOX SIGN, V6, P736, DOI 10.1089/1523086041361622; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin W, 2007, J THROMB HAEMOST, V5, P1034, DOI 10.1111/j.1538-7836.2007.02476.x; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kanaji T, 2002, BLOOD, V100, P2102, DOI 10.1182/blood-2002-03-0997; Kasirer-Friede A, 2002, J BIOL CHEM, V277, P11949, DOI 10.1074/jbc.M108727200; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lopez JA, 2005, J THROMB HAEMOST, V3, P1737, DOI 10.1111/j.1538-7836.2005.01463.x; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; LOPEZ JA, 1994, J BIOL CHEM, V269, P23716; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Michal P, 2009, EUR J PHARMACOL, V606, P50, DOI 10.1016/j.ejphar.2009.01.028; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUSZBEK L, 1989, J BIOL CHEM, V264, P9716; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; Peng YD, 2004, BLOOD, V104, P3971, DOI 10.1182/blood-2004-07-2544; Perrault C, 2001, THROMB HAEMOSTASIS, V86, P1238, DOI 10.1055/s-0037-1616057; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Wu GX, 1996, BLOOD, V87, P2782, DOI 10.1182/blood.V87.7.2782.bloodjournal8772782	50	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21315	21323		10.1074/jbc.M110.202549	http://dx.doi.org/10.1074/jbc.M110.202549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507943	Green Published, hybrid			2022-12-27	WOS:000291464700030
J	Martin, G; Burke, B; Thai, R; Dey, AK; Combes, O; Heyd, B; Geonnotti, AR; Montefiori, DC; Kan, E; Lian, Y; Sun, YD; Abache, T; Ulmer, JB; Madaoui, H; Guerois, R; Barnett, SW; Srivastava, IK; Kessler, P; Martin, L				Martin, Gregoire; Burke, Brian; Thai, Robert; Dey, Antu K.; Combes, Olivier; Heyd, Bernadette; Geonnotti, Anthony R.; Montefiori, David C.; Kan, Elaine; Lian, Ying; Sun, Yide; Abache, Toufik; Ulmer, Jeffrey B.; Madaoui, Hocine; Guerois, Raphael; Barnett, Susan W.; Srivastava, Indresh K.; Kessler, Pascal; Martin, Loic			Stabilization of HIV-1 Envelope in the CD4-bound Conformation through Specific Cross-linking of a CD4 Mimetic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120-CD4 RECEPTOR COMPLEX; CHAIN POLYPEPTIDE ANALOG; CORECEPTOR BINDING-SITE; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; SUBTYPE-B; PARTIAL DELETION; TYPE-1 ENVELOPE; VACCINE DESIGN	CD4 binding on gp120 leads to the exposure of highly conserved regions recognized by the HIV co-receptor CCR5 and by CD4-induced (CD4i) antibodies. A covalent gp120-CD4 complex was shown to elicit CD4i antibody responses in monkeys, which was correlated with control of the HIV virus infection (DeVico, A., Fouts, T., Lewis, G. K., Gallo, R. C., Godfrey, K., Charurat, M., Harris, I., Galmin, L., and Pal, R. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 17477-17482). Because the inclusion of CD4 in a vaccine formulation should be avoided, due to potential autoimmune reactions, we engineered small sized CD4 mimetics (miniCD4s) that are poorly immunogenic and do not induce anti-CD4 antibodies. We made covalent complexes between such an engineered miniCD4 and gp120 or gp140, through a site-directed coupling reaction. These complexes were recognized by CD4i antibodies as well as by the HIV co-receptor CCR5. In addition, they elicit CD4i antibody responses in rabbits and therefore represent potential vaccine candidates that mimic an important HIV fusion intermediate, without autoimmune hazard.	[Martin, Gregoire; Thai, Robert; Combes, Olivier; Heyd, Bernadette; Abache, Toufik; Kessler, Pascal; Martin, Loic] CEA, IBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Burke, Brian; Dey, Antu K.; Kan, Elaine; Lian, Ying; Sun, Yide; Ulmer, Jeffrey B.; Barnett, Susan W.; Srivastava, Indresh K.] Novartis Vaccines & Diagnost Corp, Cambridge, MA 02139 USA; [Geonnotti, Anthony R.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Madaoui, Hocine; Guerois, Raphael] CEA, IBiTecS, Serv Bioenerget Biol Struct & Mecanismes, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Duke University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kessler, P (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.	pascal.kessler@cea.fr; loic.martin@cea.fr	MARTIN, Loïc/E-1627-2011; Dey, Antu/A-1305-2013; , raph/AAF-4380-2019	MARTIN, Loïc/0000-0002-7940-2955; Thai, Robert/0000-0001-9438-4225; Dey, Antu/0000-0001-7438-9379; Martin, Gregoire/0000-0001-8240-6108	National Institutes of Health; NIAID, Department of Health and Human Services [5P01AI066287]; French National Agency for Research on AIDS and Viral Hepatitis [447-52D]; European Union [QLKZ-CT-1999-00609]; United Kingdom Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French National Agency for Research on AIDS and Viral Hepatitis(ANRS); European Union(European Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health HIV Research and Development Grant 5P01AI066287 from NIAID, Department of Health and Human Services (supervised by Novartis Vaccines and Diagnostics, Inc.). This work was also supported by the French National Agency for Research on AIDS and Viral Hepatitis Grant 447-52D.; We acknowledge Dr. M. Parmentier for the generous gift of stable CHO-CCR5 cells and Drs. D. P. Burton, P. Parren, D. Katinger, A. Osterhaus, M. Schutten, and the National Institute for Biological Standards and Control Centre for AIDS Reagents (supported by the European Union Programme EVA (Contract QLKZ-CT-1999-00609) and the United Kingdom Medical Research Council. HIV-1 V3 mAb (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health) was provided by Dr. Susan Zolla-Pazner.	Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Cerutti N, 2010, J BIOL CHEM, V285, P25743, DOI 10.1074/jbc.M110.144121; Cohen J, 2003, SCIENCE, V302, P1309; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Devico A, 1996, VIROLOGY, V218, P258, DOI 10.1006/viro.1996.0188; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Finzi A, 2010, J VIROL METHODS, V168, P155, DOI 10.1016/j.jviromet.2010.05.008; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Gallo RC, 2005, LANCET, V366, P1894, DOI 10.1016/S0140-6736(05)67395-3; Girard MP, 2006, VACCINE, V24, P4062, DOI 10.1016/j.vaccine.2006.02.031; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; He YX, 2003, VACCINE, V21, P4421, DOI 10.1016/S0264-410X(03)00451-1; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; KANG CY, 1994, J VIROL, V68, P5854, DOI 10.1128/JVI.68.9.5854-5862.1994; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; TSCHACHLER E, 1990, J VIROL, V64, P2250, DOI 10.1128/JVI.64.5.2250-2259.1990; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xu R, 2006, VIROLOGY, V349, P276, DOI 10.1016/j.virol.2006.01.043; Zhang MY, 2004, ANTIVIR RES, V61, P161, DOI 10.1016/j.antiviral.2003.09.009; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o	55	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21706	21716		10.1074/jbc.M111.232272	http://dx.doi.org/10.1074/jbc.M111.232272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21487012	Green Published, hybrid			2022-12-27	WOS:000291464700067
J	Benfield, CTO; Mansur, DS; McCoy, LE; Ferguson, BJ; Bahar, MW; Oldring, AP; Grimes, JM; Stuart, DI; Graham, SC; Smith, GL				Benfield, Camilla T. O.; Mansur, Daniel S.; McCoy, Laura E.; Ferguson, Brian J.; Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.; Smith, Geoffrey L.			Mapping the I kappa B Kinase beta (IKK beta)-binding Interface of the B14 Protein, a Vaccinia Virus Inhibitor of IKK beta-mediated Activation of Nuclear Factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; RNA HELICASE DDX3; VIRULENCE FACTOR; N1L PROTEIN; RECEPTOR; TARGETS; COMPLEX; ALPHA; INDUCTION; REVEALS	The I kappa B kinase (IKK) complex regulates activation of NF-kappa B, a critical transcription factor in mediating inflammatory and immune responses. Not surprisingly, therefore, many viruses seek to inhibit NF-kappa B activation. The vaccinia virus B14 protein contributes to virus virulence by binding to the IKK beta subunit of the IKK complex and preventing NF-kappa B activation in response to pro-inflammatory stimuli. Previous crystallographic studies showed that the B14 protein has a Bcl-2-like fold and forms homodimers in the crystal. However, multi-angle light scattering indicated that B14 is in monomer-dimer equilibrium in solution. This transient self-association suggested that the hydrophobic dimerization interface of B14 might also mediate its interaction with IKK beta, and this was investigated by introducing amino acid substitutions on the dimer interface. One mutant (Y35E) was entirely monomeric but still co-immunoprecipitated with IKK beta and blocked both NF-kappa B nuclear translocation and NF-kappa B-dependent gene expression. Therefore, B14homodimerization is nonessential for binding and inhibition of IKK beta. In contrast, a second monomeric mutant (F130K) neither bound IKK beta nor inhibited NF-kappa B-dependent gene expression, demonstrating that this residue is required for the B14-IKK beta interaction. Thus, the dimerization and IKK beta-binding interfaces overlap and lie on a surface used for protein-protein interactions in many viral and cellular Bcl-2-like proteins.	[Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford Prot Prod Facil, Oxford OX3 7BN, England; [Benfield, Camilla T. O.; Mansur, Daniel S.; McCoy, Laura E.; Ferguson, Brian J.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Grimes, Jonathan M.; Stuart, David I.] Diamond Light Source Ltd, Div Sci, Didcot OX11 0DE, Oxon, England; [Graham, Stephen C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 0XY, England; [Graham, Stephen C.] Addenbrookes Hosp, Cambridge CB2 0XY, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Diamond Light Source; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Graham, SC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	scg34@cam.ac.uk; geoffrey.l.smith@imperial.ac.uk	Mansur, Daniel/AAQ-8062-2020; Smith, Geoffrey L/G-2894-2012	Benfield, Camilla/0000-0001-7851-4181; Mansur, Daniel/0000-0001-6773-9334; Graham, Stephen/0000-0003-4547-4034; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389; McCoy, Laura/0000-0001-9503-7946; Ferguson, Brian/0000-0002-6873-1032; Smith, Geoffrey L/0000-0002-3730-9955	Wellcome Trust [075491/Z/04]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Poxvirus T Cell Vaccine Discovery Consortium (PTVDC); Bill and Melinda Gates Foundation; Medical Research Council (United Kingdom); European Commission [031220FP6]; Medical Research Council [G1100525, G19/3, G1000099] Funding Source: researchfish; MRC [G19/3, G1000099] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Poxvirus T Cell Vaccine Discovery Consortium (PTVDC); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust Grant 075491/Z/04, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil; to D. S. M.), the Poxvirus T Cell Vaccine Discovery Consortium (PTVDC) under the Collaboration for AIDS Vaccine Discovery with support from the Bill and Melinda Gates Foundation (to L. E. M.), the Medical Research Council (United Kingdom), and European Commission Contract 031220FP6 (SPINE2-COMPLEXES).	Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486	36	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20727	20735		10.1074/jbc.M111.231381	http://dx.doi.org/10.1074/jbc.M111.231381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474453	Green Published, hybrid			2022-12-27	WOS:000291267600058
J	Nagele, V; Heesemann, J; Schielke, S; Jimenez-Soto, LF; Kurzai, O; Ackermann, N				Naegele, Virginie; Heesemann, Juergen; Schielke, Stephanie; Jimenez-Soto, Luisa F.; Kurzai, Oliver; Ackermann, Nikolaus			Neisseria meningitidis Adhesin NadA Targets beta 1 Integrins FUNCTIONAL SIMILARITY TO YERSINIA INVASIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST RECEPTOR RECOGNITION; OUTER-MEMBRANE PROTEINS; HUMAN DENDRITIC-CELLS; EPITHELIAL-CELLS; ESCHERICHIA-COLI; MUCOSAL IMMUNITY; COLLAGEN-BINDING; LYMPHOID-TISSUE; III SECRETION; YADA PROTEIN	Meningococci are facultative-pathogenic bacteria endowed with a set of adhesins allowing colonization of the human upper respiratory tract, leading to fulminant meningitis and septicemia. The Neisseria adhesin NadA was identified in about 50% of N. meningitidis isolates and is closely related to the Yersinia adhesin YadA, the prototype of the oligomeric coiled-coil adhesin (Oca) family. NadA is known to be involved in cell adhesion, invasion, and induction of proinflammatory cytokines. Because of the enormous diversity of neisserial cell adhesins the analysis of the specific contribution of NadA in meningococcal host interactions is limited. Therefore, we used a non-invasive Y. enterocolitica mutant as carrier to study the role of NadA in host cell interaction. NadA was shown to be efficiently produced and localized in its oligomeric form on the bacterial surface of Y. enterocolitica. Additionally, NadA mediated a beta 1 integrin-dependent adherence with subsequent internalization of yersiniae by a beta 1 integrin-positive cell line. Using recombinant NadA(24-210) protein and human and murine beta 1 integrin-expressing cell lines we could demonstrate the role of the beta 1 integrin subunit as putative receptor for NadA. Subsequent inhibition assays revealed specific interaction of NadA(24-210) with the human beta 1 integrin subunit. Cumulatively, these results indicate that Y. enterocolitica is a suitable toolbox system for analysis of the adhesive properties of NadA, revealing strong evidence that beta 1 integrins are important receptors for NadA. Thus, this study demonstrated for the first time a direct interaction between the Oca-family member NadA and human beta 1 integrins.	[Naegele, Virginie; Heesemann, Juergen; Jimenez-Soto, Luisa F.; Ackermann, Nikolaus] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Schielke, Stephanie; Kurzai, Oliver] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany; [Kurzai, Oliver] Univ Jena, Sept Res Ctr, D-07745 Jena, Germany	University of Munich; University of Wurzburg; Friedrich Schiller University of Jena	Ackermann, N (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Pettenkoferstr 9A, D-80336 Munich, Germany.	ackermann@mvp.uni-muenchen.de		Kurzai, Oliver/0000-0002-7277-2646; Dille, Stephanie/0000-0002-7712-6002; Dille, Stephanie/0000-0001-9465-8345	Friedrich-Baur-Stiftung; Munich Centre for Integrated Protein Science (CIPSM); German Research Foundation (DFG) [SFB594, SFB479]	Friedrich-Baur-Stiftung; Munich Centre for Integrated Protein Science (CIPSM); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Friedrich-Baur-Stiftung, the Munich Centre for Integrated Protein Science (CIPSM) and by the German Research Foundation (DFG) Grant SFB594. This work was also supported in part by the DFG Grant SFB479 (to O. K.).	Ackermann N, 2008, J BACTERIOL, V190, P5031, DOI 10.1128/JB.00161-08; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Grassl GA, 2003, CELL MICROBIOL, V5, P957, DOI 10.1046/j.1462-5822.2003.00339.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J INFECT DIS, V147, P107, DOI 10.1093/infdis/147.1.107; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kolb-Maurer A, 2001, INFECT IMMUN, V69, P6912, DOI 10.1128/IAI.69.11.6912-6922.2001; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kuespert Katharina, 2009, V470, P57, DOI 10.1007/978-1-59745-204-5_5; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Kurzai O, 2005, CELL MICROBIOL, V7, P1319, DOI 10.1111/j.1462-5822.2005.00559.x; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; MACK D, 1994, MED MICROBIOL IMMUN, V183, P217; Mazzon C, 2007, J IMMUNOL, V179, P3904, DOI 10.4049/jimmunol.179.6.3904; MCNEIL G, 1994, MICROB PATHOGENESIS, V16, P153, DOI 10.1006/mpat.1994.1016; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; ROGGENKAMP A, 1995, MOL MICROBIOL, V16, P1207, DOI 10.1111/j.1365-2958.1995.tb02343.x; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471; TAMM A, 1993, MOL MICROBIOL, V10, P995, DOI 10.1111/j.1365-2958.1993.tb00971.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2005, CURR OPIN MICROBIOL, V8, P4, DOI 10.1016/j.mib.2004.12.009; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	50	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20536	20546		10.1074/jbc.M110.188326	http://dx.doi.org/10.1074/jbc.M110.188326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471204	Green Published, hybrid			2022-12-27	WOS:000291267600040
J	Dasgupta, S; Samantaray, S; Sahal, D; Roy, RP				Dasgupta, Sayani; Samantaray, Sharmishtha; Sahal, Dinkar; Roy, Rajendra P.			Isopeptide Ligation Catalyzed by Quintessential Sortase A MECHANISTIC CUES FROM CYCLIC AND BRANCHED OLIGOMERS OF INDOLICIDIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; CELL-WALL; CORYNEBACTERIUM-DIPHTHERIAE; STREPTOCOCCUS-PNEUMONIAE; STABILIZING ISOPEPTIDE; PILUS ADHESIN; PEPTIDE; BONDS	The housekeeping transpeptidase sortase A (SrtA) from Staphyloccocus aureus catalyzes the covalent anchoring of surface proteins to the cell wall by linking the threonyl carboxylate of the LPXTG recognition motif to the amino group of the pentaglycine cross-bridge of the peptidoglycan. SrtA-catalyzed ligation of an LPXTG containing polypeptide with an aminoglycine-terminated moiety occurs efficiently in vitro and has inspired the use of this enzyme as a synthetic tool in biological chemistry. Here we demonstrate the propensity of SrtA to catalyze "isopeptide" ligation. Using model peptide sequences, we show that SrtA can transfer LPXTG peptide substrates to the epsilon-amine of specific Lys residues and form cyclized and/or a gamut of branched oligomers. Our results provide insights about principles governing isopeptide ligation reactions catalyzed by SrtA and suggest that although cyclization is guided by distance relationship between Lys (epsilon-amine) and Thr (alpha-carboxyl) residues, facile branched oligomerization requires the presence of a stable and long-lived acyl-enzyme intermediate.	[Dasgupta, Sayani; Samantaray, Sharmishtha; Roy, Rajendra P.] Natl Inst Immunol, New Delhi 110067, India; [Sahal, Dinkar] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Roy, RP (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	rproy@nii.res.in	SAHAL, DINKAR/GYD-7570-2022	Dasgupta, Sayani/0000-0003-4782-7956	Department of Biotechnology, Government of India [BT/PR-9934/BRB/10/579/2007]; Department of Biotechnology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology	This work was supported by Grant BT/PR-9934/BRB/10/579/2007 from the Department of Biotechnology, Government of India (to R. P. R.), and core grants from the Department of Biotechnology to the National Institute of Immunology.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Guo XQ, 2009, J AM CHEM SOC, V131, P9878, DOI 10.1021/ja903231v; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; HOMANDBERG GA, 1979, BIOCHEMISTRY-US, V18, P586, DOI 10.1021/bi00571a006; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ito T, 2010, BIOCHEMISTRY-US, V49, P2604, DOI 10.1021/bi100094g; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; WALLACE CJA, 1995, CURR OPIN BIOTECH, V6, P403, DOI 10.1016/0958-1669(95)80069-7; Wu S, 2010, BIOTECHNOL LETT, V32, P1713, DOI 10.1007/s10529-010-0349-y; Wu ZM, 2010, J AM CHEM SOC, V132, P1567, DOI 10.1021/ja906611x; Yamamoto T, 2009, CHEM COMMUN, P1022, DOI 10.1039/b818792d	48	23	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23996	24006		10.1074/jbc.M111.247650	http://dx.doi.org/10.1074/jbc.M111.247650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566128	hybrid, Green Published			2022-12-27	WOS:000292294900042
J	Choi, ES; Stralfors, A; Castillo, AG; Durand-Dubief, M; Ekwall, K; Allshire, RC				Choi, Eun Shik; Stralfors, Annelie; Castillo, Araceli G.; Durand-Dubief, Mickael; Ekwall, Karl; Allshire, Robin C.			Identification of Noncoding Transcripts from within CENP-A Chromatin at Fission Yeast Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPREHENSIVE ANALYSIS; EPIGENETIC REGULATION; RNA; HETEROCHROMATIN; PROTEIN; GENE; KINETOCHORES; COMPONENTS; TURNOVER; DYNAMICS	The histone H3 variant CENP-A is the most favored candidate for an epigenetic mark that specifies the centromere. In fission yeast, adjacent heterochromatin can direct CENP-A(Cnp1) chromatin establishment, but the underlying features governing where CENP-A(Cnp1) chromatin assembles are unknown. We show that, in addition to centromeric regions, a low level of CENP-A(Cnp1) associates with gene promoters where histone H3 is depleted by the activity of the Hrp1(Chd1) chromatin-remodeling factor. Moreover, we demonstrate that noncoding RNAs are transcribed by RNA polymerase II (RNAPII) from CENP-A(Cnp1) chromatin at centromeres. These analyses reveal a similarity between centromeres and a subset of RNAPII genes and suggest a role for remodeling at RNAPII promoters within centromeres that influences the replacement of histone H3 with CENP-A(Cnp1).	[Stralfors, Annelie; Durand-Dubief, Mickael; Ekwall, Karl] Karolinska Inst, Novum, Dept Biosci & Nutr, Ctr Biosci, S-14157 Huddinge, Sweden; [Choi, Eun Shik; Castillo, Araceli G.; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Choi, Eun Shik; Castillo, Araceli G.; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Karolinska Institutet; University of Edinburgh; University of Edinburgh	Ekwall, K (corresponding author), Karolinska Inst, Novum, Dept Biosci & Nutr, Ctr Biosci, S-14157 Huddinge, Sweden.	karl.ekwall@ki.se; robin.allshire@ed.ac.uk	Castillo, Araceli G/C-5158-2013; Durand-Dubief, Mickael/O-2315-2019	Castillo, Araceli G/0000-0003-3990-5475; Durand-Dubief, Mickael/0000-0002-8556-4459; Ekwall, Karl/0000-0002-3029-4041; Choi, Eun Shik/0000-0002-2306-2103; Allshire, Robin/0000-0002-8005-3625	European Molecular Biology Organization; Wellcome Trust [065061/Z]; Swedish Research Council (VR); Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine; Cancer Society (CF)	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council (VR)(Swedish Research Council); Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine; Cancer Society (CF)	This work was supported by a European Molecular Biology Organization long-term fellowship (to E. S. C.), Wellcome Trust Programme Grant (065061/Z (to R. C. A.), the Swedish Research Council (VR; to K. E.), the Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine (to K. E.), and the Cancer Society (CF; to K. E.).	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2009, CELL, V136, P610, DOI 10.1016/j.cell.2009.02.004; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Durand-Dubief Mickael, 2009, V529, P279, DOI 10.1007/978-1-59745-538-1_18; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2000, P NATL ACAD SCI USA, V97, P12583, DOI 10.1073/pnas.97.23.12583; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; RIEDER CL, 1979, J CELL BIOL, V80, P1, DOI 10.1083/jcb.80.1.1; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang SW, 2005, MOL CELL BIOL, V25, P2288, DOI 10.1128/MCB.25.6.2288-2296.2005; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807	42	90	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23600	23607		10.1074/jbc.M111.228510	http://dx.doi.org/10.1074/jbc.M111.228510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531710	Green Published, hybrid			2022-12-27	WOS:000292025000090
J	Jha, S; Patil, SM; Gibson, J; Nelson, CE; Alder, NN; Alexandrescu, AT				Jha, Suman; Patil, Sharadrao M.; Gibson, Jason; Nelson, Craig E.; Alder, Nathan N.; Alexandrescu, Andrei T.			Mechanism of Amylin Fibrillization Enhancement by Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-AMYLOID-POLYPEPTIDE; FIBRIL FORMATION; IN-VITRO; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; BETA-CELLS; AGGREGATION; PEPTIDE; BINDING; CYTOTOXICITY	We characterized the interaction of amylin with heparin fragments of defined length, which model the glycosaminoglycan chains associated with amyloid deposits found in type 2 diabetes. Binding of heparin fragments to the positively charged N-terminal half of monomeric amylin depends on the concentration of negatively charged saccharides but is independent of oligosaccharide length. By contrast, amylin fibrillogenesis has a sigmoidal dependence on heparin fragment length, with an enhancement observed for oligosaccharides longer than four monomers and a leveling off of effects beyond 12 monomers. The length dependence suggests that the negatively charged helical structure of heparin electrostatically complements the positively charged surface of the fibrillar amylin cross-beta structure. Fluorescence resonance energy transfer and total internal reflection fluorescence microscopy experiments indicate that heparin associates with amylin fibrils, rather than enhancing fibrillogenesis catalytically. Short heparin fragments containing two-or eight-saccharide monomers protect against amylin cytotoxicity toward a MIN6 mouse cell model of pancreatic beta-cells.	[Jha, Suman; Patil, Sharadrao M.; Gibson, Jason; Nelson, Craig E.; Alder, Nathan N.; Alexandrescu, Andrei T.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	andrei@uconn.edu	Jha, Suman/AAD-5041-2019	Jha, Suman/0000-0003-3139-7621; Alder, Nathan/0000-0003-4474-7803	American Diabetes Association [1-10-BS-04]; National Institutes of Health National Center for Research Resources [1S10RR016760]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016760] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Basic Science Award 1-10-BS-04 from the American Diabetes Association.; NMR instrumentation was funded in part by Grant 1S10RR016760 from the National Institutes of Health National Center for Research Resources. We thank Dr. Anil Rustgi (University of Pennsylvania) for the MIN6 cell line.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2006, BIOCHEMISTRY-US, V45, P9228, DOI 10.1021/bi0510936; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Brender JR, 2010, J AM CHEM SOC, V132, P8973, DOI 10.1021/ja1007867; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Garrett R. H., 1999, BIOCHEMISTRY-US, P234; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Green A, 2003, DIABETES-METAB RES, V19, P3, DOI 10.1002/dmrr.340; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Knight JD, 2008, PROTEIN SCI, V17, P1850, DOI 10.1110/ps.036350.108; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Patil SM, 2011, BIOCHEMISTRY-US, V50, P2808, DOI 10.1021/bi101908m; Potter K., 2007, CLIN INVEST MED, V30, pS92; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Sheftic SR, 2009, METHOD ENZYMOL, V466, P233, DOI 10.1016/S0076-6879(09)66010-9; UCHIYAMA H, 1981, J BIOCHEM-TOKYO, V89, P185, DOI 10.1093/oxfordjournals.jbchem.a133180; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zdrojewicz Z., 2006, DIABETOLOGIA DOOESWI, V6, P169; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	60	57	57	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22894	22904		10.1074/jbc.M110.215814	http://dx.doi.org/10.1074/jbc.M110.215814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555785	Green Published, hybrid			2022-12-27	WOS:000292025000024
J	Khan, SZ; Mitra, D				Khan, Sohrab Zafar; Mitra, Debashis			Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; CELL-ACTIVATION; IN-VITRO; LENTIVIRAL REPLICATION; VIRAL REPLICATION; BINDING DOMAIN; 7SK SNRNA; TAT; PROTEIN	Human immunodeficiency virus-1 (HIV-1) exploits a number of host cellular factors for successful survival and propagation. The viral protein Nef plays an important role in HIV-1 pathogenesis by interacting with various cellular proteins. In the present work, we identified Cyclin K (CycK) as a novel Nef-interacting protein, and for the first time, we showed that CycK inhibits HIV-1 gene expression and replication in a Nef-dependent manner. The positive elongation factor b complex comprising cyclin-dependent kinase 9 (CDK9) and Cyclin T1 is a critical cellular complex required for viral gene expression and replication. Enhanced expression of CycK in the presence of Nef induced CycK-CDK9 binding, which prevented CDK9-Cyclin T1 complex formation and nuclear translocation of CDK9, resulting in inhibition of HIV-1 long terminal repeat-driven gene expression. Furthermore, this effect of CycK was not observed with Nef-deleted virus, indicating the importance of Nef in this phenomenon. Finally, silencing of CycK in HIV-1-infected cells resulted in increased translocation of CDK9 into the nucleus, leading to increased viral gene expression and replication. These data also suggest that endogenous CycK might act as an inhibitory factor for HIV-1 gene expression and replication in T-cells. Thus, our results clearly demonstrate that CycK utilizes HIV-1 Nef protein to displace CycT1 from the positive elongation factor b complex, resulting in inhibition of HIV-1 gene expression and replication.	[Khan, Sohrab Zafar; Mitra, Debashis] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Mitra, D (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune 411007, Maharashtra, India.	dmitra@nccs.res.in	Khan, Sohrab/H-4074-2019	Khan, Sohrab/0000-0002-9564-5092	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; Arora VK, 2002, MICROBES INFECT, V4, P189, DOI 10.1016/S1286-4579(01)01527-1; Baek K, 2007, J MOL BIOL, V366, P563, DOI 10.1016/j.jmb.2006.11.057; Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Collette Y, 1999, VIROLOGY, V265, P173, DOI 10.1006/viro.1999.0053; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Das SR, 2005, INDIAN J MED RES, V121, P315; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 2001, J VIROL, V75, P6601, DOI 10.1128/JVI.75.14.6601-6608.2001; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Glushakova S, 1999, J VIROL, V73, P3968, DOI 10.1128/JVI.73.5.3968-3974.1999; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; Joseph AM, 2003, FEBS LETT, V548, P37, DOI 10.1016/S0014-5793(03)00725-7; Jubier-Maurin V, 1999, AIDS RES HUM RETROV, V15, P23, DOI 10.1089/088922299311673; Kamp W, 2000, EUR J CLIN INVEST, V30, P740; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lundquist CA, 2004, J VIROL, V78, P6287, DOI 10.1128/JVI.78.12.6287-6296.2004; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Napolitano G, 2002, J CELL PHYSIOL, V192, P209, DOI 10.1002/jcp.10130; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Saksela Kalle, 1997, Frontiers in Bioscience, V2, pD606; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Shimizu S, 2007, AIDS, V21, P575, DOI 10.1097/QAD.0b013e32801424a5; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Stoddart CA, 2003, J VIROL, V77, P2124, DOI 10.1128/JVI.77.3.2124-2133.2003; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Urano E, 2008, AIDS, V22, P1081, DOI 10.1097/QAD.0b013e3282fc7319; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	51	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22943	22954		10.1074/jbc.M110.201194	http://dx.doi.org/10.1074/jbc.M110.201194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555514	Green Published, hybrid			2022-12-27	WOS:000292025000029
J	Kim, KB; Yi, JS; Nguyen, N; Lee, JH; Kwon, YC; Ahn, BY; Cho, H; Kim, YK; Yoo, HJ; Lee, JS; Ko, YG				Kim, Ki-Bum; Yi, Jae-Sung; Nga Nguyen; Lee, Joo-Hyung; Kwon, Young-Chan; Ahn, Byung-Yoon; Cho, Hana; Kim, Yoon Ki; Yoo, Hee-Jung; Lee, Jae-Seon; Ko, Young-Gyu			Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAFT PROTEOME REVEALS; ACID BINDING-PROTEIN; ATP SYNTHASE COMPLEX; LIPID RAFTS; GLOBULAR HEADS; CUTTING EDGE; ADHESION; TARGET; CD44; LOCALIZATION	We previously demonstrated that the receptor for the complement component C1q (gC1qR) is a lipid raft protein that is indispensable for adipogenesis and insulin signaling. Here, we provide the first report that gC1qR is an essential component of lamellipodia in human lung carcinoma A549 cells. Cell-surface gC1qR was concentrated in the lamellipodia along with CD44, monosialoganglioside, actin, and phosphorylated focal adhesion kinase in cells stimulated with insulin, IGF-1, EGF, or serum. The growth factor-induced lamellipodia formation and cell migration were significantly decreased in gC1qR-depleted cells, with a concomitant blunt activation of the focal adhesion kinase and the respective receptor tyrosine kinases. Moreover, the gC1qR-depleted cells exhibited a reduced proliferation rate in culture as well as diminished tumorigenic and metastatic activities in grafted mice. We therefore conclude that cell-surface gC1qR regulates lamellipodia formation and metastasis via receptor tyrosine kinase activation.	[Kim, Ki-Bum; Yi, Jae-Sung; Nga Nguyen; Lee, Joo-Hyung; Kwon, Young-Chan; Ahn, Byung-Yoon; Cho, Hana; Kim, Yoon Ki; Ko, Young-Gyu] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Yoo, Hee-Jung; Lee, Jae-Seon] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea	Korea University; Korea Institute of Radiological & Medical Sciences	Ko, YG (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 1,5 Ka, Seoul 136701, South Korea.	ygko@korea.ac.kr	Lee, Joo-Hyung/ABB-7759-2021	Lee, Joo-Hyung/0000-0001-5345-1102; Kim, Yoon Ki/0000-0003-1303-072X; Cho, Hana/0000-0002-7520-7108	Korea Research Foundation [0001197, 20100025943]; Ministry of Health, Welfare and Family Affairs [09201800]	Korea Research Foundation(National Research Foundation of Korea); Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Basic Research Laboratory Program of the Korea Research Foundation Grant 0001197 (to Y.-G. K.), National R&D Program for Cancer Control, Ministry of Health, Welfare and Family Affairs Grant 09201800, and Nuclear Research and Development Program of Korea Research Foundation Grant 20100025943 (to J.-S. L.).	Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Chen YB, 2009, J SURG ONCOL, V100, P382, DOI 10.1002/jso.21329; Choi Y, 2008, VIROLOGY, V381, P178, DOI 10.1016/j.virol.2008.08.035; Chowdhury A. R., 2009, HYALURONAN BINDING P, P51; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Feng XD, 2002, J IMMUNOL, V168, P2441, DOI 10.4049/jimmunol.168.5.2441; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kim KB, 2009, PROTEOMICS, V9, P2373, DOI 10.1002/pmic.200800811; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kindzelskii AL, 2004, J IMMUNOL, V172, P4681, DOI 10.4049/jimmunol.172.8.4681; Lim BL, 1996, J BIOL CHEM, V271, P26739, DOI 10.1074/jbc.271.43.26739; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Menzies CA, 2008, FASEB J, V22; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Park JH, 2010, P NATL ACAD SCI USA, V107, P981, DOI 10.1073/pnas.0909565107; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Sanchez-Martin D, 2011, J BIOL CHEM, V286, P5197, DOI 10.1074/jbc.M110.161927; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435	39	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23093	23101		10.1074/jbc.M111.233304	http://dx.doi.org/10.1074/jbc.M111.233304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536672	hybrid, Green Published			2022-12-27	WOS:000292025000043
J	Matsuda, M; Takeshita, K; Kurokawa, T; Sakata, S; Suzuki, M; Yamashita, E; Okamura, Y; Nakagawa, A				Matsuda, Makoto; Takeshita, Kohei; Kurokawa, Tatsuki; Sakata, Souhei; Suzuki, Mamoru; Yamashita, Eiki; Okamura, Yasushi; Nakagawa, Atsushi			Crystal Structure of the Cytoplasmic Phosphatase and Tensin Homolog (PTEN)-like Region of Ciona intestinalis Voltage-sensing Phosphatase Provides Insight into Substrate Specificity and Redox Regulation of the Phosphoinositide Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR; CI-VSP; MEMBRANE-BINDING; PTEN; DOMAIN; SENSOR; DEPHOSPHORYLATES; MECHANISM; GENE	Ciona intestinalis voltage-sensing phosphatase (Ci-VSP) has a transmembrane voltage sensor domain and a cytoplasmic region sharing similarity to the phosphatase and tensin homolog (PTEN). It dephosphorylates phosphatidylinositol 4,5-bis-phosphate and phosphatidylinositol 3,4,5-trisphosphate upon membrane depolarization. The cytoplasmic region is composed of a phosphatase domain and a putative membrane interaction domain, C2. Here we determined the crystal structures of the Ci-VSP cytoplasmic region in three distinct constructs, wildtype (248-576), wild-type (236-576), and G365A mutant (248-576). The crystal structure of WT-236 and G365A-248 had the disulfide bond between the catalytic residue Cys-363 and the adjacent residue Cys-310. On the other hand, the disulfide bond was not present in the crystal structure of WT-248. These suggest the possibility that Ci-VSP is regulated by reactive oxygen species as found in PTEN. These structures also revealed that the conformation of the TI loop in the active site of the Ci-VSP cytoplasmic region was distinct from the corresponding region of PTEN; Ci-VSP has glutamic acid (Glu-411) in the TI loop, orienting toward the center of active site pocket. Mutation of Glu-411 led to acquirement of increased activity toward phosphatidylinositol 3,5-bisphosphate, suggesting that this site is required for determining substrate specificity. Our results provide the basic information of the enzymatic mechanism of Ci-VSP.	[Kurokawa, Tatsuki; Sakata, Souhei; Okamura, Yasushi] Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Dept Physiol, Suita, Osaka 5650871, Japan; [Matsuda, Makoto; Takeshita, Kohei; Suzuki, Mamoru; Yamashita, Eiki; Nakagawa, Atsushi] Osaka Univ, Grad Sch Med, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Okamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Dept Physiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yokamura@phys2.med.osaka-u.ac.jp; atsushi@protein.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/M-5731-2019; Suzuki, Mamoru/G-6576-2016; Nakagawa, Atsushi/D-4329-2009	Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology; Human Frontier Science Program; Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research [21229003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (to Y. O. and A. N.), a research grant from the Human Frontier Science Program (to Y. O.), and the Japan Aerospace Exploration Agency-Granada Crystallization Facility High Quality Protein Crystallization Project on the Protein Structure and Function Analysis for Application (to A. N.).	Afonine PV, 2005, CCP4 NEWSL, V42; Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; AITKEN RJ, 1995, J CELL SCI, V108, P2017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Buhrman G, 2005, BIOCHEMISTRY-US, V44, P5307, DOI 10.1021/bi047449f; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Chu HM, 2007, PROTEINS, V66, P996, DOI 10.1002/prot.21262; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kishore AI, 2003, BIOPHYS J, V85, P3848, DOI 10.1016/S0006-3495(03)74799-7; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogasawara M, 2011, GENE EXPR PATTERNS, V11, P233, DOI 10.1016/j.gep.2010.12.004; Okamura Y, 2007, PFLUG ARCH EUR J PHY, V454, P361, DOI 10.1007/s00424-007-0222-6; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215	42	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23368	23377		10.1074/jbc.M110.214361	http://dx.doi.org/10.1074/jbc.M110.214361			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543329	hybrid, Green Published			2022-12-27	WOS:000292025000068
J	Farris, SD; Hu, JH; Krishnan, R; Emery, I; Chu, T; Du, L; Kremen, M; Dichek, HL; Gold, E; Ramsey, SA; Dichek, DA				Farris, Stephen D.; Hu, Jie Hong; Krishnan, Ranjini; Emery, Isaac; Chu, Talyn; Du, Liang; Kremen, Michal; Dichek, Helen L.; Gold, Elizabeth; Ramsey, Stephen A.; Dichek, David A.			Mechanisms of Urokinase Plasminogen Activator (uPA)-mediated Atherosclerosis ROLE OF THE uPA RECEPTOR AND S100A8/A9 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; E-DEFICIENT MICE; IN-VIVO; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; KNOCKOUT MICE; VESSEL WALL; RECEPTOR; MACROPHAGES	Data from clinical studies, cell culture, and animal models implicate the urokinase plasminogen activator (uPA)/uPA receptor (uPAR)/plasminogen system in the development of atherosclerosis and aneurysms. However, the mechanisms through which uPA/uPAR/plasminogen stimulate these diseases are not yet defined. We used genetically modified, atherosclerosis-prone mice, including mice with macrophage-specific uPA overexpression and mice genetically deficient in uPAR to elucidate mechanisms of uPA/uPAR/plasminogen-accelerated atherosclerosis and aneurysm formation. We found that macrophage-specific uPA overexpression accelerates atherosclerosis and causes aortic root dilation in fat-fed Ldlr(-/-) mice (as we previously reported in Apoe(-/-) mice). Macrophage-expressed uPA accelerates atherosclerosis by stimulation of lesion progression rather than initiation and causes disproportionate lipid accumulation in early lesions. uPA-accelerated atherosclerosis and aortic dilation are largely, if not completely, independent of uPAR. In the absence of uPA overexpression, however, uPAR contributes modestly to both atherosclerosis and aortic dilation. Microarray studies identified S100A8 and S100A9 mRNA as the most highly up-regulated transcripts in uPA-overexpressing macrophages; up-regulation of S100A9 protein in uPA-overexpressing macrophages was confirmed by Western blotting. S100A8/A9, which are atherogenic in mice and are expressed in human atherosclerotic plaques, are also up-regulated in the aortae of mice with uPA-overexpressing macrophages, and macrophage S100A9 mRNA is up-regulated by exposure of wild-type macrophages to medium from uPA-overexpressing macrophages. Macrophage microarray data suggest significant effects of uPA overexpression on cell migration and cell-matrix interactions. Our results confirm in a second animal model that macrophage-expressed uPA stimulates atherosclerosis and aortic dilation. They also reveal uPAR independence of these actions and implicate specific pathways in uPA/Plg-accelerated atherosclerosis and aneurysmal disease.	[Dichek, David A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dichek, Helen L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gold, Elizabeth; Ramsey, Stephen A.] Inst Syst Biol, Seattle, WA 98103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Dichek, DA (corresponding author), 1959 NE Pacific St,Box 357710, Seattle, WA 98195 USA.	ddichek@uw.edu	Emery, Isaac/G-6601-2011	Emery, Isaac/0000-0002-8757-2698; Dichek, David/0000-0002-5224-2736	National Institutes of Health [R01HL080597]; John L. Locke, Jr. Charitable Trust; Howard Hughes Medical Institute; NHLBI, National Institutes of Health [T32HL07828, K25HL098807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, K25HL098807, R01HL080597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John L. Locke, Jr. Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL080597. This work was also supported by the John L. Locke, Jr. Charitable Trust.; Supported by a Howard Hughes Medical Institute Medical Student Fellowship.; Supported by NHLBI, National Institutes of Health Grant T32HL07828.; Supported by NHLBI, National Institutes of Health Grant K25HL098807.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Cozen AE, 2004, CIRCULATION, V109, P2129, DOI 10.1161/01.CIR.0000127369.24127.03; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dichek HL, 2004, J LIPID RES, V45, P551, DOI 10.1194/jlr.M300459-JLR200; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Falkenberg M, 1998, CARDIOVASC PATHOL, V7, P223, DOI 10.1016/S1054-8807(97)00114-2; Folsom AR, 2001, ARTERIOSCL THROM VAS, V21, P611, DOI 10.1161/01.ATV.21.4.611; Fuhrman B, 2007, ATHEROSCLEROSIS, V195, pE108, DOI 10.1016/j.atherosclerosis.2007.06.025; Fuhrman B, 2008, ARTERIOSCL THROM VAS, V28, P1361, DOI 10.1161/ATVBAHA.108.166041; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Hu JH, 2010, CIRCULATION, V121, P1637, DOI 10.1161/CIRCULATIONAHA.109.914945; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Irizarry R. A., 2003, ANAL GENE EXPRESSION, P102; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Kienast J, 1998, THROMB HAEMOSTASIS, V79, P579; Kremen M, 2008, P NATL ACAD SCI USA, V105, P17109, DOI 10.1073/pnas.0808650105; Krishnan R, 2009, ARTERIOSCL THROM VAS, V29, P1737, DOI 10.1161/ATVBAHA.109.195529; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; LAU W, 1995, J CLIN INVEST, V95, P1957, DOI 10.1172/JCI117879; Li XH, 2010, ARTERIOSCL THROM VAS, V30, P582, DOI 10.1161/ATVBAHA.109.202044; LIJNEN HR, 1981, THROMB RES, V24, P151, DOI 10.1016/0049-3848(81)90040-2; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lijnen HR, 2002, BIOCHEM SOC T, V30, P163, DOI 10.1042/bst0300163; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; May AE, 2002, BLOOD, V100, P3611, DOI 10.1182/blood-2002-03-0778; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Newton RA, 1998, J IMMUNOL, V160, P1427; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Piguet PF, 1999, CIRCULATION, V99, P3315, DOI 10.1161/01.CIR.99.25.3315; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sakkinen PA, 1999, ARTERIOSCL THROM VAS, V19, P499, DOI 10.1161/01.ATV.19.3.499; SCHNEIDERMAN J, 1995, J CLIN INVEST, V96, P639, DOI 10.1172/JCI118079; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; SHI GY, 1992, J BIOL CHEM, V267, P19363; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Veniant MM, 2001, ARTERIOSCL THROM VAS, V21, P1567, DOI 10.1161/hq1001.097780; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Virmani R, 2002, PROG CARDIOVASC DIS, V44, P349, DOI 10.1053/pcad.2002.122475; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821	65	41	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22665	22677		10.1074/jbc.M110.202135	http://dx.doi.org/10.1074/jbc.M110.202135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536666	Green Published, hybrid			2022-12-27	WOS:000291719900073
J	Clarke, CJ; Mediwala, K; Jenkins, RW; Sutton, CA; Tholanikunnel, BG; Hannun, YA				Clarke, Christopher J.; Mediwala, Krutika; Jenkins, Russell W.; Sutton, Che A.; Tholanikunnel, Baby G.; Hannun, Yusuf A.			Neutral Sphingomyelinase-2 Mediates Growth Arrest by Retinoic Acid through Modulation of Ribosomal S6 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BREAST-CANCER CELLS; MAMMALIAN TARGET; UP-REGULATION; CERAMIDE; ACTIVATION; PROTEIN; DIFFERENTIATION; INHIBITION; SMPD3	All-trans-retinoic acid (ATRA) induces growth arrest of many cell types. Previous studies have reported that ATRA can modulate cellular sphingolipids, but the role of sphingolipids in the ATRA response is not clear. Using MCF-7 cells as a model system, we show that ATRA stimulates an increase in ceramide levels followed by G(0)/G(1) growth arrest. Notably, induction of nSMase2 was the primary effect of ATRA on the sphingolipid network and was both time-and dose-dependent. Importantly, pretreatment with nSMase2 siRNA significantly inhibited ATRA effects on ceramide levels and growth arrest. In contrast, nSMase2 overexpression was sufficient to increase ceramide levels and induce G(0)/G(1) growth arrest of asynchronous MCF-7 cells. Surprisingly, neither ATRA stimulation nor nSMase2 overexpression had significant effects on classical cell cycle regulators such as p21/WAF1 or retinoblastoma. In contrast, ATRA suppressed phosphorylation of ribosomal S6 kinase (S6K) and its downstream targets S6 and eIF4B. Importantly, these effects were significantly inhibited by nSMase2 siRNA. Reciprocally, nSMase2 overexpression was sufficient to suppress S6K phosphorylation and signaling. Notably, neither ATRA effects nor nSMase2 effects on S6K phosphorylation required the ceramide-activated protein phosphatase PP2A, previously identified as important for S6K regulation. Finally, nSMase2 overexpression was sufficient to decrease translation as measured by methionine incorporation and analysis of polyribosome profiles. Taken together, these results implicate nSMase2 as a major component of ATRA-induced growth arrest of MCF-7 cells and identify S6K as a novel downstream target of nSMase2.	[Clarke, Christopher J.; Mediwala, Krutika; Jenkins, Russell W.; Sutton, Che A.; Tholanikunnel, Baby G.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [GM 43825]; American Heart Association; National Center for Research Resources [C06 RR01882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 43825 (to Y. A. H.). This work was also supported by an American Heart Association predoctoral fellowship (to R. W. J.). Work conducted in the Lipidomics Core was supported by NIH grant C06 RR01882 from the extramural research program of the National Center for Research Resources.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Chae YM, 2009, BMB REP, V42, P86, DOI 10.5483/BMBRep.2009.42.2.086; Cho JY, 2006, GENE, V372, P71, DOI 10.1016/j.gene.2005.12.010; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Corlazzoli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004305; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DELEENHEER AP, 1982, J LIPID RES, V23, P1362; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ito H, 2009, BBA-GENE REGUL MECH, V1789, P681, DOI 10.1016/j.bbagrm.2009.08.006; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Lal L, 2005, BLOOD, V105, P1669, DOI 10.1182/blood-2004-06-2078; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; MAZARS P, 1995, FEBS LETT, V362, P295, DOI 10.1016/0014-5793(95)00247-7; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012	43	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21565	21576		10.1074/jbc.M110.193375	http://dx.doi.org/10.1074/jbc.M110.193375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536668	Green Published, hybrid			2022-12-27	WOS:000291464700054
J	Guo, BH; Lin, JZ; Ye, KQ				Guo, Bihong; Lin, Jinzhong; Ye, Keqiong			Structure of the Autocatalytic Cysteine Protease Domain of Potyvirus Helper-component Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO-ETCH-POTYVIRUS; LONG-DISTANCE MOVEMENT; HYPOVIRULENCE-ASSOCIATED VIRUS; CHESTNUT BLIGHT FUNGUS; SMALL RNA-BINDING; HC-PRO; MULTIFUNCTIONAL PROTEIN; SILENCING SUPPRESSION; GENOME AMPLIFICATION; APHID TRANSMISSION	The helper-component proteinase (HC-Pro) of potyvirus is involved in polyprotein processing, aphid transmission, and suppression of antiviral RNA silencing. There is no high resolution structure reported for any part of HC-Pro, hindering mechanistic understanding of its multiple functions. We have determined the crystal structure of the cysteine protease domain of HC-Pro from turnip mosaic virus at 2.0 angstrom resolution. As a protease, HC-Pro only cleaves a Gly-Gly dipeptide at its own C terminus. The structure represents a postcleavage state in which the cleaved C terminus remains tightly bound at the active site cleft to prevent trans activity. The structure adopts a compact alpha/beta-fold, which differs from papain-like cysteine proteases and shows weak similarity to nsP2 protease from Venezuelan equine encephalitis alphavirus. Nevertheless, the catalytic cysteine and histidine residues constitute an active site that is highly similar to these in papain-like and nsP2 proteases. HC-Pro recognizes a consensus sequence YXVGG around the cleavage site between the two glycine residues. The structure delineates the sequence specificity at sites P1-P4. Structural modeling and covariation analysis across the Potyviridae family suggest a tryptophan residue accounting for the glycine specificity at site P1'. Moreover, a surface of the protease domain is conserved in potyvirus but not in other genera of the Potyviridae family, likely due to extra functional constrain. The structure provides insight into the catalysis mechanism, cis-acting mode, cleavage site specificity, and other functions of the HC-Pro protease domain.	[Guo, Bihong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Guo, Bihong; Lin, Jinzhong; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing	Ye, KQ (corresponding author), 7 Sci Pk Rd, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2010CB835402, 2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	This work was supported by the Chinese Ministry of Science and Technology through projects 973 (2010CB835402) and 863 (2008AA022310) and the Beijing Municipal Government.	Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Blanc S, 1998, J GEN VIROL, V79, P3119, DOI 10.1099/0022-1317-79-12-3119; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; CARRINGTON JC, 1992, VIROLOGY, V187, P308, DOI 10.1016/0042-6822(92)90319-K; CARRINGTON JC, 1989, J VIROL, V63, P4459, DOI 10.1128/JVI.63.10.4459-4463.1989; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; CARRINGTON JC, 1989, EMBO J, V8, P365, DOI 10.1002/j.1460-2075.1989.tb03386.x; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; CHOI GH, 1991, VIROLOGY, V183, P747, DOI 10.1016/0042-6822(91)91004-Z; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; CRONIN S, 1995, PLANT CELL, V7, P549, DOI 10.1105/tpc.7.5.549; DeLano W.L, PYMOL MOL GRAPHICS S; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; DOLJA VV, 1993, J VIROL, V67, P5968, DOI 10.1128/JVI.67.10.5968-5975.1993; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAUQUET CM, 2005, VIRUS TAXONOMY 8 REP, P819; GOVIER DA, 1974, VIROLOGY, V61, P420, DOI 10.1016/0042-6822(74)90278-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KASSCHAU KD, 1995, VIROLOGY, V209, P268, DOI 10.1006/viro.1995.1254; Kasschau KD, 1997, VIROLOGY, V228, P251, DOI 10.1006/viro.1996.8368; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li WM, 2008, VIRUS RES, V135, P213, DOI 10.1016/j.virusres.2008.03.015; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maia IG, 1996, J GEN VIROL, V77, P1335, DOI 10.1099/0022-1317-77-7-1335; MAVANKAL G, 1991, VIROLOGY, V185, P721, DOI 10.1016/0042-6822(91)90543-K; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OH CS, 1989, VIROLOGY, V173, P692, DOI 10.1016/0042-6822(89)90582-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng YH, 1998, J GEN VIROL, V79, P897, DOI 10.1099/0022-1317-79-4-897; Plisson C, 2003, J BIOL CHEM, V278, P23753, DOI 10.1074/jbc.M302512200; POLGAR L, 2004, HDB PROTEOLYTIC ENZY, P1072; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Ruiz-Ferrer V, 2005, J VIROL, V79, P3758, DOI 10.1128/JVI.79.6.3758-3765.2005; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHAPIRA R, 1991, J BIOL CHEM, V266, P19419; Shi XM, 1997, VIROLOGY, V231, P35, DOI 10.1006/viro.1997.8488; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Stenger DC, 2005, J VIROL, V79, P12077, DOI 10.1128/JVI.79.18.12077-12080.2005; Torres-Barcelo C, 2008, GENETICS, V180, P1039, DOI 10.1534/genetics.108.091363; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Varrelmann M, 2007, J GEN VIROL, V88, P1005, DOI 10.1099/vir.0.82200-0; VERCHOT J, 1991, VIROLOGY, V185, P527, DOI 10.1016/0042-6822(91)90522-D; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	56	29	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21937	21943		10.1074/jbc.M111.230706	http://dx.doi.org/10.1074/jbc.M111.230706			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21543324	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000291464700088
J	Lintner, NG; Kerou, M; Brumfield, SK; Graham, S; Liu, HT; Naismith, JH; Sdano, M; Peng, N; She, QX; Copie, V; Young, MJ; White, MF; Lawrence, CM				Lintner, Nathanael G.; Kerou, Melina; Brumfield, Susan K.; Graham, Shirley; Liu, Huanting; Naismith, James H.; Sdano, Matthew; Peng, Nan; She, Qunxin; Copie, Valerie; Young, Mark J.; White, Malcolm F.; Lawrence, C. Martin			Structural and Functional Characterization of an Archaeal Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated Complex for Antiviral Defense (CASCADE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; RNA RECOGNITION MOTIF; PROTEIN-STRUCTURE; SULFOLOBUS-SOLFATARICUS; IMMUNE-SYSTEM; CRISPR; BACTERIA; GENUS; ALIGNMENT; SEQUENCE	In response to viral infection, many prokaryotes incorporate fragments of virus-derived DNA into loci called clustered regularly interspaced short palindromic repeats (CRISPRs). The loci are then transcribed, and the processed CRISPR transcripts are used to target invading viral DNA and RNA. The Escherichia coli "CRISPR-associated complex for antiviral defense" (CASCADE) is central in targeting invading DNA. Here we report the structural and functional characterization of an archaeal CASCADE (aCASCADE) from Sulfolobus solfataricus. Tagged Csa2 (Cas7) expressed in S. solfataricus co-purifies with Cas5a-, Cas6-, Csa5-, and Cas6-processed CRISPR-RNA (crRNA). Csa2, the dominant protein in aCASCADE, forms a stable complex with Cas5a. Transmission electron microscopy reveals a helical complex of variable length, perhaps due to substoichiometric amounts of other CASCADE components. A recombinant Csa2-Cas5a complex is sufficient to bind crRNA and complementary ssDNA. The structure of Csa2 reveals a crescent-shaped structure unexpectedly composed of a modified RNA-recognition motif and two additional domains present as insertions in the RNA-recognition motif. Conserved residues indicate potential crRNA- and target DNA-binding sites, and the H160A variant shows significantly reduced affinity for crRNA. We propose a general subunit architecture for CASCADE in other bacteria and Archaea.	[Kerou, Melina; Graham, Shirley; Liu, Huanting; Naismith, James H.; White, Malcolm F.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Lintner, Nathanael G.; Brumfield, Susan K.; Sdano, Matthew; Copie, Valerie; Young, Mark J.; Lawrence, C. Martin] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Lintner, Nathanael G.; Sdano, Matthew; Copie, Valerie; Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Brumfield, Susan K.; Young, Mark J.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Peng, Nan; She, Qunxin] Univ Copenhagen, Dept Biol, Archaea Ctr, DK-2200 Copenhagen N, Denmark	University of St Andrews; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Copenhagen	White, MF (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	mfw2@st-and.ac.uk; lawrence@chemistry.montana.edu	White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; She, Qunxin/E-4311-2012; Kerou, Melina/V-7485-2019; Lawrence, C. Martin/AAH-3420-2020; Copie, Valerie/GPW-9767-2022; Naismith, James Henderson/H-3408-2012; Peng, Nan/K-3819-2016	White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; She, Qunxin/0000-0002-4448-6669; Kerou, Melina/0000-0003-1657-3041; Lawrence, C. Martin/0000-0002-5398-466X; Copie, Valerie/0000-0002-2778-1463; Naismith, James Henderson/0000-0001-6744-5061; Peng, Nan/0000-0002-1637-6729; Graham, Shirley/0000-0002-2608-3815	National Science Foundation [MCB-0628732, MCB-0920312]; Biotechnology and Biological Sciences Research Council [BB/G011400/1]; Molecular Biosciences Program; National Science Foundation; Montana State University [DGE 0654336]; Danish Council for Independent Research [09-062932/FTP]; Murdock Foundation; BBSRC [BB/G011400/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: researchfish; Direct For Biological Sciences [0920312] Funding Source: National Science Foundation; Emerging Frontiers [0802200] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Molecular Biosciences Program; National Science Foundation(National Science Foundation (NSF)); Montana State University; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Murdock Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants MCB-0628732 and MCB-0920312 and Biotechnology and Biological Sciences Research Council Grant BB/G011400/1.; Supported by fellowships from the Molecular Biosciences Program and the National Science Foundation Integrated Graduate Education and Research Training Program in Geobiological Systems Grant DGE 0654336 from the Montana State University.; Supported by the Danish Council for Independent Research Grant 09-062932/FTP.; We thank Paul Talbot and Donald L. Alsbury for technical assistance and Dr. Christophe Rouillon and Dr. Jing Zhang for scientific discussion. Portions of this work were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. The Macromolecular Diffraction Laboratory at Montana State University was supported, in part, by a grant from the Murdock Foundation. We thank the Mass Spectrometry facility in St. Andrews supported by the Wellcome Trust.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Botting CH, 2010, ARCHAEA, V2010, DOI 10.1155/2010/106341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; DeLano W.L, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P1928, DOI 10.1016/j.febslet.2009.04.047; Han D, 2009, FEBS LETT, V583, P771, DOI 10.1016/j.febslet.2009.01.024; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; JORE MJ, 2011, NAT STRUCT IN PRESS; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft P, 2004, J VIROL, V78, P7438, DOI 10.1128/JVI.78.14.7438-7442.2004; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martusewitsch E, 2000, J BACTERIOL, V182, P2574, DOI 10.1128/JB.182.9.2574-2581.2000; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Peng X, 2003, J BACTERIOL, V185, P2410, DOI 10.1128/JB.185.8.2410-2417.2003; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014	65	159	183	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21643	21656		10.1074/jbc.M111.238485	http://dx.doi.org/10.1074/jbc.M111.238485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507944	Green Published, hybrid			2022-12-27	WOS:000291464700061
J	Refaat, A; Zhou, Y; Suzuki, S; Takasaki, I; Koizumi, K; Yamaoka, S; Tabuchi, Y; Saiki, I; Sakurai, H				Refaat, Alaa; Zhou, Yue; Suzuki, Shunsuke; Takasaki, Ichiro; Koizumi, Keiichi; Yamaoka, Shoji; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki			Distinct Roles of Transforming Growth Factor-beta-activated Kinase 1 (TAK1)-c-Rel and Interferon Regulatory Factor 4 (IRF4) Pathways in Human T Cell Lymphotropic Virus 1-transformed T helper 17 Cells Producing Interleukin-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; HTLV-1 TAX; TRANSCRIPTION FACTOR; SPASTIC PARAPARESIS; SIGNALING PATHWAY; ARSENIC TRIOXIDE; GENE-EXPRESSION; LEUKEMIA; LEUKEMIA/LYMPHOMA	Investigation of helper T cell markers in HTLV-1-transformed cell lines demonstrated that HuT-102 has an IL-9-producing Th17 phenotype. We confirmed the vital role of retinoic acid-related orphan receptor C, a Th17 transcription factor, in the expression of IL-17. Interferon regulatory factor 4 (IRF4), a transcription factor overexpressed in all HTLV-1-infected cells, regulated IL-17 and IL-9 concomitantly. We further demonstrated a novel pathway for the regulation of Tax-induced cytokines, IL-9 and IL-6, through TAK1-mediated nuclear accumulation of c-Rel. A microarray analysis for IRF4 knocked down HuT-102 cells showed a significant up-regulation in the set of genes related to Th1, mainly IFN-gamma and several transcription factors. T-bet and IRF1, but not STAT1 and IRF9, participated in counteracting the inhibitory effect of IRF4 on the production of IFN-gamma. Finally, suppression of both IRF4 and c-Rel resulted in the reduced proliferation. Collectively, these findings indicate that TAK1-c-Rel and IRF4 pathways play distinct roles in the maintenance of IL-9-producing Th17 phenotype of HTLV-1-transformed cells.	[Refaat, Alaa; Zhou, Yue; Suzuki, Shunsuke; Koizumi, Keiichi; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Takasaki, Ichiro] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 9300194, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan	University of Toyama; University of Toyama; Tokyo Medical & Dental University (TMDU)	Sakurai, H (corresponding author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@inm.u-toyama.ac.jp	Koizumi, Keiichi/AAG-6915-2019; Sakurai, Hiroaki/AAE-4294-2019; Refaat, Alaa/F-3596-2018	Refaat, Alaa/0000-0002-7821-2500; Zhou, Yue/0000-0002-1335-5703; Tabuchi, Yoshiaki/0000-0002-6007-6176; Sakurai, Hiroaki/0000-0003-0657-9570	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [19590063, 20890078]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research (C) 19590063 and Young Scientist Start-up 20890078 from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and a grant from the Takeda Science Foundation.	Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016/S1470-2045(04)01608-0; Bazarbachi A, 1999, BLOOD, V93, P278, DOI 10.1182/blood.V93.1.278.401k22_278_283; Bazarbachi A, 2000, LEUKEMIA, V14, P716, DOI 10.1038/sj.leu.2401742; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen J, 2008, BLOOD, V111, P5163, DOI 10.1182/blood-2007-09-113654; Dodon MD, 2004, J GEN VIROL, V85, P1921, DOI 10.1099/vir.0.79921-0; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; GESSAIN A, 1985, LANCET, V2, P407; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; HARA H, 1994, J EXP MED, V180, P831, DOI 10.1084/jem.180.3.831; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Inagaki A, 2006, INT J CANCER, V118, P3054, DOI 10.1002/ijc.21688; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; OSAME M, 1986, LANCET, V2, P104; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476; SUZUKI T, 1994, ONCOGENE, V9, P3099; Takasaki I, 2007, J CELL BIOCHEM, V102, P1472, DOI 10.1002/jcb.21369; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; YAMASHITA I, 1994, BLOOD, V84, P1573; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	41	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21092	21099		10.1074/jbc.M110.200907	http://dx.doi.org/10.1074/jbc.M110.200907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498517	hybrid, Green Published			2022-12-27	WOS:000291464700008
J	Cailotto, F; Reboul, P; Sebillaud, S; Netter, P; Jouzeau, JY; Bianchi, A				Cailotto, Frederic; Reboul, Pascal; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud			Calcium Input Potentiates the Transforming Growth Factor (TGF)-beta 1-dependent Signaling to Promote the Export of Inorganic Pyrophosphate by Articular Chondrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDRATE DEPOSITION DISEASE; PRIMARY HYPERPARATHYROIDISM; MAP KINASE; PARATHYROID-HORMONE; GENE-EXPRESSION; CA2+ INFLUX; FACTOR-BETA; PROTEIN; CELLS; SP1	Transforming growth factor (TGF)-beta 1 stimulates extracellular PPi (ePP(i)) generation and promotes chondrocalcinosis, which also occurs secondary to hyperparathyroidism-induced hypercalcemia. We previously demonstrated that ANK was upregulated by TGF-beta 1 activation of ERK1/2 and Ca2+-dependent protein kinase C (PKC alpha). Thus, we investigated mechanisms by which calcium could affect ePP(i) metabolism, especially its main regulating proteins ANK and PC-1 (plasma cell membrane glycoprotein-1). We stimulated articular chondrocytes with TGF-beta 1 under extracellular (eCa(2+)) or cytosolic Ca2+ (cCa(2+)) modulations. We studied ANK, PC-1 expression (quantitative RT-PCR, Western blotting), ePP(i) levels (radiometric assay), and cCa(2+) input (fluorescent probe). Voltage-operated Ca2+-channels (VOC) and signaling pathways involved were investigated with selective inhibitors. Finally, Ank promoter activity was evaluated (gene reporter). TGF-beta 1 elevated cCa(2+) and ePP(i) levels (by up-regulating Ank and PC-1 mRNA/proteins) in an eCa(2+) dose-dependent manner. TGF-beta 1 effects were suppressed by cCa(2+) chelation or L- and T-VOC blockade while being mostly reproduced by ionomycin. In the same experimental conditions, the activation of Ras, the phosphorylation of ERK1/2 and PKC alpha, and the stimulation of Ank promoter activity were affected similarly. Activation of SP1 (specific protein 1) and ELK-1 (Ets-like protein-1) transcription factors supported the regulatory role of Ca2+. SP1 or ELK-1 overexpression or blockade experiments demonstrated a major contribution of ELK-1, which acted synergistically with SP1 to activate Ank promoter in response to TGF-beta 1. TGF-beta 1 promotes input of eCa(2+) through opening of L- and T-VOCs, to potentiate ERK1/2 and PKC alpha signaling cascades, resulting in an enhanced activation of Ank promoter and ePP(i) production in chondrocyte.	[Cailotto, Frederic; Reboul, Pascal; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud] Nancy Univ, CNRS, UMR 7561,Fac Med, Lab Physiopathol Pharmacol & Ingn Articularies, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Cailotto, F (corresponding author), Nancy Univ, CNRS, UMR 7561,Fac Med, Lab Physiopathol Pharmacol & Ingn Articularies, Ave Foret Haye,BP184, F-54505 Vandoeuvre Les Nancy, France.	frederic.cailotto@hotmail.fr; arnaud.bianchi@medecine.uhp-nancy.fr	bianchi, arnaud/AAY-7059-2021; REBOUL, Pascal/ABA-3774-2021	bianchi, arnaud/0000-0003-4925-5269; REBOUL, Pascal/0000-0003-3546-2152; Cailotto, Frederic/0000-0002-4941-9238	University Hospital of Nancy; Fondation pour la Recherche Medicale; Region Lorraine; Conseil General [54]; Communaute Urbaine du Grand Nancy	University Hospital of Nancy; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Lorraine(Region Grand-Est); Conseil General; Communaute Urbaine du Grand Nancy(Region Grand-Est)	This work was supported by grants (Contrat de Programme de Recherche Clinique (CPRC)/Programmes Hospitaliers de Recherche Clinique (PHRC)) from the University Hospital of Nancy, the Fondation pour la Recherche Medicale, the Region Lorraine, the Conseil General 54, and the Communaute Urbaine du Grand Nancy.	BARDIN T, 1988, REV RHUM, V55, P511; Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; Cailotto F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2330; Cailotto F, 2010, J BIOL CHEM, V285, P10572, DOI 10.1074/jbc.M109.050534; Chang YH, 1999, ENDOCRINOLOGY, V140, P5883, DOI 10.1210/en.140.12.5883; DODDS WJ, 1968, AMER J ROENTGENOL RA, V104, P884, DOI 10.2214/ajr.104.4.884; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Hamade T, 2010, BIO-MED MATER ENG, V20, P209, DOI 10.3233/BME-2010-0634; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Kudirka JC, 2007, J CELL PHYSIOL, V213, P54, DOI 10.1002/jcp.21087; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; Kumar A, 1997, J LIPID RES, V38, P2240; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; MCGILL PE, 1984, SCAND J RHEUMATOL, V13, P56, DOI 10.3109/03009748409102668; McGowan TA, 2002, AM J PHYSIOL-RENAL, V282, pF910, DOI 10.1152/ajprenal.00252.2001; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Messa P, 2008, EXPERT OPIN DRUG MET, V4, P1551, DOI [10.1517/17425250802587017, 10.1517/17425250802587017 ]; Momberger TS, 2006, MATRIX BIOL, V25, P306, DOI 10.1016/j.matbio.2006.01.008; Moussaud S, 2009, CELL PHYSIOL BIOCHEM, V24, P141, DOI 10.1159/000233240; MULDOON LL, 1988, J BIOL CHEM, V263, P18834; Nakatani S, 2006, BIOCHEM BIOPH RES CO, V348, P1157, DOI 10.1016/j.bbrc.2006.07.180; Oca P, 2010, J CELL PHYSIOL, V224, P540, DOI 10.1002/jcp.22155; OYAJOBI BO, 1994, J BONE MINER RES, V9, P1259; Pawlotsky Y, 2008, J RHEUMATOL, V35, P315; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Ponce A, 2006, CELL PHYSIOL BIOCHEM, V18, P35, DOI 10.1159/000095134; Punzi L, 2003, J RHEUMATOL, V30, P420; Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228; REES JA, 1988, ANN RHEUM DIS, V47, P747, DOI 10.1136/ard.47.9.747; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROSENTHAL AK, 1993, ARTHRITIS RHEUM, V36, P539, DOI 10.1002/art.1780360415; RYAN LM, 1986, J CLIN INVEST, V77, P1689, DOI 10.1172/JCI112487; Sanchez JC, 2003, GEN PHYSIOL BIOPHYS, V22, P487; Scherle PA, 1997, BIOCHEM BIOPH RES CO, V230, P573, DOI 10.1006/bbrc.1996.5985; Secondo A, 2000, MOL PHARMACOL, V58, P1115, DOI 10.1124/mol.58.5.1115; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Volpe A, 2009, JOINT BONE SPINE, V76, P708, DOI 10.1016/j.jbspin.2009.02.001; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yellowley CE, 1999, J CELL PHYSIOL, V180, P402, DOI 10.1002/(SICI)1097-4652(199909)180:3<402::AID-JCP11>3.0.CO;2-4; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; ZHU Z, 1995, EUR J CLIN INVEST, V25, P317, DOI 10.1111/j.1365-2362.1995.tb01708.x; Zuscik MJ, 1997, BIOCHEM BIOPH RES CO, V234, P432, DOI 10.1006/bbrc.1997.6661	54	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19215	19228		10.1074/jbc.M110.175448	http://dx.doi.org/10.1074/jbc.M110.175448			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471198	Green Published, hybrid			2022-12-27	WOS:000291027700004
J	Greenfeld, M; Solomatin, SV; Herschlag, D				Greenfeld, Max; Solomatin, Sergey V.; Herschlag, Daniel			Removal of Covalent Heterogeneity Reveals Simple Folding Behavior for P4-P6 RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE; TERTIARY STRUCTURE; TETRAHYMENA RIBOZYME; CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; KINETIC TRAPS; ION CORE; DYNAMICS; BINDING; DOMAIN	RNA folding landscapes have been described alternately as simple and as complex. The limited diversity of RNA residues and the ability of RNA to form stable secondary structures prior to adoption of a tertiary structure would appear to simplify folding relative to proteins. Nevertheless, there is considerable evidence for long-lived misfolded RNA states, and these observations have suggested rugged energy landscapes. Recently, single molecule fluorescence resonance energy transfer (smFRET) studies have exposed heterogeneity in many RNAs, consistent with deeply furrowed rugged landscapes. We turned to an RNA of intermediate complexity, the P4-P6 domain from the Tetrahymena group I intron, to address basic questions in RNA folding. P4-P6 exhibited long-lived heterogeneity in smFRET experiments, but the inability to observe exchange in the behavior of individual molecules led us to probe whether there was a non-conformational origin to this heterogeneity. We determined that routine protocols in RNA preparation and purification, including UV shadowing and heat annealing, cause covalent modifications that alter folding behavior. By taking measures to avoid these treatments and by purifying away damaged P4-P6 molecules, we obtained a population of P4-P6 that gave near-uniform behavior in single molecule studies. Thus, the folding landscape of P4-P6 lacks multiple deep furrows that would trap different P4-P6 molecules in different conformations and contrasts with the molecular heterogeneity that has been seen in many smFRET studies of structured RNAs. The simplicity of P4-P6 allowed us to reliably determine the thermodynamic and kinetic effects of metal ions on folding and to now begin to build more detailed models for RNA folding behavior.	[Greenfeld, Max; Solomatin, Sergey V.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Greenfeld, Max; Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	herschla@stanford.edu			National Institutes of mental information; Training Grant in Biotechnology [5T32GM008412];  [GM49243]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412, R01GM049243, R37GM049243] Funding Source: NIH RePORTER	National Institutes of mental information; Training Grant in Biotechnology; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of mental information. Initial smP4-P6 samples were prepared as Health Grant GM49243 (to D. H.) and Training Grant in Biotechnology 5T32GM008412 (to M. G.).	Akiyama BM, 2009, METHOD ENZYMOL, V469, P27, DOI 10.1016/S0076-6879(09)69002-9; Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Al-Hashimi HM, 2003, J MOL BIOL, V329, P867, DOI 10.1016/S0022-2836(03)00517-5; Andrus A., 2001, CURR PROTOC NUCL ACI; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cappe O., 2005, SPR S STAT; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chu VB, 2009, RNA, V15, P2195, DOI 10.1261/rna.1747509; Das R, 2005, J AM CHEM SOC, V127, P8272, DOI 10.1021/ja051422h; Deras ML, 2000, BIOCHEMISTRY-US, V39, P10975, DOI 10.1021/bi0010118; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Elenko MP, 2009, J AM CHEM SOC, V131, P9866, DOI 10.1021/ja901880v; FRILANDER MJ, 2005, RNA LIGATION USING T; GARTLAND WJ, 1966, P NATL ACAD SCI USA, V55, P948, DOI 10.1073/pnas.55.4.948; Juneau K, 1999, RNA, V5, P1119, DOI 10.1017/S135583829999074X; Kobitski AY, 2007, NUCLEIC ACIDS RES, V35, P2047, DOI 10.1093/nar/gkm072; Lambert D, 2009, J MOL BIOL, V390, P791, DOI 10.1016/j.jmb.2009.04.083; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; Ma HR, 2006, J AM CHEM SOC, V128, P1523, DOI 10.1021/ja0553856; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MURPHY FL, 1993, BIOCHEMISTRY-US, V32, P5291, DOI 10.1021/bi00071a003; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan T, 1997, NAT STRUCT BIOL, V4, P931, DOI 10.1038/nsb1197-931; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; ROBERT FE, 2009, RNA METHODOLOGIES LA; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; Schlatterer JC, 2008, J MOL BIOL, V379, P859, DOI 10.1016/j.jmb.2008.04.013; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Silverman SK, 2001, RNA, V7, P161, DOI 10.1017/S1355838201001716; Solomatin S, 2009, METHOD ENZYMOL, V469, P47, DOI 10.1016/S0076-6879(09)69003-0; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Szewczak AA, 1997, RNA, V3, P838; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Takamoto K, 2002, NAT STRUCT BIOL, V9, P928, DOI 10.1038/nsb871; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Travers KJ, 2007, RNA, V13, P1205, DOI 10.1261/rna.566007; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Van Orden A, 2008, BIOPOLYMERS, V89, P1, DOI 10.1002/bip.20826; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Welch L. R., 2003, IEEE INFORM THEORY S, V53; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; Xie Z, 2004, P NATL ACAD SCI USA, V101, P534, DOI 10.1073/pnas.2636333100; Young BT, 2002, BIOCHEMISTRY-US, V41, P12271, DOI 10.1021/bi0264869; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	61	31	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19872	19879		10.1074/jbc.M111.235465	http://dx.doi.org/10.1074/jbc.M111.235465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478155	Green Published, hybrid			2022-12-27	WOS:000291027700067
J	Hosoyama, T; Nishijo, K; Prajapati, SI; Li, GH; Keller, C				Hosoyama, Tohru; Nishijo, Koichi; Prajapati, Suresh I.; Li, Guangheng; Keller, Charles			Rb1 Gene Inactivation Expands Satellite Cell and Postnatal Myoblast Pools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; STEM-CELLS; PROTEIN PHOSPHATASE-1; EXPRESSION; PROLIFERATION; TAUTOMYCETIN; INHIBITOR; PRB; DIFFERENTIATION; SPECIFICATION	Satellite cells are well known as a postnatal skeletal muscle stem cell reservoir that under injury conditions participate in repair. However, mechanisms controlling satellite cell quiescence and activation are the topic of ongoing inquiry by many laboratories. In this study, we investigated whether loss of the cell cycle regulatory factor, pRb, is associated with the re-entry of quiescent satellite cells into replication and subsequent stem cell expansion. By ablation of Rb1 using a Pax7CreER, Rb1 conditional mouse line, satellite cell number was increased 5-fold over 6 months. Furthermore, myoblasts originating from satellite cells lacking Rb1 were also increased 3-fold over 6 months, while terminal differentiation was greatly diminished. Similarly, Pax7CreER, Rb1 mice exhibited muscle fiber hypotrophy in vivo under steady state conditions as well as a delay of muscle regeneration following cardiotoxin-mediated injury. These results suggest that cell cycle re-entry of quiescent satellite cells is accelerated by lack of Rb1, resulting in the expansion of both satellite cells and their progeny in adolescent muscle. Conversely, that sustained Rb1 loss in the satellite cell lineage causes a deficit of muscle fiber formation. However, we also show that pharmacological inhibition of protein phosphatase 1 activity, which will result in pRb inactivation accelerates satellite cell activation and/or expansion in a transient manner. Together, our results raise the possibility that reversible pRb inactivation in satellite cells and inhibition of protein phosphorylation may provide a new therapeutic tool for muscle atrophy by short term expansion of the muscle stem cells and myoblast pool.	[Keller, Charles] Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97239 USA; [Hosoyama, Tohru; Nishijo, Koichi; Prajapati, Suresh I.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio	Keller, C (corresponding author), Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Pape Family Pediat Res Inst, Dept Pediat, 3181 SW Sam Jackson Pk Rd,MC L321, Portland, OR 97239 USA.	keller@ohsu.edu	Hosoyama, Tohru/ABA-2797-2021	Keller, Charles/0000-0003-2505-7487; Hosoyama, Tohru/0000-0002-1825-6923	Doernbecher Children's Hospital Foundation	Doernbecher Children's Hospital Foundation	This study was supported by start-up funds (to C. K.) from the Doernbecher Children's Hospital Foundation.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; CORBEIL HB, 1995, ONCOGENE, V11, P909; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Hosoyama Tohru, 2010, Genes Cancer, V1, P388; Hosoyama T, 2009, DIFFERENTIATION, V77, P350, DOI 10.1016/j.diff.2008.11.001; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; ISHIDA Y, 1992, J CELL PHYSIOL, V150, P484, DOI 10.1002/jcp.1041500308; Jiang Z, 2000, DEV BIOL, V227, P28, DOI 10.1006/dbio.2000.9892; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee JH, 2006, MOL CANCER THER, V5, P3222, DOI 10.1158/1535-7163.MCT-06-0455; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Leshem Y, 2002, J CELL PHYSIOL, V191, P173, DOI 10.1002/jcp.10089; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; Lussac J, 1980, Rev Odontostomatol Midi Fr, V38, P113; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Peschiaroli A, 2002, ONCOGENE, V21, P8114, DOI 10.1038/sj.onc.1206010; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051	45	31	33	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19556	19564		10.1074/jbc.M111.229542	http://dx.doi.org/10.1074/jbc.M111.229542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478154	Green Published, hybrid			2022-12-27	WOS:000291027700039
J	Kitadokoro, K; Nishimura, K; Kamitani, S; Fukui-Miyazaki, A; Toshima, H; Abe, H; Kamata, Y; Sugita-Konishi, Y; Yamamoto, S; Karatani, H; Horiguchi, Y				Kitadokoro, Kengo; Nishimura, Kousuke; Kamitani, Shigeki; Fukui-Miyazaki, Aya; Toshima, Hirono; Abe, Hiroyuki; Kamata, Yoichi; Sugita-Konishi, Yoshiko; Yamamoto, Shigeki; Karatani, Hajime; Horiguchi, Yasuhiko			Crystal Structure of Clostridium perfringens Enterotoxin Displays Features of beta-Pore-forming Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; SITE-DIRECTED MUTAGENESIS; TRANSMEMBRANE PORE; RECEPTOR-BINDING; MEMBRANE-CHANNEL; PROTEIN TOXINS; TIGHT JUNCTION; AEROLYSIN; CLAUDIN-4; REGION	Clostridium perfringens enterotoxin (CPE) is a cause of food poisoning and is considered a pore-forming toxin, which damages target cells by disrupting the selective permeability of the plasma membrane. However, the pore-forming mechanism and the structural characteristics of the pores are not well documented. Here, we present the structure of CPE determined by x-ray crystallography at 2.0A. The overall structure of CPE displays an elongated shape, composed of three distinct domains, I, II, and III. Domain I corresponds to the region that was formerly referred to as C-CPE, which is responsible for binding to the specific receptor claudin. Domains II and III comprise a characteristic module, which resembles those of beta-pore-forming toxins such as aerolysin, C. perfringens epsilon-toxin, and Laetiporus sulfureus hemolytic pore-forming lectin. The module is mainly made up of beta-strands, two of which span its entire length. Domain II and domain III have three short beta-strands each, by which they are distinguished. In addition, domain II has an alpha-helix lying on the beta-strands. The sequence of amino acids composing the alpha-helix and preceding beta-strand demonstrates an alternating pattern of hydrophobic residues that is characteristic of transmembrane domains forming beta-barrel-made pores. These structural features imply that CPE is a beta-pore-forming toxin. We also hypothesize that the transmembrane domain is inserted into the membrane upon the buckling of the two long beta-strands spanning the module, a mechanism analogous to that of the cholesterol-dependent cytolysins.	[Kamitani, Shigeki; Fukui-Miyazaki, Aya; Toshima, Hirono; Abe, Hiroyuki; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Suita, Osaka 5650871, Japan; [Kitadokoro, Kengo; Nishimura, Kousuke; Karatani, Hajime] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Kamata, Yoichi; Sugita-Konishi, Yoshiko] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan; [Yamamoto, Shigeki] Natl Inst Hlth Sci, Div Biomed Food Res, Setagaya Ku, Tokyo 1588501, Japan	Osaka University; Kyoto Institute of Technology; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Horiguchi, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	horiguti@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Kamitani, Shigeki/0000-0002-1268-4652	Ministry of Education, Culture, Science, and Technology of Japan; Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China); Grants-in-Aid for Scientific Research [23121515] Funding Source: KAKEN	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Science, and Technology of Japan.; We thank Dr. K. Matoba and Prof. S. Harada of the Kyoto Institute Technology and Dr. E. Yamashita, Dr. Y. Umena, and Prof. A. Nakagawa of SPring-8 BL44XU for help with the X-ray data collection. Diffraction data were collected at the Osaka University beamline BL44XU at SPring-8 equipped with MX225-HE (Rayonix), which is supported financially by the Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China). We also appreciate the secretarial and technical assistance of T. Suzuki and M. Kobayashi.	Briggs DC, 2010, ACTA CRYSTALLOGR F, V66, P794, DOI 10.1107/S1744309110016507; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Ebihara C, 2007, BIOCHEM PHARMACOL, V73, P824, DOI 10.1016/j.bcp.2006.11.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRANUM PE, 1985, J FOOD BIOCHEM, V9, P137, DOI 10.1111/j.1745-4514.1985.tb00344.x; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; HORIGUCHI Y, 1987, INFECT IMMUN, V55, P2912, DOI 10.1128/IAI.55.12.2912-2915.1987; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kokai-Kun JF, 1999, INFECT IMMUN, V67, P5634, DOI 10.1128/IAI.67.11.5634-5641.1999; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2009, J MOL BIOL, V385, P1193, DOI 10.1016/j.jmb.2008.11.039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Sekiya K, 1996, J BACTERIOL, V178, P6998, DOI 10.1128/jb.178.23.6998-7002.1996; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Smedley JG, 2004, INFECT IMMUN, V72, P6914, DOI 10.1128/IAI.72.12.6914-6923.2004; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x	41	77	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19549	19555		10.1074/jbc.M111.228478	http://dx.doi.org/10.1074/jbc.M111.228478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489981	Green Published, hybrid			2022-12-27	WOS:000291027700038
J	Lindsey-Boltz, LA; Sancar, A				Lindsey-Boltz, Laura A.; Sancar, Aziz			Tethering DNA Damage Checkpoint Mediator Proteins Topoisomerase II beta-binding Protein 1 (TopBP1) and Claspin to DNA Activates Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Phosphorylation of Checkpoint Kinase 1 (Chk1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEATED PHOSPHOPEPTIDE MOTIFS; EXCISION-REPAIR; ABSENCE; RECONSTITUTION; SYSTEM; BREAKS; CELLS	The ataxia-telangiectasia mutated and RAD3-related (ATR) kinase initiates DNA damage signaling pathways in human cells after DNA damage such as that induced upon exposure to ultraviolet light by phosphorylating many effector proteins including the checkpoint kinase Chk1. The conventional view of ATR activation involves a universal signal consisting of genomic regions of replication protein A-covered single-stranded DNA. However, there are some indications that the ATR-mediated checkpoint can be activated by other mechanisms. Here, using the well defined Escherichia coli lac repressor/operator system, we have found that directly tethering the ATR activator topoisomerase II beta-binding protein 1 (TopBP1) to DNA is sufficient to induce ATR phosphorylation of Chk1 in an in vitro system as well as in vivo in mammalian cells. In addition, we find synergistic activation of ATR phosphorylation of Chk1 when the mediator protein Claspin is also tethered to the DNA with TopBP1. Together, these findings indicate that crowding of checkpoint mediator proteins on DNA is sufficient to activate the ATR kinase.	[Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833( to A. S.).	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; RIGGS AD, 1970, J MOL BIOL, V51, P303, DOI 10.1016/0022-2836(70)90144-0; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	29	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19229	19236		10.1074/jbc.M111.237958	http://dx.doi.org/10.1074/jbc.M111.237958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502314	hybrid, Green Published			2022-12-27	WOS:000291027700005
J	Yadav, AK; Bachhawat, AK				Yadav, Amit Kumar; Bachhawat, Anand Kumar			CgCYN1, a Plasma Membrane Cystine-specific Transporter of Candida glabrata with Orthologues Prevalent among Pathogenic Yeast and Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATIN DECOMPOSITION; GENE DISRUPTION; ACID; GLUTATHIONE; DERMATOPHYTES; BIOSYNTHESIS; EXPRESSION; EVOLUTION; EXCHANGE; SEQUENCE	We describe a novel plasma membrane cystine transporter, CgCYN1, from Candida glabrata, the first such transporter to be described from yeast and fungi. C. glabrata met15 Delta strains, organic sulfur auxotrophs, were observed to utilize cystine as a sulfur source, and this phenotype was exploited in the discovery of CgCYN1. Heterologous expression of CgCYN1 in Saccharomyces cerevisiae met15 Delta strains conferred the ability of S. cerevisiae strains to grow on cystine. Deletion of the CgCYN1 ORF (CAGL0M00154g) in C. glabrata met15 Delta strains caused abrogation of growth on cystine with growth being restored when CgCYN1 was reintroduced. The CgCYN1 protein belongs to the amino acid permease family of transporters, with no similarity to known plasma membrane cystine transporters of bacteria and humans, or lysosomal cystine transporters of humans/yeast. Kinetic studies revealed a K-m of 18 +/- 5 mu M for cystine. Cystine uptake was inhibited by cystine, but not by other amino acids, including cysteine. The structurally similar cystathionine, lanthionine, and selenocystine alone inhibited transport, confirming that the transporter was specific for cystine. CgCYN1 localized to the plasma membrane and transport was energy-dependent. Functional orthologues could be demonstrated from other pathogenic yeast like Candida albicans and Histoplasma capsulatum, but were absent in Schizosaccharomyces pombe and S. cerevisiae.	[Bachhawat, Anand Kumar] Indian Inst Sci Educ & Res IISER Mohali, Chandigarh 160019, India; [Yadav, Amit Kumar; Bachhawat, Anand Kumar] CSIR, Inst Microbial Technol, Sector 39 A, Chandigarh 160036, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Sector 26, Mohali Transit Campus,MGSIPAP Complex, Chandigarh 160019, India.	anand@iisermohali.ac.in			Departments of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Departments of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was in part supported by a grant-in-aid project from the Departments of Science and Technology and the Department of Biotechnology, Government of India (to A. K. B.).; Recipient of a research fellowship from the Council of Scientific and Industrial Research, Government of India.	BANNAI S, 1986, J BIOL CHEM, V261, P2256; BAPTIST EW, 1977, J BACTERIOL, V131, P111, DOI 10.1128/JB.131.1.111-118.1977; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; BUTLER JD, 1993, LIFE SCI, V52, P1209, DOI 10.1016/0024-3205(93)90103-A; De Hertogh B, 2006, GENETICS, V172, P771, DOI 10.1534/genetics.105.046813; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Earley MC, 1996, GENE, V169, P111, DOI 10.1016/0378-1119(95)00805-5; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GILBERT B E, 1970, Infection and Immunity, V2, P139; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Kaur J, 2009, J BIOL CHEM, V284, P23872, DOI 10.1074/jbc.M109.029728; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; KUNERT J, 1976, Z ALLG MIKROBIOL, V16, P97, DOI 10.1002/jobm.3630160203; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Rajan DP, 2000, J BIOL CHEM, V275, P14331, DOI 10.1074/jbc.275.19.14331; Rajan DP, 1999, J BIOL CHEM, V274, P29005, DOI 10.1074/jbc.274.41.29005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; STAHL WH, 1949, ARCH BIOCHEM, V20, P422; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner MS, 1999, J BACTERIOL, V181, P2192, DOI 10.1128/JB.181.7.2192-2198.1999; Viaene J, 2000, YEAST, V16, P1205, DOI 10.1002/1097-0061(20000930)16:13&lt;1205::AID-YEA615&gt;3.0.CO;2-C; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0	28	12	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19714	19723		10.1074/jbc.M111.240648	http://dx.doi.org/10.1074/jbc.M111.240648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507960	Green Published, hybrid			2022-12-27	WOS:000291027700054
J	Barta, ML; Skaff, DA; McWhorter, WJ; Herdendorf, TJ; Miziorko, HM; Geisbrecht, BV				Barta, Michael L.; Skaff, D. Andrew; McWhorter, William J.; Herdendorf, Timothy J.; Miziorko, Henry M.; Geisbrecht, Brian V.			Crystal Structures of Staphylococcus epidermidis Mevalonate Diphosphate Decarboxylase Bound to Inhibitory Analogs Reveal New Insight into Substrate Binding and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INHERITED DISEASE; CHOLESTEROL-BIOSYNTHESIS; ACTIVE-SITE; KINASE; LIVER; MECHANISM; GALACTOKINASE; PURIFICATION; AUREUS; IDENTIFICATION	The polyisoprenoid compound undecaprenyl phosphate is required for biosynthesis of cell wall peptidoglycans in Gram-positive bacteria, including pathogenic Enterococcus, Streptococcus, and Staphylococcus spp. In these organisms, the mevalonate pathway is used to produce the precursor isoprenoid, isopentenyl 5-diphosphate. Mevalonate diphosphate decarboxylase (MDD) catalyzes formation of isopentenyl 5-diphosphate in an ATP-dependent irreversible reaction and is therefore an attractive target for inhibitor development that could lead to new antimicrobial agents. To facilitate exploration of this possibility, we report the crystal structure of Staphylococcus epidermidis MDD (1.85 angstrom resolution) and, to the best of our knowledge, the first structures of liganded MDD. These structures include MDD bound to the mevalonate 5-diphosphate analogs diphosphoglycolyl proline (2.05 angstrom resolution) and 6-fluoromevalonate diphosphate (FMVAPP; 2.2 angstrom resolution). Comparison of these structures provides a physical basis for the significant differences in K-i values observed for these inhibitors. Inspection of enzyme/inhibitor structures identified the side chain of invariant Ser(192) as making potential contributions to catalysis. Significantly, Ser -> Ala substitution of this side chain decreases k(cat) by similar to 10(3)-fold, even though binding interactions between FMVAPP and this mutant are similar to those observed with wild type MDD, as judged by the 2.1 angstrom cocrystal structure of S192A with FMVAPP. Comparison of microbial MDD structures with those of mammalian counterparts reveals potential targets at the active site periphery that may be exploited to selectively target the microbial enzymes. These studies provide a structural basis for previous observations regarding the MDD mechanism and inform future work toward rational inhibitor design.	[Skaff, D. Andrew; Herdendorf, Timothy J.; Miziorko, Henry M.] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Barta, Michael L.; McWhorter, William J.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Miziorko, HM (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	MiziorkoH@umkc.edu; GeisbrechtB@umkc.edu			National Institutes of Health [AI071028, AI090149]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028, R21AI090149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI071028 and AI090149.; We acknowledge the generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for comments on the manuscript. Drs. Imogen Wilding and William Hunter generously provided plasmids used for production and characterization of S. aureus MDD and T. brucei MDD, respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory. A list of supporting member institutions may be found on the SER-CAT website.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALVEAR M, 1982, BIOCHEMISTRY-US, V21, P4646, DOI 10.1021/bi00262a020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; Brons-Poulsen Jesper, 2002, Methods Mol Biol, V182, P71; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; CHIEW YE, 1987, BIOCHIM BIOPHYS ACTA, V916, P271, DOI 10.1016/0167-4838(87)90170-1; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; DeLano W.L, PYMOL MOL GRAPHICS S; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan CG, 2009, J BIOL CHEM, V284, P20240, DOI 10.1074/jbc.M109.027425; Fromm H J, 1979, Methods Enzymol, V63, P467; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; JABALQUINTO AM, 1989, BIOCHIM BIOPHYS ACTA, V996, P257, DOI 10.1016/0167-4838(89)90256-2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Krepkiy DV, 2005, BIOCHEMISTRY-US, V44, P2671, DOI 10.1021/bi0484217; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michihara A, 1997, J BIOCHEM, V122, P647; NAVE JF, 1985, BIOCHEM J, V227, P247, DOI 10.1042/bj2270247; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; REARDON JE, 1987, BIOCHEMISTRY-US, V26, P4717, DOI 10.1021/bi00389a018; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; Vlattas I, 1996, BIOORG MED CHEM LETT, V6, P2091, DOI 10.1016/0960-894X(96)00374-5; Voynova NE, 2008, ARCH BIOCHEM BIOPHYS, V480, P58, DOI 10.1016/j.abb.2008.08.024; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	50	28	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23900	23910		10.1074/jbc.M111.242016	http://dx.doi.org/10.1074/jbc.M111.242016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21561869	Green Published, hybrid			2022-12-27	WOS:000292294900032
J	Chang, AHK; Jeong, J; Levine, RL				Chang, Allen H. K.; Jeong, Jinsook; Levine, Rodney L.			Iron Regulatory Protein 2 Turnover through a Nonproteasomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; DEPENDENT DEGRADATION; ACONITASE ACTIVITY; MOLECULAR CONTROL; RNA-BINDING; CELL-DEATH; HOMEOSTASIS; IRP2; TRANSFERRIN; INHIBITION	Iron regulatory protein 2 (IRP2) controls the synthesis of many proteins involved in iron metabolism, and the level of IRP2 itself is regulated by varying the rate of its degradation. The proteasome is known to mediate degradation, with specificity conferred by an iron-sensing E3 ligase. Most studies on the degradation of IRP2 have employed cells overexpressing IRP2 and also rendered iron deficient to further increase IRP2 levels. We utilized a sensitive, quantitative assay for IRP2, which allowed study of endogenous IRP2 degradation in HEK293A cells under more physiologic conditions. We found that under these conditions, the proteasome plays only a minor role in the degradation of IRP2, with almost all the IRP2 being degraded by a nonproteasomal pathway. This new pathway is calcium-dependent but is not mediated by calpain. Elevating the cellular level of IRP2 by inducing iron deficiency or by transfection causes the proteasomal pathway to account for the major fraction of IRP2 degradation. We conclude that under physiological, iron-sufficient conditions, the steady-state level of IRP2 in HEK293A cells is regulated by the nonproteasomal pathway.	[Chang, Allen H. K.; Jeong, Jinsook; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), Bldg 50,Room 2351,MSC 8012, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011		NHLBI, National Institutes of Health [1Z01 HL000225]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006101, Z01HL000225] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the NHLBI, National Institutes of Health, (Project no. 1Z01 HL000225).	Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Dycke C, 2008, INT J BIOCHEM CELL B, V40, P2826, DOI 10.1016/j.biocel.2008.05.015; EVERS A, 1989, INORG CHEM, V28, P2189, DOI 10.1021/ic00310a035; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KARIN M, 1981, J BIOL CHEM, V256, P3245; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Landowski TH, 2005, CANCER RES, V65, P3828, DOI 10.1158/0008-5472.CAN-04-3684; Lee CS, 2005, BRAIN RES BULL, V67, P225, DOI 10.1016/j.brainresbull.2005.07.003; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; OCTAVE JN, 1979, FEBS LETT, V108, P127, DOI 10.1016/0014-5793(79)81193-X; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Van den Bosch L, 2002, NEUROPHARMACOLOGY, V42, P706, DOI 10.1016/S0028-3908(02)00010-2; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Zimmermann D, 2006, BIOCHEM BIOPH RES CO, V348, P673, DOI 10.1016/j.bbrc.2006.07.112	33	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23698	23707		10.1074/jbc.M110.216788	http://dx.doi.org/10.1074/jbc.M110.216788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558272	hybrid, Green Published			2022-12-27	WOS:000292294900011
J	Sardiu, ME; Washburn, MP				Sardiu, Mihaela E.; Washburn, Michael P.			Building Protein-Protein Interaction Networks with Proteomics and Informatics Tools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; TOPOLOGICAL FEATURES; INTERACTION MAP; CELL-CYCLE; COMPLEXES; YEAST; EXPRESSION; DISEASE	The systematic characterization of the whole interactomes of different model organisms has revealed that the eukaryotic proteome is highly interconnected. Therefore, biological research is progressively shifting away from classical approaches that focus only on a few proteins toward whole protein interaction networks to describe the relationship of proteins in biological processes. In this minireview, we survey the most common methods for the systematic identification of protein interactions and exemplify different strategies for the generation of protein interaction networks. In particular, we will focus on the recent development of protein interaction networks derived from quantitative proteomics data sets.	[Sardiu, Mihaela E.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Washburn, MP (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	mpw@stowers.org		Washburn, Michael/0000-0001-7568-2585	Stowers Institute for Medical Research	Stowers Institute for Medical Research	This work was supported by the Stowers Institute for Medical Research. This is the fourth article in the Thematic Minireview Series on Computational Systems Biology. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chang IF, 2006, PROTEOMICS, V6, P6158, DOI 10.1002/pmic.200600225; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kline Kelli G., 2009, Briefings in Functional Genomics & Proteomics, V8, P114, DOI 10.1093/bfgp/elp008; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pijnappel WWMP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-46; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sardiu ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007310; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang B, 2008, BIOINFORMATICS, V24, P979, DOI 10.1093/bioinformatics/btn036; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	48	46	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23645	23651		10.1074/jbc.R110.174052	http://dx.doi.org/10.1074/jbc.R110.174052			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566121	Green Published, hybrid			2022-12-27	WOS:000292294900005
J	Fort, AG; Murray, JW; Dandachi, N; Davidson, MW; Dermietzel, R; Wolkoff, AW; Spray, DC				Fort, Alfredo G.; Murray, John W.; Dandachi, Nadine; Davidson, Michael W.; Dermietzel, Rolf; Wolkoff, Allan W.; Spray, David C.			In Vitro Motility of Liver Connexin Vesicles along Microtubules Utilizes Kinesin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION FORMATION; ENDOCYTIC VESICLES; DEPENDENT MOVEMENT; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TRAFFICKING; TRANSPORT; PATHWAYS; PROTEINS; CHANNELS	Trafficking of the proteins that form gap junctions (connexins) from the site of synthesis to the junctional domain appears to require cytoskeletal delivery mechanisms. Although many cell types exhibit specific delivery of connexins to polarized cell sites, such as connexin32 (Cx32) gap junctions specifically localized to basolateral membrane domains of hepatocytes, the precise roles of actin-and tubulin-based systems remain unclear. We have observed fluorescently tagged Cx32 trafficking linearly at speeds averaging 0.25 mu m/s in a polarized hepatocyte cell line (WIF-B9), which is abolished by 50 mu M of the microtubule-disrupting agent nocodazole. To explore the involvement of cytoskeletal components in the delivery of connexins, we have used a preparation of isolated Cx32-containing vesicles from rat hepatocytes and assayed their ATP-driven motility along stabilized rhodamine-labeled microtubules in vitro. These assays revealed the presence of Cx32 and kinesin motor proteins in the same vesicles. The addition of 50 mu M ATP stimulated vesicle motility along linear microtubule tracks with velocities of 0.4-0.5 mu m/s, which was inhibited with 1 mM of the kinesin inhibitor AMP-PNP (adenylyl-imidodiphosphate) and by anti-kinesin antibody but only minimally affected by 5 mu M vanadate, a dynein inhibitor, or by anti-dynein antibody. These studies provide evidence that Cx32 can be transported intracellularly along microtubules and presumably to junctional domains in cells and highlight an important role of kinesin motor proteins in microtubule-dependent motility of Cx32.	[Fort, Alfredo G.; Dandachi, Nadine; Spray, David C.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Murray, John W.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Dermietzel, Rolf] Ruhr Univ Bochum, D-44801 Bochum, Germany	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Ruhr University Bochum	Spray, DC (corresponding author), 1300 Morris Pk Ave,Kennedy 830, Bronx, NY 10461 USA.	david.spray@einstein.yu.edu		Spray, David/0000-0001-8368-5073	National Institutes of Health [DK41918]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK41918 (to D. C. S. and A. W. W.).	Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; George CH, 1999, J BIOL CHEM, V274, P8678, DOI 10.1074/jbc.274.13.8678; Giessmann D, 2005, ANAT EMBRYOL, V209, P391, DOI 10.1007/s00429-005-0456-z; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Guo YH, 2004, CHEST, V125, p110S, DOI 10.1378/chest.125.5_suppl.110S-a; Harrison RE, 1997, CELL MOTIL CYTOSKEL, V36, P355, DOI 10.1002/(SICI)1097-0169(1997)36:4<355::AID-CM5>3.0.CO;2-4; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 2001, J CELL SCI, V114, P763; KOBAYASHI T, 1978, BIOCHEM BIOPH RES CO, V81, P1313, DOI 10.1016/0006-291X(78)91279-2; Kojima T, 2009, HISTOL HISTOPATHOL, V24, P1463, DOI 10.14670/HH-24.1463; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; LEOPOLD PL, 1992, CELL MOTIL CYTOSKEL, V23, P19, DOI 10.1002/cm.970230104; Manders M. M., 1993, J MICROSC-OXFORD, V169, P375; Martin PEM, 2001, J CELL SCI, V114, P3845; Maza J, 2005, J BIOL CHEM, V280, P21115, DOI 10.1074/jbc.M412612200; MELLER K, 1981, ANAT EMBRYOL, V163, P321, DOI 10.1007/BF00315708; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; Murray JW, 2002, ANAL BIOCHEM, V305, P55, DOI 10.1006/abio.2002.5655; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Paulson AF, 2000, J CELL SCI, V113, P3037; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; WANG YJ, 1995, J CELL SCI, V108, P3501; YOUSON JH, 1983, ANAT EMBRYOL, V167, P379, DOI 10.1007/BF00315676	36	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22875	22885		10.1074/jbc.M111.219709	http://dx.doi.org/10.1074/jbc.M111.219709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536677	hybrid, Green Published			2022-12-27	WOS:000292025000022
J	Tae, HS; Cui, YF; Karunasekara, Y; Board, PG; Dulhunty, AF; Casarotto, MG				Tae, Han-Shen; Cui, Yanfang; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.			Cyclization of the Intrinsically Disordered alpha(1S) Dihydropyridine Receptor II-III Loop Enhances Secondary Structure and in Vitro Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL RYANODINE RECEPTORS; RELEASE CHANNELS; CYTOPLASMIC LOOP; MINI-INTEINS; SPRY DOMAIN; C-REGION; MUSCLE; CONTRACTION; SEQUENCE; CALSEQUESTRIN	A key component of excitation contraction (EC) coupling in skeletal muscle is the cytoplasmic linker (II-III loop) between the second and third transmembrane repeats of the alpha(1S) subunit of the dihydropyridine receptor (DHPR). The II-III loop has been previously examined in vitro using a linear II-III loop with unrestrained N- and C-terminal ends. To better reproduce the loop structure in its native environment (tethered to the DHPR transmembrane domains), we have joined the N- and C termini using intein-mediated technology. Circular dichroism and NMR spectroscopy revealed a structural shift in the cyclized loop toward a protein with increased alpha-helical and beta-strand structure in a region of the loop implicated in its in vitro function and also in a critical region for EC coupling. The affinity of binding of the II-III loop binding to the SPRY2 domain of the skeletal ryanodine receptor (RyR1) increased 4-fold, and its ability to activate RyR1 channels in lipid bilayers was enhanced 3-fold by cyclization. These functional changes were predicted consequences of the structural enhancement. We suggest that tethering the N- and C termini stabilized secondary structural elements in the DHPR II-III loop and may reflect structural and dynamic characteristics of the loop that are inherent in EC coupling.	[Tae, Han-Shen; Cui, Yanfang; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Casarotto, MG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Dulhunty, Angela/AAO-5421-2020; Tae, Han-Shen/AAA-1904-2020; Casarotto, Marco/D-8704-2011	Tae, Han-Shen/0000-0001-8961-7194; Dulhunty, Angela/0000-0001-9493-4944; Casarotto, Marco/0000-0002-0571-7671; Cui, Yanfang/0000-0002-1041-9097	National Health and Medical Research Council [471418]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Grant 471418.	Ahern CA, 2001, BIOPHYS J, V81, P3294, DOI 10.1016/S0006-3495(01)75963-2; Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Casarotto MG, 2000, J BIOL CHEM, V275, P11631, DOI 10.1074/jbc.275.16.11631; Casarotto MG, 2001, BIOPHYS J, V80, P2715, DOI 10.1016/S0006-3495(01)76240-6; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Dulhunty AF, 2005, FRONT BIOSCI, V10, P1368, DOI 10.2741/1626; Dulhunty AF, 2005, BIOCHEM J, V385, P803, DOI 10.1042/BJ20041152; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; ELHAYEK R, 1995, J BIOL CHEM, V270, P22116, DOI 10.1074/jbc.270.38.22116; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Green D, 2003, BIOCHEM J, V370, P517, DOI 10.1042/BJ20021488; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Kugler G, 2004, ARCH BIOCHEM BIOPHYS, V427, P91, DOI 10.1016/j.abb.2004.04.007; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P7791, DOI 10.1074/jbc.273.14.7791; LU XY, 1994, J BIOL CHEM, V269, P6511; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Oddoux S, 2009, J BIOL CHEM, V284, P34918, DOI 10.1074/jbc.M109.022442; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shrivastava IH, 2004, BIOPHYS J, V87, P2255, DOI 10.1529/biophysj.104.040592; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Stange M, 2001, BIOPHYS J, V81, P1419, DOI 10.1016/S0006-3495(01)75797-9; Tae HS, 2009, CLIN EXP PHARMACOL P, V36, P346, DOI 10.1111/j.1440-1681.2008.05130.x; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098; Williams NK, 2005, J MOL BIOL, V346, P1095, DOI 10.1016/j.jmb.2004.12.037; Williams NK, 2002, J BIOL CHEM, V277, P7790, DOI 10.1074/jbc.M110303200; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5	49	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22589	22599		10.1074/jbc.M110.205476	http://dx.doi.org/10.1074/jbc.M110.205476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525002	Green Published, hybrid			2022-12-27	WOS:000291719900066
J	Talfournier, F; Stines-Chaumeil, C; Branlant, G				Talfournier, Francois; Stines-Chaumeil, Claire; Branlant, Guy			Methylmalonate-semialdehyde Dehydrogenase from Bacillus subtilis SUBSTRATE SPECIFICITY AND COENZYME A BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; SITE-DIRECTED MUTAGENESIS; STREPTOCOCCUS-MUTANS; PSEUDOMONAS-AERUGINOSA; CATALYTIC MECHANISM; STEADY-STATE; ACTIVE-SITE; RAT-LIVER; DEFICIENCY	Methylmalonate-semialdehyde dehydrogenase (MSDH) belongs to the CoA-dependent aldehyde dehydrogenase subfamily. It catalyzes the NAD-dependent oxidation of methylmalonate semialdehyde (MMSA) to propionyl-CoA via the acylation and deacylation steps. MSDH is the only member of the aldehyde dehydrogenase superfamily that catalyzes a beta-decarboxylation process in the deacylation step. Recently, we demonstrated that the beta-decarboxylation is rate-limiting and occurs before CoA attack on the thiopropionyl enzyme intermediate. Thus, this prevented determination of the transthioesterification kinetic parameters. Here, we have addressed two key aspects of the mechanism as follows: 1) the molecular basis for recognition of the carboxylate of MMSA; and 2) how CoA binding modulates its reactivity. We substituted two invariant arginines, Arg-124 and Arg-301, by Leu. The second-order rate constant for the acylation step for both mutants was decreased by at least 50-fold, indicating that both arginines are essential for efficient MMSA binding through interactions with the carboxylate group. To gain insight into the transthioesterification, we substituted MMSA with propionaldehyde, as both substrates lead to the same thiopropionyl enzyme intermediate. This allowed us to show the following: 1) the pK(app) of CoA decreases by similar to 3 units upon binding to MSDH in the deacylation step; and 2) the catalytic efficiency of the transthioesterification is increased by at least 10(4)-fold relative to a chemical model. Moreover, we observed binding of CoA to the acylation complex, supporting a CoA-binding site distinct from that of NAD(H).	[Talfournier, Francois; Stines-Chaumeil, Claire; Branlant, Guy] Nancy Univ, Fac Sci & Technol, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS,Univ Henri Poincare AREMS 7, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Talfournier, F (corresponding author), Nancy Univ, Fac Sci & Technol, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS,Univ Henri Poincare AREMS 7, Bd Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	francois.talfournier@maem.uhp-nancy.fr; guy.branlant@maem.uhp-nancy.fr			CNRS; University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine(Region Grand-Est); French Research Ministry(Ministry of Research, France)	This work was supported in part by the CNRS, the University of Nancy I, the Institut Federatif de Recherche 111 Bioingenierie, and local funds from the Region Lorraine.; Supported by the French Research Ministry.	BANNERJEE D, 1970, J BIOL CHEM, V245, P1828; BRADBURY SL, 1971, J BIOL CHEM, V246, P1834; Chambliss KL, 2000, J INHERIT METAB DIS, V23, P497, DOI 10.1023/A:1005616315087; CHASE JFA, 1966, BIOCHEM BIOPH RES CO, V23, P208, DOI 10.1016/0006-291X(66)90529-8; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fry J, 2001, MOL PLANT MICROBE IN, V14, P1016, DOI 10.1094/MPMI.2001.14.8.1016; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; GRAY RGF, 1987, BIOCHEM MED METAB B, V38, P121, DOI 10.1016/0885-4505(87)90069-7; HUPE DJ, 1977, J AM CHEM SOC, V99, P451, DOI 10.1021/ja00444a023; JOCELYN PC, 1972, BIOCH SH GROUP; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; KUPIECKI FP, 1960, BIOCH PREP, V7, P69; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MACGIBBON AKH, 1977, BIOCHEM J, V167, P469, DOI 10.1042/bj1670469; Marchal S, 2002, J BIOL CHEM, V277, P39235, DOI 10.1074/jbc.M205633200; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; Roe CR, 1998, MOL GENET METAB, V65, P35, DOI 10.1006/mgme.1998.2737; SHONE CC, 1981, BIOCHEMISTRY-US, V20, P7494, DOI 10.1021/bi00529a026; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; STEELE MI, 1992, J BIOL CHEM, V267, P13585; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tanaka N, 2005, J PROTEOME RES, V4, P1575, DOI 10.1021/pr050114f; VALLARI RC, 1981, ARCH BIOCHEM BIOPHYS, V212, P9, DOI 10.1016/0003-9861(81)90338-6; Vedadi M, 1997, EUR J BIOCHEM, V246, P698, DOI 10.1111/j.1432-1033.1997.t01-1-00698.x; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Zhang YX, 1996, J BACTERIOL, V178, P490, DOI 10.1128/jb.178.2.490-495.1996	31	24	26	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21971	21981		10.1074/jbc.M110.213280	http://dx.doi.org/10.1074/jbc.M110.213280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515690	Green Published, hybrid			2022-12-27	WOS:000291719900004
J	Guzik-Lendrum, S; Nagy, A; Takagi, Y; Houdusse, A; Sellers, JR				Guzik-Lendrum, Stephanie; Nagy, Attila; Takagi, Yasuharu; Houdusse, Anne; Sellers, James R.			Drosophila melanogaster Myosin-18 Represents a Highly Divergent Motor with Actin Tethering Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM MYOSIN; TUMOR-SUPPRESSOR GENE; SKELETAL-MUSCLE MYOSIN; KINETIC MECHANISM; ADENOSINE-TRIPHOSPHATASE; HEAVY-MEROMYOSIN; BINDING DOMAIN; SMOOTH-MUSCLE; IN-VITRO; ACTOMYOSIN	The gene encoding Drosophila myosin-18 is complex and can potentially yield six alternatively spliced mRNAs. One of the major features of this myosin is an N-terminal PDZ domain that is included in some of the predicted alternatively spliced products. To explore the biochemical properties of this protein, we engineered two minimal motor domain (MMD)-like constructs, one that contains the N-terminal PDZ (myosin-18 M-PDZ) domain and one that does not (myosin-18 M-Delta PDZ). These two constructs were expressed in the baculovirus/Sf9 system. The results suggest that Drosophila myosin-18 is highly divergent from most other myosins in the superfamily. Neither of the MMD constructs had an actin-activated MgATPase activity, nor did they even bind ATP. Both myosin-18 M-PDZ and M-Delta PDZ proteins bound to actin with K-d values of 2.61 and 1.04 mu M, respectively, but only about 50-75% of the protein bound to actin even at high actin concentrations. Unbound proteins from these actin binding assays reiterated the 60% saturation maximum, suggesting an equilibrium between actin-binding and non-actin-binding conformations of Drosophila myosin-18 in vitro. Neither the binding affinity nor the substoichiometric binding was significantly affected by ATP. Optical trapping of single molecules in three-bead assays showed short lived interactions of the myosin-18 motors with actin filaments. Combined, these data suggest that this highly divergent motor may function as an actin tethering protein.	[Guzik-Lendrum, Stephanie; Nagy, Attila; Takagi, Yasuharu; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Guzik-Lendrum, Stephanie] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Houdusse, Anne] Inst Curie CNRS, UMR144, F-75248 Paris 05, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov			NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health intramural funds from the NHLBI.	Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; BATTERS C, 2004, J BIOL CHEM, V359, P1895; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Harlow E., 2006, COLD SPRING HARB PRO, V2006; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; HEMMINGS L, 1996, P NATL ACAD SCI USA, V109, P2715; HOMSHER E, 1992, J AM PHYSL, V262, pC714; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; JANSON LW, 1992, CELL MOTIL CYTOSKEL, V22, P274, DOI 10.1002/cm.970220407; Kempler K, 2007, BIOCHEMISTRY-US, V46, P4280, DOI 10.1021/bi062112u; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Nakano T, 2005, GENE CHROMOSOME CANC, V43, P162, DOI 10.1002/gcc.20180; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1997, BIOCHEMISTRY-US, V36, P3767, DOI 10.1021/bi9630772; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rio D. C., 2010, COLD SPRING HARB PRO; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sellers J. R., 1999, MYOSINS; Sellers JR, 1996, J MUSCLE RES CELL M, V17, P7, DOI 10.1007/BF00140320; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; WINDER SJ, 1995, J CELL SCI, V108, P63; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Yanaihara N, 2004, INT J CANCER, V112, P150, DOI 10.1002/ijc.20339; Zolkiewski M, 1996, BIOPHYS CHEM, V59, P365, DOI 10.1016/0301-4622(95)00129-8	55	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21755	21766		10.1074/jbc.M111.218669	http://dx.doi.org/10.1074/jbc.M111.218669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498886	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000291464700071
J	Luoto, HH; Belogurov, GA; Baykov, AA; Lahti, R; Malinen, AM				Luoto, Heidi H.; Belogurov, Georgiy A.; Baykov, Alexander A.; Lahti, Reijo; Malinen, Anssi M.			Na+-translocating Membrane Pyrophosphatases Are Widespread in the Microbial World and Evolutionarily Precede H+-translocating Pyrophosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; SEQUENCE; EXPRESSION; SODIUM; PPASE; ARABIDOPSIS; GENE	Membrane pyrophosphatases (PPases), divided into K+-dependent and K+-independent subfamilies, were believed to pump H+ across cell membranes until a recent demonstration that some K+-dependent PPases function as Na+ pumps. Here, we have expressed seven evolutionarily important putative PPases in Escherichia coli and estimated their hydrolytic, Na+ transport, and H+ transport activities as well as their K+ and Na+ requirements in inner membrane vesicles. Four of these enzymes (from Anaerostipes caccae, Chlorobium limicola, Clostridium tetani, and Desulfuromonas acetoxidans) were identified as K+-dependent Na+ transporters. Phylogenetic analysis led to the identification of a monophyletic clade comprising characterized and predicted Na+-transporting PPases (Na+-PPases) within the K+-dependent subfamily. H+-transporting PPases (H+-PPases) are more heterogeneous and form at least three independent clades in both subfamilies. These results suggest that rather than being a curious rarity, Na+-PPases predominantly constitute the K+-dependent subfamily. Furthermore, Na+-PPases possibly preceded H+-PPases in evolution, and transition from Na+ to H+ transport may have occurred in several independent enzyme lineages. Site-directed mutagenesis studies facilitated the identification of a specific Glu residue that appears to be central in the transport mechanism. This residue is located in the cytoplasm-membrane interface of transmembrane helix 6 in Na+-PPases but shifted to within the membrane or helix 5 in H+-PPases. These results contribute to the prediction of the transport specificity and K+ dependence for a particular membrane PPase sequence based on its position in the phylogenetic tree, identity of residues in the K+ dependence signature, and position of the membrane-located Glu residue.	[Luoto, Heidi H.; Belogurov, Georgiy A.; Lahti, Reijo; Malinen, Anssi M.] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland; [Baykov, Alexander A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	University of Turku; Lomonosov Moscow State University	Malinen, AM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Vatselankatu 2, FIN-20014 Turku, Finland.	anssi.malinen@utu.fi	Baykov, Alexander A/C-7981-2012; Baykov, Alexander/AAH-5301-2021	Belogurov, Georgiy/0000-0002-3070-6843; Malinen, Anssi/0000-0003-2987-2649; Baykov, Alexander/0000-0002-2495-8200	Academy of Finland [114706, 130581, 139031]; Ministry of Education of Finland; Russian Foundation for Basic Research [09-04-00869]	Academy of Finland(Academy of Finland); Ministry of Education of Finland; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by Academy of Finland Grants 114706, 130581, and 139031; a grant from the Ministry of Education of Finland (for the National Graduate School in Informational and Structural Biology); and Russian Foundation for Basic Research Grant 09-04-00869.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baumer Sebastian, 2002, Archaea, V1, P1, DOI 10.1155/2002/371325; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; Biegel E, 2011, J BIOL CHEM, V286, P6080, DOI 10.1074/jbc.M110.192823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2008, CURR PHARM DESIGN, V14, P882, DOI 10.2174/138161208784041079; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukuda A, 2006, PLANT PHYSIOL BIOCH, V44, P351, DOI 10.1016/j.plaphy.2006.06.012; Garcia-Contreras R, 2004, J BACTERIOL, V186, P6651, DOI 10.1128/JB.186.19.6651-6655.2004; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lopez-Marques RL, 2004, J BACTERIOL, V186, P5418, DOI 10.1128/JB.186.16.5418-5426.2004; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; MOYLE J, 1972, FEBS LETT, V23, P233, DOI 10.1016/0014-5793(72)80349-1; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Mulkidjanian AY, 2009, TRENDS BIOCHEM SCI, V34, P206, DOI 10.1016/j.tibs.2009.01.005; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JA, 2011, PLANT PHYSIOL BIOCH, V49, P33, DOI 10.1016/j.plaphy.2010.09.014; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	53	42	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21633	21642		10.1074/jbc.M111.244483	http://dx.doi.org/10.1074/jbc.M111.244483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527638	hybrid, Green Published			2022-12-27	WOS:000291464700060
J	Masuho, I; Wakasugi-Masuho, H; Posokhova, EN; Patton, JR; Martemyanov, KA				Masuho, Ikuo; Wakasugi-Masuho, Hideko; Posokhova, Ekaterina N.; Patton, Joseph R.; Martemyanov, Kirill A.			Type 5 G Protein beta Subunit (G beta 5) Controls the Interaction of Regulator of G Protein Signaling 9 (RGS9) with Membrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; DEP DOMAIN; PROTEOLYTIC STABILITY; MICE LACKING; EXPRESSION; R7BP; COMPLEX; R9AP; LOCALIZATION; RECEPTOR	The R7 family of regulators of G protein signaling (RGS) proteins, comprising RGS6, RGS7, RGS9, and RGS11, regulate neuronal G protein signaling pathways. All members of the R7 RGS form trimeric complexes with the atypical G protein beta subunit, G beta 5, and membrane anchor R7BP or R9AP. Association with G beta 5 and membrane anchors has been shown to be critical for maintaining proteolytic stability of the R7 RGS proteins. However, despite its functional importance, the mechanism of how R7 RGS forms complexes with G beta 5 and membrane anchors remains poorly understood. Here, we used protein-protein interaction, co-localization, and protein stability assays to show that association of RGS9 with membrane anchors requires G beta 5. We further establish that the recruitment of R7BP to the complex requires an intact interface between the N-terminal lobe of RGS9 and protein interaction surface of G beta 5. Site-directed mutational analysis reveals that distinct molecular determinants in the interface between G beta 5 and N-terminal Dishevelled, EGL-10, Pleckstrin/DEP Helical Extension (DEP/DHEY) domains are differentially involved in R7BP binding and proteolytic stabilization. On the basis of these findings, we conclude that G beta 5 contributes to the formation of the binding site to the membrane anchors and thus is playing a central role in the assembly of the proteolytically stable trimeric complex and its correct localization in the cell.	[Masuho, Ikuo; Wakasugi-Masuho, Hideko; Posokhova, Ekaterina N.; Patton, Joseph R.; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Sci, 130 Scripps Way,3C2, Jupiter, FL 33458 USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014		National Institutes of Health [EY018139, DA026405, DA021743]; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021743, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA026405 (to K. A. M.), and DA021743 (to K. A. M.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2010, J NEUROSCI, V30, P13784, DOI 10.1523/JNEUROSCI.1191-10.2010; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Kehrl JH, 2006, IMMUNOL RES, V34, P211, DOI 10.1385/IR:34:3:211; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Keresztes G, 2003, MOL CELL NEUROSCI, V24, P687, DOI 10.1016/S1044-7431(03)00231-8; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porter MY, 2010, J BIOL CHEM, V285, P41100, DOI 10.1074/jbc.M110.163600; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5	47	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21806	21813		10.1074/jbc.M111.241513	http://dx.doi.org/10.1074/jbc.M111.241513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21511947	hybrid, Green Published			2022-12-27	WOS:000291464700075
J	Unsworth, AJ; Smith, H; Gissen, P; Watson, SP; Pears, CJ				Unsworth, Amanda J.; Smith, Holly; Gissen, Paul; Watson, Steve P.; Pears, Catherine J.			Submaximal Inhibition of Protein Kinase C Restores ADP-induced Dense Granule Secretion in Platelets in the Presence of Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED HUMAN PLATELETS; INTACT HUMAN PLATELETS; THROMBUS FORMATION; INTEGRIN ALPHA(IIB)BETA(3); FUNCTIONAL-RESPONSES; FIBRINOGEN RECEPTOR; PHOSPHOLIPASE A(2); GLYCOPROTEIN-VI; ISOFORM 4B; PKC-THETA	Protein kinase C (PKC) is a family of serine/threonine kinases that play isoform-specific inhibitory and stimulatory roles in platelet activation. We show here that the pan-PKC inhibitor Ro31-8220 can be used to dissect these events following platelet activation by ADP. Submaximal concentrations of Ro31-8220 potentiated aggregation and dense granule secretion to ADP in plasma anticoagulated with citrate, in D-Phe-Pro-Arg-chloromethyl ketone-anticoagulated plasma, which has physiological levels of Ca2+, and in washed platelets. Potentiation was retained on inhibition of cyclooxygenase and was associated with an increase in intracellular Ca2+. Potentiation of aggregation and secretion was abolished by a maximally effective concentration of Ro31-8220, consistent with a critical role of PKC in secretion. ADP-induced secretion was potentiated in the presence of an inhibitor of PKC beta but not in the presence of available inhibitors of other PKC isoforms in human and mouse platelets. ADP-induced secretion was also potentiated in mouse platelets deficient in PKC beta but not PKC theta. These results demonstrate that partial blockade of PKC potentiates aggregation and dense granule secretion by ADP in association with increased Ca2+. This provides a molecular explanation for the inability of ADP to induce secretion in plasma in the presence of physiological Ca2+ concentrations, and it reveals a novel role for PKC in inhibiting platelet activation by ADP in vivo. These results also demonstrate isoform-specific inhibitory effects of PKC in platelets.	[Unsworth, Amanda J.; Pears, Catherine J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Inst Biomed Res,Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Pears, CJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	catherine.pears@bioch.ox.ac.uk	Watson, Stephen P/Q-6292-2016; Gissen, Paul/A-4352-2010; Unsworth, Amanda J/Q-7742-2017; Unsworth, Amanda/ABG-9141-2020	Watson, Stephen P/0000-0002-7846-7423; Gissen, Paul/0000-0002-9712-6122; Unsworth, Amanda/0000-0003-3809-5984; Pears, Catherine/0000-0003-1290-8326	British Heart Foundation [FS/08/010/24527]; Medical Research Council	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grant number FS/08/010/24527.; Supported by a British Heart Foundation Ph.D. studentship.; Supported by a Medical Research Council Ph.D. studentship.	Atkinson BT, 2001, EUR J BIOCHEM, V268, P5242, DOI 10.1046/j.0014-2956.2001.02448.x; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cattaneo M, 2002, BLOOD, V99, P3868, DOI 10.1182/blood-2002-01-0313; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x; Harper MT, 2010, CELL CALCIUM, V48, P333, DOI 10.1016/j.ceca.2010.10.006; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Iorio P, 1996, FEBS LETT, V381, P244, DOI 10.1016/0014-5793(96)00117-2; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; KING WG, 1989, J BIOL CHEM, V264, P6070; KNIGHT DE, 1980, THROMB RES, V20, P437, DOI 10.1016/0049-3848(80)90282-0; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; MUSTARD JF, 1975, AM J PHYSIOL, V228, P1757, DOI 10.1152/ajplegacy.1975.228.6.1757; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nucciarelli F, 1999, FEBS LETT, V450, P39, DOI 10.1016/S0014-5793(99)00436-6; PACKHAM MA, 1989, THROMB HAEMOSTASIS, V62, P968; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Pulcinelli FM, 1999, FEBS LETT, V460, P37, DOI 10.1016/S0014-5793(99)01313-7; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; RYU SH, 1990, J BIOL CHEM, V265, P17941; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; Wan TC, 2003, THROMB HAEMOSTASIS, V89, P122; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	64	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21073	21082		10.1074/jbc.M110.187138	http://dx.doi.org/10.1074/jbc.M110.187138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21489985	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000291464700006
J	Hamouda, AK; Stewart, DS; Husain, SS; Cohen, JB				Hamouda, Ayman K.; Stewart, Deirdre S.; Husain, S. Shaukat; Cohen, Jonathan B.			Multiple Transmembrane Binding Sites for p-Trifluoromethyldiazirinyl-etomidate, a Photoreactive Torpedo Nicotinic Acetylcholine Receptor Allosteric Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NONCOMPETITIVE ANTAGONISTS; MOLECULAR-MECHANISMS; ANESTHETIC ETOMIDATE; OPEN-STATE; IDENTIFICATION; AGONIST; TIME; SUBUNIT; PROTON	Photoreactive derivatives of the general anesthetic etomidate have been developed to identify their binding sites in gamma-aminobutyric acid, type A and nicotinic acetylcholine receptors. One such drug, [H-3]TDBzl-etomidate (4-[3-(trifluoromethyl)3H-diazirin-3-yl]benzyl-[H-3]1-(1-phenylethyl)-1H-imidazole-5- carboxylate), acts as a positive allosteric potentiator of Torpedo nACh receptor (nAChR) and binds to a novel site in the transmembrane domain at the gamma-alpha subunit interface. To extend our understanding of the locations of allosteric modulator binding sites in the nAChR, we now characterize the interactions of a second aryl diazirine etomidate derivative, TFD-etomidate (ethyl-1-(1-(4-(3-trifluoromethyl)-3H-diazirin-3-yl)phenylethyl)1H-imidazole-5-carboxylate). TFD-etomidate inhibited acetylcholine-induced currents with an IC50 = 4 mu M, whereas it inhibited the binding of [H-3]phencyclidine to the Torpedo nAChR ion channel in the resting and desensitized states with IC50 values of 2.5 and 0.7 mM, respectively. Similar to [H-3] TDBzl-etomidate, [H-3]TFD-etomidate bound to a site at the gamma-alpha subunit interface, photolabeling alpha M2-10 (alpha Ser-252) and gamma Met-295 and gamma Met-299 within gamma M3, and to a site in the ion channel, photolabeling amino acids within each subunit M2 helix that line the lumen of the ion channel. In addition, [H-3]TFD-etomidate photolabeled in an agonist-dependent manner amino acids within the delta subunit M2-M3 loop (delta Ile-288) and the delta subunit transmembrane helix bundle (delta Phe-232 and delta Cys-236 within delta M1). The fact that TFD-etomidate does not compete with ion channel blockers at concentrations that inhibit acetylcholine responses indicates that binding to sites at the gamma-alpha subunit interface and/or within delta subunit helix bundle mediates the TFD-etomidate inhibitory effect. These results also suggest that the gamma-alpha subunit interface is a binding site for Torpedo nAChR negative allosteric modulators (TFD-etomidate) and for positive modulators (TDBzl-etomidate).	[Hamouda, Ayman K.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Stewart, Deirdre S.; Husain, S. Shaukat] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	Jonathan_Cohen@hms.harvard.edu		Hamouda, Ayman/0000-0001-7819-3074	United States Public Health Service [GM-58448]; Howard Hughes Biomedical Research Support Program for Medical Schools; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Biomedical Research Support Program for Medical Schools; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grant GM-58448 (to J. B. C., Stuart Forman, and Keith W. Miller) and by an award to Harvard Medical School from the Howard Hughes Biomedical Research Support Program for Medical Schools.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Chiara DC, 2009, MOL PHARMACOL, V75, P1084, DOI 10.1124/mol.108.054353; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	43	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20466	20477		10.1074/jbc.M111.219071	http://dx.doi.org/10.1074/jbc.M111.219071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498509	Green Published, hybrid			2022-12-27	WOS:000291267600034
J	Han, Y; Noam, Y; Lewis, AS; Gallagher, JJ; Wadman, WJ; Baram, TZ; Chetkovich, DM				Han, Ye; Noam, Yoav; Lewis, Alan S.; Gallagher, Johnie J.; Wadman, Wytse J.; Baram, Tallie Z.; Chetkovich, Dane M.			Trafficking and Gating of Hyperpolarization-activated Cyclic Nucleotide-gated Channels Are Regulated by Interaction with Tetratricopeptide Repeat-containing Rab8b-interacting Protein (TRIP8b) and Cyclic AMP at Distinct Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HCN PACEMAKER CHANNELS; IMPORT RECEPTOR PEX5P; SURFACE EXPRESSION; CAMP MODULATION; SUBUNITS	Ion channel trafficking and gating are often influenced by interactions with auxiliary subunits. Tetratricopeptide repeat-containing Rab8b-interacting protein (TRIP8b) is an auxiliary subunit for neuronal hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. TRIP8b interacts directly with two distinct sites of HCN channel pore-forming subunits to control channel trafficking and gating. Here we use mutagenesis combined with electrophysiological studies to define and distinguish the functional importance of the HCN/TRIP8b interaction sites. Interaction with the last three amino acids of the HCN1 C terminus governed the effect of TRIP8b on channel trafficking, whereas TRIP8b interaction with the HCN1 cyclic nucleotide binding domain (CNBD) affected trafficking and gating. Biochemical studies revealed that direct interaction between TRIP8b and the HCN1 CNBD was disrupted by cAMP and that TRIP8b binding to the CNBD required an arginine residue also necessary for cAMP binding. In accord, increasing cAMP levels in cells antagonized the up-regulation of HCN1 channels mediated by a TRIP8b construct binding the CNBD exclusively. These data illustrate the distinct roles of the two TRIP8b-HCN interaction domains and suggest that TRIP8b and cAMP may directly compete for binding the HCN CNBD to control HCN channel gating, kinetics, and trafficking.	[Han, Ye; Lewis, Alan S.; Gallagher, Johnie J.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Noam, Yoav; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Noam, Yoav; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Noam, Yoav; Wadman, Wytse J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Amsterdam	Chetkovich, DM (corresponding author), 303 E Chicago Ave,Ward Bldg,Room 10-201, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Baram, Tallie Z/J-6447-2014; Lewis, Alan/AAV-9582-2021; Chetkovich, Dane/AAV-5457-2021	Lewis, Alan/0000-0002-7165-5376; 	National Institutes of Health [NS05595, NS059934, NS064757, NS35439]; Brain Research Foundation; Dutch Epilepsy Fund (NEF) [08-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934, R37NS035439, F30NS064757, R01NS035439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; Dutch Epilepsy Fund (NEF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS05595 and NS059934 (to D. M. C.), NS064757 (to A. S. L.), and NS35439 (to T. Z. B. and Y. N.). This work was also supported by the Brain Research Foundation (to D. M. C.) and the Dutch Epilepsy Fund (NEF #08-01; to W. J. W. and Y. N.).	Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Noam Y, 2008, J PHYSIOL-LONDON, V586, P3629, DOI 10.1113/jphysiol.2008.153486; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shimozawa N, 1999, BIOCHEM BIOPH RES CO, V262, P504, DOI 10.1006/bbrc.1999.1232; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	23	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20823	20834		10.1074/jbc.M111.236125	http://dx.doi.org/10.1074/jbc.M111.236125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504900	Green Published, hybrid			2022-12-27	WOS:000291267600067
J	El-Osta, MA; Idkowiak-Baldys, J; Hannun, YA				El-Osta, Mohamad A.; Idkowiak-Baldys, Jola; Hannun, Yusuf A.			Delayed Phosphorylation of Classical Protein Kinase C (PKC) Substrates Requires PKC Internalization and Formation of the Pericentrion in a Phospholipase D (PLD)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; RECYCLING ENDOSOMES; INTRACELLULAR TRAFFICKING; MEDIATED ENDOCYTOSIS; MEMBRANE TRAFFICKING; PERINUCLEAR REGION; DEPENDENT MANNER; EPITHELIAL-CELLS; PLASMA-MEMBRANE; DOWN-REGULATION	It was previously demonstrated that sustained activation (30-60 min) of protein kinase C (PKC) results in translocation of PKC alpha and beta II to the pericentrion, a dynamic subset of the recycling compartment whose formation is dependent on PKC and phospholipase D (PLD). Here we investigated whether the formation of the pericentrion modulates the ability of PKC to phosphorylate substrates, especially if it reduces substrate phosphorylation by sequestering PKC. Surprisingly, using an antibody that detects phosphosubstrates of classical PKCs, the results showed that the majority of PKC phosphosubstrates are phosphorylated with delayed kinetics, correlating with the time frame of PKC translocation to the pericentrion. Substrate phosphorylation was blocked by PLD inhibitors and was not observed in response to activation of a PKC beta II mutant (F663D) that is defective in interaction with PLD and in internalization. Phosphorylation was also inhibited by blocking clathrin-dependent endocytosis, demonstrating a requirement for endocytosis for the PKC-dependent major phosphorylation effects. Serotonin receptor activation by serotonin showed a similar response to phorbol 12-myristate 13-acetate, implicating a potential role of delayed kinetics in G protein-coupled receptor signaling. Evaluation of candidate substrates revealed that the phosphorylation of the PKC substrate p70S6K kinase behaved in a similar manner. Gradient-based fractionation revealed that the majority of these PKC substrates reside within the pericentrion-enriched fractions and not in the plasma membrane. Finally, proteomic analysis of the pericentrion-enriched fractions revealed several proteins as known PKC substrates and/or proteins involved in endocytic trafficking. These results reveal an important role for PKC internalization and for the pericentrion as key determinants/amplifiers of PKC action.	[El-Osta, Mohamad A.; Idkowiak-Baldys, Jola; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [HL-43707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-43707.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; BORGHINI I, 1994, P NATL ACAD SCI USA, V91, P6211, DOI 10.1073/pnas.91.13.6211; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; DAVIS RJ, 1987, J BIOL CHEM, V262, P16041; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Hu TH, 2005, BIOCHEM BIOPH RES CO, V333, P750, DOI 10.1016/j.bbrc.2005.05.184; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Matafora V, 2001, J CELL SCI, V114, P4509; MAY WS, 1984, P NATL ACAD SCI-BIOL, V81, P2016, DOI 10.1073/pnas.81.7.2016; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Padovano V, 2009, AM J PHYSIOL-CELL PH, V297, pC835, DOI 10.1152/ajpcell.00212.2009; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; PEARSON RB, 1991, METHOD ENZYMOL A, V200, P62; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schoijet AC, 2008, J BIOL CHEM, V283, P31541, DOI 10.1074/jbc.M801367200; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; TOKER A, 1994, J BIOL CHEM, V269, P32358; Tunaitis V., 2005, BIOLOGIJA, V1, P24; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; White D, 2007, J EXP BIOL, V210, P4053, DOI 10.1242/jeb.007013; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x	57	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19340	19353		10.1074/jbc.M110.152330	http://dx.doi.org/10.1074/jbc.M110.152330			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478146	Green Published, hybrid			2022-12-27	WOS:000291027700016
J	Mao, P; Hever, MP; Niemaszyk, LM; Haghkerdar, JM; Yanco, EG; Desai, D; Beyrouthy, MJ; Kerley-Hamilton, JS; Freemantle, SJ; Spinella, MJ				Mao, Pingping; Hever, Mary P.; Niemaszyk, Lynne M.; Haghkerdar, Jessica M.; Yanco, Esty G.; Desai, Damayanti; Beyrouthy, Maroun J.; Kerley-Hamilton, Joanna S.; Freemantle, Sarah J.; Spinella, Michael J.			Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DNA-DAMAGE; DAP-KINASE; P53-INDUCIBLE REGULATOR; APOPTOTIC CHECKPOINT; GENOTOXIC STRESS; DEATH; DRAK2; TRANSCRIPTION; RESISTANCE	Testicular cancer is highly curable with cisplatin-based therapy, and testicular cancer-derived human embryonal carcinoma (EC) cells undergo a p53-dominant transcriptional response to cisplatin. In this study, we have discovered that a poorly characterized member of the death-associated protein family of serine/threonine kinases, STK17A (also called DRAK1), is a novel p53 target gene. Cisplatin-mediated induction of STK17A in the EC cell line NT2/D1 was prevented with p53 siRNA. Furthermore, STK17A was induced with cisplatin in HCT116 and MCF10A cells but to a much lesser extent in isogenic p53-suppressed cells. A functional p53 response element that binds endogenous p53 in a cisplatin-dependent manner was identified 5 kb upstream of the first coding exon of STK17A. STK17A is not present in the mouse genome, but the closely related gene STK17B is induced with cisplatin in mouse NIH3T3 cells, although this induction is p53-independent. Interestingly, in human cells containing both STK17A and STK17B, only STK17A is induced with cisplatin. Knockdown of STK17A conferred resistance to cisplatin-induced growth suppression and apoptotic cell death in EC cells. This was associated with the up-regulation of detoxifying and antioxidant genes, including metallothioneins MT1H, MT1M, and MT1X that have previously been implicated in cisplatin resistance. In addition, knockdown of STK17A resulted in decreased cellular reactive oxygen species, whereas STK17A overexpression increased reactive oxygen species. In summary, we have identified STK17A as a novel direct target of p53 and a modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.	[Spinella, Michael J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Spinella, Michael J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Spinella, MJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, 7650 Remsen, Hanover, NH 03755 USA.	michael.spinella@dartmouth.edu	Spinella, Michael/B-7210-2014		National Institutes of Health [R21-CA124817]; United States Department of Defense [PR093629]; Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [R21CA124817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-CA124817. This work was also supported by United States Department of Defense Investigator-Initiated Research Award PR093629 and a Prouty development award from the Norris Cotton Cancer Center.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Fitzgerald J, 2004, TRENDS GENET, V20, P408, DOI 10.1016/j.tig.2004.07.002; Gatzka M, 2009, J IMMUNOL, V183, P285, DOI 10.4049/jimmunol.0803530; Giuliano CJ, 2006, CURR CANCER THER REV, V2, P255, DOI 10.2174/157339406777934681; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Houldsworth J, 2006, J CLIN ONCOL, V24, P5512, DOI 10.1200/JCO.2006.08.4285; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kerley-Hamilton JS, 2007, BBA-GENE STRUCT EXPR, V1769, P209, DOI 10.1016/j.bbaexp.2007.02.002; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Knipp M, 2009, CURR MED CHEM, V16, P522, DOI 10.2174/092986709787458452; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuwahara H, 2006, BIOL PHARM BULL, V29, P225, DOI 10.1248/bpb.29.225; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Lin Y, 2010, FEBS J, V277, P48, DOI 10.1111/j.1742-4658.2009.07411.x; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Michie AM, 2010, FEBS J, V277, P74, DOI 10.1111/j.1742-4658.2009.07414.x; PENG HQ, 1993, CANCER RES, V53, P3574; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tang H, 2007, ANTI-CANCER DRUG, V18, P633, DOI 10.1097/CAD.0b013e3280200428; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wittig R, 2002, CANCER RES, V62, P6698; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	52	34	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19381	19391		10.1074/jbc.M111.218040	http://dx.doi.org/10.1074/jbc.M111.218040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489989	hybrid, Green Published			2022-12-27	WOS:000291027700020
J	Meiringer, CTA; Rethmeier, R; Auffarth, K; Wilson, J; Perz, A; Barlowe, C; Schmitt, HD; Ungermann, C				Meiringer, Christoph T. A.; Rethmeier, Ralf; Auffarth, Kathrin; Wilson, Joshua; Perz, Angela; Barlowe, Charles; Schmitt, Hans Dieter; Ungermann, Christian			The Dsl1 Protein Tethering Complex Is a Resident Endoplasmic Reticulum Complex, Which Interacts with Five Soluble NSF (N-Ethylmaleimide-sensitive Factor) Attachment Protein Receptors (SNAREs) IMPLICATIONS FOR FUSION AND FUSION REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; RETRIEVAL-SYSTEM; GOLGI-COMPLEX; YEAST; VESICLE; TRANSPORT; ER; REQUIRES; SEC22P; ZW10	Retrograde vesicular transport from the Golgi to the ER requires the Dsl1 tethering complex, which consists of the three subunits Dsl1, Dsl3, and Tip20. It forms a stable complex with the SNAREs Ufe1, Use1, and Sec20 to mediate fusion of COPI vesicles with the endoplasmic reticulum. Here, we analyze molecular interactions between five SNAREs of the ER (Ufe1, Use1, Sec20, Sec22, and Ykt6) and the Dsl1 complex in vitro and in vivo. Of the two R-SNAREs, Sec22 is preferred over Ykt6 in the Dsl-SNARE complex. The NSF homolog Sec18 can displace Ykt6 but not Sec22, suggesting a regulatory function for Ykt6. In addition, our data also reveal that subunits of the Dsl1 complex (Dsl1, Dsl3, and Tip20), as well as the SNAREs Ufe1 and Sec20, are ER-resident proteins that do not seem to move into COPII vesicles. Our data support a model, in which a tethering complex is stabilized at the organelle membrane by binding to SNAREs, recognizes the incoming vesicle via its coat and then promotes its SNARE-mediated fusion.	[Meiringer, Christoph T. A.; Rethmeier, Ralf; Auffarth, Kathrin; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Dept Biol & Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Wilson, Joshua; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Schmitt, Hans Dieter] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37070 Gottingen, Germany	University Osnabruck; Dartmouth College; Max Planck Society	Ungermann, C (corresponding author), Univ Osnabruck, Dept Biol & Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de			Deutsche Forschungsgemeinschaft [SFB 431, 944, UN111/4-2]; Hans-Muhlenhoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052549] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Muhlenhoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 431, 944, and UN111/4-2) and the Hans-Muhlenhoff Foundation (to C. U.).	Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Arasaki K, 2007, BIOCHEM BIOPH RES CO, V359, P811, DOI 10.1016/j.bbrc.2007.05.188; Ballensiefen W, 1998, J CELL SCI, V111, P1507; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Frigerio G, 1998, YEAST, V14, P633, DOI 10.1002/(SICI)1097-0061(199805)14:7<633::AID-YEA267>3.0.CO;2-3; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x; Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	37	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25039	25046		10.1074/jbc.M110.215327	http://dx.doi.org/10.1074/jbc.M110.215327			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21550981	Green Published, hybrid			2022-12-27	WOS:000292547900052
J	Burkhalter, RJ; Symowicz, J; Hudson, LG; Gottardi, CJ; Stack, MS				Burkhalter, Rebecca J.; Symowicz, Jaime; Hudson, Laurie G.; Gottardi, Cara J.; Stack, M. Sharon			Integrin Regulation of beta-Catenin Signaling in Ovarian Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; E-CADHERIN; CELL-ADHESION; PLASMINOGEN-ACTIVATOR; LYSOPHOSPHATIDIC ACID; EPITHELIAL TUMORS; WNT PATHWAY; MICROENVIRONMENTAL REGULATION; PHENOTYPIC PLASTICITY; EXPRESSION	Reversible modulation of integrin-regulated cell-matrix adhesion and epithelial (E)-cadherin-mediated cell-cell adhesion plays a critical role in the establishment of ovarian cancer metastases. In contrast to most epithelial cell-derived tumors that down-regulate E-cadherin expression during progression, acquisition of E-cadherin expression accompanies malignant transformation of the ovarian surface epithelium and is maintained in peritoneal metastases. Metastatic epithelial ovarian cancer cells are disseminated intraperitoneally and preferentially adhere via integrins to interstitial collagens in the peritoneal cavity. This study was undertaken to determine whether integrin engagement influences E-cadherin and beta-catenin localization and function. The data demonstrate that multivalent integrin engagement results in increased internalization of E-cadherin, inhibition of GSK-3 beta, elevated levels of nuclear beta-catenin, increased beta-catenin-regulated promoter activation, and transcriptional activation of Wnt/beta-catenin target genes. Blocking beta-catenin transcriptional control with inhibitor of beta-catenin and Tcf-4 reduces cellular invasion, suggesting a key role for beta-catenin nuclear signaling in EOC invasion and metastasis. These studies support a model wherein cell-matrix engagement regulates the functional integrity of cell-cell contacts, leading to increased beta-catenin nuclear signaling and enhanced cellular invasive activity. Furthermore, these results provide a mechanism for activation of Wnt/beta-catenin signaling in the absence of activating mutations in this pathway.	[Burkhalter, Rebecca J.; Stack, M. Sharon] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Burkhalter, Rebecca J.; Stack, M. Sharon] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Symowicz, Jaime] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Med Sch, Chicago, IL 60612 USA; [Gottardi, Cara J.] Northwestern Univ, Dept Med, Feinberg Med Sch, Div Pulm & Crit Care, Chicago, IL 60612 USA; [Hudson, Laurie G.] Univ New Mexico, Dept Pharmaceut Sci, Coll Pharm, Albuquerque, NM 87131 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of New Mexico	Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, 1234 Notre Dame Ave,A200D Harper Hall, Notre Dame, IN 46617 USA.	Sharon.Stack.11@nd.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health [T32CA09560, RO1 CA086984, RO1 CA109545, RO1 CA90492, RO1 GM076561, 3RO1CA086984-11S1]; University of Missouri; NATIONAL CANCER INSTITUTE [R01CA090492, R01CA086984, T32CA009560, R01CA109545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32CA09560 (training grant to J. S.), RO1 CA086984 (to M. S. S.), RO1 CA109545 (to M. S. S.), RO1 CA90492 (to L. G. H.), and RO1 GM076561 (to C. J. G.), and Research Supplement 3RO1CA086984-11S1 to Promote Diversity (to R. J. B.). This work was also supported by a Life Sciences Fellowship from the University of Missouri (to R. J. B.).	Ahmed N, 2005, BRIT J CANCER, V92, P1475, DOI 10.1038/sj.bjc.6602495; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; AUERSPERG N, 1994, LAB INVEST, V71, P510; Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223; Barbolina M. V., 2011, BIOCH J IN PRESS; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davies BR, 1998, HISTOPATHOLOGY, V32, P69; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Ferrandina G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-182; Fishman DA, 2001, CANCER RES, V61, P3194; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fujioka T, 2001, ONCOL REP, V8, P249; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Ghosh S, 2006, J BIOL CHEM, V281, P13021, DOI 10.1074/jbc.M508526200; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Huang LW, 2000, GYNECOL ONCOL, V77, P369, DOI 10.1006/gyno.2000.5806; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jin HY, 2010, INT J CANCER, V126, P2102, DOI 10.1002/ijc.24901; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Karbova E, 2002, INT J SURG PATHOL, V10, P175, DOI 10.1177/106689690201000302; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Lessan K, 1999, AM J PATHOL, V154, P1525, DOI 10.1016/S0002-9440(10)65406-5; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Menczer J, 2009, EUR J GYNAECOL ONCOL, V30, P531; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NIEDBALA MJ, 1987, CANCER RES, V47, P4634; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Sagae S, 1999, JPN J CANCER RES, V90, P510, DOI 10.1111/j.1349-7006.1999.tb00777.x; Sakata K, 2000, INT J ONCOL, V17, P673; Santala M, 1998, BRIT J CANCER, V77, P1825, DOI 10.1038/bjc.1998.303; Skubitz Amy P N, 2002, Cancer Treat Res, V107, P305; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Tago K, 2000, GENE DEV, V14, P1741; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Tuhkanen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-289; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wang L, 2009, GYNECOL ONCOL, V114, P265, DOI 10.1016/j.ygyno.2009.04.031; Wang Y, 2006, BRIT J CANCER, V94, P686, DOI 10.1038/sj.bjc.6602988; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu R, 2001, CANCER RES, V61, P8247; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Young TN, 1996, GYNECOL ONCOL, V62, P89, DOI 10.1006/gyno.1996.0195; YOUNG TN, 1994, AM J OBSTET GYNECOL, V170, P1285; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	78	43	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23467	23475		10.1074/jbc.M110.199539	http://dx.doi.org/10.1074/jbc.M110.199539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518759	Green Published, hybrid			2022-12-27	WOS:000292025000077
J	Mager, T; Rimon, A; Padan, E; Fendler, K				Mager, Thomas; Rimon, Abraham; Padan, Etana; Fendler, Klaus			Transport Mechanism and pH Regulation of the Na+/H+ Antiporter NhaA from Escherichia coli AN ELECTROPHYSIOLOGICAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; LOOP-VIII-IX; STRUCTURAL INTERACTIONS; CHARGE TRANSLOCATION; BINDING; H+; MEMBRANES; DYNAMICS; PERMEASE; MODEL	Using an electrophysiological assay the activity of NhaA was tested in a wide pH range from pH 5.0 to 9.5. Forward and reverse transport directions were investigated at zero membrane potential using preparations with inside-out and right side-out-oriented transporters with Na+ or H+ gradients as the driving force. Under symmetrical pH conditions with a Na+ gradient for activation, both the wt and the pH-shifted G338S variant exhibit highly symmetrical transport activity with bell-shaped pH dependences, but the optimal pH was shifted 1.8 pH units to the acidic range in the variant. In both strains the pH dependence was associated with a systematic increase of the K-m for Na+ at acidic pH. Under symmetrical Na+ concentration with a pH gradient for NhaA activation, an unexpected novel characteristic of the antiporter was revealed; rather than being down-regulated, it remained active even at pH as low as 5. These data allowed a transport mechanism to advance based on competing Na+ and H+ binding to a common transport site and a kinetic model to develop quantitatively explaining the experimental results. In support of these results, both alkaline pH and Na+ induced the conformational change of NhaA associated with NhaA cation translocation as demonstrated here by trypsin digestion. Furthermore, Na+ translocation was found to be associated with the displacement of a negative charge. In conclusion, the electrophysiological assay allows the revelation of the mechanism of NhaA antiport and sheds new light on the concept of NhaA pH regulation.	[Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de		Fendler, Klaus/0000-0002-5699-7060; Mager, Thomas/0000-0002-9571-7033	Deutsche Forschungsgemeinschaft [SFB 807]; EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation [20050130]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft SFB 807.; Supported by EDICT (European Drug Initiative on Channels and Transporters) Grant EU EP7 and by USA-Israel Binational Science Foundation Grant BSF#20050130.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ADLER LW, 1977, J SUPRAMOL STR CELL, V7, P15, DOI 10.1002/jss.400070103; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Everberg H, 2006, J CHROMATOGR A, V1118, P244, DOI 10.1016/j.chroma.2006.03.123; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Ganea C, 2009, BBA-BIOENERGETICS, V1787, P706, DOI 10.1016/j.bbabio.2009.02.002; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Meyer-Lipp K, 2006, J BIOL CHEM, V281, P25882, DOI 10.1074/jbc.M601259200; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Stein W. D., 1986, TRANSPORT DIFFUSION, P404; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Venturi M., 2002, PRACTICAL GUIDE MEMB, P179; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	40	73	76	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23570	23581		10.1074/jbc.M111.230235	http://dx.doi.org/10.1074/jbc.M111.230235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566125	hybrid, Green Published			2022-12-27	WOS:000292025000087
J	Noble, E; Mathews, DH; Chen, JL; Turner, DH; Takimoto, T; Kim, B				Noble, Erin; Mathews, David H.; Chen, Jonathan L.; Turner, Douglas H.; Takimoto, Toru; Kim, Baek			Biophysical Analysis of Influenza A Virus RNA Promoter at Physiological Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-RNA; ENDONUCLEASE ACTIVITY; SECONDARY STRUCTURE; INFECTED-CELLS; POLYMERASE; TRANSCRIPTION; PANHANDLE; BINDING; VRNA; NUCLEOPROTEIN	Each segment of the influenza A virus (IAV) genome contains conserved sequences at the 5'- and 3'-terminal ends, which form the promoter region necessary for polymerase binding and initiation of RNA synthesis. Although several models of interaction have been proposed it remains unclear if these two short, partially complementary, and highly conserved sequences can form a stable RNA duplex at physiological temperatures. First, our time-resolved FRET analysis revealed that a 14-mer 3'-RNA and a 15-mer 5'-RNA associate in solution, even at 42 degrees C. We also found that a nonfunctional RNA promoter containing the 3'-G3U mutation, as well as a promoter containing the compensatory 3'-G3U/C8A mutations, was able to form a duplex as efficiently as wild type. Second, UV melting analysis demonstrated that the wild-type and mutant RNA duplexes have similar stabilities in solution. We also observed an increase in thermostability for a looped promoter structure. The absence of differences in the stability and binding kinetics between wild type and a nonfunctional sequence suggests that the IAV promoter can be functionally inactivated without losing the capability to form a stable RNA duplex. Finally, using uridine specific chemical probing combined with mass spectrometry, we confirmed that the 5' and 3' sequences form a duplex which protects both RNAs from chemical modification, consistent with the previously published panhandle structure. These data support that these short, conserved promoter sequences form a stable complex at physiological temperatures, and this complex likely is important for polymerase recognition and viral replication.	[Noble, Erin; Takimoto, Toru; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Mathews, David H.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Chen, Jonathan L.; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			National Institutes of Health (NIH) [HHSN266200700008C]; Oral Cellular and Molecular Biology Training Grant [T32 DE007202];  [GM22939];  [R01HG004002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Cellular and Molecular Biology Training Grant; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health (NIH) contract granted to the New York Influenza Center of Excellence (NIH/NIAID HHSN266200700008C), the Oral Cellular and Molecular Biology Training Grant (T32 DE007202), GM22939 (to D. H. T.), and R01HG004002 (to D. H. M.).	Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Flick R, 1996, RNA, V2, P1046; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gonzalez S, 1999, J VIROL, V73, P631; HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Ishihama A, 1996, BIOCHIMIE, V78, P1097, DOI 10.1016/S0300-9084(97)86735-1; Kim HJ, 1997, J GEN VIROL, V78, P353, DOI 10.1099/0022-1317-78-2-353; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kobasa D, 2005, CURR MOL MED, V5, P791, DOI 10.2174/156652405774962281; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Leahy MB, 2001, J VIROL, V75, P7042, DOI 10.1128/JVI.75.15.7042-7049.2001; Lee KH, 1998, J GEN VIROL, V79, P1923, DOI 10.1099/0022-1317-79-8-1923; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schroeder SJ, 2009, METHOD ENZYMOL, V468, P371, DOI 10.1016/S0076-6879(09)68017-4; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Turner KB, 2009, RNA, V15, P1605, DOI 10.1261/rna.1615409	23	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22965	22970		10.1074/jbc.M111.239509	http://dx.doi.org/10.1074/jbc.M111.239509			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555520	Green Published, hybrid			2022-12-27	WOS:000292025000031
J	Shoulders, MD; Raines, RT				Shoulders, Matthew D.; Raines, Ronald T.			Interstrand Dipole-Dipole Interactions Can Stabilize the Collagen Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; HYDROXYLATION-INDUCED STABILIZATION; EARTHWORM CUTICLE COLLAGEN; XAA POSITION; AQUEOUS-SOLUTION; MODEL PEPTIDES; ELECTROSTATIC INTERACTIONS; MELTING CURVES; PROLINE; 4-FLUOROPROLINE	The amino acid sequence of collagen is composed of GlyXaaYaa repeats. A prevailing paradigm maintains that stable collagen triple helices form when (2S)-proline (Pro) or Pro derivatives that prefer the C-gamma-endo ring pucker are in the Xaa position and Pro derivatives that prefer the C-gamma-exo ring pucker are in the Yaa position. Anomalously, an amino acid sequence in an invertebrate collagen has (2S, 4R)-4-hydroxyproline (Hyp), a C-gamma-exo-puckered Pro derivative, in the Xaa position. In certain contexts, triple helices with Hyp in the Xaa position are now known to be hyperstable. Most intriguingly, the sequence (GlyHypHyp)(n) forms a more stable triple helix than does the sequence (GlyProHyp)(n). Competing theories exist for the physicochemical basis of the hyperstability of (GlyHypHyp) n triple helices. By synthesizing and analyzing triple helices with different C-gamma-exo-puckered proline derivatives in the Xaa and Yaa positions, we conclude that interstrand dipole-dipole interactions are the primary determinant of their additional stability. These findings provide a new framework for understanding collagen stability.	[Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Shoulders, Matthew D.; Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	National Institutes of Health [R01 AR044276, S10 RR13790, P41RR02301]; United States Dept. of Homeland Security; ACS Division of Medicinal Chemistry; NSF [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Homeland Security; ACS Division of Medicinal Chemistry; NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grant R01 AR044276 from the National Institutes of Health.; Supported by graduate fellowships from the United States Dept. of Homeland Security and ACS Division of Medicinal Chemistry.; We thank Dr. D. R. McCaslin for both experimental aid and helpful discussions. CD spectroscopy, DSC, analytical ultracentrifugation, and MALDI-TOF mass spectrometry were performed at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which was established with Grants BIR-9512577 (NSF) and S10 RR13790 (National Institutes of Health). NMR spectroscopy was performed at the National Magnetic Resonance Facility at Madison, which is supported by Grant P41RR02301 (National Institutes of Health).	Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BERG RA, 1970, J BIOL CHEM, V245, P5759; Berisio R, 2004, J AM CHEM SOC, V126, P11402, DOI 10.1021/ja047069h; Breslauer K J, 1994, Methods Mol Biol, V26, P347; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v; Doi M, 2005, J PEPT SCI, V11, P609, DOI 10.1002/psc.671; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Durschlag H., 1994, PROG COLLOID POLYM S, V94, P20; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Glendening E. D., 2001, NBO 5 0; GOLDSTEIN A, 1970, J BIOL CHEM, V245, P5478; Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Improta R, 2002, J AM CHEM SOC, V124, P7857, DOI 10.1021/ja020187p; Improta R, 2001, J AM CHEM SOC, V123, P12568, DOI 10.1021/ja010599i; Improta R, 2008, PROTEIN SCI, V17, P955, DOI 10.1110/ps.073301908; INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7; Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m; Kotch FW, 2008, J AM CHEM SOC, V130, P2952, DOI 10.1021/ja800225k; Kumin M, 2007, J AM CHEM SOC, V129, P466, DOI 10.1021/ja067148o; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457; Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MUIR L, 1970, J BIOL CHEM, V245, P502; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Okuyama K, 2010, ACTA CRYSTALLOGR D, V66, P88, DOI 10.1107/S0907444909046642; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; PANASIK N, 1994, INT J PEPT PROT RES, V44, P262; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Ruzza P, 2006, J PEPT SCI, V12, P462, DOI 10.1002/psc.750; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Shoulders MD, 2008, BIOPOLYMERS, V89, P443, DOI 10.1002/bip.20864; Shoulders MD, 2006, J AM CHEM SOC, V128, P8112, DOI 10.1021/ja061793d; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shoulders MD, 2009, BIOORG MED CHEM LETT, V19, P3859, DOI 10.1016/j.bmcl.2009.03.168; Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115; Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w; Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V	58	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22905	22912		10.1074/jbc.M110.199984	http://dx.doi.org/10.1074/jbc.M110.199984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21482820	hybrid, Green Published			2022-12-27	WOS:000292025000025
J	Mekler, V; Minakhin, L; Severinov, K				Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin			A Critical Role of Downstream RNA Polymerase-Promoter Interactions in the Formation of Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-R PROMOTER; CONFORMATIONAL-CHANGES; TRANSCRIPTION INITIATION; SIGMA(70) SUBUNIT; ANGSTROM RESOLUTION; NONTEMPLATE STRAND; STRUCTURAL BASIS; DNA-BINDING; START SITE; HOLOENZYME	Nucleation of promoter melting in bacteria is coupled with RNA polymerase (RNAP) binding to a conserved - 10 promoter element located at the upstream edge of the transcription bubble. The mechanism of downstream propagation of the transcription bubble to include the transcription start site is unclear. Here we introduce new model downstream fork junction promoter fragments that specifically bind RNAP and mimic the downstream segment of promoter complexes. We demonstrate that RNAP binding to downstream fork junctions is coupled with DNA melting around the transcription start point. Consequently, certain downstream fork junction probes can serve as transcription templates. Using a protein beacon fluorescent method, we identify structural determinants of affinity and transcription activity of RNAP-downstream fork junction complexes. Measurements of RNAP interaction with double-stranded promoter fragments reveal that the strength of RNAP interactions with downstream DNA plays a critical role in promoter opening and that the length of the downstream duplex must exceed a critical length for efficient formation of transcription competent open promoter complex.	[Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 119334, Russia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences	Mekler, V (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016		National Institutes of Health [R01 GM64530]; Russian Academy of Sciences Presidium; Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" [02.740.11.0771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences Presidium(Russian Academy of Sciences); Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64530. This work was also supported by a Molecular and Cell Biology Program grant from the Russian Academy of Sciences Presidium and Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia 2009-2013," State Contract 02.740.11.0771 (to K. S.).	Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; Colland F, 1998, MOL MICROBIOL, V27, P819, DOI 10.1046/j.1365-2958.1998.00729.x; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ederth J, 2002, MOL GENET GENOMICS, V267, P587, DOI 10.1007/s00438-002-0689-y; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; HESSELBACH BA, 1975, NATURE, V258, P354, DOI 10.1038/258354a0; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Kontur WS, 2006, BIOCHEMISTRY-US, V45, P2161, DOI 10.1021/bi051835v; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; McCullagh M, 2008, J PHYS CHEM B, V112, P11415, DOI 10.1021/jp802378a; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 1999, J MOL BIOL, V289, P815, DOI 10.1006/jmbi.1999.2782; PFEFFER SR, 1977, J BIOL CHEM, V252, P5403; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Roberts CW, 1996, CELL, V86, P495; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Schroder O, 2003, P NATL ACAD SCI USA, V100, P934, DOI 10.1073/pnas.242735699; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Sclavi Bianca, 2009, P38, DOI 10.1039/9781847559982-00038; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wigneshweraraj SR, 2005, J BIOL CHEM, V280, P36176, DOI 10.1074/jbc.M506416200; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Zenkin N, 2004, P NATL ACAD SCI USA, V101, P4396, DOI 10.1073/pnas.0400886101	52	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22600	22608		10.1074/jbc.M111.247080	http://dx.doi.org/10.1074/jbc.M111.247080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525530	Green Published, hybrid			2022-12-27	WOS:000291719900067
J	Vidal-Dupiol, J; Ladriere, O; Destoumieux-Garzon, D; Sautiere, PE; Meistertzheim, AL; Tambutte, E; Tambutte, S; Duval, D; Foure, L; Adjeroud, M; Mitta, G				Vidal-Dupiol, Jeremie; Ladriere, Ophelie; Destoumieux-Garzon, Delphine; Sautiere, Pierre-Eric; Meistertzheim, Anne-Leila; Tambutte, Eric; Tambutte, Sylvie; Duval, David; Foure, Laurent; Adjeroud, Mehdi; Mitta, Guillaume			Innate Immune Responses of a Scleractinian Coral to Vibriosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER ACANTHOSCURRIA-GOMESIANA; CHANNEL-BLOCKING TOXINS; ANTIMICROBIAL PEPTIDE; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; ANTIBACTERIAL PEPTIDE; CRASSOSTREA-GIGAS; INSECT IMMUNITY; SCORPION TOXINS; PCR DATA	Scleractinian corals are the most basal eumetazoan taxon and provide the biological and physical framework for coral reefs, which are among the most diverse of all ecosystems. Over the past three decades and coincident with climate change, these phototrophic symbiotic organisms have been subject to increasingly frequent and severe diseases, which are now geographically widespread and a major threat to these ecosystems. Although coral immunity has been the subject of increasing study, the available information remains fragmentary, especially with respect to coral antimicrobial responses. In this study, we characterized damicornin from Pocillopora damicornis, the first scleractinian antimicrobial peptide (AMP) to be reported. We found that its precursor has a segmented organization comprising a signal peptide, an acidic proregion, and the C-terminal AMP. The 40-residue AMP is cationic, C-terminally amidated, and characterized by the presence of six cysteine molecules joined by three intramolecular disulfide bridges. Its cysteine array is common to another AMP and toxins from cnidarians; this suggests a common ancestor, as has been proposed for AMPs and toxins from arthropods. Damicornin was active in vitro against Gram-positive bacteria and the fungus Fusarium oxysporum. Damicornin expression was studied using a combination of immunohistochemistry, reverse phase HPLC, and quantitative RT-PCR. Our data show that damicornin is constitutively transcribed in ectodermal granular cells, where it is stored, and further released in response to nonpathogenic immune challenge. Damicornin gene expression was repressed by the coral pathogen Vibrio coralliilyticus. This is the first evidence of AMP gene repression in a host-Vibrio interaction.	[Vidal-Dupiol, Jeremie; Meistertzheim, Anne-Leila; Duval, David; Adjeroud, Mehdi; Mitta, Guillaume] Univ Perpignan Via Domitia, CNRS UPVD EPHE, UMR 5244, F-66000 Perpignan, France; [Ladriere, Ophelie] Univ Liege, Unite Ecol Marine, Lab Ecol Anim & Ecotoxicol, B-4000 Liege, Belgium; [Destoumieux-Garzon, Delphine] Univ Montpellier 2, CNRS, IFREMER, UMR 5119, F-34095 Montpellier, France; [Sautiere, Pierre-Eric] Univ Lille 1, CNRS FRE 3249, IFR 147, Univ Lille Nord France, F-59655 Villeneuve Dascq, France; [Tambutte, Eric; Tambutte, Sylvie] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Foure, Laurent] Aquarium Cap dAgde, F-34300 Cap Dagde, France; [Adjeroud, Mehdi] Inst Rech Dev, Unite 227 CoReUs2, Noumea 98848, New Caledonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; University of Liege; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Institut de Recherche pour le Developpement (IRD)	Mitta, G (corresponding author), Univ Perpignan Via Domitia, UMR CNRS UPVD EPHE 5244, 52 Ave Paul Alduy, F-66860 Perpignan, France.	mitta@univ-perp.fr	Vidal-Dupiol, Jeremie/ABG-8874-2020; MITTA, Guillaume/A-6489-2010; Vidal-Dupiol, Jérémie/B-3165-2010; Meistertzheim, Anne-Leïla AL/C-7365-2009; DUVAL, David/B-8586-2011; Adjeroud, Mehdi/J-6411-2016; Destoumieux-Garzón, Delphine/O-3328-2014	Vidal-Dupiol, Jeremie/0000-0002-0577-2953; Meistertzheim, Anne-Leïla AL/0000-0002-5005-9794; Adjeroud, Mehdi/0000-0002-6825-8759; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; SAUTIERE, Pierre-Eric/0000-0003-4974-7116; Duval, David/0000-0001-6933-3354; mitta, guillaume/0000-0003-1188-1467	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNRS.	Alessandri-Haber N, 1999, J BIOL CHEM, V274, P35653, DOI 10.1074/jbc.274.50.35653; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Baumann T, 2010, CELL MOL LIFE SCI, V67, P2787, DOI 10.1007/s00018-010-0364-0; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; BULET P, 1991, J BIOL CHEM, V266, P24520; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Choquet G, 2003, DIS AQUAT ORGAN, V57, P109, DOI 10.3354/dao057109; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V28, P261, DOI 10.1016/j.fsi.2009.11.005; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Geffen Y, 2009, FEMS MICROBIOL LETT, V295, P103, DOI 10.1111/j.1574-6968.2009.01590.x; Gendeh GS, 1997, BIOCHEMISTRY-US, V36, P11461, DOI 10.1021/bi970253d; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; HANCOCK CD, 1992, METHODS MOL BIOL IMM, P33; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herbiniere J, 2005, DEV COMP IMMUNOL, V29, P489, DOI 10.1016/j.dci.2004.11.001; HETRU C, 1997, ANTIBACTERIAL PEPTID, P35; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Karlsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-37; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Kushmaro A, 1998, MAR ECOL PROG SER, V171, P131, DOI 10.3354/meps171131; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Li C, 2008, DEV COMP IMMUNOL, V32, P1430, DOI 10.1016/j.dci.2008.06.013; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Mateo DR, 2009, J INVERTEBR PATHOL, V102, P50, DOI 10.1016/j.jip.2009.06.008; Mitta G, 1999, J CELL SCI, V112, P4233; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; MURTHY ASN, 1986, J BIOL CHEM, V261, P1815; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; PORATH J, 1983, BIOCHEMISTRY-US, V22, P1621, DOI 10.1021/bi00276a015; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Rees JA, 1997, INSECT BIOCHEM MOLEC, V27, P413, DOI 10.1016/S0965-1748(97)00013-1; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2004, CORAL HEALTH AND DISEASE, P445; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Rozenblat YBH, 2004, CORAL HEALTH AND DISEASE, P301; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; STEFANSKY W, 1972, TECHNOMETRICS, V14, P469, DOI 10.2307/1267436; VAITUKAITIS J, 1971, J CLIN ENDOCR METAB, V33, P988, DOI 10.1210/jcem-33-6-988; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	79	79	80	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22688	22698		10.1074/jbc.M110.216358	http://dx.doi.org/10.1074/jbc.M110.216358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536670	Green Published, hybrid			2022-12-27	WOS:000291719900075
J	Heissler, SM; Manstein, DJ				Heissler, Sarah M.; Manstein, Dietmar J.			Comparative Kinetic and Functional Characterization of the Motor Domains of Human Nonmuscle Myosin-2C Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; II-C; ADENOSINE-TRIPHOSPHATASE; ATPASE ACTIVITY; ACTIN AFFINITY; CHAIN; ADP; MAGNESIUM; DISSOCIATION; ASSOCIATION	Nonmuscle myosins are widely distributed and play important roles in the maintenance of cell morphology and cytokinesis. In this study, we compare the detailed kinetic and functional characterization of naturally occurring transcript variants of the motor domain of human nonmuscle myosin heavy chain (NMHC)-2C. NMHC-2C is alternatively spliced both in loop-1 and loop-2. Isoform 2C0 contains no inserts in either of the loops and represents the shortest isoform. An 8-amino acid extension in the loop-1 region is present in isoforms 2C1 and 2C1C2. Isoform 2C1C2 additionally displays a 33-amino acid extension in the loop-2 region. Transient kinetic experiments indicate increased rate constants for F-actin binding by isoform 2C1C2 in the absence and presence of nucleotide, which can be attributed to the loop-2 extension. ADP binding shows only minor differences for the three transcript variants. In contrast, larger differences are observed for the rates of ADP release both in the absence and presence of F-actin. The largest differences are observed between isoforms 2C0 and 2C1C2. In the absence and presence of F-actin, isoform 2C1C2 displays a 5-7-fold increase in ADP affinity. Moreover, our results indicate that the ADP release kinetics of all three isoforms are modulated by changes in the concentration of free Mg2+ ions. The greatest responsiveness of the NMHC-2C isoforms is observed in the physiological range from 0.2 to 1.5 mM free Mg2+ ions, affecting their duty ratio, velocity, and tension-bearing properties.	[Heissler, Sarah M.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neubert Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147	Deutsche Forschungsgemeinschaft [Ma 1081/16-1]; Cluster of Excellence "Rebirth"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"	This work was supported by Deutsche Forschungsgemeinschaft Grant Ma 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.).	Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Clark R, 2005, J BIOL CHEM, V280, P30935, DOI 10.1074/jbc.M504698200; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Kawahara K, 2008, CHRONOBIOL INT, V25, P868, DOI 10.1080/07420520802536387; Kengyel A, 2010, J MUSCLE RES CELL M, V31, P163, DOI 10.1007/s10974-010-9220-y; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MAUPIN P, 1994, J CELL SCI, V107, P3077; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329	61	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21191	21202		10.1074/jbc.M110.212290	http://dx.doi.org/10.1074/jbc.M110.212290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21478157	Green Published, hybrid			2022-12-27	WOS:000291464700019
J	Zweytick, D; Deutsch, G; Andra, J; Blondelle, SE; Vollmer, E; Jerala, R; Lohner, K				Zweytick, Dagmar; Deutsch, Guenter; Andra, Joerg; Blondelle, Sylvie E.; Vollmer, Ekkehard; Jerala, Roman; Lohner, Karl			Studies on Lactoferricin-derived Escherichia coli Membrane-active Peptides Reveal Differences in the Mechanism of N-Acylated Versus Nonacylated Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-BINDING PROTEIN; X-RAY; ENDOTOXIN NEUTRALIZATION; ANTIMICROBIAL PEPTIDES; PHASE; ANTIBIOTICS; DERIVATIVES; BACTERIA; DESIGN	To improve the low antimicrobial activity of LF11, an 11-mer peptide derived from human lactoferricin, mutant sequences were designed based on the defined structure of LF11 in the lipidic environment. Thus, deletion of noncharged polar residues and strengthening of the hydrophobic N-terminal part upon adding a bulky hydrophobic amino acid or N-acylation resulted in enhanced antimicrobial activity against Escherichia coli, which correlated with the peptides' degree of perturbation of bacterial membrane mimics. Nonacylated and N-acylated peptides exhibited different effects at a molecular level. Nonacylated peptides induced segregation of peptide-enriched and peptide-poor lipid domains in negatively charged bilayers, although N-acylated peptides formed small heterogeneous domains resulting in a higher degree of packing defects. Additionally, only N-acylated peptides perturbed the lateral packing of neutral lipids and exhibited increased permeability of E. coli lipid vesicles. The latter did not correlate with the extent of improvement of the antimicrobial activity, which could be explained by the fact that elevated binding of N-acylated peptides to lipopolysaccharides of the outer membrane of Gram-negative bacteria seems to counteract the elevated membrane permeabilization, reflected in the respective minimal inhibitory concentration for E. coli. The antimicrobial activity of the peptides correlated with an increase of membrane curvature stress and hence bilayer instability. Transmission electron microscopy revealed that only the N-acylated peptides induced tubular protrusions from the outer membrane, whereas all peptides caused detachment of the outer and inner membrane of E. coli bacteria. Viability tests demonstrated that these bacteria were dead before onset of visible cell lysis.	[Zweytick, Dagmar; Deutsch, Guenter; Lohner, Karl] Austrian Acad Sci, Inst Biophys & Nanosyst Res, A-8042 Graz, Austria; [Andra, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany; [Blondelle, Sylvie E.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Vollmer, Ekkehard] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin & Expt Pathol, D-23845 Borstel, Germany; [Jerala, Roman] Univ Ljubljana, EN FIST Ctr Excellence, Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Austrian Academy of Sciences; Forschungszentrum Borstel; Torrey Pines Institute for Molecular Studies, California; Forschungszentrum Borstel; National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana	Lohner, K (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res, Schmiedlstr 6, A-8042 Graz, Austria.	karl.lohner@oeaw.ac.at	; Jerala, Roman/H-9850-2015	Zweytick, Dagmar/0000-0002-4766-7713; Jerala, Roman/0000-0002-6337-5251	EC [QLK2-CT-2002-01001]; German Science Foundation [AN301/5-1]; Slovenian Research Agency; EN-FIST Centre of Excellence	EC(European CommissionEuropean Commission Joint Research Centre); German Science Foundation(German Research Foundation (DFG)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence	This work was supported in part by EC-specific RTD Programme Grant QLK2-CT-2002-01001, "Antimicrobial Endotoxin Neutralizing Peptides to Combat Infectious Diseases."; Supported by German Science Foundation Grant AN301/5-1.; Supported by the Slovenian Research Agency and EN-FIST Centre of Excellence.	Andra J, 2005, BIOCHEM J, V385, P135, DOI 10.1042/BJ20041270; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Blondelle SE, 2005, Peptides 2004, Proceedings, P81; Blondelle SE, 2004, PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, P877; Brandenburg K, 2002, EUR J BIOCHEM, V269, P5972, DOI 10.1046/j.1432-1033.2002.03333.x; Brandenburg Klaus, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P9; DEUTSCH G, 2006, THESIS GRAZ U TECHNO; DEUTSCH G, 2006, BIOPHYS J, V90; EKLUND KK, 1989, CHEM PHYS LIPIDS, V50, P71, DOI 10.1016/0009-3084(89)90028-5; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GRIFFITH OH, 1972, P NATL ACAD SCI USA, V69, P561, DOI 10.1073/pnas.69.3.561; HAHN F L, 1956, Pharm Zentralhalle Dtschl, V95, P309; Hickel A, 2008, BBA-BIOMEMBRANES, V1778, P2325, DOI 10.1016/j.bbamem.2008.05.014; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Japelj B, 2007, J AM CHEM SOC, V129, P1022, DOI 10.1021/ja067419v; Jurgens G, 2002, J ENDOTOXIN RES, V8, P115, DOI 10.1179/096805102125000263; Latal A, 1997, EUR J BIOCHEM, V248, P938, DOI 10.1111/j.1432-1033.1997.00938.x; Lockwood NA, 2004, BIOCHEM J, V378, P93, DOI 10.1042/BJ20031393; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; OFEK I, 1994, ANTIMICROB AGENTS CH, V38, P374, DOI 10.1128/AAC.38.2.374; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Pabst G, 2003, J APPL CRYSTALLOGR, V36, P1378, DOI 10.1107/S0021889803017527; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; Sanchez-Gomez S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-196; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; SORENSEN MARGRETHE, 1939, Comptes rendus des Travaux du Laboratoire Carlsberg, V23, P55; Staudegger E, 2000, BBA-BIOMEMBRANES, V1468, P213, DOI 10.1016/S0005-2736(00)00260-1; Strom MB, 2002, BIOCHEM CELL BIOL, V80, P65, DOI 10.1139/o01-236; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Wakabayashi H, 1999, ANTIMICROB AGENTS CH, V43, P1267, DOI 10.1128/AAC.43.5.1267; Wakabayashi H, 2003, CURR PHARM DESIGN, V9, P1277, DOI 10.2174/1381612033454829; WHITE DA, 1972, J BACTERIOL, V109, P686, DOI 10.1128/JB.109.2.686-690.1972; Wilkinson S.G., 1988, MICROBIAL LIPIDS, V1, P299; Willumeit R, 2005, BBA-BIOMEMBRANES, V1669, P125, DOI 10.1016/j.bbamem.2005.01.011; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015; Zweytick D, 2008, BIOCHEM BIOPH RES CO, V369, P395, DOI 10.1016/j.bbrc.2008.01.176; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032	44	50	55	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21266	21276		10.1074/jbc.M110.195412	http://dx.doi.org/10.1074/jbc.M110.195412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515687	Green Published, hybrid			2022-12-27	WOS:000291464700025
J	Cheng, L; Yung, A; Covarrubias, M; Radice, GL				Cheng, Lan; Yung, Aaron; Covarrubias, Manuel; Radice, Glenn L.			Cortactin Is Required for N-cadherin Regulation of Kv1.5 Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VENTRICULAR MYOCYTES; POTASSIUM CHANNEL; K+ CURRENTS; HETEROGENEOUS EXPRESSION; TARGETED DELETION; SODIUM-CHANNELS; UNEXPECTED ROLE; HEART-FAILURE; SUDDEN-DEATH; LONG QT	The intercalated disc serves as an organizing center for various cell surface components at the termini of the cardiomyocyte, thus ensuring proper mechanoelectrical coupling throughout the myocardium. The cell adhesion molecule, N-cadherin, is an essential component of the intercalated disc. Cardiac-specific deletion of N-cadherin leads to abnormal electrical conduction and sudden arrhythmic death in mice. The mechanisms linking the loss of N-cadherin in the heart and spontaneous malignant ventricular arrhythmias are poorly understood. To investigate whether ion channel remodeling contributes to arrhythmogenesis in N-cadherin conditional knock-out (N-cad CKO) mice, cardiac myocyte excitability and voltage-gated potassium channel ( Kv), as well as inwardly rectifying K+ channel remodeling, were investigated in N-cad CKO cardiomyocytes by whole cell patch clamp recordings. Action potential duration was prolonged in N-cad CKO ventricle myocytes compared with wild type. Relative to wild type, I-K,I-slow density was significantly reduced consistent with decreased expression of Kv1.5 and Kv accessory protein, Kcne2, in the N-cad CKO myocytes. The decreased Kv1.5/Kcne2 expression correlated with disruption of the actin cytoskeleton and reduced cortactin at the sarcolemma. Biochemical experiments revealed that cortactin co-immunoprecipitates with Kv1.5. Finally, cortactin was required for N-cadherin-mediated enhancement of Kv1.5 channel activity in a heterologous expression system. Our results demonstrate a novel mechanistic link among the cell adhesion molecule, N-cadherin, the actin-binding scaffold protein, cortactin, and Kv channel remodeling in the heart. These data suggest that in addition to gap junction remodeling, aberrant Kv1.5 channel function contributes to the arrhythmogenic phenotype in N-cad CKO mice.	[Cheng, Lan; Yung, Aaron; Radice, Glenn L.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Radice, GL (corresponding author), Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Rm 309,Coll Bldg,1025 Walnut St, Philadelphia, PA 19107 USA.	glenn.radice@jefferson.edu		Covarrubias, Manuel/0000-0002-0881-4143; CHENG, LAN/0000-0002-3620-3366	National Institutes of Health [HL081569]; National Institutes of Health Cancer Center [5 P30 CA-56036]; American Heart Association [0440114N]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL081569 (to G. L. R.). This work was also supported in part by National Institutes of Health Cancer Center Core Grant 5 P30 CA-56036 (to the Kimmel Cancer Center) and American Heart Association Established Investigator Grant 0440114N (to G. L. R.).	Ackerman MJ, 2010, CIRC RES, V107, P457, DOI 10.1161/CIRCRESAHA.110.224592; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Brunner M, 2003, AM J PHYSIOL-HEART C, V285, pH194, DOI 10.1152/ajpheart.00971.2002; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Cunha SR, 2008, CIRC RES, V103, P779, DOI 10.1161/CIRCRESAHA.108.186460; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; El Sayegh TY, 2005, MOL BIOL CELL, V16, P5514, DOI 10.1091/mcbE05-05-0410; El Sayegh TY, 2004, J CELL SCI, V117, P5117, DOI 10.1242/jcs.01385; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; Fedida D, 2003, CIRC RES, V93, P744, DOI 10.1161/01.RES.0000096362.60730.AE; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jeron A, 2000, AM J PHYSIOL-HEART C, V278, pH1891, DOI 10.1152/ajpheart.2000.278.6.H1891; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Li HL, 2004, AM J PHYSIOL-HEART C, V286, pH319, DOI 10.1152/ajpheart.00665.2003; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Marionneau C, 2008, J MOL CELL CARDIOL, V44, P1002, DOI 10.1016/j.yjmcc.2008.03.023; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mathur R, 2006, BIOCHEM BIOPH RES CO, V342, P1, DOI 10.1016/j.bbrc.2006.01.110; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nerbonne JM, 2002, J CARDIOVASC ELECTR, V13, P406, DOI 10.1046/j.1540-8167.2002.00406.x; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Saffitz JE, 2006, J CARDIOVASC ELECTR, V17, P225, DOI 10.1111/j.1540-8167.2006.00365.x; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Shahidullah M, 2003, BIOCHEMISTRY-US, V42, P11243, DOI 10.1021/bi034738f; Shimoni Y, 1999, J PHYSIOL-LONDON, V514, P735, DOI 10.1111/j.1469-7793.1999.735ad.x; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; UNDROVINAS AI, 1995, AM J PHYSIOL-HEART C, V269, pH203, DOI 10.1152/ajpheart.1995.269.1.H203; VanWagoner DR, 1997, CIRC RES, V80, P772; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang XJ, 2002, J PHYSIOL-LONDON, V541, P411, DOI 10.1113/jphysiol.2002.019562; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	53	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20478	20489		10.1074/jbc.M111.218560	http://dx.doi.org/10.1074/jbc.M111.218560			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507952	Green Published, hybrid			2022-12-27	WOS:000291267600035
J	Jaschke, PR; Hardjasa, A; Digby, EL; Hunter, CN; Beatty, JT				Jaschke, Paul R.; Hardjasa, Amelia; Digby, Elizabeth L.; Hunter, C. Neil; Beatty, J. Thomas			A bchD (Magnesium Chelatase) Mutant of Rhodobacter sphaeroides Synthesizes Zinc Bacteriochlorophyll through Novel Zinc-containing Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM ACIDIPHILIUM-RUBRUM; CHLOROPHYLL ISOCYCLIC RING; DELTA-AMINOLEVULINIC ACID; RHODOPSEUDOMONAS-SPHEROIDES; ESCHERICHIA-COLI; PROTOPORPHYRIN CHELATASE; EARLY EVOLUTION; MG-CHELATASE; BIOSYNTHESIS; PHOTOSYNTHESIS	Heme and bacteriochlorophyll a (BChl) biosyntheses share the same pathway to protoporphyrin IX, which then branches as follows. Fe2+ chelation into the macrocycle by ferrochelatase results in heme formation, and Mg2+ addition by Mg-chelatase commits the porphyrin to BChl synthesis. It was recently discovered that a bchD (Mg-chelatase) mutant of Rhodobacter sphaeroides produces an alternative BChl in which Mg2+ is substituted by Zn2+. Zn-BChl has been found in only one other organism before, the acidophilic Acidiphilium rubrum. Our objectives in this work on the bchD mutant were to 1) elucidate the Zn-BChl biosynthetic pathway in this organism and 2) understand causes for the low amounts of Zn-BChl produced. The bchD mutant was found to contain a Zn-protoporphyrin IX pool, analogous to the Mg-protoporphyrin IX pool found in the wild type strain. Inhibition of ferrochelatase with N-methylprotoporphyrin IX caused Zn-protoporphyrin IX and Zn-BChl levels to decline by 80-90% in the bchD mutant, whereas in the wild type strain, Mg-protoporphyrin IX and Mg-BChl levels increased by 170-240%. Two early metabolites of the Zn-BChl pathway were isolated from the bchD mutant and identified as Zn-protoporphyrin IX monomethyl ester and divinyl-Zn-protochlorophyllide. Our data support a model in which ferrochelatase synthesizes Zn-protoporphyrin IX, and this metabolite is acted on by enzymes of the BChl pathway to produce Zn-BChl. Finally, the low amounts of Zn-BChl in the bchD mutant may be due, at least in part, to a bottleneck upstream of the step where divinyl-Zn-protochlorophyllide is converted to monovinyl-Zn-protochlorophyllide.	[Jaschke, Paul R.; Hardjasa, Amelia; Digby, Elizabeth L.; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of British Columbia; University of Sheffield	Beatty, JT (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	j.beatty@ubc.ca	Jaschke, Paul R/D-7244-2017	Jaschke, Paul R/0000-0003-2359-1301; Digby, Elizabeth/0000-0002-9799-0498	University of British Columbia; Pacific Century Graduate Fellowship; John Richard Turner Fellowship in Microbiology; Natural Sciences and Engineering Research Council; Killam Research Fellowship; Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish	University of British Columbia; Pacific Century Graduate Fellowship; John Richard Turner Fellowship in Microbiology; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Research Fellowship; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a University of British Columbia Graduate Fellowship, a Pacific Century Graduate Fellowship, and the John Richard Turner Fellowship in Microbiology (to P.R.J.); a Biodiversity Research: Integrative Training and Education scholarship (to A.H.) from the University of British Columbia; a Natural Sciences and Engineering Research Council Discovery Grant and a Killam Research Fellowship (to J.T.B.); and funding from the Biotechnology and Biological Sciences Research Council (United Kingdom) (to C.N.H.).	BARRETT J, 1978, BIOCHEM J, V174, P277, DOI 10.1042/bj1740277; Bauer Carl E., 2009, V28, P707; Beck Richard, 1997, Biochemical Society Transactions, V25, p77S; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; BURNHAM BF, 1963, BIOCHEM J, V87, P462, DOI 10.1042/bj0870462; Chekounova E, 2001, MOL GENET GENOMICS, V266, P363, DOI 10.1007/s004380100574; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; DAILEY HA, 1982, J BIOL CHEM, V257, P4714; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; GIBSON LCD, 1994, FEBS LETT, V352, P127, DOI 10.1016/0014-5793(94)00934-1; Gomelsky L, 2008, J BACTERIOL, V190, P8106, DOI 10.1128/JB.01094-08; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; Hartwich G, 1998, J AM CHEM SOC, V120, P3675, DOI 10.1021/ja970874u; Ikegami I, 2005, PLANT CELL PHYSIOL, V46, P729, DOI 10.1093/pcp/pci079; Jacobs JM, 1998, TOXICOLOGY, V125, P95, DOI 10.1016/S0300-483X(97)00164-9; Jaschke PR, 2007, BIOCHEMISTRY-US, V46, P12491, DOI 10.1021/bi701407k; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; JONES MS, 1970, BIOCHEM J, V119, P453, DOI 10.1042/bj1190453; Kanazireva E, 1996, GENE, V170, P149, DOI 10.1016/0378-1119(96)00845-1; Kannangara CG, 1997, MOL GEN GENET, V254, P85, DOI 10.1007/s004380050394; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KIKUCHI G, 1958, BIOCHIM BIOPHYS ACTA, V28, P219, DOI 10.1016/0006-3002(58)90461-X; Labbe RF, 1999, CLIN CHEM, V45, P2060; LASCELLES J, 1960, J GEN MICROBIOL, V23, P487, DOI 10.1099/00221287-23-3-487; Lascelles J, 1968, Biochem Soc Symp, V28, P49; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; Lide D. R., 2009, CRC HDB CHEM PHYS, V90th, P8; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Lundqvist J, 2009, J STRUCT BIOL, V167, P227, DOI 10.1016/j.jsb.2009.06.013; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Masuda T, 1999, J BIOL CHEM, V274, P33594, DOI 10.1074/jbc.274.47.33594; Masuda T, 2006, ANAL BIOCHEM, V355, P307, DOI 10.1016/j.ab.2006.04.008; MAZANOWSKA AM, 1966, BIOCHEM J, V98, P117, DOI 10.1042/bj0980117; MOODY MD, 1985, J BACTERIOL, V161, P1074, DOI 10.1128/JB.161.3.1074-1079.1985; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; NEIDLE EL, 1993, J BACTERIOL, V175, P2304, DOI 10.1128/JB.175.8.2304-2313.1993; NIEDERMAN RA, 1976, BIOCHIM BIOPHYS ACTA, V440, P429, DOI 10.1016/0005-2728(76)90076-1; NISBET EG, 1995, NATURE, V373, P479, DOI 10.1038/373479a0; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Pappas CT, 2004, J BACTERIOL, V186, P4748, DOI 10.1128/JB.186.14.4748-4758.2004; PRETLOW TP, 1967, BIOCHIM BIOPHYS ACTA, V148, P629, DOI 10.1016/0304-4165(67)90036-0; Rebeiz CA, 2002, HEME CHLOROPHYLL BIL, P111; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; Sambrook J., 2002, MOL CLONING LAB MANU; Sawicki A, 2008, J BIOL CHEM, V283, P31294, DOI 10.1074/jbc.M805792200; Scheumann V, 1996, EUR J BIOCHEM, V242, P163, DOI 10.1111/j.1432-1033.1996.0163r.x; Scheumann V, 1996, Z NATURFORSCH C, V51, P185; SHIOI Y, 1988, ARCH BIOCHEM BIOPHYS, V267, P69, DOI 10.1016/0003-9861(88)90009-4; STILLMAN LC, 1978, ANAL BIOCHEM, V91, P166, DOI 10.1016/0003-2697(78)90827-8; TUBOI S, 1970, ARCH BIOCHEM BIOPHYS, V138, P155, DOI 10.1016/0003-9861(70)90294-8; WACKER WEC, 1965, BIOCHEMISTRY-US, V4, P940, DOI 10.1021/bi00881a021; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004; Williams RJP, 1997, CELL MOL LIFE SCI, V53, P816, DOI 10.1007/s000180050102; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Willows Robert D., 2009, V28, P57; Wohlleben W, 2002, CHEM BIOL, V9, P1163, DOI 10.1016/S1074-5521(02)00267-3; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Xiong J, 2002, J MOL BIOL, V322, P1025, DOI 10.1016/S0022-2836(02)00822-7; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; YUBISUI T, 1972, ARCH BIOCHEM BIOPHYS, V150, P77, DOI 10.1016/0003-9861(72)90012-4; ZEILSTRARYALLS JH, 1995, J BACTERIOL, V177, P6422, DOI 10.1128/jb.177.22.6422-6431.1995	67	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20313	20322		10.1074/jbc.M110.212605	http://dx.doi.org/10.1074/jbc.M110.212605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502322	Green Published, hybrid			2022-12-27	WOS:000291267600019
J	Qi, XF; Jiang, JJ; Zhu, MQ; Wu, QY				Qi, Xiaofei; Jiang, Jingjing; Zhu, Mingqing; Wu, Qingyu			Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE PROTEASES; PROATRIAL NATRIURETIC PEPTIDE; PLASMA SOLUBLE CORIN; ZYMOGEN ACTIVATION; MOLECULAR-CLONING; CARDIAC-MUSCLE; HEART-FAILURE; EXPRESSION; GENE; HYPERTENSION	Corin is a cardiac serine protease that activates natriuretic peptides. It consists of an N-terminal cytoplasmic tail, a transmembrane domain, and an extracellular region with a C-terminal trypsin-like protease domain. The transmembrane domain anchors corin on the surface of cardiomyocytes. To date, the function of the corin cytoplasmic tail remains unknown. By examining the difference between human and mouse corin cytoplasmic tails, analyzing their gene sequences, and verifying mRNA expression in hearts, we show that both human and mouse corin genes have alternative exons encoding different cytoplasmic tails. Human corin isoforms E1 and E1a have 45 and 15 amino acids, respectively, in their cytoplasmic tails. In transfected HEK 293 cells and HL-1 cardiomyocytes, corin isoforms E1 and E1a were expressed at similar levels. Compared with isoform E1a, however, isoform E1 was more active in processing natriuretic peptides. By cell surface labeling, glycosidase digestion, Western blotting, and flow cytometry, we found that corin isoform E1 was activated more readily as a result of more efficient cell surface targeting. By mutagenesis, we identified a DDNN motif in the cytoplasmic tail of isoform E1 (which is absent in isoform E1a) that promotes corin surface targeting in both HEK 293 and HL-1 cells. Our data indicate that the sequence in the cytoplasmic tail plays an important role in corin cell surface targeting and zymogen activation.	[Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Qi, Xiaofei; Jiang, Jingjing; Wu, Qingyu] Cleveland Clin, Dept Nephrol, Cleveland, OH 44195 USA; [Qi, Xiaofei; Jiang, Jingjing; Wu, Qingyu] Cleveland Clin, Dept Hypertens, Cleveland, OH 44195 USA; [Qi, Xiaofei; Zhu, Mingqing; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou 215123, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Soochow University - China	Wu, QY (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315	National Institutes of Health [HL089298, HL089298-S1, HD064634]; Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; Jiangsu Higher Education Institutions; National Natural Science Foundation of China [31070716, 30811130467]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089298, HL089298-S1, and HD064634. This work was also supported by grants from the Ralph Wilson Medical Foundation, the Bakken Heart-Brain Institute, and the Priority Academic Program Development of Jiangsu Higher Education Institutions and by National Natural Science Foundation of China Grants 31070716 and 30811130467.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brown D, 2000, KIDNEY INT, V57, P816, DOI 10.1046/j.1523-1755.2000.00920.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Gladysheva IP, 2008, J MOL CELL CARDIOL, V44, P131, DOI 10.1016/j.yjmcc.2007.10.002; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jiang W, 2005, EUR J PHARMACOL, V507, P153, DOI 10.1016/j.ejphar.2004.11.023; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Knappe S, 2003, J BIOL CHEM, V278, P52363, DOI 10.1074/jbc.M309991200; Langenickel TH, 2004, AM J PHYSIOL-HEART C, V287, pH1516, DOI 10.1152/ajpheart.00947.2003; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; Mikosch M, 2009, CURR OPIN PLANT BIOL, V12, P685, DOI 10.1016/j.pbi.2009.09.020; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Rame JE, 2009, CIRC-HEART FAIL, V2, P541, DOI 10.1161/CIRCHEARTFAILURE.109.866822; Shrestha K, 2010, J CARD FAIL, V16, P621, DOI 10.1016/j.cardfail.2010.03.010; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tran KL, 2004, AM J PHYSIOL-HEART C, V287, pH1625, DOI 10.1152/ajpheart.00298.2004; Tsukada T, 2006, GEN COMP ENDOCR, V147, P31, DOI 10.1016/j.ygcen.2005.09.009; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamaguchi N, 2002, J BIOL CHEM, V277, P6806, DOI 10.1074/jbc.M103645200; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926	46	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20963	20969		10.1074/jbc.M110.217570	http://dx.doi.org/10.1074/jbc.M110.217570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518754	hybrid, Green Published			2022-12-27	WOS:000291267600080
J	Verdegem, D; Badillo, A; Wieruszeski, JM; Landrieu, I; Leroy, A; Bartenschlager, R; Penin, F; Lippens, G; Hanoulle, X				Verdegem, Dries; Badillo, Aurelie; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Leroy, Arnaud; Bartenschlager, Ralf; Penin, Francois; Lippens, Guy; Hanoulle, Xavier			Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic alpha-Helical Propensity and Is a Substrate of Cyclophilin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APOLIPOPROTEIN-E; REPLICATION IN-VITRO; NONSTRUCTURAL PROTEIN; CYCLOSPORINE-A; RNA REPLICATION; CORE PROTEIN; ISOMERASE ACTIVITY; ESCHERICHIA-COLI; BINDING-PROTEIN; LIPID DROPLET	Nonstructural protein 5A (NS5A) is essential for hepatitis C virus (HCV) replication and constitutes an attractive target for antiviral drug development. Although structural data for its in-plane membrane anchor and domain D1 are available, the structure of domains 2 (D2) and 3 (D3) remain poorly defined. We report here a comparative molecular characterization of the NS5A-D3 domains of the HCV JFH-1 (genotype 2a) and Con1 (genotype 1b) strains. Combining gel filtration, CD, and NMR spectroscopy analyses, we show that NS5A-D3 is natively unfolded. However, NS5A-D3 domains from both JFH-1 and Con1 strains exhibit a propensity to partially fold into an alpha-helix. NMR analysis identifies two putative alpha-helices, for which a molecular model could be obtained. The amphipathic nature of the first helix and its conservation in all genotypes suggest that it might correspond to a molecular recognition element and, as such, promote the interaction with relevant biological partner(s). Because mutations conferring resistance to cyclophilin inhibitors have been mapped into NS5A-D3, we also investigated the functional interaction between NS5A-D3 and cyclophilin A (CypA). CypA indeed interacts with NS5A-D3, and this interaction is completely abolished by cyclosporin A. NMR heteronuclear exchange experiments demonstrate that CypA has in vitro peptidyl-prolyl cis/trans-isomerase activity toward some, but not all, of the peptidyl-prolyl bonds in NS5A-D3. These studies lead to novel insights into the structural features of NS5A-D3 and its relationships with CypA.	[Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] Univ Lille Nord France, F-59000 Lille, France; [Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] IFR 147, UGSF, USTL, F-59650 Villeneuve Dascq, France; [Badillo, Aurelie; Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR BioSci Gerland Lyon Sud, F-69397 Lyon, France; [Leroy, Arnaud] Univ Paris 11, Lab Biochim Appl, Fac Pharm, F-92296 Chatenay Malabry, France; [Bartenschlager, Ralf] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg	Hanoulle, X (corresponding author), Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct,IFR 147, F-59655 Villeneuve Dascq, France.	xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Landrieu, Isabelle/AAF-8495-2019; Hanoulle, Xavier/AAK-7236-2021; Bartenschlager, Ralf/L-2582-2015	Landrieu, Isabelle/0000-0002-4883-2637; Hanoulle, Xavier/0000-0002-3755-2680; Lippens, Guy/0000-0002-8236-0901; Bartenschlager, Ralf/0000-0001-5601-9307	French Centre National de la Recherche Scientifique; University of Lille; University of Lyon; French National Agency for Research on AIDS and Viral Hepatitis; European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance); Region Nord-Pas de Calais (France); CNRS; University of Lille 1; University of Lille 2; Institut Pasteur de Lille; German Research Council [SFB 638, A5]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Lille; University of Lyon; French National Agency for Research on AIDS and Viral Hepatitis(ANRS); European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance)(European CommissionEuropean Commission Joint Research Centre); Region Nord-Pas de Calais (France)(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; University of Lille 2; Institut Pasteur de Lille; German Research Council(German Research Foundation (DFG))	This work was supported by the French Centre National de la Recherche Scientifique and Universities of Lille and Lyon, and grants from the French National Agency for Research on AIDS and Viral Hepatitis and from the European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance). The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), CNRS, the Universities of Lille 1 and Lille 2, and the Institut Pasteur de Lille.; Supported by the German Research Council (SFB 638, Teilprojekt A5).	Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CammersGoodwin A, 1996, J AM CHEM SOC, V118, P3082, DOI 10.1021/ja952900z; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Landrieu I, 2010, BIOCHEMISTRY-US, V49, P4679, DOI 10.1021/bi1003266; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lin C, 1997, J VIROL, V71, P6465, DOI 10.1128/JVI.71.9.6465-6471.1997; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MONTEILHET C, 1993, GENE, V125, P223, DOI 10.1016/0378-1119(93)90333-X; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; *NIH, 2002, HEPATOLOGY S1, V36, pS2; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WANG AC, 1995, J AM CHEM SOC, V117, P1810, DOI 10.1021/ja00111a021; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v	80	79	79	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20441	20454		10.1074/jbc.M110.182436	http://dx.doi.org/10.1074/jbc.M110.182436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489988	Green Published, hybrid			2022-12-27	WOS:000291267600032
J	Tarallo, V; Lepore, L; Marcellini, M; Dal Piaz, F; Tudisco, L; Ponticelli, S; Lund, FW; Roepstorff, P; Orlandi, A; Pisano, C; De Tommasi, N; De Falco, S				Tarallo, Valeria; Lepore, Laura; Marcellini, Marcella; Dal Piaz, Fabrizio; Tudisco, Laura; Ponticelli, Salvatore; Lund, Frederik Wendelboe; Roepstorff, Peter; Orlandi, Augusto; Pisano, Claudio; De Tommasi, Nunziatina; De Falco, Sandro			The Biflavonoid Amentoflavone Inhibits Neovascularization Preventing the Activity of Proangiogenic Vascular Endothelial Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CHEMOPREVENTION; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; FACTOR RECEPTOR-1; CRYSTAL-STRUCTURE; VEGF FAMILY; PATHWAYS; APIGENIN; THERAPY; PROTEIN	The proangiogenic members of VEGF family and related receptors play a central role in the modulation of pathological angiogenesis. Recent insights indicate that, due to the strict biochemical and functional relationship between VEGFs and related receptors, the development of a new generation of agents able to target contemporarily more than one member of VEGFs might amplify the antiangiogenic response representing an advantage in term of therapeutic outcome. To identify molecules that are able to prevent the interaction of VEGFs with related receptors, we have screened small molecule collections consisting of > 100 plant extracts. Here, we report the isolation and identification from an extract of the Malian plant Chrozophora senegalensis of the biflavonoid amentoflavone as an antiangiogenic bioactive molecule. Amentoflavone can to bind VEGFs preventing the interaction and phosphorylation of VEGF receptor 1 and 2 (VEGFR-1, VEGFR-2) and to inhibit endothelial cell migration and capillary-like tube formation induced by VEGF-A or placental growth factor 1 (PlGF-1) at low mu M concentration. In vivo, amentoflavone is able to inhibit VEGF-A-induced chorioallantoic membrane neovascularization as well as tumor growth and associated neovascularization, as assessed in orthotropic melanoma and xenograft colon carcinoma models. In addition structural studies performed on the amentoflavone. PlGF-1 complex have provided evidence that this biflavonoid effectively interacts with the growth factor area crucial for VEGFR-1 receptor recognition. In conclusion, our results demonstrate that amentoflavone represents an interesting new antiangiogenic molecule that is able to prevent the activity of proangiogenic VEGF family members and that the biflavonoid structure is a new chemical scaffold to develop powerful new antiangiogenic molecules.	[Lepore, Laura; Dal Piaz, Fabrizio; De Tommasi, Nunziatina] Univ Salerno, Dept Pharmaceut Sci, I-84084 Salerno, Italy; [Tarallo, Valeria; Tudisco, Laura; Ponticelli, Salvatore; De Falco, Sandro] CNR, Angiogenesis Lab, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Tarallo, Valeria; Tudisco, Laura; Ponticelli, Salvatore; De Falco, Sandro] Inst Genet & Biophys, Stem Cell Fate Lab, I-80131 Naples, Italy; [Marcellini, Marcella; Pisano, Claudio] Sigma Tau Pharmaceut Co, Ind Farmaceut Riunite, Res & Dev Oncol Area, I-00040 Rome, Italy; [Lund, Frederik Wendelboe; Roepstorff, Peter] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Orlandi, Augusto] Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Inst Pathol Anat, I-00133 Rome, Italy	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Leadiant Biosciences; University of Southern Denmark; University of Rome Tor Vergata	Dal Piaz, F (corresponding author), Univ Salerno, Dept Pharmaceut Sci, I-84084 Salerno, Italy.	fdalpiaz@unisa.it; defalco@igb.cnr.it	Orlandi, Augusto/AHE-8753-2022; Dal Piaz, Fabrizio/D-1843-2010; De Falco, Sandro/P-6724-2015; De Tommasi, Nunziatina/A-7768-2011	Dal Piaz, Fabrizio/0000-0002-8643-5018; De Tommasi, Nunziatina/0000-0003-1707-4156; De Falco, Sandro/0000-0002-6501-1697; orlandi, augusto/0000-0001-7202-5854; Tarallo, Valeria/0000-0002-6920-4402; Lund, Frederik Wendelboe/0000-0002-8261-0309; pisano, claudio/0000-0001-8624-2980	Associazione Italiana Ricerca sul Cancro [4840]; Telethon Italy [GGP08062]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon Italy(Fondazione Telethon)	This work was supported by Associazione Italiana Ricerca sul Cancro Grant 4840 and Telethon Italy Grant GGP08062 (to S. D. F).	Albini A, 2007, CLIN CANCER RES, V13, P4320, DOI 10.1158/1078-0432.CCR-07-0069; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHOLBI MR, 1991, EXPERIENTIA, V47, P195, DOI 10.1007/BF01945426; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; Fang J, 2005, FASEB J, V19, P342, DOI 10.1096/fj.04-2175com; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gigante B, 2006, FASEB J, V20, P970, DOI 10.1096/fj.05-4481fje; Gillet A, 2005, STRUCTURE, V13, P483, DOI 10.1016/j.str.2005.01.009; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guruvayoorappan C, 2008, BIOCHEMISTRY-MOSCOW+, V73, P209, DOI 10.1134/S0006297908020132; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim HK, 1998, ARCH PHARM RES, V21, P406, DOI 10.1007/BF02974634; Kim HP, 2008, ARCH PHARM RES, V31, P265, DOI 10.1007/s12272-001-1151-3; Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3; Lin YM, 1999, PLANTA MED, V65, P120, DOI 10.1055/s-1999-13971; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Ma SC, 2001, BIOL PHARM BULL, V24, P311, DOI 10.1248/bpb.24.311; MAGLIONE D, 1993, ONCOGENE, V8, P925; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Osada M, 2004, FEBS LETT, V575, P59, DOI 10.1016/j.febslet.2004.08.036; Patel D, 2007, INT J ONCOL, V30, P233; Ponticelli S, 2008, PLANTA MED, V74, P401, DOI 10.1055/s-2008-1034346; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Renzone Giovanni, 2007, Current Proteomics, V4, P1; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Tarallo V, 2010, CANCER RES, V70, P1804, DOI 10.1158/0008-5472.CAN-09-2609; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381	45	32	33	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19641	19651		10.1074/jbc.M110.186239	http://dx.doi.org/10.1074/jbc.M110.186239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471210	Green Published, hybrid			2022-12-27	WOS:000291027700047
J	Tominaga, T; Abe, H; Ueda, O; Goto, C; Nakahara, K; Murakami, T; Matsubara, T; Mima, A; Nagai, K; Araoka, T; Kishi, S; Fukushima, N; Jishage, K; Doi, T				Tominaga, Tatsuya; Abe, Hideharu; Ueda, Otoya; Goto, Chisato; Nakahara, Kunihiko; Murakami, Taichi; Matsubara, Takeshi; Mima, Akira; Nagai, Kojiro; Araoka, Toshikazu; Kishi, Seiji; Fukushima, Naoshi; Jishage, Kou-ichi; Doi, Toshio			Activation of Bone Morphogenetic Protein 4 Signaling Leads to Glomerulosclerosis That Mimics Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; MESANGIAL MATRIX EXPANSION; GROWTH-FACTOR-BETA; GLOMERULAR BASEMENT-MEMBRANE; GENE-EXPRESSION; ANGIOTENSIN-II; IV COLLAGEN; RECEPTOR; MOUSE; CELLS	Diabetic nephropathy (DN) is the most common cause of chronic kidney disease. We have previously reported that Smad1 transcriptionally regulates the expression of extracellular matrix (ECM) proteins in DN. However, little is known about the regulatory mechanisms that induce and activate Smad1. Here, bone morphogenetic protein 4 (Bmp4) was found to up-regulate the expression of Smad1 in mesangial cells and subsequently to phosphorylate Smad1 downstream of the advanced glycation end product-receptor for advanced glycation end product signaling pathway. Moreover, Bmp4 utilized Alk3 and affected the activation of Smad1 and Col4 expressions in mesangial cells. In the diabetic mouse, Bmp4 was remarkably activated in the glomeruli, and the mesangial area was expanded. To elucidate the direct function of Bmp4 action in the kidneys, we generated transgenic mice inducible for the expression of Bmp4. Tamoxifen treatment dramatically induced the expression of Bmp4, especially in the glomeruli of the mice. Notably, in the nondiabetic condition, the mice exhibited not only an expansion of the mesangial area and thickening of the basement membrane but also remarkable albuminuria, which are consistent with the distinct glomerular injuries in DN. ECM protein overexpression and activation of Smad1 in the glomeruli were also observed in the mice. The mesangial expansion in the mice was significantly correlated with albuminuria. Furthermore, the heterozygous Bmp4 knock-out mice inhibited the glomerular injuries compared with wild type mice in diabetic conditions. Here, we show that BMP4 may act as an upstream regulatory molecule for the process of ECM accumulation in DN and thereby reveals a new aspect of the molecular mechanisms involved in DN.	[Tominaga, Tatsuya; Abe, Hideharu; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Araoka, Toshikazu; Kishi, Seiji; Doi, Toshio] Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan; [Ueda, Otoya; Goto, Chisato; Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan; [Nakahara, Kunihiko] Hubit Genomix Inc, Tokyo 1020092, Japan; [Fukushima, Naoshi] Chugai Pharmaceut Co Ltd, Tokyo 1030092, Japan; [Matsubara, Takeshi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068507, Japan	Tokushima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kyoto University	Doi, T (corresponding author), Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan.	doi@clin.med.tokushima-u.ac.jp			Japan Society for the Promotion of Science [21591033, 19590973, 22390169]; Japan Science and Technology Agency [AS2115050G]; Mitsui Sumitomo Welfare Foundation; Kidney Foundation of Japan [JKFB09-41]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mitsui Sumitomo Welfare Foundation; Kidney Foundation of Japan	This work was supported by Grants-in-aid for Scientific Research of the Japan Society for the Promotion of Science 21591033, 19590973, and 22390169, Japan Science and Technology Agency Grant AS2115050G, the Mitsui Sumitomo Welfare Foundation, and The Kidney Foundation of Japan Grant JKFB09-41.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; [Anonymous], 1993, NEW ENGL J MED, V329, P977; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; Fogo AB, 2000, AM J KIDNEY DIS, V35, P179, DOI 10.1016/S0272-6386(00)70324-6; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Fukami K, 2004, KIDNEY INT, V66, P2137, DOI 10.1111/j.1523-1755.2004.66004.x; HASSLACHER C, 1984, DIABETOLOGIA, V26, P150; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huang SX, 2000, GENE, V258, P43, DOI 10.1016/S0378-1119(00)00396-6; Iehara N, 1996, KIDNEY INT, V50, P1166, DOI 10.1038/ki.1996.424; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; KANWAR YS, 1983, P NATL ACAD SCI-BIOL, V80, P2272, DOI 10.1073/pnas.80.8.2272; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; McCauley DW, 2004, EVOL DEV, V6, P411, DOI 10.1111/j.1525-142X.2004.04054.x; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Miyazaki Y, 2006, BIOCHEM BIOPH RES CO, V340, P681, DOI 10.1016/j.bbrc.2005.12.055; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohashi S, 2004, J BIOL CHEM, V279, P19816, DOI 10.1074/jbc.M310428200; PIRART J, 1977, DIABETES METAB, V3, P245; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Yamamoto Y, 2005, ANN NY ACAD SCI, V1043, P562, DOI 10.1196/annals.1333.064; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	49	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20109	20116		10.1074/jbc.M110.179382	http://dx.doi.org/10.1074/jbc.M110.179382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471216	Green Published, hybrid			2022-12-27	WOS:000291027700087
J	Back, JH; Rezvani, HR; Zhu, YC; Guyonnet-Duperat, V; Athar, M; Ratner, D; Kim, AL				Back, Jung Ho; Rezvani, Hamid Reza; Zhu, Yucui; Guyonnet-Duperat, Veronique; Athar, Mohammad; Ratner, Desiree; Kim, Arianna L.			Cancer Cell Survival Following DNA Damage-mediated Premature Senescence Is Regulated by Mammalian Target of Rapamycin (mTOR)-dependent Inhibition of Sirtuin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CHEMOTHERAPY; ARREST; PRAS40; STRESS; TRANSLATION; PROOXIDANT; INDUCTION; SUBSTRATE; PATHWAY	DNA-damaging agents can induce premature senescence in cancer cells, which contributes to the static effects of cancer. However, senescent cancer cells may re-enter the cell cycle and lead to tumor relapse. Understanding the mechanisms that control the viability of senescent cells may be helpful in eliminating these cells before they can regrow. Treating human squamous cell carcinoma (SCC) cells with the anti-cancer compounds, resveratrol and doxorubicin, triggered p53-independent premature senescence by invoking oxidative stress-mediated DNA damage. This process involved the mTOR-dependent phosphorylation of SIRT1 at serine 47, resulting in the inhibition of the deacetylase activity of SIRT1. SIRT1 phosphorylation caused concomitant increases in p65/RelA NF-kappa B acetylation and the expression of an anti-apoptotic Bfl-1/A1. SIRT1 physically interacts with the mTOR-Raptor complex, and a single amino acid substitution in the TOS (TOR signaling) motif in the SIRT1 prevented Ser-47 phosphorylation and Bfl-1/A1 induction. The pharmacologic and genetic inhibition of mTOR, unphosphorylatable S47A, or F474A TOS mutants restored SIRT1 deacetylase activity, blocked Bfl-1/A1 induction, and sensitized prematurely senescent SCC cells for apoptosis. We further show that the treatment of UVB-induced SCCs with doxorubicin transiently stabilized tumor growth but was followed by tumor regrowth upon drug removal in p53(+/-)/SKH-1 mice. The subsequent treatment of stabilized SCCs with rapamycin decreased tumor size and induced caspase-3 activation. These results demonstrate that the inhibition of SIRT1 by mTOR fosters survival of DNA damage-induced prematurely senescent SCC cells via Bfl-1/A1 in the absence of functional p53.	[Back, Jung Ho; Zhu, Yucui; Ratner, Desiree; Kim, Arianna L.] Columbia Univ, Med Ctr, Dept Dermatol, New York, NY 10032 USA; [Rezvani, Hamid Reza] Inserm 1035, F-33076 Bordeaux, France; [Rezvani, Hamid Reza; Guyonnet-Duperat, Veronique] Univ Bordeaux Segalen, SFR TransBioMed, F-33076 Bordeaux, France; [Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35205 USA	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Alabama System; University of Alabama Birmingham	Kim, AL (corresponding author), 1150 St Nicholas St 318A, New York, NY 10032 USA.	ak309@columbia.edu	Rezvani, Hamid Reza/G-3734-2013	Rezvani, Hamid Reza/0000-0001-8067-1338; Ratner, Desiree/0000-0002-1217-1929	National Institutes of Health [R01 ES015323, K01-AR048582, R03 CA125855]; Irving Scholar Award; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA138998, R03CA125855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Scholar Award; Skin Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES015323 (to M. A.) and K01-AR048582 and R03 CA125855 (to A. L. K.). This work was also supported by an Irving Scholar Award and Skin Cancer Foundation grant (to A. L. K.).	Ami AS, 2006, FEBS LETT, V580, P533, DOI 10.1016/j.febslet.2005.12.059; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Elmore LW, 2005, CLIN CANCER RES, V11, P2637, DOI 10.1158/1078-0432.CCR-04-1462; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Jacobs JJL, 2005, CELL CYCLE, V4, P1364, DOI 10.4161/cc.4.10.2104; Kim AL, 2002, J INVEST DERMATOL, V118, P818, DOI 10.1046/j.1523-1747.2002.01734.x; Kim AL, 2006, EXP DERMATOL, V15, P538, DOI 10.1111/j.1600-0625.2006.00445.x; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Ling YH, 2000, ANTICANCER RES, V20, P693; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Macip S, 2006, ONCOGENE, V25, P6037, DOI 10.1038/sj.onc.1209629; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Ota H, 2009, J AM COLL CARDIOL, V53, P2298, DOI 10.1016/j.jacc.2009.01.072; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Rezvani HR, 2011, J CLIN INVEST, V121, P195, DOI 10.1172/JCI40087; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Roninson IB, 2003, CANCER RES, V63, P2705; Saretzki G, 2010, CURR PHARM DESIGN, V16, P79, DOI 10.2174/138161210789941874; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; te Poele RH, 2002, CANCER RES, V62, P1876; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; van Kranen HJ, 2005, MUTAT RES-FUND MOL M, V571, P81, DOI 10.1016/j.mrfmmm.2004.07.018; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	46	54	56	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19100	19108		10.1074/jbc.M111.240598	http://dx.doi.org/10.1074/jbc.M111.240598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471201	Green Published, hybrid			2022-12-27	WOS:000290785700079
J	Bei, L; Huang, WQ; Wang, H; Shah, C; Horvath, E; Eklund, E				Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth			HoxA10 Activates CDX4 Transcription and Cdx4 Activates HOXA10 Transcription in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; HUMAN HEMATOPOIETIC-CELLS; GENE-EXPRESSION; HOMEOBOX GENE; DNA-BINDING; IN-VITRO; DIRECT TARGET; STEM-CELLS; LEUKEMIA; MLL	HoxA10 is a homeodomain transcription factor that influences a number of developmental processes, including hematopoiesis. During definitive hematopoiesis, expression of HoxA10 is maximal in committed myeloid progenitor cells and decreases as differentiation proceeds. Aberrantly increased expression of HoxA10 was found in bone marrow cells in a poor prognosis subset of human acute myeloid leukemia (AML). Consistent with this, AML developed in mice transplanted with HoxA10-overexpressing bone marrow. However, relatively few target genes have been identified that explain the role of HoxA10 in leukemogenesis. In the current study, we identified CDX4 as a HoxA10 target gene. Cdx4 is a homeodomain transcription factor that was also implicated in myeloid leukemogenesis. Although relatively few Cdx4 target genes have been identified, Cdx4 was known to influence HOX gene transcription. We identified a HoxA10-binding cis element in the CDX4 promoter that activated transcription. We also identified a Cdx4-binding cis element that activated the HOXA10 promoter. Therefore, increased Cdx4 expression in HoxA10-overexpressing cells augmented transcription of the endogenous HOXA10 gene. Increased endogenous HoxA10 in these cells induced additional CDX4 transcription. We found that Cdx4 influenced transcription of HoxA10 target genes in a HoxA10-dependent manner. Similarly, HoxA10 influenced transcription of HOX genes in a Cdx4-dependent manner. We previously found that HoxA10-overexpressing myeloid progenitors were hypersensitive to a variety of cytokines. In the current studies, we found that Cdx4 knockdown decreased cytokine hypersensitivity of HoxA10-overexpressing cells. Therefore, these studies identified a positive feedback relationship between HoxA10 and Cdx4, which potentially amplified the contribution of either transcription factor to the pathogenesis of AML.	[Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bei, Ling; Huang, Weiqi; Wang, Hao; Shah, Chirag; Horvath, Elizabeth; Eklund, Elizabeth] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Huang, Weiqi; Horvath, Elizabeth; Eklund, Elizabeth] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, E (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Shah, Chirag/C-6770-2011	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717 (to E. E.). This work was also supported by a Veterans Affairs Merit Review (to E. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Hu YL, 2007, BLOOD, V109, P4732, DOI 10.1182/blood-2006-08-043356; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KOO S, 2011, HAEMATOLOGI IN PRESS; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	45	19	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19047	19064		10.1074/jbc.M110.213983	http://dx.doi.org/10.1074/jbc.M110.213983			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471217	Green Published, hybrid			2022-12-27	WOS:000290785700075
J	Piette, AS; Derua, R; Waelkens, E; Boutry, M; Duby, G				Piette, Anne-Sophie; Derua, Rita; Waelkens, Etienne; Boutry, Marc; Duby, Geoffrey			A Phosphorylation in the C-terminal Auto-inhibitory Domain of the Plant Plasma Membrane H+-ATPase Activates the Enzyme with No Requirement for Regulatory 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PROTON PUMP ATPASE; PHOSPHOPROTEOMIC ANALYSIS; BINDING; ARABIDOPSIS; RESIDUES; YEAST; TRANSFORMATION; FUSICOCCIN; HEXAMER	The plant plasma membrane H+-ATPase is regulated by an auto-inhibitory C-terminal domain that can be displaced by phosphorylation of the penultimate residue, a Thr, and the subsequent binding of 14-3-3 proteins. By mass spectrometric analysis of plasma membrane H+-ATPase isoform 2 (PMA2) isolated from Nicotiana tabacum plants and suspension cells, we identified a new phosphorylation site, Thr-889, in a region of the C-terminal domain upstream of the 14-3-3 protein binding site. This residue was mutated into aspartate or alanine, and the mutated H+-ATPases expressed in the yeast Saccharomyces cerevisiae. Unlike wild-type PMA2, which could replace the yeast H+-ATPases, the PMA2-Thr889Ala mutant did not allow yeast growth, whereas the PMA2-Thr889Asp mutant resulted in improved growth and increased H+-ATPase activity despite reduced phosphorylation of the PMA2 penultimate residue and reduced 14-3-3 protein binding. To determine whether the regulation taking place at Thr-889 was independent of phosphorylation of the penultimate residue and 14-3-3 protein binding, we examined the effect of combining the PMA2-Thr889Asp mutation with mutations of other residues that impair phosphorylation of the penultimate residue and/or binding of 14-3-3 proteins. The results showed that in yeast, PMA2Thr-889 phosphorylation could activate H+-ATPase if PMA2 was also phosphorylated at its penultimate residue. However, binding of 14-3-3 proteins was not required, although 14-3-3 binding resulted in further activation. These results were confirmed in N. tabacum suspension cells. These data define a new H+-ATPase activation mechanism that can take place without 14-3-3 proteins.	[Piette, Anne-Sophie; Boutry, Marc; Duby, Geoffrey] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Boutry, M (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Croix Sud 4-15, B-1348 Louvain, Belgium.	marc.boutry@uclouvain.be		Boutry, Marc/0000-0002-2315-6900	Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services); Belgian National Fund for Scientific Research; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium)	Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services) and the Belgian National Fund for Scientific Research.; Recipient of a fellowship from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium).	Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bobik K, 2010, PLANT J, V62, P291, DOI 10.1111/j.1365-313X.2010.04147.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo H, 1999, PLANT PHYSIOL, V119, P627, DOI 10.1104/pp.119.2.627; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ookura T, 2005, JARQ-JPN AGR RES Q, V39, P99, DOI 10.6090/jarq.39.99; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Speth C, 2010, EUR J CELL BIOL, V89, P145, DOI 10.1016/j.ejcb.2009.10.015; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Treco D. A., 2001, CURRENT PROTOCOLS MO; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Woloszynska M, 2003, ANN NY ACAD SCI, V986, P198, DOI 10.1111/j.1749-6632.2003.tb07160.x; Zhao RM, 1999, PLANT SCI, V149, P157, DOI 10.1016/S0168-9452(99)00155-7	33	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18474	18482		10.1074/jbc.M110.211953	http://dx.doi.org/10.1074/jbc.M110.211953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21482822	Green Published, hybrid			2022-12-27	WOS:000290785700020
J	Yanagi, K; Ashizaki, M; Yagi, H; Sakurai, K; Lee, YH; Goto, Y				Yanagi, Kotaro; Ashizaki, Mizue; Yagi, Hisashi; Sakurai, Kazumasa; Lee, Young-Ho; Goto, Yuji			Hexafluoroisopropanol Induces Amyloid Fibrils of Islet Amyloid Polypeptide by Enhancing Both Hydrophobic and Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORINE-SUBSTITUTED ALCOHOLS; ALPHA-SYNUCLEIN; PROTEIN; PEPTIDE; GROWTH; BETA(2)-MICROGLOBULIN; TRIFLUOROETHANOL; FLUORESCENCE; AGGREGATION; PROPAGATION	Although amyloid fibrils deposit with various proteins, the comprehensive mechanism by which they form remains unclear. We studied the formation of fibrils of human islet amyloid polypeptide associated with type II diabetes in the presence of various concentrations of 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) under acidic and neutral pH conditions using CD, amyloid-specific thioflavin T fluorescence, fluorescence imaging with thioflavin T, and atomic force microscopy. At low pH, the formation of fibrils was promoted by HFIP with an optimum at 5% (v/v). At neutral pH in the absence of HFIP, significant amounts of amorphous aggregates formed in addition to the fibrils. The addition of HFIP suppressed the formation of amorphous aggregates, leading to a predominance of fibrils with an optimum effect at 25% (v/v). Under both conditions, higher concentrations of HFIP dissolved the fibrils and stabilized the alpha-helical structure. The results indicate that fibrils and amorphous aggregates are different types of precipitates formed by exclusion from water-HFIP mixtures. The exclusion occurs through the combined effects of hydrophobic interactions and electrostatic interactions, both of which are strengthened by low concentrations of HFIP, and a subtle balance between the two types of interactions determines whether the fibrils or amorphous aggregates dominate. We suggest a general view of how the structure of precipitates varies dramatically from single crystals to amyloid fibrils and amorphous aggregates.	[Yanagi, Kotaro; Ashizaki, Mizue; Yagi, Hisashi; Sakurai, Kazumasa; Lee, Young-Ho; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to H.Y.).	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pechmann S, 2010, MOL BIOSYST, V6, P2490, DOI 10.1039/c005160h; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2010, J BIOL CHEM, V285, P19660, DOI 10.1074/jbc.M109.076505; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006	46	65	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23959	23966		10.1074/jbc.M111.226688	http://dx.doi.org/10.1074/jbc.M111.226688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566116	hybrid, Green Published			2022-12-27	WOS:000292294900038
J	Hsu, CY; Henry, J; Raymond, AA; Mechin, MC; Pendaries, V; Nassar, D; Hansmann, B; Balica, S; Burlet-Schiltz, O; Schmitt, AM; Takahara, H; Paul, C; Serre, G; Simon, M				Hsu, Chiung-Yueh; Henry, Julie; Raymond, Anne-Aurelie; Mechin, Marie-Claire; Pendaries, Valerie; Nassar, Dany; Hansmann, Britta; Balica, Stefana; Burlet-Schiltz, Odile; Schmitt, Anne-Marie; Takahara, Hidenari; Paul, Carle; Serre, Guy; Simon, Michel			Deimination of Human Filaggrin-2 Promotes Its Proteolysis by Calpain 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; STRATUM-CORNEUM MOISTURIZATION; CALCIUM-BINDING PROTEINS; N-TERMINAL DOMAIN; CORNIFIED ENVELOPE; PEPTIDYLARGININE DEIMINASE; EPIDERMAL DIFFERENTIATION; BARRIER FUNCTION; IMMUNOHISTOCHEMICAL LOCALIZATION; STRUCTURAL PROTEINS	Filaggrin-2 (FLG2), a member of the S100-fused type protein family, shares numerous features with filaggrin (FLG), a key protein implicated in the epidermal barrier functions. Both display a related structural organization, an identical pattern of expression and localization in human epidermis, and proteolytic processing of a large precursor. Here, we tested whether FLG2 was a substrate of calpain 1, a calcium-dependent protease directly involved in FLG catabolism. In addition, deimination being critical for FLG degradation, we analyzed whether FLG2 deimination interfered with its proteolytic processing. With this aim, we first produced a recombinant form of FLG2 corresponding to subunits B7 to B10 fused to a COOH-terminal His tag. Incubation with calpain 1 in the presence of calcium induced a rapid degradation of the recombinant protein and the production of several peptides, as shown by Coomassie Blue-stained gels and Western blotting with anti-FLG2 or anti-His antibodies. MALDI-TOF mass spectrometry confirmed this result and further evidenced the production of non-immunoreactive smaller peptides. The degradation was not observed when a calpain 1-specific inhibitor was added. The calpain cleavage sites identified by Edman degradation were regularly present in the B-type repeats of FLG2. Moreover, immunohistochemical analysis of normal human skin revealed colocalization of FLG2 and calpain 1 in the upper epidermis. Finally, the FLG2 deiminated by human peptidylarginine deiminases was shown to be more susceptible to calpain 1 than the unmodified protein. Altogether, these data demonstrate that calpain 1 is essential for the proteolytic processing of FLG2 and that deimination accelerates this process.	[Simon, Michel] CHU Purpan, CNRS, UMR5165, UPS, F-31059 Toulouse 9, France; [Hsu, Chiung-Yueh; Henry, Julie; Raymond, Anne-Aurelie; Mechin, Marie-Claire; Pendaries, Valerie; Burlet-Schiltz, Odile; Paul, Carle; Serre, Guy; Simon, Michel] Univ Toulouse, UPS, F-31000 Toulouse, France; [Raymond, Anne-Aurelie; Burlet-Schiltz, Odile] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Nassar, Dany] St Antoine Res Ctr, INSERM, U938, Paris, France; [Balica, Stefana; Paul, Carle] Larrey Hosp, Dept Dermatol, F-31059 Toulouse, France; [Schmitt, Anne-Marie] Pierre Fabre Dermocosmet, Ctr Europeen Rech Peau & Epitheliums Revetement, F-31025 Toulouse, France; [Hansmann, Britta] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Takahara, Hidenari] Ibaraki Univ, Sch Agr, Ibaraki 30003, Japan	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; University of Kiel; Schleswig Holstein University Hospital; Ibaraki University	Simon, M (corresponding author), CHU Purpan, CNRS, UMR5165, UPS, Pl Dr Baylac TSA40031, F-31059 Toulouse 9, France.	michel.simon@udear.cnrs.fr	Simon, Michel/B-7308-2011	Simon, Michel/0000-0003-3655-6329; Schiltz, Odile/0000-0002-3606-2356; HSU, Chiung-Yueh/0000-0002-4671-0919; RAYMOND, Anne-Aurelie/0000-0003-2697-9352; Takahara, Hidenari/0000-0003-2373-8588; Nassar, Dany/0000-0001-6780-0721; Paul, Carle/0000-0003-0165-5263	CNRS; INSERM; Toulouse III University; Toulouse University Hospital; Region Midi-Pyrenees; Pierre Fabre Dermo-Cosmetique; French Society for Dermatological Research (SRD)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Toulouse III University; Toulouse University Hospital; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Pierre Fabre Dermo-Cosmetique; French Society for Dermatological Research (SRD)	This work was supported by CNRS, INSERM, Toulouse III University, Toulouse University Hospital, the "Region Midi-Pyrenees," Pierre Fabre Dermo-Cosmetique and the French Society for Dermatological Research (SRD).	Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; DALE BA, 1985, AM J DERMATOPATH, V7, P65; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Elias PM, 2004, J INVEST DERMATOL, V122, pXXXVI, DOI 10.1046/j.0022-202X.2004.22233.x; Garach-Jehoshua O, 1998, BRIT J DERMATOL, V139, P950; HARDING CR, 1983, J MOL BIOL, V170, P651, DOI 10.1016/S0022-2836(83)80126-0; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; Ishida-Yamamoto A, 2002, J INVEST DERMATOL, V118, P282, DOI 10.1046/j.0022-202x.2001.01671.x; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kezic S, 2008, J INVEST DERMATOL, V128, P2117, DOI 10.1038/jid.2008.29; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; LEE SC, 1993, J INVEST DERMATOL, V100, P65, DOI 10.1111/1523-1747.ep12354504; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Listwan P, 2004, METHOD CELL BIOL, V78, P817; MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; MANABE M, 1991, DIFFERENTIATION, V48, P43, DOI 10.1111/j.1432-0436.1991.tb00241.x; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rawlings AV, 2005, J INVEST DERMATOL, V124, P1099, DOI 10.1111/j.1523-1747.2005.23726.x; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; RESING KA, 1995, J BIOL CHEM, V270, P28193; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; SIMON M, 1995, J INVEST DERMATOL, V105, P432, DOI 10.1111/1523-1747.ep12321148; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yamazaki M, 1997, BIOCHEM BIOPH RES CO, V235, P652, DOI 10.1006/bbrc.1997.6809; Zhang D, 2002, J INVEST DERMATOL, V119, P905, DOI 10.1046/j.1523-1747.2002.00133.x	59	55	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23222	23233		10.1074/jbc.M110.197400	http://dx.doi.org/10.1074/jbc.M110.197400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531719	hybrid, Green Published			2022-12-27	WOS:000292025000056
J	Taylor, MR; Conrad, JA; Wahl, D; O'Brien, PJ				Taylor, Mark R.; Conrad, John A.; Wahl, Daniel; O'Brien, Patrick J.			Kinetic Mechanism of Human DNA Ligase I Reveals Magnesium-dependent Changes in the Rate-limiting Step That Compromise Ligation Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PROTEIN APRATAXIN; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; CELLS; CDNA; STABILITY; COMPLEXES; REPAIR; RNA	DNA ligase I (LIG1) catalyzes the ligation of single-strand breaks to complete DNA replication and repair. The energy of ATP is used to form a new phosphodiester bond in DNA via a reaction mechanism that involves three distinct chemical steps: enzyme adenylylation, adenylyl transfer to DNA, and nick sealing. We used steady state and pre-steady state kinetics to characterize the minimal mechanism for DNA ligation catalyzed by human LIG1. The ATP dependence of the reaction indicates that LIG1 requires multiple Mg2+ ions for catalysis and that an essential Mg2+ ion binds more tightly to ATP than to the enzyme. Further dissection of the magnesium ion dependence of individual reaction steps revealed that the affinity for Mg2+ changes along the reaction coordinate. At saturating concentrations of ATP and Mg2+ ions, the three chemical steps occur at similar rates, and the efficiency of ligation is high. However, under conditions of limiting Mg2+, the nick-sealing step becomes rate-limiting, and the adenylylated DNA intermediate is prematurely released into solution. Subsequent adenylylation of enzyme prevents rebinding to the adenylylated DNA intermediate comprising an Achilles' heel of LIG1. These ligase-generated 5'-adenylylated nicks constitute persistent breaks that are a threat to genomic stability if they are not repaired. The kinetic and thermodynamic framework that we have determined for LIG1 provides a starting point for understanding the mechanism and specificity of mammalian DNA ligases.	[Taylor, Mark R.; Conrad, John A.; Wahl, Daniel; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu			Rackham Graduate School at the University of Michigan; Dept. of Biological Chemistry	Rackham Graduate School at the University of Michigan(University of Michigan System); Dept. of Biological Chemistry	This work was supported in part by a research grant from the Rackham Graduate School at the University of Michigan (to P. J. O.) and a graduate fellowship from the Dept. of Biological Chemistry (to M. R. T.).	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; CRONIN CN, 1987, BIOCHEM J, V247, P41, DOI 10.1042/bj2470041; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gunther T, 2006, MAGNESIUM RES, V19, P225; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LEHMAN IR, 1974, SCIENCE, V186, P790; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; OSULLIVAN WJ, 1964, BIOCHEMISTRY-US, V3, P18, DOI 10.1021/bi00889a005; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PETRINI JHJ, 1995, MOL CELL BIOL, V15, P4303; PHILLIPS RC, 1966, J AM CHEM SOC, V88, P2631, DOI 10.1021/ja00964a002; Rass U, 2008, J BIOL CHEM, V283, P33994, DOI 10.1074/jbc.M807124200; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Song W, 2009, DNA REPAIR, V8, P912, DOI 10.1016/j.dnarep.2009.05.002; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TERAOKA H, 1993, J BIOL CHEM, V268, P24156; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Waas WF, 2003, BIOCHEMISTRY-US, V42, P2960, DOI 10.1021/bi027171w; YANG SW, 1992, J BIOL CHEM, V267, P8117	29	24	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23054	23062		10.1074/jbc.M111.248831	http://dx.doi.org/10.1074/jbc.M111.248831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561855	hybrid, Green Published			2022-12-27	WOS:000292025000040
J	Yang, D; He, QY; Kim, H; Ma, WB; Zhou, SY				Yang, Dong; He, Quanyuan; Kim, Hyeung; Ma, Wenbin; Zhou Songyang			TIN2 Protein Dyskeratosis Congenita Missense Mutants Are Defective in Association with Telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; LENGTH REGULATOR; APLASTIC-ANEMIA; STEM-CELLS; COMPLEX; MUTATIONS; TRF2; MAINTENANCE; COMPONENT	Dyskeratosis congenita (DC) is a progressive and heterogeneous congenital disorder that affects multiple systems and is characterized by bone marrow failure and a triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia. One common feature for all DC patients is abnormally short telomeres and defects in telomere biology. Most of the known DC mutations have been found to affect core components of the telomerase holoenzyme. Recently, multiple mutations in the gene encoding the telomeric protein TIN2 have been identified in DC patients with intact telomerase genes, but the molecular mechanisms underlying TIN2 mutation-mediated DC remain unknown. Here, we demonstrate that ectopic expression of TIN2 with DC missense mutations in human cells led to accelerated telomere shortening, similar to the telomere phenotypes found in DC patients. However, this telomere shortening was not accompanied by changes in total telomerase activity, localization of TIN2, or telomere end protection status. Interestingly, we found TIN2 to participate in the TPP1-dependent recruitment of telomerase activity. Furthermore, DC mutations in TIN2 led to its decreased ability to associate with TERC and telomerase activity. Taken together, our data suggest that TIN2 mutations in DC may compromise the telomere recruitment of telomerase, leading to telomere shortening and the associated pathogenesis.	[Yang, Dong; He, Quanyuan; Kim, Hyeung; Ma, Wenbin; Zhou Songyang] Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ma, Wenbin; Zhou Songyang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Baylor College of Medicine; Sun Yat Sen University	Ma, WB (corresponding author), Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wma@bcm.edu; songyang@bcm.edu		Ma, Wenbin/0000-0001-8774-7593	NCI [CA133249]; NIGMS [GM081627]; Welch Foundation [Q-1673]; National Basic Research Program [2010CB945400]; NATIONAL CANCER INSTITUTE [R01CA133249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Basic Research Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133249 from NCI and Grant GM081627 from NIGMS. This work was also supported by Welch Foundation Grant Q-1673 and National Basic Research Program Grant 2010CB945400.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cerone MA, 2005, CELL CYCLE, V4, P585; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Du HY, 2009, PEDIATR BLOOD CANCER, V52, P687, DOI 10.1002/pbc.21903; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kaminker P, 2005, J CELL SCI, V118, P1321, DOI 10.1242/jcs.01709; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sasa G., 2011, CLIN GENET IN PRESS; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tsangaris E, 2008, HUM GENET, V124, P507, DOI 10.1007/s00439-008-0576-7; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wong JMY, 2004, HUM GENET, V115, P448, DOI 10.1007/s00439-004-1178-7; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	57	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23022	23030		10.1074/jbc.M111.225870	http://dx.doi.org/10.1074/jbc.M111.225870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536674	hybrid, Green Published			2022-12-27	WOS:000292025000037
J	Bhattacharya, S; Qian, J; Tzimas, C; Baker, DP; Koumenis, C; Diehl, JA; Fuchs, SY				Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Baker, Darren P.; Koumenis, Constantinos; Diehl, J. Alan; Fuchs, Serge Y.			Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCEPHALITIS-VIRUS INFECTION; ABL-EXPRESSING CELLS; ALPHA RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MAP KINASE; PATHWAY; STRESS; REPLICATION	Phosphorylation-dependent ubiquitination and degradation of the IFNAR1 chain of type I interferon (IFN) receptor is a robust and specific mechanism that limits the magnitude and duration of IFN alpha/beta signaling. Besides the ligand-inducible IFNAR1 degradation, the existence of an "inside-out" signaling that accelerates IFNAR1 turnover in the cells undergoing the endoplasmic reticulum (ER) stress and activated unfolded protein responses has been recently described. The latter pathway does not require either presence of ligands (IFN alpha/beta) or catalytic activity of Janus kinases (JAK). Instead, this pathway relies on activation of the PKR-like ER kinase (PERK) and ensuing specific priming phosphorylation of IFNAR1. Here, we describe studies that identify the stress activated p38 protein kinase as an important regulator of IFNAR1 that acts downstream of PERK. Results of the experiments using pharmacologic p38 kinase inhibitors, RNA interference approach, and cells from p38 alpha knock-out mice suggest that p38 kinase activity is required for priming phosphorylation of IFNAR1 in cells undergoing unfolded protein response. We further demonstrate an important role of p38 kinase in the ligand-independent stimulation of IFNAR1 ubiquitination and degradation and ensuing attenuation of IFN alpha/beta signaling and anti-viral defenses. We discuss the distinct importance of p38 kinase in regulating the overall responses to type I IFN in cells that have been already exposed to IFN alpha/beta versus those cells that are yet to encounter these cytokines.	[Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Koumenis, Constantinos] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Biogen; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Koumenis, Constantinos/B-2002-2008	Koumenis, Costas/0000-0001-5945-4726	National Institutes of Health [CA92900, CA142425, CA94214, CA104838]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA092900, R01CA094214, R01CA142425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 and CA142425 ( to S. Y. F.), CA94214 ( to C. K.), and CA104838 ( to J. A. D.). This work was also supported by a grant with the Pennsylvania Department of Health ( to J. A. D., C. K., and S. Y. F.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Chang WW, 2008, J VIRAL HEPATITIS, V15, P490, DOI [10.1111/j.1365-2893.2008.00968.x, 10.1111/j.1365-2893.2007.00968.x]; Chen CJ, 2002, J GEN VIROL, V83, P1897, DOI 10.1099/0022-1317-83-8-1897; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Hale KK, 1999, J IMMUNOL, V162, P4246; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Johnson RA, 1999, ANTIVIR RES, V41, P101, DOI 10.1016/S0166-3542(99)00002-9; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Karaca G, 2004, VIROLOGY, V329, P142, DOI 10.1016/j.virol.2004.08.020; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kono M, 2008, ANTIVIR RES, V77, P150, DOI 10.1016/j.antiviral.2007.10.011; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; KYRIAKIS JM, 2000, SCI STKE, pPE1; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; PFEFFER LM, 1991, PHARMACOL THERAPEUT, V52, P149, DOI 10.1016/0163-7258(91)90005-7; Pfeffer LM, 1998, CANCER RES, V58, P2489; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Si XN, 2005, J VIROL, V79, P13875, DOI 10.1128/JVI.79.22.13875-13881.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	52	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22069	22076		10.1074/jbc.M111.238766	http://dx.doi.org/10.1074/jbc.M111.238766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540188	Green Published, hybrid			2022-12-27	WOS:000291719900013
J	Kleinau, G; Mueller, S; Jaeschke, H; Grzesik, P; Neumann, S; Diehl, A; Paschke, R; Krause, G				Kleinau, Gunnar; Mueller, Sandra; Jaeschke, Holger; Grzesik, Paul; Neumann, Susanne; Diehl, Anne; Paschke, Ralf; Krause, Gerd			Defining Structural and Functional Dimensions of the Extracellular Thyrotropin Receptor Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE-RECEPTOR; THYROID-STIMULATING HORMONE; LEUCINE-RICH DOMAIN; HUMAN TSH RECEPTOR; HINGE REGION; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; INVERSE AGONIST; GONADOTROPIN RECEPTORS; SIGNAL-TRANSDUCTION	The extracellular region of the thyrotropin receptor (TSHR) can be subdivided into the leucine-rich repeat domain (LRRD) and the hinge region. Both the LRRD and the hinge region interact with thyrotropin (TSH) or autoantibodies. Structural data for the TSHR LRRD were previously determined by crystallization (amino acids Glu(30)-Thr(257), 10 repeats), but the structure of the hinge region is still undefined. Of note, the amino acid sequence (Trp(258)-Tyr(279)) following the crystallized LRRD comprises a pattern typical for leucine-rich repeats with conserved hydrophobic side chains stabilizing the repeat fold. Moreover, functional data for amino acids between the LRRD and the transmembrane domain were fragmentary. We therefore investigated systematically these TSHR regions by mutagenesis to reveal insights into their functional contribution and potential structural features. We found that mutations of conserved hydrophobic residues between Thr(257) and Tyr(279) cause TSHR misfold, which supports a structural fold of this peptide, probably as an additional leucine-rich repeat. Furthermore, we identified several new mutations of hydrophilic amino acids in the entire hinge region leading to partial TSHR inactivation, indicating that these positions are important for intramolecular signal transduction. In summary, we provide new information regarding the structural features and functionalities of extracellular TSHR regions. Based on these insights and in context with previous results, we suggest an extracellular activation mechanism that supports an intramolecular agonistic unit as a central switch for activating effects at the extracellular region toward the serpentine domain.	[Kleinau, Gunnar; Grzesik, Paul; Diehl, Anne; Krause, Gerd] Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Mueller, Sandra; Jaeschke, Holger; Paschke, Ralf] Univ Leipzig, Dept Internal Med Neurol & Dermatol, D-04103 Leipzig, Germany; [Neumann, Susanne] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany.	gkrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Diehl, Anne/0000-0001-7295-9972	National Institutes of Health, NIDDK; Medical Faculty, University of Leipzig [NBL Formel.1-108]; Deutsche Forschungsgemeinschaft [KL2334/2-1, KR1273/1-2,3, Pa 423/15-1,2]	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Faculty, University of Leipzig; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by the National Institutes of Health, NIDDK, Intramural Research Program. This work was also supported by Medical Faculty, University of Leipzig, Grant NBL Formel.1-108 and by Deutsche Forschungsgemeinschaft Grants KL2334/2-1, KR1273/1-2,3, and Pa 423/15-1,2.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Bernard MP, 1998, BIOCHEM J, V335, P611, DOI 10.1042/bj3350611; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bozon W, 2002, PROTEIN EXPRES PURIF, V25, P114, DOI 10.1006/prep.2002.1617; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Chen CR, 2009, ENDOCRINOLOGY, V150, P3401, DOI 10.1210/en.2008-1800; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; Dias JA, 2005, NATURE, V433, P203, DOI 10.1038/433203a; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; Ho SC, 2005, MOL CELL ENDOCRINOL, V245, P158, DOI 10.1016/j.mce.2005.11.008; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Ho SC, 2008, THYROID, V18, P1313, DOI 10.1089/thy.2008.0240; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Latif R, 2009, ENDOCRIN METAB CLIN, V38, P319, DOI 10.1016/j.ecl.2009.01.006; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; NUNEZ MR, 2004, THYROID, V14, P991; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders J, 2006, THYROID, V16, P1195, DOI 10.1089/thy.2006.16.1195; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	62	21	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22622	22631		10.1074/jbc.M110.211193	http://dx.doi.org/10.1074/jbc.M110.211193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525003	hybrid, Green Published			2022-12-27	WOS:000291719900069
J	Manzano, M; Reichert, ED; Polo, S; Falgout, B; Kasprzak, W; Shapiro, BA; Padmanabhan, R				Manzano, Mark; Reichert, Erin D.; Polo, Stephanie; Falgout, Barry; Kasprzak, Wojciech; Shapiro, Bruce A.; Padmanabhan, Radhakrishnan			Identification of Cis-Acting Elements in the 3 '-Untranslated Region of the Dengue Virus Type 2 RNA That Modulate Translation and Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; PARALLEL GENETIC ALGORITHM; SECONDARY STRUCTURE-ANALYSIS; CAP-DEPENDENT TRANSLATION; 3 UNTRANSLATED REGION; STEM-LOOP STRUCTURE; DE-NOVO SYNTHESIS; CYCLIZATION SEQUENCES; VIRAL REPLICATION; FLAVIVIRUS RNA	Using the massively parallel genetic algorithm for RNA folding, we show that the core region of the 3'-untranslated region of the dengue virus (DENV) RNA can form two dumbbell structures (5' - and 3' -DBs) of unequal frequencies of occurrence. These structures have the propensity to form two potential pseudoknots between identical five-nucleotide terminal loops 1 and 2 (TL1 and TL2) and their complementary pseudoknot motifs, PK2 and PK1. Mutagenesis using a DENV2 replicon RNA encoding the Renilla luciferase reporter indicated that all four motifs and the conserved sequence 2 (CS2) element within the 3' -DB are important for replication. However, for translation, mutation of TL1 alone does not have any effect; TL2 mutation has only a modest effect in translation, but translation is reduced by similar to 60% in the TL1/TL2 double mutant, indicating that TL1 exhibits a cooperative synergy with TL2 in translation. Despite the variable contributions of individual TL and PK motifs in translation, WT levels are achieved when the complementarity between TL1/PK2 and TL2/PK1 is maintained even under conditions of inhibition of the translation initiation factor 4E function mediated by LY294002 via a noncanonical pathway. Taken together, our results indicate that the cis-acting RNA elements in the core region of DENV2 RNA that include two DB structures are required not only for RNA replication but also for optimal translation.	[Shapiro, Bruce A.] NCI, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA; [Manzano, Mark; Reichert, Erin D.; Padmanabhan, Radhakrishnan] Georgetown Univ Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Polo, Stephanie; Falgout, Barry] US FDA, Ctr Biol Evaluat & Review, Bethesda, MD 20892 USA; [Kasprzak, Wojciech] SAIC Frederick Inc, Basic Sci Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; US Food & Drug Administration (FDA); Science Applications International Corporation (SAIC); SAIC-Frederick	Shapiro, BA (corresponding author), NCI, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA.	shapirbr@mail.nih.gov; rp55@georgetown.edu	Manzano, Mark/AAV-4057-2020		National Institutes of Health (NIH) [AI 57705, AI 70791]; NCI, NIH [NO1-CO-12400, HHSN261200800001E]; NCI, NIH, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057705, R01AI070791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI 57705 and AI 70791 (to R. P.); by NCI, NIH, Contracts NO1-CO-12400 and HHSN261200800001E (to W. K.); and by the Intramural Research Program of the NCI, NIH, Center for Cancer Research. This work constitutes a partial fulfillment of the requirements for the degree of Doctor of Philosophy at Georgetown University School of Medicine for E. R. and M. M.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10; Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09; Gee AH, 2006, J BIOMOL STRUCT DYN, V23, P417, DOI 10.1080/07391102.2006.10531236; Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kasprzak W, 1999, BIOINFORMATICS, V15, P16, DOI 10.1093/bioinformatics/15.1.16; Kasprzak W, 2005, NUCLEIC ACIDS RES, V33, P7151, DOI 10.1093/nar/gki1015; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Linnstaedt SD, 2006, RNA, V12, P1521, DOI 10.1261/rna.89306; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; MOHAN PM, 1991, GENE, V108, P185, DOI 10.1016/0378-1119(91)90433-C; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Olsthoorn RCL, 2001, RNA, V7, P1370; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; RIBAS JC, 1992, P NATL ACAD SCI USA, V89, P2185, DOI 10.1073/pnas.89.6.2185; Romero TA, 2006, J GEN VIROL, V87, P3291, DOI 10.1099/vir.0.82182-0; Shapiro BA, 1996, J MOL GRAPH MODEL, V14, P194, DOI 10.1016/S0263-7855(96)00063-X; Shapiro BA, 1996, COMPUT APPL BIOSCI, V12, P171; SHAPIRO BA, 1994, J SUPERCOMPUT, V8, P195, DOI 10.1007/BF01204728; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Shapiro BA, 2001, BIOINFORMATICS, V17, P137, DOI 10.1093/bioinformatics/17.2.137; Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004; Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; Suzuki R, 2008, J VIROL, V82, P6942, DOI 10.1128/JVI.00662-08; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Wu JC, 1999, J BIOMOL STRUCT DYN, V17, P581, DOI 10.1080/07391102.1999.10508388; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; Zhang JC, 2006, J VIROL, V80, P9181, DOI 10.1128/JVI.00295-06; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	75	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22521	22534		10.1074/jbc.M111.234302	http://dx.doi.org/10.1074/jbc.M111.234302			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515677	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000291719900060
J	Wu, ZY; Yu, DJ; Soong, TW; Dawe, GS; Bian, JS				Wu, Zhi-Yuan; Yu, De-Jie; Soong, Tuck Wah; Dawe, Gavin S.; Bian, Jin-Song			Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; CARDIAC TIME INTERVALS; INFANT-DEATH-SYNDROME; MENSTRUAL-CYCLE; ENDOPLASMIC-RETICULUM; GOLGI TRANSPORT; PREGNANCY; PROTEIN; PROLONGATION; ARRHYTHMIAS	The prolongation of QT intervals in both mothers and fetuses during the later period of pregnancy implies that higher levels of progesterone may regulate the function of the human ether-ago- go-related gene (HERG) potassium channel, a key ion channel responsible for controlling the length of QT intervals. Here, we studied the effect of progesterone on the expression, trafficking, and function of HERG channels and the underlying mechanism. Treatment with progesterone for 24 h decreased the abundance of the fully glycosylated form of the HERG channel in rat neonatal cardiac myocytes and HERG-HEK293 cells, a cell line stably expressing HERG channels. Progesterone also concentration-dependently decreased HERG current density, but had no effect on voltage-gated L-type Ca2+ and K+ channels. Immunofluorescence microscopy and Western blot analysis show that progesterone preferentially decreased HERG channel protein abundance in the plasma membrane, induced protein accumulation in the dilated endoplasmic reticulum (ER), and increased the protein expression of C/EBP homologous protein, a hallmark of ER stress. Application of 2-hydroxypropyl-beta-cyclodextrin (a sterol-binding agent) or overexpression of Rab9 rescued the progesterone-induced HERG trafficking defect and ER stress. Disruption of intracellular cholesterol homeostasis with simvastatin, imipramine, or exogenous application of cholesterol mimicked the effect of progesterone on HERG channel trafficking. Progesterone may impair HERG channel folding in the ER and/or block its trafficking to the Golgi complex by disrupting intracellular cholesterol homeostasis. Our findings may reveal a novel molecular mechanism to explain the QT prolongation and high risk of developing arrhythmias during late pregnancy.	[Wu, Zhi-Yuan; Dawe, Gavin S.; Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Yu, De-Jie; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Bian, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore.	phcbjs@nus.edu.sg		Dawe, Gavin/0000-0001-6119-701X; Bian, Jinsong/0000-0002-7741-598X	National Medical Research Council [NMRC0881/2004]; Biomedical Research Council [BMRC 04/1/21/19/335]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by National Medical Research Council Research Grant NMRC0881/2004 (to J.-S. B.) and Biomedical Research Council Research Grant BMRC 04/1/21/19/335 (to J.-S. B.).	Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; AISIEN AO, 1994, INT J GYNECOL OBSTET, V47, P27, DOI 10.1016/0020-7292(94)90457-X; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Beinder E, 2003, PRENATAL DIAG, V23, P1097, DOI 10.1002/pd.702; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhuiyan ZA, 2008, HEART RHYTHM, V5, P553, DOI 10.1016/j.hrthm.2008.01.020; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Chia EL, 2005, PRENATAL DIAG, V25, P546, DOI 10.1002/pd.1184; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gowda RM, 2003, INT J CARDIOL, V88, P129, DOI 10.1016/S0167-5273(02)00601-0; Hulot JS, 2003, EUR HEART J, V24, P1663, DOI 10.1016/S0195-668X(03)00436-6; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kahler C, 2002, PRENATAL DIAG, V22, P408, DOI 10.1002/pd.322; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lechmanova M., 2002, Archives of Gynecology and Obstetrics, V266, P145, DOI 10.1007/s00404-001-0254-7; Lechmanova M, 2002, PHYSIOL RES, V51, P121; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Nakagawa M, 2006, PACE, V29, P607, DOI 10.1111/j.1540-8159.2006.00407.x; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Rashba EJ, 1998, CIRCULATION, V97, P451; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Seth R, 2007, J AM COLL CARDIOL, V49, P1092, DOI 10.1016/j.jacc.2006.09.054; SHEN BQ, 1995, J BIOL CHEM, V270, P25102, DOI 10.1074/jbc.270.42.25102; SNART RS, 1967, NATURE, V215, P964, DOI 10.1038/215964a0; Teng GQ, 2008, CIRC RES, V103, P1483, DOI 10.1161/CIRCRESAHA.108.177055; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Wu ZY, 2008, ENDOCRINOLOGY, V149, P5061, DOI 10.1210/en.2007-1802; Xu K, 2009, ATHEROSCLEROSIS, V207, P123, DOI 10.1016/j.atherosclerosis.2009.04.019; CENT PROG ASS MAN	38	29	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22186	22194		10.1074/jbc.M110.198853	http://dx.doi.org/10.1074/jbc.M110.198853			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525004	Green Published, hybrid			2022-12-27	WOS:000291719900025
J	Zuo, XF; Fogelgren, B; Lipschutz, JH				Zuo, Xiaofeng; Fogelgren, Ben; Lipschutz, Joshua H.			The Small GTPase Cdc42 Is Necessary for Primary Ciliogenesis in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; SPINDLE ORIENTATION; AUTOSOMAL-DOMINANT; PRIMARY CILIUM; EXOCYST; POLARITY; CYSTOGENESIS; MEMBRANE; COMPLEX; RAC1	Primary cilia are found on many epithelial cell types, including renal tubular epithelial cells, where they participate in flow sensing. Disruption of cilia function has been linked to the pathogenesis of polycystic kidney disease. We demonstrated previously that the exocyst, a highly conserved eight-protein membrane trafficking complex, localizes to primary cilia of renal tubular epithelial cells, is required for ciliogenesis, biochemically and genetically interacts with polycystin-2 (the protein product of the polycystic kidney disease 2 gene), and, when disrupted, results in MAPK pathway activation both in vitro and in vivo. The small GTPase Cdc42 is a candidate for regulation of the exocyst at the primary cilium. Here, we demonstrate that Cdc42 biochemically interacts with Sec10, a crucial component of the exocyst complex, and that Cdc42 colocalizes with Sec10 at the primary cilium. Expression of dominant negative Cdc42 and shRNA-mediated knockdown of both Cdc42 and Tuba, a Cdc42 guanine nucleotide exchange factor, inhibit ciliogenesis in Madin-Darby canine kidney cells. Furthermore, exocyst Sec8 and polycystin-2 no longer localize to primary cilia or the ciliary region following Cdc42 and Tuba knockdown. We also show that Sec10 directly interacts with Par6, a member of the Par complex that itself directly interacts with Cdc42. Finally, we show that Cdc42 knockdown results in activation of the MAPK pathway, something observed in cells with dysfunctional primary cilia. These data support a model in which Cdc42 localizes the exocyst to the primary cilium, whereupon the exocyst then targets and docks vesicles carrying proteins necessary for ciliogenesis.	[Zuo, Xiaofeng; Fogelgren, Ben; Lipschutz, Joshua H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Philadelphia Vet Affairs Med Ctr, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Lipschutz, JH (corresponding author), 413 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	jhlipsch@mail.med.upenn.edu			National Institutes of Health [DK069909, K01DK087852]; Veterans Affairs; Satellite Healthcare; University of Pennsylvania Translational Medicine Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, R01DK069909, K01DK087852] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Satellite Healthcare; University of Pennsylvania Translational Medicine Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK069909 (to J. H. L.) and K01DK087852 (to B. F.). This work was also supported by a Veterans Affairs Merit Award (to J. H. L.), a Satellite Healthcare Norman S. Coplon extramural research grant (to J. H. L.), and a University of Pennsylvania Translational Medicine Institute pilot grant (to J. H. L).	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FAWCETT DW, 1954, J MORPHOL, V94, P221, DOI 10.1002/jmor.1050940202; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Park KM, 2010, AM J PHYSIOL-RENAL, V298, pF818, DOI 10.1152/ajprenal.00596.2009; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Smyth BJ, 2003, INT REV CYTOL, V231, P51, DOI 10.1016/S0074-7696(03)31002-2; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WEBBER WA, 1975, ANAT RECORD, V182, P339, DOI 10.1002/ar.1091820307; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	41	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22469	22477		10.1074/jbc.M111.238469	http://dx.doi.org/10.1074/jbc.M111.238469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543338	Green Published, hybrid			2022-12-27	WOS:000291719900055
J	Lokappa, SB; Ulmer, TS				Lokappa, Sowmya Bekshe; Ulmer, Tobias S.			alpha-Synuclein Populates Both Elongated and Broken Helix States on Small Unilamellar Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; EXTENDED HELIX; PROTEIN; MEMBRANE; BINDING; MUTATION; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; ARRANGEMENT	The misfolding of the protein alpha-synuclein (alpha S) has been implicated in the molecular chain of events leading to Parkinson disease. Physiologically, alpha S undergoes a transition from a random coil to helical conformation upon encountering synaptic vesicle membranes. On analogous small unilamellar vesicles (SUVs), the conformation of alpha S is dominated by a single elongated alpha S helix. However, alternative broken helix states have been postulated, mandating experimental clarification. Here, the upper limit for the free energy difference between elongated and broken helix conformations on SUVs resembling synaptic vesicles was determined to be 1.2 +/- 0.4 kcal/mol, which amounts to a population ratio of 7.6:1 between both states (12% broken helices). In response to helix breaks at different positions, alpha S rearranged in an opportunistic manner, thereby minimizing helix abrogations to as little as one to two turns. Enthalpy and entropy measurements of gel state SUV-alpha S interactions indicated that broken helix states retain the ability to relieve membrane-packing stress. Thus, broken helix states are a distinct physiological feature of the vesicle-bound alpha S state, making it a "checkered" protein of multiple parallel conformations. A continuous interconversion between structural states may contribute to pathological alpha S misfolding.	[Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ulmer, TS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, ZNI 111,1501 San Pablo St, Los Angeles, CA 90033 USA.	tulmer@usc.edu			John Douglas French Alzheimer's Foundation; National Institutes of Health [HL089726]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	John Douglas French Alzheimer's Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by The John Douglas French Alzheimer's Foundation, National Institutes of Health Grant HL089726, and the American Heart Association. To whom correspondence should be addressed: University of Southern California, ZNI 111, 1501 San Pablo St., Los Angeles, CA 90033. Tel.: 323-442-4326; Fax: 323-442-4404; E-mail: tulmer@usc.edu.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; EGERDIE B, 1982, CHEM PHYS LIPIDS, V31, P75, DOI 10.1016/0009-3084(82)90020-2; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; PARENTE RA, 1984, BIOCHEMISTRY-US, V23, P2353, DOI 10.1021/bi00306a005; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Rao JN, 2009, J MOL BIOL, V390, P516, DOI 10.1016/j.jmb.2009.05.058; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suk JE, 2010, BIOCHEMISTRY-US, V49, P1533, DOI 10.1021/bi901753h; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; TENCHOV BG, 1985, BIOCHIM BIOPHYS ACTA, V816, P122, DOI 10.1016/0005-2736(85)90400-6; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	72	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21450	21457		10.1074/jbc.M111.224055	http://dx.doi.org/10.1074/jbc.M111.224055			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524999	hybrid, Green Published			2022-12-27	WOS:000291464700043
J	Lu, CY; Yeh, SR				Lu, Changyuan; Yeh, Syun-Ru			Ferryl Derivatives of Human Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; CYTOCHROME-C PEROXIDASE; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; TRYPTOPHAN 2,3-DIOXYGENASE; SUBSTRATE-BINDING; NITRIC-OXIDE; COMPOUND-II; MECHANISM; INTERMEDIATE	The critical role of the ferryl intermediate in catalyzing the oxygen chemistry of monooxygenases, oxidases, or peroxidases has been known for decades. In contrast, its involvement in heme-based dioxygenases, such as human indoleamine 2,3-dioxygenase (hIDO), was not recognized until recently. In this study, H2O2 was used as a surrogate to generate the ferryl intermediate of hIDO. Spectroscopic data demonstrate that the ferryl species is capable of oxidizing azinobis(3-ethylbenzothiazoline-6-sulfonic acid) but not L-Trp. Kinetic studies reveal that the conversion of the ferric enzyme to the ferryl intermediate facilitates the L-Trp binding rate by >400-fold; conversely, L-Trp binding to the enzyme retards the peroxide reaction rate by similar to 9-fold, because of the significant elevation of the entropic barrier. The unfavorable entropic factor for the peroxide reaction highlights the scenario that the structure of hIDO is not optimized for utilizing H2O2 as a co-substrate for oxidizing L-Trp. Titration studies show that the ferryl intermediate possesses two substrate-binding sites with a K-d of 0.3 and 440 mu M and that the electronic properties of the ferryl moiety are sensitive to the occupancy of the two substrate-binding sites. The implications of the data are discussed in the context of the structural and functional relationships of the enzyme.	[Lu, Changyuan; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Yeh, SR (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	syun-ru.yeh@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health [GM086482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086482] Funding Source: NIH RePORTER; Division Of Chemistry [1026788] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086482 (to S.-R. Y.).	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BALNY C, 1987, FEBS LETT, V221, P349, DOI 10.1016/0014-5793(87)80954-7; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; BRUNORI M, 1971, BIOCHEMISTRY-US, V10, P1604, DOI 10.1021/bi00785a016; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; CHUANG WJ, 1992, J BIOL CHEM, V267, P13293; DALEYYATES PT, 1988, TOXICOL APPL PHARM, V96, P222, DOI 10.1016/0041-008X(88)90082-8; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; DUNFORD HB, 1976, COORDIN CHEM REV, V19, P187, DOI 10.1016/S0010-8545(00)80316-1; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; Ferry G, 2005, BIOCHEM J, V388, P205, DOI 10.1042/BJ20042075; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; GREENGARD O, 1962, J BIOL CHEM, V237, P1903; Groves J. T., 2004, CYTOCHROME P450 STRU, P1; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HARBURY HA, 1957, J BIOL CHEM, V225, P1009; HAREL S, 1988, FREE RADICAL RES COM, V5, P21, DOI 10.3109/10715768809068555; HEWSON WD, 1975, CAN J CHEM, V53, P1928, DOI 10.1139/v75-268; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Khan KK, 1998, EUR J BIOCHEM, V257, P547, DOI 10.1046/j.1432-1327.1998.2570547.x; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; LOO S, 1975, BIOCHEMISTRY-US, V14, P3467, DOI 10.1021/bi00686a027; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; McCormick CG, 2000, BIOCHEM J, V350, P709, DOI 10.1042/0264-6021:3500709; MORISHIMA I, 1978, BIOCHEM BIOPH RES CO, V83, P946, DOI 10.1016/0006-291X(78)91487-0; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Nickel E, 2009, J BIOL CHEM, V284, P31548, DOI 10.1074/jbc.M109.039859; Ogura T, 2004, BBA-BIOENERGETICS, V1655, P290, DOI 10.1016/j.bbabio.2003.10.013; PAENG KJ, 1988, J AM CHEM SOC, V110, P7913, DOI 10.1021/ja00231a073; PALANIAPPAN V, 1989, J BIOL CHEM, V264, P16046; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Prasad S, 2002, BBA-PROTEIN STRUCT M, V1596, P63, DOI 10.1016/S0167-4838(02)00205-4; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P13201, DOI 10.1021/bi001150p; RUBIN BY, 1988, J INTERFERON RES, V8, P691, DOI 10.1089/jir.1988.8.691; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; SATO K, 1995, BBA-PROTEIN STRUCT M, V1253, P94, DOI 10.1016/0167-4838(95)00144-J; SCHUTZ G, 1972, J BIOL CHEM, V247, P5333; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; SMITH AT, 1992, EUR J BIOCHEM, V207, P507, DOI 10.1111/j.1432-1033.1992.tb17077.x; SONO M, 1989, J BIOL CHEM, V264, P1616; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; TAKIKAWA O, 1983, J BIOL CHEM, V258, P6808; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36; YIM MB, 1993, J BIOL CHEM, V268, P4099	63	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21220	21230		10.1074/jbc.M111.221507	http://dx.doi.org/10.1074/jbc.M111.221507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21502325	Green Published, hybrid			2022-12-27	WOS:000291464700021
J	Garg, R; Peddada, N; Sagar, A; Nihalani, D; Ashish				Garg, Renu; Peddada, Nagesh; Sagar, Amin; Nihalani, Deepak; Ashish			Visual Insight into How Low pH Alone Can Induce Actin-severing Ability in Gelsolin under Calcium-free Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; ILL SURGICAL-PATIENTS; PLASMA GELSOLIN; REGULATORY PROTEIN; TERMINAL HALF; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CYTOSOLIC ACIDIFICATION; INTRACELLULAR PH; ACTIVATION	Gelsolin is a key actin cytoskeleton-modulating protein primarily regulated by calcium and phosphoinositides. In addition, low pH has also been suggested to activate gelsolin in the absence of Ca2+ ions, although no structural insight on this pathway is available except for a reported decrement in its diffusion coefficient at low pH. We also observed similar to 1.6-fold decrease in the molecular mobility of recombinant gelsolin when buffer pH was lowered from 9 to 5. Analysis of the small angle x-ray scattering data collected over the same pH range indicated that the radius of gyration and maximum linear dimension of gelsolin molecules increased from 30.3 to 34.1 angstrom and from 100 to 125 angstrom, respectively. Models generated for each dataset indicated that similar to the Ca2+ -induced process, low pH also promotes unwinding of this six-domain protein but only partially. It appeared that pH is able to induce extension of the G1 domain from the rest of the five domains, whereas the Ca2+ sensitive latch between G2 and G6 domains remains closed. Interestingly, increasing the free Ca2+ level to merely similar to 40 nM, the partially open pH 5 shape "sprung open" to a shape seen earlier for this protein at pH 8 and 1 mM free Ca2+. Also, pH alone could induce a shape where the g3-g4 linker of gelsolin was open when we truncated the C-tail latch from this protein. Our results provide insight into how under physiological conditions, a drop in pH can fully activate the F-actin-severing shape of gelsolin with micromolar levels of Ca2+ available.	[Garg, Renu; Peddada, Nagesh; Sagar, Amin; Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Nihalani, Deepak] Univ Penn, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Garg, R (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	rgarg@imtech.res.in; ashgang@imtech.res.in	Sagar, Amin/AAF-4044-2021; nihalani, deepak/AAK-9453-2020; Peddada, Nagesh/L-6760-2019	Sagar, Amin/0000-0002-6207-9557; Peddada, Nagesh/0000-0003-4033-7305	National Institutes of Health through the NIDDK [K01 DK072047-03, 5K01DK072047-04, RO1 1R01DK087956]; Department of Science and Technology [SR/WOS-A/LS-106/2009]; CSIR, India; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK072047, R01DK087956] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Department of Science and Technology(Department of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants K01 DK072047-03 and 5K01DK072047-04 and RO1 1R01DK087956 through the NIDDK.; Recipient of a Department of Science and Technology, Women Scientist Scheme A (SR/WOS-A/LS-106/2009) award.; Recipients of Junior Research Fellowships from CSIR, India.; Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886. Travel support to the synchrotron was provided by CSIR-INDIA (SIP10 and FAC-03). We acknowledge the consistent support from the faculty and staff of the Institute of Microbial Technology.	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hirko AC, 2007, MOL THER, V15, P1623, DOI 10.1038/sj.mt.6300253; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; Lagarrigue E, 2003, EUR J BIOCHEM, V270, P4105, DOI 10.1046/j.1432-1033.2003.03803.x; Lagarrigue E, 2003, EUR J BIOCHEM, V270, P2236, DOI 10.1046/j.1432-1033.2003.03591.x; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin KM, 1997, J BIOL CHEM, V272, P20443, DOI 10.1074/jbc.272.33.20443; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Narayan K, 2003, FEBS LETT, V552, P82, DOI 10.1016/S0014-5793(03)00933-5; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; SELVE N, 1987, EUR J BIOCHEM, V168, P111, DOI 10.1111/j.1432-1033.1987.tb13394.x; Spies CD, 1997, ALCOHOL CLIN EXP RES, V21, P1653, DOI 10.1097/00000374-199712000-00015; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TSUNODA Y, 1991, EXP CELL RES, V193, P356, DOI 10.1016/0014-4827(91)90107-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	43	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20387	20397		10.1074/jbc.M111.236943	http://dx.doi.org/10.1074/jbc.M111.236943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498516	hybrid, Green Published			2022-12-27	WOS:000291267600026
J	Liu, ZM; Yang, A; Wang, ZQ; Bunting, KD; Davuluri, G; Green, MR; Devireddy, LR				Liu, Zhuoming; Yang, Amy; Wang, Zhengqi; Bunting, Kevin D.; Davuluri, Gangarao; Green, Michael R.; Devireddy, Laxminarayana R.			Multiple Apoptotic Defects in Hematopoietic Cells from Mice Lacking Lipocalin 24p3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FAMILY; C-KIT; MOUSE; THYMOCYTES; IL-3; SUPPRESSION; EXPRESSION; INFECTION; LIGAND; GENE	The lipocalin mouse 24p3 has been implicated in diverse physiological processes, including apoptosis, iron trafficking, development and innate immunity. Studies from our laboratory as well as others demonstrated the proapoptotic activity of 24p3 in a variety of cultured models. However, a general role for the lipocalin 24p3 in the hematopoietic system has not been tested in vivo. To study the role of 24p3, we derived 24p3 null mice and back-crossed them onto C57BL/6 and 129/SVE backgrounds. Homozygous 24p3(-/-) mice developed a progressive accumulation of lymphoid, myeloid, and erythroid cells, which was not due to enhanced hematopoiesis because competitive repopulation and recovery from myelosuppression were the same as for wild type. Instead, apoptotic defects were unique to many mature hematopoietic cell types, including neutrophils, cytokine-dependent mast cells, thymocytes, and erythroid cells. Thymocytes isolated from 24p3 null mice also displayed resistance to apoptosis-induced by dexamethasone. Bim response to various apoptotic stimuli was attenuated in 24p3(-/-) cells, thus explaining their resistance to the ensuing cell death. The results of these studies, in conjunction with those of previous studies, reveal 24p3 as a regulator of the hematopoietic compartment with important roles in normal physiology and disease progression. Interestingly, these functions are limited to relatively mature blood cell compartments.	[Yang, Amy; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Yang, Amy; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; [Liu, Zhuoming; Davuluri, Gangarao; Devireddy, Laxminarayana R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Liu, Zhuoming; Davuluri, Gangarao; Devireddy, Laxminarayana R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Blood Disorders Serv, Atlanta, GA 30322 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University; Case Western Reserve University; Emory University; Emory University	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu; LXD59@case.edu	Liu, Zhuoming/I-6950-2013	Liu, Zhuoming/0000-0002-8466-3199	National Institutes of Health [R01DK059380, K01CA113838, R01DK081395, R01CA115817]; Case Western Reserve University; March of Dimes; American Society of Hematology; NATIONAL CANCER INSTITUTE [K01CA113838, R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380, R01DK081395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; March of Dimes(March of Dimes); American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK059380 (to K. D. B.), K01CA113838 and R01DK081395 (to L. R. D.), and R01CA115817 (to M. R. G.). This work was also supported by Case Western Reserve University start up funds (to L. R. D.).; Recipient of career developmental awards from March of Dimes and the American Society of Hematology.	Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; MEKORI YA, 1993, J IMMUNOL, V151, P3775; Metcalfe D D, 1995, Exp Dermatol, V4, P227, DOI 10.1111/j.1600-0625.1995.tb00250.x; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Park S, 2009, J BIOL CHEM, V284, P2187, DOI 10.1074/jbc.M806131200; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; TISO M, 1995, AM J PATHOL, V147, P434; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang J, 2000, J IMMUNOL, V165, P2970, DOI 10.4049/jimmunol.165.6.2970	30	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20606	20614		10.1074/jbc.M110.216549	http://dx.doi.org/10.1074/jbc.M110.216549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507940	Green Published, hybrid			2022-12-27	WOS:000291267600047
J	Shahzad-ul-Hussan, S; Gustchina, E; Ghirlando, R; Clore, GM; Bewley, CA				Shahzad-ul-Hussan, Syed; Gustchina, Elena; Ghirlando, Rodolfo; Clore, G. Marius; Bewley, Carole A.			Solution Structure of the Monovalent Lectin Microvirin in Complex with Man alpha(1-2)Man Provides a Basis for Anti-HIV Activity with Low Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOVIRIN-N; OLIGOSACCHARIDE STRUCTURES; SEDIMENTATION EQUILIBRIUM; MICROCYSTIS-AERUGINOSA; INACTIVATING PROTEIN; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; VIRUS; BINDING; FUSION	Lectins that bind surface envelope glycoprotein gp120 of HIV with high avidity can potently inhibit viral entry. Yet properties such as multivalency that facilitate strong interactions can also cause nonspecific binding and toxicity. The cyanobacterial lectin microvirin (MVN) is unusual as it potently inhibits HIV-1 with negligible toxicity compared with cyanovirin-N (CVN), its well studied antiviral homolog. To understand the structural and mechanistic basis for these differences, we solved the solution structure of MVN free and in complex with its ligand Man alpha(1-2)Man, and we compared specificity and time windows of inhibition with CVN and Man alpha(1-2)Man-specific mAb 2G12. We show by NMR and analytical ultracentrifugation that MVN is monomeric in solution, and we demonstrate by NMR that Man alpha(1-2)Man-terminating carbohydrates interact with a single carbohydrate-binding site. Synchronized infectivity assays show that 2G12, MVN, and CVN inhibit entry with distinct kinetics. Despite shared specificity for Man alpha(12) Man termini, combinations of the inhibitors are synergistic suggesting they recognize discrete glycans and/or dynamic glycan conformations on gp120. Entry assays employing amphotropic viruses show that MVN is inactive, whereas CVN potently inhibits both. In addition to demonstrating that HIV-1 can be inhibited through monovalent interactions, given the similarity of the carbohydrate-binding site common to MVN and CVN, these data suggest that gp120 behaves as a clustered glycan epitope and that multivalent-protein interactions achievable with CVN but not MVN are required for inhibition of some viruses.	[Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Gustchina, Elena; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bewley, CA (corresponding author), 8 Ctr Dr, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008; Ghirlando, Rodolfo/A-8880-2009	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Bewley, Carole/0000-0003-2203-0852	National Institutes of Health (NIDDK); Intramural AIDS Targeted Antiviral Program of the Office of the Director; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK029038, ZIADK032103, ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program of the Office of the Director; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NIDDK) and the Intramural AIDS Targeted Antiviral Program of the Office of the Director (to C. A. B. and G. M. C.).	Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Bernardi A, 2004, CARBOHYD RES, V339, P967, DOI 10.1016/j.carres.2003.11.013; Bewley CA, 2004, J MOL BIOL, V339, P901, DOI 10.1016/j.jmb.2004.04.019; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 2002, J MOL BIOL, V322, P881, DOI 10.1016/S0022-2836(02)00842-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CREIGHTON TE, 1979, J MOL BIOL, V129, P235, DOI 10.1016/0022-2836(79)90279-1; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gallo SA, 2004, BIOCHEMISTRY-US, V43, P8230, DOI 10.1021/bi049957v; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P7; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Percudani R, 2005, PROTEINS, V60, P670, DOI 10.1002/prot.20543; POLONOFF E, 1982, J BIOL CHEM, V257, P4023; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; ROBERTSON JS, 1982, J GEN VIROL, V58, P13, DOI 10.1099/0022-1317-58-1-13; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Shahzad-Ul-Hussan S, 2009, J AM CHEM SOC, V131, P16500, DOI 10.1021/ja905929c; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Taiwo B, 2010, J ANTIMICROB CHEMOTH, V65, P1100, DOI 10.1093/jac/dkq096; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Tiwari V, 2009, ANTIVIR RES, V84, P67, DOI 10.1016/j.antiviral.2009.07.014; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; YEH JC, 1993, BIOCHEMISTRY-US, V32, P11087, DOI 10.1021/bi00092a019	60	65	68	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20788	20796		10.1074/jbc.M111.232678	http://dx.doi.org/10.1074/jbc.M111.232678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471192	Green Published, hybrid			2022-12-27	WOS:000291267600064
J	Foley, JH; Cook, PF; Nesheim, ME				Foley, Jonathan H.; Cook, Paul F.; Nesheim, Michael E.			Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE B; THERMAL-STABILITY; TAFI; MECHANISM; ZYMOGEN; CARBOXYPEPTIDASE; THRESHOLD; VARIANTS; RESPECT; SYSTEM	Partial digestion of fibrin by plasmin exposes C-terminal lysine residues, which comprise new binding sites for both plasminogen and tissue-type plasminogen activator (tPA). This binding increases the catalytic efficiency of plasminogen activation by 3000-fold compared with tPA alone. The activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrinolysis by removing these residues, which causes a 97% reduction in tPA catalytic efficiency. The aim of this study was to determine the kinetics of TAFIa-catalyzed lysine cleavage from fibrin degradation products and the kinetics of loss of plasminogen-binding sites. We show that the k(cat) and K-m of Glu(1)-plasminogen (Glu-Pg)-binding site removal are 2.34 s(-1) and 142.6 nM, respectively, implying a catalytic efficiency of 16.21 mu M-1 s(-1). The corresponding values of Lys(77)/Lys(78)-plasminogen (Lys-Pg)-binding site removal are 0.89 s(-1) and 96 nM implying a catalytic efficiency of 9.23 mu M-1 s(-1). These catalytic efficiencies of plasminogen-binding site removal by TAFIa are the highest of any TAFIa-catalyzed reaction with a biological substrate reported to date and suggest that plasmin-modified fibrin is a primary physiological substrate for TAFIa. We also show that the catalytic efficiency of cleavage of all C-terminal lysine residues, whether they are involved in plasminogen binding or not, is 1.10 mu M-1 s(-1). Interestingly, this value increases to 3.85 mu M-1 s(-1) in the presence of Glu-Pg. These changes are due to a decrease in K-m. This suggests that an interaction between TAFIa and plasminogen comprises a component of the reaction mechanism, the plausibility of which was established by showing that TAFIa binds both Glu-Pg and Lys-Pg.	[Foley, Jonathan H.; Nesheim, Michael E.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Nesheim, Michael E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Queens University - Canada; Queens University - Canada; University of Oklahoma System; University of Oklahoma - Norman	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@queensu.ca		Foley, Jonathan/0000-0002-4593-0469	National Institutes of Health [HL46703]; Heart and Stroke Foundation of Ontario [T5575]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL46703 (Project 4; to M. E. N.). This work was also supported by Heart and Stroke Foundation of Ontario Grant T5575.; Supported by a doctoral fellowship from the Heart and Stroke Foundation of Canada.	Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Foley JH, 2008, J BIOL CHEM, V283, P8863, DOI 10.1074/jbc.M800127200; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2176; Jia ZC, 2008, BLOOD, V112, P2597, DOI 10.1182/blood-2008-07-167734; Kim PYG, 2008, ANAL BIOCHEM, V372, P32, DOI 10.1016/j.ab.2007.09.034; Leurs J, 2004, J THROMB HAEMOST, V2, P416, DOI 10.1111/j.1538-7836.2004.00605.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Morser J, 2010, J THROMB HAEMOST, V8, P868, DOI 10.1111/j.1538-7836.2010.03787.x; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Neill EKT, 2004, ANAL BIOCHEM, V330, P332, DOI 10.1016/j.ab.2004.04.007; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Walker JB, 2004, J BIOL CHEM, V279, P27896, DOI 10.1074/jbc.M401027200; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xu HY, 2006, BIOCHEMISTRY-US, V45, P12156, DOI 10.1021/bi0610808	24	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19280	19286		10.1074/jbc.M110.215061	http://dx.doi.org/10.1074/jbc.M110.215061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467042	hybrid, Green Published			2022-12-27	WOS:000291027700010
J	Taxman, DJ; Holley-Guthrie, EA; Huang, MTH; Moore, CB; Bergstralh, DT; Allen, IC; Lei, Y; Gris, D; Ting, JPY				Taxman, Debra J.; Holley-Guthrie, Elizabeth A.; Huang, Max Tze-Han; Moore, Chris B.; Bergstralh, Daniel T.; Allen, Irving C.; Lei, Yu; Gris, Denis; Ting, Jenny Pan-Yun			The NLR Adaptor ASC/PYCARD Regulates DUSP10, Mitogen-activated Protein Kinase (MAPK), and Chemokine Induction Independent of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SPECK-LIKE PROTEIN; PORPHYROMONAS-GINGIVALIS; IMMUNE-RESPONSES; ANTIINFLAMMATORY CYTOKINES; DIFFERENTIAL ACTIVATION; PERIODONTAL PATHOGENS; SIGNALING PATHWAYS; INDUCED ARTHRITIS; GENE-EXPRESSION	ASC/PYCARD is a common adaptor for a diverse set of inflammasomes that activate caspase-1, most prominently the NLR-based inflammasome. Mounting evidence indicates that ASC and these NLRs also elicit non-overlapping functions, but the molecular basis for this difference is unclear. To address this, we performed microarray and network analysis of ASC shRNA knockdown cells. In pathogen-infected cells, an ASC-dependent interactome is centered on the mitogen-activated protein kinase (MAPK) ERK and on multiple chemokines. ASC did not affect the expression of MAPK but affected its phosphorylation by pathogens and Toll-like receptor agonists via suppression of the dual-specificity phosphatase, DUSP10/MKP5. Chemokine induction, DUSP function, and MAPK phosphorylation were independent of caspase-1 and IL-1 beta. MAPK activation by pathogen was abrogated in Asc(-/-) but not Nlrp3(-/-), Nlrc4(-/-), or Casp1(-/-) macrophages. These results demonstrate a function for ASC that is distinct from the inflammasome in modulating MAPK activity and chemokine expression and further identify DUSP10 as a novel ASC target.	[Taxman, Debra J.; Holley-Guthrie, Elizabeth A.; Huang, Max Tze-Han; Moore, Chris B.; Bergstralh, Daniel T.; Allen, Irving C.; Gris, Denis; Ting, Jenny Pan-Yun] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lei, Yu] Univ N Carolina, N Carolina Oral Hlth Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu	Lei, Yu Leo/ABF-1293-2020; Gris, Denis/AGA-1192-2022; Gris, Denis/ABE-5229-2021	Lei, Yu Leo/0000-0002-9868-9824; Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Allen, Irving/0000-0001-9573-5250; Bergstralh, Dan/0000-0003-1689-3715	National Institutes of Health [RO1-DE016326]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DE016326 (to J. P.- Y. T.).	Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Conway KE, 2000, CANCER RES, V60, P6236; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; Hasegawa M, 2009, J IMMUNOL, V182, P7655, DOI 10.4049/jimmunol.0800448; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lin DM, 2007, J PERIODONTOL, V78, P833, DOI 10.1902/jop.2007.060201; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	43	58	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19605	19616		10.1074/jbc.M111.221077	http://dx.doi.org/10.1074/jbc.M111.221077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487011	Green Published, hybrid			2022-12-27	WOS:000291027700044
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			Protonation of Glutamate 208 Induces the Release of Agmatine in an Outward-facing Conformation of an Arginine/Agmatine Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ACID RESISTANCE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; PK(A) VALUES; TRANSPORTER; MECHANISM; SUPERFAMILY; ARGININE; RATIONALIZATION	Virulent enteric pathogens have developed several systems that maintain intracellular pH to survive extreme acidic conditions. One such mechanism is the exchange of arginine (Arg(+)) from the extracellular region with its intracellular decarboxylated form, agmatine (Agm(2+)). The net result of this process is the export of a virtual proton from the cytoplasm per antiport cycle. Crystal structures of the arginine/agmatine antiporter from Escherichia coli, AdiC, have been recently resolved in both the apo and Arg(+)-bound outward-facing conformations, which permit us to assess for the first time the time-resolved mechanisms of interactions that enable the specific antiporter functionality of AdiC. Using data from similar to 1 mu s of molecular dynamics simulations, we show that the protonation of Glu-208 selectively causes the dissociation and release of Agm(2+), but not Arg(+), to the cell exterior. The impact of Glu-208 protonation is transmitted to the substrate binding pocket via the reorientation of Ile-205 carbonyl group at the irregular portion of transmembrane (TM) helix 6. This effect, which takes place only in the subunits where Agm(2+) is released, invites attention to the functional role of the unwound portion of TM helices (TM6 Trp-202-Glu-208 in AdiC) in facilitating substrate translocation, reminiscent of the behavior observed in structurally similar Na+-coupled transporters.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		National Institutes of Health [1R01GM086238-01, 1U54GM087519-01A1]; National Science Foundation [TG-MCB100108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM086238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01GM086238-01 and 1U54GM087519-01A1. This work was also supported by the National Science Foundation through TeraGrid resources provided by Kraken (National Institute for Computational Sciences) and Ranger (Texas Advanced Computing Center) under Grant TG-MCB100108.	Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FOSTER JW, 1994, MICROBIOL-SGM, V140, P341, DOI 10.1099/13500872-140-2-341; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POOLMAN B, 1990, MOL MICROBIOL, V4, P1629, DOI 10.1111/j.1365-2958.1990.tb00539.x; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	28	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19693	19701		10.1074/jbc.M110.202085	http://dx.doi.org/10.1074/jbc.M110.202085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487006	Green Published, hybrid			2022-12-27	WOS:000291027700052
J	Fukuda, T; Hashimoto, H; Okayasu, N; Kameyama, A; Onogi, H; Nakagawasai, O; Nakazawa, T; Kurosawa, T; Hao, Y; Isaji, T; Tadano, T; Narimatsu, H; Taniguchi, N; Gu, JG				Fukuda, Tomohiko; Hashimoto, Hirokazu; Okayasu, Natsumi; Kameyama, Akihiko; Onogi, Hiroshi; Nakagawasai, Osamu; Nakazawa, Takahiro; Kurosawa, Tomoyo; Hao, Yan; Isaji, Tomoya; Tadano, Takeshi; Narimatsu, Hisashi; Taniguchi, Naoyuki; Gu, Jianguo			alpha 1,6-Fucosyltransferase-deficient Mice Exhibit Multiple Behavioral Abnormalities Associated with a Schizophrenia-like Phenotype IMPORTANCE OF THE BALANCE BETWEEN THE DOPAMINE AND SEROTONIN SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT GLYCOPROTEIN-SYNDROME; PREPULSE INHIBITION; LOCOMOTOR-ACTIVITY; GDP-FUCOSE; N-GLYCANS; ALPHA-3-BETA-1 INTEGRIN; CORE FUCOSYLATION; FRONTAL-CORTEX; EXPRESSION; LACKING	Previously, we reported that alpha 1,6-fucosyltransferase (Fut8)-deficient (Fut8(-/-)) mice exhibit emphysema-like changes in the lung and severe growth retardation due to dysregulation of TGF-beta 1 and EGF receptors and to abnormal integrin activation, respectively. To study the role of alpha 1,6-fucosylation in brain tissue where Fut8 is highly expressed, we examined Fut8(-/-) mice using a combination of neurological and behavioral tests. Fut8(-/-) mice exhibited multiple behavioral abnormalities consistent with a schizophrenia-like phenotype. Fut8(-/-) mice displayed increased locomotion compared with wild-type (Fut8(+/+)) and heterozygous (Fut8(-/-)) mice. In particular, Fut8(-/-) mice showed strenuous hopping behavior in a novel environment. Working memory performance was impaired in Fut8(-/-) mice as evidenced by the Y-maze tests. Furthermore, Fut8(-/-) mice showed prepulse inhibition (PPI) deficiency. Intriguingly, although there was no significant difference between Fut8(+/+) and Fut8(+/-) mice in the PPI test under normal conditions, Fut8(+/-) mice showed impaired PPI after exposure to a restraint stress. This result suggests that reduced expression of Fut8 is a plausible cause of schizophrenia and related disorders. The levels of serotonin metabolites were significantly decreased in both the striatum and nucleus accumbens of the Fut8(-/-) mice. Likewise, treatment with haloperidol, which is an antipsychotic drug that antagonizes dopaminergic and serotonergic receptors, significantly reduced hopping behaviors. The present study is the first to clearly demonstrate that alpha 1,6-fucosylation plays an important role in the brain, and that it might be related to schizophrenia-like behaviors. Thus, the results of the present study provide new insights into the underlying mechanisms responsible for schizophrenia and related disorders.	[Fukuda, Tomohiko; Hashimoto, Hirokazu; Okayasu, Natsumi; Kurosawa, Tomoyo; Hao, Yan; Isaji, Tomoya; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Onogi, Hiroshi; Nakagawasai, Osamu; Tadano, Takeshi] Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Nakazawa, Takahiro] Tohoku Pharmaceut Univ, Dept Nat Prod Chem, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab C2, Tsukuba, Ibaraki 3058568, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, Dept Dis Glyc, Osaka 5670047, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; RIKEN	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsusima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/I-4182-2014; Isaji, Tomoya/ABC-9285-2021; Nakagawasai, Osamu/AAB-4201-2022; Narimatsu, Hisashi/M-4757-2018; Kameyama, Akihiko/A-9641-2008; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; Nakagawasai, Osamu/0000-0002-4061-0802; Narimatsu, Hisashi/0000-0002-8402-133X; Kameyama, Akihiko/0000-0002-8229-4449; 	Japan Society for the Promotion of Science [21370059, 22590071]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Scientific Research Grants-in-aid 21370059 (to J. G.) and 22590071 (to T. F.) from the Japan Society for the Promotion of Science and the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; CARLSON JN, 1991, BRAIN RES, V550, P313, DOI 10.1016/0006-8993(91)91333-V; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Druhan JP, 1996, SYNAPSE, V24, P135, DOI 10.1002/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Garnock-Jones Karly P, 2009, Paediatr Drugs, V11, P203, DOI 10.2165/00148581-200911030-00005; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Halberstadt AL, 2009, NEUROPSYCHOPHARMACOL, V34, P1958, DOI 10.1038/npp.2009.29; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hyman SE, 2000, B WORLD HEALTH ORGAN, V78, P455; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Kapur S, 2000, NEUROPSYCHOPHARMACOL, V23, P595, DOI 10.1016/S0893-133X(00)00139-1; KAROUM F, 1992, BRIT J PHARMACOL, V105, P703, DOI 10.1111/j.1476-5381.1992.tb09042.x; KITAICHI K, 1994, JPN J PHARMACOL, V66, P181, DOI 10.1254/jjp.66.181; Kopelowicz A, 2006, SCHIZOPHRENIA BULL, V32, pS12, DOI 10.1093/schbul/sbl023; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Marquardt T, 1999, J PEDIATR-US, V134, P681, DOI 10.1016/S0022-3476(99)70281-7; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moy SS, 2006, BRAIN RES, V1089, P186, DOI 10.1016/j.brainres.2006.03.073; Nakagawasai O, 2009, LIFE SCI, V84, P512, DOI 10.1016/j.lfs.2009.01.009; Nakakita S, 2005, J BIOCHEM, V138, P277, DOI 10.1093/jb/mvi125; Nakazawa T, 2003, BIOL PHARM BULL, V26, P474, DOI 10.1248/bpb.26.474; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Noda K, 2003, CANCER RES, V63, P6282; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pierce RC, 1997, PSYCHOPHARMACOLOGY, V133, P188, DOI 10.1007/s002130050390; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Seeman P, 2009, J PSYCHIATR NEUROSCI, V34, P143; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; SHIMIZU H, 1993, J BIOCHEM-TOKYO, V114, P334, DOI 10.1093/oxfordjournals.jbchem.a124177; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sitges M, 1998, EUR NEUROPSYCHOPHARM, V8, P105, DOI 10.1016/S0924-977X(97)00053-9; Soleimani L, 2008, GENES BRAIN BEHAV, V7, P334, DOI 10.1111/j.1601-183X.2007.00358.x; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	64	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18434	18443		10.1074/jbc.M110.172536	http://dx.doi.org/10.1074/jbc.M110.172536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471224	Green Published, hybrid			2022-12-27	WOS:000290785700016
J	Lu, BGC; Sofian, T; Law, RHP; Coughlin, PB; Horvath, AJ				Lu, Bernadine G. C.; Sofian, Trifina; Law, Ruby H. P.; Coughlin, Paul B.; Horvath, Anita J.			Contribution of Conserved Lysine Residues in the alpha(2)-Antiplasmin C Terminus to Plasmin Binding and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERPIN; SITE; ALPHA-2-ANTIPLASMIN; ANTIPLASMIN; KINETICS	alpha(2)-Antiplasmin is the physiological inhibitor of plasmin and is unique in the serpin family due to N- and C-terminal extensions beyond its core domain. The C-terminal extension comprises 55 amino acids from Asn-410 to Lys-464, and the lysine residues (Lys-418, Lys-427, Lys-434, Lys-441, Lys-448, and Lys-464) within this region are important in mediating the initial interaction with kringle domains of plasmin. To understand the role of lysine residues within the C terminus of alpha(2)-antiplasmin, we systematically and sequentially mutated the C-terminal lysines, studied the effects on the rate of plasmin inhibition, and measured the binding affinity for plasmin via surface plasmon resonance. We determined that the C-terminal lysine (Lys-464) is individually most important in initiating binding to plasmin. Using two independent methods, we also showed that the conserved internal lysine residues play a major role mediating binding of the C terminus of alpha(2)-antiplasmin to kringle domains of plasmin and in accelerating the rate of interaction between alpha(2)-antiplasmin and plasmin. When the C terminus of alpha(2)-antiplasmin was removed, the binding affinity for active site-blocked plasmin remained high, suggesting additional exosite interactions between the serpin core and plasmin.	[Lu, Bernadine G. C.; Sofian, Trifina; Coughlin, Paul B.; Horvath, Anita J.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Law, Ruby H. P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Coughlin, Paul B.] Monash Univ, Box Hill Hosp, Dept Med & Haematol, Box Hill, Vic 3128, Australia	Monash University; Monash University; Box Hill Hospital; Monash University	Horvath, AJ (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 6 Burnet Bldg,89 Commercial Rd, Melbourne, Vic 3004, Australia.	anita.horvath@monash.edu		law, ruby/0000-0001-5432-5781	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia.	Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; CLEMMENSEN I, 1981, EUR J BIOCHEM, V120, P105, DOI 10.1111/j.1432-1033.1981.tb05675.x; Coughlin PB, 2005, FEBS J, V272, P4852, DOI 10.1111/j.1742-4658.2005.04881.x; Frank PS, 2003, BIOCHEMISTRY-US, V42, P1078, DOI 10.1021/bi026917n; Gerber SS, 2010, CELL MOL LIFE SCI, V67, P1505, DOI 10.1007/s00018-010-0264-3; Gross PL, 2009, CLIN PHARMACOL THER, V86, P139, DOI 10.1038/clpt.2009.98; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Lee KN, 2000, J BIOL CHEM, V275, P37382, DOI 10.1074/jbc.M003375200; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Matsuno H, 2006, CURR PHARM DESIGN, V12, P841, DOI 10.2174/138161206776056038; Morris EC, 2003, BIOCHEM J, V371, P165, DOI 10.1042/BJ20021567; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; SHIEH BH, 1987, J BIOL CHEM, V262, P6055; Wang HY, 2003, EUR J BIOCHEM, V270, P2023, DOI 10.1046/j.1432-1033.2003.03578.x; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408	19	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24544	24552		10.1074/jbc.M111.229013	http://dx.doi.org/10.1074/jbc.M111.229013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543325	hybrid, Green Published			2022-12-27	WOS:000292547900004
J	Maudet, C; Bertrand, M; Le Rouzic, E; Lahouassa, H; Ayinde, D; Nisole, S; Goujon, C; Cimarelli, A; Margottin-Goguet, F; Transy, C				Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Goujon, Caroline; Cimarelli, Andrea; Margottin-Goguet, Florence; Transy, Catherine			Molecular Insight into How HIV-1 Vpr Protein Impairs Cell Growth through Two Genetically Distinct Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CUL4A-DDB1(DCAF1) UBIQUITIN LIGASE; CYCLE ARREST; G(2) ARREST; MUTATIONAL ANALYSIS; IN-VIVO; PROTEASOMAL DEGRADATION; MACROPHAGE INFECTION; NUCLEAR-LOCALIZATION; REGULATORY PROTEIN	Vpr, a small HIV auxiliary protein, hijacks the CUL4 ubiquitin ligase through DCAF1 to inactivate an unknown cellular target, leading to cell cycle arrest at the G(2) phase and cell death. Here we first sought to delineate the Vpr determinants involved in the binding to DCAF1 and to the target. On the one hand, the three alpha-helices of Vpr are necessary and sufficient for binding to DCAF1; on the other hand, nonlinear determinants in Vpr are required for binding to the target, as shown by using protein chimeras. We also underscore that a SRIG motif conserved in the C-terminal tail of Vpr proteins from HIV-1/SIVcpz and HIV-2/SIVsmm lineages is critical for G(2) arrest. Our results suggest that this motif may be predictive of the ability of Vpr proteins from other SIV lineages to mediate G(2) arrest. We took advantage of the characterization of a subset of G(2) arrest-defective, but DCAF1 binding-proficient mutants, to investigate whether Vpr interferes with cell viability independently of its ability to induce G(2) arrest. These mutants inhibited cell colony formation in HeLa cells and are cytotoxic in lymphocytes, unmasking a G(2) arrest-independent cytopathic effect of Vpr. Furthermore these mutants do not block cell cycle progression at the G(1) or S phases but trigger apoptosis through caspase 3. Disruption of DCAF1 binding restored efficiency of colony formation. However, DCAF1 binding per se is not sufficient to confer cytopathicity. These data support a model in which Vpr recruits DCAF1 to induce the degradation of two host proteins independently required for proper cell growth.	[Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] CNRS, UMR8104, F-75014 Paris, France; [Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] Univ Paris 05, F-75006 Paris, France; [Goujon, Caroline] Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England; [Cimarelli, Andrea] Ecole Normale Super Lyon, LaboRetro, Unite Virol Humaine, F-69007 Lyon, France; [Cimarelli, Andrea] INSERM, U758, F-69007 Lyon, France; [Cimarelli, Andrea] Univ Lyon, BioSci Lyon Gerland IFR128, F-69007 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Margottin-Goguet, F (corresponding author), 27 Rue Faubourg St Jacques,Bat G Roussy, F-75014 Paris, France.	florence.margottin-goguet@inserm.fr; catherine.transy@inserm.fr	Nisole, Sébastien/ABA-2367-2021; Goujon, Caroline/B-3914-2014; Maudet, Claire/AAH-1728-2019; Margottin-Goguet, Florence/F-9272-2013	Nisole, Sébastien/0000-0001-9793-419X; Goujon, Caroline/0000-0001-8571-1108; Maudet, Claire/0000-0001-8856-0819; Margottin-Goguet, Florence/0000-0002-3124-6690; CIMARELLI, Andrea/0000-0003-0892-0488	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales; Fondation de France; Sidaction; University Paris Diderot; INSERM; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); Fondation de France(Fondation de France); Sidaction; University Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by grants from the Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales, Sidaction, and Fondation de France.; Received support from University Paris Diderot.; Received support from INSERM.; Received support from Ministere de l'Enseignement Superieur et de la Recherche.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Andersen JL, 2005, CELL DEATH DIFFER, V12, P326, DOI 10.1038/sj.cdd.4401565; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Azuma A, 2006, MICROBES INFECT, V8, P670, DOI 10.1016/j.micinf.2005.09.002; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Bolton DL, 2007, J VIROL, V81, P8878, DOI 10.1128/JVI.00122-07; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crews CM, 2003, CURR OPIN CHEM BIOL, V7, P534, DOI 10.1016/j.cbpa.2003.08.002; DeHart JL, 2008, J VIROL, V82, P9265, DOI 10.1128/JVI.00377-08; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Elder RT, 2000, VIRUS RES, V68, P161, DOI 10.1016/S0168-1702(00)00167-2; Gao QS, 2002, CANCER RES, V62, P3315; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sitterlin D, 2000, ONCOGENE, V19, P4417, DOI 10.1038/sj.onc.1203771; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Stivahtis GL, 1997, J VIROL, V71, P4331, DOI 10.1128/JVI.71.6.4331-4338.1997; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yuan HD, 2003, J VIROL, V77, P2063, DOI 10.1128/JVI.77.3.2063-2070.2003; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	79	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23742	23752		10.1074/jbc.M111.220780	http://dx.doi.org/10.1074/jbc.M111.220780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566118	Green Published, hybrid			2022-12-27	WOS:000292294900016
J	Dreaden, TM; Chen, J; Rexroth, S; Barry, BA				Dreaden, Tina M.; Chen, Jun; Rexroth, Sascha; Barry, Bridgette A.			N-Formylkynurenine as a Marker of High Light Stress in Photosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLVING PHOTOSYSTEM-II; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; SITE-DIRECTED MUTAGENESIS; SINGLET OXYGEN; TRYPTOPHAN OXIDATION; CRYSTAL-STRUCTURE; D1 PROTEIN; CHLORIDE REQUIREMENT; RAMAN-SPECTROSCOPY	Photosystem II (PSII) is the membrane protein complex that catalyzes the photo-induced oxidation of water at a manganese-calcium active site. Light-dependent damage and repair occur in PSII under conditions of high light stress. The core reaction center complex is composed of the D1, D2, CP43, and CP47 intrinsic polypeptides. In this study, a new chromophore formed from the oxidative post-translational modification of tryptophan is identified in the CP43 subunit. Tandem mass spectrometry peptide sequencing is consistent with the oxidation of the CP43 tryptophan side chain, Trp-365, to produce N-formylkynurenine (NFK). Characterization with ultraviolet visible absorption and ultraviolet resonance Raman spectroscopy supports this assignment. An optical assay suggests that the yield of NFK increases 2-fold (2.2 +/- 0.5) under high light illumination. A concomitant 2.4 +/- 0.5-fold decrease is observed in the steady-state rate of oxygen evolution under the high light conditions. NFK is the product formed from reaction of tryptophan with singlet oxygen, which can be produced under high light stress in PSII. Reactive oxygen species reactions lead to oxidative damage of the reaction center, D1 protein turnover, and inhibition of electron transfer. Our results are consistent with a role for the CP43 NFK modification in photoinhibition.	Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Barry, BA (corresponding author), 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu	Chen, Jun/K-2332-2015; Chen, Jun/M-9608-2016; Rexroth, Sascha/H-3702-2011	Chen, Jun/0000-0002-4114-3046; Rexroth, Sascha/0000-0003-3819-2127	National Science Foundation [MCB 08-42246]; Div Of Molecular and Cellular Bioscience [0842246] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by Grant MCB 08-42246 from the National Science Foundation (to B. A. B.).	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Anderson LB, 2004, J AM CHEM SOC, V126, P8399, DOI 10.1021/ja0478781; Anderson LB, 2000, J BIOL CHEM, V275, P4920, DOI 10.1074/jbc.275.7.4920; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASHER SA, 1993, ANAL CHEM, V65, pA59, DOI 10.1021/ac00052a715; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BIEKER L, 1979, FEBS LETT, V106, P268, DOI 10.1016/0014-5793(79)80511-6; BOWYER JR, 1992, J BIOL CHEM, V267, P5424; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; CALDWELL CR, 1993, PLANT PHYSIOL, V101, P947, DOI 10.1104/pp.101.3.947; CHALAPATHI VV, 1968, J MOL SPECTROSC, V26, P444, DOI 10.1016/S0022-2852(68)80058-X; Chen J, 2008, PHOTOCHEM PHOTOBIOL, V84, P815, DOI 10.1111/j.1751-1097.2008.00298.x; Chen J, 2009, J PHYS CHEM B, V113, P11367, DOI 10.1021/jp906491r; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eilstein J, 2006, CHEM RES TOXICOL, V19, P1248, DOI 10.1021/tx0601408; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fedorova M, 2010, PROTEOMICS, V10, P2692, DOI 10.1002/pmic.201000147; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; FUJIMORI E, 1981, FEBS LETT, V135, P257, DOI 10.1016/0014-5793(81)80795-8; Galetskiy D, 2011, RAPID COMMUN MASS SP, V25, P184, DOI 10.1002/rcm.4855; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HAM JS, 1952, J CHEM PHYS, V20, P335, DOI 10.1063/1.1700403; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; HUANG HV, 1983, METHOD ENZYMOL, V91, P318; Hunzinger C, 2006, J PROTEOME RES, V5, P625, DOI 10.1021/pr050377+; JACOBSON KB, 1978, ARCH BIOCHEM BIOPHYS, V186, P84, DOI 10.1016/0003-9861(78)90466-6; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; Knoepfle N, 1999, BIOCHEMISTRY-US, V38, P1582, DOI 10.1021/bi9821418; KNOX JP, 1985, PHYTOCHEMISTRY, V24, P889, DOI 10.1016/S0031-9422(00)83147-7; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MACDONALD GM, 1994, BIOCHEMISTRY-US, V33, P4393, DOI 10.1021/bi00180a037; Mamedov F, 2002, PHOTOSYNTH RES, V74, P61, DOI 10.1023/A:1020835822266; MEHLER AH, 1950, J BIOL CHEM, V187, P431; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Ouellette AJA, 1998, P NATL ACAD SCI USA, V95, P2204, DOI 10.1073/pnas.95.5.2204; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; PURANIK PG, 1959, J MOL SPECTROSC, V3, P486, DOI 10.1016/0022-2852(59)90043-8; Rexroth S, 2007, J BIOL CHEM, V282, P27802, DOI 10.1074/jbc.M704394200; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Rinalducci S, 2005, J PROTEOME RES, V4, P2327, DOI 10.1021/pr0502368; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; Rosenberg C, 1999, BIOCHEMISTRY-US, V38, P15994, DOI 10.1021/bi991326r; SANDUSKY PO, 1984, BIOCHIM BIOPHYS ACTA, V766, P603, DOI 10.1016/0005-2728(84)90121-X; SANDUSKY PO, 1986, BIOCHIM BIOPHYS ACTA, V849, P85, DOI 10.1016/0005-2728(86)90099-X; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharma J, 1997, J BIOL CHEM, V272, P33158, DOI 10.1074/jbc.272.52.33158; SIMAT T, 1994, J CHROMATOGR A, V661, P93, DOI 10.1016/0021-9673(94)85180-8; STADTMAN ER, 1990, BIOCHEMISTRY-US, V29, P6323, DOI 10.1021/bi00479a001; TELFER A, 1994, J BIOL CHEM, V269, P13244; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; VIRGIN I, 1988, FEBS LETT, V233, P408, DOI 10.1016/0014-5793(88)80472-1; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge JP, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P4381; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yang CY, 1999, BIOCHEMISTRY-US, V38, P15903, DOI 10.1021/bi991464g; Yang CY, 1997, FREE RADICAL BIO MED, V23, P82, DOI 10.1016/S0891-5849(96)00624-7; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhao H, 2009, J BIOL CHEM, V284, P23344, DOI 10.1074/jbc.M109.022517; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	90	49	49	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22632	22641		10.1074/jbc.M110.212928	http://dx.doi.org/10.1074/jbc.M110.212928			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527632	Green Published, hybrid			2022-12-27	WOS:000291719900070
J	Iwasa, H; Meshitsuka, S; Hongo, K; Mizobata, T; Kawata, Y				Iwasa, Hisanori; Meshitsuka, Shunsuke; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi			Covalent Structural Changes in Unfolded GroES That Lead to Amyloid Fibril Formation Detected by NMR INSIGHT INTO INTRINSICALLY DISORDERED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-CHAPERONIN GROES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PRION PROTEIN; ISOASPARTATE FORMATION; PARKINSONS-DISEASE; ASPARTYL RESIDUES; BETA OLIGOMERS; HUMAN LENS; DEAMIDATION	Co-chaperonin GroES from Escherichia coli works with chaperonin GroEL to mediate the folding reactions of various proteins. However, under specific conditions, i.e. the completely disordered state in guanidine hydrochloride, this molecular chaperone forms amyloid fibrils similar to those observed in various neurodegenerative diseases. Thus, this is a good model system to understand the amyloid fibril formation mechanism of intrinsically disordered proteins. Here, we identified a critical intermediate of GroES in the early stages of this fibril formation using NMR and mass spectroscopy measurements. A covalent rearrangement of the polypeptide bond at Asn(45)-Gly(46) and/or Asn(51)-Gly(52) that eventually yield beta-aspartic acids via deamidation of asparagine was observed to precede fibril formation. Mutation of these asparagines to alanines resulted in delayed nucleus formation. Our results indicate that peptide bond rearrangement at Asn-Gly enhances the formation of GroES amyloid fibrils. The finding provides a novel insight into the structural process of amyloid fibril formation from a disordered state, which may be applicable to intrinsically disordered proteins in general.	[Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan; [Meshitsuka, Shunsuke; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 6808552, Japan	Tottori University; Tottori University	Kawata, Y (corresponding author), Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan.	kawata@bio.tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global COE Program; Organization for Regional Industrial Academic Cooperation of Tottori University; Grants-in-Aid for Scientific Research [21570113] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Organization for Regional Industrial Academic Cooperation of Tottori University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Global COE Program, and a grant from the Organization for Regional Industrial Academic Cooperation of Tottori University. Mass spectrometry measurements were performed using the facilities of the Research Center for Bioscience and Technology (Venture Business Laboratory) of Tottori University.	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; BISCHOFF R, 1994, J CHROMATOGR B, V662, P261, DOI 10.1016/0378-4347(94)00203-7; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; CHOU FCH, 1976, J BIOL CHEM, V251, P2671; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; GEIGER T, 1987, J BIOL CHEM, V262, P785; Goddard D., 2008, SPARKY 3; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Higurashi T, 2005, J MOL BIOL, V351, P1057, DOI 10.1016/j.jmb.2005.07.006; Higurashi T, 2003, J MOL BIOL, V333, P605, DOI 10.1016/j.jmb.2003.08.056; Higurashi T, 1999, J MOL BIOL, V291, P703, DOI 10.1006/jmbi.1999.2994; Horst R, 2006, P NATL ACAD SCI USA, V103, P15445, DOI 10.1073/pnas.0607141103; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kitamura A, 2010, FEBS J, V277, P1369, DOI 10.1111/j.1742-4658.2010.07570.x; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Makio T, 1999, J MOL BIOL, V293, P125, DOI 10.1006/jmbi.1999.3142; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sandmeier E, 1999, BIOCHEM BIOPH RES CO, V261, P578, DOI 10.1006/bbrc.1999.1056; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shewmaker F, 2001, J BIOL CHEM, V276, P31257, DOI 10.1074/jbc.M102765200; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; Weber DJ, 1998, BIOCHEM BIOPH RES CO, V246, P606, DOI 10.1006/bbrc.1998.8672; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yagi H, 2008, J MOL BIOL, V377, P1593, DOI 10.1016/j.jmb.2008.02.012; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9	60	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21796	21805		10.1074/jbc.M111.228445	http://dx.doi.org/10.1074/jbc.M111.228445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507961	hybrid, Green Published			2022-12-27	WOS:000291464700074
J	Matta, H; Gopalakrishnan, R; Punj, V; Yi, H; Suo, YL; Chaudhary, PM				Matta, Hittu; Gopalakrishnan, Ramakrishnan; Punj, Vasu; Yi, Han; Suo, Yulan; Chaudhary, Preet M.			A20 Is Induced by Kaposi Sarcoma-associated Herpesvirus-encoded Viral FLICE Inhibitory Protein (vFLIP) K13 and Blocks K13-induced Nuclear Factor-kappa B in a Negative Feedback Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; GENE; EXPRESSION; ACTIVATION; DEATH; INDUCTION; LYMPHOMA; TNF	Expression of A20, a negative regulator of the NF-kappa B pathway, is frequently lost in several subtypes of Hodgkin and non-Hodgkin lymphoma. We report that A20 is expressed in Kaposi sarcoma-associated herpesvirus (KSHV)-infected primary effusion lymphoma cell lines, and its expression correlates closely with the expression of KSHV-encoded viral FLICE inhibitory protein K13. Ectopic expression of K13 induced A20 expression through NF-kappa B-mediated activation of A20 promoter. In turn, A20 blocked K13-induced NF-kappa B activity and up-regulation of pro-inflammatory cytokines CCL20 and IL-8 in a negative feedback fashion. Both the N-terminal deubiquitinating domain and the C-terminal zinc finger domain of A20 were involved in the inhibition of K13-induced NF-kappa B activity. Overexpression of A20 blocked K13-induced I kappa B alpha phosphorylation, NF-kappa B nuclear translocation, and cellular transformation. Consistent with the above, K13-induced I kappa B alpha phosphorylation and NF-kappa B transcriptional activation were enhanced in A20-deficient cells. Finally, A20 was found to interact physically with K13. Taken collectively, these results demonstrate that K13 is a key determinant of A20 expression in KSHV-infected cells, and A20 is a key negative regulator of K13-induced NF-kappa B activity. A20 might serve to control the inflammatory response to KSHV infection and protect KSHV-infected cells from apoptosis.	[Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chaudhary, PM (corresponding author), Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018; Gopalakrishnan, Ramakrishnan/N-3454-2015	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886	National Institutes of Health [CA85177, CA124621, DE019811]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA085177, R01CA124621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85177, CA124621, and DE019811. This work was also supported by the Leukemia and Lymphoma Society.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chaudhary PM, 1999, J BIOL CHEM, V274, P19211, DOI 10.1074/jbc.274.27.19211; Chaudhary Preet M., 2008, V1, P186, DOI 10.1159/000141519; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Keller SA, 2000, BLOOD, V96, P2537; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu YY, 2007, J GEN VIROL, V88, P46, DOI 10.1099/vir.0.82375-0; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	47	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21555	21564		10.1074/jbc.M111.224048	http://dx.doi.org/10.1074/jbc.M111.224048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531730	Green Published, hybrid			2022-12-27	WOS:000291464700053
J	Shiozaki, K; Yamaguchi, K; Takahashi, K; Moriya, S; Miyagi, T				Shiozaki, Kazuhiro; Yamaguchi, Kazunori; Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko			Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; HUMAN COLORECTAL-CANCER; CARCINOMA CELLS; E-SELECTIN; APOPTOSIS SUPPRESSION; UP-REGULATION; HYPOXIA; TUMOR; GLYCOSYLATION; PROGRESSION	Sialyl Lewis antigens, sialyl Lewis a and sialyl Lewis x, are utilized as tumor markers, and their increase in cancer is associated with tumor progression by enhancement of cancer cell adhesion to endothelial E-selectin. However, regulation mechanisms are not fully understood. We previously demonstrated that NEU4 is the only sialidase efficiently acting on mucins and it is down-regulated in colon cancer. To elucidate the significance of NEU4 down-regulation, we investigated sialyl Lewis antigens as endogenous substrates for the sialidase. NEU4 was found to hydrolyze the antigens in vitro and decrease cell surface levels much more effectively than other sialidases. Western blot, thin layer chromatography, and metabolic inhibition studies of desialylation products revealed NEU4 to preferentially catalyze sialyl Lewis antigens expressed on O-glycans. Cell adhesion to and motility and growth on E-selectin were significantly reduced by NEU4. E-selectin stimulation of colon cancer cells enhanced cell motility through activation of the p38/Hsp27/actin reorganization pathway, whereas NEU4 attenuated the signaling. On immunocytochemical analysis, some NEU4 molecules were localized at cell surfaces. Under hypoxia conditions whereby the antigens were increased concomitantly with several sialyl-and fucosyltransferases, NEU4 expression was markedly decreased. These results suggest that NEU4 plays an important role in control of sialyl Lewis antigen expression and its impairment in colon cancer.	[Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Marine Biochem Lab, Kagoshima 8900056, Japan; [Yamaguchi, Kazunori] Miyagi Canc Ctr, Res Inst, Div Biochem, Natori, Miyagi 9811293, Japan; [Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Sendai, Miyagi 9818558, Japan	Kagoshima University; Miyagi Cancer Center; Tohoku Medical & Pharmaceutical University	Miyagi, T (corresponding author), 4-4-1 Komatsushima,Aobu Ku, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp		Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan [20013047]; Grants-in-Aid for Scientific Research [21570122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas in Cancer (20013047) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bardoni A, 1999, FEBS LETT, V451, P75, DOI 10.1016/S0014-5793(99)00547-5; BERG EL, 1991, J BIOL CHEM, V266, P14869; Bigi A, 2010, GLYCOBIOLOGY, V20, P148, DOI 10.1093/glycob/cwp156; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gout S, 2006, CANCER RES, V66, P9117, DOI 10.1158/0008-5472.CAN-05-4605; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Inata J, 2007, INT J CANCER, V120, P2643, DOI 10.1002/ijc.22613; Izawa M, 2000, CANCER RES, V60, P1410; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kobayashi M, 2007, J HISTOCHEM CYTOCHEM, V55, P263, DOI 10.1369/jhc.6A7097.2006; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Kudo T, 1998, LAB INVEST, V78, P797; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lafferriere J, 2004, CLIN EXP METASTAS, V21, P257, DOI 10.1023/B:CLIN.0000037708.09420.9a; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Miyagi T, 2008, P JPN ACAD B-PHYS, V84, P407, DOI 10.2183/pjab.84.407; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Nakagoe T, 2002, J CLIN GASTROENTEROL, V34, P408, DOI 10.1097/00004836-200204000-00005; Ouchi K, 1996, CANCER, V78, P2313, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2313::AID-CNCR7>3.0.CO;2-N; SAUL R, 1983, ARCH BIOCHEM BIOPHYS, V221, P593, DOI 10.1016/0003-9861(83)90181-9; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Srinivas U, 1996, SCAND J IMMUNOL, V44, P197, DOI 10.1046/j.1365-3083.1996.d01-302.x; Steplewska-Mazur K, 2000, HYBRIDOMA, V19, P129, DOI 10.1089/02724570050031167; Tsuchida A, 2003, J BIOL CHEM, V278, P22787, DOI 10.1074/jbc.M211034200; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamanami H, 2007, CANCER SCI, V98, P299, DOI 10.1111/j.1349-7006.2007.00403.x; Yang WQ, 2004, CHEM BIOL, V11, P439, DOI 10.1016/j.chembiol.2004.03.021; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383	45	53	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21052	21061		10.1074/jbc.M111.231191	http://dx.doi.org/10.1074/jbc.M111.231191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521691	Green Published, hybrid			2022-12-27	WOS:000291464700004
J	Islam, ST; Gold, AC; Taylor, VL; Anderson, EM; Ford, RC; Lam, JS				Islam, Salim T.; Gold, Alexander C.; Taylor, Veronique L.; Anderson, Erin M.; Ford, Robert C.; Lam, Joseph S.			Dual Conserved Periplasmic Loops Possess Essential Charge Characteristics That Support a Catch-and-Release Mechanism of O-antigen Polymerization by Wzy in Pseudomonas aeruginosa PAO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-MEMBRANE-PROTEINS; LIPID-A-CORE; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CHAIN-LENGTH; POLYSACCHARIDE; BINDING; LIPOPOLYSACCHARIDE; POLYMERASE; TOPOLOGY	Heteropolymeric B-band lipopolysaccharide in Pseudomonas aeruginosa PAO1 is synthesized via the so-called Wzy-dependent pathway, requiring a functional Wzy for polymerization of O-antigen repeat units in the periplasm. Wzy is an integral inner membrane protein for which the detailed topology has been mapped in a recent investigation (Islam, S. T., Taylor, V. L., Qi, M., and Lam, J. S. (2010) mBio 1, e00189-10), revealing two principal periplasmic loops (PL), PL3 and PL5, each containing an RX(10)G motif. Despite considerable sequence conservation between the two loops, the isoelectric point for each peptide displayed marked differences, with PL3 exhibiting a net-positive charge and PL5 showing a net-negative charge. Data from site-directed mutagenesis of amino acids in each PL have led to the identification of several key Arg residues within the two RX(10)G motifs that are important for Wzy function, of which Arg(176), Arg(290), and Arg(291) could not be functionally substituted with Lys. These observations support the proposed role of each PL in a catch-and-release mechanism for Wzy-mediated O-antigen polymerization.	[Islam, Salim T.; Gold, Alexander C.; Taylor, Veronique L.; Anderson, Erin M.; Lam, Joseph S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca	Islam, Salim/P-1323-2019; Islam, Salim/G-8608-2011	Islam, Salim/0000-0001-6853-8446; Islam, Salim/0000-0001-6853-8446; Ford, Robert/0000-0002-0958-1505	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR) [MOP-14687]	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from Cystic Fibrosis Canada and the Canadian Institutes of Health Research (CIHR) (Grant MOP-14687).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; Abeyrathne PD, 2007, CAN J MICROBIOL, V53, P526, DOI 10.1139/W07-007; Augustin DK, 2007, J BACTERIOL, V189, P2203, DOI 10.1128/JB.01839-06; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Burrows LL, 1999, J BACTERIOL, V181, P973, DOI 10.1128/JB.181.3.973-980.1999; Coyne MJ, 1995, GENE, V167, P81, DOI 10.1016/0378-1119(95)00595-1; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; DEKIEVIT TR, 1995, MOL MICROBIOL, V16, P565; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Elumalai P, 2010, PROTOPLASMA, V247, P13, DOI 10.1007/s00709-010-0132-x; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Kim TH, 2010, J BIOL CHEM, V285, P27839, DOI 10.1074/jbc.M110.143859; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; LAM JS, 1987, INFECT IMMUN, V55, P1051, DOI 10.1128/IAI.55.5.1051-1057.1987; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Mazur A, 2003, J BACTERIOL, V185, P2503, DOI 10.1128/JB.185.8.2503-2511.2003; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351	33	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20600	20605		10.1074/jbc.C110.204651	http://dx.doi.org/10.1074/jbc.C110.204651			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498511	Green Published, hybrid			2022-12-27	WOS:000291267600046
J	Jo, YH; Donier, E; Martinez, A; Garret, M; Toulme, E; Boue-Grabot, E				Jo, Young-Hwan; Donier, Emmanuelle; Martinez, Audrey; Garret, Maurice; Toulme, Estelle; Boue-Grabot, Eric			Cross-talk between P2X4 and gamma-Aminobutyric Acid, Type A Receptors Determines Synaptic Efficacy at a Central Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; ATP; TRAFFICKING; RELEASE; NEURONS; CHANNEL; HYPOTHALAMUS; TRANSMISSION; MODULATION; CALCIUM	The essence of neuronal function is to generate outputs in response to synaptic potentials. Synaptic integration at postsynaptic sites determines neuronal outputs in the CNS. Using immunohistochemical and electrophysiological approaches, we first reveal that steroidogenic factor 1 (SF-1) green fluorescent protein (GFP)-positive neurons in the ventromedial nucleus of the hypothalamus express P2X4 subunits that are activated by exogenous ATP. Increased membrane expression of P2X4 channels by using a peptide competing with P2X4 intracellular endocytosis motif enhances neuronal excitability of SF-1 GFP-positive neurons. This increased excitability is inhibited by a P2X receptor antagonist. Furthermore, increased surface P2X4 receptor expression significantly decreases the frequency and the amplitude of GABAergic postsynaptic currents of SF-1 GFP-positive neurons. Co-immunopurification and pulldown assays reveal that P2X4 receptors complex with aminobutyric acid, type A (GABA(A)) receptors and demonstrate that two amino acids in the carboxyl tail of the P2X4 subunit are crucial for its physical association with GABA(A) receptors. Mutation of these two residues prevents the physical association, thereby blocking cross-inhibition between P2X4 and GABA(A) receptors. Moreover, disruption of the physical coupling using competitive peptides containing the identified motif abolishes current inhibition between P2X4 and GABA(A) receptors in recombinant system and P2X4 receptor-mediated GABAergic depression in SF-1 GFP-positive neurons. Our present work thus provides evidence for cross-talk between excitatory and inhibitory receptors that appears to be crucial in determining GABAergic synaptic strength at a central synapse.	[Jo, Young-Hwan] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Donier, Emmanuelle; Martinez, Audrey; Garret, Maurice; Toulme, Estelle; Boue-Grabot, Eric] Univ Bordeaux, F-33000 Bordeaux, France; [Donier, Emmanuelle; Martinez, Audrey; Toulme, Estelle; Boue-Grabot, Eric] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Garret, Maurice] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, F-33000 Bordeaux, France	Yeshiva University; Albert Einstein College of Medicine; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10467 USA.	young-hwan.jo@einstein.yu.edu; eric.boue-grabot@u-bordeaux2.fr	Boué-Grabot, Eric/AAQ-2061-2020	Boué-Grabot, Eric/0000-0003-2187-9037; Jo, Young-Hwan/0000-0001-6939-8000	CNRS; Conseil Regional Aquitaine; Agence Nationale de la Recherche [ANR-JC-05-0057]; American Diabetes Association	CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR)); American Diabetes Association(American Diabetes Association)	This work was supported by CNRS, Conseil Regional Aquitaine, Agence Nationale de la Recherche Grant ANR-JC-05-0057), and a junior faculty award from the American Diabetes Association (to Y.-H.J.).	Aguayo LG, 1998, PFLUG ARCH EUR J PHY, V435, P382, DOI 10.1007/s004240050527; Barajas-Lopez C, 1998, J PHYSIOL-LONDON, V513, P671, DOI 10.1111/j.1469-7793.1998.671ba.x; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Boue-Grabot E, 2003, J NEUROSCI, V23, P1246, DOI 10.1523/JNEUROSCI.23-04-01246.2003; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hugel S, 2000, J NEUROSCI, V20, P2121; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jo YH, 2002, J NEUROSCI, V22, P4794, DOI 10.1523/JNEUROSCI.22-12-04794.2002; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Karanjia R, 2006, EUR J NEUROSCI, V23, P3259, DOI 10.1111/j.1460-9568.2006.04861.x; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Rodrigues RJ, 2006, J MOL NEUROSCI, V30, P173, DOI 10.1385/JMN:30:1:173; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Seguela P, 1996, J NEUROSCI, V16, P448; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Sokolova E, 2001, J NEUROSCI, V21, P4958, DOI 10.1523/JNEUROSCI.21-14-04958.2001; Stallings NR, 2002, ENDOCR RES, V28, P497, DOI 10.1081/ERC-120016829; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tobet SA, 1999, J COMP NEUROL, V405, P88, DOI 10.1002/(SICI)1096-9861(19990301)405:1<88::AID-CNE7>3.0.CO;2-0; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	39	44	45	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19993	20004		10.1074/jbc.M111.231324	http://dx.doi.org/10.1074/jbc.M111.231324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482824	Green Published, hybrid			2022-12-27	WOS:000291027700077
J	Miyazawa, M; Tashiro, E; Kitaura, H; Maita, H; Suto, H; Iguchi-Ariga, SMM; Ariga, H				Miyazawa, Makoto; Tashiro, Erika; Kitaura, Hirotake; Maita, Hiroshi; Suto, Hiroo; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Prefoldin Subunits Are Protected from Ubiquitin-Proteasome System-mediated Degradation by Forming Complex with Other Constituent Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L23; MYC-BINDING PROTEIN; FUNCTION IN-VIVO; TUMOR-SUPPRESSOR; C-MYC; EUKARYOTIC PREFOLDIN; CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; ACTIN; MM-1	The molecular chaperone prefoldin (PFD) is a complex comprised of six different subunits, PFD1-PFD6, and delivers newly synthesized unfolded proteins to cytosolic chaperonin TRiC/CCT to facilitate the folding of proteins. PFD subunits also have functions different from the function of the PFD complex. We previously identified MM-1 alpha/PFD5 as a novel c-Myc-binding protein and found that MM-1 alpha suppresses transformation activity of c-Myc. However, it remains unclear how cells regulate protein levels of individual subunits and what mechanisms alter the ratio of their activities between subunits and their complex. In this study, we found that knockdown of one subunit decreased protein levels of other subunits and that transfection of five subunits other than MM-1 alpha into cells increased the level of endogenous MM-1 alpha. We also found that treatment of cells with MG132, a proteasome inhibitor, increased the level of transfected/overexpressed MM-1 alpha but not that of endogenous MM-1 alpha, indicating that overexpressed MM-1 alpha, but not endogenous MM-1 alpha, was degraded by the ubiquitin proteasome system (UPS). Experiments using other PFD subunits showed that the UPS degraded a monomer of PFD subunits, though extents of degradation varied among subunits. Furthermore, the level of one subunit was increased after cotransfection with the respective subunit, indicating that there are specific combinations between subunits to be stabilized. These results suggest mutual regulation of protein levels among PFD subunits and show how individual subunits form the PFD complex without degradation.	[Miyazawa, Makoto; Tashiro, Erika; Kitaura, Hirotake; Maita, Hiroshi; Suto, Hiroo; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Miyazawa, Makoto; Tashiro, Erika; Suto, Hiroo] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Ariga, Sanae/H-9647-2013; Maita, Hiroshi/D-5495-2012	Ariga, Hiroyoshi/0000-0001-7384-2143; 	Ministry of Education, Science, Culture and Sports; National Institute of Biomedical Innovation (NIBIO) of Japan; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan.	Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; CHEN XY, 1994, P NATL ACAD SCI USA, V91, P9111, DOI 10.1073/pnas.91.19.9111; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Drose S, 1997, J EXP BIOL, V200, P1; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Her C, 2003, CANCER RES, V63, P865; Herberg JA, 1998, J MOL BIOL, V277, P839, DOI 10.1006/jmbi.1998.1637; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	36	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19191	19203		10.1074/jbc.M110.216259	http://dx.doi.org/10.1074/jbc.M110.216259			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478150	Green Published, hybrid			2022-12-27	WOS:000291027700002
J	Yang, SY; Xu, HY; Yu, SB; Cao, HL; Fan, J; Ge, CX; Fransceschi, RT; Dong, HH; Xiao, GZ				Yang, Shengyong; Xu, Haiyan; Yu, Shibing; Cao, Huiling; Fan, Jie; Ge, Chunxi; Fransceschi, Renny T.; Dong, Henry H.; Xiao, Guozhi			Foxo1 Mediates Insulin-like Growth Factor 1 (IGF1)/Insulin Regulation of Osteocalcin Expression by Antagonizing Runx2 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; MARROW STROMAL CELLS; GENE-EXPRESSION; PARATHYROID-HORMONE; SIGNALING PATHWAYS; BONE-FORMATION; CLEIDOCRANIAL DYSPLASIA; IN-VIVO; DEPENDENT ACTIVATION; SKELETAL DEVELOPMENT	In this study, we determined the molecular mechanisms whereby forkhead transcription factor Foxo1, a key downstream signaling molecule of insulin-like growth factor 1 (IGF1)/insulin actions, regulates Runx2 activity and expression of the mouse osteocalcin gene 2 (Bglap2) in osteoblasts in vitro. We showed that Foxo1 inhibited Runx2-dependent transcriptional activity and osteocalc in mRNA expression and Bglap2 promoter activity in MC-4 preosteoblasts. Co-immunoprecipitation assay showed that Foxo1 physically interacted with Runx2 via its C-terminal region in osteoblasts or when co-expressed in COS-7 cells. Electrophoretic mobility shift assay demonstrated that Foxo1 suppressed Runx2 binding to its cognate site within the Bglap2 promoter. IGF1 and insulin prevented Foxo1 from inhibiting Runx2 activity by promoting Foxo1 phosphorylation and nuclear exclusion. In contrast, a neutralizing anti-IGF1 antibody decreased Runx2 activity and osteocalcin expression in osteoblasts. Chromatin immunoprecipitation assay revealed that IGF1 increased Runx2 interaction with a chromatin fragment of the proximal Bglap2 promoter in a PI3K/AKT-dependent manner. Conversely, knockdown of Foxo1 increased Runx2 interaction with the promoter. This study establishes that Foxo1 is a novel negative regulator of osteoblast-specific transcription factor Runx2 and modulates IGF1/insulin-dependent regulation of osteocalcin expression in osteoblasts.	[Yang, Shengyong; Yu, Shibing; Cao, Huiling; Xiao, Guozhi] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15240 USA; [Yang, Shengyong] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing 400016, Peoples R China; [Xu, Haiyan] Rhode Isl Hosp, Brown Med Sch, Hallett Ctr Diabet & Endocrinol, Providence, RI 02901 USA; [Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15240 USA; [Ge, Chunxi; Fransceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Fransceschi, Renny T.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Dong, Henry H.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15240 USA; [Xiao, Guozhi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chongqing Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nankai University	Xiao, GZ (corresponding author), VA Pittsburgh Healthcare Syst, Rm 2E-107,151-U, Pittsburgh, PA 15240 USA.	xiaog@upmc.edu	YU, SHIBING/B-7648-2012	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [DK072230, AR059647, DK066301]; Department of Defense [W81XWH-07-1-0160]; Chinese Ministry of Science and Technology [2009CB918902]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230, R01DK066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072230, AR059647, and DK066301 and by Department of Defense Grant W81XWH-07-1-0160 and by Chinese Ministry of Science and Technology Grant 2009CB918902.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Aslam F, 1999, ENDOCRINOLOGY, V140, P63, DOI 10.1210/en.140.1.63; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; BENSON MD, 1998, J BONE MINER RES  S1, V12, pS277; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Javed A, 2000, J CELL SCI, V113, P2221; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	65	55	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19149	19158		10.1074/jbc.M110.197905	http://dx.doi.org/10.1074/jbc.M110.197905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471200	hybrid, Green Published			2022-12-27	WOS:000290785700084
J	Zhou, L; Opalinska, J; Sohal, D; Yu, YT; Mo, YK; Bhagat, T; Abdel-Wahab, O; Fazzari, M; Figueroa, M; Alencar, C; Zhang, JH; Kambhampati, S; Parmar, S; Nischal, S; Hueck, C; Suzuki, M; Freidman, E; Pellagatti, A; Boultwood, J; Steidl, U; Sauthararajah, Y; Yajnik, V; Mcmahon, C; Gore, SD; Platanias, LC; Levine, R; Melnick, A; Wickrema, A; Greally, JM; Vermaa, A				Zhou, Li; Opalinska, Joanna; Sohal, Davendra; Yu, Yiting; Mo, Yongkai; Bhagat, Tushar; Abdel-Wahab, Omar; Fazzari, Melissa; Figueroa, Maria; Alencar, Cristina; Zhang, Jinghang; Kambhampati, Suman; Parmar, Simrit; Nischal, Sangeeta; Hueck, Christoph; Suzuki, Masako; Freidman, Ellen; Pellagatti, Andrea; Boultwood, Jacqueline; Steidl, Ulrich; Sauthararajah, Yogen; Yajnik, Vijay; Mcmahon, Christine; Gore, Steven D.; Platanias, Leonidas C.; Levine, Ross; Melnick, Ari; Wickrema, Amittha; Greally, John M.; Vermaa, Amit			Aberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; EXPRESSION PROFILES; POOR-PROGNOSIS; CD34(+) CELLS; LEUKEMIA; KINASE; HYPERMETHYLATION; PREDICTS; CANCER	Myelodysplastic syndromes (MDS) are characterized by abnormal and dysplastic maturation of all blood lineages. Even though epigenetic alterations have been seen in MDS marrow progenitors, very little is known about the molecular alterations in dysplastic peripheral blood cells. We analyzed the methylome of MDS leukocytes by the HELP assay and determined that it was globally distinct from age-matched controls and was characterized by numerous novel, aberrant hypermethylated marks that were located mainly outside of CpG islands and preferentially affected GTPase regulators and other cancer-related pathways. Additionally, array comparative genomic hybridization revealed that novel as well as previously characterized deletions and amplifications could also be visualized in peripheral blood leukocytes, thus potentially reducing the need for bone marrow samples for future studies. Using integrative analysis, potentially pathogenic genes silenced by genetic deletions and aberrant hypermethylation in different patients were identified. DOCK4, a GTPase regulator located in the commonly deleted 7q31 region, was identified by this unbiased approach. Significant hypermethylation and reduced expression of DOCK4 in MDS bone marrow stem cells was observed in two large independent datasets, providing further validation of our findings. Finally, DOCK4 knockdown in primary marrow CD34(+) stem cells led to decreased erythroid colony formation and increased apoptosis, thus recapitulating the bone marrow failure seen in MDS. These findings reveal widespread novel epigenetic alterations in myelodysplastic leukocytes and implicate DOCK4 as a pathogenic gene located on the 7q chromosomal region.	[Zhou, Li; Opalinska, Joanna; Sohal, Davendra; Yu, Yiting; Mo, Yongkai; Bhagat, Tushar; Fazzari, Melissa; Alencar, Cristina; Zhang, Jinghang; Nischal, Sangeeta; Hueck, Christoph; Suzuki, Masako; Freidman, Ellen; Steidl, Ulrich; Mcmahon, Christine; Greally, John M.; Vermaa, Amit] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Abdel-Wahab, Omar; Levine, Ross] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Figueroa, Maria; Melnick, Ari] Weill Cornell Med Sch, New York, NY 10065 USA; [Kambhampati, Suman] Kansas City Vet Affairs Med Ctr, Kansas City, MO 64128 USA; [Parmar, Simrit] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pellagatti, Andrea; Boultwood, Jacqueline] John Radcliffe Hosp, Oxford OX3 9DU, England; [Wickrema, Amittha] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Sauthararajah, Yogen] Cleveland Clin, Cleveland, OH 44195 USA; [Yajnik, Vijay] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gore, Steven D.] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Texas System; UTMD Anderson Cancer Center; University of Oxford; University of Chicago; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Greally, JM (corresponding author), Albert Einstein Coll Med, Bronx, NY 10461 USA.	john.greally@einstein.yu.edu; amit.verma@einstein.yu.edu	Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020; Melnick, Ari/AAA-5763-2020; levine, ross/AAE-7658-2019; Figueroa, Maria/AAE-8662-2019	Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Fazzari, Melissa/0000-0002-5674-3589; Pellagatti, Andrea/0000-0002-6122-0221; Boultwood, Jacqueline/0000-0002-4330-2928; Abdel-Wahab, Omar/0000-0002-3907-6171; Figueroa, Maria Eugenia/0000-0003-4887-4981	National Institutes of Health [RO1HL082846, RO1AG02913801, CA009173]; American Cancer Society; Gabrielle Angel Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Gabrielle Angel Foundation	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL082846, RO1AG02913801, and CA009173. This work was also supported by American Cancer Society, Partnership for Cures grant and the Gabrielle Angel Foundation.	Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Liang H, 2005, CANCER GENET CYTOGEN, V162, P151, DOI 10.1016/j.cancergencyto.2005.03.019; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	44	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25211	25223		10.1074/jbc.M111.235028	http://dx.doi.org/10.1074/jbc.M111.235028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21532034	Green Published, hybrid			2022-12-27	WOS:000292547900067
J	Nelson, O; Supnet, C; Tolia, A; Horre, K; De Strooper, B; Bezprozvanny, I				Nelson, Omar; Supnet, Charlene; Tolia, Alexandra; Horre, Katrien; De Strooper, Bart; Bezprozvanny, Ilya			Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; DISEASE-LINKED MUTATIONS; ALZHEIMERS-DISEASE; CATALYTIC PORE; IN-VIVO; COMPLEX; SITE; ENDOPROTEOLYSIS; RECONSTITUTION	Missense mutations in presenilin 1 (PS1) and presenilin 2 (PS2) proteins are a major cause of familial Alzheimer disease. Presenilins are proteins with nine transmembrane (TM) domains that function as catalytic subunits of the gamma-secretase complex responsible for the cleavage of the amyloid precursor protein and other type I transmembrane proteins. The water-filled cavity within presenilin is necessary to mediate the intramembrane proteolysis reaction. Consistent with this idea, cysteine-scanning mutagenesis and NMR studies revealed a number of water-accessible residues within TM7 and TM9 of mouse PS1. In addition to gamma-secretase function, presenilins also demonstrate a low conductance endoplasmic reticulum Ca2+ leak function, and many familial Alzheimer disease presenilin mutations impair this function. To map the potential Ca2+ conductance pore in PS1, we systematically evaluated endoplasmic reticulum Ca2+ leak activity supported by a series of cysteine point mutants in TM6, TM7, and TM9 of mouse PS1. The results indicate that TM7 and TM9, but not TM6, could play an important role in forming the conductance pore of PS1. These results are consistent with previous cysteine-scanning mutagenesis and NMR analyses of PS1 and provide further support for our hypothesis that the hydrophilic catalytic cavity of presenilins may also constitute a Ca2+ conductance pore.	[Nelson, Omar; Supnet, Charlene; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] VIB, Dept Mol & Dev Genet, B-3000 Leuven, Belgium	University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven; Flanders Institute for Biotechnology (VIB)	Bezprozvanny, I (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND12-200AA, Dallas, TX 75390 USA.	ilya.bezprozvanny@utsouthwestern.edu	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Supnet, Charlene/0000-0001-6917-770X; Horre, Katrien/0000-0002-6801-3137	National Institutes of Health [R01AG030746, F31]; King Foundation; McKnight Brain Disorders award; Flemish Government; Katholieke Universiteit Leuven; Fund for Scientific Research (Flanders, Belgium); Federal Office for Scientific Affairs (Belgium) [IUAP P6/43]; Division of Basic Science; NATIONAL INSTITUTE ON AGING [R01AG030746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Foundation; McKnight Brain Disorders award; Flemish Government(European Commission); Katholieke Universiteit Leuven(KU Leuven); Fund for Scientific Research (Flanders, Belgium)(FWO); Federal Office for Scientific Affairs (Belgium); Division of Basic Science; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG030746 (to I. B.). This work was also supported by a King Foundation award and a McKnight Brain Disorders award (to I. B.), a Methusalem grant from the Flemish Government and the Katholieke Universiteit Leuven, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43, Belgium).; Supported by a Division of Basic Science training grant and a National Institutes of Health predoctoral fellowship award for minority students (F31). Present address: Dept. of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hebert SS, 2003, BIOCHEM BIOPH RES CO, V301, P119, DOI 10.1016/S0006-291X(02)02984-4; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hofer AM, 1999, METH MOL B, V114, P249; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Khandelwal A, 2007, P NATL ACAD SCI USA, V104, P13337, DOI 10.1073/pnas.0702038104; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010	43	56	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22339	22347		10.1074/jbc.M111.243063	http://dx.doi.org/10.1074/jbc.M111.243063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531718	hybrid, Green Published			2022-12-27	WOS:000291719900043
J	Van Montfort, T; Melchers, M; Isik, G; Menis, S; Huang, PS; Matthews, K; Michael, E; Berkhout, B; Schief, WR; Moore, JP; Sanders, RW				Van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Menis, Sergey; Huang, Po-Ssu; Matthews, Katie; Michael, Elizabeth; Berkhout, Ben; Schief, William R.; Moore, John P.; Sanders, Rogier W.			A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; DNA VACCINE; IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; MACAQUE MONKEYS; MOUTH-DISEASE; DOUBLE-BLIND; TNF-ALPHA; GP120	An effective HIV-1 vaccine should ideally induce strong humoral and cellular immune responses that provide sterilizing immunity over a prolonged period. Current HIV-1 vaccines have failed in inducing such immunity. The viral envelope glycoprotein complex (Env) can be targeted by neutralizing antibodies to block infection, but several Env properties limit the ability to induce an antibody response of sufficient quantity and quality. We hypothesized that Env immunogenicity could be improved by embedding an immunostimulatory protein domain within its sequence. A stabilized Env trimer was therefore engineered with the granulocyte-macrophage colony-stimulating factor (GM-CSF) inserted into the V1V2 domain of gp120. Probing with neutralizing antibodies showed that both the Env and GM-CSF components of the chimeric protein were folded correctly. Furthermore, the embedded GM-CSF domain was functional as a cytokine in vitro. Mouse immunization studies demonstrated that chimeric Env(GM-CSF) enhanced Env-specific antibody and T cell responses compared with wild-type Env. Collectively, these results show that targeting and activation of immune cells using engineered cytokine domains within the protein can improve the immunogenicity of Env subunit vaccines.	[Van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Menis, Sergey; Huang, Po-Ssu; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Matthews, Katie; Michael, Elizabeth; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; Cornell University	Sanders, RW (corresponding author), Meibergdreef 15, NL-1100 DE Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Schief, William/ABF-3645-2020	Schief, William/0000-0002-1120-0150; Isik, Gozde/0000-0002-1329-6782; Huang, Possu/0000-0002-7948-2895	National Institutes of Health [AI36082, AI45463]; AIDS Fund (Amsterdam) [2008013, 2009012, 2005021]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045463, R37AI036082, R01AI036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36082 and AI45463 (to J. P. M.). This work was also supported by Grants 2008013 and 2009012 (to R. W. S.) and 2005021 (to B. B.) from the AIDS Fund (Amsterdam) and by the International AIDS Vaccine Initiative.	ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BOGERS WM, 1995, AIDS, V9, P13; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; Deresinski SC, 1999, AIDS, V13, P633, DOI 10.1097/00002030-199904160-00003; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Foresman L, 1998, AIDS RES HUM RETROV, V14, P1035, DOI 10.1089/aid.1998.14.1035; Fujiwara Y, 2010, PROTEIN EXPRES PURIF, V72, P125, DOI 10.1016/j.pep.2010.02.008; FURMAN WL, 1991, J CLIN ONCOL, V9, P1022, DOI 10.1200/JCO.1991.9.6.1022; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; GIBELLINI D, 1994, MICROBIOLOGICA, V17, P85; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hu XD, 2010, VACCINE, V28, P2408, DOI 10.1016/j.vaccine.2009.12.076; Kim JJ, 1998, J INTERF CYTOK RES, V18, P537, DOI 10.1089/jir.1998.18.537; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kusakabe K, 2000, J IMMUNOL, V164, P3102, DOI 10.4049/jimmunol.164.6.3102; LING P, 1995, J IMMUNOL, V154, P116; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; Nimal S, 2007, VACCINE, V25, P2306, DOI 10.1016/j.vaccine.2006.11.059; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reddy KS, 2010, FEMS IMMUNOL MED MIC, V60, P261, DOI 10.1111/j.1574-695X.2010.00739.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2006, VIROLOGY, V352, P285, DOI 10.1016/j.virol.2006.02.011; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shibata R, 1997, J VIROL, V71, P8141, DOI 10.1128/JVI.71.11.8141-8148.1997; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Song RJ, 2006, J INTERF CYTOK RES, V26, P380, DOI 10.1089/jir.2006.26.380; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; STUTE N, 1995, J PHARM SCI-US, V84, P824, DOI 10.1002/jps.2600840708; Su BW, 2008, VACCINE, V26, P5111, DOI 10.1016/j.vaccine.2008.03.089; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Zhang C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-7; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	70	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22250	22261		10.1074/jbc.M111.229625	http://dx.doi.org/10.1074/jbc.M111.229625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515681	Green Published, hybrid			2022-12-27	WOS:000291719900033
J	Agarwal, V; Metlitskaya, A; Severinov, K; Nair, SK				Agarwal, Vinayak; Metlitskaya, Anastasiya; Severinov, Konstantin; Nair, Satish K.			Structural Basis for Microcin C7 Inactivation by the MccE Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CAP-BINDING; MACROMOLECULAR STRUCTURES; PLASMID GENES; PROTEIN; REFINEMENT; RECOGNITION; SUPERFAMILY; MATURATION; ENZYME	The antibiotic microcin C7 (McC) acts as a bacteriocide by inhibiting aspartyl-tRNA synthetase and stalling the protein translation machinery. McC is synthesized as a heptapeptide-nucleotide conjugate, which is processed by cellular peptidases within target strains to yield the biologically active compound. As unwanted processing of intact McC can result in self-toxicity, producing strains utilize multiple mechanisms for autoimmunity against processed McC. We have shown previously that the mccE gene within the biosynthetic cluster can inactivate processed McC by acetylating the antibiotic. Here, we present the characterization of this acetylation mechanism through biochemical and structural biological studies of the MccE acetyltransferase domain (MccE(AcTase)). We have also determined five crystal structures of the MccE-acetyl-CoA complex with bound substrates, inhibitor, and reaction product. The structural data reveal an unexpected mode of substrate recognition through pi-stacking interactions similar to those found in cap-binding proteins and nucleotidyltransferases. These studies provide a rationale for the observation that MccE(AcTase) can detoxify a range of aminoacylnucleotides, including those that are structurally distinct from microcin C7.	[Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Metlitskaya, Anastasiya; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 11934, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 11934, Russia	Rutgers State University New Brunswick; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rutgers State University New Brunswick; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu; snair@illinois.edu	Severinov, Konstantin/C-8545-2016; Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017		Rutgers University; Russian Academy of Sciences; Russian Foundation for Basic Research [06-04-48865]	Rutgers University; Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by a Technology Commercialization Fund grant from Rutgers University (to K.S.) and a Molecular and Cell Biology Program grant from the Russian Academy of Sciences. A.M. was supported by Grant 06-04-48865 from the Russian Foundation for Basic Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunzelle JS, 2004, PROTEINS, V57, P850, DOI 10.1002/prot.10601; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fomenko DE, 2003, ANTIMICROB AGENTS CH, V47, P2868, DOI 10.1128/AAC.47.9.2868-2874.2003; GONZALEZPASTOR JE, 1995, J BACTERIOL, V177, P7131, DOI 10.1128/jb.177.24.7131-7140.1995; GONZALEZPASTOR JE, 1994, NATURE, V369, P281, DOI 10.1038/369281a0; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novikova M, 2007, J BACTERIOL, V189, P8361, DOI 10.1128/JB.01028-07; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pohlmann J., 2004, Current Drug Targets - Infectious Disorders, V4, P261, DOI 10.2174/1568005043340515; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Stefanska AL, 2000, J ANTIBIOT, V53, P1346, DOI 10.7164/antibiotics.53.1346; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Zeng Y, 2009, ANTIMICROB AGENTS CH, V53, P4619, DOI 10.1128/AAC.00782-09	40	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21295	21303		10.1074/jbc.M111.226282	http://dx.doi.org/10.1074/jbc.M111.226282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507941	hybrid, Green Published			2022-12-27	WOS:000291464700028
J	Mescam, M; Vinnakota, KC; Beard, DA				Mescam, Muriel; Vinnakota, Kalyan C.; Beard, Daniel A.			Identification of the Catalytic Mechanism and Estimation of Kinetic Parameters for Fumarase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG-HEART FUMARASE; ISO-MECHANISMS; PRODUCT INHIBITION; ENZYMES; CYCLE; SITE	The enzyme fumarase catalyzes the reversible hydration of fumarate to malate. The reaction catalyzed by fumarase is critical for cellular energetics as a part of the tricarboxylic acid cycle, which produces reducing equivalents to drive oxidative ATP synthesis. A catalytic mechanism for the fumarase reaction that can account for the kinetic behavior of the enzyme observed in both isotope exchange studies and initial velocity studies has not yet been identified. In the present study, we develop an 11-state kinetic model of the enzyme based on the current consensus on its catalytic mechanism and design a series of experiments to estimate the model parameters and identify the major flux routes through the mechanism. The 11-state mechanism accounts for competitive binding of inhibitors and activation by different anions, including phosphate and fumarate. The model is identified from experimental time courses of the hydration of fumarate to malate obtained over a wide range of buffer and substrate concentrations. Further, the 11-state model is found to effectively reduce to a five-state model by lumping certain successive steps together to yield a mathematically less complex representation that is able to match the data. Analysis suggests the primary reaction route of the catalytic mechanism, with fumarate binding to the free unprotonated enzyme and a proton addition prior to malate release in the fumarate hydration reaction. In the reverse direction (malate dehydration), malate binds the protonated form of the enzyme, and a proton is generated before fumarate is released from the active site.	Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Beard, DA (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dbeard@mcw.edu	Mescam, Muriel/F-5855-2013; Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213	National Institutes of Health [HL094317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL094317.	ALBERTY RA, 1954, J AM CHEM SOC, V76, P2485, DOI 10.1021/ja01638a053; ALBERTY RA, 2003, THERMODYNAMICS BIOCH, P47; ALBERTY RA, 1959, ENZYMES; BEARD DA, 2008, CHEM BIOPHYSICS QUAN, P36; Beeckmans S, 1998, J BIOL CHEM, V273, P31661, DOI 10.1074/jbc.273.48.31661; CORNISHBOWDEN A, 1994, BIOCHEM J, V301, P621, DOI 10.1042/bj3010621; HANSEN JN, 1969, J BIOL CHEM, V244, P6270; HASINOFF BB, 1986, BIOCHEM J, V235, P891, DOI 10.1042/bj2350891; HILL RL, 1971, ENZYMES, P552; Li X, 2010, J PHYS CHEM B, V114, P16068, DOI 10.1021/jp911381p; MASSEY V, 1953, BIOCHEM J, V53, P67, DOI 10.1042/bj0530067; MASSEY V, 1953, BIOCHEM J, V55, P172, DOI 10.1042/bj0550172; NORTHROP DB, 1994, ANAL BIOCHEM, V216, P285, DOI 10.1006/abio.1994.1043; Northrop DB, 1997, ARCH BIOCHEM BIOPHYS, V342, P317, DOI 10.1006/abbi.1997.0131; REBHOLZ KL, 1994, ARCH BIOCHEM BIOPHYS, V312, P227, DOI 10.1006/abbi.1994.1303; REBHOLZ KL, 1993, BIOCHEM J, V296, P355, DOI 10.1042/bj2960355; ROSE IA, 1992, BIOCHEMISTRY-US, V31, P9993, DOI 10.1021/bi00156a019; Rose IA, 1997, BIOCHEMISTRY-US, V36, P12346, DOI 10.1021/bi971258d; ROSE IA, 1993, BIOCHEMISTRY-US, V32, P8504, DOI 10.1021/bi00084a016; Rose IA, 2004, P NATL ACAD SCI USA, V101, P3393, DOI 10.1073/pnas.0307524101; Rose IA, 1998, BIOCHEMISTRY-US, V37, P17651, DOI 10.1021/bi9821521; Tian ZM, 2009, HYPERTENSION, V54, P255, DOI 10.1161/HYPERTENSIONAHA.109.129528; Vinnakota KC, 2009, METHOD ENZYMOL, V454, P29, DOI 10.1016/S0076-6879(08)03802-0	23	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21100	21109		10.1074/jbc.M110.214452	http://dx.doi.org/10.1074/jbc.M110.214452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498518	Green Published, hybrid			2022-12-27	WOS:000291464700009
J	Park, SJ; Kleffmann, T; Hessian, PA				Park, Sun Jin; Kleffmann, Torsten; Hessian, Paul A.			The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81 COMPARISON OF WILD-TYPE RAGE WITH THE G82S POLYMORPHIC VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLATED N-GLYCANS; CELL-SURFACE RECEPTOR; AMYLOID-BETA PEPTIDE; ENDOTHELIAL-CELLS; INFLAMMATORY RESPONSE; PATTERN-RECOGNITION; ALZHEIMERS-DISEASE; CIRCULATING LEVELS; NEURITE OUTGROWTH; MASS-SPECTROMETRY	Interaction between the receptor for advanced glycation end products (RAGE) and its ligands amplifies the proinflammatory response. N-Linked glycosylation of RAGE plays an important role in the regulation of ligand binding. Two potential sites for N-linked glycosylation, at Asn(25) and Asn(81), are implicated, one of which is potentially influenced by a naturally occurring polymorphism that substitutes Gly(82) with Ser. This G82S polymorphic RAGE variant displays increased ligand binding and downstream signaling. We hypothesized that the G82S polymorphism affects RAGE glycosylation and thereby affects ligand binding. WT or various mutant forms of RAGE protein, including N25Q, N81Q, N25Q/G82S, and N25Q/N81Q, were produced by transfecting HEK293 cells. The glycosylation patterns of expressed proteins were compared. Enzymatic deglycosylation showed that WT RAGE and the G82S polymorphic variant are glycosylated to the same extent. Our data also revealed N-linked glycosylation of N25Q and N81Q mutants, suggesting that both Asn(25) and Asn(81) can be utilized for N-linked glycosylation. Using mass spectrometry analysis, we found that Asn(81) may or may not be glycosylated in WT RAGE, whereas in G82S RAGE, Asn(81) is always glycosylated. Furthermore, RAGE binding to S100B ligand is affected by Asn(81) glycosylation, with consequences for NF-kappa B activation. Therefore, the G82S polymorphism promotes N-linked glycosylation of Asn(81), which has implications for the structure of the ligand binding region of RAGE and might explain the enhanced function associated with the G82S polymorphic RAGE variant.	[Hessian, Paul A.] Univ Otago, Leukocyte Inflammat Res Lab, Dept Physiol, Dunedin Sch Med Sci, Dunedin 9054, New Zealand; [Kleffmann, Torsten] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago; University of Otago	Hessian, PA (corresponding author), Univ Otago, Leukocyte Inflammat Res Lab, Dept Physiol, Dunedin Sch Med Sci, Wellcome Bldg,POB 913, Dunedin 9054, New Zealand.	paul.hessian@stonebow.otago.ac.nz		Kleffmann, Torsten/0000-0001-9305-5980	Arthritis New Zealand; Health Research Council of New Zealand	Arthritis New Zealand; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by Arthritis New Zealand and the Health Research Council of New Zealand.	Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 1998, DIABETES, V47, P1155, DOI 10.2337/diabetes.47.7.1155; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Huttunen HJ, 2002, CANCER RES, V62, P4805; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Kuster B, 1999, ANAL CHEM, V71, P1431, DOI 10.1021/ac981012u; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2006, BIOCHEM BIOPH RES CO, V347, P4, DOI 10.1016/j.bbrc.2006.04.077; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Pullerits R, 2005, ARTHRITIS RES THER, V7, pR817, DOI 10.1186/ar1749; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Schmidt AM, 2000, SEMIN THROMB HEMOST, V26, P485, DOI 10.1055/s-2000-13204; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Srikrishna G, 2005, BIOCHEM BIOPH RES CO, V332, P1020, DOI 10.1016/j.bbrc.2005.05.056; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Srikrishna G, 2001, J IMMUNOL, V166, P624, DOI 10.4049/jimmunol.166.1.624; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1997, NATURE, V389, P689; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	43	38	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21384	21392		10.1074/jbc.M111.241281	http://dx.doi.org/10.1074/jbc.M111.241281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21511948	hybrid, Green Published			2022-12-27	WOS:000291464700037
J	Charvet, C; Liao, WL; Heo, GY; Laird, J; Salomon, RG; Turko, IV; Pikuleva, IA				Charvet, Casey; Liao, Wei-Li; Heo, Gun-Young; Laird, James; Salomon, Robert G.; Turko, Illarion V.; Pikuleva, Irina A.			Isolevuglandins and Mitochondrial Enzymes in the Retina MASS SPECTROMETRY DETECTION OF POST-TRANSLATIONAL MODIFICATION OF STEROL-METABOLIZING CYP27A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450C27 CYP27; PROTEIN ADDUCTS; CEREBROTENDINOUS-XANTHOMATOSIS; MACULAR DEGENERATION; DENSITY-LIPOPROTEIN; ISOPROSTANE PATHWAY; LIPID-PEROXIDATION; LEVUGLANDIN E(2); 27-HYDROXYLASE; CHOLESTEROL	We report the first peptide mapping and sequencing of an in vivo isolevuglandin-modified protein. Mitochondrial cytochrome P450 27A1 (CYP27A1) is a ubiquitous multifunctional sterol C27-hydroxylase that eliminates cholesterol and likely 7-ketocholesterol from the retina and many other tissues. We investigated the post-translational modification of this protein with isolevuglandins, arachidonate oxidation products. Treatment of purified recombinant CYP27A1 with authentic iso[4]levuglandin E-2 (iso[4]LGE(2)) in vitro diminished enzyme activity in a time-and phospholipid-dependent manner. A multiple reaction monitoring protocol was then developed to identify the sites and extent of iso[4]LGE2 adduction. CYP27A1 exhibited only three Lys residues, Lys(134), Lys(358), and Lys(476), that readily interact with iso[4]LGE(2) in vitro. Such selective modification enabled the generation of an internal standard, N-15-labeled CYP27A1 modified with iso[4]LGE(2), for the subsequent analysis of a human retinal sample. Two multiple reaction monitoring transitions arising from the peptide AVLK(358)(-C20H26O3)ETLR in the retinal sample were observed that co-eluted with the corresponding two N-15 transitions from the supplemented standard. These data demonstrate that modified CYP27A1 is present in the retina. We suggest that such protein modification impairs sterol elimination and likely has other pathological sequelae. We also propose that the post-translational modifications identified in CYP27A1 exemplify a general mechanism whereby oxidative stress and inflammation deleteriously affect protein function, contributing, for example, to cholesterol-rich lesions associated with age-related macular degeneration and cardiovascular disease. The proteomic protocols developed in this study are generally applicable to characterization of lipid-derived oxidative protein modifications occurring in vivo, including proteins bound to membranes.	[Turko, Illarion V.] Natl Inst Stand & Technol, Div Analyt Chem, Gaithersburg, MD 20899 USA; [Liao, Wei-Li; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Laird, James; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Charvet, Casey; Heo, Gun-Young; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	National Institute of Standards & Technology (NIST) - USA; Case Western Reserve University; Case Western Reserve University	Pikuleva, IA (corresponding author), 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu	Salomon, Robert G/C-3463-2008	Pikuleva, Irina/0000-0001-9742-6232; Salomon, Robert/0000-0001-9456-3557	National Institutes of Health [EY018383, AG024336, GM21249, T32 EY007157, P30 EY11373]; NATIONAL EYE INSTITUTE [R01EY018383, T32EY007157, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018383 and AG024336 (to I. A. P.), GM21249 (to R. G. S.), Fellowship T32 EY007157 (to C. C.), and Core Grant P30 EY11373 (to Case Visual Sciences Research Center).	*AV POL LIP, 2010, PREP LIP; Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; BENGA G, 1978, EUR J BIOCHEM, V84, P625, DOI 10.1111/j.1432-1033.1978.tb12205.x; BJORKHEM I, 1994, SCAND J GASTROENTERO, V29, P68, DOI 10.3109/00365529409103629; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; BRODY TM, 1952, J BIOL CHEM, V195, P685; Brown AJ, 2000, J BIOL CHEM, V275, P27627; Davies SS, 2007, NAT PROTOC, V2, P2079, DOI 10.1038/nprot.2007.298; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DIFRANCO E, 1995, CHEM RES TOXICOL, V8, P61, DOI 10.1021/tx00043a008; Dotti MT, 2001, J INHERIT METAB DIS, V24, P696, DOI 10.1023/A:1012981019336; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUJIYAMA J, 1991, CLIN CHIM ACTA, V200, P1, DOI 10.1016/0009-8981(91)90328-A; Govindarajan B, 2008, BIOCHEMISTRY-US, V47, P817, DOI 10.1021/bi701517m; Griffiths JR, 2007, J AM SOC MASS SPECTR, V18, P1423, DOI 10.1016/j.jasms.2007.04.021; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; HAMILTON JG, 1988, LIPIDS, V23, P1146, DOI 10.1007/BF02535281; HEO GY, 2011, J LIPID RES, V10, P241; Hollyfield JG, 2003, ADV EXP MED BIOL, V533, P83; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; KOBIERSKI ME, 1994, J ORG CHEM, V59, P6044, DOI 10.1021/jo00099a040; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Li CM, 2007, EXP EYE RES, V85, P192, DOI 10.1016/j.exer.2007.04.002; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Liao WL, 2010, ANAL CHEM, V82, P5760, DOI 10.1021/ac100811x; Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mollah S, 2007, RAPID COMMUN MASS SP, V21, P3357, DOI 10.1002/rcm.3227; MORGAN SJ, 1989, BRIT J OPHTHALMOL, V73, P1011, DOI 10.1136/bjo.73.12.1011; Murtazina D, 2002, J BIOL CHEM, V277, P37582, DOI 10.1074/jbc.M204909200; OMURA T, 1964, J BIOL CHEM, V239, P2379; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pikuleva IA, 1998, J BIOL CHEM, V273, P18153, DOI 10.1074/jbc.273.29.18153; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Pikuleva IA, 1999, J BIOL CHEM, V274, P2045, DOI 10.1074/jbc.274.4.2045; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Poliakov E, 2004, CHEM RES TOXICOL, V17, P613, DOI 10.1021/tx034185+; Reiss AB, 1997, J LIPID RES, V38, P1254; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Salomon RG, 2005, ANTIOXID REDOX SIGN, V7, P185, DOI 10.1089/ars.2005.7.185; Salomon RG, 1999, J BIOL CHEM, V274, P20271, DOI 10.1074/jbc.274.29.20271; Subbanagounder G, 1997, J ORG CHEM, V62, P7658, DOI 10.1021/jo970858f; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; Tallman KA, 2007, CHEM RES TOXICOL, V20, P227, DOI 10.1021/tx600331s; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6	53	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20413	20422		10.1074/jbc.M111.232546	http://dx.doi.org/10.1074/jbc.M111.232546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498512	Green Published, hybrid			2022-12-27	WOS:000291267600029
J	Ling, AS; Trotter, JR; Hendriks, EF				Ling, Alexandra S.; Trotter, James R.; Hendriks, Edward F.			A Zinc Finger Protein, TbZC3H20, Stabilizes Two Developmentally Regulated mRNAs in Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; CCCH PROTEIN; LIFE-CYCLE; POSTTRANSCRIPTIONAL CONTROL; LEISHMANIA-MAJOR; BRUCEI; GENOME; TRISTETRAPROLIN; BINDING; DIFFERENTIATION	CCCH zinc finger proteins (ZC3Hs) are a novel class of RNA-binding protein involved in post-transcriptional mechanisms controlling gene expression. We show TbZC3H20 from Trypanosoma brucei, the causative agent of sleeping sickness and other diseases, stabilizes two developmentally regulated transcripts encoding a mitochondrial carrier protein (MCP12) and trans-sialidase (TS-like E). TbZC3H20 is shown to be an RNA-binding protein that is enriched in insect procyclic form T. brucei and is the first ZC3H discovered controlling gene expression through modulating mRNA abundance in trypanosomes. Previous studies have demonstrated that RNA recognition motif-containing and PUF family RNA-binding proteins can control gene expression by stabilizing specific target mRNA levels. This work is the first to describe a ZC3H stabilizing rather than destabilizing target mRNAs as a regulatory mechanism and the first report of a ZC3H regulating a gene encoding a mitochondrial protein. This suggests a broader role for ZC3Hs in post-transcriptional regulation of gene expression than previously thought.	[Ling, Alexandra S.; Trotter, James R.; Hendriks, Edward F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Hendriks, EF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, S Kensington Campus, London SW7 2AZ, England.	e.hendriks@imperial.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; HENDRIKS E, 2007, POSTTRANSCRIPTIONAL, P210; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Hendriks EF, 2005, MOL MICROBIOL, V57, P706, DOI 10.1111/j.1365-2958.2005.04679.x; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Matthews KR, 2004, TRENDS PARASITOL, V20, P40, DOI 10.1016/j.pt.2003.10.016; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Paterou A, 2006, J BIOL CHEM, V281, P39002, DOI 10.1074/jbc.M604280200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rotureau B, 2005, EXP PARASITOL, V111, P207, DOI 10.1016/j.exppara.2005.07.003; Silva MS, 2009, PARASITOL RES, V105, P1223, DOI 10.1007/s00436-009-1542-6; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	55	28	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20152	20162		10.1074/jbc.M110.139261	http://dx.doi.org/10.1074/jbc.M110.139261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467035	Green Published, hybrid			2022-12-27	WOS:000291267600004
J	Braun, RJ; Sommer, C; Carmona-Gutierrez, D; Khoury, CM; Ring, J; Buttner, S; Madeo, F				Braun, Ralf J.; Sommer, Cornelia; Carmona-Gutierrez, Didac; Khoury, Chamel M.; Ring, Julia; Buettner, Sabrina; Madeo, Frank			Neurotoxic 43-kDa TAR DNA-binding Protein (TDP-43) Triggers Mitochondrion-dependent Programmed Cell Death in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; DROSOPHILA MODEL; REGULATES APOPTOSIS; OXIDATIVE STRESS; ACETIC-ACID; TOXICITY; DISEASE	Pathological neuronal inclusions of the 43-kDa TAR DNA-binding protein (TDP-43) are implicated in dementia and motor neuron disorders; however, the molecular mechanisms of the underlying cell loss remain poorly understood. Here we used a yeast model to elucidate cell death mechanisms upon expression of human TDP-43. TDP-43-expressing cells displayed markedly increased markers of oxidative stress, apoptosis, and necrosis. Cytotoxicity was dose-and age-dependent and was potentiated upon expression of disease-associated variants. TDP-43 was localized in perimitochondrial aggregate-like foci, which correlated with cytotoxicity. Although the deleterious effects of TDP-43 were significantly decreased in cells lacking functional mitochondria, cell death depended neither on the mitochondrial cell death proteins apoptosis-inducing factor, endonuclease G, and cytochrome c nor on the activity of cell death proteases like the yeast caspase 1. In contrast, impairment of the respiratory chain attenuated the lethality upon TDP-43 expression with a stringent correlation between cytotoxicity and the degree of respiratory capacity or mitochondrial DNA stability. Consistently, an increase in the respiratory capacity of yeast resulted in enhanced TDP-43-triggered cytotoxicity, oxidative stress, and cell death markers. These data demonstrate that mitochondria and oxidative stress are important to TDP-43-triggered cell death in yeast and may suggest a similar role in human TDP-43 pathologies.	[Braun, Ralf J.; Sommer, Cornelia; Carmona-Gutierrez, Didac; Khoury, Chamel M.; Ring, Julia; Buettner, Sabrina; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Braun, Ralf J.] Univ Bayreuth, Inst Cell Biol, D-95440 Bayreuth, Germany	University of Graz; University of Bayreuth	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	frank.madeo@uni-graz.at	Braun, Ralf/B-9123-2008	Braun, Ralf/0000-0003-4234-8163; Madeo, Frank/0000-0002-5070-1329; Buttner, Sabrina/0000-0002-2786-8542; Ring, Julia/0000-0003-4991-9328; Carmona-Gutierrez, Didac/0000-0001-7548-7771	German Research Foundation (Deutsche Forschungsgemeinschaft) [BR 3706/1-1]; Fonds zur Forderung der Wissenschaftlichen Forschung [W1226-B18]; DKplus Metabolic and Cardiovascular Disease [S-9304-B05, T-414-B09]; European Commission	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); DKplus Metabolic and Cardiovascular Disease(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant BR 3706/1-1 (a postdoctoral fellowship to R. J. B.); by Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung) Grants W1226-B18 DKplus Metabolic and Cardiovascular Disease (to C. S. and F. M.), S-9304-B05 (to C. M. K. and F. M.), "Lipotox" (to D. C.-G., C. M. K., and F. M.), and T-414-B09 (a Hertha-Firnberg Fellowship to S. B.); and by the European Commission Project Apoptosis Systems Biology Applied to Cancer and AIDS (APO-SYS) (to F. M.).	Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Braun RJ, 2010, TRENDS BIOCHEM SCI, V35, P135, DOI 10.1016/j.tibs.2009.10.005; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Eisenberg T, 2010, APOPTOSIS, V15, P257, DOI 10.1007/s10495-009-0453-4; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fang J, 2003, FREE RADICAL BIO MED, V34, P478, DOI 10.1016/S0891-5849(02)01328-X; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gitler AD, 2008, NEUROSIGNALS, V16, P52, DOI 10.1159/000109759; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hauptmann P, 2008, J BIOL CHEM, V283, P19151, DOI 10.1074/jbc.M801303200; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Ocampo A, 2010, FASEB J, V24, P1431, DOI 10.1096/fj.09-148601; Outeiro Tiago Fleming, 2006, Biotechnology Journal, V1, P258, DOI 10.1002/biot.200500043; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887; Zischka H, 2006, MOL CELL PROTEOMICS, V5, P2185, DOI 10.1074/mcp.T600018-MCP200	65	71	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19958	19972		10.1074/jbc.M110.194852	http://dx.doi.org/10.1074/jbc.M110.194852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471218	hybrid, Green Published			2022-12-27	WOS:000291027700074
J	Hozoji-Inada, M; Munehira, Y; Nagao, K; Kioka, N; Ueda, K				Hozoji-Inada, Masako; Munehira, Youichi; Nagao, Kohjiro; Kioka, Noriyuki; Ueda, Kazumitsu			Liver X Receptor beta (LXR beta) Interacts Directly with ATP-binding Cassette A1 (ABCA1) to Promote High Density Lipoprotein Formation during Acute Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER A1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; EXTRACELLULAR DOMAIN; APOA-I; EFFLUX; MUTATIONS; ALPHA; GENE; LOCALIZATION	Cells have evolved multiple mechanisms for maintaining cholesterol homeostasis, and, among these, ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux is highly regulated at the transcriptional level through the activity of the nuclear receptor liver X receptor (LXR). Here, we show that in addition to its well defined role in transcription, LXR beta directly binds to the C-terminal region ((LTSFL2251)-L-2247) of ABCA1 to mediate its post-translational regulation. In the absence of cholesterol accumulation in the macrophage-like cell line THP-1, the ABCA1-LXR beta complex stably localizes to the plasma membrane, but apolipoprotein A-I (apoA-I) binding or cholesterol efflux does not occur. Exogenously added LXR ligands, which mimic cholesterol accumulation, cause LXR beta to dissociate from ABCA1, thus freeing ABCA1 for apoA-I binding and subsequent cholesterol efflux. Photoaffinity labeling experiments with 8-azido-[alpha-P-32] ATP showed that the interaction of LXR beta with ABCA1 inhibits ATP binding by ABCA1. This is the first study to show that a protein-protein interaction with the endogenous protein suppresses the function of ABC proteins by inhibiting ATP binding. LXR beta can cause a post-translational response by binding directly to ABCA1, as well as a transcriptional response, to maintain cholesterol homeostasis.	[Hozoji-Inada, Masako; Nagao, Kohjiro; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Munehira, Youichi; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kioka, Noriyuki/0000-0002-2708-537X; Ueda, Kazumitsu/0000-0003-2980-6078	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan; Takeda Scientific Foundation; World Premier International Research Center Initiative, MEXT, Japan; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan, by a grant from the Takeda Scientific Foundation, and by the World Premier International Research Center Initiative, MEXT, Japan.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Costet P, 2000, J BIOL CHEM, V275, P28240; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Hashimoto K, 2002, HEPATOLOGY, V36, P1236, DOI 10.1053/jhep.2002.36368; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nagao K, 2009, J LIPID RES, V50, P1165, DOI 10.1194/jlr.M800597-JLR200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Prufer K, 2007, J CELL BIOCHEM, V100, P69, DOI 10.1002/jcb.21006; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Szakacs G, 2001, BIOCHEM BIOPH RES CO, V288, P1258, DOI 10.1006/bbrc.2001.5905; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Takeda Y, 1998, BBA-BIOMEMBRANES, V1373, P131, DOI 10.1016/S0005-2736(98)00099-6; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Wellington CL, 2002, J LIPID RES, V43, P1939, DOI 10.1194/jlr.M200277-JLR200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	37	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20117	20124		10.1074/jbc.M111.235846	http://dx.doi.org/10.1074/jbc.M111.235846			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507939	hybrid, Green Published			2022-12-27	WOS:000291027700088
J	Park, BH; Lee, SB; Stolz, DB; Lee, YJ; Lee, BC				Park, Bae-Hang; Lee, Sean-Bong; Stolz, Donna B.; Lee, Yong J.; Lee, Byeong-Chel			Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma) Agonist in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND TROGLITAZONE; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; CARCINOMA CELLS; TUMOR-CELLS; DNA-DAMAGE; PHASE-II; IN-VIVO; AUTOPHAGY; GROWTH	Here, we demonstrate that troglitazone (Rezulin), a peroxisome proliferator-activated receptor agonist, acted in synergy with heregulin to induce massive cell death in breast cancer cells. Although the combination of heregulin and troglitazone (HRG/TGZ) induced both apoptosis and necrosis, the main mode of cell death was caspase-independent and occurred via necrosis. This combination increased generation of superoxide in mitochondria, which in turn destabilized mitochondria potential. Pretreatment with N-acetyl-L-cysteine and catalase expression ameliorated cell death induced by the combination treatment, indicating a role of oxidative stress in mediating HRG/TGZ-induced cell death. Notably, pretreatment with pyruvate significantly prevented the cell death, suggesting a potential mechanistic link between metabolic stress and HRG/TGZ-induced cell death. The activation of the HRG signaling axis has been considered as a poor prognostic factor in breast cancer and confers resistance to gefitinib (Iressa) and tamoxifen. However, our data presented here paradoxically suggest that HRG expression can actually be beneficial when it comes to treating breast cancer with peroxisome proliferator-activated receptor-gamma ligands. Taken together, the combination of HRG and TGZ may provide a basis for the development of a novel strategy in the treatment of apoptosis-resistant and/or hormone-refractory breast cancer.	[Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; [Park, Bae-Hang; Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol & Oncol, Pittsburgh, PA 15213 USA; [Lee, Sean-Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BC (corresponding author), Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Univ Pittsburgh Canc Inst, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	leeb4@upmc.edu		Lee, Sean/0000-0001-6211-3498	National Institutes of Health [CA140554]; Department of Defense [W81XWH-09-1-0350]; University of Pittsburgh Cancer Institute; Hillman Foundation; NATIONAL CANCER INSTITUTE [R01CA140554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Pittsburgh Cancer Institute; Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA140554 (to Y. J. L.). This work was also supported by Department of Defense Grant W81XWH-09-1-0350 and University of Pittsburgh Cancer Institute (to B.-C. L.).; Recipient of a research scholar grant from The Hillman Foundation. To whom correspondence should be addressed: University of Pittsburgh Cancer Institute, Hillman Cancer Center, 5117 Centre Ave., Pittsburgh, PA 15213. Tel.: 412-623-2285; Fax: 412-623-7828; E-mail: leeb4@upmc.edu.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Atlas E, 2003, MOL CANCER RES, V1, P165; Blanchard F, 2002, MOL BIOL CELL, V13, P1536, DOI 10.1091/mbc.02-02-0010; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Boone JJM, 2009, MOL CANCER THER, V8, P3015, DOI 10.1158/1535-7163.MCT-09-0219; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Cardillo M, 1996, CANCER IMMUNOL IMMUN, V43, P19, DOI 10.1007/s002620050298; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gawlitta D, 2004, CYTOTECHNOLOGY, V46, P139, DOI 10.1007/s10616-005-2551-7; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Izumi Y, 1997, J NEUROSCI, V17, P9448; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Krane IM, 1996, ONCOGENE, V12, P1781; Kulke MH, 2002, CANCER J, V8, P395, DOI 10.1097/00130404-200209000-00010; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Le XF, 2002, APOPTOSIS, V7, P483, DOI 10.1023/A:1020682807922; Le XF, 2001, ONCOGENE, V20, P8258, DOI 10.1038/sj.onc.1205039; Le XF, 2000, CLIN CANCER RES, V6, P260; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu ZH, 2007, DEV CELL, V12, P484, DOI 10.1016/j.devcel.2007.03.016; Lucarelli E, 2002, INT J CANCER, V98, P344, DOI 10.1002/ijc.10203; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Mackay K, 1999, J BIOL CHEM, V274, P6272, DOI 10.1074/jbc.274.10.6272; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nicol CJ, 2004, CARCINOGENESIS, V25, P1747, DOI 10.1093/carcin/bgh160; Power CP, 2004, J IMMUNOL, V173, P5229, DOI 10.4049/jimmunol.173.8.5229; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sirohi B, 2008, ANN ONCOL, V19, P1847, DOI 10.1093/annonc/mdn395; Sun HG, 2005, CANCER RES, V65, P4442, DOI 10.1158/0008-5472.CAN-04-4200; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Vadlamudi R, 1999, CANCER RES, V59, P2843; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Xu FJ, 1999, CLIN CANCER RES, V5, P3653; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Yin F, 2004, ONCOGENE, V23, P4614, DOI 10.1038/sj.onc.1207598; Yoshizawa K, 2002, CANCER-AM CANCER SOC, V95, P2243, DOI 10.1002/cncr.10906	56	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20087	20099		10.1074/jbc.M110.191718	http://dx.doi.org/10.1074/jbc.M110.191718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467033	Green Published, hybrid			2022-12-27	WOS:000291027700085
J	Benjdia, A; Martens, EC; Gordon, JI; Berteau, O				Benjdia, Alhosna; Martens, Eric C.; Gordon, Jeffrey I.; Berteau, Olivier			Sulfatases and a Radical S-Adenosyl-L-methionine (AdoMet) Enzyme Are Key for Mucosal Foraging and Fitness of the Prominent Human Gut Symbiont, Bacteroides thetaiotaomicron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLGLYCINE-GENERATING ENZYME; IN-VIVO; MATURATING ENZYMES; BACTERIAL SYMBIONT; MICROBIOMES; PROKARYOTES; INTESTINE; COLITIS; SYSTEM; TWINS	The large-scale application of genomic and metagenomic sequencing technologies has yielded a number of insights about the metabolic potential of symbiotic human gut microbes. Nevertheless, the molecular basis of the interactions between commensal bacteria and their host remained to be investigated. Bacteria colonizing the mucosal layer that overlies the gut epithelium are exposed to highly sulfated glycans (i.e. mucin and glycosaminoglycans). These polymers can serve as potential nutrient sources, but their high sulfate content usually prevents their degradation. Commensal bacteria such as Bacteroides thetaiotaomicron possess more predicted sulfatase genes than in the human genome, the physiological functions of which are largely unknown. To be active, sulfatases must undergo a critical post-translational modification catalyzed in anaerobic bacteria by the radical AdoMet enzyme anaerobic sulfatase-maturating enzyme (anSME). In the present study, we have tested the role of this pathway in Bacteroides thetaiotaomicron which, in addition to 28 predicted sulfatases, possesses a single predicted anSME. In vitro studies revealed that deletion of the gene encoding its anSME (BT0238) results in loss of sulfatase activity and impaired ability to use sulfated polysaccharides as carbon sources. Co-colonization of formerly germ-free mice with both isogenic strains (i.e. wild-type or Delta anSME), or invasion experiments involving introduction of one followed by the other strain established that anSME activity and the sulfatases activated via this pathway, are important fitness factors for B. thetaiotaomicron, especially when mice are fed a simple sugar diet that requires this saccharolytic bacterium to adaptively forage on host glycans as nutrients. Whole genome transcriptional profiling of wild-type and the anSME mutant in vivo revealed that loss of this enzyme alters expression of genes involved in mucin utilization and that this disrupted ability to access mucosal glycans likely underlies the observed pronounced colonization defect. Comparative genomic analysis reveals that 100% of 46 fully sequenced human gut Bacteroidetes contain homologs of BT0238 and genes encoding sulfatases, suggesting that this is an important and evolutionarily conserved feature for bacterial adaptation to life in this habitat.	[Benjdia, Alhosna; Berteau, Olivier] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Martens, Eric C.; Gordon, Jeffrey I.] Washington Univ Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Martens, Eric C.] Univ Michigan Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); University of Michigan System; University of Michigan	Berteau, O (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	Olivier.Berteau@jouy.inra.fr	Berteau, Olivier/AAF-9080-2019; Benjdia, Alhosna/AAM-7415-2021	Berteau, Olivier/0000-0002-3434-5168; Benjdia, Alhosna/0000-0002-3544-2541	Agence Nationale de la Recherche [ANR-08-BLAN-0224-02]; INRA department AlimH [ANSSD-2008]; National Institutes of Health [DK30292, DK084214]; Crohn's and Colitis Foundation of America; Region Ile-de-France; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084214, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA department AlimH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Region Ile-de-France(Region Ile-de-France); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from Agence Nationale de la Recherche (ANR-08-BLAN-0224-02), ANSSD-2008 from INRA department AlimH, the National Institutes of Health (DK30292 and DK084214), and the Crohn's and Colitis Foundation of America.; Recipient of a PhD grant from the Region Ile-de-France.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lee JK, 2003, GLYCOBIOLOGY, V13, P245, DOI 10.1093/glycob/cwg018; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; SALYERS AA, 1988, APPL ENVIRON MICROB, V54, P1970, DOI 10.1128/AEM.54.8.1970-1976.1988; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	31	102	105	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25973	25982		10.1074/jbc.M111.228841	http://dx.doi.org/10.1074/jbc.M111.228841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21507958	Green Published, hybrid			2022-12-27	WOS:000293073000056
J	Fiehn, O; Barupal, DK; Kind, T				Fiehn, Oliver; Barupal, Dinesh K.; Kind, Tobias			Extending Biochemical Databases by Metabolomic Surveys	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; BIOLOGICAL PATHWAYS; MASS-SPECTROMETRY; PROTEIN SUPERFAMILIES; ENZYME PROMISCUITY; PLANT METABOLOMICS; INFORMATION-SYSTEM; STRUCTURAL BASIS; KEGG ATLAS; GC-MS	Metabolomics can map the large metabolic diversity in species, organs, or cell types. In addition to gains in enzyme specificity, many enzymes have retained substrate and reaction promiscuity. Enzyme promiscuity and the large number of enzymes with unknown enzyme function may explain the presence of a plethora of unidentified compounds in metabolomic studies. Cataloguing the identity and differential abundance of all detectable metabolites in metabolomic repositories may detail which compounds and pathways contribute to vital biological functions. The current status in metabolic databases is reviewed concomitant with tools to map and visualize the metabolome.	[Fiehn, Oliver; Barupal, Dinesh K.; Kind, Tobias] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Barupal, Dinesh K/A-9341-2010; Kind, Tobias/A-7553-2010	barupal, dinesh/0000-0002-9954-8628				Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Antonov AV, 2009, FEBS J, V276, P2084, DOI 10.1111/j.1742-4658.2009.06943.x; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Arita M, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-7; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bais P, 2010, PLANT PHYSIOL, V152, P1807, DOI 10.1104/pp.109.151027; Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47; Bencharit S, 2003, NAT STRUCT BIOL, V10, P349, DOI 10.1038/nsb919; Bottcher C, 2008, PLANT PHYSIOL, V147, P2107, DOI 10.1104/pp.108.117754; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Buckingham J, 2010, DICT NATURAL PRODUCT; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Degtyarenko K., 2009, CURR PROTOC BIOINFOR; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, TRAC-TREND ANAL CHEM, V27, P261, DOI 10.1016/j.trac.2008.01.007; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Grennan AK, 2009, PLANT PHYSIOL, V151, P1701, DOI 10.1104/pp.109.900308; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hettne KM, 2010, J CHEMINFORMATICS, V2, DOI [10.1186/1758-2946-2-3, 10.1186/1758-2946-2-4]; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Hummel Jan, 2007, V18, P75, DOI 10.1007/4735_2007_0229; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kind T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005440; Kono N, 2009, PLOS ONE, V4, pA47, DOI 10.1371/journal.pone.0007710; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; Pachkov M, 2007, GENE, V396, P215, DOI 10.1016/j.gene.2007.02.033; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; STEIN SE, 1995, J AM SOC MASS SPECTR, V6, P644, DOI 10.1016/1044-0305(95)00291-K; Steinbeck C, 2004, PHYTOCHEMISTRY, V65, P2711, DOI 10.1016/j.phytochem.2004.08.027; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; Taglieber A., 2007, ANGEW CHEM, V119, P8751; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Whitley KM, 2002, J AM SOC INF SCI TEC, V53, P1210, DOI 10.1002/asi.10192; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yamanishi Y, 2009, BIOINFORMATICS, V25, pI179, DOI 10.1093/bioinformatics/btp223; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376	79	64	66	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23637	23643		10.1074/jbc.R110.173617	http://dx.doi.org/10.1074/jbc.R110.173617			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566124	hybrid, Green Published			2022-12-27	WOS:000292294900004
J	Decarreau, JA; James, NG; Chrin, LR; Berger, CL				Decarreau, Justin A.; James, Nicholas G.; Chrin, Lynn R.; Berger, Christopher L.			Switch I Closure Simultaneously Promotes Strong Binding to Actin and ADP in Smooth Muscle Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL LIGHT-CHAIN; KINETIC MECHANISM; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; MOTOR DOMAIN; LEVER ARM; SUBFRAGMENT-1; NUCLEOTIDE; MOVEMENT; COMPLEX	The motor protein myosin uses energy derived from ATP hydrolysis to produce force and motion. Important conserved components (P-loop, switch I, and switch II) help propagate small conformational changes at the active site into large scale conformational changes in distal regions of the protein. Structural and biochemical studies have indicated that switch I may be directly responsible for the reciprocal opening and closing of the actin and nucleotide-binding pockets during the ATPase cycle, thereby aiding in the coordination of these important substrate-binding sites. Smooth muscle myosin has displayed the ability to simultaneously bind tightly to both actin and ADP, although it is unclear how both substrate-binding clefts could be closed if they are rigidly coupled to switch I. Here we use single tryptophan mutants of smooth muscle myosin to determine how conformational changes in switch I are correlated with structural changes in the nucleotide and actin-binding clefts in the presence of actin and ADP. Our results suggest that a closed switch I conformation in the strongly bound actomyosin-ADP complex is responsible for maintaining tight nucleotide binding despite an open nucleotide-binding pocket. This unique state is likely to be crucial for prolonged tension maintenance in smooth muscle.	[Chrin, Lynn R.; Berger, Christopher L.] Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Decarreau, Justin A.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [James, Nicholas G.] John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Vermont; University of Vermont	Berger, CL (corresponding author), Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	cberger@uvm.edu	James, Nicholas/G-3666-2011	, Nicholas/0000-0003-1539-2759	National Institutes of Health [R01-HL63798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL63798 (to C. L. B.).	Ajtai K, 1999, BIOCHEMISTRY-US, V38, P6428, DOI 10.1021/bi990149r; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P3309, DOI 10.1021/bi00465a023; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Naber N, 2007, BIOPHYS J, V92, P172, DOI 10.1529/biophysj.106.090035; Naber N, 2010, J MOL BIOL, V396, P937, DOI 10.1016/j.jmb.2009.12.035; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Robertson CI, 2005, BIOPHYS J, V89, P1882, DOI 10.1529/biophysj.105.059840; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SOBIESZEK A, 1977, EUR J BIOCHEM, V73, P477, DOI 10.1111/j.1432-1033.1977.tb11340.x; SPENCER RD, 1970, J CHEM PHYS, V52, P1654, DOI 10.1063/1.1673201; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sun MX, 2006, J BIOL CHEM, V281, P5711, DOI 10.1074/jbc.M508103200; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200; Yengo CM, 1998, P NATL ACAD SCI USA, V95, P12944, DOI 10.1073/pnas.95.22.12944	50	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22300	22307		10.1074/jbc.M111.219014	http://dx.doi.org/10.1074/jbc.M111.219014			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536675	Green Published, hybrid			2022-12-27	WOS:000291719900038
J	Safavi-Hemami, H; Siero, WA; Kuang, ZH; Williamson, NA; Karas, JA; Page, LR; MacMillan, D; Callaghan, B; Kompella, SN; Adams, DJ; Norton, RS; Purcell, AW				Safavi-Hemami, Helena; Siero, William A.; Kuang, Zhihe; Williamson, Nicholas A.; Karas, John A.; Page, Louise R.; MacMillan, David; Callaghan, Brid; Kompella, Shiva Nag; Adams, David J.; Norton, Raymond S.; Purcell, Anthony W.			Embryonic Toxin Expression in the Cone Snail Conus victoriae PRIMED TO KILL OR DIVERGENT FUNCTION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PERFORMANCE LIQUID-CHROMATOGRAPHY; ALPHA-CONOTOXINS VC1.1; TORSION ANGLE DYNAMICS; ROOT GANGLION NEURONS; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL-CHARACTERIZATION; PROTEIN STRUCTURES; CALCIUM-CHANNELS	Predatory marine cone snails (genus Conus) utilize complex venoms mainly composed of small peptide toxins that target voltage-and ligand-gated ion channels in their prey. Although the venoms of a number of cone snail species have been intensively profiled and functionally characterized, nothing is known about the initiation of venom expression at an early developmental stage. Here, we report on the expression of venom mRNA in embryos of Conus victoriae and the identification of novel alpha- and O-conotoxin sequences. Embryonic toxin mRNA expression is initiated well before differentiation of the venom gland, the organ of venom biosynthesis. Structural and functional studies revealed that the embryonic alpha-conotoxins exhibit the same basic three-dimensional structure as the most abundant adult toxin but significantly differ in their neurological targets. Based on these findings, we postulate that the venom repertoire of cone snails undergoes ontogenetic changes most likely reflecting differences in the biotic interactions of these animals with their prey, predators, or competitors. To our knowledge, this is the first study to show toxin mRNA transcripts in embryos, a finding that extends our understanding of the early onset of venom expression in animals and may suggest alternative functions of peptide toxins during development.	[Safavi-Hemami, Helena; Williamson, Nicholas A.; Karas, John A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Safavi-Hemami, Helena; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Siero, William A.; MacMillan, David; Norton, Raymond S.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Kuang, Zhihe] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Page, Louise R.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Callaghan, Brid; Kompella, Shiva Nag; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Victoria; Royal Melbourne Institute of Technology (RMIT); Monash University	Purcell, AW (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	apurcell@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Adams, David John/K-3578-2019; Adams, David/J-9125-2014; Callaghan, Brid/N-1764-2019; Karas, John/AAE-9729-2019; Purcell, Anthony/AAH-1942-2019; Safavi-Hemami, Helena/E-7624-2015	Williamson, Nicholas A/0000-0002-2173-3452; Adams, David John/0000-0002-7030-2288; Adams, David/0000-0002-7030-2288; Callaghan, Brid/0000-0001-7251-8851; Karas, John/0000-0002-3800-5152; Purcell, Anthony/0000-0003-0532-8331; Safavi-Hemami, Helena/0000-0002-1984-2721; Kompella, Shiva/0000-0001-5625-2491; Norton, Raymond/0000-0001-8893-0584	Australian Research Council [DP110101331]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council Grant DP110101331 (to A. W. P. and N. A. W.).; Recipient of a National Health and Medical Research Council of Australia principal research fellowship.	Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; BALL AD, 1999, SEAGRASS FLORA FAUNA, P137; Ball Alexander D., 2002, Bollettino Malacologico, V38, P51; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brandhorst B P, 1985, Dev Biol (N Y 1985), V1, P525; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; COLL JC, 1995, MAR BIOL, V123, P1432; Cowart JD, 2000, MAR BIOL, V136, P993, DOI 10.1007/s002270000271; Craig AG, 2001, TOXICON, V39, P809, DOI 10.1016/S0041-0101(00)00211-7; Cummins SF, 2010, PEPTIDES, V31, P394, DOI 10.1016/j.peptides.2009.10.010; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DEGNAN BM, 1995, ROUX ARCH DEV BIOL, V205, P97, DOI 10.1007/BF00188848; Drago J, 2003, CELL MOL LIFE SCI, V60, P1267, DOI 10.1007/s00018-003-2259-9; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escoubas P, 2002, RAPID COMMUN MASS SP, V16, P403, DOI 10.1002/rcm.595; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; FEIN A, 1971, DEV BIOL, V24, P520, DOI 10.1016/0012-1606(71)90062-5; FRANC A, 1943, THESIS FS U ALGER, P1; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gatton ML, 2006, AM J TROP MED HYG, V75, P212, DOI 10.4269/ajtmh.2006.75.212; Genikhovich G, 2006, DEV BIOL, V289, P466, DOI 10.1016/j.ydbio.2005.10.028; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; HOWDEN ME, 1974, CROWN OF THORNS STAR; HOWELL AM, 1987, J MOL EVOL, V25, P29, DOI 10.1007/BF02100038; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Jones A, 1996, RAPID COMMUN MASS SP, V10, P138, DOI 10.1002/(SICI)1097-0231(19960115)10:1<138::AID-RCM442>3.0.CO;2-3; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaplan N, 2007, J MOL BIOL, V369, P553, DOI 10.1016/j.jmb.2007.02.106; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOHN AJ, 1972, SCIENCE, V176, P49, DOI 10.1126/science.176.4030.49; KOHN AJ, 1994, J MAR BIOL ASSOC UK, V74, P744; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurzen H, 2005, EXP DERMATOL, V14, P155, DOI 10.1111/j.0906-6705.2005.0266i.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Gall F, 1999, TOXICON, V37, P985, DOI 10.1016/S0041-0101(98)00227-X; LINDQUIST N, 1991, EXPERIENTIA, V47, P504, DOI 10.1007/BF01959957; LINDQUIST N, 1992, ECOL MONOGR, V62, P547, DOI 10.2307/2937316; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lips KS, 2002, NEUROSCIENCE, V115, P1, DOI 10.1016/S0306-4522(02)00274-9; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo S, 2006, J PEPT SCI, V12, P693, DOI 10.1002/psc.781; Marshall J, 2002, BIOL BULL, V203, P27, DOI 10.2307/1543455; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Moran Y, 2008, J MOL BIOL, V380, P437, DOI 10.1016/j.jmb.2008.05.011; Moran Y, 2009, J MOL EVOL, V69, P115, DOI 10.1007/s00239-009-9258-x; NASH MA, 1987, J CELL BIOL, V104, P1133, DOI 10.1083/jcb.104.5.1133; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; NYBAKKEN J, 1988, MAR BIOL, V98, P239, DOI 10.1007/BF00391200; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Pantin C. F. A., 1946, NOTES MICROSCOPICAL; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; PERRON FE, 1981, MAR BIOL, V61, P215, DOI 10.1007/BF00386662; PERRON FE, 1980, J EXP MAR BIOL ECOL, V42, P27, DOI 10.1016/0022-0981(80)90164-1; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Safavi-Hemami H, 2010, J BIOL CHEM, V285, P12735, DOI 10.1074/jbc.M109.078691; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slattery M, 1999, CORAL REEFS, V18, P75, DOI 10.1007/s003380050158; Stock DW, 1996, GENOMICS, V37, P234, DOI 10.1006/geno.1996.0548; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; VREUGDENHIL E, 1988, J NEUROSCI, V8, P4184; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	90	26	40	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22546	22557		10.1074/jbc.M110.217703	http://dx.doi.org/10.1074/jbc.M110.217703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504902	hybrid, Green Published			2022-12-27	WOS:000291719900062
J	Shapovalov, Y; Hoffman, D; Zuch, D; Bentley, KLD; Elisee, RA				Shapovalov, Yuriy; Hoffman, David; Zuch, Daniel; Bentley, Karen L. de Mesy; Elisee, Roman A.			Mitochondrial Dysfunction in Cancer Cells Due to Aberrant Mitochondrial Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; HUMAN PERIPHERAL LYMPHOCYTES; OXIDATIVE-PHOSPHORYLATION; CARBOHYDRATE-METABOLISM; FREE NUCLEAR; OSTEOSARCOMA; GLYCOLYSIS; EXPRESSION; STIMULATION; MAINTENANCE	Warburg effect is a hallmark of cancer manifested by continuous prevalence of glycolysis and dysregulation of oxidative metabolism. Glycolysis provides survival advantage to cancer cells. To investigate molecular mechanisms underlying the Warburg effect, we first compared oxygen consumption among hFOB osteoblasts, benign osteosarcoma cells, Saos2, and aggressive osteosarcoma cells, 143B. We demonstrate that, as both proliferation and invasiveness increase in osteosarcoma, cells utilize significantly less oxygen. We proceeded to evaluate mitochondrial morphology and function. Electron microscopy showed that in 143B cells, mitochondria are enlarged and increase in number. Quantitative PCR revealed an increase in mtDNA in 143B cells when compared with hFOB and Saos2 cells. Gene expression studies showed that mitochondrial single-strand DNA-binding protein (mtSSB), a key catalyst of mitochondrial replication, was significantly up-regulated in 143B cells. In addition, increased levels of the mitochondrial respiratory complexes were accompanied by significant reduction of their activities. These changes indicate hyperactive mitochondrial replication in 143B cells. Forced overexpression of mtSSB in Saos2 cells caused an increase in mtDNA and a decrease in oxygen consumption. In contrast, knockdown of mtSSB in 143B cells was accompanied by a decrease in mtDNA, increase in oxygen consumption, and retardation of cell growth in vitro and in vivo. In summary, we have found that mitochondrial dysfunction in cancer cells correlates with abnormally increased mitochondrial replication, which according to our gain- and loss-of-function experiments, may be due to overexpression of mtSSB. Our study provides insight into mechanisms of mitochondrial dysfunction in cancer and may offer potential therapeutic targets.	[Shapovalov, Yuriy; Zuch, Daniel; Elisee, Roman A.] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Hoffman, David] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Bentley, Karen L. de Mesy] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Elisee, RA (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, 575 Elmwood Ave, Rochester, NY 14642 USA.	Roman_Eliseev@urmc.rochester.edu		Hoffman, David/0000-0002-8661-3291; Zuch, Daniel/0000-0001-8245-4492	National Institutes of Health [KL2 RR 024136]; James P. Wilmot Foundation; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James P. Wilmot Foundation; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health KL2 RR 024136 (Center for Research Resources; to R. A. E.). This work was also supported by the James P. Wilmot Foundation and the Karen D'Amico Foundation.	Arakaki N, 2006, BBA-GEN SUBJECTS, V1760, P1364, DOI 10.1016/j.bbagen.2006.05.012; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Butler LM, 2000, CANCER RES, V60, P5165; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; Ellinger J, 2009, BJU INT, V104, P48, DOI 10.1111/j.1464-410X.2008.08289.x; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Longley MJ, 2009, METHODS MOL BIOL, V554, P73, DOI 10.1007/978-1-59745-521-3_5; LOOS JA, 1973, EXP CELL RES, V79, P136, DOI 10.1016/0014-4827(73)90498-9; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Muller-Hocker J, 2001, APPL IMMUNOHISTO M M, V9, P276, DOI 10.1097/00022744-200109000-00013; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I; Tomaska L, 2001, BIOL CHEM, V382, P179, DOI 10.1515/BC.2001.025; Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O. H., 1930, METABOLISM TUMOURS I; Zachariah RR, 2008, OBSTET GYNECOL, V112, P843, DOI 10.1097/AOG.0b013e3181867bc0; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhang PY, 2008, CLIN CANCER RES, V14, P2962, DOI 10.1158/1078-0432.CCR-07-1992	35	42	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22331	22338		10.1074/jbc.M111.250092	http://dx.doi.org/10.1074/jbc.M111.250092			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536680	Green Published, hybrid			2022-12-27	WOS:000291719900042
J	Singh, NK; Wang, D; Kundumani-Sridharan, V; Quyen, DV; Niu, JX; Rao, GN				Singh, Nikhlesh K.; Wang, Dong; Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Niu, Jixiao; Rao, Gadiparthi N.			15-Lipoxygenase-1-enhanced Src-Janus Kinase 2-Signal Transducer and Activator of Transcription 3 Stimulation and Monocyte Chemoattractant Protein-1 Expression Require Redox-sensitive Activation of Epidermal Growth Factor Receptor in Vascular Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RAT CAROTID-ARTERY; LOW-DENSITY-LIPOPROTEIN; NEOINTIMA FORMATION; INTIMAL HYPERPLASIA; ARACHIDONIC-ACID; JAK/STAT PATHWAY; DEFICIENT MICE; EGF RECEPTOR; INJURY	To understand the mechanisms by which 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) activates signal transducer and activator of transcription 3 (STAT3), we studied the role of epidermal growth factor receptor (EGFR). 15(S)-HETE stimulated tyrosine phosphorylation of EGFR in a time-dependent manner in vascular smooth muscle cells (VSMCs). Interference with EGFR activation blocked 15(S)-HETE-induced Src and STAT3 tyrosine phosphorylation, monocyte chemoattractant protein-1 (MCP-1) expression and VSMC migration. 15(S)-HETE also induced tyrosine phosphorylation of Janus kinase 2 (Jak2) in VSMCs, and its inhibition substantially reduced STAT3 phosphorylation, MCP-1 expression, and VSMC migration. In addition, Src formed a complex with EGFR and Jak2, and its inhibition completely blocked Jak2 and STAT3 phosphorylation, MCP-1 expression, and VSMC migration. 15(S)-HETE induced the production of H2O2 via an NADPH oxidase-dependent manner and its scavengers, N-acetyl cysteine (NAC) and catalase suppressed 15(S)-HETE-stimulated EGFR, Src, Jak2, and STAT3 phosphorylation and MCP-1 expression. Balloon injury (BI) induced EGFR, Src, Jak2, and STAT3 phosphorylation, and inhibition of these signaling molecules attenuated BI-induced MCP-1 expression and smooth muscle cell migration from the medial to the luminal surface resulting in reduced neointima formation. In addition, inhibition of EGFR blocked BI-induced Src, Jak2, and STAT3 phosphorylation. Similarly, interference with Src activation suppressed BI-induced Jak2 and STAT3 phosphorylation. Furthermore, adenovirus-mediated expression of dnJak2 also blocked BI-induced STAT3 phosphorylation. Consistent with the effects of 15(S)-HETE on the activation of EGFR-Src-Jak2-STAT3 signaling in VSMCs in vitro, adenovirus-mediated expression of 15-lipoxygenase 1 (15-Lox1) enhanced BI-induced EGFR, Src, Jak2, and STAT3 phosphorylation leading to enhanced MCP-1 expression in vivo. Blockade of Src or Jak2 suppressed BI-induced 15-Lox1-enhanced STAT3 phosphorylation, MCP-1 expression, and neointima formation. In addition, whereas dominant negative Src blocked BI-induced 15-Lox1-enhanced Jak2 phosphorylation, dnJak2 had no effect on Src phosphorylation. Together, these observations demonstrate for the first time that the 15-Lox1-15(S)-HETE axis activates EGFR via redox-sensitive manner, which in turn mediates Src-Jak2-STAT3-dependent MCP-1 expression leading to vascular wall remodeling.	[Singh, Nikhlesh K.; Wang, Dong; Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Niu, Jixiao; Rao, Gadiparthi N.] Univ Tennessee Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL064165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL064165 (NHLBI; to G. N. R.).	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Chan AK, 2003, J VASC SURG, V37, P644, DOI 10.1067/mva.2003.92; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Gschwind A, 2002, CANCER RES, V62, P6329; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; HUGOU I, 1995, ATHEROSCLEROSIS, V113, P189, DOI 10.1016/0021-9150(94)05446-P; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; LIN L, 1994, CIRC RES, V74, P197, DOI 10.1161/01.RES.74.2.197; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rao GN, 1996, ONCOGENE, V13, P713; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwaiberger AV, 2010, ARTERIOSCL THROM VAS, V30, P2475, DOI 10.1161/ATVBAHA.110.212654; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seki Y, 2000, CIRC RES, V87, P12, DOI 10.1161/01.RES.87.1.12; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	50	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22478	22488		10.1074/jbc.M111.225060	http://dx.doi.org/10.1074/jbc.M111.225060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536676	Green Published, hybrid			2022-12-27	WOS:000291719900056
J	Voordeckers, K; Kimpe, M; Haesendonckx, S; Louwet, W; Versele, M; Thevelein, JM				Voordeckers, Karin; Kimpe, Marlies; Haesendonckx, Steven; Louwet, Wendy; Versele, Matthias; Thevelein, Johan M.			Yeast 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Orthologs Pkh1-3 Differentially Regulate Phosphorylation of Protein Kinase A (PKA) and the Protein Kinase B (PKB)/S6K Ortholog Sch9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; BINDING POCKET; RAS PROTEINS; DOCKING SITE; AGC KINASES; IN-VIVO	Pkh1, -2, and -3 are the yeast orthologs of mammalian 3-phosphoinositide- dependent protein kinase-1 (PDK1). Although essential for viability, their functioning remains poorly understood. Sch9, the yeast protein kinase B and/or S6K ortholog, has been identified as one of their targets. We now have shown that in vitro interaction of Pkh1 and Sch9 depends on the hydrophobic PDK1-interacting fragment pocket in Pkh1 and requires the complementary hydrophobic motif in Sch9. We demonstrated that Pkh1 phosphorylates Sch9 both in vitro and in vivo on its PDK1 site and that this phosphorylation is essential for a wild type cell size. In vivo phosphorylation on this site disappeared during nitrogen deprivation and rapidly increased again upon nitrogen resupplementation. In addition, we have shown here for the first time that the PDK1 site in protein kinase A is phosphorylated by Pkh1 in vitro, that this phosphorylation is Pkh-dependent in vivo and occurs during or shortly after synthesis of the protein kinase A catalytic subunits. Mutagenesis of the PDK1 site in Tpk1 abolished binding of the regulatory subunit and cAMP dependence. As opposed to PDK1 site phosphorylation of Sch9, phosphorylation of the PDK1 site in Tpk1 was not regulated by nitrogen availability. These results bring new insight into the control and prevalence of PDK1 site phosphorylation in yeast by Pkh protein kinases.	[Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium; Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Thevelein, JM (corresponding author), VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, B-3001 Louvain, Flanders, Belgium.	Johan.Thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Thevelein, Johan M./0000-0002-2626-0180	Fund for Scientific Research-Flanders (FWO); Agency for Innovation by Science and Technology (IWT-Flanders); Belgian Federal Science Policy Office; Interuniversity Attraction Poles Network [P5/30, P6/14]; KULeuven	Fund for Scientific Research-Flanders (FWO)(FWO); Agency for Innovation by Science and Technology (IWT-Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); KULeuven(KU Leuven)	This work was supported by a Ph.D. fellowship from the Fund for Scientific Research-Flanders (FWO) (to K. V. and M. K.), a fellowship from the Agency for Innovation by Science and Technology (IWT-Flanders) (to S. H.), a return grant from the Belgian Federal Science Policy Office (to M. V.), and grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P5/30 and P6/14 and the Research Fund of the KULeuven (Concerted Research Actions) (to J. M. T.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Crauwels M, 1997, MICROBIOL-UK, V143, P2627, DOI 10.1099/00221287-143-8-2627; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Geyskens I, 2000, NATO SCI S A LIF SCI, V316, P117; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; LEVIN LR, 1988, SCIENCE, V240, P68, DOI 10.1126/science.2832943; LEVIN LR, 1990, MOL CELL BIOL, V10, P1066, DOI 10.1128/MCB.10.3.1066; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Portela P, 2006, CELL SIGNAL, V18, P1072, DOI 10.1016/j.cellsig.2005.09.001; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; SHOJI S, 1979, J BIOL CHEM, V254, P6211; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tang Y, 2004, GENETICS, V168, P1843, DOI 10.1534/genetics.104.032466; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TONERWEBB J, 1992, J BIOL CHEM, V267, P25174; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626	53	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22017	22027		10.1074/jbc.M110.200071	http://dx.doi.org/10.1074/jbc.M110.200071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531713	Green Published, hybrid			2022-12-27	WOS:000291719900008
J	Hammani, K; des Francs-Small, CC; Takenaka, M; Tanz, SK; Okuda, K; Shikanai, T; Brennicke, A; Small, I				Hammani, Kamel; des Francs-Small, Catherine Colas; Takenaka, Mizuki; Tanz, Sandra K.; Okuda, Kenji; Shikanai, Toshiharu; Brennicke, Axel; Small, Ian			The Pentatricopeptide Repeat Protein OTP87 Is Essential for RNA Editing of nad7 and atp1 Transcripts in Arabidopsis Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-ACTING ELEMENTS; PPR PROTEIN; CHLOROPLAST TRANSCRIPTS; COMPARATIVE GENOMICS; ELECTRON-TRANSPORT; MULTIPLE SITES; MESSENGER-RNA; DYW PROTEIN; IDENTIFICATION; RECOGNITION	In plant organelles, RNA editing is a post-transcriptional mechanism that converts specific cytidines to uridines in RNA of both mitochondria and plastids, altering the information encoded by the gene. The cytidine to be edited is determined by a cis-element surrounding the editing site that is specifically recognized and bound by a trans-acting factor. All the trans-acting editing factors identified so far in plant organelles are members of a large protein family, the pentatricopeptide repeat (PPR) proteins. We have identified the Organelle Transcript Processing 87 (OTP87) gene, which is required for RNA editing of the nad7-C24 and atp1-C1178 sites in Arabidopsis mitochondria. OTP87 encodes an E-subclass PPR protein with an unusually short E-domain. The recombinant protein expressed in Escherichia coli specifically binds to RNAs comprising 30 nucleotides upstream and 10 nucleotides downstream of the nad7-C24 and atp1-C1178 editing sites. The loss-of-function of OTP87 results in small plants with growth and developmental delays. In the otp87 mutant, the amount of assembled respiratory complex V (ATP synthase) is highly reduced compared with the wild type suggesting that the amino acid alteration in ATP1 caused by loss of editing at the atp1-C1178 site affects complex V assembly in mitochondria.	[Hammani, Kamel; des Francs-Small, Catherine Colas; Tanz, Sandra K.; Small, Ian] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Hammani, Kamel] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Okuda, Kenji; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Takenaka, Mizuki; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany	University of Western Australia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Ulm University	Hammani, K (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	khammani@uoregon.edu	Francs-Small, Catherine Colas des/N-2992-2019; Takenaka, Mizuki/AAK-9884-2020; Takenaka, Mizuki/B-2636-2013; Small, Ian D/C-1168-2008; Small, Ian/AAR-5506-2021; Tanz, Sandra K/C-2686-2011; Francs-Small, Catherine C Colas des/E-6279-2011; Shikanai, Toshiharu/AAK-9112-2020	Francs-Small, Catherine Colas des/0000-0002-6386-5672; Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092; Small, Ian D/0000-0001-5300-1216; Small, Ian/0000-0001-5300-1216; Francs-Small, Catherine C Colas des/0000-0002-6386-5672; Tanz, Sandra/0000-0002-0632-4095; Hammani, Kamel/0000-0001-5759-5955	Australian Research Council [CE0561495]; Australian Government Department of Innovation, Industry, Science and Research [CG120098]; Centre National de la Recherche Scientifique; Deutsche Forschungsgeminschaft; Region of Alsace; University of Western Australia; Ministry of Education, Culture, Sport, Science, and Technology of Japan [17GS0316, 16085206]; Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry, and Fishers of Japan [GPN0008]; Grants-in-Aid for Scientific Research [23657032] Funding Source: KAKEN	Australian Research Council(Australian Research Council); Australian Government Department of Innovation, Industry, Science and Research(Australian GovernmentDepartment of Industry, Innovation and Science); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Deutsche Forschungsgeminschaft(German Research Foundation (DFG)); Region of Alsace(Region Grand-Est); University of Western Australia; Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry, and Fishers of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded through the Australian Research Council Centres of Excellence scheme (CE0561495), an International Science Linkages Grant (CG120098) from the Australian Government Department of Innovation, Industry, Science and Research, the Centre National de la Recherche Scientifique, the Deutsche Forschungsgeminschaft and scholarships from the Region of Alsace and the University of Western Australia.; Supported by Grants-in-aid (17GS0316 and 16085206) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and by Genomics for Agricultural Innovation (GPN0008) from the Ministry of Agriculture, Forestry, and Fishers of Japan.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; DEPAEPE R, 1993, P NATL ACAD SCI USA, V90, P5934, DOI 10.1073/pnas.90.13.5934; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370; Hirose Tetsuro, 2004, Methods Mol Biol, V265, P333; Kobayashi Y, 2008, NUCLEIC ACIDS RES, V36, P311, DOI 10.1093/nar/gkm1026; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kuzmin EV, 2004, J BIOL CHEM, V279, P20672, DOI 10.1074/jbc.M400640200; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Munshi MK, 2005, PLANT J, V44, P1036, DOI [10.1111/j.1365-313X.2005.02604, 10.1111/j.1365-313X.2005.02604.x]; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2011, FEBS LETT, V585, P700, DOI 10.1016/j.febslet.2011.01.037; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795; WARMKE HE, 1978, SCIENCE, V200, P561, DOI 10.1126/science.200.4341.561; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	65	67	72	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21361	21371		10.1074/jbc.M111.230516	http://dx.doi.org/10.1074/jbc.M111.230516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504904	Green Published, hybrid			2022-12-27	WOS:000291464700035
J	Larson, MR; Rajashankar, KR; Crowley, PJ; Kelly, C; Mitchell, TJ; Brady, LJ; Deivanayagam, C				Larson, Matthew R.; Rajashankar, Kanagalaghatta R.; Crowley, Paula J.; Kelly, Charles; Mitchell, Tim J.; Brady, L. Jeannine; Deivanayagam, Champion			Crystal Structure of the C-terminal Region of Streptococcus mutans Antigen I/II and Characterization of Salivary Agglutinin Adherence Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; STAPHYLOCOCCUS-AUREUS; STABILIZING ISOPEPTIDE; ORAL STREPTOCOCCI; BINDING DOMAIN; SEROTYPE-C; PROTEIN; ADHESIN; IDENTIFICATION; RECEPTOR	The Streptococcus mutans antigen I/II (AgI/II) is a cell surface-localized protein that adheres to salivary components and extracellular matrix molecules. Here we report the 2.5 angstrom resolution crystal structure of the complete C-terminal region of AgI/II. The C-terminal region is comprised of three major domains: C-1, C-2, and C-3. Each domain adopts a DE-variant IgG fold, with two beta-sheets whose A and F strands are linked through an intramolecular isopeptide bond. The adherence of the C-terminal AgI/II fragments to the putative tooth surface receptor salivary agglutinin (SAG), as monitored by surface plasmon resonance, indicated that the minimal region of binding was contained within the first and second DE-variant-IgG domains (C1 and C2) of the C terminus. The minimal C-terminal region that could inhibit S. mutans adherence to SAG was also confirmed to be within the C-1 and C-2 domains. Competition experiments demonstrated that the C-and N-terminal regions of AgI/II adhere to distinct sites on SAG. A cleft formed at the intersection between these C-1 and C-2 domains bound glucose molecules from the cryo-protectant solution, revealing a putative binding site for its highly glycosylated receptor SAG. Finally, electron microscopy images confirmed the elongated structure of AgI/II and enabled building a composite tertiary model that encompasses its two distinct binding regions.	[Larson, Matthew R.; Deivanayagam, Champion] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Larson, Matthew R.; Deivanayagam, Champion] Univ Alabama, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Deivanayagam, Champion] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Crowley, Paula J.; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Kelly, Charles] Kings Coll London, Guys Hosp, Inst Dent, London SE1 9RT, England; [Mitchell, Tim J.] Univ Glasgow, Div Infect & Immun, Glasgow G12 8TA, Lanark, Scotland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Glasgow	Deivanayagam, C (corresponding author), Univ Alabama, Dept Physiol & Biophys, 1025 18th St S,CBSE 100, Birmingham, AL 35294 USA.	champy@cbse.uab.edu	Brady, L. Jeannine/P-5059-2019	Mitchell, Timothy/0000-0002-8309-5556; Deivanayagam, Champion/0000-0003-2972-1824	National Institutes of Health [RO1 DE017737]; NIDCR [NIDCR T-32 DE0176707]; National Center for Research Resources [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DE017737 (to C. D.) through the Dental Academic Research Training grant NIDCR Training Grant NIDCR T-32 DE0176707 (to M. R. L.); We thank Shaan Khaled and Manisha Patel for help with the purification AgI/II fragments. M. R. L. and C. D. also thank the University of Alabama Comprehensive Cancer Center X-Ray Core. We thank the North Eastern Collaborative Access Team facility at the Advanced Photon Source/Argonne National Laboratory, which is supported by National Center for Research Resources Award RR-15301 and United States Department of Energy under Contract DE-AC02-06CH11357.	Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; Brooks W, 1997, INFECT IMMUN, V65, P3753, DOI 10.1128/IAI.65.9.3753-3758.1997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DEMUTH DR, 1990, J BIOL CHEM, V265, P7120; Demuth DR, 2001, INFECT IMMUN, V69, P5736, DOI 10.1128/IAI.69.9.5736-5741.2001; DUAN Y, 1994, INFECT IMMUN, V62, P5220, DOI 10.1128/IAI.62.12.5220-5226.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Love RM, 2000, INFECT IMMUN, V68, P1359, DOI 10.1128/IAI.68.3.1359-1365.2000; MA JKC, 1991, INFECT IMMUN, V59, P2686, DOI 10.1128/IAI.59.8.2686-2694.1991; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Matsumoto-Nakano M, 2009, ORAL MICROBIOL IMMUN, V24, P427, DOI 10.1111/j.1399-302X.2009.00521.x; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pecharki D, 2005, ORAL MICROBIOL IMMUN, V20, P366, DOI 10.1111/j.1399-302X.2005.00244.x; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1978, ARCH ORAL BIOL, V23, P7, DOI 10.1016/0003-9969(78)90047-X; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	43	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21657	21666		10.1074/jbc.M111.231100	http://dx.doi.org/10.1074/jbc.M111.231100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21505225	Green Published, hybrid			2022-12-27	WOS:000291464700062
J	Beigneux, AP; Davies, BSJ; Tat, S; Chen, J; Gin, P; Voss, CV; Weinstein, MM; Bensadoun, A; Pullinger, CR; Fong, LG; Young, SG				Beigneux, Anne P.; Davies, Brandon S. J.; Tat, Shelly; Chen, Jenny; Gin, Peter; Voss, Constance V.; Weinstein, Michael M.; Bensadoun, Andre; Pullinger, Clive R.; Fong, Loren G.; Young, Stephen G.			Assessing the Role of the Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1) Three-finger Domain in Binding Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; FUNCTIONAL EPITOPE; HEPARIN-BINDING; CHYLOMICRONS; RECEPTOR; IDENTIFICATION; RESIDUES; MELEDA	Glycosylphosphatidylinositol-anchored high density lipoprotein- binding protein 1 (GPIHBP1) is an endothelial cell protein that transports lipoprotein lipase (LPL) from the subendothelial spaces to the capillary lumen. GPIHBP1 contains two main structural motifs, an amino-terminal acidic domain enriched in aspartates and glutamates and a lymphocyte antigen 6 (Ly6) motif containing 10 cysteines. All of the cysteines in the Ly6 domain are disulfide-bonded, causing the protein to assume a three-fingered structure. The acidic domain of GPIHBP1 is known to be important for LPL binding, but the involvement of the Ly6 domain in LPL binding requires further study. To assess the importance of the Ly6 domain, we created a series of GPIHBP1 mutants in which each residue of the Ly6 domain was changed to alanine. The mutant proteins were expressed in Chinese hamster ovary (CHO) cells, and their expression level on the cell surface and their ability to bind LPL were assessed with an immunofluorescence microscopy assay and a Western blot assay. We identified 12 amino acids within GPIHBP1, aside from the conserved cysteines, that are important for LPL binding; nine of those were clustered in finger 2 of the GPIHBP1 three-fingered motif. The defective GPIHBP1 proteins also lacked the ability to transport LPL from the basolateral to the apical surface of endothelial cells. Our studies demonstrate that the Ly6 domain of GPIHBP1 is important for the ability of GPIHBP1 to bind and transport LPL.	[Beigneux, Anne P.; Davies, Brandon S. J.; Tat, Shelly; Gin, Peter; Voss, Constance V.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Chen, Jenny; Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94158 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [R01 HL094732, P01 HL090553, R01 HL087228]; American Heart Association, National Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL094732, R01HL087228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, National Office(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094732 (to A. P. B.), P01 HL090553 (to S. G. Y.), and R01 HL087228 (to S. G. Y.). This work was also supported by a Scientist Development Award from the American Heart Association, National Office (to A. P. B.).	Beigneux AP, 2008, J LIPID RES, V49, P1312, DOI 10.1194/jlr.M700593-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; COCAPRIETO I, 2011, J INTERN ME IN PRESS; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Favre B, 2007, J INVEST DERMATOL, V127, P301, DOI 10.1038/sj.jid.5700551; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Gin P, 2007, BBA-MOL CELL BIOL L, V1771, P1464, DOI 10.1016/j.bbalip.2007.10.005; HATA A, 1993, J BIOL CHEM, V268, P8447; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; MA YH, 1994, J LIPID RES, V35, P2049; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Sendak RA, 1998, J LIPID RES, V39, P1310; Yerebakan O, 2003, CLIN EXP DERMATOL, V28, P542, DOI 10.1046/j.1365-2230.2003.01342.x; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	22	44	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19735	19743		10.1074/jbc.M111.242024	http://dx.doi.org/10.1074/jbc.M111.242024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478160	hybrid, Green Published			2022-12-27	WOS:000291027700056
J	De Francesco, MA; Baronio, M; Poiesi, C				De Francesco, Maria A.; Baronio, Manuela; Poiesi, Claudio			HIV-1 p17 Matrix Protein Interacts with Heparan Sulfate Side Chain of CD44v3, Syndecan-2, and Syndecan-4 Proteoglycans Expressed on Human Activated CD4(+) T Cells Affecting Tumor Necrosis Factor alpha and Interleukin 2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HOMING RECEPTOR CD44; BINDING; REPLICATION; LYMPHOCYTES; RANTES; ASSOCIATION; APOPTOSIS; MEMBRANE; TURNOVER	HIV-1 p17 contains C-and N-terminal sequences with positively charged residues and a consensus cluster for heparin binding. We have previously demonstrated by affinity chromatography that HIV-1 p17 binds strongly to heparin-agarose at physiological pH and to human activated CD4(+) T cells. In this study we demonstrated that the viral protein binds to heparan sulfate side chains of syndecan-2, syndecan-4, and CD44v3 purified from HeLa cells and that these heparan sulfate proteoglycans (HSPGs) co-localize with HIV-1 p17 on activated human CD4(+) T cells by confocal fluorescence analysis. Moreover, we observed a stimulatory or inhibitory activity when CD4(+) T cells were activated with mitogens together with nanomolar or micromolar concentrations of the matrix protein.	[Poiesi, Claudio] Spedali Civil Brescia, Inst Microbiol & Virol, Lab Microbiol & Virol, I-25123 Brescia, Italy; [De Francesco, Maria A.] Univ Brescia, Sch Med, Inst Microbiol, I-25123 Brescia, Italy; [Baronio, Manuela] Osped St Orsola, Dept Intens Care Unit, I-27 Brescia, Italy	Hospital Spedali Civili Brescia; University of Brescia	Poiesi, C (corresponding author), Spedali Civil Brescia, Inst Microbiol & Virol, Lab Microbiol & Virol, Piazzale Spedali Civili 1, I-25123 Brescia, Italy.	claudio.poiesi@tiscali.it	De Francesco, M.A./H-3456-2019	De Francesco, M.A./0000-0003-2221-6286	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica.	Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Appay V, 2000, INT IMMUNOL, V12, P1173, DOI 10.1093/intimm/12.8.1173; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borland G, 1998, IMMUNOLOGY, V93, P139; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; Carey DJ, 1997, BIOCHEM J, V327, P1; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Conte MR, 1998, VIROLOGY, V246, P191, DOI 10.1006/viro.1998.9206; COSTES S, 2002, P MICROSC MICROANAL, V8; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; LASKIN JD, 1991, LEUKEMIA RES, V15, P515, DOI 10.1016/0145-2126(91)90063-Y; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; LORIES V, 1986, EUR J BIOCHEM, V158, P351, DOI 10.1111/j.1432-1033.1986.tb09758.x; LU W, 1995, NAT MED, V1, P386, DOI 10.1038/nm0595-386b; Poiesi C, 2008, VIRUS RES, V132, P25, DOI 10.1016/j.virusres.2007.10.006; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Schacker TW, 2006, CLIN VACCINE IMMUNOL, V13, P556, DOI 10.1128/CVI.13.5.556-560.2006; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seddon B, 2003, CURR OPIN IMMUNOL, V15, P321, DOI 10.1016/S0952-7915(03)00049-9; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	47	20	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19541	19548		10.1074/jbc.M110.191270	http://dx.doi.org/10.1074/jbc.M110.191270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482826	Green Published, hybrid			2022-12-27	WOS:000291027700037
J	Kumar, A; Saigal, K; Malhotra, K; Sinha, KM; Taneja, B				Kumar, Atul; Saigal, Kashyap; Malhotra, Ketan; Sinha, Krishna Murari; Taneja, Bhupesh			Structural and Functional Characterization of Rv2966c Protein Reveals an RsmD-like Methyltransferase from Mycobacterium tuberculosis and the Role of Its N-terminal Domain in Target Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M(2) G-METHYLTRANSFERASES; RIBOSOMAL-RNA; DEPENDENT METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; GENE ENCODES; IN-VITRO; DNA; 16S; IDENTIFICATION	Nine of ten methylated nucleotides of Escherichia coli 16 S rRNA are conserved in Mycobacterium tuberculosis. All the 10 different methyltransferases are known in E. coli, whereas only TlyA and GidB have been identified in mycobacteria. Here we have identified Rv2966c of M. tuberculosis as an ortholog of RsmD protein of E. coli. We have shown that rv2966c can complement rsmD-deleted E. coli cells. Recombinant Rv2966c can use 30 S ribosomes purified from rsmD-deleted E. coli as substrate and methylate G966 of 16 S rRNA in vitro. Structure determination of the protein shows the protein to be a two-domain structure with a short hairpin domain at the N terminus and a C-terminal domain with the S-adenosylmethionine-MT-fold. We show that the N-terminal hairpin is a minimalist functional domain that helps Rv2966c in target recognition. Deletion of the N-terminal domain prevents binding to nucleic acid substrates, and the truncated protein fails to carry out the m(2)G966 methylation on 16 S rRNA. The N-terminal domain also binds DNA efficiently, a property that may be utilized under specific conditions of cellular growth.	[Saigal, Kashyap; Malhotra, Ketan; Sinha, Krishna Murari] IMM, New Delhi 110020, India; [Kumar, Atul; Taneja, Bhupesh] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sinha, KM (corresponding author), IMM, 254 Okhla Ind Estate,Phase 3, New Delhi 110020, India.	krishna@immindia.org; btaneja@igib.res.in		Kumar, Atul/0000-0001-6839-2299; Malhotra, Ketan/0000-0002-3965-2431; Malhotra, Ketan/0000-0001-9934-8557	Council of Scientific and Industrial Research [FAC-02]; Institute of Molecular Medicine	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Institute of Molecular Medicine	This work was supported by of Council of Scientific and Industrial Research Project Grant FAC-02 (to B. T.) This work was also supported by an institutional start-up fund from the Institute of Molecular Medicine (to K. M. S.).	Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basturea GN, 2007, RNA, V13, P1969, DOI 10.1261/rna.700507; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Das G, 2008, EMBO J, V27, P840, DOI 10.1038/emboj.2008.20; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; Gupta A, 2001, J MOL BIOL, V312, P381, DOI 10.1006/jmbi.2001.4935; Gutgsell NS, 2005, RNA, V11, P1141, DOI 10.1261/rna.2550105; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeltsch A, 1999, J BIOL CHEM, V274, P19538, DOI 10.1074/jbc.274.28.19538; Jeltsch A, 2001, BIOL CHEM, V382, P707, DOI 10.1515/BC.2001.084; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lesnyak DV, 2007, J BIOL CHEM, V282, P5880, DOI 10.1074/jbc.M608214200; Lesnyak DV, 2006, J MOL BIOL, V364, P20, DOI 10.1016/j.jmb.2006.09.009; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Rastogi N, 2000, ANTIMICROB AGENTS CH, V44, P2848, DOI 10.1128/AAC.44.10.2848-2852.2000; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sergiev PV, 2006, J MOL BIOL, V364, P26, DOI 10.1016/j.jmb.2006.09.008; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; Varshney U, 2004, NUCLEIC ACIDS RES, V32, P1018, DOI 10.1093/nar/gkh207; World Health Organization, 2006, WHOHTM2006361	46	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19652	19661		10.1074/jbc.M110.200428	http://dx.doi.org/10.1074/jbc.M110.200428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474448	Green Published, hybrid			2022-12-27	WOS:000291027700048
J	Rakovich, T; Boland, C; Bernstein, I; Chikwana, VM; Iwata-Reuyl, D; Kelly, VP				Rakovich, Tatsiana; Boland, Coilin; Bernstein, Ilana; Chikwana, Vimbai M.; Iwata-Reuyl, Dirk; Kelly, Vincent P.			Queuosine Deficiency in Eukaryotes Compromises Tyrosine Production through Increased Tetrahydrobiopterin Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE-HYDROXYLASE ACTIVITY; TRANSFER-RNA; ENDOTHELIAL DYSFUNCTION; HELA-CELLS; DIHYDROFOLATE-REDUCTASE; IN-VIVO; QUEUINE; GENE; BASE; MICE	Queuosine is a modified pyrrolopyrimidine nucleoside found in the anticodon loop of transfer RNA acceptors for the amino acids tyrosine, asparagine, aspartic acid, and histidine. Because it is exclusively synthesized by bacteria, higher eukaryotes must salvage queuosine or its nucleobase queuine from food and the gut microflora. Previously, animals made deficient in queuine died within 18 days of withdrawing tyrosine, a nonessential amino acid, from the diet (Marks, T., and Farkas, W. R. (1997) Biochem. Biophys. Res. Commun. 230, 233-237). Here, we show that human HepG2 cells deficient in queuine and mice made deficient in queuosine-modified transfer RNA, by disruption of the tRNA guanine transglycosylase enzyme, are compromised in their ability to produce tyrosine from phenylalanine. This has similarities to the disease phenylketonuria, which arises from mutation in the enzyme phenylalanine hydroxylase or from a decrease in the supply of its cofactor tetrahydrobiopterin (BH4). Immunoblot and kinetic analysis of liver from tRNA guanine transglycosylase-deficient animals indicates normal expression and activity of phenylalanine hydroxylase. By contrast, BH4 levels are significantly decreased in the plasma, and both plasma and urine show a clear elevation in dihydrobiopterin, an oxidation product of BH4, despite normal activity of the salvage enzyme dihydrofolate reductase. Our data suggest that queuosine modification limits BH4 oxidation in vivo and thereby potentially impacts on numerous physiological processes in eukaryotes.	[Rakovich, Tatsiana; Boland, Coilin; Kelly, Vincent P.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Bernstein, Ilana] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Chikwana, Vimbai M.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Trinity College Dublin; University of Newcastle; Portland State University	Kelly, VP (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	kellyvp@tcd.ie	Kelly, Vincent P/I-2151-2017; Rakovich, Tatsiana/H-5087-2018	Kelly, Vincent P/0000-0001-7067-5407; Rakovich, Tatsiana/0000-0001-7903-9968; Boland, Coilin/0000-0001-6763-3767	Science Foundation Ireland [05-IN3-I761]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Programme Grant 05-IN3-I761 from Science Foundation Ireland.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Boland C, 2009, J BIOL CHEM, V284, P18218, DOI 10.1074/jbc.M109.002477; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Chen YC, 2010, RNA, V16, P958, DOI 10.1261/rna.1997610; Christensen R, 2002, MOL GENET METAB, V76, P313, DOI 10.1016/S1096-7192(02)00101-4; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Darlington G J, 1987, Methods Enzymol, V151, P19, DOI 10.1016/S0076-6879(87)51006-0; Du YH, 2008, CIRCULATION, V117, P1045, DOI 10.1161/CIRCULATIONAHA.107.748236; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; FARKAS WR, 1984, BIOCHIM BIOPHYS ACTA, V781, P64, DOI 10.1016/0167-4781(84)90124-6; FARKAS WR, 1980, J BIOL CHEM, V255, P6832; Gaur R, 2007, J BIOSCIENCES, V32, P747, DOI 10.1007/s12038-007-0074-4; Gersting SW, 2010, J BIOL CHEM, V285, P30686, DOI 10.1074/jbc.M110.124016; HAGGERTY DF, 1975, J BIOL CHEM, V250, P8428; Hasegawa H, 2005, MOL GENET METAB, V86, pS2, DOI 10.1016/j.ymgme.2005.09.002; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Iwata-Reuyl D., 2009, DNA RNA MODIFICATION; KATZE JR, 1982, SCIENCE, V216, P55; KAUFMAN S, 1991, NEUROCHEM RES, V16, P1031, DOI 10.1007/BF00965847; Kelly VP, 2005, MOL CELL BIOL, V25, P3658, DOI 10.1128/MCB.25.9.3658-3669.2005; Kirsch M, 2003, J BIOL CHEM, V278, P24481, DOI 10.1074/jbc.M211779200; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; LANGGUT W, 1990, FEBS LETT, V265, P33, DOI 10.1016/0014-5793(90)80877-L; LANGGUT W, 1995, BIOCHEM BIOPH RES CO, V207, P306, DOI 10.1006/bbrc.1995.1188; Lichter-Konecki U, 1999, MOL GENET METAB, V67, P308, DOI 10.1006/mgme.1999.2880; MAHR U, 1990, Biofactors, V2, P185; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Morris RC, 1999, J BIOMOL STRUCT DYN, V16, P757, DOI 10.1080/07391102.1999.10508291; MURALIDHAR G, 1988, ANAL BIOCHEM, V171, P346, DOI 10.1016/0003-2697(88)90496-4; NICOSIA A, 1992, NUCLEIC ACIDS RES, V20, P5321, DOI 10.1093/nar/20.20.5321; NISHIMURA S, 1983, PROG NUCLEIC ACID RE, V28, P49, DOI 10.1016/S0079-6603(08)60082-3; OTT G, 1982, FEBS LETT, V146, P311, DOI 10.1016/0014-5793(82)80941-1; Pathak C, 2005, MOL BIOL REP, V32, P191, DOI 10.1007/s11033-004-6941-2; Pathak C, 2008, BIOSCIENCE REP, V28, P73, DOI 10.1042/BSR20070011; Pey AL, 2006, FASEB J, V20, P2130, DOI 10.1096/fj.06-5835fje; Phillips G, 2010, J BIOL CHEM, V285, P12706, DOI 10.1074/jbc.M110.102236; REISSER T, 1994, EUR J BIOCHEM, V221, P979, DOI 10.1111/j.1432-1033.1994.tb18814.x; REYNIERS JP, 1981, J BIOL CHEM, V256, P1591; Sawabe K, 2004, J PHARMACOL SCI, V96, P124, DOI 10.1254/jphs.FP0040280; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; SIARD TJ, 1991, BIOFACTORS, V3, P41; SZABO L, 1988, Biofactors, V1, P241; Takeda M, 2009, CIRC J, V73, P955, DOI 10.1253/circj.CJ-08-0850; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; WEBBER S, 1985, ARCH BIOCHEM BIOPHYS, V236, P681, DOI 10.1016/0003-9861(85)90674-5; XIA T, 1994, J BIOL CHEM, V269, P24657; Yang W. K., 1971, METHOD ENZYMOL, V20, P44	56	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19354	19363		10.1074/jbc.M111.219576	http://dx.doi.org/10.1074/jbc.M111.219576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487017	Green Published, hybrid			2022-12-27	WOS:000291027700017
J	Allison, SE; D'Elia, MA; Arar, S; Monteiro, MA; Brown, ED				Allison, Sarah E.; D'Elia, Michael A.; Arar, Sharif; Monteiro, Mario A.; Brown, Eric D.			Studies of the Genetics, Function, and Kinetic Mechanism of TagE, the Wall Teichoic Acid Glycosyltransferase in Bacillus subtilis 168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL 3-PHOSPHATE CYTIDYLYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; POLY(GLYCEROL PHOSPHATE); D-ALANINE; ACCEPTOR; CATALYZES; GENES; BACTERIOPHAGE; RESISTANCE; PRODUCT	The biosynthetic enzymes involved in wall teichoic acid biogenesis in Gram-positive bacteria have been the subject of renewed investigation in recent years with the benefit of modern tools of biochemistry and genetics. Nevertheless, there have been only limited investigations into the enzymes that glycosylate wall teichoic acid. Decades-old experiments in the model Gram-positive bacterium, Bacillus subtilis 168, using phage-resistant mutants implicated tagE (also called gtaA and rodD) as the gene coding for the wall teichoic acid glycosyltransferase. This study and others have provided only indirect evidence to support a role for TagE in wall teichoic acid glycosylation. In this work, we showed that deletion of tagE resulted in the loss of alpha-glucose at the C-2 position of glycerol in the poly(glycerol phosphate) polymer backbone. We also reported the first kinetic characterization of pure, recombinant wall teichoic acid glycosyltransferase using clean synthetic substrates. We investigated the substrate specificity of TagE using a wide variety of acceptor substrates and found that the enzyme had a strong kinetic preference for the transfer of glucose from UDP-glucose to glycerol phosphate in polymeric form. Further, we showed that the enzyme recognized its polymeric (and repetitive) substrate with a sequential kinetic mechanism. This work provides direct evidence that TagE is the wall teichoic acid glycosyltransferase in B. subtilis 168 and provides a strong basis for further studies of the mechanism of wall teichoic acid glycosylation, a largely uncharted aspect of wall teichoic acid biogenesis.	[Allison, Sarah E.; D'Elia, Michael A.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Allison, Sarah E.; D'Elia, Michael A.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Arar, Sharif; Monteiro, Mario A.] Univ Guelph, Dept Chem, Guelph, ON N1G 2W1, Canada	McMaster University; McMaster University; University of Guelph	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca	Arar, Sharif Husni/F-9337-2017	Arar, Sharif Husni/0000-0001-9396-0518	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-15496]; Canada Research Chair; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Grant MOP-15496, a Canada Research Chair (to E. D. B.), and an Ontario Graduate Scholarship (to S. E. A.).	Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Bhavsar AP, 2001, J BACTERIOL, V183, P6688, DOI 10.1128/JB.183.22.6688-6693.2001; Cleland W. W, 1970, ENZYMES, V2, P1; CUTTING SM, 1990, MOL BIOL METHODS BAC, P175; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1964, J BIOL CHEM, V239, P3187; Ha S, 1999, J AM CHEM SOC, V121, P8415, DOI 10.1021/ja991556t; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; MAUEL C, 1991, J GEN MICROBIOL, V137, P929, DOI 10.1099/00221287-137-4-929; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PARK YS, 1993, J BIOL CHEM, V268, P16648; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P337; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sambrook J., 1989, MOL CLONING, pA1; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; YASBIN RE, 1976, J BACTERIOL, V125, P1120, DOI 10.1128/JB.125.3.1120-1126.1976; YOUNG FE, 1969, J BACTERIOL, V98, P1087, DOI 10.1128/JB.98.3.1087-1097.1969; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	34	35	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23708	23716		10.1074/jbc.M111.241265	http://dx.doi.org/10.1074/jbc.M111.241265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558268	Green Published, hybrid			2022-12-27	WOS:000292294900012
J	Makarova, AM; Lebedeva, TV; Nassar, T; Higazi, AA; Xue, J; Carinato, ME; Bdeir, K; Cines, DB; Stepanova, V				Makarova, Anastasia M.; Lebedeva, Tatiana V.; Nassar, Taher; Higazi, Abd Al-Roof; Xue, Jing; Carinato, Maria E.; Bdeir, Khalil; Cines, Douglas B.; Stepanova, Victoria			Urokinase-type Plasminogen Activator (uPA) Induces Pulmonary Microvascular Endothelial Permeability through Low Density Lipoprotein Receptor-related Protein (LRP)-dependent Activation of Endothelial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; KINASE-A PHOSPHORYLATION; BLOOD-BRAIN-BARRIER; ACUTE LUNG INJURY; FIBRIN DEPOSITION; ADENYLYL-CYCLASE; CELL BARRIER; VASCULAR-PERMEABILITY; MEDIATED ENDOCYTOSIS; ISCHEMIA-REPERFUSION	Urokinase plasminogen activator (uPA) and PA inhibitor type 1 (PAI-1) are elevated in acute lung injury, which is characterized by a loss of endothelial barrier function and the development of pulmonary edema. Two-chain uPA and uPA-PAI-1 complexes (1-20 nM) increased the permeability of monolayers of human pulmonary microvascular endothelial cells (PMVECs) in vitro and lung permeability in vivo. The effects of uPA-PAI-1 were abrogated by the nitric-oxide synthase (NOS) inhibitor L-NAME (N-D-nitro-L-arginine methyl ester). Two-chain uPA (1-20 nM) and uPA-PAI-1 induced phosphorylation of endothelial NOS-Ser(1177) in PMVECs, which was followed by generation of NO and the nitrosylation and dissociation of beta-catenin from VE-cadherin. uPA-induced phosphorylation of eNOS was decreased by anti-low density lipoprotein receptor-related protein-1 (LRP) antibody and an LRP antagonist, receptor-associated protein (RAP), and when binding to the uPA receptor was blocked by the isolated growth factor-like domain of uPA. uPA-induced phosphorylation of eNOS was also inhibited by the protein kinase A (PKA) inhibitor, myristoylated PKI, but was not dependent on PI3K-Akt signaling. LRP blockade and inhibition of PKA prevented uPA- and uPA-PAI-1-induced permeability of PMVEC monolayers in vitro and uPA-induced lung permeability in vivo. These studies identify a novel pathway involved in regulating PMVEC permeability and suggest the utility of uPA-based approaches that attenuate untoward permeability following acute lung injury while preserving its salutary effects on fibrinolysis and airway remodeling.	[Makarova, Anastasia M.; Lebedeva, Tatiana V.; Higazi, Abd Al-Roof; Xue, Jing; Carinato, Maria E.; Bdeir, Khalil; Cines, Douglas B.; Stepanova, Victoria] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Nassar, Taher; Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Xue, Jing] Tianjin Huanhu Hosp, Dept Lab Med, Tianjin 300060, Peoples R China	University of Pennsylvania; Hebrew University of Jerusalem; Hadassah University Medical Center	Stepanova, V (corresponding author), 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vstepano@mail.med.upenn.edu			National Institutes of Health [HL-077760, 5T32 HL07971-07, NS053410-04S1, HD057355, HL076406, CA141228]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA141228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971, R01HL077760, P01HL076406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-077760 (to A. A. H.), 5T32 HL07971-07, NS053410-04S1, HD057355, and HL076406 (to D. B. C.), and CA141228 (to V. S.).	Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644; ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644; Armstead WM, 2008, J NEUROTRAUM, V25, P1375, DOI 10.1089/neu.2008.0666; Armstead WM, 2005, STROKE, V36, P2265, DOI 10.1161/01.STR.0000181078.74698.b0; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; BACHOFEN M, 1982, CLIN CHEST MED, V3, P35; Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089; BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Bindewald K, 2004, AM J PHYSIOL-CELL PH, V287, pC1246, DOI 10.1152/ajpcell.00132.2004; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913; BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Chen HI, 2003, J BIOMED SCI, V10, P588, DOI 10.1159/000073523; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dear AE, 1998, EUR J BIOCHEM, V252, P185, DOI 10.1046/j.1432-1327.1998.2520185.x; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; Goretzki L, 1997, J CELL SCI, V110, P1395; Hardaway RM, 2001, AM SURGEON, V67, P377; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Hiroi YK, 2008, FASEB J, V22, P1450, DOI 10.1096/fj.07-9309com; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; Idell S, 1994, New Horiz, V2, P566; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; ISCHIROPOULOS H, 1994, AM J RESP CRIT CARE, V150, P337, DOI 10.1164/ajrccm.150.2.8049812; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Kao SJ, 2003, J BIOMED SCI, V10, P58, DOI 10.1159/000068090; KASAI S, 1985, J BIOL CHEM, V260, P2377; Klein RC, 1999, NEUROSCI LETT, V273, P171, DOI 10.1016/S0304-3940(99)00649-7; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; Lardot CG, 1998, AM J RESP CRIT CARE, V157, P617, DOI 10.1164/ajrccm.157.2.9707052; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; LI H, 1994, J BIOL CHEM, V269, P8153; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765; MAJNO G, 1969, J CELL BIOL, V42, P647, DOI 10.1083/jcb.42.3.647; Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Mundy AL, 2000, BRIT J ANAESTH, V85, P570, DOI 10.1093/bja/85.4.570; Nagata K, 2003, CHEST, V124, P2293, DOI 10.1378/chest.124.6.2293; Namiki A, 1992, JPN J PHARM S2, V58, p326P; Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; NEUHOF H, 1986, RESUSCITATION, V14, P23, DOI 10.1016/0300-9572(86)90004-3; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SEEKAMP A, 1993, AM J PATHOL, V142, P1217; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Sugiura H, 1999, AM J RESP CRIT CARE, V160, P663, DOI 10.1164/ajrccm.160.2.9807160; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	92	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23044	23053		10.1074/jbc.M110.210195	http://dx.doi.org/10.1074/jbc.M110.210195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540184	Green Published, hybrid			2022-12-27	WOS:000292025000039
J	Yanagawa, M; Yamashita, T; Shichida, Y				Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori			Comparative Fluorescence Resonance Energy Transfer Analysis of Metabotropic Glutamate Receptors IMPLICATIONS ABOUT THE DIMERIC ARRANGEMENT AND REARRANGEMENT UPON LIGAND BINDINGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MUTATIONAL ANALYSIS; ACTIVATION; RHODOPSIN; DOMAIN; OLIGOMERIZATION; DIMERIZATION; ENVIRONMENT; ANTAGONIST; MODULATOR	Dimerization of G protein-coupled receptors has received much attention as a regulatory system of physiological function. Metabotropic glutamate receptors (mGluRs) are suitable models for studying the physiological significance of G protein-coupled receptor dimers because they form constitutive homodimers and function through dimeric rearrangement of their extracellular ligand binding domains. However, the molecular architecture of the transmembrane domains (TMDs) and their rearrangement upon agonist binding are still largely unknown. Here we show that the two helix Vs are arranged as the closest part in the dimeric TMDs and change their positions through synergistic control by the binding of two glutamates. The possibility that helix V is involved in an inter-protomer communication was first suggested by the finding that constitutively active mutation sites were identified on both sides of helix V. Then, comprehensive fluorescence resonance energy transfer (FRET) analysis using mGluRs whose cytoplasmic loops were labeled with donor and acceptor fluorescent proteins revealed that the third intracellular loop connecting helices V and VI of one protomer was in close proximity to the second and third intracellular loops of the other protomer and that all the intracellular loops became closer during the activation. Furthermore, FRET analysis of heterodimers in which only one protomer had ligand binding ability revealed the synergistic effect of the binding of two glutamates on the dimeric rearrangements of the TMD. Thus, the glutamate-dependent synergistic relocation of the helix Vs in the dimer is important for the signal flow from the extracellular ligand binding domain to the cytoplasmic surface of the mGluR.	[Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp	Yanagawa, Masataka/C-3789-2017	Yanagawa, Masataka/0000-0001-7832-0918	Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan) [20227002, 21026019]; Global Center of Excellence Program [A06]; Japan Society for the Promotion of Science [08J01259]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Japan) (Grants-in-aid for Scientific Research 20227002 and 21026019 and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research; from Genome to Ecosystem" (Program A06)) and by Japan Society for the Promotion of Science Research Fellowship for Young Scientists Grant 08J01259.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Terakita A, 1996, VISUAL NEUROSCI, V13, P539, DOI 10.1017/S095252380000821X; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yamashita T, 2004, J NEUROCHEM, V91, P484, DOI 10.1111/j.1471-4159.2004.02739.x; Yamashita T, 2008, J NEUROCHEM, V106, P850, DOI 10.1111/j.1471-4159.2008.05443.x; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549	35	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22971	22981		10.1074/jbc.M110.206870	http://dx.doi.org/10.1074/jbc.M110.206870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550987	Green Published, hybrid			2022-12-27	WOS:000292025000032
J	Fernandez-Alvarez, A; Alvarez, MS; Gonzalez, R; Cucarella, C; Muntane, J; Casado, M				Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Gonzalez, Raul; Cucarella, Carme; Muntane, Jordi; Casado, Marta			Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor alpha (PPAR alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; X-RECEPTOR; CHOLESTEROL HOMEOSTASIS; GENE-EXPRESSION; RAT HEPATOCYTES; HEPATOMA-CELLS; CROSS-TALK; PROMOTER; INSULIN	Sterol regulatory element binding proteins (SREBPs) regulate the expression of a number of enzymes, which catalyze the synthesis of fatty acids, cholesterol, triglycerides, and phospholipids. SREBP1c is the most relevant isoform in the adult liver, and its expression is controlled by the nutritional state. Transcriptional regulation studies into the SREBP1c gene, performed in the last few years, have improved our knowledge of the variability of signals that converge on its promoter region. Insulin, cholesterol derivatives, T3 and other endogenous molecules have been demonstrated to regulate the SREBP1c expression, particularly in rodents. The present study aimed to perform a detailed analysis of the human SREBP1c gene promoter structure in liver cells by focusing on responses to diverse metabolic signals. Serial deletion and mutation assays reveal that both SREBP (SRE) and LXR (LXRE) response elements are involved in SREBP1c transcription regulation mediated by insulin and cholesterol derivatives. We discovered that peroxisome proliferation-activated receptor alpha (PPAR alpha) agonists enhance the activity of the SREBP1c promoter; a DR1 element, at -453 in the human promoter was involved in this activation. Moreover, PPAR alpha agonists act in cooperation with LXR or insulin to induce lipogenesis. Collectively, our results identify PPAR alpha as a novel regulatory factor in SREBP1c regulation which plays a relevant role in the interplay between lipids and insulin metabolic regulation.	[Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta] CSIC, IBV, Valencia 46010, Spain; [Gonzalez, Raul; Muntane, Jordi] Reina Sofia Univ Hosp, Liver Res Unit, Cordoba 14004, Spain; [Gonzalez, Raul; Muntane, Jordi; Casado, Marta] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Hospital Universitario Reina Sofia - Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Casado, M (corresponding author), CSIC, IBV, Jaime Roig 11, Valencia 46010, Spain.	mcasado@ibv.csic.es	Casado, Marta/L-2078-2014	Casado, Marta/0000-0001-6457-4650; Fernandez-Alvarez, Ana/0000-0002-5296-5678	Spanish Ministry of Science and Innovation [SAF2006-06760, SAF2009-12602]; Carlos III Health Institute [FIS-RECAVA RD06/0014/0025]; Consejo Superior de Investigaciones Cientificas (Spanish National Research Council)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientificas (Spanish National Research Council)	This work was supported by the Spanish Ministry of Science and Innovation (SAF2006-06760; SAF2009-12602) and the Carlos III Health Institute (Red de Centros FIS-RECAVA RD06/0014/0025).; Supported by a fellowship from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council) (JAE-predoctoral).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Fernandez-Alvarez A, 2008, FEBS LETT, V582, P177, DOI 10.1016/j.febslet.2007.11.083; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Fernandez-Miranda C, 2008, DIGEST LIVER DIS, V40, P200, DOI 10.1016/j.dld.2007.10.002; Ferrini J B, 1998, Methods Mol Biol, V107, P341; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; Le Jossic-Corcos C, 2004, BBA-MOL CELL BIOL L, V1683, P49, DOI 10.1016/j.bbalip.2004.04.004; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Patel DD, 2001, J LIPID RES, V42, P328; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Tarling E, 2004, BIOCHEM SOC T, V32, P107, DOI 10.1042/BST0320107; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	36	91	94	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21466	21477		10.1074/jbc.M110.209973	http://dx.doi.org/10.1074/jbc.M110.209973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21540177	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000291464700045
J	Keeling, CI; Madilao, LL; Zerbe, P; Dullat, HK; Bohlmann, J				Keeling, Christopher I.; Madilao, Lina L.; Zerbe, Philipp; Dullat, Harpreet K.; Bohlmann, Joerg			The Primary Diterpene Synthase Products of Picea abies Levopimaradiene/Abietadiene Synthase (PaLAS) Are Epimers of a Thermally Unstable Diterpenol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABIETADIENOL/ABIETADIENAL OXIDASE PTAO; RESIN ACID BIOSYNTHESIS; ENT-KAURENE SYNTHASE; PRE-STEADY-STATE; ABIETADIENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; INITIATED CYCLIZATION; PHYSCOMITRELLA-PATENS; MONOTERPENE SYNTHASE; MUTATIONAL ANALYSIS	The levopimaradiene/abietadiene synthase from Norway spruce (Picea abies; PaLAS) has previously been reported to produce a mixture of four diterpene hydrocarbons when incubated with geranylgeranyl diphosphate as the substrate: levopimaradiene, abietadiene, neoabietadiene, and palustradiene. However, variability in the assay products observed by GC-MS of this and orthologous conifer diterpene synthases over the past 15 years suggested that these diterpenes may not be the initial enzyme assay products but are rather the products of dehydration of an unstable alcohol. We have identified epimers of the thermally unstable allylic tertiary alcohol 13-hydroxy-8(14)-abietene as the products of PaLAS. The identification of these compounds, not previously described in conifers, as the initial products of PaLAS has considerable implications for our understanding of the complexity of the biosynthetic pathway of the structurally diverse diterpene resin acids of conifer defense.	[Keeling, Christopher I.; Madilao, Lina L.; Zerbe, Philipp; Dullat, Harpreet K.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Zerbe, Philipp/H-8348-2015; Zerbe, Philipp/A-2590-2013; Keeling, Christopher I./I-3371-2012	Zerbe, Philipp/0000-0001-5163-9523; Keeling, Christopher I./0000-0001-7885-8558	Natural Sciences and Engineering Research Council of Canada (NSERC); Genome British Columbia; Government of Canada through Genome Canada; University of British Columbia; Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome British Columbia; Government of Canada through Genome Canada(Genome Canada); University of British Columbia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; to J. B.) and by Genome British Columbia and the Government of Canada through Genome Canada in support of the Treenomix Conifer Forest Health Project (to J. B.) and the Tria Project (to J. B. and C. I. K.).; Supported in part by the University of British Columbia Distinguished University Scholars Program and a Natural Sciences and Engineering Research Council Steacie Memorial Fellowship.	ANTHONSE.T, 1973, ACTA CHEM SCAND, V27, P1073, DOI 10.3891/acta.chem.scand.27-1073; Cane DE, 1997, BIOCHEMISTRY-US, V36, P8332, DOI 10.1021/bi963018o; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Gu Q, 2006, STEROIDS, V71, P96, DOI 10.1016/j.steroids.2005.08.008; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kollner TG, 2006, ARCH BIOCHEM BIOPHYS, V448, P83, DOI 10.1016/j.abb.2005.10.011; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Mathis JR, 1997, BIOCHEMISTRY-US, V36, P8340, DOI 10.1021/bi963019g; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Ro DK, 2006, PHYTOCHEMISTRY, V67, P1572, DOI 10.1016/j.phytochem.2006.01.011; Ro DK, 2005, P NATL ACAD SCI USA, V102, P8060, DOI 10.1073/pnas.0500825102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang NY, 2010, PHYTOCHEMISTRY, V71, P1528, DOI 10.1016/j.phytochem.2010.06.008; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zhang CL, 2005, CHINESE CHEM LETT, V16, P727; Zulak KG, 2009, PLANT J, V60, P1015, DOI 10.1111/j.1365-313X.2009.04020.x	38	43	47	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21145	21153		10.1074/jbc.M111.245951	http://dx.doi.org/10.1074/jbc.M111.245951			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518766	Green Published, hybrid			2022-12-27	WOS:000291464700014
J	Redmann, V; Oresic, K; Tortorella, LL; Cook, JP; Lord, M; Tortorella, D				Redmann, Veronika; Oresic, Kristina; Tortorella, Lori L.; Cook, Jonathan P.; Lord, Michael; Tortorella, Domenico			Dislocation of Ricin Toxin A Chains in Human Cells Utilizes Selective Cellular Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; A-CHAIN; SACCHAROMYCES-CEREVISIAE; B-CHAIN; RETRO-TRANSLOCATION; GOLGI TRANSPORT; PROTEIN TOXINS; CYTOSOL; ER	Ricin is a potent A-B toxin that is transported from the cell surface to the cytosol, where it inactivates ribosomes, leading to cell death. Ricin enters cells via endocytosis, where only a minute number of ricin molecules reach the endoplasmic reticulum (ER) lumen. Subsequently, the ricin A chain traverses the ER bilayer by a process referred to as dislocation or retrograde translocation to gain access to the cytosol. To study the molecular processes of ricin A chain dislocation, we have established, for the first time, a human cell system in which enzymatically attenuated ricin toxin A chains (RTA(E177D) and RTA(Delta 177-181)) are expressed in the cell and directed to the ER. Using this human cell-based system, we found that ricin A chains underwent a rapid dislocation event that was quite distinct from the dislocation of a canonical ER soluble misfolded protein, null Hong Kong variant of alpha(1)-antitrypsin. Remarkably, ricin A chain dislocation occurred via a membrane-integrated intermediate and utilized the ER protein SEL1L for transport across the ER bilayer to inhibit protein synthesis. The data support a model in which ricin A chain dislocation occurs via a novel strategy of utilizing the hydrophobic nature of the ER membrane and selective ER components to gain access to the cytosol.	[Redmann, Veronika; Oresic, Kristina; Tortorella, Lori L.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Cook, Jonathan P.; Lord, Michael] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Icahn School of Medicine at Mount Sinai; University of Warwick	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,POB 1124, New York, NY 10029 USA.	domenico.tortorella@mssm.edu	Cook, Jonathan/D-5704-2011	Cook, Jonathan/0000-0003-3690-555X; Tortorella, Domenico/0000-0003-0961-3535	National Institutes of Health [AI060905]; Defense Threat Reduction Agency [W81XWH-10-2-0048]; Irma T. Hirschl Trust; United States Public Health Service [AI07647]; Kadlec Medical Center Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Irma T. Hirschl Trust; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Kadlec Medical Center Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060905. This work was also supported by Defense Threat Reduction Agency Contract W81XWH-10-2-0048 and the Irma T. Hirschl Trust.; Predoctoral trainee supported in part by United States Public Health Service Institutional Research Training Award AI07647 and the Kadlec Medical Center Foundation.	Allen SCH, 2007, FEBS J, V274, P5586, DOI 10.1111/j.1742-4658.2007.06080.x; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; CHADDOCK JA, 1993, PROTEIN ENG, V6, P425, DOI 10.1093/protein/6.4.425; Day PJ, 2001, J BIOL CHEM, V276, P7202, DOI 10.1074/jbc.M009499200; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Di Cola A, 2005, PLANT PHYSIOL, V137, P287, DOI 10.1104/pp.104.055434; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; EIKLID K, 1980, EXP CELL RES, V126, P321, DOI 10.1016/0014-4827(80)90270-0; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; FRANKEL A, 1989, MOL CELL BIOL, V9, P415, DOI 10.1128/MCB.9.2.415; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; LEHAR SM, 1994, PROTEIN ENG, V7, P1261, DOI 10.1093/protein/7.10.1261; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Llorente A, 1998, J CELL BIOL, V140, P553, DOI 10.1083/jcb.140.3.553; LONDON E, 1989, BIOCHEM BIOPH RES CO, V160, P333, DOI 10.1016/0006-291X(89)91660-4; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; OLSNES S, 1975, EUR J BIOCHEM, V60, P281, DOI 10.1111/j.1432-1033.1975.tb21001.x; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Teckman JH, 1996, HEPATOLOGY, V24, P1504, DOI 10.1002/hep.510240635; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	47	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21231	21238		10.1074/jbc.M111.234708	http://dx.doi.org/10.1074/jbc.M111.234708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527639	Green Published, hybrid			2022-12-27	WOS:000291464700022
J	Xu, Z; Xiao, SB; Xu, P; Xie, Q; Cao, L; Wang, D; Luo, R; Zhong, Y; Chen, HC; Fang, LR				Xu, Zheng; Xiao, Shao-Bo; Xu, Peng; Xie, Qian; Cao, Lu; Wang, Dang; Luo, Rui; Zhong, Yao; Chen, Huan-Chun; Fang, Liu-Rong			miR-365, a Novel Negative Regulator of Interleukin-6 Gene Expression, Is Cooperatively Regulated by Sp1 and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; MICRORNA; ACTIVATION; PROMOTER; PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; INDUCTION; TARGETS	Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a central role in host defense. IL-6 expression can be regulated at both a transcriptional and a post-transcriptional level. We used a combination of bioinformatics and experimental techniques to demonstrate that the miR-365 is a direct negative regulator of IL-6. Overexpression of miR-365 mimics decreased activity of a luciferase reporter containing the IL-6 3'-UTR and led to repression of IL-6 protein. In contrast, ectopic expression of a miR-365 inhibitor elevated IL-6 expression. The negative regulation of miR-365 was strictly dependent on a microRNA binding element in the 3'-UTR of IL-6 mRNA. Deletion mutant analysis of the miR-365 promoter showed that two transcription factors, Sp1 and NF-kappa B, are essential for the transcriptional regulation of miR-365. We also demonstrate that the MAPK/ERK pathway contributes to the regulation of miR-365. Furthermore, miR-365 exhibited a greater negative regulatory effect on IL-6 than hsa-let-7a, a previously identified microRNA negatively regulating IL-6. Taken together, our results show that miR-365 is a novel negative regulator of IL-6.	[Xu, Zheng; Xiao, Shao-Bo; Xu, Peng; Xie, Qian; Cao, Lu; Wang, Dang; Luo, Rui; Zhong, Yao; Chen, Huan-Chun; Fang, Liu-Rong] Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, Wuhan 430070, Peoples R China.	vet@mail.hzau.edu.cn; fanglr@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	New Century Excellent Talent Project [NCET-07-0347]; National Natural Sciences Foundation of China [30972189, 30871871]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	New Century Excellent Talent Project(Program for New Century Excellent Talents in University (NCET)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the New Century Excellent Talent Project (NCET-07-0347), the National Natural Sciences Foundation of China (30972189, 30871871), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0726).	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Borghaei RC, 2009, BIOCHEM BIOPH RES CO, V382, P269, DOI 10.1016/j.bbrc.2009.03.002; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kim BH, 2006, EUR J PHARMACOL, V543, P158, DOI 10.1016/j.ejphar.2006.05.042; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; STADE BG, 1990, IMMUNOBIOLOGY, V182, P79, DOI 10.1016/S0171-2985(11)80585-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	59	97	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21401	21412		10.1074/jbc.M110.198630	http://dx.doi.org/10.1074/jbc.M110.198630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518763	hybrid, Green Published			2022-12-27	WOS:000291464700039
J	Varley, ZK; Pizzarelli, R; Antonelli, R; Stancheva, SH; Kneussel, M; Cherubini, E; Zacchi, P				Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Kneussel, Matthias; Cherubini, Enrico; Zacchi, Paola			Gephyrin Regulates GABAergic and Glutamatergic Synaptic Transmission in Hippocampal Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPSES; GABA(A) RECEPTOR; RELEASE PROBABILITY; ADHESION MOLECULES; GLYCINE RECEPTOR; NEUREXIN COMPLEX; DEFICIENT MICE; NEUROLIGIN; NEURONS; COLLYBISTIN	Gephyrin is a scaffold protein essential for stabilizing glycine and GABA(A) receptors at inhibitory synapses. Here, recombinant intrabodies against gephyrin (scFv-gephyrin) were used to assess whether this protein exerts a transynaptic action on GABA and glutamate release. Pair recordings from interconnected hippocampal cells in culture revealed a reduced probability of GABA release in scFv-gephyrin-transfected neurons compared with controls. This effect was associated with a significant decrease in VGAT, the vesicular GABA transporter, and in neuroligin 2 (NLG2), a protein that, interacting with neurexins, ensures the cross-talk between the post-and presynaptic sites. Interestingly, hampering gephyrin function also produced a significant reduction in VGLUT, the vesicular glutamate transporter, an effect accompanied by a significant decrease in frequency of miniature excitatory postsynaptic currents. Overexpressing NLG2 in gephyrin-deprived neurons rescued GABAergic but not glutamatergic innervation, suggesting that the observed changes in the latter were not due to a homeostatic compensatory mechanism. Pulldown experiments demonstrated that gephyrin interacts not only with NLG2 but also with NLG1, the isoform enriched at excitatory synapses. These results suggest a key role of gephyrin in regulating transynaptic signaling at both inhibitory and excitatory synapses.	[Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Cherubini, Enrico; Zacchi, Paola] Int Sch Adv Studies SISSA, Dept Neurobiol, I-34136 Trieste, Italy; [Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Cherubini, Enrico; Zacchi, Paola] Int Sch Adv Studies SISSA, Italian Inst Technol Unit, I-34136 Trieste, Italy; [Kneussel, Matthias] Univ Hamburg, Ctr Mol Neurobiol, Zentrum Mol Neurobiol, Sch Med, D-20251 Hamburg, Germany; [Zacchi, Paola] Cluster Biomed, I-34136 Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zacchi, P (corresponding author), SISSA, Neurobiol Sector, Via Bonomea 265, I-34136 Trieste, Italy.	zacchi@sissa.it	antonelli, roberta/AAV-2890-2021	Kneussel, Matthias/0000-0003-4900-366X	Ministero Istruzione, Universita e Ricerca (MIUR)	Ministero Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from Ministero Istruzione, Universita e Ricerca (MIUR) (to E. C.).	Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Andjus PR, 1997, J PHYSIOL-LONDON, V504, P103, DOI 10.1111/j.1469-7793.1997.103bf.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Jones MV, 2001, BIOPHYS J, V81, P2660, DOI 10.1016/S0006-3495(01)75909-7; Katz B., 1969, RELEASE NEURAL TRANS; Kneussel M, 2005, EMBO REP, V6, P22, DOI 10.1038/sj.embor.7400319; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Marchionni I, 2009, NEUROSCIENCE, V164, P552, DOI 10.1016/j.neuroscience.2009.07.063; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Studler B, 2005, J COMP NEUROL, V484, P344, DOI 10.1002/cne.20472; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; YANG J, 1993, DEV BRAIN RES, V71, P19, DOI 10.1016/0165-3806(93)90100-O; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zacchi P, 2008, J MOL NEUROSCI, V34, P141, DOI 10.1007/s12031-007-9018-6; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	44	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20942	20951		10.1074/jbc.M111.234641	http://dx.doi.org/10.1074/jbc.M111.234641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507951	Green Published, hybrid			2022-12-27	WOS:000291267600078
J	Kendall, RT; Strungs, EG; Rachidi, SM; Lee, MH; El-Shewy, HM; Luttrell, DK; Janech, MG; Luttrell, LM				Kendall, Ryan T.; Strungs, Erik G.; Rachidi, Saleh M.; Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Janech, Michael G.; Luttrell, Louis M.			The beta-Arrestin Pathway-selective Type 1A Angiotensin Receptor (AT(1A)) Agonist [Sar(1), Ile(4), Ile(8)] Angiotensin II Regulates a Robust G Protein-independent Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIVATION; PHOSPHORYLATION; KINASE; SET; CYCLOOXYGENASE-1; BETA-ARRESTIN-2; STIMULATION; COMPLEXES; SYNTHASE	The angiotensin II peptide analog [Sar(1), Ile(4), Ile(8)] AngII (SII) is a biased AT(1A) receptor agonist that stimulates receptor phosphorylation, beta-arrestin recruitment, receptor internalization, and beta-arrestin-dependent ERK1/2 activation without activating heterotrimeric G-proteins. To determine the scope of G-protein- independent AT(1A) receptor signaling, we performed a gelbased phosphoproteomic analysis of AngII and SII-induced signaling in HEK cells stably expressing AT(1A) receptors. A total of 34 differentially phosphorylated proteins were detected, of which 16 were unique to SII and eight to AngII stimulation. MALDI-TOF/TOF mass fingerprinting was employed to identify 24 SII-sensitive phosphoprotein spots, of which three (two peptide inhibitors of protein phosphatase 2A (I1PP2A and I2PP2A) and prostaglandin E synthase 3 (PGES3)) were selected for validation and further study. We found that phosphorylation of I2PP2A was associated with rapid and transient inhibition of a beta-arrestin 2-associated pool of protein phosphatase 2A, leading to activation of Akt and increased phosphorylation of glycogen synthase kinase 3 beta in an arrestin signalsome complex. SII-stimulated PGES3 phosphorylation coincided with an increase in beta-arrestin 1-associated PGES3 and an arrestin-dependent increase in cyclooxygenase 1-dependent prostaglandin E-2 synthesis. These findings suggest that AT(1A) receptors regulate a robust G protein-independent signaling network that affects protein phosphorylation and autocrine/paracrine prostaglandin production and that these pathways can be selectively modulated by biased ligands that antagonize G protein activation.	[Kendall, Ryan T.; Strungs, Erik G.; Rachidi, Saleh M.; Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; [Luttrell, Deirdre K.; Janech, Michael G.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Janech, Michael G.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,MSC 624, Charleston, SC 29425 USA.	luttrell@musc.edu	janech, michael/AAA-1011-2019	Luttrell, Louis/0000-0003-2805-6949; Janech, Michael/0000-0002-3202-4811	National Institutes of Health [R01 DK055524, T32 HL07260]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; Nephcure Young Investigator Award; Cancer Center [P30 CA138313]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000061, UL1TR000062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; Nephcure Young Investigator Award; Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK055524 (to L. M. L.) and T32 HL07260 (to R. T. K.). This work was also supported by the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center (to L. M. L. and M. G. J.) and the Nephcure Young Investigator and Department of Veterans Affairs Career Development Awards (to M. G. J.). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 (to the Hollings Cancer Center, Medical University of South Carolina).	ALEXANDER RW, 1976, P NATL ACAD SCI USA, V73, P1617, DOI 10.1073/pnas.73.5.1617; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; CHICZ RM, 1990, METHOD ENZYMOL, V182, P392; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; GIMBRONE MA, 1975, SCIENCE, V189, P219, DOI 10.1126/science.1138377; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; Kobayashi T, 2004, BIOCHEM J, V381, P59, DOI 10.1042/BJ20040118; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lymperopoulos A, 2009, P NATL ACAD SCI USA, V106, P5825, DOI 10.1073/pnas.0811706106; Morinelli TA, 2009, J PHARMACOL EXP THER, V330, P118, DOI 10.1124/jpet.109.151829; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Schilling M, 2008, J PROTEOME RES, V7, P4164, DOI 10.1021/pr800120f; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200	33	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19880	19891		10.1074/jbc.M111.233080	http://dx.doi.org/10.1074/jbc.M111.233080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502318	Green Published, hybrid			2022-12-27	WOS:000291027700068
J	Marom, B; Heining, E; Knaus, P; Henis, YI				Marom, Barak; Heining, Eva; Knaus, Petra; Henis, Yoav I.			Formation of Stable Homomeric and Transient Heteromeric Bone Morphogenetic Protein (BMP) Receptor Complexes Regulates Smad Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA RECEPTORS; GERMLINE MUTATIONS; II RECEPTOR; OLIGOMERIC STRUCTURE; MODE; ENDOCYTOSIS; MECHANISMS; MEMBRANE; BINDING; KINASE	The type I and type II bone morphogenetic protein receptors (BMPRI and BMPRII) are present at the plasma membrane as monomers and homomeric and heteromeric complexes, which are modulated by ligand binding. The complexes of their extracellular domains with ligand were shown to form heterotetramers. However, the dynamics of the oligomeric interactions among the full-length receptors in live cell membranes were not explored, and the roles of BMP receptor homodimerization were unknown. Here, we investigated these issues by combining patching/immobilization of an epitope-tagged BMP receptor at the cell surface with measurements of the lateral diffusion of a co-expressed, differently tagged BMP receptor by fluorescence recovery after photobleaching (FRAP). These studies led to several novel conclusions. (a) All homomeric complexes (without or with BMP-2) were stable on the patch/FRAP time scale (minutes), whereas the heterocomplexes were transient, a difference that may affect signaling. (b) Patch/FRAP between HA- and myc-tagged BMPRII combined with competition by untagged BMPRIb showed that the heterocomplexes form at the expense of homodimers. (c) Stabilization of BMPRII.BMPRIb heterocomplexes (but not homomeric complexes) by IgG binding to same-tag receptors elevated phospho-Smad formation both without and with BMP-2. These findings suggest two mechanisms that may suppress the tendency of preformed BMP receptor hetero-oligomers to signal without ligand: (a) competition between homo- and heterocomplex formation, which reduces the steady-state level of the latter, and (b) the transient nature of the heterocomplexes, which limits the time during which BMPRI can be phosphorylated by BMPRII in the heterocomplex.	[Marom, Barak; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Heining, Eva; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-1495 Berlin, Germany	Tel Aviv University; Free University of Berlin	Henis, YI (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	henis@post.tau.ac.il		Henis, Yoav/0000-0002-1408-3877	German-Israeli Foundation for Scientific Research and Development [932-244.13/2006]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This work was supported in part by Grant 932-244.13/2006 from the German-Israeli Foundation for Scientific Research and Development (to Y. I. H. and P. K.).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Derynck Rik, 2008, P29; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ehrlich M, 2001, J CELL SCI, V114, P1777; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Rechtman MM, 2009, J BIOL CHEM, V284, P7843, DOI 10.1074/jbc.M809215200; Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Sebald W, 2003, TRENDS BIOCHEM SCI, V28, P518, DOI 10.1016/j.tibs.2003.08.001; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sieber C, 2006, BIOL CHEM, V387, P451, DOI 10.1515/BC.2006.060; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wells RG, 1999, J BIOL CHEM, V274, P5716, DOI 10.1074/jbc.274.9.5716; Zhang W, 2009, P NATL ACAD SCI USA, V106, P15679, DOI 10.1073/pnas.0908279106	47	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19287	19296		10.1074/jbc.M110.210377	http://dx.doi.org/10.1074/jbc.M110.210377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471205	hybrid, Green Published			2022-12-27	WOS:000291027700011
J	Lo Buono, N; Parrotta, R; Morone, S; Bovino, P; Nacci, G; Ortolan, E; Horenstein, AL; Inzhutova, A; Ferrero, E; Funaro, A				Lo Buono, Nicola; Parrotta, Rossella; Morone, Simona; Bovino, Paola; Nacci, Giulia; Ortolan, Erika; Horenstein, Alberto L.; Inzhutova, Alona; Ferrero, Enza; Funaro, Ada			The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; CELL-ADHESION; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; UROKINASE RECEPTOR; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; MEMBRANE RAFTS; HUMAN CD38; CD157	CD157, a member of the CD38 gene family, is an NAD-metabolizing ectoenzyme and a signaling molecule whose role in polarization, migration, and diapedesis of human granulocytes has been documented; however, the molecular events underpinning this role remain to be elucidated. This study focused on the role exerted by CD157 in monocyte migration across the endothelial lining and adhesion to extracellular matrix proteins. The results demonstrated that anti-CD157 antibodies block monocyte transmigration and adhesion to fibronectin and fibrinogen but that CD157 cross-linking is sufficient to overcome the block, suggesting an active signaling role for the molecule. Consistent with this is the observation that CD157 is prevalently located within the detergent-resistant membrane microdomains to which, upon clustering, it promotes the recruitment of beta(1) and beta(2) integrin, which, in turn, leads to the formation of a multimolecular complex favoring signal transduction. This functional cross-talk with integrins allows CD157 to act as a receptor despite its intrinsic structural inability to do so on its own. Intracellular signals mediated by CD157 rely on the integrin/Src/FAK (focal adhesion kinase) pathway, resulting in increased activity of the MAPK/ERK1/2 and the PI3K/Akt downstream signaling pathways, which are crucial in the control of monocyte transendothelial migration. Collectively, these findings indicate that CD157 acts as a molecular organizer of signaling-competent membrane microdomains and that it forms part of a larger molecular machine ruled by integrins. The CD157-integrin partnership provides optimal adhesion and transmigration of human monocytes.	[Lo Buono, Nicola; Parrotta, Rossella; Morone, Simona; Bovino, Paola; Nacci, Giulia; Ortolan, Erika; Horenstein, Alberto L.; Inzhutova, Alona; Ferrero, Enza; Funaro, Ada] Univ Turin, Immunogenet Lab, Dept Genet Biol & Biochem, Sch Med, I-10126 Turin, Italy; [Ortolan, Erika; Horenstein, Alberto L.; Ferrero, Enza; Funaro, Ada] Univ Turin, Res Ctr Expt Med CeRMS, Sch Med, I-10126 Turin, Italy	University of Turin; University of Turin	Funaro, A (corresponding author), Univ Turin, Immunogenet Lab, Dept Genet Biol & Biochem, Sch Med, Via Santena 19, I-10126 Turin, Italy.	ada.funaro@unito.it	Lo Buono, Nicola/F-4817-2013; Funaro, Ada/AAC-3203-2019	Lo Buono, Nicola/0000-0001-5538-6869; ORTOLAN, Erika/0000-0003-2287-9020; Funaro, Ada/0000-0001-6341-1817	Italian Ministry for University and Scientific Research [PRIN 2008]; University of Torino; Ricerca Sanitaria Finalizzata (Regione Piemonte); Italian Association for Cancer Research [MFAG 6312]; Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS); Ricerca Sanitaria Finalizzata	Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Torino; Ricerca Sanitaria Finalizzata (Regione Piemonte)(Regione Piemonte); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS); Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was supported by grants from the Italian Ministry for University and Scientific Research (PRIN 2008 to A. F.) and from the University of Torino (to A. F.), Ricerca Sanitaria Finalizzata (Regione Piemonte 2008-2009 to A. F.), and the Italian Association for Cancer Research (MFAG 6312 to E. O.). The Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS) provided financial and administrative assistance.; Supported by a Regione Piemonte fellowship (Ricerca Sanitaria Finalizzata 2009).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Deaglio S, 2002, BLOOD, V99, P2490, DOI 10.1182/blood.V99.7.2490; Ferrero E, 1999, J LEUKOCYTE BIOL, V65, P151, DOI 10.1002/jlb.65.2.151; Florey O, 2010, J IMMUNOL, V185, P1878, DOI 10.4049/jimmunol.1001305; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Funaro A, 2004, BLOOD, V104, P4269, DOI 10.1182/blood-2004-06-2129; FUNARO A, 1993, EUR J IMMUNOL, V23, P2407, DOI 10.1002/eji.1830231005; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Holleran BJ, 2003, J LEUKOCYTE BIOL, V73, P243, DOI 10.1189/jlb.0902439; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; JIANG YL, 1992, J IMMUNOL, V148, P2423; Kamei M, 2010, CURR OPIN HEMATOL, V17, P43, DOI 10.1097/MOH.0b013e3283333949; Korpos E, 2009, CURR PHARM DESIGN, V15, P1349, DOI 10.2174/138161209787846685; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; Leitinger B, 2002, J CELL SCI, V115, P963; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luzzatto L, 2006, CURR OPIN GENET DEV, V16, P317, DOI 10.1016/j.gde.2006.04.015; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Ortolan E, 2006, BLOOD, V108, P4214, DOI 10.1182/blood-2006-04-017160; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; RANDOLPH GJ, 1995, J IMMUNOL, V155, P3610; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SHEN JK, 1995, MICROVASC RES, V50, P360, DOI 10.1006/mvre.1995.1064; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sitrin RG, 2004, AM J RESP CELL MOL, V30, P233, DOI 10.1165/rcmb.2003-0079OC; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80	52	39	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18681	18691		10.1074/jbc.M111.227876	http://dx.doi.org/10.1074/jbc.M111.227876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478153	Green Published, hybrid			2022-12-27	WOS:000290785700041
J	Luo, QZ; Joubert, MK; Stevenson, R; Ketchem, RR; Narhi, LO; Wypych, J				Luo, Quanzhou; Joubert, Marisa K.; Stevenson, Riki; Ketchem, Randal R.; Narhi, Linda O.; Wypych, Jette			Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; MONOCLONAL-ANTIBODY; METHIONINE OXIDATION; MASS-SPECTROMETRY; DEAMIDATION; BINDING; FORMULATION; STABILITY; HISTIDINE; PEPTIDES	In this study, we characterized the chemical modifications in the monoclonal antibody (IgG(2)) aggregates generated under various conditions, including mechanical, chemical, and thermal stress treatment, to provide insight into the mechanism of protein aggregation and the types of aggregate produced by the different stresses. In a separate study, additional biophysical characterization was performed to arrange these aggregates into a classification system (Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., and Narhi, L. O. (2011) J. Biol. Chem. 286, 25118-25133). Here, we report that different aggregates possessed different types and levels of chemical modification. For chemically treated samples, metal-catalyzed oxidation using copper showed site-specific oxidation of Met(246), His(304), and His(427) in the Fc portion of the antibody, which might be attributed to a putative copper-binding site. For the hydrogen peroxide-treated sample, in contrast, four solvent-exposed Met residues in the Fc portion were completely oxidized. Met and/or Trp oxidation was observed in the mechanically stressed samples, which is in agreement with the proposed model of protein interaction at the air-liquid interface. Heat treatment resulted in significant deamidation but almost no oxidation, which is consistent with thermally induced aggregates being generated by a different pathway, primarily by perturbing conformational stability. These results demonstrate that chemical modifications are present in protein aggregates; furthermore, the type, locations, and severity of the modifications depend on the specific conditions that generated the aggregates.	[Luo, Quanzhou; Wypych, Jette] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA; [Joubert, Marisa K.; Stevenson, Riki; Narhi, Linda O.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen; Amgen	Luo, QZ (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA.	qluo@amgen.com; jwypych@amgen.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682				Baalp A., 2002, HYBRIDOMA HYBRIDOM, V21, P45; Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002; Bee JS, 2009, J PHARM SCI-US, V98, P3290, DOI 10.1002/jps.21707; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chi EY, 2003, PROTEIN SCI, V12, P903, DOI 10.1110/ps.0235703; Churnsae C, 2007, J CHROMATOGR B, V850, P285, DOI 10.1016/j.jchromb.2006.11.050; Cruickshank D. W., 1959, INT TABLES XRAY CRYS, V2, P331; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; GEIGER T, 1987, J BIOL CHEM, V262, P785; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hlavaty JJ, 1997, BIOCHEMISTRY-US, V36, P15514, DOI 10.1021/bi970574p; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; Ji JA, 2009, J PHARM SCI-US, V98, P4485, DOI 10.1002/jps.21746; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kerwin BA, 2008, J PHARM SCI-US, V97, P2924, DOI 10.1002/jps.21190; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; LI SH, 1995, BIOCHEMISTRY-US, V34, P5762, DOI 10.1021/bi00017a008; Lim J, 2003, ANAL CHEM, V75, P1164, DOI 10.1021/ac026206v; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Mahler HC, 2005, EUR J PHARM BIOPHARM, V59, P407, DOI 10.1016/j.ejpb.2004.12.004; MARIA CS, 1995, FEBS LETT, V374, P85; Men L, 2007, J PROTEOME RES, V6, P216, DOI 10.1021/pr0603809; Nonaka Y, 2008, PROTEINS, V72, P313, DOI 10.1002/prot.21927; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Ryan ME, 1996, CLIN PEDIATR, V35, P23, DOI 10.1177/000992289603500105; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schoneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Zhao F, 1997, J BIOL CHEM, V272, P9019; Zheng ZQ, 2004, ANAL CHEM, V76, P6374, DOI 10.1021/ac0491206	48	144	148	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25134	25144		10.1074/jbc.M110.160440	http://dx.doi.org/10.1074/jbc.M110.160440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21518762	Green Published, hybrid			2022-12-27	WOS:000292547900061
J	Ryu, JM; Han, HJ				Ryu, Jung Min; Han, Ho Jae			L-Threonine Regulates G(1)/S Phase Transition of Mouse Embryonic Stem Cells via PI3K/Akt, MAPKs, and mTORC Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; SIGNALING PATHWAYS; RAFT MICRODOMAINS; MAMMALIAN TARGET; HEPATOMA-CELLS; RAPAMYCIN; EXPRESSION; MEMBRANE; GROWTH; DIFFERENTIATION	Although amino acids can function as signaling molecules in the regulation of many cellular processes, mechanisms surrounding L-threonine involvement in embryonic stem cell (ESC) functions have not been explored. Thus, we investigated the effect of L-threonine on regulation of mouse (m) ESC self-renewal and related signaling pathways. In L-threonine-depleted mESC culture media mRNA of self-renewal marker genes, [H-3] thymidine incorporation, expression of c-Myc, Oct4, and cyclins protein was attenuated. In addition, resupplying L-threonine (500 mu M) after depletion restores/maintains the mESC proliferation. Disruption of the lipid raft/caveolae microdomain through treatment with methyl-beta-cyclodextrin or transfection with caveolin-1 specific small interfering RNA blocked L-threonine-induced proliferation of mESCs. Addition of L-threonine induced phosphorylation of Akt, ERK, p38, JNK/SAPK, and mTOR in a time-dependent manner. This activity was blocked by LY 294002 (PI3K inhibitor), wortmannin (PI3K inhibitor), or an Akt inhibitor. L-threonine-induced activation of mTOR, p70S6K, and 4E-BP1 as well as cyclins and Oct4 were blocked by PD 98059 (ERK inhibitor), SB 203580 (p38 inhibitor) or SP 600125 (JNK inhibitor). Furthermore, L-threonine induced phosphorylation of raptor and rictor binding to mTOR was completely inhibited by 24 h treatment with rapamycin (mTOR inhibitor); however, a 10 min treatment with rapamycin only partially inhibited rictor phosphorylation. L-Threonine induced translocation of rictor from the membrane to the cytosol/nuclear, which blocked by pretreatment with rapamycin. In addition, rapamycin blocked L-threonine-induced increases in mRNA expressions of trophoectoderm and mesoderm marker genes and mESC proliferation. In conclusion, L-threonine stimulated ESC G(1)/S transition through lipid raft/caveolae-dependent PI3K/Akt, MAPKs, mTOR, p70S6K, and 4E-BP1 signaling pathways.	[Ryu, Jung Min; Han, Ho Jae] Chonnam Natl Univ, Dept Vet Physiol, Coll Vet Med, Biotherapy Human Resources Ctr BK21, Kwangju 500757, South Korea	Chonnam National University	Han, HJ (corresponding author), Chonnam Natl Univ, Dept Vet Physiol, Coll Vet Med, Biotherapy Human Resources Ctr BK21, Kwangju 500757, South Korea.	hjhan@chonnam.ac.kr	Ryu, Jung Min/G-5233-2011; Han, Ho Jae/M-1476-2016	Han, Ho Jae/0000-0002-0657-1766; Ryu, Jung Min/0000-0002-2519-090X	Korean government (MEST) [2009-0081395, 2010-0020265]; Ministry of Education, Science and Technology, Republic of Korea	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation Grant funded by the Korean government (MEST No. 2009-0081395 and No. 2010-0020265), and graduate fellowship of the Brain Korea 21 project provided by the Ministry of Education, Science and Technology, Republic of Korea.	Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETT CM, 1993, PHARM RES-DORDR, V10, P423, DOI 10.1023/A:1018948608211; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gardner DK, 1998, THERIOGENOLOGY, V49, P83, DOI 10.1016/S0093-691X(97)00404-4; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kwak JO, 2005, J NEPHROL, V18, P681; Liu X, 2009, BIOCHEM BIOPH RES CO, V384, P530, DOI 10.1016/j.bbrc.2009.05.014; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; O'Kane RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1167, DOI 10.1152/ajpendo.00193.2003; Pantaleon M, 2008, BIOL REPROD, V78, P595, DOI 10.1095/biolreprod.107.062877; Que Jianwen, 2007, J Mol Signal, V2, P9, DOI 10.1186/1750-2187-2-9; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; van Sluijters DA, 2000, BIOCHEM J, V351, P545, DOI 10.1042/0264-6021:3510545; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	37	51	54	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23667	23678		10.1074/jbc.M110.216283	http://dx.doi.org/10.1074/jbc.M110.216283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21550972	Green Published, hybrid			2022-12-27	WOS:000292294900008
J	Gu, DM; Tonthat, NK; Lee, M; Ji, H; Bhat, KP; Hollingsworth, F; Aldape, KD; Schumacher, MA; Zwaka, TP; McCrea, PD				Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Ji, Hong; Bhat, Krishna P.; Hollingsworth, Faith; Aldape, Kenneth D.; Schumacher, Maria A.; Zwaka, Thomas P.; McCrea, Pierre D.			Caspase-3 Cleavage Links delta-Catenin to the Novel Nuclear Protein ZIFCAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; E-CADHERIN; CELL-ADHESION; DESMOSOMAL CADHERIN; SIGNALING PATHWAY; APOPTOSIS; CANCER; P120-CATENIN; PROTEOLYSIS; MECHANISMS	delta-Catenin is an Armadillo protein of the p120-catenin subfamily capable of modulating cadherin stability, small GTPase activity, and nuclear transcription. From yeast two-hybrid screening of a human embryonic stem cell cDNA library, we identified delta-catenin as a potential interacting partner of the caspase-3 protease, which plays essential roles in apoptotic as well as non-apoptotic processes. Interaction of delta-catenin with caspase-3 was confirmed using cleavage assays conducted in vitro, in Xenopus apoptotic extracts, and in cell line chemically induced contexts. The cleavage site, a highly conserved caspase consensus motif (DELD) within Armadillo repeat 6 of delta-catenin, was identified through peptide sequencing. Cleavage thus generates an amino-terminal (residues 1-816) and carboxyl-terminal (residues 817-1314) fragment, each containing about half of the central Armadillo domain. We found that cleavage of delta-catenin both abolishes its association with cadherins and impairs its ability to modulate small GTPases. Interestingly, 817-1314 possesses a conserved putative nuclear localization signal that may facilitate the nuclear targeting of delta-cateninin defined contexts. To probe for novel nuclear roles of delta-catenin, we performed yeast two-hybrid screening of a mouse brain cDNA library, resolving and then validating interaction with an uncharacterized KRAB family zinc finger protein, ZIFCAT. Our results indicate that ZIFCAT is nuclear and suggest that it may associate with DNA as a transcriptional repressor. We further determined that other p120 subfamily catenins are similarly cleaved by caspase-3 and likewise bind ZIFCAT. Our findings potentially reveal a simple yet novel signaling pathway based upon caspase-3 cleavage of p120-catenin subfamily members, facilitating the coordinate modulation of cadherins, small GTPases, and nuclear functions.	[Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Schumacher, Maria A.; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Ji, Hong; Schumacher, Maria A.; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bhat, Krishna P.; Hollingsworth, Faith; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zwaka, Thomas P.] Dept Mol & Cellular Biol, Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	McCrea, PD (corresponding author), Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Gu, Dongmin/C-9048-2013		National Institutes of Health [RO1 GM52112]; National Institutes of Health, NCI [CA-16672]; Texas ARP Grant; March of Dimes [1-FY-07-461-01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112, R01GM077442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Texas ARP Grant; March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM52112 (to P. D. M.), and assistance with DNA sequencing and other core facilities was provided by National Institutes of Health, NCI, Core Grant CA-16672 (to M. D. Anderson Cancer Center). This work was also supported by a Texas ARP Grant and March of Dimes Grant 1-FY-07-461-01 (to P. D. M.).	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; DAVIDOFF AN, 1992, LEUKEMIA RES, V16, P1077, DOI 10.1016/0145-2126(92)90046-A; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; FISHMAN JA, 1985, AM J PATHOL, V118, P398; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Hunter I, 2001, J BONE MINER RES, V16, P466, DOI 10.1359/jbmr.2001.16.3.466; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kessler T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-15; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kornbluth S., 2001, CURRENT PROTOCOLS CE; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lu JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-304; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McCusker Catherine D, 2009, Commun Integr Biol, V2, P155; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Solary E, 1998, CELL BIOL TOXICOL, V14, P121, DOI 10.1023/A:1007481921502; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Suzanne Magali, 2009, Journal of Biology (London), V8, P49, DOI 10.1186/jbiol152; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Weiske J, 2004, METH MOL B, V289, P175; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	68	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23178	23188		10.1074/jbc.M110.167544	http://dx.doi.org/10.1074/jbc.M110.167544			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561870	hybrid, Green Published			2022-12-27	WOS:000292025000052
J	Gutsch, R; Kandemir, JD; Pietsch, D; Cappello, C; Meyer, J; Simanowski, K; Huber, R; Brand, K				Gutsch, Romina; Kandemir, Judith D.; Pietsch, Daniel; Cappello, Christian; Meyer, Johann; Simanowski, Kathrin; Huber, Rene; Brand, Korbinian			CCAAT/Enhancer-binding Protein beta Inhibits Proliferation in Monocytic Cells by Affecting the Retinoblastoma Protein/E2F/Cyclin E Pathway but Is Not Directly Required for Macrophage Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; C/EBP-BETA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; TRANSLATIONAL CONTROL; FAMILY-MEMBERS; TOLERANT CELLS; DEFICIENT MICE; GROWTH ARREST; C-MYC	Monocytic differentiation is orchestrated by complex networks that are not fully understood. This study further elucidates the involvement of transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta). Initially, we demonstrated a marked increase in nuclear C/EBP beta-liver-enriched activating protein* (LAP*)/liver-enriched activating protein (LAP) levels and LAP/liver- enriched inhibiting protein (LIP) ratios in phorbol 12-myristate 13-acetate (PMA)-treated differentiating THP-1 premonocytic cells accompanied by reduced proliferation. To directly study C/EBP beta effects on monocytic cells, we generated novel THP-1-derived (low endogenous C/EBP beta) cell lines stably overexpressing C/EBP beta isoforms. Most importantly, cells predominantly overexpressing LAP* (C/EBP beta-long), but not those overexpressing LIP (C/EBP beta-short), exhibited a reduced proliferation, with no effect on morphology. PMA-induced inhibition of proliferation was attenuated in C/EBP beta-short cells. In C/EBP beta(WT) macrophage-like cells (high endogenous C/EBP beta), we measured a reduced proliferation/cycling index compared with C/EBP beta(KO). The typical macrophage morphology was only observed in C/EBP beta(WT), whereas C/EBP beta(KO) stayed round. C/EBP beta alpha did not compensate for C/EBP beta effects on proliferation/morphology. Serum reduction, an independent approach known to inhibit proliferation, induced macrophage morphology in C/EBP beta(KO) macrophage-like cells but not THP-1. In PMA-treated THP-1 and C/EBP beta-long cells, a reduced phosphorylation of cell cycle repressor retinoblastoma was found. In addition, C/EBP beta-long cells showed reduced c-Myc expression accompanied by increased CDK inhibitor p27 and reduced cyclin D1 levels. Finally, C/EBP beta-long and C/EBP beta(WT) cells exhibited low E2F1 and cyclin E levels, and C/EBP beta overexpression was found to inhibit cyclin E1 promoter-dependent transcription. Our results suggest that C/EBP beta reduces monocytic proliferation by affecting the retinoblastoma/E2F/cyclin E pathway and that it may contribute to, but is not directly required for, macrophage morphology. Inhibition of proliferation by C/EBP beta may be important for coordinated monocytic differentiation.	[Gutsch, Romina; Kandemir, Judith D.; Pietsch, Daniel; Cappello, Christian; Simanowski, Kathrin; Huber, Rene; Brand, Korbinian] Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Huber, R (corresponding author), Hannover Med Sch, Inst Clin Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	huber.rene@mh-hannover.de; brand.korbinian@mh-hannover.de		Huber, Rene/0000-0002-1041-9935	Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin	Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin	This work was supported by the Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin.	Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bergh G, 1999, BLOOD, V94, P1971; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cappello C, 2009, CELL SIGNAL, V21, P1918, DOI 10.1016/j.cellsig.2009.08.009; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen S, 2009, LEUKEMIA RES, V33, P1108, DOI 10.1016/j.leukres.2008.10.016; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gagliardi M, 2003, J BIOL CHEM, V278, P43846, DOI 10.1074/jbc.M304085200; Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Huber R, 2003, Z RHEUMATOL, V62, P378, DOI 10.1007/S00393-003-0472-4; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Li-Weber M, 2001, EUR J IMMUNOL, V31, P3694, DOI 10.1002/1521-4141(200112)31:12<3694::AID-IMMU3694>3.0.CO;2-S; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Matsushita H, 2008, ONCOGENE, V27, P6749, DOI 10.1038/onc.2008.285; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park MH, 2008, FEBS LETT, V582, P415, DOI 10.1016/j.febslet.2008.01.001; Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200; Prosch S, 2001, J BIOL CHEM, V276, P40712, DOI 10.1074/jbc.M009815200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; RAMP U, 1990, VIRCHOWS ARCH B, V59, P271, DOI 10.1007/BF02899414; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Screpanti I, 1996, J EXP MED, V184, P1561, DOI 10.1084/jem.184.4.1561; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Studzinski GP, 1997, EXP CELL RES, V232, P376, DOI 10.1006/excr.1997.3484; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tissieres P, 2009, J BIOL CHEM, V284, P26261, DOI 10.1074/jbc.M109.042580; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Weber M, 2003, J BIOL CHEM, V278, P23586, DOI 10.1074/jbc.M211646200; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Zahnow CA, 2001, CANCER RES, V61, P261; Zhu SY, 1999, MOL CELL BIOL, V19, P7181; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	60	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22716	22729		10.1074/jbc.M110.152538	http://dx.doi.org/10.1074/jbc.M110.152538			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558273	Green Published, hybrid			2022-12-27	WOS:000292025000006
J	Lin, ZH; Jin, S; Duan, XH; Wang, T; Martini, S; Hulamm, P; Cha, BY; Hubbard, A; Donowitz, M; Guggino, SE				Lin, Zhihong; Jin, Shi; Duan, Xiaohong; Wang, Tong; Martini, Sabrina; Hulamm, Phuson; Cha, Boyoung; Hubbard, Ann; Donowitz, Mark; Guggino, Sandra E.			Chloride Channel (Clc)-5 Is Necessary for Exocytic Trafficking of Na+/H+ Exchanger 3 (NHE3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOSOMAL CLC PROTEINS; KNOCKOUT MOUSE MODEL; DENTS-DISEASE; PROXIMAL TUBULE; BRUSH-BORDER; IMPAIRS ENDOCYTOSIS; REGULATORY PROTEIN; NULL MICE; KIDNEY; INHIBITION	ClC-5, a chloride/proton exchanger, is predominantly expressed and localized in subapical endosomes of the renal proximal tubule. Mutations of the CLCN5 gene cause Dent disease. The symptoms of Dent disease are replicated in Clcn5 knockout mice. Absence of ClC-5 in mice is associated with reduced surface expression of NHE3 in proximal tubules. The molecular basis for this change is not fully understood. In this study, we investigated the mechanisms by which ClC-5 regulates trafficking of NHE3. Whether ClC-5-dependent endocytosis, exocytosis, or both contributed to the altered distribution of NHE3 was examined. First, NHE3 activity in proximal tubules of wild type (WT) and Clcn5 KO mice was determined by two-photon microscopy. Basal and dexamethasone-stimulated NHE3 activity of Clcn5 KO mice was decreased compared with that seen in WT mice, whereas the degree of inhibition of NHE3 activity by increasing cellular concentration of cAMP (forskolin) or Ca2+ (A23187) was not different in WT and Clcn5 KO mice. Second, NHE3-dependent absorption of HCO3-, measured by single tubule perfusion, was reduced in proximal tubules of Clcn5 KO mice. Third, by cell surface biotinylation, trafficking of NHE3 was examined in short hairpin RNA (shRNA) plasmid-transfected opossum kidney cells. Surface NHE3 was reduced in opossum kidney cells with reduced expression of ClC-5, whereas the total protein level of NHE3 did not change. Parathyroid hormone decreased NHE3 surface expression, but the extent of decrease and the rate of endocytosis observed in both scrambled and ClC-5 knockdown cells were not significantly different. However, the rates of basal and dexamethasone-stimulated exocytosis of NHE3 were attenuated in ClC-5 knockdown cells. These results show that ClC-5 plays an essential role in exocytosis of NHE3.	[Lin, Zhihong; Jin, Shi; Duan, Xiaohong; Martini, Sabrina; Hulamm, Phuson; Cha, Boyoung; Donowitz, Mark; Guggino, Sandra E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Donowitz, Mark; Guggino, Sandra E.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hubbard, Ann] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Wang, Tong] Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06520 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Yale University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu		Jin, Shi/0000-0003-0177-5716	National Institutes of Health [PO1 DK72084, RO1 DK26523, RO1 DK61765, R24 DK64388, P30 DK079310]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Technologico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, R24DK064388, P30DK079310, P01DK072084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Technologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 DK72084, RO1 DK26523, RO1 DK61765, R24 DK64388, and P30 DK079310.; Supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Technologico. Present address: Inst. de Biophysica Carlos Chagas, University Federal do Rio De Janeiro, Rio De Janeiro, Brazil 21941.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; Bacic D, 2003, PFLUG ARCH EUR J PHY, V446, P475, DOI 10.1007/s00424-003-1057-4; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Cebotaru V, 2005, KIDNEY INT, V68, P642, DOI 10.1111/j.1523-1755.2005.00442.x; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; DENT CE, 1964, ARCH DIS CHILD, V39, P240, DOI 10.1136/adc.39.205.240; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; Devuyst Olivier, 2005, Nephron Physiology, V99, P69; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; FISHER SE, 1994, HUM MOL GENET, V3, P2053; Guggino SE, 2007, NAT CLIN PRACT NEPHR, V3, P449, DOI 10.1038/ncpneph0541; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; JENTSCH TJ, 1993, ANN NY ACAD SCI, V707, P285, DOI 10.1111/j.1749-6632.1993.tb38059.x; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Ludwig M, 2006, NEPHROL DIAL TRANSPL, V21, P2708, DOI 10.1093/ndt/gfl346; Luyckx VA, 1998, AM J PHYSIOL-RENAL, V275, pF761, DOI 10.1152/ajprenal.1998.275.5.F761; McDonough AA, 2003, CURR OPIN NEPHROL HY, V12, P533, DOI 10.1097/00041552-200309000-00009; Moulin P, 2003, KIDNEY INT, V63, P1285, DOI 10.1046/j.1523-1755.2003.00851.x; MURER H, 1992, J AM SOC NEPHROL, V2, P1649; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; POOK MA, 1993, HUM MOL GENET, V2, P2129, DOI 10.1093/hmg/2.12.2129; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Silva IV, 2003, J BONE MINER RES, V18, P615, DOI 10.1359/jbmr.2003.18.4.615; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Wang YH, 2005, AM J PHYSIOL-RENAL, V289, pF850, DOI 10.1152/ajprenal.00011.2005; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	49	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22833	22845		10.1074/jbc.M111.224998	http://dx.doi.org/10.1074/jbc.M111.224998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561868	Green Published, hybrid			2022-12-27	WOS:000292025000018
J	Rodriguez, M; Cabal-Hierro, L; Carcedo, MT; Iglesias, JM; Artime, N; Darnay, BG; Lazo, PS				Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Darnay, Bryant G.; Lazo, Pedro S.			NF-kappa B Signal Triggering and Termination by Tumor Necrosis Factor Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; TNF RECEPTOR-2; TRAF2; ACTIVATION; KINASE; DEGRADATION; COMPLEX; P80; UBIQUITINATION	Tumor necrosis factor receptor 2 (TNFR2) activates transcription factor kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK). The mechanisms mediating these activations are dependent on the recruitment of TNF receptor-associated factor 2 (TRAF2) to the intracellular region of the receptor. TNFR2 also induces TRAF2 degradation. We show that in addition to the well characterized TRAF2 binding motif 402-SKEE-405, the human receptor contains another sequence located at the C-terminal end (amino acids 425-439), which also recruits TRAF2 and activates NF-kappa B. In addition to that, human TNFR2 contains a conserved region (amino acids 338-379) which is responsible for TRAF2 degradation and therefore of terminating NF-kappa B signaling. TRAF2 degradation and the lack of NF-kappa B activation when both TNFR1 and TNFR2 are co-expressed results in an enhanced ability of TNFR1 to induce cell death, showing that the cross-talk between both receptors is of a great biological relevance. Induction of TRAF2 degradation appears to be independent of TRAF2 binding to the receptor. Amino acids 343-TGSSDSS-349 are essential for inducing TRAF2 degradation because deletion mutants of this region or point mutations at serine residues 345 and 346 or 348 and 349 obliterate the ability of TNFR2 to induce TRAF2 degradation.	[Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Lazo, Pedro S.] Univ Oviedo, Dept Bioquim & Biol Mol, E-33071 Oviedo, Spain; [Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Lazo, Pedro S.] Univ Oviedo, IUOPA, E-33071 Oviedo, Spain; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Texas System; UTMD Anderson Cancer Center	Lazo, PS (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33071 Oviedo, Spain.	pslazo@uniovi.es	Lazo, Pranvera/I-5299-2019; Cabal-Hierro, Lucía/AAB-4119-2019; Lazo, Pedro/C-4087-2008	Lazo, Pranvera/0000-0002-7202-4058; Cabal-Hierro, Lucía/0000-0003-3552-2215; Lazo, Pedro/0000-0002-1278-6878	Spanish Ministry of Science and Technology (MICINN) [SAF2009-07227]; Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI) [IB09-066]; Obra Social Cajastur; Spanish Ministry of Education; PCTI	Spanish Ministry of Science and Technology (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI); Obra Social Cajastur; Spanish Ministry of Education(Spanish Government); PCTI	This work was supported by Grant SAF2009-07227 from the Spanish Ministry of Science and Technology (MICINN) and by Grant IB09-066 from the Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI). The IUOPA is supported by Obra Social Cajastur.; Recipient of a fellowship from the Spanish Ministry of Education.; Recipients of fellowships from the PCTI.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Darnay BG, 1997, FEBS LETT, V406, P101, DOI 10.1016/S0014-5793(97)00251-2; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; ESPEVIK T, 1990, SCAND J CLIN LAB INV, V50, P160; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grech AP, 2005, J BIOL CHEM, V280, P31572, DOI 10.1074/jbc.M504849200; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; PENNICA D, 1993, BIOCHEMISTRY-US, V32, P3131, DOI 10.1021/bi00063a027; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Weiss T, 1997, J IMMUNOL, V158, P2398; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e	39	42	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22814	22824		10.1074/jbc.M111.225631	http://dx.doi.org/10.1074/jbc.M111.225631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558270	hybrid, Green Published			2022-12-27	WOS:000292025000016
J	Allen, MJ; Gemel, J; Beyer, EC; Lal, R				Allen, Michael J.; Gemel, Joanna; Beyer, Eric C.; Lal, Ratnesh			Atomic Force Microscopy of Connexin40 Gap Junction Hemichannels Reveals Calcium-dependent Three-dimensional Molecular Topography and Open-Closed Conformations of Both the Extracellular and Cytoplasmic Faces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNELS; SURFACE; CX43	Atomic force microscopy was used to study the three-dimensional molecular topography and calcium-sensitive conformational changes of Connexin40 hemichannels (connexons) reconstituted in 1,2-dioeloyl-sn-glycero-3-phosphatidylcholine lipid bilayers. Two classes of objects were observed that differed in their protrusion heights above the bilayer (2.6 versus 4.2 nm). Comparison to reconstituted connexons containing Connexin40 truncated to eliminate most of its C-terminal cytoplasmic domain showed that the two height classes corresponded to the shorter extracellular and taller cytoplasmic aspects of the hemichannels and that the C-terminal tail of Connexin40 contributes similar to 1.6nm in thickness. Hemichannels imaged in solutions containing < 10 mu M Ca2+ showed 3.1-3.2 nm depressions (openings) in 30% of the cytoplasmic faces and 65% of the extracellular faces, and high-resolution three-dimensional topography of extracellular or cytoplasmic aspects of some connexons was observed. After addition of 3.6 mM Ca2+, > 75% of the connexons in either orientation adopted closed conformations. In contrast, hemichannels imaged in the presence of 0.1mM EDTA showed large (5.6- to 5.8-nm diameter) openings in nearly all hemichannels regardless of orientation, and detailed topography was visible in many connexons. Real-time imaging following the addition of 3.6 mM Ca2+ showed transitions of both extracellular and cytoplasmic orientations from "open" into "closed" conformations within several minutes. These studies provide the first high-resolution topographic information regarding a connexin with a large cytoplasmic domain and suggest that the extramembranous portions of Connexin40 contribute to a channel entrance that is relaxed by chelation of residual divalent cations.	[Gemel, Joanna; Beyer, Eric C.] Univ Chicago, Dept Pediat, Hematol Oncol Sect, Chicago, IL 60637 USA; [Allen, Michael J.] Univ Chicago, Dept Med, Ctr Nanomed, Sect Pulm Crit Care, Chicago, IL 60637 USA; [Lal, Ratnesh] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Lal, Ratnesh] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Chicago; University of Chicago; University of California System; University of California San Diego; University of California System; University of California San Diego	Beyer, EC (corresponding author), Univ Chicago, Dept Pediat, Hematol Oncol Sect, KCBD 5152,900 E 57th St, Chicago, IL 60637 USA.	ecbeyer@uchicago.edu	Beyer, Eric/V-1317-2019; Lal, Ratnesh/AAG-5424-2019	Beyer, Eric/0000-0001-8044-1356; 	National Institutes of Health [HL59199, NS067247, DA024871, DA025296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024871, R01DA025296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL59199 (to E. C. B.), NS067247 (to M. J. A.), and DA024871 and DA025296 (to R. L.).	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Bao XY, 2005, J BIOL CHEM, V280, P8647, DOI 10.1074/jbc.M413536200; Berthoud VM, 2001, EUR J CELL BIOL, V80, P11, DOI 10.1078/0171-9335-00132; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Gemel J, 2004, J CELL SCI, V117, P2469, DOI 10.1242/jcs.01084; Gemel J, 2008, BIOCHEM BIOPH RES CO, V369, P388, DOI 10.1016/j.bbrc.2008.02.040; Gemel J, 2006, J CELL SCI, V119, P2258, DOI 10.1242/jcs.02953; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968, DOI 10.1152/ajpcell.1995.268.4.C968; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Liu F, 2006, J BIOL CHEM, V281, P23207, DOI 10.1074/jbc.M605048200; LOEWENST.WR, 1966, ANN NY ACAD SCI, V137, P441, DOI 10.1111/j.1749-6632.1966.tb50175.x; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MANJUNATH CK, 1985, AM J PHYSIOL, V248, pH783, DOI 10.1152/ajpheart.1985.248.6.H783; MANJUNATH CK, 1984, AM J PHYSIOL, V246, pH865, DOI 10.1152/ajpheart.1984.246.6.H865; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Pfahnl A, 1999, PFLUG ARCH EUR J PHY, V437, P345, DOI 10.1007/s004240050788; Puljung MC, 2004, J GEN PHYSIOL, V124, P587, DOI 10.1085/jgp.200409023; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Unger VM, 1999, J STRUCT BIOL, V128, P98, DOI 10.1006/jsbi.1999.4184; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; Wang M, 2007, J CELL SCI, V120, P320, DOI 10.1242/jcs.03343	31	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22139	22146		10.1074/jbc.M111.240002	http://dx.doi.org/10.1074/jbc.M111.240002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543330	Green Published, hybrid			2022-12-27	WOS:000291719900020
J	Beuster, G; Zarse, K; Kaleta, C; Thierbach, R; Kiehntopf, M; Steinberg, P; Schuster, S; Ristow, M				Beuster, Gregor; Zarse, Kim; Kaleta, Christoph; Thierbach, Rene; Kiehntopf, Michael; Steinberg, Pablo; Schuster, Stefan; Ristow, Michael			Inhibition of Alanine Aminotransferase in Silico and in Vivo Promotes Mitochondrial Metabolism to Impair Malignant Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; GLUTAMINE-METABOLISM; OXIDATIVE-METABOLISM; GLUCOSE-METABOLISM; TUMOR-CELLS; SWEET TOOTH; DICHLOROACETATE; VITRO; 2-DEOXY-D-GLUCOSE; NEUROBLASTOMA	Cancer cells commonly exhibit increased nonoxidative D-glucose metabolism whereas induction of mitochondrial metabolism may impair malignant growth. We have first used an in silico method called elementary mode analysis to identify inhibition of ALAT (L-alanine aminotransferase) as a putative target to promote mitochondrial metabolism. We then experimentally show that two competitive inhibitors of ALAT, L-cycloserine and beta-chloro-L-alanine, inhibit L-alanine production and impair D-glucose uptake of LLC1 Lewis lung carcinoma cells. The latter inhibition is linked to an initial energy deficit, as quantified by decreased ATP content, which is then followed by an activation of AMP-activated protein kinase and subsequently increased respiration rates and mitochondrial production of reactive oxygen species, culminating in ATP replenishment in ALAT-inhibited LLC1 cells. Moreover, we observe altered phosphorylation of p38 MAPK (mitogen-activated protein kinase 14), ERK (extracellular signal-regulated kinase 1/2), and Rb1 (retinoblastoma 1) proteins, as well as decreased expression of Cdc25a (cell decision cycle 25 homolog A) and Cdk4 (cyclin-dependent kinase 4). Importantly, these sequelae of ALAT inhibition culminate in similarly reduced anchorage-dependent and anchorage-independent growth rates of LLC1 cells, together suggesting that inhibition of ALAT efficiently impairs cancer growth by counteracting the Warburg effect due to compensatory activation of mitochondrial metabolism.	[Beuster, Gregor; Zarse, Kim; Ristow, Michael] Univ Jena, Inst Nutr, Dept Human Nutr, D-07743 Jena, Germany; [Ristow, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Nuthetal, Germany; [Kaleta, Christoph; Schuster, Stefan] Univ Jena, Sch Biol & Pharmaceut, Dept Bioinformat, D-07743 Jena, Germany; [Thierbach, Rene; Steinberg, Pablo] Univ Vet Med Hannover, Dept Food Toxicol & Complementary Methods Anim Te, D-30173 Hannover, Germany; [Kiehntopf, Michael] Univ Jena, Inst Clin Chem & Lab Med, D-07743 Jena, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Friedrich Schiller University of Jena; University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Ristow, M (corresponding author), Univ Jena, Inst Nutr, Dept Human Nutr, D-07743 Jena, Germany.	mristow@mristow.org	Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Kaleta, Christoph/0000-0001-8004-9514	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [0315581]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work is part of the research program of the Jena Centre for Systems Biology of Ageing, JenAge, funded by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) Grant 0315581.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; CAY O, 1992, CANCER RES, V52, P5794; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Cinatl J, 1999, ANTICANCER RES, V19, P5349; CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DROGE W, 1986, J IMMUNOL, V137, P1383; Fruman David A, 2008, Biochem J, V412, pe3, DOI 10.1042/BJ20080823; GOLICHOWSKI A, 1978, ARCH BIOCHEM BIOPHYS, V189, P109, DOI 10.1016/0003-9861(78)90122-4; GOODGAME JT, 1978, CANCER, V42, P800, DOI 10.1002/1097-0142(197808)42:2<800::AID-CNCR2820420253>3.0.CO;2-O; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLM E, 1995, CANCER RES, V55, P1373; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; LASKE R, 1989, ARCH PHARM, V322, P857, DOI 10.1002/ardp.19893221205; MANNING JM, 1974, P NATL ACAD SCI USA, V71, P417, DOI 10.1073/pnas.71.2.417; MARQUEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P667, DOI 10.1016/0003-9861(89)90335-4; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Neermann J, 1996, J CELL PHYSIOL, V166, P152; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; Semenza G L, 2001, Novartis Found Symp, V240, P251; STACPOOLE PW, 1992, DIABETES CARE, V15, P785, DOI 10.2337/diacare.15.6.785; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sweetman L, 1991, TECHNIQUES DIAGNOSTI, P143; Thierbach R, 2009, ANAL BIOCHEM, V387, P318, DOI 10.1016/j.ab.2009.01.029; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Zhu ZJ, 2005, CANCER RES, V65, P7023, DOI 10.1158/0008-5472.CAN-05-0453; Ziegler A, 2001, CANCER RES, V61, P5595; Zimmermann S, 2008, HORM METAB RES, V40, P29, DOI 10.1055/s-2007-1004542	45	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22323	22330		10.1074/jbc.M110.205229	http://dx.doi.org/10.1074/jbc.M110.205229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540181	hybrid, Green Published			2022-12-27	WOS:000291719900041
J	Stepanek, O; Kalina, T; Draber, P; Skopcova, T; Svojgr, K; Angelisova, P; Horejsi, V; Weiss, A; Brdicka, T				Stepanek, Ondrej; Kalina, Tomas; Draber, Peter; Skopcova, Tereza; Svojgr, Karel; Angelisova, Pavla; Horejsi, Vaclav; Weiss, Arthur; Brdicka, Tomas			Regulation of Src Family Kinases Involved in T Cell Receptor Signaling by Protein-tyrosine Phosphatase CD148	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; ANTIGEN RECEPTOR; MOLECULAR-CLONING; IMMUNE CELLS; IN-VITRO; CD45; ACTIVATION; EXPRESSION; DEP-1; PHOSPHORYLATION	CD148 is a receptor-like protein-tyrosine phosphatase known to inhibit transduction of mitogenic signals in non-hematopoietic cells. Similarly, in the hematopoietic lineage, CD148 inhibited signal transduction downstream of T cell receptor. However, it also augmented immunoreceptor signaling in B cells and macrophages via dephosphorylating C-terminal tyrosine of Src family kinases (SFK). Accordingly, endogenous CD148 compensated for the loss of the main SFK activator CD45 in murine B cells and macrophages but not in T cells. Hypothetical explanations for the difference between T cells and other leukocyte lineages include the inability of CD148 to dephosphorylate a specific set of SFKs involved in T cell activation or the lack of CD148 expression during critical stages of T cell development. Here we describe striking differences in CD148 expression between human and murine thymocyte subsets, the only unifying feature being the absence of CD148 during the positive selection when the major developmental block occurs under CD45 deficiency. Moreover, we demonstrate that similar to CD45, CD148 has both activating and inhibitory effects on the SFKs involved in TCR signaling. However, in the absence of CD45, activating effects prevail, resulting in functional complementation of CD45 deficiency in human T cell lines. Importantly, this is independent of the tyrosines in the CD148 C-terminal tail, contradicting the recently proposed phosphotyrosine displacement model as a mechanism of SFK activation by CD148. Collectively, our data suggest that differential effects of CD148 in T cells and other leukocyte subsets cannot be explained by the CD148 inability to activate T cell SFKs but rather by its dual inhibitory/activatory function and specific expression pattern.	[Stepanek, Ondrej; Draber, Peter; Skopcova, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Kalina, Tomas; Svojgr, Karel] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague 15006, Czech Republic; [Kalina, Tomas; Svojgr, Karel] Charles Univ Prague, Fac Med 2, Childhood Leukemia Invest Prague, Prague 15006, Czech Republic; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brdicka, T (corresponding author), Inst Mol Genet ASCR, Videnska 1083, Prague 14220, Czech Republic.	tomas.brdicka@img.cas.cz	Brdicka, Tomas/G-6205-2014; Horejsi, Vaclav/G-3113-2014; Stepanek, Ondrej/F-8882-2013; Stepanek, Ondrej/AAG-3180-2020; Angelisova, Pavla/G-3131-2014; Kalina, Tomas/AAE-5036-2019; Draber, Peter/G-3141-2014; Kalina, Tomas/AAC-6655-2019; Kalina, Tomas/C-1078-2009	Brdicka, Tomas/0000-0002-1560-4398; Horejsi, Vaclav/0000-0003-4925-0142; Stepanek, Ondrej/0000-0002-2735-3311; Stepanek, Ondrej/0000-0002-2735-3311; Kalina, Tomas/0000-0003-4475-2872; Draber, Peter/0000-0001-8658-4614; Kalina, Tomas/0000-0003-4475-2872	National Institutes of Health [AI066120]; National Program of Research II Project [2B06064]; Ministry of Education, Youth, and Sports of the Czech Republic [1M0506]; Faculty of Science, Charles University, Prague; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Program of Research II Project; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University, Prague; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066120. This work was also supported by National Program of Research II Project 2B06064 and Center of Molecular and Cellular Immunology Project 1M0506 from Ministry of Education, Youth, and Sports of the Czech Republic.; Ph.D. students supported in part by the Faculty of Science, Charles University, Prague.	Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; Ellison S, 2010, J THROMB HAEMOST, V8, P1575, DOI 10.1111/j.1538-7836.2010.03865.x; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HONDA H, 1994, BLOOD, V84, P4186, DOI 10.1182/blood.V84.12.4186.bloodjournal84124186; Keane MM, 1996, CANCER RES, V56, P4236; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kung C, 2000, NAT MED, V6, P343; Kuramochi S, 1996, FEBS LETT, V378, P7, DOI 10.1016/0014-5793(95)01415-2; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Palou E, 1997, IMMUNOL LETT, V57, P101, DOI 10.1016/S0165-2478(97)00069-2; PATEL DD, 1995, LEUKOCYTE TYPING, V5, P1725; PEYRON JF, 1991, INT IMMUNOL, V3, P1357, DOI 10.1093/intimm/3.12.1357; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Schabath R, 2003, BEST PRACT RES CL HA, V16, P613, DOI 10.1016/S1521-6926(03)00087-2; SCHRAVEN B, 1997, LEUCOCYTE TYPING, V6, P576; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; STAUDER R, 1995, LEUKOCYTE TYPING, V5, P1719; Tangye SG, 1998, J IMMUNOL, V161, P3249; Tangye SG, 1998, J IMMUNOL, V161, P3803; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wuchter C, 2002, BLOOD, V99, P4109, DOI 10.1182/blood.V99.11.4109; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	51	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22101	22112		10.1074/jbc.M110.196733	http://dx.doi.org/10.1074/jbc.M110.196733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543337	Green Published, hybrid			2022-12-27	WOS:000291719900016
J	Adler, LN; Gomez, TA; Clarke, SG; Linster, CL				Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.			A Novel GDP-D-glucose Phosphorylase Involved in Quality Control of the Nucleoside Diphosphate Sugar Pool in Caenorhabditis elegans and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GALACTOSE PHOSPHORYLASE; ASCORBATE BIOSYNTHESIS; VITAMIN-C; L-2-HYDROXYGLUTARIC ACIDURIA; MANNOSE PYROPHOSPHORYLASE; EXPRESSION; PURIFICATION; MANNAN; GUANYLTRANSFERASE; GLUCOMANNAN	The plant VTC2 gene encodes GDP-L-galactose phosphorylase, a rate-limiting enzyme in plant vitamin C biosynthesis. Genes encoding apparent orthologs of VTC2 exist in both mammals, which produce vitamin C by a distinct metabolic pathway, and in the nematode worm Caenorhabditis elegans where vitamin C biosynthesis has not been demonstrated. We have now expressed cDNAs of the human and worm VTC2 homolog genes (C15orf58 and C10F3.4, respectively) and found that the purified proteins also display GDP-hexose phosphorylase activity. However, as opposed to the plant enzyme, the major reaction catalyzed by these enzymes is the phosphorolysis of GDP-D-glucose to GDP and D-glucose 1-phosphate. We detected activities with similar substrate specificity in worm and mouse tissue extracts. The highest expression of GDP-D-glucose phosphorylase was found in the nervous and male reproductive systems. A C. elegans C10F3.4 deletion strain was found to totally lack GDP-D-glucose phosphorylase activity; this activity was also found to be decreased in human HEK293T cells transfected with siRNAs against the human C15orf58 gene. These observations confirm the identification of the worm C10F3.4 and the human C15orf58 gene expression products as the GDP-D-glucose phosphorylases of these organisms. Significantly, we found an accumulation of GDP-D-glucose in the C10F3.4 mutant worms, suggesting that the GDP-D-glucose phosphorylase may function to remove GDP-D-glucose formed by GDP-D-mannose pyrophosphorylase, an enzyme that has previously been shown to lack specificity for its physiological D-mannose 1-phosphate substrate. We propose that such removal may prevent the misincorporation of glucosyl residues for mannosyl residues into the glycoconjugates of worms and mammals.	[Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Linster, Carole L.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universite Catholique Louvain	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu; carole.linster@uclouvain.be		Linster, Carole/0000-0001-7143-0719	National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; UCLA; Fonds de la Recherche Scientifique (FNRS); European Union [FP7/2007-2013, 276814]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 and AG032303 (to S. G. C.). This work was also supported by a Senior Scholar in Aging Award from the Ellison Medical Foundation (to S. G. C.).; Supported by a UCLA Philip Whitcome Fellowship.; Supported by the Fonds de la Recherche Scientifique (FNRS) and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 276814. To whom correspondence may be addressed: de Duve Inst., Universite catholique de Louvain, BCHM 7539, Ave. Hippocrate 75, B-1200 Brussels, Belgium. Tel.: 32-2-7647561; Fax: 32-2-7647598; E-mail: carole.linster@uclouvain.be.	BARBER GA, 1985, FEBS LETT, V183, P129, DOI 10.1016/0014-5793(85)80969-8; BEHRENS NH, 1968, J BIOL CHEM, V243, P502; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; BRENNER C, 2007, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.00020545; BRENNER S, 1974, GENETICS, V77, P71; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; CARLSON DM, 1962, J BIOL CHEM, V237, P1260; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ELBEIN AD, 1969, J BIOL CHEM, V244, P1608; Guranowski A, 2010, FEBS LETT, V584, P93, DOI 10.1016/j.febslet.2009.11.003; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; MASSIE HR, 1991, EXP GERONTOL, V26, P487, DOI 10.1016/0531-5565(91)90037-M; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; Nihira T, 2007, ANAL BIOCHEM, V371, P259, DOI 10.1016/j.ab.2007.07.012; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; PIRO G, 1993, PLANTA, V190, P206, DOI 10.1007/BF00196613; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; SMITH MM, 1976, BIOCHIMIE, V58, P1195, DOI 10.1016/S0300-9084(76)80119-8; SMOOT JW, 1985, EUR J BIOCHEM, V148, P83, DOI 10.1111/j.1432-1033.1985.tb08810.x; SPIRO MJ, 1984, DIABETOLOGIA, V26, P70; Struwe WB, 2010, METHOD ENZYMOL, V480, P477, DOI 10.1016/S0076-6879(10)80021-7; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SZUMILO T, 1993, J BIOL CHEM, V268, P17943; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; VARKI A, 2009, ESSENTIALS GLYCOBIOL, P50; VERACHTERT H, 1966, J BIOL CHEM, V241, P2007; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Zea CJ, 2005, BIOPOLYMERS, V79, P106, DOI 10.1002/bip.20338	43	24	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21511	21523		10.1074/jbc.M111.238774	http://dx.doi.org/10.1074/jbc.M111.238774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507950	Green Published, hybrid			2022-12-27	WOS:000291464700049
J	Gan, Q; Thiebaud, P; Theze, N; Jin, L; Xu, GF; Grant, P; Owens, GK				Gan, Qiong; Thiebaud, Pierre; Theze, Nadine; Jin, Li; Xu, Guofeng; Grant, Patrick; Owens, Gary K.			WD Repeat-containing Protein 5, a Ubiquitously Expressed Histone Methyltransferase Adaptor Protein, Regulates Smooth Muscle Cell-selective Gene Activation through Interaction with Pituitary Homeobox 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SERUM RESPONSE FACTOR; MOLECULAR REGULATION; H3K4 METHYLATION; TARGET GENES; DIFFERENTIATION; COMPLEX; RECRUITMENT; LYSINE-4; BINDING	WD repeat-containing protein 5 (WDR5) is a common component of mammalian mixed lineage leukemia methyltransferase family members and is important for histone H3 lysine 4 methylation (H3K4me), which has been implicated in control of activation of cell lineage genes during embryogenesis. However, WDR5 has not been considered to play a specific regulatory role in epigenetic programming of cell lineage because it is ubiquitously expressed. Previous work from our laboratory showed the appearance of histone H3K4me within smooth muscle cell (SMC)-marker gene promoters during the early stages of development of SMC from multipotential embryonic cells but did not elucidate the underlying mechanisms that mediate SMC-specific and locus-selective H3K4me. Results presented herein show that knockdown of WDR5 significantly decreased SMC-marker gene expression in cultured SMC differentiation systems and in Xenopus laevis embryos in vivo. In addition, we showed that WDR5 complexes within SMC progenitor cells contained H3K4 methyltransferase enzymatic activity and that knockdown of WDR5 selectively decreased H3K4me1 and H3K4me3 enrichment within SMC-marker gene promoter loci. Moreover, we present evidence that it is recruited to these gene promoter loci through interaction with a SMC-selective pituitary homeobox 2 (Pitx2). Taken together, studies provide evidence for a novel mechanism for epigenetic control of SMC-marker gene expression during development through interaction of WDR5, homeodomain proteins, and chromatin remodeling enzymes.	[Gan, Qiong; Jin, Li; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Xu, Guofeng] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Grant, Patrick] Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA; [Thiebaud, Pierre; Theze, Nadine] Univ Bordeaux 2, F-33076 Bordeaux, France	University of Virginia; University of Virginia; University of Virginia; UDICE-French Research Universities; Universite de Bordeaux	Owens, GK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	gko@virginia.edu	Xu, Guofeng/I-3063-2016	THIEBAUD, Pierre/0000-0003-1174-1616	National Institutes of Health [P01 HL19242, R01 HL57353, R01 HL 38854]; American Hearth Association [09POST2250363]; CNRS; University of Bordeaux 2; Association Francaise contre les Myopathies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057353, R01HL038854, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearth Association(American Heart Association); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux 2; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL19242, R01 HL57353, and R01 HL 38854 (to G. K. O.). This work was also supported by American Hearth Association Grant 09POST2250363 (to Q. G.). Work in the laboratory of P. T. and N. T. was supported by the CNRS, the University of Bordeaux 2, and the Association Francaise contre les Myopathies.	Barillot W, 2008, DEV DYNAM, V237, P3373, DOI 10.1002/dvdy.21749; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Campione M, 1999, DEVELOPMENT, V126, P1225; Chang DF, 2007, P NATL ACAD SCI USA, V104, P157, DOI 10.1073/pnas.0605635103; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rodenberg JM, 2010, AM J PHYSIOL-CELL PH, V299, pC1058, DOI 10.1152/ajpcell.00080.2010; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weiskirchen R, 2000, BIOCHEM BIOPH RES CO, V274, P655, DOI 10.1006/bbrc.2000.3187; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	52	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21853	21864		10.1074/jbc.M111.233098	http://dx.doi.org/10.1074/jbc.M111.233098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531708	Green Published, hybrid			2022-12-27	WOS:000291464700080
J	Locatelli, A; Lange, CA				Locatelli, Alessia; Lange, Carol A.			Met Receptors Induce Sam68-dependent Cell Migration by Activation of Alternate Extracellular Signal-regulated Kinase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; BINDING PROTEIN SAM68; FACTOR SCATTER FACTOR; MAMMALIAN MAP KINASE; BREAST-TUMOR KINASE; CHRONIC LEG ULCERS; RNA-BINDING; C-MET; ADAPTER PROTEIN; CANCER CELLS	The hepatocyte growth factor (HGF)/Met receptor signaling pathway is deregulated in diverse human malignancies and plays a central role in oncogenesis, tumor progression, and invasive cancer growth. Similarly, altered expression and splicing (i.e. inclusion of variant exon 5, "v5") of the cell adhesion marker, CD44, is associated with advanced cancer phenotypes. We sought to further understand how HGF regulates CD44v5 expression. Immortalized nontumorigenic keratinocyte (HaCaT) cells abundantly express both Met receptors and CD44v5 transmembrane glycoproteins. HGF stimulated CD44v5 protein expression and HaCaT cell migration; these events required activation of the ERK1/2 MAPK module and Sam68, a protein involved in RNA processing, splicing, and v5 inclusion. Similar to HaCaT cells, highly migratory MDA-MB-231 breast cancer cells also required Sam68 expression for HGF-induced migration. However, MDA-MB-231 cell migration occurred independently of ERK1/2 and CD44v5 expression and instead required ERK5 signaling to Sam68. Phospho-mutant, but not WT-Sam68, blocked HGF-induced cell migration in both cell types; MDA-MB-435 cells behaved similarly. These results suggest that Sam68 acts as a convergence point for ERK signaling to cell migration; blockade of phospho-Sam68 may provide a new avenue for therapeutic inhibition of metastatic cancers.	[Lange, Carol A.] Univ Minnesota, Masonic Canc Ctr, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; Univ Minnesota, Masonic Canc Ctr, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lange, CA (corresponding author), Univ Minnesota, Masonic Canc Ctr, Dept Med, Div Hematol Oncol & Transplantat, 420 Delaware St SE,MMC 806, Minneapolis, MN 55455 USA.	lange047@umn.edu		Lange, Carol/0000-0003-2751-3976	National Institutes of Health from NCI [CA107547]; American Cancer Society [RSG TBE-107800]; NATIONAL CANCER INSTITUTE [R01CA107547] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107547 from NCI (to C. A. L.). This work was also supported by American Cancer Society RSG TBE-107800 (to C. A. L.).	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Borland G, 1998, IMMUNOLOGY, V93, P139; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Gunthert U, 1993, Curr Top Microbiol Immunol, V184, P47; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hong W, 2002, MOL CANCER RES, V1, P48; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huot ME, 2009, J BIOL CHEM, V284, P31903, DOI 10.1074/jbc.M109.018465; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; Jabado N, 1998, J IMMUNOL, V161, P2798; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Jiang WG, 1997, HISTOL HISTOPATHOL, V12, P537; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Lawe DC, 1997, ONCOGENE, V14, P223, DOI 10.1038/sj.onc.1200821; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu K, 2000, J BIOL CHEM, V275, P40195, DOI 10.1074/jbc.M006194200; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nayeri F, 2005, J DERMATOL SCI, V37, P75, DOI 10.1016/j.jdermsci.2004.11.002; Nayeri F, 2002, J DERMATOL TREAT, V13, P81, DOI 10.1080/095466302317584449; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; NUSRAT A, 1994, J CLIN INVEST, V93, P2056, DOI 10.1172/JCI117200; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2003, ONCOGENE, V22, P8707, DOI 10.1038/sj.onc.1207016; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RUSSELL WE, 1984, J CELL PHYSIOL, V119, P183, DOI 10.1002/jcp.1041190207; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wu ST, 2003, J FORMOS MED ASSOC, V102, P229; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	63	19	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21062	21072		10.1074/jbc.M110.211409	http://dx.doi.org/10.1074/jbc.M110.211409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21489997	Green Published, hybrid			2022-12-27	WOS:000291464700005
J	Phillips, NJ; Adin, DM; Stabb, EV; McFall-Ngai, MJ; Apicella, MA; Gibson, BW				Phillips, Nancy J.; Adin, Dawn M.; Stabb, Eric V.; McFall-Ngai, Margaret J.; Apicella, Michael A.; Gibson, Bradford W.			The Lipid A from Vibrio fischeri Lipopolysaccharide A UNIQUE STRUCTURE BEARING A PHOSPHOGLYCEROL MOIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; O-SPECIFIC POLYSACCHARIDE; GRAM-NEGATIVE BACTERIA; ION-TRAP; FRANCISELLA-TULARENSIS; GLYCEROL PHOSPHATE; EUPRYMNA-SCOLOPES; LIGHT ORGAN; SYMBIOSIS	Vibrio fischeri, a bioluminescent marine bacterium, exists in an exclusive symbiotic relationship with the Hawaiian bobtail squid, Euprymna scolopes, whose light organ it colonizes. Previously, it has been shown that the lipopolysaccharide (LPS) or free lipid A of V. fischeri can trigger morphological changes in the juvenile squid's light organ that occur upon colonization. To investigate the structural features that might be responsible for this phenomenon, the lipid A from V. fischeri ES114 LPS was isolated and characterized by multistage mass spectrometry (MSn). A microheterogeneous mixture of mono- and diphosphorylated diglucosamine disaccharides was observed with variable states of acylation ranging from tetra- to octaacylated forms. All lipid A species, however, contained a set of conserved primary acyl chains consisting of an N-linked C14:0(3-OH) at the 2-position, an unusual N-linked C14:1(3-OH) at the 2'-position, and two O-linked C12:0(3-OH) fatty acids at the 3- and 3'-positions. The fatty acids found in secondary acylation were considerably more variable, with either a C12:0 or C16:1 at the 2-position, C14:0 or C14:0(3-OH) at the 2'-position, and C12:0 or no substituent at the 3'-position. Most surprising was the presence of an unusual set of modifications at the secondary acylation site of the 3-position consisting of phosphoglycerol (GroP), lysophosphatidic acid (GroP bearing C12:0, C16:0, or C16:1), or phosphatidic acid (GroP bearing either C16:0 + C12:0 or C16:0 + C16:1). Given their unusual nature, it is possible that these features of the V. fischeri lipid A may underlie the ability of E. scolopes to recognize its symbiotic partner.	[Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Phillips, Nancy J.; Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Adin, Dawn M.; Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [McFall-Ngai, Margaret J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Apicella, Michael A.] Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	Buck Institute for Research on Aging; University of California System; University of California San Francisco; University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Gibson, BW (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	bgibson@buckinstitute.org		Adin, Dawn/0000-0002-7341-3952	National Institutes of Health [AI-50661]; Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health, NCI, Cancer Center [P30 CA082103, DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, R01AI050661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health, NCI, Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-50661 (to M. J. M.-N.).; We are grateful to Dr. Haichuan Liu for acquisition of reflectron spectra on the 4800 TOF/TOF instrument. Mass spectrometry analysis on the LTQ XL and 4800 TOF/TOF instruments was performed at the University of California (San Francisco, CA) Sandler-Moore Mass Spectrometry Core Facility (supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, National Institutes of Health, NCI, Cancer Center Support Grant P30 CA082103, and DE-AC02-05CH11231).	ADAMS J, 1986, J AM CHEM SOC, V108, P6915, DOI 10.1021/ja00282a014; Adin DA, 2008, APPL ENVIRON MICROB, V74, P633, DOI 10.1128/AEM.02138-07; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; ANDERSON R, 1985, J BIOL CHEM, V260, P2219; Apicella Michael A., 2008, V431, P3; Aussel L, 2000, RAPID COMMUN MASS SP, V14, P595, DOI 10.1002/(SICI)1097-0231(20000415)14:7<595::AID-RCM919>3.0.CO;2-4; Bedoux G, 2004, J MASS SPECTROM, V39, P505, DOI 10.1002/jms.611; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Boue SM, 2000, J MASS SPECTROM, V35, P361, DOI 10.1002/(SICI)1096-9888(200003)35:3<361::AID-JMS943>3.0.CO;2-D; BROADY KW, 1981, EUR J BIOCHEM, V115, P463; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Corcoran AT, 2006, FEMS MICROBIOL LETT, V257, P228, DOI 10.1111/j.1574-6968.2006.00177.x; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; El-Aneed A, 2005, RAPID COMMUN MASS SP, V19, P1683, DOI 10.1002/rcm.1971; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Hankins JV, 2009, J BIOL CHEM, V284, P25804, DOI 10.1074/jbc.M109.022772; Jachymek W, 1999, EUR J BIOCHEM, V266, P53, DOI 10.1046/j.1432-1327.1999.00813.x; Jeyaretnam B, 2002, J BIOL CHEM, V277, P41802, DOI 10.1074/jbc.M112140200; KOCHAROVA NA, 1994, EUR J BIOCHEM, V219, P653, DOI 10.1111/j.1432-1033.1994.tb19981.x; Kolodziejska K, 2006, FEMS IMMUNOL MED MIC, V47, P267, DOI 10.1111/j.1574-695X.2006.00084.x; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Krasikova IN, 2004, EUR J BIOCHEM, V271, P2895, DOI 10.1111/j.1432-1033.2004.04212.x; Kussak A, 2002, ANAL BIOCHEM, V307, P131, DOI 10.1016/S0003-2697(02)00004-0; Lee CS, 2004, J MASS SPECTROM, V39, P514, DOI 10.1002/jms.614; Mikhail I, 2005, ANAL BIOCHEM, V340, P303, DOI 10.1016/j.ab.2005.02.020; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Pupo E, 2004, ELECTROPHORESIS, V25, P2156, DOI 10.1002/elps.200405980; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Schilling B, 2007, ANAL CHEM, V79, P1034, DOI 10.1021/ac061654e; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Silipo A, 2008, J MASS SPECTROM, V43, P478, DOI 10.1002/jms.1333; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; Wang Z, 2008, CARBOHYD RES, V343, P483, DOI 10.1016/j.carres.2007.11.016; Weil K, 2002, LIPIDS, V37, P317, DOI 10.1007/s11745-002-0897-z; YAN H, 1989, J BIOL CHEM, V264, P18667; Yang YL, 2006, J LIPID RES, V47, P1823, DOI 10.1194/jlr.M600034-JLR200	44	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21203	21219		10.1074/jbc.M111.239475	http://dx.doi.org/10.1074/jbc.M111.239475			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498521	Green Published, hybrid			2022-12-27	WOS:000291464700020
J	von Rossum, A; Krall, R; Escalante, NK; Choy, JC				von Rossum, Anna; Krall, Randall; Escalante, Nichole K.; Choy, Jonathan C.			Inflammatory Cytokines Determine the Susceptibility of Human CD8 T Cells to Fas-mediated Activation-induced Cell Death through Modulation of FasL and c-FLIPS Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MULTIPLE-SCLEROSIS; CUTTING EDGE; ALLOGENEIC RESPONSES; RECEPTOR EXPRESSION; CARDIAC ALLOGRAFTS; UP-REGULATION; APOPTOSIS; DIFFERENTIATION; RESISTANCE	The nature of inflammatory signals determines the outcome of T cell responses. However, little is known about how inflammatory cytokines provided to human CD8 T cells during activation affects their susceptibility to post-activation cell death. We have examined and compared the effects of the inflammatory cytokine IL-12, as well as the combination of IL-1, IL-6, and IL-23 (IL-1/6/23) on the susceptibility of primary human CD8 T cells to post-activation cell death. Human CD8 T cells activated in the presence of IL-1/6/23 underwent significantly less cell death after activation as compared with those activated in IL-12. This was due to reduced susceptibility to Fas-mediated activation-induced cell death (AICD). Mechanistically, the reduced level of cell death in CD8 T cells activated in IL-1/6/23 was a result of a low level of FasL expression and high level of c-FLIPS expression. When the effect of IL-1, IL-6, and IL-23 individually was examined, IL-1 or IL-6 alone was sufficient to inhibit CD8 T cell death that occurs after activation in IL-12. IL-1, but not IL-6, inhibited expression of FasL, whereas IL-6, but not IL-1, increased c-FLIPS expression. Our findings show that the presence of IL-1 and/or IL-6 during activation of human CD8 T cells attenuates Fas-mediated AICD, whereas IL-12 increases the susceptibility of activated CD8 T cells to this form of cell death.	[von Rossum, Anna; Krall, Randall; Escalante, Nichole K.; Choy, Jonathan C.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Choy, JC (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	jonathan.choy@sfu.ca		Choy, Jonathan/0000-0003-1837-8514; Escalante, Nichole/0000-0003-4037-1634	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of British Columbia Yukon	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia Yukon	This work was supported, in whole or in part, by an operating grant from the Canadian Institutes of Health Research (CIHR, to J. C. C.) and a Grant-in-Aid from the Heart and Stroke Foundation of British Columbia & Yukon (to J. C. C.). J. C. C. is a recipient of a CIHR New Investigator Award.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Choy JC, 2009, AM J TRANSPLANT, V9, P2281, DOI 10.1111/j.1600-6143.2009.02771.x; Choy JC, 2007, P NATL ACAD SCI USA, V104, P1313, DOI 10.1073/pnas.0607731104; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; CRUSIUS JBA, 1995, LANCET, V346, P979, DOI 10.1016/S0140-6736(95)91607-5; DESAI BB, 1992, J IMMUNOL, V148, P3125; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; FONG TAT, 1990, J IMMUNOL, V144, P1744; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; HIRATA Y, 1989, J IMMUNOL, V143, P2900; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Husted TL, 2006, INFLAMM RES, V55, P177, DOI 10.1007/s00011-006-0073-1; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lee SW, 2003, J IMMUNOL, V170, P2456, DOI 10.4049/jimmunol.170.5.2456; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MIZUOCHI T, 1988, J IMMUNOL, V141, P1571; Monteleone I, 2006, GASTROENTEROLOGY, V130, P389, DOI 10.1053/j.gastro.2005.10.021; MORGAN CJ, 1993, TRANSPLANTATION, V55, P919, DOI 10.1097/00007890-199304000-00042; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Semra YK, 2001, J NEUROIMMUNOL, V113, P268, DOI 10.1016/S0165-5728(00)00443-4; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; SHIRAISHI M, 1995, J SURG RES, V58, P465, DOI 10.1006/jsre.1995.1073; Snoeijs MGJ, 2010, CURR OPIN ORGAN TRAN, V15, P190, DOI 10.1097/MOT.0b013e32833593eb; Syrjala SO, 2010, J HEART LUNG TRANSPL, V29, P1047, DOI 10.1016/j.healun.2010.04.012; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Vukmanovic-Stejic M, 2000, BLOOD, V95, P231; Wan S, 1996, J THORAC CARDIOV SUR, V111, P469, DOI 10.1016/S0022-5223(96)70458-0; Wang XJ, 1998, BLOOD, V91, P3308, DOI 10.1182/blood.V91.9.3308.3308_3308_3314; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yu Y, 2009, BLOOD, V114, P1026, DOI 10.1182/blood-2009-03-210153; Zhang YY, 2008, J IMMUNOL, V181, P190, DOI 10.4049/jimmunol.181.1.190	55	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21137	21144		10.1074/jbc.M110.197657	http://dx.doi.org/10.1074/jbc.M110.197657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518761	Green Published, hybrid			2022-12-27	WOS:000291464700013
J	Chigaev, A; Smagley, Y; Zhang, YA; Waller, A; Haynes, MK; Amit, O; Wang, W; Larson, RS; Sklar, LA				Chigaev, Alexandre; Smagley, Yelena; Zhang, Yinan; Waller, Anna; Haynes, Mark K.; Amit, Or; Wang, Wei; Larson, Richard S.; Sklar, Larry A.			Real-time Analysis of the Inside-out Regulation of Lymphocyte Function-associated Antigen-1 Revealed Similarities to and Differences from Very Late Antigen-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ACUTE MYELOGENOUS LEUKEMIA; FORMYL PEPTIDE RECEPTOR; CELL-ADHESION; CONFORMATIONAL REGULATION; INTEGRIN ACTIVATION; BINDING-SITE; GUINEA-PIG; I-DOMAIN; ALPHA(4)BETA(1) INTEGRIN	Ten years ago, we introduced a fluorescent probe that shed light on the inside-out regulation of one of the major leukocyte integrins, very late antigen-4 (VLA-4, CD49d/CD29). Here we describe the regulation of another leukocyte integrin, lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18) using a novel small fluorescent probe in real time on live cells. We found that multiple signaling mechanisms regulate LFA-1 conformation in a manner analogous to VLA-4. LFA-1 can be rapidly activated by G alpha(i)-coupled G protein-coupled receptors (GPCRs) and deactivated by G alpha(s)-coupled GPCRs. The effects of G alpha(s)-coupled GPCR agonists can be reversed in real time by receptor-specific antagonists. The specificity of the fluorescent probe binding has been assessed in a competition assay using the natural LFA-1 ligand ICAM-1 and the LFA-1-specific alpha I allosteric antagonist BIRT0377. Similar to VLA-4 integrin, modulation of the ligand dissociation rate can be observed for different LFA-1 affinity states. However, we also found a striking difference in the binding of the small fluorescent ligand. In the absence of inside-out activation ligand, binding to LFA-1 is extremely slow, at least 10 times slower than expected for diffusion-limited binding. This implies that an additional structural mechanism prevents ligand binding to inactive LFA-1. We propose that such a mechanism explains the inability of LFA-1 to support cell rolling, where the absence of its rapid engagement by a counterstructure in the inactive state leads to a requirement for a selectin-mediated rolling step.	[Chigaev, Alexandre; Smagley, Yelena; Waller, Anna; Haynes, Mark K.; Amit, Or; Larson, Richard S.; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Chigaev, Alexandre; Smagley, Yelena; Waller, Anna; Haynes, Mark K.; Amit, Or; Larson, Richard S.; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA; [Zhang, Yinan; Wang, Wei] Univ New Mexico, Hlth Sci Ctr, Dept Chem, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Chigaev, A (corresponding author), MSC08 4630,915 Camino Salud, Albuquerque, NM 87131 USA.	achigaev@salud.unm.edu; lsklar@salud.unm.edu	Zhang, Yinan/AAY-5941-2020; Chigaev, Alexandre/A-3103-2010; Zhang, Yinan/D-5769-2016	Zhang, Yinan/0000-0002-0362-1473; Chigaev, Alexandre/0000-0002-7726-638X; Zhang, Yinan/0000-0002-0362-1473; Waller, Anna/0000-0003-3676-2501	National Institutes of Health [U54 MH084690, HL081062]; Leukemia and Lymphoma Society [7388-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 MH084690 and HL081062. This work was also supported by Leukemia and Lymphoma Society Grant 7388-06.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Alon R, 2009, MICROCIRCULATION, V16, P3, DOI 10.1080/10739680802026076; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; BENSCHOP RJ, 1994, BRIT J PHARMACOL, V113, P1311, DOI 10.1111/j.1476-5381.1994.tb17141.x; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BOOZE RM, 1989, J PHARMACOL EXP THER, V249, P911; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Chen LL, 1999, J BIOL CHEM, V274, P13167, DOI 10.1074/jbc.274.19.13167; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2011, J BIOL CHEM, V286, P5455, DOI 10.1074/jbc.M110.162636; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Dimitrov S, 2010, J IMMUNOL, V184, P503, DOI 10.4049/jimmunol.0902189; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Eniola AO, 2005, BIOPHYS J, V89, P3577, DOI 10.1529/biophysj.104.057729; Ezeamuzie CI, 2000, BRIT J PHARMACOL, V131, P482, DOI 10.1038/sj.bjp.0703556; Fabbri M, 1999, INFLAMM RES, V48, P239, DOI 10.1007/s000110050454; FOREMAN JC, 1986, BRIT J PHARMACOL, V87, P37, DOI 10.1111/j.1476-5381.1986.tb10154.x; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Hyduk SJ, 2009, MICROCIRCULATION, V16, P17, DOI 10.1080/10739680802425195; Hyun YM, 2009, IMMUNOL RES, V45, P195, DOI 10.1007/s12026-009-8101-1; Johnston B, 1996, J EXP MED, V183, P1995, DOI 10.1084/jem.183.5.1995; Keating SM, 2006, PROTEIN SCI, V15, P290, DOI 10.1110/ps.051583406; Kelly TA, 1999, J IMMUNOL, V163, P5173; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Last-Barney K, 2001, J AM CHEM SOC, V123, P5643, DOI 10.1021/ja0104249; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Laudanna C, 2005, NAT IMMUNOL, V6, P429, DOI 10.1038/ni0505-429; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIGGETT SB, 1989, EUR J PHARMACOL, V163, P171, DOI 10.1016/0014-2999(89)90414-7; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MILLER LJ, 1986, J IMMUNOL, V137, P2891; Njus BH, 2009, ASSAY DRUG DEV TECHN, V7, P507, DOI 10.1089/adt.2009.0203; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Sarantos MR, 2005, J BIOL CHEM, V280, P28290, DOI 10.1074/jbc.M501662200; Schedlowski M, 1996, J IMMUNOL, V156, P93; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shayo C, 1997, MOL PHARMACOL, V51, P983, DOI 10.1124/mol.51.6.983; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Stanley P, 1998, J BIOL CHEM, V273, P3358, DOI 10.1074/jbc.273.6.3358; STANLEY P, 1994, EMBO J, V13, P1790, DOI 10.1002/j.1460-2075.1994.tb06447.x; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Wang LL, 2002, J RES NATL INST STAN, V107, P339, DOI 10.6028/jres.107.027; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104; ZHANG L, 1990, AM J PHYSIOL, V259, pG436, DOI 10.1152/ajpgi.1990.259.3.G436; Zhuang GQ, 2001, J BIOSCI BIOENG, V92, P330, DOI 10.1263/jbb.92.330; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3; Zwartz GJ, 2004, J BIOL CHEM, V279, P38277, DOI 10.1074/jbc.M402944200	81	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20375	20386		10.1074/jbc.M110.206185	http://dx.doi.org/10.1074/jbc.M110.206185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515675	Green Published, hybrid			2022-12-27	WOS:000291267600025
J	Ying, Z; Wang, HF; Fan, HD; Wang, GH				Ying, Zheng; Wang, Hongfeng; Fan, Huadong; Wang, Guanghui			The Endoplasmic Reticulum (ER)-associated Degradation System Regulates Aggregation and Degradation of Mutant Neuroserpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTILITY FACTOR-RECEPTOR; UBIQUITIN LIGASE; PRION PROTEIN; CUE DOMAIN; GP78; ERAD; TOXICITY; DEMENTIA; E3; RETROTRANSLOCATION	Familial encephalopathy with neuroserpin inclusion bodies is a neurodegenerative disorder characterized by the accumulation of neuroserpin polymers in the endoplasmic reticulum (ER) of cortical and subcortical neurons in the CNS because of neuroserpin point mutations. ER-associated degradation (ERAD) is involved in mutant neuroserpin degradation. In this study, we demonstrate that two ER-associated E3 ligases, Hrd1 and gp78, are involved in the ubiquitination and degradation of mutant neuroserpin. Overexpression of Hrd1 and gp78 decreases the mutant neuroserpin protein level, whereas Hrd1 and gp78 knockdown increases mutant neuroserpin stability. Moreover, ERAD impairment by mutant valosin-containing protein increases the mutant neuroserpin protein level and aggregate formation. Thus, these findings identify mutant neuroserpin as an ERAD target and show that Hrd1 and gp78 mediate mutant neuroserpin turnover through the ERAD pathway.	[Ying, Zheng; Wang, Hongfeng; Fan, Huadong; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Key Lab Brain Funct & Dis,Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, HF (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China.	hfwang4@mail.ustc.edu.cn; ghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017; Fan, Huadong/AAD-2321-2019	Wang, Guanghui/0000-0001-8551-6468; Fan, Huadong/0000-0001-5282-4843	National Natural Sciences Foundation of China [30970921, 31000473]; National High-Tech Research and Development Program of China 973 Projects [2011CB504102]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China 973 Projects(National Basic Research Program of China)	This work was supported in part by National Natural Sciences Foundation of China Grants 30970921 and 31000473 and by National High-Tech Research and Development Program of China 973 Projects Grant 2011CB504102.	Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; RON I, HUM MOL GENET, V19, P3771; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	38	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20835	20844		10.1074/jbc.M110.200808	http://dx.doi.org/10.1074/jbc.M110.200808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507957	Green Published, hybrid			2022-12-27	WOS:000291267600068
J	Dutta, D; Chattopadhyay, S; Bagchi, P; Halder, UC; Nandi, S; Mukherjee, A; Kobayashi, N; Taniguchi, K; Chawla-Sarkar, M				Dutta, Dipanjan; Chattopadhyay, Shiladitya; Bagchi, Parikshit; Halder, Umesh Chandra; Nandi, Satabdi; Mukherjee, Anupam; Kobayashi, Nobumichi; Taniguchi, Koki; Chawla-Sarkar, Mamta			Active Participation of Cellular Chaperone Hsp90 in Regulating the Function of Rotavirus Nonstructural Protein 3 (NSP3) (Publication with Expression of Concern. See vol. 294, pg. 15118, 2019) (Withdrawn Publication. See vol. 295, pg. 13696, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							RESPIRATORY SYNCYTIAL VIRUS; MESSENGER-RNA; SIGNALING PATHWAYS; GENE-EXPRESSION; BINDING; CELLS; INITIATION; RECOGNITION; ACTIVATION; INFECTION	Heat shock protein 90 (Hsp90) has been reported to positively regulate rotavirus replication by modulating virus induced PI3K/Akt and NF kappa B activation. Here, we report the active association of Hsp90 in the folding and stabilization of rotavirus nonstructural protein 3 (NSP3). In pCD-NSP3-transfected cells, treatment with Hsp90 inhibitor (17-N, N-dimethylethylenedia-mine-geldanamycin (17DMAG)) resulted in the proteasomal degradation of NSP3. Sequence analysis and deletion mutations revealed that the region spanning amino acids 225-258 within the C-terminal eIF4G-binding domain of NSP3 is a putative Hsp90 binding region. Co-immunoprecipitation and mammalian two-hybrid experiments revealed direct interaction of the C-terminal 12-kDa domain of Hsp90 (C90) with residues 225258 of NSP3. NSP3-Hsp90 interaction is important for the formation of functionally active mature NSP3, because full-length NSP3 in the presence of the Hsp90 inhibitor or NSP3 lacking the amino acid 225-258 region did not show NSP3 dimers following in vitro coupled transcription-translation followed by chase. Disruption of residues 225-258 within NSP3 also resulted in poor RNA binding and eIF4G binding activity. In addition, inhibition of Hsp90 by 17DMAG resulted in reduced nuclear translocation of poly(A)-binding protein and translation of viral proteins. These results highlight the crucial role of Hsp90 chaperone in the regulation of assembly and functionality of a viral protein during the virus replication and propagation in host cells.	[Dutta, Dipanjan; Chattopadhyay, Shiladitya; Bagchi, Parikshit; Halder, Umesh Chandra; Nandi, Satabdi; Mukherjee, Anupam; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Scheme XM, Kolkata 700010, India; [Kobayashi, Nobumichi] Sapporo Med Univ, Dept Hyg, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Aichi 4701100, Japan	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Sapporo Medical University; Fujita Health University	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Scheme XM, P-33 Calcutta Improvement Trust Rd, Kolkata 700010, India.	chawlam70@gmail.com	Mukherjee, Anupam/ABB-9438-2020	Mukherjee, Anupam/0000-0002-0612-2258	Indian Council of Medical Research (ICMR), New Delhi; Ministry of Education, Culture, Sports, Science, and Technology, Japan; University Grants Commission (UGC), India; ICMR; Council of Scientific and Industrial Research (CSIR), India; CSIR	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University Grants Commission (UGC), India(University Grants Commission, India); ICMR(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Indian Council of Medical Research (ICMR), New Delhi, and the Program for Funding Research Centers for Emerging and Reemerging Infectious Diseases (Okayama University-National Institute of Cholera and Enteric Diseases, India) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.; Supported by a senior research fellowship from the University Grants Commission (UGC), India.; Supported by a senior research fellowship from ICMR.; These authors were supported by senior research fellowships from the Council of Scientific and Industrial Research (CSIR), India.; Supported by a junior research fellowship from CSIR.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Autret A, 2008, J VIROL, V82, P3796, DOI 10.1128/JVI.02020-07; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Gilmore R, 1998, J BIOL CHEM, V273, P15227, DOI 10.1074/jbc.273.24.15227; Glotzer JB, 2000, NATURE, V407, P207, DOI 10.1038/35025102; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Guerrero CA, 2002, J VIROL, V76, P4096, DOI 10.1128/JVI.76.8.4096-4102.2002; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Hennig L, 1999, BIOTECHNIQUES, V26, P1170, DOI 10.2144/99266bc02; Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hung JJ, 2002, J VIROL, V76, P1379, DOI 10.1128/JVI.76.3.1379-1390.2002; Jolly CL, 2000, VIROLOGY, V275, P89, DOI 10.1006/viro.2000.0470; Joosten M, 2004, J BIOL CHEM, V279, P38169, DOI 10.1074/jbc.M401283200; KASPAR RL, 1992, J BIOL CHEM, V267, P508; Keryer-Bibens C, 2009, BIOCHEM BIOPH RES CO, V390, P302, DOI 10.1016/j.bbrc.2009.09.115; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; LODISH HF, 1971, J BIOL CHEM, V246, P7131; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Nollen EAA, 2002, J CELL SCI, V115, P2809; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Vitour D, 2004, J VIROL, V78, P3851, DOI 10.1128/JVI.78.8.3851-3862.2004; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WHITE MW, 1990, BIOCHEM J, V268, P657, DOI 10.1042/bj2680657; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	58	27	28	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20065	20077		10.1074/jbc.M111.231878	http://dx.doi.org/10.1074/jbc.M111.231878			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489987	hybrid, Green Published			2022-12-27	WOS:000291027700083
J	Narula, G; Annamalai, T; Aedo, S; Cheng, B; Sorokin, E; Wong, A; Tse-Dinh, YC				Narula, Gagandeep; Annamalai, Thirunavukkarasu; Aedo, Sandra; Cheng, Bokun; Sorokin, Elena; Wong, Agnes; Tse-Dinh, Yuk-Ching			The Strictly Conserved Arg-321 Residue in the Active Site of Escherichia coli Topoisomerase I Plays a Critical Role in DNA Rejoining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIVALENT METAL-IONS; BACTERIAL; CLEAVAGE; COMPLEX; BINDING; PROTEIN; IDENTIFICATION; PURIFICATION; INHIBITION	The strictly conserved arginine residue proximal to the active site tyrosine of type IA topoisomerases is required for the relaxation of supercoiled DNA and was hypothesized to be required for positioning of the scissile phosphate for DNA cleavage to take place. Mutants of recombinant Yersinia pestis topoisomerase I with hydrophobic substitutions at this position were found in genetic screening to exhibit a dominant lethal phenotype, resulting in drastic loss in Escherichia coli viability when over-expressed. In depth biochemical analysis of E. coli topoisomerase I with the corresponding Arg-321 mutation showed that DNA cleavage can still take place in the absence of this arginine function if Mg2+ is present to enhance the interaction of the enzyme with the scissile phosphate. However, DNA rejoining is inhibited in the absence of this conserved arginine, resulting in accumulation of the cleaved covalent intermediate and loss of relaxation activity. These new experimental results demonstrate that catalysis of DNA rejoining by type IA topoisomerases has a more stringent requirement than DNA cleavage. In addition to the divalent metal ions, the side chain of this arginine residue is required for the precise positioning of the phosphotyrosine linkage for nucleophilic attack by the 3'-OH end to result in DNA rejoining. Small molecules that can interfere or distort the enzyme-DNA interactions required for DNA rejoining by bacterial type IA topoisomerases could be developed into novel antibacterial drugs.	[Narula, Gagandeep; Annamalai, Thirunavukkarasu; Aedo, Sandra; Cheng, Bokun; Sorokin, Elena; Wong, Agnes; Tse-Dinh, Yuk-Ching] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Tse-Dinh, YC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	yuk-ching_tse-dinh@nymc.edu			National Institutes of Health [R01 GM054226, AI069313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM054226 and AI069313.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Bradbury BJ, 2008, CURR OPIN PHARMACOL, V8, P574, DOI 10.1016/j.coph.2008.04.009; Caron PR, 1999, METH MOL B, V94, P279; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Chen SJ, 1998, J BIOL CHEM, V273, P6050, DOI 10.1074/jbc.273.11.6050; Cheng B, 2005, J BIOL CHEM, V280, P38489, DOI 10.1074/jbc.M509722200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, P1017, DOI 10.1093/nar/gkm1126; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DEPEW RE, 1978, J BIOL CHEM, V253, P511; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Doyle SA, 2005, METH MOL B, V310, P107; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; GOTO T, 1984, J BIOL CHEM, V259, P422; HEITMAN J, 1991, GENE, V103, P1, DOI 10.1016/0378-1119(91)90383-M; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Narula G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-41; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Sorokin EP, 2008, NUCLEIC ACIDS RES, V36, P4788, DOI 10.1093/nar/gkn460; Stern JC, 2001, BIOCHEMISTRY-US, V40, P11586, DOI 10.1021/bi010877q; Strahs D, 2006, NUCLEIC ACIDS RES, V34, P1785, DOI 10.1093/nar/gkl109; TSE YC, 1980, J BIOL CHEM, V255, P5560; Tse-Dinh YC, 1998, BBA-GENE STRUCT EXPR, V1400, P19, DOI 10.1016/S0167-4781(98)00125-0; TSEDINH YC, 1986, J BIOL CHEM, V261, P931; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2002, J BIOL CHEM, V277, P1203, DOI 10.1074/jbc.M109436200; Zhu CX, 1999, METH MOL B, V94, P145; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	40	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18673	18680		10.1074/jbc.M111.229450	http://dx.doi.org/10.1074/jbc.M111.229450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478161	Green Published, hybrid			2022-12-27	WOS:000290785700040
J	Ghosh, S; Vassilev, AP; Zhang, JM; Zhao, YM; DePamphilis, ML				Ghosh, Soma; Vassilev, Alex P.; Zhang, Junmei; Zhao, Yingming; DePamphilis, Melvin L.			Assembly of the Human Origin Recognition Complex Occurs through Independent Nuclear Localization of Its Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; ORC6 PROTEIN; IN-VIVO; CELLS; BINDING; ARCHITECTURE; RECRUITMENT; CENTROSOME; INITIATION; SEQUENCE	Initiation of eukaryotic genome duplication begins when a six-subunit origin recognition complex (ORC) binds to DNA. However, the mechanism by which this occurs in vivo and the roles played by individual subunits appear to differ significantly among organisms. Previous studies identified a soluble human ORC(2-5) complex in the nucleus, an ORC(1-5) complex bound to chromatin, and an Orc6 protein that binds weakly, if at all, to other ORC subunits. Here we show that stable ORC(1-6) complexes also can be purified from human cell extracts and that Orc6 and Orc1 each contain a single nuclear localization signal that is essential for nuclear localization but not for ORC assembly. The Orc6 nuclear localization signal, which is essential for Orc6 function, is facilitated by phosphorylation at its cyclin-dependent kinase consensus site and by association with Kpna6/1, nuclear transport proteins that did not co-purify with other ORC subunits. These and other results support a model in which Orc6, Orc1, and ORC(2-5) are transported independently to the nucleus where they can either assemble into ORC(1-6) or function individually.	[Ghosh, Soma; Vassilev, Alex P.; DePamphilis, Melvin L.] NICHD, NIH, Bethesda, MD 20892 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	DePamphilis, ML (corresponding author), NICHD, NIH, Bldg 6-3A-15,9000 Rockville Pike, Bethesda, MD 20892 USA.	depamphm@mail.nih.gov		Vassilev, Alex/0000-0002-5483-3791	National Institutes of Health (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health intramural research programs (NICHD).	Asano T, 2007, FEMS YEAST RES, V7, P1256, DOI 10.1111/j.1567-1364.2007.00299.x; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Brand N, 2007, MOL GENET GENOMICS, V278, P623, DOI 10.1007/s00438-007-0278-1; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chesnokov IN, 2007, INT REV CYTOL, V256, P69, DOI 10.1016/S0074-7696(07)56003-1; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; CHOOK YM, 2010, BIOCHIM BIO IN PRESS; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DePamphilis M. L., 2010, GENOME DUPLICATION C; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Diaz-Trivino S, 2005, NUCLEIC ACIDS RES, V33, P5404, DOI 10.1093/nar/gki854; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; ELION EA, 2007, CURR PROTOC PROTEIN, pCH19; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Huijbregts RPH, 2009, MOL BIOL CELL, V20, P270, DOI 10.1091/mbc.E08-07-0754; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Plant KE, 2006, PHARMACOGENET GENOM, V16, P647, DOI 10.1097/01.fpc.0000220570.82842.4d; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sivaprasad Umasundari, 2006, V47, P63; Stuermer A, 2007, EUR J CELL BIOL, V86, P37, DOI 10.1016/j.ejcb.2006.09.002; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Zhou G, 2005, PROTEOMICS, V5, P3814, DOI 10.1002/pmic.200401230	41	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23831	23841		10.1074/jbc.M110.215988	http://dx.doi.org/10.1074/jbc.M110.215988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21555516	Green Published, hybrid			2022-12-27	WOS:000292294900026
J	Graham, SA; Antonopoulos, A; Hitchen, PG; Haslam, SM; Dell, A; Drickamer, K; Taylor, ME				Graham, Sarah A.; Antonopoulos, Aristotelis; Hitchen, Paul G.; Haslam, Stuart M.; Dell, Anne; Drickamer, Kurt; Taylor, Maureen E.			Identification of Neutrophil Granule Glycoproteins as Lewis(x)-containing Ligands Cleared by the Scavenger Receptor C-type Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCAN-BINDING RECEPTORS; CYSTEINE-RICH DOMAIN; LEWIS-X RESIDUES; CELL-ADHESION; DC-SIGN; HUMAN-GRANULOCYTES; MANNOSE RECEPTOR; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; HUMAN LACTOFERRIN	The scavenger receptor C-type lectin (SRCL) is a glycanbinding receptor that has the capacity to mediate endocytosis of glycoproteins carrying terminal Lewis(x) groups (Gal beta 1-4(Fuc alpha 1-3) GlcNAc). A screen for glycoprotein ligands for SRCL using affinity chromatography on immobilized SRCL followed by mass spectrometry-based proteomic analysis revealed that soluble glycoproteins from secondary granules of neutrophils, including lactoferrin and matrix metalloproteinases 8 and 9, are major ligands. Binding competition and surface plasmon resonance analysis showed affinities in the low micromolar range. Comparison of SRCL binding to neutrophil and milk lactoferrin indicates that the binding is dependent on cell-specific glycosylation in the neutrophils, as the milk form of the glycoprotein is a much poorer ligand. Binding to neutrophil glycoproteins is fucose-dependent, and mass spectrometry-based glycomic analysis of neutrophil and milk lactoferrin was used to establish a correlation between high affinity binding to SRCL and the presence of multiple clustered terminal Lewis(x) groups on a heterogeneous mixture of branched glycans, some with poly N-acetyllactosamine extensions. The ability of SRCL to mediate uptake of neutrophil lactoferrin was confirmed using fibroblasts transfected with SRCL. The common presence of Lewisx groups in granule protein glycans can thus target granule proteins for clearance by SRCL. PCR and immunohistochemical analysis confirm that SRCL is widely expressed on endothelial cells and thus represents a distributed system that could scavenge released neutrophil glycoproteins both locally at sites of inflammation or systemically when they are released in the circulation.	[Graham, Sarah A.; Antonopoulos, Aristotelis; Hitchen, Paul G.; Haslam, Stuart M.; Dell, Anne; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Biochem Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Graham, Sarah/G-7765-2014	Graham, Sarah/0000-0003-2521-2416; Taylor, Maureen/0000-0001-8300-4987; Drickamer, Kurt/0000-0001-5026-5996	Wellcome Trust [075565]; Biotechnology and Biological Sciences Research Council [B19088, SF19107, BBF0083091, BBC5196701]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T. and K. D.) and Grants B19088, SF19107, BBF0083091, and BBC5196701 from the Biotechnology and Biological Sciences Research Council (to A. D.).	ALBRECHTSEN M, 1989, BRIT J HAEMATOL, V72, P312, DOI 10.1111/j.1365-2141.1989.tb07710.x; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Bogoevska V, 2007, GLYCOBIOLOGY, V17, P324, DOI 10.1093/glycob/cwl073; BUESCHER ES, 1990, ANAT REC, V228, P306, DOI 10.1002/ar.1092280310; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Coombs PJ, 2010, J MOL BIOL, V396, P685, DOI 10.1016/j.jmb.2009.11.073; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; DERISBOURG P, 1990, BIOCHEM J, V269, P821, DOI 10.1042/bj2690821; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Elola MT, 2007, BREAST CANCER RES TR, V101, P161, DOI 10.1007/s10549-006-9286-9; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FUKUDA M, 1984, J BIOL CHEM, V259, P925; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Imberty A, 1997, CURR OPIN STRUC BIOL, V7, P617, DOI 10.1016/S0959-440X(97)80069-3; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KERR MA, 1992, HISTOCHEM J, V24, P811, DOI 10.1007/BF01046353; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; MATSUMOTO A, 1982, J BIOCHEM-TOKYO, V91, P143, DOI 10.1093/oxfordjournals.jbchem.a133671; MCCARTHY NC, 1985, BIOSCIENCE REP, V5, P933, DOI 10.1007/BF01119906; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MIROLI AA, 1986, J IMMUNOL METHODS, V88, P91, DOI 10.1016/0022-1759(86)90055-4; MOLLICONE R, 1995, TRANSFUS CLIN BIOL, V2, P235, DOI 10.1016/S1246-7820(05)80089-8; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nauseef WM, 1999, J LEUKOCYTE BIOL, V66, P867, DOI 10.1002/jlb.66.6.867; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pipirou Z, 2011, GLYCOBIOLOGY, V21, P806, DOI 10.1093/glycob/cwr008; Powlesland AS, 2009, GLYCOBIOLOGY, V19, P899, DOI 10.1093/glycob/cwp065; Resnick D, 1996, J BIOL CHEM, V271, P26924, DOI 10.1074/jbc.271.43.26924; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Samsen A, 2010, EUR J CELL BIOL, V89, P87, DOI 10.1016/j.ejcb.2009.11.018; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SHEPHERD VL, 1990, AM J RESP CELL MOL, V2, P335, DOI 10.1165/ajrcmb/2.4.335; SKUBITZ KM, 1987, J IMMUNOL, V139, P1631; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; TERSTAPPEN LWMM, 1990, J LEUKOCYTE BIOL, V48, P138, DOI 10.1002/jlb.48.2.138; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; vanBerkel PHC, 1996, BIOCHEM J, V319, P117, DOI 10.1042/bj3190117; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	57	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24336	24349		10.1074/jbc.M111.244772	http://dx.doi.org/10.1074/jbc.M111.244772			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21561871	Green Published, hybrid			2022-12-27	WOS:000292294900074
J	Pantoom, S; Vetter, IR; Prinz, H; Suginta, W				Pantoom, Supansa; Vetter, Ingrid R.; Prinz, Heino; Suginta, Wipa			Potent Family-18 Chitinase Inhibitors X-RAY STRUCTURES, AFFINITIES, AND BINDING MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT CYCLOPENTAPEPTIDE INHIBITORS; ACIDIC MAMMALIAN CHITINASE; HIGH-RESOLUTION STRUCTURES; GLIOCLADIUM SP FTD-0668; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURES; ARGIFIN; ALLOSAMIDIN; COMPLEX; SPECIFICITY	Six novel inhibitors of Vibrio harveyi chitinase A (VhChiA), a family-18 chitinase homolog, were identified by in vitro screening of a library of pharmacologically active compounds. Unlike the previously identified inhibitors that mimicked the reaction intermediates, crystallographic evidence from 14 VhChiA-inhibitor complexes showed that all of the inhibitor molecules occupied the outer part of the substrate-binding cleft at two hydrophobic areas. The interactions at the aglycone location are well defined and tightly associated with Trp-397 and Trp-275, whereas the interactions at the glycone location are patchy, indicating lower affinity and a loose interaction with two consensus residues, Trp-168 and Val-205. When Trp-275 was substituted with glycine (W275G), the binding affinity toward all of the inhibitors dramatically decreased, and in most structures two inhibitor molecules were found to stack against Trp-397 at the aglycone site. Such results indicate that hydrophobic interactions are important for binding of the newly identified inhibitors by the chitinase. X-ray data and isothermal microcalorimetry showed that the inhibitors occupied the active site of VhChiA in three different binding modes, including single-site binding, independent two-site binding, and sequential two-site binding. The inhibitory effect of dequalinium in the low nanomolar range makes this compound an extremely attractive lead compound for plausible development of therapeutics against human diseases involving chitinase-mediated pathologies.	[Pantoom, Supansa; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Pantoom, Supansa; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Biochem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Vetter, Ingrid R.; Prinz, Heino] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Suranaree University of Technology; Suranaree University of Technology; Max Planck Society	Vetter, IR (corresponding author), Otto Hahn Str 11, D-44227 Dortmund, Germany.	ingrid.vetter@mpi-dortmund.mpg.de; heino.prinz@mpi-dortmund.mpg.de; wipa@sut.ac.th		Pantoom, Supansa/0000-0001-9630-1999	Thailand Research Fund [PHD/0238/2549]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by the Thailand Research Fund through Royal Golden Jubilee Ph.D. Program Grant PHD/0238/2549.	Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Arai N, 2000, J ANTIBIOT, V53, P609, DOI 10.7164/antibiotics.53.609; Arai N, 2000, CHEM PHARM BULL, V48, P1442, DOI 10.1248/cpb.48.1442; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOLLER T, 1988, METHOD ENZYMOL, V161, P430; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Cederkvist FH, 2007, BIOCHEMISTRY-US, V46, P12347, DOI 10.1021/bi701029u; Dixon MJ, 2009, ORG BIOMOL CHEM, V7, P259, DOI 10.1039/b815077j; Dixon MJ, 2005, BIOORG MED CHEM LETT, V15, P4717, DOI 10.1016/j.bmcl.2005.07.068; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Hirose T, 2010, P JPN ACAD B-PHYS, V86, P85, DOI 10.2183/pjab.86.85; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, P NATL ACAD SCI USA, V99, P9127, DOI 10.1073/pnas.132060599; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kumar A, 2010, BBA-GEN SUBJECTS, V1800, P526, DOI 10.1016/j.bbagen.2010.01.014; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Omura S, 2000, J ANTIBIOT, V53, P603, DOI 10.7164/antibiotics.53.603; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2003, ACTA CRYSTALLOGR D, V59, P400, DOI 10.1107/S0907444902021923; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Petter C, 2008, J MOL RECOGNIT, V21, P401, DOI 10.1002/jmr.911; Prinz Heino, 2008, J Chem Biol, V1, P95, DOI 10.1007/s12154-008-0011-5; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; Sakuda S, 1998, BIOORG MED CHEM LETT, V8, P2987, DOI 10.1016/S0960-894X(98)00542-3; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2475, DOI 10.1016/S0040-4039(00)84560-8; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P27278, DOI 10.1074/jbc.M604048200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Sunazuka T, 2009, BIOORGAN MED CHEM, V17, P2751, DOI 10.1016/j.bmc.2009.02.047; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	47	25	27	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24312	24323		10.1074/jbc.M110.183376	http://dx.doi.org/10.1074/jbc.M110.183376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531720	Green Published, hybrid			2022-12-27	WOS:000292294900072
J	Brautigam, CA; Wynn, RM; Chuang, JL; Naik, MT; Young, BB; Huang, TH; Chuang, DT				Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Naik, Mandar T.; Young, Brittany B.; Huang, Tai-huang; Chuang, David T.			Structural and Thermodynamic Basis for Weak Interactions between Dihydrolipoamide Dehydrogenase and Subunit-binding Domain of the Branched-chain alpha-Ketoacid Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; PROTEIN COMPLEX; HOT-SPOTS; ACID; COMPONENT; SEQUENCE; ENERGY	The purified mammalian branched-chain alpha-ketoacid dehydrogenase complex (BCKDC), which catalyzes the oxidative decarboxylation of branched-chain alpha-keto acids, is essentially devoid of the constituent dihydrolipoamide dehydrogenase component (E3). The absence of E3 is associated with the low affinity of the subunit-binding domain of human BCKDC (hSBDb) for hE3. In this work, sequence alignments of hSBDb with the E3-binding domain (E3BD) of the mammalian pyruvate dehydrogenase complex show that hSBDb has an arginine at position 118, where E3BD features an asparagine. Substitution of Arg-118 with an asparagine increases the binding affinity of the R118N hSBDb variant (designated hSBDb*) for hE3 by nearly 2 orders of magnitude. The enthalpy of the binding reaction changes from endothermic with the wild-type hSBDb to exothermic with the hSBDb* variant. This higher affinity interaction allowed the determination of the crystal structure of the hE3/hSBDb* complex to 2.4-angstrom resolution. The structure showed that the presence of Arg-118 poses a unique, possibly steric and/or electrostatic incompatibility that could impede E3 interactions with the wild-type hSBDb. Compared with the E3/E3BD structure, the hE3/hSBDb* structure has a smaller interfacial area. Solution NMR data corroborated the interactions of hE3 with Arg-118 and Asn-118 in wild-type hSBDb and mutant hSBDb*, respectively. The NMR results also showed that the interface between hSBDb and hE3 does not change significantly from hSBDb to hSBDb*. Taken together, our results represent a starting point for explaining the long standing enigma that the E2b core of the BCKDC binds E3 far more weakly relative to other alpha-ketoacid dehydrogenase complexes.	[Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Young, Brittany B.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Brautigam, Chad A.; Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Naik, Mandar T.; Huang, Tai-huang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Huang, Tai-huang] Natl Taiwan Normal Univ, Dept Phys, Taipei 10677, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Academia Sinica - Taiwan; National Taiwan Normal University	Brautigam, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chad.brautigam@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338; Naik, Mandar/0000-0002-7016-572X; Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK26758, DK62306]; Welch Foundation [I-1286]; National Science Council, Taiwan [NSC98-2113-M-001-014]; National Health Research Institute, Taiwan [NHRI-EX99-9933B1]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Research Program for Genomic Medicine, the Republic of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK026758, R01DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Research Program for Genomic Medicine, the Republic of China(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK26758 and DK62306 (to D. T. C.), Grant I-1286 from the Welch Foundation (to D. T. C.), Grant NSC98-2113-M-001-014 from the National Science Council, Taiwan (to T. H. H.), and Grant NHRI-EX99-9933B1 from National Health Research Institute, Taiwan (to T.-h. H.).; The x-ray data are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago at Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The NMR spectra were acquired at the High-field NMR Center Taiwan, which is supported by the National Research Program for Genomic Medicine, the Republic of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; Chang CF, 2006, J BIOL CHEM, V281, P28345, DOI 10.1074/jbc.M605005200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang DT, 2006, J NUTR, V136, p243S, DOI 10.1093/jn/136.1.243S; CHUANG DT, 1984, J BIOL CHEM, V259, P9277; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; DANNER DJ, 1988, METHOD ENZYMOL, V166, P298; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Goddard D., 2008, SPARKY 3; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Jung HI, 2002, PROTEIN SCI, V11, P1091, DOI 10.1110/ps.4970102; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; PAXTON R, 1982, J BIOL CHEM, V257, P4433; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625	36	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23476	23488		10.1074/jbc.M110.202960	http://dx.doi.org/10.1074/jbc.M110.202960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543315	Green Published, hybrid			2022-12-27	WOS:000292025000078
J	Malle, E; Zhou, HW; Neuhold, J; Spitzenberger, B; Klepsch, F; Pollak, T; Bergner, O; Ecker, GF; Stolt-Bergner, PC				Malle, Elisabeth; Zhou, Hongwen; Neuhold, Jana; Spitzenberger, Bettina; Klepsch, Freya; Pollak, Thomas; Bergner, Oliver; Ecker, Gerhard F.; Stolt-Bergner, Peggy C.			Random Mutagenesis of the Prokaryotic Peptide Transporter YdgR Identifies Potential Periplasmic Gating Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; MEMBRANE; PROTEINS; MUTATIONS; MECHANISM; PATHWAY; HPEPT1; FAMILY; DOMAIN	The peptide transporter (PTR) family represents a group of proton-coupled secondary transporters responsible for bulk uptake of amino acids in the form of di- and tripeptides, an essential process employed across species ranging from bacteria to humans. To identify amino acids critical for peptide transport in a prokaryotic PTR member, we have screened a library of mutants of the Escherichia coli peptide transporter YdgR using a high-throughput substrate uptake assay. We have identified 35 single point mutations that result in a full or partial loss of transport activity. Additional analysis, including homology modeling based on the crystal structure of the Shewanella oneidensis peptide transporter PepT(so), identifies Glu(56) and Arg(305) as potential periplasmic gating residues. In addition to providing new insights into transport by members of the PTR family, these mutants provide valuable tools for further study of the mechanism of peptide transport.	[Malle, Elisabeth; Zhou, Hongwen; Neuhold, Jana; Spitzenberger, Bettina; Pollak, Thomas; Bergner, Oliver; Stolt-Bergner, Peggy C.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Zhou, Hongwen; Neuhold, Jana] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria; [Klepsch, Freya; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Stolt-Bergner, PC (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stolt@imp.ac.at		Trasischker, Freya/0000-0003-1410-695X; Ecker, Gerhard/0000-0003-4209-6883; Stolt-Bergner, Peggy/0000-0002-5887-2915	Austrian Science Fund [SFB35, F3507, F3502]; Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative [253275]; Boehringer Ingelheim; Austrian Science Fund (FWF) [F 3507] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative; Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund, SFB35 projects F3507 and F3502, the Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative project Number 253275, and Boehringer Ingelheim.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bolger MB, 1998, J PHARM SCI-US, V87, P1286, DOI 10.1021/js980090u; Brandsch M, 2008, J PHARM PHARMACOL, V60, P543, DOI 10.1211/jpp.60.5.0002; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; DANIEL H, 1992, J BIOL CHEM, V267, P9565; Fei YJ, 1998, BIOCHEM BIOPH RES CO, V246, P39, DOI 10.1006/bbrc.1998.8566; GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Harder D, 2008, FEBS J, V275, P3290, DOI 10.1111/j.1742-4658.2008.06477.x; Hauser M, 2005, MOL MEMBR BIOL, V22, P215, DOI 10.1080/09687860500093248; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; Kulkarni AA, 2003, J BIOL CHEM, V278, P51833, DOI 10.1074/jbc.M308356200; Kulkarni AA, 2003, BIOCHEM BIOPH RES CO, V306, P177, DOI 10.1016/S0006-291X(03)00926-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; PAULSEN IT, 1994, TRENDS BIOCHEM SCI, V19, P404, DOI 10.1016/0968-0004(94)90087-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	31	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23121	23131		10.1074/jbc.M111.239657	http://dx.doi.org/10.1074/jbc.M111.239657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558271	Green Published, hybrid			2022-12-27	WOS:000292025000046
J	Park, H; Valencia-Gallardo, C; Sharff, A; Guy, TVN; Izard, T				Park, HaJeung; Valencia-Gallardo, Cesar; Sharff, Andrew; Guy Tran Van Nhieu; Izard, Tina			Novel Vinculin Binding Site of the IpaA Invasin of Shigella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTININ; TALIN ROD; PROTEIN; ENTRY; ACTIVATION; IDENTIFICATION; ASSOCIATION; MUTAGENESIS; DYNAMICS; FLEXNERI	Internalization of Shigella into host epithelial cells, where the bacteria replicates and spreads to neighboring cells, requires a type 3 secretion system (T3SS) effector coined IpaA. IpaA binds directly to and activates the cytoskeletal protein vinculin after injection in the host cell cytosol, and this was previously thought to be directed by two amphipathic alpha-helical vinculin-binding sites (VBS) found in the C-terminal tail domain of IpaA. Here, we report a third VBS, IpaA-VBS3, that is located N-terminal to the other two VBSs of IpaA and show that one IpaA molecule can bind up to three vinculin molecules. Biochemical in vitro Shigella invasion assays and the 1.6 angstrom crystal structure of the vinculin.IpaA-VBS3 complex showed that IpaA-VBS3 is functionally redundant with the other two IpaA-VBSs in cell invasion and in activating the latent F-actin binding functions of vinculin. Multiple VBSs in IpaA are reminiscent of talin, which harbors 11 VBSs. However, most of the talin VBSs have low affinity and are buried in helix bundles, whereas all three of the VBSs of IpaA are high affinity, readily available, and in close proximity to each other in the IpaA structure. Although deletion of IpaA-VBS3 has no detectable effects on Shigella invasion of epithelial cells, deletion of all three VBSs impaired bacterial invasion to levels found in an ipaA null mutant strain. Thus, IpaA-directed mimicry of talin in activating vinculin occurs through three high affinity VBSs that are essential for Shigella pathogenesis.	[Park, HaJeung; Izard, Tina] Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA; [Valencia-Gallardo, Cesar; Guy Tran Van Nhieu] Coll France, INSERM, Unite Commun Intercellulaire & Infect Microbienne, U971, F-75005 Paris, France; [Sharff, Andrew] Global Phasing Ltd, Cambridge CB3 0AX, England	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Global Phasing Limited	Izard, T (corresponding author), Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA.	mkernick@scripps.edu	Van Nhieu, Guy Tran/Y-6359-2018	Van Nhieu, Guy Tran/0000-0002-3901-2186	National Institutes of Health; State of Florida	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida	This work was supported, in whole or in part, by National Institutes of Health grants (to T. I.). This work was also supported by start-up funds provided to Scripps Florida from the State of Florida (to T. I.).	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Bricogne G., 2010, BUSTER VERSION 2 9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; LEE SW, 1992, J BIOL CHEM, V267, P16355; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MENARD R, 1993, J BACTERIOL, V175, P5899; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Niyogi SK, 2005, J MICROBIOL, V43, P133; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; Sansonetti PJ, 1998, ANTON LEEUW INT J G, V74, P191, DOI 10.1023/A:1001519806727; Smart O. S., 2008, ANN M AM CRYST ASS A; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Van Nhieu GT, 2007, EMBO J, V26, P4588; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zamir E, 2001, J CELL SCI, V114, P3583; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	44	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23214	23221		10.1074/jbc.M110.184283	http://dx.doi.org/10.1074/jbc.M110.184283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525010	hybrid, Green Published			2022-12-27	WOS:000292025000055
J	Wu, CS; Agrawal, S; Vasanji, A; Drazba, J; Sarkaria, S; Xie, J; Welch, CM; Liu, ML; Anand-Apte, B; Horowitz, A				Wu, Chuanshen; Agrawal, Sudesh; Vasanji, Amit; Drazba, Judy; Sarkaria, Sandeep; Xie, Jing; Welch, Christopher M.; Liu, Miaoliang; Anand-Apte, Bela; Horowitz, Arie			Rab13-dependent Trafficking of RhoA Is Required for Directional Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE EXCHANGE FACTOR; CELL-CELL JUNCTIONS; TIGHT JUNCTIONS; BRANCHING MORPHOGENESIS; ENDOCYTIC TRAFFICKING; GTPASE; PROTEIN; DOMAIN; JRAB/MICAL-L2; BINDING	Angiogenesis requires concomitant remodeling of cell junctions and migration, as exemplified by recent observations of extensive endothelial cell movement along growing blood vessels. We report that a protein complex that regulates cell junctions is required for VEGF-driven directional migration and for angiogenesis in vivo. The complex consists of RhoA and Syx, a RhoA guanine exchange factor cross-linked by the Crumbs polarity protein Mupp1 to angiomotin, a phosphatidylinositol-binding protein. The Syx-associated complex translocates to the leading edge of migrating cells by membrane trafficking that requires the tight junction recycling GTPase Rab13. In turn, Rab13 associates with Grb2, targeting Syx and RhoA to Tyr(1175)-phosphorylated VEGFR2 at the leading edge. Rab13 knockdown in zebrafish impeded sprouting of intersegmental vessels and diminished the directionality of their tip cells. These results indicate that endothelial cell mobility in sprouting vessels is facilitated by shuttling the same protein complex from disassembling junctions to the leading edges of cells.	[Vasanji, Amit] Cleveland Clin, Lerner Coll Med, Dept Biomed Engn, Cleveland, OH 44195 USA; [Xie, Jing; Anand-Apte, Bela] Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Drazba, Judy] Cleveland Clin, Lerner Coll Med, Imaging Core Facil, Cleveland, OH 44195 USA; [Welch, Christopher M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Horowitz, Arie] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Liu, Miaoliang] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Wu, Chuanshen; Agrawal, Sudesh; Sarkaria, Sandeep; Horowitz, Arie] Cleveland Clin, Lerner Coll Med, Dept Mol Cardiol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Dartmouth College; Case Western Reserve University; Cleveland Clinic Foundation	Horowitz, A (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	horowia@ccf.org	Horowitz, Arie/AAT-9482-2021; Horowitz, Arie/F-4628-2015	Horowitz, Arie/0000-0001-6239-1287	National Institutes of Health [F30-HL-094020, T32-GM-80079]; National Research Service Award [HL007914]; American Heart Association; NATIONAL EYE INSTITUTE [R01EY016490, R01EY020861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094020, T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowships F30-HL-094020 and T32-GM-80079 (to C. M. W.).; Supported by National Research Service Award Training Grant HL007914.; Supported by an American Heart Association summer undergraduate research fellowship.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Janssens K, 2010, P NATL ACAD SCI USA, V107, P7323, DOI 10.1073/pnas.0915075107; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Thisse B., 2001, DIRECT DATA SUBMISSI; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wells Claire M., 2004, V294, P31; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101; Zicha D, 1997, Methods Mol Biol, V75, P449	60	37	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23511	23520		10.1074/jbc.M111.245209	http://dx.doi.org/10.1074/jbc.M111.245209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543326	Green Published, hybrid			2022-12-27	WOS:000292025000081
J	De Franceschi, G; Frare, E; Pivato, M; Relini, A; Penco, A; Greggio, E; Bubacco, L; Fontana, A; de Laureto, PP				De Franceschi, Giorgia; Frare, Erica; Pivato, Micaela; Relini, Annalisa; Penco, Amanda; Greggio, Elisa; Bubacco, Luigi; Fontana, Angelo; de Laureto, Patrizia Polverino			Structural and Morphological Characterization of Aggregated Species of alpha-Synuclein Induced by Docosahexaenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SOLUTION NMR-SPECTROSCOPY; PARKINSONS-DISEASE; IN-VITRO; PHOSPHOLIPID-BINDING; METHIONINE OXIDATION; SECONDARY STRUCTURE; PROTEIN ADDUCTS; LEWY-BODY; BRAIN	The interaction of brain lipids with alpha-synuclein may play an important role in the pathogenesis of Parkinson disease (PD). Docosahexaenoic acid (DHA) is an abundant fatty acid of neuronal membranes, and it is presents at high levels in brain areas with alpha-synuclein inclusions of patients with PD. In animal models, an increase of DHA content in the brain induces alpha-synuclein oligomer formation in vivo. However, it is not clear whether these oligomeric species are the precursors of the larger aggregates found in Lewy bodies of post-mortem PD brains. To characterize these species and to define the role of fatty acids in amyloid formation, we investigated the aggregation process of alpha-synuclein in the presence of DHA. We found that DHA readily promotes alpha-synuclein aggregation and that the morphology of these aggregates is dependent on the ratio between the protein and DHA. In the presence of a molar ratio protein/DHA of 1:10, amyloid-like fibrils are formed. These fibrils are morphologically different from those formed by alpha-synuclein alone and have a less packed structure. At a protein/DHA molar ratio of 1:50, we observe the formation of stable oligomers. Moreover, chemical modifications, methionine oxidations, and protein-lipid adduct formations are induced by increasing concentrations of DHA. The extent of these modifications defines the structure and the stability of aggregates. We also show that alpha-synuclein oligomers are more toxic if generated in the presence of DHA in dopaminergic neuronal cell lines, suggesting that these species might be important in the neurodegenerative process associated with PD.	[De Franceschi, Giorgia; Frare, Erica; Pivato, Micaela; Fontana, Angelo; de Laureto, Patrizia Polverino] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Ctr Biotechnol, I-35121 Padua, Italy; [Relini, Annalisa; Penco, Amanda] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Greggio, Elisa; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Padua; University of Genoa; University of Padua	de Laureto, PP (corresponding author), Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Ctr Biotechnol, Viale G Colombo 3, I-35121 Padua, Italy.	patrizia.polverinodelaureto@unipd.it	Bubacco, Luigi/B-5602-2012; Relini, Annalisa/AHC-3105-2022; Fontana, Angelo/C-3354-2012; Greggio, Elisa/H-6119-2013	Bubacco, Luigi/0000-0001-7927-9208; Fontana, Angelo/0000-0002-5453-461X; Greggio, Elisa/0000-0002-8172-3598; RELINI, ANNALISA/0000-0002-4040-9279	Ministero dell'Istruzione, dell'Universita e della Ricerca; Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale [2008SYP79]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale	Supported by Ministero dell'Istruzione, dell'Universita e della Ricerca ("Rientro dei Cervelli" Program).; Supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale 2008 (Protocol 2008SYP79).	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Frankel E.N., 2005, LIPID OXIDATION; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kim KS, 2005, B KOREAN CHEM SOC, V26, P1255; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu W, 2007, BBA-PROTEINS PROTEOM, V1774, P258, DOI 10.1016/j.bbapap.2006.11.014; Liu Wei, 2008, Current Proteomics, V5, P62, DOI 10.2174/157016408783955119; Liu XB, 2008, J BIOL CHEM, V283, P34887, DOI 10.1074/jbc.M805682200; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shibamoto T, 2006, J PHARMACEUT BIOMED, V41, P12, DOI 10.1016/j.jpba.2006.01.047; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Trostchansky A, 2007, AMINO ACIDS, V32, P517, DOI 10.1007/s00726-006-0426-7; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2006, BIOCHEMISTRY-US, V45, P8135, DOI 10.1021/bi052584t	49	77	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22262	22274		10.1074/jbc.M110.202937	http://dx.doi.org/10.1074/jbc.M110.202937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527634	hybrid, Green Published			2022-12-27	WOS:000291719900034
J	Huber, K; Doyon, G; Plaks, J; Fyne, E; Mellors, JW; Sluis-Cremer, N				Huber, Kelly; Doyon, Genevieve; Plaks, Joseph; Fyne, Elizabeth; Mellors, John W.; Sluis-Cremer, Nicolas			Inhibitors of Histone Deacetylases CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV TYPE 1 (HIV- 1) FROM LATENTLY INFECTED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; VALPROIC ACID; POSTINTEGRATION LATENCY; T-CELLS; EXPRESSION; RESERVOIR; RECRUITMENT; LINE; IDENTIFICATION	Deacetylation of histone proteins at the HIV type 1 (HIV-1) long terminal repeat (LTR) by histone deactylases (HDACs) can promote transcriptional repression and virus latency. As such, HDAC inhibitors (HDACI) could be used to deplete reservoirs of persistent, quiescent HIV-1 proviral infection. However, the development of HDACI to purge latent HIV-1 requires knowledge of the HDAC isoforms contributing to viral latency and the development of inhibitors specific to these isoforms. In this study, we identify the HDACs responsible for HIV-1 latency in Jurkat J89GFP cells using a chemical approach that correlates HDACI isoform specificity with their ability to reactivate latent HIV-1 expression. We demonstrate that potent inhibition or knockdown of HDAC1, an HDAC isoform reported to drive HIV-1 into latency, was not sufficient to de-repress the viral LTR. Instead, we found that inhibition of HDAC3 was necessary to activate latent HIV-1. Consistent with this finding, we identified HDAC3 at the HIV-1 LTR by chromatin immunoprecipitation. Interestingly, we show that valproic acid is a weak inhibitor of HDAC3 (IC50 = 5.5 mM) relative to HDAC1 (IC50 = 170 mu M). Because the total therapeutic concentration of valproic acid ranges from 275 to 700 mu M in adults, these data may explain why this inhibitor has no effect on the decay of latent HIV reservoirs in patients. Taken together, our study suggests an important role for HDAC3 in HIV-1 latency and, importantly, describes a chemical approach that can readily be used to identify the HDAC isoforms that contribute to HIV-1 latency in other cell types.	[Huber, Kelly; Doyon, Genevieve; Plaks, Joseph; Fyne, Elizabeth; Mellors, John W.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sluis-Cremer, N (corresponding author), S817 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	nps2@pitt.edu	Huber, Kelly/AAE-3449-2020					ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malcolm T, 2007, VIRUS GENES, V35, P215, DOI 10.1007/s11262-007-0109-9; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Ying H, 2010, INT J MOL MED, V26, P265, DOI 10.3892/ijmm_00000461; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	38	110	114	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22211	22218		10.1074/jbc.M110.180224	http://dx.doi.org/10.1074/jbc.M110.180224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531716	Green Published, hybrid			2022-12-27	WOS:000291719900028
J	Kumar, A; John, L; Maity, S; Manchanda, M; Sharma, A; Saini, N; Chakraborty, K; Sengupta, S				Kumar, Arun; John, Lijo; Maity, Shuvadeep; Manchanda, Mini; Sharma, Abhay; Saini, Neeru; Chakraborty, Kausik; Sengupta, Shantanu			Converging Evidence of Mitochondrial Dysfunction in a Yeast Model of Homocysteine Metabolism Imbalance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CORONARY-ARTERY-DISEASE; SACCHAROMYCES-CEREVISIAE; ENDOTHELIAL DYSFUNCTION; S-ADENOSYLHOMOCYSTEINE; OXIDATIVE STRESS; GENE-EXPRESSION; REGULATORY ASSOCIATIONS; FLUORESCENT PROTEINS; INDUCED APOPTOSIS	An elevated level of homocysteine, a thiol amino acid, is associated with various complex disorders. The cellular effects of homocysteine and its precursors S-adenosylhomocysteine (AdoHcy) and S-adenosylmethionine (AdoMet) are, however, poorly understood. We used Saccharomyces cerevisiae as a model to understand the basis of pathogenicity induced by homocysteine and its precursors. Both homocysteine and AdoHcy but not AdoMet inhibited the growth of the str4 Delta strain (which lacks the enzyme that converts homocysteine to cystathionine-mimicking vascular cells). Addition of AdoMet abrogated the inhibitory effect of AdoHcy but not that of homocysteine indicating that an increase in the AdoMet/AdoHcy ratio is sufficient to overcome the AdoHcy-mediated growth defect but not that of homocysteine. Also, the transcriptomic profile of AdoHcy and homocysteine showed gross dissimilarity based on gene enrichment analysis. Furthermore, compared with homocysteine, AdoHcy treatment caused a higher level of oxidative stress in the cells. However, unlike a previously reported response in wild type (Kumar, A., John, L., Alam, M. M., Gupta, A., Sharma, G., Pillai, B., and Sengupta, S. (2006) Biochem. J. 396, 61-69), the str4 Delta strain did not exhibit an endoplasmic reticulum stress response. This suggests that homocysteine induces varied response depending on the flux of homocysteine metabolism. We also observed altered expression of mitochondrial genes, defective membrane potential, and fragmentation of the mitochondrial network together with the increased expression of fission genes indicating that the imbalance in homocysteine metabolism has a major effect on mitochondrial functions. Furthermore, treatment of cells with homocysteine or AdoHcy resulted in apoptosis as revealed by annexin V staining and TUNEL assay. Cumulatively, our results suggest that elevated levels of homocysteine lead to mitochondrial dysfunction, which could potentially initiate pro-apoptotic pathways, and this could be one of the mechanisms underlying homocysteine-induced pathogenicity.	[Kumar, Arun; John, Lijo; Maity, Shuvadeep; Manchanda, Mini; Sharma, Abhay; Saini, Neeru; Chakraborty, Kausik; Sengupta, Shantanu] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sengupta, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.	shantanus@igib.res.in	Maity, Shuvadeep/I-7846-2019; Chakraborty, Kausik/AAL-5748-2021	Maity, Shuvadeep/0000-0002-6031-4744; KUMAR, ARUN/0000-0001-8706-8558; Sharma, Abhay/0000-0003-1306-1497; chakraborty, kausik/0000-0001-6000-8379	Council of Scientific and Industrial Research, India [CMM 0018/NWP 0034]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Grant CMM 0018/NWP 0034 from the Council of Scientific and Industrial Research, India.	Applebaum J, 2004, J PSYCHIATR RES, V38, P413, DOI 10.1016/j.jpsychires.2004.01.003; Ara AI, 2008, HEPATOLOGY, V47, P1655, DOI 10.1002/hep.22231; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Brune B, 2005, ANTIOXID REDOX SIGN, V7, P497, DOI 10.1089/ars.2005.7.497; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cavalca V, 2001, CLIN CHEM, V47, P887; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Kumar A, 2001, NAT REV GENET, V2, P302, DOI 10.1038/35066084; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin HC, 2008, BIOFACTORS, V34, P81, DOI 10.1002/biof.5520340201; Lindquist S, 2001, PHILOS T ROY SOC B, V356, P169, DOI 10.1098/rstb.2000.0762; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PALELLA TD, 1982, J LAB CLIN MED, V100, P269; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Priault M, 2003, FEMS YEAST RES, V4, P15, DOI 10.1016/S1567-1356(03)00143-0; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; Rounds S, 1998, AM J PHYSIOL-LUNG C, V275, pL379, DOI 10.1152/ajplung.1998.275.2.L379; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Sundaramoorthy E, 2008, PROTEINS, V71, P1475, DOI 10.1002/prot.21846; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Tanriverdi H, 2007, CARDIOLOGY, V107, P313, DOI 10.1159/000099068; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Guldener C, 2003, CLIN CHEM LAB MED, V41, P1412; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Weiss N, 2003, CLIN CHEM LAB MED, V41, P1455, DOI 10.1515/CCLM.2003.223; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zinellu A, 2009, ATHEROSCLEROSIS, V206, P40, DOI 10.1016/j.atherosclerosis.2009.01.035	81	13	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21779	21795		10.1074/jbc.M111.228072	http://dx.doi.org/10.1074/jbc.M111.228072			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504896	hybrid, Green Published			2022-12-27	WOS:000291464700073
J	Feng, Y; Wang, JX; Asher, S; Hoang, L; Guardiani, C; Ivanov, I; Zheng, YG				Feng, You; Wang, Juxian; Asher, Sabrina; Hoang, Linh; Guardiani, Carlo; Ivanov, Ivaylo; Zheng, Y. George			Histone H4 Acetylation Differentially Modulates Arginine Methylation by an in Cis Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; ACETYLTRANSFERASE ACTIVITY; CHROMATIN MODIFICATIONS; SUBSTRATE-SPECIFICITY; COACTIVATORS P300; MSL COMPLEX; TRANSCRIPTION; DNA	Histone H4 undergoes extensive post-translational modifications (PTMs) at its N-terminal tail. Many of these PTMs profoundly affect the on and off status of gene transcription. The molecular mechanism by which histone PTMs modulate genetic and epigenetic processes is not fully understood. In particular, how a PTM mark affects the presence and level of other histone modification marks needs to be addressed and is essential for better understanding the molecular basis of histone code hypothesis. To dissect the interplaying relationship between different histone modification marks, we investigated how individual lysine acetylations and their different combinations at the H4 tail affect Arg-3 methylation in cis. Our data reveal that the effect of lysine acetylation on arginine methylation depends on the site of acetylation and the type of methylation. Although certain acetylations present a repressive impact on PRMT1-mediated methylation (type I methylation), lysine acetylation generally is correlated with enhanced methylation by PRMT5 (type II dimethylation). In particular, Lys-5 acetylation decreases the activity of PRMT1 but increases that of PRMT5. Furthermore, circular dichroism study and computer simulation demonstrate that hyperacetylation increases the content of ordered secondary structures at the H4 tail region. These findings provide new insights into the regulatory mechanism of Arg-3 methylation by H4 acetylation and unravel the complex intercommunications that exist between different the PTM marks in cis. The divergent activities of PRMT1 and PRMT5 with respect to different acetyl-H4 substrates suggest that type I and type II protein-arginine methyltransferases use distinct molecular determinants for substrate recognition and catalysis.	[Zheng, Y. George] Georgia State Univ, Dept Chem, Program Mol Basis Dis, Atlanta, GA 30302 USA; Georgia State Univ, Dept Biol, Program Mol Basis Dis, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Zheng, YG (corresponding author), Georgia State Univ, Dept Chem, Program Mol Basis Dis, Atlanta, GA 30302 USA.	yzheng@gsu.edu	Ivanov, Ivaylo/A-7613-2013; Zheng, Yujun/H-9122-2012; Guardiani, Carlo/AHB-1217-2022; Zheng, Yujun/P-8975-2014	Ivanov, Ivaylo/0000-0002-5306-1005; Zheng, Yujun/0000-0001-7116-3067; Guardiani, Carlo/0000-0002-8914-9260; Feng, You/0000-0002-4710-7396	National Institutes of Health [R01GM086717]; American Heart Association [09BGIA2220207]; Georgia State University; Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Georgia State University; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086717 (to Y.G.Z.). This work was also supported by American Heart Association Grant 09BGIA2220207 (to Y.G.Z.) and by Georgia State University Molecular Basis of Disease Program (to S.A. and L.H.).; Computational resources were provided through an INCITE allocation (to I.I.) at the Oak Ridge Leadership Computing Facility, supported by the Department of Energy under Contract DE-AC05-00OR22725.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Babin V., 2008, AMBER; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; CUOMO A, 2010, AMINO ACIDS; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TURNER BM, 1989, EXP CELL RES, V182, P206, DOI 10.1016/0014-4827(89)90292-9; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vyskot B, 1999, GENOME, V42, P343, DOI 10.1139/gen-42-2-343; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120	61	54	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20323	20334		10.1074/jbc.M110.207258	http://dx.doi.org/10.1074/jbc.M110.207258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502321	Green Published, hybrid			2022-12-27	WOS:000291267600020
J	Truschel, ST; Sengupta, D; Foote, A; Heroux, A; Macbeth, MR; Linstedt, AD				Truschel, Steven T.; Sengupta, Debrup; Foote, Adam; Heroux, Annie; Macbeth, Mark R.; Linstedt, Adam D.			Structure of the Membrane-tethering GRASP Domain Reveals a Unique PDZ Ligand Interaction That Mediates Golgi Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STACKING; PHOSPHORYLATION; GM130	Biogenesis of the ribbon-like membrane network of the mammalian Golgi requires membrane tethering by the conserved GRASP domain in GRASP65 and GRASP55, yet the tethering mechanism is not fully understood. Here, we report the crystal structure of the GRASP55 GRASP domain, which revealed an unusual arrangement of two tandem PDZ folds that more closely resemble prokaryotic PDZ domains. Biochemical and functional data indicated that the interaction between the ligand-binding pocket of PDZ1 and an internal ligand on PDZ2 mediates the GRASP self-interaction, and structural analyses suggest that this occurs via a unique mode of internal PDZ ligand recognition. Our data uncover the structural basis for ligand specificity and provide insight into the mechanism of GRASP-dependent membrane tethering of analogous Golgi cisternae.	[Truschel, Steven T.; Sengupta, Debrup; Foote, Adam; Macbeth, Mark R.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Heroux, Annie] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	Carnegie Mellon University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@andrew.cmu.edu		Truschel, Steven/0000-0003-3394-6006	National Institutes of Health [GM-56779]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; NCI, National Institutes of Health [P41RR012408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A.D.L.).; We thank Collin Bachert and Somshuvra Mukhopadhyay for critical reading of the manuscript. Some data for this study were measured at beamline X25 at the National Synchrotron Light Source where financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the NCI, National Institutes of Health, Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	23	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20125	20129		10.1074/jbc.C111.245324	http://dx.doi.org/10.1074/jbc.C111.245324			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515684	Green Published, hybrid			2022-12-27	WOS:000291267600001
J	Carnes, J; Soares, CZ; Wickham, C; Stuart, K				Carnes, Jason; Soares, Carmen Zelaya; Wickham, Carey; Stuart, Kenneth			Endonuclease Associations with Three Distinct Editosomes in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING COMPLEX; MESSENGER-RNA; EDITING COMPLEX; IN-VITRO; STRUCTURAL INTEGRITY; U-INSERTION; DELETION; MITOCHONDRIA; PROTEINS; MECHANISM	Three distinct editosomes, typified by mutually exclusive KREN1, KREN2, or KREN3 endonucleases, are essential for mitochondrial RNA editing in Trypanosoma brucei. The three editosomes differ in substrate endoribonucleolytic cleavage specificity, which may reflect the vast number of editing sites that need insertion or deletion of uridine nucleotides (Us). Each editosome requires the single RNase III domain in each endonuclease for catalysis. Studies reported here show that the editing endonucleases do not form homodimeric domains, and may therefore function as intermolecular heterodimers, perhaps with KREPB4 and/or KREPB5. Editosomes isolated via TAP tag fused to KREPB6, KREPB7, or KREPB8 have a common set of 12 proteins. In addition, KREN3 is only found in KREPB6 editosomes, KREN2 is only found in KREPB7 editosomes, and KREN1 is only found in KREPB8 editosomes. These are the same associations previously found in editosomes isolated via the TAP-tagged endonucleases KREN1, KREN2, or KREN3. Furthermore, TAP-tagged KREPB6, KREPB7, and KREPB8 complexes isolated from cells in which expression of their respective endonuclease were knocked down were disrupted and lacked the heterotrimeric insertion subcomplex (KRET2, KREPA1, and KREL2). These results and published data suggest that KREPB6, KREPB7, and KREPB8 associate with the deletion subcomplex, whereas the KREN1, KREN2, and KREN3 endonucleases associate with the insertion subcomplex.	[Carnes, Jason; Soares, Carmen Zelaya; Wickham, Carey; Stuart, Kenneth] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Stuart, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N,Suite 500, Seattle, WA 98109 USA.	ken.stuart@seattlebiomed.org		Carnes, Jason/0000-0001-7302-1935	National Institutes of Health [AI014102]; Economic Development Administration; United States Department of Commerce; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014102, R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic Development Administration; United States Department of Commerce; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI014102, the Economic Development Administration, United States Department of Commerce, and the M. J. Murdock Charitable Trust.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; Hans J, 2007, RNA, V13, P881, DOI 10.1261/rna.486107; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kang XD, 2006, P NATL ACAD SCI USA, V103, P13944, DOI 10.1073/pnas.0604476103; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wu MT, 2011, J STRUCT BIOL, V174, P124, DOI 10.1016/j.jsb.2010.10.007	51	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19320	19330		10.1074/jbc.M111.228965	http://dx.doi.org/10.1074/jbc.M111.228965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474442	Green Published, hybrid			2022-12-27	WOS:000291027700014
J	Farghaian, H; Chen, Y; Fu, AWY; Fu, AKY; Ip, JPK; Ip, NY; Turnley, AM; Cole, AR				Farghaian, Hovik; Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.; Turnley, Ann M.; Cole, Adam R.			Scapinin-induced Inhibition of Axon Elongation Is Attenuated by Phosphorylation and Translocation to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE INHIBITORS; SUBSTRATE SPECIFICITIES; CYTOCHALASIN-B; ACTIN; BINDING; FAMILY; GROWTH; PHOSPHATASE-1; UPDATE	Scapinin is an actin-and PP1-binding protein that is exclusively expressed in the brain; however, its function in neurons has not been investigated. Here we show that expression of scapinin in primary rat cortical neurons inhibits axon elongation without affecting axon branching, dendritic outgrowth, or polarity. This inhibitory effect was dependent on its ability to bind actin because a mutant form that does not bind actin had no effect on axon elongation. Immunofluorescence analysis showed that scapinin is predominantly located in the distal axon shaft, cell body, and nucleus of neurons and displays a reciprocal staining pattern to phalloidin, consistent with previous reports that it binds actin monomers to inhibit polymerization. We show that scapinin is phosphorylated at a highly conserved site in the central region of the protein (Ser-277) by Cdk5 in vitro. Expression of a scapinin phospho-mimetic mutant (S277D) restored normal axon elongation without affecting actin binding. Instead, phosphorylated scapinin was sequestered in the cytoplasm of neurons and away from the axon. Because its expression is highest in relatively plastic regions of the adult brain (cortex, hippocampus), scapinin is a new regulator of neurite outgrowth and neuroplasticity in the brain.	[Farghaian, Hovik; Cole, Adam R.] Garvan Inst Med Res, Neurosignalling Grp, Sydney, NSW 2010, Australia; [Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	Garvan Institute of Medical Research; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Melbourne	Cole, AR (corresponding author), Garvan Inst Med Res, Neurosignalling Grp, 384 Victoria St, Sydney, NSW 2010, Australia.	a.cole@garvan.org.au	Turnley, Ann/A-8125-2010; Ip, Jacque Pak Kan/AAH-1744-2020	Ip, Jacque Pak Kan/0000-0003-4545-8261; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Turnley, Ann/0000-0002-8442-127X	Australian National Health and Medical Research Council (NHMRC) [454886]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by an Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship (454886).	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MORRIS JR, 1984, J CELL BIOL, V98, P2064, DOI 10.1083/jcb.98.6.2064; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Worch S, 2006, CYTOGENET GENOME RES, V115, P23, DOI 10.1159/000094797	18	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19724	19734		10.1074/jbc.M110.205781	http://dx.doi.org/10.1074/jbc.M110.205781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487013	Green Published, hybrid			2022-12-27	WOS:000291027700055
J	Pareek, G; Samaddar, M; D'Silva, P				Pareek, Gautam; Samaddar, Madhuja; D'Silva, Patrick			Primary Sequence That Determines the Functional Overlap between Mitochondrial Heat Shock Protein 70 Ssc1 and Ssc3 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; PROTEIN IMPORT MOTOR; SUBSTRATE-BINDING DOMAIN; HSP70 CHAPERONES; INNER-MEMBRANE; ALLOSTERIC REGULATION; INTERDOMAIN LINKER; ATPASE DOMAIN; TRANSLOCATION; MATRIX	The evolutionary diversity of the HSP70 gene family at the genetic level has generated complex structural variations leading to altered functional specificity and mode of regulation in different cellular compartments. By utilizing Saccharomyces cerevisiae as a model system for better understanding the global functional cooperativity between Hsp70 paralogs, we have dissected the differences in functional properties at the biochemical level between mitochondrial heat shock protein 70 (mtHsp70) Ssc1 and an uncharacterized Ssc3 paralog. Based on the evolutionary origin of Ssc3 and a high degree of sequence homology with Ssc1, it has been proposed that both have a close functional overlap in the mitochondrial matrix. Surprisingly, our results demonstrate that there is no functional cross-talk between Ssc1 and Ssc3 paralogs. The lack of in vivo functional overlap is due to altered conformation and significant lower stability associated with Ssc3. The substrate-binding domain of Ssc3 showed poor affinity toward mitochondrial client proteins and Tim44 due to the open conformation in ADP-bound state. In addition to that, the nucleotide-binding domain of Ssc3 showed an altered regulation by the Mge1 co-chaperone due to a high degree of conformational plasticity, which strongly promotes aggregation. Besides, Ssc3 possesses a dysfunctional inter-domain interface thus rendering it unable to perform functions similar to generic Hsp70s. Moreover, we have identified the critical amino acid sequence of Ssc1 and Ssc3 that can "make or break" mtHsp70 chaperone function. Together, our analysis provides the first evidence to show that the nucleotide-binding domain of mtHsp70s plays a critical role in determining the functional specificity among paralogs and orthologs across kingdoms.	[Pareek, Gautam; Samaddar, Madhuja; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019; PAREEK, GAUTAM/AAN-4638-2020; Samaddar, Madhuja/AAJ-7908-2020	PAREEK, GAUTAM/0000-0001-8430-9870; Samaddar, Madhuja/0000-0001-5046-1604	Wellcome Trust [WT081643MA]; Council of Scientific and Industrial Research	Wellcome Trust(Wellcome TrustEuropean Commission); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Wellcome Trust International Senior Research Fellowship WT081643MA in Biomedical Science (to P. D.) and Council of Scientific and Industrial Research fellowships (to G. P. and M. S.).	Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Knieszner H, 2005, J BIOL CHEM, V280, P28966, DOI 10.1074/jbc.M503031200; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Lussier M, 1997, GENETICS, V147, P435; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Sakasegawa Y, 2003, BIOCHEM BIOPH RES CO, V309, P217, DOI 10.1016/S0006-291X(03)01548-1; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sehorn MG, 2002, BIOCHEMISTRY-US, V41, P8499, DOI 10.1021/bi025810x; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Strub A, 2002, EMBO J, V21, P2626, DOI 10.1093/emboj/21.11.2626; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19001	19013		10.1074/jbc.M110.197434	http://dx.doi.org/10.1074/jbc.M110.197434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474445	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000290785700071
J	Akai, M; Onai, K; Kusano, M; Sato, M; Redestig, H; Toyooka, K; Morishita, M; Miyake, H; Hazama, A; Checchetto, V; Szabo, I; Matsuoka, K; Saito, K; Yasui, M; Ishiura, M; Uozumi, N				Akai, Masaro; Onai, Kiyoshi; Kusano, Miyako; Sato, Mayuko; Redestig, Henning; Toyooka, Kiminori; Morishita, Megumi; Miyake, Hiroshi; Hazama, Akihiro; Checchetto, Vanessa; Szabo, Ildiko; Matsuoka, Ken; Saito, Kazuki; Yasui, Masato; Ishiura, Masahiro; Uozumi, Nobuyuki			Plasma Membrane Aquaporin AqpZ Protein Is Essential for Glucose Metabolism during Photomixotrophic Growth of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; LACTIC-ACID BACTERIA; DEPENDENT K+ UPTAKE; ESCHERICHIA-COLI; GENE-EXPRESSION; WATER CHANNELS; FUNCTIONAL-CHARACTERIZATION; PHOTOSYSTEM STOICHIOMETRY; HETEROTROPHIC GROWTH; POTASSIUM CHANNEL	The genome of Synechocystis PCC 6803 contains a single gene encoding an aquaporin, aqpZ. The AqpZ protein functioned as a water-permeable channel in the plasma membrane. However, the physiological importance of AqpZ in Synechocystis remains unclear. We found that growth in glucose-containing medium inhibited proper division of Delta aqpZ cells and led to cell death. Deletion of a gene encoding a glucose transporter in the Delta aqpZ background alleviated the glucose-mediated growth inhibition of the Delta aqpZ cells. The Delta aqpZ cells swelled more than the wild type after the addition of glucose, suggesting an increase in cytosolic osmolarity. This was accompanied by a down-regulation of the pentose phosphate pathway and concurrent glycogen accumulation. Metabolite profiling by GC/TOF-MS of wild-type and Delta aqpZ cells revealed a relative decrease of intermediates of the tricarboxylic acid cycle and certain amino acids in the mutant. The changed levels of metabolites may have been the cause for the observed decrease in growth rate of the Delta aqpZ cells along with decreased PSII activity at pH values ranging from 7.5 to 8.5. A mutant in sll1961, encoding a putative transcription factor, and a Delta hik31 mutant, lacking a putative glucose-sensing kinase, both exhibited higher glucose sensitivity than the Delta aqpZ cells. Examination of protein expression indicated that sll1961 functioned as a positive regulator of aqpZ gene expression but not as the only regulator. Overall, the Delta aqpZ cells showed defects in macronutrient metabolism, pH homeostasis, and cell division under photomixotrophic conditions, consistent with an essential role of AqpZ in glucose metabolism.	[Akai, Masaro; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kusano, Miyako; Sato, Mayuko; Redestig, Henning; Toyooka, Kiminori; Matsuoka, Ken; Saito, Kazuki] RIKEN, Plant Sci Ctr, Kanagawa 2300045, Japan; [Miyake, Hiroshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648603, Japan; [Hazama, Akihiro] Fukushima Med Univ, Sch Med, Dept Physiol, Fukushima 9601295, Japan; [Checchetto, Vanessa; Szabo, Ildiko] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Matsuoka, Ken] Kyushu Univ, Fac Agr, Lab Plant Nutr, Higashi Ku, Fukuoka 8128581, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2638522, Japan; [Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1608582, Japan	Tohoku University; Nagoya University; RIKEN; Nagoya University; Fukushima Medical University; University of Padua; Kyushu University; Chiba University; Keio University	Uozumi, N (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019; Toyooka, Kiminori/B-5027-2011; Matsuoka, Ken/E-3215-2010; Saito, Kazuki/D-2670-2009; Yasui, Masato/L-3312-2013; Szabo, Ildiko/AAW-5972-2021; Kusano, Miyako/A-3879-2012; Padova, Ildiko/K-5344-2016	Saito, Kazuki/0000-0001-6310-5342; Szabo, Ildiko/0000-0002-3637-3947; Kusano, Miyako/0000-0002-0052-6155; Uozumi, Nobuyuki/0000-0003-4268-1126; Redestig, Henning/0000-0003-2130-9288; Matsuoka, Ken/0000-0001-7229-7294; checchetto, vanessa/0000-0001-8911-6146; Onai, Kiyoshi/0000-0001-9062-2548	MEXT; Japan Society for the Promotion of Science [22020002, 22380056]; Salt Science Research Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Salt Science Research Foundation	This work was supported by MEXT and Japan Society for the Promotion of Science Grants-in-aid for Scientific Research 22020002 and 22380056 (to N. U.) and the Salt Science Research Foundation.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Azad AK, 2011, PLANT SCI, V180, P375, DOI 10.1016/j.plantsci.2010.10.010; Bandell M, 1997, J BIOL CHEM, V272, P18140, DOI 10.1074/jbc.272.29.18140; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Chakrabarti N, 2004, J MOL BIOL, V343, P493, DOI 10.1016/j.jmb.2004.08.036; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; DAESCHEL MA, 1988, APPL ENVIRON MICROB, V54, P1627, DOI 10.1128/AEM.54.6.1627-1629.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delamarche C, 1999, J BACTERIOL, V181, P4193, DOI 10.1128/JB.181.14.4193-4197.1999; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; Froger A, 2001, MICROBIOL-SGM, V147, P1129, DOI 10.1099/00221287-147-5-1129; Fujimori T, 2005, PLANT PHYSIOL, V139, P408, DOI 10.1104/pp.105.064782; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; Hibuse T, 2006, BBA-BIOMEMBRANES, V1758, P1004, DOI 10.1016/j.bbamem.2006.01.008; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Inaba M, 2001, J BACTERIOL, V183, P1376, DOI 10.1128/JB.183.4.1376-1384.2001; Jonsson P, 2004, ANAL CHEM, V76, P1738, DOI 10.1021/ac0352427; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Knowles VL, 2003, PLANT CELL PHYSIOL, V44, P758, DOI 10.1093/pcp/pcg086; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Korithoski B, 2005, J BACTERIOL, V187, P4451, DOI 10.1128/JB.187.13.4451-4456.2005; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Lee S, 2007, PLANT PHYSIOL, V145, P1018, DOI 10.1104/pp.107.105023; Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102; MA TH, 1993, BIOCHEM BIOPH RES CO, V197, P654, DOI 10.1006/bbrc.1993.2529; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Meetam M, 1999, PLANT PHYSIOL, V121, P1267, DOI 10.1104/pp.121.4.1267; Mikkat S, 2000, PLANT CELL ENVIRON, V23, P549, DOI 10.1046/j.1365-3040.2000.00565.x; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Ryu JY, 2004, J BIOL CHEM, V279, P25320, DOI 10.1074/jbc.M402541200; Sakuragi Y, 2006, PLANT PHYSIOL, V141, P508, DOI 10.1104/pp.105.074765; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; SCHMETTERER GR, 1990, PLANT MOL BIOL, V14, P697, DOI 10.1007/BF00016502; Shapiguzov A, 2005, MICROBIOL-SGM, V151, P447, DOI 10.1099/mic.0.27530-0; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soupene E, 2002, J BACTERIOL, V184, P4304, DOI 10.1128/JB.184.15.4304-4307.2002; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Sundaram S, 1998, MICROBIOL-SGM, V144, P1549, DOI 10.1099/00221287-144-6-1549; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; Williams J. G. K., 1988, METHOD ENZYMOL, V167, P776; Wintour EM, 2006, TRENDS ENDOCRIN MET, V17, P77, DOI 10.1016/j.tem.2006.01.009; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Yang C, 2002, APPL MICROBIOL BIOT, V58, P813, DOI 10.1007/s00253-002-0949-0; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118; Zhang CC, 1998, FEMS MICROBIOL LETT, V161, P285, DOI 10.1016/S0378-1097(98)00084-6; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zulkifli L, 2006, J BACTERIOL, V188, P7985, DOI 10.1128/JB.00886-06; Zulkifli L, 2010, J BACTERIOL, V192, P5063, DOI 10.1128/JB.00569-10	72	22	22	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25224	25235		10.1074/jbc.M111.236380	http://dx.doi.org/10.1074/jbc.M111.236380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21558269	Green Published, hybrid			2022-12-27	WOS:000292547900068
J	Contreras-Jurado, C; Garcia-Serrano, L; Gomez-Ferreria, M; Costa, C; Paramio, JM; Aranda, A				Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Costa, Clotilde; Paramio, Jesus M.; Aranda, Ana			The Thyroid Hormone Receptors as Modulators of Skin Proliferation and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; NEGATIVE RESPONSE ELEMENTS; SPECIFICITY PHOSPHATASE 1; NITRIC-OXIDE SYNTHASE; HUMAN HAIR FOLLICLE; CELL-PROLIFERATION; MEDIATED TRANSCRIPTION; GENE-TRANSCRIPTION; TUMOR INVASIVENESS	We have analyzed the role of the thyroid hormone receptors (TRs) in epidermal homeostasis. Reduced keratinocyte proliferation is found in interfollicular epidermis of mice lacking the thyroid hormone binding isoforms TR alpha 1 and TR beta (KO mice). Similar results were obtained in hypothyroid animals, showing the important role of the liganded TRs in epidermal proliferation. In addition, KO and hypothyroid animals display decreased hyperplasia in response to 12-O-tetradecanolyphorbol-13-acetate. Both receptor isoforms play overlapping functional roles in the skin because mice lacking individually TR alpha 1 or TR beta also present a proliferative defect but not as marked as that found in double KO mice. Defective proliferation in KO mice is associated with reduction of cyclin D1 expression and up-regulation of the cyclin-dependent kinase inhibitors p19 and p27. Paradoxically, ERK and AKT activity and expression of downstream targets, such as AP-1 components, are increased in KO mice. Increased p65/NF-kappa B and STAT3 phosphorylation and, as a consequence, augmented expression of chemokines and proinflammatory cytokines is also found in these animals. These results show that thyroid hormones and their receptors are important mediators of skin proliferation and demonstrate that TRs act as endogenous inhibitors of skin inflammation, most likely due to interference with AP-1, NF-kappa B, and STAT3 activation.	[Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Aranda, Ana] CSIC, Inst Invest Biomed Madrid, Madrid 28029, Spain; [Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Aranda, Ana] Univ Autonoma Madrid, Madrid 28029, Spain; [Costa, Clotilde; Paramio, Jesus M.] Ctr Invest Energet Medioambientales & Tecnol, Div Biomed, Mol Oncol Unit, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Paramio, JM (corresponding author), Ave Complutense 22, Madrid 28040, Spain.	jesusm.paramio@ciemat.es; aaranda@iib.uam.es	Contreras-Jurado, Constanza/K-9028-2014; Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020	Contreras-Jurado, Constanza/0000-0002-4578-801X; Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Costa, Clotilde/0000-0001-7327-2259	Ministerio de Ciencia e Innovacion [BFU2007-62402, SAF2008-00121]; Fondo de Investigaciones Sanitarias [RD06/0020/0036, RD06/0020/0029]; European CRESCENDO [FP-018652]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European CRESCENDO	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2007-62402 and SAF2008-00121, Fondo de Investigaciones Sanitarias Grants RD06/0020/0036 and RD06/0020/0029, and European CRESCENDO Grant FP-018652.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; ARGYRIS TS, 1985, CRC CR REV TOXICOL, V14, P211, DOI 10.3109/10408448509037459; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Bell S, 2003, CELL SIGNAL, V15, P1, DOI 10.1016/S0898-6568(02)00080-3; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Chung WY, 2007, CARCINOGENESIS, V28, P1224, DOI 10.1093/carcin/bgm005; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Garcia-Silva S, 2011, ONCOGENE, V30, P854, DOI 10.1038/onc.2010.464; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Lasa M, 2010, MOL ENDOCRINOL, V24, P412, DOI 10.1210/me.2009-0298; Li JJ, 2010, BIOORG MED CHEM LETT, V20, P306, DOI 10.1016/j.bmcl.2009.10.109; Martinez-Iglesias O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006428; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Medeiros R, 2009, BIOCHEM PHARMACOL, V78, P390, DOI 10.1016/j.bcp.2009.04.021; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; PEREZ P, 1994, BIOCHEM BIOPH RES CO, V205, P135, DOI 10.1006/bbrc.1994.2640; Porlan E, 2008, ONCOGENE, V27, P2795, DOI 10.1038/sj.onc.1210936; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; RAICK AN, 1973, CANCER RES, V33, P269; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Rodriguez-Puebla ML, 1998, CELL GROWTH DIFFER, V9, P31; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Santos M, 2002, J BIOL CHEM, V277, P19122, DOI 10.1074/jbc.M201001200; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Segrelles C, 2008, MOL BIOL CELL, V19, P137, DOI 10.1091/mbc.E07-08-0764; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; THIBOUTOT DM, 1995, J CLIN ENDOCR METAB, V80, P3082, DOI 10.1210/jc.80.10.3082; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Wondisford FE, 2003, J INVEST MED, V51, P215, DOI 10.1136/jim-51-04-22; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	69	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24079	24088		10.1074/jbc.M111.218487	http://dx.doi.org/10.1074/jbc.M111.218487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566120	Green Published, hybrid			2022-12-27	WOS:000292294900050
J	Muthurajan, UM; McBryant, SJ; Lu, X; Hansen, JC; Luger, K				Muthurajan, Uma M.; McBryant, Steven J.; Lu, Xu; Hansen, Jeffrey C.; Luger, Karolin			The Linker Region of MacroH2A Promotes Self-association of Nucleosomal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; AMINO-ACID-COMPOSITION; STRUCTURAL-CHARACTERIZATION; HISTONE VARIANTS; CHROMATIN FIBER; IN-VITRO; DOMAIN; DYNAMICS; BINDING	MacroH2A is a histone variant found in higher eukaryotes localized at the inactive X chromosome and is known to maintain heterochromatic regions in the genome. MacroH2A consists of a conserved histone domain and a macro domain connected by a linker region. To understand the contributions of the three domains to chromatin condensation, we incorporated various constructs of macroH2A into defined nucleosomal arrays and analyzed their impact on in vitro chromatin compaction. The folding and oligomerization properties of arrays containing full-length macroH2A (macroH2A(FL)), macroH2A(1-161) (encompassing the histone domain and linker region), and macroH2A(1-122) (histone domain only) were compared with major-type H2A arrays. Analytical ultracentrifugation and atomic force microscope imaging indicate that macroH2A(1-161)-containing arrays favor condensation under conditions where major-type arrays are nearly fully extended. In contrast, arrays with macroH2A(FL) exhibit behavior similar to that of major-type arrays. This suggests that the linker region of macroH2A facilitates array condensation and that this behavior is inhibited by the macro domain. Furthermore, chimeric major-type H2A arrays containing the macroH2A linker domain (H2A(ML)) exhibited the same condensation properties as macroH2A(1-161) arrays, thus emphasizing the intriguing behavior of the macroH2A linker region.	[Muthurajan, Uma M.; Hansen, Jeffrey C.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; [McBryant, Steven J.] Gevo Inc, Englewood, CO 80112 USA; [Lu, Xu] Univ Findlay, Findlay, OH 45840 USA	Colorado State University; Colorado State University; Howard Hughes Medical Institute; University of Findlay	Luger, K (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	karolin.luger@colostate.edu		SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [GM061909, P01GM088409, GM45916]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409, R01GM045916, R01GM061909, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061909 and P01GM088409 (to K. L.) and GM45916 (to J. C. H.).; Supported by the Howard Hughes Medical Institute. To whom correspondence should be addressed. Tel.: 970-491-6405; Fax: 970-491-5113; E-mail: karolin.luger@colostate.edu.	Abbott DW, 2004, BIOCHEMISTRY-US, V43, P1352, DOI 10.1021/bi035859i; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chakravarthy S, 2004, COLD SPRING HARB SYM, V69, P227, DOI 10.1101/sqb.2004.69.227; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Chakravarthy S, 2006, J BIOL CHEM, V281, P25522, DOI 10.1074/jbc.M602258200; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; HANSEN JC, 1994, BIOCHEMISTRY-US, V33, P13155, DOI 10.1021/bi00249a001; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lohr Dennis, 2008, V464, P123; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Montel F, 2009, BIOPHYS J, V97, P544, DOI 10.1016/j.bpj.2009.04.042; Nusinow DA, 2007, J MOL BIOL, V371, P11, DOI 10.1016/j.jmb.2007.05.063; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Qian R L, 1997, Cell Res, V7, P143; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, P NATL ACAD SCI USA, V95, P12169, DOI 10.1073/pnas.95.21.12169	41	37	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23852	23864		10.1074/jbc.M111.244871	http://dx.doi.org/10.1074/jbc.M111.244871			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21532035	Green Published, hybrid			2022-12-27	WOS:000292294900028
J	Stjepanovic, G; Kapp, K; Bange, G; Graf, C; Parlitz, R; Wild, K; Mayer, MP; Sinning, I				Stjepanovic, Goran; Kapp, Katja; Bange, Gert; Graf, Christian; Parlitz, Richard; Wild, Klemens; Mayer, Matthias P.; Sinning, Irmgard			Lipids Trigger a Conformational Switch That Regulates Signal Recognition Particle (SRP)-mediated Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SRP; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; MEMBRANE-BINDING; INNER-MEMBRANE; BETA-SUBUNIT; RECEPTOR; DOMAIN; FTSY; PHOSPHATIDYLETHANOLAMINE	Co-translational protein targeting to the membrane is mediated by the signal recognition particle and its receptor (FtsY). Their homologous GTPase domains interact at the membrane and form a heterodimer in which both GTPases are activated. The prerequisite for protein targeting is the interaction of FtsY with phospholipids. However, the mechanism of FtsY regulation by phospholipids remained unclear. Here we show that the N terminus of FtsY (A domain) is natively unfolded in solution and define the complete membrane-targeting sequence. We show that the membrane-targeting sequence is highly dynamic in solution, independent of nucleotides and directly responds to the density of anionic phospholipids by a random coil-helix transition. This conformational switch is essential for tethering FtsY to membranes and activates the GTPase for its subsequent interaction with the signal recognition particle. Our results underline the dynamics of lipid-protein interactions and their importance in the regulation of protein targeting and translocation across biological membranes.	[Stjepanovic, Goran; Bange, Gert; Parlitz, Richard; Wild, Klemens; Sinning, Irmgard] Heidelberg Univ, Biochem Zentrum BZH, D-69120 Heidelberg, Germany; [Kapp, Katja; Graf, Christian; Mayer, Matthias P.] Heidelberg Univ, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Zentrum BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013; Bange, Gert/AAB-3734-2021; Stjepanovic, Goran/A-7902-2010	Mayer, Matthias P./0000-0002-7859-3112; Stjepanovic, Goran/0000-0002-4841-9949; Bange, Gert/0000-0002-7826-0932	German-Israeli Foundation; Deutsche Forschungsgemeinschaft [GRK1188, SFB638]	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German-Israeli Foundation and Deutsche Forschungsgemeinschaft Grants GRK1188 and SFB638.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Erez E, 2010, J BIOL CHEM, V285, P40508, DOI 10.1074/jbc.M110.140921; Facey SJ, 2010, CELL MOL LIFE SCI, V67, P2343, DOI 10.1007/s00018-010-0303-0; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Montoya G, 1997, PROTEINS, V28, P285, DOI 10.1002/(SICI)1097-0134(199706)28:2<285::AID-PROT15>3.0.CO;2-E; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; SAMUELSSON T, 1993, NUCLEIC ACIDS RES, V21, P847, DOI 10.1093/nar/21.4.847; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Vanounou S, 2003, MOL MICROBIOL, V49, P1067, DOI 10.1046/j.1365-2958.2003.03614.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; WILSON C, 1988, J CELL BIOL, V107, P69, DOI 10.1083/jcb.107.1.69; YOUNG JC, 1995, J BIOL CHEM, V270, P15650, DOI 10.1074/jbc.270.26.15650; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	49	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23489	23497		10.1074/jbc.M110.212340	http://dx.doi.org/10.1074/jbc.M110.212340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543314	Green Published, hybrid			2022-12-27	WOS:000292025000079
J	Zhao, X; Kuja-Panula, J; Rouhiainen, A; Chen, YC; Panula, P; Rauvala, H				Zhao, Xiang; Kuja-Panula, Juha; Rouhiainen, Ari; Chen, Yu-chia; Panula, Pertti; Rauvala, Heikki			High Mobility Group Box-1 (HMGB1; Amphoterin) Is Required for Zebrafish Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; CATECHOLAMINERGIC NEURONS; NERVOUS-SYSTEM; FOREBRAIN; PROTEIN; EXPRESSION; GENE; ACTIVATION; CELLS; PAX6	Hmgb1 (high mobility group box-1; amphoterin) is highly expressed in brain during early development of vertebrate and nonvertebrate species. However, its role in brain development remains elusive. Here we have cloned the zebrafish Hmgb1 and specifically manipulated Hmgb1 expression using injection of morpholino antisense oligonucleotides or Hmgb1 cRNA. The HMGB1 knockdown morphants produced by injection of three different morpholino oligonucleotides display a characteristic phenotype with smaller size, smaller brain width, and shorter distance between the eyes. Closer examination of the phenotype reveals severe defects in the development of the forebrain that largely lacks catecholaminergic neural networks. The HMGB1 morphant is deficient in survival and proliferation of neural progenitors and displays fewer cell groups expressing the transcription factor Pax6a in the forebrain and aberrant Wnt8 signaling. The mechanism of HMGB1-dependent progenitor survival involves the neuronal transmembrane protein AMIGO (amphoterin-induced gene and orf), the expression of which is regulated by HMGB1 in vivo. Our data demonstrate that HMGB1 is a critical factor for brain development, enabling survival and proliferation of neural progenitors that will form the forebrain structures.	[Zhao, Xiang; Kuja-Panula, Juha; Rouhiainen, Ari; Chen, Yu-chia; Panula, Pertti; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Chen, Yu-chia; Panula, Pertti] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Rauvala, H (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56,Viikinkaari 4, FIN-00014 Helsinki, Finland.	heikki.rauvala@helsinki.fi	Zhao, Xiang/AAK-9641-2020	Zhao, Xiang/0000-0002-3339-4806; Rouhiainen, Ari/0000-0003-2492-4788; Panula, Pertti/0000-0002-1189-5132; Rauvala, Heikki/0000-0001-7809-9811	Academy of Finland; Sigrid Juselius Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Graduate School in Biotechnology and Molecular Biology	This work was supported by the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Helsinki Graduate School in Biotechnology and Molecular Biology.	Appel B, 2000, DEV DYNAM, V219, P155, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1052>3.3.CO;2-B; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Huang XW, 2005, INT J DEV BIOL, V49, P49, DOI 10.1387/ijdb.041915xh; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kim JD, 2009, BIOCHEM BIOPH RES CO, V381, P717, DOI 10.1016/j.bbrc.2009.02.135; KINOSHITA M, 1994, FEBS LETT, V352, P191, DOI 10.1016/0014-5793(94)00909-0; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Mueller T., 2005, ATLAS EARLY ZEBRAFIS, P29; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Ono T, 2003, J NEUROSCI, V23, P5887; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; RAUVALA H, 1988, J CELL BIOL, V107, P2293, DOI 10.1083/jcb.107.6.2293; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Thisse C, 2005, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Wullimann MF, 2002, BRAIN RES BULL, V57, P363, DOI 10.1016/S0361-9230(01)00666-9; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512	45	43	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23200	23213		10.1074/jbc.M111.223834	http://dx.doi.org/10.1074/jbc.M111.223834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21527633	hybrid, Green Published			2022-12-27	WOS:000292025000054
J	Ho, CW; Chen, HT; Hwang, J				Ho, Chia-Wen; Chen, Hung-Ta; Hwang, Jaulang			UBC9 Autosumoylation Negatively Regulates Sumoylation of Septins in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SUMOYLATION; SUMO-1 MODIFICATION; CELL-CYCLE; UBIQUITIN; COMPLEX; BINDING; CONJUGATION; RANGAP1; CHAIN; AUTOUBIQUITINATION	Sumoylation regulates a wide range of cellular processes. However, little is known about the regulation of the SUMO machinery. In this study, we demonstrate that two lysine residues (Lys-153 and Lys-157) in the C-terminal region of the yeast E2-conjugating enzyme Ubc9 are the major and minor autosumoylation sites, respectively. Surprisingly, mutation of Lys-157 (ubc9(K157R)) significantly stimulates the level of Ubc9 autosumoylation at Lys-153. The functional role of Ubc9 autosumoylation is exemplified in our findings that cell cycle-dependent sumoylation of cytoskeletal septin proteins is inversely correlated with the Ubc9 autosumoylation level and that mutation of the Ubc9 autosumoylation sites results in aberrant cell morphology. Our study elucidates a regulatory mechanism that utilizes automodification of the E2 enzyme of the sumoylation machinery to control substrate sumoylation.	[Ho, Chia-Wen; Chen, Hung-Ta; Hwang, Jaulang] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Ho, Chia-Wen; Hwang, Jaulang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chen, HT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	htchen@imb.sinica.edu.tw; jaulangh@imb.sinica.edu.tw	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382	National Science Council in Taiwan [NSC98-2311-B-001-008-MY3]; Institute of Molecular Biology, Academia Sinica	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council in Taiwan Grant NSC98-2311-B-001-008-MY3 and by the Institute of Molecular Biology, Academia Sinica.	ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jacquiau HR, 2005, J BIOL CHEM, V280, P23566, DOI 10.1074/jbc.M500947200; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knop AE, 1999, GENE THER, V6, P373, DOI 10.1038/sj.gt.3300822; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	48	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21826	21834		10.1074/jbc.M111.234914	http://dx.doi.org/10.1074/jbc.M111.234914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518767	hybrid, Green Published			2022-12-27	WOS:000291464700077
J	Li, H; Solomon, E; Muggy, SD; Sun, DQ; Zolkiewska, A				Li, Hui; Solomon, Emilia; Muggy, Sara Duhachek; Sun, Danqiong; Zolkiewska, Anna			Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN BREAST; INTRACELLULAR DOMAIN; EXTRACELLULAR-MATRIX; FAMILY-MEMBERS; CROSS-TALK; ACTIVATION; PATHWAY; CANCER; CELLS	Metalloprotease-disintegrin ADAM12 is overexpressed and frequently mutated in breast cancer. We report here that ADAM12 expression in cultured mammalian cells is up-regulated by Notch signals. Expression of a constitutively active form of Notch1 in murine fibroblasts, myoblasts, or mammary epithelial cells or activation of the endogenous Notch signaling by co-culture with ligand-expressing cells increases ADAM12 protein and mRNA levels. Up-regulation of ADAM12 expression by Notch requires new transcription, is activated in a CSL-dependent manner, and is abolished upon inhibition of I kappa B kinase. Expression of a constitutively active Notch1 in NIH3T3 cells increases the stability of Adam12 mRNA. We further show that the microRNA-29 family, which has a predicted conserved site in the 3'-untranslated region of mouse Adam12, plays a critical role in mediating the stimulatory effect of Notch on ADAM12 expression. In human cells, Notch up-regulates the expression of the long form, but not the short form, of ADAM12 containing a divergent 3'-untranslated mRNA region. These studies uncover a novel paradigm in Notch signaling and establish Adam12 as a Notch-related gene.	[Li, Hui; Solomon, Emilia; Muggy, Sara Duhachek; Sun, Danqiong; Zolkiewska, Anna] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011; Solomon, Emilia/AAH-9319-2021	LI, HUI/0000-0002-4114-8349; Solomon, Emilia/0000-0003-0265-9792	National Institutes of Health [CA151065]; Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE [R15CA151065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA151065 (to A. Z.). This work was also supported by an Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at Kansas State University.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Aifantis I, 2007, CELL CYCLE, V6, P403, DOI 10.4161/cc.6.4.3858; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Conigliaro A, 2008, CELL DEATH DIFFER, V15, P123, DOI 10.1038/sj.cdd.4402236; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Hao L, 2010, ONCOGENE, V29, P201, DOI 10.1038/onc.2009.323; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Luna C, 2009, MOL VIS, V15, P2488; Mareddy S, 2010, TISSUE ENG PT A, V16, P749, DOI [10.1089/ten.tea.2009.0307, 10.1089/ten.TEA.2009.0307]; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Ray A, 2010, MOL CANCER RES, V8, P1261, DOI 10.1158/1541-7786.MCR-10-0212; Ray BK, 2011, P NATL ACAD SCI USA, V108, P103, DOI 10.1073/pnas.1008831108; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	75	33	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21500	21510		10.1074/jbc.M110.207951	http://dx.doi.org/10.1074/jbc.M110.207951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518768	Green Published, hybrid			2022-12-27	WOS:000291464700048
J	Marek, M; Milles, S; Schreiber, G; Daleke, DL; Dittmar, G; Herrmann, A; Muller, P; Pomorski, TG				Marek, Magdalena; Milles, Sigrid; Schreiber, Gabriele; Daleke, David L.; Dittmar, Gunnar; Herrmann, Andreas; Mueller, Peter; Pomorski, Thomas Guenther			The Yeast Plasma Membrane ATP Binding Cassette (ABC) Transporter Aus1 PURIFICATION, CHARACTERIZATION, AND THE EFFECT OF LIPIDS ON ITS ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; DIETARY-CHOLESTEROL; STEROL UPTAKE; PROTEIN; HYDROLYSIS; GENE; OVEREXPRESSION; TRANSLOCATION; OPTIMIZATION; SUPERFAMILY	The ATP binding cassette (ABC) transporter Aus1 is expressed under anaerobic growth conditions at the plasma membrane of the yeast Saccharomyces cerevisiae and is required for sterol uptake. These observations suggest that Aus1 promotes the translocation of sterols across membranes, but the precise transport mechanism has yet to be identified. In this study, an extraction and purification procedure was developed to characterize the Aus1 transporter. The detergent-solubilized protein was able to bind and hydrolyze ATP. Mutagenesis of the conserved lysine to methionine in the Walker A motif abolished ATP hydrolysis. Likewise, ATP hydrolysis was inhibited by classical inhibitors of ABC transporters. Upon reconstitution into proteoliposomes, the ATPase activity of Aus1 was specifically stimulated by phosphatidylserine (PS) in a stereoselective manner. We also found that Aus1-dependent sterol uptake, but not Aus1 expression and trafficking to the plasma membrane, was affected by changes in cellular PS levels. These results suggest a direct interaction between Aus1 and PS that is critical for the activity of the transporter.	[Marek, Magdalena; Pomorski, Thomas Guenther] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol,Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Mueller, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Daleke, David L.] Indiana Univ, Dept Biochem & Mol Biol, Bloomington, IN 47405 USA; [Dittmar, Gunnar] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Danmarks Grundforskningsfond; University of Copenhagen; Humboldt University of Berlin; Indiana University System; Indiana University Bloomington; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pomorski, TG (corresponding author), Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol,Fac Life Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	tgp@life.ku.dk	Dittmar, Gunnar/B-6383-2016; Daleke, David/T-3123-2019; Pomorski, Thomas Günther/G-4804-2014; Dittmar, Gunnar/C-6333-2019	Dittmar, Gunnar/0000-0003-3647-8623; Pomorski, Thomas Günther/0000-0002-4889-0829; Dittmar, Gunnar/0000-0003-3647-8623; Marek, Magdalena/0000-0001-6901-920X	Marie Curie Flippase Network; Carlsberg Foundation; Deutsche Forschungsgemeinschaft [MU 1017/5]	Marie Curie Flippase Network; Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Marie Curie Flippase Network (to M. M. and A. H.), the Carlsberg Foundation (to T. G. P.), and Deutsche Forschungsgemeinschaft Grant MU 1017/5 (to P. M. and T. G. P.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Ketchum CJ, 2001, J BIOL CHEM, V276, P29007, DOI 10.1074/jbc.M100810200; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kohut P, 2011, BIOCHEM BIOPH RES CO, V404, P233, DOI 10.1016/j.bbrc.2010.11.099; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Langheim S, 2005, J LIPID RES, V46, P1732, DOI 10.1194/jlr.M500115-JLR200; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rahimi Y, 2008, BIOCHEM BIOPH RES CO, V370, P57, DOI 10.1016/j.bbrc.2008.03.034; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	48	29	30	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21835	21843		10.1074/jbc.M111.244525	http://dx.doi.org/10.1074/jbc.M111.244525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521689	Green Published, hybrid			2022-12-27	WOS:000291464700078
J	Reisetter, AC; Stebounova, LV; Baltrusaitis, J; Powers, L; Gupta, A; Grassian, VH; Monick, MM				Reisetter, Anna C.; Stebounova, Larissa V.; Baltrusaitis, Jonas; Powers, Linda; Gupta, Amit; Grassian, Vicki H.; Monick, Martha M.			Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIESEL EXHAUST PARTICLES; HOST-CELL DEATH; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; ALVEOLAR MACROPHAGES; ULTRAFINE PARTICLES; IN-VIVO; PULMONARY INFLAMMATION; LIPID MEDIATORS	Inhalation of nanoparticles has been implicated in respiratory morbidity and mortality. In particular, carbon black nanoparticles are found in many different environmental exposures. Macrophages take up inhaled nanoparticles and respond via release of inflammatory mediators and in some cases cell death. Based on new data, we propose that exposure of macrophages (both a macrophage cell line and primary human alveolar macrophages) to carbon black nanoparticles induces pyroptosis, an inflammasome-dependent form of cell death. Exposure of macrophages to carbon black nanoparticles resulted in inflammasome activation as defined by cleavage of caspase 1 to its active form and downstream IL-1 beta release. The cell death that occurred with carbon black nanoparticle exposure was identified as pyroptosis by the protective effect of a caspase 1 inhibitor and a pyroptosis inhibitor. These data demonstrate that carbon black nanoparticle exposure activates caspase 1, increases IL-1 beta release after LPS priming, and induces the proinflammatory cell death, pyroptosis. The identification of pyroptosis as a cellular response to carbon nanoparticle exposure is novel and relates to environmental and health impacts of carbon-based particulates.	[Monick, Martha M.] Univ Iowa, EMRB, Div Pulm Crit Care & Occupat Med, Dept Med, Iowa City, IA 52242 USA; [Stebounova, Larissa V.; Baltrusaitis, Jonas; Grassian, Vicki H.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Monick, MM (corresponding author), Univ Iowa, EMRB, Div Pulm Crit Care & Occupat Med, Dept Med, Rm 100, Iowa City, IA 52242 USA.	martha-monick@uiowa.edu	Baltrusaitis, Jonas/AAT-3166-2020; Baltrusaitis, Jonas/F-9367-2013; Baltrusaitis, Jonas/AAW-6072-2021	Baltrusaitis, Jonas/0000-0001-5634-955X	National Institutes of Health [R01 HL079901, R01HL96625]; National Center for Research Resources, National Institutes of Health [UL1RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, R01HL079901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901 and R01HL96625 (to M. M. M.) and R01HL96625 (to V. H. G.). This publication was made possible by National Center for Research Resources, National Institutes of Health Grant UL1RR024979.	Aam BB, 2007, ARCH TOXICOL, V81, P441, DOI 10.1007/s00204-006-0164-3; Baltrusaitis J, 2007, PHYS CHEM CHEM PHYS, V9, P3011, DOI 10.1039/b617697f; Barlow PG, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-11; Beck-Speier I, 2005, FREE RADICAL BIO MED, V38, P1080, DOI 10.1016/j.freeradbiomed.2005.01.004; Beck-Speier I, 2001, ENVIRON HEALTH PERSP, V109, P613, DOI 10.2307/3454679; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Brown DM, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215104; Cassee FR., 1999, DEV MODEL HUMAN RAT; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Davis MJ, 2010, J LEUKOCYTE BIOL, V88, P813, DOI 10.1189/jlb.0310159; Dick CAJ, 2003, INHAL TOXICOL, V15, P39, DOI 10.1080/08958370304454; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; HARADA RN, 1985, CHEST, V87, P247, DOI 10.1378/chest.87.2.247; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001; Ito T, 2000, ENVIRON TOXICOL PHAR, V9, P1, DOI 10.1016/S1382-6689(00)00053-3; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kinney PL, 2000, ENVIRON HEALTH PERSP, V108, P213, DOI 10.2307/3454436; Koike E, 2006, CHEMOSPHERE, V65, P946, DOI 10.1016/j.chemosphere.2006.03.078; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; LOEFFLER J, 2010, NANOROAD SME EUROPEA; Lundborg M, 2001, ENVIRON RES, V86, P244, DOI 10.1006/enrs.2001.4269; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Mauderly J L, 1994, Res Rep Health Eff Inst, P1; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moller W, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-7; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Moss OR, 2006, INHAL TOXICOL, V18, P711, DOI 10.1080/08958370600747770; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; OBERDORSTER G, 1994, ANN OCCUP HYG, V38, P601, DOI 10.1093/annhyg/38.4.601; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Renwick LC, 2004, OCCUP ENVIRON MED, V61, P442, DOI 10.1136/oem.2003.008227; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Stoeger T, 2006, ENVIRON HEALTH PERSP, V114, P328, DOI 10.1289/ehp.8266; Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370; Stone V, 1998, TOXICOL IN VITRO, V12, P649, DOI 10.1016/S0887-2333(98)00050-2; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Twigg HL, 2004, SEMIN RESP CRIT CARE, V25, P21, DOI 10.1055/s-2004-822302; Val Stephanie, 2009, Inhal Toxicol, V21 Suppl 1, P115, DOI 10.1080/08958370902942533; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	78	128	133	6	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21844	21852		10.1074/jbc.M111.238519	http://dx.doi.org/10.1074/jbc.M111.238519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525001	Green Published, hybrid			2022-12-27	WOS:000291464700079
J	Soss, SE; Yue, YY; Dhe-Paganon, S; Chazin, WJ				Soss, Sarah E.; Yue, Yuanyuan; Dhe-Paganon, Sirano; Chazin, Walter J.			E2 Conjugating Enzyme Selectivity and Requirements for Function of the E3 Ubiquitin Ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U-BOX; PROTEIN LIGASES; C-TERMINUS; COMPLEX; DEGRADATION; CHAINS; IDENTIFICATION; UBIQUITYLATION; INSIGHTS; POLYUBIQUITINATION	The transfer of ubiquitin (Ub) to a substrate protein requires a cascade of E1 activating, E2 conjugating, and E3 ligating enzymes. E3 Ub ligases containing U-box and RING domains bind both E2 similar to Ub conjugates and substrates to facilitate transfer of the Ub molecule. Although the overall mode of action of E3 ligases is well established, many of the mechanistic details that determine the outcome of ubiquitination are poorly understood. CHIP (carboxyl terminus of Hsc70-interacting protein) is a U-box E3 ligase that serves as a co-chaperone to heat shock proteins and is critical for the regulation of unfolded proteins in the cytosol. We have performed a systematic analysis of the interactions of CHIP with E2 conjugating enzymes and found that only a subset bind and function. Moreover, some E2 enzymes function in pairs to create products that neither create individually. Characterization of the products of these reactions showed that different E2 enzymes produce different ubiquitination products, i.e. that E2 determines the outcome of Ub transfer. Site-directed mutagenesis on the E2 enzymes Ube2D1 and Ube2L3 (UbcH5a and UbcH7) established that an SPA motif in loop 7 of E2 is required for binding to CHIP but is not sufficient for activation of the E2 similar to Ub conjugate and consequent ubiquitination activity. These data support the proposal that the E2 SPA motif provides specificity for binding to CHIP, whereas activation of the E2 similar to Ub conjugate is derived from other molecular determinants.	[Soss, Sarah E.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Soss, Sarah E.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Yue, Yuanyuan] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	Vanderbilt University; Vanderbilt University; Vanderbilt University; Lanzhou University; University of Toronto; Structural Genomics Consortium; University of Toronto	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			National Institutes of Health [R01GM075156, T32CA009582, F32GM087050]; China Scholarship Council; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087050, R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM075156 (to W.J.C.) and Grants T32CA009582 and F32GM087050 (to S.E.S.). This work was also supported by the China Scholarship Council (to Y.Y.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Goddard T. D., 2006, SPARKY 3; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wang DX, 2005, J PROTEOME RES, V4, P1554, DOI 10.1021/pr050104e; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	41	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21277	21286		10.1074/jbc.M111.224006	http://dx.doi.org/10.1074/jbc.M111.224006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518764	Green Published, hybrid			2022-12-27	WOS:000291464700026
J	Wang, YC; Lee, CM; Lee, LC; Tung, LC; Hsieh-Li, HM; Lee-Chen, GJ; Su, MT				Wang, Yu-Chun; Lee, Chi-Mei; Lee, Li-Ching; Tung, Li-Chu; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen; Su, Ming-Tsan			Mitochondrial Dysfunction and Oxidative Stress Contribute to the Pathogenesis of Spinocerebellar Ataxia Type 12 (SCA12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; CELL-DEATH; DROSOPHILA; APOPTOSIS; MUTATION; PPP2R2B; LOCALIZATION; SURVIVAL; FISSION	Spinal cerebellar ataxia type 12 (SCA12) has been attributed to the elevated expression of ppp2r2b. To better elucidate the pathomechanism of the neuronal disorder and to search for a pharmacological treatment, Drosophila models of SCA12 were generated by overexpression of a human ppp2r2b and its Drosophila homolog tws. Ectopic expression of ppp2r2b or tws caused various pathological features, including neurodegeneration, apoptosis, and shortened life span. More detailed analysis revealed that elevated ppp2r2b and tws induced fission of mitochondria accompanied by increases in cytosolic reactive oxygen species (ROS), cytochrome c, and caspase 3 activity. Transmission electron microscopy revealed that fragmented mitochondria with disrupted cristae were engulfed by autophagosomes in photoreceptor neurons of flies overexpressing tws. Additionally, transgenic flies were more susceptible to oxidative injury induced by paraquat. By contrast, ectopic Drosophila Sod2 expression and antioxidant treatment reduced ROS and caspase 3 activity and extended the life span of the SCA12 fly model. In summary, our study demonstrates that oxidative stress induced by mitochondrial dysfunction plays a causal role in SCA12, and reduction of ROS is a potential therapeutic intervention for this neuropathy.	[Wang, Yu-Chun; Lee, Chi-Mei; Lee, Li-Ching; Tung, Li-Chu; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen; Su, Ming-Tsan] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11677, Taiwan	National Taiwan Normal University	Su, MT (corresponding author), 88,Sect 4,Ting Chou Rd, Taipei 11677, Taiwan.	mtsu@ntnu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020		National Science Council of Taiwan [NSC 95-2311-B-003-006-MY2, NSC 96-2311-B-003-005]; National Taiwan Normal University [96TOP001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University	This work was supported by the National Science Council Grants NSC 95-2311-B-003-006-MY2 and NSC 96-2311-B-003-005 of Taiwan and National Taiwan Normal University Grant 96TOP001.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Bajpai R, 2004, DEVELOPMENT, V131, P1007, DOI 10.1242/dev.00980; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabu C, 2009, DEV BIOL, V330, P399, DOI 10.1016/j.ydbio.2009.04.014; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Cheng WT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-91; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COX DR, 1972, J R STAT SOC B, V34, P187; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; GOMES R, 1993, J CELL SCI, V104, P583; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Holmes SE, 2003, CYTOGENET GENOME RES, V100, P189, DOI 10.1159/000072854; Holmes SE, 2001, BRAIN RES BULL, V56, P397, DOI 10.1016/S0361-9230(01)00596-2; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin CH, 2010, HUM GENET, V128, P205, DOI 10.1007/s00439-010-0843-2; Louie K, 2008, COMP BIOCHEM PHYS A, V151, P159, DOI 10.1016/j.cbpa.2008.06.023; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Trujillo-Martin MM, 2009, MOVEMENT DISORD, V24, P1111, DOI 10.1002/mds.22564; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Owusu-Ansah E., 2008, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2008.1023., DOI 10.1038/NPROT.2008.1023, 10.1038/nprot.2008.1023,http://www.nature.com/protocolexchange/protocols/414]; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Sinha KK, 2004, J NEUROL NEUROSUR PS, V75, P448, DOI 10.1136/jnnp.2002.004895; Todd Amy M., 2004, Drosophila Information Service, V87, P101; UEMURA T, 1993, GENE DEV, V7, P429, DOI 10.1101/gad.7.3.429; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007; Yarovinsky TO, 2000, BIOTECHNIQUES, V28, P1160, DOI 10.2144/00286st06; Yeh PA, 2010, BIOCHEM BIOPH RES CO, V391, P510, DOI 10.1016/j.bbrc.2009.11.089; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	47	41	42	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21742	21754		10.1074/jbc.M110.160697	http://dx.doi.org/10.1074/jbc.M110.160697			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21471219	Green Published, hybrid			2022-12-27	WOS:000291464700070
J	Ahmady, E; Deeke, SA; Rabaa, S; Kouri, L; Kenney, L; Stewart, AFR; Burgon, PG				Ahmady, Elmira; Deeke, Shelley A.; Rabaa, Seham; Kouri, Lara; Kenney, Laura; Stewart, Alexandre F. R.; Burgon, Patrick G.			Identification of a Novel Muscle A-type Lamin-interacting Protein (MLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD PROGERIA; TRANSCRIPTION FACTOR MOK2; INNER NUCLEAR-MEMBRANE; IN-VITRO INTERACTION; DILATED CARDIOMYOPATHY; RETINOBLASTOMA PROTEIN; LMNA MUTATIONS; A/C EXPRESSION; GENE	Mutations in the A-type lamin (LMNA) gene are associated with age-associated degenerative disorders of mesenchymal tissues, such as dilated cardiomyopathy, Emery-Dreifuss muscular dystrophy, and limb-girdle muscular dystrophy. The molecular mechanisms that connect mutations in LMNA with different human diseases are poorly understood. Here, we report the identification of a Muscle-enriched A-type Lamin-interacting Protein, MLIP (C6orf142 and 2310046A06rik), a unique single copy gene that is an innovation of amniotes (reptiles, birds, and mammals). MLIP encodes alternatively spliced variants (23-57 kDa) and possesses several novel structural motifs not found in other proteins. MLIP is expressed ubiquitously and most abundantly in heart, skeletal, and smooth muscle. MLIP interacts directly and co-localizes with lamin A and C in the nuclear envelope. MLIP also co-localizes with promyelocytic leukemia (PML) bodies within the nucleus. PML, like MLIP, is only found in amniotes, suggesting that a functional link between the nuclear envelope and PML bodies may exist through MLIP. Down-regulation of lamin A/C expression by shRNA results in the up-regulation and mislocalization of MLIP. Given that MLIP is expressed most highly in striated and smooth muscle, it is likely to contribute to the mesenchymal phenotypes of laminopathies.	[Ahmady, Elmira; Deeke, Shelley A.; Rabaa, Seham; Kouri, Lara; Kenney, Laura; Stewart, Alexandre F. R.; Burgon, Patrick G.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	Burgon, PG (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	pburgon@ottawaheart.ca	Burgon, Patrick/ABB-1027-2021; Stewart, Alexandre F.R./A-5677-2011	Stewart, Alexandre/0000-0003-2673-9164; Burgon, Patrick/0000-0003-4771-023X	Canadian Institute of Health Research [MOP77682, MOP82748]; Ontario Graduate Student Science and Technology stipend; Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Student Science and Technology stipend; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Operating Grants MOP77682 (to A. F. R. S.) and MOP82748 (to P. G. B.), an Ontario Graduate Student Science and Technology stipend (to E. A.), and a Canadian Institute of Health Research stipend (to L. K.).	Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Broers JLV, 1999, J CELL SCI, V112, P3463; Charniot JC, 2003, HUM MUTAT, V21, P473, DOI 10.1002/humu.10170; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2000, J CELL SCI, V113, P3473; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fairley EAL, 1999, J CELL SCI, V112, P2571; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Harper M, 2009, FEBS J, V276, P3137, DOI 10.1111/j.1742-4658.2009.07032.x; Hegele RA, 2005, CLIN GENET, V68, P31, DOI 10.1111/j.1399-0004.2005.00447.x; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Lattanzi G, 2003, BIOCHEM BIOPH RES CO, V303, P764, DOI 10.1016/S0006-291X(03)00415-7; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Martelli AM, 2000, CANCER RES, V60, P815; Martelli AM, 2002, J CELL BIOCHEM, V86, P320, DOI 10.1002/jcb.10227; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Raharjo WH, 2001, J CELL SCI, V114, P4447; ROBER RA, 1989, DEVELOPMENT, V105, P365; Sakaki M, 2001, J BIOCHEM-TOKYO, V129, P321, DOI 10.1093/oxfordjournals.jbchem.a002860; Sasseville AMJ, 1998, FEBS LETT, V425, P485, DOI 10.1016/S0014-5793(98)00294-4; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tang KQ, 2000, BIOCHEMISTRY-US, V39, P3185, DOI 10.1021/bi992664v; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Vaughan OA, 2001, J CELL SCI, V114, P2577; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x	50	23	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19702	19713		10.1074/jbc.M110.165548	http://dx.doi.org/10.1074/jbc.M110.165548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498514	hybrid, Green Published			2022-12-27	WOS:000291027700053
J	Nocchi, L; Tomasetti, M; Amati, M; Neuzil, J; Santarelli, L; Saccucci, F				Nocchi, Linda; Tomasetti, Marco; Amati, Monica; Neuzil, Jiri; Santarelli, Lory; Saccucci, Franca			Thrombomodulin Is Silenced in Malignant Mesothelioma by a Poly(ADP-ribose) Polymerase-1-mediated Epigenetic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; CHROMATIN MODIFICATIONS; UNMETHYLATED STATE; ADHESION MOLECULE; EXPRESSION; METHYLATION; CANCER; GENE; INVASIVENESS; EPITHELIUM	Malignant mesothelioma (MM) is often complicated by thromboembolic episodes, with thrombomodulin (TM) playing a critical role in the anticoagulant process. Heterogeneous expression of TM has been observed in cancer, and low or no TM expression in cancer cells is associated with poor prognosis. In this study, we analyzed TM expression in biopsies of MM patients and compared them with normal mesothelial tissue. The role of DNA methylation-associated gene silencing in TM expression was investigated. To evaluate poly(ADP-ribose) polymerase-1 (PARP1) as responsible for gene promoter epigenetic modifications, nonmalignant mesothelial cells (Met-5A) and MM cells (H28) were silenced for PARP1 and the DNA methylation/acetylation-associated TM expression evaluated. A correlation between low TM expression and high level of TM promoter methylation was found in MM biopsies. Low expression of TM was restored in MM cells by their treatment with 5-aza-2'-deoxycytidine and, to a lesser extent, with trichostatin, whereas the epigenetic agents did not affect TM expression in Met-5A cells. Silencing of PARP1 resulted in a strong down-regulation of TM expression in Met-5A cells, while restoring TM expression in H28 cells. PARP1 silencing induced TM promoter methylation in Met-5A cells and demethylation in MM cells, and this was paralleled by corresponding changes in the DNA methyltransferase activity. We propose that methylation of the TM promoter is responsible for silencing of TM expression in MM tissue, a process that is regulated by PARP1.	[Nocchi, Linda; Saccucci, Franca] Polytech Univ Marche, Dept Biochem Biol & Genet, I-60126 Ancona, Italy; [Tomasetti, Marco; Amati, Monica; Santarelli, Lory] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, I-60126 Ancona, Italy; [Neuzil, Jiri] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4222, Australia; [Neuzil, Jiri] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Neuzil, Jiri] Acad Sci Czech Republ, Mol Therapy Grp, Inst Biotechnol, Prague 14220, Czech Republic	Marche Polytechnic University; Marche Polytechnic University; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Tomasetti, M (corresponding author), Tronto 10-A Torrette, I-60126 Ancona, Italy.	m.tomasetti@univpm.it	santarelli, lory/I-7429-2012; Santarelli, Lory/AAU-4494-2020; Neuzil, Jiri/H-7204-2014	Neuzil, Jiri/0000-0002-2478-2460; Saccucci, Franca/0000-0002-8407-2516; santarelli, lory/0000-0003-1015-7098; Nocchi, Linda/0000-0002-2113-9031	National Institute against Occupational Injury Insurance; Australian Research Council; Grant Agency of the Czech Republic [204/08/0811]	National Institute against Occupational Injury Insurance; Australian Research Council(Australian Research Council); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported in part by a grant from the National Institute against Occupational Injury Insurance (to L. S. and M. T.).; Supported in part by grants from the Australian Research Council and the Grant Agency of the Czech Republic (204/08/0811).	Ames PRJ, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-3; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; CHAHINIAN AP, 1982, ANN INTERN MED, V96, P746, DOI 10.7326/0003-4819-96-6-746; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; De Capoa A, 1999, FASEB J, V13, P89; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faraone-Mennella MR, 2005, BIOCHEM CELL BIOL, V83, P396, DOI 10.1139/o05-042; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; FERRERO E, 2010, ANN VASC SURG, V24; Furuta J, 2005, MELANOMA RES, V15, P15, DOI 10.1097/00008390-200502000-00004; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; HILLERDAL G, 1983, BRIT J DIS CHEST, V77, P321, DOI 10.1016/S0007-0971(83)80069-2; Kaneda A, 2002, CANCER RES, V62, P6645; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LAGER DJ, 1995, AM J PATHOL, V146, P933; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Matsushita Y, 1998, CANCER LETT, V127, P195, DOI 10.1016/S0304-3835(98)00038-X; Nguyen D, 2008, ANN THORAC SURG, V85, P1032, DOI 10.1016/j.athoracsur.2007.11.064; Niforas P, 1996, GENE, V176, P139, DOI 10.1016/0378-1119(96)00238-7; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Obama H, 1999, ANTICANCER RES, V19, P1143; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; Prandoni P, 1999, HAEMATOLOGICA, V84, P437; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; RUSCH VW, 1995, CHEST, V107, pS322, DOI 10.1378/chest.107.6_Supplement.322S; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; SIERO E, 2010, THROMB RES, V125, P71; Sperry JL, 2003, CIRC RES, V92, P41, DOI 10.1161/01.RES.0000048196.11060.A0; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUEHIRO T, 1995, HEPATOLOGY, V21, P1285, DOI 10.1002/hep.1840210511; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	42	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19478	19488		10.1074/jbc.M110.217331	http://dx.doi.org/10.1074/jbc.M110.217331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489980	hybrid, Green Published			2022-12-27	WOS:000291027700031
J	Razidlo, GL; Katafiasz, D; Taylor, GS				Razidlo, Gina L.; Katafiasz, Dawn; Taylor, Gregory S.			Myotubularin Regulates Akt-dependent Survival Signaling via Phosphatidylinositol 3-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; SKELETAL-MUSCLE ATROPHY; PHOSPHATASE MYOTUBULARIN; LIPID PHOSPHATASES; MAMMALIAN-CELLS; MYOPATHY; PROTEIN; PHOSPHOINOSITIDES; AUTOPHAGY; PATHWAY	Myotubularin is a 3-phosphoinositide phosphatase that is mutated in X-linked myotubular myopathy, a severe neonatal disorder in which skeletal muscle development and/or regeneration is impaired. In this report we provide evidence that siRNA-mediated silencing of myotubularin expression markedly inhibits growth factor-stimulated Akt phosphorylation, leading to activation of caspase-dependent pro-apoptotic signaling in HeLa cells and primary human skeletal muscle myotubes. Myotubularin silencing also inhibits Akt-dependent signaling through the mammalian target of rapamycin complex 1 as assessed by p70 S6-kinase and 4E-BP1 phosphorylation. Similarly, phosphorylation of FoxO transcription factors is also significantly reduced in myotubularin-deficient cells. Our data further suggest that inhibition of Akt activation and downstream survival signaling in myotubularin-deficient cells is caused by accumulation of the MTMR substrate lipid phosphatidylinositol 3-phosphate generated from the type II phosphatidylinositol 3-kinase PIK3C2B. Our findings are significant because they suggest that myotubularin regulates Akt activation via a cellular pool of phosphatidylinositol 3-phosphate that is distinct from that generated by the type III phosphatidylinositol 3-kinase hVps34. Because impaired Akt signaling has been tightly linked to skeletal muscle atrophy, we hypothesize that loss of Akt-dependent growth/survival cues due to impaired myotubularin function may be a critical factor underlying the severe skeletal muscle atrophy characteristic of muscle fibers in patients with X-linked myotubular myopathy.	[Taylor, Gregory S.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Taylor, GS (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, DRC7044,985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	gstaylor@unmc.edu		Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health (National Center for Research Resources); Gladys Pearson Research Foundation in Pediatric Cancer and Genetics	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gladys Pearson Research Foundation in Pediatric Cancer and Genetics	This work was supported, in whole or in part, by a National Institutes of Health CoBRe grant (National Center for Research Resources; to the Nebraska Center for Cellular Signaling (to G. S. T.).; Supported by a fellowship from the Gladys Pearson Research Foundation in Pediatric Cancer and Genetics. Present address: Dept. of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Guggenheim 1637, Rochester, MN 55905.	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Berger P, 2011, J CELL MOL MED, V15, P307, DOI 10.1111/j.1582-4934.2009.00967.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Botelho RJ, 2009, BIOESSAYS, V31, P1127, DOI 10.1002/bies.200900060; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; CHEEK DB, 1985, EARLY HUM DEV, V12, P211, DOI 10.1016/0378-3782(85)90144-6; Chojnowski A, 2007, NEUROBIOL DIS, V26, P323, DOI 10.1016/j.nbd.2006.12.018; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Deretic V, 2007, BIOCHEM SOC SYMP, V74, P141, DOI 10.1042/BSS2007c13; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Dove SK, 2007, BIOCHEM SOC SYMP, V74, P129, DOI 10.1042/BSS2007c12; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fritzius T, 2006, BIOCHEM J, V399, P9, DOI 10.1042/BJ20060511; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2001, ANN NEUROL, V50, P42, DOI 10.1002/ana.1033; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; McLoughlin TJ, 2009, AM J PHYSIOL-CELL PH, V297, pC548, DOI 10.1152/ajpcell.00502.2008; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Previtali Stefano C., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000439; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ribeiro I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001295; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2006, MOL BIOL CELL, V17, P146, DOI 10.1091/mbc.e05-08-0763; Suter U, 2007, CELL MOL LIFE SCI, V64, P3261, DOI 10.1007/s00018-007-7381-7; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; VANWIJNG.GK, 1969, NEUROLOGY, V19, P901, DOI 10.1212/WNL.19.9.901; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	60	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20005	20019		10.1074/jbc.M110.197749	http://dx.doi.org/10.1074/jbc.M110.197749			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478156	hybrid, Green Published			2022-12-27	WOS:000291027700078
J	Rabiet, MJ; Macari, L; Dahlgren, C; Boulay, F				Rabiet, Marie-Josephe; Macari, Laurence; Dahlgren, Claes; Boulay, Francois			N-Formyl Peptide Receptor 3 (FPR3) Departs from the Homologous FPR2/ALX Receptor with Regard to the Major Processes Governing Chemoattractant Receptor Regulation, Expression at the Cell Surface, and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C5A ANAPHYLATOXIN RECEPTOR; BETA-ARRESTIN; DENDRITIC CELLS; BETA(2)-ADRENERGIC RECEPTOR; DIFFERENTIAL REGULATION; ACTIVATES NEUTROPHILS; ELICITED MACROPHAGES; CARBOXYL-TERMINUS; CLATHRIN ADAPTER; HL-60 CELLS	Among human N-formyl peptide chemoattractant receptors, FPR2/ALX and FPR3 share the highest degree of amino acid identity (83%), and trigger similar cell responses upon ligand binding. Although FPR2/ALX is a promiscuous receptor, FPR3 has only one specific high affinity ligand, F2L, and a more restricted tissue/cell distribution. In this study, we showed that FPR2/ALX behaved as the prototypical receptor FPR1. The agonist-dependent phosphorylation used a hierarchical mechanism with a prominent role of Ser(329), Thr(332), and Thr(335). Phosphorylation of FPR2/ALX was essential for its desensitization but the lack of phosphorylation did not result in enhanced or sustained responses. In contrast, resting FPR3 displayed a marked level of phosphorylation, which was only slightly increased upon agonist stimulation. Another noticeable difference between the two receptors was their subcellular distribution in unstimulated cells. Although FPR2/ALX was evenly distributed at the plasma membrane FPR3 was localized in small intracellular vesicles. By swapping domains between FPR2/ALX and FPR3, we uncovered the determinants involved in the basal phosphorylation of FPR3. Experiments aimed at monitoring receptor-bound antibody uptake showed that the intracellular distribution of FPR3 resulted from a constitutive internalization that was independent of C terminus phosphorylation. Unexpectedly, exchanging residues 1 to 53, which encompass the N-terminal extracellular region and the first transmembrane domain, between FPR2/ALX and FPR3 switched localization of the receptors from the plasma membrane to intracellular vesicles and vice versa. A clathrin-independent, possibly caveolae-dependent, mechanism was involved in FPR3 constitutive internalization. The peculiar behavior of FPR3 most probably serves distinct physiological functions that remain largely unknown.	[Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] INSERM, U1036, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] CEA, DSV iRTSV, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] CNRS, ERL 5261, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] Univ Grenoble 1, F-38041 Grenoble, France; [Dahlgren, Claes] Univ Gothenburg, Dept Rheumatol & Inflammat Res, S-41346 Gothenburg, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Gothenburg	Boulay, F (corresponding author), CEA Grenoble, Lab Biol Canc & Infect, Inst Rech Technol & Sci Vivant, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marie-josephe.rabiet@cea.fr						ALI H, 1993, J BIOL CHEM, V268, P24247; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bennett TA, 2001, J BIOL CHEM, V276, P49195, DOI 10.1074/jbc.M106414200; Braun L, 2003, J BIOL CHEM, V278, P4277, DOI 10.1074/jbc.M210120200; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kiss AL, 1997, EUR J CELL BIOL, V73, P19; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Naik N, 1997, J CELL SCI, V110, P2381; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Tardif M, 1998, J IMMUNOL, V161, P6885; TARDIF M, 1993, J IMMUNOL, V150, P3534; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Xu ZQD, 2007, ACTA PHYSIOL, V190, P39, DOI 10.1111/j.1365-201X.2007.01695.x; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	46	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26718	26731		10.1074/jbc.M111.244590	http://dx.doi.org/10.1074/jbc.M111.244590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21543323	Green Published, hybrid			2022-12-27	WOS:000293078200049
J	Jurkowska, RZ; Rajavelu, A; Anspach, N; Urbanke, C; Jankevicius, G; Ragozin, S; Nellen, W; Jeltsch, A				Jurkowska, Renata Z.; Rajavelu, Arumugam; Anspach, Nils; Urbanke, Claus; Jankevicius, Gytis; Ragozin, Sergey; Nellen, Wolfgang; Jeltsch, Albert			Oligomerization and Binding of the Dnmt3a DNA Methyltransferase to Parallel DNA Molecules HETEROCHROMATIC LOCALIZATION AND ROLE OF Dnmt3L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME INACTIVATION; DE-NOVO METHYLATION; HUMAN-DISEASE; PWWP DOMAIN; CHROMATIN; PROTEIN; EPIGENETICS; MECHANISM; CANCER; ULTRACENTRIFUGATION	Structural studies showed that Dnmt3a has two interfaces for protein-protein interaction in the heterotetrameric Dnmt3a/3L C-terminal domain complex: the RD interface (mediating the Dnmt3a-3a contact) and the FF interface (mediating the Dnmt3a-3L contact). Here, we demonstrate that Dnmt3a-C forms dimers via the FF interface as well, which further oligomerize via their RD interfaces. Each RD interface of the Dnmt3a-C oligomer creates an independent DNA binding site, which allows for binding of separate DNA molecules oriented in parallel. Because Dnmt3L does not have an RD interface, it prevents Dnmt3a oligomerization and binding of more than one DNA molecule. Both interfaces of Dnmt3a are necessary for the heterochromatic localization of the enzyme in cells. Overexpression of Dnmt3L in cells leads to the release of Dnmt3a from heterochromatic regions, which may increase its activity for methylation of euchromatic targets like the differentially methylated regions involved in imprinting.	[Jeltsch, Albert] Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Anspach, Nils; Nellen, Wolfgang; Jeltsch, Albert] Univ Kassel, CINSaT, Abt Genet, D-34132 Kassel, Germany; [Urbanke, Claus] Hannover Med Sch, Abt Strukturanal OE 8830, D-30625 Hannover, Germany; [Jankevicius, Gytis] Jacobs Univ Bremen, MoLife Grad Program, Sch Engn & Sci, D-28759 Bremen, Germany	Jacobs University; Universitat Kassel; Hannover Medical School; Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Albert Jeltsch Sch Engn & Sci, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Jurkowska, Renata/AAE-2504-2020; Rajavelu, Arumugam/B-7832-2013; Jeltsch, Albert/O-7404-2014; Jankevicius, Gytis/C-7126-2015	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Jankevicius, Gytis/0000-0002-0212-3923; Rajavelu, Arumugam/0000-0001-6666-8925	DFG [JE 252/6]	DFG(German Research Foundation (DFG))	This work was supported by the DFG (JE 252/6).	Allis CD, 2007, EPIGENETICS; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hata K, 2002, DEVELOPMENT, V129, P1983; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hore TA, 2007, TRENDS GENET, V23, P440, DOI 10.1016/j.tig.2007.07.003; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	51	68	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24200	24207		10.1074/jbc.M111.254987	http://dx.doi.org/10.1074/jbc.M111.254987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566127	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000292294900062
J	Mitra, N; Banda, K; Altheide, TK; Schaffer, L; Johnson-Pais, TL; Beuten, J; Leach, RJ; Angata, T; Varki, N; Varki, A				Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Schaffer, Lana; Johnson-Pais, Teresa L.; Beuten, Joke; Leach, Robin J.; Angata, Takashi; Varki, Nissi; Varki, Ajit			SIGLEC12, a Human-specific Segregating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; ACUTE MYELOID-LEUKEMIA; NEGATIVE REGULATION; UP-REGULATION; GENE FUSIONS; CANCER; EVOLUTION; IDENTIFICATION; TRANSCRIPTION; MACROPHAGES	The primate SIGLEC12 gene encodes one of the CD33-related Siglec family of signaling molecules in immune cells. We had previously reported that this gene harbors a human-specific missense mutation of the codon for an Arg residue required for sialic acid recognition. Here we show that this R122C mutation of the Siglec-XII protein is fixed in the human population, i.e. it occurred prior to the origin of modern humans. Additional mutations have since completely inactivated the SIGLEC12 gene in some but not all humans. The most common inactivating mutation with a global allele frequency of 58% is a single nucleotide frame-shift that markedly shortens the open reading frame. Unlike other CD33-related Siglecs that are primarily found on immune cells, we found that Siglec-XII protein is expressed not only on some macrophages but also on various epithelial cell surfaces in humans and chimpanzees. We also found expression on certain human prostate epithelial carcinomas and carcinoma cell lines. This expression correlates with the presence of the nonframeshifted, intact SIGLEC12 allele. Although SIGLEC12 allele status did not predict prostate carcinoma incidence, restoration of expression in a prostate carcinoma cell line homozygous for the frameshift mutation induced altered regulation of several genes associated with carcinoma progression. These stably transfected Siglec-XII-expressing prostate cancer cells also showed enhanced growth in nude mice. Finally, monoclonal antibodies against the protein were internalized by Siglec-XII-expressing prostate carcinoma cells, allowing targeting of a toxin to such cells. Polymorphic expression of Siglec-XII in humans thus has implications for prostate cancer biology and therapeutics.	[Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Pathol, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Schaffer, Lana] Scripps Res Inst, La Jolla, CA 92037 USA; [Johnson-Pais, Teresa L.; Beuten, Joke; Leach, Robin J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Texas System; University of Texas Health San Antonio	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Mitra, Nivedita/0000-0003-3799-5681; Leach, Robin/0000-0002-3201-5579	National Institutes of Health [U01CA128442, R01CA38701]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA038701, U01CA128442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant U01CA128442 and R01CA38701 (to A. V.). This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation.	Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; Altheide TK, 2006, J BIOL CHEM, V281, P25689, DOI 10.1074/jbc.M604221200; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Angata T, 2001, J BIOL CHEM, V276, P40282, DOI 10.1074/jbc.M105926200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Avril T, 2006, BIOCHEM SOC T, V34, P1024, DOI 10.1042/BST0341024; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Beuten J, 2010, CANCER EPIDEM BIOMAR, V19, P588, DOI 10.1158/1055-9965.EPI-09-0864; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Cao H, 2008, EUR J IMMUNOL, V38, P2303, DOI 10.1002/eji.200738078; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Cao H, 2009, IMMUNOGENETICS, V61, P401, DOI 10.1007/s00251-009-0372-0; CARON PC, 1992, CANCER RES, V52, P6761; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cheng L, 1996, AM J PATHOL, V148, P1375; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Consortium Y. C., 2002, GENOME RES, V12, P339, DOI DOI 10.1101/GR.217602; Cornish Ann L., 1998, Blood, V92, P2123; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kohls MD, 2000, BIOTECHNIQUES, V28, P162, DOI 10.2144/00281pf01; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Linden ECMBVD, 2007, GLYCOBIOLOGY, V17, P922, DOI 10.1093/glyco/cwm065; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; McMillan SJ, 2008, CARBOHYD RES, V343, P2050, DOI 10.1016/j.carres.2008.01.009; Miyake H, 2000, CANCER RES, V60, P3058; Nguyen DH, 2006, EXP HEMATOL, V34, P728, DOI 10.1016/j.exphem.2006.03.003; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sarrats A, 2010, PROSTATE, V70, P1, DOI 10.1002/pros.21031; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schmitz M, 2007, INT J CANCER, V120, P1284, DOI 10.1002/ijc.22359; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; UMBAS R, 1994, CANCER RES, V54, P3929; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A., 2009, ESSENTIALS GLYCOBIOL, P459; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Verhagen PCMS, 2006, J PATHOL, V208, P699, DOI 10.1002/path.1929; Vestergaard EM, 2010, INT J CANCER, V127, P1857, DOI 10.1002/ijc.25209; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Yu ZB, 2001, J BIOL CHEM, V276, P23816, DOI 10.1074/jbc.M102394200; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	62	38	38	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23003	23011		10.1074/jbc.M111.244152	http://dx.doi.org/10.1074/jbc.M111.244152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555517	Green Published, hybrid			2022-12-27	WOS:000292025000035
J	Myeku, N; Figueiredo-Pereira, ME				Myeku, Natura; Figueiredo-Pereira, Maria E.			Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy ASSOCIATION WITH SEQUESTOSOME 1/p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; NEURODEGENERATIVE DISEASE; PROXIMITY LIGATION; SEQUESTOSOME 1/P62; PROSTAGLANDIN J2; BASAL AUTOPHAGY; CELL-DEATH; INHIBITION; ASSAYS; MICE	Proteotoxicity resulting from accumulation of damaged/unwanted proteins contributes prominently to cellular aging and neurodegeneration. Proteasomal removal of these proteins upon covalent polyubiquitination is highly regulated. Recent reports proposed a role for autophagy in clearance of diffuse ubiquitinated proteins delivered by p62/SQSTM1. Here, we compared the turnover dynamics of endogenous ubiquitinated proteins by proteasomes and autophagy by assessing the effect of their inhibitors. Autophagy inhibitors bafilomycin A1, ammonium chloride, and 3-methyladenine failed to increase ubiquitinated protein levels. The proteasome inhibitor epoxomicin raised ubiquitinated protein levels at least 3-fold higher than the lysosomotropic agent chloroquine. These trends were observed in SK-N-SH cells under serum or serum-free conditions and in WT or Atg5(-/-) mouse embryonic fibroblasts (MEFs). Notably, chloroquine considerably inhibited proteasomes in SK-N-SH cells and MEFs. In these cells, elevation of p62/SQSTM1 was greater upon proteasome inhibition than with all autophagy inhibitors tested and was reduced in Atg5(-/-) MEFs. With epoxomicin, soluble p62/SQSTM1 associated with proteasomes and p62/SQSTM1 aggregates contained inactive proteasomes, ubiquitinated proteins, and autophagosomes. Prolonged autophagy inhibition (96 h) failed to elevate ubiquitinated proteins in rat cortical neurons, although epoxomicin did. Moreover, prolonged autophagy inhibition in cortical neurons markedly increased p62/SQSTM1, supporting its degradation mainly by autophagy and not by proteasomes. In conclusion, we clearly demonstrate that pharmacologic or genetic inhibition of autophagy fails to elevate ubiquitinated proteins unless the proteasome is affected. We also provide strong evidence that p62/SQSTM1 associates with proteasomes and that autophagy degrades p62/SQSTM1. Overall, the function of p62/SQSTM1 in the proteasomal pathway and autophagy requires further elucidation.	[Myeku, Natura; Figueiredo-Pereira, Maria E.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Figueiredo-Pereira, ME (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu			National Institutes of Health [NS41073]; NIA [AG028847]; NCRR/CTSC [UL-RR024996]; NIGMS/RCMI [RR03037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR/CTSC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS41073 (SNRP) NINDS (to M. E. F.-P.), AG028847 from NIA (to M. E. F.-P.), UL-RR024996 from NCRR/CTSC (TL1 training award to N. M.), and RR03037 from NIGMS/RCMI (infrastructure to Hunter College, City University of New York).	Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; FREDRIKSSON S, 2009, NAT METHODS, V6, pR1; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Qiao LY, 2009, NEUROSCI LETT, V456, P15, DOI 10.1016/j.neulet.2009.03.085; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shimizu S, 2010, AUTOPHAGY, V6, P290, DOI 10.4161/auto.6.2.11127; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wang ZY, 2005, MOL CELL NEUROSCI, V29, P222, DOI 10.1016/j.mcn.2005.02.011; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	53	158	161	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22426	22440		10.1074/jbc.M110.149252	http://dx.doi.org/10.1074/jbc.M110.149252			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536669	Green Published, hybrid			2022-12-27	WOS:000291719900052
J	Wu, BX; Clarke, CJ; Matmati, N; Montefusco, D; Bartke, N; Hannun, YA				Wu, Bill X.; Clarke, Christopher J.; Matmati, Nabil; Montefusco, David; Bartke, Nana; Hannun, Yusuf A.			Identification of Novel Anionic Phospholipid Binding Domains in Neutral Sphingomyelinase 2 with Selective Binding Preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID-BINDING; LUNG EPITHELIAL-CELLS; PLASMA-MEMBRANE; ACTIVATION; CERAMIDE; NSMASE2; METABOLISM; GROWTH	Sphingolipids such as ceramide are recognized as vital regulators of many biological processes. Neutral sphingomyelinase 2 (nSMase2) is one of the key enzymes regulating ceramide production. It was previously shown that the enzymatic activity of nSMase2 was dependent on anionic phospholipids (APLs). In this study, the structural requirements for APL-selective binding of nSMase2 were determined and characterized. Using lipid-protein overlay assays, nSMase2 interacted specifically and directly with several APLs, including phosphatidylserine and phosphatidic acid. Lipid-protein binding studies of deletion mutants identified two discrete APL binding domains in the N terminus of nSMase2. Further, mutagenesis experiments pinpointed the core sequences and major cationic amino acids in the domains that are necessary for the cooperative activation of nSMase2 by APLs. The first domain included the first amino-terminal hydrophobic segment and Arg-33, which were essential for nSMase2 to interact with APLs. The second binding domain was comprised of the second hydrophobic segment and Arg-92 and Arg-93. Moreover, mutation of one or both domains decreased APL binding and APL-dependent catalytic activity of nSMase2. Further, mutation of both domains in nSMase2 reduced its plasma membrane localization. Finally, these binding domains are also important for the capability of nSMase2 to rescue the defects of yeast lacking the nSMase homologue, ISC1. In conclusion, these data have identified the APL binding domains of nSMase2 for the first time. The analysis of interactions between nSMase2 and APLs will contribute to our understanding of signaling pathways mediated by sphingolipid metabolites.	[Wu, Bill X.; Clarke, Christopher J.; Matmati, Nabil; Montefusco, David; Bartke, Nana; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Bartke, Nana] Ctr Specialised Nutr, D-61381 Friedrichsdorf, Germany	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [GM 43825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant GM 43825 (to Y. A. H.).	Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Corbalan-Garcia S, 2003, BIOCHEMISTRY-US, V42, P11661, DOI 10.1021/bi034850d; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; NATARAJAN V, 1993, J BIOL CHEM, V268, P930; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sethu S, 2008, J IMMUNOL, V180, P6027, DOI 10.4049/jimmunol.180.9.6027; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580	53	22	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22362	22371		10.1074/jbc.M110.156471	http://dx.doi.org/10.1074/jbc.M110.156471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550973	hybrid, Green Published			2022-12-27	WOS:000291719900046
J	Zhao, YJ; Zhang, HM; Lam, CMC; Hao, Q; Lee, HC				Zhao, Yong Juan; Zhang, Hong Min; Lam, Connie Mo Ching; Hao, Quan; Lee, Hon Cheung			Cytosolic CD38 Protein Forms Intact Disulfides and Is Active in Elevating Intracellular Cyclic ADP-ribose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; LENTIVIRAL-VECTORS; CALCIUM-RELEASE; BOND FORMATION; PRION PROTEIN; CA2+ STORES; TRANSMEMBRANE; HYDROLYSIS; EXPRESSION; NAD(+)	CD38 catalyzes the synthesis of cyclic ADP-ribose (cADPR), a Ca2+ messenger responsible for regulating a wide range of physiological functions. It is generally regarded as an ectoenzyme, but its intracellular localization has also been well documented. It is not known if internal CD38 is enzymatically active and contributes to the Ca2+ signaling function. In this study, we engineered a novel soluble form of CD38 that can be efficiently expressed in the cytosol and use cytosolic NAD as a substrate to produce cADPR intracellularly. The activity of the engineered CD38 could be decreased by mutating the catalytic residue Glu-226 and increased by the double mutation E146A/T221F, which increased its cADPR synthesis activity by > 11-fold. Remarkably, the engineered CD38 exhibited the ability to form the critical disulfide linkages required for its enzymatic activity. This was verified by using a monoclonal antibody generated against a critical disulfide, Cys-254-Cys-275. The specificity of the antibody was established by x-ray crystallography and site-directed mutagenesis. The engineered CD38 is thus a novel example challenging the general belief that cytosolic proteins do not possess disulfides. As a further refinement of this approach, the engineered CD38 was placed under the control of tetracycline using an autoregulated construct. This study has set the stage for in vivo manipulation of cADPR metabolism.	[Zhao, Yong Juan; Zhang, Hong Min; Lam, Connie Mo Ching; Hao, Quan; Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, 4-F Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	leehc@hku.hk	Zhao, Yongjuan/AAS-9919-2021; Zhang, Hongmin/C-4503-2009; Hao, Quan/C-4304-2009; Lee, Hon Cheung/C-4329-2009; Zhang, Hongmin/S-9953-2017	Zhang, Hongmin/0000-0001-6357-4106; Zhang, Hongmin/0000-0003-4356-3615; Hao, Quan/0000-0002-9642-0514; Zhao, Yong Juan/0000-0003-4564-1912	Hong Kong General Research Fund [769107, 768408, 769309, 770610, 765909, 766510, 785110]; National Natural Science Foundation of China/Research Grants Council [N_HKU 722/08]	Hong Kong General Research Fund; National Natural Science Foundation of China/Research Grants Council(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong General Research Fund Grants 769107, 768408, 769309, and 770610 (to H. C. L.), 765909 and 766510 (to Q. H.), and 785110 (to H. M. Z.) and National Natural Science Foundation of China/Research Grants Council Joint Research Scheme Grant N_HKU 722/08 (to H. C. L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Centlivre M, 2010, GENE THER, V17, P14, DOI 10.1038/gt.2009.109; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Khoo KM, 2000, J BIOL CHEM, V275, P24807, DOI 10.1074/jbc.M908231199; Kou W, 2009, J NEUROSCI RES, V87, P2326, DOI 10.1002/jnr.22060; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Robinson LC, 2008, BIOCHEM BIOPH RES CO, V368, P593, DOI 10.1016/j.bbrc.2008.01.127; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Tate CG, 2010, SCIENCE, V328, P1644, DOI 10.1126/science.1193065; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Yalcintepe L, 2005, EXP CELL RES, V303, P14, DOI 10.1016/j.yexcr.2004.09.010; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zocchi E, 2001, FASEB J, V15, P1610, DOI 10.1096/fj.00-0803fje; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	54	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22170	22177		10.1074/jbc.M111.228379	http://dx.doi.org/10.1074/jbc.M111.228379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21524995	Green Published, hybrid			2022-12-27	WOS:000291719900023
J	Kamani, M; Mylvaganam, M; Tian, R; Rigat, B; Binnington, B; Lingwood, C				Kamani, Mustafa; Mylvaganam, Murugesapillai; Tian, Robert; Rigat, Brigitte; Binnington, Beth; Lingwood, Clifford			Adamantyl Glycosphingolipids Provide a New Approach to the Selective Regulation of Cellular Glycosphingolipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ALPHA-GALACTOSIDASE; GROWTH-FACTOR RECEPTOR; ACID BETA-GLUCOSIDASE; GAUCHER-DISEASE; GLUCOSYLCERAMIDE SYNTHASE; STORAGE DISEASES; GLYCOLIPID CONFORMATION; GLOBOTRIAOSYL CERAMIDE; MONOCLONAL-ANTIBODY; IMPROVED INHIBITORS	Mammalian glycosphingolipid (GSL) precursor monohexosylceramides are either glucosyl-or galactosylceramide (GlcCer or GalCer). Most GSLs derive from GlcCer. Substitution of the GSL fatty acid with adamantane generates amphipathic mimics of increased water solubility, retaining receptor function. We have synthesized adamantyl GlcCer (adaGlcCer) and adamantyl GalCer (adaGalCer). AdaGlcCer and adaGalCer partition into cells to alter GSL metabolism. At low dose, adaGlcCer increased cellular GSLs by inhibition of glucocerebrosidase (GCC). Recombinant GCC was inhibited at pH 7 but not pH 5. In contrast, adaGalCer stimulated GCC at pH 5 but not pH 7 and, like adaGlcCer, corrected N370S mutant GCC traffic from the endoplasmic reticulum to lysosomes. AdaGalCer reduced GlcCer levels in normal and lysosomal storage disease (LSD) cells. At 40 mu M adaGlcCer, lactosylceramide (LacCer) synthase inhibition depleted LacCer (and more complex GSLs), such that only GlcCer remained. In Vero cell microsomes, 40 mu M adaGlcCer was converted to adaLacCer, and LacCer synthesis was inhibited. AdaGlcCer is the first cell LacCer synthase inhibitor. At 40 mu M adaGalCer, cell synthesis of only Gb(3) and Gb(4) was significantly reduced, and a novel product, adamantyl digalactosylceramide (adaGb(2)), was generated, indicating substrate competition for Gb(3) synthase. AdaGalCer also inhibited cell sulfatide synthesis. Microsomal Gb(3) synthesis was inhibited by adaGalCer. Metabolic labeling of Gb(3) in Fabry LSD cells was selectively reduced by adaGalCer, and adaGb(2) was produced. AdaGb(2) in cells was 10-fold more effectively shed into the medium than the more polar Gb(3), providing an easily eliminated "safety valve" alternative to Gb(3) accumulation. Adamantyl monohexosyl ceramides thus provide new tools to selectively manipulate normal cellular GSL metabolism and reduce GSL accumulation in cells from LSD patients.	[Kamani, Mustafa; Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Kamani, Mustafa; Mylvaganam, Murugesapillai; Tian, Robert; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Rigat, Brigitte] Hosp Sick Children, Res Inst, Div Genet & Genome Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lingwood, C (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca	Tian, Rui/E-5637-2011		Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics	Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics.	ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; BAILLY P, 1986, BIOCHEM BIOPH RES CO, V141, P84, DOI 10.1016/S0006-291X(86)80338-2; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Chatterjee S, 2008, CURR DRUG TARGETS, V9, P272, DOI 10.2174/138945008783954952; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Colsch B, 2008, J NEUROIMMUNOL, V193, P52, DOI 10.1016/j.jneuroim.2007.10.008; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; De Rosa MF, 2008, J BIOL CHEM, V283, P4501, DOI 10.1074/jbc.M705473200; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Heese BA, 2008, SEMIN PEDIATR NEUROL, V15, P119, DOI 10.1016/j.spen.2008.05.005; Hoffmann B, 2005, NEUROPEDIATRICS, V36, P285, DOI 10.1055/s-2005-872810; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lingwood Clifford, 2006, V347, P305; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lloyd DH, 2007, VET DERMATOL, V18, P197, DOI 10.1111/j.1365-3164.2007.00594.x; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Mamelak D, 2001, CARBOHYD RES, V335, P91, DOI 10.1016/S0008-6215(01)00209-9; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Norez C, 2009, AM J RESP CELL MOL, V41, P217, DOI 10.1165/rcmb.2008-0285OC; Nutikka Anita, 2003, Methods Mol Med, V73, P197; Park HJ, 2009, CHEM BIOL, V16, P461, DOI 10.1016/j.chembiol.2009.02.014; Pastores GM, 2002, J AM SOC NEPHROL, V13, pS130, DOI 10.1097/01.ASN.0000015236.70757.C4; RADIN NS, 1993, ADV LIPID RES, V26, P183; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sillence DJ, 2007, INT REV CYTOL, V262, P151, DOI 10.1016/S0074-7696(07)62003-8; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Whetstone H, 2003, BIOCHEMISTRY-US, V42, P1611, DOI 10.1021/bi026735t; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103	63	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21413	21426		10.1074/jbc.M110.207670	http://dx.doi.org/10.1074/jbc.M110.207670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518770	hybrid, Green Published			2022-12-27	WOS:000291464700040
J	Kasamatsu, A; Nakao, M; Smith, BC; Comstock, LR; Ono, T; Kato, J; Denu, JM; Moss, J				Kasamatsu, Atsushi; Nakao, Motoyuki; Smith, Brian C.; Comstock, Lindsay R.; Ono, Tohru; Kato, Jiro; Denu, John M.; Moss, Joel			Hydrolysis of O-Acetyl-ADP-ribose Isomers by ADP-ribosylhydrolase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; NAD(+)-DEPENDENT DEACETYLASES; RIBOSYLARGININE HYDROLASES; TURKEY ERYTHROCYTES; SIR2 FAMILY; RIBOSYLTRANSFERASES; IDENTIFICATION; RIBOSYLATION; METABOLITE; PRODUCT	O-Acetyl-ADP-ribose (OAADPr), produced by the Sir2-catalyzed NAD(+)-dependent histone/protein deacetylase reaction, regulates diverse biological processes. Interconversion between two OAADPr isomers with acetyl attached to the C-2 '' and C-3 '' hydroxyl of ADP-ribose (ADPr) is rapid. We reported earlier that ADP-ribosylhydrolase 3 (ARH3), one of three ARH proteins sharing structural similarities, hydrolyzed OAADPr to ADPr and acetate, and poly(ADPr) to ADPr monomers. ARH1 also hydrolyzed OAADPr and poly(ADPr) as well as ADP-ribose-arginine, with arginine in alpha-anomeric linkage to C-1 '' of ADP-ribose. Because both ARH3- and ARH1-catalyzed reactions involve nucleophilic attacks at the C-1 '' position, it was perplexing that the ARH3 catalytic site would cleave OAADPr at either the 2 ''- or 3 ''-position, and we postulated the existence of a third isomer, 1 ''-OAADPr, in equilibrium with 2 ''- and 3 ''-isomers. A third isomer, consistent with 1 ''-OAADPr, was identified at pH 9.0. Further, ARH3 OAADPr hydrolase activity was greater at pH 9.0 than at neutral pH where 3 ''-OAADPr predominated. Consistent with our hypothesis, IC50 values for ARH3 inhibition by 2 ''- and 3 ''-N-acetyl-ADPr analogs of OAADPr were significantly higher than that for ADPr. ARH1 also hydrolyzed OAADPr more rapidly at alkaline pH, but cleavage of ADP-ribose-arginine was faster at neutral pH than pH 9.0. ARH3-catalyzed hydrolysis of OAADPr in H-2 O-18 resulted in incorporation of one O-18 into ADP-ribose by mass spectrometric analysis, consistent with cleavage at the C-1 '' position. Together, these data suggest that ARH family members, ARH1 and ARH3, catalyze hydrolysis of the 1 ''-O linkage in their structurally diverse substrates.	[Kasamatsu, Atsushi; Nakao, Motoyuki; Ono, Tohru; Kato, Jiro; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Smith, Brian C.; Comstock, Lindsay R.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wisconsin System; University of Wisconsin Madison	Moss, J (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Rm 6D05,Bldg 10,MSC 1590, Bethesda, MD 20892 USA.	mossj@nhlbi.nih.gov	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768; Comstock, Lindsay/0000-0003-0764-7344	National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program, National Institutes of Health, NHLBI.	Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Diefenbach J, 2005, CELL MOL LIFE SCI, V62, P721, DOI 10.1007/s00018-004-4503-3; FERRO AM, 1978, P NATL ACAD SCI USA, V75, P809, DOI 10.1073/pnas.75.2.809; FISHMAN PH, 1990, ADP RIBOSYLATING TOX, P127; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; MIWA M, 1981, J BIOL CHEM, V256, P2916; MOSS J, 1988, BIOCHEMISTRY-US, V27, P5819, DOI 10.1021/bi00415a063; MOSS J, 1986, BIOCHEMISTRY-US, V25, P5408, DOI 10.1021/bi00367a010; Moss J, 1997, ADV EXP MED BIOL, V419, P25; MOSS J, 1992, J BIOL CHEM, V267, P10481; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Williamson K., 1990, ADP RIBOSYLATING TOX, P493	27	36	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21110	21117		10.1074/jbc.M111.237636	http://dx.doi.org/10.1074/jbc.M111.237636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498885	Green Published, hybrid			2022-12-27	WOS:000291464700010
J	Ryu, SY; Beutner, G; Kinnally, KW; Dirksen, RT; Sheu, SS				Ryu, Shin-Young; Beutner, Gisela; Kinnally, Kathleen W.; Dirksen, Robert T.; Sheu, Shey-Shing			Single Channel Characterization of the Mitochondrial Ryanodine Receptor in Heart Mitoplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE CONDUCTANCE CHANNEL; INNER MEMBRANE; K+ CHANNELS; CA2+ UPTAKE; RAT-HEART; INTRACELLULAR CALCIUM; VENTRICULAR MYOCYTES; POTASSIUM CHANNELS; RELEASE CHANNEL; ATP SYNTHASE	Heart mitochondria utilize multiple Ca2+ transport mechanisms. Among them, the mitochondrial ryanodine receptor provides a fast Ca2+ uptake pathway across the inner membrane to control "excitation and metabolism coupling." In the present study, we identified a novel ryanodine-sensitive channel in the native inner membrane of heart mitochondria and characterized its pharmacological and biophysical properties by directly patch clamping mitoplasts. Four distinct channel conductances of similar to 100, similar to 225, similar to 700, and similar to 1,000 picosiemens (pS) in symmetrical 150 mM CsCl were observed. The 225 pS cation-selective channel exhibited multiple subconductance states and was blocked by high concentrations of ryanodine and ruthenium red, known inhibitors of ryanodine receptors. Ryanodine exhibited a concentration-dependent modulation of this channel, with low concentrations stabilizing a subconductance state and high concentrations abolishing activity. The 100, 700, and 1,000 pS conductances exhibited different channel characteristics and were not inhibited by ryanodine. Taken together, these findings identified a novel 225 pS channel as the native mitochondrial ryanodine receptor channel activity in heart mitoplasts with biophysical and pharmacological properties that distinguish it from previously identified mitochondrial ion channels.	[Ryu, Shin-Young; Beutner, Gisela; Dirksen, Robert T.; Sheu, Shey-Shing] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Ryu, Shin-Young; Kinnally, Kathleen W.] NYU, Dept Basic Sci, New York, NY 10010 USA; [Sheu, Shey-Shing] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Rochester; New York University; Jefferson University	Sheu, SS (corresponding author), 1025 Walnut St, Philadelphia, PA 19107 USA.	shey-shing.sheu@jefferson.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601	National Institutes of Health [HL-033333, HL-093671, AR-44657, GM57249]; American Heart Association [0525951T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333, R01HL093671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-033333 and HL-093671 (to S.-S.S.), AR-44657 (to R.T.D.), and GM57249 (to K.W.K.) and American Heart Association Postdoctoral Fellowship Grant 0525951T to S.-Y.R.	Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Beavis AD, 1996, J BIOENERG BIOMEMBR, V28, P207, DOI 10.1007/BF02110652; Bednarezyk P, 2005, FEBS LETT, V579, P1625, DOI 10.1016/j.febslet.2005.01.077; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; DAS AM, 1990, BIOCHEM SOC T, V18, P554, DOI 10.1042/bst0180554; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0; FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Grigoriev SM, 2004, INT REV CYTOL, V238, P227, DOI 10.1016/S0074-7696(04)38005-8; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; KINNALLY KW, 1991, BIOCHEM BIOPH RES CO, V176, P1183, DOI 10.1016/0006-291X(91)90410-9; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kushnareva YE, 1999, ARCH BIOCHEM BIOPHYS, V366, P107, DOI 10.1006/abbi.1999.1190; Lin L, 2007, PFLUG ARCH EUR J PHY, V454, P395, DOI 10.1007/s00424-007-0257-8; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Muro C, 2003, BIOPHYS J, V84, P2981, DOI 10.1016/S0006-3495(03)70024-1; Murphy RC, 1998, FEBS LETT, V425, P259, DOI 10.1016/S0014-5793(98)00245-2; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pickel VM, 1997, J COMP NEUROL, V386, P625, DOI 10.1002/(SICI)1096-9861(19971006)386:4<625::AID-CNE8>3.0.CO;2-4; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Ryu SY, 2010, FEBS LETT, V584, P1948, DOI 10.1016/j.febslet.2010.01.032; Ryu SY, 2005, J MOL CELL CARDIOL, V39, P874, DOI 10.1016/j.yjmcc.2005.08.011; Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com; SZABO I, 1991, J BIOL CHEM, V266, P3376; Szewczyk A, 2006, BBA-BIOENERGETICS, V1757, P715, DOI 10.1016/j.bbabio.2006.05.002; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Uehara K, 2004, CELL TISSUE RES, V317, P137, DOI 10.1007/s00441-004-0904-8; Xu JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1717, DOI 10.1152/ajpcell.00105.2004; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049; ZOROV DB, 1992, BIOCHIM BIOPHYS ACTA, V1105, P263, DOI 10.1016/0005-2736(92)90203-X	54	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21324	21329		10.1074/jbc.C111.245597	http://dx.doi.org/10.1074/jbc.C111.245597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524998	Green Published, hybrid			2022-12-27	WOS:000291464700031
J	Siemens, N; Patenge, N; Otto, J; Fiedler, T; Kreikemeyer, B				Siemens, Nikolai; Patenge, Nadja; Otto, Juliane; Fiedler, Tomas; Kreikemeyer, Bernd			Streptococcus pyogenes M49 Plasminogen/Plasmin Binding Facilitates Keratinocyte Invasion via Integrin-Integrin-linked Kinase (ILK) Pathways and Protects from Macrophage Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HYALURONIC-ACID CAPSULE; FIBRONECTIN-BINDING; EPITHELIAL-CELLS; PLASMIN RECEPTOR; VIRULENCE FACTOR; SKIN INFECTION; SEROTYPE M49; HOST-CELLS; ADHERENCE	The entry into epithelial cells and the prevention of primary immune responses are a prerequisite for a successful colonization and subsequent infection of the human host by Streptococcus pyogenes (group A streptococci, GAS). Here, we demonstrate that interaction of GAS with plasminogen promotes an integrin-mediated internalization of the bacteria into keratinocytes, which is independent from the serine protease activity of potentially generated plasmin. alpha(1)beta(1)- and alpha(5)beta(1)-integrins were identified as the major keratinocyte receptors involved in this process. Inhibition of integrin-linked kinase (ILK) expression by siRNA silencing or blocking of PI3K and Akt with specific inhibitors, reduced the GAS M49-plasminogen/plasmin-mediated invasion of keratinocytes. In addition, blocking of actin polymerization significantly reduced GAS internalization into keratinocytes. Altogether, these results provide a first model of plasminogen-mediated GAS invasion into keratinocytes. Furthermore, we demonstrate that plasminogen binding protects the bacteria against macrophage killing.	[Siemens, Nikolai; Patenge, Nadja; Otto, Juliane; Fiedler, Tomas; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Univ Hosp, Inst Med Microbiol Virol & Hyg, Schillingallee 70, D-18057 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de		Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098; Siemens, Nikolai/0000-0003-0657-3822	Medical Faculty of the University of Rostock; BMBF (German Federal Ministry of Education and Research)	Medical Faculty of the University of Rostock; BMBF (German Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Medical Faculty of the University of Rostock in the framework of the FORUN program 2010 and by grants from the BMBF (German Federal Ministry of Education and Research) in the framework of the ERANet PathoGenoMics II and SysMO II programs (to B. K.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; BRODER CC, 1991, J BIOL CHEM, V266, P4922; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chavakis T, 2005, Hamostaseologie, V25, P33; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cue D, 2001, MICROB PATHOGENESIS, V31, P231, DOI 10.1006/mpat.2001.0467; Cue DR, 1998, INFECT IMMUN, V66, P4577; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Edwards ML, 2004, MICROBES INFECT, V6, P1156, DOI 10.1016/j.micinf.2004.06.007; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Hampton MB, 1999, J IMMUNOL METHODS, V232, P15, DOI 10.1016/S0022-1759(99)00147-7; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; KULISEK ES, 1989, ANAL BIOCHEM, V177, P78, DOI 10.1016/0003-2697(89)90017-1; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Lishko VK, 2004, BLOOD, V104, P719, DOI 10.1182/blood-2003-09-3016; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Oliver SL, 2007, J CLIN MICROBIOL, V45, P3050, DOI 10.1128/JCM.02015-06; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Serrano RL, 1996, BIOCHEM J, V313, P171, DOI 10.1042/bj3130171; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang BN, 2007, CELL MICROBIOL, V9, P1519, DOI 10.1111/j.1462-5822.2007.00889.x; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x	64	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21612	21622		10.1074/jbc.M110.202671	http://dx.doi.org/10.1074/jbc.M110.202671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521694	hybrid, Green Published			2022-12-27	WOS:000291464700058
J	Silva, LP; Yu, RH; Calmettes, C; Yang, X; Moraes, TF; Schryvers, AB; Schriemer, DC				Silva, Leslie P.; Yu, Ronghua; Calmettes, Charles; Yang, Xue; Moraes, Trevor F.; Schryvers, Anthony B.; Schriemer, David C.			Conserved Interaction between Transferrin and Transferrin-binding Proteins from Porcine Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RECEPTOR PROTEIN; NEISSERIA-MENINGITIDIS; ACTINOBACILLUS-PLEUROPNEUMONIAE; SERUM TRANSFERRIN; IRON TRANSPORT; HAEMOPHILUS-INFLUENZAE; BOUND IRON; C-LOBE; IDENTIFICATION; GONORRHOEAE	Gram-negative porcine pathogens from the Pasteurellaceae family possess a surface receptor complex capable of acquiring iron from porcine transferrin (pTf). This receptor consists of transferrin-binding protein A (TbpA), a transmembrane iron transporter, and TbpB, a surface-exposed lipoprotein. Questions remain as to how the receptor complex engages pTf in such a way that iron is positioned for release, and whether divergent strains present distinct recognition sites on Tf. In this study, the TbpB-pTf interface was mapped using a combination of mass shift analysis and molecular docking simulations, localizing binding uniquely to the pTf Clobe for multiple divergent strains of Actinobacillus plueropneumoniae and suis. The interface was further characterized and validated with site-directed mutagenesis. Although targeting a common lobe, variants differ in preference for the two sublobes comprising the iron coordination site. Sublobes C1 and C2 participate in high affinity binding, but sublobe C1 contributes in a minor fashion to the overall affinity. Further, the TbpB-pTf complex does not release iron independent of other mediators, based on competitive iron binding studies. Together, our findings support a model whereby TbpB efficiently captures and presents iron-loaded pTf to other elements of the uptake pathway, even under low iron conditions.	[Silva, Leslie P.; Schryvers, Anthony B.; Schriemer, David C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Yu, Ronghua; Yang, Xue; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON M5A 2N4, Canada	University of Calgary; University of Calgary; University of Toronto	Schryvers, AB (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada.	schryver@ucalgary.ca; dschriem@ucalgary.ca	Schryvers, Anthony B./AAF-3417-2020	calmettes, charles/0000-0002-2542-4382	Canadian Foundation for Innovation; Canada Research Chair program; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair program(Canada Research Chairs); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Foundation for Innovation, the Canada Research Chair program, the Alberta Heritage Foundation for Medical Research, and the Canadian Institutes of Health Research.	ALCANTARA J, 1993, MOL MICROBIOL, V8, P1135, DOI 10.1111/j.1365-2958.1993.tb01658.x; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; Baltes N, 2002, FEMS MICROBIOL LETT, V209, P283, DOI 10.1111/j.1574-6968.2002.tb11145.x; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Bobst CE, 2009, J MOL BIOL, V388, P954, DOI 10.1016/j.jmb.2009.03.044; Boulton IC, 1998, BIOCHEM J, V334, P269, DOI 10.1042/bj3340269; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; CRIADO MT, 1993, RES MICROBIOL, V144, P77, DOI 10.1016/0923-2508(93)90217-P; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; DeRocco AJ, 2007, INFECT IMMUN, V75, P3220, DOI 10.1128/IAI.00072-07; DYER DW, 1987, INFECT IMMUN, V55, P2171, DOI 10.1128/IAI.55.9.2171-2175.1987; Giannetti AM, 2005, STRUCTURE, V13, P1613, DOI 10.1016/j.str.2005.07.016; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P3809, DOI 10.1128/IAI.63.10.3809-3815.1995; Halbrooks PJ, 2003, BIOCHEMISTRY-US, V42, P3701, DOI 10.1021/bi027071q; Hall DR, 2002, ACTA CRYSTALLOGR D, V58, P70, DOI 10.1107/S0907444901017309; Hirose M, 2000, BIOSCI BIOTECH BIOCH, V64, P1328, DOI 10.1271/bbb.64.1328; Jacques M, 2004, CAN J VET RES, V68, P81; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; LEE BC, 1988, MOL MICROBIOL, V2, P827, DOI 10.1111/j.1365-2958.1988.tb00095.x; Ling JML, 2010, MOL MICROBIOL, V77, P1301, DOI 10.1111/j.1365-2958.2010.07289.x; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; MICKELSEN PA, 1981, INFECT IMMUN, V33, P555, DOI 10.1128/IAI.33.2.555-564.1981; MICKELSEN PA, 1982, INFECT IMMUN, V35, P915, DOI 10.1128/IAI.35.3.915-920.1982; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Nemish U, 2003, BIOCHEM CELL BIOL, V81, P275, DOI 10.1139/O03-057; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Renauld-Mongenie G, 1998, FEMS MICROBIOL LETT, V169, P171; RENAULDMONGE NIEG, 2004, J INFECTION, V72, P3461; Retzer MD, 1999, MOL MICROBIOL, V32, P111, DOI 10.1046/j.1365-2958.1999.01331.x; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SHEN ZM, 1992, PROTEIN SCI, V1, P1477, DOI 10.1002/pro.5560011109; Shouldice SR, 2003, J BIOL CHEM, V278, P11513, DOI 10.1074/jbc.M211780200; Siburt CJP, 2009, METALLOMICS, V1, P249, DOI 10.1039/b902860a; Slysz GW, 2008, ANAL CHEM, V80, P7004, DOI 10.1021/ac800897q; VOGEL W, 1989, KLIN WOCHENSCHR, V67, P538, DOI 10.1007/BF01719780; VONDERHAAR RA, 1994, J BACTERIOL, V176, P6207, DOI 10.1128/jb.176.20.6207-6213.1994; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WEST SEH, 1985, INFECT IMMUN, V47, P388, DOI 10.1128/IAI.47.2.388-394.1985; YU RH, 1993, MICROB PATHOGENESIS, V15, P433, DOI 10.1006/mpat.1993.1092	42	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21353	21360		10.1074/jbc.M111.226449	http://dx.doi.org/10.1074/jbc.M111.226449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21487007	Green Published, hybrid			2022-12-27	WOS:000291464700034
J	Zhang, XP; Dong, CM; Wu, QJ; Balch, WE; Wu, GY				Zhang, Xiaoping; Dong, Chunmin; Wu, Qiong J.; Balch, William E.; Wu, Guangyu			Di-acidic Motifs in the Membrane-distal C Termini Modulate the Transport of Angiotensin II Receptors from the Endoplasmic Reticulum to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ER EXPORT; TYPE-2 RECEPTOR; COPII COAT; CARBOXYL-TERMINUS; CARDIAC MYOCYTES; SELECTIVE EXPORT; STRUCTURAL BASIS; RAB1 GTPASE; TRAFFICKING	The molecular mechanisms underlying the endoplasmic reticulum (ER) export and cell surface transport of nascent G protein-coupled receptors (GPCRs) have just begun to be revealed and previous studies have shown that hydrophobic motifs in the putative amphipathic 8th alpha-helical region within the membrane-proximal C termini play an important role. In this study, we demonstrate that di-acidic motifs in the membrane-distal, nonstructural C-terminal portions are required for the exit from the ER and transport to the plasma membrane of angiotensin II receptors, but not adrenergic receptors. More interestingly, distinct di-acidic motifs dictate optimal export trafficking of different angiotensin II receptors and export ability of each acidic residue in the di-acidic motifs cannot be fully substituted by other acidic residue. Moreover, the function of the di-acidic motifs is likely mediated through facilitating the recruitment of the receptors onto the ER-derived COPII transport vesicles. Therefore, the di-acidic motifs located in the membrane-distal C termini may represent the first linear motifs which recruit selective GPCRs onto the COPII vesicles to control their export from the ER.	[Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Zhang, Xiaoping; Dong, Chunmin; Wu, Qiong J.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Scripps Research Institute	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu			National Institutes of Health [R01GM076167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301, R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM076167 (to G. W.).	Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gallinat S, 2000, AM J PHYSIOL-ENDOC M, V278, pE357, DOI 10.1152/ajpendo.2000.278.3.E357; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Heymann JAW, 1997, P NATL ACAD SCI USA, V94, P4966, DOI 10.1073/pnas.94.10.4966; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nufer O, 2002, J CELL SCI, V115, P619; Olivares-Reyes JA, 2001, J BIOL CHEM, V276, P37761; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014; Zhuang XL, 2010, BIOCHEM BIOPH RES CO, V396, P874, DOI 10.1016/j.bbrc.2010.05.014; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	56	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20525	20535		10.1074/jbc.M111.222034	http://dx.doi.org/10.1074/jbc.M111.222034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507945	Green Published, hybrid			2022-12-27	WOS:000291267600039
J	Kemp, MG; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz			The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-A; H2AX PHOSPHORYLATION; CHECKPOINT KINASE; UV-IRRADIATION; CELL-LINE; RADIOSENSITIZING AGENT; STRAND BREAKS; ACTIVATION; BINDING	A variety of environmental, carcinogenic, and chemotherapeutic agents form bulky lesions on DNA that activate DNA damage checkpoint signaling pathways in human cells. To identify the mechanisms by which bulky DNA adducts induce damage signaling, we developed an in vitro assay using mammalian cell nuclear extract and plasmid DNA containing bulky adducts formed by N-acetoxy-2-acetylaminofluorene or benzo(a) pyrene diol epoxide. Using this cell-free system together with a variety of pharmacological, genetic, and biochemical approaches, we identified the DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) as bulky DNA damage-stimulated kinases that phosphorylate physiologically important residues on the checkpoint proteins p53, Chk1, and RPA. Consistent with these results, purified DNA-PK and ATM were directly stimulated by bulky adduct-containing DNA and preferentially associated with damaged DNA in vitro. Because the DNA damage response kinase ATM and Rad3-related (ATR) is also stimulated by bulky DNA adducts, we conclude that a common biochemical mechanism exists for activation of DNA-PK, ATM, and ATR by bulky adduct-containing DNA.	[Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM32833 (to A. S.).	ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Callegari AJ, 2010, P NATL ACAD SCI USA, V107, P8219, DOI 10.1073/pnas.1003449107; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoppe BS, 2000, RADIAT RES, V153, P125, DOI 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; LEVY DD, 1995, CARCINOGENESIS, V16, P1557, DOI 10.1093/carcin/16.7.1557; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Tsuchida R, 2002, RADIAT RES, V158, P195, DOI 10.1667/0033-7587(2002)158[0195:DOAGMI]2.0.CO;2; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	64	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19237	19246		10.1074/jbc.M111.235036	http://dx.doi.org/10.1074/jbc.M111.235036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487018	Green Published, hybrid			2022-12-27	WOS:000291027700006
J	Laederich, MB; Degnin, CR; Lunstrum, GP; Holden, P; Horton, WA				Laederich, Melanie B.; Degnin, Catherine R.; Lunstrum, Gregory P.; Holden, Paul; Horton, William A.			Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client IMPLICATIONS FOR THERAPEUTIC MANIPULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTANT BIOLOGIC ACTIVITIES; MULTIPLE-MYELOMA; ACTIVATING MUTATIONS; DEGRADATIVE PATHWAY; KINASE-ACTIVITY; IN-VITRO; CHAPERONE; INHIBITOR; CHIP; BINDING	Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of growth and differentiation, whose aberrant activation causes a number of genetic diseases including achondroplasia and cancer. Hsp90 is a specialized molecular chaperone involved in stabilizing a select set of proteins termed clients. Here, we delineate the relationship of Hsp90 and co-chaperone Cdc37 with FGFR3 and the FGFR family. FGFR3 strongly associates with these chaperone complexes and depends on them for stability and function. Inhibition of Hsp90 function using the geldanamycin analog 17-AAG induces the ubiquitination and degradation of FGFR3 and reduces the signaling capacity of FGFR3. Other FGFRs weakly interact with these chaperones and are differentially influenced by Hsp90 inhibition. The Hsp90-related ubiquitin ligase CHIP is able to interact and destabilize FGFR3. Our results establish FGFR3 as a strong Hsp90 client and suggest that modulating Hsp90 chaperone complexes may beneficially influence the stability and function of FGFR3 in disease.	[Horton, William A.] Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, Portland, OR 97239 USA; [Laederich, Melanie B.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Holden, Paul; Horton, William A.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Horton, WA (corresponding author), Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	wah@shcc.org			Shriners Hospitals for Children; PhRMA Foundation	Shriners Hospitals for Children; PhRMA Foundation	This work was supported by research and fellowship training grants from the Shriners Hospitals for Children.; Recipient of a predoctoral fellowship from the PhRMA Foundation.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Avantaggiati ML, 1996, EMBO J, V15, P2236, DOI 10.1002/j.1460-2075.1996.tb00577.x; Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chiosis G, 2003, MOL CANCER THER, V2, P123; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Germano S, 2006, J BIOL CHEM, V281, P21710, DOI 10.1074/jbc.M602014200; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Hikri E, 2009, CELL SIGNAL, V21, P588, DOI 10.1016/j.cellsig.2008.12.011; Jeong JH, 2008, J CELL BIOCHEM, V105, P585, DOI 10.1002/jcb.21859; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Lievens PMJ, 2006, J MOL BIOL, V357, P783, DOI 10.1016/j.jmb.2006.01.058; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nakashima T, 2010, CLIN CANCER RES, V16, P2792, DOI 10.1158/1078-0432.CCR-09-3112; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Sun XP, 2010, P NATL ACAD SCI USA, V107, P3146, DOI 10.1073/pnas.0910717107; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Terry J, 2005, CLIN CANCER RES, V11, P5631, DOI 10.1158/1078-0432.CCR-05-0398; Theodoraki MA, 2007, EXP CELL RES, V313, P3851, DOI 10.1016/j.yexcr.2007.06.022; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	53	33	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19597	19604		10.1074/jbc.M110.206151	http://dx.doi.org/10.1074/jbc.M110.206151			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487019	Green Published, hybrid			2022-12-27	WOS:000291027700043
J	Li, X; Apel, D; Gaynor, EC; Tanner, ME				Li, Xu; Apel, Dmitry; Gaynor, Erin C.; Tanner, Martin E.			5 '-Methylthioadenosine Nucleosidase Is Implicated in Playing a Key Role in a Modified Futalosine Pathway for Menaquinone Biosynthesis in Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; TRANSITION-STATE ANALOGS; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; AUTOINDUCER-2; MICROORGANISMS; IDENTIFICATION; VITAMIN-K-2; SIMILARITY; INHIBITORS	Menaquinone (vitamin K(2)) serves as an electron carrier in the electron transport chain required for respiration in many pathogenic bacteria. Most bacteria utilize a common menaquinone biosynthetic pathway as exemplified by Escherichia coli. Recently, a novel biosynthetic pathway, the futalosine pathway, was discovered in Streptomyces. Bioinformatic analysis strongly suggests that this pathway is also operative in the human pathogens Campylobacter jejuni and Helicobacter pylori. Here, we provide compelling evidence that a modified futalosine pathway is operative in C. jejuni and that it utilizes 6-amino-6-deoxyfutalosine instead of futalosine. A key step in the Streptomyces pathway involves a nucleosidase called futalosine hydrolase. The closest homolog in C. jejuni has been annotated as a 5'-methylthioadenosine nucleosidase (MTAN). We have shown that this C. jejuni enzyme has MTAN activity but negligible futalosine hydrolase activity. However, the C. jejuni MTAN is able to hydrolyze 6-amino-6-deoxyfutalosine at a rate comparable with that of its known substrates. This suggests that the adenine-containing version of futalosine is the true biosynthetic intermediate in this organism. To demonstrate this in vivo, we constructed a C. jejuni mutant strain deleted for mqnA2, which is predicted to encode for the enzyme required to synthesize 6-amino-6-deoxyfutalosine. Growth of this mutant was readily rescued by the addition of 6-amino-6-deoxyfutalosine, but not futalosine. This provides the first direct evidence that a modified futalosine pathway is operative in C. jejuni. It also highlights the tremendous versatility of the C. jejuni MTAN, which plays key roles in S-adenosylmethionine recycling, the biosynthesis of autoinducer molecules, and the biosynthesis of menaquinone.	[Apel, Dmitry; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Li, Xu; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	egaynor@mail.ubc.ca; mtanner@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Burroughs Wellcome Fund; Canada Research Chair Award; Canadian Institutes of Health Research [MOP-68981]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; to M. E. T.) and by a Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences, a Canada Research Chair Award, and Canadian Institutes of Health Research Operating Grant MOP-68981 (to E. C. G.).	Arai R, 2009, J STRUCT BIOL, V168, P575, DOI 10.1016/j.jsb.2009.07.007; Arakawa C, 2011, ANTIMICROB AGENTS CH, V55, P913, DOI 10.1128/AAC.01362-10; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; CARLONE GM, 1983, J GEN MICROBIOL, V129, P3385; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COLLINS MD, 1984, ARCH MICROBIOL, V137, P168, DOI 10.1007/BF00414461; Cornell KA, 1998, BBA-GENE STRUCT EXPR, V1396, P8, DOI 10.1016/S0167-4781(97)00169-3; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Dairi T, 2009, J ANTIBIOT, V62, P347, DOI 10.1038/ja.2009.46; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; DUERRE JA, 1962, J BIOL CHEM, V237, P3737; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Evans GB, 2004, J MED CHEM, V47, P3275, DOI 10.1021/jm0306475; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Hiratsuka T, 2009, BIOSCI BIOTECH BIOCH, V73, P1137, DOI 10.1271/bbb.80906; Ikejiri M, 2008, BIOORG MED CHEM LETT, V18, P4638, DOI 10.1016/j.bmcl.2008.07.015; KALCKAR HM, 1947, J BIOL CHEM, V167, P429; KLENOW H, 1952, BIOCHEM J, V50, P404, DOI 10.1042/bj0500404; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Lee JE, 2005, J MOL BIOL, V352, P559, DOI 10.1016/j.jmb.2005.07.027; Lee JE, 2005, BIOCHEMISTRY-US, V44, P11049, DOI 10.1021/bi050493q; Lee JE, 2005, J BIOL CHEM, V280, P18274, DOI 10.1074/jbc.M414471200; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li X, 2010, TETRAHEDRON LETT, V51, P6463, DOI 10.1016/j.tetlet.2010.10.010; Marcelli SW, 1996, FEMS MICROBIOL LETT, V138, P59; MEDEIROS GC, 1971, BIOCHIM BIOPHYS ACTA, V238, P1, DOI 10.1016/0005-2787(71)90002-5; Meganathan R, 2001, VITAM HORM, V61, P173; MOSS CW, 1990, J CLIN MICROBIOL, V28, P395, DOI 10.1128/JCM.28.2.395-397.1990; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x	42	40	44	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19392	19398		10.1074/jbc.M111.229781	http://dx.doi.org/10.1074/jbc.M111.229781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489995	hybrid, Green Published			2022-12-27	WOS:000291027700021
J	Martin-Galiano, AJ; Oliva, MA; Sanz, L; Bhattacharyya, A; Serna, M; Yebenes, H; Valpuesta, JM; Andreu, JM				Martin-Galiano, Antonio J.; Oliva, Maria A.; Sanz, Laura; Bhattacharyya, Anamitra; Serna, Marina; Yebenes, Hugo; Valpuesta, Jose M.; Andreu, Jose M.			Bacterial Tubulin Distinct Loop Sequences and Primitive Assembly Properties Support Its Origin from a Eukaryotic Tubulin Ancestor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; ALPHA-BETA-TUBULIN; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; BINDING; RING; MICROTUBULES; HYDROLYSIS; STABILITY; PLASMID	The structure of the unique bacterial tubulin BtubA/B from Prosthecobacter is very similar to eukaryotic alpha beta-tubulin but, strikingly, BtubA/B fold without eukaryotic chaperones. Our sequence comparisons indicate that BtubA and BtubB do not really correspond to either alpha- or beta-tubulin but have mosaic sequences with intertwining features from both. Their nucleotide-binding loops are more conserved, and their more divergent sequences correspond to discrete surface zones of tubulin involved in microtubule assembly and binding to eukaryotic cytosolic chaperonin, which is absent from the Prosthecobacter dejongeii draft genome. BtubA/B cooperatively assembles over a wider range of conditions than alpha beta-tubulin, forming pairs of protofilaments that coalesce into bundles instead of microtubules, and it lacks the ability to differentially interact with divalent cations and bind typical tubulin drugs. Assembled BtubA/B contain close to one bound GTP and GDP. Both BtubA and BtubB subunits hydrolyze GTP, leading to disassembly. The mutant BtubA/B-S144G in the tubulin signature motif GGG((T/S) under bar )G(S/T)G has strongly inhibited GTPase, but BtubA-T147G/B does not, suggesting that BtubB is a more active GTPase, like beta-tubulin. BtubA/B chimera bearing the beta-tubulin loops M, H1-S2, and S9-S10 in BtubB fold, assemble, and have reduced GTPase activity. However, introduction of the alpha-tubulin loop S9-S10 with its unique eight-residue insertion impaired folding. From the sequence analyses, its primitive assembly features, and the properties of the chimeras, we propose that BtubA/B were acquired shortly after duplication of a spontaneously folding alpha- and beta-tubulin ancestor, possibly by horizontal gene transfer from a primitive eukaryotic cell, followed by divergent evolution.	[Martin-Galiano, Antonio J.; Oliva, Maria A.; Sanz, Laura; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Sanz, Laura; Serna, Marina; Yebenes, Hugo; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Bhattacharyya, Anamitra] Integrated Genom, Mt Prospect, IL 60056 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Andreu, JM (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	j.m.andreu@cib.csic.es	Oliva, Marian/H-8867-2015; Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017	Oliva, Marian/0000-0002-2215-4639; Valpuesta, José M/0000-0001-7468-8053; Andreu, Jose M/0000-0001-8064-6933; Serna, Marina/0000-0002-6827-496X; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Yebenes, Hugo/0000-0002-0448-217X	Ministerio de Ciencia e Innovacion [BFU2008-00013, BFU2010-15703]; Juan de la Cierva; Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores; Formacion de Personal Universitario fellowship; Madrid Regional Government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Juan de la Cierva(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores; Formacion de Personal Universitario fellowship; Madrid Regional Government	This work was supported in part by Ministerio de Ciencia e Innovacion Grants BFU2008-00013 (to J. M. A.) and BFU2010-15703 (to J. M. V.) and contracts Juan de la Cierva (to A. J. M.-G. and M. A. O.), a contract from the Consejo Superior de Investigaciones Cientificas Junta de Ampliacion de Estudios-Doctores (to A. J. M.-G.), a Formacion de Personal Universitario fellowship (to L. S.), and a fellowship from the Madrid Regional Government (to M. S.).	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreu JM, 1998, BIOCHEMISTRY-US, V37, P8356, DOI 10.1021/bi9728553; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Barbier P, 1998, BIOCHEMISTRY-US, V37, P758, DOI 10.1021/bi970568t; Bertrand S, 2005, J MOL BIOL, V346, P319, DOI 10.1016/j.jmb.2004.11.054; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GASKIN F, 1981, BIOCHEMISTRY-US, V20, P1318, DOI 10.1021/bi00508a043; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HAMEL E, 1982, BIOCHEMISTRY-US, V21, P503, DOI 10.1021/bi00532a014; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Jenkins C, 2002, P NATL ACAD SCI USA, V99, P17049, DOI 10.1073/pnas.012516899; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Lewis SA, 2002, NAT MED, V8, P1202, DOI 10.1038/nm1102-1202; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 2009, ASCB 49 ANN M SAN DI, P116; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; OOSAWA F, 1975, THERMODYNAMICS POLYM, P25; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; Perez-Ramirez B, 1998, BIOCHEMISTRY-US, V37, P1646, DOI 10.1021/bi971344d; Petroni G, 2000, P NATL ACAD SCI USA, V97, P1813, DOI 10.1073/pnas.030438197; PEYROT V, 1989, J BIOL CHEM, V264, P21296; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; STALEY JT, 1976, A VAN LEEUW J MICROB, V42, P333, DOI 10.1007/BF00394132; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Takeda M, 2008, INT J SYST EVOL MICR, V58, P1561, DOI 10.1099/ijs.0.65787-0; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Yee B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-37; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	66	25	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19789	19803		10.1074/jbc.M111.230094	http://dx.doi.org/10.1074/jbc.M111.230094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467045	Green Published, hybrid			2022-12-27	WOS:000291027700061
J	Chen, LS; Zheng, JS; Yang, N; Li, H; Guo, S				Chen, Lishan; Zheng, Jiashun; Yang, Nan; Li, Hao; Guo, Su			Genomic Selection Identifies Vertebrate Transcription Factor Fezf2 Binding Sites and Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER GENE; PROTEIN-DNA INTERACTIONS; IN-VIVO; ZEBRAFISH FOREBRAIN; REGULATORY PATHWAYS; NEURONS; EXPRESSION; DIFFERENTIATION; MOTIFS; NEUROGENESIS	Identification of transcription factor targets is critical to understanding gene regulatory networks. Here, we uncover transcription factor binding sites and target genes employing systematic evolution of ligands by exponential enrichment (SELEX). Instead of selecting randomly synthesized DNA oligonucleotides as in most SELEX studies, we utilized zebrafish genomic DNA to isolate fragments bound by Fezf2, an evolutionarily conserved gene critical for vertebrate forebrain development. This is, to our knowledge, the first time that SELEX is applied to a vertebrate genome. Computational analysis of bound genomic fragments predicted a core consensus binding site, which identified response elements that mediated Fezf2-dependent transcription both in vitro and in vivo. Fezf2-bound fragments were enriched for conserved sequences. Surprisingly, similar to 20% of these fragments overlapped well annotated protein-coding exons. Through loss of function, gain of function, and chromatin immunoprecipitation, we further identified and validated eomesa/tbr2 and lhx2b as biologically relevant target genes of Fezf2. Mutations in eomesa/tbr2 cause microcephaly in humans, whereas lhx2b is a critical regulator of cell fate and axonal targeting in the developing forebrain. These results demonstrate the feasibility of employing genomic SELEX to identify vertebrate transcription factor binding sites and target genes and reveal Fezf2 as a transcription activator and a candidate for evaluation in human microcephaly.	[Chen, Lishan; Yang, Nan; Guo, Su] Univ Calif San Francisco, Program Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Chen, Lishan; Yang, Nan; Guo, Su] Univ Calif San Francisco, Program Biol Sci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Zheng, Jiashun; Li, Hao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zheng, Jiashun; Li, Hao] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Guo, S (corresponding author), Univ Calif San Francisco, Program Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	su.guo@ucsf.edu	Zheng, Jiashun/A-3098-2012; Yang, Nan/H-3174-2012	Yang, Nan/0000-0003-3663-1288	National Institutes of Health [NS042626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042626 (to S. G.).	Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berberoglu MA, 2009, GENE EXPR PATTERNS, V9, P411, DOI 10.1016/j.gep.2009.06.002; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Chin J, 2004, METHOD ENZYMOL, V376, P3; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Liu X, 2001, Pac Symp Biocomput, P127; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Porter FD, 1997, DEVELOPMENT, V124, P2935; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Shtatland T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e93; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	45	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18641	18649		10.1074/jbc.M111.236471	http://dx.doi.org/10.1074/jbc.M111.236471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471212	Green Published, hybrid			2022-12-27	WOS:000290785700036
J	Flynn, AN; Tillu, DV; Asiedu, MN; Hoffman, J; Vagner, J; Price, TJ; Boitano, S				Flynn, Andrea N.; Tillu, Dipti V.; Asiedu, Marina N.; Hoffman, Justin; Vagner, Josef; Price, Theodore J.; Boitano, Scott			The Protease-activated Receptor-2-specific Agonists 2-Aminothiazol-4-yl-LIGRL-NH2 and 6-Aminonicotinyl-LIGRL-NH2 Stimulate Multiple Signaling Pathways to Induce Physiological Responses in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; RECEPTOR 2; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; INFLAMMATORY PAIN; MOLECULAR-CLONING; SERINE PROTEASES; CANCER PAIN; HYPERALGESIA; MECHANISMS; LIGANDS	Protease-activated receptor-2 (PAR(2)) is one of four protease-activated G-protein-coupled receptors. PAR(2) is expressed on multiple cell types where it contributes to cellular responses to endogenous and exogenous proteases. Proteolytic cleavage of PAR(2) reveals a tethered ligand that activates PAR(2) and two major downstream signaling pathways: mitogen-activated protein kinase (MAPK) and intracellular Ca2+ signaling. Peptides or peptidomimetics can mimic binding of the tethered ligand to stimulate signaling without the nonspecific effects of proteases. The most commonly used peptide activators of PAR(2) (e.g. SLIGRL-NH2 and SLIGKV-NH2) lack potency at the receptor. However, although the potency of 2-furoyl-LIGRLO-NH2 (2-f-LIGRLO-NH2) underscores the use of peptidomimetic PAR(2) ligands as a mechanism to enhance pharmacological action at PAR(2), 2-f-LIGRLO-NH2 has not been thoroughly evaluated. We evaluated the known agonist 2-f-LIGRLO-NH2 and two recently described pentapeptidomimetic PAR(2)-specific agonists, 2-aminothiazol-4-yl-LIGRL-NH2 (2-at-LIGRL-NH2) and 6-aminonicotinyl-LIGRL-NH2 (6-an-LIGRL-NH2). All peptidomimetic agonists stimulated PAR(2)-dependent in vitro physiological responses, MAPK signaling, and Ca2+ signaling with an overall rank order of potency of 2-f-LIGRLO-NH2 approximate to 2-at-LIGRL-NH2 > 6-an-LIGRL-NH2 >> SLIGRL-NH2. Because PAR(2) plays a major role in pathological pain conditions and to test potency of the peptidomimetic agonists in vivo, we evaluated these agonists in models relevant to nociception. All three agonists activated Ca2+ signaling in nociceptors in vitro, and both 2-at-LIGRL-NH2 and 2-f-LIGRLO-NH2 stimulated PAR(2)-dependent thermal hyperalgesia in vivo. We have characterized three high potency ligands that can be used to explore the physiological role of PAR(2) in a variety of systems and pathologies.	[Flynn, Andrea N.; Hoffman, Justin; Boitano, Scott] Arizona Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Boitano, Scott] Arizona Hlth Sci Ctr, Dept Physiol, Tucson, AZ 85724 USA; [Tillu, Dipti V.; Asiedu, Marina N.; Price, Theodore J.] Arizona Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Vagner, Josef; Price, Theodore J.; Boitano, Scott] Arizona Hlth Sci Ctr, Collaborat Res Inst Bio5, Tucson, AZ 85724 USA	University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences	Boitano, S (corresponding author), Arizona Hlth Sci Ctr, Arizona Resp Ctr, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	sboitano@email.arizona.edu	Price, Theodore/A-5094-2010; Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221	NIEHS [ES 04940]; Semiconductor Research Corp. [425.024]; State of Arizona Technology and Research Initiative;  [R01NS065926];  [T32-HL007249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065926, R01NS073664] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Semiconductor Research Corp.; State of Arizona Technology and Research Initiative; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 04940 from the NIEHS Superfund (to S. B.), Grant R01NS065926 (to T. J. P.), and Training Grant T32-HL007249 (to A. N. F.). This work was also supported by Semiconductor Research Corp. Project 425.024 (to S. B.) and by the State of Arizona Technology and Research Initiative Fund awarded through Bio5 (to J. V.). This work is part of a multi-principal investigator collaboration between J. V., T. J. P., and S. B.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Boitano S, 2011, J MED CHEM, V54, P1308, DOI 10.1021/jm1013049; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ewen D, 2010, CLIN EXP ALLERGY, V40, P435, DOI 10.1111/j.1365-2222.2010.03453.x; Gardell LR, 2008, J PHARMACOL EXP THER, V327, P799, DOI 10.1124/jpet.108.142570; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hollenberg MD, 2008, J PHARMACOL EXP THER, V326, P453, DOI 10.1124/jpet.108.136432; Josan JS, 2008, INT J PEPT RES THER, V14, P293, DOI 10.1007/s10989-008-9150-3; Kanke T, 2005, J PHARMACOL SCI, V97, P38, DOI 10.1254/jphs.FMJ04005X7; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Lam DK, 2010, PAIN, V149, P263, DOI 10.1016/j.pain.2010.02.010; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McGuire JJ, 2002, J PHARMACOL EXP THER, V303, P985, DOI 10.1124/jpet.102.040352; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Vagner J, 2008, ANGEW CHEM INT EDIT, V47, P1685, DOI 10.1002/anie.200702770; Vergnolle N, 1998, P NATL ACAD SCI USA, V95, P7766, DOI 10.1073/pnas.95.13.7766; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	44	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19076	19088		10.1074/jbc.M110.185264	http://dx.doi.org/10.1074/jbc.M110.185264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467041	hybrid, Green Published			2022-12-27	WOS:000290785700077
J	Velasco, J; Li, J; DiPietro, L; Stepp, MA; Sandy, JD; Plaas, A				Velasco, Jennifer; Li, Jun; DiPietro, Luisa; Stepp, Mary Ann; Sandy, John D.; Plaas, Anna			Adamts5 Deletion Blocks Murine Dermal Repair through CD44-mediated Aggrecan Accumulation and Modulation of Transforming Growth Factor beta 1 (TGF beta 1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; WOUND REPAIR; HUMAN-SKIN; EXTRACELLULAR-MATRIX; HAIR FOLLICLE; FIBROBLASTS; HYALURONAN; EXPRESSION; CELLS; COLLAGEN	ADAMTS5 has been implicated in the degradation of cartilage aggrecan in human osteoarthritis. Here, we describe a novel role for the enzyme in the regulation of TGF beta 1 signaling in dermal fibroblasts both in vivo and in vitro. Adamts5(-/-) mice, generated by deletion of exon 2, exhibit impaired contraction and dermal collagen deposition in an excisional wound healing model. This was accompanied by accumulation in the dermal layer of cell aggregates and fibroblastic cells surrounded by a pericellular matrix enriched in full-length aggrecan. Adamts5(-/-) wounds exhibit low expression ( relative to wild type) of collagen type I and type III but show a persistently elevated expression of tgfbRII and alk1. Aggrecan deposition and impaired dermal repair in Adamts5(-/-) mice are both dependent on CD44, and Cd44(-/-)/Adamts5(-/-) mice display robust activation of TGF beta receptor II and collagen type III expression and the dermal regeneration seen in WT mice. TGF beta 1 treatment of newborn fibroblasts from wild type mice results in Smad2/3 phosphorylation, whereas cells from Adamts5(-/-) mice phosphorylate Smad1/5/8. The altered TGF beta 1 response in the Adamts5(-/-) cells is dependent on the presence of aggrecan and expression of CD44, because Cd44(-/-)/Adamts5(-/-) cells respond like WT cells. We propose that ADAMTS5 deficiency in fibrous tissues results in a poor repair response due to the accumulation of aggrecan in the pericellular matrix of fibroblast progenitor cells, which prevents their transition to mature fibroblasts. Thus, the capacity of ADAMTS5 to modulate critical tissue repair signaling events suggests a unique role for this enzyme, which sets it apart from other members of the ADAMTS family of proteases.	[Velasco, Jennifer; Sandy, John D.; Plaas, Anna] Rush Univ Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Li, Jun; Plaas, Anna] Rush Univ Med Ctr, Dept Internal Med Rheumatol, Chicago, IL 60612 USA; [DiPietro, Luisa] Univ Illinois, Coll Dent, Ctr Wound Repair & Regenerat, Chicago, IL 60612 USA; [Stepp, Mary Ann] George Washington Univ Med Sch, Dept Anat & Regenerat Biol, Washington, DC 20037 USA	Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Plaas, A (corresponding author), Rush Univ Med Ctr, Dept Biochem, Chicago, IL 60612 USA.	anna_plaas@rush.edu	Stepp, Mary Ann/ABF-2702-2020	Stepp, Mary Ann/0000-0001-5623-2538	National Institutes of Health [AR007590]; Katz/Rubschlager Endowment for OA Research; Rush Arthritis Institute, Rush University Medical Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katz/Rubschlager Endowment for OA Research; Rush Arthritis Institute, Rush University Medical Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant AR007590 (to J. V.). This work was also supported by the Katz/Rubschlager Endowment for OA Research and the Rush Arthritis Institute, Rush University Medical Center (to A. P. and J. D. S.).	Arufe MC, 2010, J CELL BIOCHEM, V111, P834, DOI 10.1002/jcb.22768; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bell R. M., 2010, T ORTHOP RES SOC, V35, P1098; Bell R. M., 2010, T ORTHOP RES SOC, V35, P276; Bell R. M., 2009, T ORTHOP RES SOC, V34, P1399; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Carrino DA, 2003, J BIOL CHEM, V278, P17566, DOI 10.1074/jbc.M300124200; Chen YL, 2006, ARTHRITIS RHEUM-US, V54, P1309, DOI 10.1002/art.21725; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; Derwin KA, 2001, J ORTHOP RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2; EPSTEIN EH, 1978, J BIOL CHEM, V253, P1336; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Kenagy RD, 2005, J HISTOCHEM CYTOCHEM, V53, P131, DOI 10.1369/jhc.4A6493.2005; Kenagy RD, 2006, TRENDS CARDIOVAS MED, V16, P209, DOI 10.1016/j.tcm.2006.03.011; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; KNUDSON CB, 1987, DEV BIOL, V124, P82, DOI 10.1016/0012-1606(87)90462-3; Lemire JM, 2006, MECH AGEING DEV, V127, P660, DOI 10.1016/j.mad.2006.03.004; Lemke AK, 2010, CELL TISSUE RES, V340, P179, DOI 10.1007/s00441-010-0941-4; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Li J, 2011, J ORTHOP RES, V29, P516, DOI 10.1002/jor.21215; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Malfait AM, 2010, OSTEOARTHR CARTILAGE, V18, P572, DOI 10.1016/j.joca.2009.11.013; Malgouries S, 2008, BRIT J DERMATOL, V158, P234, DOI 10.1111/j.1365-2133.2007.08339.x; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Patel KP, 2007, SPINE, V32, P2596, DOI 10.1097/BRS.0b013e318158cb85; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; PLAAS AHK, 1993, MATRIX, V13, P135, DOI 10.1016/S0934-8832(11)80072-7; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Saed GM, 2004, WOUND REPAIR REGEN, V12, P557, DOI 10.1111/j.1067-1927.2004.012508.x; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x; Sumiyoshi K, 2003, BRIT J DERMATOL, V149, P464, DOI 10.1046/j.1365-2133.2003.05490.x; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Voros G, 2006, BBA-GEN SUBJECTS, V1760, P1837, DOI 10.1016/j.bbagen.2006.08.016; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Wang Z, 2007, J PLAST RECONSTR AES, V60, P1193, DOI 10.1016/j.bjps.2006.05.007; Wilson CG, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2862; Yu Q, 2000, GENE DEV, V14, P163	54	57	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26016	26027		10.1074/jbc.M110.208694	http://dx.doi.org/10.1074/jbc.M110.208694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21566131	Green Published, hybrid			2022-12-27	WOS:000293073000060
J	Ghosh, S; Paez-Cortez, JR; Boppidi, K; Vasconcelos, M; Roy, M; Cardoso, W; Ai, XB; Fine, A				Ghosh, Shamik; Paez-Cortez, Jesus R.; Boppidi, Karthik; Vasconcelos, Michelle; Roy, Monideepa; Cardoso, Wellington; Ai, Xingbin; Fine, Alan			Activation Dynamics and Signaling Properties of Notch3 Receptor in the Developing Pulmonary Artery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR-GROWTH; PATHWAY; LUNG; LOOP; HYPERTENSION; TRAFFICKING; EXPRESSION; APOPTOSIS; DELETION	Notch3 signaling is fundamental for arterial specification of systemic vascular smooth muscle cells (VSMCs). However, the developmental role and signaling properties of the Notch3 receptor in the mouse pulmonary artery remain unknown. Here, we demonstrate that Notch3 is expressed selectively in pulmonary artery VSMCs, is activated from late fetal to early postnatal life, and is required to maintain the morphological characteristics and smooth muscle gene expression profile of the pulmonary artery after birth. Using a conditional knock-out mouse model, we show that Notch3 receptor activation in VSMCs is Jagged1-dependent. In vitro VSMC lentivirus-mediated Jagged1 knockdown, confocal localization analysis, and co-culture experiments revealed that Notch3 activation is cell-autonomous and occurs through the physical engagement of Notch3 and VSMC-derived Jagged1 in the interior of the same cell. Although the current models of mammalian Notch signaling involve a two-cell system composed of a signal-receiving cell that expresses a Notch receptor on its surface and a neighboring signal-sending cell that provides membrane-bound activating ligand, our data suggest that pulmonary artery VSMC Notch3 activation is cell-autonomous. This unique mechanism of Notch activation may play an important role in the maturation of the pulmonary artery during the transition to air breathing.	[Ghosh, Shamik; Paez-Cortez, Jesus R.; Boppidi, Karthik; Vasconcelos, Michelle; Cardoso, Wellington; Ai, Xingbin; Fine, Alan] Boston Univ Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Roy, Monideepa] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fine, A (corresponding author), Boston Univ Sch Med, Ctr Pulm, R-304,80 E Concord St, Boston, MA 02118 USA.	afine@bu.edu		Ai, Xingbin/0000-0002-2178-0080; Fine, Alan/0000-0001-9351-3048; Cardoso, Wellington/0000-0002-2550-3697	National Institutes of Health [HL-089795]; United States Army Medical Research Acquisition Activity; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research Acquisition Activity; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-089795. This work was also supported by a grant from the United States Army Medical Research Acquisition Activity.	Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; White TA, 2010, AM J RESP CELL MOL, V43, P35, DOI 10.1165/rcmb.2009-0144OC; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; ZHU JH, 2010, AM J PHYSIOL-HEART C, V300, P1762	36	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22678	22687		10.1074/jbc.M111.241224	http://dx.doi.org/10.1074/jbc.M111.241224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536678	hybrid, Green Published			2022-12-27	WOS:000291719900074
J	Barthel, SR; Antonopoulos, A; Cedeno-Laurent, F; Schaffer, L; Hernandez, G; Patil, SA; North, SJ; Dell, A; Matta, KL; Neelamegham, S; Haslam, SM; Dimitroff, CJ				Barthel, Steven R.; Antonopoulos, Aristotelis; Cedeno-Laurent, Filiberto; Schaffer, Lana; Hernandez, Gilberto; Patil, Shilpa A.; North, Simon J.; Dell, Anne; Matta, Khushi L.; Neelamegham, Sriram; Haslam, Stuart M.; Dimitroff, Charles J.			Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire of N- and O-Glycans without Direct Incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGAND; LYMPHOCYTE-ASSOCIATED ANTIGEN; SKIN-HOMING RECEPTORS; PROSTATE TUMOR-CELLS; MAJOR E-SELECTIN; SIALYL-LEWIS-X; P-SELECTIN; PLASMA-MEMBRANE; CANCER CELLS; EXPRESSION	Prior studies have shown that treatment with the peracetylated 4-fluorinated analog of glucosamine (4-F-GlcNAc) elicits anti-skin inflammatory activity by ablating N-acetyllactosamine (LacNAc), sialyl Lewis X (sLe(X)), and related lectin ligands on effector leukocytes. Based on anti-sLe(X) antibody and lectin probing experiments on 4-F-GlcNAc-treated leukocytes, it was hypothesized that 4-F-GlcNAc inhibited sLe(X) formation by incorporating into LacNAc and blocking the addition of galactose or fucose at the carbon 4-position of 4-F-GlcNAc. To test this hypothesis, we determined whether 4-F-GlcNAc is directly incorporated into N- and O-glycans released from 4-F-GlcNAc-treated human sLe(X) (+) T cells and leukemic KG1a cells. At concentrations that abrogated galectin-1 (Gal-1) ligand and E-selectin ligand expression and related LacNAc and sLe(X) structures, MALDI-TOF and MALDI-TOF/TOF mass spectrometry analyses showed that 4-F-GlcNAc 1) reduced content and structural diversity of tri- and tetra-antennary N-glycans and of O-glycans, 2) increased biantennary N-glycans, and 3) reduced LacNAc and sLe(X) on N-glycans and on core 2 O-glycans. Moreover, MALDI-TOF MS did not reveal any m/z ratios relating to the presence of fluorine atoms, indicating that 4-F-GlcNAc did not incorporate into glycans. Further analysis showed that 4-F-GlcNAc treatment had minimal effect on expression of 1200 glycome-related genes and did not alter the activity of LacNAc-synthesizing enzymes. However, 4-F-GlcNAc dramatically reduced intracellular levels of uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), a key precursor of LacNAc synthesis. These data show that Gal-1 and E-selectin ligand reduction by 4-F-GlcNAc is not caused by direct 4-F-GlcNAc glycan incorporation and consequent chain termination but rather by interference with UDP-GlcNAc synthesis.	[Barthel, Steven R.; Cedeno-Laurent, Filiberto; Dimitroff, Charles J.] Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Barthel, Steven R.; Cedeno-Laurent, Filiberto; Dimitroff, Charles J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Antonopoulos, Aristotelis; North, Simon J.; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Schaffer, Lana; Hernandez, Gilberto] Scripps Res Inst, La Jolla, CA 92037 USA; [Patil, Shilpa A.; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Matta, Khushi L.] Roswell Pk Canc Inst, Dept Canc Biol, Buffalo, NY 14263 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Imperial College London; Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Dimitroff, CJ (corresponding author), HIM, Rm 662,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cdimitroff@rics.bwh.harvard.edu		Neelamegham, Sriram/0000-0002-1371-8500	National Institutes of Health (NIH), NCI [RO1 CA118124]; NIH, NCCAM [RO1 AT004268]; NIH Analytical Glycotechnology Core [62116]; Biotechnology and Biological Sciences Research Council [BBF0083091, B19088]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA118124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Analytical Glycotechnology Core; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant RO1 CA118124 (to C. J. D.); NIH, NCCAM, Grant RO1 AT004268 (to C. J. D.); and NIH Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics Grant GM 62116. This work was also supported by Biotechnology and Biological Sciences Research Council Grants BBF0083091 and B19088 and the Wellcome Trust (to S. M. H. and A. D.).	Barthel SR, 2008, GLYCOBIOLOGY, V18, P806, DOI 10.1093/glycob/cwn070; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernacki R, 1977, Adv Enzyme Regul, V16, P217, DOI 10.1016/0065-2571(78)90075-4; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; BURGHARDT C, 2007, Patent No. 1431397; Cedeno-Laurent F, 2010, J IMMUNOL, V185, P4659, DOI 10.4049/jimmunol.1000715; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Dell Anne, 1993, Current Opinion in Biotechnology, V4, P52, DOI 10.1016/0958-1669(93)90032-R; Descheny L, 2006, J INVEST DERMATOL, V126, P2065, DOI 10.1038/sj.jid.5700364; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Dimitroff CJ, 2003, BLOOD, V101, P602, DOI 10.1182/blood-2002-06-1736; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Foster MM, 2003, CANCER RES, V63, P2775; Gainers ME, 2007, J IMMUNOL, V179, P8509, DOI 10.4049/jimmunol.179.12.8509; Hou YM, 1996, BIOCHEMISTRY-US, V35, P3963, DOI 10.1021/bi9524575; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; WOOD TC, 1994, BIOCHEM BIOPH RES CO, V198, P1119, DOI 10.1006/bbrc.1994.1159; WOYNAROWSKA B, 1994, J BIOL CHEM, V269, P22797; Woynarowska B, 1996, GLYCOCONJUGATE J, V13, P663, DOI 10.1007/BF00731455; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	51	52	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21717	21731		10.1074/jbc.M110.194597	http://dx.doi.org/10.1074/jbc.M110.194597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21493714	hybrid, Green Published			2022-12-27	WOS:000291464700068
J	Ikezawa, N; Gopfert, JC; Nguyen, DT; Kim, SU; O'Maille, PE; Spring, O; Ro, DK				Ikezawa, Nobuhiro; Goepfert, Jens Christian; Nguyen, Don Trinh; Kim, Soo-Un; O'Maille, Paul E.; Spring, Otmar; Ro, Dae-Kyun			Lettuce Costunolide Synthase (CYP71BL2) and Its Homolog (CYP71BL1) from Sunflower Catalyze Distinct Regio- and Stereoselective Hydroxylations in Sesquiterpene Lactone Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPITATE GLANDULAR TRICHOMES; ANTIMALARIAL-DRUG PRECURSOR; BIOLOGICAL-ACTIVITIES; ARTEMISINIC ACID; SAUSSUREA-LAPPA; ASTERACEAE; GENES; CHARACTERS; EXPRESSION; ANALOGS	Sesquiterpene lactones (STLs) are terpenoid natural products possessing the gamma-lactone, well known for their diverse biological and medicinal activities. The occurrence of STLs is sporadic in nature, but most STLs have been isolated from plants in the Asteraceae family. Despite the implication of the gamma-lactone group in many reported bioactivities of STLs, the biosynthetic origins of the gamma-lactone ring remains elusive. Germacrene A acid (GAA) has been suggested as a central precursor of diverse STLs. The regioselective (C6 or C8) and stereoselective (alpha or beta) hydroxylation on a carbon of GAA adjacent to its carboxylic acid at C12 is responsible for the gamma-lactone formation. Here, we report two cytochrome P450 monooxygenases (P450s) capable of catalyzing 6 alpha- and 8 beta-hydroxylation of GAA from lettuce and sunflower, respectively. To identify these P450s, sunflower trichomes were isolated to generate a trichome-specific transcript library, from which 10 P450 clones were retrieved. Expression of these clones in a yeast strain metabolically engineered to synthesize substrate GAA identified a P450 catalyzing 8 beta-hydroxylation of GAA, but the STL was not formed by spontaneous lactonization. Subsequently, we identified the closest homolog of the GAA 8 beta-hydroxylase from lettuce and discovered 6 alpha-hydroxylation of GAA by the recombinant enzyme. The resulting 6 alpha-hydroxy-GAA spontaneously undergoes a lactonization to yield the simplest form of STL, costunolide. Furthermore, we demonstrate the milligram per liter scale de novo synthesis of costunolide using the lettuce P450 in an engineered yeast strain, an important advance that will enable exploitation of STLs. Evolution and homology models of these two P450s are discussed.	[Ikezawa, Nobuhiro; Nguyen, Don Trinh; Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Goepfert, Jens Christian; Spring, Otmar] Univ Hohenheim, Inst Bot, D-70599 Stuttgart, Germany; [Kim, Soo-Un] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151951, South Korea; [O'Maille, Paul E.] Inst Food Res, John Innes Ctr, Norwich NR4 7UH, Norfolk, England	University of Calgary; University Hohenheim; Seoul National University (SNU); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Nguyen, Trinh-Don/0000-0002-2759-5791	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Canada Foundation for Innovation; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [SP292/20-2]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0644] Funding Source: researchfish; BBSRC [BBS/E/J/000C0644] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant, Canada Research Chair program Alberta Innovates Bio Solutions, and Canada Foundation for Innovation (to D.-K. R.) and by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to N. I.). This work was also supported by German Research Foundation Grant (Deutsche Forschungsgemeinschaft) SP292/20-2 (to O. S. and J. C. G.).	Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; BRECKNELL DJ, 1979, AUST J CHEM, V32, P2455, DOI 10.1071/CH9792455; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Christensen SB, 1999, BIOORGAN MED CHEM, V7, P1273; Dall'Acqua S, 2006, CHEM PHARM BULL, V54, P1187, DOI 10.1248/cpb.54.1187; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Eliza J, 2009, CHEM-BIOL INTERACT, V179, P329, DOI 10.1016/j.cbi.2008.10.017; FISCHER NH, 1990, RECENT ADV PHYTOCHEM, V24, P161; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; GOTOH O, 1992, J BIOL CHEM, V267, P83; HOLUB M, 1987, BIOCHEM SYST ECOL, V15, P321, DOI 10.1016/0305-1978(87)90006-8; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Park SH, 2001, PLANTA MED, V67, P358, DOI 10.1055/s-2001-14315; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; RAO AS, 1960, TETRAHEDRON, V9, P275, DOI 10.1016/0040-4020(60)80017-8; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinson A, 2008, BIOORG MED CHEM LETT, V18, P4015, DOI 10.1016/j.bmcl.2008.06.008; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; Satou T, 2002, VET PARASITOL, V104, P131, DOI 10.1016/S0304-4017(01)00619-7; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Sessa RA, 2000, J BIOL CHEM, V275, P26877; TAKASUGI M, 1985, J CHEM SOC CHEM COMM, P621, DOI 10.1039/c39850000621; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X	36	86	95	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21601	21611		10.1074/jbc.M110.216804	http://dx.doi.org/10.1074/jbc.M110.216804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515683	hybrid, Green Published			2022-12-27	WOS:000291464700057
J	Leung, JW; Leitch, A; Wood, JL; Shaw-Smith, C; Metcalfe, K; Bicknell, LS; Jackson, AP; Chen, JJ				Leung, Justin W.; Leitch, Andrea; Wood, Jamie L.; Shaw-Smith, Charles; Metcalfe, Kay; Bicknell, Louise S.; Jackson, Andrew P.; Chen, Junjie			SET Nuclear Oncogene Associates with Microcephalin/MCPH1 and Regulates Chromosome Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; ACTIVATING FACTOR-I; CHROMATIN DECONDENSATION; PROTEIN; TRANSCRIPTION; BRIT1/MCPH1; ACETYLATION; ONCOPROTEIN; HISTONE; PATHWAY	Primary microcephaly is an autosomal recessive disorder characterized by marked reduction in human brain size. Microcephalin (MCPH1), one of the genes mutated in primary microcephaly, plays an important role in DNA damage checkpoint control and mitotic entry. Additionally, MCPH1 ensures the proper temporal activation of chromosome condensation during mitosis, by acting as a negative regulator of the condensin II complex. We previously found that deletion of the of the MCPH1 N terminus leads to the premature chromosome condensation (PCC) phenotype. In the present study, we unexpectedly observed that a truncated form of MCPH1 appears to be expressed in MCPH1(S25X/S25X) patient cells. This likely results from utilization of an alternative translational start codon, which would produce a mutant MCPH1 protein with a small deletion of its N-terminal BRCT domain. Furthermore, missense mutations in the MCPH1 cluster at its N terminus, suggesting that intact function of this BRCT protein-interaction domain is required both for coordinating chromosome condensation and human brain development. Subsequently, we identified the SET nuclear oncogene as a direct binding partner of the MCPH1 N-terminal BRCT domain. Cells with SET knockdown exhibited abnormal condensed chromosomes similar to those observed in MCPH1-deficient mouse embryonic fibroblasts. Condensin II knockdown rescued the abnormal chromosome condensation phenotype in SET-depleted cells. In addition, MCPH1 V50G/I51V missense mutations, impair binding to SET and fail to fully rescue the abnormal chromosome condensation phenotype in Mcph1(-/-) mouse embryonic fibroblasts. Collectively, our findings suggest that SET is an important regulator of chromosome condensation/decondensation and that disruption of the MCPH1-SET interaction might be important for the pathogenesis of primary microcephaly.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, Houston, TX 77030 USA; [Leitch, Andrea; Bicknell, Louise S.; Jackson, Andrew P.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Wood, Jamie L.] Univ Minnesota, Sch Med, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; [Shaw-Smith, Charles] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Metcalfe, Kay] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities; Wellcome Trust Sanger Institute; University of Manchester	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Room Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Bicknell, Louise/GLR-4215-2022; Bicknell, Louise/AAL-8003-2020; Jackson, Andrew/D-3442-2009	Bicknell, Louise/0000-0001-6899-9322; Jackson, Andrew/0000-0002-8739-2646; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312]; Medical Research Council; Lister Institute of Preventative Medicine; Department of Defense [W81XWH-05-1-0470]; MRC [MC_U127580972] Funding Source: UKRI; Medical Research Council [MC_U127580972] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventative Medicine; Department of Defense(United States Department of Defense); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants (CA089239 and CA092312) from the National Institutes of Health (to J.C.).; A Medical Research Council Senior Clinical Fellow and supported by the Medical Research Council and Lister Institute of Preventative Medicine.; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of M.D. Anderson Cancer Center (CA016672). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, Unit 66, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Room Y3.6006, Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5369; E-mail: jchen8@mdanderson.org.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Matsumoto K, 1999, FEBS LETT, V463, P285, DOI 10.1016/S0014-5793(99)01632-4; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200	26	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21393	21400		10.1074/jbc.M110.208793	http://dx.doi.org/10.1074/jbc.M110.208793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515671	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000291464700038
J	Kreft, SG; Hochstrasser, M				Kreft, Stefan G.; Hochstrasser, Mark			An Unusual Transmembrane Helix in the Endoplasmic Reticulum Ubiquitin Ligase Doa10 Modulates Degradation of Its Cognate E2 Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; IN-VIVO; MAT-ALPHA-2 REPRESSOR; LUMINAL PROTEIN; TRANSLOCATION; MACHINERY; CUE1P; CONJUGATION; CYTOSOL	In the endoplasmic reticulum (ER), nascent membrane and secreted proteins that are misfolded are retrotranslocated into the cytosol and degraded by the proteasome. For most ER-associated degradation (ERAD) substrates, ubiquitylation is essential for both their retrotranslocation and degradation. Yeast Doa10 is a polytopic membrane ubiquitin ligase (E3) that along with its cognate ubiquitin-conjugating enzymes (E2s), Ubc7 and the C-terminally membrane-anchored Ubc6, makes a major contribution to ER-associated degradation. Ubc6 is also a substrate of Doa10. One highly conserved Doa10 element, the uncharacterized similar to 130-residue TEB4-Doa10 domain, includes three transmembrane helices (TMs). We find that the first of these, TM5, includes an absolutely conserved Phi P Phi XXG motif that is required for Doa10 function, as well as highly conserved negatively charged glutamate and aspartate residues. The conservative exchange of the TM5 glutamate to aspartate (doa10-E633D) results in complete stabilization of Ubc6 but has little if any effect on other substrates. Unexpectedly, mutating the glutamate to glutamine (doa10-E633Q) specifically accelerates Ubc6 degradation by similar to 5-fold. Other substrates are weakly stabilized in doa10-E633Q cells, consistent with reduced Ubc6 levels. Notably, catalytically inactive ubc6-C87A is degraded in doa10-E633Q but not wild-type cells, but an active version of Ubc6 is required in trans. Fusion of the Ubc6 TM to a soluble protein yields a protein that is degraded in a doa10-E633Q-dependent manner, whereas fusion of the C-terminal TM from an unrelated protein does not. These results suggest that the TEB4-Doa10 domain regulates Doa10 association with the Ubc6 membrane anchor, thereby controlling the degradation rate of the E2.	[Kreft, Stefan G.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Kreft, Stefan G.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of Konstanz; Yale University	Kreft, SG (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	stefan.kreft@uni-konstanz.de; mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM046904]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R37GM046904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM046904 (to M.H.).	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	47	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20163	20174		10.1074/jbc.M110.196360	http://dx.doi.org/10.1074/jbc.M110.196360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467040	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000291267600005
J	Lu, YF; Li, T; Qureshi, HY; Han, D; Paudel, HK				Lu, Yifan; Li, Tong; Qureshi, Hamid Y.; Han, Dong; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR EGR-1; CYCLIN-DEPENDENT PROTEIN-KINASE-5; NEURONAL CDC2-LIKE KINASE; NF-KAPPA-B; ALZHEIMERS-DISEASE; MOUSE MODEL; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO	In the normal brain, tau protein is phosphorylated at a number of proline-and non-proline directed sites, which reduce tau microtubule binding and thus regulate microtubule dynamics. In Alzheimer disease (AD), tau is abnormally hyperphosphorylated, leading to neurofibrillary tangle formation and microtubule disruption, suggesting a loss of regulatory mechanisms controlling tau phosphorylation. Early growth response 1 (Egr-1) is a transcription factor that is significantly up-regulated in AD brain. The pathological significance of this up-regulation is not known. In this study, we found that lentivirus-mediated overexpression of Egr-1 in rat brain hippocampus and primary neurons in culture activates proline-directed kinase Cdk5, inactivates PP1, promotes tau phosphorylation at both proline-directed Ser(396/404) and non-proline-directed Ser(262) sites, and destabilizes microtubules. Furthermore, in Egr-1(-/-) mouse brain, Cdk5 activity was decreased, PP1 activity was increased, and tau phosphorylation was reduced at both proline-directed and non-proline-directed sites. By using nerve growth factor-exposed PC12 cells, we determined that Egr-1 activates Cdk5 to promote phosphorylation of tau and inactivates PP1 via phosphorylation. When Cdk5 was inhibited, tau phosphorylation at both proline-and non-proline directed sites and PP1 phosphorylation were blocked, indicating that Egr-1 acts through Cdk5. By using an in vitro kinase assay and HEK-293 cells transfected with tau, PP1, and Cdk5, we found that Cdk5 phosphorylates Ser(396/404) directly. In addition, by phosphorylating and inactivating PP1, Cdk5 promotes tau phosphorylation at Ser(262) indirectly. Our results indicate that Egr-1 is an in vivo regulator of tau phosphorylation and suggest that in AD brain increased levels of Egr-1 aberrantly activate an Egr-1/Cdk5/PP1 pathway, leading to accumulation of hyperphosphorylated tau, thus destabilizing the microtubule cytoskeleton.	[Lu, Yifan; Li, Tong; Qureshi, Hamid Y.; Han, Dong; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada; Natural Sciences and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institute for Health Research, Alzheimer's Society of Canada, and Natural Sciences and Engineering Research Council of Canada.	ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Broussau S, 2008, MOL THER, V16, P500, DOI 10.1038/sj.mt.6300383; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P20, DOI 10.1097/01.wad.0000155068.23937.9b; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giri RK, 2005, AM J PHYSIOL-CELL PH, V289, pC264, DOI 10.1152/ajpcell.00461.2004; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Han SS, 1999, CLIN IMMUNOL, V93, P152, DOI 10.1006/clim.1999.4769; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Huang RP, 1998, INT J CANCER, V77, P880, DOI 10.1002/(SICI)1097-0215(19980911)77:6<880::AID-IJC14>3.0.CO;2-5; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Krones-Herzig A, 2003, P NATL ACAD SCI USA, V100, P3233, DOI 10.1073/pnas.2628034100; Kudo T, 2000, NEUROBIOL AGING, V21, P215, DOI 10.1016/S0197-4580(00)00129-9; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Liu J, 2001, INT J ONCOL, V18, P863; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Merrick SE, 1997, J NEUROSCI, V17, P5726; Moon Y, 2005, J PHARMACOL EXP THER, V315, P788, DOI 10.1124/jpet.105.084434; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Paudel HK, 1997, J BIOL CHEM, V272, P28328, DOI 10.1074/jbc.272.45.28328; Paudel HK, 1997, J BIOL CHEM, V272, P1777; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P3406, DOI 10.1161/01.ATV.17.12.3406; Pendurthi UR, 2000, THROMB RES, V97, P179, DOI 10.1016/S0049-3848(99)00148-6; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rohn TT, 2008, J NEUROSCI, V28, P3051, DOI 10.1523/JNEUROSCI.5620-07.2008; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461	75	42	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20569	20581		10.1074/jbc.M111.220962	http://dx.doi.org/10.1074/jbc.M111.220962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489990	Green Published, hybrid			2022-12-27	WOS:000291267600043
J	Blanco, MA; Aleckovic, M; Hua, YL; Li, T; Wei, Y; Xu, Z; Cristea, IM; Kang, YB				Blanco, Mario Andres; Aleckovic, Masa; Hua, Yuling; Li, Tuo; Wei, Yong; Xu, Zhen; Cristea, Ileana M.; Kang, Yibin			Identification of Staphylococcal Nuclease Domain-containing 1 (SND1) as a Metadherin-interacting Protein with Metastasis-promoting Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE-ELEVATED GENE-1; BREAST-CANCER METASTASIS; TUDOR-SN; TUMOR PROGRESSION; SUPPRESSOR GENE; P100; RNA; COACTIVATOR; ACTIVATION; RESISTANCE	Metastasis is the deadliest and most poorly understood feature of malignant diseases. Recent work has shown that Metadherin (MTDH) is overexpressed in over 40% of breast cancer patients and promotes metastasis and chemoresistance in experimental models of breast cancer progression. Here we applied mass spectrometry-based screen to identify staphylococcal nuclease domain-containing 1 (SND1) as a candidate MTDH-interacting protein. After confirming the interaction between SND1 and MTDH, we tested the role of SND1 in breast cancer and found that it strongly promotes lung metastasis. SND1 was further shown to promote resistance to apoptosis and to regulate the expression of genes associated with metastasis and chemoresistance. Analyses of breast cancer clinical microarray data indicated that high expression of SND1 in primary tumors is strongly associated with reduced metastasis-free survival in multiple large scale data sets. Thus, we have uncovered SND1 as a novel MTDH-interacting protein and shown that it is a functionally and clinically significant mediator of metastasis.	[Blanco, Mario Andres; Aleckovic, Masa; Hua, Yuling; Li, Tuo; Wei, Yong; Xu, Zhen; Cristea, Ileana M.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL255 Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu	Li, Tuo/L-6958-2015; Xu, Zhen/P-3029-2014	Xu, Zhen/0000-0002-2190-3861; Kang, Yibin/0000-0002-1626-6730; Blanco, M. Andres/0000-0003-4404-2301; Aleckovic, Masa/0000-0001-5653-8502	National Institutes of Health [R01CA134519]; National Research Service Award; United States Department of Defense; Brewster Foundation; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Brewster Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y. K.) and a National Research Service Award predoctoral fellowship (to M. A. B.). This work was also supported by grants from the United States Department of Defense and the Brewster Foundation.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Bhutia SK, 2010, P NATL ACAD SCI USA, V107, P22243, DOI 10.1073/pnas.1009479107; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2009, CANCER RES, V69, P8529, DOI 10.1158/0008-5472.CAN-09-1846; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; TONG X, 1995, MOL CELL BIOL, V15, P4735; Townsend AJ, 2001, CHEM-BIOL INTERACT, V130, P261, DOI 10.1016/S0009-2797(00)00270-2; Wei Y, 2009, CELL CYCLE, V8, P2132; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	59	89	94	2	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19982	19992		10.1074/jbc.M111.240077	http://dx.doi.org/10.1074/jbc.M111.240077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478147	Green Published, hybrid			2022-12-27	WOS:000291027700076
J	Kuhnle, S; Kogel, U; Glockzin, S; Marquardt, A; Ciechanover, A; Matentzoglu, K; Scheffner, M				Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Marquardt, Andreas; Ciechanover, Aaron; Matentzoglu, Konstantin; Scheffner, Martin			Physical and Functional Interaction of the HECT Ubiquitin-protein Ligases E6AP and HERC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS TYPE-16 E6; ANGELMAN SYNDROME; E6-ASSOCIATED PROTEIN; SELF-UBIQUITINATION; CERVICAL-CANCER; HUMAN-DISEASE; GENE UBE3A; E6-AP; DEGRADATION; MICE	Deregulation of the ubiquitin-protein ligase E6AP contributes to the development of the Angelman syndrome and to cervical carcinogenesis suggesting that the activity of E6AP needs to be under tight control. However, how E6AP activity is regulated at the post-translational level under non-pathologic conditions is poorly understood. In this study, we report that the giant protein HERC2, which is like E6AP a member of the HECT family of ubiquitin-protein ligases, binds to E6AP. The interaction is mediated by the RCC1-like domain 2 of HERC2 and a region spanning amino acid residues 150-200 of E6AP. Furthermore, we provide evidence that HERC2 stimulates the ubiquitin-protein ligase activity of E6AP in vitro and within cells and that this stimulatory effect does not depend on the ubiquitin-protein ligase activity of HERC2. Thus, the data obtained indicate that HERC2 acts as a regulator of E6AP.	[Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Matentzoglu, Konstantin; Scheffner, Martin] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Matentzoglu, Konstantin; Scheffner, Martin] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78457 Constance, Germany; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	University of Konstanz; University of Konstanz; University of Konstanz; Technion Israel Institute of Technology	Scheffner, M (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	martin.scheffner@uni-konstanz.de	Scheffner, Martin/K-2940-2012; Ciechanover, Aaron J/C-9166-2017	Scheffner, Martin/0000-0003-2229-0128; Kuhnle, Simone/0000-0001-9382-3142	Deutsche Forschungsgemeinschaft; German-Israeli Foundation for Scientific Research and Development; European Union Network of Excellence RUBICON	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); European Union Network of Excellence RUBICON(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the German-Israeli Foundation for Scientific Research and Development, and the European Union Network of Excellence RUBICON.	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Vos RM, 2009, J VIROL, V83, P8885, DOI 10.1128/JVI.00605-09; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107	37	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19410	19416		10.1074/jbc.M110.205211	http://dx.doi.org/10.1074/jbc.M110.205211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21493713	Green Published, hybrid			2022-12-27	WOS:000291027700023
J	Andra, J; Goldmann, T; Ernst, CM; Peschel, A; Gutsmann, T				Andrae, Joerg; Goldmann, Torsten; Ernst, Christoph M.; Peschel, Andreas; Gutsmann, Thomas			Multiple Peptide Resistance Factor (MprF)-mediated Resistance of Staphylococcus aureus against Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NK-LYSIN; ANTIBACTERIAL ACTIVITY; CYTOLYTIC ACTIVITY; MOLECULAR-BASIS; CELL-MEMBRANE; IN-VITRO; LIPID-II; MELITTIN; MODE; LIPOPOLYSACCHARIDE	Modification of the membrane lipid phosphatidylglycerol (PG) of Staphylococcus aureus by enzymatic transfer of a L-lysine residue leading to lysyl-PG converts the net charge of PG from -1 to +1 and is thought to confer resistance to cationic antimicrobial peptides (AMPs). Lysyl-PG synthesis and translocation to the outer leaflet of the bacterial membrane are achieved by the membrane protein MprF. Consequently, mutants lacking a functional mprF gene are in particular vulnerable to the action of AMPs. Hence, we aim at elucidating whether and to which extent lysyl-PG modulates membrane binding, insertion, and permeabilization by various AMPs. Lysyl-PG was incorporated into artificial lipid bilayers, mimicking the cytoplasmic membrane of S. aureus. Moreover, we determined the activity of the peptides against a clinical isolate of S. aureus strain SA113 and two mutants lacking a functional mprF gene and visualized peptide-induced ultrastructural changes of bacteria by transmission electron microscopy. The studied peptides were: (i) NK-2, an alpha-helical fragment of mammalian NK-lysin, (ii) arenicin-1, a lugworm alpha-sheet peptide, and (iii) bee venom melittin. Biophysical data obtained by FRET spectroscopy, Fourier transform infrared spectroscopy, and electrical measurements with planar lipid bilayers were correlated with the biological activities of the peptides. They strongly support the hypothesis that peptide-membrane interactions are a prerequisite for eradication of S. aureus. However, degree and mode of modulation of membrane properties such as fluidity, capacitance, and conductivity were unique for each of the peptides. Altogether, our data support and underline the significance of lysyl-PG for S. aureus resistance to AMPs.	[Andrae, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany; [Ernst, Christoph M.; Peschel, Andreas] Univ Tubingen, Cellular & Mol Microbiol Div, Interfac Inst Microbiol & Infect Med, D-72074 Tubingen, Germany	Forschungszentrum Borstel; Eberhard Karls University of Tubingen	Andra, J (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, Pk Allee 10, D-23845 Borstel, Germany.	jandrae@fz-borstel.de	Goldmann, Torsten/E-5906-2010; Gutsmann, Thomas/E-6100-2011	Goldmann, Torsten/0000-0002-1621-560X; Ernst, Christoph/0000-0002-5575-1325	Deutsche Forschungsgemeinschaft [SFB617 A17, GU 568/4-1, AN301/5-1, SFB766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB617 A17 and GU 568/4-1 (to T. G.), AN301/5-1 (to J. A.), and SFB766 (to A. P.).	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Andra J, 1996, FEBS LETT, V385, P96, DOI 10.1016/0014-5793(96)00359-6; Andra J, 1999, MED MICROBIOL IMMUN, V188, P117, DOI 10.1007/s004300050113; Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Andra J, 2009, BIOL CHEM, V390, P337, DOI 10.1515/BC.2009.039; BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003; COLLINS SH, 1976, J BACTERIOL, V126, P1224, DOI 10.1128/JB.126.3.1224-1231.1976; Danner S, 2008, BIOPHYS J, V94, P2150, DOI 10.1529/biophysj.107.123422; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Gutsmann T, 2005, J ENDOTOXIN RES, V11, P167, DOI 10.1179/096805105X37330; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Kilelee E, 2010, ANTIMICROB AGENTS CH, V54, P4476, DOI 10.1128/AAC.00191-10; Koo SP, 1996, INFECT IMMUN, V64, P1070, DOI 10.1128/IAI.64.3.1070-1074.1996; LEIPPE M, 1994, P NATL ACAD SCI USA, V91, P2602, DOI 10.1073/pnas.91.7.2602; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; Ovchinnikova TV, 2004, FEBS LETT, V577, P209, DOI 10.1016/j.febslet.2004.10.012; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Russell PJ, 2004, CANCER IMMUNOL IMMUN, V53, P411, DOI 10.1007/s00262-003-0457-9; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; Schroder-Borm H, 2003, BBA-BIOMEMBRANES, V1612, P164, DOI 10.1016/S0005-2736(03)00115-9; Schromm AB, 1996, FEBS LETT, V399, P267, DOI 10.1016/S0014-5793(96)01338-5; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Staubitz P, 2004, FEMS MICROBIOL LETT, V231, P67, DOI 10.1016/S0378-1097(03)00921-2; WARD JB, 1968, BIOCHEM J, V106, P391, DOI 10.1042/bj1060391; WERKMEISTER JA, 1993, BIOCHIM BIOPHYS ACTA, V1157, P50, DOI 10.1016/0304-4165(93)90077-L; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Wiese A, 2000, METH MOL B, V145, P355; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	44	71	72	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18692	18700		10.1074/jbc.M111.226886	http://dx.doi.org/10.1074/jbc.M111.226886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474443	hybrid, Green Published			2022-12-27	WOS:000290785700042
J	Chua, HN; Roth, FP				Chua, Hon Nian; Roth, Frederick P.			Discovering the Targets of Drugs Via Computational Systems Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MODE-OF-ACTION; INTERACTION NETWORKS; BIOACTIVE COMPOUNDS; EXPRESSION PROFILES; YEAST; GENOME; IDENTIFICATION; SCREEN; GENES; PREDICTION	Computational systems biology is empowering the study of drug action. Studies on biological effects of chemical compounds have increased in scale and accessibility, allowing integration with other large-scale experimental data types. Here, we review computational approaches for elucidating the mechanisms of both intended and undesirable effects of drugs, with the collective potential to change the nature of drug discovery and pharmacological therapy.	[Chua, Hon Nian; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Roth, Frederick P.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Roth, FP (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	fritz_roth@hms.harvard.edu	Roth, Frederick P/H-6308-2011	Roth, Frederick/0000-0002-6628-649X	Agency of Science, Technology and Research, Singapore; National Institutes of Health [HG003224]; Canada Excellence Research Chairs Program; Canadian Institute for Advanced Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER	Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Excellence Research Chairs Program(Canada Research Chairs); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by the Agency of Science, Technology and Research, Singapore.; Supported in part by National Institutes of Health Grant HG003224, the Canada Excellence Research Chairs Program, and a Canadian Institute for Advanced Research fellowship. To whom correspondence should be addressed. E-mail: fritz_roth@hms.harvard.edu.	Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brown D, 2007, DRUG DISCOV TODAY, V12, P1007, DOI 10.1016/j.drudis.2007.10.017; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dueck D, 2005, BIOINFORMATICS, V21, pI144, DOI 10.1093/bioinformatics/bti1041; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lenoir Tim, 2006, J Biomed Discov Collab, V1, P11, DOI 10.1186/1747-5333-1-11; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LINDSLEY DL, 1972, GENETICS, V71, P157; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STOCKLEIN W, 1980, ANTIMICROB AGENTS CH, V18, P863, DOI 10.1128/AAC.18.6.863; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatonetti NP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-238; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231	54	26	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23653	23658		10.1074/jbc.R110.174797	http://dx.doi.org/10.1074/jbc.R110.174797			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566122	Green Published, hybrid			2022-12-27	WOS:000292294900006
J	Munkacsi, AB; Chen, FW; Brinkman, MA; Higaki, K; Gutierrez, GD; Chaudhari, J; Layer, JV; Tong, A; Bard, M; Boone, C; Ioannou, YA; Sturley, SL				Munkacsi, Andrew B.; Chen, Fannie W.; Brinkman, Matthew A.; Higaki, Katsumi; Gutierrez, Giselle Dominguez; Chaudhari, Jagruti; Layer, Jacob V.; Tong, Amy; Bard, Martin; Boone, Charles; Ioannou, Yiannis A.; Sturley, Stephen L.			An "Exacerbate-reverse" Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; MOUSE MODEL; PROTEIN; REVEALS; BINDING; EXPRESSION; MUTATIONS; HOMOLOG; DOMAIN; CELLS	Niemann-Pick type C (NP-C) disease is a fatal lysosomal lipid storage disorder for which no effective therapy exists. A genome-wide, conditional synthetic lethality screen was performed using the yeast model of NP-C disease during anaerobiosis, an auxotrophic condition that requires yeast to utilize exogenous sterol. We identified 12 pathways and 13 genes as modifiers of the absence of the yeast NPC1 ortholog (NCR1) and quantified the impact of loss of these genes on sterol metabolism in ncr1 Delta strains grown under viable aerobic conditions. Deletion of components of the yeast NuA4 histone acetyltransferase complex in ncr1 Delta strains conferred anaerobic inviability and accumulation of multiple sterol intermediates. Thus, we hypothesize an imbalance in histone acetylation in human NP-C disease. Accordingly, we show that the majority of the 11 histone deacetylase (HDAC) genes are transcriptionally up-regulated in three genetically distinct fibroblast lines derived from patients with NP-C disease. A clinically approved HDAC inhibitor (suberoylanilide hydroxamic acid) reverses the dysregulation of the majority of the HDAC genes. Consequently, three key cellular diagnostic criteria of NP-C disease are dramatically ameliorated as follows: lysosomal accumulation of both cholesterol and sphingolipids and defective esterification of LDL-derived cholesterol. These data suggest HDAC inhibition as a candidate therapy for NP-C disease. We conclude that pathways that exacerbate lethality in a model organism can be reversed in human cells as a novel therapeutic strategy. This "exacerbate-reverse" approach can potentially be utilized in any model organism for any disease.	[Gutierrez, Giselle Dominguez; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Munkacsi, Andrew B.; Brinkman, Matthew A.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Chen, Fannie W.; Chaudhari, Jagruti; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Higaki, Katsumi] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Layer, Jacob V.; Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; [Tong, Amy; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Tong, Amy; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet & Microbiol, Toronto, ON M5S 3E1, Canada	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Tottori University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University of Toronto	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Munkacsi, Andrew/0000-0003-3033-395X	National Institutes of Health [DK54320, T32 HL07343, DK082712, GM62104]; Ara Parseghian Medical Research Foundation; Dana Angels Research Trust; Irving Institute for Clinical and Translational Science; Ministry of Education, Culture, Science, Sports and Technology of Japan [20790728]; Genome Canada through Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082712, R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; Dana Angels Research Trust; Irving Institute for Clinical and Translational Science; Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genome Canada through Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.). This work was also supported by the Ara Parseghian Medical Research Foundation and the Dana Angels Research Trust.; Supported by National Institutes of Health Postdoctoral Fellow in Arteriosclerosis Grant T32 HL07343, as a Charles H. Revson Senior Fellow in the Biomedical Sciences, and by the Irving Institute for Clinical and Translational Science.; Supported by National Institutes of Health Grant DK082712.; Supported by Ministry of Education, Culture, Science, Sports and Technology of Japan Grant 20790728.; Supported by National Institutes of Health Grant GM62104.; Supported by Genome Canada through Ontario Genomics Institute Grant 2004-OGI-3-01 and Canadian Institutes of Health Research Grant GSP-41567.	ALMANZARPARAMIO D, 2006, THESIS COLUMBIA U NE; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Berger AC, 2005, EUKARYOT CELL, V4, P1851, DOI 10.1128/EC.4.11.1851-1862.2005; Bhuiyan MSA, 1999, BIOSCI BIOTECH BIOCH, V63, P1075, DOI 10.1271/bbb.63.1075; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bu BT, 2002, J NEUROSCI, V22, P6515; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dittmar JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-353; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Garver WS, 2002, J LIPID RES, V43, P579; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Heinicke S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000766; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madra M, 2010, CLIN LIPIDOL, V5, P387, DOI 10.2217/CLP.10.19; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Munkacsi AB, 2007, FUTURE LIPIDOL, V2, P357, DOI 10.2217/17460875.2.3.357; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PIPALIA NH, 2011, P NATL ACA IN PRESS; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; Taniguchi M, 2001, BRAIN DEV-JPN, V23, P414, DOI 10.1016/S0387-7604(01)00252-2; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	44	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23842	23851		10.1074/jbc.M111.227645	http://dx.doi.org/10.1074/jbc.M111.227645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21489983	Green Published, hybrid			2022-12-27	WOS:000292294900027
J	Schurmann, K; Anton, M; Ivanov, I; Richter, C; Kuhn, H; Walther, M				Schurmann, Kathrin; Anton, Monika; Ivanov, Igor; Richter, Constanze; Kuhn, Hartmut; Walther, Matthias			Molecular Basis for the Reduced Catalytic Activity of the Naturally Occurring T560M Mutant of Human 12/15-Lipoxygenase That Has Been Implicated in Coronary Artery Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 15-LIPOXYGENASE; CARDIOVASCULAR-DISEASE; LIPOXYGENASE PATHWAYS; HUMAN ATHEROGENESIS; SULFOXIDE FORMATION; SELF-INACTIVATION; ATHEROSCLEROSIS; DETERMINANTS; RETICULOCYTE; INFLAMMATION	Lipoxygenases have been implicated in cardiovascular disease. A rare single-nucleotide polymorphism causing T560M exchange has recently been described, and this mutation leads to a near null variant of the enzyme encoded for by the ALOX15 gene. When we inspected the three-dimensional structure of the rabbit ortholog, we localized Thr-560 outside the active site and identified a hydrogen bridge between its side chain and Gln-294. This interaction is part of a complex hydrogen bond network that appears to be conserved in other mammalian lipoxygenases. Gln-294 and Asn-287 are key amino acids in this network, and we hypothesized that disturbance of this hydrogen bond system causes the low activity of the T560M mutant. To test this hypothesis, we first mutated Thr-560 to amino acids not capable of forming side chain hydrogen bridges (T560M and T560A) and obtained enzyme variants with strongly reduced catalytic activity. In contrast, enzymatic activity was retained after T560S exchange. Enzyme variants with strongly reduced activity were also obtained when we mutated Gln-294 (binding partner of Thr-560) and Asn-287 (binding partner of Gln-294 and Met-418) to Leu. Basic kinetic characterization of the T560M mutant indicated that the enzyme lacks a kinetic lag phase but is rapidly inactivated. These data suggest that the low catalytic efficiency of the naturally occurring T560M mutant is caused by alterations of a hydrogen bond network interconnecting this residue with active site constituents. Disturbance of this bonding network increases the susceptibility of the enzyme for suicidal inactivation.	[Schurmann, Kathrin; Anton, Monika; Ivanov, Igor; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Richter, Constanze] Tech Univ Berlin, Inst Food Chem & Toxicol, D-13355 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Kuhn, H (corresponding author), Charite, Inst Biochem, Oudenarder Str 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de	Ivanov, Igor V./I-5606-2016	Ivanov, Igor V./0000-0003-0543-2067	Deutsche Forschungsgemeinschaft [GRK1673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK1673.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Assimes TL, 2008, ATHEROSCLEROSIS, V198, P136, DOI 10.1016/j.atherosclerosis.2007.09.003; Bishnoi M, 2005, METHOD FIND EXP CLIN, V27, P465, DOI 10.1358/mf.2005.27.7.920929; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; GAN QF, 1995, BIOCHEMISTRY-US, V34, P7069, DOI 10.1021/bi00021a019; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hersberger M, 2010, CLIN CHEM LAB MED, V48, P1063, DOI 10.1515/CCLM.2010.212; Hersberger M, 2009, ATHEROSCLEROSIS, V205, P192, DOI 10.1016/j.atherosclerosis.2008.11.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanov I, 2005, FEBS J, V272, P2523, DOI 10.1111/j.1742-4658.2005.04673.x; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Krishnaswamy Guha, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P234; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1997, J CLIN INVEST, V99, P888, DOI 10.1172/JCI119253; Liu SH, 2010, BRIT J PHARMACOL, V160, P1963, DOI 10.1111/j.1476-5381.2010.00804.x; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; RAPOPORT S, 1984, EUR J BIOCHEM, V139, P573, DOI 10.1111/j.1432-1033.1984.tb08043.x; RAPOPORT SM, 1979, EUR J BIOCHEM, V96, P545, DOI 10.1111/j.1432-1033.1979.tb13068.x; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; SCHILSTRA MJ, 1992, BIOCHEMISTRY-US, V31, P7692, DOI 10.1021/bi00148a033; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	36	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23920	23927		10.1074/jbc.M110.211821	http://dx.doi.org/10.1074/jbc.M110.211821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558275	Green Published, hybrid			2022-12-27	WOS:000292294900034
J	Flannery, AR; Huynh, C; Mittra, B; Mortara, RA; Andrews, NW				Flannery, Andrew R.; Huynh, Chau; Mittra, Bidyottam; Mortara, Renato A.; Andrews, Norma W.			LFR1 Ferric Iron Reductase of Leishmania amazonensis Is Essential for the Generation of Infective Parasite Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHELATE REDUCTASE; NADPH OXIDASE; ARABIDOPSIS-THALIANA; ACQUISITION; PROTEIN; PROMASTIGOTES; TRANSFERRIN; ANTIGEN; FAMILY	The protozoan parasite Leishmania is the causative agent of serious human infections worldwide. The parasites alternate between insect and vertebrate hosts and cause disease by invading macrophages, where they replicate. Parasites lacking the ferrous iron transporter LIT1 cannot grow intracellularly, indicating that a plasma membrane-associated mechanism for iron uptake is essential for the establishment of infections. Here, we identify and functionally characterize a second member of the Leishmania iron acquisition pathway, the ferric iron reductase LFR1. The LFR1 gene is up-regulated under iron deprivation and accounts for all the detectable ferric reductase activity exposed on the surface of Leishmania amazonensis. LFR1 null mutants grow normally as promastigote insect stages but are defective in differentiation into the vertebrate infective forms, metacyclic promastigotes and amastigotes. LFR1 overexpression partially restores the abnormal morphology of infective stages but markedly reduces parasite viability, precluding its ability to rescue LFR1 null replication in macrophages. However, LFR1 overexpression is not toxic for amastigotes lacking the ferrous iron transporter LIT1 and rescues their growth defect. In addition, the intracellular growth of both LFR1 and LIT1 null parasites is rescued in macrophages loaded with exogenous iron. This indicates that the Fe3+ reductase LFR1 functions upstream of LIT1 and suggests that LFR1 overexpression results in excessive Fe2+ production, which impairs parasite viability after intracellular transport by LIT1.	[Flannery, Andrew R.; Huynh, Chau; Mittra, Bidyottam; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, Brazil	University System of Maryland; University of Maryland College Park; Universidade Federal de Sao Paulo (UNIFESP)	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA.	andrewsn@umd.edu	Mortara, Renato A./C-1864-2012	Mortara, Renato A./0000-0002-2311-8349; Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [R01 AI067979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI067979 (to N. W. A.).	ANDERSON E, 1983, TISSUE CELL, V15, P853, DOI 10.1016/0040-8166(83)90054-X; ANDERSON GJ, 1992, J INORG BIOCHEM, V47, P249, DOI 10.1016/0162-0134(92)84070-4; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Becker SM, 2009, IMMUNOBIOLOGY, V214, P495, DOI 10.1016/j.imbio.2008.11.006; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courret N, 1999, EUR J IMMUNOL, V29, P762, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;762::AID-IMMU762&gt;3.0.CO;2-4; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GOLDBERG MW, 1992, J CELL BIOL, V119, P1429, DOI 10.1083/jcb.119.6.1429; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jacques I, 2010, MOL BIOCHEM PARASIT, V170, P28, DOI 10.1016/j.molbiopara.2009.12.003; Kar S, 2000, J BIOL CHEM, V275, P37789, DOI 10.1074/jbc.M002149200; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; MORRIS CJ, 1995, INT J BIOCHEM CELL B, V27, P109, DOI 10.1016/1357-2725(94)00084-O; Olakanmi O, 1997, J BIOL CHEM, V272, P2599, DOI 10.1074/jbc.272.5.2599; Pinto-da-Silva LH, 2005, INT J PARASITOL, V35, P757, DOI 10.1016/j.ijpara.2005.03.004; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Schagerlof U, 2006, PLANT MOL BIOL, V62, P215, DOI 10.1007/s11103-006-9015-0; SEGOVIA M, 1989, ANN TROP MED PARASIT, V83, P357, DOI 10.1080/00034983.1989.11812357; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SOTERIADOU K, 1995, J ANTIMICROB CHEMOTH, V35, P23, DOI 10.1093/jac/35.1.23; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Vasconcelos M, 2006, PLANTA, V224, P1116, DOI 10.1007/s00425-006-0293-1; Waters BM, 2002, PLANT PHYSIOL, V129, P85, DOI 10.1104/pp.010829; Wilson ME, 2002, EXP PARASITOL, V100, P196, DOI 10.1016/S0014-4894(02)00018-8; WILSON ME, 1994, INFECT IMMUN, V62, P3262, DOI 10.1128/IAI.62.8.3262-3269.1994; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Zhang DL, 2006, BBA-GEN SUBJECTS, V1760, P1903, DOI 10.1016/j.bbagen.2006.07.019	46	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23266	23279		10.1074/jbc.M111.229674	http://dx.doi.org/10.1074/jbc.M111.229674			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558274	hybrid, Green Published			2022-12-27	WOS:000292025000060
J	Noinaj, N; Bosserman, MA; Schickli, MA; Piszczek, G; Kharel, MK; Pahari, P; Buchanan, SK; Rohr, J				Noinaj, Nicholas; Bosserman, Mary A.; Schickli, M. Alexandra; Piszczek, Grzegorz; Kharel, Madan K.; Pahari, Pallab; Buchanan, Susan K.; Rohr, Juergen			The Crystal Structure and Mechanism of an Unusual Oxidoreductase, GilR, Involved in Gilvocarcin V Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BERBERINE BRIDGE ENZYME; COVALENTLY ATTACHED FAD; COMBINATORIAL BIOSYNTHESIS; ACLACINOMYCIN OXIDOREDUCTASE; DNA; DRUG; OXIDASE; BINDING; RAVIDOMYCIN; FLAVOENZYME	GilR is a recently identified oxidoreductase that catalyzes the terminal step of gilvocarcin V biosynthesis and is a unique enzyme that establishes the lactone core of the polyketide-derived gilvocarcin chromophore. Gilvocarcin-type compounds form a small distinct family of anticancer agents that are involved in both photo-activated DNA-alkylation and histone H3 cross-linking. High resolution crystal structures of apoGilR and GilR in complex with its substrate pregilvocarcin V reveals that GilR belongs to the small group of a relatively new type of the vanillyl-alcohol oxidase flavoprotein family characterized by bicovalently tethered cofactors. GilR was found as a dimer, with the bicovalently attached FAD cofactor mediated through His-65 and Cys-125. Subsequent mutagenesis and functional assays indicate that Tyr-445 may be involved in reaction catalysis and in mediating the covalent attachment of FAD, whereas Tyr-448 serves as an essential residue initiating the catalysis by swinging away from the active site to accommodate binding of the 6R-configured substrate and consequently abstracting the proton of the hydroxyl residue of the substrate hemiacetal 6-OH group. These studies lay the groundwork for future enzyme engineering to broaden the substrate specificity of this bottleneck enzyme of the gilvocarcin biosynthetic pathway for the development of novel anti-cancer therapeutics.	[Bosserman, Mary A.; Schickli, M. Alexandra; Kharel, Madan K.; Pahari, Pallab; Rohr, Juergen] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Noinaj, Nicholas; Buchanan, Susan K.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, NIH, Bethesda, MD 20892 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rohr, J (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone St, Lexington, KY 40536 USA.	jrohr2@email.uky.edu	Pahari, Pallab/AAF-5664-2019; Piszczek, Grzegorz/GYU-2029-2022; Rohr, Jurgen/G-5375-2014	Rohr, Jurgen/0000-0001-6447-5951; Pahari, Pallab/0000-0003-3662-2015	National Institutes of Health [CA102102, CA091901]; NATIONAL CANCER INSTITUTE [R01CA102102, R01CA091901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102102 and CA091901 (to J. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALEGRIA AE, 1995, PHOTOCHEM PHOTOBIOL, V62, P409, DOI 10.1111/j.1751-1097.1995.tb02361.x; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Baig I, 2008, J NAT PROD, V71, P199, DOI 10.1021/np0705763; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Beam MP, 2009, BIOCHEMISTRY-US, V48, P4476, DOI 10.1021/bi8023509; Borchardt JK, 1999, MODERN DRUG DISCOV, V2, P22; CARTER GT, 1984, TETRAHEDRON LETT, V25, P255, DOI 10.1016/S0040-4039(00)99854-X; CARTER GT, 1985, J ANTIBIOT, V38, P242, DOI 10.7164/antibiotics.38.242; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cropp TA, 2002, BIOTECHNOL GENET ENG, V19, P159, DOI 10.1080/02648725.2002.10648028; ELESPURU RK, 1984, SCIENCE, V223, P69, DOI 10.1126/science.6229029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer C, 2003, J AM CHEM SOC, V125, P7818, DOI 10.1021/ja034781q; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GLOCK GE, 1952, NATURE, V170, P119, DOI 10.1038/170119a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Hutchinson CR, 2000, SPR DESKT EDIT CHEM, P233; Hutchinson CR, 1998, CURR OPIN MICROBIOL, V1, P319, DOI 10.1016/S1369-5274(98)80036-2; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kharel MK, 2007, J AM CHEM SOC, V129, P3780, DOI 10.1021/ja0680515; Kharel MK, 2010, CHEMBIOCHEM, V11, P523, DOI 10.1002/cbic.200900673; Kharel MK, 2009, CHEMBIOCHEM, V10, P1305, DOI 10.1002/cbic.200900130; Khosla C, 1996, TRENDS BIOTECHNOL, V14, P335, DOI 10.1016/0167-7799(96)10046-9; KNOBLER RM, 1992, NUCLEIC ACIDS RES, V20, P4553, DOI 10.1093/nar/20.17.4553; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leadlay PF, 1997, CURR OPIN CHEM BIOL, V1, P162, DOI 10.1016/S1367-5931(97)80005-1; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Lerner MG, 2006, APBS PLUGIN PYMOL; Liu T, 2004, J AM CHEM SOC, V126, P12262, DOI 10.1021/ja0467521; Luzhetskyy A, 2005, MOL MICROBIOL, V58, P3, DOI 10.1111/j.1365-2958.2005.04815.x; MATSUMOTO A, 1994, PHOTOCHEM PHOTOBIOL, V60, P225, DOI 10.1111/j.1751-1097.1994.tb05095.x; Matsumoto A, 2000, CANCER RES, V60, P3921; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCGEE LR, 1990, J AM CHEM SOC, V112, P2386, DOI 10.1021/ja00162a046; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; MISRA R, 1985, J ANTIBIOT, V38, P1280, DOI 10.7164/antibiotics.38.1280; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyola R, 1997, PHOTOCHEM PHOTOBIOL, V65, P802, DOI 10.1111/j.1751-1097.1997.tb01927.x; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Rohr J, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P227; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Shepherd MD, 2010, ORG BIOMOL CHEM, V8, P3851, DOI 10.1039/c0ob00036a; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Sultana A, 2007, ACTA CRYSTALLOGR D, V63, P149, DOI 10.1107/S0907444906044271; TAKAHASHI K, 1983, J ANTIBIOT, V36, P1531, DOI 10.7164/antibiotics.36.1531; TSEDINH YC, 1987, BIOCHEM BIOPH RES CO, V143, P808, DOI 10.1016/0006-291X(87)90320-2; Van Lanen Steven G, 2006, Drug Discov Today Technol, V3, P285, DOI 10.1016/j.ddtec.2006.09.014; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Yamashita Y., 1988, NUCLEIC ACIDS S SER, V20, P65; Zhang WJ, 2008, J MED CHEM, V51, P2629, DOI 10.1021/jm701269v; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012	71	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23533	23543		10.1074/jbc.M111.247833	http://dx.doi.org/10.1074/jbc.M111.247833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561854	Green Published, hybrid			2022-12-27	WOS:000292025000083
J	Pavlyukov, MS; Antipova, NV; Balashova, MV; Vinogradova, TV; Kopantzev, EP; Shakhparonov, MI				Pavlyukov, Marat S.; Antipova, Nadezhda V.; Balashova, Maria V.; Vinogradova, Tatjana V.; Kopantzev, Evgenij P.; Shakhparonov, Mihail I.			Survivin Monomer Plays an Essential Role in Apoptosis Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MICROTUBULE DYNAMICS; INHIBITS APOPTOSIS; MEDIATED APOPTOSIS; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; CELL-CYCLE; CANCER; SMAC/DIABLO; ACTIVATION	Survivin was initially described as an inhibitor of apoptosis and attracted growing attention as one of the most tumor-specific genes in the human genome and a promising target for cancer therapy. Lately, it has been shown that survivin is a multifunctional protein that takes part in several crucial cell processes. At first, it was supposed that survivin functions only as a homodimer, but now data indicate that many processes require monomeric survivin. Moreover, recent studies reveal a special mechanism regulating the balance between monomeric and dimeric forms of the protein. In this paper we studied the mutant form of survivin that was unable to dimerize and investigated its role in apoptosis. We showed that survivin monomer interacts with Smac/DIABLO and X-linked inhibitor of apoptosis protein (XIAP) both in vitro and in vivo. Due to this feature, it protects cells from caspase-dependent apoptosis even more efficiently than the wild-type survivin. We also identified that mutant monomeric survivin prevents apoptosis-inducing factor release from the mitochondrial intermembrane space, protecting human fibrosarcoma HT1080 cells from caspase-independent apoptosis. On the other hand, our results indicate that only wild-type survivin, but not the monomer mutant form, enhances tubulin stability in cells. These findings suggest that survivin partly performs its functions as a monomer and partly as a dimer. The mechanism of dimer-monomer balance regulation may also work as a "switcher" between survivin functions and thereby explain remarkable functional diversities of this protein.	[Pavlyukov, Marat S.; Antipova, Nadezhda V.; Balashova, Maria V.; Vinogradova, Tatjana V.; Kopantzev, Evgenij P.; Shakhparonov, Mihail I.] Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Shakhparonov, MI (corresponding author), Ul Marshala Timoshenko 36, Moscow 121359, Russia.	shakhparonov.m@mail.ru	Pavlyukov, Marat S/ABB-6791-2021; Shakhparonov, Mikhail I/E-8377-2014; Pavlyukov, Marat S/E-7314-2014; Antipova, Nadine/E-7356-2014	Antipova, Nadine/0000-0002-5799-7767	presidium of Russian Academy of Science [2395.2008.4]; Department of Education and Science of Russian Federation [2007-02-2.2-05-01-006]; Russian Foundation for Basic Research [10-04-01206]; Fund for Assistance to Innovative Enterprises (FASIE)	presidium of Russian Academy of Science(Russian Academy of Sciences); Department of Education and Science of Russian Federation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Fund for Assistance to Innovative Enterprises (FASIE)	This work was supported by President Grant 2395.2008.4 for Scientific Schools, a grant from the Basic Research Program (Physico-Chemical Biology) of the presidium of Russian Academy of Science, Federal Program of the Department of Education and Science of Russian Federation Grant 2007-02-2.2-05-01-006, Russian Foundation for Basic Research (grant 10-04-01206), and by the Fund for Assistance to Innovative Enterprises (FASIE).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chan KS, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.34; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Chen JT, 2008, AM J RESP CELL MOL, V38, P559, DOI 10.1165/rcmb.2007-0001OC; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Engelsma D, 2007, TRAFFIC, V8, P1495, DOI 10.1111/j.1600-0854.2007.00629.x; Fortugno P, 2002, J CELL SCI, V115, P575; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Henkels KM, 1999, CANCER RES, V59, P3077; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; King MA, 2007, CYTOM PART A, V71A, P668, DOI 10.1002/cyto.a.20428; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; Liu T, 2006, J INVEST DERMATOL, V126, P2247, DOI 10.1038/sj.jid.5700381; McNeish IA, 2005, EXP CELL RES, V302, P69, DOI 10.1016/j.yexcr.2004.08.029; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Norberg E, 2010, EMBO J, V29, P3869, DOI 10.1038/emboj.2010.253; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Song ZY, 2004, MOL BIOL CELL, V15, P1287, DOI 10.1091/mbc.E03-07-0512; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Watanabe A, 2009, HUM REPROD, V24, P3172, DOI 10.1093/humrep/dep305; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223	42	61	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23296	23307		10.1074/jbc.M111.237586	http://dx.doi.org/10.1074/jbc.M111.237586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536684	Green Published, hybrid			2022-12-27	WOS:000292025000062
J	Liu, ZF; Bryant, DA				Liu, Zhenfeng; Bryant, Donald A.			Identification of a Gene Essential for the First Committed Step in the Biosynthesis of Bacteriochlorophyll c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROBIUM-TEPIDUM CHLOROSOMES; C-20 METHYLTRANSFERASE; REACTION CENTERS; CHLOROPHYLL; REDUCTASE; LIGHT; BCHU; INACTIVATION; AGGREGATION; BACTERIA	Bacteriochlorophylls (BChls) c, d, and e are the major chlorophylls in chlorosomes, which are the largest and one of the most efficient antennae produced by chlorophototrophic organisms. In the biosynthesis of these three BChls, a C-13(2)-methylcarboxyl group found in all other chlorophylls (Chls) must be removed. This reaction is postulated to be the first committed step in the synthesis of these BChls. Analyses of gene neighborhoods of (B)Chl biosynthesis genes and distribution patterns in organisms producing chlorosomes helped to identify a gene (bciC) that appeared to be a good candidate to produce the enzyme involved in this biochemical reaction. To confirm that this was the case, a deletion mutant of an open reading frame orthologous to bciC, CT1077, was constructed in Chlorobaculum tepidum, a genetically tractible green sulfur bacterium. The CT1077 deletion mutant was unable to synthesize BChl c but still synthesized BChl a and Chl a. The deletion mutant accumulated large amounts of various (bacterio)pheophorbides, all of which still had C-13(2)-methylcarboxyl groups. A C. tepidum strain in which CT1077 was replaced by an orthologous gene, Cabther_B0031 from "Candidatus Chloracidobacterium thermophilum" was constructed. Although the product of Cabther_B0031 was only 28% identical to the product of CT1077, this strain synthesized BChl c, BChl a, and Chl a in amounts similar to wild-type C. tepidum cells. To indicate their roles in the first committed step of BChl c, d, and e biosynthesis, open reading frames CT1077 and Cabther_B0031 have been redesignated bciC. The potential mechanism by which BciC removes the C-13(2)-methylcarboxyl moiety of chlorophyllide a is discussed.	[Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Liu, Zhenfeng/B-8252-2015	Liu, Zhenfeng/0000-0001-5892-6429	United States Department of Energy [DE-FG02-94ER20137]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.).	Airs RL, 2000, RAPID COMMUN MASS SP, V14, P125, DOI 10.1002/(SICI)1097-0231(20000215)14:3&lt;125::AID-RCM847&gt;3.0.CO;2-6; Beatty JT, 2005, P NATL ACAD SCI USA, V102, P9306, DOI 10.1073/pnas.0503674102; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Bryant DA, 2002, BIOCHEMISTRY-US, V41, P14403, DOI 10.1021/bi026599s; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Chew AGM, 2004, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Harada J, 2005, FEBS LETT, V579, P1983, DOI 10.1016/j.febslet.2005.01.087; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; KATZ JJ, 1975, PORPHYRINS METALLOPO, P399; KEELY BJ, 1990, ENERG FUEL, V4, P737, DOI 10.1021/ef00024a020; Kunieda M, 2004, PHOTOCHEM PHOTOBIOL, V79, P55, DOI 10.1111/j.1751-1097.2004.tb09857.x; Manske AK, 2005, APPL ENVIRON MICROB, V71, P8049, DOI 10.1128/AEM.71.12.8049-8060.2005; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; MEYER M, 1995, PHOTOSYNTH RES, V44, P55, DOI 10.1007/BF00018296; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; Oostergetel GT, 2007, FEBS LETT, V581, P5435, DOI 10.1016/j.febslet.2007.10.045; Pedersen MO, 2008, BIOCHEMISTRY-US, V47, P1435, DOI 10.1021/bi701616r; Sadekar S, 2006, MOL BIOL EVOL, V23, P2001, DOI 10.1093/molbev/msl079; Saga Y, 2004, J PHOTOCH PHOTOBIO B, V75, P89, DOI 10.1016/j.jphotobiol.2004.05.012; Scheer Hugo, 2006, V25, P1; SCHOCH S, 1981, Z NATURFORSCH C, V36, P827; Steensgaard DB, 2000, J PHYS CHEM B, V104, P10379, DOI 10.1021/jp0013356; Suzuki Y, 2006, PLANT PHYSIOL, V140, P716, DOI 10.1104/pp.105.071290; Suzuki Y, 2002, PHOTOSYNTH RES, V74, P225, DOI 10.1023/A:1020919929608; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Wada K, 2006, J MOL BIOL, V360, P839, DOI 10.1016/j.jmb.2006.05.057	40	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22393	22402		10.1074/jbc.M111.249433	http://dx.doi.org/10.1074/jbc.M111.249433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550979	Green Published, hybrid			2022-12-27	WOS:000291719900049
J	Golubkov, VS; Aleshin, AE; Strongin, AY				Golubkov, Vladislav S.; Aleshin, Alexander E.; Strongin, Alex Y.			Potential Relation of Aberrant Proteolysis of Human Protein Tyrosine Kinase 7 (PTK7) chuzhoi by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) to Congenital Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; NEURAL CREST MIGRATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; CANCER-CELLS; OFF-TRACK; RECEPTOR; INVASION; FAMILY; GASTRULATION	Membrane PTK7 pseudo-kinase plays an essential role in planar cell polarity and the non-canonical Wnt pathway in vertebrates. Recently, a new N-ethyl-N-nitrosourea-induced mutant named chuzhoi (chz) was isolated in mice. chz embryos have severe birth defects, including a defective neural tube, defective heart and lung development, and a shortened anterior-posterior body axis. The chz mutation was mapped to the Ala-Asn-Pro tripeptide insertion into the junction region between the fifth and the sixth Ig-like domains of PTK7. Unexpectedly, chz reduced membrane localization of the PTK7 protein. We hypothesized and then proved that the chz mutation caused an insertion of an additional membrane type 1 matrix metalloproteinase cleavage site in PTK7 and that the resulting aberrant proteolysis of chz affected the migratory parameters of the cells. It is likely that aberrations in the membrane type 1 matrix metalloproteinase/PTK7 axis are detrimental to cell movements that shape the body plan and that chz represents a novel model system for increasing our understanding of the role of proteolysis in developmental pathologies, including congenital defects.	[Golubkov, Vladislav S.; Aleshin, Alexander E.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A. Y. S.).	Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dale TC, 1998, BIOCHEM J, V329, P209; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Katoh M, 2005, ONCOL REP, V14, P1583; LEE HK, 2011, BLOOD IN PRESS; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Park SK, 1996, J BIOCHEM, V119, P235; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Polakis P, 2000, GENE DEV, V14, P1837; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wagner G, 2010, BIOCHEM BIOPH RES CO, V402, P402, DOI 10.1016/j.bbrc.2010.10.044; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8	52	20	20	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20970	20976		10.1074/jbc.M111.237669	http://dx.doi.org/10.1074/jbc.M111.237669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518755	Green Published, hybrid			2022-12-27	WOS:000291267600081
J	Testoni, B; Vollenkle, C; Guerrieri, F; Gerbal-Chaloin, S; Blandino, G; Levrero, M				Testoni, Barbara; Voellenkle, Christine; Guerrieri, Francesca; Gerbal-Chaloin, Sabine; Blandino, Giovanni; Levrero, Massimo			Chromatin Dynamics of Gene Activation and Repression in Response to Interferon alpha (IFN alpha) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C; TARGET GENES; EXPRESSION; CELLS; COMPLEX; PROTEIN; IMMUNOPRECIPITATION; IDENTIFICATION; MECHANISMS; PATHWAY	Signal transducer and activator of transcription 2 (STAT2), the critical component of type I interferons signaling, is a prototype latent cytoplasmic signal-dependent transcription factor. Activated tyrosine-phosphorylated STAT2 associates with STAT1 and IRF9 to bind the ISRE elements in the promoters of a subset of IFN-inducible genes (ISGs). In addition to activate hundreds of ISGs, IFN alpha also represses numerous target genes but the mechanistic basis for this dual effect and transcriptional repression is largely unknown. We investigated by ChIP-chip the binding dynamics of STAT2 and "active" phospho(P)-STAT2 on 113 putative IFN alpha direct target promoters before and after IFN alpha induction in Huh7 cells and primary human hepatocytes (PHH). STAT2 is already bound to 62% of our target promoters, including most "classical" ISGs, before IFN alpha treatment. 31% of STAT2 basally bound promoters also show P-STAT2 positivity. By correlating in vivo promoter occupancy with gene expression and changes in histone methylation marks we found that: 1) STAT2 plays a role in regulating ISGs expression, independently from its phosphorylation; 2) P-STAT2 is involved in ISGs repression; 3) "activated" ISGs are marked by H3K4me1 and H3K4me3 before IFN alpha; 4) "repressed" genes are marked by H3K27me3 and histone methylation plays a dominant role in driving IFN alpha-mediated ISGs repression.	[Testoni, Barbara; Levrero, Massimo] Univ Roma La Sapienza, DMISM, I-00161 Rome, Italy; [Testoni, Barbara; Voellenkle, Christine; Guerrieri, Francesca; Levrero, Massimo] Fdn A Cesalpino, Gene Express Lab, I-00161 Rome, Italy; [Testoni, Barbara; Voellenkle, Christine; Blandino, Giovanni; Levrero, Massimo] Regina Elena Inst Canc Res, Rome Oncogen Ctr, I-00144 Rome, Italy; [Guerrieri, Francesca; Levrero, Massimo] INSERM, LEA U785, I-00161 Rome, Italy; [Gerbal-Chaloin, Sabine] INSERM, U632, Inst Rech Biotherapie, F-34090 Montpellier, France; [Blandino, Giovanni] Regina Elena Inst Canc Res, Translat Oncogen Unit, I-00144 Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Testoni, B (corresponding author), Univ Roma La Sapienza, DMISM, Viale Policlin 155, I-00161 Rome, Italy.	barbara.testoni@uniroma1.it; massimo.levrero@uniroma1.it	Guerrieri, Francesca/K-5504-2016; guerrieri, francesca/G-3908-2013; Voellenkle, Christine/J-8144-2016; Voellenkle, Christine/AAD-3092-2021; GERBAL-CHALOIN, sabine/M-8783-2017; Levrero, Massimo/G-5680-2016; TESTONI, Barbara/F-3767-2017	Guerrieri, Francesca/0000-0003-2751-6050; Voellenkle, Christine/0000-0003-0824-060X; GERBAL-CHALOIN, sabine/0000-0002-2549-7899; Levrero, Massimo/0000-0002-4978-0875; TESTONI, Barbara/0000-0001-5588-5465; Guerrieri, Francesca/0000-0002-2021-4394	AIRC; European Community [LSHC-CT-2004-503576]; MIUR-Cofin; Progetti di Ateneo; Sapienza University of Rome; Schering-Plough; AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A. Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	AIRC(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); MIUR-Cofin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Progetti di Ateneo; Sapienza University of Rome; Schering-Plough(Merck & CompanySchering Plough Corporation); AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A. Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	This work was supported in part by grants from AIRC, European Community (LSHC-CT-2004-503576), MIUR-Cofin, and Progetti di Ateneo, Sapienza University of Rome and Schering-Plough (to M.L.). This work was also supported in part by fellowships from the AICF (American Italian Cancer Foundation) and from the Fondazione Adriano Buzzati-Traverso (to B.T.) and fellowships from the Fondazione A. Cesalpino and Rome Oncogenomic Center at the Regina Elena Cancer Institute (to F.G.).	Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Barry Michele, 2006, Sci STKE, V2006, ppe21; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; D'Acunto CW, 2010, ANTICANCER RES, V30, P887; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Geiss GK, 2003, J VIROL, V77, P6367, DOI 10.1128/JVI.77.11.6367-6375.2003; Gerber SA, 2008, J IMMUNOL, V181, P1052, DOI 10.4049/jimmunol.181.2.1052; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gupta S, 1999, J IMMUNOL, V163, P3834; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hong SW, 2009, MOL CELLS, V27, P243, DOI 10.1007/s10059-009-0030-2; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kraus TA, 2003, J BIOL CHEM, V278, P13033, DOI 10.1074/jbc.M212972200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Noskov VN, 1998, MOL CELL BIOL, V18, P4914, DOI 10.1128/MCB.18.8.4914; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Park BL, 2007, BIOCHEM BIOPH RES CO, V363, P776, DOI 10.1016/j.bbrc.2007.09.026; Pichard-Garcia L, 2002, METHOD ENZYMOL, V357, P311; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shi Zheng-Zheng, 2007, Journal of Zhejiang University-Science B, V8, P170, DOI 10.1631/jzus.2007.B0170; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; TESTONI B, 2011, ONCOGENE IN PRESS; Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; Wohrle S, 2007, MOL CELL BIOL, V27, P8164, DOI 10.1128/MCB.00555-07; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wormald S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-254; Wu WZ, 2005, WORLD J GASTROENTERO, V11, P6613, DOI 10.3748/wjg.v11.i42.6613; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	69	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20217	20227		10.1074/jbc.M111.231068	http://dx.doi.org/10.1074/jbc.M111.231068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498520	hybrid, Green Published			2022-12-27	WOS:000291267600009
J	Horsch, M; Seeburg, PH; Adler, T; Aguilar-Pimentel, JA; Becker, L; Calzada-Wack, J; Garrett, L; Gotz, A; Hans, W; Higuchi, M; Holter, SM; Naton, B; Prehn, C; Puk, O; Racz, I; Rathkolb, B; Rozman, J; Schrewe, A; Adamski, J; Busch, DH; Esposito, I; Graw, J; Ivandic, B; Klingenspor, M; Klopstock, T; Mempel, M; Ollert, M; Schulz, H; Wolf, E; Wurst, W; Zimmer, A; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Beckers, J				Horsch, Marion; Seeburg, Peter H.; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Becker, Lore; Calzada-Wack, Julia; Garrett, Lilian; Goetz, Alexander; Hans, Wolfgang; Higuchi, Miyoko; Hoelter, Sabine M.; Naton, Beatrix; Prehn, Cornelia; Puk, Oliver; Racz, Ildiko; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adamski, Jerzy; Busch, Dirk H.; Esposito, Irene; Graw, Jochen; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Mempel, Martin; Ollert, Markus; Schulz, Holger; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Beckers, Johannes			Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT GLUR-B; PREPULSE INHIBITION; RECEPTOR; GENE; EXPRESSION; ADENOSINE; SCHIZOPHRENIA; DEFICIENT; LETHALITY; EPILEPSY	ADAR2, an RNA editing enzyme that converts specific adenosines to inosines in certain pre-mRNAs, often leading to amino acid substitutions in the encoded proteins, is mainly expressed in brain. Of all ADAR2-mediated edits, a single one in the pre-mRNA of the AMPA receptor subunit GluA2 is essential for survival. Hence, early postnatal death of mice lacking ADAR2 is averted when the critical edit is engineered into both GluA2 encoding Gria2 alleles. Adar2(-/-)/Gria2(R/R) mice display normal appearance and life span, but the general phenotypic effects of global lack of ADAR2 have remained unexplored. Here we have employed the Adar2(-/-)/Gria2(R/R) mouse line, and Gria2(R/R) mice as controls, to study the phenotypic consequences of loss of all ADAR2-mediated edits except the critical one in GluA2. Our extended phenotypic analysis covering similar to 320 parameters identified significant changes related to absence of ADAR2 in behavior, hearing ability, allergy parameters and transcript profiles of brain.	[Horsch, Marion; Hans, Wolfgang; Naton, Beatrix; Prehn, Cornelia; Schrewe, Anja; Adamski, Jerzy; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Seeburg, Peter H.; Higuchi, Miyoko] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Seeburg, Peter H.; Higuchi, Miyoko] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Mempel, Martin; Ollert, Markus] TUM Helmholtz Zentrum Munchen GmbH, Clin Res Div Mol & Clin Allergotoxicol, Dept Dermatol & Allergy, D-85764 Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio; Mempel, Martin] TUM Helmholtz Zentrum Munchen GmbH, Div Environm Dermatol & Allergy, D-85764 Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Calzada-Wack, Julia; Esposito, Irene] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Pathol, D-85764 Neuherberg, Germany; [Garrett, Lilian; Hoelter, Sabine M.; Puk, Oliver; Graw, Jochen; Wurst, Wolfgang] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Goetz, Alexander; Schulz, Holger] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-85764 Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53125 Bonn, Germany; [Rathkolb, Birgit] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany; [Schrewe, Anja; Ivandic, Boris] Univ Heidelberg, Otto Meyerhof Zentrum, Dept Med 3, Div Cardiol, D-69120 Heidelberg, Germany; [Adamski, Jerzy; de Angelis, Martin Hrabe; Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Esposito, Irene] Tech Univ Munich, Klinikum Rechts Isar, Inst Allgemeine Pathol & Pathol Anat, D-81675 Munich, Germany; [Mempel, Martin] Univ Gottingen, Dept Dermatol Venerol & Allergy, D-37073 Gottingen, Germany; [Schulz, Holger] Tech Univ Munich, Chair Dev Genet, D-85350 Freising Weihenstephan, Germany; [Wurst, Wolfgang] Helmholtz Zentrum Munchen GmbH, German Res Ctr Environm Hlth, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Max Planck Society; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; University of Gottingen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Seeburg, PH (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	seeburg@mpimf-heidelberg.mpg.de	Klingenspor, Martin/K-5033-2019; Hölter, Sabine M./N-5868-2014; Becker, Lore/E-3717-2010; Naton, Beatrix/B-5392-2013; Rathkolb, Birgit/F-7041-2013; Zimmer, Andreas/B-8357-2009; Schulz, Holger/J-5643-2015; Racz, I./C-3074-2009; Becker, Lore/AAJ-1203-2020; Gailus-Durner, Valerie/M-7337-2014; Rozman, Jan/A-2540-2010; Graw, Jochen/D-9336-2013; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Beckers, Johannes/K-7237-2012; Puk, Oliver/E-1443-2013; Klingenspor, Martin/D-6930-2011	Hölter, Sabine M./0000-0003-4878-5241; Naton, Beatrix/0000-0002-9453-8877; Schulz, Holger/0000-0002-1157-200X; Racz, I./0000-0002-1549-3616; Becker, Lore/0000-0002-6890-4984; Rozman, Jan/0000-0002-8035-8904; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Beckers, Johannes/0000-0001-7874-3822; Klingenspor, Martin/0000-0002-4502-6664; Wurst, Wolfgang/0000-0003-4422-7410; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Calzada, Julia/0000-0003-0816-9305; Ollert, Markus W./0000-0002-8055-0103; Graw, Jochen/0000-0003-0298-9660; Wolf, Eckhard/0000-0002-0430-9510; Garrett, Lillian/0000-0003-4880-7076	Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus) [01GS0850, 01GS0851, 01GS0852, 01GS0868, 01GS0869, 01GS0853, 01GS0854]; European Union (German Mouse Clinic) [EUMODIC LSHG-2006037188]	Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); European Union (German Mouse Clinic)(European Commission)	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) Nationales Genomforschungsnetz (NGFN-Plus) Grants 01GS0850, 01GS0851, 01GS0852, 01GS0868, 01GS0869, 01GS0853, and 01GS0854) and by European Union Grant EUMODIC LSHG-2006037188 (German Mouse Clinic).	Alessandrini F, 2001, INT ARCH ALLERGY IMM, V124, P25, DOI 10.1159/000053659; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Corteling Randolph, 2004, BMC Pharmacology, V4, P4, DOI 10.1186/1471-2210-4-4; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Ferkey DM, 2007, NEURON, V53, P39, DOI 10.1016/j.neuron.2006.11.015; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Heale BSE, 2009, CELL CYCLE, V8, P4011, DOI 10.4161/cc.8.24.10214; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Holt AG, 2005, J NEUROCHEM, V93, P1069, DOI 10.1111/j.1471-4159.2005.03090.x; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Kask K, 1998, P NATL ACAD SCI USA, V95, P13777, DOI 10.1073/pnas.95.23.13777; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas Stefan, 2006, RNA Biol, V3, P1; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Noguchi E, 2001, J ALLERGY CLIN IMMUN, V108, P382, DOI 10.1067/mai.2001.117456; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; SCHMAUSS C, 2002, SCI STKE, pPE26; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seymour Brian W P, 2002, Dev Immunol, V9, P47, DOI 10.1080/1044667021000003989; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Zaranek AW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000954	41	68	70	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18614	18622		10.1074/jbc.M110.200881	http://dx.doi.org/10.1074/jbc.M110.200881			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467037	hybrid, Green Published			2022-12-27	WOS:000290785700033
J	Shimizu, T; Tanaka, T; Iso, T; Matsui, H; Ooyama, Y; Kawai-Kowase, K; Arai, M; Kurabayashi, M				Shimizu, Takehisa; Tanaka, Toru; Iso, Tatsuya; Matsui, Hiroki; Ooyama, Yoshiaki; Kawai-Kowase, Keiko; Arai, Masashi; Kurabayashi, Masahiko			Notch Signaling Pathway Enhances Bone Morphogenetic Protein 2 (BMP2) Responsiveness of Msx2 Gene to Induce Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; ENDOTHELIAL-CELLS; STEM-CELLS; CALCIFICATION; EXPRESSION; TARGET; TRANSCRIPTION; ARTERIES; RUNX2; MICE	Vascular calcification is regulated in a process similar to bone formation. BMP2 (bone morphogenetic protein 2) is essential for osteoblastic differentiation of mesenchymal progenitor cells and thus has been implicated in the development of vascular calcification. Here we examined whether Notch signaling interacts with BMP2 signaling to regulate osteogenic differentiation and mineralization of vascular smooth muscle cells (SMCs). BMP2 alone scarcely induced the expression of alkaline phosphatase (ALP), an ectoenzyme crucially required for active biomineralization, in human aortic SMCs (HASMCs), despite its strong induction in osteoblast precursor MC3T3-E1 cells. Notably, overexpression of the Notch1 intracellular domain (N1-ICD) markedly enhanced BMP2-mediated induction of ALP activity and mineralization of HASMCs. In HASMCs, expression of Msx2 gene, a well documented BMP2 target gene in osteoblasts, was barely induced by BMP2 alone, and N1-ICD clearly enhanced the BMP2-driven Msx2 gene expression. Deletion and site-directed mutation analysis of Msx2 gene promoter revealed that the RBPJk-binding site was necessary for BMP2 responsiveness. Using the RBPJk-deficient cells and siRNA for RBPJk, we showed that RBPJk was required for BMP2 induction of Msx2 gene expression and ALP activity. Moreover, we showed that Smad1, a transcription factor downstream of BMP2 signaling, interacted with N1-ICD to form a complex within the Msx2 promoter. Immunohistochemistry of human calcifying atherosclerotic plaques revealed colocalized expression of Notch1, BMP2, and Msx2. These results indicate that the Notch intracellular domain.RBPJk complex enhances the BMP2-induced Msx2 gene expression by cooperating with Smad1 and suggest that Notch signaling makes vascular SMC responsive to BMP2 and promotes vascular calcification.	[Shimizu, Takehisa; Tanaka, Toru; Iso, Tatsuya; Matsui, Hiroki; Ooyama, Yoshiaki; Kawai-Kowase, Keiko; Arai, Masashi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma 3718511, Japan; [Iso, Tatsuya] Gunma Univ, Grad Sch Med, Educ & Res Ctr, Gunma 3718511, Japan	Gunma University; Gunma University	Kurabayashi, M (corresponding author), 3-39-15 Showa Machi, Gunma 3718511, Japan.	mkuraba@med.gunma-u.ac.jp	Matsui, Hiroki/P-4033-2019	Matsui, Hiroki/0000-0003-3243-333X; Iso, Tatsuya/0000-0001-5045-1676	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Research Promotion Society for Cardiovascular Disease; Grants-in-Aid for Scientific Research [23590661] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Promotion Society for Cardiovascular Disease; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. K.), a memorial research grant from the Japan Research Promotion Society for Cardiovascular Disease (to T. T.), and Initiatives for Attractive Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Marijanovic I, 2009, COLLEGIUM ANTROPOL, V33, P919; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shimizu T, 2009, ARTERIOSCL THROM VAS, V29, P1104, DOI 10.1161/ATVBAHA.109.187856; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	42	52	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19138	19148		10.1074/jbc.M110.175786	http://dx.doi.org/10.1074/jbc.M110.175786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471203	Green Published, hybrid			2022-12-27	WOS:000290785700083
J	Mavridou, DAI; Saridakis, E; Kritsiligkou, P; Goddard, AD; Stevens, JM; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Saridakis, Emmanuel; Kritsiligkou, Paraskevi; Goddard, Alan D.; Stevens, Julie M.; Ferguson, Stuart J.; Redfield, Christina			Oxidation State-dependent Protein-Protein Interactions in Disulfide Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C MATURATION; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BOND FORMATION; ACTIVE-SITE; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; DSBD; ISOMERASE	Bacterial growth and pathogenicity depend on the correct formation of disulfide bonds, a process controlled by the Dsb system in the periplasm of Gram-negative bacteria. Proteins with a thioredoxin fold play a central role in this process. A general feature of thiol-disulfide exchange reactions is the need to avoid a long lived product complex between protein partners. We use a multidisciplinary approach, involving NMR, x-ray crystallography, surface plasmon resonance, mutagenesis, and in vivo experiments, to investigate the interaction between the two soluble domains of the transmembrane reductant conductor DsbD. Our results show oxidation state-dependent affinities between these two domains. These observations have implications for the interactions of the ubiquitous thioredoxin-like proteins with their substrates, provide insight into the key role played by a unique redox partner with an immunoglobulin fold, and are of general importance for oxidative protein-folding pathways in all organisms.	[Mavridou, Despoina A. I.; Kritsiligkou, Paraskevi; Goddard, Alan D.; Stevens, Julie M.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Saridakis, Emmanuel] Natl Ctr Sci Res Demokritos, Inst Phys Chem, GR-15310 Athens, Greece	University of Oxford; National Centre of Scientific Research "Demokritos"	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Kritsiligkou, Paraskevi/W-9399-2019; Goddard, Alan/E-9328-2013; Mavridou, Despoina/ABG-5940-2020	Kritsiligkou, Paraskevi/0000-0003-2452-141X; Mavridou, Despoina/0000-0002-7449-1151; Goddard, Alan/0000-0003-4950-7470; Redfield, Christina/0000-0001-7297-7708	Wellcome Trust [079440, 092532]; Value-in-People Award; Edward Penley Abraham Cephalosporin Fund; EMBL Hamburg [RII3-CT-2004-506008]; Biotechnology and Biological Sciences Research Council [BBE004865/1, BBD523019/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Edward Penley Abraham Cephalosporin Fund; EMBL Hamburg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Wellcome Trust Grants 079440 and 092532 and a Value-in-People Award.; Supported by the Edward Penley Abraham Cephalosporin Fund.; Supported by EMBL Hamburg (Research Infrastructure Action under the "Structuring the European Research Area Programme" RII3-CT-2004-506008).; Supported by Biotechnology and Biological Sciences Research Council Grants BBE004865/1 and BBD523019/1.	Ausubel FM, 1988, MOL REPROD DEV; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; COLE JA, 1974, J GEN MICROBIOL, V85, P11, DOI 10.1099/00221287-85-1-11; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2009, J BIOL CHEM, V284, P3219, DOI 10.1074/jbc.M805963200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Pan JL, 2008, J MOL BIOL, V377, P1433, DOI 10.1016/j.jmb.2008.01.058; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; POPE NR, 1982, J GEN MICROBIOL, V128, P219; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P8577, DOI 10.1021/bi800884w; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Rozhkova A, 2008, J MOL BIOL, V380, P783, DOI 10.1016/j.jmb.2008.05.050; Rozhkova A, 2007, J MOL BIOL, V367, P1162, DOI 10.1016/j.jmb.2006.12.033; Stevens JM, 2004, FEBS LETT, V576, P81, DOI 10.1016/j.febslet.2004.08.067; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vlamis-Gardikas A, 2008, BBA-GEN SUBJECTS, V1780, P1170, DOI 10.1016/j.bbagen.2008.03.013	56	19	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24943	24956		10.1074/jbc.M111.236141	http://dx.doi.org/10.1074/jbc.M111.236141			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543317	Green Published, hybrid			2022-12-27	WOS:000292547900043
J	Egger, S; Chaikuad, A; Kavanagh, KL; Oppermann, U; Nidetzky, B				Egger, Sigrid; Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo; Nidetzky, Bernd			Structure and Mechanism of Human UDP-glucose 6-Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE REVEALS; CATALYTIC MECHANISM; HYALURONAN; CANCER; INHIBITION; BREAST; DINUCLEOTIDE; RESIDUES; BINDING; DESIGN	Elevated production of the matrix glycosaminoglycan hyaluronan is strongly implicated in epithelial tumor progression. Inhibition of synthesis of the hyaluronan precursor UDP-glucuronic acid (UDP-GlcUA) therefore presents an emerging target for cancer therapy. Human UDP-glucose 6-dehydrogenase (hUGDH) catalyzes, in two NAD(+)-dependent steps without release of intermediate aldehyde, the biosynthetic oxidation of UDP-glucose (UDP-Glc) to UDP-GlcUA. Here, we present a structural characterization of the hUGDH reaction coordinate using crystal structures of the apoenzyme and ternary complexes of the enzyme bound with UDP-Glc/NADH and UDP-GlcUA/NAD(+). The quaternary structure of hUGDH is a disc-shaped trimer of homodimers whose subunits consist of two discrete alpha/beta domains with the active site located in the interdomain cleft. Ternary complex formation is accompanied by rigid-body and restrained movement of the N-terminal NAD(+) binding domain, sequestering substrate and coenzyme in their reactive positions through interdomain closure. By alternating between conformations in and out of the active site during domain motion, Tyr(14), Glu(161), and Glu(165) participate in control of coenzyme binding and release during 2-fold oxidation. The proposed mechanism of hUGDH involves formation and breakdown of thiohemiacetal and thioester intermediates whereby Cys(276) functions as the catalytic nucleophile. Stopped-flow kinetic data capture the essential deprotonation of Cys(276) in the course of the first oxidation step, allowing the thiolate side chain to act as a trap of the incipient aldehyde. Because thiohemiacetal intermediate accumulates at steady state under physiological reaction conditions, hUGDH inhibition might best explore ligand binding to the NAD(+) binding domain.	[Egger, Sigrid; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England	Graz University of Technology; University of Oxford; University of Oxford	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Chaikuad, Apirat/0000-0003-1120-2209; Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund DK Molecular Enzymology [W901-B05]; Wellcome Trust [1097737]; GlaxoSmithKline [1097737]; Genome Canada [1097737]; Canadian Institutes of Health Research [1097737]; Ontario Innovation Trust [1097737]; Ontario Research and Development Challenge Fund [1097737]; Canadian Foundation for Innovation [1097737]; Vinnova [1097737]; Swedish Strategic Research Foundation [1097737]; Knut and Alice Wallenberg Foundation [1097737]; Karolinska Institutet [1097737]; NIHR Oxford Biomedical Research Unit; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund DK Molecular Enzymology(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Research and Development Challenge Fund(General Electric); Canadian Foundation for Innovation(Canada Foundation for Innovation); Vinnova(Vinnova); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); NIHR Oxford Biomedical Research Unit; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund DK Molecular Enzymology W901-B05 and the Structural Genomics Consortium registered charity (number 1097737) funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Research and Development Challenge Fund, the Canadian Foundation for Innovation, Vinnova, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, and the Karolinska Institutet. This work was additionally supported by the NIHR Oxford Biomedical Research Unit.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CAMPBELL RE, 1997, ANGEW CHEM INT EDIT, V36, P3; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1981, TRENDS BIOCHEM SCI, V6, P103, DOI 10.1016/0968-0004(81)90038-4; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Ge X, 2008, J MED CHEM, V51, P4571, DOI 10.1021/jm8002284; Graham CE, 2006, BIOCHEM J, V394, P67, DOI 10.1042/BJ20050918; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Huang DL, 2010, INT J CANCER, V126, P315, DOI 10.1002/ijc.24820; Huh JW, 2007, J BIOCHEM MOL BIOL, V40, P690; Huh JW, 2005, BIOTECHNOL LETT, V27, P1229, DOI 10.1007/s10529-005-0022-z; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; Lee HS, 2009, ARCH BIOCHEM BIOPHYS, V486, P35, DOI 10.1016/j.abb.2009.03.017; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Pival SL, 2009, BIOCHEM J, V421, P43, DOI 10.1042/BJ20090128; SCHILLER JG, 1972, CARBOHYD RES, V21, P249, DOI 10.1016/S0008-6215(00)82151-5; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Singh R, 2009, METHODS MOL BIOL, V575, P93, DOI 10.1007/978-1-60761-274-2_4; Slomiany MG, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P19, DOI 10.1016/B978-012374178-3.10002-X; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vander Jagt DL, 2000, CURR MED CHEM, V7, P479, DOI 10.2174/0929867003375119; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Wei Q, 2009, CANCER RES, V69, P2332, DOI 10.1158/0008-5472.CAN-08-3083; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	49	48	50	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23877	23887		10.1074/jbc.M111.234682	http://dx.doi.org/10.1074/jbc.M111.234682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21502315	Green Published, hybrid			2022-12-27	WOS:000292294900030
J	Wu, SF; Zang, WJ; Li, X; Sun, HZ				Wu, Shufang; Zang, Weijin; Li, Xu; Sun, Hongzhi			RETRACTED: Proepithelin Stimulates Growth Plate Chondrogenesis via Nuclear Factor-kappa B-p65-dependent Mechanisms (Retracted article. See vol. 295, pg. 8874, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							GRANULIN-EPITHELIN PRECURSOR; NF-KAPPA-B; LONGITUDINAL BONE-GROWTH; FACTOR-I; SIGNALING PATHWAYS; ACTIVATION; PROLIFERATION; PROGRANULIN; CELLS; DIFFERENTIATION	Proepithelin, a previously unrecognized growth factor in cartilage, has recently emerged as an important regulator for cartilage formation and function. In the present study, we provide several lines of evidences in proepithelin-mediated induction of cell proliferation, differentiation, and apoptosis in the metatarsal growth plate. Proepithelin-mediated stimulation of metatarsal growth and growth plate chondrogenesis was neutralized by pyrrolidine dithiocarbamate, a known NF-kappa B inhibitor. In rat growth plate chondrocytes, proepithelin induced NF-kappa B-p65 nuclear translocation, and nuclear NF-kappa B-p65 initiated its target gene cyclin D1 to regulate chondrocyte functions. The inhibition of NF-kappa B-p65 expression and activity (by p65 short interfering RNA (siRNA) and pyrrolidine dithiocarbamate, respectively) in chondrocytes reversed the proepithelin-mediated induction of cell proliferation and differentiation and the proepithelin-mediated prevention of cell apoptosis. Moreover, the inhibition of the phosphatidylinositol 3-kinase and Akt abolished the effects of proepithelin on NF-kappa B activation. Finally, using siRNA and antisense strategies, we demonstrated that endogenously produced proepithelin by chondrocytes is important for chondrocyte growth in serum-deprived conditions. These results support the hypothesis that the induction of NF-kappa B activity of in growth plate chondrocytes is critical in proepithelin-mediated growth plate chondrogenesis and longitudinal bone growth.	[Wu, Shufang; Zang, Weijin; Li, Xu; Sun, Hongzhi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Environm & Genes Related Dis, Minist Educ,Med Sch, Xian 710061, Peoples R China	Xi'an Jiaotong University	Wu, SF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Environm & Genes Related Dis, Minist Educ,Med Sch, Xian 710061, Peoples R China.	shufangw@hotmail.com; sunhongzhi@mail.xjtu.edu.cn			National Natural Science Foundation of China [30930105, 30971392, 81071440/H0601]; National Basic Research Program of China (973 Program) [2007CB512005]; Ministry of Education, China [NCET-08-0435]; Xi'an Jiaotong University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Education, China(Ministry of Education, China); Xi'an Jiaotong University, China(Xi'an Jiaotong University)	This work was supported by grants from the National Natural Science Foundation of China (Key Program Grant 30930105, General Program Grant 30971392, and General Program Grant 81071440/H0601), the National Basic Research Program of China (973 Program, Grant 2007CB512005). This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China (Grant NCET-08-0435) and the "Tengfei" Supporting Program of Xi'an Jiaotong University, China.	Abbaspour A, 2008, BONE, V42, P98, DOI 10.1016/j.bone.2007.08.031; AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baixeras E, 2001, ENDOCRINOLOGY, V142, P2968, DOI 10.1210/en.142.7.2968; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Ciarmatori S, 2007, J MOL ENDOCRINOL, V38, P493, DOI 10.1677/jme.1.02179; Davis L, 2006, BIOCHEM BIOPH RES CO, V342, P259, DOI 10.1016/j.bbrc.2006.01.132; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Gottifredi V, 1999, J VIROL, V73, P1427, DOI 10.1128/JVI.73.2.1427-1437.1999; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; Wang WG, 2006, CLIN CANCER RES, V12, P49, DOI 10.1158/1078-0432.CCR-05-0929; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Wu SF, 2004, FASEB J, V18, P143, DOI 10.1096/fj.03-0294fje; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Wu SF, 2006, ENDOCRINOLOGY, V147, P3761, DOI 10.1210/en.2005-1672; Wu SF, 2009, CELL CYCLE, V8, P3218, DOI 10.4161/cc.8.19.9759; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Zanocco-Marani T, 1999, CANCER RES, V59, P5331	38	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24057	24067		10.1074/jbc.M110.201368	http://dx.doi.org/10.1074/jbc.M110.201368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566130	Green Published, hybrid			2022-12-27	WOS:000292294900048
J	Chang, N; Liang, T; Lin, XG; Kang, YH; Xie, HL; Feng, ZP; Gaisano, HY				Chang, Nathan; Liang, Tao; Lin, Xianguang; Kang, Youhou; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.			Syntaxin-1A Interacts with Distinct Domains within Nucleotide-binding Folds of Sulfonylurea Receptor 1 to Inhibit beta-Cell ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; K+ CHANNELS; SUR1; COMPLEX; GLIBENCLAMIDE; PROTEINS; SUBUNIT; FUSION; MGADP	The ATP-sensitive potassium (K-ATP) channel regulates pancreatic beta-cell function by linking metabolic status to electrical activity. Syntaxin-1A (Syn-1A), a SNARE protein mediating exocytotic fusion, binds and inhibits the K-ATP channel via the nucleotide-binding folds (NBFs) of its sulfonylurea receptor-1 (SUR1) regulatory subunit. In this study, we elucidated the precise regions within the NBFs required for Syn-1A-mediated K-ATP inhibition, using in vitro binding assays, whole cell patch clamp and FRET assay. Specifically, NBF1 and NBF2 were each divided into three subregions, Walker A (W-A), signature sequence linker, and Walker B (W-B), to make GST fusion proteins. In vitro binding assays revealed that Syn-1A associates with W-A and W-B regions of both NBFs. Patch clamp recordings on INS-1 and primary rat beta-cells showed that Syn-1A-mediated channel inhibition was reversed by co-addition of NBF1-W-B (not NBF1-W-A), NBF2-W-A, and NBF2-W-B. The findings were corroborated by FRET studies showing that these truncates disrupted Syn-1A interactions with full-length SUR1. To further identify the binding sites, series single-site mutations were made in the Walker motifs of the NBFs. Only NBF1-W-A (K719M) or NBF2-W-A (K1385M) mutant no longer bound to Syn-1A; K1385M failed to disrupt Syn-1A-mediated inhibition of K-ATP channels. These data suggest that NBF1-W-A (Lys-719) and NBF2-W-A (Lys-1385) are critical for Syn-1A-K-ATP channel interaction. Taken together, Syn-1A intimately and functionally associates with the SUR1-NBF1/2 dimer via direct interactions with W-A motifs and sites adjacent to W-B motifs of NBF1 and NBF2 but transduces its inhibitory actions on K-ATP channel activity via some but not all of these NBF domains.	[Chang, Nathan; Liang, Tao; Lin, Xianguang; Kang, Youhou; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Hlth Network, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gaisano, HY (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 69083]; Heart and Stroke Foundation of Ontario [T-6064]; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes for Health Research Grant MOP 69083 and Heart and Stroke Foundation of Ontario Grant T-6064 (to H. Y. G.).; Recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada.	Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashford M L, 1986, Adv Exp Med Biol, V211, P69; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kang YH, 2011, J BIOL CHEM, V286, P5876, DOI 10.1074/jbc.M109.089607; Lang Thorsten, 2008, V184, P107; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Michaelevski L, 2002, J BIOL CHEM, V277, P34909, DOI 10.1074/jbc.M203943200; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NIKI I, 1990, BIOCHEM J, V268, P713, DOI 10.1042/bj2680713; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313	33	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23308	23318		10.1074/jbc.M111.217950	http://dx.doi.org/10.1074/jbc.M111.217950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540180	Green Published, hybrid			2022-12-27	WOS:000292025000063
J	Huang, W; Bansode, RR; Xie, Y; Rowland, L; Mehta, M; Davidson, NO; Mehta, KD				Huang, Wei; Bansode, Rishipal R.; Xie, Yan; Rowland, Leslie; Mehta, Madhu; Davidson, Nicholas O.; Mehta, Kamal D.			Disruption of the Murine Protein Kinase C beta Gene Promotes Gallstone Formation and Alters Biliary Lipid and Hepatic Cholesterol Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY RAT HEPATOCYTES; X RECEPTOR-ALPHA; 7-ALPHA-HYDROXYLASE GENE; BILE-ACIDS; DIETARY FATS; CELL DIFFERENTIATION; GALLBLADDER MOTILITY; INSULIN-RECEPTOR; WEIGHT-LOSS; PKC-BETA	The protein kinase C (PKC) family of Ca2+ and/or lipid-activated serine-threonine protein kinases is implicated in the pathogenesis of obesity and insulin resistance. We recently reported that protein kinase C beta(PKC beta), a calcium-, diacylglycerol-, and phospholipid-dependent kinase, is critical for maintaining whole body triglyceride homeostasis. We now report that PKC beta deficiency has profound effects on murine hepatic cholesterol metabolism, including hypersensitivity to diet-induced gallstone formation. The incidence of gallstones increased from 9% in control mice to 95% in PKC beta(-/-) mice. Gallstone formation in the mutant mice was accompanied by hyposecretion of bile acids with no alteration in fecal bile acid excretion, increased biliary cholesterol saturation and hydrophobicity indices, as well as hepatic p42/44(MAPK) activation, all of which enhance susceptibility to gallstone formation. Lithogenic diet-fed PKC beta(-/-) mice also displayed decreased expression of hepatic cholesterol-7 alpha-hydroxylase (CYP7A1) and sterol 12 alpha-hydroxylase (CYP8b1). Finally, feeding a modified lithogenic diet supplemented with milk fat, instead of cocoa butter, both increased the severity of and shortened the interval for gallstone formation in PKC beta(-/-) mice and was associated with dramatic increases in cholesterol saturation and hydrophobicity indices. Taken together, the findings reveal a hitherto unrecognized role of PKC beta in fine tuning diet-induced cholesterol and bile acid homeostasis, thus identifying PKC beta as a major physiological regulator of both triglyceride and cholesterol homeostasis.	[Huang, Wei; Bansode, Rishipal R.; Rowland, Leslie; Mehta, Kamal D.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Mehta, Madhu] Ohio State Univ, Coll Med, Dept Med, Columbus, OH 43210 USA; [Xie, Yan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL)	Mehta, KD (corresponding author), Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, 464 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Mehta.80@osu.edu	Huang, Wei/E-3270-2011; Bansode, Rishipal/E-9293-2010	Bansode, Rishipal/0000-0001-7826-2711	National Institutes of Health [HL79091, DK56260, HL-38180, DK52574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180, R01HL038180, R01HL079091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL79091 (to K. D. M.) and DK56260, HL-38180, and DK52574 (to N. O. D.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Amigo L, 2000, GASTROENTEROLOGY, V118, P772, DOI 10.1016/S0016-5085(00)70147-8; Bansode RR, 2008, J BIOL CHEM, V283, P231, DOI 10.1074/jbc.M707268200; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Blanquart C, 2004, MOL ENDOCRINOL, V18, P1906, DOI 10.1210/me.2003-0327; Bouchard G, 2002, J LIPID RES, V43, P1105, DOI 10.1194/jlr.M200102-JLR200; BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG300, DOI 10.1152/ajpgi.1995.268.2.G300; CAREY MC, 1978, J LIPID RES, V19, P945; Cheema SK, 1997, J LIPID RES, V38, P315; Couture P, 1999, J LIPID RES, V40, P1883; Crestani M, 1998, J LIPID RES, V39, P2192; Davis RA, 2002, J LIPID RES, V43, P533; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P1619; DUAN RD, 1995, AM J PHYSIOL-GASTR L, V268, pG1060, DOI 10.1152/ajpgi.1995.268.6.G1060; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; EVERHART JE, 1993, ANN INTERN MED, V119, P1029, DOI 10.7326/0003-4819-119-10-199311150-00010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gbaguidi GF, 2004, NUCLEIC ACIDS RES, V32, P1113, DOI 10.1093/nar/gkh260; Gineste R, 2008, MOL ENDOCRINOL, V22, P2433, DOI 10.1210/me.2008-0092; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Graewin SJ, 2004, J GASTROINTEST SURG, V8, P824, DOI 10.1016/j.gassur.2004.06.014; Graewin SJ, 2004, SURGERY, V136, P431, DOI 10.1016/j.surg.2004.05.020; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Hyogo H, 2003, J LIPID RES, V44, P1232, DOI 10.1194/jlr.M300029-JLR200; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Ishizuka T, 2004, ENDOCR RES, V30, P287, DOI 10.1081/ERC-120039580; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; JONNALAGADDA SS, 1995, LIPIDS, V30, P415, DOI 10.1007/BF02536299; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kano M, 2002, J LAB CLIN MED, V139, P285, DOI 10.1067/mlc.2002.122863; Kuroki T, 2000, MUTAT RES-REV MUTAT, V462, P189, DOI 10.1016/S1383-5742(00)00036-3; Lammert F, 2001, GASTROENTEROLOGY, V120, P221, DOI 10.1053/gast.2001.20878; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li Y, 2005, LIPIDS, V40, P455, DOI 10.1007/s11745-005-1404-2; Lyons MA, 2005, MAMM GENOME, V16, P152, DOI 10.1007/s00335-004-2446-5; Lyons MA, 2006, GASTROENTEROLOGY, V131, P1943, DOI 10.1053/j.gastro.2006.10.024; Marrapodi M, 2000, J LIPID RES, V41, P514; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mendez-Sanchez N, 2003, FRONT BIOSCI-LANDMRK, V8, pE420, DOI 10.2741/1110; Mendez-Sanchez N, 2007, CLIN CHIM ACTA, V376, P1, DOI 10.1016/j.cca.2006.08.036; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Miyake JH, 2002, ARTERIOSCL THROM VAS, V22, P121, DOI 10.1161/hq0102.102588; Miyasaka K, 2002, J GASTROENTEROL, V37, P102, DOI 10.1007/BF03326426; Mizuguchi K., 1997, NIPPON YAKURIGAKU ZA, V110, p50P; NISHINA PM, 1993, J LIPID RES, V34, P1413; NISHINA PM, 1990, J LIPID RES, V31, P859; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Ohshima A, 1996, LIPIDS, V31, P949, DOI 10.1007/BF02522688; Ortega RM, 1997, J AM COLL NUTR, V16, P88, DOI 10.1080/07315724.1997.10718655; Osterhoff MA, 2008, MOL GENET METAB, V93, P210, DOI 10.1016/j.ymgme.2007.09.004; Paigen B., 2002, GENETIC BASIS COMMON, P298; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Rask-Madsen C, 2005, ARTERIOSCL THROM VAS, V25, P487, DOI 10.1161/01.ATV.0000155325.41507.e0; RINCHIK EM, 1992, MAMM GENOME, V3, pS104, DOI 10.1007/BF00648425; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; STRAVITZ RT, 1995, J LIPID RES, V36, P1359; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; TANG EY, 1993, FEBS LETT, V326, P117, DOI 10.1016/0014-5793(93)81774-T; Tran KQ, 2003, J SURG RES, V113, P56, DOI 10.1016/S0022-4804(03)00157-4; TURLEY SD, 1978, J LIPID RES, V19, P924; Wang David Q-H, 2004, Curr Gastroenterol Rep, V6, P140, DOI 10.1007/s11894-004-0042-1; Wang DQH, 2009, J LIPID RES, V50, pS406, DOI 10.1194/jlr.R800075-JLR200; Wang SN, 2006, EUR J CLIN INVEST, V36, P176, DOI 10.1111/j.1365-2362.2006.01611.x; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; Xie Y, 2009, J BIOL CHEM, V284, P16860, DOI 10.1074/jbc.M109.010173; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Yamamoto T, 2010, J LIPID RES, V51, P1859, DOI 10.1194/jlr.M004234; Yan SF, 2006, J AM COLL CARDIOL, V48, pA47, DOI 10.1016/j.jacc.2006.05.063; YANG HY, 1992, DIGEST DIS SCI, V37, P912, DOI 10.1007/BF01300390; Zhu J, 2005, WORLD J GASTROENTERO, V11, P1685	86	12	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22795	22805		10.1074/jbc.M111.250282	http://dx.doi.org/10.1074/jbc.M111.250282			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550971	Green Published, hybrid			2022-12-27	WOS:000292025000014
J	Panter, G; Jerala, R				Panter, Gabriela; Jerala, Roman			The Ectodomain of the Toll-like Receptor 4 Prevents Constitutive Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; LPS BINDING-PROTEIN; LIPOPOLYSACCHARIDE LPS; NEUTROPHIL ELASTASE; SIGNAL-TRANSDUCTION; ADAPTIVE IMMUNITY; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; DENDRITIC CELLS; INNATE IMMUNITY	Toll-like receptor 4 (TLR4) is involved in activation of the innate immune response in a large number of different diseases. Despite numerous studies, the role of separate domains of TLR4 in the regulation of receptor activation is poorly understood. Replacement of the TLR4 ectodomain with LPS-binding proteins MD-2 or CD14 resulted in a robust ligand-independent constitutive activation comparable with the maximal stimulation of the receptor with LPS. The same effect was achieved by the replacement of the ectodomain with a monomeric fluorescent protein or a 24-kDa gyrase B fragment. This demonstrates an intrinsic dimerization propensity of the transmembrane and cytoplasmic domains of TLR4 and reveals a previously unknown function of the ectodomain in inhibiting spontaneous receptor dimerization. Constitutive activation was abolished by the replacement of the ectodomain by a bulkier protein ovalbumin. N-terminal deletion variants of TLR4 revealed that the smallest segment of the ectodomain that already prevents constitutive activity comprises only 90 residues (542 to 631) of the total 608 residues. We conclude that TLR4 represents a receptor with a low threshold of activation that can be rapidly activated by the release of inhibition exerted by its ectodomain. This is important for the sensitivity of TLR4 to activation by different agonists. The TLR4 ectodomain has multiple roles in enabling ligand regulated activation, providing proper localization while serving as an inhibitor to prevent spontaneous, ligand-independent dimerization.	[Panter, Gabriela; Jerala, Roman] Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Ljubljana 1000, Slovenia; [Panter, Gabriela; Jerala, Roman] Univ Ljubljana, Excellent NMR Future Innovat Sustainable Technol, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; University of Ljubljana	Jerala, R (corresponding author), Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si			Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Slovenian Research Agency.	Akashi-Takamura Sachiko, 2006, Journal of Infection and Chemotherapy, V12, P233, DOI 10.1007/s10156-006-0477-4; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Bulut Y, 2009, INFECT IMMUN, V77, P2683, DOI 10.1128/IAI.00248-09; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Farrar MA, 2000, METHOD ENZYMOL, V327, P421, DOI 10.1016/S0076-6879(00)27293-5; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; Gay Nicholas J., 2008, V183, P181; GILBERT EJ, 1994, MOL MICROBIOL, V12, P365, DOI 10.1111/j.1365-2958.1994.tb01026.x; Gomi K, 2002, J IMMUNOL, V168, P2939, DOI 10.4049/jimmunol.168.6.2939; Hasan UA, 2004, BIOCHEM BIOPH RES CO, V321, P124, DOI 10.1016/j.bbrc.2004.06.134; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Koskinen R, 1999, J IMMUNOL, V162, P4115; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Treeby M, 2009, BIOCHEM BIOPH RES CO, V381, P65, DOI 10.1016/j.bbrc.2009.02.017; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Veerman C, 2003, INT J BIOL MACROMOL, V33, P121, DOI 10.1016/S0141-8130(03)00076-X; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	67	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23334	23344		10.1074/jbc.M110.205419	http://dx.doi.org/10.1074/jbc.M110.205419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543336	Green Published, hybrid			2022-12-27	WOS:000292025000065
J	Susan-Resiga, D; Essalmani, R; Hamelin, J; Asselin, MC; Benjannet, S; Chamberland, A; Day, R; Szumska, D; Constam, D; Bhattacharya, S; Prat, A; Seidah, NG				Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Benjannet, Suzanne; Chamberland, Ann; Day, Robert; Szumska, Dorota; Constam, Daniel; Bhattacharya, Shoumo; Prat, Annik; Seidah, Nabil G.			Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE FURIN; CELL-SURFACE; IN-VITRO; PROTEOLYTIC ACTIVATION; PROHORMONE CONVERTASES; PRO-PROTEIN; INHIBITORS; EXPRESSION; IDENTIFICATION; PRECURSOR	Bone morphogenetic protein 10 (BMP10) is a member of the TGF-beta superfamily and plays a critical role in heart development. In the postnatal heart, BMP10 is restricted to the right atrium. The inactive pro-BMP10 (similar to 60 kDa) is processed into active BMP10 (similar to 14 kDa) by an unknown protease. Proteolytic cleavage occurs at the RIRR316 down arrow site (human), suggesting the involvement of proprotein convertase(s) (PCs). In vitro digestion of a 12-mer peptide encompassing the predicted cleavage site with furin, PACE4, PC5/6, and PC7, showed that furin cleaves the best, whereas PC7 is inactive on this peptide. Ex vivo studies in COS-1 cells, a cell line lacking PC5/6, revealed efficient processing of pro-BMP10 by endogenous PCs other than PC5/6. The lack of processing of overexpressed pro-BMP10 in the furin-and PACE4-deficient cell line, CHO-FD11, and in furin-deficient LoVo cells, was restored by stable (CHO-FD11/Fur cells) or transient (LoVo cells) expression of furin. Use of cell-permeable and cell surface inhibitors suggested that endogenous PCs process pro-BMP10 mostly intracellularly, but also at the cell surface. Ex vivo experiments in mouse primary hepatocytes (wild type, PC5/6 knock-out, and furin knock-out) corroborated the above findings that pro-BMP10 is a substrate for endogenous furin. Western blot analyses of heart right atria extracts from wild type and PACE4 knock-out adult mice showed no significant difference in the processing of pro-BMP10, implying no in vivo role of PACE4. Overall, our in vitro, ex vivo, and in vivo data suggest that furin is the major convertase responsible for the generation of BMP10.	[Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Benjannet, Suzanne; Chamberland, Ann; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Constam, Daniel] Swiss Inst Expt Canc Res, Sch Life Sci, Swiss Fed Inst Technol Lausanne, CH-1015 Lausanne, Switzerland	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Sherbrooke; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Seidah, NG (corresponding author), 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Seidah, Nabil/I-3596-2013; Bhattacharya, Shoumo/F-4127-2010	Prat, Annik/0000-0002-8007-5277; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Seidah, Nabil/0000-0001-6503-9342; Bhattacharya, Shoumo/0000-0002-5571-0478; Szumska, Dorota/0000-0001-7764-9551; Constam, Daniel B./0000-0002-6256-3891	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]; British Heart Foundation [CH/09/003]; Wellcome Trust [075491/Z/04];  [PG/08/045/25069]; British Heart Foundation [RG/10/17/28553, PG/07/045/22690] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ; British Heart Foundation(British Heart Foundation)	This work was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, Canada Chair Grant 216684, British Heart Foundation Chair Award CH/09/003 (to S. Bhattacharya) and Project Grant Award PG/08/045/25069 (to S. B.), and Wellcome Trust Core Grant Award 075491/Z/04.	Bessa PC, 2009, PROTEIN EXPRES PURIF, V63, P89, DOI 10.1016/j.pep.2008.09.014; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Constam DB, 2000, DEVELOPMENT, V127, P245; Constam DB, 2000, GENE DEV, V14, P1146; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gordon VM, 1997, INFECT IMMUN, V65, P3370, DOI 10.1128/IAI.65.8.3370-3375.1997; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	46	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22785	22794		10.1074/jbc.M111.233577	http://dx.doi.org/10.1074/jbc.M111.233577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550985	hybrid, Green Published			2022-12-27	WOS:000292025000013
J	Zotti, T; Uva, A; Ferravante, A; Vessichelli, M; Scudiero, I; Ceccarelli, M; Vito, P; Stilo, R				Zotti, Tiziana; Uva, Antonio; Ferravante, Angela; Vessichelli, Mariangela; Scudiero, Ivan; Ceccarelli, Michele; Vito, Pasquale; Stilo, Romania			TRAF7 Protein Promotes Lys-29-linked Polyubiquitination of I kappa B Kinase (IKK gamma)/NF-kappa B Essential Modulator (NEMO) and p65/RelA Protein and Represses NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; DEGRADATION; TERMINATION; APOPTOSIS; PATHWAY; TARGET; CHAINS; CELLS; A20; UBIQUITINATION	Tumor necrosis factor receptor-associated factor (TRAF) proteins are cytoplasmic regulatory molecules that function as signal transducers for receptors involved in both innate and adaptive humoral immune responses. In this study, we show that TRAF7, the unique noncanonical member of the TRAF family, physically associates with I kappa B kinase/NF-kappa B essential modulator (NEMO) and with the RelA/p65 (p65) member of the NF-kappa B transcription factor family. TRAF7 promotes Lys-29-linked polyubiquitination of NEMO and p65 that results in lysosomal degradation of both proteins and altered activation. TRAF7 also influences p65 nuclear distribution. Microarray expression data are consistent with an inhibitory role for TRAF7 on NF-kappa B and a positive control of AP-1 transcription factor. Finally, functional data indicate that TRAF7 promotes cell death. Thus, this study identifies TRAF7 as a NEMO- and p65-interacting molecule and brings important information on the ubiquitination events that control NF-kappa B transcriptional activity.	[Vito, Pasquale] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; BioGeM Consortium, I-83031 Ariano Irpino, Italy	University of Sannio	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Via PortArsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Ceccarelli, Michele/AGP-1739-2022	Zotti, Tiziana/0000-0003-4753-116X; ferravante, angela/0000-0002-4932-3877; Ceccarelli, Michele/0000-0002-4702-6617; vito, pasquale/0000-0002-5721-7716; scudiero, ivan/0000-0001-5559-5548				Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cazals V, 1999, BBA-MOL CELL RES, V1448, P349, DOI 10.1016/S0167-4889(98)00095-0; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hampson L, 2001, Hematol J, V2, P150, DOI 10.1038/sj.thj.6200102; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lang CH, 1999, AM J PHYSIOL-GASTR L, V276, pG719, DOI 10.1152/ajpgi.1999.276.3.G719; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tsikitis M, 2010, EMBO REP, V11, P969, DOI 10.1038/embor.2010.154; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	35	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22924	22933		10.1074/jbc.M110.215426	http://dx.doi.org/10.1074/jbc.M110.215426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518757	hybrid, Green Published			2022-12-27	WOS:000292025000027
J	Chiou, TT; Bonhomme, B; Jin, HB; Miralles, CP; Xiao, HY; Fu, ZY; Harvey, RJ; Harvey, K; Vicini, S; De Blas, AL				Chiou, Tzu-Ting; Bonhomme, Bevan; Jin, Hongbing; Miralles, Celia P.; Xiao, Haiyan; Fu, Zhanyan; Harvey, Robert J.; Harvey, Kirsten; Vicini, Stefano; De Blas, Angel L.			Differential Regulation of the Postsynaptic Clustering of gamma-Aminobutyric Acid Type A (GABA(A)) Receptors by Collybistin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; INHIBITORY SYNAPSE FORMATION; GABAERGIC SYNAPSES; RAT-BRAIN; EXCHANGE FACTOR; IMMUNOCYTOCHEMICAL LOCALIZATION; NONSYNAPTIC LOCALIZATION; GLUTAMATERGIC SYNAPSES; MONOCLONAL-ANTIBODIES; GLYCINE RECEPTOR	Collybistin promotes submembrane clustering of gephyrin and is essential for the postsynaptic localization of gephyrin and gamma-aminobutyric acid type A (GABA(A)) receptors at GABAergic synapses in hippocampus and amygdala. Four collybistin isoforms are expressed in brain neurons; CB2 and CB3 differ in the C terminus and occur with and without the Src homology 3 (SH3) domain. We have found that in transfected hippocampal neurons, all collybistin isoforms (CB2(SH3+), CB2(SH3-), CB3(SH3+), and CB3(SH3-)) target to and concentrate at GABAergic postsynapses. Moreover, in non-transfected neurons, collybistin concentrates at GABAergic synapses. Hippocampal neurons co-transfected with CB2(SH3-) and gephyrin developed very large postsynaptic gephyrin and GABA(A) receptor clusters (superclusters). This effect was accompanied by a significant increase in the amplitude of miniature inhibitory postsynaptic currents. Co-transfection with CB2(SH3+) and gephyrin induced the formation of many (supernumerary) non-synaptic clusters. Transfection with gephyrin alone did not affect cluster number or size, but gephyrin potentiated the clustering effect of CB2(SH3-) or CB2(SH3+). Co-transfection with CB2(SH3-) or CB2(SH3+) and gephyrin did not affect the density of presynaptic GABAergic terminals contacting the transfected cells, indicating that collybistin is not synaptogenic. Nevertheless, the synaptic superclusters induced by CB2(SH3-) and gephyrin were accompanied by enlarged presynaptic GABAergic terminals. The enhanced clustering of gephyrin and GABA(A) receptors induced by collybistin isoforms was not accompanied by enhanced clustering of neuroligin 2. Moreover, during the development of GABAergic synapses, the clustering of gephyrin and GABA(A) receptors preceded the clustering of neuroligin 2. We propose a model in which the SH3- isoforms play a major role in the postsynaptic accumulation of GABA(A) receptors and in GABAergic synaptic strength.	[Chiou, Tzu-Ting; Bonhomme, Bevan; Jin, Hongbing; Miralles, Celia P.; Xiao, Haiyan; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Fu, Zhanyan; Vicini, Stefano] Georgetown Univ Sch Med, Dept Physiol & Biophys, Washington, DC 20057 USA; [Harvey, Robert J.; Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of Connecticut; Georgetown University; University of London; University College London; University of London School of Pharmacy	De Blas, AL (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	angel.deblas@uconn.edu	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664; Vicini, Stefano/0000-0001-8671-5194	National Institutes of Health (NIH), NINDS [NS38752]; NIH, NIMH [MH085224]; Medical Research Council [G0501258]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752] Funding Source: NIH RePORTER; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0501258, G0800498] Funding Source: UKRI	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant NS38752 (to A. L. D.) and NIH, NIMH, Grant MH085224 (to Z. F.). This work was also supported by Medical Research Council Grant G0501258 (to K. H.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2003, J COMP NEUROL, V456, P361, DOI 10.1002/cne.10535; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Christie SB, 2002, PROG BRAIN RES, V136, P157; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; EWERT M, 1992, BRAIN RES, V569, P57, DOI 10.1016/0006-8993(92)90368-J; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Li XJ, 2009, J BIOL CHEM, V284, P17253, DOI 10.1074/jbc.M109.008870; Li YF, 2010, J COMP NEUROL, V518, P3439, DOI 10.1002/cne.22390; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Miralles CP, 1999, J COMP NEUROL, V413, P535; MORENO JI, 1994, J COMP NEUROL, V350, P260, DOI 10.1002/cne.903500209; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Riquelme R, 2002, J NEUROSCI, V22, P10720; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Studler B, 2005, J COMP NEUROL, V484, P344, DOI 10.1002/cne.20472; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; VITORICA J, 1988, J NEUROSCI, V8, P615; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yu W, 2008, J NEUROCHEM, V105, P2300, DOI 10.1111/j.1471-4159.2008.05311.x; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	76	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22456	22468		10.1074/jbc.M111.236190	http://dx.doi.org/10.1074/jbc.M111.236190			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540179	hybrid, Green Published			2022-12-27	WOS:000291719900054
J	Iwaki, S; Lu, YB; Xie, ZH; Druey, KM				Iwaki, Shoko; Lu, Yunbiao; Xie, Zhihui; Druey, Kirk M.			p53 Negatively Regulates RGS13 Protein Expression in Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELLS; GENE-EXPRESSION; TRANSCRIPTION; RESPONSIVENESS; RESPONSES; LYMPHOMA	RGS13, a member of the regulator of G protein signaling (RGS) family, inhibits G protein-coupled receptor signaling in B cells and mast cells (MCs) and suppresses IgE-antigen-induced MC degranulation and anaphylaxis. Although RGS13 expression is induced by immune receptor and chemokine receptor stimulation, the molecular regulation of RGS13 transcription is unknown. Here, we investigated the role of two p53 response elements (REs) in the regulation of RGS13 promoter activity and expression. We found that a 1000-bp DNA fragment upstream of the ATG translation start site (TSS) had promoter activity in reporter gene assays, and deletion or mutation of a p53-binding motif nearest the TSS abolished promoter activity. Notably, p53 bound to both REs in the RGS13 promoter in vivo as assessed by chromatin immunoprecipitation, suggesting that the p53 RE most distal to the TSS is physiologically inactive. We detected reduced RGS13 expression in MCs exogenously expressing p53 or treated with doxorubicin, which induces genotoxic stress and leads to p53 accumulation. RNA silencing of p53 up-regulated RGS13 expression in B lymphocytes, and bone marrow-derived MCs from p53(-/-) mice had increased RGS13 expression. Finally, p53-depleted B cells with increased RGS13 expression had reduced Ca2+ mobilization in response to sphingosine 1-phosphate. These studies indicate that p53 may modulate immune responses through suppression of RGS13 transcription in MCs and B cells.	[Iwaki, Shoko; Lu, Yunbiao; Xie, Zhihui; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Druey, KM (corresponding author), NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Room 11N242,10 Ctr Dr, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov			National Institutes of Health, NIAID [AI000939-06 LAD]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000939, ZIAAI000746] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant AI000939-06 LAD from NIAID.	Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; KEMLER I, 1990, FASEB J, V4, P1444, DOI 10.1096/fasebj.4.5.2407588; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Marcel V, 2010, ONCOGENE, V29, P2691, DOI 10.1038/onc.2010.26; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Takemoto CM, 2010, J IMMUNOL, V184, P4349, DOI 10.4049/jimmunol.0900927; Wang JM, 2010, CARCINOGENESIS, V31, P1755, DOI 10.1093/carcin/bgq138; Wang JH, 2010, J IMMUNOL, V184, P442, DOI 10.4049/jimmunol.0900870; Xie ZH, 2010, J MOL CELL BIOL, V2, P357, DOI 10.1093/jmcb/mjq031; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07	28	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22219	22226		10.1074/jbc.M111.228924	http://dx.doi.org/10.1074/jbc.M111.228924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531726	Green Published, hybrid			2022-12-27	WOS:000291719900029
J	Li, X; Wen, WH; Liu, KD; Zhu, F; Malakhova, M; Peng, C; Li, TT; Kim, HG; Ma, WY; Cho, YY; Bode, AM; Dong, ZM; Dong, ZG				Li, Xiang; Wen, Weihong; Liu, Kangdong; Zhu, Feng; Malakhova, Margarita; Peng, Cong; Li, Tingting; Kim, Hong-Gyum; Ma, Weiya; Cho, Yong Yeon; Bode, Ann M.; Dong, Ziming; Dong, Zigang			Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-PAK; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; ACTIVATION; DEATH; EXPRESSION; GROWTH; AUTOPHOSPHORYLATION; ONCOLOGY; CLEAVAGE	p21-activated kinase (PAK) 2, a member of the PAK family of serine/threonine protein kinases, plays an important role in physiological processes such as motility, survival, mitosis, and apoptosis. However, the role of PAK2 in resistance to chemotherapy is unclear. Here we report that PAK2 is highly expressed in human breast cancer cell lines and human breast invasive carcinoma tissue compared with a human non-tumorigenic mammary epithelial cell line and adjacent normal breast tissue, respectively. Interestingly, we found that PAK2 can bind with caspase-7 and phosphorylate caspase-7 at the Ser-30, Thr-173, and Ser-239 sites. Functionally, the phosphorylation of caspase-7 decreases its activity, thereby inhibiting cellular apoptosis. Our data indicate that highly expressed PAK2 mediates chemotherapeutic resistance in human breast invasive ductal carcinoma by negatively regulating caspase-7 activity.	[Li, Xiang; Liu, Kangdong; Dong, Ziming] Zhengzhou Univ, Physiol & Pathophysiol Basic Med Sch, Zhengzhou 450001, Henan, Peoples R China; [Li, Xiang; Wen, Weihong; Liu, Kangdong; Zhu, Feng; Malakhova, Margarita; Peng, Cong; Kim, Hong-Gyum; Ma, Weiya; Cho, Yong Yeon; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Li, Tingting] Luoyang Cent Hosp, Dept Radiotherapy, Luoyang 471009, Henan, Peoples R China	Zhengzhou University; University of Minnesota System; Zhengzhou University	Dong, ZM (corresponding author), Zhengzhou Univ, Physiol & Pathophysiol Basic Med Sch, Zhengzhou 450001, Henan, Peoples R China.	dongzm@zzu.edu.cn; zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; ZHU, Feng/C-1303-2010; Cho, Yong-Yeon/AAD-4263-2020; peng, cong/A-9454-2012; 温, 家琦/GYV-3177-2022	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, CA120388, CAR37CA081064, ES016548]; Hormel Foundation; Minnesota Partnership for Biotechnology and Medical Genomics Grant [L9046001101]; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; Minnesota Partnership for Biotechnology and Medical Genomics Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA120388, CAR37CA081064, and ES016548. This work was also supported by The Hormel Foundation and Minnesota Partnership for Biotechnology and Medical Genomics Grant L9046001101.	Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cillessen SAGM, 2007, CLIN CANCER RES, V13, P7012, DOI 10.1158/1078-0432.CCR-06-2891; Dowsett M, 2005, ENDOCR-RELAT CANCER, V12, pS113, DOI 10.1677/erc.1.01044; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Gee JM, 2005, ENDOCR-RELAT CANCER, V12, pS99, DOI 10.1677/erc.1.01005; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Haagenson KK, 2010, CANCER METAST REV, V29, P143, DOI 10.1007/s10555-010-9208-5; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hara S, 2001, J UROLOGY, V166, P2491, DOI 10.1016/S0022-5347(05)65622-4; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kim PKM, 2001, DRUG RESIST UPDATE, V4, P293, DOI 10.1054/drup.2001.0223; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kuribayashi K, 2006, CANCER BIOL THER, V5, P763, DOI 10.4161/cbt.5.7.3228; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marlin JW, 2009, NEOPLASIA, V11, P286, DOI 10.1593/neo.81446; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Nheu T, 2004, CELL CYCLE, V3, P71; Puglisi F, 2006, EXPERT OPIN PHARMACO, V7, P2309, DOI 10.1517/14656566.7.16.2309; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Tuazon PT, 2002, FEBS LETT, V515, P84, DOI 10.1016/S0014-5793(02)02444-4; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; 2003, CENT EUR J PUBLIC HL, V11, P177	43	51	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22291	22299		10.1074/jbc.M111.236596	http://dx.doi.org/10.1074/jbc.M111.236596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21555521	Green Published, hybrid			2022-12-27	WOS:000291719900037
J	McCluskey, JT; Hamid, M; Guo-Parke, H; McClenaghan, NH; Gomis, R; Flatt, PR				McCluskey, Jane T.; Hamid, Muhajir; Guo-Parke, Hong; McClenaghan, Neville H.; Gomis, Ramon; Flatt, Peter R.			Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO GROWTH; GLUCOSE; ESTABLISHMENT; ISLETS; DIFFERENTIATION; GLUCOKINASE; RESPONSES; BRIN-BD11; PATHWAY; GENE	Three novel human insulin-releasing cell lines designated 1.1B4, 1.4E7, and 1.1E7 were generated by electrofusion of freshly isolated of human pancreatic beta cells and the immortal human PANC-1 epithelial cell line. Functional studies demonstrated glucose sensitivity and responsiveness to known modulators of insulin secretion. Western blot, RT-PCR, and immunohistochemistry showed expression of the major genes involved in proinsulin processing and the pancreatic beta cell stimulus-secretion pathway including PC1/3, PC2, GLUT-1, glucokinase, and K-ATP channel complex (Sur1 and Kir6.2) and the voltage-dependent L-type Ca2+ channel. The cells stained positively for insulin, and 1.1B4 cells were used to demonstrate specific staining for insulin, C-peptide, and proinsulin together with insulin secretory granules by electron microscopy. Analysis of metabolic function indicated intact mechanisms for glucose uptake, oxidation/utilization, and phosphorylation by glucokinase. Glucose, alanine, and depolarizing concentrations of K+ were all able to increase [Ca2+](i) in at least two of the cell lines tested. Insulin secretion was also modulated by other nutrients, hormones, and drugs acting as stimulators or inhibitors in normal beta cells. Subscapular implantation of the 1.1B4 cell line improved hyperglycemia and resulted in glucose lowering in streptozotocin-diabetic SCID mice. These novel human electrofusion- derived beta cell lines therefore exhibit stable characteristics reminiscent of normal pancreatic beta cells, thereby providing an unlimited source of human insulin-producing cells for basic biochemical studies and pharmacological drug testing plus proof of concept for cellular insulin replacement therapy.	[McCluskey, Jane T.; Hamid, Muhajir; Guo-Parke, Hong; McClenaghan, Neville H.; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Gomis, Ramon] Univ Barcelona, CIBERDEM, IDIBAPS, Hosp Clin Univ,Endocrinol & Diabet Unit, E-08007 Barcelona, Spain	Ulster University; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Guo-Parke, H (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	jt.mccluskey@ulster.ac.uk		Guo-Parke, Hong/0000-0001-8210-5321; Flatt, Peter/0000-0001-8548-7943; Hamid, Muhajir/0000-0002-2475-7628	University of Ulster; Diabetes UK; Innovation Ulster	University of Ulster; Diabetes UK(Diabetes UK); Innovation Ulster	This work was supported by grants from University of Ulster Research Strategy Funding, Diabetes UK, Innovation Ulster, and University of Ulster Vice Chancellor Studentships (to M. H. and H. G.-P.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT SJH, 1986, DIABETOLOGIA, V29, P727, DOI 10.1007/BF00870283; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CHICK WL, 1977, P NATL ACAD SCI USA, V74, P628, DOI 10.1073/pnas.74.2.628; de la Tour DD, 2001, MOL ENDOCRINOL, V15, P476; Efrat Shimon, 1996, P438; Ehses JA, 2001, J BIOL CHEM, V276, P23667, DOI 10.1074/jbc.M103023200; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Gartner W, 2006, NEUROENDOCRINOLOGY, V83, P123, DOI 10.1159/000094875; GUELI N, 1987, J EXP CLIN CANC RES, V6, P281; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hellman B., 1992, NUTR REGULATION INSU, P213; HENQUIN JC, 1992, NUTR REGULATION INSU, P172; JARRETT RJ, 1966, LANCET, V1, P633; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kramer W, 1996, HORM METAB RES, V28, P464, DOI 10.1055/s-2007-979838; LENZEN S, 1986, BIOCHEM PHARMACOL, V35, P2841, DOI 10.1016/0006-2952(86)90202-9; LENZEN S, 1994, BIOCHEM SOC T, V22, P1; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; MacFarlane WM, 1999, J BIOL CHEM, V274, P34059, DOI 10.1074/jbc.274.48.34059; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; Miguel JC, 2004, CELL CALCIUM, V36, P43, DOI 10.1016/j.ceca.2003.11.007; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; OHNEDA M, 1994, AM J PHYSIOL, V267, pE9668; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P381, DOI 10.1016/0896-8411(91)90154-5; THIVOLET C, 1986, CR ACAD SCI III-VIE, V303, P381; THIVOLET CH, 1988, DIABETES, V37, P1279, DOI 10.2337/diabetes.37.9.1279; Tsang WG, 2007, TRANSPLANTATION, V83, P685, DOI 10.1097/01.tp.0000256178.57359.4f; Wang S, 1997, CELL TRANSPLANT, V6, P59, DOI 10.1016/S0963-6897(96)00120-0; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	35	104	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21982	21992		10.1074/jbc.M111.226795	http://dx.doi.org/10.1074/jbc.M111.226795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515691	Green Published, hybrid			2022-12-27	WOS:000291719900005
J	Wang, SH; Wang, Y; Ma, J; Ding, YC; Zhang, SC				Wang, Shaohui; Wang, Yuan; Ma, Jie; Ding, Yunchao; Zhang, Shicui			Phosvitin Plays a Critical Role in the Immunity of Zebrafish Embryos via Acting as a Pattern Recognition Receptor and an Antimicrobial Effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPHIOXUS BRANCHIOSTOMA-BELCHERI; MATERNAL COMPLEMENT COMPONENTS; IGM-BEARING CELLS; IMMUNOGLOBULIN PROTEIN; DICENTRARCHUS-LABRAX; KATSUWONUS-PELAMIS; GENE TRANSCRIPTS; ATLANTIC SALMON; INNATE IMMUNITY; SKIPJACK TUNA	How fish embryos that develop externally survive microbial attacks is poorly understood. Here, we clearly demonstrated that the embryo extract of zebrafish and its early embryo both displayed antimicrobial activity against microbes, including pathogenic Aeromonas hydrophila, and phosvitin (Pv), a nutritional protein abundant in eggs, was related to this antimicrobial activity. We also showed that recombinant Pv (rPv) acted as a pattern recognition receptor capable of recognizing the microbial signature molecules LPS, lipoteichoic acid, and peptidoglycan, as well as binding the Gram-negative and -positive microbes Escherichia coli, A. hydrophila, and Staphylococcus aureus and functioned as an antimicrobial agent capable of killing the microbes. Furthermore, we revealed that its C-terminal 55 residues (Pt5) with the functional sites Arg(242) and Ala(201)/Ile(203) were indispensable for Pv antimicrobial activity. Importantly, microinjection of rPv or Pt5 into early embryos significantly enhanced their resistance to A. hydrophila challenge, and this enhanced bacterial resistance was markedly reduced by co-injection of anti-Pv antibody plus rPv (or Pt5) but not by injection of anti-actin antibody plus rPv. Moreover, the generated mutants with in vitro antimicrobial activity, when injected into the embryos, could also promote their resistance to A. hydrophila, but those without in vitro antimicrobial activity could not. It is thus proposed that Pv participates in the protection of early embryos against pathogenic attacks via binding and disrupting potential pathogens. This work also opens a new way for the study of the immunological roles of yolk proteins in oviparous animals that rely on yolk proteins for embryonic development.	[Wang, Shaohui; Wang, Yuan; Ma, Jie; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Ding, Yunchao; Zhang, Shicui] Ocean Univ China, Lab Evolut & Dev, Dept Marine Biol, Qingdao 266003, Peoples R China	Ocean University of China; Ocean University of China	Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Rm 205,Ke Xue Guan,5 Yushan Rd, Qingdao 266003, Peoples R China.	sczhang@ouc.edu.cn	Wang, Shaohui/G-7247-2012		Natural Science Foundation of China [30972274, 30730072]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 30972274 and 30730072 from the Natural Science Foundation of China (to S. Z.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An Y, 2009, MOL IMMUNOL, V46, P2666, DOI 10.1016/j.molimm.2009.04.001; BILDFELL R J, 1992, Journal of Aquatic Animal Health, V4, P97, DOI 10.1577/1548-8667(1992)004&lt;0097:PAPCOA&gt;2.3.CO;2; BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Choi JH, 2002, FISHERIES SCI, V68, P1367, DOI 10.1046/j.1444-2906.2002.00576.x; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Ellis A. E., 1988, Fish vaccination., P20; Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; Gotoh M, 2005, IMMUNOL LETT, V98, P297, DOI 10.1016/j.imlet.2004.12.004; GROGAN J, 1987, J INORG BIOCHEM, V29, P33, DOI 10.1016/0162-0134(87)80010-7; Hanif A, 2004, FISH SHELLFISH IMMUN, V17, P411, DOI 10.1016/j.fsi.2004.04.013; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; ITOH T, 1983, J FOOD SCI, V48, P1755, DOI 10.1111/j.1365-2621.1983.tb05077.x; Jung WK, 2003, INT J BIOCHEM CELL B, V35, P255, DOI 10.1016/S1357-2725(02)00176-0; Khan MAS, 2000, J AGR FOOD CHEM, V48, P1503, DOI 10.1021/jf990700r; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu J, 2009, MOL IMMUNOL, V46, P3117, DOI 10.1016/j.molimm.2009.06.001; LOSSO JN, 1994, EGG USES PROCESSING, P150; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Picchietti S, 2006, FISH SHELLFISH IMMUN, V20, P398, DOI 10.1016/j.fsi.2005.06.001; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Roque ACA, 2004, J MOL RECOGNIT, V17, P262, DOI 10.1002/jmr.661; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Swain P, 2006, FISH SHELLFISH IMMUN, V20, P519, DOI 10.1016/j.fsi.2005.06.011; TABORSKY G, 1983, ADV INORG BIOCHEM, V5, P235; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; VANLOON JJA, 1981, COMP DEV IMMUNOL, V1, P469; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; YOUSIF AN, 1991, DIS AQUAT ORGAN, V10, P45, DOI 10.3354/dao010045; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhang SC, 2009, REPROD BIOL PHYLOGEN, V8B, P485, DOI 10.1201/b10257-13	52	69	75	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22653	22664		10.1074/jbc.M111.247635	http://dx.doi.org/10.1074/jbc.M111.247635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531722	Green Published, hybrid			2022-12-27	WOS:000291719900072
J	Suaud, L; Miller, K; Alvey, L; Yan, WS; Robay, A; Kebler, C; Kreindler, JL; Guttentag, S; Hubbard, MJ; Rubenstein, RC				Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Guttentag, Susan; Hubbard, Michael J.; Rubenstein, Ronald C.			ERp29 Regulates Delta F508 and Wild-type Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Trafficking to the Plasma Membrane in Cystic Fibrosis (CF) and Non-CF Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM PROTEIN; MOLECULAR CHAPERONE HSC70; HEAT-SHOCK PROTEINS; SODIUM 4-PHENYLBUTYRATE; XENOPUS OOCYTES; INTRACELLULAR TRAFFICKING; NUCLEOTIDE-BINDING; LUMENAL PROTEIN; RAT-LIVER; DEGRADATION	Sodium 4-phenylbutyrate (4PBA) improves the intracellular trafficking of Delta F508-CFTR in cystic fibrosis (CF) epithelial cells. The underlying mechanism is uncertain, but 4PBA modulates the expression of some cytosolic molecular chaperones. To identify other 4PBA-regulated proteins that might regulate Delta F508-CFTR trafficking, we performed a differential display RT-PCR screen on IB3-1 CF bronchiolar epithelial cells exposed to 4PBA. One transcript up-regulated by 4PBA encoded ERp29, a luminal resident of the endoplasmic reticulum (ER) thought to be a novel molecular chaperone. We tested the hypothesis that ERp29 is a 4PBA-regulated ER chaperone that influences Delta F508-CFTR trafficking. ERp29 mRNA and protein expression was significantly increased (similar to 1.5-fold) in 4PBA-treated IB3-1 cells. In Xenopus oocytes, ERp29 overexpression increased the functional expression of both wild-type and Delta F508-CFTR over 3-fold and increased wild-type cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane expression. In CFBE41o- WT-CFTR cells, expression of and short circuit currents mediated by CFTR decreased upon depletion of ERp29 as did maturation of newly synthesized CFTR. In IB3-1 cells, Delta F508-CFTR co-immunoprecipitated with endogenous ERp29, and overexpression of ERp29 led to increased Delta F508-CFTR expression at the plasma membrane. These data suggest that ERp29 is a 4PBA-regulated ER chaperone that regulates WT-CFTR biogenesis and can promote Delta F508-CFTR trafficking in CF epithelial cells.	[Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Guttentag, Susan] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Kreindler, James L.; Guttentag, Susan; Rubenstein, Ronald C.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Hubbard, Michael J.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Hubbard, Michael J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Melbourne; University of Melbourne	Rubenstein, RC (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Abramson 410C,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rrubenst@mail.med.upenn.edu	Hubbard, Mike (Michael) J/AAE-6573-2022; Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Hubbard, Mike (Michael) J/0000-0002-5432-9421; Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health, NIDDK [R01 DK058046, R01 DK073185]; NHLBI [R01 HL059959, K08 HL081080]; American Pediatric Society-Society for Pediatric Research [T35 HD0744]; American Heart Association; Cystic Fibrosis Foundation; Lottery Health Research New Zealand; Melbourne Research Unit for Facial Disorders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059959, K08HL081080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073185, R01DK058046] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Pediatric Society-Society for Pediatric Research; American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Lottery Health Research New Zealand; Melbourne Research Unit for Facial Disorders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK058046 and R01 DK073185 from the NIDDK (to R. C. R.), R01 HL059959 (to S. G.) and K08 HL081080 from the NHLBI (to J. L. K.), and T35 HD0744 (a student research fellowship to L. A. through the American Pediatric Society-Society for Pediatric Research). This work was also supported by grants from the Pennsylvania-Delaware Chapter of the American Heart Association (to L. S.) and the Cystic Fibrosis Foundation (to R. C. R.).; Supported by Lottery Health Research New Zealand and a professorial fellowship from the Melbourne Research Unit for Facial Disorders.	Ahner A, 2007, MOL BIOL CELL, V18; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Barak NN, 2009, J MOL BIOL, V385, P1630, DOI 10.1016/j.jmb.2008.11.052; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Demmer J, 1997, FEBS LETT, V402, P145, DOI 10.1016/S0014-5793(96)01513-X; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Hermann VM, 2005, J BIOL CHEM, V280, P13529, DOI 10.1074/jbc.M410889200; Hubbard MJ, 2004, BIOCHEM J, V383, P589, DOI 10.1042/BJ20040983; Hubbard MJ, 2000, EUR J BIOCHEM, V267, P1945, DOI 10.1046/j.1432-1327.2000.01193.x; Hubbard MJ, 2002, PROTEOMICS, V2, P1069, DOI 10.1002/1615-9861(200209)2:9<1069::AID-PROT1069>3.0.CO;2-R; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; MCGRATH SA, 1993, AM J RESP CELL MOL, V8, P201, DOI 10.1165/ajrcmb/8.2.201; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Okiyoneda T, 2002, FEBS LETT, V526, P87, DOI 10.1016/S0014-5793(02)03134-4; Park S, 2005, MOL BIOL REP, V32, P7, DOI 10.1007/s11033-004-3069-3; PIND S, 1994, J BIOL CHEM, V269, P12784; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rubenstein RC, 2005, CURR OPIN PEDIATR, V17, P385, DOI 10.1097/01.mop.0000158846.95469.6f; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Samaha FF, 2004, J BIOL CHEM, V279, P23900, DOI 10.1074/jbc.M401941200; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Sen J, 2000, DEVELOPMENT, V127, P5541; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Suaud L, 2002, J BIOL CHEM, V277, P8928, DOI 10.1074/jbc.M111482200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wright JM, 2004, PHYSIOL GENOMICS, V16, P204, DOI 10.1152/physiolgenomics.00160.2003; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	68	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21239	21253		10.1074/jbc.M111.240267	http://dx.doi.org/10.1074/jbc.M111.240267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525008	Green Published, hybrid			2022-12-27	WOS:000291464700023
J	Venugopalan, SR; Li, X; Amen, MA; Florez, S; Gutierrez, D; Cao, HJ; Wang, JB; Amendt, BA				Venugopalan, Shankar R.; Li, Xiao; Amen, Melanie A.; Florez, Sergio; Gutierrez, Diana; Cao, Huojun; Wang, Jianbo; Amendt, Brad A.			Hierarchical Interactions of Homeodomain and Forkhead Transcription Factors in Regulating Odontogenic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOOTH DEVELOPMENT; EPITHELIAL-CELLS; DLX2 EXPRESSION; RIEGER-SYNDROME; BETA-CATENIN; PITX2; PROTEIN; FOXJ1; DIFFERENTIATION	FoxJ1 is a forkhead transcription factor expressed in multiple tissues during development and a major regulator of cilia development. FoxJ1(-/-) mice present with defects in odontogenesis, and we correlate these defects to hierarchical interactions between homeodomain factors Pitx2 and Dlx2 with FoxJ1 in regulating their expression through direct physical interactions. Chromatin immunoprecipitation assays reveal endogenous Pitx2 and Dlx2 binding to the Dlx2 promoter and Dlx2 binding to the FoxJ1 promoter as well as Dlx2 and FoxJ1 binding to the amelogenin promoter. PITX2 activation of the Dlx2 promoter is attenuated by a direct Dlx2 physical interaction with PITX2. Dlx2 autoregulates its promoter, and Dlx2 transcriptionally activates the downstream gene FoxJ1. Dlx2 and FoxJ1 physically interact and synergistically regulate both Dlx2 and FoxJ1 promoters. Dlx2 and FoxJ1 also activate the amelogenin promoter, and amelogenin is required for enamel formation and late stage tooth development. FoxJ1(-/-) mice maxillary and mandibular incisors are reduced in length and width and have reduced amelogenin expression. FoxJ1(-/-) mice show a reduced and defective ameloblast layer, revealing a biological effect of these transcription factor hierarchies during tooth morphogenesis. These transcriptional mechanisms may contribute to other developmental processes such as neuronal, pituitary, and heart development.	[Venugopalan, Shankar R.; Li, Xiao; Amen, Melanie A.; Florez, Sergio; Gutierrez, Diana; Cao, Huojun; Wang, Jianbo; Amendt, Brad A.] TAMU Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA		Amendt, BA (corresponding author), TAMU Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	bamendt@ibt.tamhsc.edu	Rengasamy Venugopalan, Shankar/GPX-7671-2022; Li, Xiao/X-3429-2019; cao, huojun/M-5431-2017	Li, Xiao/0000-0001-8527-4438; Cao, Huojun/0000-0003-4428-8686; Amendt, Brad A./0000-0001-6524-1006; Gutierrez Lopez, Diana E./0000-0003-0158-8558	National Institutes of Health [DE 18885]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DE 18885 (NIDCR; to B.A.A.).	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bei M, 2004, DEV DYNAM, V231, P758, DOI 10.1002/dvdy.20182; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Lezot F, 2000, J BONE MINER RES, V15, P430, DOI 10.1359/jbmr.2000.15.3.430; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Lin L, 2005, J IMMUNOL, V175, P951, DOI 10.4049/jimmunol.175.2.951; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Thomas BL, 2000, DEVELOPMENT, V127, P217; Thomas BL, 1995, CONNECT TISSUE RES, V32, P27, DOI 10.3109/03008209509013702; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhou QP, 2004, NUCLEIC ACIDS RES, V32, P884, DOI 10.1093/nar/gkh233	36	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21372	21383		10.1074/jbc.M111.252031	http://dx.doi.org/10.1074/jbc.M111.252031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504905	Green Published, hybrid			2022-12-27	WOS:000291464700036
J	Yuan, KF; Huang, CH; Fox, J; Gaid, M; Weaver, A; Li, GP; Singh, BB; Gao, HW; Wu, M				Yuan, Kefei; Huang, Canhua; Fox, John; Gaid, Madeleine; Weaver, Andrew; Li, Guoping; Singh, Brij B.; Gao, Hongwei; Wu, Min			Elevated Inflammatory Response in Caveolin-1-deficient Mice with Pseudomonas aeruginosa Infection Is Mediated by STAT3 Protein and Nuclear Factor kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; VENTILATOR-ASSOCIATED PNEUMONIA; CAVEOLIN GENE FAMILY; RICH MEMBRANE RAFTS; LIPID RAFTS; ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; PLASMA-MEMBRANE; T-CELLS; ACTIVATION	Caveolin-1 (Cav-1), an important composition protein within the flask-shaped membrane invaginations termed caveolae, may play a role in host defense against infections. However, the phenotype in Pseudomonas aeruginosa-infected cav1 knock-out (KO) mice is still unresolved, and the mechanism involved is almost entirely unknown. Using a respiratory infection model, we confirmed a crucial role played by Cav-1 in host defense against this pathogen because Cav-1 KO mice showed increased mortality, severe lung injury, and systemic dissemination as compared with wild-type (WT) littermates. In addition, cav1 KO mice exhibited elevated inflammatory cytokines (IL-6, TNF-alpha, and IL-12a), decreased phagocytic ability of macrophages, and increased superoxide release in the lung, liver, and kidney. We further studied relevant cellular signaling processes and found that STAT3 and NF-kappa B are markedly activated. Our data revealed that the Cav-1/STAT3/NF-kappa B axis is responsible for a dysregulated cytokine response, which contributes to increased mortality and disease progression. Moreover, down-regulating Cav-1 in cell culture with a dominant negative strategy demonstrated that STAT3 activation was essential for the translocation of NF-kappa B into the nucleus, confirming the observations from cav1 KO mice. Collectively, our studies indicate that Cav-1 is critical for inflammatory responses regulating the STAT3/NF-kappa B pathway and thereby impacting P. aeruginosa infection.	[Yuan, Kefei; Huang, Canhua] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Med Sch, Boston, MA 02115 USA; [Fox, John; Gaid, Madeleine; Weaver, Andrew; Li, Guoping; Singh, Brij B.; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA	Sichuan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks	Huang, CH (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	hcanhua@hotmail.com; min.wu@med.und.edu	Yuan, Kefei/AGX-5504-2022	Wu, Min/0000-0003-1205-982X; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [ES014690, 5R01HL092905-04, 3R01HL092905-02S1]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES014690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014690 (to M. W.) and 5R01HL092905-04 and 3R01HL092905-02S1 (to H. G.). This work was also supported by an American Heart Association scientist development grant (to M. W.).	Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Arita Y, 2008, WORLD J GASTROENTERO, V14, P4473, DOI 10.3748/wjg.14.4473; Barar J, 2007, BIOCHEM BIOPH RES CO, V359, P360, DOI 10.1016/j.bbrc.2007.05.106; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; DUNN M, 1995, CLIN CHEST MED, V16, P95; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Gadjeva M, 2010, J IMMUNOL, V184, P296, DOI 10.4049/jimmunol.0900604; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Ivashkiv LB, 2010, CELL HOST MICROBE, V8, P132, DOI 10.1016/j.chom.2010.07.011; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; KENNETH RF, 2005, CLIN CANCER RES, V11, pA277; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; OZAKI T, 1989, AM REV RESPIR DIS, V140, P1595, DOI 10.1164/ajrccm/140.6.1595; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Priebe GP, 2002, INFECT IMMUN, V70, P1507, DOI 10.1128/IAI.70.3.1507-1517.2002; RENIER M, 1995, HUM GENE THER, V6, P1275, DOI 10.1089/hum.1995.6.10-1275; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Shaykhiev R, 2010, FASEB J, V24, P4756, DOI 10.1096/fj.09-151332; Shen-Tu G, 2010, LAB INVEST, V90, P266, DOI 10.1038/labinvest.2009.131; Sugahara K, 2010, AM J RESP CRIT CARE, V181; Suntres ZE, 2002, MICROB PATHOGENESIS, V32, P27, DOI 10.1006/mpat.2001.0475; Takeda K, 1998, J IMMUNOL, V161, P4652; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thomas S, 2004, ARCH IMMUNOL THER EX, V52, P215; Thomas S, 2004, MOL IMMUNOL, V41, P399, DOI 10.1016/j.molimm.2004.03.022; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang L, 2007, ONCOGENE, V26, P2851, DOI 10.1038/sj.onc.1210092; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wisniowski PE, 2000, AM J RESP CRIT CARE, V162, P733, DOI 10.1164/ajrccm.162.2.9808015; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; WU M, 1995, BIOCONJUGATE CHEM, V6, P587, DOI 10.1021/bc00035a013; Wu M, 2001, P NATL ACAD SCI USA, V98, P14589, DOI 10.1073/pnas.251451498; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10; Wu M, 2009, J NEUROCHEM, V111, P1011, DOI 10.1111/j.1471-4159.2009.06390.x; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200	64	68	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21814	21825		10.1074/jbc.M111.237628	http://dx.doi.org/10.1074/jbc.M111.237628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515682	Green Published, hybrid			2022-12-27	WOS:000291464700076
J	Roy, R; Rodig, S; Bielenberg, D; Zurakowski, D; Moses, MA				Roy, Roopali; Rodig, Scott; Bielenberg, Diane; Zurakowski, David; Moses, Marsha A.			ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth A DISTINCT ROLE FOR ADAM12-S PROTEIN IN TUMOR METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							12 MELTRIN ALPHA; CELL-PROLIFERATION; FAMILY-MEMBERS; CANCER; METALLOPROTEINASES; DISINTEGRIN; PROGRESSION; EXPRESSION; APOPTOSIS; STAGE	Increased levels of ADAM12 have been reported in a variety of human cancers. We have previously reported that urinary ADAM12 is predictive of disease status in breast cancer patients and that ADAM12 protein levels in urine increase with progression of disease. On the basis of these findings, the goal of this study was to elucidate the contribution of ADAM12 in breast tumor growth and progression. Overexpression of both the ADAM12-L (transmembrane) and ADAM12-S (secreted) isoforms in human breast tumor cells resulted in a significantly higher rate of tumor take and increased tumor size. Cells expressing the enzymatically inactive form of the secreted isoform, ADAM12-S, had tumor take rates and tumor volumes similar to those of wild-type cells, suggesting that the tumor-promoting activity of ADAM12-S was a function of its proteolytic activity. Of the two isoforms, only the secreted isoform, ADAM12-S, enhanced the ability of tumor cells to migrate and invade in vitro and resulted in a higher incidence of local and distant metastasis in vivo. This stimulatory effect of ADAM12-S on migration and invasion was dependent on its catalytic activity. Expression of both ADAM12 isoforms was found to be significantly elevated in human malignant breast tissue. Taken together, our results suggest that ADAM12 overexpression results in increased tumor take, tumor size, and metastasis in vivo. These findings suggest that ADAM12 may represent a potential therapeutic target in breast cancer.	[Moses, Marsha A.] Childrens Hosp Boston, Karp Family Res Labs, Program Vasc Biol, Boston, MA 02115 USA; Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA; [Zurakowski, David] Childrens Hosp Boston, Dept Orthoped, Boston, MA 02115 USA; [Rodig, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Roy, Roopali; Rodig, Scott; Bielenberg, Diane; Zurakowski, David; Moses, Marsha A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Moses, MA (corresponding author), Childrens Hosp Boston, Karp Family Res Labs, Program Vasc Biol, 300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	Rodig, Scott/Y-3889-2019		National Institutes of Health [PO1 CA45548, R01 CA118764]; Breast Cancer Research Foundation; JoAnn Webb Fund for Angiogenesis Research; Ellison Foundation; Fortin Foundation; NATIONAL CANCER INSTITUTE [P01CA045548, R01CA118764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; JoAnn Webb Fund for Angiogenesis Research; Ellison Foundation(Lawrence Ellison Foundation); Fortin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA45548 and R01 CA118764. This work was also supported by The Breast Cancer Research Foundation, The JoAnn Webb Fund for Angiogenesis Research, The Ellison Foundation, and The Fortin Foundation.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; PERROTTE P, 1997, MOL UROL, V1, P299; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Rocks N, 2008, CELL PROLIFERAT, V41, P988, DOI 10.1111/j.1365-2184.2008.00557.x; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; ROY R, 2011, BREAST CANC IN PRESS; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	29	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20758	20768		10.1074/jbc.M110.216036	http://dx.doi.org/10.1074/jbc.M110.216036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493715	Green Published, hybrid			2022-12-27	WOS:000291267600061
J	Xiao, L; Hu, C; Feng, CZ; Chen, YZ				Xiao, Lin; Hu, Chun; Feng, Chunzhi; Chen, Yizhang			Switching of N-Methyl-D-aspartate (NMDA) Receptor-favorite Intracellular Signal Pathways from ERK1/2 Protein to p38 Mitogen-activated Protein Kinase Leads to Developmental Changes in NMDA Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; MEDIATED BIDIRECTIONAL CONTROL; CULTURED HIPPOCAMPAL-NEURONS; CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; DIFFERENTIAL ROLES; GLUTAMATE RECEPTORS; CORTICAL-NEURONS; IN-VITRO; TYROSINE-PHOSPHATASE	Excitotoxicity mediated by overactivation of N-methyl-D-aspartate receptors (NMDARs) has been implicated in a variety of neuropathological conditions in the central nervous system (CNS). It has been suggested that N-methyl-D-aspartate (NMDA) neurotoxicity is developmentally regulated, but the definite pattern of the regulation has been controversial, and the underlying mechanism remains largely unknown. Here, we show that NMDA treatment leads to significant cell death in mature (9 and 12 days in vitro) hippocampal neurons or hippocampi of young postnatal day 12 and adult rats but not in immature (3 and 6 days in vitro) neurons or embryonic day 18 and neonatal rat hippocampi. In contrast, NMDA promotes survival of immature neurons against tropic deprivation. Interestingly, it is found that NMDA preferentially activates p38 MAPK in mature neuron and adult rat hippocampus, but it favors ERK1/2 activation in immature neuron and postnatal day 0 rat hippocampus. Moreover, it is shown that NMDA neurotoxicity in mature neuron is mediated via p38 MAPK activation, and neuroprotection in immature neuron is mediated via ERK1/2 activation, whereas all these effects are NR2B-containing NMDAR-dependent, as well as Ca2+-dependent. We also revealed that mature and immature neurons showed no difference in the amplitude of NMDA-induced intracellular calcium ([Ca2+](i)) increase. However, the basal level of [Ca2+](i) is shown to elevate with the maturation of neuron, and this elevation is attributable to the changes in NMDA neurotoxicity but not to the switch of the NMDAR signaling pathway. Taken together, our results suggest that a switch of NMDA receptor-favorite intracellular signal pathways from ERK1/2 to p38 MAPK and the elevated basal level of [Ca2+](i) with age might be critical for the developmental changes in NMDA neurotoxicity in the hippocampal neuron.	[Xiao, Lin; Hu, Chun; Chen, Yizhang] Second Mil Med Univ, Inst Neurosci, Key Lab Mol Neurobiol, Minist Educ,Neurosci Ctr,Changzheng Hosp, Shanghai 200433, Peoples R China; [Feng, Chunzhi] Fudan Univ, Univ Hosp, Shanghai 200433, Peoples R China	Naval Medical University; Fudan University	Xiao, L (corresponding author), Second Mil Med Univ, Inst Neurosci, Key Lab Mol Neurobiol, Minist Educ,Neurosci Ctr,Changzheng Hosp, Shanghai 200433, Peoples R China.	liuyangxiaolin@yahoo.com.cn; yzchen0928@yahoo.com			National Natural Science Foundation of China [30900431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 30900431 from the National Natural Science Foundation of China.	ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; Bubenikova-Valesova V, 2006, NEUROCHEM INT, V48, P515, DOI 10.1016/j.neuint.2006.01.019; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Chohan MO, 2006, J ALZHEIMERS DIS, V10, P81; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fogal B, 2005, NEUROSCIENCE, V132, P929, DOI 10.1016/j.neuroscience.2005.01.036; FRANDSEN A, 1990, INT J DEV NEUROSCI, V8, P209, DOI 10.1016/0736-5748(90)90013-R; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2006, J PHYSIOL-LONDON, V572, P614, DOI 10.1113/jphysiol.2006.109603; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Johnson KA, 2009, CNS NEUROL DISORD-DR, V8, P475, DOI 10.2174/187152709789824606; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; LAI TW, 2011, TRENDS MOL IN PRESS; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Liu Z, 1996, DEV BRAIN RES, V97, P178, DOI 10.1016/S0165-3806(96)00141-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; Marks JD, 2000, DEV BRAIN RES, V124, P101, DOI 10.1016/S0165-3806(00)00096-1; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mizuta I, 1998, CELL MOL LIFE SCI, V54, P721, DOI 10.1007/s000180050199; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Rao A, 1998, J NEUROSCI, V18, P1217; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sattler R, 1998, J NEUROCHEM, V71, P2349; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Wenzel A, 1997, J NEUROCHEM, V68, P469; XIA Y, 1995, NEUROCHEM RES, V20, P617, DOI 10.1007/BF01694545; Xiao L, 2005, ENDOCRINOLOGY, V146, P4036, DOI 10.1210/en.2004-1652; Xiao L, 2010, MOL ENDOCRINOL, V24, P497, DOI 10.1210/me.2009-0422; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; ZHONG J, 1994, MOL PHARMACOL, V45, P846; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	85	25	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20175	20193		10.1074/jbc.M110.188854	http://dx.doi.org/10.1074/jbc.M110.188854			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474451	hybrid, Green Published			2022-12-27	WOS:000291267600006
J	Boubekeur, S; Boute, N; Pagesy, P; Zilberfarb, V; Christeff, N; Issad, T				Boubekeur, Samira; Boute, Nicolas; Pagesy, Patrick; Zilberfarb, Vladimir; Christeff, Nevena; Issad, Tarik			A New Highly Efficient Substrate-trapping Mutant of Protein Tyrosine Phosphatase 1B (PTP1B) Reveals Full Autoactivation of the Insulin Receptor Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; LIVING CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATOR; ACTIVATION STATE; KINASE-ACTIVITY; BREAST-CANCER	PTP1B is a protein tyrosine-phosphatase located on the cytosolic side of the endoplasmic reticulum that plays an important role in the regulation of the insulin receptor (IR). Replacement of the conserved Asp-181 by alanine is known to convert PTP1B into a substrate-trapping protein that binds to but cannot dephosphorylate its substrates. In this work, we have studied the effect of an additional mutation (Y46F) on the substrate-trapping efficiency of PTP1B-D181A. We observed that this mutation converts PTP1B-D181A into a highly efficient substrate-trapping mutant, resulting in much higher recovery of tyrosine-phosphorylated proteins coimmunoprecipitated with PTP1B. Bioluminescence resonance energy transfer (BRET) experiments were also performed to compare the dynamics of interaction of the IR with these mutants. Basal BRET, which mainly reflects the interaction of PTP1B with the IR precursor during its biosynthesis in the endoplasmic reticulum, was markedly increased with the PTP1B-D181A-Y46F mutant. In contrast, insulin-induced BRET was markedly reduced with PTP1B-D181A-Y46F. I-125 insulin binding experiments indicated that PTP1B-D181-Y46F reduced the expression of IR at the plasma membrane. Reduced expression at the cell surface was associated with higher amounts of the uncleaved IR precursor in the cell. Moreover, we observed that substantial amounts of the uncleaved IR precursor reached the Tris-phosphorylated, fully activated form in an insulin independent fashion. These results support the notion that PTP1B plays a crucial role in the control of the activity of the IR precursor during its biosynthesis. In addition, this new substrate-trapping mutant may be a valuable tool for the identification of new PTP1B substrates.	INSERM, U1016, F-75014 Paris, France; CNRS, UMR8104, F-75014 Paris, France; Univ Paris 05, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Inst Cochin, Dept Endocrinol Metab & Canc, 22 Rue Mechain, F-75014 Paris, France.	tarik.issad@inserm.fr	Pagesy, Patrick/GLN-4814-2022; Pagesy, Patrick/M-9345-2017	Pagesy, Patrick/0000-0002-6153-8926; Issad, Tarik/0000-0002-2638-6330	Institut de Recherche Servier; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris	Institut de Recherche Servier; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris	This work was supported by the Institut de Recherche Servier, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, and the Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris.	AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Blanquart C, 2010, BIOCHEM BIOPH RES CO, V392, P83, DOI 10.1016/j.bbrc.2009.12.176; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; ISSAD T, 1989, BIOCHEM J, V264, P217, DOI 10.1042/bj2640217; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Issad T, 2005, BIOCHIMIE, V87, P111, DOI 10.1016/j.biochi.2004.12.008; Issad T, 2003, DIABETES METAB, V29, P111, DOI 10.1016/S1262-3636(07)70016-2; Issad T, 2002, BIOCHEM PHARMACOL, V64, P813, DOI 10.1016/S0006-2952(02)01143-7; ISSAD T, 1992, FEBS LETT, V296, P41, DOI 10.1016/0014-5793(92)80399-2; Issad T, 2007, EXPERT OPIN THER TAR, V11, P541, DOI 10.1517/14728222.11.4.541; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KING MJ, 1991, BIOCHEM J, V275, P413, DOI 10.1042/bj2750413; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tao JC, 2001, J BIOL CHEM, V276, P29520, DOI 10.1074/jbc.M103721200; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	53	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19373	19380		10.1074/jbc.M111.222984	http://dx.doi.org/10.1074/jbc.M111.222984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487008	hybrid, Green Published			2022-12-27	WOS:000291027700019
J	Daleke, MH; Cascioferro, A; de Punder, K; Ummels, R; Abdallah, AM; van der Wel, N; Peters, PJ; Luirink, J; Manganelli, R; Bitter, W				Daleke, Maria H.; Cascioferro, Alessandro; de Punder, Karin; Ummels, Roy; Abdallah, Abdallah M.; van der Wel, Nicole; Peters, Peter J.; Luirink, Joen; Manganelli, Riccardo; Bitter, Wilbert			Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) Protein Domains Target LipY Lipases of Pathogenic Mycobacteria to the Cell Surface via the ESX-5 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGRS PROTEINS; SIGNAL PEPTIDE; GENE-CLUSTER; TUBERCULOSIS; SECRETION; VIRULENCE; TRIACYLGLYCEROL; PLASMID; LOCALIZATION; EXPRESSION	The type VII secretion system ESX-5 is a major pathway for export of PE and PPE proteins in pathogenic mycobacteria. These mycobacteria-specific protein families are characterized by conserved N-terminal domains of 100 and 180 amino acids, which contain the proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE) motifs after which they are named. Here we investigated secretion of the triacylglycerol lipase LipY, which in fast-growing mycobacteria contains a signal sequence, but in slow-growing species appears to have replaced the signal peptide with a PE or PPE domain. Selected LipY homologues were expressed in wild-type Mycobacterium marinum and its corresponding ESX-5 mutant, and localization of the proteins was investigated by immunoblotting and electron microscopy. Our study shows that Mycobacterium tuberculosis PE-LipY (LipY(tub)) and M. marinum PPE-LipY (LipY(mar)) are both secreted to the bacterial surface in an ESX-5-dependent fashion. After transport, the PE/PPE domains are removed by proteolytic cleavage. In contrast, Mycobacterium gilvum LipY, which has a signal sequence, is not transported to the cell surface. Furthermore, we show that LipY(tub) and LipY(mar) require their respective PE and PPE domains for ESX-5-dependent secretion. The role of the PE domain in ESX-5 secretion was confirmed in a whole cell lipase assay, in which wild-type bacteria expressing full-length LipY(tub), but not LipY(tub) lacking its PE domain, were shown to hydrolyze extracellular lipids. In conclusion, both PE and PPE domains contain a signal required for secretion of LipY by the ESX-5 system, and these domains are proteolytically removed upon translocation.	[Daleke, Maria H.; Ummels, Roy; Abdallah, Abdallah M.; Bitter, Wilbert] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, NL-1081 BT Amsterdam, Netherlands; [Daleke, Maria H.; Luirink, Joen; Bitter, Wilbert] Vrije Univ Amsterdam, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Cascioferro, Alessandro; Manganelli, Riccardo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; [de Punder, Karin; Abdallah, Abdallah M.; van der Wel, Nicole; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Padua; Netherlands Cancer Institute	Bitter, W (corresponding author), Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	w.bitter@vumc.nl	Manganelli, Riccardo/A-7361-2009; Bitter, Wilbert/ABG-3726-2020; Bitter, Wilbert/AAA-6872-2019; Van Der Wel, Nicole/AAE-7569-2020; Bitter, W/CAJ-5778-2022; Luirink, Joen/AAB-8658-2021; Abdallah, Abdallah Musa/AAW-1826-2020; Cascioferro, Alessandro/E-3445-2017	Manganelli, Riccardo/0000-0003-0940-7336; Bitter, Wilbert/0000-0001-8347-6511; Luirink, J./0000-0001-8431-0804; Cascioferro, Alessandro/0000-0001-7751-7348; Abdallah, Abdallah Musa/0000-0002-9773-8700; van der Wel, Nicole/0000-0001-6392-3417	Netherlands Organization for Scientific Research (NWO); European Community [201762]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by funding from an "Earth and Life Sciences (ALW) Open Program" grant from the Netherlands Organization for Scientific Research (NWO) (to M. H. D.) and from the European Community Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201762.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bachrach G, 2000, MICROBIOL-UK, V146, P297, DOI 10.1099/00221287-146-2-297; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DALEKE MH, UNPUB; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; DeanRoss D, 1996, APPL MICROBIOL BIOT, V46, P307, DOI 10.1007/s002530050822; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; GHRAYEB J, 1985, J BIOL CHEM, V260, P961; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; HERMANS PWM, 1992, J BACTERIOL, V174, P4157, DOI 10.1128/jb.174.12.4157-4165.1992; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stolt P, 1996, MICROBIOL-SGM, V142, P2795, DOI 10.1099/13500872-142-10-2795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUOMINEN I, 1995, MICROBIOL-UK, V141, P649, DOI 10.1099/13500872-141-3-649; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; VANDENBROUCKEGR.J, 2007, NAT REV MICROBIOL, V5, P883; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044	55	106	112	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19024	19034		10.1074/jbc.M110.204966	http://dx.doi.org/10.1074/jbc.M110.204966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471225	Green Published, hybrid			2022-12-27	WOS:000290785700073
J	Viktorovskaya, OV; Appling, FD; Schneider, DA				Viktorovskaya, Olga V.; Appling, Francis D.; Schneider, David A.			Yeast Transcription Elongation Factor Spt5 Associates with RNA Polymerase I and RNA Polymerase II Directly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COMPLEX; PROTEIN; RECRUITMENT; BINDING; DSIF; ARCHITECTURE; MACHINERY; SPT4-SPT5; SUBUNIT	Spt5 is a transcription factor conserved in all three domains of life. Spt5 homologues from bacteria and archaea bind the largest subunit of their respective RNA polymerases. Here we demonstrate that Spt5 directly associates with RNA polymerase (Pol) I and RNA Pol II in yeast through its central region containing conserved NusG N-terminal homology and KOW domains. Deletion analysis of SPT5 supports our biochemical data, demonstrating the importance of the KOW domains in Spt5 function. Far Western blot analysis implicates A190 of Pol I as well as Rpb1 of Pol II in binding Spt5. Three additional subunits of Pol I may also participate in this interaction. One of these subunits, A49, has known roles in transcription elongation by Pol I. Interestingly, spt5 truncation mutations suppress the cold-sensitive phenotype of rpa49 Delta strain, which lacks the A49 subunit in the Pol I complex. Finally, we observed that Spt5 directly binds to an essential Pol I transcription initiation factor, Rrn3, and to the ribosomal RNA. Based on these data, we propose a model in which Spt5 is recruited to the rDNA early in transcription and propose that it plays an important role in ribosomal RNA synthesis through direct binding to the Pol I complex.	[Viktorovskaya, Olga V.; Appling, Francis D.; Schneider, David A.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), 720 20th St S,Rm 442, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM084946]; Alabama Health Science Foundation; University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Health Science Foundation; University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084946 (to D. A. S.). This work was also supported by the Alabama Health Science Foundation and grants from the University of Alabama at Birmingham Comprehensive Cancer Center Young Supporters Board.	Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Bier M, 2004, FEBS LETT, V564, P41, DOI 10.1016/S0014-5793(04)00311-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; EDMONDSON D, 2001, CURRENT PROTOCOLS PR; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Lindstrom DL, 2001, GENETICS, V159, P487; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Philippi A, 2010, NUCLEIC ACIDS RES, V38, P5315, DOI 10.1093/nar/gkq264; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; SWANSON MS, 1992, GENETICS, V132, P325; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220	40	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18825	18833		10.1074/jbc.M110.202119	http://dx.doi.org/10.1074/jbc.M110.202119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467036	Green Published, hybrid			2022-12-27	WOS:000290785700055
J	Zhuang, LN; Hu, WX; Zhang, ML; Xin, SM; Jia, WP; Zhao, J; Pei, G				Zhuang, Le-nan; Hu, Wen-xiang; Zhang, Ming-liang; Xin, Shun-mei; Jia, Wei-ping; Zhao, Jian; Pei, Gang			beta-Arrestin-1 Protein Represses Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ENERGY-BALANCE; BETA-ARRESTIN; PPAR-GAMMA; RAT-BRAIN; FAT; ACTIVATION; PHOSPHORYLATION; CONTRIBUTES; SENSITIVITY	Diet-related obesity is a major metabolic disorder. Excessive fat mass is associated with type 2 diabetes, hepatic steatosis, and arteriosclerosis. Dysregulation of lipid metabolism and adipose tissue function contributes to diet-induced obesity. Here, we report that beta-arrestin-1 knock-out mice are susceptible to diet-induced obesity. Knock-out of the gene encoding beta-arrestin-1 caused increased fat mass accumulation and decreased whole-body insulin sensitivity in mice fed a high-fat diet. In beta-arrestin-1 knock-out mice, we observed disrupted food intake and energy expenditure and increased macrophage infiltration in white adipose tissue. At the molecular level, beta-arrestin-1 deficiency affected the expression of many lipid metabolic genes and inflammatory genes in adipose tissue. Consistently, transgenic overexpression of beta-arrestin-1 repressed diet-induced obesity and improved glucose tolerance and systemic insulin sensitivity. Thus, our findings reveal that beta-arrestin-1 plays a role in metabolism regulation.	[Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhuang, Le-nan; Hu, Wen-xiang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Zhang, Ming-liang; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China; [Zhang, Ming-liang; Jia, Wei-ping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017; Zhuang, Lenan/GZG-7254-2022; Zhao, Jian/E-2008-2019	Hu, Wenxiang/0000-0002-6754-5625; Zhao, Jian/0000-0002-8862-0591; Zhuang, Lenan/0000-0001-9561-8396	Ministry of Science and Technology [2007CB947100, 2009CB940903, 2011CB910202]; National Natural Science Foundation of China [30871285, 90713047]; Chinese Academy of Sciences [XDA01010302]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported in part by Ministry of Science and Technology Grants 2007CB947100, 2009CB940903, and 2011CB910202; National Natural Science Foundation of China Grants 30871285 and 90713047; and Chinese Academy of Sciences Grant XDA01010302.; Supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program. To whom correspondence may be addressed. E-mail: jzhao@sibs.ac.cn.	Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Diaz A, 2002, NEUROSCIENCE, V112, P345, DOI 10.1016/S0306-4522(02)00073-8; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; HERBERG L, 1974, J LIPID RES, V15, P580; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pagliassotti MJ, 1997, ANN NY ACAD SCI, V827, P431, DOI 10.1111/j.1749-6632.1997.tb51853.x; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Shen HQ, 1999, METABOLISM, V48, P965, DOI 10.1016/S0026-0495(99)90191-9; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	31	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28396	28402		10.1074/jbc.M111.223206	http://dx.doi.org/10.1074/jbc.M111.223206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21543334	hybrid, Green Published			2022-12-27	WOS:000293557800055
J	Kean, MJ; Ceccarelli, DF; Goudreault, M; Sanches, M; Tate, S; Larsen, B; Gibson, LCD; Derry, WB; Scott, IC; Pelletier, L; Baillie, GS; Sicheri, F; Gingras, AC				Kean, Michelle J.; Ceccarelli, Derek F.; Goudreault, Marilyn; Sanches, Mario; Tate, Stephen; Larsen, Brett; Gibson, Lucien C. D.; Derry, W. Brent; Scott, Ian C.; Pelletier, Laurence; Baillie, George S.; Sicheri, Frank; Gingras, Anne-Claude			Structure-Function Analysis of Core STRIPAK Proteins A SIGNALING COMPLEX IMPLICATED IN GOLGI POLARIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR INTEGRITY; CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; STRIATIN FAMILY; PHOSPHATASE 2A; GENOME-SCALE; RHO GTPASES; KINASE; PATHWAY	Cerebral cavernous malformations (CCMs) are alterations in brain capillary architecture that can result in neurological deficits, seizures, or stroke. We recently demonstrated that CCM3, a protein mutated in familial CCMs, resides predominantly within the STRIPAK complex (striatin interacting phosphatase and kinase). Along with CCM3, STRIPAK contains the Ser/Thr phosphatase PP2A. The PP2A holoenzyme consists of a core catalytic subunit along with variable scaffolding and regulatory subunits. Within STRIPAK, striatin family members act as PP2A regulatory subunits. STRIPAK also contains all three members of a subfamily of Sterile 20 kinases called the GCKIII proteins (MST4, STK24, and STK25). Here, we report that striatins and CCM3 bridge the phosphatase and kinase components of STRIPAK and map the interacting regions on each protein. We show that striatins and CCM3 regulate the Golgi localization of MST4 in an opposite manner. Consistent with a previously described function for MST4 and CCM3 in Golgi positioning, depletion of CCM3 or striatins affects Golgi polarization, also in an opposite manner. We propose that STRIPAK regulates the balance between MST4 localization at the Golgi and in the cytosol to control Golgi positioning.	[Kean, Michelle J.; Ceccarelli, Derek F.; Goudreault, Marilyn; Sanches, Mario; Larsen, Brett; Pelletier, Laurence; Sicheri, Frank; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kean, Michelle J.; Derry, W. Brent; Scott, Ian C.; Pelletier, Laurence; Sicheri, Frank; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tate, Stephen] AB SCIEX, Concord, ON L4K 4V8, Canada; [Gibson, Lucien C. D.] Univ Glasgow, Inst Psychol & Neurosci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Derry, W. Brent; Scott, Ian C.; Baillie, George S.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Glasgow; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,Rm 992, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca	Derry, Brent/CAF-4503-2022; Pelletier, Laurence/F-8858-2013; Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Ceccarelli, Derek/0000-0002-2674-9234; Scott, Ian/0000-0001-6665-1410; tate, stephen/0000-0001-5508-0819; Derry, Brent/0000-0002-1977-8475	Canadian Institutes of Health Research [MOP-36399, MOP-84314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36399 (to F. S.) and MOP-84314 (to A.-C. G.).	Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gonon EM, 2005, FEBS LETT, V579, P6169, DOI 10.1016/j.febslet.2005.09.090; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Helliwell SB, 1998, GENETICS, V148, P99; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xiang QJ, 2002, GENETICS, V160, P169; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	49	97	99	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25065	25075		10.1074/jbc.M110.214486	http://dx.doi.org/10.1074/jbc.M110.214486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561862	Green Published, hybrid			2022-12-27	WOS:000292547900055
J	Rahmaniyan, M; Curley, RW; Obeid, LM; Hannun, YA; Kraveka, JM				Rahmaniyan, Mehrdad; Curley, Robert W.; Obeid, Lina M.; Hannun, Yusuf A.; Kraveka, Jacqueline M.			Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLITE 4-OXO-FENRETINIDE; IRREVERSIBLE INHIBITION; ORAL FENRETINIDE; BREAST-CANCER; CELL-DEATH; CERAMIDE; SPHINGOLIPIDS; APOPTOSIS; CHEMOPREVENTION; BIOSYNTHESIS	The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide. We previously demonstrated that fenretinide (4-HPR) inhibited DES activity in SMS-KCNR neuroblastoma cells. In this study, we investigated whether 4-HPR acted directly on the enzyme in vitro. N-C8:0-D-erythro-dihydroceramide (C-8-dhCer) was used as a substrate to study the conversion of dihydroceramide into ceramide in vitro using rat liver microsomes, and the formation of tritiated water after the addition of the tritiated substrate was detected and used to measure DES activity. NADH served as a cofactor. The apparent K-m for C-8-dhCer and NADH were 1.92 +/- 0.36 mu M and 43.4 +/- 6.47 mu M, respectively; and the V-max was 3.16 +/- 0.24 and 4.11 +/- 0.18 nmol/min/g protein. Next, the effects of 4-HPR and its metabolites on DES activity were investigated. 4-HPR was found to inhibit DES in a dose-dependent manner. At 20 min, the inhibition was competitive; however, longer incubation times demonstrated the inhibition to be irreversible. Among the major metabolites of 4-HPR, 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR) showed the highest inhibitory effect with substrate concentration of 0.5 mu M, with an IC50 of 1.68 mu M as compared with an IC50 of 2.32 mu M for 4-HPR. N-(4-Methoxyphenyl) retinamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl) retinamide (4-oxo-4-MPR) had minimal effects on DES activity. A known competitive inhibitor of DES, C-8-cyclopropenylceramide was used as a positive control. These studies define for the first time a direct in vitro target for 4-HPR and suggest that inhibitors of DES may be used as therapeutic interventions to regulate ceramide desaturation and consequent function.	[Rahmaniyan, Mehrdad; Kraveka, Jacqueline M.] Med Univ S Carolina, Dept Pediat, Div Hematol Oncol, Charleston, SC USA; [Curley, Robert W.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Obeid, Lina M.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; University System of Ohio; Ohio State University; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kraveka, JM (corresponding author), Med Univ S Carolina, Dept Pediat Hematol Oncol, 135 Rutledge Ave,MSC 558, Charleston, SC 29425 USA.	kravekjm@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [K01-CA100767, P01-CA97132, R01-AG016583, R01-CA49837, C06-RR018823]; Office of Research and Development; Department of Veterans Affairs; Ralph H. Johnson VA Medical Center (Charleston, SC) from the National Center for Research Resources [P20-RR17677]; Rally Foundation for Childhood Cancer Research; Monica Kreber Golf Tournament; Chase After a Cure Foundation; Hyundai Hope on Wheels; NATIONAL CANCER INSTITUTE [K01CA100767, R01CA087584, R01CA049837, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development; Department of Veterans Affairs(US Department of Veterans Affairs); Ralph H. Johnson VA Medical Center (Charleston, SC) from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rally Foundation for Childhood Cancer Research; Monica Kreber Golf Tournament; Chase After a Cure Foundation; Hyundai Hope on Wheels; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K01-CA100767 (to J. M. K.), P01-CA97132 (to Y. A. H. and L. M. O.), R01-AG016583 (to L. M. O.), R01-CA49837 (to R. W. C.), C06-RR018823 (Lipidomics Core), and by a MERIT award by the Office of Research and Development (to L. M. O.). This work was also supported by the Department of Veterans Affairs, Ralph H. Johnson VA Medical Center (Charleston, SC) by Grant P20-RR17677 from the National Center for Research Resources and by grants from the Rally Foundation for Childhood Cancer Research, the Monica Kreber Golf Tournament, the Chase After a Cure Foundation, and Hyundai Hope on Wheels (to J. M. K.).	BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; CHIESA F, 1993, J CELL BIOCHEM, P255; DiPietrantonio AM, 1998, INT J CANCER, V78, P53, DOI 10.1002/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6; Formelli F, 2008, CANCER CHEMOTH PHARM, V62, P655, DOI 10.1007/s00280-007-0649-7; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Marachelian A, 2009, J CLIN ONCOL, V27; Mershon SM, 2007, BIOORG MED CHEM LETT, V17, P836, DOI 10.1016/j.bmcl.2006.10.050; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Rege B, 2002, DRUG METAB DISPOS, V30, P1337, DOI 10.1124/dmd.30.12.1337; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Sukhodub Andrey L., 2005, Journal of Pharmacological and Toxicological Methods, V52, P330, DOI 10.1016/j.vascn.2005.04.016; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; TIPTON KF, 1983, BIOCHEM J, V209, P235, DOI 10.1042/bj2090235; Torrisi R, 2001, DRUGS, V61, P909, DOI 10.2165/00003495-200161070-00002; Triola G, 2004, MOL PHARMACOL, V66, P1671, DOI 10.1124/mol.104.003681; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; Triola G, 2001, ANGEW CHEM INT EDIT, V40, P1960, DOI 10.1002/1521-3773(20010518)40:10<1960::AID-ANIE1960>3.3.CO;2-M; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	41	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24754	24764		10.1074/jbc.M111.250779	http://dx.doi.org/10.1074/jbc.M111.250779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543327	hybrid, Green Published			2022-12-27	WOS:000292547900026
J	Rybchyn, MS; Slater, M; Conigrave, AD; Mason, RS				Rybchyn, Mark S.; Slater, Michael; Conigrave, Arthur D.; Mason, Rebecca S.			An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BONE-FORMATION; BETA-CATENIN; KINASE-B; VERTEBRAL FRACTURE; IN-VITRO; RECEPTOR; CALCIUM; EXPRESSION; PROMOTES	Sclerostin is an important regulator of bone homeostasis and canonical Wnt signaling is a key regulator of osteogenesis. Strontium ranelate is a treatment for osteoporosis that has been shown to reduce fracture risk, in part, by increasing bone formation. Here we show that exposure of human osteoblasts in primary culture to strontium increased mineralization and decreased the expression of sclerostin, an osteocyte-specific secreted protein that acts as a negative regulator of bone formation by inhibiting canonical Wnt signaling. Strontium also activated, in an apparently separate process, an Akt-dependent signaling cascade via the calcium-sensing receptor that promoted the nuclear translocation of beta-catenin. We propose that two discrete pathways linked to canonical Wnt signaling contribute to strontium-induced osteogenic effects in osteoblasts.	[Rybchyn, Mark S.; Slater, Michael; Mason, Rebecca S.] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; [Rybchyn, Mark S.; Slater, Michael; Conigrave, Arthur D.; Mason, Rebecca S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Mason, RS (corresponding author), Univ Sydney, Dept Physiol, Anderson Stuart Bldg,F13, Sydney, NSW 2006, Australia.	rebeccam@physiol.usyd.edu.au	Mason, Rebecca/AHB-5478-2022	Mason, Rebecca/0000-0003-1534-9697; Rybchyn, Mark/0000-0002-4336-6227; Conigrave, Arthur/0000-0002-7232-3891	National Health and Medical Research Council of Australia [21124]; Servier, France	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Servier, France(Servier)	This work was supported by the National Health and Medical Research Council of Australia (Grant 21124 to A. D. C. and R. S. M.) and by Servier, France. The research project was funded by Servier, France, which markets strontium ranelate as an agent for the treatment of osteoporosis. The research proposal originated from the authors group. Servier had no input into the conduct of the research, analysis of data, or preparation of this manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Arlot ME, 2008, J BONE MINER RES, V23, P215, DOI 10.1359/JBMR.071012; Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Barve V, 2006, J MED CHEM, V49, P3800, DOI 10.1021/jm051068y; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blake GM, 2005, J BONE MINER RES, V20, P1901, DOI 10.1359/JBMR.050810; Boivin G, 2010, OSTEOPOROSIS INT, V21, P667, DOI 10.1007/s00198-009-1005-z; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; BOWERS GN, 1986, CLIN CHEM, V32, P1437; Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x; Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Grebenova D, 2003, J PHOTOCH PHOTOBIO B, V69, P71, DOI 10.1016/S1011-1344(02)00410-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Malluche H.H., 1986, ATLAS MINERALIZED BO, P10; Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6; Meunier PJ, 2002, J CLIN ENDOCR METAB, V87, P2060, DOI 10.1210/jc.87.5.2060; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Reginster JY, 2009, BONE, V45, P1059, DOI 10.1016/j.bone.2009.08.004; Reginster JY, 2002, OSTEOPOROSIS INT, V13, P925, DOI 10.1007/s001980200129; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; SLATER M, 1995, J ORTHOP RES, V13, P655, DOI 10.1002/jor.1100130504; SLATER M, 1994, AM J PHYSIOL-ENDOC M, V267, pE990, DOI 10.1152/ajpendo.1994.267.6.E990; SLATER M, 1994, J BONE MINER RES, V9, P161; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	58	82	89	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23771	23779		10.1074/jbc.M111.251116	http://dx.doi.org/10.1074/jbc.M111.251116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566129	Green Published, hybrid			2022-12-27	WOS:000292294900019
J	Watson, AA; Lebedev, AA; Hall, BA; Fenton-May, AE; Vagin, AA; Dejnirattisai, W; Felce, J; Mongkolsapaya, J; Palma, AS; Liu, Y; Feizi, T; Screaton, GR; Murshudov, GN; O'Callaghan, CA				Watson, Aleksandra A.; Lebedev, Andrey A.; Hall, Benjamin A.; Fenton-May, Angharad E.; Vagin, Alexei A.; Dejnirattisai, Wanwisa; Felce, James; Mongkolsapaya, Juthathip; Palma, Angelina S.; Liu, Yan; Feizi, Ten; Screaton, Gavin R.; Murshudov, Garib N.; O'Callaghan, Christopher A.			Structural Flexibility of the Macrophage Dengue Virus Receptor CLEC5A IMPLICATIONS FOR LIGAND BINDING AND SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE MICROARRAYS; CRYSTAL-STRUCTURE; LECTIN-LIKE; RECOGNITION; DOMAIN; CELLS; MDL-1; EXPRESSION; PROTEINS; TRANSDUCTION	The human C-type lectin-like molecule CLEC5A is a critical macrophage receptor for dengue virus. The binding of dengue virus to CLEC5A triggers signaling through the associated adapter molecule DAP12, stimulating proinflammatory cytokine release. We have crystallized an informative ensemble of CLEC5A structural conformers at 1.9-angstrom resolution and demonstrate how an on-off extension to a beta-sheet acts as a binary switch regulating the flexibility of the molecule. This structural information together with molecular dynamics simulations suggests a mechanism whereby extracellular events may be transmitted through the membrane and influence DAP12 signaling. We demonstrate that CLEC5A is homodimeric at the cell surface and binds to dengue virus serotypes 1-4. We used blotting experiments, surface analyses, glycan microarray, and docking studies to investigate the ligand binding potential of CLEC5A with particular respect to dengue virus. This study provides a rational foundation for understanding the dengue virus-macrophage interaction and the role of CLEC5A in dengue virus-induced lethal disease.	[O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England; [Lebedev, Andrey A.; Vagin, Alexei A.; Murshudov, Garib N.] Univ York, Struct Biol Lab, Dept Chem, York YO10 5YW, N Yorkshire, England; [Hall, Benjamin A.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3QU, England; [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, London W12 0NN, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Bangkok 10700, Thailand; [Palma, Angelina S.; Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, Dept Med, London HA1 3UJ, England; [Palma, Angelina S.] Univ Nova Lisboa, Rede Quim & Tecnol REQUIMTE, Dept Chem, Fac Sci & Technol, P-2829516 Caparica, Portugal; [Felce, James] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; University of York - UK; University of Oxford; Imperial College London; Mahidol University; Imperial College London; Universidade Nova de Lisboa; University of Oxford	O'Callaghan, CA (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk	Hall, Ben/AAA-4981-2020; Palma, Angelina S/D-2052-2013; Liu, Yan/D-9117-2013	Hall, Ben/0000-0003-0355-2946; Palma, Angelina S/0000-0001-5797-6555; Fenton-May, Angharad/0000-0002-6267-1315; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Screaton, Gavin/0000-0002-3549-4309; Felce, James/0000-0001-5531-9244	UK Medical Research Council, National Institute for Health; UK Research Council [GR/S79268]; Engineering and Physical Research Council [EP/G037604/1]; Portuguese Foundation for Science and Technology; National Institutes of Health [GM62116]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F001134/1] Funding Source: researchfish; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish; Medical Research Council [G116/165, G0400720, G0801508] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; BBSRC [BB/F001134/1] Funding Source: UKRI; EPSRC [EP/G037604/1] Funding Source: UKRI; MRC [G0801508, G116/165, G0400720] Funding Source: UKRI	UK Medical Research Council, National Institute for Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Council; Engineering and Physical Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council, National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program, UK Research Councils Basic Technology Grant GR/S79268 ("Glycoarrays"), Engineering and Physical Research Councils Translational Grant EP/G037604/1, and the Portuguese Foundation for Science and Technology.; We thank Mark Ellis at the Synchrotron Radiation Source, Daresbury, UK and Keith Morris, Paul Young, Aleksandra Flanagan, Jon Grimes, Geoff Sutton, and Mark Sansom for useful conversations. We acknowledge colleagues in the Glycosciences Laboratory: Wengang Chai, Yibing Zhang, Maria Campanero-Rhodes, and Robert Childs for help with microarrays. We acknowledge The Protein-Glycan Interaction Core (H) of The Consortium for Functional Glycomics (funded by National Institutes of Health Grant GM62116 from the NIGMS) for the glycan array analysis.	Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Dimasi N, 2004, IMMUNOL RES, V30, P95, DOI 10.1385/IR:30:1:095; DRICKAMER K, 1989, BIOCHEM SOC T, V17, P13, DOI 10.1042/bst0170013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Moore JO, 2009, STRUCTURE, V17, P1195, DOI 10.1016/j.str.2009.07.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Watson AA, 2005, ACTA CRYSTALLOGR F, V61, P1094, DOI 10.1107/S1744309105037991; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Watson AA, 2010, ACTA CRYSTALLOGR F, V66, P29, DOI 10.1107/S1744309109047915; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; *WHO, 2009, 117 WHO; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Yim D, 2001, CELL IMMUNOL, V209, P42, DOI 10.1006/cimm.2001.1782; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	53	36	39	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24208	24218		10.1074/jbc.M111.226142	http://dx.doi.org/10.1074/jbc.M111.226142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566123	Green Published, hybrid			2022-12-27	WOS:000292294900063
J	Brown, MJ; Thoren, KL; Krantz, BA				Brown, Michael J.; Thoren, Katie L.; Krantz, Bryan A.			Charge Requirements for Proton Gradient-driven Translocation of Anthrax Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ANTIGEN; PROTEIN TRANSLOCATION; LETHAL FACTOR; PRECURSOR PROTEINS; CRYSTAL-STRUCTURE; PORE FORMATION; EDEMA FACTORS; ATP SYNTHASE; MITOCHONDRIAL; MECHANISM	Anthrax lethal toxin is used as a model system to study protein translocation. The toxin is composed of a translocase channel, called protective antigen (PA), and an enzyme, called lethal factor (LF). A proton gradient (Delta pH) can drive LF unfolding and translocation through PA channels; however, the mechanism of Delta pH-mediated force generation, substrate unfolding, and establishment of directionality are poorly understood. One recent hypothesis suggests that the Delta pH may act through changes in the protonation state of residues in the substrate. Here we report the charge requirements of LF's amino-terminal binding domain (LFN) using planar lipid bilayer electrophysiology. We found that acidic residues are required in LFN to utilize a proton gradient for translocation. Constructs lacking negative charges in the unstructured presequence of LFN translocate independently of the Delta pH driving force. Acidic residues markedly increase the rate of Delta pH-driven translocation, and the presequence is optimized in its natural acidic residue content for efficient Delta pH-driven unfolding and translocation. We discuss a Delta pH-driven charge state Brownian ratchet mechanism for translocation, where glutamic and aspartic acid residues in the substrate are the "molecular teeth" of the ratchet. Our Brownian ratchet model includes a mechanism for unfolding and a novel role for positive charges, which we propose chaperone negative charges through the PA channel during Delta pH translocation.	[Brown, Michael J.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thoren, Katie L.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krantz, BA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 476 Stanley Hall,3220, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu		Krantz, Bryan/0000-0002-4911-5824	National Institutes of Health [R01-AI077703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI077703.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Feynman R., 1963, FEYNMAN LECT PHYS, V1; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GLICK BS, 1993, PROTEIN SCI, V2, P1901, DOI 10.1002/pro.5560021112; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Huang SH, 2002, NAT STRUCT BIOL, V9, P301, DOI 10.1038/nsb772; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oster G, 1999, STRUCTURE, V7, pR67, DOI 10.1016/S0969-2126(99)80046-X; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pentelute BL, 2010, ACS CHEM BIOL, V5, P359, DOI 10.1021/cb100003r; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shariff K, 2004, BIOPHYS J, V86, P3647, DOI 10.1529/biophysj.104.040865; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yamano K, 2008, J BIOL CHEM, V283, P27325, DOI 10.1074/jbc.M805249200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	53	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23189	23199		10.1074/jbc.M111.231167	http://dx.doi.org/10.1074/jbc.M111.231167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21507946	hybrid, Green Published			2022-12-27	WOS:000292025000053
J	Roche, CJ; Malashkevich, V; Balazs, TC; Dantsker, D; Chen, Q; Moreira, J; Almo, SC; Friedman, JM; Hirsch, RE				Roche, Camille J.; Malashkevich, Vladimir; Balazs, Tatiana C.; Dantsker, David; Chen, Qiuying; Moreira, Juan; Almo, Steven C.; Friedman, Joel M.; Hirsch, Rhoda Elison			Structural and Functional Studies Indicating Altered Redox Properties of Hemoglobin E IMPLICATIONS FOR PRODUCTION OF BIOACTIVE NITRIC OXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-BETA-THALASSEMIA; PULMONARY-HYPERTENSION; REDUCTASE-ACTIVITY; BLOOD-CELLS; HEME REDOX; OXYGEN-AFFINITY; REACTIVITY; DEOXYHEMOGLOBIN; HEMOLYSIS; IRON	Hemoglobin (Hb) E (beta-Glu26Lys) remains an enigma in terms of its contributions to red blood cell (RBC) pathophysiological mechanisms; for example, EE individuals exhibit a mild chronic anemia, and HbE/beta-thalassemia individuals show a range of clinical manifestations, including high morbidity and death, often resulting from cardiac dysfunction. The purpose of this study was to determine and evaluate structural and functional consequences of the HbE mutation that might account for the pathophysiology. Functional studies indicate minimal allosteric consequence to both oxygen and carbon monoxide binding properties of the ferrous derivatives of HbE. In contrast, redox-sensitive reactions are clearly impacted as seen in the following: 1) the similar to 2.5 times decrease in the rate at which HbE catalyzes nitrite reduction to nitric oxide (NO) relative to HbA, and 2) the accelerated rate of reduction of aquometHbE by L-cysteine (L-Cys). Sol-gel encapsulation studies imply a shift toward a higher redox potential for both the T and R HbE structures that can explain the origin of the reduced nitrite reductase activity of deoxyHbE and the accelerated rate of reduction of aquometHbE by cysteine. Deoxy- and CO HbE crystal structures (derived from crystals grown at or near physiological pH) show loss of hydrogen bonds in the microenvironment of beta Lys-26 and no significant tertiary conformational perturbations at the allosteric transition sites in the R and T states. Together, these data suggest a model in which the HbE mutation, as a consequence of a relative change in redox properties, decreases the overall rate of Hb-mediated production of bioactive NO.	[Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Malashkevich, Vladimir; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Balazs, Tatiana C.; Chen, Qiuying; Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu; rhoda.hirsch@einstein.yu.edu			National Institutes of Health [R21 DK064123, R21 HL106421]; American Heart Association [0755906T]; FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK064123 (to R. E. H.) and R21 HL106421 (to R. E. H. and J. M. F.). This work was also supported by American Heart Association Heritage Affiliate Grant-in-aid 0755906T (to R. E. H.) and FJC, a foundation of philanthropic funds (to J. M. F.).	Adachi K, 2003, BIOCHEMISTRY-US, V42, P10252, DOI 10.1021/bi030095s; Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN JM, 1980, J MOL BIOL, V136, P103, DOI 10.1016/0022-2836(80)90308-3; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bonaventura C, 2002, J BIOL CHEM, V277, P14557, DOI 10.1074/jbc.M107658200; Bonaventura C, 2007, IUBMB LIFE, V59, P498, DOI 10.1080/15216540601188546; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; BUNN HF, 1972, J CLIN INVEST, V51, P2299, DOI [10.1172/JCI107040, 10.1172/JCI107125]; CABRALES P., 2007, TRANSFUS ALTERN TRAN, V9, P281; Cao ZL, 2009, AM J PHYSIOL-HEART C, V297, pH1494, DOI 10.1152/ajpheart.01233.2008; Chakraborty I, 2010, ANN ACAD MED SINGAP, V39, P13; CHAVEZ MD, 1990, BIOCHEMISTRY-US, V29, P4844, DOI 10.1021/bi00472a014; Chen QY, 2006, FEBS LETT, V580, P4485, DOI 10.1016/j.febslet.2006.07.021; Chen QY, 2004, BLOOD CELL MOL DIS, V33, P303, DOI 10.1016/j.bcmd.2004.07.006; Chiu DTY, 1996, FREE RADICAL BIO MED, V21, P89, DOI 10.1016/0891-5849(96)00035-4; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Conran N, 2009, CLIN BIOCHEM, V42, P1824, DOI 10.1016/j.clinbiochem.2009.06.024; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dantsker D, 2002, J MOL BIOL, V315, P239, DOI 10.1006/jmbi.2001.5218; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fucharoen S, 2000, J PEDIAT HEMATOL ONC, V22, P552, DOI 10.1097/00043426-200011000-00022; Fucharoeon S., 2001, DISORDERS HEMOGLOBIN; GACON G, 1974, FEBS LETT, V41, P147, DOI 10.1016/0014-5793(74)80975-0; Geraci G, 1981, Methods Enzymol, V76, P262; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gow AJ, 2005, AM J RESP CELL MOL, V32, P479, DOI 10.1165/rcmb.F299; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; HIRSCH RE, 1988, J BIOL CHEM, V263, P5936; Hirsch RE, 1996, J BIOL CHEM, V271, P372, DOI 10.1074/jbc.271.1.372; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huang J, 1999, BIOCHEMISTRY-US, V38, P4514, DOI 10.1021/bi982724h; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jia YL, 1996, J APPL PHYSIOL, V80, P404, DOI 10.1152/jappl.1996.80.2.404; Kato GJ, 2010, BRIT J HAEMATOL, V148, P690, DOI 10.1111/j.1365-2141.2009.08004.x; Kato GJ, 2009, BRIT J HAEMATOL, V145, P506, DOI 10.1111/j.1365-2141.2009.07658.x; Kaul DK, 2008, AM J PHYSIOL-HEART C, V295, pH39, DOI 10.1152/ajpheart.00162.2008; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Khan I, 2000, BIOCHEMISTRY-US, V39, P16099, DOI 10.1021/bi000536x; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kukongviriyapan V, 2008, PEDIATR CARDIOL, V29, P130, DOI 10.1007/s00246-007-9107-x; LALEZARI I, 1990, BIOCHEMISTRY-US, V29, P1515, DOI 10.1021/bi00458a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; MACDONALD VW, 1983, J LAB CLIN MED, V102, P762; Manconi B, 2010, BBA-GEN SUBJECTS, V1800, P327, DOI 10.1016/j.bbagen.2009.10.010; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; Morris CR, 2008, CURR MOL MED, V8, P620, DOI 10.2174/156652408786241447; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Nuntakarn L, 2009, BLOOD CELL MOL DIS, V42, P32, DOI 10.1016/j.bcmd.2008.09.002; Olivieri NF, 2000, J PEDIAT HEMATOL ONC, V22, P593, DOI 10.1097/00043426-200011000-00029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perutz M. F., 1970, BIOCHEM J, V119, P31; Peterson ES, 2004, BIOCHEMISTRY-US, V43, P4832, DOI 10.1021/bi035481o; Premawardhena A, 2005, ANN NY ACAD SCI, V1054, P33, DOI 10.1196/annals.1345.005; Puddu Paolo, 2010, Can J Cardiol, V26, P140; Rees DC, 2000, J PEDIAT HEMATOL ONC, V22, P567, DOI 10.1097/00043426-200011000-00025; Rees DC, 1998, BLOOD, V92, P2141, DOI 10.1182/blood.V92.6.2141.418k05_2141_2146; Rifkind JM, 2009, ADV EXP MED BIOL, V645, P27, DOI 10.1007/978-0-387-85998-9_5; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; ROMERO FJ, 1992, J BIOL CHEM, V267, P1680; Safo MK, 2003, METH MOLEC MED, V82, P1; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, BIOCHEMISTRY-US, V43, P13674, DOI 10.1021/bi048531d; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Samuni Uri, 2008, V9, P133; SASSAROLI M, 1987, BIOCHEMISTRY-US, V26, P3092, DOI 10.1021/bi00385a022; Sen U, 2004, BIOCHEMISTRY-US, V43, P12477, DOI 10.1021/bi048903i; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SHAKLAI N, 1981, P NATL ACAD SCI-BIOL, V78, P65, DOI 10.1073/pnas.78.1.65; SHAKLAI N, 1977, BIOCHEMISTRY-US, V16, P5585, DOI 10.1021/bi00644a031; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; SHINAR E, 1990, ANN NY ACAD SCI, V612, P118; Singer ST, 2005, BRIT J HAEMATOL, V131, P378, DOI 10.1111/j.1365-2141.2005.05768.x; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takeoka S, 1997, BIOCONJUGATE CHEM, V8, P539, DOI 10.1021/bc970091y; TRAEGER J, 1980, NATURE, V288, P497, DOI 10.1038/288497a0; Vekilov PG, 2003, METH MOLEC MED, V82, P155; Vichinsky E., 2007, AM SOC HEMATOLOGY ED, P79; Watanapokasin Y, 2000, HEMOGLOBIN, V24, P105, DOI 10.3109/03630260009003429; Weatherall DJ, 2000, J PEDIAT HEMATOL ONC, V22, P551, DOI 10.1097/00043426-200011000-00021; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; WINICHAGOON P, 1985, AM J HEMATOL, V20, P217, DOI 10.1002/ajh.2830200303; Winichagoon P, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P241	109	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23452	23466		10.1074/jbc.M110.183186	http://dx.doi.org/10.1074/jbc.M110.183186			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531715	Green Published, hybrid			2022-12-27	WOS:000292025000076
J	Warnatz, HJ; Schmidt, D; Manke, T; Piccini, I; Sultan, M; Borodina, T; Balzereit, D; Wruck, W; Soldatov, A; Vingron, M; Lehrach, H; Yaspo, ML				Warnatz, Hans-Joerg; Schmidt, Dominic; Manke, Thomas; Piccini, Ilaria; Sultan, Marc; Borodina, Tatiana; Balzereit, Daniela; Wruck, Wasco; Soldatov, Alexey; Vingron, Martin; Lehrach, Hans; Yaspo, Marie-Laure			The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR VAULT PROTEIN; TRANSCRIPTION FACTOR BACH1; RNA-POLYMERASE-II; HEME OXYGENASE-1; BINDING-SITES; EXPRESSION; ASSOCIATION; PATHWAY; DOMAIN; CHIP	The regulation of gene expression in response to environmental signals and metabolic imbalances is a key step in maintaining cellular homeostasis. BTB and CNC homology 1 (BACH1) is a heme-binding transcription factor repressing the transcription from a subset of MAF recognition elements at low intracellular heme levels. Upon heme binding, BACH1 is released from the MAF recognition elements, resulting in increased expression of antioxidant response genes. To systematically address the gene regulatory networks involving BACH1, we combined chromatin immunoprecipitation sequencing analysis of BACH1 target genes in HEK 293 cells with knockdown of BACH1 using three independent types of small interfering RNAs followed by transcriptome profiling using microarrays. The 59 BACH1 target genes identified by chromatin immunoprecipitation sequencing were found highly enriched in genes showing expression changes after BACH1 knockdown, demonstrating the impact of BACH1 repression on transcription. In addition to known and new BACH1 targets involved in heme degradation (HMOX1, FTL, FTH1, ME1, and SLC48A1) and redox regulation (GCLC, GCLM, and SLC7A11), we also discovered BACH1 target genes affecting cell cycle and apoptosis pathways (ITPR2, CALM1, SQSTM1, TFE3, EWSR1, CDK6, BCL2L11, and MAFG) as well as subcellular transport processes (CLSTN1, PSAP, MAPT, and vault RNA). The newly identified impact of BACH1 on genes involved in neurodegenerative processes and proliferation provides an interesting basis for future dissection of BACH1-mediated gene repression in neurodegeneration and virus-induced cancerogenesis.	[Warnatz, Hans-Joerg; Schmidt, Dominic; Piccini, Ilaria; Sultan, Marc; Borodina, Tatiana; Balzereit, Daniela; Wruck, Wasco; Soldatov, Alexey; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Manke, Thomas; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society	Yaspo, ML (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 63-73, D-14195 Berlin, Germany.	yaspo@molgen.mpg.de	Manke, Thomas/L-9075-2019; Soldatov, Alexey/V-2383-2019	Borodina, Tatiana/0000-0002-6978-016X; Warnatz, Hans-Jorg/0000-0002-0327-9209; Manke, Thomas/0000-0003-3702-0868	Max Planck Society (Munich, Germany); European Commission [LSHG-CT-2006-037627]	Max Planck Society (Munich, Germany)(Max Planck Society); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society (Munich, Germany) and the European Commission under its Sixth Framework Programme Grant AnEUploidy LSHG-CT-2006-037627.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; BUSSOLATI O, 1992, J BIOL CHEM, V267, P8330; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x; Iwashita K, 2010, CANCER SCI, V101, P920, DOI [10.1111/j.1349-7006.2009.01481.x, 10.1111/j.1349-7006.2010.01481.x]; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kremmidiotis G, 2001, GENOMICS, V76, P58, DOI 10.1006/geno.2001.6560; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Miyazaki T, 2010, CANCER SCI, V101, P1409, DOI 10.1111/j.1349-7006.2010.01550.x; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller C, 2010, J ALZHEIMERS DIS, V19, P1081, DOI 10.3233/JAD-2010-1303; Nijman SMB, 2006, J BIOL CHEM, V281, P21582, DOI 10.1074/jbc.M602312200; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Okada S, 2010, J BIOL CHEM, V285, P23581, DOI 10.1074/jbc.M109.068197; Paspalas CD, 2009, CEREB CORTEX, V19, P1666, DOI 10.1093/cercor/bhn203; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Ryu SJ, 2009, EXPERT OPIN THER TAR, V13, P479, DOI [10.1517/14728220902832705 , 10.1517/14728220902832705]; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Singh VB, 2009, BIOCHEM BIOPH RES CO, V379, P710, DOI 10.1016/j.bbrc.2008.12.141; Slesina M, 2006, CELL TISSUE RES, V324, P403, DOI 10.1007/s00441-006-0158-8; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Taylor J., 2007, CURR PROTOC BIOINFOR; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Warnatz HJ, 2010, NUCLEIC ACIDS RES, V38, P6112, DOI 10.1093/nar/gkq402; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; WU CL, 1995, MOL CELL BIOL, V15, P2536; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	74	113	118	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23521	23532		10.1074/jbc.M111.220178	http://dx.doi.org/10.1074/jbc.M111.220178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555518	hybrid, Green Published			2022-12-27	WOS:000292025000082
J	Zhu, YB; Sheng, ZH				Zhu, Yi-Bing; Sheng, Zu-Hang			Increased Axonal Mitochondrial Mobility Does Not Slow Amyotrophic Lateral Sclerosis (ALS)-like Disease in Mutant SOD1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; ALS-LINKED SOD1; RESPIRATORY-CHAIN FUNCTION; WILD-TYPE; TRANSPORT DEFECTS; SKELETAL-MUSCLE; TRANSGENIC MICE; INHERITED ALS; MOUSE MODEL; DYNEIN	Reduced axonal mitochondrial transport has been observed in major neurodegenerative diseases, including fALS patients and SOD1(G93A) mice. However, it is unclear whether this defect plays a critical role in axonal degeneration or simply reflects sequelae of general transport alteration. Using genetic mouse models combined with time-lapse imaging of live neurons, we previously discovered that axon-targeted syntaphilin (SNPH) acts as a docking receptor specific for axonal mitochondria. Deletion of the snph gene in mice results in a substantially higher proportion of axonal mitochondria in the mobile state without any effect on the transport of other axonal organelles. Here we address whether increased (rescued) axonal mitochondrial mobility changes the disease course by crossing fALS-linked transgenic SOD1(G93A) and snph(-/-) knock-out mice. We found that a 2-fold increase in axonal mitochondrial mobility in SOD1(G93A)/snph(-/-) mice did not affect the onset of ALS-like symptoms. Both SOD1(G93A) and SOD1(G93A)/snph(-/-) mice exhibit similar weight loss, deterioration in motor function and motor neuron loss, significant gliosis, and a lifespan of 152-154 days. Thus, for the first time, our study provides genetic and pathological evidence that the impairment of mitochondrial transport seen in SOD1(G93A) mice plays a minimal role in the rapid-onset of fALS-linked pathology.	[Zhu, Yi-Bing; Sheng, Zu-Hang] NINDS, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sheng, ZH (corresponding author), NINDS, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	shengz@ninds.nih.gov			NINDS, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946, ZIANS003029] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the Intramural Research Program of the NINDS, National Institutes of Health (to Z.-H. S.).	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Guipponi M, 2010, J MOL NEUROSCI, V41, P172, DOI 10.1007/s12031-009-9317-1; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kong JM, 1998, J NEUROSCI, V18, P3241; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2009, HUM MOL GENET, V18, P4552, DOI 10.1093/hmg/ddp421; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Tateno M, 2009, HUM MOL GENET, V18, P942, DOI 10.1093/hmg/ddn422; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	52	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23432	23440		10.1074/jbc.M111.237818	http://dx.doi.org/10.1074/jbc.M111.237818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518771	Green Published, hybrid			2022-12-27	WOS:000292025000074
J	Chen, K; Xu, XM; Kobayashi, S; Timm, D; Jepperson, T; Liang, QR				Chen, Kai; Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Jepperson, Tyler; Liang, Qiangrong			Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEART-FAILURE; SIGNALING PATHWAY; OXIDATIVE STRESS; IN-VITRO; DIETARY SUPPLEMENTATION; REGULATES AUTOPHAGY; ENERGY RESTRICTION; TRANSGENIC MICE; CANCER-THERAPY	Caloric restriction (CR) is a dietary intervention known to enhance cardiovascular health. The glucose analog 2-deoxy-D-glucose (2-DG) mimics CR effects in several animal models. However, whether 2-DG is beneficial to the heart remains obscure. Here, we tested the ability of 2-DG to reduce cardiomyocyte death triggered by doxorubicin (DOX, 1 mu M), an antitumor drug that can cause heart failure. Treatment of neonatal rat cardiomyocytes with 0.5 mM 2-DG dramatically suppressed DOX cytotoxicity as indicated by a decreased number of cells that stained positive for propidium iodide and reduced apoptotic markers. 2-DG decreased intracellular ATP levels by 17.9%, but it prevented DOX-induced severe depletion of ATP, which may contribute to 2-DG-mediated cytoprotection. Also, 2-DG increased the activity of AMP-activated protein kinase (AMPK). Blocking AMPK signaling with compound C or small interfering RNA-mediated knockdown of the catalytic subunit markedly attenuated the protective effects of 2-DG. Conversely, AMPK activation by pharmacological or genetic approach reduced DOX cardiotoxicity but did not produce additive effects when used together with 2-DG. In addition, 2-DG induced autophagy, a cellular degradation pathway whose activation could be either protective or detrimental depending on the context. Paradoxically, despite its ability to activate autophagy, 2-DG prevented DOX-induced detrimental autophagy. Together, these results suggest that the CR mimetic 2-DG can antagonize DOX-induced cardiomyocyte death, which is mediated through multiple mechanisms, including the preservation of ATP content, the activation of AMPK, and the inhibition of autophagy.	[Chen, Kai; Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Jepperson, Tyler; Liang, Qiangrong] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA	Sanford Health; University of South Dakota	Liang, QR (corresponding author), Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA.	Qiangrong.Liang@sanfordhealth.org			National Institutes of Health [2P20RR017662-06A1]; American Diabetes Association [1-09-CD-09, 1-2007-741]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P20RR017662-06A1 (Project 3) from the NCRR (to Q. L.).; Supported by Juvenile Diabetes Research Foundation Research Grant 1-2007-741 and Career Development Grant 1-09-CD-09 from the American Diabetes Association.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Dwarukanath BS, 2004, CANCER BIOL THER, V3, P864, DOI 10.4161/cbt.3.9.1040; Dwivedi M, 2009, BMB REP, V42, P65, DOI 10.5483/BMBRep.2009.42.2.065; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Farooque A, 2009, J CANCER RES THER, V5, P32, DOI 10.4103/0973-1482.55138; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kritchevsky D, 2003, J NUTR, V133, p3827S, DOI 10.1093/jn/133.11.3827S; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lane Mark A, 2007, Methods Mol Biol, V371, P143; Lee HT, 2002, J AM SOC NEPHROL, V13, P2753, DOI 10.1097/01.ASN.0000032421.79225.6E; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lipshultz SE, 2010, LANCET ONCOL, V11, P950, DOI 10.1016/S1470-2045(10)70204-7; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Martin Bronwen, 2007, IBS J Sci, V2, P35; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011; Matsuda F, 2009, AUTOPHAGY, V5, P484, DOI 10.4161/auto.5.4.7760; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitra MS, 2007, TOXICOL APPL PHARM, V225, P90, DOI 10.1016/j.taap.2007.07.018; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muthukumar A, 2003, J CLIN IMMUNOL, V23, P23, DOI 10.1023/A:1021996130672; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Paiva M, 2009, J CARDIOVASC PHARM, V53, P373, DOI 10.1097/FJC.0b013e31819fd4e7; Perumal V, 2009, J CANCER RES THER, V5, P48, DOI 10.4103/0973-1482.55142; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Raeini-Sarjaz M, 2001, AM J CLIN NUTR, V73, P262; Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Sun XH, 2001, CANCER RES, V61, P3382; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; THAKKAR NS, 1993, CANCER RES, V53, P2057; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; Wan RQ, 2003, FASEB J, V17, P1133, DOI 10.1096/fj.02-0996fje; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8	88	50	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21993	22006		10.1074/jbc.M111.225805	http://dx.doi.org/10.1074/jbc.M111.225805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521688	Green Published, hybrid			2022-12-27	WOS:000291719900006
J	Murata, T; Noda, C; Saito, S; Kawashima, D; Sugimoto, A; Isomura, H; Kanda, T; Yokoyama, KK; Tsurumi, T				Murata, Takayuki; Noda, Chieko; Saito, Shinichi; Kawashima, Daisuke; Sugimoto, Atsuko; Isomura, Hiroki; Kanda, Teru; Yokoyama, Kazunari K.; Tsurumi, Tatsuya			Involvement of Jun Dimerization Protein 2 (JDP2) in the Maintenance of Epstein-Barr Virus Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZLF1 GENE PROMOTER; AP-1 REPRESSOR PROTEIN; LYTIC-SWITCH; TRANSCRIPTION FACTOR; INSERTIONAL MUTAGENESIS; DEPENDENT TRANSCRIPTION; HISTONE ACETYLATION; BINDING; IDENTIFICATION; DIFFERENTIATION	Reactivation of the Epstein-Barr virus from latency is dependent on expression of the BZLF1 viral immediate-early protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found that Jun dimerization protein 2 (JDP2) plays a significant role in suppressing Zp activity. Reporter, EMSA, and ChIP assays of a Zp mutant virus revealed JDP2 association with Zp at the ZII cis-element, a binding site for CREB/ATF/AP-1. Suppression of Zp activity by JDP2 correlated with HDAC3 association and reduced levels of histone acetylation. Although introduction of point mutations into the ZII element of the viral genome did not increase the level of BZLF1 production, silencing of endogenous JDP2 gene expression by RNA interference increased the levels of viral early gene products and viral DNA replication. These results indicate that JDP2 plays a role as a repressor of Zp and that its replacement by CREB/ATF/AP-1 at ZII is crucial to triggering reactivation from latency to lytic replication.	[Murata, Takayuki; Noda, Chieko; Saito, Shinichi; Kawashima, Daisuke; Sugimoto, Atsuko; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Ctr Canc, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	Aichi Cancer Center; Kaohsiung Medical University	Tsurumi, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Kanda, Teru/J-7313-2019	Murata, Takayuki/0000-0001-7228-0839; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [20390137, 21022055, 20790362, 22790448]; Uehara Memorial Research Fund; Japan Leukaemia Research Fund	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Research Fund(Uehara Memorial Foundation); Japan Leukaemia Research Fund	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan 20390137 and 21022055 (to T. T.) and 20790362 and 22790448 (to T. M.), and grants from the Uehara Memorial Research Fund (to T. T.) and the Japan Leukaemia Research Fund (to T. M.).	Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bhende PM, 2007, J VIROL, V81, P7363, DOI 10.1128/JVI.00154-07; Bitton-Worms K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-54; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Ellis AL, 2010, J VIROL, V84, P6139, DOI 10.1128/JVI.02706-09; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kraus RJ, 2003, J VIROL, V77, P199, DOI 10.1128/JVI.77.1.199-207.2003; Lerdrup M, 2005, BBA-MOL CELL RES, V1745, P29, DOI 10.1016/j.bbamcr.2005.06.008; Liu PF, 1998, J VIROL, V72, P8230, DOI 10.1128/JVI.72.10.8230-8239.1998; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Nakayama S, 2010, J VIROL, V84, P12589, DOI 10.1128/JVI.01394-10; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Rasmussen MH, 2005, VIROLOGY, V337, P353, DOI 10.1016/j.virol.2005.04.027; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Thomas C, 2003, J GEN VIROL, V84, P959, DOI 10.1099/vir.0.18740-0; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu XM, 2007, PLOS PATHOG, V3, P1993, DOI 10.1371/journal.ppat.0030194; Zhang Q, 1999, VIROLOGY, V255, P160, DOI 10.1006/viro.1998.9588	42	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22007	22016		10.1074/jbc.M110.199836	http://dx.doi.org/10.1074/jbc.M110.199836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525011	Green Published, hybrid			2022-12-27	WOS:000291719900007
J	Samai, P; Shuman, S				Samai, Poulami; Shuman, Stewart			Structure-Function Analysis of the OB and Latch Domains of Chlorella Virus DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; NICK RECOGNITION; MECHANISM; YEAST	Chlorella virus DNA ligase (ChVLig) is a minimized eukaryal ATP-dependent DNA sealing enzyme with an intrinsic nick-sensing function. ChVLig consists of three structural domains, nucleotidyltransferase (NTase), OB-fold, and latch, that envelop the nicked DNA as a C-shaped protein clamp. The OB domain engages the DNA minor groove on the face of the duplex behind the nick, and it makes contacts to amino acids in the NTase domain surrounding the ligase active site. The latch module occupies the DNA major groove flanking the nick. Residues at the tip of the latch contact the NTase domain to close the ligase clamp. Here we performed a structure-guided mutational analysis of the OB and latch domains. Alanine scanning defined seven individual amino acids as essential in vivo (Lys-274, Arg-285, Phe-286, and Val-288 in the OB domain; Asn-214, Phe-215, and Tyr-217 in the latch), after which structure-activity relations were clarified by conservative substitutions. Biochemical tests of the composite nick sealing reaction and of each of the three chemical steps of the ligation pathway highlighted the importance of Arg-285 and Phe-286 in the catalysis of the DNA adenylylation and phosphodiester synthesis reactions. Phe-286 interacts with the nick 5'-phosphate nucleotide and the 3'-OH base pair and distorts the DNA helical conformation at the nick. Arg-285 is a key component of the OB-NTase interface, where it forms a salt bridge to the essential Asp-29 side chain, which is imputed to coordinate divalent metal catalysts during the nick sealing steps.	[Samai, Poulami; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611 (to S. S.).	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9661, DOI 10.1074/jbc.M110613200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903	22	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22642	22652		10.1074/jbc.M111.245399	http://dx.doi.org/10.1074/jbc.M111.245399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527793	Green Published, hybrid			2022-12-27	WOS:000291719900071
J	Boltz, A; Piater, B; Toleikis, L; Guenther, R; Kolmar, H; Hock, B				Boltz, Achim; Piater, Birgit; Toleikis, Lars; Guenther, Ralf; Kolmar, Harald; Hock, Bjoern			Bi-specific Aptamers Mediating Tumor Cell Lysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; FC-GAMMA-RIII; CHAIN ANTIBODY CONSTRUCT; DNA APTAMERS; IN-VIVO; EFFECTIVE ELIMINATION; BIVALENT APTAMER; TYROSINE KINASE; LEUKEMIC-CELLS; MET ANTIBODY	Antibody-dependent cellular cytotoxicity plays a pivotal role in antibody-based tumor therapies and is based on the recruitment of natural killer cells to antibody-bound tumor cells via binding of the Fc gamma receptor III (CD16). Here we describe the generation of chimeric DNA aptamers that simultaneously bind to CD16 alpha and c-Met, a receptor that is overexpressed in many tumors. By application of the systematic evolution of ligands by exponential enrichment (SELEX) method, CD16 alpha specific DNA aptamers were isolated that bound with high specificity and affinity (91 pM-195 nM) to their respective recombinant and cellularly expressed target proteins. Two optimized CD16 alpha specific aptamers were coupled to each of two c-Met specific aptamers using different linkers. Bi-specific aptamers retained suitable binding properties and displayed simultaneous binding to both antigens. Moreover, they mediated cellular cytotoxicity dependent on aptamer and effector cell concentration. Displacement of a bi-specific aptamer from CD16 alpha by competing antibody 3G8 reduced cytotoxicity and confirmed the proposed mode of action. These results represent the first gain of a tumor-effective function of two distinct oligonucleotides by linkage into a bi-specific aptamer mediating cellular cytotoxicity.	[Boltz, Achim; Piater, Birgit; Toleikis, Lars; Guenther, Ralf; Hock, Bjoern] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol Dept, D-64293 Darmstadt, Germany; Tech Univ Darmstadt, Clemens Schoepf Inst Organ Chem & Biochem, D-64289 Darmstadt, Germany	Merck KGaA; EMD Serono Inc.; Technical University of Darmstadt	Hock, B (corresponding author), Merck KGaA, Merck Serono, Prot Engn & Antibody Technol Dept, Frankfurter Str 250, D-64293 Darmstadt, Germany.	Bjoern.Hock@merck.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Doerner, Achim/0000-0002-4741-8039				Aarden L, 2008, CURR OPIN IMMUNOL, V20, P431, DOI 10.1016/j.coi.2008.06.011; Arndt MAE, 1999, BLOOD, V94, P2562, DOI 10.1182/blood.V94.8.2562.420k20_2562_2568; Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bates Paula J., 2009, V542, P379, DOI 10.1007/978-1-59745-561-9_21; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bluemel C, 2010, CANCER IMMUNOL IMMUN, V59, P1197, DOI 10.1007/s00262-010-0844-y; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Bruenke J, 2004, BRIT J HAEMATOL, V125, P167, DOI 10.1111/j.1365-2141.2004.04893.x; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Constantinou A, 2010, BIOTECHNOL LETT, V32, P609, DOI 10.1007/s10529-010-0214-z; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Desjarlais JR, 2007, DRUG DISCOV TODAY, V12, P898, DOI 10.1016/j.drudis.2007.08.009; Di Giusto DA, 2006, CHEMBIOCHEM, V7, P535, DOI 10.1002/cbic.200500316; Di Giusto DA, 2004, J BIOL CHEM, V279, P46483, DOI 10.1074/jbc.M408037200; Dollins CM, 2008, CHEM BIOL, V15, P675, DOI 10.1016/j.chembiol.2008.05.016; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farag SS, 2003, INT J HEMATOL, V78, P7, DOI 10.1007/BF02983234; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; HARRISON D, 1991, J IMMUNOL, V147, P3459; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; HUIZINGA TWJ, 1994, BRIT J HAEMATOL, V87, P459, DOI 10.1111/j.1365-2141.1994.tb08298.x; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kaur G, 2008, EXPERT OPIN INV DRUG, V17, P43, DOI 10.1517/13543784.17.1.43; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kim Y, 2008, P NATL ACAD SCI USA, V105, P5664, DOI 10.1073/pnas.0711803105; Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Kugler M, 2010, BRIT J HAEMATOL, V150, P574, DOI 10.1111/j.1365-2141.2010.08300.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; Li P, 2007, J BIOL CHEM, V282, P6210, DOI 10.1074/jbc.M609064200; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; McCall AM, 1999, MOL IMMUNOL, V36, P433, DOI 10.1016/S0161-5890(99)00057-7; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Muller J, 2007, CHEMBIOCHEM, V8, P2223, DOI 10.1002/cbic.200700535; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Orava EW, 2010, BBA-BIOMEMBRANES, V1798, P2190, DOI 10.1016/j.bbamem.2010.02.004; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224; Peng CG, 2007, NUCLEIC ACIDS RES, V35, P4977, DOI 10.1093/nar/gkm520; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Roda JM, 2006, CANCER RES, V66, P517, DOI 10.1158/0008-5472.CAN-05-2429; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Santulli-Marotto S, 2003, CANCER RES, V63, P7483; Sazani PL, 2004, J AM CHEM SOC, V126, P8370, DOI 10.1021/ja049171k; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shaw JP, 1995, PHARMACEUT RES, V12, P1937, DOI 10.1023/A:1016243923195; Singer H, 2010, J IMMUNOTHER, V33, P599, DOI 10.1097/CJI.0b013e3181dda225; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Stellrecht CM, 2009, CANCER LETT, V280, P1, DOI 10.1016/j.canlet.2008.10.045; Tahiri-Alaoui A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e45; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Taylor RJ, 2009, CANCER IMMUNOL IMMUN, V58, P997, DOI 10.1007/s00262-008-0613-3; Tsang J, 1996, J MOL BIOL, V262, P31, DOI 10.1006/jmbi.1996.0496; TSARFATY I, 1994, SCIENCE, V263, P98, DOI 10.1126/science.7505952; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wallace ME, 2005, SPRINGER SEMIN IMMUN, V27, P49, DOI 10.1007/s00281-004-0195-x; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zompi S, 2005, IMMUNOL LETT, V97, P31, DOI 10.1016/j.imlet.2004.10.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	80	92	99	6	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21896	21905		10.1074/jbc.M111.238261	http://dx.doi.org/10.1074/jbc.M111.238261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531729	Green Published, hybrid			2022-12-27	WOS:000291464700084
J	Goto, Y; Ogawa, K; Hattori, A; Tsujimoto, M				Goto, Yoshikuni; Ogawa, Kenji; Hattori, Akira; Tsujimoto, Masafumi			Secretion of Endoplasmic Reticulum Aminopeptidase 1 Is Involved in the Activation of Macrophages Induced by Lipopolysaccharide and Interferon-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCYL-SPECIFIC AMINOPEPTIDASE; PLACENTAL LEUCINE AMINOPEPTIDASE/OXYTOCINASE; ANTIGEN-PROCESSING MACHINERY; EXTRACELLULAR TNFR1 RELEASE; HAMSTER OVARY CELLS; ANKYLOSING-SPONDYLITIS; OXYTOCINASE SUBFAMILY; ENZYMATIC-PROPERTIES; CERVICAL-CARCINOMA; ENDOTHELIAL-CELLS	Endoplasmic reticulum aminopeptidase 1 (ERAP1) is a multifunctional enzyme with an important role in processing antigenic peptides presented to class I major histocompatibility complex in the endoplasmic reticulum. In this study, we found that endoplasmic reticulum-retained ERAP1 was secreted from macrophages in response to activation by treatment with lipopolysaccharide (LPS) and interferon (IFN)-gamma and enhanced their phagocytic activity. Enhancement of the phagocytic activity of murine macrophage RAW264.7 cells induced by LPS/IFN-gamma was inhibited by a potent aminopeptidase inhibitor, amastatin. The addition of recombinant wild-type but not inactive mutant ERAP1 to culture medium enhanced phagocytosis. These results suggest that enhancement of phagocytic activity is at least in part mediated by secreted ERAP1 through the generation of active peptides processed by the enzyme. Our data reveal ERAP1-mediated activation of macrophages for the first time and will provide new insights into the role of this enzyme in innate immunity.	[Goto, Yoshikuni; Tsujimoto, Masafumi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba 2900193, Japan; [Goto, Yoshikuni; Ogawa, Kenji; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Hattori, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Chemotherapy & Mol Sci, Kyoto 6068501, Japan	RIKEN; Kyoto University	Tsujimoto, M (corresponding author), Teikyo Heisei Univ, Fac Pharmaceut Sci, 4-1 Uruido Minami, Chiba 2900193, Japan.	tsujimot@thu.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Suzuken Memorial Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan and a grant from Suzuken Memorial Foundation.	Adamik B, 2008, BIOCHEM BIOPH RES CO, V371, P505, DOI 10.1016/j.bbrc.2008.04.103; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2008, BIOCHEM J, V416, P109, DOI 10.1042/BJ20080965; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; IWAKI S, 1986, J BIOCHEM-TOKYO, V99, P1317, DOI 10.1093/oxfordjournals.jbchem.a135599; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Masuda S, 2003, EUR J BIOCHEM, V270, P1988, DOI 10.1046/j.1432-1033.2003.03570.x; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Mehta AM, 2009, GENE CHROMOSOME CANC, V48, P410, DOI 10.1002/gcc.20648; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; NAJJAR VA, 1970, NATURE, V228, P672, DOI 10.1038/228672a0; Nakamura H, 2000, ENDOCRINOLOGY, V141, P4481, DOI 10.1210/en.141.12.4481; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; NIHIRA S, 1983, J BIOCHEM-TOKYO, V94, P565, DOI 10.1093/oxfordjournals.jbchem.a134388; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Taranta A, 2009, NEPHROL DIAL TRANSPL, V24, P1851, DOI 10.1093/ndt/gfn720; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Tsujimoto M, 2008, HEART FAIL REV, V13, P285, DOI 10.1007/s10741-007-9064-8; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Yamada Y, 2007, INT J MOL MED, V19, P791; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047; Yamazaki T, 2004, BLOOD, V104, P2345, DOI 10.1182/blood-2003-12-4260	44	61	61	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21906	21914		10.1074/jbc.M111.239111	http://dx.doi.org/10.1074/jbc.M111.239111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531727	Green Published, hybrid			2022-12-27	WOS:000291464700085
J	Ikner, A; Ashkenazi, A				Ikner, Aminah; Ashkenazi, Avi			TWEAK Induces Apoptosis through a Death-signaling Complex Comprising Receptor-interacting Protein 1 (RIP1), Fas-associated Death Domain (FADD), and Caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; TNF-ALPHA; ACTIVATION; NECROSIS; FN14; C-IAP2; UBIQUITINATION; INHIBITOR; CYTOKINE	The tumor necrosis factor (TNF) superfamily member TNF-like weak inducer of apoptosis (TNFSF12, CD255) (TWEAK) can stimulate apoptosis in certain cancer cells. Previous studies suggest that TWEAK activates cell death indirectly, by inducing TNF alpha-mediated autocrine signals. However, the underlying death-signaling mechanism has not been directly defined. Consistent with earlier work, TWEAK assembled a proximal signaling complex containing its cognate receptor FN14, the adaptor TRAF2, and cellular inhibitor of apoptosis protein 1 (cIAP1). Neither the death domain adaptor Fas-associated death domain nor the apoptosis-initiating protease caspase-8 associated with this primary complex. Rather, TWEAK induced TNF alpha secretion and TNF receptor 1-dependent assembly of a death-signaling complex containing receptor-interacting protein 1 (RIP1), FADD, and caspase-8. Knockdown of RIP1 by siRNA prevented TWEAK-induced association of FADD with caspase-8 but not formation of the FN14-TRAF2-cIAP1 complex and inhibited apoptosis activation. Depletion of the RIP1 E3 ubiquitin ligase cIAP1 enhanced assembly of the RIP1-FADD-caspase-8 complex and augmented cell death. Conversely, knockdown of the RIP1 deubiquitinase CYLD inhibited these functions. Depletion of FADD, caspase-8, BID, or BAX and BAK but not RIP3 attenuated TWEAK-induced cell death. Pharmacologic inhibition of the NF-kappa B pathway or siRNA knockdown of RelA attenuated TWEAK induction of TNF alpha and association of RIP1 with FADD and caspase-8. These results suggest that TWEAK triggers apoptosis by promoting assembly of a RIP1-FADD-caspse-8 complex via autocrine TNF alpha-TNFR1 signaling. The proapoptotic activity of TWEAK is modulated by cIAP1 and CYLD and engages both the extrinsic and intrinsic signaling pathways.	[Ikner, Aminah; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashwell JD, 2008, J CELL BIOL, V182, P15, DOI 10.1083/jcb.200806036; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Gao HX, 2009, CYTOKINE, V46, P24, DOI 10.1016/j.cyto.2008.12.001; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Ortiz A, 2009, CYTOKINE GROWTH F R, V20, P251, DOI 10.1016/j.cytogfr.2009.05.002; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2006, CELL DEATH DIFFER, V13, P1842, DOI 10.1038/sj.cdd.4402027; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	60	75	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21546	21554		10.1074/jbc.M110.203745	http://dx.doi.org/10.1074/jbc.M110.203745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525013	Green Published, hybrid			2022-12-27	WOS:000291464700052
J	Kwon, S; Christian, JL				Kwon, Sunjong; Christian, Jan L.			Sortilin Associates with Transforming Growth Factor-beta Family Proteins to Enhance Lysosome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIN RECEPTOR; TRAFFICKING; DOMAIN; PRODOMAIN; BRAIN; ENDOCYTOSIS; SORLA/LR11; VESICLES; CLEAVAGE; FURIN	Transforming growth factor (TGF)-beta family proteins are synthesized as precursors that are cleaved to generate an active ligand. Previous studies suggest that TGF-beta activity can be controlled by lysosomal degradation of both precursor proteins and ligands, but how these soluble proteins are trafficked to the lysosome is incompletely understood. The current studies show that sortilin selectively co-immunoprecipitates with the cleaved prodomain and/or precursor form of TGF-beta family members. Furthermore, sortilin co-localizes with, and enhances accumulation of a nodal family member in the Golgi. Co-expression of sortilin with TGF-beta family members leads to decreased accumulation of precursor proteins and cleavage products and this is attenuated by lysosomal, but not proteosomal inhibitors. In Xenopus embryos, overexpression of sortilin leads to a decrease in phospho-Smad2 levels and phenocopies loss of nodal signaling. Conversely, down-regulation of sortilin expression in HeLa cells leads to an up-regulation of endogenous bone morphogenic protein pathway activation, as indicated by an increase in phospho-Smad1/5/8 levels. Our results suggest that sortilin negatively regulates TGF-beta signaling by diverting trafficking of precursor proteins to the lysosome during transit through the biosynthetic pathway.	[Kwon, Sunjong; Christian, Jan L.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Christian, JL (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	christia@ohsu.edu			National Institutes of Health [R03HD058841, RO1 HD37976]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037976] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R03HD058841 and RO1 HD37976 (to J. L. C.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blanchet MH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1165027; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Chang CB, 2006, J BIOL CHEM, V281, P30794, DOI 10.1074/jbc.M607054200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Moon R. T., 1989, TECHNIQUE, V1, P76; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakayama T, 1998, DEVELOPMENT, V125, P857; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SOPORY S, 2006, METHODS SIGNAL TRANS, P37; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Tian J, 2008, DEVELOPMENT, V135, P2649, DOI 10.1242/dev.019794; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	51	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21876	21885		10.1074/jbc.M111.228262	http://dx.doi.org/10.1074/jbc.M111.228262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521695	Green Published, hybrid			2022-12-27	WOS:000291464700082
J	Sato, I; Shimatani, K; Fujita, K; Abe, T; Shimizu, M; Fujii, T; Hoshino, T; Takaya, N				Sato, Ikuo; Shimatani, Kanami; Fujita, Kensaku; Abe, Tsuyoshi; Shimizu, Motoyuki; Fujii, Tatsuya; Hoshino, Takayuki; Takaya, Naoki			Glutathione Reductase/Glutathione Is Responsible for Cytotoxic Elemental Sulfur Tolerance via Polysulfide Shuttle in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; FUSARIUM-OXYSPORUM; SACCHAROMYCES-CEREVISIAE; WOLINELLA-SUCCINOGENES; HYDROGEN-SULFIDE; REDUCTASE; THIOREDOXIN; GROWTH; FERMENTATION; MECHANISM	Fungi that can reduce elemental sulfur to sulfide are widely distributed, but the mechanism and physiological significance of the reaction have been poorly characterized. Here, we purified elemental sulfur-reductase (SR) and cloned its gene from the elemental sulfur-reducing fungus Fusarium oxysporum. We found that NADPH-glutathione reductase (GR) reduces elemental sulfur via glutathione as an intermediate. Aloss-of-function mutant of the SR/GR gene generated less sulfide from elemental sulfur than the wild-type strain. Its growth was hypersensitive to elemental sulfur, and it accumulated higher levels of oxidized glutathione, indicating that the GR/glutathione system confers tolerance to cytotoxic elemental sulfur by reducing it to less harmful sulfide. The SR/GR reduced polysulfide as efficiently as elemental sulfur, which implies that soluble polysulfide shuttles reducing equivalents to exocellular insoluble elemental sulfur and generates sulfide. The ubiquitous distribution of the GR/glutathione system together with our findings that GR-deficient mutants derived from Saccharomyces cerevisiae and Aspergillus nidulans reduced less sulfur and that their growth was hypersensitive to elemental sulfur indicated a wide distribution of the system among fungi. These results indicate a novel biological function of the GR/glutathione system in elemental sulfur reduction, which is distinguishable from bacterial and archaeal mechanisms of glutathione-independent sulfur reduction.	[Sato, Ikuo; Shimatani, Kanami; Fujita, Kensaku; Abe, Tsuyoshi; Shimizu, Motoyuki; Fujii, Tatsuya; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	Fujii, Tatsuya/M-8202-2018; SATO, Ikuo/F-8365-2012	Fujii, Tatsuya/0000-0001-7247-9442; 	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan; Grants-in-Aid for Scientific Research [21380055] Funding Source: KAKEN	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Bio-oriented Technology Research Advancement Institution and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports, Japan.	Abe T, 2007, BIOSCI BIOTECH BIOCH, V71, P2402, DOI 10.1271/bbb.70083; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BEERS RF, 1952, J BIOL CHEM, V195, P133; BOULEGUE J, 1978, PHOSPHORUS SULFUR, V5, P127, DOI 10.1080/03086647808069875; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Chueh PJ, 2002, BIOCHEMISTRY-US, V41, P3732, DOI 10.1021/bi012041t; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; FAUQUE GD, 1994, METHOD ENZYMOL, V243, P353; Fuji T, 2008, BIOSCI BIOTECH BIOCH, V72, P412, DOI 10.1271/bbb.70538; GIGGENBACH W, 1972, INORG CHEM, V11, P1201, DOI 10.1021/ic50112a009; GOODHEW CF, 1990, BIOCHEM J, V271, P707, DOI 10.1042/bj2710707; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Herst PM, 2008, FEMS YEAST RES, V8, P897, DOI 10.1111/j.1567-1364.2008.00418.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; IKEDA S, 1972, TALANTA, V19, P1650, DOI 10.1016/0039-9140(72)80240-6; Kaden J, 2002, ARCH MICROBIOL, V178, P53, DOI 10.1007/s00203-002-0425-3; KING TE, 1967, METHOD ENZYMOL, V10, P634; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Lee J, 1997, J BIOL CHEM, V272, P23042, DOI 10.1074/jbc.272.37.23042; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; MASSEY V, 1965, J BIOL CHEM, V240, P4470; MCALLAN SEA, 1931, CONTR BOYCE TOMPSON, V3, P13; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Prisner T, 2003, J BIOL INORG CHEM, V8, P419, DOI 10.1007/s00775-002-0432-5; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Roy AB, 1970, BIOCH INORGANIC COMP; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; SCHUTZ M, 1977, AM J ENOL VITICULT, V28, P137; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Sluiter E, 1930, BIOCHEM J, V24, P549, DOI 10.1042/bj0240549; Straub KL, 2003, FEMS MICROBIOL LETT, V220, P229, DOI 10.1016/S0378-1097(03)00130-7; SUGIO T, 1987, J BACTERIOL, V169, P4916, DOI 10.1128/jb.169.11.4916-4922.1987; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Tweedy B. G., 1981, RESIDUE REV, V78, P43; WOODS JP, 1993, J BACTERIOL, V175, P636, DOI 10.1128/JB.175.3.636-641.1993	43	35	35	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20283	20291		10.1074/jbc.M111.225979	http://dx.doi.org/10.1074/jbc.M111.225979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474441	hybrid, Green Published			2022-12-27	WOS:000291267600016
J	Satoh, K; Matsu-ura, T; Enomoto, M; Nakamura, H; Michikawa, T; Mikoshiba, K				Satoh, Kanayo; Matsu-ura, Toru; Enomoto, Masahiro; Nakamura, Hideki; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Highly Cooperative Dependence of Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) 2a Pump Activity on Cytosolic Calcium in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; SARCOPLASMIC-RETICULUM; FUNCTIONAL COMPARISONS; IMPROVED FLUORESCENCE; CA2+ OSCILLATIONS; STRUCTURAL BASIS; RECEPTOR; PROTEIN; CA2+-ATPASE; TRANSPORT	Sarco/endoplasmic reticulum (SR/ER) Ca2+-ATPase (SERCA) is an intracellular Ca2+ pump localized on the SR/ER membrane. The role of SERCA in refilling intracellular Ca2+ stores is pivotal for maintaining intracellular Ca2+ homeostasis, and disturbed SERCA activity causes many disease phenotypes, including heart failure, diabetes, cancer, and Alzheimer disease. Although SERCA activity has been described using a simple enzyme activity equation, the dynamics of SERCA activity in living cells is still unknown. To monitor SERCA activity in living cells, we constructed an enhanced CFP (ECFP)- and FlAsH-tagged SERCA2a, designated F-L577, which retains the ATP-dependent Ca2+ pump activity. The FRET efficiency between ECFP and FlAsH of F-L577 is dependent on the conformational state of the molecule. ER luminal Ca2+ imaging confirmed that the FRET signal changes directly reflect the Ca2+ pump activity. Dual imaging of cytosolic Ca2+ and the FRET signals of F-L577 in intact COS7 cells revealed that SERCA2a activity is coincident with the oscillatory cytosolic Ca2+ concentration changes evoked by ATP stimulation. The Ca2+ pump activity of SERCA2a in intact cells can be expressed by the Hill equation with an apparent affinity for Ca2+ of 0.41 +/- 0.0095 +/- mu M and a Hill coefficient of 5.7 +/- 0.73. These results indicate that in the cellular environment the Ca2+ dependence of ATPase activation is highly cooperative and that SERCA2a acts as a rapid switch to refill Ca2+ stores in living cells for shaping the intracellular Ca2+ dynamics. F-L577 will be useful for future studies on Ca2+ signaling involving SERCA2a activity.	[Satoh, Kanayo; Matsu-ura, Toru; Enomoto, Masahiro; Nakamura, Hideki; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Satoh, Kanayo] Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Int Cooperat Res Project, Kawaguchi, Saitama 3320012, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Solut Oriented Res Sci & Technol, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST)	Michikawa, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Matsu-ura, Toru/P-3461-2017; Enomoto, Masahiro/L-2209-2019	Matsu-ura, Toru/0000-0002-9876-3086; Enomoto, Masahiro/0000-0002-9411-2999; Satoh, Kanayo/0000-0001-9684-239X; Nakamura, Hideki/0000-0003-2749-8323	Ministry of Education, Culture, Sports, Science and Technology of Japan [20370054, 2022007]; Grants-in-Aid for Scientific Research [23650197] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 20370054 (to T. M.) and 2022007 (to K. M.).	Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Engelender S, 1996, MOL PHARMACOL, V50, P1243; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herman Brian, 2004, Methods Mol Biol, V261, P351; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirose K, 1998, J PHYSIOL-LONDON, V506, P407, DOI 10.1111/j.1469-7793.1998.407bw.x; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1988, METHOD ENZYMOL, V157, P154; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; Kubala M, 2006, PROTEINS, V64, P1, DOI 10.1002/prot.20969; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; TEPIKIN AV, 1992, BIOCHIM BIOPHYS ACTA, V1137, P197, DOI 10.1016/0167-4889(92)90202-M; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yano K, 2004, BIOCHEM J, V383, P353, DOI 10.1042/BJ20040629	45	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20591	20599		10.1074/jbc.M110.204685	http://dx.doi.org/10.1074/jbc.M110.204685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515674	hybrid, Green Published			2022-12-27	WOS:000291267600045
J	Wickham, SE; Hotze, EM; Farrand, AJ; Polekhina, G; Nero, TL; Tomlinson, S; Parker, MW; Tweten, RK				Wickham, Stephanie E.; Hotze, Eileen M.; Farrand, Allison J.; Polekhina, Galina; Nero, Tracy L.; Tomlinson, Stephen; Parker, Michael W.; Tweten, Rodney K.			Mapping the Intermedilysin-Human CD59 Receptor Interface Reveals a Deep Correspondence with the Binding Site on CD59 for Complement Binding Proteins C8 alpha and C9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PORE-FORMING TOXINS; CLOSTRIDIUM-PERFRINGENS; THETA-TOXIN; REGULATORY PROTEIN; PERFRINGOLYSIN-O; MEMBRANE-BINDING; ACTIVE-SITE; C5B-9; MECHANISM	CD59 is a glycosylphosphatidylinositol-anchored protein that inhibits the assembly of the terminal complement membrane attack complex (MAC) pore, whereas Streptococcus intermedius intermedilysin (ILY), a pore forming cholesterol-dependent cytolysin (CDC), specifically binds to human CD59 (hCD59) to initiate the formation of its pore. The identification of the residues of ILY and hCD59 that form their binding interface revealed a remarkably deep correspondence between the hCD59 binding site for ILY and that for the MAC proteins C8 alpha and C9. ILY disengages from hCD59 during the prepore to pore transition, suggesting that loss of this interaction is necessary to accommodate specific structural changes associated with this transition. Consistent with this scenario, mutants of hCD59 or ILY that increased the affinity of this interaction decreased the cytolytic activity by slowing the transition of the prepore to pore but not the assembly of the prepore oligomer. A signature motif was also identified in the hCD59 binding CDCs that revealed a new hCD59-binding member of the CDC family. Although the binding site on hCD59 for ILY, C8 alpha, and C9 exhibits significant homology, no similarity exists in their binding sites for hCD59. Hence, ILY and the MAC proteins interact with common amino acids of hCD59 but lack detectable conservation in their binding sites for hCD59.	[Wickham, Stephanie E.; Hotze, Eileen M.; Farrand, Allison J.; Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Polekhina, Galina; Nero, Tracy L.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Oklahoma System; University of Oklahoma Health Sciences Center; St. Vincent's Institute of Medical Research; Medical University of South Carolina; University of Melbourne	Tweten, RK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB-1053, Oklahoma City, OK 73104 USA.	Rod-Tweten@ouhsc.edu	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138; Nero, Tracy/0000-0002-3393-1843	National Institutes of Health [AI063444 (NIAID), AI47386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047386, R01AI063444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063444 (NIAID) (to R. K. T.) and AI47386 (to S. T.).	Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Farkas I, 2002, J PHYSIOL-LONDON, V539, P537, DOI 10.1113/jphysiol.2001.013381; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Farrand S, 2008, BIOCHEMISTRY-US, V47, P7097, DOI 10.1021/bi8005835; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; HAMILTON KK, 1990, BLOOD, V76, P2572; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; Huang YX, 2005, J BIOL CHEM, V280, P34073, DOI 10.1074/jbc.M504922200; Hughes TR, 2009, MOL IMMUNOL, V46, P1561, DOI 10.1016/j.molimm.2009.01.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leath KJ, 2007, ACTA CRYSTALLOGR F, V63, P648, DOI 10.1107/S1744309107033477; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Nagamune H, 2004, MICROBIOL IMMUNOL, V48, P677, DOI 10.1111/j.1348-0421.2004.tb03479.x; OHNOIWASHITA Y, 1988, EUR J BIOCHEM, V176, P95, DOI 10.1111/j.1432-1033.1988.tb14255.x; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; TWETEN RK, 1991, J BIOL CHEM, V266, P12449; TWETEN RK, 1988, INFECT IMMUN, V56, P3228, DOI 10.1128/IAI.56.12.3228-3234.1988; Yu JH, 1997, J EXP MED, V185, P745, DOI 10.1084/jem.185.4.745; Zhao XJ, 1998, J BIOL CHEM, V273, P10665, DOI 10.1074/jbc.273.17.10665	40	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20952	20962		10.1074/jbc.M111.237446	http://dx.doi.org/10.1074/jbc.M111.237446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507937	Green Published, hybrid			2022-12-27	WOS:000291267600079
J	Kurotani, R; Okumura, S; Matsubara, T; Yokoyama, U; Buckley, JR; Tomita, T; Kezuka, K; Nagano, T; Esposito, D; Taylor, TE; Gillette, WK; Ishikawa, Y; Abe, H; Ward, JM; Kimura, S				Kurotani, Reiko; Okumura, Satoshi; Matsubara, Tsutomu; Yokoyama, Utako; Buckley, John R.; Tomita, Takeshi; Kezuka, Kyohei; Nagano, Tomokazu; Esposito, Dominic; Taylor, Troy E.; Gillette, William K.; Ishikawa, Yoshihiro; Abe, Hiroyuki; Ward, Jerrold M.; Kimura, Shioko			Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor beta Signaling Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTEROGLOBIN-RELATED PROTEIN-1; ALLERGIC AIRWAY INFLAMMATION; INDUCED LUNG FIBROSIS; INTERFERON-GAMMA; IFN-GAMMA; GENE-EXPRESSION; BREAST-CANCER; MOUSE; INHIBITION; RECEPTOR	With increasing worldwide rates of morbidity and mortality of pulmonary fibrosis, the development of effective therapeutics for this disease is of great interest. Secretoglobin (SCGB) 3A2, a novel cytokine-like molecule predominantly expressed in pulmonary airways epithelium, exhibits anti-inflammatory and growth factor activities. In the current study SCGB3A2 was found to inhibit TGF beta-induced differentiation of fibroblasts to myofibroblasts, a hallmark of the fibrogenic process, using pulmonary fibroblasts isolated from adult mice. This induction was through increased phosphorylation of STAT1 and expression of SMAD7 and decreased phosphorylation of SMAD2 and SMAD3. To demonstrate the effect of SCGB3A2 on the TGF beta signaling in vivo, a bleomycin-induced pulmonary fibrosis mouse model was used. Mice were administered bleomycin intratracheally followed by intravenous injection of recombinant SCGB3A2. Histological examination in conjunction with inflammatory cell counts in bronchoalveolar lavage fluids demonstrated that SCGB3A2 suppressed bleomycin-induced pulmonary fibrosis. Microarray analysis was carried out using RNAs from lungs of bleomycin-treated mice with or without SCGB3A2 and normal mice treated with SCGB3A2. The results demonstrated that SCGB3A2 affects TGF beta signaling and reduces the expression of genes involved in fibrosis. This study suggests the potential utility of SCGB3A2 for targeting TGF beta signaling in the treatment of pulmonary fibrosis.	[Kurotani, Reiko; Matsubara, Tsutomu; Buckley, John R.; Tomita, Takeshi; Nagano, Tomokazu; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kurotani, Reiko; Okumura, Satoshi; Yokoyama, Utako; Kezuka, Kyohei; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan; [Kurotani, Reiko; Abe, Hiroyuki] Yamagata Univ, Fac Engn, Yamagata 9928510, Japan; [Esposito, Dominic; Taylor, Troy E.; Gillette, William K.] NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21701 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med & Med Cardiol, Newark, NJ 07103 USA; [Ward, Jerrold M.] Global VetPathol, Montgomery Village, MD 20866 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yokohama City University; Yamagata University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bldg 37,Rm 3106, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Esposito, Dominic/0000-0002-9987-1687; Gillette, William/0000-0002-8592-3642; Tomita, Takeshi/0000-0001-6815-2244	National Institutes of Health, Center for Cancer Research (NCI; NIH) [0010190305, Z01 BC010449-06];  [21790207]; NATIONAL CANCER INSTITUTE [ZIABC010449, Z01BC010449] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936, 21380171] Funding Source: KAKEN	National Institutes of Health, Center for Cancer Research (NCI; NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institutes of Health, Center for Cancer Research (Intramural Research Program of the NCI; NIH 0010190305 and Z01 BC010449-06, to S. K.). This work was also supported by Grant-in-aid for Young Scientists (B) (21790207, to R. K.).	Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma A, 2005, AM J RESP CELL MOL, V32, P93, DOI 10.1165/rcmb.2003-0374OC; Bin LH, 2003, J IMMUNOL, V171, P924, DOI 10.4049/jimmunol.171.2.924; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Chiba Y, 2005, IMMUNOL LETT, V97, P123, DOI 10.1016/j.imlet.2004.10.013; Chiba Y, 2004, AM J PHYSIOL-LUNG C, V287, pL1193, DOI 10.1152/ajplung.00263.2004; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Culleton J, 2007, INT J CANCER, V120, P1087, DOI 10.1002/ijc.22471; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Inoue Keiichi, 2008, Allergol Int, V57, P57, DOI 10.2332/allergolint.O-07-493; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kurotani R, 2002, J ENDOCRINOL, V172, P477, DOI 10.1677/joe.0.1720477; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Lee YJ, 1996, J IMMUNOL, V157, P1559; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Luppi F, 2009, SARCOIDOSIS VASC DIF, V26, P64; Maeng HG, 2009, IMMUNOBIOLOGY, V214, P311, DOI 10.1016/j.imbio.2008.09.003; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Miele L, 2000, ANN NY ACAD SCI, V923, P128; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mukherjee AB, 1999, CELL MOL LIFE SCI, V55, P771, DOI 10.1007/s000180050331; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Papatheodoridis GV, 2005, J VIRAL HEPATITIS, V12, P199, DOI 10.1111/j.1365-2893.2005.00582.x; Puente Napoleon A, 2007, Med Health R I, V90, P43; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2003, AM J RESP CRIT CARE, V167, P945, DOI 10.1164/rccm.2301004; Senft AP, 2010, AM J RESP CELL MOL, V42, P404, DOI 10.1165/rcmb.2008-0229OC; Seo JY, 2009, CYTOKINE, V46, P51, DOI 10.1016/j.cyto.2008.12.008; Shijubo N, 2003, CURR PHARM DESIGN, V9, P1139, DOI 10.2174/1381612033455026; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tamai M, 2006, J LAB CLIN MED, V147, P182, DOI 10.1016/j.lab.2005.12.001; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tomita T, 2008, J BIOL CHEM, V283, P25617, DOI 10.1074/jbc.M805140200; Tzortzaki EG, 2007, RESP MED, V101, P1821, DOI 10.1016/j.rmed.2007.02.006; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Watson MA, 1996, CANCER RES, V56, P860; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	50	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19682	19692		10.1074/jbc.M111.239046	http://dx.doi.org/10.1074/jbc.M111.239046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478551	Green Published, hybrid			2022-12-27	WOS:000291027700051
J	Motta-Mena, LB; Smith, SA; Mallory, MJ; Jackson, J; Wang, JR; Lynch, KW				Motta-Mena, Laura B.; Smith, Sarah A.; Mallory, Michael J.; Jackson, Jason; Wang, Jiarong; Lynch, Kristen W.			A Disease-associated Polymorphism Alters Splicing of the Human CD45 Phosphatase Gene by Disrupting Combinatorial Repression by Heterogeneous Nuclear Ribonucleoproteins (hnRNPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POINT MUTATION; EXON; ACTIVATION; KINASE; RNA	Alternative splicing is typically controlled by complexes of regulatory proteins that bind to sequences within or flanking variable exons. The identification of regulatory sequence motifs and the characterization of sequence motifs bound by splicing regulatory proteins have been essential to predicting splicing regulation. The activation-responsive sequence (ARS) motif has previously been identified in several exons that undergo changes in splicing upon T cell activation. hnRNP L binds to this ARS motif and regulates ARS-containing exons; however, hnRNP L does not function alone. Interestingly, the proteins that bind together with hnRNP L differ for different exons that contain the ARS core motif. Here we undertake a systematic mutational analysis of the best characterized context of the ARS motif, namely the ESS1 sequence from CD45 exon 4, to understand the determinants of binding specificity among the components of the ESS1 regulatory complex and the relationship between protein binding and function. We demonstrate that different mutations within the ARS motif affect specific aspects of regulatory function and disrupt the binding of distinct proteins. Most notably, we demonstrate that the C77G polymorphism, which correlates with autoimmune disease susceptibility in humans, disrupts exon silencing by preventing the redundant activity of hnRNPs K and E2 to compensate for the weakened function of hnRNP L. Therefore, these studies provide an important example of the functional relevance of combinatorial function in splicing regulation and suggest that additional polymorphisms may similarly disrupt function of the ESS1 silencer.	[Motta-Mena, Laura B.; Jackson, Jason; Wang, Jiarong; Lynch, Kristen W.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Smith, Sarah A.; Mallory, Michael J.; Lynch, Kristen W.] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Lynch, KW (corresponding author), 422 Curie Blvd, Philadelphia, PA 19104 USA.	klync@mail.med.upenn.edu			National Institutes of Health [R01 GM067719, GM084034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067719, R01GM084034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM067719 and GM084034 (to K. W. L.).	Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Evsyukova I, 2010, RNA BIOL, V7, P462, DOI 10.4161/rna.7.4.12301; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Tchilian EZ, 2001, AIDS, V15, P1892, DOI 10.1097/00002030-200109280-00024; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	26	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20043	20053		10.1074/jbc.M111.218727	http://dx.doi.org/10.1074/jbc.M111.218727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507955	Green Published, hybrid			2022-12-27	WOS:000291027700081
J	Wethkamp, N; Hanenberg, H; Funke, S; Suschek, CV; Wetzel, W; Heikaus, S; Grinstein, E; Ramp, U; Engers, R; Gabbert, HE; Mahotka, C				Wethkamp, Nils; Hanenberg, Helmut; Funke, Sarah; Suschek, Christoph V.; Wetzel, Wiebke; Heikaus, Sebastian; Grinstein, Edgar; Ramp, Uwe; Engers, Rainer; Gabbert, Helmut E.; Mahotka, Csaba			Daxx-beta and Daxx-gamma, Two Novel Splice Variants of the Transcriptional Co-repressor Daxx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENIC DOMAINS PODS; LEUKEMIA PROTEIN PML; INDUCED APOPTOSIS; P53-DEPENDENT APOPTOSIS; INTERACTING PROTEIN; NUCLEAR-BODIES; JNK ACTIVATION; P53 ACTIVITY; CELL-DEATH; RECEPTOR	Daxx is involved in transcriptional control and apoptosis. It comprises several domains, including a regulatory C terminus that is responsible for the interaction with numerous proteins such as p53, promyelocytic leukemia protein (PML), and Hsp27. Here, we describe the identification and characterization of two novel variants of Daxx termed Daxx-beta and Daxx-gamma, which are generated by alternative splicing. Alternative splicing results in a truncated regulatory C terminus in both proteins. As a consequence, Daxx-beta and Daxx-gamma show a markedly decreased affinity to PML, which in turn is associated with a different subnuclear localization of these proteins compared with Daxx. Although Daxx is localized mainly in PML-oncogenic domains (PODs) Daxx-beta and Daxx-gamma display a distinct distribution pattern. Furthermore, Daxx-beta and Daxx-gamma show a decreased affinity to p53 also due to the truncated C terminus. We provide evidence that the p53 recruitment into PODs is Daxx isoform-dependent. The decreased affinity of Daxx-beta/-gamma to p53 and PML results in a diffuse localization of p53 throughout the nucleus. In contrast to Daxx, Daxx-beta and Daxx-gamma are unable to repress p53-mediated transcription. Therefore, alternative splicing of Daxx might indicate an additional level in the cellular apoptosis network.	[Wethkamp, Nils; Funke, Sarah; Heikaus, Sebastian; Ramp, Uwe; Engers, Rainer; Gabbert, Helmut E.; Mahotka, Csaba] Univ Dusseldorf, Fac Med, Inst Pathol, Univ Hosp, D-40225 Dusseldorf, Germany; [Hanenberg, Helmut] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Univ Dusseldorf, Sch Med, Dept Otorhinolaryngol, D-40225 Dusseldorf, Germany; [Suschek, Christoph V.; Wetzel, Wiebke] Univ Dusseldorf, Inst Mol Biol & Biochem 2, Fac Med, D-40225 Dusseldorf, Germany; [Grinstein, Edgar] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Mahotka, C (corresponding author), Univ Dusseldorf, Fac Med, Inst Pathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	mahotka@uni-duesseldorf.de			Dr. Mildred-Scheel-Stiftung fur Krebsforschung	Dr. Mildred-Scheel-Stiftung fur Krebsforschung(Deutsche Krebshilfe)	This work was supported in part by a grant from the Dr. Mildred-Scheel-Stiftung fur Krebsforschung.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Doucas V, 1996, BBA-REV CANCER, V1288, pM25, DOI 10.1016/S0304-419X(96)00028-5; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; HUGHES DPM, 1995, J EXP MED, V182, P1395, DOI 10.1084/jem.182.5.1395; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim YY, 2003, BIOCHEM BIOPH RES CO, V312, P426, DOI 10.1016/j.bbrc.2003.10.144; Kiriakidou M, 1997, DNA CELL BIOL, V16, P1289, DOI 10.1089/dna.1997.16.1289; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Mahotka C, 1999, CANCER RES, V59, P6097; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Salomoni P, 2006, CELL DEATH DIFFER, V13, P672, DOI 10.1038/sj.cdd.4401820; Shkreta L, 2011, J BIOL CHEM, V286, P331, DOI 10.1074/jbc.M110.162644; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	43	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19576	19588		10.1074/jbc.M110.196311	http://dx.doi.org/10.1074/jbc.M110.196311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482821	Green Published, hybrid			2022-12-27	WOS:000291027700041
J	Anderson, SJ; Sikes, ML; Zhang, YF; French, SL; Salgia, S; Beyer, AL; Nomura, M; Schneider, DA				Anderson, Susan J.; Sikes, Martha L.; Zhang, Yinfeng; French, Sarah L.; Salgia, Shilpa; Beyer, Ann L.; Nomura, Masayasu; Schneider, David A.			The Transcription Elongation Factor Spt5 Influences Transcription by RNA Polymerase I Positively and Negatively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; PAF1 COMPLEX; CAPPING ENZYME; FISSION YEAST; ACTIVE GENES; DSIF; PHOSPHORYLATION; CHROMATIN; PROMOTER	Spt5p is a universally conserved transcription factor that plays multiple roles in eukaryotic transcription elongation. Spt5p forms a heterodimer with Spt4p and collaborates with other transcription factors to pause or promote RNA polymerase II transcription elongation. We have shown previously that Spt4p and Spt5p also influence synthesis of ribosomal RNA by RNA polymerase (Pol) I; however, previous studies only characterized defects in Pol I transcription induced by deletion of SPT4. Here we describe two new, partially active mutations in SPT5 and use these mutant strains to characterize the effect of Spt5p on Pol I transcription. Genetic interactions between spt5 and rpa49 Delta mutations together with measurements of ribosomal RNA synthesis rates, rDNA copy number, and Pol I occupancy of the rDNA demonstrate that Spt5p plays both positive and negative roles in transcription by Pol I. Electron microscopic analysis of mutant and WT strains confirms these observations and supports the model that Spt4/5 may contribute to pausing of RNA polymerase I early during transcription elongation but promotes transcription elongation downstream of the pause(s). These findings bolster the model that Spt5p and related homologues serve diverse critical roles in the control of transcription.	[Anderson, Susan J.; Zhang, Yinfeng; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Sikes, Martha L.; French, Sarah L.; Beyer, Ann L.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; [Salgia, Shilpa; Nomura, Masayasu] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of Alabama System; University of Alabama Birmingham; University of Virginia; University of California System; University of California Irvine	Schneider, DA (corresponding author), 720 20th St S,Rm 442, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM63952, GM35949, GM84946]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035949, R01GM035949, R01GM084946, R01GM063952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63952 (to A. L. B.), GM35949 (to M. N.), and GM84946 (to D. A. S.).	Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Malagon F, 1996, CURR GENET, V30, P101, DOI 10.1007/s002940050107; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; NOMURA M, 2004, NUCLEOLUS; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; SWANSON MS, 1992, GENETICS, V132, P325; VIKTOROVSKAYA OV, 2011, J BIOL CHEM IN PRESS, V286; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; WINSTON F, 1984, GENETICS, V107, P179; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	52	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18816	18824		10.1074/jbc.M110.202101	http://dx.doi.org/10.1074/jbc.M110.202101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467039	Green Published, hybrid			2022-12-27	WOS:000290785700054
J	Haldimann, P; Muriset, M; Vigh, L; Goloubinoff, P				Haldimann, Pierre; Muriset, Maude; Vigh, Laszlo; Goloubinoff, Pierre			The Novel Hydroxylamine Derivative NG-094 Suppresses Polyglutamine Protein Toxicity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; DELAYS DISEASE PROGRESSION; MEMBRANE-LIPID THERAPY; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; MOUSE MODEL; NEURODEGENERATIVE DISEASES; C-ELEGANS; GLUTAMINE REPEATS; HSP70 CHAPERONE	Aggregation-prone polyglutamine (polyQ) expansion proteins cause several neurodegenerative disorders, including Huntington disease. The pharmacological activation of cellular stress responses could be a new strategy to combat protein conformational diseases. Hydroxylamine derivatives act as co-inducers of heat-shock proteins (HSPs) and can enhance HSP expression in diseased cells, without significant adverse effects. Here, we used Caenorhabditis elegans expressing polyQ expansions with 35 glutamines fused to the yellow fluorescent protein (Q35-YFP) in body wall muscle cells as a model system to investigate the effects of treatment with a novel hydroxylamine derivative, NG-094, on the progression of polyQ diseases. NG-094 significantly ameliorated polyQ-mediated animal paralysis, reduced the number of Q35-YFP aggregates and delayed polyQ-dependent acceleration of aging. Micromolar concentrations of NG-094 in animal tissues with only marginal effects on the nematode fitness sufficed to confer protection against polyQ proteotoxicity, even when the drug was administered after disease onset. NG-094 did not reduce insulin/insulin-like growth factor 1-like signaling, but conferred cytoprotection by a mechanism involving the heat-shock transcription factor HSF-1 that potentiated the expression of stress-inducible HSPs. NG-094 is thus a promising candidate for tests on mammalian models of polyQ and other protein conformational diseases.	[Haldimann, Pierre; Muriset, Maude; Goloubinoff, Pierre] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Vigh, Laszlo] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, H-6726 Szeged, Hungary	University of Lausanne; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Haldimann, P (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	pierre.haldimann@bluewin.ch; pierre.goloubinoff@unil.ch		Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290, NRP57]; Hungarian National Scientific Research Foundation [OTKA NN 76716]; National Institutes of Health National Center for Research Resources	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part from Grants 3100A0-109290 and NRP57, both from the Swiss National Science Foundation and from the Hungarian National Scientific Research Foundation, OTKA NN 76716.; We thank Dr. R. I. Morimoto and Dr. A. Ben-Zvi (Northwestern University, Evanston, IL) for providing the Q35 and Q0 C. elegans strains and advice on motility assay, Dr. F. Muller (University of Fribourg, Switzerland) for information on C. elegans manipulation, and Dr. C. D. Link (Colorado University) for providing the HSP16.2 antibody. We thank Dr. Maria Peter and Dr. Ibolya Horvath for the determination of the concentration of NG-094 in animal tissues and for helpful comments on the manuscript. We thank the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources, for providing some of the strains used in this study and N-Gene Research Laboratories, Inc. (Budapest, Hungary) for providing NG-094.	Adachi H, 2003, J NEUROSCI, V23, P2203; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BRENNER S, 1974, GENETICS, V77, P71; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Torok Z, 2003, P NATL ACAD SCI USA, V100, P3131, DOI 10.1073/pnas.0438003100; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	70	27	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18784	18794		10.1074/jbc.M111.234773	http://dx.doi.org/10.1074/jbc.M111.234773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471208	Green Published, hybrid			2022-12-27	WOS:000290785700051
J	Ceccarelli, DF; Laister, RC; Mulligan, VK; Kean, MJ; Goudreault, M; Scott, IC; Derry, WB; Chakrabartty, A; Gingras, AC; Sicheri, F				Ceccarelli, Derek F.; Laister, Rob C.; Mulligan, Vikram Khipple; Kean, Michelle J.; Goudreault, Marilyn; Scott, Ian C.; Derry, W. Brent; Chakrabartty, Avijit; Gingras, Anne-Claude; Sicheri, Frank			CCM3/PDCD10 Heterodimerizes with Germinal Center Kinase III (GCKIII) Proteins Using a Mechanism Analogous to CCM3 Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; IN-FRAME DELETION; MUTATIONS; INSIGHTS; ACTIVATION; INTERACTS; PATHWAY; COMPLEX; PDCD10; PAK1	CCM3 mutations give rise to cerebral cavernous malformations (CCMs) of the vasculature through a mechanism that remains unclear. Interaction of CCM3 with the germinal center kinase III (GCKIII) subfamily of Sterile 20 protein kinases, MST4, STK24, and STK25, has been implicated in cardiovascular development in the zebrafish, raising the possibility that dysregulated GCKIII function may contribute to the etiology of CCM disease. Here, we show that the amino-terminal region of CCM3 is necessary and sufficient to bind directly to the C-terminal tail region of GCKIII proteins. This same region of CCM3 was shown previously to mediate homodimerization through the formation of an interdigitated alpha-helical domain. Sequence conservation and binding studies suggest that CCM3 may preferentially heterodimerize with GCKIII proteins through a manner structurally analogous to that employed for CCM3 homodimerization.	[Ceccarelli, Derek F.; Kean, Michelle J.; Goudreault, Marilyn; Gingras, Anne-Claude; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Laister, Rob C.] Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Mulligan, Vikram Khipple; Chakrabartty, Avijit] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Univ Hlth Network,Dept Biochem, Toronto, ON M5G 1L7, Canada; [Kean, Michelle J.; Scott, Ian C.; Derry, W. Brent; Gingras, Anne-Claude; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Scott, Ian C.; Derry, W. Brent] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Chakrabartty, Avijit] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; sicheri@lunenfeld.ca	Derry, Brent/CAF-4503-2022; Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Derry, Brent/0000-0002-1977-8475; Mulligan, Vikram/0000-0001-6038-8922; Ceccarelli, Derek/0000-0002-2674-9234; Scott, Ian/0000-0001-6665-1410; Chakrabartty, Avi/0000-0001-7002-8381	Canadian Institutes of Health Research [MOP-36399, MOP-84314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36399 (to F. S.) and MOP-84314 (to A.-C. G.).	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Dibble CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011740; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	25	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25056	25064		10.1074/jbc.M110.213777	http://dx.doi.org/10.1074/jbc.M110.213777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561863	hybrid, Green Published			2022-12-27	WOS:000292547900054
J	Park, J; Arakawa-Takeuchi, S; Jinno, S; Okayama, H				Park, Jung-ha; Arakawa-Takeuchi, Shiho; Jinno, Shigeki; Okayama, Hiroto			Rho-associated Kinase Connects a Cell Cycle-controlling Anchorage Signal to the Mammalian Target of Rapamycin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; DOMINANTLY INHERITED CANCER; SCLEROSIS TSC2 GENE; EKER RAT MODEL; TUBEROUS SCLEROSIS; PROTEIN-KINASE; S-PHASE; ACTIVATION; GROWTH; PHOSPHORYLATION	When deprived of anchorage to the extracellular matrix, fibroblasts arrest in G(1) phase at least in part due to inactivation of G(1) cyclin-dependent kinases. Despite great effort, how anchorage signals control the G(1)-S transition of fibroblasts remains highly elusive. We recently found that the mammalian target of rapamycin ( mTOR) cascade might convey an anchorage signal that regulates S phase entry. Here, we show that Rho-associated kinase connects this signal to the TSC1/TSC2-RHEB-mTOR pathway. Expression of a constitutively active form of ROCK1 suppressed all of the anchorage deprivation effects suppressible by tsc2 mutation in rat embryonic fibroblasts. TSC2 contains one evolutionarily conserved ROCK target-like sequence, and an alanine substitution for Thr(1203) in this sequence severely impaired the ability of ROCK1 to counteract the anchorage loss-imposed down-regulation of both G(1) cell cycle factors and mTORC1 activity. Moreover, TSC2 Thr(1203) underwent ROCK-dependent phosphorylation in vivo and could be phosphorylated by bacterially expressed active ROCK1 in vitro, providing biochemical evidence for a direct physical interaction between ROCK and TSC2.	[Okayama, Hiroto] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (S) and the Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Huveneers S, 2007, INT J RADIAT BIOL, V83, P743, DOI 10.1080/09553000701481808; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KOBAYASHI T, 1995, NUCLEIC ACIDS RES, V23, P2608, DOI 10.1093/nar/23.14.2608; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; KUME K, 1992, NEW BIOL, V4, P504; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Momose S, 2002, HUM MOL GENET, V11, P2997, DOI 10.1093/hmg/11.24.2997; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olsson PG, 1996, MAMM GENOME, V7, P212, DOI 10.1007/s003359900057; OTSUKA H, 1976, J CELL PHYSIOL, V87, P213, DOI 10.1002/jcp.1040870209; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Philips A, 1999, ONCOGENE, V18, P1819, DOI 10.1038/sj.onc.1202530; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; ROGNE S, 1985, J CELL PHYSIOL, V125, P528, DOI 10.1002/jcp.1041250324; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schulze A, 1996, MOL CELL BIOL, V16, P4632; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XIAO GH, 1995, ONCOGENE, V11, P81; XIAO GH, 1995, CELL GROWTH DIFFER, V6, P1185; XU L, 1995, GENOMICS, V27, P475, DOI 10.1006/geno.1995.1079; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	57	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23132	23141		10.1074/jbc.M110.209114	http://dx.doi.org/10.1074/jbc.M110.209114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561859	Green Published, hybrid			2022-12-27	WOS:000292025000047
J	Sun, XX; DeVine, T; Challagundla, KB; Dai, MS				Sun, Xiao-Xin; DeVine, Tiffany; Challagundla, Kishore B.; Dai, Mu-Shui			Interplay between Ribosomal Protein S27a and MDM2 Protein in p53 Activation in Response to Ribosomal Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; CELL-CYCLE ARREST; NUCLEOLAR DISRUPTION; DEGRADATION; INHIBITION; L11; BIOGENESIS; UBIQUITIN; PATHWAY; HDM2	Ribosomal proteins play a critical role in tightly coordinating p53 signaling with ribosomal biogenesis. Several ribosomal proteins have been shown to induce and activate p53 via inhibition of MDM2. Here, we report that S27a, a small subunit ribosomal protein synthesized as an 80-amino acid ubiquitin C-terminal extension protein (CEP80), functions as a novel regulator of the MDM2-p53 loop. S27a interacts with MDM2 at the central acidic domain of MDM2 and suppresses MDM2-mediated p53 ubiquitination, leading to p53 activation and cell cycle arrest. Knockdown of S27a significantly attenuates the p53 activation in cells in response to treatment with ribosomal stress-inducing agent actinomycin D or 5-fluorouracil. Interestingly, MDM2 in turn ubiquitinates S27a and promotes proteasomal degradation of S27a in response to actinomycin D treatment, thus forming a mutual-regulatory loop. Altogether, our results reveal that S27a plays a non-redundant role in mediating p53 activation in response to ribosomal stress via interplaying with MDM2.	[Dai, Mu-Shui] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu	Challagundla, Kishore B./H-8189-2019	Challagundla, Kishore B./0000-0001-8654-7717	National Institutes of Health [R00CA127134]; Department of Defense [W81XWH-10-1-1029]; Medical Research Foundation of Oregon; Oregon Health and Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA127134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Medical Research Foundation of Oregon; Oregon Health and Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA127134. This work was also supported by a grant from Department of Defense under Award W81XWH-10-1-1029, a grant from Medical Research Foundation of Oregon, and by a startup fund from the Oregon Health and Science University (to M.-S.D.).; Recipient of a Cancer Research Development Award from the OHSU Knight Cancer Institute. To whom correspondence should be addressed: Dept. of Molecular and Medical Genetics, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239. Tel.: 503-494-9917; Fax: 503-494-4411; E-mail: daim@ohsu.edu.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	44	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22730	22741		10.1074/jbc.M111.223651	http://dx.doi.org/10.1074/jbc.M111.223651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561866	Green Published, hybrid			2022-12-27	WOS:000292025000007
J	Dolan, KT; Duguid, EM; He, C				Dolan, Kyle T.; Duguid, Erica M.; He, Chuan			Crystal Structures of SlyA Protein, a Master Virulence Regulator of Salmonella, in Free and DNA-bound States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-SENSING MECHANISM; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; GLOBAL REGULATOR; TRANSCRIPTION; MARR; MEXR; IDENTIFICATION; TYPHIMURIUM; EXPRESSION	SlyA is a master virulence regulator that controls the transcription of numerous genes in Salmonella enterica. We present here crystal structures of SlyA by itself and bound to a high-affinity DNA operator sequence in the slyA gene. SlyA interacts with DNA through direct recognition of a guanine base by Arg-65, as well as interactions between conserved Arg-86 and the minor groove and a large network of non-base-specific contacts with the sugar phosphate backbone. Our structures, together with an unpublished structure of SlyA bound to the small molecule effector salicylate (Protein Data Bank code 3DEU), reveal that, unlike many other MarR family proteins, SlyA dissociates from DNA without large conformational changes when bound to this effector. We propose that SlyA and other MarR global regulators rely more on indirect readout of DNA sequence to exert control over many genes, in contrast to proteins (such as OhrR) that recognize a single operator.	[Dolan, Kyle T.; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dolan, Kyle T.; Duguid, Erica M.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Dolan, Kyle T.; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St,GCIS 319B, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Duguid, Erica/0000-0003-4319-1030	National Institutes of Health [AI074658]; Predoctoral Training Program in Chemistry Biology [GM008720]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Program in Chemistry Biology; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 and Predoctoral Training Program in Chemistry & Biology Grant GM008720 (to K. T. D.). This work was also supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Haider F, 2009, INT MICROBIOL, V11, P245, DOI 10.2436/20.1501.01.68; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu RY, 2003, J BIOL CHEM, V278, P20240, DOI 10.1074/jbc.M300292200	31	64	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22178	22185		10.1074/jbc.M111.245258	http://dx.doi.org/10.1074/jbc.M111.245258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550983	Green Published, hybrid			2022-12-27	WOS:000291719900024
J	Flach, RJR; Qin, H; Zhang, L; Bennett, AM				Flach, Rachel J. Roth; Qin, Hui; Zhang, Lei; Bennett, Anton M.			Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC)/Fat-specific Protein 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-SPECIFIC PROTEIN-27; LEPTIN-DEFICIENT MICE; PPAR-GAMMA; MAP KINASE; RECEPTOR-GAMMA; ADIPOSE-TISSUE; POTENTIAL ROLE; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; MOUSE MODELS	The integration of metabolic signals required for the regulation of hepatic lipid homeostasis is complex. Previously, we showed that mice lacking expression of the mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) have increased fatty acid oxidation and are protected from the development of hepatic steatosis. Here, we show that leptin receptor-deficient (db/db) mice lacking MKP-1 are also resistant to the development of hepatic steatosis. Microarray analyses of livers from db/db mice lacking MKP-1 showed suppression of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes. We identified the fat-specific protein 27 (Fsp27), which promotes PPAR gamma-mediated hepatic steatosis, as repressed in livers of both db/db and high fat diet-fed mice lacking MKP-1. Hepatocytes from MKP-1-deficient mice exhibited reduced PPAR gamma-induced lipid droplet formation. Mechanistically, loss of MKP-1 inhibited PPAR gamma function by increasing MAPK-dependent phosphorylation on PPAR gamma at its inhibitory residue of serine 112. These results demonstrate that in addition to inhibiting hepatic fatty acid oxidation, MKP-1 promotes hepatic lipogenic gene expression through PPAR gamma. Hence, MKP-1 plays an important role in MAPK-mediated control of hepatic lipid homeostasis.	[Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA	Yale University; Yale University	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu		Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [R01 DK75776, DK57751, T32 DK07356]; Yale Liver Center [P30 DK34989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, T32DK007356, R01DK075776, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK75776 and DK57751 (to A.M.B.). This work was also supported by Yale Liver Center Grant P30 DK34989.; Supported by National Institutes of Health Grant T32 DK07356. Present address: Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Aguilo F, 2010, BIOCHEM J, V427, P255, DOI 10.1042/BJ20090851; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; BOYER JL, 1990, METHOD ENZYMOL, V192, P501; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1997, J BIOL CHEM, V272, P10811; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Flach RJR, 2010, AGING-US, V2, P170, DOI 10.18632/aging.100135; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reddy ST, 2004, ARTERIOSCL THROM VAS, V24, P1676, DOI 10.1161/01.ATV.0000138342.94314.64; Roth RJ, 2009, J CLIN INVEST, V119, P3817, DOI 10.1172/JCI39054; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin R, 2006, ACTA PHARMACOL SIN, V27, P1146, DOI 10.1111/j.1745-7254.2006.00359.x; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	46	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22195	22202		10.1074/jbc.M110.210237	http://dx.doi.org/10.1074/jbc.M110.210237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521693	Green Published, hybrid			2022-12-27	WOS:000291719900026
J	Shin, J; Chakraborty, G; Bharatham, N; Kang, CB; Tochio, N; Koshiba, S; Kigawa, T; Kim, W; Kim, KT; Yoon, HS				Shin, Joon; Chakraborty, Goutam; Bharatham, Nagakumar; Kang, CongBao; Tochio, Naoya; Koshiba, Seizo; Kigawa, Takanori; Kim, Wanil; Kim, Kyong-Tai; Yoon, Ho Sup			NMR Solution Structure of Human Vaccinia-related Kinase 1 (VRK1) Reveals the C-terminal Tail Essential for Its Structural Stability and Autocatalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; BIOLOGICAL MACROMOLECULES; BINDING-SITE; PHOSPHORYLATION; ACTIVATION; SYSTEM; BAF; CRYSTALLOGRAPHY; MECHANISM; CHROMATIN	Vaccinia-related kinase 1 (VRK1) is one of the mitotic kinases that play important roles in cell cycle, nuclear condensation, and transcription regulation. Kinase domain structures of two other VRK family members (VRK2 and VRK3) have been determined previously. However, the structure of VRK1, the most extensively studied and constitutively active VRK member, is yet to be characterized. Here, we present the nuclear magnetic resonance (NMR) solution structure of a catalytically active form of human VRK1 with its extended C-terminal tail (residues 1-361). The NMR structure of human VRK1 reveals that the C-terminal tail orients toward the catalytic site and forms a number of interactions that are critical for structural stability and catalysis. The role of this unique C-terminal tail was further investigated by deletion mutant studies where deletion of the terminal tail resulted in a dramatic reduction in the autocatalytic activity of VRK1. NMR titration studies carried out with ATP or an ATP analog confirm that ATP/ATP analogs interact with all of the crucial residues present in important motifs of the protein kinase such as the hinge region, catalytic loop, DYG motif, and thereby suggest that the catalytic domain of VRK1 is not atypical. In addition to the conventional interactions, some of the residues present on the extended C-terminal tail also interact with the ligands. These observations also substantiate the role of the extended C-terminal tail in the biological activity of VRK1.	[Shin, Joon; Chakraborty, Goutam; Bharatham, Nagakumar; Kang, CongBao; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tochio, Naoya; Koshiba, Seizo; Kigawa, Takanori] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Kim, Wanil; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; RIKEN; Pohang University of Science & Technology (POSTECH)	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	hsyoon@ntu.edu.sg	Kigawa, Takanori/A-7679-2010; Tochio, Naoya/E-9495-2012; Yoon, Ho Sup/A-2193-2011; Kang, Congbao/AAP-7572-2020	Kigawa, Takanori/0000-0003-0146-9719; Yoon, Ho Sup/0000-0002-8243-3904; Kang, Congbao/0000-0002-9886-9374; KIM, KYONG-TAI/0000-0001-7292-2627	National Medical Research Council of Singapore [NMRC/1177/2008]; Core Research Program/Anti-aging and Well-being Research Center; Ministry of Education, Science, and Technology; National Research Foundation of Korea [20090063547, 20090081464]	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Core Research Program/Anti-aging and Well-being Research Center; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by National Medical Research Council of Singapore Grant NMRC/1177/2008; grants from the Core Research Program/Anti-aging and Well-being Research Center; the Brain Korea 21 program of the Ministry of Education, Science, and Technology; and National Research Foundation of Korea Grants 20090063547 and 20090081464 (the Original Technology Research Program for Brain Science).	Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; BOSSEMEYER D, 1995, FEBS LETT, V369, P57, DOI 10.1016/0014-5793(95)00580-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Goddard TD, 2007, SPARKY VERSION 3; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shchemelinin I, 2006, FOLIA BIOL-PRAGUE, V52, P81; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; TRAKTMAN P, 1989, J BIOL CHEM, V264, P21458; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012	40	32	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22131	22138		10.1074/jbc.M110.200162	http://dx.doi.org/10.1074/jbc.M110.200162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543316	hybrid, Green Published			2022-12-27	WOS:000291719900019
J	Levy-Ontman, O; Arad, S; Harvey, DJ; Parsons, TB; Fairbanks, A; Tekoah, Y				Levy-Ontman, Oshrat; Arad, Shoshana (Malis); Harvey, David J.; Parsons, Thomas B.; Fairbanks, Antony; Tekoah, Yoram			Unique N-Glycan Moieties of the 66-kDa Cell Wall Glycoprotein from the Red Microalga Porphyridium sp.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-MANNOSIDASE; SCALE-ASSOCIATED GLYCOPROTEINS; LASER-DESORPTION IONIZATION; EXTRACELLULAR POLYSACCHARIDE; LINKED OLIGOSACCHARIDES; NEGATIVE-IONS; INSECT CELLS; RAT-LIVER; IDENTIFICATION; FRAGMENTATION	We report here the structural determination of the N-linked glycans in the 66-kDa glycoprotein, part of the unique sulfated complex cell wall polysaccharide of the red microalga Porphyridium sp. Structures were elucidated by a combination of normal phase/reverse phase HPLC, positive ion MALDI-TOF MS, negative ion electrospray ionization, and MS/MS. The sugar moieties of the glycoprotein consisted of at least four fractions of N-linked glycans, each composed of the same four monosaccharides, GlcNAc, Man, 6-O-MeMan, and Xyl, with compositions Man(8-9)Xyl(1-2)Me(3)GlcNAc(2). The present study is the first report of N-glycans with the terminal Xyl attached to the 6-mannose branch of the 6-antenna and to the 3-oxygen of the penultimate (core) GlcNAc. Another novel finding was that all four glycans contain three O-methylmannose residues in positions that have never been reported before. Although it is known that some lower organisms are able to methylate terminal monosaccharides in glycans, the present study on Porphyridium sp. is the first describing an organism that is able to methylate non-terminal mannose residues. This study will thus contribute to understanding of N-glycosylation in algae and might shed light on the evolutionary development from prokaryotes to multicellular organisms. It also may contribute to our understanding of the red algae polysaccharide formation. The additional importance of this research lies in its potential for biotechnological applications, especially in evaluating the use of microalgae as cell factories for the production of therapeutic proteins.	[Levy-Ontman, Oshrat; Arad, Shoshana (Malis); Tekoah, Yoram] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Parsons, Thomas B.] Chem Res Lab, Oxford OX1 3TA, England; [Fairbanks, Antony] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand	Ben Gurion University; University of Oxford; University of Oxford; University of Canterbury	Levy-Ontman, O (corresponding author), Sami Shamoon Coll Engn, Dept Chem Engn, IL-84100 Beer Sheva, Israel.	oshrale@sce.ac.il	Harvey, David/A-5579-2013; Parsons, Thomas/AAC-8142-2021; Fairbanks, Antony John/I-9313-2019	Fairbanks, Antony John/0000-0002-9975-3269; Harvey, David/0000-0003-0544-771X; levy-ontman, oshrat/0000-0002-3977-7066	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altmann F, 1998, EUR J BIOCHEM, V252, P118, DOI 10.1046/j.1432-1327.1998.2520118.x; ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Arad (Malis) S, 1999, CHEM MICROALGAE, P282; Arad S., 2004, Handbook of microalgal culture: biotechnology and applied phycology, P289; Arad S., 2003, BIOMEDIC, V1, P32; Arad S. M., 1988, ALGAL BIOTECHNOLOGY, P65; Arad S, 2010, CURR OPIN BIOTECH, V21, P358, DOI 10.1016/j.copbio.2010.02.008; BALSHUSEMANN D, 1990, EUR J BIOCHEM, V192, P231, DOI 10.1111/j.1432-1033.1990.tb19220.x; Becker B, 1996, PLANTA, V199, P503; Becker B, 1995, EUR J PHYCOL, V30, P307, DOI 10.1080/09670269500651091; BECKER D, 1992, EUR J CELL BIOL, V57, P109; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; Dolashka-Angelova P, 2003, BIOCHEM J, V374, P185, DOI 10.1042/BJ20030291; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; GERESH S, 1992, PHYTOCHEMISTRY, V31, P4181, DOI 10.1016/0031-9422(92)80439-L; GERESH S, 1991, BIORESOURCE TECHNOL, V38, P195, DOI 10.1016/0960-8524(91)90154-C; GERESH S, 1990, CARBOHYD RES, V208, P301, DOI 10.1016/0008-6215(90)80116-K; Geresh S, 2009, CARBOHYD RES, V344, P343, DOI 10.1016/j.carres.2008.11.012; Gloaguen V, 2004, CARBOHYD RES, V339, P97, DOI 10.1016/j.carres.2003.09.020; Godel S, 2000, PROTIST, V151, P147, DOI 10.1078/1434-4610-00015; GRUNOW A, 1993, EUR J CELL BIOL, V61, P10; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUILE GR, 1994, ANAL BIOCHEM, V222, P231, DOI 10.1006/abio.1994.1478; Gutternigg M, 2004, EUR J BIOCHEM, V271, P1348, DOI 10.1111/j.1432-1033.2004.04045.x; HALL RL, 1977, BIOCHEM J, V165, P173, DOI 10.1042/bj1650173; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; HEANEYKIERAS J, 1976, CARBOHYD RES, V52, P169, DOI 10.1016/S0008-6215(00)85957-1; Kamerling JP, 1997, N COMP BIOC B, P123; KHOO K-H, 1991, Glycobiology, V1, P163, DOI 10.1093/glycob/1.2.163; Khoo KH, 1997, GLYCOBIOLOGY, V7, P663, DOI 10.1093/glycob/7.5.663; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lapidot M, 2010, CELL ORIG LIFE EXTRE, V13, P205, DOI 10.1007/978-90-481-3795-4_11; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Lommerse JPM, 1997, EUR J BIOCHEM, V249, P195, DOI 10.1111/j.1432-1033.1997.00195.x; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; LUPESCU N, 1991, CARBOHYD RES, V210, P349, DOI 10.1016/0008-6215(91)80136-B; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; MURAKATA C, 1992, CARBOHYD RES, V235, P95, DOI 10.1016/0008-6215(92)80081-B; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Shrestha RP, 2004, J PHYCOL, V40, P568, DOI 10.1111/j.1529-8817.2004.02177.x; SHRESTHA RP, 1999, THESIS BENGURION U N; Simon-Bercovitch B, 1999, J PHYCOL, V35, P78, DOI 10.1046/j.1529-8817.1999.3510078.x; Simon-Bercovitch B, 1997, THESIS BENGURION U N; STOEVA S, 1995, COMP BIOCHEM PHYS B, V110, P761, DOI 10.1016/0305-0491(94)00201-5; Stoeva S, 1999, BBA-PROTEIN STRUCT M, V1435, P94, DOI 10.1016/S0167-4838(99)00198-3; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; Taylor ME, 2003, INTRO GLYCOBIOLOGY; Tennant-Eyles RJ, 2000, TETRAHEDRON-ASYMMETR, V11, P231, DOI 10.1016/S0957-4166(99)00494-2; TRIMBLE RB, 1978, J BIOL CHEM, V253, P4508; Ucko M, 1999, J PHYCOL, V35, P1276, DOI 10.1046/j.1529-8817.1999.3561276.x; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vliegenthart J. F. G., 1995, GLYCOPROTEINS, P13; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1	67	42	44	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21340	21352		10.1074/jbc.M110.175042	http://dx.doi.org/10.1074/jbc.M110.175042			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515680	Green Published, hybrid			2022-12-27	WOS:000291464700033
J	Xie, SZ; Ni, J; Lee, YF; Liu, S; Li, GH; Shyr, CR; Chang, CS				Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Shyr, Chih-Rong; Chang, Chawnshang			Increased Acetylation in the DNA-binding Domain of TR4 Nuclear Receptor by the Coregulator ARA55 Leads to Suppression of TR4 Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TESTICULAR ORPHAN RECEPTOR-4; PROSTATE-CANCER CELLS; REVERSIBLE ACETYLATION; CEREBELLAR DEVELOPMENT; LYSINE ACETYLATION; EXPRESSION; COACTIVATOR; GENE; PHOSPHORYLATION	The nuclear receptor TR4 is a key regulator for many physiological processes, including growth, development, and metabolism. However, how the transcriptional activity of TR4 is regulated in the absence of ligand(s) remains largely unknown. Here we found that an androgen receptor (AR) coactivator, ARA55, might function as a corepressor to suppress TR4 transactivation. Molecular mechanistic dissection with mutation analysis found that ARA55 could enhance TR4 acetylation at the conserved acetylation sites of lysine 175 and lysine 176 in the DNA-binding domain via recruiting proteins with histone acetyl transferase activity, which might then reduce significantly the TR4 DNA binding activity that resulted in the suppression of TR4 transactivation. These results are in contrast to the classic ARA55 coactivator function to enhance AR transactivation partially via increased AR acetylation in the hinge/ligand-binding domain. Together, these results not only provide a novel functional mechanism showing that acetylation of different nuclear receptors at different domains by coregulator may lead to differential receptor transactivation activity but also provide a new way for small molecules to control TR4 transactivation via altering TR4 acetylation levels, and such small molecules may have potential therapeutic applications in the future.	[Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Shyr, Chih-Rong; Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.	chang@urmc.rochester.edu		Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [DK06312]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; George Whipple Professorship Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial and Research Center of Excellence; George Whipple Professorship Endowment	This work was supported, in whole or in part, by National Institutes of Health Grant DK06312. This work was also supported by a George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University, Taiwan).	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chan HM, 2001, J CELL SCI, V114, P2363; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen YT, 2008, CEREBELLUM, V7, P9, DOI 10.1007/s12311-008-0006-3; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guerrero-Santoro J, 2004, J CELL BIOCHEM, V92, P810, DOI 10.1002/jcb.20109; Heitzer MD, 2007, STEROIDS, V72, P218, DOI 10.1016/j.steroids.2006.11.010; Heitzer Marjet D, 2006, Nucl Recept Signal, V4, pe019; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Huq MDM, 2006, MOL CELL PROTEOMICS, V5, P2072, DOI 10.1074/mcp.M600180-MCP200; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146; Kim E, 2003, J BIOL CHEM, V278, P46919, DOI 10.1074/jbc.M304088200; Kim YS, 2010, CEREBELLUM, V9, P310, DOI 10.1007/s12311-010-0163-z; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8; Li G, 2008, ENDOCRINOLOGY, V149, P3490, DOI 10.1210/en.2008-0121; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Liu NC, 2009, ENDOCRINE, V36, P211, DOI 10.1007/s12020-009-9220-0; Luhrs H, 2002, INT J CANCER, V97, P567, DOI 10.1002/ijc.10098; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Rahman MM, 2003, P NATL ACAD SCI USA, V100, P5124, DOI 10.1073/pnas.0530097100; Shyr CR, 2009, ENDOCRINOLOGY, V150, P2454, DOI 10.1210/en.2008-1165; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tsai NP, 2009, BBA-GENE REGUL MECH, V1789, P734, DOI 10.1016/j.bbagrm.2009.09.010; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang YQ, 2007, MOL ENDOCRINOL, V21, P908, DOI 10.1210/me.2006-0219; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	55	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21129	21136		10.1074/jbc.M110.208181	http://dx.doi.org/10.1074/jbc.M110.208181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515881	Green Published, hybrid			2022-12-27	WOS:000291464700012
J	Bader, JR; Kasuboski, JM; Winding, M; Vaughan, PS; Hinchcliffe, EH; Vaughan, KT				Bader, Jason R.; Kasuboski, James M.; Winding, Michael; Vaughan, Patricia S.; Hinchcliffe, Edward H.; Vaughan, Kevin T.			Polo-like Kinase1 Is Required for Recruitment of Dynein to Kinetochores during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; LIGHT INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; HUMAN-CELLS; PHOSPHORYLATION; DYNACTIN; ZW10; REVEALS; CYTOKINESIS; ASSOCIATION	Kinetochore dynein has been implicated in microtubule capture, correcting inappropriate microtubule attachments, chromosome movement, and checkpoint silencing. It remains unclear how dynein coordinates this diverse set of functions. Phosphorylation is responsible for some dynein heterogeneity (Whyte, J., Bader, J. R., Tauhata, S. B., Raycroft, M., Hornick, J., Pfister, K. K., Lane, W. S., Chan, G. K., Hinchcliffe, E. H., Vaughan, P. S., and Vaughan, K. T. (2008) J. Cell Biol. 183, 819-834), and phosphorylated and dephosphorylated forms of dynein coexist at prometaphase kinetochores. In this study, we measured the impact of inhibiting polo-like kinase 1 (Plk1) on both dynein populations. Phosphorylated dynein was ablated at kinetochores after inhibiting Plk1 with a small molecule inhibitor (5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide) or chemical genetic approaches. The total complement of kinetochore dynein was also reduced but not eliminated, reflecting the presence of some dephosphorylated dynein after Plk1 inhibition. Although Plk1 inhibition had a profound effect on dynein, kinetochore populations of dynactin, spindly, and zw10 were not reduced. Plk1-independent dynein was reduced after p150(Glued) depletion, consistent with the binding of dephosphorylated dynein to dynactin. Plk1 phosphorylated dynein intermediate chains at Thr-89 in vitro and generated the phospho-Thr-89 phospho-epitope on recombinant dynein intermediate chains. Finally, inhibition of Plk1 induced defects in microtubule capture and persistent microtubule attachment, suggesting a role for phosphorylated dynein in these functions during prometaphase. These findings suggest that Plk1 is a dynein kinase required for recruitment of phosphorylated dynein to kinetochores.	[Bader, Jason R.; Kasuboski, James M.; Winding, Michael; Vaughan, Patricia S.; Vaughan, Kevin T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hinchcliffe, Edward H.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Notre Dame; University of Minnesota System	Vaughan, KT (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	Vaughan.4@nd.edu		Winding, Michael James/0000-0003-1965-3266	National Institutes of Health [GM60560, GM072754]; American Cancer Society [RSG 05-117-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060560, R01GM072754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60560 (to K. T. V.) and GM072754 (E. H. H.). This work was also supported by American Cancer Society Grant RSG 05-117-01 (to K. T. V.).	Addinall SG, 2001, J BIOL CHEM, V276, P15939, DOI 10.1074/jbc.M011628200; Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bader JR, 2010, SEMIN CELL DEV BIOL, V21, P269, DOI 10.1016/j.semcdb.2009.12.015; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Dell KR, 2000, TRAFFIC, V1, P38, DOI 10.1034/j.1600-0854.2000.010107.x; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; GORBSKY GJ, 1993, J CELL BIOL, V122, P1311, DOI 10.1083/jcb.122.6.1311; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Savoian MS, 2000, NAT CELL BIOL, V2, P948, DOI 10.1038/35046605; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Starr DA, 2000, J CELL SCI, V113, P1939; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	35	25	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20769	20777		10.1074/jbc.M111.226605	http://dx.doi.org/10.1074/jbc.M111.226605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507953	Green Published, hybrid			2022-12-27	WOS:000291267600062
J	Gray, DW; Breneman, SR; Topper, LA; Sharkey, TD				Gray, Dennis W.; Breneman, Steven R.; Topper, Lauren A.; Sharkey, Thomas D.			Biochemical Characterization and Homology Modeling of Methylbutenol Synthase and Implications for Understanding Hemiterpene Synthase Evolution in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; ISOPRENE SYNTHASE; TERPENE SYNTHASES; SWISS-MODEL; DIMETHYLALLYL DIPHOSPHATE; MONOTERPENE CYCLASE; ENZYMATIC-SYNTHESIS; EXPRESSION; 2-METHYL-3-BUTEN-2-OL; EMISSION	2-Methyl-3-buten-2-ol (MBO) is a five-carbon alcohol produced and emitted in large quantities by many species of pine native to western North America. MBO is structurally and bio-synthetically related to isoprene and can have an important impact on regional atmospheric chemistry. The gene for MBO synthase was identified from Pinus sabiniana, and the protein encoded was functionally characterized. MBO synthase is a bifunctional enzyme that produces both MBO and isoprene in a ratio of similar to 90:1. Divalent cations are required for activity, whereas monovalent cations are not. MBO production is enhanced by K+, whereas isoprene production is inhibited by K+ such that, at physiologically relevant [K+], little or no isoprene emission should be detected from MBO-emitting trees. The K-m of MBO synthase for dimethylallyl diphosphate (20mM) is comparable with that observed for angiosperm isoprene synthases and 3 orders of magnitude higher than that observed for monoterpene and sesquiterpene synthases. Phylogenetic analysis showed that MBO synthase falls into the TPS-d1 group (gymnosperm monoterpene synthases) and is most closely related to linalool synthase from Picea abies. Structural modeling showed that up to three phenylalanine residues restrict the size of the active site and may be responsible for making this a hemiterpene synthase rather than a monoterpene synthase. One of these residues is homologous to a Phe residue found in the active site of isoprene synthases. The remaining two Phe residues do not have homologs in isoprene synthases but occupy the same space as a second Phe residue that closes off the isoprene synthase active site.	[Gray, Dennis W.; Breneman, Steven R.; Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Topper, Lauren A.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Michigan State University; University of New Mexico	Sharkey, TD (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	tsharkey@msu.edu	Sharkey, Thomas D/B-4032-2009; Sharkey, Thomas/ABF-1317-2020	Sharkey, Thomas D/0000-0002-4423-3223; Sharkey, Thomas/0000-0002-4423-3223	National Science Foundation [IOS-0950574]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0950574 and a gift from ZuvaChem, Inc. A patent has been filed covering the MBO gene sequence.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Copolovici LO, 2005, CHEMOSPHERE, V61, P1390, DOI 10.1016/j.chemosphere.2005.05.003; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fisher AJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P128, DOI 10.1006/abbi.2000.2051; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Green S, 2009, J BIOL CHEM, V284, P8652, DOI 10.1074/jbc.M807140200; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanson DT, 1999, AM J BOT, V86, P634, DOI 10.2307/2656571; Harley P, 1998, J GEOPHYS RES-ATMOS, V103, P25479, DOI 10.1029/98JD00820; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iraci LT, 1999, J ATMOS CHEM, V33, P321, DOI 10.1023/A:1006169029230; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; Lerdau M, 2003, NEW PHYTOL, V157, P199, DOI 10.1046/j.1469-8137.2003.00673.x; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Miller B, 2001, PLANTA, V213, P483, DOI 10.1007/s004250100557; NEET KE, 1995, METHOD ENZYMOL, V249, P519; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pechous SW, 2004, PLANTA, V219, P84, DOI 10.1007/s00425-003-1191-4; RAJAONARIVONY JIM, 1992, ARCH BIOCHEM BIOPHYS, V296, P49, DOI 10.1016/0003-9861(92)90543-6; Sasaki K, 2005, FEBS LETT, V579, P2514, DOI 10.1016/j.febslet.2005.03.066; Schade GW, 2000, ATMOS ENVIRON, V34, P3535, DOI 10.1016/S1352-2310(00)00120-5; Schnitzler JP, 2005, PLANTA, V222, P777, DOI 10.1007/s00425-005-0022-1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; SILVER GM, 1991, PLANT PHYSIOL, V97, P1588, DOI 10.1104/pp.97.4.1588; SILVER GM, 1995, J BIOL CHEM, V270, P13010, DOI 10.1074/jbc.270.22.13010; Trapp SC, 2001, GENETICS, V158, P811; Vickers CE, 2010, PLANT MOL BIOL, V73, P547, DOI 10.1007/s11103-010-9642-3; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k	48	39	43	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20582	20590		10.1074/jbc.M111.237438	http://dx.doi.org/10.1074/jbc.M111.237438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504898	Green Published, hybrid			2022-12-27	WOS:000291267600044
J	Kim, S; Brandon, S; Zhou, Z; Cobb, CE; Edwards, SJ; Moth, CW; Parry, CS; Smith, JA; Lybrand, TP; Hustedt, EJ; Beth, AH				Kim, Sunghoon; Brandon, Suzanne; Zhou, Zheng; Cobb, Charles E.; Edwards, Sarah J.; Moth, Christopher W.; Parry, Christian S.; Smith, Jarrod A.; Lybrand, Terry P.; Hustedt, Eric J.; Beth, Albert H.			Determination of Structural Models of the Complex between the Cytoplasmic Domain of Erythrocyte Band 3 and Ankyrin-R Repeats 13-24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOMA CELLS; INTERNAL CA2+ RELEASE; ANION-EXCHANGER; MEMBRANE BAND-3; SPIN LABELS; DISTANCE CONSTRAINTS; CRYSTAL-STRUCTURE; OLIGOMERIC STATE; PROTEIN DOCKING; BINDING SITE	The adaptor protein ankyrin-R interacts via its membrane binding domain with the cytoplasmic domain of the anion exchange protein (AE1) and via its spectrin binding domain with the spectrin-based membrane skeleton in human erythrocytes. This set of interactions provides a bridge between the lipid bilayer and the membrane skeleton, thereby stabilizing the membrane. Crystal structures for the dimeric cytoplasmic domain of AE1 (cdb3) and for a 12-ankyrin repeat segment (repeats 13-24) from the membrane binding domain of ankyrin-R (AnkD34) have been reported. However, structural data on how these proteins assemble to form a stable complex have not been reported. In the current studies, site-directed spin labeling, in combination with electron paramagnetic resonance (EPR) and double electron-electron resonance, has been utilized to map the binding interfaces of the two proteins in the complex and to obtain inter-protein distance constraints. These data have been utilized to construct a family of structural models that are consistent with the full range of experimental data. These models indicate that an extensive area on the peripheral domain of cdb3 binds to ankyrin repeats 18-20 on the top loop surface of AnkD34 primarily through hydrophobic interactions. This is a previously uncharacterized surface for binding of cdb3 to AnkD34. Because a second dimer of cdb3 is known to bind to ankyrin repeats 7-12 of the membrane binding domain of ankyrin-R, the current models have significant implications regarding the structural nature of a tetrameric form of AE1 that is hypothesized to be involved in binding to full-length ankyrin-R in the erythrocyte membrane.	[Beth, Albert H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Edwards, Sarah J.; Moth, Christopher W.; Parry, Christian S.; Lybrand, Terry P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Smith, Jarrod A.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Beth, AH (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 727 Light Hall, Nashville, TN 37232 USA.	al.beth@vanderbilt.edu		kim, sunghoon/0000-0002-1570-3230	National Institutes of Health [P01 GM080513]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086, P01GM080513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM080513 (to A. H. B.).	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhatnagar J, 2010, BIOCHEMISTRY-US, V49, P3824, DOI 10.1021/bi100055m; Blackman SM, 1998, BIOPHYS J, V75, P1117, DOI 10.1016/S0006-3495(98)77601-5; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P17917, DOI 10.1074/jbc.270.30.17917; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Che A, 1997, BIOCHEMISTRY-US, V36, P9588, DOI 10.1021/bi971074z; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, SEMIN CELL DEV BIOL, V22, P166, DOI 10.1016/j.semcdb.2010.09.013; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DAVIS L, 1989, J BIOL CHEM, V264, P9665; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; Ding Y, 1996, J BIOL CHEM, V271, P22494, DOI 10.1074/jbc.271.37.22494; DING Y, 1994, J BIOL CHEM, V269, P32201; Fajer MI, 2007, J AM CHEM SOC, V129, P13840, DOI 10.1021/ja071404v; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hanspal M, 1998, BLOOD, V92, P329, DOI 10.1182/blood.V92.1.329.413k20_329_338; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; KALOMIRIS EL, 1988, J CELL BIOL, V106, P319, DOI 10.1083/jcb.106.2.319; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; LI ZP, 1993, J BIOL CHEM, V268, P11489; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nilsson KR, 2009, J CARDIOVASC PHARM, V54, P106, DOI 10.1097/FJC.0b013e3181b2b6ed; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Sale K, 2005, J AM CHEM SOC, V127, P9334, DOI 10.1021/ja051652w; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Stefanovic M, 2007, P NATL ACAD SCI USA, V104, P13972, DOI 10.1073/pnas.0706266104; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; WILLARDSON BM, 1989, J BIOL CHEM, V264, P15893; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; ZHOU Z, 2006, THESIS VANDERBILT U; Zhou Z, 2007, BIOCHEMISTRY-US, V46, P10248, DOI 10.1021/bi700948p	49	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20746	20757		10.1074/jbc.M111.230326	http://dx.doi.org/10.1074/jbc.M111.230326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493712	Green Published, hybrid			2022-12-27	WOS:000291267600060
J	Lingner, U; Munch, S; Deising, HB; Sauer, N				Lingner, Ulrike; Muench, Steffen; Deising, Holger B.; Sauer, Norbert			Hexose Transporters of a Hemibiotrophic Plant Pathogen FUNCTIONAL VARIATIONS AND REGULATORY DIFFERENCES AT DIFFERENT STAGES OF INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLETOTRICHUM-GRAMINICOLA; SACCHAROMYCES-CEREVISIAE; SUCROSE TRANSPORTERS; GLUCOSE-TRANSPORT; YEAST; GENES; SIGNAL; IDENTIFICATION; TRANSFORMATION; VIRULENCE	Plant pathogenic fungi use a wide range of different strategies to gain access to the carbon sources of their host plants. The hemibiotrophic maize pathogen Colletotrichum graminicola (teleomorph Glomerella graminicola) colonizes its host plants, and, after a short biotrophic phase, switches to destructive, necrotrophic development. Here we present the identification of five hexose transporter genes from C. graminicola, CgHXT1 to CgHXT5, the functional characterization of the encoded proteins, and detailed expression studies for these genes during vegetative and pathogenic development. Whereas CgHXT4 is expressed under all conditions analyzed, transcript abundances of CgHXT1 and CgHXT3 are transiently up-regulated during the biotrophic phase, and CgHXT2 and CgHXT5 are expressed exclusively during necrotrophic development. Analyses of the encoded proteins characterized CgHXT5 as a low-affinity/high-capacity hexose transporter with a narrow substrate specificity for glucose and mannose. In contrast, CgHXT1 to CgHXT3 are high affinity/low capacity transporters that also accept other substrates, including fructose, galactose, or xylose. CgHXT4, the largest of the identified proteins, has only little transport activity and may function as a sugar sensor. Phylogenetic studies revealed hexose transporters closely related to the five CgHXT proteins also in other pathogenic fungi suggesting conserved functions of these proteins during fungal pathogenesis.	[Sauer, Norbert] Univ Erlangen Nurnberg, Erlangen Ctr Plant Sci CROPS, D-91058 Erlangen, Germany; [Deising, Holger B.] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res, D-06120 Halle, Saale, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg	Sauer, N (corresponding author), Univ Erlangen Nurnberg, Erlangen Ctr Plant Sci CROPS, Staudtstr 5, D-91058 Erlangen, Germany.	nsauer@biologie.uni-erlangen.de		Deising, Holger Bruno/0000-0001-5789-4269	Deutsche Forschungsgemeinschaft [FOR666-DE 403-16, FOR666-SA 382-21]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR666-DE 403-16 (to H. B. D.) and FOR666-SA 382-21 (to N. S.).	Behr M, 2010, MOL PLANT MICROBE IN, V23, P879, DOI 10.1094/MPMI-23-7-0879; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; DELROT S, 1981, PLANT PHYSIOL, V67, P560, DOI 10.1104/pp.67.3.560; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kliebenstein DJ, 2008, PLANT SCI, V174, P551, DOI 10.1016/j.plantsci.2008.03.005; Korripally P, 2010, FUNGAL GENET BIOL, V47, P237, DOI 10.1016/j.fgb.2009.12.006; Krijger JJ, 2008, MOL PLANT MICROBE IN, V21, P1325, DOI 10.1094/MPMI-21-10-1325; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Leonardi MG, 1998, AM J PHYSIOL-REG I, V274, pR1372, DOI 10.1152/ajpregu.1998.274.5.R1372; Li HM, 2010, EUR J DERMATOL, V20, P378, DOI 10.1684/ejd.2010.0904; Madi L, 1997, GENETICS, V146, P499; Maier A, 2002, FEMS YEAST RES, V2, P539, DOI 10.1016/S1567-1356(02)00140-X; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Meyer S, 2000, PLANT J, V24, P869, DOI 10.1046/j.1365-313x.2000.00934.x; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; OKAZAWA H, 2007, PROTEIN REV, V6, P451, DOI DOI 10.1007/978-0-387-36534-3_; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qin JC, 2009, STEROIDS, V74, P786, DOI 10.1016/j.steroids.2009.04.011; RUSSEL JB, 1990, NATURE, V56, P3304; SAUER N, 1994, PLANT J, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Sauer N, 2004, PLANT J, V40, P120, DOI 10.1111/j.1365-313X.2004.02196.x; Schussler A, 2006, NATURE, V444, P933, DOI 10.1038/nature05364; TOURNAS V, 1994, CRIT REV MICROBIOL, V20, P243, DOI 10.3109/10408419409113558; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Zheng Y, 2011, MOL PLANT MICROBE IN, V24, P13, DOI 10.1094/MPMI-10-09-0240	41	41	41	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20913	20922		10.1074/jbc.M110.213678	http://dx.doi.org/10.1074/jbc.M110.213678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502323	Green Published, hybrid			2022-12-27	WOS:000291267600075
J	Roder, G; Geironson, L; Rasmussen, M; Harndahl, M; Buus, S; Paulsson, K				Roder, Gustav; Geironson, Linda; Rasmussen, Michael; Harndahl, Mikkel; Buus, Soren; Paulsson, Kajsa			Tapasin Discriminates Peptide-Human Leukocyte Antigen-A*02:01 Complexes Formed with Natural Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ALPHA-2 DOMAIN; MOLECULES; REGION; TAP; IMMUNODOMINANCE; POLYMORPHISM; STABILITY; MECHANISM; PROVIDES	A plethora of peptides are generated intracellularly, and most peptide-human leukocyte antigen (HLA)-I interactions are of a transient, unproductive nature. Without a quality control mechanism, the HLA-I system would be stressed by futile attempts to present peptides not sufficient for the stable peptide-HLA-I complex formation required for long term presentation. Tapasin is thought to be central to this essential quality control, but the underlying mechanisms remain unknown. Here, we report that the N-terminal region of tapasin, Tpn(1-87), assisted folding of peptide-HLA-A*02: 01 complexes according to the identity of the peptide. The facilitation was also specific for the identity of the HLA-I heavy chain, where it correlated to established tapasin dependence hierarchies. Two large sets of HLA-A*02: 01 binding peptides, one extracted from natural HLA-I ligands from the SYFPEITHI database and one consisting of medium to high affinity non-SYFPEITHI ligands, were studied in the context of HLA-A*02: 01 binding and stability. We show that the SYFPEITHI peptides induced more stable HLAA*02:01 molecules than the other ligands, although affinities were similar. Remarkably, Tpn(1-87) could functionally discriminate the selected SYFPEITHI peptides from the other peptide binders with high sensitivity and specificity. We suggest that this HLA-I- and peptide-specific function, together with the functions exerted by the more C-terminal parts of tapasin, are major features of tapasin-mediated HLA-I quality control. These findings are important for understanding the biogenesis of HLA-I molecules, the selection of presented T-cell epitopes, and the identification of immunogenic targets in both basic research and vaccine design.	[Paulsson, Kajsa] Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14, SE-22184 Lund, Sweden; [Roder, Gustav; Rasmussen, Michael; Harndahl, Mikkel; Buus, Soren; Paulsson, Kajsa] Univ Copenhagen, Expt Immunol Lab, Inst Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark	Lund University; University of Copenhagen	Paulsson, K (corresponding author), Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14, SE-22184 Lund, Sweden.	kajsa_m.paulsson@med.lu.se	Buus, Soren/F-5446-2010	Buus, Soren/0000-0001-8363-1999	National Institutes of Health [HHSN266200400025C]; Novo Nordisk Foundation; Lundbeck Foundation; Wedell-Wedellsborgs Foundation; Benzon Foundation; Swedish Medical Research Council [2006-6500]; Crafoord Foundation; Royal Physiographic Society in Lund; Thelma Zoegas Foundation; Magnus Bergvalls Foundation; Groshinskys Foundation; Greta and Johan Kocks Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Wedell-Wedellsborgs Foundation; Benzon Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Royal Physiographic Society in Lund; Thelma Zoegas Foundation; Magnus Bergvalls Foundation; Groshinskys Foundation; Greta and Johan Kocks Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN266200400025C. This work was also supported by the Novo Nordisk Foundation, the Lundbeck Foundation, the Wedell-Wedellsborgs Foundation, the Benzon Foundation, the Copenhagen Cluster of Immunology, Swedish Medical Research Council Grant 2006-6500, the Crafoord Foundation, the Royal Physiographic Society in Lund, and the Thelma Zoegas, Magnus Bergvalls, Groshinskys, and Greta and Johan Kocks Foundations.	Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chen MN, 2002, BIOCHEMISTRY-US, V41, P14539, DOI 10.1021/bi020521u; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ferre H, 2003, PROTEIN SCI, V12, P551, DOI 10.1110/ps.0233003; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; HARNDAHL M, 2010, J IMMUNOL M IN PRESS; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; PARHAM P, 1979, J IMMUNOL, V123, P342; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Paulsson KM, 2004, FASEB J, V18, P31, DOI 10.1096/fj.03-0846rev; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Paulsson KM, 2001, INT IMMUNOL, V13, P23, DOI 10.1093/intimm/13.1.23; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Purcell AW, 2008, CURR OPIN IMMUNOL, V20, P75, DOI 10.1016/j.coi.2007.12.005; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rizvi SM, 2006, P NATL ACAD SCI USA, V103, P18220, DOI 10.1073/pnas.0605131103; Roder G, 2009, EUR J IMMUNOL, V39, P2682, DOI 10.1002/eji.200939364; Stryhn A, 1996, EUR J IMMUNOL, V26, P1911, DOI 10.1002/eji.1830260836; Thirdborough SM, 2008, EUR J IMMUNOL, V38, P364, DOI 10.1002/eji.200737832; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	40	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20547	20557		10.1074/jbc.M111.230151	http://dx.doi.org/10.1074/jbc.M111.230151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518758	Green Published, hybrid			2022-12-27	WOS:000291267600041
J	Tateno, H; Toyota, M; Saito, S; Onuma, Y; Ito, Y; Hiemori, K; Fukumura, M; Matsushima, A; Nakanishi, M; Ohnuma, K; Akutsu, H; Umezawa, A; Horimoto, K; Hirabayashi, J; Asashima, M				Tateno, Hiroaki; Toyota, Masashi; Saito, Shigeru; Onuma, Yasuko; Ito, Yuzuru; Hiemori, Keiko; Fukumura, Mihoko; Matsushima, Asako; Nakanishi, Mio; Ohnuma, Kiyoshi; Akutsu, Hidenori; Umezawa, Akihiro; Horimoto, Katsuhisa; Hirabayashi, Jun; Asashima, Makoto			Glycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin Microarray	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; STRATEGY; OLIGOSACCHARIDES; SPECIFICITY; TECHNOLOGY; DYSTROPHIN; MODEL	Induced pluripotent stem cells (iPSCs) can now be produced from various somatic cell (SC) lines by ectopic expression of the four transcription factors. Although the procedure has been demonstrated to induce global change in gene and microRNA expressions and even epigenetic modification, it remains largely unknown how this transcription factor-induced reprogramming affects the total glycan repertoire expressed on the cells. Here we performed a comprehensive glycan analysis using 114 types of human iPSCs generated from five different SCs and compared their glycomes with those of human embryonic stem cells (ESCs; nine cell types) using a high density lectin microarray. In unsupervised cluster analysis of the results obtained by lectin microarray, both undifferentiated iPSCs and ESCs were clustered as one large group. However, they were clearly separated from the group of differentiated SCs, whereas all of the four SCs had apparently distinct glycome profiles from one another, demonstrating that SCs with originally distinct glycan profiles have acquired those similar to ESCs upon induction of pluripotency. Thirty-eight lectins discriminating between SCs and iPSCs/ESCs were statistically selected, and characteristic features of the pluripotent state were then obtained at the level of the cellular glycome. The expression profiles of relevant glycosyltransferase genes agreed well with the results obtained by lectin microarray. Amongthe 38 lectins, rBC2LCN was found to detect only undifferentiated iPSCs/ESCs and not differentiated SCs. Hence, the high density lectin microarray has proved to be valid for not only comprehensive analysis of glycans but also diagnosis of stem cells under the concept of the cellular glycome.	[Tateno, Hiroaki; Hiemori, Keiko; Fukumura, Mihoko; Matsushima, Asako; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Toyota, Masashi; Akutsu, Hidenori; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Saito, Shigeru] Infocom Corp, Shibuya Ku, Tokyo 1500001, Japan; [Onuma, Yasuko; Ito, Yuzuru; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Nakanishi, Mio; Ohnuma, Kiyoshi; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Center for Child Health & Development - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Hirabayashi, J (corresponding author), AIST, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Saito, Shigeru/B-2785-2012; Ito, Yuzuru/M-1085-2018; Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018; Onuma, Yasuko/L-7083-2018; Asashima, Makoto/O-8389-2018	Saito, Shigeru/0000-0002-8708-9102; Ito, Yuzuru/0000-0001-7923-865X; Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; Onuma, Yasuko/0000-0002-9330-194X; Asashima, Makoto/0000-0002-0012-026X; Ohnuma, Kiyoshi/0000-0002-2272-3643	New Energy and Industrial Technology Development Organization in Japan	New Energy and Industrial Technology Development Organization in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization in Japan.	BREMER EG, 1984, J BIOL CHEM, V259, P4773; Cui CH, 2011, HUM MOL GENET, V20, P235, DOI 10.1093/hmg/ddq458; Ebe Y, 2006, J BIOCHEM, V139, P323, DOI 10.1093/jb/mvj070; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Gupta G, 2010, OMICS, V14, P419, DOI 10.1089/omi.2009.0150; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Kawamichi Y, 2010, J CELL PHYSIOL, V223, P695, DOI 10.1002/jcp.22076; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kuno A, 2008, J PROTEOM BIOINFORM, V1, P68, DOI DOI 10.4172/JPB.1000011; Kuno A, 2009, MOL CELL PROTEOMICS, V8, P99, DOI 10.1074/mcp.M800308-MCP200; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; NATUNEN S, 2011, GLYCOBIOLOG IN PRESS; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; SAITO S, 2010, 4 INT C COMP SYST BI, P381; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2010, BIOCHEM BIOPH RES CO, V401, P480, DOI 10.1016/j.bbrc.2010.09.085; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260; Uchiyama N, 2008, PROTEOMICS, V8, P3042, DOI 10.1002/pmic.200701114; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wearne KA, 2008, GLYCOCONJUGATE J, V25, P121, DOI 10.1007/s10719-007-9064-x; Wearne KA, 2006, GLYCOBIOLOGY, V16, P981, DOI 10.1093/glycob/cwl019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	50	140	148	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20345	20353		10.1074/jbc.M111.231274	http://dx.doi.org/10.1074/jbc.M111.231274			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471226	Green Published, hybrid			2022-12-27	WOS:000291267600022
J	Larabee, JL; Shakir, SM; Hightower, L; Ballard, JD				Larabee, Jason L.; Shakir, Salika M.; Hightower, Logan; Ballard, Jimmy D.			Adenomatous Polyposis Coli Protein Associates with C/EBP beta and Increases Bacillus anthracis Edema Toxin-stimulated Gene Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; KINASE-A; PHOSPHORYLATION; TRANSCRIPTION; CATENIN; BINDING; CREB; DIFFERENTIATION; LOCALIZATION; INACTIVATION	The production of cAMP from Bacillus anthracis edema toxin (ET) activates gene expression in macrophages through a complex array of signaling pathways, most of which remain poorly defined. In this study, the tumor suppressor protein adenomatous polyposis coli (APC) was found to be important for the up-regulation of previously defined ET-stimulated genes (Vegfa, Ptgs2, Arg2, Cxcl2, Sdc1, and Cebpb). A reduction in the expression of these genes after ET exposure was observed when APC was disrupted in macrophages using siRNA or in bone marrow-derived macrophages obtained from C57BL/6J-Apc(Min) mice, which are heterozygous for a truncated form of APC. In line with this observation, ET increased the expression of APC at the transcriptional level, leading to increased amounts of APC in the nucleus. The mechanism utilized by APC to increase ET-induced gene expression was determined to depend on the ability of APC to interact with C/EBP beta, which is a transcription factor activated by cAMP. Coimmunoprecipitation experiments found that APC associated with C/EBP beta and that levels of this complex increase after ET exposure. A further connection was uncovered when silencing APC was determined to reduce the ET-induced phosphorylation of C/EBP beta at Thr-188. This ET-mediated phosphorylation of C/EBP beta was blocked by glycogen synthase kinase 3 (GSK-3) inhibitors, suggesting that GSK-3 is involved in the activation of C/EBP beta and supporting the idea of APC helping direct interactions between GSK-3 and C/EBP beta. These results indicate that ET stimulates gene expression by promoting the formation of an inducible protein complex consisting of APC and C/EBP beta.	[Larabee, Jason L.; Shakir, Salika M.; Hightower, Logan; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BRC-358,975 NE 10th St, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	NIAID National Institutes of Health [U19 AI062629-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID National Institutes of Health Grant U19 AI062629-6 (to J. D. B.).	BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Comer JE, 2006, MICROB PATHOGENESIS, V41, P96, DOI 10.1016/j.micpath.2006.05.001; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gorgoni B, 2001, J BIOL CHEM, V276, P40769, DOI 10.1074/jbc.M106865200; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kouzmenko AP, 2008, ONCOGENE, V27, P4888, DOI 10.1038/onc.2008.127; Kouzmenko AP, 2008, GENES CELLS, V13, P723, DOI 10.1111/j.1365-2443.2008.01200.x; Larabee JL, 2008, INFECT IMMUN, V76, P4895, DOI 10.1128/IAI.00889-08; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu XD, 2001, AM J PHYSIOL-RENAL, V281, pF649, DOI 10.1152/ajprenal.2001.281.4.F649; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Raymond B, 2007, PLOS PATHOG, V3, P1907, DOI 10.1371/journal.ppat.0030187; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Strom A, 2007, DEVELOPMENT, V134, P2719, DOI 10.1242/dev.02875; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Yeager LA, 2009, INFECT IMMUN, V77, P2530, DOI 10.1128/IAI.00905-08; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001	35	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19364	19372		10.1074/jbc.M111.224543	http://dx.doi.org/10.1074/jbc.M111.224543			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487015	hybrid, Green Published			2022-12-27	WOS:000291027700018
J	Shibata, T; Shimozu, Y; Wakita, C; Shibata, N; Kobayashi, M; Machida, S; Kato, R; Itabe, H; Zhu, XC; Sayre, LM; Uchida, K				Shibata, Takahiro; Shimozu, Yuuki; Wakita, Chika; Shibata, Noriyuki; Kobayashi, Makio; Machida, Sachiko; Kato, Rina; Itabe, Hiroyuki; Zhu, Xiaochun; Sayre, Lawrence M.; Uchida, Koji			Lipid Peroxidation Modification of Protein Generates N-epsilon-(4-Oxononanoyl)lysine as a Pro-inflammatory Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDIZED LDL RECEPTOR-1; ARTERY ENDOTHELIAL-CELLS; CROSS-LINKING; ATHEROSCLEROTIC LESIONS; DECOMPOSITION PRODUCTS; SCAVENGER RECEPTOR; LOX-1 EXPRESSION; MICHAEL ADDUCTS; OX-LDL	4-Oxo-2(E)-nonenal (ONE), a peroxidation product of omega-6 polyunsaturated fatty acids, covalently reacts with lysine residues to generate a 4-ketoamide-type ONE-lysine adduct, N-epsilon-(4oxononanoyl) lysine (ONL). Using an ONL-coupled protein as the immunogen, we raised the monoclonal antibody (mAb) 9K3 directed to the ONL and conclusively demonstrated that the ONL was produced during the oxidative modification of a low density lipoprotein (LDL) in vitro. In addition, we observed that the ONL was present in atherosclerotic lesions, in which an intense immunoreactivity was mainly localized in the vascular endothelial cells and macrophage-and vascular smooth muscle cell-derived foam cells. Using liquid chromatography with on-line electrospray ionization tandem mass spectrometry, we also established a highly sensitive method for quantification of the ONL and confirmed that the ONL was indeed formed during the lipid peroxidation-mediated modification of protein in vitro and in vivo. To evaluate the biological implications for ONL formation, we examined the recognition of ONL by the scavenger receptor lectin-like oxidized LDL receptor-1 (LOX-1). Using CHO cells stably expressing LOX-1, we evaluated the ability of ONL to compete with the acetylated LDL and found that both the ONE-modified and ONL-coupled proteins inhibited the binding and uptake of the modified LDL. In addition, we demonstrated that the ONL-coupled protein was incorporated into differentiated THP-1 cells via LOX-1. Finally, we examined the effect of ONL on the expression of the inflammation-associated gene in THP-1 and observed that the ONL-coupled proteins significantly induced the expression of atherogenesis-related genes, such as the monocyte chemoattractant protein-1 and tumor necrosis factor-alpha, in a LOX-1-dependent manner. Thus, ONL was identified to be a potential endogenous ligand for LOX-1.	[Shibata, Takahiro; Shimozu, Yuuki; Wakita, Chika; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Noriyuki; Kobayashi, Makio] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan; [Machida, Sachiko] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Kato, Rina; Itabe, Hiroyuki] Showa Univ, Dept Biol Chem, Sch Pharm, Tokyo 1428555, Japan; [Zhu, Xiaochun; Sayre, Lawrence M.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Nagoya University; Tokyo Women's Medical University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Showa University; Case Western Reserve University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	板部板部, 洋之/ABC-7746-2020; Shimozu, Yuuki/AAW-1504-2021; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Iijima Memorial Foundation	Iijima Memorial Foundation	This work was supported by grants-in-aid for scientific research on innovative areas (research in a proposed research area), Japan (to K. U.), and The Iijima Memorial Foundation (to T. S.).	Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Draude G, 1999, BIOCHEM PHARMACOL, V57, P383, DOI 10.1016/S0006-2952(98)00313-X; Duryee MJ, 2003, BIOCHEM PHARMACOL, V66, P1045, DOI 10.1016/S0006-2952(03)00416-7; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, CHEM RES TOXICOL, V3, P77, DOI 10.1021/tx00014a001; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Honjo M, 2003, P NATL ACAD SCI USA, V100, P1274, DOI 10.1073/pnas.0337528100; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Ishino K, 2010, J BIOL CHEM, V285, P15302, DOI 10.1074/jbc.M109.068023; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; JURGENS G, 1986, BIOCHIM BIOPHYS ACTA, V875, P103, DOI 10.1016/0005-2760(86)90016-0; Kakutani M, 2000, P NATL ACAD SCI USA, V97, P360, DOI 10.1073/pnas.97.1.360; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kawai Y, 2004, FREE RADICAL BIO MED, V36, P529, DOI 10.1016/j.freeradbiomed.2003.12.006; Kawai Y, 2002, CARCINOGENESIS, V23, P485, DOI 10.1093/carcin/23.3.485; Kume N, 1998, CIRC RES, V83, P322, DOI 10.1161/01.RES.83.3.322; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; Matsunaga S, 2007, EXP CELL RES, V313, P1203, DOI 10.1016/j.yexcr.2007.01.007; Mehta JL, 2002, J AM COLL CARDIOL, V39, P1429, DOI 10.1016/S0735-1097(02)01803-X; Moriwaki H, 1998, FEBS LETT, V440, P29, DOI 10.1016/S0014-5793(98)01414-8; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; RAMOS P, 1995, J LIPID RES, V36, P2113; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Rindgen D, 2000, CHEM RES TOXICOL, V13, P846, DOI 10.1021/tx0000771; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Shi XH, 2001, J CELL SCI, V114, P1273; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Shimozu Y, 2009, CHEM RES TOXICOL, V22, P957, DOI 10.1021/tx900059k; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; Williams MV, 2007, CHEM RES TOXICOL, V20, P767, DOI 10.1021/tx600289r; Xu GZ, 1999, CHEM RES TOXICOL, V12, P855, DOI 10.1021/tx990056a; Xu GZ, 1998, CHEM RES TOXICOL, V11, P247, DOI 10.1021/tx980003d; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j; Zhu X, 2009, CHEM RES TOXICOL, V22, P1386, DOI 10.1021/tx9000072; Zhu X, 2009, CHEM RES TOXICOL, V22, P1050, DOI 10.1021/tx9000144	61	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19943	19957		10.1074/jbc.M110.187047	http://dx.doi.org/10.1074/jbc.M110.187047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471194	hybrid, Green Published			2022-12-27	WOS:000291027700073
J	Thompson, S; Pearson, AN; Ashley, MD; Jessick, V; Murphy, BM; Gafken, P; Henshall, DC; Morris, KT; Simon, RP; Meller, R				Thompson, Simon; Pearson, Andrea N.; Ashley, Michelle D.; Jessick, Veronica; Murphy, Brona M.; Gafken, Philip; Henshall, David C.; Morris, Kate T.; Simon, Roger P.; Meller, Robert			Identification of a Novel Bcl-2-interacting Mediator of Cell Death (Bim) E3 Ligase, Tripartite Motif-containing Protein 2 (TRIM2), and Its Role in Rapid Ischemic Tolerance-induced Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED KINASES 1/2; BH3-ONLY PROTEIN; DEPENDENT APOPTOSIS; UBIQUITIN LIGASES; PHOSPHORYLATION; DEGRADATION; BIM(EL); ADENOSINE; FAMILY; CHAIN	We have previously shown that the cell death-promoting protein Bcl-2-interacting mediator of cell death (Bim) is ubiquitinated and degraded following a neuroprotection-conferring episode of brief ischemia (preconditioning). Here, we identify the E3 ligase that ubiquitinates Bim in this model, using a proteomics approach. Using phosphorylated GST-Bim as bait, we precipitated and identified by mass spectrometry tripartite motif protein 2 (TRIM2), a RING (really interesting new gene) domain-containing protein. The reaction between TRIM2 and Bim was confirmed using co-immunoprecipitation followed by immunoblotting. We show that TRIM2 binds to Bim when it is phosphorylated by p42/p44 MAPK but does not interact with a nonphosphorylatable Bim mutant (3ABim). 12-O-tetradecanoylphorbol-13-acetate activation of p42/p44 MAPK drives Bim ubiquitination in mouse embryonic fibroblast cells and is associated with an increased interaction between TRIM2 and Bim. One hour following preconditioning ischemia, the binding of Bim to TRIM2 increased, consistent with the time window of enhanced Bim degradation. Blocking p42/p44 MAPK activation following preconditioning ischemia with U0126 or using the nonphosphorylatable 3ABim reduced the binding between Bim and TRIM2. Immunodepletion of TRIM2 from cell lysates prepared from preconditioned cells reduced Bim ubiquitination. Finally, suppression of TRIM2 expression, using lentivirus transduction of shRNAmir, stabilized Bim protein levels and blocked neuroprotection observed in rapid ischemic tolerance. Taken together, these data support a role for TRIM2 in mediating the p42/p44 MAPK-dependent ubiquitination of Bim in rapid ischemic tolerance.	[Pearson, Andrea N.; Simon, Roger P.; Meller, Robert] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Thompson, Simon; Pearson, Andrea N.; Ashley, Michelle D.; Jessick, Veronica; Simon, Roger P.; Meller, Robert] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97208 USA; [Gafken, Philip] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA; [Murphy, Brona M.; Henshall, David C.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Morris, Kate T.; Meller, Robert] Legacy Res, Canc Res Labs, Portland, OR 97210 USA	Morehouse School of Medicine; Fred Hutchinson Cancer Center; Royal College of Surgeons - Ireland	Meller, R (corresponding author), Morehouse Sch Med, Inst Neurosci, 720 Westview Dr SW, Atlanta, GA 30310 USA.	rmeller@msm.edu	Murphy, Brona/P-2544-2019; Henshall, David/C-3364-2012; Murphy, Brona/D-4873-2012	Murphy, Brona/0000-0002-6740-8858; Murphy, Brona/0000-0002-6740-8858; Henshall, David/0000-0001-6237-9632; Thompson, Simon/0000-0003-0769-8555	National Institutes of Health [NS50669, NS59588, NS24728, NS39016]; National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes [G12-RR03034, U54 NS060659]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024728, U54NS060659, R01NS039016, R01NS059588, R21NS050669] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants NS50669 and NS59588 (to R. M.) and NS24728 and NS39016 (to R. P. S.). This work was also supported by National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes Grants G12-RR03034 and U54 NS060659 (to Morehouse School of Medicine).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Cleary SP, 2002, J BIOL CHEM, V277, P5562, DOI 10.1074/jbc.M106532200; El Chami N, 2005, J CELL BIOL, V171, P651, DOI 10.1083/jcb.200507076; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miyatake T, 2007, INT J CANCER, V120, P2068, DOI 10.1002/ijc.22264; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Nakamura M, 2002, J CEREBR BLOOD F MET, V22, P161, DOI 10.1097/00004647-200202000-00004; Ohkawa N, 2001, J NEUROCHEM, V78, P75, DOI 10.1046/j.1471-4159.2001.00373.x; Ordonez Andrea Nicole, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P36; Perez-Pinzon MA, 1999, NEUROSCIENCE, V89, P453, DOI 10.1016/S0306-4522(98)00560-0; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Reshef A, 2000, ADV EXP MED BIOL, V486, P217; Reshef A, 2000, NEUROREPORT, V11, P463, DOI 10.1097/00001756-200002280-00007; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Wiggins CM, 2007, CELL SIGNAL, V19, P2605, DOI 10.1016/j.cellsig.2007.08.008; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	31	39	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19331	19339		10.1074/jbc.M110.197707	http://dx.doi.org/10.1074/jbc.M110.197707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478148	Green Published, hybrid			2022-12-27	WOS:000291027700015
J	Donninger, H; Allen, N; Henson, A; Pogue, J; Williams, A; Gordon, L; Kassler, S; Dunwell, T; Latif, F; Clark, GJ				Donninger, Howard; Allen, Nadia; Henson, Adrianna; Pogue, Jennifer; Williams, Andrew; Gordon, Laura; Kassler, Susannah; Dunwell, Thomas; Latif, Farida; Clark, Geoffrey J.			Salvador Protein Is a Tumor Suppressor Effector of RASSF1A with Hippo Pathway-independent Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; RAS TRANSFORMATION; SIGNALING PATHWAY; KINASE MST2; ORGAN SIZE; APOPTOSIS; CANCER; P73; YAP; PROLIFERATION	The RASSF1A tumor suppressor binds and activates proapoptotic MST kinases. The Salvador adaptor protein couples MST kinases to the LATS kinases to form the hippo pathway. Upon activation by RASSF1A, LATS1 phosphorylates the transcriptional regulator YAP, which binds to p73 and activates its proapoptotic effects. However, although serving as an adaptor for MST and LATS, Salvador can also bind RASSF1A. The functional role of the RASSF1A/Salvador interaction is unclear. Although Salvador is a novel tumor suppressor in Drosophila and mice, its role in human systems remains largely unknown. Here we show that Salvador promotes apoptosis in human cells and that Salvador inactivation deregulates the cell cycle and enhances the transformed phenotype. Moreover, we show that although the salvador gene is seldom mutated or epigenetically inactivated in human cancers, it is frequently down-regulated posttranscriptionally. Surprisingly, we also find that although RASSF1A requires the presence of Salvador for full apoptotic activity and to activate p73, this effect does not require a direct interaction of RASSF1A with MST kinases or the activation of the hippo pathway. Thus, we confirm a role for Salvador as a human tumor suppressor and RASSF1A effector and show that Salvador allows RASSF1A to modulate p73 independently of the hippo pathway.	[Donninger, Howard; Henson, Adrianna; Pogue, Jennifer; Williams, Andrew; Gordon, Laura; Kassler, Susannah; Clark, Geoffrey J.] Univ Louisville, Mol Targets Program, JG Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Allen, Nadia] QIAGEN, Gaithersburg, MD 20878 USA; [Dunwell, Thomas; Latif, Farida] Univ Birmingham, Sect Med & Mol Genet, Edgbaston B15 2TT, W Midlands, England	University of Louisville; University of Birmingham	Clark, GJ (corresponding author), 505 S Hancock St,Rm 417, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Dunwell, Thomas/0000-0001-9985-3828	National Institutes of Health [RR18733]; NCI, National Institutes of Health; Cancer Research UK; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR18733 and NCI, National Institutes of Health intramural funds (to G. J. C.). F. L. was supported by Cancer Research UK.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Antonsson A, 2009, ANTICANCER RES, V29, P2893; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2009, BIOFACTORS, V35, P338, DOI 10.1002/biof.47; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tomkova K, 2004, CANCER RES, V64, P6390, DOI 10.1158/0008-5472.CAN-04-2176; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Vos MD, 2006, METHOD ENZYMOL, V407, P311, DOI 10.1016/S0076-6879(05)07026-6; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	45	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18483	18491		10.1074/jbc.M110.214874	http://dx.doi.org/10.1074/jbc.M110.214874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21489991	hybrid, Green Published			2022-12-27	WOS:000290785700021
J	Feng, S; Rodat-Despoix, L; Delmas, P; Ong, ACM				Feng, Shuang; Rodat-Despoix, Lise; Delmas, Patrick; Ong, Albert C. M.			A Single Amino Acid Residue Constitutes the Third Dimerization Domain Essential for the Assembly and Function of the Tetrameric Polycystin-2 (TRPP2) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; CYSTIC TISSUE; RECEPTOR; COMPLEX; PKD1; IDENTIFICATION; LOCALIZATION; GENE; ASSOCIATION; ACTIVATION	Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited cause of kidney failure, is caused by mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 protein, polycystin-2 (PC2 or TRPP2), is a member of the transient receptor potential (TRP) superfamily and functions as a nonselective calcium channel. PC2 has been found to form oligomers in native tissues, suggesting that similar to other TRP channels, it may form functional homo- or heterotetramers with other TRP subunits. We have recently demonstrated that the homodimerization of PC2 is mediated by both N-terminal and C-terminal domains, and it is known that PC2 can heterodimerize with PC1, TRPC1, and TRPV4. In this paper, we report that a single cysteine residue, Cys(632), mutated in a known PKD2 pedigree, constitutes the third dimerization domain for PC2. PC2 truncation mutants lacking both N and C termini could still dimerize under nonreducing conditions. Mutation of Cys(632) alone abolished dimerization in these mutants, indicating that it was the critical residue mediating disulfide bond formation between PC2 monomers. Co-expression of C632A PC2 mutants with wild-type PC2 channels reduced ATP-sensitive endoplasmic reticulum Ca2+ release in HEK293 cells. The combination of C632A and mutations disrupting the C-terminal coiled-coil domain (Val(846), Ile(853), Ile(860), Leu(867) or 4M) nearly abolished dimer formation and ATP-dependent Ca2+ release. However, unlike the 4M PC2 mutant, a C632A mutant could still heterodimerize with polycystin-1 (PC1). Our results indicate that PC2 homodimerization is regulated by three distinct domains and that these events regulate formation of the tetrameric PC2 channel.	[Feng, Shuang; Ong, Albert C. M.] Univ Sheffield, Sch Med, Kidney Genet Grp, Acad Unit Nephrol,Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Rodat-Despoix, Lise; Delmas, Patrick] Univ Mediterrane, Ctr Rech Neurophysiol & Neurobiol Marseille, CNRS, CS80011,UMR 6231, F-13344 Marseille 15, France	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ong, ACM (corresponding author), Univ Sheffield, Sch Med, Kidney Genet Grp, Acad Unit Nephrol,Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400; Despoix, Lise/0000-0002-2456-6039	Wellcome Trust [GR071201]; Sheffield Kidney Research Foundation; Sheffield Area Kidney Association	Wellcome Trust(Wellcome TrustEuropean Commission); Sheffield Kidney Research Foundation; Sheffield Area Kidney Association	This work was funded by Wellcome Trust Grant GR071201 (to A. C. M. O.) and a Sheffield Kidney Research Foundation (to A. C. M. O.).; Brayshaw Research Associate and holder of a Ph.D. studentship from the Sheffield Area Kidney Association.	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Fu X, 2008, J AM SOC NEPHROL, V19, P1342, DOI 10.1681/ASN.2007070730; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; HIRS CHW, 1967, METHOD ENZYMOL, V11, P198; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106	32	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18994	19000		10.1074/jbc.M110.192286	http://dx.doi.org/10.1074/jbc.M110.192286			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474446	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000290785700070
J	Wu, LC; Pfeiffer, DR; Calhoon, EA; Madiai, F; Marcucci, G; Liu, SJ; Jurkowitz, MS				Wu, Lai-Chu; Pfeiffer, Douglas R.; Calhoon, Elisabeth A.; Madiai, Francesca; Marcucci, Guido; Liu, Shujun; Jurkowitz, Marianne S.			Purification, Identification, and Cloning of Lysoplasmalogenase, the Enzyme That Catalyzes Hydrolysis of the Vinyl Ether Bond of Lysoplasmalogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; ZINC-FINGER PROTEIN; PHOSPHOLIPID-COMPOSITION; LYSOPHOSPHATIDIC ACID; CELL-LINE; PLASMALOGEN; BRAIN; BIOSYNTHESIS; METABOLISM; DISEASE	Lysoplasmalogenase (EC 3.3.2.2 and EC 3.3.2.5) is an enzyme that catalyzes hydrolytic cleavage of the vinyl ether bond of lysoplasmalogen, forming fatty aldehyde and glycerophosphoethanolamine or glycerophosphocholine and is specific for the sn-2-deacylated form of plasmalogen. Here we report the purification, characterization, identification, and cloning of lysoplasmalogenase. Rat liver microsomal lysoplasmalogenase was solubilized with octyl glucoside and purified 500-fold to near homogeneity using four chromatography steps. The purified enzyme has apparent K-m values of similar to 50 mu M for both lysoplasmenylcholine and lysoplasmenylethanolamine and apparent 0 values of 24.5 and 17.5 mu mol/min/mg protein for the two substrates, respectively. The pH optimum was 7.0. Lysoplasmalogenase was competitively inhibited by lysophosphatidic acid (K-i similar to 20 mu M). The predominant band on a gel at similar to 19 kDa was subjected to trypsinolysis, and the peptides were identified by mass spectrometry as Tmem86b, a protein of unknown function. Transient transfection of human embryonic kidney (HEK) 293T cells showed that TMEM86b cDNA yielded lysoplasmalogenase activity, and Western blot analyses confirmed the synthesis of TMEM86b protein. The protein was localized in the membrane fractions. The TMEM86b gene was also transformed into Escherichia coli, and its expression was verified by Western blot and activity analyses. Tmem86b is a hydrophobic transmembrane protein of the YhhN family. Northern blot analyses demonstrated that liver expressed the highest level of Tmem86b, which agreed with tissue distribution of activity. Overexpression of TMEM86b in HEK 293T cells resulted in decreased levels of plasmalogens, suggesting that the enzyme may be important in regulating plasmalogen levels in animal cells.	[Wu, Lai-Chu; Pfeiffer, Douglas R.; Jurkowitz, Marianne S.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wu, Lai-Chu; Marcucci, Guido; Liu, Shujun] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Calhoon, Elisabeth A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Madiai, Francesca; Marcucci, Guido; Liu, Shujun] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Jurkowitz, MS (corresponding author), 1645 Neil Ave,Rm 310,Hamilton Hall, Columbus, OH 43210 USA.	jurkowitz.1@osu.edu	Wu, Lai-Chu/E-4328-2011	Wu, Lai-Chu/0000-0002-1348-269X	Ohio State University [306500]; Columbus Medical Research Foundation; National Institutes of Health (NCI) [CA149623]; NATIONAL CANCER INSTITUTE [R01CA149623] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); Columbus Medical Research Foundation; National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ohio State University Development fund Grant 306500 (from Daniel S. and Amy E. F. Jurkowitz) (to M. S. J.) and a grant from the Columbus Medical Research Foundation (to L.-C. W.). The work was also supported by National Institutes of Health (NCI) ROI Grant CA149623 (to S. L.).	Allen CE, 2002, GENE CHROMOSOME CANC, V35, P287, DOI 10.1002/gcc.10128; ARTHUR G, 1986, BIOCHEM J, V236, P475, DOI 10.1042/bj2360475; BLANK ML, 1995, BBA-LIPID LIPID MET, V1254, P295, DOI 10.1016/0005-2760(94)00189-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Broderson S. H., 1967, THESIS STATE U NEW Y; CORR PB, 1984, CIRC RES, V55, P135, DOI 10.1161/01.RES.55.2.135; CORR PB, 1981, CIRC RES, V49, P354, DOI 10.1161/01.RES.49.2.354; ELLINGSON JS, 1968, LIPIDS, V3, P111, DOI 10.1007/BF02531727; FREEMAN NM, 1984, NEUROCHEM INT, V6, P273, DOI 10.1016/0197-0186(84)90103-7; Gaposchkin DP, 1999, J LIPID RES, V40, P495; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; GOTTFRIED EL, 1962, J BIOL CHEM, V237, P329; Graham J M, 1993, Methods Mol Biol, V19, P19; GUNAWAN J, 1985, J NEUROCHEM, V44, P370, DOI 10.1111/j.1471-4159.1985.tb05426.x; GUNAWAN J, 1979, H-S Z PHYSIOL CHEM, V360, P971, DOI 10.1515/bchm2.1979.360.2.971; GUNAWAN J, 1982, J NEUROCHEM, V39, P693, DOI 10.1111/j.1471-4159.1982.tb07948.x; GUNAWAN J, 1981, H-S Z PHYSIOL CHEM, V362, P445, DOI 10.1515/bchm2.1981.362.1.445; HAN XL, 1991, BIOCHIM BIOPHYS ACTA, V1069, P37, DOI 10.1016/0005-2736(91)90101-D; Horrocks L.A., 1982, NEW COMPR BIOCH, V4, P51, DOI [10.1016/s0167-7306(08)60006-x, DOI 10.1016/S0167-7306(08)60006-X]; HOWARD BV, 1972, CANCER RES, V32, P1533; HUNTER MJ, 1961, BIOCHIM BIOPHYS ACTA, V47, P580, DOI 10.1016/0006-3002(61)90553-4; HUQUE T, 1987, COMP BIOCHEM PHYS B, V86, P135, DOI 10.1016/0305-0491(87)90188-X; JAFFE ER, 1968, J CLIN INVEST, V47, P1375, DOI 10.1172/JCI105829; Jurkowitz MS, 1999, BBA-MOL CELL BIOL L, V1437, P142, DOI 10.1016/S1388-1981(99)00013-X; JURKOWITZALEXANDER M, 1989, BIOCHIM BIOPHYS ACTA, V1002, P203, DOI 10.1016/0005-2760(89)90288-9; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P79; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P483; KRAMER RM, 1983, J BIOL CHEM, V258, P3806; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Mutch DM, 2004, PHYSIOL GENOMICS, V17, P11, DOI 10.1152/physiolgenomics.00150.2003; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; NIETO ML, 1991, J BIOL CHEM, V266, P18699; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Schonefeld M, 1996, KIDNEY INT, V49, P1289, DOI 10.1038/ki.1996.184; SNYDER F, 1972, ETHER LIPIDS CHEM BI, P273; Snyder F., 1972, ETHER LIPIDS CHEM BI, DOI DOI 10.1016/B978-0-12-654150-2.50014-2; SOODSMA JF, 1970, CANCER RES, V30, P309; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VANCE JE, 1990, BIOCHIM BIOPHYS ACTA, V1045, P128, DOI 10.1016/0005-2760(90)90141-J; Von Jagow G., 1994, PRACTICAL GUIDE MEMB, P68; WARNER HR, 1961, J BIOL CHEM, V236, P2404; White MC, 2007, AM J PHYSIOL-CELL PH, V293, pC1467, DOI 10.1152/ajpcell.00290.2007; Williams SD, 1997, FEBS LETT, V420, P33, DOI 10.1016/S0014-5793(97)01482-8; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; WYKLE RL, 1974, J BIOL CHEM, V249, P1742; ZHANG Y, 1988, J BIOL CHEM, V263, P9965	56	35	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24916	24930		10.1074/jbc.M111.247163	http://dx.doi.org/10.1074/jbc.M111.247163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21515882	Green Published, hybrid			2022-12-27	WOS:000292547900041
J	Astle, MV; Ooms, LM; Cole, AR; Binge, LC; Dyson, JM; Layton, MJ; Petratos, S; Sutherland, C; Mitchell, CA				Astle, Megan V.; Ooms, Lisa M.; Cole, Adam R.; Binge, Lauren C.; Dyson, Jennifer M.; Layton, Meredith J.; Petratos, Steven; Sutherland, Calum; Mitchell, Christina A.			Identification of a Proline-rich Inositol Polyphosphate 5-Phosphatase (PIPP)center dot Collapsin Response Mediator Protein 2 (CRMP2) Complex That Regulates Neurite Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NEURONAL POLARITY; ALZHEIMERS-DISEASE; GSK-3 PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; MEMBRANE RUFFLES; AXON FORMATION; FEEDBACK LOOP; GROWTH CONES; RHO-KINASE	Neuron polarization is essential for the formation of one axon and multiple dendrites, establishing the neuronal circuitry. Phosphoinositide 3-kinase (PI3K) signaling promotes axon selection and elongation. Here we report in hippocampal neurons siRNA knockdown of the proline-rich inositol polyphosphate 5-phosphatase (PIPP), which degrades PI3K-generated PtdIns(3,4,5)P-3, results in multiple hyperelongated axons consistent with a polarization defect. We identify collapsin response mediator protein 2 (CRMP2), which regulates axon selection by promoting WAVE1 delivery via Kinesin-1 motors to the axon growth cone, as a PIPP-interacting protein by Y2H screening, direct binding studies, and coimmunoprecipitation of an endogenous PIPP, CRMP2, and Kinesin-1 complex from brain lysates. The C-terminal growth cone-targeting domain of PIPP facilitates its interaction with CRMP2. PIPP growth cone localization is CRMP2-dependent. PIPP knockdown in PC12 cells promotes neurite elongation, WAVE1 and Kinesin-1 growth cone localization, whereas knockdown of CRMP2 exhibits the opposite phenotype, with shorter neurites and decreased WAVE1/Kinesin-1 at the growth cone. In contrast, CRMP2 overexpression promotes neurite elongation, a phenotype rescued by full-length PIPP, or expression of the CRMP2-binding PIPP domain. Therefore this study identifies PIPP and CRMP2 exert opposing roles in promoting axon selection and neurite elongation and the complex between these proteins serves to regulate the localization of effectors that promote neurite extension.	[Astle, Megan V.; Ooms, Lisa M.; Binge, Lauren C.; Dyson, Jennifer M.; Layton, Meredith J.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Cole, Adam R.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Petratos, Steven] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia; [Petratos, Steven] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia; [Sutherland, Calum] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland	Monash University; Garvan Institute of Medical Research; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); University of Dundee	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Ooms, Lisa/AGZ-7420-2022	Sutherland, Calum/0000-0003-4398-7434; Ooms, Lisa Michelle/0000-0002-8918-9932; Mitchell, Christina A/0000-0001-9372-3192	National Health and Medical Research Council, Australia [436638]; Australian Research Council, Australia [DP110103655]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council, Australia(Australian Research Council); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council, Australia, Grant 436638 and Australian Research Council, Australia, Grant DP110103655.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; CLEVELAND DW, 1983, CELL, V34, P330, DOI 10.1016/0092-8674(83)90366-5; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GORDONWEEKS PR, 1991, BIOESSAYS, V13, P235, DOI 10.1002/bies.950130506; Goslin K., 1991, RAT HIPPOCAMPAL NEUR; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; He Y, 2002, J NEUROSCI, V22, P5982; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Liu HK, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-14; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Mochizuki Y, 1999, J BIOL CHEM, V274, P36790, DOI 10.1074/jbc.274.51.36790; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ooms LM, 2006, MOL BIOL CELL, V17, P607, DOI 10.1091/mbc.E05-05-0469; Pawlik M, 2007, BIOCHEM BIOPH RES CO, V355, P907, DOI 10.1016/j.bbrc.2007.02.047; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wang LH, 1996, J NEUROSCI, V16, P6197; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	61	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23407	23418		10.1074/jbc.M110.214247	http://dx.doi.org/10.1074/jbc.M110.214247			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550974	Green Published, hybrid			2022-12-27	WOS:000292025000072
J	Quintanar-Audelo, M; Yusoff, P; Sinniah, S; Chandramouli, S; Guy, GR				Quintanar-Audelo, Martina; Yusoff, Permeen; Sinniah, Saravanan; Chandramouli, Sumana; Guy, Graeme R.			Sprouty-related Ena/Vasodilator-stimulated Phosphoprotein Homology 1-Domain-containing Protein (SPRED1), a Tyrosine-Protein Phosphatase Non-receptor Type 11 (SHP2) Substrate in the Ras/Extracellular Signal-regulated Kinase (ERK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; FACTOR RECEPTOR STIMULATION; SOMATIC PTPN11 MUTATIONS; OF-FUNCTION MUTATIONS; CAUSE NOONAN-SYNDROME; DROSOPHILA-SPROUTY; RAS; ACTIVATION; GERMLINE; PHOSPHORYLATION	SHP2 is a tyrosine phosphatase involved in the activation of the Ras/ERK signaling pathway downstream of a number of receptor tyrosine kinases. One of the proposed mechanisms involving SHP2 in this context is to dephosphorylate and inactivate inhibitors of the Ras/ERK pathway. Two protein families bearing a unique, common domain, Sprouty and SPRED proteins, are possible candidates because they have been reported to inhibit the Ras/ERK pathway upon FGF activation. We tested whether any of these proteins are likely substrates of SHP2. Our findings indicate that Sprouty2 binds to the C-terminal tail of SHP2, which is an unlikely substrate binding site, whereas SPRED proteins bind to the tyrosine phosphatase domain that is known to be the binding site for its substrates. Overexpressed SHP2 was able to dephosphorylate SPREDs but not Sprouty2. Finally, we found two tyrosine residues on SPRED1 that are required, when phosphorylated, to inhibit Ras/ERK activation and identified Tyr-420 as a specific dephosphorylation target of SHP2. The evidence obtained indicates that SPRED1 is a likely substrate of SHP2, whose tyrosine dephosphorylation is required to attenuate the inhibitory action of SPRED1 in the Ras/ERK pathway.	[Quintanar-Audelo, Martina; Yusoff, Permeen; Sinniah, Saravanan; Guy, Graeme R.] Inst Mol & Cell Biol, Signal Transduct Lab, Proteos 138673, Singapore; [Chandramouli, Sumana] Novartis Vaccines & Diagnost, Cambridge, MA 02139 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Novartis	Guy, GR (corresponding author), Inst Mol & Cell Biol, Signal Transduct Lab, 61 Biopolis Dr, Proteos 138673, Singapore.	mcbgg@imcb.a-star.edu.sg		Chandramouli, Sumana/0000-0001-6994-506X	Agency of Science, Technology, and Research (A-STAR), Singapore	Agency of Science, Technology, and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science, Technology, and Research (A-STAR), Singapore.	Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	35	24	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23102	23112		10.1074/jbc.M110.212662	http://dx.doi.org/10.1074/jbc.M110.212662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531714	Green Published, hybrid			2022-12-27	WOS:000292025000044
J	Wood, P; Mulay, V; Darabi, M; Chan, KC; Heeren, J; Pol, A; Lambert, G; Rye, KA; Enrich, C; Grewal, T				Wood, Peta; Mulay, Vishwaroop; Darabi, Masoud; Chan, Karen Cecilia; Heeren, Joerg; Pol, Albert; Lambert, Gilles; Rye, Kerry-Anne; Enrich, Carlos; Grewal, Thomas			Ras/Mitogen-activated Protein Kinase (MAPK) Signaling Modulates Protein Stability and Cell Surface Expression of Scavenger Receptor SR-BI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PDZ-INTERACTING DOMAIN; CHOLESTEROL EFFLUX; PPAR-GAMMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PEROXISOME PROLIFERATORS; ABCA1 TRANSPORTER; ALPHA; PHOSPHORYLATION	The mitogen-activated protein kinase (MAPK) Erk1/2 has been implicated to modulate the activity of nuclear receptors, including peroxisome proliferator activator receptors (PPARs) and liver X receptor, to alter the ability of cells to export cholesterol. Here, we investigated if the Ras-Raf-Mek-Erk1/2 signaling cascade could affect reverse cholesterol transport via modulation of scavenger receptor class BI (SR-BI) levels. We demonstrate that in Chinese hamster ovary (CHO) and human embryonic kidney (HEK293) cells, Mek1/2 inhibition reduces PPAR alpha-inducible SR-BI protein expression and activity, as judged by reduced efflux onto high density lipoprotein (HDL). Ectopic expression of constitutively active H-Ras and Mek1 increases SR-BI protein levels, which correlates with elevated PPAR alpha Ser-21 phosphorylation and increased cholesterol efflux. In contrast, SR-BI levels are insensitive to Mek1/2 inhibitors in PPAR alpha-depleted cells. Most strikingly, Mek1/2 inhibition promotes SR-BI degradation in SR-BI-overexpressing CHO cells and human HuH7 hepatocytes, which is associated with reduced uptake of radiolabeled and 1,1'-dioctadecyl-3,3,3',3'-tetra-methylindocarbocyane-labeled HDL. Loss of Mek1/2 kinase activity reduces SR-BI expression in the presence of bafilomycin, an inhibitor of lysosomal degradation, indicating down-regulation of SR-BI via proteasomal pathways. In conclusion, Mek1/2 inhibition enhances the PPAR alpha-dependent degradation of SR-BI in hepatocytes.	[Pol, Albert; Enrich, Carlos] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Pol, Albert] Univ Barcelona, Fac Med, Inst Catalana Recerca & Estudis Avancats, Barcelona 7, Spain; [Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol 2, D-20246 Hamburg, Germany; [Wood, Peta; Mulay, Vishwaroop; Darabi, Masoud; Chan, Karen Cecilia; Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Lambert, Gilles; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW 2042, Australia	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sydney; University of Sydney; Heart Research Institute	Enrich, C (corresponding author), Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Casanova 143, Barcelona, Spain.	enrich@ub.edu; thomas.grewal@sydney.edu.au	Darabi, Masoud/B-3525-2008; Pol, Albert/M-1865-2014	Darabi, Masoud/0000-0001-6380-272X; Pol, Albert/0000-0002-1750-1085; Grewal, Thomas/0000-0002-7937-8887; Enrich, Carlos/0000-0003-0382-2993	National Health and Medical Research Council of Australia [510293, 510294]; National Heart Foundation of Australia [G06S2559]; Ministerio de Ciencia y Tecnologia [BFU2009- 10335]; Ministerio de Sanidad y Consumo [RTICC-2006 ISCIII]; Fundacio Marato TV3, Barcelona, Spain [PI040236]; CONSOLIDER-INGENIO2010 [CSD2009-00016]; National Heart Foundation/National Health and Medical Research Council of Australia; Tabriz University of Medical Sciences (Iran); ICREA Funding Source: Custom	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Fundacio Marato TV3, Barcelona, Spain; CONSOLIDER-INGENIO2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Heart Foundation/National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia); Tabriz University of Medical Sciences (Iran); ICREA(ICREA)	This work was supported by Grants 510293 and 510294 from the National Health and Medical Research Council of Australia and Grant G06S2559 from the National Heart Foundation of Australia (to T. G.) and Grants BFU2009- 10335 from Ministerio de Ciencia y Tecnologia, RTICC-2006 ISCIII from Ministerio de Sanidad y Consumo, and PI040236 from Fundacio Marato TV3, Barcelona, Spain and CONSOLIDER-INGENIO2010 (CSD2009-00016) (to C. E.).; Recipient of a National Heart Foundation/National Health and Medical Research Council of Australia postgraduate scholarship.; Recipient of a travel and research scholarship from the Tabriz University of Medical Sciences (Iran).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chinetti G, 2006, BIOCHEM SOC T, V34, P1128, DOI 10.1042/BST0341128; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; George J, 2004, ARTERIOSCL THROM VAS, V24, P363, DOI 10.1161/01.ATV.0000112021.98971.f0; George J, 2002, CIRCULATION, V105, P2416, DOI 10.1161/01.CIR.0000016065.90068.96; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heuvel JPV, 1999, J NUTR, V129, p575S, DOI 10.1093/jn/129.2.575S; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Kee P, 2006, ARTERIOSCL THROM VAS, V26, P884, DOI 10.1161/01.ATV.0000201064.89581.35; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Mineo C, 2007, TRENDS CARDIOVAS MED, V17, P156, DOI 10.1016/j.tcm.2007.03.005; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Miura S, 2004, ATHEROSCLEROSIS, V175, P235, DOI 10.1016/j.atherosclerosis.2004.04.017; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Niemeier A, 2009, ATHEROSCLEROSIS, V202, P169, DOI 10.1016/j.atherosclerosis.2008.04.018; Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200; Nofer JR, 2001, THROMB HAEMOSTASIS, V85, P730; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Qiu LX, 2008, J BIOL CHEM, V283, P17175, DOI 10.1074/jbc.M801791200; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Rokos CL, 1997, J BIOL CHEM, V272, P13452, DOI 10.1074/jbc.272.20.13452; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Tamasi V, 2008, MOL PHARMACOL, V73, P968, DOI 10.1124/mol.107.036780; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	74	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23077	23092		10.1074/jbc.M111.236398	http://dx.doi.org/10.1074/jbc.M111.236398			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525007	Green Published, hybrid			2022-12-27	WOS:000292025000042
J	Xiao, YP; Morice, AH; Compton, SJ; Sadofsky, L				Xiao, Yu Pei; Morice, Alyn H.; Compton, Steven J.; Sadofsky, Laura			N-Linked Glycosylation Regulates Human Proteinase-activated Receptor-1 Cell Surface Expression and Disarming via Neutrophil Proteinases and Thermolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET THROMBIN RECEPTOR; TETHERED LIGAND; CATHEPSIN-G; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; COUPLED RECEPTORS; PROTEASES; CLEAVAGE; TRYPTASE; DESENSITIZATION	Proteinase-activated receptor 1 (PAR(1)) induces activation of platelet and vascular cells after proteolytic cleavage of its extracellular N terminus by thrombin. In pathological situations, other proteinases may be generated in the circulation and might modify the responses of PAR(1) by cleaving extracellular domains. In this study, epitope-tagged wild-type human PAR(1) (hPAR(1)) and a panel of N-linked glycosylation-deficient mutant receptors were permanently expressed in epithelial cells (Kirsten murine sarcoma virus-transformed rat kidney cells and CHO cells). We have analyzed the role of N-linked glycosylation in regulating proteinase activation/disarming and cell global expression of hPAR(1). We reported for the first time that glycosylation in the N terminus of hPAR(1) downstream of the tethered ligand (especially Asn(75)) governs receptor disarming to trypsin, thermolysin, and the neutrophil proteinases elastase and proteinase 3 but not cathepsin G. In addition, hPAR1 is heavily N-linked glycosylated and sialylated in epithelial cell lines, and glycosylation occurs at all five consensus sites, namely, Asn(35), Asn(62), Asn(75), Asn(250), and Asn(259). Removing these N-linked glycosylation sequons affected hPAR(1) cell surface expression to varying degrees, and N-linked glycosylation at extracellular loop 2 (especially Asn(250)) of hPAR(1) is essential for optimal receptor cell surface expression and receptor stability.	[Xiao, Yu Pei; Morice, Alyn H.; Compton, Steven J.; Sadofsky, Laura] Univ Hull, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU16 5JQ, E Yorkshire, England	University of Hull; University of York - UK	Sadofsky, L (corresponding author), Univ Hull, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU16 5JQ, E Yorkshire, England.	L.R.Sadofsky@Hull.ac.uk	Sadofsky, Laura/AAK-2029-2020					BRASS LF, 1994, J BIOL CHEM, V269, P2943; BRASS LF, 1992, J BIOL CHEM, V267, P13795; Chen XL, 1996, BIOCHEM J, V314, P603, DOI 10.1042/bj3140603; Compton SJ, 2003, DRUG DEVELOP RES, V59, P350, DOI 10.1002/ddr.10303; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Hamilton JR, 1999, BRIT J PHARMACOL, V127, P617, DOI 10.1038/sj.bjp.0702583; Hansen KK, 2004, IMMUNOLOGY, V112, P183, DOI 10.1111/j.1365-2567.2004.01870.x; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nakayama T, 2003, BRIT J PHARMACOL, V138, P121, DOI 10.1038/sj.bjp.0705008; NORTON KJ, 1993, BLOOD, V82, P2125; OPDENAKKER G, 1993, FASEB J, V7, P1330, DOI 10.1096/fasebj.7.14.8224606; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; RAO NV, 1991, J BIOL CHEM, V266, P9540; Renesto P, 1997, BLOOD, V89, P1944, DOI 10.1182/blood.V89.6.1944; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; TORDAI A, 1995, BIOCHEM BIOPH RES CO, V206, P857, DOI 10.1006/bbrc.1995.1122; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; Ubl JJ, 2000, J PHYSIOL-LONDON, V525, P319, DOI 10.1111/j.1469-7793.2000.00319.x; Uehara A, 2002, J IMMUNOL, V169, P4594, DOI 10.4049/jimmunol.169.8.4594; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356	36	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22991	23002		10.1074/jbc.M110.204271	http://dx.doi.org/10.1074/jbc.M110.204271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550978	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000292025000034
J	Cheng, SB; Quinn, JA; Graeber, CT; Filardo, EJ				Cheng, Shi-Bin; Quinn, Jeffrey A.; Graeber, Carl T.; Filardo, Edward J.			Down-modulation of the G-protein-coupled Estrogen Receptor, GPER, from the Cell Surface Occurs via a trans-Golgi-Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ENDOCYTOSIS; BREAST-CANCER; BETA-ARRESTIN; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; INDUCED INTERNALIZATION; ENDOPLASMIC-RETICULUM; CARBOXYL-TERMINUS; TRAFFICKING; CLATHRIN	GPER is a G(s)-coupled seven-transmembrane receptor that has been linked to specific estrogen binding and signaling activities that are manifested by plasma membrane-associated enzymes. However, in many cell types, GPER is predominately localized to the endoplasmic reticulum (ER), and only minor amounts of receptor are detectable at the cell surface, an observation that has caused controversy regarding its role as a plasma membrane estrogen receptor. Here, we show that GPER constitutively buds intracellularly into EEA-1+ endosomes from clathrin-coated pits. Nonvisual arrestins-2/-3 do not co-localize with GPER, and expression of arrestin-2 dominant-negative mutants lacking clathrin-or beta-adaptin interaction sites fails to block GPER internalization suggesting that arrestins are not involved in GPER endocytosis. Like beta 1AR, which recycles to the plasma membrane, GPER co-traffics with transferrin+, Rab11+ recycling endosomes. However, endocytosed GPER does not recycle to the cell surface, but instead returns to the trans-Golgi network (TGN) and does not re-enter the ER. GPER is ubiquitinated at the cell surface, exhibits a short half-life (t(1/2) < 1 h), and is protected from degradation by the proteasome inhibitor, MG132. Disruption of the TGN by brefeldin A induces the accumulation of endocytosed GPER in Rab11+ perinuclear endosomes and prevents GPER degradation. Our results provide an explanation as to why GPER is not readily detected on the cell surface in some cell types and further suggest that TGN serves as the checkpoint for degradation of endocytosed GPER.	[Filardo, Edward J.] Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; Brown Univ, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Filardo, EJ (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, 593 Eddy St,Aldrich Bldg,Rm 708, Providence, RI 02903 USA.	edward_filardo@brown.edu		Filardo, Edward/0000-0002-3930-324X	National Institutes of Health [R01 CA119165-01A2]; NATIONAL CANCER INSTITUTE [R01CA119165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA119165-01A2 (to E. J. F.).	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; BENOVIC JL, 2000, REGULATION G PROTEIN, P4; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; CHENG SB, 2011, STEROIDS IN PRESS; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Cross BCS, 2009, J CELL SCI, V122, P1768, DOI 10.1242/jcs.046094; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2003, IDENTITIES OF MEMBRANE STEROID RECEPTORS -- AND OTHER PROTEINS MEDIATING NONGENOMIC STEROID ACTION, P139; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Forster R, 1998, J IMMUNOL, V160, P1522; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Innamorati G, 1999, J RECEPT SIGNAL TR R, V19, P315, DOI 10.3109/10799899909036654; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Lamb ME, 2001, BIOCHEM J, V355, P741, DOI 10.1042/bj3550741; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Lok CN, 1998, BIOL SIGNAL RECEPT, V7, P157; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romisch K, 1999, J CELL SCI, V112, P4185; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Trischler M, 1999, J CELL SCI, V112, P4773; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	64	85	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22441	22455		10.1074/jbc.M111.224071	http://dx.doi.org/10.1074/jbc.M111.224071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540189	hybrid, Green Published			2022-12-27	WOS:000291719900053
J	ZeRuth, GT; Yang, XP; Jetten, AM				ZeRuth, Gary T.; Yang, Xiao-Ping; Jetten, Anton M.			Modulation of the Transactivation Function and Stability of Kruppel-like Zinc Finger Protein Gli-similar 3 (Glis3) by Suppressor of Fused	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; BETA-CELL FUNCTION; NEGATIVE REGULATOR; TRANSCRIPTION FACTOR; PRIMARY CILIA; SUFU; LOCI; ASSOCIATION; MUTATIONS; ROLES	Glis3 is a member of the Glis subfamily of Kruppel-like zinc finger transcription factors. Recently, Glis3 has been linked to both type I and type II diabetes and shown to positively regulate insulin gene expression. In this study, we have identified a region within the N terminus of Glis3 that shares high levels of homology with the Cubitus interruptus (Ci)/Gli family of proteins. We demonstrated that Glis3 interacts with Suppressor of Fused (SUFU), which involves a VYGHF motif located within this conserved region. We further showed that SUFU is able to inhibit the activation of the insulin promoter by Glis3 but not the activation by a Glis3 mutant deficient in its ability to bind SUFU, suggesting that the inhibitory effect is dependent on the interaction between the two proteins. Exogenous SUFU did not affect the nuclear localization of Glis3; however, Glis3 promoted the nuclear accumulation of SUFU. Additionally, we demonstrated that SUFU stabilizes Glis3 in part by antagonizing the Glis3 association with a Cullin 3-based E3 ubiquitin ligase that promotes the ubiquitination and degradation of Glis3. This is the first reported instance of Glis3 interacting with SUFU and suggests a novel role for SUFU in the modulation of Glis3 signaling. Given the critical role of Glis3 in pancreatic beta-cell generation and maintenance, the elevated Glis3 expression in several cancers, and the established role of SUFU as a tumor suppressor, these data provide further insight into Glis3 regulation and its function in development and disease.	[ZeRuth, Gary T.; Yang, Xiao-Ping; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institutes of Health, NIEHS [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100485] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01-ES-100485 from the Intramural Research Program of the NIEHS.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES, V22, P1234, DOI 10.1359/JBMR.070503; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Leung A, 2009, ERNST SCHERING FOUND, V1, P75, DOI 10.1007/2789_2008_102; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Nakanishi G, 2006, J INVEST DERMATOL, V126, P49, DOI 10.1038/sj.jid.5700018; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Stone DM, 1999, J CELL SCI, V112, P4437; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Yusenko MV, 2009, HISTOPATHOLOGY, V55, P687, DOI 10.1111/j.1365-2559.2009.03449.x; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	50	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22077	22089		10.1074/jbc.M111.224964	http://dx.doi.org/10.1074/jbc.M111.224964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543335	Green Published, hybrid			2022-12-27	WOS:000291719900014
J	Fukuda, K; Knight, JDR; Piszczek, G; Kothary, R; Qin, J				Fukuda, Koichi; Knight, James D. R.; Piszczek, Grzegorz; Kothary, Rashmi; Qin, Jun			Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK) CROSS-VALIDATION OF THE PSEUDOKINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; CRYSTAL-STRUCTURE; ALPHA-PARVIN; PROTEIN; BINDING; PINCH; COMPLEX; CRYSTALLOGRAPHY; LOCALIZATION; EXPRESSION	Integrin-linked kinase (ILK) is one of the few evolutionarily conserved focal adhesion proteins involved in diverse cell adhesion-dependent physiological and pathological responses. Despite more than a decade of studies and extensive literature, the kinase function of ILK is controversial. ILK contains a highly degraded kinase active site but it has been argued that ILK may be an unusual manganese (Mn)-dependent serine-threonine kinase that targets specific substrates such as glycogen synthase kinase-3 beta (GSK-3 beta). In this study, we have tackled this issue by a systematic bottom-up biochemical, proteomic, structural, and thermodynamic analysis of ILK. We show that recombinant ILK from either bacteria or mammalian cells exhibits no kinase activity on GSK-3 beta in the presence of either Mn2+ or the conventional kinase co-factor Mg2+. A comprehensive and unbiased whole cell-based kinase assay using entire mammalian CG-4 and C2C12 cell lysate did not identify any specific ILK substrates. High resolution crystallographic structure analysis further confirmed that the Mn-bound ILK adopts the same pseudo active site conformation as that of the Mg-bound ILK. More importantly, thermodynamic analysis revealed that the K220M mutation, previously thought to inactivate ILK by disrupting ATP binding, significantly impairs the structural integrity and stability of ILK, which provides a new basis for understanding how this mutation caused renal agenesis, a failure of fetal kidney development. Collectively, our data provide strong evidence that ILK lacks intrinsic kinase function. It is a bona fide pseudokinase that likely evolved from an ancestral catalytic counterpart to act as a distinct scaffold to mediate protein-protein interactions during focal adhesion assembly and many other cellular events.	[Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Knight, James D. R.; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Piszczek, Grzegorz] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Mail Code NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Piszczek, Grzegorz/GYU-2029-2022	Kothary, Rashmi/0000-0002-9239-7310; Qin, Jun/0000-0002-2647-9270	National Institute of Health; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Kirschstein-NRSA (the National Institutes of Health); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Kirschstein-NRSA (the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institute of Health (to J. Q.) and from Canadian Institutes of Health Research and the Multiple Sclerosis Society of Canada (to R. K.).; Supported by the Kirschstein-NRSA institutional research training grants (the National Institutes of Health).	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perez VAD, 2011, J CELL BIOL, V192, P171, DOI 10.1083/jcb.201008060; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; ROUSSEL A, 1991, TURBO FRODO SILICON; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	51	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21886	21895		10.1074/jbc.M111.240093	http://dx.doi.org/10.1074/jbc.M111.240093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524996	Green Published, hybrid			2022-12-27	WOS:000291464700083
J	Tipton, AR; Wang, KX; Link, L; Bellizzi, JJ; Huang, HM; Yen, T; Liu, ST				Tipton, Aaron R.; Wang, Kexi; Link, Laura; Bellizzi, John J.; Huang, Haomin; Yen, Tim; Liu, Song-Tao			BUBR1 and Closed MAD2 (C-MAD2) Interact Directly to Assemble a Functional Mitotic Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; SPINDLE CHECKPOINT; CONFORMATIONAL DIMERIZATION; PROTEIN BUBR1; CDC20; ACTIVATION; P31(COMET); APC/C; INHIBITION; REQUIRES	The mitotic checkpoint maintains genomic stability by ensuring that chromosomes are accurately segregated during mitosis. When the checkpoint is activated, the mitotic checkpoint complex (MCC), assembled from BUBR1, BUB3, CDC20, and MAD2, directly binds and inhibits the anaphase-promoting complex/cyclosome (APC/C) until all chromosomes are properly attached and aligned. The mechanisms underlying MCC assembly and MCC-APC/C interaction are not well characterized. Here, we show that a novel interaction between BUBR1 and closed MAD2 (C-MAD2) is essential for MCC-mediated inhibition of APC/C. Intriguingly, Arg(133) and Gln(134) in C-MAD2 are required for BUBR1 interaction. The same residues are also critical for MAD2 dimerization and MAD2 binding to p31(comet), a mitotic checkpoint silencing protein. Along with previously characterized BUBR1-CDC20 and C-MAD2-CDC20 interactions, our results underscore the integrity of the MCC for its activity and suggest the fundamental importance of the MAD2 alpha C helix in modulating mitotic checkpoint activation and silencing.	[Tipton, Aaron R.; Wang, Kexi; Link, Laura; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Bellizzi, John J.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA; [Huang, Haomin; Yen, Tim] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Fox Chase Cancer Center	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579; Bellizzi, John/0000-0003-4833-2795; Yen, Tim/0000-0003-2159-0997	National Institutes of Health [GM86877, GM44762, CA06927]; Commonwealth of Pennsylvania; Greenberg Fund; Ohio Cancer Research Associates; University of Toledo; National Science Foundation [MCB-1052413]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877, R01GM044762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Greenberg Fund; Ohio Cancer Research Associates; University of Toledo; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants GM86877 and GM44762, Core Grant CA06927, an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund.; Supported by the deArce Memorial Fund, Ohio Cancer Research Associates, the University of Toledo Interdisciplinary Research Initiation Award, and National Science Foundation Grant MCB-1052413.	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Serebriiskii I, 1999, J BIOL CHEM, V274, P17080, DOI 10.1074/jbc.274.24.17080; Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	33	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21173	21179		10.1074/jbc.M111.238543	http://dx.doi.org/10.1074/jbc.M111.238543			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525009	hybrid, Green Published			2022-12-27	WOS:000291464700017
J	Cheng, NH; Liu, JZ; Liu, X; Wu, QY; Thompson, SM; Lin, J; Chang, J; Whitham, SA; Park, S; Cohen, JD; Hirschi, KD				Cheng, Ning-Hui; Liu, Jian-Zhong; Liu, Xing; Wu, Qingyu; Thompson, Sean M.; Lin, Julie; Chang, Joyce; Whitham, Steven A.; Park, Sunghun; Cohen, Jerry D.; Hirschi, Kendal D.			Arabidopsis Monothiol Glutaredoxin, AtGRXS17, Is Critical for Temperature-dependent Postembryonic Growth and Development via Modulating Auxin Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MERISTEM DEVELOPMENT; GENE-EXPRESSION; STRESS-RESPONSE; TGA FACTORS; PLANT; TRANSPORT; THIOREDOXIN; ACID; BIOSYNTHESIS	Global environmental temperature changes threaten innumerable plant species. Although various signaling networks regulate plant responses to temperature fluctuations, the mechanisms unifying these diverse processes are largely unknown. Here, we demonstrate that an Arabidopsis monothiol glutaredoxin, AtGRXS17 (At4g04950), plays a critical role in redox homeostasis and hormone perception to mediate temperature-dependent postembryonic growth. AtGRXS17 expression was induced by elevated temperatures. Lines altered in AtGRXS17 expression were hypersensitive to elevated temperatures and phenocopied mutants altered in the perception of the phytohormone auxin. We show that auxin sensitivity and polar auxin transport were perturbed in these mutants, whereas auxin biosynthesis was not altered. In addition, atgrxs17 plants displayed phenotypes consistent with defects in proliferation and/or cell cycle control while accumulating higher levels of reactive oxygen species and cellular membrane damage under high temperature. Together, our findings provide a nexus between reactive oxygen species homeostasis, auxin signaling, and temperature responses.	[Cheng, Ning-Hui; Lin, Julie; Chang, Joyce; Hirschi, Kendal D.] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX 77030 USA; [Liu, Jian-Zhong; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Liu, Xing; Cohen, Jerry D.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Liu, Xing; Cohen, Jerry D.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Wu, Qingyu; Park, Sunghun] Kansas State Univ, Dept Hort Forestry & Recreat Resources, Manhattan, KS 66506 USA; [Thompson, Sean M.; Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Kansas State University; Texas A&M University System; Texas A&M University College Station	Cheng, NH (corresponding author), Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX 77030 USA.	ncheng@bcm.tmc.edu	Liu, Jianzhong/B-9205-2012; Wu, Qingyu/AAF-3675-2020; Wu, Qingyu/E-4636-2017; hirschi, kendal/GNP-0351-2022; Cohen, Jerry/AAF-3737-2020	Wu, Qingyu/0000-0003-3064-2445; Wu, Qingyu/0000-0003-3064-2445; Cohen, Jerry/0000-0003-2816-8676; Liu, Jianzhong/0000-0001-7826-7045; Liu, Xing/0000-0001-9677-4470; Thompson, Sean/0000-0002-6847-0397	United States National Science Foundation [MCB-0725149, OIS-PGRP-0606666, OIS-PGRP-0923960, PGRP-0820642]; United States Department of Agriculture, National Research Initiative [2005-35318-16197]; United States Department of Agriculture/Agricultural Research Service [6250-51000-055]; National Science Foundation [NSF 90344350]; Designing Foods for Health Grant [CSREES 2005-34404-16401]; Direct For Biological Sciences [0820642] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture, National Research Initiative(United States Department of Agriculture (USDA)); United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); Designing Foods for Health Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by United States National Science Foundation Grants MCB-0725149, OIS-PGRP-0606666, OIS-PGRP-0923960, and PGRP-0820642 and the United States Department of Agriculture, National Research Initiative 2005-35318-16197 (to J. D. C. and S. A. W.) and United States Department of Agriculture/Agricultural Research Service under Cooperation Agreement 6250-51000-055 (to N.-H. C.). This work was also supported by National Science Foundation Grant NSF 90344350) and Designing Foods for Health Grant CSREES 2005-34404-16401) (to K. D. H.).	Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barkawi LS, 2010, NAT PROTOC, V5, P1609, DOI 10.1038/nprot.2010.118; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Beveridge CA, 2007, CURR OPIN PLANT BIOL, V10, P44, DOI 10.1016/j.pbi.2006.11.011; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cheng NH, 2008, FEBS LETT, V582, P848, DOI 10.1016/j.febslet.2008.02.006; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GARDNER G, 1989, PLANT PHYSIOL, V90, P291, DOI 10.1104/pp.90.1.291; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ilic N, 1996, PLANT PHYSIOL, V111, P781, DOI 10.1104/pp.111.3.781; Jiang K, 2003, DEVELOPMENT, V130, P1429, DOI 10.1242/dev.00359; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099; Ludwig-Muller J, 2000, PLANT PHYSIOL, V123, P949, DOI 10.1104/pp.123.3.949; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Mei H, 2009, NEW PHYTOL, V183, P95, DOI 10.1111/j.1469-8137.2009.02831.x; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sundaram S, 2010, PLANTA, V231, P361, DOI 10.1007/s00425-009-1055-7; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	68	98	100	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20398	20406		10.1074/jbc.M110.201707	http://dx.doi.org/10.1074/jbc.M110.201707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515673	Green Published, hybrid			2022-12-27	WOS:000291267600027
J	Lee, YJ; Burlet, E; Galiano, F; Circu, ML; Aw, TY; Williams, BJ; Witt, SN				Lee, Yong Joo; Burlet, Elodie; Galiano, Floyd; Circu, Magdalena L.; Aw, Tak Yee; Williams, B. Jill; Witt, Stephan N.			Phosphate and Succinate Use Different Mechanisms to Inhibit Sugar-induced Cell Death in Yeast INSIGHT INTO THE CRABTREE EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; LIFE-SPAN; GLUCOSE; GROWTH; FRUCTOSE-1,6-BISPHOSPHATE; PHOSPHORYLATION; MITOCHONDRIA; ACTIVATION; TRANSPORT	Stationary-phase Saccharomyces cerevisiae cells transferred from spent rich media into water live for weeks, whereas the same cells die within hours if transferred into water with 2% glucose in a process called sugar-induced cell death (SICD). Our hypothesis is that SICD is due to a dysregulated Crabtree effect, which is the phenomenon whereby glucose transiently inhibits respiration and ATP synthesis. We found that stationary-phase cells in glucose/water consume 21 times more O-2 per cell than exponential-phase cells in rich media, and such excessive O-2 consumption causes reactive oxygen species to accumulate. We also found that inorganic phosphate and succinate protect against SICD but by different mechanisms. Phosphate protects by triggering the synthesis of Fru-1,6-P-2, which inhibits respiration in isolated mitochondria. Succinate protects in wild-type cells but fails to protect in dic1 Delta cells. DIC1 codes for a mitochondrial inner membrane protein that exchanges cytosolic succinate for matrix phosphate. We propose that succinate depletes matrix phosphate, which in turn inhibits respiration and ATP synthesis. In sum, restoring the Crabtree effect, whether with phosphate or succinate, protects cells from SICD.	[Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Circu, Magdalena L.; Aw, Tak Yee] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71130 USA; [Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Dept Urol, Shreveport, LA 71130 USA; [Galiano, Floyd; Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	switt1@lsuhsc.edu	Witt, Stephan N/M-7922-2013	Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health, NINDS [NS057656]; NIDDK [DK44510]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057656 from NINDS (to S.N.W.) and Grant DK44510 from NIDDK (to T.Y.A. for support of M.L.C.).	BANUELOS M, 1977, J BIOL CHEM, V252, P6394; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BLOCHFRANKENTHAL L, 1959, CANCER RES, V19, P835; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Ehringer WD, 2002, LIPIDS, V37, P885, DOI 10.1007/s11745-002-0975-2; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; GRANOT D, 1993, YEAST, V9, P465, DOI 10.1002/yea.320090503; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; Granot D, 1997, CELL DEATH DIFFER, V4, P555, DOI 10.1038/sj.cdd.4400280; Hardin CD, 2001, AM J PHYSIOL-HEART C, V281, pH2654, DOI 10.1152/ajpheart.2001.281.6.H2654; KATCHMAN BERNARD J., 1955, JOUR BACT, V69, P607; KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127; Lemasters J J, 1979, Methods Enzymol, V56, P530; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCammon MT, 1996, GENETICS, V144, P57; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; RIQUELME PT, 1983, P NATL ACAD SCI-BIOL, V80, P4301, DOI 10.1073/pnas.80.14.4301; SALHANY JM, 1975, P NATL ACAD SCI USA, V72, P4966, DOI 10.1073/pnas.72.12.4966; SENER A, 1988, J BIOL CHEM, V263, P1904; Shirahama K, 1996, PLANT CELL PHYSIOL, V37, P1090, DOI 10.1093/oxfordjournals.pcp.a029058; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; TSUIKI S, 1968, ARCH BIOCHEM BIOPHYS, V126, P436, DOI 10.1016/0003-9861(68)90428-1; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZIZI M, 1994, J BIOL CHEM, V269, P1614	37	14	16	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20267	20274		10.1074/jbc.M110.209379	http://dx.doi.org/10.1074/jbc.M110.209379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515692	Green Published, hybrid			2022-12-27	WOS:000291267600014
J	Wegmann, S; Scholer, J; Bippes, CA; Mandelkow, E; Muller, DJ				Wegmann, Susanne; Schoeler, Jonas; Bippes, Christian A.; Mandelkow, Eckhard; Muller, Daniel J.			Competing Interactions Stabilize Pro- and Anti-aggregant Conformations of Human Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TITIN IMMUNOGLOBULIN DOMAINS; FULL-LENGTH TAU; PROTEIN-TAU; IN-VITRO; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; BETA-STRUCTURE; AGGREGATION; FORCE	Aggregation of Tau into amyloid-like fibrils is a key process in neurodegenerative diseases such as Alzheimer. To understand how natively disordered Tau stabilizes conformations that favor pathological aggregation, we applied single-molecule force spectroscopy. Intramolecular interactions that fold polypeptide stretches of similar to 19 and similar to 42 amino acids in the functionally important repeat domain of full-length human Tau (hTau40) support aggregation. In contrast, the unstructured N terminus randomly folds long polypeptide stretches > 100 amino acids that prevent aggregation. The pro-aggregant mutant hTau40 Delta K280 observed in frontotemporal dementia favored the folding of short polypeptide stretches and suppressed the folding of long ones. This trend was reversed in the anti-aggregant mutant hTau40 Delta K280/PP. The aggregation inducer heparin introduced strong interactions in hTau40 and hTau40 Delta K280 that stabilized aggregation-prone conformations. We show that the conformation and aggregation of Tau are regulated through a complex balance of different intra-and intermolecular interactions.	[Mandelkow, Eckhard] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Wegmann, Susanne; Bippes, Christian A.; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Schoeler, Jonas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Mandelkow, Eckhard] CAESAR, German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mandelkow, E (corresponding author), DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de; daniel.mueller@bsse.ethz.ch	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665	Deutsche Forschungsgemeinschaft; ETH Zurich; Max-Planck Society; VW Foundation [1/82544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ETH Zurich(ETH Zurich); Max-Planck Society(Max Planck SocietyFoundation CELLEX); VW Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and ETH Zurich (to D. J. M.), the Max-Planck Society (to D. J. M. and E. M.), and VW Foundation Grant 1/82544 (to E. M.).	Abraha A, 2000, J CELL SCI, V113, P3737; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn Stefan, 2004, V299, P35; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bippes CA, 2009, J BIOL CHEM, V284, P18651, DOI 10.1074/jbc.M109.004267; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; CROWTHER RA, 1990, BIOCHIM BIOPHYS ACTA, V1096, P1, DOI 10.1016/0925-4439(90)90004-9; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Goedert M, 1996, COLD SPRING HARB SYM, V61, P565; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Perez M, 1996, J NEUROCHEM, V67, P1183; Puchner EM, 2008, BIOPHYS J, V95, P426, DOI 10.1529/biophysj.108.129999; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Schaap IAT, 2007, J STRUCT BIOL, V158, P282, DOI 10.1016/j.jsb.2006.11.010; Schlierf M, 2006, BIOPHYS J, V90, pL33, DOI 10.1529/biophysj.105.077982; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yao TM, 2003, J BIOCHEM, V134, P91, DOI 10.1093/jb/mvg116; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077	74	34	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20512	20524		10.1074/jbc.M111.237875	http://dx.doi.org/10.1074/jbc.M111.237875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498513	Green Published, hybrid			2022-12-27	WOS:000291267600038
J	Wu, N; Castel, D; Debily, MA; Vigano, MA; Alibert, O; Mantovani, R; Iljin, K; Romeo, PH; Gidrol, X				Wu, Ning; Castel, David; Debily, Marie-Anne; Vigano, Maria Alessandra; Alibert, Olivier; Mantovani, Roberto; Iljin, Kristina; Romeo, Paul-Henri; Gidrol, Xavier			Large Scale RNAi Screen Reveals That the Inhibitor of DNA Binding 2 (ID2) Protein Is Repressed by p53 Family Member p63 and Functions in Human Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; CELL-CYCLE; GENE-EXPRESSION; CANCER-CELLS; REGULATES PROLIFERATION; CHROMATID COHESION; GROWTH; IDENTIFICATION; PATHWAY; TARGETS	The inhibitor of DNA binding 2, dominant negative helix-loop-helix protein, ID2, acts as an oncogene and elevated levels of ID2 have been reported in several malignancies. Whereas some inducers of the ID2 gene have been characterized, little is known regarding the proteins capable to repress its expression. We developed siRNA microarrays to perform a large scale loss-of-function screen in human adult keratinocytes engineered to express GFP under the control of the upstream region of ID2 gene. We screened the effect of siRNA-dependent inhibition of 220 cancer-associated genes on the expression of the ID2:: GFP reporter construct. Three genes NBN, RAD21, and p63 lead to a repression of ID2 promoter activity. Strikingly NBN and RAD21 are playing on major role in cell cycle progression and mitosis arrest. These results underline the pregnant need to silence ID2 expression at transcript level to promote cell cycle exit. Central to this inhibitory mechanism we find p63, a key transcription factor in epithelial development and differentiation, which binds specific cis-acting sequence within the ID2 gene promoter both in vitro and in vivo. P63 would not suppress ID2 expression, but would rather prevent excessive expression of that protein to enable the onset of keratinocyte differentiation.	[Wu, Ning; Castel, David; Gidrol, Xavier] CEA, IRTSV, Lab Biopuces, F-38054 Grenoble 9, France; [Wu, Ning; Debily, Marie-Anne; Alibert, Olivier; Romeo, Paul-Henri; Gidrol, Xavier] CEA, IRCM, Lab Explorat Fonct Genomes, F-91057 Evry, France; [Debily, Marie-Anne] Univ Evry Val dEssonne, F-91025 Evry, France; [Vigano, Maria Alessandra; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Iljin, Kristina] Univ Turku, Turku, Finland; [Iljin, Kristina] VTT Tech Res Ctr, Turku, Finland	CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Milan; University of Turku; VTT Technical Research Center Finland	Gidrol, X (corresponding author), CEA, IRTSV, Lab Biopuces, 17 Rue Martyrs, F-38054 Grenoble 9, France.	xavier.gidrol@cea.fr	Romeo, Paul-Henri/L-5989-2017; Debily, Marie-Anne/X-7697-2018; Castel, David/D-5353-2018	Romeo, Paul-Henri/0000-0002-8294-0367; Debily, Marie-Anne/0000-0002-8509-6165; Castel, David/0000-0003-0247-080X; Iljin, Kristiina/0000-0002-5161-0584; Gidrol, Xavier/0000-0002-4233-3749; vigano, maria alessandra/0000-0003-2009-0384	Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer (ARC); CEA	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CEA(French Atomic Energy Commission)	This work was funded by CEA (to N. W. and D. C.), a fellowship from the "Fondation pour la Recherche Medicale" (to N. W.), and an Association pour la Recherche sur le Cancer (ARC) Fellowship (to D. C.).	Alaminos M, 2005, PEDIATR BLOOD CANCER, V45, P909, DOI 10.1002/pbc.20505; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200; Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Belletti B, 2001, J BIOL CHEM, V276, P13867, DOI 10.1074/jbc.M010509200; Beretta C, 2005, CELL CYCLE, V4, P1625, DOI 10.4161/cc.4.11.2135; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Drewelus I, 2010, CELL CYCLE, V9, P580, DOI 10.4161/cc.9.3.10593; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kleeff J, 1998, CANCER RES, V58, P3769; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Memezawa A, 2007, ONCOGENE, V26, P5038, DOI 10.1038/sj.onc.1210320; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Rotzer D, 2006, ONCOGENE, V25, P2070, DOI 10.1038/sj.onc.1209230; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Scobey MJ, 2004, J BIOL CHEM, V279, P16064, DOI 10.1074/jbc.M309298200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Simbulan-Rosenthal CM, 2005, ONCOGENE, V24, P5443, DOI 10.1038/sj.onc.1208709; Stighall M, 2005, INT J CANCER, V115, P403, DOI 10.1002/ijc.20875; Tokuriki A, 2009, CARCINOGENESIS, V30, P1645, DOI 10.1093/carcin/bgp172; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2007, CELL CYCLE, V6, P233, DOI 10.4161/cc.6.3.3802; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang Y, 2006, CELL RES, V16, P45, DOI 10.1038/sj.cr.7310007	57	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20870	20879		10.1074/jbc.M110.169433	http://dx.doi.org/10.1074/jbc.M110.169433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21478550	hybrid, Green Published			2022-12-27	WOS:000291267600071
J	Alves, MS; Reis, PAB; Dadalto, SP; Faria, JAQA; Fontes, EPB; Fietto, LG				Alves, Murilo S.; Reis, Pedro A. B.; Dadalto, Silvana P.; Faria, Jerusa A. Q. A.; Fontes, Elizabeth P. B.; Fietto, Luciano G.			A Novel Transcription Factor, ERD15 (Early Responsive to Dehydration 15), Connects Endoplasmic Reticulum Stress with an Osmotic Stress-induced Cell Death Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; C-MYC; DOMAIN; NUCLEAR; GENE; EXPRESSION; PROMOTER; ER; IDENTIFICATION	As in all other eukaryotic organisms, endoplasmic reticulum (ER) stress triggers the evolutionarily conserved unfolded protein response in soybean, but it also communicates with other adaptive signaling responses, such as osmotic stress-induced and ER stress-induced programmed cell death. These two signaling pathways converge at the level of gene transcription to activate an integrated cascade that is mediated by N-rich proteins (NRPs). Here, we describe a novel transcription factor, GmERD15 (Glycine max Early Responsive to Dehydration 15), which is induced by ER stress and osmotic stress to activate the expression of NRP genes. GmERD15 was isolated because of its capacity to stably associate with the NRP-B promoter in yeast. It specifically binds to a 187-bp fragment of the NRP-B promoter in vitro and activates the transcription of a reporter gene in yeast. Furthermore, GmERD15 was found in both the cytoplasm and the nucleus, and a ChIP assay revealed that it binds to the NRP-B promoter in vivo. Expression of GmERD15 in soybean protoplasts activated the NRP-B promoter and induced expression of the NRP-B gene. Collectively, these results support the interpretation that GmERD15 functions as an upstream component of stress-induced NRP-B-mediated signaling to connect stress in the ER to an osmotic stress-induced cell death signal.	[Alves, Murilo S.; Reis, Pedro A. B.; Dadalto, Silvana P.; Faria, Jerusa A. Q. A.; Fontes, Elizabeth P. B.; Fietto, Luciano G.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil; [Alves, Murilo S.; Reis, Pedro A. B.; Fontes, Elizabeth P. B.; Fietto, Luciano G.] Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, BR-36571000 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Fontes, EPB (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil.	bbfontes@ufv.br; lgfietto@ufv.br	Alves, Murilo/X-9772-2018; Alves, Murilo/H-9891-2013; Fietto, Luciano G/F-9908-2012; Reis, Pedro Augusto Braga/U-4103-2019; Faria, Jerusa Araujo Quintao Arantes/AAB-5215-2020; Fontes, Elizabeth/K-3159-2012	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Faria, Jerusa Araujo Quintao Arantes/0000-0001-7974-0295; Fontes, Elizabeth/0000-0002-7986-1369; Fietto, Luciano/0000-0002-2674-6471	Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [559602/2009-0, 573600/2008-2, 470878/2006-1]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CBB-APQ-00070-09]; Financiadora de Estudos e Projetos (FINEP) [01.09.0625.00]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 559602/2009-0, 573600/2008-2, and 470878/2006-1 (to E. P. B. F.), as well as by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Grant CBB-APQ-00070-09 and Financiadora de Estudos e Projetos (FINEP) Grant 01.09.0625.00 (to E. P. B. F.).; Supported by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) graduate fellowship.; Supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) graduate fellowship.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Amberg D. C., 2005, METHODS YEAST GENETI, P135; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Carvalho CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000247; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Cormack RS, 1998, PLANT J, V14, P685, DOI 10.1046/j.1365-313x.1998.00169.x; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; Desveaux D, 2000, PLANT CELL, V12, P1477, DOI 10.1105/tpc.12.8.1477; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; GEITZ RD, 1993, MOL GENETICS YEAST P, P121; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; KAMADA S, 1992, GENE, V119, P229, DOI 10.1016/0378-1119(92)90276-U; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; KIYOSUE T, 1994, PLANT PHYSIOL, V106, P1707, DOI 10.1104/pp.106.4.1707; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Ludwig AA, 2001, EUR J PLANT PATHOL, V107, P323, DOI 10.1023/A:1011202225323; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Saleh A, 2006, PLANT J, V46, P747, DOI 10.1111/j.1365-313X.2006.02742.x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SMIDT MP, 1995, NUCLEIC ACIDS RES, V23, P2389, DOI 10.1093/nar/23.13.2389; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tenhaken R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-169; Urade R, 2009, BIOFACTORS, V35, P326, DOI 10.1002/biof.45; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Wang XF, 2004, PLANT MOL BIOL, V54, P85, DOI 10.1023/B:PLAN.0000028771.70969.6b; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	45	45	52	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20020	20030		10.1074/jbc.M111.233494	http://dx.doi.org/10.1074/jbc.M111.233494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482825	Green Published, hybrid			2022-12-27	WOS:000291027700079
J	Nakagawa, S; Gong, XQ; Maeda, S; Dong, YH; Misumi, Y; Tsukihara, T; Bai, DL				Nakagawa, So; Gong, Xiang-Qun; Maeda, Shoji; Dong, Yuhua; Misumi, Yuko; Tsukihara, Tomitake; Bai, Donglin			Asparagine 175 of Connexin32 Is a Critical Residue for Docking and Forming Functional Heterotypic Gap Junction Channels with Connexin26	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; EXTRACELLULAR LOOP; SELECTIVE INTERACTIONS; MISSENSE MUTATION; PLASMA-MEMBRANE; TRAFFICKING; DOMAINS; PROTEIN; DETERMINANT; MUTANTS	The gap junction channel is formed by proper docking of two hemichannels. Depending on the connexin(s) in the hemichannels, homotypic and heterotypic gap junction channels can be formed. Previous studies suggest that the extracellular loop 2 (E2) is an important molecular domain for heterotypic compatibility. Based on the crystal structure of the Cx26 gap junction channel and homology models of heterotypic channels, we analyzed docking selectivity for several hemichannel pairs and found that the hydrogen bonds between E2 domains are conserved in a group of heterotypically compatible hemichannels, including Cx26 and Cx32 hemichannels. According to our model analysis, Cx32N175Y mutant destroys three hydrogen bonds in the E2-E2 interactions due to steric hindrance at the heterotypic docking interface, which makes it unlikely to dock with the Cx26 hemichannel properly. Our experimental data showed that Cx26-red fluorescent protein (RFP) and Cx32-GFP were able to traffic to cell-cell interfaces forming gap junction plaques and functional channels in transfected HeLa/N2A cells. However, Cx32N175Y-GFP exhibited mostly intracellular distribution and was occasionally observed in cell-cell junctions. Double patch clamp analysis demonstrated that Cx32N175Y did not form functional homotypic channels, and dye uptake assay indicated that Cx32N175Y could form hemichannels on the cell surface similar to wild-type Cx32. When Cx32N175Y-GFP- and Cx26-RFP-transfected cells were co-cultured, no colocalization was found at the cell-cell junctions between Cx32N175YGFP- and Cx26-RFP-expressing cells; also, no functional Cx32N175Y-GFP/Cx26-RFP heterotypic channels were identified. Both our modeling and experimental data suggest that Asn(175) of Cx32 is a critical residue for heterotypic docking and functional gap junction channel formation between the Cx32 and Cx26 hemichannels.	[Gong, Xiang-Qun; Dong, Yuhua; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Nakagawa, So; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Maeda, Shoji] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Misumi, Yuko; Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Western University (University of Western Ontario); Osaka University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Hyogo	Bai, DL (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	donglin.bai@schulich.uwo.ca	Bai, Donglin/A-5799-2008; Bai, Donglin/ABB-9924-2021	Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947; Maeda, Shoji/0000-0002-7762-9793; Misumi, Yuko/0000-0003-3434-6678	Japan Society for the Promotion of Science; Osaka University; Institutional Program for Young Researcher Overseas Visits; Ministry of Education, Culture, Sports, Science and Technology of Japan [10188101, 10179101, 16087206, 18207006]; Canadian Institutes of Health Research; government of Ontario	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University; Institutional Program for Young Researcher Overseas Visits; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); government of Ontario	This work was supported by a grant-in-aid for Japan Society for the Promotion of Science Fellow, the Global Centers of Excellence Program "Global Education and Research Center for Bio-Environmental Chemistry" of Osaka University; Institutional Program for Young Researcher Overseas Visits (to S.N.); Grants-in-aid for Scientific Research 10188101, 10179101, 16087206, and 18207006 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. T.); a grant from the Canadian Institutes of Health Research (to D. B.); and an Early Researcher Award from the government of Ontario (to D. B.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUZZONE R, 1994, J CELL SCI, V107, P955; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falk MM, 2000, J CELL SCI, V113, P4109; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; Gong XQ, 2006, J BIOL CHEM, V281, P31801, DOI 10.1074/jbc.M605961200; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOH JH, 1993, BIOPHYS J, V65, P149, DOI 10.1016/S0006-3495(93)81074-9; Iwai M, 2000, J HEPATOL, V32, P11, DOI 10.1016/S0168-8278(00)80184-1; JOHN SA, 1991, BIOCHEM BIOPH RES CO, V178, P1312, DOI 10.1016/0006-291X(91)91037-D; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kochanski Andrzej, 2004, Journal of Applied Genetics, V45, P95; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martin PEM, 2001, CELL COMMUN ADHES, V8, P243, DOI 10.3109/15419060109080731; Martin PEM, 2001, J CELL SCI, V114, P3845; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Primignani P, 2003, CLIN GENET, V63, P516, DOI 10.1034/j.1399-0004.2003.00079.x; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Silander K, 1998, HUM MUTAT, V12, P59, DOI 10.1002/(SICI)1098-1004(1998)12:1<59::AID-HUMU9>3.3.CO;2-1; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; SOSINSKY G, 1995, P NATL ACAD SCI USA, V92, P9210, DOI 10.1073/pnas.92.20.9210; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; Suga M, 2009, ACTA CRYSTALLOGR D, V65, P758, DOI 10.1107/S0907444909014711; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Yeager C. M., 2000, GAP JUNCTIONS ADV MO, P31; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	54	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19672	19681		10.1074/jbc.M110.204958	http://dx.doi.org/10.1074/jbc.M110.204958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478159	hybrid, Green Published			2022-12-27	WOS:000291027700050
J	Patterson, AD; Bonzo, JA; Li, F; Krausz, KW; Eichler, GS; Aslam, S; Tigno, X; Weinstein, JN; Hansen, BC; Idle, JR; Gonzalez, FJ				Patterson, Andrew D.; Bonzo, Jessica A.; Li, Fei; Krausz, Kristopher W.; Eichler, Gabriel S.; Aslam, Sadaf; Tigno, Xenia; Weinstein, John N.; Hansen, Barbara C.; Idle, Jeffrey R.; Gonzalez, Frank J.			Metabolomics Reveals Attenuation of the SLC6A20 Kidney Transporter in Nonhuman Primate and Mouse Models of Type 2 Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE-CARBOXYKINASE GENE; NUCLEAR-MAGNETIC-RESONANCE; GLYCINE BETAINE EXCRETION; METABONOMIC ANALYSIS; PIPECOLIC ACID; PLASMA; RAT; EXPRESSION; MONKEY; METABOLISM	To enhance understanding of the metabolic indicators of type 2 diabetes mellitus (T2DM) disease pathogenesis and progression, the urinary metabolomes of well characterized rhesus macaques (normal or spontaneously and naturally diabetic) were examined. High-resolution ultra-performance liquid chromatography coupled with the accurate mass determination of time-of-flight mass spectrometry was used to analyze spot urine samples from normal (n = 10) and T2DM (n = 11) male monkeys. The machine-learning algorithm random forests classified urine samples as either from normal or T2DM monkeys. The metabolites important for developing the classifier were further examined for their biological significance. Random forests models had a misclassification error of less than 5%. Metabolites were identified based on accurate masses (<10 ppm) and confirmed by tandem mass spectrometry of authentic compounds. Urinary compounds significantly increased (p < 0.05) in the T2DM when compared with the normal group included glycine betaine (9-fold), citric acid (2.8-fold), kynurenic acid (1.8-fold), glucose (68-fold), and pipecolic acid (6.5-fold). When compared with the conventional definition of T2DM, the metabolites were also useful in defining the T2DM condition, and the urinary elevations in glycine betaine and pipecolic acid (as well as proline) indicated defective re-absorption in the kidney proximal tubules by SLC6A20, a Na+-dependent transporter. The mRNA levels of SLC6A20 were significantly reduced in the kidneys of monkeys with T2DM. These observations were validated in the db/db mouse model of T2DM. This study provides convincing evidence of the power of metabolomics for identifying functional changes at many levels in the omics pipeline.	[Patterson, Andrew D.; Bonzo, Jessica A.; Li, Fei; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Eichler, Gabriel S.; Weinstein, John N.] NCI, Genom & Bioinformat Grp, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Aslam, Sadaf; Tigno, Xenia; Hansen, Barbara C.] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA; [Aslam, Sadaf; Tigno, Xenia; Hansen, Barbara C.] Univ S Florida, Dept Pediat, Tampa, FL 33612 USA; [Idle, Jeffrey R.] Univ Bern, Dept Clin Pharmacol, CH-3010 Bern, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Bern	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Patterson, Andrew/ABF-1575-2020; Hansen, Barbara C/J-8723-2012; Patterson, Andrew/G-3852-2012; Li, Fei/F-6849-2013; Idle, Jeff/B-1152-2012	Patterson, Andrew/0000-0003-2073-0070; Hansen, Barbara C/0000-0001-9646-3525; Patterson, Andrew/0000-0003-2073-0070; Idle, Jeff/0000-0002-6143-1520; Weinstein, John/0000-0001-9401-6908	National Institutes of Health [NO1-AG-3-1012, AG-42100, HHSN26300800022C]; National Cancer Institute; NIGMS, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG042100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NO1-AG-3-1012 (to B. C. H.), AG-42100 (to B. C. H.), and HHSN26300800022C and the National Cancer Institute, Intramural Research Program.; Supported by Pharmacology Research Associate in Training Fellowships from the NIGMS, National Institutes of Health.	Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Baas JCM, 2002, J INHERIT METAB DIS, V25, P699; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Bonzo JA, 2010, MOL ENDOCRINOL, V24, P2343, DOI 10.1210/me.2010-0130; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broer A, 2006, PFLUG ARCH EUR J PHY, V451, P511, DOI 10.1007/s00424-005-1481-8; Cassuto H, 1997, FEBS LETT, V412, P597, DOI 10.1016/S0014-5793(97)00867-3; Cassuto H, 2003, GENE, V318, P177, DOI 10.1016/S0378-1119(03)00775-3; Cusumano AM, 2002, AM J KIDNEY DIS, V40, P1075, DOI 10.1053/ajkd.2002.36348; D'Amato E, 2008, PEDIATR NEPHROL, V23, P137, DOI 10.1007/s00467-007-0609-9; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Dellow WJ, 2001, DIABETES RES CLIN PR, V52, P165, DOI 10.1016/S0168-8227(01)00237-6; Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fardet A, 2008, J PROTEOME RES, V7, P2388, DOI 10.1021/pr800034h; Frank S, 1998, DNA CELL BIOL, V17, P679, DOI 10.1089/dna.1998.17.679; Freitas HS, 2009, MOL CELL ENDOCRINOL, V305, P63, DOI 10.1016/j.mce.2009.02.014; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HANSEN BC, 2004, DIABETES MELLITUS FU, P1059; Hodavance MS, 2007, ANAL BIOANAL CHEM, V387, P533, DOI 10.1007/s00216-006-0979-z; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Johnson MA, 2005, EXP EYE RES, V80, P37, DOI 10.1016/j.exer.2004.08.006; Khalifah RG, 1996, BIOCHEMISTRY-US, V35, P4645, DOI 10.1021/bi9525942; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; Kim SY, 2004, INVEST OPHTH VIS SCI, V45, P4543, DOI 10.1167/iovs.04-0519; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; KORNER A, 1994, DIABETES, V43, P629, DOI 10.2337/diabetes.43.5.629; LAM S, 1986, BIOCHIM BIOPHYS ACTA, V882, P254, DOI 10.1016/0304-4165(86)90162-5; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; LEVER M, 1994, BBA-GEN SUBJECTS, V1200, P259, DOI 10.1016/0304-4165(94)90165-1; LOHR J, 1990, J PHARMACOL EXP THER, V252, P154; Mache CJ, 2002, PEDIATR NEPHROL, V17, P1021, DOI 10.1007/s00467-002-0975-2; Major HJ, 2006, RAPID COMMUN MASS SP, V20, P3295, DOI 10.1002/rcm.2732; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Misener S., 2000, BIOINFORMATICS METHO; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005; NUMA S, 1972, BIOCH SOC S, V35, P27; Ortmeyer HK, 2005, AM J PHYSIOL-REG I, V288, pR1509, DOI 10.1152/ajpregu.00692.2004; Otsuji T, 2002, EXP EYE RES, V75, P201, DOI 10.1006/exer.2002.2020; Pare M, 2007, J COMP NEUROL, V501, P543, DOI 10.1002/cne.21262; Peduto A, 2004, MOL GENET METAB, V82, P224, DOI 10.1016/j.ymgme.2004.04.010; Pennisi E, 2007, SCIENCE, V316, P218, DOI 10.1126/science.316.5822.218; Pennisi E, 2007, SCIENCE, V316, P216, DOI 10.1126/science.316.5822.216; Rashed MS, 2001, CLIN CHEM, V47, P2124; Ringeissen S, 2003, BIOMARKERS, V8, P240, DOI 10.1080/1354750031000149124; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Standaert ML, 2002, DIABETES, V51, P2936, DOI 10.2337/diabetes.51.10.2936; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; TAKEUCHI F, 1989, J NUTR SCI VITAMINOL, V35, P111, DOI 10.3177/jnsv.35.111; Tanimoto M, 2007, METABOLISM, V56, P160, DOI 10.1016/j.metabol.2006.08.026; Tigno XT, 2006, CLIN HEMORHEOL MICRO, V34, P273; Tigno XT, 2004, J GERONTOL A-BIOL, V59, P1081, DOI 10.1093/gerona/59.11.1081; TIGNO XT, 2007, HDB EXPT ANIMALS, P451; Verrey F, 2009, PFLUG ARCH EUR J PHY, V458, P53, DOI 10.1007/s00424-009-0638-2; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Zhang J, 2009, ANAL CHIM ACTA, V650, P16, DOI 10.1016/j.aca.2009.02.027; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhen Y, 2007, MOL ENDOCRINOL, V21, P2136, DOI 10.1210/me.2007-0150; 2005, J AM SOC NEPHROL, V16, P1886	75	54	57	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19511	19522		10.1074/jbc.M111.221739	http://dx.doi.org/10.1074/jbc.M111.221739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487016	hybrid, Green Published			2022-12-27	WOS:000291027700034
J	Ramathal, C; Wang, W; Hunt, E; Bagchi, IC; Bagchi, MK				Ramathal, Cyril; Wang, Wei; Hunt, Elizabeth; Bagchi, Indrani C.; Bagchi, Milan K.			Transcription Factor CCAAT Enhancer-binding Protein beta (C/EBP beta) Regulates the Formation of a Unique Extracellular Matrix That Controls Uterine Stromal Differentiation and Embryo Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANES; CELL-PROLIFERATION; TROPHOBLAST CELLS; MESSENGER-RNA; IN-VITRO; LAMININ; MOUSE; DECIDUALIZATION; EXPRESSION; LOCALIZATION	During implantation, the uterine stromal cells undergo terminal differentiation into decidual cells, which support the proper progression of maternal-embryo interactions to successful establishment of pregnancy. The decidual cells synthesize extracellular matrix (ECM) components, such as laminins and collagens, which assemble into a unique basal lamina-like network that surrounds these cells. The functional significance of this matrix during implantation is unknown. We previously showed that the transcription factor CCAAT enhancer-binding protein beta (C/EBP beta) critically regulates decidualization in the mouse. We now provide evidence that C/EBP beta directly controls the Lamc1 gene, which encodes a predominant laminin constituent of the ECM produced by the decidual cells. Suppression of Lamc1 expression in mouse primary endometrial stromal cells prevented the assembly of this ECM and impaired stromal differentiation. Attenuation of expression of integrin beta 1, a major constituent of the integrin receptors targeted by decidual laminins, also inhibited this differentiation process. Disruption of laminin-integrin interactions led to impaired activation of the focal adhesion kinase, an integrin-mediated regulator of cytoskeletal remodeling during decidualization. To further analyze the role of the decidual ECM in modulating maternal-embryo interactions, we monitored trophoblast invasion into differentiating uterine stromal monolayers, using a co-culture system. Silencing of stromal Lamc1 expression, which prevented formation of the basal lamina-like matrix, resulted in marked reduction in trophoblast outgrowth. Collectively, our findings identified C/EBP beta as a critical regulator of the unique ECM that controls decidual cell architecture and differentiation, and it provided new insights into the mechanisms by which the uterine stromal microenvironment controls the progression of embryo implantation.	[Wang, Wei; Hunt, Elizabeth; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Ramathal, Cyril] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Ramathal, Cyril; Wang, Wei; Hunt, Elizabeth; Bagchi, Indrani C.; Bagchi, Milan K.] Univ Illinois, Ctr Res Reprod & Infertil, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, MK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	mbagchi@life.illinois.edu			National Institutes of Health Eunice Kennedy Shriver NICHD [U54 HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	National Institutes of Health Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Eunice Kennedy Shriver NICHD Cooperative Agreement U54 HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.	Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Babiarz B, 1996, DEV DYNAM, V206, P330, DOI 10.1002/(SICI)1097-0177(199607)206:3<330::AID-AJA10>3.0.CO;2-3; Bagchi MK, 2006, CELL CYCLE, V5, P922, DOI 10.4161/cc.5.9.2712; Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Cheon YP, 2004, J BIOL CHEM, V279, P10357, DOI 10.1074/jbc.M309434200; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; FARRAR JD, 1992, BIOL REPROD, V46, P1095, DOI 10.1095/biolreprod46.6.1095; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GLASSER SR, 1987, DIFFERENTIATION, V35, P132, DOI 10.1111/j.1432-0436.1987.tb00161.x; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; GU Y, 1999, ENCY REPROD, P836; Irwin J. C., 1999, ENCY REPROD, V1, P823; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kim JY, 2008, MOL CELL BIOL, V28, P1770, DOI 10.1128/MCB.01556-07; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Klaffky EJ, 2006, DEV BIOL, V292, P277, DOI 10.1016/j.ydbio.2005.12.033; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mardon H, 2007, SEMIN REPROD MED, V25, P410, DOI 10.1055/s-2007-991038; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Murray P, 2001, J CELL SCI, V114, P931; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Plante BJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-15; Ramathal C, 2010, MOL CELL BIOL, V30, P1607, DOI 10.1128/MCB.00872-09; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rasband Wayne, 2010, IMAGEJ; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SENIOR PV, 1988, DEVELOPMENT, V104, P431; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; UTANI A, 1994, J BIOL CHEM, V269, P19167; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; WEWER UM, 1985, LAB INVEST, V53, P624; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	47	22	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19860	19871		10.1074/jbc.M110.191759	http://dx.doi.org/10.1074/jbc.M110.191759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471197	Green Published, hybrid			2022-12-27	WOS:000291027700066
J	Verhoog, NJD; Du Toit, A; Avenant, C; Hapgood, JP				Verhoog, Nicolette J. D.; Du Toit, Andrea; Avenant, Chanel; Hapgood, Janet P.			Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) alpha-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor A POTENTIAL MECHANISM FOR PROTECTION AGAINST AN EXCESSIVE INFLAMMATORY RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CREB-BINDING-PROTEIN; FEMALE GENITAL-TRACT; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CROSS-TALK; TRANSCRIPTIONAL ACTIVITY; ANTIINFLAMMATORY ACTION	TNF alpha signaling and cytokine levels play a crucial role in cervical immunity and the host response to infections. We investigated the role of liganded and unliganded glucocorticoid receptor (GR) in IL-6 and IL-8 gene regulation in response to TNF alpha in the End1/E6E7 immortalized human endocervical epithelial cell line. In the absence of glucocorticoids, both decreasing GR protein levels by an siRNA strategy and results with the GR antagonist RU486 suggest a role for the unliganded GR in reduction of TNF alpha-induced IL-6 and IL-8 mRNA levels in End1/E6E7 cells. Moreover, GR-dependent repression of endogenous IL-6 mRNA as well as a minimal IL-6 promoter-reporter gene is also demonstrated in COS-1 cells in the absence of GR ligand, suggesting a transcriptional mechanism that is not cell-specific. TNF alpha induced recruitment of both the unliganded GR and GR-interacting protein type 1 (GRIP-1) to the IL-6 promoter. This, together with GRIP-1 overexpression studies, suggests a function for GRIP-1 as a GR co-repressor in this context. TNF alpha was shown to induce phosphorylation of the unliganded human GR at Ser-226 but not Ser-211, unlike dexamethasone, which induced hyperphosphorylation at both serine residues. Ser-226 is shown to be required for the ligand-independent GR-mediated repression of IL-6 in response to TNF alpha. Taken together, these results support a model whereby the unliganded GR attenuates TNF alpha-stimulated IL-6 transcription by a mechanism involving selective phosphorylation and recruitment of the unliganded GR and GRIP-1 to the IL-6 promoter. These findings suggest the presence of a novel autoregulatory mechanism that may prevent overproduction of IL-6 in the endocervix, possibly protecting against negative effects of excessive inflammation.	[Verhoog, Nicolette J. D.; Du Toit, Andrea; Avenant, Chanel; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa	University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Private Bag X3, ZA-7701 Rondebosch, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018	Hapgood, Janet P/0000-0002-4414-4861; Verhoog, Nicolette/0000-0002-3786-6452				Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; An BS, 2006, J BIOL CHEM, V281, P20817, DOI 10.1074/jbc.M600743200; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; BARCLAY CG, 1993, AM J OBSTET GYNECOL, V169, P625, DOI 10.1016/0002-9378(93)90634-U; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Brogan IJ, 1999, MOL CELL ENDOCRINOL, V157, P95, DOI 10.1016/S0303-7207(99)00156-2; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Cadepond F, 1997, ANNU REV MED, V48, P129; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Bosscher K, 2001, MOL ENDOCRINOL, V15, P219, DOI 10.1210/me.15.2.219; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Griekspoor A., 2007, NUCL RECEPT SIGNAL, V9, pE003, DOI DOI 10.1621/NRS.05003; Herbein G, 2008, TRENDS IMMUNOL, V29, P61, DOI 10.1016/j.it.2007.10.008; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; IGLESIAS M, 1995, AM J PATHOL, V146, P944; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones RL, 2005, HUM REPROD, V20, P2724, DOI 10.1093/humrep/dei140; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Ma H, 2003, METHOD ENZYMOL, V364, P284; MALEJCZYK J, 1991, CELL IMMUNOL, V136, P155, DOI 10.1016/0008-8749(91)90390-W; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; NG SB, 1994, J BIOL CHEM, V269, P19021; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Oakeshott P, 2003, INT J STD AIDS, V14, P289, DOI 10.1258/095646203321264962; PARTRIDGE M, 1991, J INVEST DERMATOL, V96, P771, DOI 10.1111/1523-1747.ep12471723; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sarabdjitsingh RA, 2010, BRAIN RES, V1331, P1, DOI 10.1016/j.brainres.2010.03.052; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SMITH CL, 1993, P NATL ACAD SCI USA, V90, P6120, DOI 10.1073/pnas.90.13.6120; Tanaka H, 1996, J IMMUNOL, V156, P1601; Tremblay A, 2001, J STEROID BIOCHEM, V77, P19, DOI 10.1016/S0960-0760(01)00031-0; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957; Weigel Nancy L, 2007, Nucl Recept Signal, V5, pe005; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; WOODWORTH CD, 1993, AM J PATHOL, V142, P1544; YOSHIZAKI K, 1990, Cytokine, V2, P381, DOI 10.1016/1043-4666(90)90069-6; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	90	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19297	19310		10.1074/jbc.M110.193672	http://dx.doi.org/10.1074/jbc.M110.193672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474440	Green Published, hybrid			2022-12-27	WOS:000291027700012
J	Naik, RJ; Chandra, P; Mann, A; Ganguli, M				Naik, Rangeetha J.; Chandra, Pallavi; Mann, Anita; Ganguli, Munia			Exogenous and Cell Surface Glycosaminoglycans Alter DNA Delivery Efficiency of Arginine and Lysine Homopeptides in Distinctly Different Ways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MEMBRANE-ASSOCIATED PROTEOGLYCANS; PROTEIN TRANSDUCTION DOMAINS; MEDIATED GENE-TRANSFER; PENETRATING PEPTIDES; RICH PEPTIDES; EXTRACELLULAR GLYCOSAMINOGLYCANS; INTERNALIZATION MECHANISMS; TAT PROTEIN; IN-VITRO	Glycosaminoglycans (GAGs) expressed ubiquitously on the cell surface are known to interact with a variety of ligands to mediate different cellular processes. However, their role in the internalization of cationic gene delivery vectors such as liposomes, polymers, and peptides is still ambiguous and seems to be controlled by multiple factors. In this report, taking peptides as model systems, we show that peptide chemistry is one of the key factors that determine the dependence on cell surface glycosaminoglycans for cellular internalization and gene delivery. Arginine peptides and their complexes with plasmid DNA show efficient uptake and functional gene transfer independent of the cell surface GAGs. On the other hand, lysine peptides and complexes primarily enter through a GAG-dependent pathway. The peptide-DNA complexes also show differential interaction with soluble GAGs. In the presence of exogenous GAGs under certain conditions, arginine peptide-DNA complexes show increased transfection efficiency that is not observed with lysine. This is attributed to a change in the complex nature that ensures better protection of the compacted DNA in the case of arginine complexes, whereas the lysine complexes get destabilized under these conditions. The presence of a GAG coating also ensures better cell association of arginine complexes, resulting in increased uptake. Our results indicate that the role of both the cell surface and exogenous glycosaminoglycans in gene delivery is controlled by the nature of the peptide and its complex with DNA.	[Ganguli, Munia] Inst Genom & Integrat Biol, Lab 203, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Ganguli, M (corresponding author), Inst Genom & Integrat Biol, Lab 203, Mall Rd,Jubilee Hall, Delhi 110007, India.	mganguli@igib.res.in	Mann, Anita/B-6756-2014; Mann, Anita/GQP-9814-2022	Mann, Anita/0000-0002-8368-4262; 	Council of Scientific and Industrial Research, Government of India [NWP35]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, Government of India (Project NWP35).; Recipients of fellowships from Department of Biotechnology, Government of India and Council of Scientific and Industrial Research.	Belting M, 1999, BIOCHEM J, V342, P281, DOI 10.1042/0264-6021:3420281; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Burke RS, 2008, BIOCONJUGATE CHEM, V19, P693, DOI 10.1021/bc700388u; Chen Y, 2008, MOL CELLS, V26, P415; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Mann A, 2008, DRUG DISCOV TODAY, V13, P152, DOI 10.1016/j.drudis.2007.11.008; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Mounkes LC, 1998, J BIOL CHEM, V273, P26164, DOI 10.1074/jbc.273.40.26164; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Ruponen M, 2001, J BIOL CHEM, V276, P33875, DOI 10.1074/jbc.M011553200; Ruponen M, 1999, BBA-BIOMEMBRANES, V1415, P331, DOI 10.1016/S0005-2736(98)00199-0; Ruponen M, 2004, J GENE MED, V6, P405, DOI 10.1002/jgm.522; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	35	44	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18982	18993		10.1074/jbc.M111.227793	http://dx.doi.org/10.1074/jbc.M111.227793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471199	hybrid, Green Published			2022-12-27	WOS:000290785700069
J	Maurin, G; Fresquet, J; Granio, O; Wychowski, C; Cosset, FL; Lavillette, D				Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Wychowski, Czeslaw; Cosset, Francois-Loic; Lavillette, Dimitri			Identification of Interactions in the E1E2 Heterodimer of Hepatitis C Virus Important for Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAINS; E2 GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; HYPERVARIABLE REGION-1; ENVELOPE GLYCOPROTEINS; CHARGED RESIDUES; RECEPTOR; CD81; PSEUDOPARTICLES; LOCALIZATION	Several conserved domains critical for E1E2 assembly and hepatitis C virus entry have been identified in E1 and E2 envelope glycoproteins. However, the role of less conserved domains involved in cross-talk between either glycoprotein must be defined to fully understand how E1E2 undergoes conformational changes during cell entry. To characterize such domains and to identify their functional partners, we analyzed a set of intergenotypic E1E2 heterodimers derived from E1 and E2 of different genotypes. The infectivity of virions indicated that Con1 E1 did not form functional heterodimers when associated with E2 from H77. Biochemical analyses demonstrated that the reduced infectivity was not related to alteration of conformation and incorporation of Con1 E1/H77 E2 heterodimers but rather to cell entry defects. Thus, we generated chimeric E1E2 glycoproteins by exchanging different domains of each protein in order to restore functional heterodimers. We found that both the ectodomain and transmembrane domain of E1 influenced infectivity. Site-directed mutagenesis highlighted the role of amino acids 359, 373, and 375 in transmembrane domain in entry. In addition, we identified one domain involved in entry within the N-terminal part of E1, and we isolated a motif at position 219 that is critical for H77 function. Interestingly, using additional chimeric E1E2 complexes harboring substitutions in this motif, we found that the transmembrane domain of E1 acts as a partner of this motif. Therefore, we characterized domains of E1 and E2 that have co-evolved inside a given genotype to optimize their interactions and allow efficient entry.	[Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Cosset, Francois-Loic; Lavillette, Dimitri] Univ Lyon 1, INSERM, IFR128, U758, F-69007 Lyon, France; [Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Cosset, Francois-Loic; Lavillette, Dimitri] Ecole Normale Super Lyon, F-69007 Lyon, France; [Wychowski, Czeslaw] Univ Lille Nord France, Inst Pasteur Lille, INSERM, Ctr Infect & Immun Lille,CNRS,U1019,UMR8204, F-59021 Lille, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Cosset, FL (corresponding author), Ecole Normale Super Lyon, Unite Virol Humaine, INSERM, U758, 46 Allee Italie, F-69364 Lyon 07, France.	Flcosset@ens-lyon.fr; Dimitri.lavillette@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019	Cosset, François-Loïc/0000-0001-8842-3726; Lavillette, Dimitri/0000-0002-4706-1519	Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales; FINOVI foundation; European Research Council [ERC-2008-AdG-233130-HEPCENT]	Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales(French National Research Agency (ANR)); FINOVI foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales, the FINOVI foundation, and by the European Research Council (ERC-2008-AdG-233130-HEPCENT).	Albecka A, 2011, J VIROL, V85, P1777, DOI 10.1128/JVI.02170-10; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; BOWEN WD, 1992, J PHARMACOL EXP THER, V262, P32; Ciczora Y, 2005, J GEN VIROL, V86, P2793, DOI 10.1099/vir.0.81140-0; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cocquerel L, 2002, EMBO J, V21, P2893, DOI 10.1093/emboj/cdf295; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Leroux-Roels G, 2005, HUM VACCINES, V1, P61, DOI 10.4161/hv.1.2.1554; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2007, FLAVIVIRIDAE VIRUSES, V1, P1001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Mottola G, 2000, J BIOL CHEM, V275, P24070, DOI 10.1074/jbc.M910400199; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Patel J, 2001, VIROLOGY, V279, P58, DOI 10.1006/viro.2000.0693; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Rothwangl KB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-12; Russell RS, 2009, J VIRAL HEPATITIS, V16, P621, DOI 10.1111/j.1365-2893.2009.01111.x; Sandrin V, 2005, J GEN VIROL, V86, P3189, DOI 10.1099/vir.0.81428-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	52	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23865	23876		10.1074/jbc.M110.213942	http://dx.doi.org/10.1074/jbc.M110.213942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21555519	Green Published, hybrid			2022-12-27	WOS:000292294900029
J	France, KA; Anderson, JL; Park, A; Denny, CT				France, Kelly A.; Anderson, Jennifer L.; Park, Ann; Denny, Christopher T.			Oncogenic Fusion Protein EWS/FLI1 Down-regulates Gene Expression by Both Transcriptional and Posttranscriptional Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; EWINGS-SARCOMA; TARGET GENE; FAMILY TUMORS; NIH3T3 CELLS; EWS; ONCOPROTEINS; EWS-FLI1; DOMAIN; TRANSLOCATION	Ewing family tumors are characterized by a translocation between the RNA binding protein EWS and one of five ETS transcription factors, most commonly FLI1. The fusion protein produced by the translocation has been thought to act as an aberrant transcription factor, leading to changes in gene expression and cellular transformation. In this study, we investigated the specific processes EWS/FLI1 utilizes to alter gene expression. Using both heterologous NIH 3T3 and human Ewing Family Tumor cell lines, we have demonstrated by quantitative pre-mRNA analysis that EWS/FLI1 repressed the expression of previously validated direct target genes at the level of transcript synthesis. ChIP experiments showed that EWS/FLI1 decreases the amount of Pol II at the promoter of down-regulated genes in both murine and human model systems. However, in down-regulated target genes, there was a significant disparity between the modulation of cognate mRNA and pre-mRNAs, suggesting that these genes could also be regulated at a posttranscriptional level. Confirming this, we found that EWS/FLI1 decreased the transcript half-life of insulin-like growth factor binding protein 3, a down-regulated direct target gene in human tumor-derived Ewing's sarcoma cell lines. Additionally, we have shown through reexpression experiments that full EWS/FLI1-mediated transcriptional repression requires intact EWS and ETS domains. Together these data demonstrate that EWS/FLI1 can dictate steady-state target gene expression by modulating both transcript synthesis and degradation.	[Denny, Christopher T.] Univ Calif Los Angeles, Med Ctr, Inst Mol Biol, Los Angeles, CA 90095 USA; [Denny, Christopher T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, Ann; Denny, Christopher T.] Univ Calif Los Angeles, Dept Pediat, Gwynne Hazen Cherry Mem Labs, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Denny, CT (corresponding author), Univ Calif Los Angeles, Med Ctr, Inst Mol Biol, A2-312 MDCC, Los Angeles, CA 90095 USA.	cdenny@ucla.edu			National Institutes of Health [CA087771]; Ruth L. Kirschstein National Research Service Award [GM007185]; NATIONAL CANCER INSTITUTE [R01CA087771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA087771. This work was also supported by Ruth L. Kirschstein National Research Service Award GM007185 (to K. A. F. and J. L. A.).	Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Im YH, 2000, CANCER RES, V60, P1536; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Matsunobu T, 2006, CANCER RES, V66, P803, DOI 10.1158/0008-5472.CAN-05-1972; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Melet F, 1996, MOL CELL BIOL, V16, P2708; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Ng KP, 2007, P NATL ACAD SCI USA, V104, P479, DOI 10.1073/pnas.0607007104; Papas Takis S., 1997, Leukemia (Basingstoke), V11, P557; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; SETH A, 1992, CELL GROWTH DIFFER, V3, P327; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SPENCER CA, 1990, ONCOGENE, V5, P777; Teitell MA, 1999, LAB INVEST, V79, P1535; Thompson AD, 1999, ONCOGENE, V18, P5506, DOI 10.1038/sj.onc.1202928; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; TURCCAREL C, 1983, CR ACAD SCI III-VIE, V296, P1101; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	40	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22750	22757		10.1074/jbc.M111.225433	http://dx.doi.org/10.1074/jbc.M111.225433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531709	Green Published, hybrid			2022-12-27	WOS:000292025000009
J	Kroh, HK; Panizzi, P; Tchaikovski, S; Baird, TR; Wei, N; Krishnaswamy, S; Tans, G; Rosing, J; Furie, B; Furie, BC; Bock, PE				Kroh, Heather K.; Panizzi, Peter; Tchaikovski, Svetlana; Baird, T. Regan; Wei, Nancy; Krishnaswamy, Sriram; Tans, Guido; Rosing, Jan; Furie, Bruce; Furie, Barbara C.; Bock, Paul E.			Active Site-labeled Prothrombin Inhibits Prothrombinase in Vitro and Thrombosis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR SUBSTRATE RECOGNITION; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; VEIN ENDOTHELIAL-CELLS; REGULATORY EXOSITE-I; PLATELET P-SELECTIN; FACTOR-XA; FACTOR-VA; TISSUE FACTOR; CATALYZED ACTIVATION	Mouse and human prothrombin (ProT) active site specifically labeled with D-Phe-Pro-Arg-CH2Cl (FPR-ProT) inhibited tissue factor-initiated thrombin generation in platelet-rich and platelet-poor mouse and human plasmas. FPR-prethrombin 1 (Pre 1), fragment 1 (F1), fragment 1.2 (F1.2), and FPR-thrombin produced no significant inhibition, demonstrating the requirement for all three ProT domains. Kinetics of inhibition of ProT activation by the inactive ProT(S195A) mutant were compatible with competitive inhibition as an alternate nonproductive substrate, although FPR-ProT deviated from this mechanism, implicating a more complex process. FPR-ProT exhibited similar to 10-fold more potent anticoagulant activity compared with ProT(S195A) as a result of conformational changes in the ProT catalytic domain that induce a more proteinase-like conformation upon FPR labeling. Unlike ProT and ProT(S195A), the pathway of FPR-ProT cleavage by prothrombinase was redirected from meizothrombin toward formation of the FPR-prethrombin 2 (Pre 2).F1.2 inhibitory intermediate. Localization of ProT labeled with Alexa Fluor (R) 660 tethered through FPR-CH2Cl ([AF660]FPR-ProT) during laser-induced thrombus formation in vivo in murine arterioles was examined in real time wide-field and confocal fluorescence microscopy. [AF660]FPR-ProT bound rapidly to the vessel wall at the site of injury, preceding platelet accumulation, and subsequently to the thrombus proximal, but not distal, to the vessel wall. [AF660]FPR-ProT inhibited thrombus growth, whereas [AF660]FPR-Pre 1, lacking the F1 membrane-binding domain did not bind or inhibit. Labeled F1.2 localized similarly to [AF660]FPR-ProT, indicating binding to phosphatidylserine-rich membranes, but did not inhibit thrombosis. The studies provide new insight into the mechanism of ProT activation in vivo and in vitro, and the properties of a unique exosite-directed prothrombinase inhibitor.	[Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Tchaikovski, Svetlana; Tans, Guido; Rosing, Jan] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Baird, T. Regan; Furie, Bruce; Furie, Barbara C.] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Baird, T. Regan; Wei, Nancy; Furie, Bruce] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Krishnaswamy, Sriram] Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Vanderbilt University; Auburn University System; Auburn University; Maastricht University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019; Krishnaswamy, Sriram/Z-4380-2019	Panizzi, Peter/0000-0003-0141-8807; 	National Institutes of Health [RO1 HL038779, R37 HL071544, K99 HL094533, PO1 HL87203, RO1 HL095084, RO1 HL92125, PO1 HL74124, T32 HL0007751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095084, K99HL094533, R01HL092125, T32HL007751, P01HL074124, P01HL087203, R01HL038779, R37HL071544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL038779 and R37 HL071544 (to P. E. B.), K99 HL094533 (to P. P.), PO1 HL87203 and RO1 HL095084 (to B. F.), RO1 HL92125 (to B. C. F.), and PO1 HL74124 (to S. K.).; Supported in part by National Institutes of Health Grant T32 HL0007751.	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Arocas V, 1998, THROMB HAEMOSTASIS, V79, P1157, DOI 10.1055/s-0037-1615033; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Curvers J, 2002, THROMB HAEMOSTASIS, V87, P483, DOI 10.1055/s-0037-1613029; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1980, EUR J BIOCHEM, V104, P549, DOI 10.1111/j.1432-1033.1980.tb04458.x; Dubois C, 2007, PLATELETS, 2ND EDITION, P611, DOI 10.1016/B978-012369367-9/50796-5; Dubois C, 2007, J CLIN INVEST, V117, P953, DOI 10.1172/JCI30537; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Furie B, 2004, TRENDS MOL MED, V10, P171, DOI 10.1016/j.molmed.2004.02.008; GAJDUSEK C, 1986, J CELL BIOL, V103, P419, DOI 10.1083/jcb.103.2.419; Gross PL, 2005, J LEUKOCYTE BIOL, V78, P1318, DOI 10.1189/jlb.0405193; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Koenen RR, 2003, BLOOD, V102, P1686, DOI 10.1182/blood-2003-02-0620; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1990, BLOOD, V76, P1; MARUYAMA I, 1984, J CLIN INVEST, V74, P224, DOI 10.1172/JCI111405; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; RODGERS GM, 1983, P NATL ACAD SCI-BIOL, V80, P7001, DOI 10.1073/pnas.80.22.7001; RODGERS GM, 1988, FASEB J, V2, P116, DOI 10.1096/fasebj.2.2.3277885; RODGERS GM, 1988, J CLIN INVEST, V81, P1911, DOI 10.1172/JCI113538; ROSING J, 1985, BLOOD, V65, P319; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SHAPIRO SS, 1969, J CLIN INVEST, V48, P1292, DOI 10.1172/JCI106095; STERN DM, 1984, J CLIN INVEST, V74, P1910, DOI 10.1172/JCI111611; TANS G, 1991, J BIOL CHEM, V266, P21864; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; TIJBURG PNM, 1991, J BIOL CHEM, V266, P4017; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1983, J BIOL CHEM, V258, P7264; Van Zutphen L.F., 2001, PRINCIPLES LAB ANIMA, Vfirst; Vandendries ER, 2007, P NATL ACAD SCI USA, V104, P288, DOI 10.1073/pnas.0610188104; Wilkens M, 2002, J BIOL CHEM, V277, P9366, DOI 10.1074/jbc.M110848200; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	69	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23345	23356		10.1074/jbc.M111.230292	http://dx.doi.org/10.1074/jbc.M111.230292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531712	Green Published, hybrid			2022-12-27	WOS:000292025000066
J	Czarna, A; Breitkreuz, H; Mahrenholz, CC; Arens, J; Strauss, HM; Wolf, E				Czarna, Anna; Breitkreuz, Helena; Mahrenholz, Carsten C.; Arens, Julia; Strauss, Holger M.; Wolf, Eva			Quantitative Analyses of Cryptochrome-mBMAL1 Interactions MECHANISTIC INSIGHTS INTO THE TRANSCRIPTIONAL REGULATION OF THE MAMMALIAN CIRCADIAN CLOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; BLUE-LIGHT PHOTORECEPTOR; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; FEEDBACK LOOP; C-TERMINUS; CLOCK; CRY2; BMAL1; ACETYLATION	The mammalian cryptochromes mCRY1 and mCRY2 act as transcriptional repressors within the 24-h transcription-translational feedback loop of the circadian clock. The C-terminal tail and a preceding predicted coiled coil (CC) of the mCRYs as well as the C-terminal region of the transcription factor mBMAL1 are involved in transcriptional feedback repression. Here we show by fluorescence polarization and isothermal titration calorimetry that purified mCRY1/2CCtail proteins form stable heterodimeric complexes with two C-terminal mBMAL1 fragments. The longer mBMAL1 fragment (BMAL490) includes Lys-537, which is rhythmically acetylated by mCLOCK in vivo. mCRY1 (but not mCRY2) has a lower affinity to BMAL490 than to the shorter mBMAL1 fragment (BMAL577) and a K537Q mutant version of BMAL490. Using peptide scan analysis we identify two mBMAL1 binding epitopes within the coiled coil and tail regions of mCRY1/2 and document the importance of positively charged mCRY1 residues for mBMAL1 binding. A synthetic mCRY coiled coil peptide binds equally well to the short and to the long (wild-type and K537Q mutant) mBMAL1 fragments. In contrast, a peptide including the mCRY1 tail epitope shows a lower affinity to BMAL490 compared with BMAL577 and BMAL490(K537Q). We propose that Lys-537(mBMAL1) acetylation enhances mCRY1 binding by affecting electrostatic interactions predominantly with the mCRY1 tail. Our data reveal different molecular interactions of the mCRY1/2 tails with mBMAL1, which may contribute to the non-redundant clock functions of mCRY1 and mCRY2. Moreover, our study suggests the design of peptidic inhibitors targeting the interaction of the mCRY1 tail with mBMAL1.	[Wolf, Eva] Max Planck Inst Biochem, Dept Struct Cell Biol, Grp Struct Chronobiol, D-82152 Martinsried, Germany; [Breitkreuz, Helena; Arens, Julia] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Mahrenholz, Carsten C.] Charite, Inst Med Immunol, Mol Lib, D-10115 Berlin, Germany; [Mahrenholz, Carsten C.] Charite, Inst Med Immunol, Recognit Grp, D-10115 Berlin, Germany; [Strauss, Holger M.] Gesell Kolloidanalyt mbH, Nanolyt, D-14476 Potsdam, Germany	Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wolf, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Grp Struct Chronobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	ewolf@biochem.mpg.de	Strauss, Holger Martin/I-8403-2012	Czarna, Anna/0000-0003-1068-0671	Deutsche Forschungsgemeinschaft [WO-695/3, WO-695/4, WO-695/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants WO-695/3, WO-695/4, and WO-695/5 (to E. W.).	Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	34	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22414	22425		10.1074/jbc.M111.244749	http://dx.doi.org/10.1074/jbc.M111.244749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521686	Green Published, hybrid			2022-12-27	WOS:000291719900051
J	Kwezi, L; Ruzvidzo, O; Wheeler, JI; Govender, K; Iacuone, S; Thompson, PE; Gehring, C; Irving, HR				Kwezi, Lusisizwe; Ruzvidzo, Oziniel; Wheeler, Janet I.; Govender, Kershini; Iacuone, Sylvana; Thompson, Philip E.; Gehring, Chris; Irving, Helen R.			The Phytosulfokine (PSK) Receptor Is Capable of Guanylate Cyclase Activity and Enabling Cyclic GMP-dependent Signaling in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE GROWTH-FACTOR; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; IN-VITRO; BINDING PROTEINS; GENE-EXPRESSION; MESOPHYLL-CELLS; MEMBRANE FORM; CGMP LEVELS; IDENTIFICATION	Phytosulfokines (PSKs) are sulfated pentapeptides that stimulate plant growth and differentiation mediated by the PSK receptor (PSKR1), which is a leucine-rich repeat receptor-like kinase. We identified a putative guanylate cyclase (GC) catalytic center in PSKR1 that is embedded within the kinase domain and hypothesized that the GC works in conjunction with the kinase in downstream PSK signaling. We expressed the recombinant complete kinase (cytoplasmic) domain of AtPSKR1 and show that it has serine/threonine kinase activity using the Ser/Thr peptide 1 as a substrate with an approximate K-m of 7.5 mu M and V-max of 1800 nmol min(-1) mg(-1) of protein. This same recombinant protein also has GC activity in vitro that is dependent on the presence of either Mg2+ or Mn2+. Overexpression of the full-length AtPSKR1 receptor in Arabidopsis leaf protoplasts raised the endogenous basal cGMP levels over 20-fold, indicating that the receptor has GC activity in vivo. In addition, PSK-alpha itself, but not the non-sulfated backbone, induces rapid increases in cGMP levels in protoplasts. Together these results indicate that the PSKR1 contains dual GC and kinase catalytic activities that operate in vivo and that this receptor constitutes a novel class of enzymes with overlapping catalytic domains.	[Kwezi, Lusisizwe; Wheeler, Janet I.; Iacuone, Sylvana; Thompson, Philip E.; Irving, Helen R.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Kwezi, Lusisizwe; Ruzvidzo, Oziniel; Govender, Kershini; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Div Chem Life Sci & Engn, Thuwal 239556900, Saudi Arabia	Monash University; University of the Western Cape; King Abdullah University of Science & Technology	Irving, HR (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia.	helen.irving@monash.edu	Irving, Helen/B-4425-2019	Irving, Helen/0000-0002-1514-0909; Thompson, Philip/0000-0002-5910-7625; Gehring, Christoph/0000-0003-4355-4591	Australian Research Council [DP0878194]; National Research Fund South Africa	Australian Research Council(Australian Research Council); National Research Fund South Africa	This work was supported by the Australian Research Council Discovery funding scheme (Project Number DP0878194) and by the National Research Fund South Africa.	Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; ASSMANN SM, 1995, PLANT PHYSIOL, V108, P885, DOI 10.1104/pp.108.3.885; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; BOWLER C, 1994, CELL, V77, P73, DOI 10.1016/0092-8674(94)90236-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Cousson A, 1998, PLANTA, V206, P308, DOI 10.1007/s004250050405; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Donaldson L, 2004, FEBS LETT, V569, P317, DOI 10.1016/j.febslet.2004.06.016; Hanai H, 2000, FEBS LETT, V470, P97, DOI 10.1016/S0014-5793(00)01299-0; Kaplan B, 2007, FEBS LETT, V581, P2237, DOI 10.1016/j.febslet.2007.02.017; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kitagawa K, 2001, J ORG CHEM, V66, P1, DOI 10.1021/jo000895y; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Kwezi L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000449; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Linder JU, 2002, MOL CELL BIOCHEM, V230, P149, DOI 10.1023/A:1014200325422; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lorbiecke R, 2002, PLANT SCI, V163, P321, DOI 10.1016/S0168-9452(02)00101-2; Ludidi N, 2003, J BIOL CHEM, V278, P6490, DOI 10.1074/jbc.M210983200; Maathuis FJM, 2006, PLANT J, V45, P700, DOI 10.1111/j.1365-313X.2005.02616.x; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 1996, BIOCHEM BIOPH RES CO, V225, P209, DOI 10.1006/bbrc.1996.1155; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Meier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008904; Motose H, 2009, PLANT PHYSIOL, V150, P437, DOI 10.1104/pp.109.135954; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; NEWTON RP, 1984, PHYTOCHEMISTRY, V23, P1367, DOI 10.1016/S0031-9422(00)80467-7; Newton RP, 1999, NEW PHYTOL, V143, P427, DOI 10.1046/j.1469-8137.1999.00478.x; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Pharmawati M, 1998, PLANT SCI, V137, P107, DOI 10.1016/S0168-9452(98)00135-6; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Shults MD, 2003, J AM CHEM SOC, V125, P14248, DOI 10.1021/ja0380502; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Szmidt-Jaworska A, 2008, J PLANT PHYSIOL, V165, P858, DOI 10.1016/j.jplph.2007.02.010; Szmidt-Jaworska A, 2009, J PLANT GROWTH REGUL, V28, P367, DOI 10.1007/s00344-009-9105-8; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Volotovski ID, 1998, PLANT PHYSIOL, V117, P1023, DOI 10.1104/pp.117.3.1023; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang YH, 2007, FUNCT PLANT BIOL, V34, P645, DOI 10.1071/FP06316; Wheeler JI, 2010, FUNCT PLANT BIOL, V37, P382, DOI 10.1071/FP09242; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Yang HP, 1999, P NATL ACAD SCI USA, V96, P13560, DOI 10.1073/pnas.96.23.13560; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	58	78	85	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22580	22588		10.1074/jbc.M110.168823	http://dx.doi.org/10.1074/jbc.M110.168823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504901	hybrid, Green Published			2022-12-27	WOS:000291719900065
J	Miranda-Laferte, E; Gonzalez-Gutierrez, G; Schmidt, S; Zeug, A; Ponimaskin, EG; Neely, A; Hidalgo, P				Miranda-Laferte, Erick; Gonzalez-Gutierrez, Giovanni; Schmidt, Silke; Zeug, Andre; Ponimaskin, Evgeni G.; Neely, Alan; Hidalgo, Patricia			Homodimerization of the Src Homology 3 Domain of the Calcium Channel beta-Subunit Drives Dynamin-dependent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; GUANYLATE KINASE DOMAIN; TUMOR-SUPPRESSOR; SYNAPTIC PROTEIN; CONSERVED MOTIF; SH3 DOMAINS; MEMBRANE; COMPLEX; PALMITOYLATION; LOCALIZATION	Voltage-dependent calcium channels constitute the main entry pathway for calcium into excitable cells. They are heteromultimers formed by an alpha(1) pore-forming subunit (Ca-V alpha(1)) and accessory subunits. To achieve a precise coordination of calcium signals, the expression and activity of these channels is tightly controlled. The accessory beta-subunit (Ca-V beta), a membrane associated guanylate kinase containing one guanylate kinase (beta-GK) and one Src homology 3 (beta-SH3) domain, has antagonistic effects on calcium currents by regulating different aspects of channel function. Although beta-GK binds to a conserved site within the alpha(1)-pore-forming subunit and facilitates channel opening, beta-SH3 binds to dynamin and promotes endocytosis. Here, we investigated the molecular switch underlying the functional duality of this modular protein. We show that beta-SH3 homodimerizes through a single disulfide bond. Substitution of the only cysteine residue abolishes dimerization and impairs internalization of L-type Ca(V)1.2 channels expressed in Xenopus oocytes while preserving dynamin binding. Covalent linkage of the beta-SH3 dimerization-deficient mutant yields a concatamer that binds to dynamin and restores endocytosis. Moreover, using FRET analysis, we show in living cells that Ca-V beta form oligomers and that this interaction is reduced by Ca-V alpha(1). Association of Ca-V beta with a polypeptide encoding the binding motif in Ca-V alpha(1) inhibited endocytosis. Together, these findings reveal that beta-SH3 dimerization is crucial for endocytosis and suggest that channel activation and internalization are two mutually exclusive functions of Ca-V beta . We propose that a change in the oligomeric state of Ca-V beta is the functional switch between channel activator and channel internalizer.	[Miranda-Laferte, Erick; Gonzalez-Gutierrez, Giovanni; Schmidt, Silke; Zeug, Andre; Ponimaskin, Evgeni G.; Hidalgo, Patricia] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Neely, Alan] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2349400, Chile	Hannover Medical School; Universidad de Valparaiso	Hidalgo, P (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	hidalgo.patricia@mh-hannover.de	Zeug, Andre/X-3208-2019; Hidalgo, Patricia/I-7506-2013	Zeug, Andre/0000-0001-9858-5841; Hidalgo, Patricia/0000-0002-4162-6590; Gonzalez-Gutierrez, Giovanni/0000-0002-1044-943X; Ponimaskin, evgeni/0000-0002-4570-5130; Neely, Alan/0000-0002-6007-2159	Deutsche Forschungsgemeinschaft [DFG Hi 800/3-1, 4-1]; Red de Anillo de Ciencia y Tecnologia [RED-24]; Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Red de Anillo de Ciencia y Tecnologia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica	This work was supported by grants from the Deutsche Forschungsgemeinschaft Grants DFG Hi 800/3-1 and 4-1 (to P. H.), Red de Anillo de Ciencia y Tecnologia Grant RED-24 (to A. N.), and the German-Chilean Scientific Cooperation Program Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica 2010 (to P. H. and A. N.).	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Brenman JE, 1998, J NEUROSCI, V18, P8805; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cingolani E, 2007, CIRC RES, V101, P166, DOI 10.1161/CIRCRESAHA.107.155721; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dzhura I, 2003, BIOPHYS J, V85, P274, DOI 10.1016/S0006-3495(03)74473-7; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; Lao QZ, 2010, FASEB J, V24, P5013, DOI 10.1096/fj.10-165381; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2009, GLYCOCONJUGATE J, V26, P749, DOI 10.1007/s10719-008-9187-8; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203	65	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22203	22210		10.1074/jbc.M110.201871	http://dx.doi.org/10.1074/jbc.M110.201871			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21502319	hybrid, Green Published			2022-12-27	WOS:000291719900027
J	Nonaka, M; Ma, BY; Imaeda, H; Kawabe, K; Kawasaki, N; Hodohara, K; Kawasaki, N; Andoh, A; Fujiyama, Y; Kawasaki, T				Nonaka, Motohiro; Ma, Bruce Yong; Imaeda, Hirotsugu; Kawabe, Keiko; Kawasaki, Nobuko; Hodohara, Keiko; Kawasaki, Nana; Andoh, Akira; Fujiyama, Yoshihide; Kawasaki, Toshisuke			Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Recognizes a Novel Ligand, Mac-2-binding Protein, Characteristically Expressed on Human Colorectal Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOEMBRYONIC ANTIGEN; COLON-CANCER; LINKED OLIGOSACCHARIDES; IMMUNE-RESPONSES; APOPTOSIS; CEACAM1; INNATE; CEA; DIFFERENTIATION; GLYCOSYLATION	Dendritic cell (DC)-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a type II transmembrane C-type lectin expressed on DCs such as myeloid DCs and monocyte-derived DCs (MoDCs). Recently, we have reported that DC-SIGN interacts with carcinoembryonic antigen (CEA) expressed on colorectal carcinoma cells. CEA is one of the most widely used tumor markers for gastrointestinal cancers such as colorectal cancer. On the other hand, other groups have reported that the level of Mac-2-binding protein (Mac-2BP) increases in patients with pancreatic, breast, and lung cancers, virus infections such as human immunodeficiency virus and hepatitis C virus, and autoimmune diseases. Here, we first identified Mac-2BP expressed on several colorectal carcinoma cell lines as a novel DC-SIGN ligand through affinity chromatography and mass spectrometry. Interestingly, we found that DC-SIGN selectively recognizes Mac-2BP derived from some colorectal carcinomas but not from the other ones. Furthermore, we found that the alpha 1-3,4-fucose moieties of Le glycans expressed on DC-SIGN-binding Mac-2BP were important for recognition. DC-SIGN-dependent cellular interactions between immature MoDCs and colorectal carcinoma cells significantly inhibited MoDC functional maturation, suggesting that Mac-2BP may provide a tolerogenic microenvironment for colorectal carcinoma cells through DC-SIGN-dependent recognition. Importantly, Mac-2BP was detected as a predominant DC-SIGN	[Nonaka, Motohiro; Ma, Bruce Yong; Kawabe, Keiko; Kawasaki, Nobuko; Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5250058, Japan; [Imaeda, Hirotsugu; Hodohara, Keiko; Fujiyama, Yoshihide] Shiga Univ Med Sci, Grad Sch Med, Dept Med, Shiga 5202192, Japan; [Andoh, Akira] Shiga Univ Med Sci, Grad Sch Med, Div Mucosal Immunol, Shiga 5202192, Japan; [Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Ma, Bruce Yong] Muroran Inst Technol, Dept Comp Sci & Syst Engn, Muroran, Hokkaido 0508585, Japan; [Ma, Bruce Yong] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Jiangsu 213164, Peoples R China	Ritsumeikan University; Shiga University of Medical Science; Shiga University of Medical Science; National Institute of Health Sciences - Japan; Muroran Institute of Technology; Changzhou University	Ma, BY (corresponding author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5250058, Japan.	bruceyongma@gmail.com; tkawasak@fc.ritsumei.ac.jp	Andoh, Akira/AAB-9303-2022; Imaeda, Hirotsugu/B-9907-2016	Imaeda, Hirotsugu/0000-0002-5516-8527	JSPS [20370052, 20890255, 21590543, 22-9530, 17005]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology (Osaka, Japan)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology (Osaka, Japan)	This work was supported by Grants-in-aid for Scientific Research B 20370052 (to T. K.) and C 21590543 (to B. Y. M.), for Young Scientists Start-up 20890255 (to M. N.), and for Japan Society for the Promotion of Science (JSPS) Fellows 22-9530 (to M. N.) from JSPS, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, JSPS Core-to-Core Program Strategic Research Networks (17005) from JSPS, and Research Proposal Grants from Japan Foundation for Applied Enzymology (Osaka, Japan; to B. Y. M.).	AHNEN DJ, 1982, CANCER, V49, P2077, DOI 10.1002/1097-0142(19820515)49:10<2077::AID-CNCR2820491020>3.0.CO;2-X; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Duffy MJ, 2001, CLIN CHEM, V47, P624; FERNANDES B, 1991, CANCER RES, V51, P718; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HAMADA Y, 1985, CANCER, V55, P136, DOI 10.1002/1097-0142(19850101)55:1<136::AID-CNCR2820550121>3.0.CO;2-P; Kiertscher SM, 2000, J IMMUNOL, V164, P1269, DOI 10.4049/jimmunol.164.3.1269; LAFERTE S, 1992, BIOCHEM J, V283, P193, DOI 10.1042/bj2830193; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; MIDIRI G, 1985, CANCER, V55, P2624, DOI 10.1002/1097-0142(19850601)55:11<2624::AID-CNCR2820551115>3.0.CO;2-#; Nittka S, 2008, ONCOGENE, V27, P3721, DOI 10.1038/sj.onc.1211033; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Seelentag WKF, 1998, CANCER RES, V58, P5559; SHI ZR, 1983, CANCER RES, V43, P4045; Shively JE, 2004, ONCOGENE, V23, P9303, DOI 10.1038/sj.onc.1208266; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006	33	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22403	22413		10.1074/jbc.M110.215301	http://dx.doi.org/10.1074/jbc.M110.215301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515679	Green Published, hybrid			2022-12-27	WOS:000291719900050
J	Shaughnessy, J; Ram, S; Bhattacharjee, A; Pedrosa, J; Tran, C; Horvath, G; Monks, B; Visintin, A; Jokiranta, TS; Rice, PA				Shaughnessy, Jutamas; Ram, Sanjay; Bhattacharjee, Arnab; Pedrosa, Joana; Tran, Connie; Horvath, Gabor; Monks, Brian; Visintin, Alberto; Jokiranta, T. Sakari; Rice, Peter A.			Molecular Characterization of the Interaction between Sialylated Neisseria gonorrhoeae and Factor H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; NORMAL HUMAN-SERA; BINDING-SITE; SIALIC-ACID; AMPLIFICATION CONVERTASE; 3-DIMENSIONAL STRUCTURE; BACTERICIDAL ACTIVITY; ENDOTHELIAL-CELLS; PROTEIN BETA-1H	Human factor H (HufH), a key inhibitor of the alternative pathway of complement, binds to Neisseria gonorrhoeae and constitutes an important mechanism of human-specific complement evasion. The C-terminal domain 20 of HufH contains the binding site for sialylated gonococci. We exploited differences in amino acid sequences between human and non-binding chimpanzee fH domain 20 to create cross-species mutations to define amino acids important for binding to sialylated gonococci. We used fH/Fc fusion constructs that contained contiguous fH domains 18-20 fused to Fc fragments of murine IgG2a. The Fc region was used both as a tag for detection of each fusion molecule on the bacterial surface and as an indicator for complement-dependent killing. Arg-1203 was critical for binding to both porin (Por) B.1A and PorB.1B strains. Modeling of the R1203N human-to-chimpanzee mutation using the crystal structure of HufH19-20 as a template showed a loss of positive charge that protrudes at the C terminus of domain 20. We tested the functional importance of Arg-1203 by incubating sialylated gonococci with normal human serum, in the presence of wildtype HufH18-20/Fc or its R1203A mutant. Gonococci bound and were killed by wild-type HufH18-20/Fc but not by the R1203A mutant. A recombinant fH/Fc molecule that contained chimpanzee domain 20, humanized only at amino acid 1203 (N1203R) also bound to sialylated gonococci and restored killing. These findings provide further insights into the species specificity of gonococcal infections and proof-of-concept of a novel therapeutic approach against gonorrhea, a disease rapidly becoming resistant to conventional antibiotics.	[Shaughnessy, Jutamas; Ram, Sanjay; Pedrosa, Joana; Tran, Connie; Horvath, Gabor; Monks, Brian; Rice, Peter A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Bhattacharjee, Arnab; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Visintin, Alberto] Pfizer Inc, Ctr Therapeut Innovat, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Helsinki; Pfizer	Shaughnessy, J (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Lazare Res Bldg,Rm 370T,364 Plantat St, Worcester, MA 01605 USA.	jutamas.shaughnessy@umassmed.edu	Jokiranta, T. Sakari/F-1906-2011; Monks, Brian/B-8362-2015; Horvath, Gabor L/J-3917-2014	Monks, Brian/0000-0003-4008-3093; Horvath, Gabor L/0000-0003-0309-595X; Bhattacharjee, Arnab/0000-0002-9613-7911; Shaughnessy, Jutamas/0000-0003-0832-9954	National Institutes of Health [AI32725, AI054544, AI084048, AI069084]; Academy of Finland [201506, 202529]; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032725, R37AI032725, R01AI054544, U19AI084048, R56AI032725, R21AI069084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI32725, AI054544, AI084048, and AI069084. This work was also supported by the Academy of Finland (Projects 201506 and 202529) and The Sigrid Juselius Foundation.	Agarwal S, 2010, J IMMUNOL, V185, P4344, DOI 10.4049/jimmunol.0904191; APICELLA MA, 1990, J INFECT DIS, V162, P506, DOI 10.1093/infdis/162.2.506; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Bhattacharjee A, 2008, MOL IMMUNOL, V45, P4125, DOI 10.1016/j.molimm.2008.08.090; BLAKE MS, 1986, BACTERIAL OUTER MEMB, P377; BRUNHAM RC, 1985, J INFECT DIS, V152, P339, DOI 10.1093/infdis/152.2.339; CANNON JG, 1983, INFECT IMMUN, V40, P816, DOI 10.1128/IAI.40.2.816-819.1983; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FEARON DT, 1977, P NATL ACAD SCI USA, V74, P1683, DOI 10.1073/pnas.74.4.1683; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jokiranta TS, 1996, FEBS LETT, V393, P297; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; Madico G, 2007, J IMMUNOL, V178, P4489, DOI 10.4049/jimmunol.178.7.4489; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MCQUILLEN DP, 1994, METHOD ENZYMOL, V236, P137; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; NAIRN CA, 1988, J GEN MICROBIOL, V134, P3295; Ngampasutadol J, 2008, J IMMUNOL, V180, P3426, DOI 10.4049/jimmunol.180.5.3426; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; OBRIEN JP, 1983, MEDICINE, V62, P395, DOI 10.1097/00005792-198311000-00005; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; PRICE RJ, 1979, FERTIL STERIL, V32, P61; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ray TD, 2011, J IMMUNOL, V186, P4881, DOI 10.4049/jimmunol.1003623; RICE PA, 1980, J IMMUNOL, V124, P2105; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; SCHOOLNIK GK, 1979, J IMMUNOL, V122, P1771; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Swanson J, 1997, J BACTERIOL, V179, P3541, DOI 10.1128/jb.179.11.3541-3548.1997; Tapsall John W, 2009, Expert Rev Anti Infect Ther, V7, P821, DOI 10.1586/eri.09.63; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; WARD ME, 1970, NATURE, V227, P382, DOI 10.1038/227382a0; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Yamasaki R, 2005, J BIOCHEM, V137, P487, DOI 10.1093/jb/mvi061	53	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22235	22242		10.1074/jbc.M111.225516	http://dx.doi.org/10.1074/jbc.M111.225516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531728	Green Published, hybrid			2022-12-27	WOS:000291719900031
J	Yamamoto, R; Akazawa, H; Fujihara, H; Ozasa, Y; Yasuda, N; Ito, K; Kudo, Y; Qin, YJ; Ueta, Y; Komuro, I				Yamamoto, Rie; Akazawa, Hiroshi; Fujihara, Hiroaki; Ozasa, Yukako; Yasuda, Noritaka; Ito, Kaoru; Kudo, Yoko; Qin, Yingjie; Ueta, Yoichi; Komuro, Issei			Angiotensin II Type 1 Receptor Signaling Regulates Feeding Behavior through Anorexigenic Corticotropin-releasing Hormone in Hypothalamus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED ENERGY-EXPENDITURE; INDUCED WEIGHT-GAIN; MICE LACKING; RAT HYPOTHALAMUS; DEFICIENT MICE; 1A RECEPTOR; FOOD-INTAKE; EXPRESSION; LEPTIN; OBESITY	The activation of renin-angiotensin system contributes to the development of metabolic syndrome and diabetes as well as hypertension. However, it remains undetermined how renin-angiotensin system is implicated in feeding behavior. Here, we show that angiotensin II type 1 (AT(1)) receptor signaling regulates the hypothalamic neurocircuit that is involved in the control of food intake. Compared with wild-type Agtr1a(+/+) mice, AT(1) receptor knock-out (Agtr1a(-/-)) mice were hyperphagic and obese with increased adiposity on an ad libitum diet, whereas Agtr1a(-/-) mice were lean with decreased adiposity on a pair-fed diet. In the hypothalamus, mRNA levels of anorexigenic neuropeptide corticotropin-releasing hormone (Crh) were lower in Agtr1a(-/-) mice than in Agtr1a(+/+) mice both on an ad libitum and pair-fed diet. Furthermore, intracerebroventricular administration of CRH suppressed food intake both in Agtr1a(+/+) and Agtr1a(-/-) mice. In addition, the Crh gene promoter was significantly transactivated via the cAMP-responsive element by angiotensin II stimulation. These results thus demonstrate that central AT(1) receptor signaling plays a homeostatic role in the regulation of food intake by maintaining gene expression of Crh in hypothalamus and suggest a therapeutic potential of central AT(1) receptor blockade in feeding disorders.	[Akazawa, Hiroshi; Komuro, Issei] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yamamoto, Rie; Ozasa, Yukako; Yasuda, Noritaka; Ito, Kaoru; Kudo, Yoko; Qin, Yingjie] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan; [Fujihara, Hiroaki; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Fukuoka 8078555, Japan	Osaka University; Chiba University; University of Occupational & Environmental Health - Japan	Komuro, I (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	komuro-tky@umin.ac.jp	Ito, Kaoru/AAZ-3440-2021	Akazawa, Hiroshi/0000-0002-3574-9607	Japan Society for the Promotion of Science [KAKENHI 20390218, 21229010]; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Association for the Advancement of Medical Equipment; Grants-in-Aid for Scientific Research [23790280, 23390213] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Association for the Advancement of Medical Equipment; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Japan Society for the Promotion of Science (KAKENHI 20390218 and 21229010); Health and Labor Sciences Research Grants (to I.K. and H.A.) and grants from Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders, The Uehara Memorial Foundation, The Ichiro Kanehara Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Suzuken Memorial Foundation (to H.A.); and a Research Fellowship from the Japan Association for the Advancement of Medical Equipment (to R.Y.).	Bailer UF, 2003, CNS NEUROL DISORD-DR, V2, P53, DOI 10.2174/1568007033338689; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; de Gasparo M, 2000, PHARMACOL REV, V52, P415; GASC JM, 1994, HYPERTENSION, V24, P531, DOI 10.1161/01.HYP.24.5.531; Hashimoto H, 2007, CLIN CANCER RES, V13, P292, DOI 10.1158/1078-0432.CCR-06-1487; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jacobson L, 1999, ENDOCRINOLOGY, V140, P310, DOI 10.1210/en.140.1.310; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Lenkei Z, 1997, FRONT NEUROENDOCRIN, V18, P383, DOI 10.1006/frne.1997.0155; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sharma AM, 2008, NAT CLIN PRACT CARD, V5, pS3, DOI 10.1038/ncpcardio0854; Sommer WH, 2008, J MOL MED, V86, P723, DOI 10.1007/s00109-008-0333-3; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; Uehara Y, 1998, DIABETES, V47, P890, DOI 10.2337/diabetes.47.6.890; Yamamori E, 2004, J MOL ENDOCRINOL, V33, P639, DOI 10.1677/jme.1.01415; Yamamori E, 2007, MOL CELL ENDOCRINOL, V264, P142, DOI 10.1016/j.mce.2006.11.001; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	32	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21458	21465		10.1074/jbc.M110.192260	http://dx.doi.org/10.1074/jbc.M110.192260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525005	Green Published, hybrid			2022-12-27	WOS:000291464700044
J	Yang, FL; Yang, YL; Liao, PC; Chou, JC; Tsai, KC; Yang, AS; Sheu, F; Lin, TL; Hsieh, PF; Wang, JT; Hua, KF; Wu, SH				Yang, Feng-Ling; Yang, Yu-Liang; Liao, Pei-Chun; Chou, Ju-Ching; Tsai, Keng-Chang; Yang, An-Suei; Sheu, Fuu; Lin, Tzu-Lung; Hsieh, Pei-Fang; Wang, Jin-Town; Hua, Kuo-Feng; Wu, Shih-Hsiung			Structure and Immunological Characterization of the Capsular Polysaccharide of a Pyrogenic Liver Abscess Caused by Klebsiella pneumoniae ACTIVATION OF MACROPHAGES THROUGH TOLL-LIKE RECEPTOR 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE STRAINS; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; NADPH PHAGOCYTE OXIDASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; SIGNALING PATHWAYS; LIPOPOLYSACCHARIDE RECOGNITION; EXPERIMENTAL SALMONELLOSIS	The active components of a primary pyrogenic liver abscess (PLA) Klebsiella pneumoniae in stimulating cytokine expression in macrophages are still unclear. The capsular polysaccharide (CPS) of PLA K. pneumoniae is important in determining clinical manifestations, and we have shown that it consists of repeating units of the trisaccharide (-> 3)-beta-D-Glc-(1 -> 4)-[2,3-(S)-pyruvate]-beta-D-GlcA-(1 -> 4)-alpha-L-Fuc-(1 ->) and has the unusual feature of extensive pyruvation of glucuronic acid and acetylation of C-2-OH or C-3-OH of fucose. We demonstrated that PLAK. pneumoniae CPS induces secretion of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by macrophages through Toll-like receptor 4 (TLR4) and that this effect was lost when pyruvation and O-acetylation were chemically destroyed. Furthermore, expression of TNF-alpha and IL-6 in PLA K. pneumoniae CPS-stimulated macrophages was shown to be regulated by the TLR4/ROS/PKC-delta/NF-kappa B, TLR4/PI3-kinase/AKT/NF-kappa B, and TLR4/MAPK signaling pathways.	[Yang, Feng-Ling; Yang, Yu-Liang; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Liao, Pei-Chun; Chou, Ju-Ching; Hua, Kuo-Feng] Natl Ilan Univ, Inst Biotechnol, Ilan 260, Taiwan; [Tsai, Keng-Chang; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 106, Taiwan; [Lin, Tzu-Lung; Hsieh, Pei-Fang; Wang, Jin-Town] Natl Taiwan Univ, Dept Microbiol, Taipei 100, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Ilan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hua, KF (corresponding author), 1,Sect 1,Shen Lung Rd, Ilan 260, Taiwan.	kfhua@niu.edu.tw; shwu@gate.sinica.edu.tw		Yang, An-Suei/0000-0002-4699-873X; Tsai, Keng-Chang/0000-0001-8277-9174; Sheu, Fuu/0000-0001-9794-3483	National Science Council of Taiwan [NSC 92-2321-B-001-019, 94-2311-B-001-045, 98-2320-B-197-003-MY2, 098-2811-B-197-001, NRPGM 96IDP003-2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan Grants NSC 92-2321-B-001-019, 94-2311-B-001-045, 98-2320-B-197-003-MY2, 098-2811-B-197-001, and NRPGM 96IDP003-2.	Anthon GE, 2003, J SCI FOOD AGR, V83, P1210, DOI 10.1002/jsfa.1525; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; CHENG D-L, 1991, Archives of Internal Medicine, V151, P1557, DOI 10.1001/archinte.151.8.1557; Choy YM, 1996, LIFE SCI, V58, pPL153, DOI 10.1016/0024-3205(95)02361-5; Chuang HC, 2009, J MICROBIOL IMMUNOL, V42, P385; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; CRYZ SJ, 1986, INFECT IMMUN, V54, P403, DOI 10.1128/IAI.54.2.403-407.1986; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; HESTRIN H, 1949, J BIOL CHEM, V180, P249; Ho CY, 2000, IMMUNOPHARMACOLOGY, V46, P1, DOI 10.1016/S0162-3109(99)00124-1; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lee CH, 2005, SCAND J INFECT DIS, V37, P905, DOI 10.1080/00365540500333624; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lin MH, 2009, MOL CELL PROTEOMICS, V8, P2613, DOI 10.1074/mcp.M900276-MCP200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; NOWAK TP, 1975, BIOCHIM BIOPHYS ACTA, V393, P115, DOI 10.1016/0005-2795(75)90221-4; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PREHM P, 1980, CARBOHYD RES, V78, P372, DOI 10.1016/0008-6215(80)90018-X; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; RAY AK, 1987, CARBOHYD RES, V165, P77, DOI 10.1016/0008-6215(87)80079-4; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thomsen RW, 2007, CLIN INFECT DIS, V44, P1194, DOI 10.1086/513201; TOMAS JM, 1991, INFECT IMMUN, V59, P2006; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verhoef R, 2002, CARBOHYD RES, V337, P1821, DOI 10.1016/S0008-6215(02)00280-X; WAEGHE TJ, 1983, CARBOHYD RES, V123, P281, DOI 10.1016/0008-6215(83)88484-5; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Williams P., 1990, Reviews in Medical Microbiology, V1, P196; Wu JH, 2006, CELL MICROBIOL, V8, P1467, DOI 10.1111/j.1462-5822.2006.00725.x; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176; Yang FL, 2004, EUR J BIOCHEM, V271, P4545, DOI 10.1111/j.1432-1033.2004.04415.x; Yeh KM, 2006, J INFECT DIS, V194, P403, DOI 10.1086/505153; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	71	42	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21041	21051		10.1074/jbc.M111.222091	http://dx.doi.org/10.1074/jbc.M111.222091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21478151	Green Published, hybrid			2022-12-27	WOS:000291464700003
J	Nakamura, K; Nemani, VM; Azarbal, F; Skibinski, G; Levy, JM; Egami, K; Munishkina, L; Zhang, J; Gardner, B; Wakabayashi, J; Sesaki, H; Cheng, YF; Finkbeiner, S; Nussbaum, RL; Masliah, E; Edwards, RH				Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Skibinski, Gaia; Levy, Jon M.; Egami, Kiyoshi; Munishkina, Larissa; Zhang, Jue; Gardner, Brooke; Wakabayashi, Junko; Sesaki, Hiromi; Cheng, Yifan; Finkbeiner, Steven; Nussbaum, Robert L.; Masliah, Eliezer; Edwards, Robert H.			Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN FRAGMENT; TRANSGENIC MICE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; GAMMA-SYNUCLEIN; KNOCKOUT MICE; LEWY BODIES; AGGREGATION; MUTATION; DYSFUNCTION	The protein alpha-synuclein has a central role in Parkinson disease, but the mechanism by which it contributes to neural degeneration remains unknown. We now show that the expression of alpha-synuclein in mammalian cells, including neurons in vitro and in vivo, causes the fragmentation of mitochondria. The effect is specific for synuclein, with more fragmentation by alpha- than beta- or gamma-isoforms, and it is not accompanied by changes in the morphology of other organelles or in mitochondrial membrane potential. However, mitochondrial fragmentation is eventually followed by a decline in respiration and neuronal death. The fragmentation does not require the mitochondrial fission protein Drp1 and involves a direct interaction of synuclein with mitochondrial membranes. In vitro, synuclein fragments artificial membranes containing the mitochondrial lipid cardiolipin, and this effect is specific for the small oligomeric forms of synuclein. alpha-Synuclein thus exerts a primary and direct effect on the morphology of an organelle long implicated in the pathogenesis of Parkinson disease.	[Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Biomed Sci, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Cell Biol, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Biomed Sci, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Cell Biol, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Skibinski, Gaia; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Skibinski, Gaia; Finkbeiner, Steven] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Skibinski, Gaia; Finkbeiner, Steven] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Egami, Kiyoshi; Cheng, Yifan] Univ Calif San Francisco, Grad Program Biophys, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Munishkina, Larissa] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; [Wakabayashi, Junko; Sesaki, Hiromi] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Dept Med, Div Med Genet, San Francisco, CA 94143 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Diego	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, 600 16th St,Genentech Hall N272B, San Francisco, CA 94158 USA.	robert.edwards@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369; Nakamura, Ken/0000-0002-9192-182X; Nemani, Venu/0000-0001-8895-7090	National Institutes of Health [GM089853]; NINDS [2R01NS39074, 1KO8NS062954-01A1, NS057096]; NIA [P01AG022074, AG18440, AG022074]; NIDA [DA10154]; Hillblom Foundation; Alzheimer's Disease Research Center; Burroughs-Wellcome Medical Scientist Fund Carrer Award; University of California San Francisco; Taube-Koret Center; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS062715, P30NS057096, K08NS062954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG022074, R01AG018440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Hillblom Foundation; Alzheimer's Disease Research Center; Burroughs-Wellcome Medical Scientist Fund Carrer Award(Burroughs Wellcome Fund); University of California San Francisco(University of California System); Taube-Koret Center; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Grant GM089853 from the National Institutes of Health (to H. S.), Grant 2R01NS39074 from NINDS and Grants 1KO8NS062954-01A1 (to K. N.), and NS057096 from NINDS (to E. M.), Grants P01AG022074, AG18440, and AG022074 from NIA, and Grant DA10154 from NIDA. This work was also supported by a postdoctoral fellowship from the Hillblom Foundation, an Alzheimer's Disease Research Center pilot grant, and a Burroughs-Wellcome Medical Scientist Fund Career Award (to K. N.), the University of California San Francisco Medical Scientist Training Program and a predoctoral fellowship from the Hillblom Foundation (to V. M. N.), postdoctoral fellowships from the Hillblom Foundation (to G. S.) and the Taube-Koret Center (to S. F.), and a Brain Disorders Award from the McKnight Foundation (to R. H. E.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; HOVIUS R, 1993, FEBS LETT, V330, P71, DOI 10.1016/0014-5793(93)80922-H; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kruger R, 2001, NEUROLOGY, V56, P1355, DOI 10.1212/WNL.56.10.1355; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Liu JH, 2003, MOL CANCER RES, V1, P892; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Ward MW, 2000, J NEUROSCI, V20, P7208; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	102	414	418	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20710	20726		10.1074/jbc.M110.213538	http://dx.doi.org/10.1074/jbc.M110.213538			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489994	Green Published, hybrid			2022-12-27	WOS:000291267600057
J	Pan, Y; Fiscus, V; Meng, WY; Zheng, ZD; Zhang, LH; Fuqua, C; Chen, LL				Pan, Yi; Fiscus, Valena; Meng, Wuyi; Zheng, Zhida; Zhang, Lian-Hui; Fuqua, Clay; Chen, Lingling			The Agrobacterium tumefaciens Transcription Factor BlcR Is Regulated via Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACETATE OPERON; STREPTOMYCES-GRISEUS; VIBRIO-CHOLERAE; ICLR REPRESSOR; DNA; GLYOXYLATE; GENE; PROTEIN	The Agrobacterium tumefaciens BlcR is a member of the emerging isocitrate lyase transcription regulators that negatively regulates metabolism of gamma-butyrolactone, and its repressing function is relieved by succinate semialdehyde (SSA). Our crystal structure showed that BlcR folded into the DNA-and SSA-binding domains and dimerized via the DNA-binding domains. Mutational analysis identified residues, including Phe(147), that are important for SSA association; BlcR(F147A) existed as tetramer. Two BlcR dimers bound to target DNA and in a cooperative manner, and the distance between the two BlcR-binding sequences in DNA was critical for BlcR-DNA association. Tetrameric BlcR(F147A) retained DNA binding activity, and importantly, this activity was not affected by the distance separating the BlcR-binding sequences in DNA. SSA did not dissociate tetrameric BlcR(F147A) or BlcR(F147A)-DNA. As well as in the SSA-binding site, Phe(147) is located in a structurally flexible loop that may be involved in BlcR oligomerization. We propose that SSA regulates BlcR DNA-binding function via oligomerization.	[Pan, Yi; Zheng, Zhida; Chen, Lingling] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; [Fiscus, Valena; Fuqua, Clay; Chen, Lingling] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Meng, Wuyi] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Chen, Lingling] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Zhang, Lian-Hui] Inst Mol & Cell Biol, Singapore 138673, Singapore	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chen, LL (corresponding author), Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Science Foundation [MCB-0416447]; National Institutes of Health [R01-GM80546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080546] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Science Foundation Grant MCB-0416447 (to L. C.) and by National Institutes of Health Grant R01-GM80546 (to C. F.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brune I, 2007, J BACTERIOL, V189, P2720, DOI 10.1128/JB.01876-06; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Chai YR, 2007, J BACTERIOL, V189, P3674, DOI 10.1128/JB.01274-06; Donald LJ, 1996, PROTEIN SCI, V5, P1613, DOI 10.1002/pro.5560050815; Donald LJ, 2001, PROTEIN SCI, V10, P1370, DOI 10.1110/ps.780101; GALINIER A, 1990, NUCLEIC ACIDS RES, V18, P3656, DOI 10.1093/nar/18.12.3656; Guazzaroni ME, 2007, J MOL BIOL, V369, P927, DOI 10.1016/j.jmb.2007.04.022; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Jiang H, 2000, J BACTERIOL, V182, P5521, DOI 10.1128/JB.182.19.5521-5529.2000; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; NEGRE D, 1992, J MOL BIOL, V228, P23, DOI 10.1016/0022-2836(92)90488-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Pan B, 1996, J BACTERIOL, V178, P3982, DOI 10.1128/jb.178.13.3982-3984.1996; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; ROMEROSTEINER S, 1994, J BACTERIOL, V176, P5771, DOI 10.1128/JB.176.18.5771-5779.1994; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; Traag BA, 2004, MOL MICROBIOL, V53, P985, DOI 10.1111/j.1365-2958.2004.04186.x; Tsoi TV, 1999, APPL ENVIRON MICROB, V65, P2151; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	40	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20431	20440		10.1074/jbc.M110.196154	http://dx.doi.org/10.1074/jbc.M110.196154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467043	Green Published, hybrid			2022-12-27	WOS:000291267600031
J	Leupin, O; Piters, E; Halleux, C; Hu, S; Kramer, I; Morvan, F; Bouwmeester, T; Schirle, M; Bueno-Lozano, M; Fuentes, FJR; Itin, PH; Boudin, E; de Freitas, F; Jennes, K; Brannetti, B; Charara, N; Ebersbach, H; Geisse, S; Lu, CX; Bauer, A; Van Hul, W; Kneissel, M				Leupin, Olivier; Piters, Elke; Halleux, Christine; Hu, Shouih; Kramer, Ina; Morvan, Frederic; Bouwmeester, Tewis; Schirle, Markus; Bueno-Lozano, Manuel; Fuentes, Feliciano J. Ramos; Itin, Peter H.; Boudin, Eveline; de Freitas, Fenna; Jennes, Karen; Brannetti, Barbara; Charara, Nadine; Ebersbach, Hilmar; Geisse, Sabine; Lu, Chris X.; Bauer, Andreas; Van Hul, Wim; Kneissel, Michaela			Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAN-BUCHEM-DISEASE; RECEPTOR-RELATED PROTEIN-5; LIMB DEVELOPMENT; MINERAL DENSITY; BMP ANTAGONIST; SOST GENE; DELETION; CELLS; AGRIN; IDENTIFICATION	Humans lacking sclerostin display progressive bone over-growth due to increased bone formation. Although it is well established that sclerostin is an osteocyte-secreted bone formation inhibitor, the underlying molecular mechanisms are not fully elucidated. We identified in tandem affinity purification proteomics screens LRP4 (low density lipoprotein-related protein 4) as a sclerostin interaction partner. Biochemical assays with recombinant proteins confirmed that sclerostin LRP4 interaction is direct. Interestingly, in vitro overexpression and RNAi-mediated knockdown experiments revealed that LRP4 specifically facilitates the previously described inhibitory action of sclerostin on Wnt1/beta-catenin signaling. We found the extracellular beta-propeller structured domain of LRP4 to be required for this sclerostin facilitator activity. Immunohistochemistry demonstrated that LRP4 protein is present in human and rodent osteoblasts and osteocytes, both presumed target cells of sclerostin action. Silencing of LRP4 by lentivirus-mediated shRNA delivery blocked sclerostin inhibitory action on in vitro bone mineralization. Notably, we identified two mutations in LRP4 (R1170W and W1186S) in patients suffering from bone overgrowth. We found that these mutations impair LRP4 interaction with sclerostin and its concomitant sclerostin facilitator effect. Together these data indicate that the interaction of sclerostin with LRP4 is required to mediate the inhibitory function of sclerostin on bone formation, thus identifying a novel role for LRP4 in bone.	[Leupin, Olivier; Halleux, Christine; Hu, Shouih; Kramer, Ina; Morvan, Frederic; Kneissel, Michaela] Novartis Pharma AG, Musculoskeletal Dis Area, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Piters, Elke; Boudin, Eveline; de Freitas, Fenna; Jennes, Karen; Van Hul, Wim] Univ Antwerp, Dept Mol Genet, Antwerp, Belgium; [Bouwmeester, Tewis; Bauer, Andreas] Cellzome AG, D-69117 Heidelberg, Germany; [Schirle, Markus] Global Discovery Chem, Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Bueno-Lozano, Manuel; Fuentes, Feliciano J. Ramos] Univ Zaragoza, Hosp Clin Univ, Fac Med, Dept Pediat, Zaragoza 50009, Spain; [Itin, Peter H.] Univ Basel Hosp, Dept Dermatol, Kantonsspital Aarau, CH-4031 Basel, Switzerland; [Brannetti, Barbara] Novartis Pharma AG, Novartis Biol, Prot Sci & Design, CH-4002 Basel, Switzerland; [Charara, Nadine; Ebersbach, Hilmar; Geisse, Sabine] Novartis Pharma AG, Novartis Biol Ctr, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Lu, Chris X.] BioMed Res Co Ltd, China Novartis Inst, Shanghai 201203, Peoples R China	Novartis; University of Antwerp; GlaxoSmithKline; Cellzome GmbH; Novartis; Universidad de la Laguna; University of Zaragoza; Kantonsspital Aarau AG (KSA); University of Basel; Novartis; Novartis	Leupin, O (corresponding author), Novartis Pharma AG, Musculoskeletal Dis Area, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.	olivier.leupin@novartis.com	BOUDIN, EVELINE/O-3966-2019	BOUDIN, EVELINE/0000-0003-4818-6804; Van Hul, Wim/0000-0002-5065-7858; , Barbara/0000-0001-9436-0362	European Commission [HEALTH-F2-2008-201099]; Fonds voor Wetenschappelijk Onderzoek [G.0117.06]; University of Antwerp; Agency for Innovation by Science and Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds voor Wetenschappelijk Onderzoek(FWO); University of Antwerp; Agency for Innovation by Science and Technology	This work was supported by the European Commission (HEALTH-F2-2008-201099, TALOS) and by "Fonds voor Wetenschappelijk Onderzoek" Grant G.0117.06 and by a grant from the Special Research Funds (Bijzonder Onderzoeksfonds TOP and Nieuwe Onderzoeksinitiatieven) of the University of Antwerp (all to W. V. H.). O. ., C. H., S. H., I. K., F. M., T. B., M. S., B. B., N. C., H. E., S. G., C. X. L., A. B., and M. K. are employees of Novartis.; Holder of a Ph.D. grant from the Agency for Innovation by Science and Technology.	Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; BUENO M, 1994, J MED GENET, V31, P976, DOI 10.1136/jmg.31.12.976; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cho MS, 2002, J BIOMED SCI, V9, P631, DOI 10.1159/000067294; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Duchesne A, 2006, GENOMICS, V88, P610, DOI 10.1016/j.ygeno.2006.05.007; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hausser HJ, 2007, HISTOCHEM CELL BIOL, V127, P363, DOI 10.1007/s00418-006-0258-2; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Itin PH, 2001, DERMATOLOGY, V202, P259, DOI 10.1159/000051649; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Kawashima N, 2005, J BONE MINER METAB, V23, P123, DOI 10.1007/s00774-004-0550-y; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	56	205	215	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19489	19500		10.1074/jbc.M110.190330	http://dx.doi.org/10.1074/jbc.M110.190330			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471202	Green Published, hybrid			2022-12-27	WOS:000291027700032
J	Lin, JS; Wilson, MA				Lin, Jiusheng; Wilson, Mark A.			Escherichia coli Thioredoxin-like Protein YbbN Contains an Atypical Tetratricopeptide Repeat Motif and Is a Negative Regulator of GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CHAPERONE; RESOLUTION; COMPLEXES; RESIDUES; TOOL	Many proteins contain a thioredoxin (Trx)-like domain fused with one or more partner domains that diversify protein function by the modular construction of new molecules. The Escherichia coli protein YbbN is a Trx-like protein that contains a C-terminal domain with low homology to tetratricopeptide repeat motifs. YbbN has been proposed to act as a chaperone or co-chaperone that aids in heat stress response and DNA synthesis. We report the crystal structure of YbbN, which is an elongated molecule with a mobile Trx domain and four atypical tetratricopeptide repeat motifs. The Trx domain lacks a canonical CXXC active site architecture and is not a functional oxidoreductase. A variety of proteins in E. coli interact with YbbN, including multiple ribosomal protein subunits and a strong interaction with GroEL. YbbN acts as a mild inhibitor of GroESL chaperonin function and ATPase activity, suggesting that it is a negative regulator of the GroESL system. Combined with previous observations that YbbN enhances the DnaK-DnaJ-GrpE chaperone system, we propose that YbbN coordinately regulates the activities of these two prokaryotic chaperones, thereby helping to direct client protein traffic initially to DnaK. Therefore, YbbN may play a role in integrating the activities of different chaperone pathways in E. coli and related bacteria.	[Wilson, Mark A.] Univ Nebraska, Beadle Ctr N118, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wilson, MA (corresponding author), Univ Nebraska, Beadle Ctr N118, Dept Biochem, Lincoln, NE 68588 USA.	mwilson13@unl.edu			National Institutes of Health [R01GM092999-01]; National Institutes of Health (NCI) [Y1-CO-1020]; NIGMS [Y1-GM-1104]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM092999-01 (to M. A. W.).; We thank Dr. Ronald Cerny and the Nebraska Mass Spectrometry Core Facility for mass spectrometry protein identification, Dr. Nandakumar Madayiputhiya and the Redox Biology Center Mass Spectrometry Core facility for assistance with lysine modification studies, Dr. James Bardwell (University of Michigan) for discussion of YbbN chaperone assays, and Drs. Todd Holyoak and Mark Fisher (University of Kansas Medical Center) for discussion of GroESL chaperone activity. GM/CA-CAT has been funded in whole or in part with federal funds from the National Institutes of Health (NCI, Y1-CO-1020; NIGMS, Y1-GM-1104). Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Caldas T, 2006, BIOCHEM BIOPH RES CO, V343, P780, DOI 10.1016/j.bbrc.2006.03.028; Cortajarena AL, 2010, FEBS J, V277, P1058, DOI 10.1111/j.1742-4658.2009.07549.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dekker C, 2011, PROTEINS, V79, P1172, DOI 10.1002/prot.22952; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fomenko DE, 2008, MOL CELLS, V26, P228; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katayama Hiroo, 2009, Journal of Structural and Functional Genomics, V10, P57, DOI 10.1007/s10969-008-9053-8; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kim SG, 2010, BBA-PROTEINS PROTEOM, V1804, P2213, DOI 10.1016/j.bbapap.2010.09.005; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Kthiri F, 2008, BIOCHEM BIOPH RES CO, V374, P668, DOI 10.1016/j.bbrc.2008.07.080; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le HT, 2011, BIOCHEM BIOPH RES CO, V405, P52, DOI 10.1016/j.bbrc.2010.12.122; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19459	19469		10.1074/jbc.M111.238741	http://dx.doi.org/10.1074/jbc.M111.238741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498507	Green Published, hybrid			2022-12-27	WOS:000291027700029
J	Ali, YO; McCormack, R; Darr, A; Zhai, RG				Ali, Yousuf O.; McCormack, Ryan; Darr, Andrew; Zhai, R. Grace			Nicotinamide Mononucleotide Adenylyltransferase Is a Stress Response Protein Regulated by the Heat Shock Factor/Hypoxia-inducible Factor 1 alpha Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; LIFE-SPAN; OXIDATIVE STRESS; IN-VIVO; DROSOPHILA-MELANOGASTER; CHAPERONE SUPPRESSION; HYPOXIA REQUIRES; HSP70 GENE; NEURODEGENERATION	Stress responses are cellular processes essential for maintenance of cellular integrity and defense against environmental and intracellular insults. Neurodegenerative conditions are linked with inadequate stress responses. Several stress-responsive genes encoding neuroprotective proteins have been identified, and among them, the heat shock proteins comprise an important group of molecular chaperones that have neuroprotective functions. However, evidence for other critical stress-responsive genes is lacking. Recent studies on the NAD synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT) have uncovered a novel neuronal maintenance and protective function against activity-, injury-, or misfolded protein-induced degeneration in Drosophila and in mammalian neurons. Here, we show that NMNAT is also a novel stress response protein required for thermotolerance and mitigation of oxidative stress-induced shortened lifespan. NMNATis transcriptionally regulated during various stress conditions including heat shock and hypoxia through heat shock factor (HSF) and hypoxia-inducible factor 1 alpha in vivo. HSF binds to nmnat promoter and induces NMNAT expression under heat shock. In contrast, under hypoxia, HIF1 alpha up-regulates NMNAT indirectly through the induction of HSF. Our studies provide an in vivo mechanism for transcriptional regulation of NMNAT under stress and establish an essential role for this neuroprotective factor in cellular stress response.	[Ali, Yousuf O.; McCormack, Ryan; Zhai, R. Grace] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Darr, Andrew] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Darr, Andrew; Zhai, R. Grace] Univ Miami, Miller Sch Med, Grad Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Zhai, RG (corresponding author), 1600 NW 10th Ave,RMSB 6069, Miami, FL 33136 USA.	gzhai@med.miami.edu	Zhai, R. Grace/AGZ-3936-2022	Zhai, Rong/0000-0002-7599-1430	American Heart Association; Miami Project Buoniconti Fund; National Institute for Neurological Disorder and Stroke [R01NS64269]; Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS064269, R01NS064269] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Miami Project Buoniconti Fund; National Institute for Neurological Disorder and Stroke; Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Fellowship (to Y. O. A.), funds from the Miami Project Buoniconti Fund (to A. D.), National Institute for Neurological Disorder and Stroke Grant R01NS64269 (to R. G. Z.), and funds from the Pew Charitable Trust (to R. G. Z.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ali YO, 2010, MOLECULES, V15, P6859, DOI 10.3390/molecules15106859; Appenzeller O, 2006, J NEUROL SCI, V247, P93, DOI 10.1016/j.jns.2006.03.021; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bruder ED, 2007, PHYSIOL GENOMICS, V29, P193, DOI 10.1152/physiolgenomics.00245.2006; Camenisch G, 2001, PFLUG ARCH EUR J PHY, V443, P240, DOI 10.1007/s004240100679; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chan K, 2008, EUKARYOT CELL, V7, P1795, DOI 10.1128/EC.00160-08; CHOMYN A, 1979, DEV GENET, V1, P77, DOI 10.1002/dvg.1020010109; Cramer C T, 1995, J Biochem Toxicol, V10, P293, DOI 10.1002/jbt.2570100603; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Dougherty CJ, 2008, MOL VIS, V14, P471; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kim SY, 2006, GENE EXPR PATTERNS, V6, P504, DOI 10.1016/j.modgep.2005.10.009; Laifenfeld D, 2010, TOXICOL SCI, V113, P254, DOI 10.1093/toxsci/kfp213; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Lee YJ, 1998, J BIOL CHEM, V273, P29857, DOI 10.1074/jbc.273.45.29857; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MORIMOTO RI, 1998, ANNU REV BIOCHEM, V16, P959; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Romero NM, 2008, MOL CELL BIOL, V28, P3410, DOI 10.1128/MCB.01027-07; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; SCHILLER P, 1988, J MOL BIOL, V203, P97, DOI 10.1016/0022-2836(88)90094-0; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x	64	26	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19089	19099		10.1074/jbc.M111.219295	http://dx.doi.org/10.1074/jbc.M111.219295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478149	Green Published, hybrid			2022-12-27	WOS:000290785700078
J	Kang, S; Chemaly, ER; Hajjar, RJ; Lebeche, D				Kang, Soojeong; Chemaly, Elie R.; Hajjar, Roger J.; Lebeche, Djamel			Resistin Promotes Cardiac Hypertrophy via the AMP-activated Protein Kinase/Mammalian Target of Rapamycin (AMPK/mTOR) and c-Jun N-terminal Kinase/Insulin Receptor Substrate 1 (JNK/IRS1) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; INSULIN-RECEPTOR; HEART-FAILURE; DIABETIC CARDIOMYOPATHY; THERAPEUTIC TARGET; MAMMALIAN TARGET; PHOSPHORYLATION; GLUCOSE; OBESITY; MTOR	Resistin has been suggested to be involved in the development of diabetes and insulin resistance. We recently reported that resistin is expressed in diabetic hearts and promotes cardiac hypertrophy; however, the mechanisms underlying this process are currently unknown. Therefore, we wanted to elucidate the mechanisms associated with resistin-induced cardiac hypertrophy and myocardial insulin resistance. Overexpression of resistin using adenoviral vector in neonatal rat ventricular myocytes was associated with inhibition of AMP-activated protein kinase (AMPK) activity, activation of tuberous sclerosis complex 2/mammalian target of rapamycin (mTOR) pathway, and increased cell size, [H-3]leucine incorporation (i.e. protein synthesis) and mRNA expression of the hypertrophic marker genes, atrial natriuretic factor, brain natriuretic peptide, and beta-myosin heavy chain. Activation of AMPK with 5-aminoimidazole-4-carbozamide-1-beta-D-ribifuranoside or inhibition of mTOR with rapamycin or mTOR siRNA attenuated these resistin-induced changes. Furthermore, resistin increased serine phosphorylation of insulin receptor substrate (IRS1) through the activation of the apoptosis signal-regulating kinase 1/c-Jun N-terminal Kinase (JNK) pathway, a module known to stimulate insulin resistance. Inhibition of JNK (with JNK inhibitor SP600125 or using dominant-negative JNK) reduced serine 307 phosphorylation of IRS1. Resistin also stimulated the activation of p70(S6K), a downstream kinase target of mTOR, and increased phosphorylation of the IRS1 serine 636/639 residues, whereas treatment with rapamycin reduced the phosphorylation of these residues. Interestingly, these in vitro signaling pathways were also operative in vivo in ventricular tissues from adult rat hearts overexpressing resistin. These data demonstrate that resistin induces cardiac hypertrophy and myocardial insulin resistance, possibly via the AMPK/mTOR/p70(S6K) and apoptosis signal-regulating kinase 1/JNK/IRS1 pathways.	[Kang, Soojeong; Chemaly, Elie R.; Hajjar, Roger J.; Lebeche, Djamel] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lebeche, D (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	djamel.lebeche@mssm.edu			NHLBI National Institutes of Health; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by an NHLBI National Institutes of Health grant (to D. L. and R. J. H.) and a National Institutes of Health training grant (to E. R. C.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chemaly ER, 2008, CIRCULATION, V118, pS487; Del Monte F, 2002, PHYSIOL GENOMICS, V9, P49, DOI 10.1152/physiolgenomics.00035.2001; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang BW, 2007, AM J PHYSIOL-HEART C, V293, pH2305, DOI 10.1152/ajpheart.00361.2007; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066	43	87	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18465	18473		10.1074/jbc.M110.200022	http://dx.doi.org/10.1074/jbc.M110.200022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478152	Green Published, hybrid			2022-12-27	WOS:000290785700019
J	Nicholls, SB; Chu, J; Abbruzzese, G; Tremblay, KD; Hardy, JA				Nicholls, Samantha B.; Chu, Jun; Abbruzzese, Genevieve; Tremblay, Kimberly D.; Hardy, Jeanne A.			Mechanism of a Genetically Encoded Dark-to-Bright Reporter for Caspase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; APOPTOSIS; ACTIVATION; STAUROSPORINE; CELLS; TIME; IDENTIFICATION; DENATURATION; INHIBITORS; INDUCTION	Fluorescent proteins have revolutionized modern biology with their ability to report the presence of tagged proteins in living systems. Although several fluorescent proteins have been described in which the excitation and emission properties can be modulated by external triggers, no fluorescent proteins have been described that can be activated from a silent dark state to a bright fluorescent state directly by the activity of an enzyme. We have developed a version of GFP in which fluorescence is completely quenched by appendage of a hydrophobic quenching peptide that tetramerizes GFP and prevents maturation of the chromophore. The fluorescence can be fully restored by catalytic removal of the quenching peptide, making it a robust reporter of proteolysis. We have demonstrated the utility of this uniquely dark state of GFP as a genetically encoded apoptosis reporter that monitors the function of caspases, which catalyze the fate-determining step in programmed cell death. Caspase Activatable-GFP (CA-GFP) can be activated both in vitro and in vivo, resulting in up to a 45-fold increase in fluorescent signal in bacteria and a 3-fold increase in mammalian cells. We used CA-GFP successfully to monitor real-time apoptosis in mammalian cells. This dark state of GFP may ultimately serve as a useful platform for probes of other enzymatic processes.	[Nicholls, Samantha B.; Chu, Jun; Abbruzzese, Genevieve; Tremblay, Kimberly D.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Chu, Jun] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 Lederle Grad Res Tower,710 N Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Tremblay, Kimberly/0000-0002-3059-9910; Hardy, Jeanne/0000-0002-3406-7997; Abbruzzese, Genevieve/0000-0002-3194-9353	National Institutes of Health [R01 GM080532]; Center of Excellence in Apoptosis Research; NSF [IGERT DGE-0654128]; MRC [G0701075] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Apoptosis Research; NSF(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM080532 and a grant from the Center of Excellence in Apoptosis Research. The work was also supported by NSF Grant IGERT DGE-0654128 (to S. B. N.).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chu J, 2008, P SOC PHOTO-OPT INS, V6857, pR8570, DOI 10.1117/12.767864; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Clontech, 2009, APOALERT ANN 5 US MA; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Gao Q, 2006, JPN J APPL PHYS 2, V45, pL929, DOI 10.1143/JJAP.45.L929; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Goode DR, 2005, ORG LETT, V7, P3529, DOI 10.1021/ol051287d; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Kawai H, 2005, J PHARMACOL SCI, V97, P361, DOI 10.1254/jphs.FP0040592; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee P, 2002, BIOTECHNIQUES, V33, P1284, DOI 10.2144/02336rr02; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patre M, 2006, J BIOL CHEM, V281, P1296, DOI 10.1074/jbc.M511717200; Ray P, 2008, CLIN CANCER RES, V14, P5801, DOI 10.1158/1078-0432.CCR-07-5244; Reed JC, 2000, CURR OPIN BIOTECH, V11, P586, DOI 10.1016/S0958-1669(00)00148-8; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wood TI, 2005, BIOCHEMISTRY-US, V44, P16211, DOI 10.1021/bi051388j; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	41	44	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24977	24986		10.1074/jbc.M111.221648	http://dx.doi.org/10.1074/jbc.M111.221648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21558267	Green Published, hybrid			2022-12-27	WOS:000292547900046
J	Stroud, MJ; Kammerer, RA; Ballestrem, C				Stroud, Matthew J.; Kammerer, Richard A.; Ballestrem, Christoph			Characterization of G2L3 (GAS2-like 3), a New Microtubule- and Actin-binding Protein Related to Spectraplakins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARREST-SPECIFIC PROTEIN; GROWTH ARREST; CH-DOMAIN; F-ACTIN; CELL-MIGRATION; GAS2; IDENTIFICATION; CALPONIN; TUBULIN; CYTOSKELETON	The microtubule (MT) and actin cytoskeletons are fundamental to cell integrity, because they control a host of cellular activities, including cell division, growth, polarization, and migration. Proteins involved in mediating the cross-talk between MT and actin cytoskeletons are key to many cellular processes and play important physiological roles. We identified a new member of the GAS2 family of MT-actin cross-linking proteins, named G2L3 (GAS2-like 3). We show that GAS2-like 3 is widely conserved throughout evolution and is ubiquitously expressed in human tissues. GAS2-like 3 interacts with filamentous actin and MTs via its single calponin homology type 3 domain and C terminus, respectively. Interestingly, the role of the putative MT-binding GAS2-related domain is to modulate the binding of GAS2-like 3 to both filamentous actin and MTs. This is in contrast to GAS2-related domains found in related proteins, where it functions as a MT-binding domain. Furthermore, we show that tubulin acetylation drives GAS2-like 3 localization to MTs and may provide functional insights into the role of GAS2-like 3.	[Stroud, Matthew J.; Kammerer, Richard A.; Ballestrem, Christoph] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Kammerer, RA (corresponding author), Paul Scherrer Inst, Lab Biomol Res, OFLC 106, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch; christoph.ballestrem@manchester.ac.uk		Ballestrem, Christoph/0000-0002-5375-7985; Stroud, Matthew John/0000-0002-3337-6851; Kammerer, Richard/0000-0003-4570-5197; Stroud, Matthew/0000-0003-0451-3367	Wellcome Trust [080878/Z/06/Z]; Biotechnology and Biological Sciences Research Council [BB/G004552/1]; BBSRC [BB/G004552/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Ph.D. studentship (to M. J. S.), a Wellcome Trust Senior Research Fellowship ((080878/Z/06/Z), to R. A. K.), and Biotechnology and Biological Sciences Research Council Grant BB/G004552/1 (to C. B.).	Applewhite DA, 2010, MOL BIOL CELL, V21, P1714, DOI 10.1091/mbc.E10-01-0011; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; BRANCOLINI C, 1994, J CELL BIOL, V124, P743, DOI 10.1083/jcb.124.5.743; Carisey A., 2011, METHODS MOL IN PRESS; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Galkin VE, 2006, J MOL BIOL, V359, P478, DOI 10.1016/j.jmb.2006.03.044; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; LEDIZET M, 1991, METHOD ENZYMOL, V196, P264; Lee KKH, 1999, DEV BIOL, V207, P14; Lee S, 2002, DEVELOPMENT, V129, P1195; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Pines MK, 2010, DEVELOPMENT, V137, P913, DOI 10.1242/dev.043224; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun DM, 2001, J CELL SCI, V114, P161; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wohnsland F, 2000, J BIOL CHEM, V275, P20873, DOI 10.1074/jbc.M910298199; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zucman-Rossi J, 1996, GENOMICS, V38, P247, DOI 10.1006/geno.1996.0625	43	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24987	24995		10.1074/jbc.M111.242263	http://dx.doi.org/10.1074/jbc.M111.242263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561867	Green Published, hybrid			2022-12-27	WOS:000292547900047
J	Lenasi, T; Peterlin, BM; Barboric, M				Lenasi, Tina; Peterlin, B. Matija; Barboric, Matjaz			Cap-binding Protein Complex Links Pre-mRNA Capping to Transcription Elongation and Alternative Splicing through Positive Transcription Elongation Factor b (P-TEFb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; FISSION YEAST; COUPLES TRANSCRIPTION; TERMINAL DOMAIN; KINASE; RECRUITMENT; GENES; TFIIH; PHOSPHORYLATION; MECHANISMS	Promoter-proximal pausing of RNAPII coincides with the formation of the cap structure at the 5' end of pre-mRNA, which is bound by the cap-binding protein complex (CBC). Although the positive transcription elongation factor b (P-TEFb) stimulates the release of RNAPII from pausing and promotes transcription elongation and alternative splicing by phosphorylating the RNAPII C-terminal domain at Ser2 (S2-P RNAPII), it is unknown whether CBC facilitates these events. In this study, we report that CBC interacts with P-TEFb and transcriptionally engaged RNAPII and is globally required for optimal levels of S2-P RNAPII. Quantitative nascent RNA immunoprecipitation and ChIP experiments reveal that depletion of CBC attenuates HIV-1 Tat transactivation and impedes transcription elongation of investigated CBC-dependent endogenous genes by decreasing the levels of P-TEFb and S2-P RNAPII, leading to accumulation of RNAPII in the body of these genes. Finally, CBC is essential for the promotion of alternative splicing through facilitating P-TEFb, S2-P RNAPII, and splicing factor 2/alternative splicing factor occupancy at a splicing minigene. These findings disclose a vital role of CBC in connecting pre-mRNA capping to transcription elongation and alternative splicing via P-TEFb.	[Lenasi, Tina; Barboric, Matjaz] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland	University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki	Lenasi, T (corresponding author), Univ Helsinki, Biomedicum Helsinki 1, Haartmaninkatu 8,Rm B333b, FIN-00290 Helsinki, Finland.	tlenasi@yahoo.com	Barboric, Matjaz/C-9918-2009; Lenasi, Tina/A-5990-2010	Barboric, Matjaz/0000-0002-9715-2291; Lenasi, Tina/0000-0001-9091-3978	National Institutes of Health [AI058708, GM082250]; Academy of Finland [1127313, 137077, 140996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P01AI058708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058708 and GM082250 (to B. M. P.). This work was also supported by Academy of Finland FiDiPro programme Grant 1127313 (to Kalle Saksela and B. M. P.) and Academy of Finland Grants 137077 and 140996 (to M. B.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Colot HV, 1996, GENE DEV, V10, P1699, DOI 10.1101/gad.10.13.1699; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fortes P, 1999, MOL CELL BIOL, V19, P6543; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gornemann J., 2005, MOL CELL, V19, P53; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Nechaev S., 2010, BIOCHIM BIOPHYS ACTA, V1809, P43; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008	42	53	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22758	22768		10.1074/jbc.M111.235077	http://dx.doi.org/10.1074/jbc.M111.235077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536667	Green Published, hybrid			2022-12-27	WOS:000292025000010
J	Sheets, JJ; Hey, TD; Fencil, KJ; Burton, SL; Ni, WT; Lang, AE; Benz, R; Aktories, K				Sheets, Joel J.; Hey, Tim D.; Fencil, Kristin J.; Burton, Stephanie L.; Ni, Weiting; Lang, Alexander E.; Benz, Roland; Aktories, Klaus			Insecticidal Toxin Complex Proteins from Xenorhabdus nematophilus STRUCTURE AND PORE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORHABDUS-LUMINESCENS; BACTERIA; GENES; PATHOGENICITY; SPP.	Toxin complexes from Xenorhabdus and Photorhabdus spp. bacteria represent novel insecticidal proteins. We purified a native toxin complex (toxin complex 1) from Xenorhabdus nematophilus. The toxin complex is composed of three different proteins, XptA2, XptB1, and XptC1, representing products from class A, B, and C toxin complex genes, respectively. We showed that recombinant XptA2 and co-produced recombinant XptB1 and XptC1 bind together with a 4: 1: 1 stoichiometry. XptA2 forms a tetramer of similar to 1,120 kDa that bound to solubilized insect brush border membranes and induced pore formation in black lipid membranes. Co-expressed XptB1 and XptC1 form a tight 1: 1 binary complex where XptC1 is C-terminally truncated, resulting in a 77-kDa protein. The similar to 30-kDa C-terminally cleaved portion of XptC1 apparently only loosely associates with this binary complex. XptA2 had only modest oral toxicity against lepidopteran insects but as a complex with co-produced XptB1 and XptC1 had high levels of insecticidal activity. Addition of co-expressed class B (TcdB2) and class C (TccC3) proteins from Photorhabdus luminescens to the Xenorhabdus XptA2 protein resulted in formation of a hybrid toxin complex protein with the same 4: 1: 1 stoichiometry as the native Xenorhabdus toxin complex 1. This hybrid toxin complex, like the native toxin complex, was highly active against insects.	[Sheets, Joel J.; Hey, Tim D.; Fencil, Kristin J.; Ni, Weiting] Dow AgroSci, Dept Biochem & Mol Biol, Indianapolis, IN 46268 USA; [Burton, Stephanie L.] Dow AgroSci, Dept Biol, Indianapolis, IN 46268 USA; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Benz, Roland] Univ Wurzburg, Deutsch Forsch Gemeinschaft Forschungszentrum Exp, Rudolf Virchow Zentrum, D-97078 Wurzburg, Germany; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28725 Bremen, Germany	Dow Chemical Company; Dow Chemical Company; University of Freiburg; University of Freiburg; University of Wurzburg; University of Bremen	Sheets, JJ (corresponding author), Dow AgroSci, Dept Biochem & Mol Biol, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	jjsheets@dow.com	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Benz, Roland/0000-0002-9510-9265	German Science Foundation Deutsche Forschungsgemeinschaft (DFG) [AK6/22-1, SFB487 TP5]; excellence cluster Centre for Biological Signalling Studies (BIOSS)	German Science Foundation Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); excellence cluster Centre for Biological Signalling Studies (BIOSS)	This work was supported by German Science Foundation Deutsche Forschungsgemeinschaft (DFG) Grant AK6/22-1 (to K. A.), the excellence cluster Centre for Biological Signalling Studies (BIOSS) (to K. A.), and DFG Grant SFB487 TP5 (to R. B.).	BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Dodd SJ, 2006, APPL ENVIRON MICROB, V72, P6584, DOI 10.1128/AEM.00954-06; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Guo LN, 1999, J BIOL CHEM, V274, P9836, DOI 10.1074/jbc.274.14.9836; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang AE, 2008, BIOCHEMISTRY-US, V47, P8406, DOI 10.1021/bi800615g; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Liu D, 2003, NAT BIOTECHNOL, V21, P1222, DOI 10.1038/nbt866; Sergeant M, 2003, APPL ENVIRON MICROB, V69, P3344, DOI 10.1128/AEM.69.6.3344-3349.2003; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Waterfield NR, 2004, NAT REV MICROBIOL, V2, P833, DOI 10.1038/nrmicro1008; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304	23	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22742	22749		10.1074/jbc.M111.227009	http://dx.doi.org/10.1074/jbc.M111.227009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21527640	Green Published, hybrid			2022-12-27	WOS:000292025000008
J	Triboulet, S; Arthur, M; Mainardi, JL; Veckerle, C; Dubee, V; NGuekam-Moumi, A; Gutmann, L; Rice, LB; Hugonnet, JE				Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Rice, Louis B.; Hugonnet, Jean-Emmanuel			Inactivation Kinetics of a New Target of beta-Lactam Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; MYCOBACTERIUM-TUBERCULOSIS; ENTEROCOCCUS-FAECIUM; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN BIOSYNTHESIS; RESISTANCE; TRANSPEPTIDASE; EXPRESSION; CLAVULANATE; INHIBITION	Peptidoglycan is predominantly cross-linked by serine DD-transpeptidases in most bacterial species. The enzymes are the essential targets of beta-lactam antibiotics. However, unrelated cysteine LD-transpeptidases have been recently recognized as a predominant mode of peptidoglycan cross-linking in Mycobacterium tuberculosis and as a bypass mechanism conferring resistance to all beta-lactams, except carbapenems such as imipenem, in Enterococcus faecium. Investigation of the mechanism of inhibition of this new beta-lactam target showed that acylation of the E. faecium enzyme (Ldt(fm)) by imipenem is irreversible. Using fluorescence kinetics, an original approach was developed to independently determine the catalytic constants for imipenem binding (k(1) = 0.061 mu M-1 min(-1)) and acylation (k(inact) = 4.5 min(-1)). The binding step was limiting at the minimal drug concentration required for bacterial growth inhibition. The Michaelis complex was committed to acylation because its dissociation was negligible. The emergence of imipenem resistance involved substitutions in Ldtfm that reduced the rate of formation of the non-covalent complex but only marginally affected the efficiency of the acylation step. The methods described in this study will facilitate development of new carbapenems active on extensively resistant M. tuberculosis.	[Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, Lab Rech Mol Antibiot,UMRS 872, F-75006 Paris, France; [Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] INSERM, U872, F-75006 Paris, France; [Mainardi, Jean-Luc; Gutmann, Laurent] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Rice, Louis B.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Hugonnet, JE (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, Lab Rech Mol Antibiot,UMRS 872, 15 Rue Ecole Med, F-75006 Paris, France.	jean-emmanuel.hugonnet@crc.jussieu.fr	HUGONNET, Jean-Emmanuel/H-3581-2014; Dubée, Vincent/F-8768-2018; Triboulet, Sebastien/AAI-8676-2020; MAINARDI, Jean-Luc/E-2714-2014; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Arthur, Michel/G-3680-2013	HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Dubée, Vincent/0000-0002-9982-4741; MAINARDI, Jean-Luc/0000-0002-4159-0129; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Arthur, Michel/0000-0003-1007-636X	National Institutes of Health, NIAID [RO1 AI45626, AI046626]; Fondation pour la Recherche Medicale [DEQ200661107918]; FRM [FDT 20080914133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045626] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FRM(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants RO1 AI45626 and AI046626. This work was also supported by the Fondation pour la Recherche Medicale (Equipe FRM 2006; DEQ200661107918).; Recipient of FRM Fellowship FDT 20080914133. To whom correspondence should be addressed: Centre de Recherche des Cordeliers, UMRS-872-Equipe 12, 15 Rue de l'Ecole de Medecine, 75006 Paris. E-mail: jean-emmanuel.hugonnet@crc.jussieu.fr.	Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; FRERE JM, 1975, EUR J BIOCHEM, V57, P343, DOI 10.1111/j.1432-1033.1975.tb02307.x; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Sifaoui F, 2001, ANTIMICROB AGENTS CH, V45, P2594, DOI 10.1128/AAC.45.9.2594-2597.2001; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	17	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22777	22784		10.1074/jbc.M111.239988	http://dx.doi.org/10.1074/jbc.M111.239988			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543331	hybrid, Green Published			2022-12-27	WOS:000292025000012
J	Jin, Y; Wu, JP; Song, XX; Song, QH; Cully, BL; Messmer-Blust, A; Xu, M; Foo, SY; Rosenzweig, A; Li, J				Jin, Yi; Wu, Jiaping; Song, Xiaoxiao; Song, Qinhui; Cully, Brittany L.; Messmer-Blust, Angela; Xu, Ming; Foo, Shi-Yin; Rosenzweig, Anthony; Li, Jian			RTEF-1, an Upstream Gene of Hypoxia-inducible Factor-1 alpha, Accelerates Recovery from Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; M-CAT ELEMENTS; FACTOR 1-ALPHA; ENDOTHELIAL-CELLS; TARGET GENES; KAPPA-B; TRANSCRIPTION; TEF-1; IDENTIFICATION; ANGIOGENESIS	The amount of available hypoxia-inducible factor (HIF)-1 alpha has been considered to be largely a consequence of post-translational modification by multiple ubiquitin-proteasome pathways. However, the role of transcriptional regulation of HIF-1 alpha is less certain, and the mechanisms of transcriptional regulation of HIF-1 alpha require further investigation. Here we report that related transcriptional enhancer factor-1 (RTEF-1), a member of the TEF transcriptional factor family, transcriptionally regulates the HIF-1 alpha gene under normoxic and hypoxic conditions. The expression of HIF-1 alpha mRNA was decreased in endothelial cells in which RTEF-1 was knocked down with siRNA. Sequential deletional analysis of the HIF-1 alpha promoter revealed that the MCAT-like element in the HIF-1 alpha promoter was essential for HIF-1 alpha transcription. Binding of RTEF-1 to the MCAT-like element was confirmed by ChIP. Treatment of endothelial cells with a HIF-1 inhibitor resulted in retardation of RTEF-1-induced proliferation and tube formation. Moreover, increased HIF-1 alpha expression was observed in transgenic mice expressing RTEF-1 under the VE-cadherin promoter (VE-Cad/RTEF-1). VE-Cad/RTEF-1 mice subjected to hindlimb ischemia demonstrated increased levels of HIF-1 alpha, accelerated recovery of blood flow, and increased capillary density compared with littermate controls. These results identify RTEF-1 as a regulator of HIF-1 alpha transcription, which results in up-regulation of HIF-1 alpha and acceleration of recovery from ischemia.	[Li, Jian] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, CardioVasc Inst,Ctr Life Sci, Boston, MA 02215 USA; [Jin, Yi; Li, Jian] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University	Li, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, CardioVasc Inst,Ctr Life Sci, CLS 909,3 Blackfan Circle, Boston, MA 02215 USA.	jli@bidmc.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019	Messmer-Blust, Angela/0000-0001-9582-5301; Jin, Yi/0000-0001-9704-973X	National Institutes of Health [HLR01082837]; China Scholarship Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	This work was supported, in whole or in part, by National Institutes of Health Grant HLR01082837 (to J. L.). This work was also supported by the China Scholarship Council (to Y. J.).	Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; Couffinhal T, 1998, AM J PATHOL, V152, P1667; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Elson DA, 2000, CANCER RES, V60, P6189; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; Fukushima K, 2008, PLACENTA, V29, P324, DOI 10.1016/j.placenta.2008.01.006; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	26	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22699	22705		10.1074/jbc.M111.237024	http://dx.doi.org/10.1074/jbc.M111.237024			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540178	Green Published, hybrid			2022-12-27	WOS:000291719900076
J	Szabo, A; Heja, D; Szakacs, D; Zboray, K; Kekesi, KA; Radisky, ES; Sahin-Toth, M; Pal, G				Szabo, Andras; Heja, David; Szakacs, David; Zboray, Katalin; Kekesi, Katalin A.; Radisky, Evette S.; Sahin-Toth, Miklos; Pal, Gabor			High Affinity Small Protein Inhibitors of Human Chymotrypsin C (CTRC) Selected by Phage Display Reveal Unusual Preference for P4 ' Acidic Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CATIONIC TRYPSINOGEN GENE; OVOMUCOID 3RD DOMAINS; SCHISTOCERCA-GREGARIA; DESERT LOCUST; SCANNING MUTAGENESIS; CHRONIC-PANCREATITIS; ACTIVE-SITE; PROCARBOXYPEPTIDASE-A; ENZYMATIC SPECIFICITY	Human chymotrypsin C (CTRC) is a pancreatic protease that participates in the regulation of intestinal digestive enzyme activity. Other chymotrypsins and elastases are inactive on the regulatory sites cleaved by CTRC, suggesting that CTRC recognizes unique sequence patterns. To characterize the molecular determinants underlying CTRC specificity, we selected high affinity substrate-like small protein inhibitors against CTRC from a phage library displaying variants of SGPI-2, a natural chymotrypsin inhibitor from Schistocerca gregaria. On the basis of the sequence pattern selected, we designed eight inhibitor variants in which amino acid residues in the reactive loop at P1 (Met or Leu), P2' (Leu or Asp), and P4' (Glu, Asp, or Ala) were varied. Binding experiments with CTRC revealed that (i) inhibitors with Leu at P1 bind 10-fold stronger than those with P1 Met; (ii) Asp at P2' (versus Leu) decreases affinity but increases selectivity, and (iii) Glu or Asp at P4' (versus Ala) increase affinity 10-fold. The highest affinity SGPI-2 variant (K-D 20 pM) bound to CTRC 575-fold tighter than the parent molecule. The most selective inhibitor variant exhibited a K-D of 110 pM and a selectivity ranging from 225- to 112,664-fold against other human chymotrypsins and elastases. Homology modeling and mutagenesis identified a cluster of basic amino acid residues (Lys(51), Arg(56), and Arg(80)) on the surface of human CTRC that interact with the P4' acidic residue of the inhibitor. The acidic preference of CTRC at P4' is unique among pancreatic proteases and might contribute to the high specificity of CTRC-mediated digestive enzyme regulation.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Heja, David; Szakacs, David; Zboray, Katalin; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Lab Prote, Inst Biol, H-1117 Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary; [Radisky, Evette S.] Mayo Clin Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Mayo Clinic	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu; palgabor@elte.hu	Kékesi, Katalin Adrienna A/H-3484-2017; Szakacs, David/K-1985-2018; Radisky, Evette S/C-8526-2012; Pal, Gabor/A-6244-2009	Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Szakacs, David/0000-0002-8758-6387; Radisky, Evette S/0000-0003-3121-109X; Pal, Gabor/0000-0001-7868-7971; Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01 DK082412-S2, R01 DK082412, R01 DK058088]; Hungarian Scientific Research Fund [NK81950, K68408]; European Union [4.2.1./B-09/KMR-2010-0003]; Janos Bolyai Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	s This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412-S2 (ARRA), R01 DK082412, and R01 DK058088 (to M. S.-T.), Hungarian Scientific Research Fund (OTKA) Grants NK81950 and K68408, the European Union and European Social Fund (TAMOP) Grant 4.2.1./B-09/KMR-2010-0003, and a Janos Bolyai Research Fellowship (to G. P.).	APOSTOL I, 1993, J PROTEIN CHEM, V12, P419, DOI 10.1007/BF01025042; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boigegrain RA, 2000, INSECT BIOCHEM MOLEC, V30, P145, DOI 10.1016/S0965-1748(99)00109-5; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; Gaspari Z, 2006, FEBS J, V273, P1831, DOI 10.1111/j.1742-4658.2006.05204.x; Gaspari Z, 2002, EUR J BIOCHEM, V269, P527, DOI 10.1046/j.0014-2956.2001.02685.x; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Grahn S, 1999, BBA-PROTEIN STRUCT M, V1431, P329, DOI 10.1016/S0167-4838(99)00059-X; Hamdaoui A, 1998, FEBS LETT, V422, P74, DOI 10.1016/S0014-5793(97)01585-8; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; KEILDLOUHA V, 1972, BIOCHIM BIOPHYS ACTA, V276, P531, DOI 10.1016/0005-2744(72)91013-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Leone P, 2008, ACTA CRYSTALLOGR D, V64, P1165, DOI 10.1107/S0907444908030400; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45; Mer G, 1996, J MOL BIOL, V258, P158, DOI 10.1006/jmbi.1996.0240; MER G, 1994, BIOCHEMISTRY-US, V33, P15397, DOI 10.1021/bi00255a021; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Pal G, 2005, PROTEIN SCI, V14, P2405, DOI 10.1110/ps.051519805; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Patthy A, 2002, ARCH BIOCHEM BIOPHYS, V398, P179, DOI 10.1006/abbi.2001.2686; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Roussel A, 2001, J BIOL CHEM, V276, P38893, DOI 10.1074/jbc.M105707200; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Simonet G, 2003, PROTEIN EXPRES PURIF, V31, P188, DOI 10.1016/S1046-5928(03)00170-0; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Szenthe B, 2004, BIOCHEMISTRY-US, V43, P3376, DOI 10.1021/bi035689+; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zani ML, 2010, BIOCHIMIE, V92, P1689, DOI 10.1016/j.biochi.2010.05.003	56	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22535	22545		10.1074/jbc.M111.235754	http://dx.doi.org/10.1074/jbc.M111.235754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515688	hybrid, Green Published			2022-12-27	WOS:000291719900061
J	Kale, A; Phansopa, C; Suwannachart, C; Craven, CJ; Rafferty, JB; Kelly, DJ				Kale, Avinash; Phansopa, Chatchawal; Suwannachart, Chatrudee; Craven, C. Jeremy; Rafferty, John B.; Kelly, David J.			The Virulence Factor PEB4 (Cj0596) and the Periplasmic Protein Cj1289 Are Two Structurally Related SurA-like Chaperones in the Human Pathogen Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; OUTER-MEMBRANE PROTEINS; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; BORDETELLA-PERTUSSIS; TRIGGER FACTOR; BINDING; BAMB; ISOMERIZATION; COMPONENT	The PEB4 protein is an antigenic virulence factor implicated in host cell adhesion, invasion, and colonization in the food-borne pathogen Campylobacter jejuni. peb4 mutants have defects in outer membrane protein assembly and PEB4 is thought to act as a periplasmic chaperone. The crystallographic structure of PEB4 at 2.2-angstrom resolution reveals a dimer with distinct SurA-like chaperone and peptidyl-prolyl cis/trans isomerase (PPIase) domains encasing a large central cavity. Unlike SurA, the chaperone domain is formed by interlocking helices from each monomer, creating a domain-swapped architecture. PEB4 stimulated the rate of proline isomerization limited refolding of denatured RNase T-1 in a juglone-sensitive manner, consistent with parvulin-like PPIase domains. Refolding and aggregation of denatured rhodanese was significantly retarded in the presence of PEB4 or of an engineered variant specifically lacking the PPIase domain, suggesting the chaperone domain possesses a holdase activity. Using bioinformatics approaches, we identified two other SurA-like proteins (Cj1289 and Cj0694) in C. jejuni. The 2.3-angstrom structure of Cj1289 does not have the domain-swapped architecture of PEB4 and thus more resembles SurA. Purified Cj1289 also enhanced RNase T1 refolding, although poorly compared with PEB4, but did not retard the refolding of denatured rhodanese. Structurally, Cj1289 is the most similar protein to SurA in C. jejuni, whereas PEB4 has most structural similarity to the Par27 protein of Bordetella pertussis. Our analysis predicts that Cj0694 is equivalent to the membrane-anchored chaperone PpiD. These results provide the first structural insights into the periplasmic assembly of outer membrane proteins in C. jejuni.	[Kale, Avinash; Phansopa, Chatchawal; Suwannachart, Chatrudee; Craven, C. Jeremy; Rafferty, John B.; Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Rafferty, JB (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, 5th Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	j.rafferty@sheffield.ac.uk; d.kelly@sheffield.ac.uk		Rafferty, John/0000-0003-1183-7474; Phansopa, Chatchawal/0000-0003-4943-9228	United Kingdom Biotechnology and Biological Sciences Research Council; Royal Thai government; BBSRC [BB/D524975/1, BB/E017576/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017576/1, BB/D524975/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a grant from the United Kingdom Biotechnology and Biological Sciences Research Council.; Supported by the Royal Thai government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Britton KL, 1998, J BIOL CHEM, V273, P9023, DOI 10.1074/jbc.273.15.9023; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clantin B, 2010, J STRUCT BIOL, V169, P253, DOI 10.1016/j.jsb.2009.11.007; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; DOUBLIE S, 1997, METHODS ENZYMOLOGY M; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hodak H, 2008, J MOL BIOL, V376, P414, DOI 10.1016/j.jmb.2007.10.088; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOROWITZ P, 1970, J BIOL CHEM, V245, P986; Hu L, 2008, INFECT IMMUN, V76, P5294, DOI 10.1128/IAI.01408-07; Ideno A, 2000, EUR J BIOCHEM, V267, P3139, DOI 10.1046/j.1432-1327.2000.01332.x; Jacobs BC, 2008, J NEUROIMMUNOL, V194, P181, DOI 10.1016/j.jneuroim.2007.11.017; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Misra R, 2007, ACS CHEM BIOL, V2, P649, DOI 10.1021/cb700212p; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MUCKE M, 1994, BIOCHEMISTRY-US, V33, P14608; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rathbun KM, 2009, FEMS MICROBIOL LETT, V300, P188, DOI 10.1111/j.1574-6968.2009.01795.x; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; Stymest KH, 2008, FEBS J, V275, P3470, DOI 10.1111/j.1742-4658.2008.06493.x; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	70	26	26	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21254	21265		10.1074/jbc.M111.220442	http://dx.doi.org/10.1074/jbc.M111.220442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524997	hybrid, Green Published			2022-12-27	WOS:000291464700024
J	Mailloux, RJ; Seifert, EL; Bouillaud, F; Aguer, C; Collins, S; Harper, ME				Mailloux, Ryan J.; Seifert, Erin L.; Bouillaud, Frederic; Aguer, Celine; Collins, Sheila; Harper, Mary-Ellen			Glutathionylation Acts as a Control Switch for Uncoupling Proteins UCP2 and UCP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PROTON LEAK; OXIDATIVE STRESS; SKELETAL-MUSCLE; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; ENERGY-METABOLISM; CELLS; ACID; OVEREXPRESSION; EXPRESSION	The mitochondrial uncoupling proteins 2 and 3 (UCP2 and -3) are known to curtail oxidative stress and participate in a wide array of cellular functions, including insulin secretion and the regulation of satiety. However, the molecular control mechanism( s) governing these proteins remains elusive. Here we reveal that UCP2 and UCP3 contain reactive cysteine residues that can be conjugated to glutathione. We further demonstrate that this modification controls UCP2 and UCP3 function. Both reactive oxygen species and glutathionylation were found to activate and deactivate UCP3-dependent increases in non-phosphorylating respiration. We identified both Cys(25) and Cys(259) as the major glutathionylation sites on UCP3. Additional experiments in thymocytes from wild-type and UCP2 null mice demonstrated that glutathionylation similarly diminishes non-phosphorylating respiration. Our results illustrate that UCP2- and UCP3-mediated state 4 respiration is controlled by reversible glutathionylation. Altogether, these findings advance our understanding of the roles UCP2 and UCP3 play in modulating metabolic efficiency, cell signaling, and oxidative stress processes.	[Mailloux, Ryan J.; Seifert, Erin L.; Aguer, Celine; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Bouillaud, Frederic] Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 8104,U1016, F-75270 Paris, France; [Collins, Sheila] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA	University of Ottawa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sanford Burnham Prebys Medical Discovery Institute	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca	Bouillaud, Frédéric R/L-3238-2017; Harper, Mary-Ellen/C-3103-2009; Aguer, Celine/K-4444-2012; Aguer, Celine/U-7848-2019	Bouillaud, Frédéric R/0000-0002-7518-9237; Aguer, Celine/0000-0001-8828-8472; Mailloux, Ryan/0000-0003-3986-9830; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes; CIHR	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes (to M. E. H.).; Supported by a CIHR postdoctoral fellowship.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P1716, DOI 10.1016/j.bbabio.2010.06.009; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Carroll AM, 2008, BBA-BIOENERGETICS, V1777, P1060, DOI 10.1016/j.bbabio.2008.04.030; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; DEQUIROGA GB, 1991, BIOCHEM J, V277, P289, DOI 10.1042/bj2770289; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gustafsson H, 2004, J NEUROSCI RES, V77, P285, DOI 10.1002/jnr.20142; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Krauss S, 1999, BBA-BIOENERGETICS, V1412, P129, DOI 10.1016/S0005-2728(99)00058-4; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	51	136	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21865	21875		10.1074/jbc.M111.240242	http://dx.doi.org/10.1074/jbc.M111.240242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515686	hybrid, Green Published			2022-12-27	WOS:000291464700081
J	Snyder, SH				Snyder, Solomon H.			Mind Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; INOSITOL HEXAKISPHOSPHATE KINASE-2; CENTRAL NERVOUS-SYSTEM; DOPAMINE RECEPTOR-BINDING; REGENERATING RAT LIVER; HIGH-AFFINITY UPTAKE; OPIATE RECEPTOR; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; POLYPHOSPHATE MULTIKINASE; ORNITHINE DECARBOXYLASE	Scientific styles vary tremendously. For me, research is largely about the unfettered pursuit of novel ideas and experiments that can test multiple ideas in a day, not a year, an approach that I learned from my mentor Julius "Julie" Axelrod. This focus on creative conceptualizations has been my metier since working in the summers during medical school at the National Institutes of Health, during my two years in the Axelrod laboratory, and throughout my forty-five years at Johns Hopkins University School of Medicine. Equally important has been the "high" that emerges from brainstorming with my students. Nothing can compare with the eureka moments when, together, we sense new insights and, better yet, when high-risk, high-payoff experiments succeed. Although I have studied many different questions over the years, a common theme emerges: simple biochemical approaches to understanding molecular messengers, usually small molecules. Equally important has been identifying, purifying, and cloning the messengers' relevant biosynthetic, degradative, or target proteins, at all times seeking potential therapeutic relevance in the form of drugs. In the interests of brevity, this Reflections article is highly selective, and, with a few exceptions, literature citations are only of findings of our laboratory that illustrate notable themes.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu						BANERJEE SP, 1973, P NATL ACAD SCI USA, V70, P2519, DOI 10.1073/pnas.70.9.2519; BENNETT JP, 1976, MOL PHARMACOL, V12, P373; BENNETT JP, 1972, SCIENCE, V178, P997, DOI 10.1126/science.178.4064.997; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BRUNS RF, 1980, P NATL ACAD SCI-BIOL, V77, P5547, DOI 10.1073/pnas.77.9.5547; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; BURT DR, 1977, SCIENCE, V196, P327, DOI 10.1126/science.847477; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chakraborty A, 2011, P NATL ACAD SCI USA, V108, P2205, DOI 10.1073/pnas.1019381108; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; COYLE JT, 1969, SCIENCE, V166, P899, DOI 10.1126/science.166.3907.899; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CREESE I, 1975, LIFE SCI, V17, P993, DOI 10.1016/0024-3205(75)90454-3; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FISCHER JE, 1965, SCIENCE, V150, P1034, DOI 10.1126/science.150.3699.1034; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; INNIS RB, 1981, P NATL ACAD SCI-BIOL, V78, P2630, DOI 10.1073/pnas.78.4.2630; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; KUHAR MJ, 1973, NATURE, V245, P447, DOI 10.1038/245447a0; LOGAN WJ, 1971, NATURE, V234, P297, DOI 10.1038/234297b0; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; MUSTAFA A, 2009, SCI SIGNAL, V10, P1; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; PASTERNAK GW, 1975, LIFE SCI, V16, P1765, DOI 10.1016/0024-3205(75)90270-2; PEROUTKA SJ, 1980, SCIENCE, V210, P88, DOI 10.1126/science.6251550; PEROUTKA SJ, 1981, SCIENCE, V212, P827, DOI 10.1126/science.7221567; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; PERT CB, 1976, P NATL ACAD SCI USA, V73, P3729, DOI 10.1073/pnas.73.10.3729; PEVSNER J, 1985, P NATL ACAD SCI USA, V82, P3050, DOI 10.1073/pnas.82.9.3050; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; RUSSELL DH, 1969, MOL PHARMACOL, V5, P253; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376, DOI 10.1073/pnas.72.11.4376; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SIMANTOV R, 1976, P NATL ACAD SCI USA, V73, P2515, DOI 10.1073/pnas.73.7.2515; SIMANTOV R, 1977, P NATL ACAD SCI USA, V74, P2167, DOI 10.1073/pnas.74.5.2167; SNYDER S, 1961, ARCH GEN PSYCHIAT, V5, P406; SNYDER S, 1961, J ABNORM SOC PSYCH, V63, P131, DOI 10.1037/h0040704; SNYDER SH, 1975, NATURE, V257, P185, DOI 10.1038/257185a0; SNYDER SH, 1965, BIOCHEM PHARMACOL, V14, P831, DOI 10.1016/0006-2952(65)90102-4; SNYDER SH, 1984, SCIENCE, V224, P22, DOI 10.1126/science.6322304; SNYDER SH, 1961, J BIOL CHEM, V236, P2996; SNYDER SH, 1964, BIOCHEM PHARMACOL, V13, P536, DOI 10.1016/0006-2952(64)90176-5; SNYDER SH, 1980, SCIENCE, V209, P976, DOI 10.1126/science.6157191; SNYDER SH, 1965, P NATL ACAD SCI USA, V53, P301, DOI 10.1073/pnas.53.2.301; SNYDER SH, 1965, SCIENCE, V149, P542, DOI 10.1126/science.149.3683.542; SNYDER SH, 1963, J CLIN ENDOCR METAB, V23, P595, DOI 10.1210/jcem-23-6-595; SNYDER SH, 1964, J PHARMACOL EXP THER, V144, P373; SNYDER SH, 1967, SCIENCE, V158, P669, DOI 10.1126/science.158.3801.669; SNYDER SH, 1968, MOL PHARMACOL, V4, P187; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR KM, 1970, SCIENCE, V168, P1487, DOI 10.1126/science.168.3938.1487; TAYLOR KM, 1971, SCIENCE, V172, P1037, DOI 10.1126/science.172.3987.1037; UPRICHARD DC, 1977, NATURE, V270, P261, DOI 10.1038/270261a0; UPRICHARD DC, 1978, SCIENCE, V199, P197, DOI 10.1126/science.202024; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; YAMAMURA HI, 1974, P NATL ACAD SCI USA, V71, P1725, DOI 10.1073/pnas.71.5.1725; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YOUNG AB, 1971, SCIENCE, V173, P247, DOI 10.1126/science.173.3993.247; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; ZUKIN SR, 1974, P NATL ACAD SCI USA, V71, P4802, DOI 10.1073/pnas.71.12.4802	78	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21023	21032		10.1074/jbc.X111.258020	http://dx.doi.org/10.1074/jbc.X111.258020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21543333	Green Published, hybrid			2022-12-27	WOS:000291464700001
J	Hajicek, N; Kukimoto-Niino, M; Mishima-Tsumagari, C; Chow, CR; Shirouzu, M; Terada, T; Patel, M; Yokoyama, S; Kozasa, T				Hajicek, Nicole; Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Chow, Christina R.; Shirouzu, Mikako; Terada, Takaho; Patel, Maulik; Yokoyama, Shigeyuki; Kozasa, Tohru			Identification of Critical Residues in G alpha(13) for Stimulation of p115RhoGEF Activity and the Structure of the G alpha(13)-p115RhoGEF Regulator of G Protein Signaling Homology (RH) Domain Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; SERUM RESPONSE FACTOR; RGRGS DOMAIN; P115 RHOGEF; TRANSITION-STATE; ALPHA-SUBUNIT; MEMBRANE; BINDING; MECHANISMS	RH-RhoGEFs are a family of guanine nucleotide exchange factors that contain a regulator of G protein signaling homology (RH) domain. The heterotrimeric G protein G alpha(13) stimulates the guanine nucleotide exchange factor (GEF) activity of RH-RhoGEFs, leading to activation of RhoA. The mechanism by which G alpha(13) stimulates the GEF activity of RH-RhoGEFs, such as p115RhoGEF, has not yet been fully elucidated. Here, specific residues in G alpha(13) that mediate activation of p115RhoGEF are identified. Mutation of these residues significantly impairs binding of G alpha(13) to p115RhoGEF as well as stimulation of GEF activity. These data suggest that the exchange activity of p115RhoGEF is stimulated allosterically by G alpha(13) and not through its interaction with a secondary binding site. A crystal structure of G alpha(13) bound to the RH domain of p115RhoGEF is also presented, which differs from a previously crystallized complex with a G alpha(13)-G alpha(11) chimera. Taken together, these data provide new insight into the mechanism by which p115RhoGEF is activated by G alpha(13).	[Hajicek, Nicole; Kozasa, Tohru] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Hajicek, Nicole; Chow, Christina R.; Patel, Maulik; Kozasa, Tohru] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Shirouzu, Mikako; Terada, Takaho; Yokoyama, Shigeyuki; Kozasa, Tohru] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; RIKEN; University of Tokyo	Kozasa, T (corresponding author), Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	kozasa@lsbm.org	Kukimoto-Niino, Mutsuko/C-6704-2017; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Yokoyama, Shigeyuki/0000-0003-3133-7338; Chow, Christina/0000-0003-3944-4234	National Institutes of Health [GM61454, GM074001]; American Heart Association; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074001, R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61454 and GM074001 (to T. K.). This work was also supported by a grant-in-aid from the Greater Midwest Affiliate of the American Heart Association (to T. K.), the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Funding Program for World-Leading Innovative R&D on Science and Technology from the Japan Society for the Promotion of Science; a predoctoral fellowship from the Greater Midwest Affiliate of the American Heart Association (to N. H.); and the Japan Society for the Promotion of Science (to N. H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vazquez-Prado J, 2004, J BIOL CHEM, V279, P54283, DOI 10.1074/jbc.M410594200; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	45	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20625	20636		10.1074/jbc.M110.201392	http://dx.doi.org/10.1074/jbc.M110.201392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507947	hybrid, Green Published			2022-12-27	WOS:000291267600049
J	Liu, J; Jha, P; Lyzogubov, VV; Tytarenko, RG; Bora, NS; Bora, PS				Liu, Juan; Jha, Purushottam; Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Bora, Nalini S.; Bora, Puran S.			Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PIGMENT EPITHELIAL-CELLS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHEMOTACTIC PROTEIN-1; ANIMAL-MODEL; FACTOR-B; ANGIOGENESIS; SUPPRESSION; VEGF	The present study investigated the interactions among the complement membrane attack complex (MAC), CCL2, and VEGF that occur in vivo during the development of choroidal neovascularization (CNV). We first investigated the sequential expression of MAC, CCL2, and VEGF during laser-induced CNV in C57BL/6 mice. Increased MAC deposition was detected at 1 h, CCL2 increased at 3 h, and VEGF was up-regulated at day 3 post-laser treatment. These results suggested that during laser-induced CNV, MAC, CCL2 and VEGF are formed and/or expressed in the following order: MAC -> CCL2 -> VEGF. To determine the cross-talk between MAC, CCL2, and VEGF during laser-induced CNV, neutralizing antibodies were injected both systemically and locally to block the bioactivity of each molecule. Blocking MAC formation inhibited CCL2 and VEGF expression and also limited CNV formation, whereas neutralization of CCL2 bioactivity did not affect MAC deposition; however, it reduced VEGF expression and CNV formation. When bioactivity of VEGF was blocked, CNV formation was significantly inhibited, but MAC deposition was not affected. Together, our results demonstrate that MAC is an upstream mediator and effect of MAC on the development of laser-induced CNV can be attributed to its direct effect on VEGF as well as its effect on VEGF that is mediated by CCL2. Understanding the interplay between immune mediators is critical to gain insight into the pathogenesis of CNV.	[Liu, Juan; Jha, Purushottam; Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Bora, Nalini S.; Bora, Puran S.] Univ Arkansas Med Sci Hosp, Dept Ophthalmol, Jones Eye Inst, Little Rock, AR 72205 USA; [Liu, Juan; Bora, Nalini S.] Univ Arkansas Med Sci Hosp, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci Hosp, Dept Ophthalmol, Jones Eye Inst, 4301 W Markham,523, Little Rock, AR 72205 USA.	NBora@UAMS.edu; PBora@UAMS.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY014623, EY018812]; Pat and Willard Walker Eye Research Center; Jones Eye Institute; University of Arkansas for Medical Sciences (Little Rock, AR); NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center; Jones Eye Institute; University of Arkansas for Medical Sciences (Little Rock, AR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY014623 and EY018812. This work was also supported by grants from the Pat and Willard Walker Eye Research Center, Jones Eye Institute, and the University of Arkansas for Medical Sciences (Little Rock, AR).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Ashikari M, 2010, INVEST OPHTH VIS SCI, V51, P3820, DOI 10.1167/iovs.09-5121; Augustin AJ, 2009, CLIN OPHTHALMOL, V3, P175; Barakat MR, 2009, EXPERT OPIN INV DRUG, V18, P637, DOI [10.1517/13543780902855316, 10.1517/13543780902855316 ]; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chung EJ, 2009, BRIT J OPHTHALMOL, V93, P958, DOI 10.1136/bjo.2008.149187; Cohen SY, 2009, RETINA-J RET VIT DIS, V29, P1062, DOI 10.1097/IAE.0b013e3181b1bb1a; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Goverdhan SV, 2008, BRIT J OPHTHALMOL, V92, P537, DOI 10.1136/bjo.2007.123190; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hwang J, 2005, CYTOKINE, V30, P254, DOI 10.1016/j.cyto.2005.01.018; Inomata Y, 2009, INVEST OPHTH VIS SCI, V50, P3970, DOI 10.1167/iovs.07-1177; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Joussen AM, 2009, DTSCH ARZTEBL INT, V106, P312, DOI 10.3238/arztebl.2009.0312; Kaliappan S, 2008, FEBS LETT, V582, P3451, DOI 10.1016/j.febslet.2008.09.009; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kilgore KS, 1996, AM J PATHOL, V149, P953; Kim SJ, 2010, EXP EYE RES, V91, P537, DOI 10.1016/j.exer.2010.07.011; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liutkeviciene R, 2010, MEDICINA-LITHUANIA, V46, P89, DOI 10.3390/medicina46020013; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Michels Stephan, 2006, Expert Opin Investig Drugs, V15, P779, DOI 10.1517/13543784.15.7.779; Miller DG, 2006, OPTOMETRY VISION SCI, V83, P316, DOI 10.1097/01.opx.0000216019.88256.eb; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; OShea JG, 1996, MED J AUSTRALIA, V165, P561, DOI 10.5694/j.1326-5377.1996.tb138643.x; Ozkiris A, 2010, EXPERT OPIN THER PAT, V20, P103, DOI 10.1517/13543770902762885; PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0; Prasad PS, 2010, MATURITAS, V66, P46, DOI 10.1016/j.maturitas.2010.02.006; Rambach Guenter, 2008, V15, P78, DOI 10.1159/000136316; Risnes I, 2003, ANN THORAC SURG, V75, P981, DOI 10.1016/S0003-4975(02)04556-3; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Selvan RS, 1998, J IMMUNOL, V161, P4388; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Suner IJ, 2004, INVEST OPHTH VIS SCI, V45, P311, DOI 10.1167/iovs.03-0733; Takahashi H, 2008, INVEST OPHTH VIS SCI, V49, P2143, DOI 10.1167/iovs.07-0523; Tettamanti G, 2006, CURR MED CHEM, V13, P2737, DOI 10.2174/092986706778521986; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Torzewski J, 1996, ARTERIOSCL THROM VAS, V16, P673, DOI 10.1161/01.ATV.16.5.673; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wang Y, 2010, EXP EYE RES, V91, P135, DOI 10.1016/j.exer.2010.02.008; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63	70	36	42	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20991	21001		10.1074/jbc.M111.226266	http://dx.doi.org/10.1074/jbc.M111.226266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515678	Green Published, hybrid			2022-12-27	WOS:000291267600083
J	Zetterstrom, P; Graffmo, KS; Andersen, PM; Brannstrom, T; Marklund, SL				Zetterstrom, Per; Graffmo, Karin S.; Andersen, Peter M.; Brannstrom, Thomas; Marklund, Stefan L.			Proteins That Bind to Misfolded Mutant Superoxide Dismutase-1 in Spinal Cords from Transgenic Amyotrophic Lateral Sclerosis (ALS) Model Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; HEAT-SHOCK PROTEINS; FAMILIAL ALS; CHAPERONE; SOD1; AGGREGATION; DEGRADATION; ARIMOCLOMOL; MECHANISM; INTERACTS	Mutant superoxide dismutase-1 (SOD1) has an unidentified toxic property that provokes ALS. Several ALS-linked SOD1 mutations cause long C-terminal truncations, which suggests that common cytotoxic SOD1 conformational species should be misfolded and that the C-terminal end cannot be involved. The cytotoxicity may arise from interaction of cellular proteins with misfolded SOD1 species. Here we specifically immunocaptured misfolded SOD1 by the C-terminal end, from extracts of spinal cords from transgenic ALS model mice. Associated proteins were identified with proteomic techniques. Two transgenic models expressing SOD1s with contrasting molecular properties were examined: the stable G93A mutant, which is abundant in the spinal cord with only a tiny subfraction misfolded, and the scarce disordered truncation mutant G127ins TGGG. For comparison, proteins in spinal cord extracts with affinity for immobilized apo G93A mutant SOD1 were determined. Two-dimensional gel patterns with a limited number of bound proteins were found, which were similar for the two SOD1 mutants. Apart from neurofilament light, the proteins identified were all chaperones and by far most abundant was Hsc70. The immobilized apo G93A SOD1, which would populate a variety of conformations, was found to bind to a considerable number of additional proteins. A substantial proportion of the misfolded SOD1 in the spinal cord extracts appeared to be chaperone-associated. Still, only about 1% of the Hsc70 appeared to be associated with misfolded SOD1. The results argue against the notion that chaperone depletion is involved in ALS pathogenesis in the transgenic models and in humans carrying SOD1 mutations.	[Zetterstrom, Per; Marklund, Stefan L.] Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden	Umea University; Umea University	Marklund, SL (corresponding author), Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden.	Stefan.Marklund@medbio.umu.se	Zetterström, Per/AAL-5018-2020	Zetterström, Per/0000-0001-8718-3249	Swedish Science Council; Swedish Brain Fund/Hallsten Fund; Swedish Medical Society; ALS Association; Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council; Kempe Foundations; King Gustaf V and Queen Victoria Foundation	Swedish Science Council; Swedish Brain Fund/Hallsten Fund; Swedish Medical Society; ALS Association; Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council; Kempe Foundations; King Gustaf V and Queen Victoria Foundation	This work was supported by the Swedish Science Council, the Swedish Brain Fund/Hallsten Fund, the Swedish Medical Society including the Bjorklund Fund for ALS Research, the ALS Association, the Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council, the Kempe Foundations, and the King Gustaf V and Queen Victoria Foundation.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Bergemalm D, 2009, MOL CELL PROTEOMICS, V8, P1306, DOI 10.1074/mcp.M900046-MCP200; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Choi JS, 2004, BIOCHEM BIOPH RES CO, V321, P574, DOI 10.1016/j.bbrc.2004.07.010; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabuta T, 2009, BIOCHEM BIOPH RES CO, V387, P121, DOI 10.1016/j.bbrc.2009.06.138; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lanka V, 2009, EXPERT OPIN INV DRUG, V18, P1907, DOI 10.1517/13543780903357486; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Marks W, 2002, COMPUTATIONAL NEUROA; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Takamiya R, 2005, AM J PHYSIOL-CELL PH, V288, pC253, DOI 10.1152/ajpcell.00014.2004; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	35	35	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20130	20136		10.1074/jbc.M111.218842	http://dx.doi.org/10.1074/jbc.M111.218842			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493711	Green Published, hybrid			2022-12-27	WOS:000291267600002
J	Polizio, AH; Chinchilla, P; Chen, XL; Kim, S; Manning, DR; Riobo, NA				Polizio, Ariel H.; Chinchilla, Pilar; Chen, Xiaole; Kim, Sangbumn; Manning, David R.; Riobo, Natalia A.			Heterotrimeric G(i) Proteins Link Hedgehog Signaling to Activation of Rho Small GTPases to Promote Fibroblast Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; CANCER; PATHWAYS; BINDING; RAC; MECHANISMS; RECEPTORS	Evidence supporting the functionality of Smoothened (SMO), an essential transducer in most pathways engaged by Hedgehog (Hh), as a G(i)-coupled receptor contrasts with the lack of an apparently consistent requirement for G(i) in Hh signal transduction. In the present study, we sought to evaluate the role of SMO-G(i) coupling in fibroblast migration induced by Sonic Hedgehog (Shh). Our results demonstrate an absolute requirement for G(i) in Shh-induced fibroblast migration. We found that Shh acutely stimulates the small Rho GTPases Rac1 and RhoA via SMO through a G(i) protein-and PI3K-dependent mechanism, and that these are required for cell migration. These responses were independent of transcription by Gli and of the C-terminal domain of SMO, as we show using a combination of molecular and genetic tools. Our findings provide a mechanistic model for fibroblast migration in response to Shh and underscore the role of SMO-Gi coupling in non-canonical Hh signaling.	[Polizio, Ariel H.; Chinchilla, Pilar; Chen, Xiaole; Kim, Sangbumn; Riobo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Manning, David R.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; University of Pennsylvania	Riobo, NA (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Bluemle Life Sci Bldg,Room 922,233 S 10th St, Philadelphia, PA 19107 USA.	natalia.riobo@jefferson.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Polizio, Ariel/0000-0001-5413-7238	National Institutes of Health [GM080396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396, R01GM088256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080396.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bailey EC, 2002, J BIOL CHEM, V277, P33632, DOI 10.1074/jbc.M202203200; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Fanelli F, 2009, CURR PROTEIN PEPT SC, V10, P173, DOI 10.2174/138920309787847554; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meyer NP, 2003, DEV BIOL, V257, P343, DOI 10.1016/S0012-1606(03)00065-4; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008824; NOBES CD, 1995, J CELL SCI, V108, P225; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Togashi H., 1998, AM J PHYSIOL, V274, P803; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Woodard AS, 1998, J CELL SCI, V111, P469; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392	42	115	121	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19589	19596		10.1074/jbc.M110.197111	http://dx.doi.org/10.1074/jbc.M110.197111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474452	Green Published, hybrid			2022-12-27	WOS:000291027700042
J	Shen, B; Kwan, HY; Ma, X; Wong, CO; Du, J; Huang, Y; Yao, XQ				Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang			cAMP Activates TRPC6 Channels via the Phosphatidylinositol 3-Kinase (PI3K)-Protein Kinase B (PKB)-Mitogen-activated Protein Kinase Kinase (MEK)-ERK1/2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; ENDOTHELIAL-CELLS; DOWN-REGULATION; CALCIUM-ENTRY; HIGH GLUCOSE; EXPRESSION; PHOSPHORYLATION; GLOMERULOSCLEROSIS; TRANSLOCATION; OSCILLATIONS	cAMP is an important second messenger that executes diverse physiological function in living cells. In this study, we investigated the effect of cAMP on canonical TRPC6 (transient receptor potential channel 6) channels in TRPC6-expressing HEK293 cells and glomerular mesangial cells. The results showed that 500 mu M8-Br-cAMP, a cell-permeable analog of cAMP, elicited [Ca2+](i) increases and stimulated a cation current at the whole-cell level in TRPC6-expressing HEK293 cells. The effect of cAMP diminished in the presence of the PI3K inhibitors wortmannin and LY294002 or the MEK inhibitors PD98059, U0126, and MEK inhibitor I. 8-Br-cAMP also induced phosphorylation of MEK and ERK1/2. Conversion of serine to glycine at an ERK1/2 phosphorylation site (S281G) abolished the cAMP activation of TRPC6 as determined by whole-cell and cell-attached single-channel patch recordings. Experiments based on a panel of pharmacological inhibitors or activators suggested that the cAMP action on TRPC6 was not mediated by PKA, PKG, or EPAC (exchange protein activated by cAMP). Total internal fluorescence reflection microscopy showed that 8-Br-cAMP did not alter the trafficking of TRPC6 to the plasma membrane. We also found that, in glomerular mesangial cells, glucagon-induced [Ca2+](i) increases were mediated through the cAMP-PI3K-PKB-MEK-ERK1/2-TRPC6 signaling pathway. In summary, this study uncovered a novel TRPC6 activation mechanism in which cAMP activates TRPC6 via the PI3KPKB- MEK-ERK1/2 signaling pathway.	[Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing; Du, Juan] Anhui Med Univ, Dept Physiol, Hefei 230032, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Anhui Medical University	Yao, XQ (corresponding author), Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017; Huang, Yvonne/D-3808-2011; Ma, Xin/G-1297-2013	Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784; KWAN, Hiu Yee/0000-0002-6088-7323; Wong, Ching On/0000-0002-8602-2125	Hong Kong Research Grants Council [CUHK477408, CUHK479109, CUHK478710]; Focused Investment Scheme; Li Ka Shing Institute of Health Sciences	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences	This work was supported by Hong Kong Research Grants Council Grants CUHK477408, CUHK479109, and CUHK478710; the Focused Investment Scheme; and the Li Ka Shing Institute of Health Sciences.	Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dietrich A., 2007, V179, P125; Ding X, 2010, EXPERT OPIN THER TAR, V14, P513, DOI 10.1517/14728221003733602; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; FERDOWS M, 1989, KIDNEY INT, V35, P783, DOI 10.1038/ki.1989.53; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Li XC, 2006, HYPERTENSION, V47, P580, DOI 10.1161/01.HYP.0000197946.81754.0a; Li XC, 2006, BIOCHEM PHARMACOL, V71, P1711, DOI 10.1016/j.bcp.2006.03.018; LI YX, 1994, P NATL ACAD SCI USA, V91, P58, DOI 10.1073/pnas.91.1.58; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P2249, DOI 10.1161/ATVBAHA.110.212084; Mountian I, 1999, CELL CALCIUM, V25, P371, DOI 10.1054/ceca.1999.0034; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; RALL TW, 1958, J BIOL CHEM, V232, P1065; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Webster CRL, 1999, AM J PHYSIOL-GASTR L, V277, pG1165, DOI 10.1152/ajpgi.1999.277.6.G1165; Welling A, 2005, MOL PHARMACOL, V67, P541, DOI 10.1124/mol.104.006049; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang XJ, 2006, J AM SOC NEPHROL, V17, P1532, DOI 10.1681/ASN.2005070776; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	37	47	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19439	19445		10.1074/jbc.M110.210294	http://dx.doi.org/10.1074/jbc.M110.210294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487005	Green Published, hybrid			2022-12-27	WOS:000291027700027
J	Picazo-Juarez, G; Romero-Suarez, S; Nieto-Posadas, A; Llorente, I; Jara-Oseguera, A; Briggs, M; McIntosh, TJ; Simon, SA; Ladron-de-Guevara, E; Islas, LD; Rosenbaum, T				Picazo-Juarez, Giovanni; Romero-Suarez, Silvina; Nieto-Posadas, Andres; Llorente, Itzel; Jara-Oseguera, Andres; Briggs, Margaret; McIntosh, Thomas J.; Simon, Sidney A.; Ladron-de-Guevara, Ernesto; Islas, Leon D.; Rosenbaum, Tamara			Identification of a Binding Motif in the S5 Helix That Confers Cholesterol Sensitivity to the TRPV1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR; MEMBRANE DOMAINS; ACTIVATION; CAPSAICIN; PROTEIN; RAFT; HYPERCHOLESTEROLEMIA; MODULATION; ANANDAMIDE; EXPRESSION	The TRPV1 ion channel serves as an integrator of noxious stimuli with its activation linked to pain and neurogenic inflammation. Cholesterol, a major component of cell membranes, modifies the function of several types of ion channels. Here, using measurements of capsaicin-activated currents in excised patches from TRPV1-expressing HEK cells, we show that enrichment with cholesterol, but not its diastereoisomer epicholesterol, markedly decreased wild-type rat TRPV1 currents. Substitutions in the S5 helix, rTRPV1-R579D, and rTRPV1-F582Q, decreased this cholesterol response and rTRPV1-L585I was insensitive to cholesterol addition. Two human TRPV1 variants, with different amino acids at position 585, had different responses to cholesterol with hTRPV1-Ile(585) being insensitive to this molecule. However, hTRPV1-I585L was inhibited by cholesterol addition similar to rTRPV1 with the same S5 sequence. In the absence of capsaicin, cholesterol enrichment also inhibited TRPV1 currents induced by elevated temperature and voltage. These data suggest that there is a cholesterol-binding site in TRPV1 and that the functions of TRPV1 depend on the genetic variant and membrane cholesterol content.	[Picazo-Juarez, Giovanni; Romero-Suarez, Silvina; Nieto-Posadas, Andres; Llorente, Itzel; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Ladron-de-Guevara, Ernesto; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Briggs, Margaret; McIntosh, Thomas J.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Simon, Sidney A.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Duke University; Duke University	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Ladrón-de-Guevara, Ernesto/F-4304-2014; Islas, Leon D/AAW-9845-2020	Ladrón-de-Guevara, Ernesto/0000-0001-5122-1848; Islas, Leon D/0000-0002-7461-5214; Rosenbaum, Tamara/0000-0002-4791-3195; Nieto-Posadas, Andres/0000-0002-3339-8604; Jara Oseguera, Andres/0000-0001-5921-9320	National Institutes of Health [GM27278, DC-01065]; Direccion General de Asuntos del Personal Academico [PAPIIT IN204111-3]; Consejo Nacional de Ciencia y Tecnologia [129474, SNI 102152]; Fundacion Miguel Aleman; Instituto de Ciencia y Technologia del Distrito Federal [PIFUTP09-262];  [IN209209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman; Instituto de Ciencia y Technologia del Distrito Federal; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM27278 (to T. J. M.) and DC-01065 (to S. A. S.) and grants Direccion General de Asuntos del Personal Academico-PAPIIT IN204111-3, Consejo Nacional de Ciencia y Tecnologia 129474, and Consejo Nacional de Ciencia y Tecnologia-SNI 102152, and a grant from Fundacion Miguel Aleman (to T. R.), and IN209209 and Instituto de Ciencia y Technologia del Distrito Federal PIFUTP09-262 (to L. D. I.).	Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Cantero-Recasens G, 2010, J BIOL CHEM, V285, P27532, DOI 10.1074/jbc.C110.159491; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Christian AE, 1997, J LIPID RES, V38, P2264; Colquhoun D., 1995, FITTING STAT ANAL SI; Culshaw AJ, 2006, J MED CHEM, V49, P471, DOI 10.1021/jm051058x; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mathew V, 2001, ATHEROSCLEROSIS, V154, P329, DOI 10.1016/S0021-9150(00)00493-7; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Oseguera AJ, 2007, BIOPHYS J, V92, P3901, DOI 10.1529/biophysj.106.102400; Pearce LV, 2004, ORG BIOMOL CHEM, V2, P2281, DOI 10.1039/b404506h; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Salton M R, 1968, J Gen Physiol, V52, P227, DOI 10.1085/jgp.52.1.227; Schumacher MA, 2010, FRONT BIOSCI-LANDMRK, V15, P872, DOI 10.2741/3651; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Szoke E, 2010, EUR J PHARMACOL, V628, P67, DOI 10.1016/j.ejphar.2009.11.052; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Tong JH, 2009, BIOPHYS J, V97, P2493, DOI 10.1016/j.bpj.2009.08.026; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Xu SH, 2008, ENDOCRINOLOGY, V149, P5540, DOI 10.1210/en.2008-0278; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008	52	98	97	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24966	24976		10.1074/jbc.M111.237537	http://dx.doi.org/10.1074/jbc.M111.237537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21555515	hybrid, Green Published			2022-12-27	WOS:000292547900045
J	Applebee, MK; Joyce, AR; Conrad, TM; Pettigrew, DW; Palsson, BO				Applebee, M. Kenyon; Joyce, Andrew R.; Conrad, Tom M.; Pettigrew, Donald W.; Palsson, Bernhard O.			Functional and Metabolic Effects of Adaptive Glycerol Kinase (GLPK) Mutants in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM EXPERIMENT; UTILIZATION IN-VIVO; PHOSPHOTRANSFERASE SYSTEM; ALLOSTERIC REGULATION; GENE-EXPRESSION; ORGANISMAL FITNESS; PROTEIN EVOLUTION; SALMONELLA-TYPHIMURIUM; SUBUNIT DISSOCIATION; MOLECULAR EVOLUTION	Herein we measure the effect of four adaptive non-synonymous mutations to the glycerol kinase (glpK) gene on catalytic function and regulation, to identify changes that correlate to increased fitness in glycerol media. The mutations significantly reduce affinity for the allosteric inhibitor fructose-1,6-bisphosphate (FBP) and formation of the tetramer, which are structurally related, in a manner that correlates inversely with imparted fitness during growth on glycerol, which strongly suggests that these enzymatic parameters drive growth improvement. Counterintuitively, the glpK mutations also increase glycerol-induced auto-catabolite repression that reduces glpK transcription in a manner that correlates to fitness. This suggests that increased specific GlpK activity is attenuated by negative feedback on glpK expression via catabolite repression, possibly to prevent methylglyoxal toxicity. We additionally report that glpK mutations were fixed in 47 of 50 independent glycerol-adapted lineages. By far the most frequently mutated locus (nucleotide 218) was mutated in 20 lineages, strongly suggesting this position has an elevated mutation rate. This study demonstrates that fitness correlations can be used to interrogate adaptive processes at the protein level and to identify the regulatory constraints underlying selection and improved growth.	[Applebee, M. Kenyon; Conrad, Tom M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pettigrew, Donald W.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station	Applebee, MK (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mapplebe@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785	National Institutes of Health [R01-GM062791-06]; Texas Agrilife Research Project [TEX09208]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Agrilife Research Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grant R01-GM062791-06 (to M. K. A., A. R. J., T. M. C., and B. O. P.) and Texas Agrilife Research Project TEX09208 (to D. W. P.).	Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060; Applebee MK, 2008, J BACTERIOL, V190, P5087, DOI 10.1128/JB.01976-07; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Booth I. R., 2005, MODULE 3 4 3 GLYCERO; Burkala E, 2007, MICROBIOL-SGM, V153, P2180, DOI 10.1099/mic.0.2007/005470-0; Bystrom CE, 1999, BIOCHEMISTRY-US, V38, P3508, DOI 10.1021/bi982460z; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chagneau C, 2001, J BACTERIOL, V183, P5675, DOI 10.1128/JB.183.19.5675-5683.2001; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Counago R, 2008, PROTEIN ENG DES SEL, V21, P19, DOI 10.1093/protein/gzm072; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; Crozat E, 2010, MOL BIOL EVOL, V27, P2113, DOI 10.1093/molbev/msq099; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DERIEL JK, 1978, BIOCHEMISTRY-US, V17, P5141, DOI 10.1021/bi00617a011; DERIEL JK, 1978, BIOCHEMISTRY-US, V17, P5134, DOI 10.1021/bi00617a010; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; FREEDBERG WB, 1971, J BACTERIOL, V108, P137, DOI 10.1128/JB.108.1.137-144.1971; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Holtman CK, 2001, J BACTERIOL, V183, P3336, DOI 10.1128/JB.183.11.3336-3344.2001; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Knight CG, 2006, NAT GENET, V38, P1015, DOI 10.1038/ng1867; KRYMKIEWICZ N, 1971, J BACTERIOL, V108, P1338, DOI 10.1128/JB.108.3.1338-1347.1971; LARSON TJ, 1987, J BIOL CHEM, V262, P15869; Le Gac M, 2010, MOL ECOL, V19, P2430, DOI 10.1111/j.1365-294X.2010.04664.x; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIU WZ, 1994, BIOCHEMISTRY-US, V33, P10120, DOI 10.1021/bi00199a040; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; NOVOTNY MJ, 1985, J BACTERIOL, V162, P810, DOI 10.1128/JB.162.2.810-816.1985; Pettigrew DW, 2009, ARCH BIOCHEM BIOPHYS, V492, P29, DOI 10.1016/j.abb.2009.10.001; PETTIGREW DW, 1990, BIOCHEMISTRY-US, V29, P8620, DOI 10.1021/bi00489a018; Pettigrew DW, 1996, J BACTERIOL, V178, P2846, DOI 10.1128/jb.178.10.2846-2852.1996; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; POSTMA PW, 1984, J BACTERIOL, V158, P351, DOI 10.1128/JB.158.1.351-353.1984; Rohwer JM, 1998, MOL MICROBIOL, V29, P641, DOI 10.1046/j.1365-2958.1998.00963.x; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Yu P, 2003, BIOCHEMISTRY-US, V42, P4243, DOI 10.1021/bi027142l; Zhu MM, 2001, METAB ENG, V3, P218, DOI 10.1006/mben.2001.0186; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970; ZWAIG N, 1966, SCIENCE, V153, P755, DOI 10.1126/science.153.3737.755	73	46	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23150	23159		10.1074/jbc.M110.195305	http://dx.doi.org/10.1074/jbc.M110.195305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550976	Green Published, hybrid			2022-12-27	WOS:000292025000049
J	Bhamidi, S; Scherman, MS; Jones, V; Crick, DC; Belisle, JT; Brennan, PJ; McNeil, MR				Bhamidi, Suresh; Scherman, Michael S.; Jones, Victoria; Crick, Dean C.; Belisle, John T.; Brennan, Patrick J.; McNeil, Michael R.			Detailed Structural and Quantitative Analysis Reveals the Spatial Organization of the Cell Walls of in Vivo Grown Mycobacterium leprae and in Vitro Grown Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; GRAM-NEGATIVE BACTERIA; MYCOLIC ACIDS; OUTER-MEMBRANE; LIPID-BILAYER; PEPTIDOGLYCAN; ARABINOGALACTAN; IDENTIFICATION; LOCATION; MODEL	The cell wall of mycobacteria consists of an outer membrane, analogous to that of Gram-negative bacteria, attached to the peptidoglycan (PG) via a connecting polysaccharide arabinogalactan (AG). Although the primary structure of these components is fairly well deciphered, issues such as the coverage of the PG layer by covalently attached mycolates in the outer membrane and the spatial details of the mycolic acid attachment to the arabinan have remained unknown. It is also not understood how these components work together to lead to the classical acid-fast staining of mycobacteria. Because the majority of Mycobacterium tuberculosis bacteria in established experimental animal infections are acid-fast negative, clearly cell wall changes are occurring. To address both the spatial properties of mycobacterial cell walls and to begin to study the differences between bacteria grown in animals and cultures, the cell walls of Mycobacterium leprae grown in armadillos was characterized and compared with that of M. tuberculosis grown in culture. Most fundamentally, it was determined that the cell wall of M. leprae contained significantly more mycolic acids attached to PG than that of in vitro grown M. tuberculosis (mycolate: PG ratios of 21: 10 versus 16: 10, respectively). In keeping with this difference, more arabinogalactan (AG) molecules, linking the mycolic acids to PG, were found. Differences in the structures of the AG were also found; the AG of M. leprae is smaller than that of M. tuberculosis, although the same basic structural motifs are retained.	[Bhamidi, Suresh; Scherman, Michael S.; Jones, Victoria; Crick, Dean C.; Belisle, John T.; Brennan, Patrick J.; McNeil, Michael R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mmcneil@colostate.edu	Brennan, Patrick J/G-6896-2017; McNeil, Michael/G-3325-2019; Crick, Dean/H-8251-2017; Belisle, John T/B-8944-2017	Crick, Dean/0000-0001-9281-7058; Belisle, John T/0000-0002-2539-2798	National Institutes of Health, USPHS NIAID [AI-33706, AI049151, AI018357]; Bill and Melinda Gates Foundation [42775]; National Institutes of Health NIAID [AI 25469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049151, R56AI049151, N01AI025469, R01AI018357, R01AI033706, R22AI018357, R37AI018357] Funding Source: NIH RePORTER	National Institutes of Health, USPHS NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-33706 (to M. R. M.), AI049151 (to D. C. C.), and AI018357 (to P. J. B.) from USPHS NIAID. This work was also supported by Grant 42775 from the Bill and Melinda Gates Foundation (to J. T. B. and D. C. C.).; We gratefully acknowledge Dr. John Spencer for providing the M. leprae cell wall core via National Institutes of Health NIAID Contract AI 25469 and Dr. Alan Schenkel for help with statistical analysis.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; AMARNACASCH C, 1970, B SOC CHIM BIOL, V52, P145; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CRICK DC, 2004, TUBERCULOSIS, P115; CUMMINS CS, 1967, J GEN MICROBIOL, V49, P377, DOI 10.1099/00221287-49-3-377; CUNTO G, 1969, BIOCHIM BIOPHYS ACTA, V192, P358, DOI 10.1016/0304-4165(69)90378-X; DAFFE M, 1990, J BIOL CHEM, V265, P6734; DAVID HL, 1983, CURR MICROBIOL, V9, P269, DOI 10.1007/BF01567199; Dmitriev BA, 2003, J BACTERIOL, V185, P3458, DOI 10.1128/JB.185.11.3458-3468.2003; Dong X, 2006, APPL ENVIRON MICROB, V72, P2601, DOI 10.1128/AEM.72.4.2601-2605.2006; DRAPER P, 1987, J GEN MICROBIOL, V133, P1187; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUNTER SW, 1990, J BIOL CHEM, V265, P14065; KUSAKA T, 1986, J GEN MICROBIOL, V132, P3403; Levy L, 1976, Lepr Rev, V47, P103; Mahapatra S, 2008, J BACTERIOL, V190, P655, DOI 10.1128/JB.00982-07; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; MINNIKIN DE, 1967, CHEM COMMUN, P916, DOI 10.1039/c19670000916; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2013; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; SMITH DPE, 1987, P NATL ACAD SCI USA, V84, P969, DOI 10.1073/pnas.84.4.969; Song SH, 2009, J MICROBIOL METH, V77, P165, DOI 10.1016/j.mimet.2009.01.023; SWEET DP, 1975, CARBOHYD RES, V40, P217, DOI 10.1016/S0008-6215(00)82604-X; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Vijayaraghavan R, 2009, SCAND J LAB ANIM SCI, V36, P167; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; WIENTJES FB, 1991, J BACTERIOL, V173, P7684, DOI 10.1128/jb.173.23.7684-7691.1991; ZARITSKY A, 1979, FEBS LETT, V98, P29, DOI 10.1016/0014-5793(79)80144-1; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	39	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23168	23177		10.1074/jbc.M110.210534	http://dx.doi.org/10.1074/jbc.M110.210534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555513	Green Published, hybrid			2022-12-27	WOS:000292025000051
J	Liu, J; Yan, YL; Liu, LJ; Xie, ZJ; Malhotra, D; Joe, B; Shapiro, JI				Liu, Jiang; Yan, Yanling; Liu, Lijun; Xie, Zijian; Malhotra, Deepak; Joe, Bina; Shapiro, Joseph I.			Impairment of Na/K-ATPase Signaling in Renal Proximal Tubule Contributes to Dahl Salt-sensitive Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS CARDIOTONIC STEROIDS; SODIUM-PUMP; BLOOD-PRESSURE; OUABAIN; MARINOBUFAGENIN; RATS; EXCHANGER; LIGANDS; LLC-PK1; PROTEIN	We have observed that, in renal proximal tubular cells, cardiotonic steroids such as ouabain in vitro signal through Na/K-ATPase, which results in inhibition of transepithelial Na-22(+) transport by redistributing Na/K-ATPase and NHE3. In the present study, we investigate the role of Na/K-ATPase signaling in renal sodium excretion and blood pressure regulation in vivo. In Sprague-Dawley rats, high salt diet activated c-Src and induced redistribution of Na/K-ATPase and NHE3 in renal proximal tubules. In Dahl salt sensitive ( S) and resistant ( R) rats given high dietary salt, we found different effects on blood pressure but, more interestingly, different effects on renal salt handling. These differences could be explained by different signaling through the proximal tubular Na/K-ATPase. Specifically, in Dahl R rats, high salt diet significantly stimulated phosphorylation of c-Src and ERK1/2, reduced Na/K-ATPase activity and NHE3 activity, and caused redistribution of Na/K-ATPase and NHE3. In contrast, these adaptations were either much less effective or not seen in the Dahl S rats. We also studied the primary culture of renal proximal tubule isolated from Dahl S and R rats fed a low salt diet. In this system, ouabain induced Na/K-ATPase/c-Src signaling and redistribution of Na/K-ATPase and NHE3 in the Dahl R rats, but not in the Dahl S rats. Our data suggested that impairment of Na/K-ATPase signaling and consequent regulation of Na/K-ATPase and NHE3 in renal proximal tubule may contribute to salt-induced hypertension in the Dahl S rat.	[Liu, Jiang; Yan, Yanling; Xie, Zijian; Malhotra, Deepak; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Hlth Sci Campus,3000 Arlington Ave, Toledo, OH 43614 USA; [Liu, Lijun; Xie, Zijian; Joe, Bina; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Yan, Yanling] Yanshan Univ, Inst Biomed Engn, Qinhuangdao, Peoples R China	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; Yanshan University	Liu, J (corresponding author), Univ Toledo, Coll Med, Dept Med, Hlth Sci Campus,3000 Arlington Ave, Toledo, OH 43614 USA.	Jiang.Liu@utoledo.edu	Yan, Yanling/AAX-1691-2020; Yan, Yanling/AAE-8460-2021; Liu, Jiang/AAF-2742-2021	Yan, Yanling/0000-0001-6549-3393; 	National Institutes of Health [GM78565, HL36573, HL020176, HL076709]; American Heart Association Ohio Valley Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL020176, P01HL036573, R01HL076709, R01HL020176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM78565 and HL36573 (to Z. X.) and HL020176 and HL076709 (to B. J.) from the National Institutes of Health and the American Heart Association Ohio Valley Affiliate (to J. L.).	Bacic D, 2003, KIDNEY INT, V64, P2133, DOI 10.1046/j.1523-1755.2003.00308.x; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bagrov AY, 2005, FRONT BIOSCI-LANDMRK, V10, P2250, DOI 10.2741/1694; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Blaustein MP, 2010, BBA-MOL BASIS DIS, V1802, P1219, DOI 10.1016/j.bbadis.2010.02.011; BLAUSTEIN MP, 1991, HYPERTENSION, V18, pS184; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; DAHL LK, 1974, CIRC RES, V34, P94, DOI 10.1161/01.RES.34.1.94; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; DAHL LK, 1969, CIRC RES, V24, pI21; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Fedorova OV, 2006, HYPERTENSION, V48, P1160, DOI 10.1161/01.HYP.0000248129.20524.d0; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; Fedorova OV, 2005, J HYPERTENS, V23, P835, DOI 10.1097/01.hjh.0000163153.27954.33; Fedorova OV, 2002, CIRCULATION, V105, P1122, DOI 10.1161/hc0902.104710; Fedorova OV, 2000, CIRCULATION, V102, P3009; Jaitovich A, 2010, LIFE SCI, V86, P73, DOI 10.1016/j.lfs.2009.10.019; Kashkin VA, 2008, EUR NEUROPSYCHOPHARM, V18, P74, DOI 10.1016/j.euroneuro.2007.05.006; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Mokry M, 2008, HYPERTENSION, V51, P922, DOI 10.1161/HYPERTENSIONAHA.107.108415; Nesher M, 2009, AM J PHYSIOL-HEART C, V297, pH2026, DOI 10.1152/ajpheart.00734.2009; Periyasamy SM, 2005, KIDNEY INT, V67, P1868, DOI 10.1111/j.1523-1755.2005.00285.x; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; RAPP JP, 1982, HYPERTENSION, V4, P753, DOI 10.1161/01.HYP.4.6.753; Ritz E, 2010, NEPHROLOGY, V15, P49, DOI 10.1111/j.1440-1797.2010.01311.x; ROMAN RJ, 1987, AM J PHYSIOL, V252, pR833, DOI 10.1152/ajpregu.1987.252.5.R833; Schoner W, 2008, NEPHROL DIAL TRANSPL, V23, P2723, DOI 10.1093/ndt/gfn325; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; YUAN C, 1993, J CARDIOVASC PHARM, V22, pS10, DOI 10.1097/00005344-199322002-00005; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	36	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22806	22813		10.1074/jbc.M111.246249	http://dx.doi.org/10.1074/jbc.M111.246249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555512	Green Published, hybrid			2022-12-27	WOS:000292025000015
J	Pantazaka, E; Taylor, CW				Pantazaka, Evangelia; Taylor, Colin W.			Differential Distribution, Clustering, and Lateral Diffusion of Subtypes of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; IP3 RECEPTORS; CA2+ WAVES; CHANNEL; TYPE-2; CALCIUM; PROTEIN; MOBILITY; LOCALIZATION; ACTIVATION	Regulation of inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) by IP3 and Ca2+ allows them to initiate and regeneratively propagate intracellular Ca2+ signals. The distribution and mobility of IP3R determines the spatial organization of these Ca2+ signals. Until now, there has been no systematic comparison of the distribution and mobility of the three mammalian IP3R subtypes in a uniform background. We used confocal microscopy and fluorescence recovery after photobleaching to define these properties for each IP3R subtype expressed heterologously in COS-7 cells. IP(3)R1 and IP(3)R3 were uniformly distributed within the membranes of the endoplasmic reticulum (ER), but the distribution of IP(3)R2 was punctate. The mobile fractions (M-f = 84 +/- 2 and 80 +/- 2%) and diffusion coefficients (D = 0.018 +/- 0.001 and 0.016 +/- 0.002 mu m(2)/s) of IP(3)R1 and IP(3)R3 were similar. Other ER membrane proteins (ryanodine receptor type 1 and sarco/endoplasmic reticulum Ca2+-ATPase type 1) and a luminal protein (enhanced GFP with a KDEL retrieval sequence) had similar mobile fractions, suggesting that IP(3)R1 and IP(3)R3 move freely within an ER that is largely, although not entirely, continuous. IP(3)R2 was less mobile, but IP(3)R2 mobility differed between perinuclear (M-f = 47 +/- 4% and D = 0.004 +/- 0.001 mu m(2)/s) and near-plasma membrane (M-f = 64 +/- 6% and D = 0.013 +/- 0.004 mu m(2)/s) regions, whereas IP(3)R3 behaved similarly in both regions. We conclude that IP(3)R1 and IP(3)R3 diffuse freely within a largely continuous ER, but IP(3)R2 is more heterogeneously distributed and less mobile, and its mobility differs between regions of the cell.	[Pantazaka, Evangelia; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	; Taylor, Colin/G-2447-2010	PANTAZAKA, EVANGELIA/0000-0001-6737-8428; Taylor, Colin/0000-0001-7771-1044	Medical Research Council UK [G0700843]; Wellcome Trust [085295]; Medical Research Council [G0700843] Funding Source: researchfish; MRC [G0700843] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council UK Grant G0700843 and Wellcome Trust Grant 085295.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Berg H. C., 1983, RANDOM WALKS BIOL; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; Chalmers M, 2006, BIOCHEM J, V394, P57, DOI 10.1042/BJ20051130; Cruttwell C, 2005, BIOL CELL, V97, P699, DOI 10.1042/BC20040503; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2006, BIOCHEM BIOPH RES CO, V342, P573, DOI 10.1016/j.bbrc.2006.02.010; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Fukatsu K, 2010, J NEUROCHEM, V114, P1720, DOI 10.1111/j.1471-4159.2010.06885.x; Gibson CJ, 2008, CELL CALCIUM, V43, P228, DOI 10.1016/j.ceca.2007.05.008; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; KWON G, 1994, CELL SIGNAL, V6, P663, DOI 10.1016/0898-6568(94)90049-3; Laflamme K, 2002, J CELL BIOCHEM, V85, P219, DOI 10.1002/jcb.10124; Mak DOD, 2000, J GEN PHYSIOL, V115, P241, DOI 10.1085/jgp.115.3.241; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Meur G, 2007, J BIOL CHEM, V282, P23096, DOI 10.1074/jbc.M702457200; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Newton T, 2003, BIOCHEM J, V371, P775, DOI 10.1042/BJ20021477; Pantazaka E, 2010, BIOCHEM J, V425, P61, DOI 10.1042/BJ20091051; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rahman T, 2009, CHANNELS, V3, P226, DOI 10.4161/chan.3.4.9247; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; Wiltgen SM, 2010, BIOPHYS J, V99, P437, DOI 10.1016/j.bpj.2010.04.037; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wolfram F, 2010, BIOCHEM J, V428, P483, DOI 10.1042/BJ20100143	48	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23378	23387		10.1074/jbc.M111.236372	http://dx.doi.org/10.1074/jbc.M111.236372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550988	hybrid, Green Published			2022-12-27	WOS:000292025000069
J	Swindall, AF; Bellis, SL				Swindall, Amanda F.; Bellis, Susan L.			Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; HUMAN COLORECTAL-CANCER; SIALYLTRANSFERASE ACTIVITY; SURFACE ANTIGEN; SUGAR CHAINS; N-GLYCANS; EXPRESSION; GLYCOSYLATION; CD95; RESISTANCE	The glycosyltransferase, ST6Gal-I, adds sialic acid in an alpha 2-6 linkage to the N-glycans of membrane and secreted glycoproteins. Up-regulation of ST6Gal-I occurs in many cancers, including colon carcinoma, and correlates with metastasis and poor prognosis. However, mechanisms by which ST6Gal-I facilitates tumor progression remain poorly understood due to limited knowledge of enzyme substrates. Herein we identify the death receptor, Fas (CD95), as an ST6Gal-I substrate, and show that alpha 2-6 sialylation of Fas confers protection against Fas-mediated apoptosis. Intriguingly, differences in ST6Gal-I activity do not affect the function of DR4 or DR5 death receptors upon treatment with TRAIL, implicating a selective effect of ST6Gal-I on the Fas receptor. Using ST6Gal-I knockdown and forced overexpression colon carcinoma cell models, we find that alpha 2-6 sialylation of Fas prevents apoptosis stimulated by FasL as well as the Fas-activating antibody, CH11, as evidenced by decreased activation of caspases 8 and 3. We also show that alpha 2-6 sialylation of Fas does not alter the binding of CH11, but rather inhibits the capacity of Fas to induce apoptosis by blocking the association of FADD with Fas cytoplasmic tails, an event that initiates death-inducing signaling complex formation. Furthermore, alpha 2-6 sialylation of Fas inhibits Fas internalization, which is required for apoptotic signaling. Although dysregulated Fas activity is a well known mechanism through which tumors evade apoptosis, the current study is the first to link Fas insensitivity to the actions of a specific sialyltransferase. This finding establishes a new paradigm by which death receptor function is impaired for the self-protection of tumors against apoptosis.	[Swindall, Amanda F.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,982A MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu	Swindall, Amanda/F-3935-2012		NCI, NIH [R01 CA84248]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA84248 (to S. L. B.) from the NCI, NIH.; Supported by the Howard Hughes Med-into-Grad Ph.D. program, as well as a pre-doctoral fellowship from the American Heart Association.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Baldwin RL, 1999, GYNECOL ONCOL, V74, P265, DOI 10.1006/gyno.1999.5448; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; BRESALIER RS, 1990, CANCER RES, V50, P1299; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DALLOLIO F, 1989, INT J CANCER, V44, P434; DALLOLIO F, 1995, BIOCHEM BIOPH RES CO, V211, P554, DOI 10.1006/bbrc.1995.1849; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; GESSNER P, 1993, CANCER LETT, V75, P143, DOI 10.1016/0304-3835(93)90056-F; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; HARVEY BE, 1992, CANCER RES, V52, P1775; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Landowski TH, 1997, BLOOD, V89, P1854, DOI 10.1182/blood.V89.6.1854; Lebel M, 1996, ONCOGENE, V12, P1127; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; LEMARER N, 1992, GLYCOBIOLOGY, V2, P49, DOI 10.1093/glycob/2.1.49; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mahmood Z, 2010, EXP CELL RES, V316, P887, DOI 10.1016/j.yexcr.2009.12.011; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; NATOLI G, 1995, ONCOGENE, V11, P1157; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; OEHM A, 1992, J BIOL CHEM, V267, P10709; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Recchi MA, 1998, CANCER RES, V58, P4066; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shirley S., 2010, CANC LETT IN PRESS; SKACEL PO, 1991, BLOOD, V78, P1452; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; VIERBUCHEN MJ, 1995, CANCER, V76, P727, DOI 10.1002/1097-0142(19950901)76:5<727::AID-CNCR2820760504>3.0.CO;2-R; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walker PR, 1997, J IMMUNOL, V158, P4521; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	54	139	141	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22982	22990		10.1074/jbc.M110.211375	http://dx.doi.org/10.1074/jbc.M110.211375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550977	Green Published, hybrid			2022-12-27	WOS:000292025000033
J	Yamaguchi, S; Jha, A; Li, Q; Soyombo, AA; Dickinson, GD; Churamani, D; Brailoiu, E; Patel, S; Muallem, S				Yamaguchi, Soichiro; Jha, Archana; Li, Qin; Soyombo, Abigail A.; Dickinson, George D.; Churamani, Dev; Brailoiu, Eugen; Patel, Sandip; Muallem, Shmuel			Transient Receptor Potential Mucolipin 1 (TRPML1) and Two-pore Channels Are Functionally Independent Organellar Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; VARITINT-WADDLER PHENOTYPE; CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; MOBILIZES CALCIUM; ACIDIC ORGANELLES; PLASMA-MEMBRANE; RELEASE CHANNEL; CA2+ RELEASE; SEA-URCHIN	NAADP is a potent second messenger that mobilizes Ca2+ from acidic organelles such as endosomes and lysosomes. The molecular basis for Ca2+ release by NAADP, however, is uncertain. TRP mucolipins (TRPMLs) and two-pore channels (TPCs) are Ca2+-permeable ion channels present within the endolysosomal system. Both have been proposed as targets for NAADP. In the present study, we probed possible physical and functional association of these ion channels. Exogenously expressed TRPML1 showed near complete colocalization with TPC2 and partial colocalization with TPC1. TRPML3 overlap with TPC2 was more modest. TRPML1 and to some extent TRPML3 co-immuno-precipitated with TPC2 but less so with TPC1. Current recording, however, showed that TPC1 and TPC2 did not affect the activity of wild-type TRPML1 or constitutively active TRPML1(V432P). N-terminally truncated TPC2 (TPC2delN), which is targeted to the plasma membrane, also failed to affect TRPML1 and TRPML1(V432P) channel function or TRPML1(V432P)-mediated Ca2+ influx. Whereas overexpression of TPCs enhanced NAADP-mediated Ca2+ signals, overexpression of TRPML1 did not, and the dominant negative TRPML1(D471K) was without affect on endogenous NAADP-mediated Ca2+ signals. Furthermore, the single channel properties of NAADP-activated TPC2delN were not affected by TRPML1. Finally, NAADP-evoked Ca2+ oscillations in pancreatic acinar cells were identical in wild-type and TRPML1(-/-) cells. We conclude that although TRPML1 and TPCs are present in the same complex, they function as two independent organellar ion channels and that TPCs, not TRPMLs, are the targets for NAADP.	[Dickinson, George D.; Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Yamaguchi, Soichiro; Li, Qin; Soyombo, Abigail A.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75235 USA; [Jha, Archana] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Brailoiu, Eugen] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA	University of London; University College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; shmuel.muallem@nih.gov	jha, archana/AAQ-2120-2020; Yamaguchi, Soichiro/Q-8563-2019; Dickinson, George/H-6609-2016; Dickinson, George/D-1461-2009; Patel, Sandip/O-9591-2015	Dickinson, George/0000-0001-7711-0388; Dickinson, George/0000-0001-7711-0388; Soyombo, Abigail/0000-0003-0850-2593; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [DE12309, DK38938, HL90804]; NIDCR/DIR [ZIA DE000735-01]; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; Uehara Memorial Foundation (Tokyo, Japan); BBSRC [BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Uehara Memorial Foundation (Tokyo, Japan)(Uehara Memorial Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DE12309 and DK38938 and the intramural NIDCR/DIR (Grant ZIA DE000735-01), National Institutes of Health (to S. M.) and HL90804 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G013721/1 (to S. P.).; Supported by the Uehara Memorial Foundation (Tokyo, Japan).	Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dickinson GD, 2010, J BIOL CHEM, V285, P13321, DOI 10.1074/jbc.C110.112573; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2010, J BIOL CHEM, V285, P16513, DOI 10.1074/jbc.M109.078204; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel SD, 2010, SURG LAPARO ENDO PER, V20, P20, DOI 10.1097/SLE.0b013e3181cd45f2; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Ruas M., 2010, CURR BIOL; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	50	64	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22934	22942		10.1074/jbc.M110.210930	http://dx.doi.org/10.1074/jbc.M110.210930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540176	hybrid, Green Published			2022-12-27	WOS:000292025000028
J	Abdou, HS; Atlas, E; Hache, RJG				Abdou, Houssein-Salem; Atlas, Ella; Hache, Robert J. G.			Liver-enriched Inhibitory Protein (LIP) Actively Inhibits Preadipocyte Differentiation through Histone Deacetylase 1 (HDAC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; PHOSPHORYLATION; ACETYLATION; EXPRESSION; DELTA; TRANSACTIVATION	The CCAAT/enhancer-binding protein beta (C/EBP beta) is expressed as three isoforms (LAP*, liver-enriched activating protein (LAP), and liver-enriched inhibitory protein (LIP)) that differentially regulate gene expression. The interplay between LAP*, LAP, and LIP in regulating cellular processes is largely unknown, and LIP has been largely regarded to repress transcription through a passive heterodimerization-dependent mechanism. Recently, we have shown that p300/GCN5 and mSin3A/HDAC1 differentially regulate the ability of C/EBP beta to stimulate preadipocyte differentiation through activation of C/ebp alpha transcription. Here, we have mapped requirements for binding of mSin3A/HDAC1 to LAP/LAP* and LIP to a 4-amino acid motif in the central region of LAP/LAP* (residues 153-156) and the N terminus of LIP. Reducing mSin3A/HDAC1 binding to LAP/LAP* and LIP through deletion of this motif reduced the recruitment of HDAC1 to the C/ebp alpha promoter and increased preadipocyte differentiation stimulated by insulin and 1-methyl-3-isobutylxanthine. Additional studies showed that the interaction of HDAC1 with LIP provides for active repression of C/ebp alpha transcription and is largely responsible for the ability of LIP and HDAC1 to repress preadipocyte differentiation. Thus, although mSin3A/HDAC1 interacted readily with LAP/LAP* in addition to LIP and that expression of LAP/LAP* was sufficient to recruitHDAC1 to the C/ebp alpha promoter, mutations in C/ebp beta that abrogated HDAC1 association to LAP/LAP* in the absence of LIP provided no additional stimulation of differentiation or transcription beyond the deletion of LIP alone. The implication of these results for the interaction between p300/GCN5 and mSin3A/HDAC1 in regulating C/EBP alpha transcription and preadipocyte differentiation are discussed.	[Hache, Robert J. G.] Univ Calgary, So Alberta Canc Res Inst, Dept Anat & Cell Biol, Calgary, AB T2N 1N4, Canada; [Abdou, Houssein-Salem] Univ Ottawa, Grad Program Biochem, Ottawa, ON K1N 6N5, Canada; [Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON KIA OK9, Canada	University of Calgary; University of Ottawa; Health Canada	Hache, RJG (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Dept Anat & Cell Biol, Calgary, AB T2N 1N4, Canada.	rjhache@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant (to R. J. G. H.) and by a studentship (to H.-S. A.) from the Canadian Institutes of Health Research.	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Elberg G, 2000, J BIOL CHEM, V275, P27815; Gantt KR, 2004, BIOCHEM BIOPH RES CO, V313, P619, DOI 10.1016/j.bbrc.2003.11.162; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Turgeon N, 2008, J CELL BIOCHEM, V103, P1573, DOI 10.1002/jcb.21544; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011	30	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21488	21499		10.1074/jbc.M110.211540	http://dx.doi.org/10.1074/jbc.M110.211540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521687	Green Published, hybrid			2022-12-27	WOS:000291464700047
J	Micheva-Viteva, S; Kobayashi, Y; Edelstein, LC; Pacchia, AL; Lee, HLR; Graci, JD; Breslin, J; Phelan, BD; Miller, LK; Colacino, JM; Gu, ZX; Ron, Y; Peltz, SW; Dougherty, JP				Micheva-Viteva, Sofiya; Kobayashi, Yoshifumi; Edelstein, Leonard C.; Pacchia, Annmarie L.; Lee, Hui-Ling Rose; Graci, Jason D.; Breslin, Jamie; Phelan, Bradley D.; Miller, Leia K.; Colacino, Joseph M.; Gu, Zhengxian; Ron, Yacov; Peltz, Stuart W.; Dougherty, Joseph P.			High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; NF-KAPPA-B; VALPROIC ACID; IN-VIVO; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; GENE-EXPRESSION; RESERVOIR; INTERLEUKIN-2	Current antiretroviral therapy (ART) provides potent suppression of HIV-1 replication. However, ART does not target latent viral reservoirs, so persistent infection remains a challenge. Small molecules with pharmacological properties that allow them to reach and activate viral reservoirs could potentially be utilized to eliminate the latent arm of the infection when used in combination with ART. Here we describe a cell-based system modeling HIV-1 latency that was utilized in a high-throughput screen to identify small molecule antagonists of HIV-1 latency. A more detailed analysis is provided for one of the hit compounds, antiviral 6 (AV6), which required nuclear factor of activated T cells for early mRNA expression while exhibiting RNA-stabilizing activity. It was found that AV6 reproducibly activated latent provirus from different lymphocyte-based clonal cell lines as well as from latently infected primary resting CD4(+) T cells without causing general T cell proliferation or activation. Moreover, AV6 complemented the latency antagonist activity of a previously described histone deacetylase (HDAC) inhibitor. This is a proof of concept showing that a high-throughput screen employing a cell-based model of HIV-1 latency can be utilized to identify new classes of compounds that can be used in concert with other persistent antagonists with the aim of viral clearance.	[Micheva-Viteva, Sofiya; Kobayashi, Yoshifumi; Edelstein, Leonard C.; Pacchia, Annmarie L.; Lee, Hui-Ling Rose; Phelan, Bradley D.; Miller, Leia K.; Ron, Yacov; Dougherty, Joseph P.] Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Graci, Jason D.; Breslin, Jamie; Colacino, Joseph M.; Gu, Zhengxian; Peltz, Stuart W.] PTC Therapeut Inc, S Plainfield, NJ 07080 USA; [Micheva-Viteva, Sofiya; Lee, Hui-Ling Rose; Phelan, Bradley D.; Miller, Leia K.; Ron, Yacov; Dougherty, Joseph P.] Rutgers State Univ, Grad Program Mol Biosci, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick	Dougherty, JP (corresponding author), Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	doughejp@umdnj.edu		Edelstein, Leonard/0000-0002-8976-6410	National Institutes of Health [AI070039, AI081307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070039, R01AI081307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070039 and AI081307 (to J. P. D.). J. D. G., J. B., Z. G., and S. W. P. declare competing financial interests.	Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Agosto LM, 2009, J VIROL, V83, P8153, DOI 10.1128/JVI.00220-09; Ahlberg C, 1999, DRUG DISCOV TODAY, V4, P370, DOI 10.1016/S1359-6446(99)01373-2; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fondere JM, 2004, J VIROL, V78, P10536, DOI 10.1128/JVI.78.19.10536-10542.2004; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Micheva-Viteva S, 2005, ANTIMICROB AGENTS CH, V49, P5185, DOI 10.1128/AAC.49.12.5185-5188.2005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Rullas J, 2004, ANTIVIR THER, V9, P545; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	44	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21083	21091		10.1074/jbc.M110.195537	http://dx.doi.org/10.1074/jbc.M110.195537			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498519	hybrid, Green Published			2022-12-27	WOS:000291464700007
J	Kozlov, G; Denisov, AY; Girard, M; Dicaire, MJ; Hamlin, J; McPherson, PS; Brais, B; Gehring, K				Kozlov, Guennadi; Denisov, Alexey Y.; Girard, Martine; Dicaire, Marie-Josee; Hamlin, Jason; McPherson, Peter S.; Brais, Bernard; Gehring, Kalle			Structural Basis of Defects in the Sacsin HEPN Domain Responsible for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE; REFINEMENT; MUTATIONS; AGGREGATION; RESOLUTION; MITOPHAGY; PROTEINS; SYSTEMS; COMMON	Sacsin is a 520-kDa protein mutated in the early-onset neuro-developmental and neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The C terminus of the protein contains an HEPN (higher eukaryotes and prokaryotes nucleotide-binding) domain of unknown function. Here, we determined the high-resolution 1.9-angstrom crystal structure of the HEPN domain from human sacsin. The structure is composed of five parallel alpha-helices with a large loop of several short helical segments. Two HEPN protomers assemble as a dimer to form a large positively charged cavity at the dimer interface that binds GTP and other nucleotides. The crystal structure reveals that the ARSACS N4549D mutation disrupts dimerization and protein folding. This study provides novel insights into the oligomerization state of sacsin and functions that are lost in mutations that cause ARSACS.	[Kozlov, Guennadi; Denisov, Alexey Y.; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Dicaire, Marie-Josee; Brais, Bernard] Ctr Hosp Univ Montreal, Ctr Rech, Lab Neurogenet Motricite, Montreal, PQ H2L 4M1, Canada; [Girard, Martine; Hamlin, Jason; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; Universite de Montreal; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Brais, Bernard/Y-3910-2019; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Fondation de l'Ataxie Charlevoix-Saguenay; Canadian Institutes of Health Research; Muscular Dystrophy Canada; ALS Society of Canada; National Science Foundation [DMR 0225180]; National Institutes of Health [RR01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Fondation de l'Ataxie Charlevoix-Saguenay; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada(Muscular Dystrophy Association); ALS Society of Canada; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Fondation de l'Ataxie Charlevoix-Saguenay, the Neuromuscular Research Partnership Program of the Canadian Institutes of Health Research, Muscular Dystrophy Canada, and the ALS Society of Canada.; We thank Francois Blondeau for help in the initial stages of the project. Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Grant RR01646.	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Erlandsen H, 2004, PROTEINS, V54, P806, DOI 10.1002/prot.10631; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Richter AM, 2004, NEUROGENETICS, V5, P165, DOI 10.1007/s10048-004-0179-y; Rose JM, 2011, HUM MOL GENET, V20, P16, DOI 10.1093/hmg/ddq428; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; TAKIYAMA Y, 2007, CEREBELLUM, P1; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	26	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20407	20412		10.1074/jbc.M111.232884	http://dx.doi.org/10.1074/jbc.M111.232884			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507954	hybrid, Green Published			2022-12-27	WOS:000291267600028
J	Lu, H; Wang, XH; Li, TS; Urvalek, AM; Yu, L; Li, JL; Zhu, JH; Lin, QS; Peng, X; Zhao, JH				Lu, Heng; Wang, Xianhui; Li, Tianshu; Urvalek, Alison M.; Yu, Lin; Li, Jieli; Zhu, Jinghua; Lin, Qishan; Peng, Xu; Zhao, Jihe			Identification of Poly (ADP-ribose) Polymerase-1 (PARP-1) as a Novel Kruppel-like Factor 8-interacting and -regulating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-CYCLE PROGRESSION; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; KLF8 TRANSCRIPTION; NUCLEAR EXPORT; IN-VIVO; CANCER; TARGET; CARCINOGENESIS	Kruppel-like factor 8 (KLF8) regulates critical gene transcription and cellular events associated with cancer. However, KLF8-interacting proteins remain largely unidentified. Using co-immunoprecipitation (co-IP), mass spectrometry, and GST pulldown assays, we identified poly(ADP-ribose) polymerase-1(PARP-1) as a novel KLF8-interacting protein. Co-IP and Western blotting indicated that KLF8 is also a PARP-1 substrate. Mutation of the cysteines in the zinc finger domain of KLF8 abolished PARP-1 interaction. Surprisingly, immunofluorescent staining revealed a cytoplasmic mislocalization of KLF8 in PARP-1(-/-) cells or when the interaction was disrupted. This mislocalization was prevented by either PARP-1 re-expression or inhibition of CRM1-dependent nuclearexport. Interestingly, co-IP indicated competition between PARP-1 and CRM1 for KLF8 binding. Cycloheximide chase assay showed a decrease in the half-life of KLF8 protein when PARP-1 expression was suppressed or KLF8-PARP-1 interaction was disrupted. Ubiquitination assays implicated KLF8 as a target of ubiquitination that was significantly higher in PARP-1(-/-) cells. Promoter reporter assays and chromatin immunoprecipitation assays showed that KLF8 activation on the cyclin D1 promoter was markedly reduced when PARP-1 was deleted or inhibited or when KLF8-PARP-1 interaction was disrupted. Overall, this work has identified PARP-1 as a novel KLF8-binding and-regulating protein and provided new insights into the mechanisms underlying the regulation of KLF8 nuclear localization, stability, and functions.	[Lu, Heng; Wang, Xianhui; Li, Tianshu; Urvalek, Alison M.; Yu, Lin; Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Zhu, Jinghua; Lin, Qishan] SUNY Albany, Ctr Funct Genom, Rensselaer, NY 12144 USA; [Li, Jieli; Peng, Xu] Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX 76504 USA	State University System of Florida; University of Central Florida; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhao, JH (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Room BBS-313, Orlando, FL 32827 USA.	jizhao@mail.ucf.edu	Li, Tianshu/L-6426-2014	Li, Tianshu/0000-0002-9972-4644; Lin, Qishan/0000-0002-1756-1432	National Institutes of Health, NCI [CA132977]; American Cancer Society [RSG CCG-111381]; Susan G. Komen for Cure [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen for Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA132977 from the NCI (to J.Z.). This work was also supported by the American Cancer Society (Grant RSG CCG-111381) and Susan G. Komen for Cure (Grants KG090444 and KG080616) (to J.Z.).	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Chang HS, 2010, INT J BIOCHEM CELL B, V42, P1831, DOI 10.1016/j.biocel.2010.07.019; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Drew Y, 2009, DRUG RESIST UPDATE, V12, P153, DOI 10.1016/j.drup.2009.10.001; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Hassa PO, 2009, FRONT BIOSCI-LANDMRK, V14, P72, DOI 10.2741/3232; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	35	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20335	20344		10.1074/jbc.M110.215632	http://dx.doi.org/10.1074/jbc.M110.215632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518760	hybrid, Green Published			2022-12-27	WOS:000291267600021
J	Patel, G; Johnson, DS; Sun, B; Pandey, M; Yu, X; Egelman, EH; Wang, MD; Patel, SS				Patel, Gayatri; Johnson, Daniel S.; Sun, Bo; Pandey, Manjula; Yu, Xiong; Egelman, Edward H.; Wang, Michelle D.; Patel, Smita S.			A257T Linker Region Mutant of T7 Helicase-Primase Protein Is Defective in DNA Loading and Rescued by T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BACTERIOPHAGE T7; CRYSTAL-STRUCTURE; GENE-4 PROTEIN; NUCLEOTIDE HYDROLYSIS; HEXAMERIC HELICASES; CENTRAL CHANNEL; RING HELICASE; REPLICATION; MECHANISM	The helicase and primase activities of the hexameric ring-shaped T7 gp4 protein reside in two separate domains connected by a linker region. This linker region is part of the subunit interface between monomers, and point mutations in this region have deleterious effects on the helicase functions. One such linker region mutant, A257T, is analogous to the A359T mutant of the homologous human mitochondrial DNA helicase Twinkle, which is linked to diseases such as progressive external opthalmoplegia. Electron microscopy studies show that A257T gp4 is normal in forming rings with dTTP, but the rings do not assemble efficiently on the DNA. Therefore, A257T, unlike the WT gp4, does not preassemble on the unwinding DNA substrate with dTTP without Mg(II), and its DNA unwinding activity in ensemble assays is slow and limited by the DNA loading rate. Single molecule assays measured a 45 times slower rate of A257T loading on DNA compared with WT gp4. Interestingly, once loaded, A257T has almost WT-like translocation and DNA unwinding activities. Strikingly, A257T preassembles stably on the DNA in the presence of T7 DNA polymerase, which restores the ensemble unwinding activity of A257T to similar to 75% of WT, and the rescue does not require DNA synthesis. The DNA loading rate of A257T, however, remains slow even in the presence of the polymerase, which explains why A257T does not support T7 phage growth. Similar types of defects in the related human mitochondrial DNA helicase may be responsible for inefficient DNA replication leading to the disease states.	[Patel, Gayatri; Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Johnson, Daniel S.; Sun, Bo; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Yu, Xiong; Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; Cornell University; Howard Hughes Medical Institute; University of Virginia	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu		Sun, Bo/0000-0002-4590-7795; Egelman, Edward/0000-0003-4844-5212; Johnson, Daniel/0000-0001-8906-0509	National Institutes of Health [GM55310, GM035269, GM059849]; National Science Foundation [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM059849, R01GM035269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55310 (to S. S. P.), GM035269 (to E. H. E.), and GM059849 (to M. D. W.). This work was also supported by National Science Foundation Grant MCB-0820293 (to M. D. W.).	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Ghosh S, 2008, J BIOL CHEM, V283, P32077, DOI 10.1074/jbc.M805062200; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; Pandey M, 2010, METHODS MOL BIOL, V587, P57, DOI 10.1007/978-1-60327-355-8_5; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rosenberg AH, 1996, J BIOL CHEM, V271, P26819, DOI 10.1074/jbc.271.43.26819; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STUDIER FW, 1972, SCIENCE, V176, P367, DOI 10.1126/science.176.4033.367; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	41	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20490	20499		10.1074/jbc.M110.201657	http://dx.doi.org/10.1074/jbc.M110.201657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515672	Green Published, hybrid			2022-12-27	WOS:000291267600036
J	Johnson, MP; Ruban, AV				Johnson, Matthew P.; Ruban, Alexander V.			Restoration of Rapidly Reversible Photoprotective Energy Dissipation in the Absence of PsbS Protein by Enhanced Delta pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II ANTENNA; CYCLIC ELECTRON FLOW; CHLOROPHYLL-A FLUORESCENCE; LIGHT-HARVESTING COMPLEXES; EXCITATION-ENERGY; XANTHOPHYLL CYCLE; IN-VIVO; CHLOROPLASTS; ARABIDOPSIS; ZEAXANTHIN	Variations in the light environment require higher plants to regulate the light harvesting process. Under high light a mechanism known as non-photochemical quenching (NPQ) is triggered to dissipate excess absorbed light energy within the photosystem II (PSII) antenna as heat, preventing photodamage to the reaction center. The major component of NPQ, known as qE, is rapidly reversible in the dark and dependent upon the transmembrane proton gradient (Delta pH), formed as a result of photosynthetic electron transport. Using diaminodurene and phenazine metasulfate, mediators of cyclic electron flow around photosystem I, to enhance Delta pH, it is demonstrated that rapidly reversible qE-type quenching can be observed in intact chloroplasts from Arabidopsis plants lacking the PsbS protein, previously believed to be indispensible for the process. The qE in chloroplasts lacking PsbS significantly quenched the level of fluorescence when all PSII reaction centers were in the open state (F-o state), protected PSII reaction centers from photoinhibition, was modulated by zeaxanthin and was accompanied by the qE-typical absorption spectral changes, known as Delta A(535). Titrations of the Delta pH dependence of qE in the absence of PsbS reveal that this protein affects the cooperativity and sensitivity of the photoprotective process to protons. The roles of PsbS and zeaxanthin are discussed in light of their involvement in the control of the proton-antenna association constant, pK, via regulation of the interconnected phenomena of PSII antenna reorganization/aggregation and hydrophobicity.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.ruban@qmul.ac.uk		Johnson, Matthew/0000-0002-1663-0205	Biotechnology and Biological Sciences Research Council UK; Engineering and Environmental Sciences Research Council UK	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Environmental Sciences Research Council UK	The work was supported by Biotechnology and Biological Sciences Research Council UK and Engineering and Environmental Sciences Research Council UK research grants	AMESZ J, 1967, BIOCHIM BIOPHYS ACTA, V143, P97, DOI 10.1016/0005-2728(67)90114-4; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRAUN G, 1992, BIOCHIM BIOPHYS ACTA, V1100, P58, DOI 10.1016/0167-4838(92)90536-M; CROFTS J, 1991, BIOCHIM BIOPHYS ACTA, V1058, P187, DOI 10.1016/S0005-2728(05)80236-1; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; HAUSKA GA, 1974, FEBS LETT, V41, P35, DOI 10.1016/0014-5793(74)80947-6; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Joliot PA, 2010, P NATL ACAD SCI USA, V107, P12728, DOI 10.1073/pnas.1006399107; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0005-2728(92)90097-L; KRIEGER A, 1993, PHOTOSYNTH RES, V37, P117, DOI 10.1007/BF02187470; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li H, 2004, PROTEINS, V55, P689, DOI 10.1002/prot.20032; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; MILLS J, 1975, ARCH BIOCHEM BIOPHYS, V170, P306, DOI 10.1016/0003-9861(75)90122-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Paulsen H, 1999, ADV PHOTOSYNTH, V8, P123; Perez-Bueno ML, 2008, FEBS LETT, V582, P1477, DOI 10.1016/j.febslet.2008.03.040; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REES D, 1990, PHOTOSYNTH RES, V25, P199, DOI 10.1007/BF00033161; REES D, 1989, FEBS LETT, V256, P85, DOI 10.1016/0014-5793(89)81723-5; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; ROTTENBERG H, 1972, EUR J BIOCHEM, V25, P54, DOI 10.1111/j.1432-1033.1972.tb01666.x; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 2001, BIOCHEMISTRY-US, V40, P9896, DOI 10.1021/bi010370f; RUBAN AV, 1993, J PHOTOCH PHOTOBIO B, V21, P229, DOI 10.1016/1011-1344(93)80188-F; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Spetea C, 1997, BBA-BIOENERGETICS, V1318, P275, DOI 10.1016/S0005-2728(96)00145-4; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Yamamoto H, 2006, PLANT CELL PHYSIOL, V47, P1355, DOI 10.1093/pcp/pcl005; Zia A, 2011, PLANTA, V233, P1253, DOI 10.1007/s00425-011-1380-5	66	103	107	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19973	19981		10.1074/jbc.M111.237255	http://dx.doi.org/10.1074/jbc.M111.237255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474447	Green Published, hybrid			2022-12-27	WOS:000291027700075
J	Prutting, S; Grissmer, S				Pruetting, Sylvia; Grissmer, Stephan			A Novel Current Pathway Parallel to the Central Pore in a Mutant Voltage-gated Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; K+ CHANNEL; BINDING-SITE; ION CONDUCTION; GATING PORE; PERMEATION; STATE; TETRAETHYLAMMONIUM; CHARYBDOTOXIN	Voltage-gated potassium channels are proteins composed of four subunits consisting of six membrane-spanning segments S1-S6, with S4 as the voltage sensor. The region between S5 and S6 forms the potassium-selective ion-conducting central alpha-pore. Recent studies showed that mutations in the voltage sensor of the Shaker channel could disclose another ion permeation pathway through the voltage-sensing domain (S1-S4) of the channel, the alpha-pore. In our studies we used the voltage-gated hKv1.3 channel, and the insertion of a cysteine at position V388C (Shaker position 438) generated a current through the alpha-pore in high potassium outside and an inward current at hyperpolarizing potentials carried by different cations like Na+, Li+, Cs+, and NH4+. The observed inward current looked similar to the omega-current described for the R1C/S Shaker mutant channel and was not affected by some pore blockers like charybdotoxin and tetraethylammonium but was inhibited by a phenylalkylamine blocker (verapamil) that acts from the intracellular side. Therefore, we hypothesize that the hKv1.3_V388C mutation in the P-region generated a channel with two ion-conducting pathways. One, the alpha-pore allowing K+ flux in the presence of K+, and the second pathway, the sigma-pore, functionally similar but physically distinct from the omega-pathway. The entry of this new pathway (alpha-pore) is presumably located at the backside of Y395 (Shaker position 445), proceeds parallel to the alpha-pore in the S6-S6 interface gap, ending between S5 and S6 at the intracellular side of one alpha-subunit, and is blocked by verapamil.	[Pruetting, Sylvia; Grissmer, Stephan] Univ Ulm, Inst Appl Physiol, D-89081 Ulm, Germany	Ulm University	Grissmer, S (corresponding author), Univ Ulm, Inst Appl Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	stephan.grissmer@uni-ulm.de			4SC AG (Martinsried); Land Baden-Wurttemberg [1423/74]; Deutsche Forschungsgemeinschaft [Gr848/14-1]	4SC AG (Martinsried); Land Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the 4SC AG (Martinsried), Land Baden-Wurttemberg Grant 1423/74, and Deutsche Forschungsgemeinschaft Grant Gr848/14-1.	AIYAR J, 1994, BIOPHYS J, V67, P2261, DOI 10.1016/S0006-3495(94)80710-6; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO, P74; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DECOURSEY TE, 1995, J GEN PHYSIOL, V106, P745, DOI 10.1085/jgp.106.4.745; Dreker T, 2005, MOL PHARMACOL, V68, P966, DOI 10.1124/mol.105.012401; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Furini S, 2009, PROTEINS, V74, P437, DOI 10.1002/prot.22163; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; GRISSMER S, 1989, J GEN PHYSIOL, V93, P609, DOI 10.1085/jgp.93.4.609; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, P131; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MCCLOSKEY MA, 1990, J GEN PHYSIOL, V95, P205, DOI 10.1085/jgp.95.2.205; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; Oliva C, 2005, BIOPHYS J, V89, P1009, DOI 10.1529/biophysj.105.060152; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Rauer H, 1996, MOL PHARMACOL, V50, P1625; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; VanDongen AMJ, 2004, P NATL ACAD SCI USA, V101, P3248, DOI 10.1073/pnas.0308743101	48	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20031	20042		10.1074/jbc.M110.185405	http://dx.doi.org/10.1074/jbc.M110.185405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498510	Green Published, hybrid			2022-12-27	WOS:000291027700080
J	Fan, HP; Guan, JL				Fan, Huaping; Guan, Jun-Lin			Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-SPECIFIC DISRUPTION; TUMOR-INITIATING CELLS; HUMAN BREAST-CANCER; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; MOUSE MODEL; V-SRC; FAK; PHOSPHORYLATION; MIGRATION	Mammary cancer stem cells (MaCSCs) have been identified as a rare population of cells capable of self-renewal to drive mammary tumorigenesis and metastasis. Nevertheless, relatively little is known about the intracellular signaling pathways regulating self-renewal and metastatic activities of MaCSCs in vivo. Using a recently developed breast cancer mouse model with focal adhesion kinase (FAK) deletion in mammary tumor cells (MFCKO-MT mice), here we present evidence suggesting a compensatory function of Pyk2, a FAK-related kinase, in the regulation of MaCSCs and metastasis in these mice. Increased expression of Pyk2 was found selectively in pulmonary metastatic nodules of MFCKO-MT mice, and its inhibition significantly reduced mammary tumor development and metastasis in these mice. Consistent with the idea of metastasis driven by MaCSCs, we detected selective up-regulation of Pyk2 in MaCSCs, but not bulk mammary tumor cells, of primary tumors developed in MFCKO-MT mice. We further showed that inhibition of Pyk2 in FAK-null MaCSCs significantly decreased their tumorsphere formation and migration in vitro as well as self-renewal, tumorigenicity, and metastatic activity in vivo. Last, we identified PI3K/Akt signaling as a major mediator of FAK regulation of MaCSCs as well as a target for the compensatory function of Pyk2 in FAK-null MaCSCs. Together, these results further advance our understanding of FAK and its related tyrosine kinase Pyk2 in regulation of MaCSCs in breast cancer and suggest that pharmaceutically targeting these kinases may hold promise as a novel treatment for the disease by targeting and eradicating MaCSCs.	[Fan, Huaping; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fan, Huaping; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Fan, Huaping/B-8762-2012		National Institutes of Health [GM052890, CA150926, HL073394]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM052890, CA150926, and HL073394 (to J.-L. G.).	Astier A, 1997, J BIOL CHEM, V272, P228; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chan PC, 1999, J BIOL CHEM, V274, P26901, DOI 10.1074/jbc.274.38.26901; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Raja S, 1997, J BIOL CHEM, V272, P10941; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhao JH, 2000, J CELL SCI, V113, P3063; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	58	47	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18573	18582		10.1074/jbc.M110.200717	http://dx.doi.org/10.1074/jbc.M110.200717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471206	Green Published, hybrid			2022-12-27	WOS:000290785700029
J	Hansen, JC; Wexler, BB; Rogers, DJ; Hite, KC; Panchenko, T; Ajith, S; Black, BE				Hansen, Jeffrey C.; Wexler, Brian B.; Rogers, Danielle J.; Hite, Kristopher C.; Panchenko, Tanya; Ajith, Sandya; Black, Ben E.			DNA Binding Restricts the Intrinsic Conformational Flexibility of Methyl CpG Binding Protein 2 (MeCP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; CHROMOSOMAL PROTEIN; MASS-SPECTROMETRY; NEURONAL MECP2; CHROMATIN; MUTATIONS; EXCHANGE; DISORDER; COMPLEX	Mass spectrometry-based hydrogen/deuterium exchange (H/DX) has been used to define the polypeptide backbone dynamics of full-length methyl CpG binding protein 2 MeCP2) when free in solution and when bound to unmethylated and methylated DNA. Essentially the entire MeCP2 polypeptide chain underwent H/DX at rates faster than could be measured i.e. complete exchange in <= 10 s), with the exception of the methyl DNA binding domain (MBD). Even the H/DX of the MBD was rapid compared with that of a typical globular protein. Thus, there is no single tertiary structure of MeCP2. Rather, the full-length protein rapidly samples many different conformations when free in solution. When MeCP2 binds to unmethylated DNA, H/DX is slowed several orders of magnitude throughout the MBD. Binding of MeCP2 to methylated DNA led to additional minor H/DX protection, and only locally within the N-terminal portion of the MBD. H/DX also was used to examine the structural dynamics of the isolated MBD carrying three frequent mutations associated with Rett syndrome. The effects of the mutations ranged from very little R106W) to a substantial increase in conformational sampling F155S). Our H/DX results have yielded fine resolution mapping of the structure of full-length MeCP2 in the absence and presence of DNA, provided a biochemical basis for understanding MeCP2 function in normal cells, and predicted potential approaches for the treatment of a subset of RTT cases caused by point mutations that destabilize the MBD.	[Hansen, Jeffrey C.; Hite, Kristopher C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Wexler, Brian B.; Rogers, Danielle J.; Panchenko, Tanya; Ajith, Sandya; Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Panchenko, Tanya; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Cell & Mol Biol, Philadelphia, PA 19104 USA; [Ajith, Sandya; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	Colorado State University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu; blackbe@mail.med.upenn.edu			National Institutes of Health [GM66834, GM82989, GM08275]; Burroughs Wellcome Fund; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, T32GM008275, R01GM066834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants to GM66834 (to J. C. H.), GM82989 (to B. E. B.), and GM08275 (University of Pennsylvania Structural Biology Training Grant) (to T. P.). This work is also supported by a career award in the biomedical sciences from the Burroughs Wellcome Fund and a Rita Allen Foundation scholar award (to B. E. B.).	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2005, BIOCHEM CELL BIOL, V83, P374, DOI 10.1139/o05-035; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Coales SJ, 2010, RAPID COMMUN MASS SP, V24, P3585, DOI 10.1002/rcm.4814; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2008, J BIOL CHEM, V283, P20523, DOI 10.1074/jbc.M803021200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; LaSalle JM, 2005, INT REV NEUROBIOL, V71, P131, DOI 10.1016/S0074-7742(05)71006-0; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tompa P, 2009, STRUCTURE FUNCTION I; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; YANG C, 2011, NUCL ACIDS IN PRESS; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	55	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18938	18948		10.1074/jbc.M111.234609	http://dx.doi.org/10.1074/jbc.M111.234609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21467044	hybrid, Green Published			2022-12-27	WOS:000290785700065
J	Nakayama, F; Yasuda, T; Umeda, S; Asada, M; Imamura, T; Meineke, V; Akashi, M				Nakayama, Fumiaki; Yasuda, Takeshi; Umeda, Sachiko; Asada, Masahiro; Imamura, Toru; Meineke, Viktor; Akashi, Makoto			Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain INVOLVEMENT OF INTERNALIZATION IN THE IN VIVO ROLE OF EXOGENOUS FGF12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; FACTOR HOMOLOGOUS FACTORS; FACTOR-I; NUCLEAR-LOCALIZATION; INTRACELLULAR PROTEIN; TAT PROTEIN; MAST-CELLS; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; FGF-1	The extracellular effect of fibroblast growth factor-12 (FGF12) remains unknown because FGF12 cannot activate any fibroblast growth factor receptors (FGFRs), and FGF12 is not currently thought to be released from cells. We reported previously that FGF12 plays an intracellular role in the inhibition of radiation-induced apoptosis. In this study, we demonstrated that recombinant FGF12 was able to be internalized into the cytoplasm of a rat intestinal epithelial cell line, IEC6, and this process was dependent on two novel cell-penetrating peptide (CPP) domains (CPP-M and CPP-C). In particular, CPP-C, composed of similar to 10 amino acids, was identified as a specific domain of FGF12 and its subfamily in the C-terminal region (residues 140149), although CPP-M was a common domain in the internal region of the FGF family. The absence of CPP-C from FGF12 or a mutation (E142L) in the CPP-C domain drastically reduced the internalization of FGF12 into cells. Therefore, CPP-C played an essential role in the internalization of FGF12. In addition, CPP-C was able to deliver other polypeptides into cells as a CPP because an FGF1/CPP-C chimeric protein was internalized into IEC6 cells more efficiently than wild-type FGF1. Finally, intraperitoneally added FGF12 inhibited radiation-induced apoptosis in the intestinal epithelial cells of BALB/c mice, and deletion of the CPP-C domain decreased the inhibition of the apoptosis. These findings suggest that exogenous FGF12 can play a role in tissues by translocating into cells through the plasma membrane, and the availability of this novel CPP provides a new tool for the intracellular delivery of bioactive molecules.	[Nakayama, Fumiaki] Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Nakayama, Fumiaki; Yasuda, Takeshi; Umeda, Sachiko; Akashi, Makoto] Natl Inst Radiol Sci, Dept Radiat Emergency Med, Inage Ku, Chiba 2638555, Japan; [Asada, Masahiro; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Signaling Mol Res Grp, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Meineke, Viktor] Univ Ulm, Bundeswehr Inst Radiobiol, D-80937 Munich, Germany	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institute of Advanced Industrial Science & Technology (AIST); Ulm University	Nakayama, F (corresponding author), Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	f_naka@nirs.go.jp	Yasuda, Takeshi/AAJ-4044-2021; ASADA, MASAHIRO/M-4086-2018	ASADA, MASAHIRO/0000-0001-6092-2080	Research Project for High-Dose Radiation Injuries at NIRS;  [22510065]; Grants-in-Aid for Scientific Research [22510065] Funding Source: KAKEN	Research Project for High-Dose Radiation Injuries at NIRS; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported as a part of the Research Project for High-Dose Radiation Injuries at NIRS and by KAKENHI (22510065).	Artuc M, 2002, J INVEST DERMATOL, V118, P391, DOI 10.1046/j.0022-202x.2001.01705.x; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hagiwara A, 2009, RADIAT RES, V172, P58, DOI 10.1667/RR1570.1; IMAMURA T, 1994, EXP CELL RES, V215, P363, DOI 10.1006/excr.1994.1353; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1995, BBA-MOL CELL RES, V1266, P124, DOI 10.1016/0167-4889(95)00009-H; Itoch N., 2011, J BIOCH, V149, P121; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Klingenberg O, 2000, J BIOL CHEM, V275, P11972, DOI 10.1074/jbc.275.16.11972; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Komi A, 1998, EXP CELL RES, V243, P408, DOI 10.1006/excr.1998.4176; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; MIGNATTI P, 1991, P NATL ACAD SCI USA, V88, P11007, DOI 10.1073/pnas.88.24.11007; Miyakawa K, 1999, GROWTH FACTORS, V16, P191, DOI 10.3109/08977199909002129; Mizukoshi E, 1999, BIOCHEM J, V343, P461, DOI 10.1042/0264-6021:3430461; Nakayama F, 2008, J RADIAT RES, V49, P491, DOI 10.1269/jrr.08021; Nakayama F, 2010, INT J RADIAT ONCOL, V78, P860, DOI 10.1016/j.ijrobp.2010.04.045; Nakayama F, 2009, EXP DERMATOL, V18, P889, DOI 10.1111/j.1600-0625.2009.00849.x; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; PEREZ F, 1992, J CELL SCI, V102, P717; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; REED JA, 1995, LAB INVEST, V72, P215; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Schoorlemmer J, 2002, J BIOL CHEM, V277, P49111, DOI 10.1074/jbc.M205520200; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Skjerpen CS, 2002, EMBO J, V21, P4058, DOI 10.1093/emboj/cdf402; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wesche J, 2005, BIOCHEMISTRY-US, V44, P6071, DOI 10.1021/bi047403m; Wesche J, 2006, J BIOL CHEM, V281, P11405, DOI 10.1074/jbc.M600477200; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066	49	43	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25823	25834		10.1074/jbc.M110.198267	http://dx.doi.org/10.1074/jbc.M110.198267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21518765	Green Published, hybrid			2022-12-27	WOS:000293073000044
J	Evans, JA; Rzhetsky, A				Evans, James A.; Rzhetsky, Andrey			Advancing Science through Mining Libraries, Ontologies, and Communities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLECULAR-INTERACTIONS; KNOWLEDGE; COLLABORATION; NETWORKS; BEHAVIOR; NAME	Life scientists today cannot hope to read everything relevant to their research. Emerging text-mining tools can help by identifying topics and distilling statements from books and articles with increased accuracy. Researchers often organize these statements into ontologies, consistent systems of reality claims. Like scientific thinking and interchange, however, text-mined information (even when accurately captured) is complex, redundant, sometimes incoherent, and often contradictory: it is rooted in a mixture of only partially consistent ontologies. We review work that models scientific reason and suggest how computational reasoning across ontologies and the broader distribution of textual statements can assess the certainty of statements and the process by which statements become certain. With the emergence of digitized data regarding networks of scientific authorship, institutions, and resources, we explore the possibility of accounting for social dependences and cultural biases in reasoning models. Computational reasoning is starting to fill out ontologies and flag internal inconsistencies in several areas of bioscience. In the not too distant future, scientists may be able to use statements and rich models of the processes that produced them to identify underexplored areas, resurrect forgotten findings and ideas, deconvolute the spaghetti of underlying ontologies, and synthesize novel knowledge and hypotheses.	[Evans, James A.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Evans, James A.; Rzhetsky, Andrey] Univ Chicago, Computat Inst, Argonne Natl Lab, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Inst Genom & Syst Biol, Dept Med, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago; University of Chicago	Evans, JA (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu; arzhetsky@uchicago.edu	McBee, David J/F-3968-2012; rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NIGMS NIH HHS [R01 GM061372] Funding Source: Medline; NLM NIH HHS [R01 LM010132] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bodenreider O, 2008, Yearb Med Inform, P67; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Feder ME, 2007, J EXP BIOL, V210, P1653, DOI 10.1242/jeb.02725; Fisher R.A., 1930, GENETICAL THEORY NAT; Friedman C., 2001, BIOINFORMATICS S1, V17, P74; Green ML, 2006, NUCLEIC ACIDS RES, V34, P3687, DOI 10.1093/nar/gkl438; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Harris Zellig, 1982, SUBLANGUAGE STUDIES, P231; Heckerman D, 2001, J MACH LEARN RES, V1, P49, DOI 10.1162/153244301753344614; Hirschman L, 2002, J BIOMED INFORM, V35, P247, DOI 10.1016/S1532-0464(03)00014-5; Horrocks I, 2006, LECT NOTES COMPUT SC, V3861, P201; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Jurafsky Daniel, 2000, SPEECH LANGUAGE PROC, V1st; KNORRCETINA K, 1999, EPISTEMIC CULTURES S, pR13; Knox KS, 2000, ANN ONCOL, V11, P1591, DOI 10.1023/A:1008309817708; Leach SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000215; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; PEARL J, 1988, PROBABILISTIC REASON, pR19; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Shortliffe EH., 1975, MATH BIOSCI, V23, P351, DOI [10.1016/0025-5564(75)90047-4, DOI 10.1016/0025-5564(75)90047-4]; Smalheiser NR, 2009, ANNU REV INFORM SCI, V43, P287; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Sunstein Cass R., 2006, INFOTOPIA MANY MINDS; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Yetisgen-Yildiz M, 2006, J BIOMED INFORM, V39, P600, DOI 10.1016/j.jbi.2005.11.010	33	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23659	23666		10.1074/jbc.R110.176370	http://dx.doi.org/10.1074/jbc.R110.176370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	786HO	21566119	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000292294900007
J	Satie, AP; Mazaud-Guittot, S; Seif, I; Mahe, D; He, ZG; Jouve, G; Jegou, B; Dejucq-Rainsford, N				Satie, Anne-Pascale; Mazaud-Guittot, Severine; Seif, Isabelle; Mahe, Dominique; He, Zhiguo; Jouve, Guilhem; Jegou, Bernard; Dejucq-Rainsford, Nathalie			Excess Type I Interferon Signaling in the Mouse Seminiferous Tubules Leads to Germ Cell Loss and Sterility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2'-5' OLIGOADENYLATE SYNTHETASE; TRANSGENIC MICE; SERTOLI-CELLS; MESSENGER-RNA; TESTOSTERONE PRODUCTION; SPERMATOGENIC CELLS; STIMULATED GENES; LEYDIG-CELLS; EXPRESSION; GAMMA	Type I (alpha and beta) interferons (IFNs) elicit antiproliferative and antiviral activities via the surface receptor IFNAR. Serendipitous observations in transgenic mice in 1988 strongly suggested that IFN alpha/beta overexpression in the testis disrupts spermatogenesis. Here, we compare a new mouse strain transgenic for IFN beta (Tg10) and a sister strain lacking the IFNAR1 subunit of IFNAR (Tg10-Ifnar1(-/-)), both strains expressing the transgene in the testis. The main source of IFN beta RNA was the spermatid population. Importantly, the Tg10 mice, but not the double mutant Tg10-Ifnar1(-/-), showed altered spermatogenesis. The first IFNAR-dependent histological alteration was a higher apoptosis index in all germ cell categories apart from non-dividing spermatogonia. This occurred 3 weeks after the onset of IFN beta production at postnatal day 20 and in the absence of somatic cell defects in terms of cell number, expression of specific cell markers, and hormonal activities. Several known interferon-stimulated genes were up-regulated in Tg10 Sertoli cells and prepachytene germ cells but not in pachytene spermatocytes and spermatids. In concordance with this, pachytene spermatocytes and spermatids isolated from wild-type testes did not display measurable amounts of IFNAR1 and phosphorylated STAT1 upon IFN beta challenge in vitro, suggesting hyporesponsiveness of these cell types to IFN. At day 60, Tg10 males were sterile, and Sertoli cells showed increased amounts of anti-Mullerian hormone and decreased production of inhibin B, both probably attributable to the massive germ cell loss. Type I interferon signaling may lead to idiopathic infertilities by affecting the interplay between germ cells and Sertoli cells.	[Satie, Anne-Pascale; Mazaud-Guittot, Severine; Mahe, Dominique; He, Zhiguo; Jouve, Guilhem; Jegou, Bernard; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, U625, Inst Federatif Rech, F-35042 Rennes, France; [Seif, Isabelle] Univ Paris 11, Ctr Natl Rech Sci, EA 3544, Fac Pharm, F-92296 Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dejucq-Rainsford, N (corresponding author), Univ Rennes 1, INSERM, U625, Inst Federatif Rech, Campus Beaulieu, F-35042 Rennes, France.	nathalie.dejucq-rainsford@inserm.fr	DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Mazaud-Guittot, Severine/I-4694-2015; Jégou, Bernard/I-4742-2015; MAHE, Dominique MD/I-7316-2015	Mazaud-Guittot, Severine/0000-0003-0566-4124; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; JEGOU, Bernard/0000-0003-0623-3609				ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; Aubry F, 2000, EUR CYTOKINE NETW, V11, P690; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; Cai LY, 2009, REPROD TOXICOL, V27, P14, DOI 10.1016/j.reprotox.2008.11.052; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Cheng CY, 2010, MOL CELL ENDOCRINOL, V315, P49, DOI 10.1016/j.mce.2009.08.004; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Dal Secco V, 2008, BIOL REPROD, V78, P234, DOI 10.1095/biolreprod.107.063578; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DEJUCQ N, 1995, ENDOCRINOLOGY, V136, P4925, DOI 10.1210/en.136.11.4925; Dejucq N, 1998, ENDOCRINOLOGY, V139, P3081, DOI 10.1210/en.139.7.3081; Dejucq N, 1997, J CELL BIOL, V139, P865, DOI 10.1083/jcb.139.4.865; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fujisawa M, 1998, ARCH ANDROLOGY, V40, P211, DOI 10.3109/01485019808987944; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guillaume E, 2001, MOL REPROD DEV, V60, P439, DOI 10.1002/mrd.1108; Guitton N, 2000, INT J ANDROL, V23, P332, DOI 10.1046/j.1365-2605.2000.00248.x; HEKMAN ACP, 1988, J BIOL CHEM, V263, P12151; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; IWAKURA Y, 1988, EMBO J, V7, P3757, DOI 10.1002/j.1460-2075.1988.tb03259.x; JEGOU B, 1983, J ANDROL, V4, P88; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanzaki M, 1998, ENDOCRINOLOGY, V139, P2636, DOI 10.1210/en.139.5.2636; Kodym R, 2009, BIOCHEM BIOPH RES CO, V388, P317, DOI 10.1016/j.bbrc.2009.07.167; KRAMER JM, 1981, DEV BIOL, V87, P37, DOI 10.1016/0012-1606(81)90058-0; Kristiansen H, 2010, J VIROL, V84, P11898, DOI 10.1128/JVI.01003-10; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Lin T, 1998, ENDOCRINOLOGY, V139, P2217, DOI 10.1210/en.139.5.2217; Mazaud S, 2002, ENDOCRINOLOGY, V143, P4775, DOI 10.1210/en.2002-220464; MEIKLE AW, 1992, J ANDROL, V13, P437; Melaine N, 2003, J REPROD IMMUNOL, V59, P53, DOI 10.1016/S0165-0378(02)00061-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; ORAVA M, 1985, BIOCHEM BIOPH RES CO, V127, P809, DOI 10.1016/S0006-291X(85)80015-2; ORAVA M, 1989, J INTERFERON RES, V9, P135, DOI 10.1089/jir.1989.9.135; ORAVA M, 1989, MOL ENDOCRINOL, V3, P887, DOI 10.1210/mend-3-6-887; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; PINEAU C, 1990, MOL CELL ENDOCRINOL, V72, P13, DOI 10.1016/0303-7207(90)90235-Z; Riccioli A, 2000, J IMMUNOL, V165, P743, DOI 10.4049/jimmunol.165.2.743; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schweyer S, 2003, BRIT J CANCER, V89, P915, DOI 10.1038/sj.bjc.6601209; SEIF I, 1991, J VIROL, V65, P664, DOI 10.1128/JVI.65.2.664-671.1991; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1991, ANN NY ACAD SCI, V637, P354, DOI 10.1111/j.1749-6632.1991.tb27322.x; Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619; TOEBOSCH AMW, 1989, J ENDOCRINOL, V122, P757, DOI 10.1677/joe.0.1220757; Ulusoy E, 2004, ARCH ANDROLOGY, V50, P379, DOI 10.1080/01485010490474823; WANG ZX, 1989, INT J ANDROL, V12, P58, DOI 10.1111/j.1365-2605.1989.tb01285.x; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; WYROBEK AJ, 1975, P NATL ACAD SCI USA, V72, P4425, DOI 10.1073/pnas.72.11.4425	62	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23280	23295		10.1074/jbc.M111.229120	http://dx.doi.org/10.1074/jbc.M111.229120			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21515676	hybrid, Green Published			2022-12-27	WOS:000292025000061
J	Dabrowska, P; Shabab, M; Brand, W; Vogel, H; Boland, W				Dabrowska, Paulina; Shabab, Mohammed; Brand, Wolfgang; Vogel, Heiko; Boland, Wilhelm			Isomerization of the Phytohormone Precursor 12-Oxophytodienoic Acid (OPDA) in the Insect Gut A MECHANISTIC AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASE A3-3; STEROID ISOMERASE ACTIVITY; PARTIAL-PURIFICATION; CRYSTAL-STRUCTURE; S-TRANSFERASE; RABBIT SERUM; FORCE-FIELD; CAT PLASMA; PROSTAGLANDIN; ENZYME	12-Oxophytodienoic acid (OPDA) is isomerized in the gut of herbivorous insects to tetrahydrodicranenone B (iso-OPDA). The transformation is achieved by a glutathione S-transferase present in the gut epithelium. Experiments with 9-[H-2]-iso-OPDA demonstrated the complete retention of the deuterium atom in the product 11-[H-2]-OPDA consistent with an intramolecular 1,3-hydrogen shift. Homology modeling based on the x-ray structure of a glutathione S-transferase from Anopheles gambiae revealed that the co-factor glutathione does not covalently bind to the substrate but appears to be involved in the initial deprotonation and enolization of the OPDA. The transformation resembles that of a mammalian GST-catalyzed isomerization of Delta(5)-3-ketosteroids to Delta(4)-3-ketosteroids or the conversion of prostaglandin A(1) to the biologically inactive prostaglandin B-1.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Brand, Wolfgang] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany; [Vogel, Heiko] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany	Max Planck Society; Max Planck Society; Leibniz Institut fur Pflanzenbiochemie		boland@ice.mpg.de	Dabrowska-Schlepp, Paulina/A-3882-2016; Boland, Wilhelm/K-7762-2012	Dabrowska-Schlepp, Paulina/0000-0002-9906-667X; Boland, Wilhelm/0000-0001-6784-2534				BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BERGOMAZ R, 1986, Journal of the Lepidopterists' Society, V40, P131; Cho HS, 1998, BIOCHEMISTRY-US, V37, P8325, DOI 10.1021/bi9801614; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; CROMBIE L, 1992, J CHEM SOC P1, V1, P1929; Dabrowska P, 2009, P NATL ACAD SCI USA, V106, P16304, DOI 10.1073/pnas.0906942106; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HEHRE WJ, 2010, SPARTAN 02; HO PPK, 1974, PREP BIOCHEM, V4, P257, DOI 10.1080/00327487408068202; Johansson AS, 2002, J BIOL CHEM, V277, P16648, DOI 10.1074/jbc.M201062200; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; JONES RL, 1972, BIOCHIM BIOPHYS ACTA, V280, P588, DOI 10.1016/0005-2760(72)90139-7; JONES RL, 1970, BIOCHEM J, V119, pP64; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Khojasteh-Bakht SC, 1999, ARCH BIOCHEM BIOPHYS, V370, P59, DOI 10.1006/abbi.1999.1361; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KUBAL G, 1995, CHEM RES TOXICOL, V8, P780, DOI 10.1021/tx00047a019; MALHOTRA SK, 1965, J AM CHEM SOC, V87, P3228, DOI 10.1021/ja01092a039; Mazumder D, 2003, J AM CHEM SOC, V125, P7553, DOI 10.1021/ja030138s; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; Pohnert G, 2004, CHEM PHYS LIPIDS, V131, P159, DOI 10.1016/j.chemphyslip.2004.04.011; Pohnert G, 1999, CHEM COMMUN, P1087, DOI 10.1039/a902020i; POLET H, 1975, ARCH BIOCHEM BIOPHYS, V168, P96, DOI 10.1016/0003-9861(75)90232-5; SAUNDERS M, 1972, J AM CHEM SOC, V94, P4049, DOI 10.1021/ja00766a085; Schulze B, 2007, CHEMBIOCHEM, V8, P208, DOI 10.1002/cbic.200600379; Stewart JJP, 2004, J MOL MODEL, V10, P6, DOI 10.1007/s00894-003-0157-6; Stewart JJP, 2004, J MOL MODEL, V10, P155, DOI 10.1007/s00894-004-0183-z; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; Tars K, 2010, J MOL BIOL, V397, P332, DOI 10.1016/j.jmb.2010.01.023; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; ZIMMERMAN DC, 1978, LIPIDS, V13, P313, DOI 10.1007/BF02533720	36	5	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22348	22354		10.1074/jbc.M111.244509	http://dx.doi.org/10.1074/jbc.M111.244509			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527631	Green Published, hybrid			2022-12-27	WOS:000291719900044
J	Francisco, AB; Singh, R; Sha, HB; Yan, X; Qi, L; Lei, XG; Long, QM				Francisco, Adam B.; Singh, Rajni; Sha, Haibo; Yan, Xi; Qi, Ling; Lei, Xingen; Long, Qiaoming			Haploid Insufficiency of Suppressor Enhancer Lin12 1-like (SEL1L) Protein Predisposes Mice to High Fat Diet-induced Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA-CELL APOPTOSIS; QUALITY-CONTROL; INSULIN-RESISTANCE; DIABETES-MELLITUS; MOUSE MODEL; ER STRESS; TYPE-2; GENE; EXPRESSION	Increasing evidence suggests that endoplasmic reticulum (ER) stress plays an important role in the pathogenesis of type 2 diabetes mellitus. SEL1L is an ER membrane protein that is highly expressed in the pancreatic islet and acinar cells. We have recently reported that a deficiency of SEL1L causes systemic ER stress and leads to embryonic lethality in mice. Here we show that mice with one functional allele of Sel1l (Sel1l(+/-)) are more susceptible to high fat diet (HFD)-induced hyperglycemia. Sel1l(+/-) mice have a markedly reduced beta-cell mass as a result of decreased beta-cell proliferation. Consequently, Sel1l(+/-) mice are severely glucose-intolerant and exhibit significantly retarded glucose-stimulated insulin secretion. Pancreatic islets from Sel1l(+/-) mice stimulated with a high concentration of glucose in vitro express significantly higher levels of unfolded protein response genes than those from wild-type control mice. Furthermore, dominant-negative interference of SEL1L function in insulinoma cell lines severely impairs, whereas overexpression of SEL1L efficiently improves protein secretion. Taken together, our results indicate that haploid insufficiency of SEL1L predispose mice to high fat diet-induced hyperglycemia. Our findings highlight a critical and previously unknown function for SEL1L in regulating adult beta-cell function and growth.	[Francisco, Adam B.; Singh, Rajni; Sha, Haibo; Yan, Xi; Qi, Ling; Lei, Xingen; Long, Qiaoming] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14850 USA	Cornell University	Long, QM (corresponding author), Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, 321 Morrison Hall, Ithaca, NY 14850 USA.	ql39@cornell.edu	Long, Qiaoming/L-5074-2017	Long, Qiaoming/0000-0001-8243-589X; Qi, Ling/0000-0001-8229-0184; Francisco, Adam B./0000-0001-8462-6569	College of Agriculture and Life Sciences; Vertebrate Functional Genomics Center, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	College of Agriculture and Life Sciences; Vertebrate Functional Genomics Center, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the College of Agriculture and Life Sciences and the Vertebrate Functional Genomics Center, Cornell University (to Q. L.).	Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li SA, 2010, FEBS LETT, V584, P4121, DOI 10.1016/j.febslet.2010.08.042; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; Oresic K, 2009, BIOSCIENCE REP, V29, P173, DOI 10.1042/BSR20080143; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rajan SS, 2007, INDIAN J MED RES, V125, P411; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	54	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22275	22282		10.1074/jbc.M111.239418	http://dx.doi.org/10.1074/jbc.M111.239418			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536682	Green Published, hybrid			2022-12-27	WOS:000291719900035
J	Holbourn, KP; Malfois, M; Acharya, KR				Holbourn, Kenneth P.; Malfois, Marc; Acharya, K. Ravi			First Structural Glimpse of CCN3 and CCN5 Multifunctional Signaling Regulators Elucidated by Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-GROWTH-FACTOR; VASCULAR ENDOTHELIAL-CELLS; IMMEDIATE-EARLY GENE; CRYSTAL-STRUCTURE; LAYERED FOLD; FAMILY; PROTEINS; NOV; EXPRESSION; DOMAINS	The CCN (cyr61, ctgf, nov) proteins (CCN1-6) are an important family of matricellular regulatory factors involved in internal and external cell signaling. They are central to essential biological processes such as adhesion, proliferation, angiogenesis, tumorigenesis, wound healing, and modulation of the extracellular matrix. They possess a highly conserved modular structure with four distinct modules that interact with a wide range of regulatory proteins and ligands. However, at the structural level, little is known although their biological function(s) seems to require cooperation between individual modules. Here we present for the first time structural determinants of two of the CCN family members, CCN3 and CCN5 (expressed in Escherichia coli), using small angle x-ray scattering. The results provide a description of the overall molecular shape and possible general three-dimensional modular arrangement for CCN proteins. These data unequivocally provide insight of the nature of CCN protein(s) in solution and thus important insight into their structure-function relationships.	[Holbourn, Kenneth P.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Malfois, Marc] Diamond Light Source, Didcot OX11 0DE, Oxon, England	University of Bath; Diamond Light Source	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk	Malfois, Marc/L-2974-2014	Malfois, Marc/0000-0001-5231-1896; Acharya, K. Ravi/0000-0002-3009-4058	Royal Society; Cancer Research UK through a Biological Sciences Committee [C397/A12744]	Royal Society(Royal Society of London); Cancer Research UK through a Biological Sciences Committee	This work was supported by a Royal Society Industry Fellowship and Cancer Research UK through a Biological Sciences Committee project grant award (C397/A12744) (to K.R.A.).	Adams JC, 2000, DEV DYNAM, V218, P280; Altschuler EL, 1997, J PEPT RES, V50, P73; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Ayer-Lelievre C., 2001, Molecular Pathology, V54, P105, DOI 10.1136/mp.54.2.105; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Davies SR, 2007, ANN SURG ONCOL, V14, P1909, DOI 10.1245/s10434-007-9376-x; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOBSON CM, 1990, NATURE, V348, P198, DOI 10.1038/348198a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Gygi D, 2003, BIOCHEM BIOPH RES CO, V311, P685, DOI 10.1016/j.bbrc.2003.10.061; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holbourn KP, 2011, BIOCHEM BIOPH RES CO, V407, P837, DOI 10.1016/j.bbrc.2011.03.122; Holbourn KP, 2009, J CELL COMMUN SIGNAL, V3, P25, DOI 10.1007/s12079-009-0048-4; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kubota S, 2006, BIOCHIMIE, V88, P1973, DOI 10.1016/j.biochi.2006.07.007; Kumar S, 1999, J BIOL CHEM, V274, P17123, DOI 10.1074/jbc.274.24.17123; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2001, B CANCER, V88, P645; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal B, 2006, ADV EXP MED BIOL, V587, P23; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Rudresh, 2002, PROTEIN ENG, V15, P627, DOI 10.1093/protein/15.8.627; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Tong ZY, 2006, J ENDOCRINOL, V188, pR1, DOI 10.1677/joe.1.06719; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	62	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22243	22249		10.1074/jbc.M111.225755	http://dx.doi.org/10.1074/jbc.M111.225755			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543320	hybrid, Green Published			2022-12-27	WOS:000291719900032
J	Molina-Sanchez, MD; Barrientos-Duran, A; Toro, N				Dolores Molina-Sanchez, Maria; Barrientos-Duran, Antonio; Toro, Nicolas			Relevance of the Branch Point Adenosine, Coordination Loop, and 3 ' Exon Binding Site for in Vivo Excision of the Sinorhizobium meliloti Group II Intron RmInt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARIAT FORMATION; ACTIVE-SITE; SELECTION; MITOCHONDRIA; RECOGNITION; MECHANISM; CIRCLES; ADENINE; INVITRO; RNAS	Excision of the bacterial group II intron RmInt1 has been demonstrated in vivo, resulting in the formation of both intron lariat and putative intron RNA circles. We show here that the bulged adenosine in domain VI of RmInt1 is required for splicing via the branching pathway, but branch site mutants produce small numbers of RNA molecules in which the first G residue of the intron is linked to the last C residue. Mutations in the coordination loop in domain I reduced splicing efficiency, but branched templates clearly predominated among splicing products. We also found that a single substitution at the EBS3 position (G329C), preventing EBS3-IBS3 pairing, resulted in the production of 50 to 100 times more RNA molecules in which the 5' and 3' extremities were joined. We provide evidence that these intron molecules may correspond to both, intron circles linked by a 2'-5' phosphodiester bond, and tandem, head-to-tail intron copies.	[Dolores Molina-Sanchez, Maria; Barrientos-Duran, Antonio; Toro, Nicolas] CSIC, Estn Expt Zaidin, Grp Ecol Genet, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Estn Expt Zaidin, Grp Ecol Genet, Calle Prof Albareda 1, E-18008 Granada, Spain.	ntoro@eez.csic.es	Molina-Sánchez, Maria Dolores/J-1925-2016; Toro, Nicolas/K-4909-2014	Molina-Sánchez, Maria Dolores/0000-0002-3627-9360; Toro, Nicolas/0000-0002-3614-807X; BARRIENTOS-DURAN, ANTONIO MANUEL/0000-0003-2236-0958	Spanish Ministerio de Ciencia e Innovacion [BIO2008-00740, CSD 2009-0006]; Junta de Andalucia [CVI-01522]; Fondo Europeo de Desarrollo Regional (Spanish Ministerio de Ciencia e Innovacion); Junta de Andalucia	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); Fondo Europeo de Desarrollo Regional (Spanish Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (BIO2008-00740 and CSD 2009-0006 of Programme Consolider-Ingenio 2010), Junta de Andalucia (CVI-01522), and Fondo Europeo de Desarrollo Regional (funding for open access charge from Programme Consolider-Ingenio 2010 from the Spanish Ministerio de Ciencia e Innovacion).; Recipient of grants from Junta de Andalucia.	AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Chillon I, 2011, NUCLEIC ACIDS RES, V39, P1095, DOI 10.1093/nar/gkq847; CHIN K, 1995, RNA, V1, P391; Chu VT, 2001, EMBO J, V20, P6866, DOI 10.1093/emboj/20.23.6866; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 2006, BIOCHIMIE, V88, P711, DOI 10.1016/j.biochi.2005.12.007; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; Hamill S, 2006, MOL CELL, V23, P831, DOI 10.1016/j.molcel.2006.07.017; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JACQUIER A, 1991, J MOL BIOL, V219, P415, DOI 10.1016/0022-2836(91)90183-7; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Li-Pook-Than J, 2006, NUCLEIC ACIDS RES, V34, P2782, DOI 10.1093/nar/gkl328; Liu QL, 1997, J MOL BIOL, V267, P163, DOI 10.1006/jmbi.1996.0845; LORSCH JR, 1995, NUCLEIC ACIDS RES, V23, P2811, DOI 10.1093/nar/23.15.2811; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Molina-Sanchez MD, 2006, J BIOL CHEM, V281, P28737, DOI 10.1074/jbc.M602695200; Munoz-Adelantado E, 2003, J MOL BIOL, V327, P931, DOI 10.1016/S0022-2836(03)00208-0; Murray HL, 2001, MOL CELL, V8, P201, DOI 10.1016/S1097-2765(01)00300-8; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; NYBERG TM, 2006, THESIS U TEXAS SW ME; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; PYLE AM, 1996, NUCLEIC ACIDS MOL BI, P75; Pyle Anna Marie, 2008, P201; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Roitzsch M, 2009, RNA, V15, P473, DOI 10.1261/rna.1392009; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; VANDERVEEN R, 1987, EMBO J, V6, P3827, DOI 10.1002/j.1460-2075.1987.tb02719.x; Vogel J, 1997, NUCLEIC ACIDS RES, V25, P2030, DOI 10.1093/nar/25.10.2030; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238	35	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21154	21163		10.1074/jbc.M110.210013	http://dx.doi.org/10.1074/jbc.M110.210013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521690	Green Published, hybrid			2022-12-27	WOS:000291464700015
J	Lee, WH; Lee, HH; Vo, MT; Kim, HJ; Ko, MS; Im, YC; Min, YJ; Lee, BJ; Cho, WJ; Park, JW				Lee, Won Hyeok; Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Ko, Myoung Seok; Im, Yeong-Cheol; Min, Young Joo; Lee, Byung Ju; Cho, Wha Ja; Park, Jeong Woo			Casein Kinase 2 Regulates the mRNA-destabilizing Activity of Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; TETRADECANOYL PHORBOL ACETATE; TGF-BETA; MAP KINASE; TUMOR-SUPPRESSOR; RECOMBINANT TRISTETRAPROLIN; NUCLEAR-LOCALIZATION; SIGNALING PATHWAY	Tristetraprolin (TTP) is an AU-rich element-binding protein that regulates mRNA stability. We previously showed that TTP acts as a negative regulator of VEGF gene expression in colon cancer cells. The p38 MAPK pathway is known to suppress the TTP activity. However, until now the signaling pathway to enhance TTP function is not well known. Here, we show that casein kinase 2 (CK2) enhances the TTP function in the regulation of the VEGF expression in colon cancer cells. CK2 increased TTP protein levels and enhanced VEGF mRNA decaying activity of TTP. TTP was not a direct target of CK2. Instead, CK2 increased the phosphorylation of MKP-1, which led to a decrease in the phosphorylation of p38 MAPK. Inhibition of MKP-1 by siRNA attenuated the increase in TTP function and the decrease of p38 phosphorylation induced by CK2 alpha overexpression. TGF-beta 1 increased the expressions of CK2 and TTP and the TTP function. The siRNA against CK2 alpha or TTP reversed TGF-beta 1-induced increases in the expression of CK2 and TTP and the TTP function. Our data suggest that CK2 enhances the protein level and activity of TTP via the modulation of the MKP-1-p38 MAPK signaling pathway and that TGF-beta 1 enhances the activity of CK2.	[Cho, Wha Ja] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 682060, South Korea; [Lee, Won Hyeok; Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Ko, Myoung Seok; Lee, Byung Ju; Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Im, Yeong-Cheol] Univ Ulsan, Ulsan Univ Hosp, Dept Surg, Coll Med, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Coll Med, Ulsan 682060, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Cho, WJ (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 682060, South Korea.	wjcho26@ulsan.ac.kr; jwpark@ulsan.ac.kr			Korean government (MOEHRD) [KRF-2005-070-C00088, BRL2009-0087350, 2009-0094050, 2009-0070260]; Ministry of Health and Welfare [A101086]	Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Korea Research Foundation Grants KRF-2005-070-C00088, BRL2009-0087350, 2009-0094050, and 2009-0070260 funded by the Korean government (MOEHRD) and by Korea Health 21 R&D Project Grant A101086 from the Ministry of Health and Welfare.	ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 1999, CRIT REV EUKAR GENE, V9, P329, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.170; Ahmed K, 2000, J CELL BIOCHEM, P130; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bian ZM, 2007, EXP EYE RES, V84, P812, DOI 10.1016/j.exer.2006.12.016; BROGI E, 1994, CIRCULATION, V90, P649, DOI 10.1161/01.CIR.90.2.649; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Guerra B, 1999, PHARMACOL THERAPEUT, V82, P303, DOI 10.1016/S0163-7258(98)00064-3; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Litchfield DW, 1996, BIOCHEM CELL BIOL, V74, P541, DOI 10.1139/o96-458; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; VARNUM BC, 1989, ONCOGENE, V4, P119; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Yamamoto T, 2001, J CELL BIOCHEM, V82, P591, DOI 10.1002/jcb.1179; Zdunek M, 2001, KIDNEY INT, V60, P2097, DOI 10.1046/j.1523-1755.2001.00041.x; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	81	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21577	21587		10.1074/jbc.M110.201137	http://dx.doi.org/10.1074/jbc.M110.201137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507959	Green Published, hybrid			2022-12-27	WOS:000291464700055
J	Adler, A; Park, YD; Larsen, P; Nagarajan, V; Wollenberg, K; Qiu, J; Myers, TG; Williamson, PR				Adler, Amos; Park, Yoon-Dong; Larsen, Peter; Nagarajan, Vijayaraj; Wollenberg, Kurt; Qiu, Jin; Myers, Timothy G.; Williamson, Peter R.			A Novel Specificity Protein 1 (SP1)-like Gene Regulating Protein Kinase C-1 (Pkc1)-dependent Cell Wall Integrity and Virulence Factors in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; CANDIDA-ALBICANS; LACCASE; CALCINEURIN; STRESS; IDENTIFICATION; EXPRESSION; INFECTION	Eukaryotic cells utilize complex signaling systems to detect their environments, responding and adapting as new conditions arise during evolution. The basidiomycete fungus Cryptococcus neoformans is a leading cause of AIDS-related death worldwide and utilizes the calcineurin and protein kinase C-1 (Pkc1) signaling pathways for host adaptation and expression of virulence. In the present studies, a C-terminal zinc finger transcription factor, homologous both to the calcineurin-responsive zinc fingers (Crz1) of ascomycetes and to the Pkc1-dependent specificity protein-1 (Sp1) transcription factors of metazoans, was identified and named SP1 because of its greater similarity to the metazoan factors. Structurally, the Cryptococcus neoformans Sp1 (Cn Sp1) protein was found to have acquired an additional zinc finger motif from that of Crz1 and showed Pkc1-dependent phosphorylation, nuclear localization, and whole genome epistatic associations under starvation conditions. Transcriptional targets of Cn Sp1 shared functional similarities with Crz1 factors, such as cell wall synthesis, but gained the regulation of processes involved in carbohydrate metabolism, including trehalose metabolism, and lost others, such as the induction of autophagy. In addition, overexpression of Cn Sp1 in a pkc1 Delta mutant showed restoration of altered phenotypes involved in virulence, including cell wall stability, nitrosative stress, and extracellular capsule production. Cn Sp1 was also found to be important for virulence of the fungus using a mouse model. In summary, these data suggest an evolutionary shift in C-terminal zinc finger proteins during fungal evolution, transforming them from calcineurin-dependent to PKC1-dependent transcription factors, helping to shape the role of fungal pathogenesis of C. neoformans.	Univ Chicago, Sect Pediat Infect Dis, Dept Pediat, Chicago, IL 60637 USA; [Adler, Amos; Williamson, Peter R.] Univ Illinois, Infect Dis Sect, Dept Med, Coll Med, Chicago, IL 60612 USA; [Park, Yoon-Dong; Qiu, Jin; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Nagarajan, Vijayaraj; Wollenberg, Kurt] NIAID, Bioinformat & Computat Biosciences Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Larsen, Peter] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Argonne National Laboratory	Williamson, PR (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 11N234,MSC 1888, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov		Myers, Timothy Gene/0000-0002-7059-5906	National Institutes of Health [AI45995, AI49371]; National Institutes of Health, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001123, R01AI045995, ZICAI001051, R01AI049371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI45995 and AI49371 and by the Intramural Research Program of the National Institutes of Health, NIAID.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bichile L S, 2001, J Assoc Physicians India, V49, P377; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Cox GM, 1996, J MED VET MYCOL, V34, P385; Cramer T, 2008, CELL SIGNAL, V20, P60, DOI 10.1016/j.cellsig.2007.08.016; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Jain N, 2009, INFECT IMMUN, V77, P128, DOI 10.1128/IAI.01079-08; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Lee J, 2010, J PHYS CHEM B, V114, P7662, DOI 10.1021/jp1017289; Liu L, 1999, INFECT IMMUN, V67, P6034, DOI 10.1128/IAI.67.11.6034-6039.1999; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; Maligie MA, 2005, ANTIMICROB AGENTS CH, V49, P2851, DOI 10.1128/AAC.49.7.2851-2856.2005; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park YD, 2010, J BIOL CHEM, V285, P34746, DOI 10.1074/jbc.M110.136812; Perez P, 2002, J BIOCHEM, V132, P513, DOI 10.1093/oxfordjournals.jbchem.a003250; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Sorrell TC, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P595; Swofford D.L., 2003, PAUP VERSION 40 B10; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Waterman SR, 2007, INFECT IMMUN, V75, P714, DOI 10.1128/IAI.01351-06; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yashiroda H, 1998, GENE, V225, P39, DOI 10.1016/S0378-1119(98)00535-6; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Yue CL, 1999, GENETICS, V153, P1601; Zhang SR, 2006, MOL MICROBIOL, V62, P1090, DOI 10.1111/j.1365-2958.2006.05422.x; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	55	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20977	20990		10.1074/jbc.M111.230268	http://dx.doi.org/10.1074/jbc.M111.230268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487010	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000291267600082
J	Krycer, JR; Brown, AJ				Krycer, James Robert; Brown, Andrew John			Cross-talk between the Androgen Receptor and the Liver X Receptor IMPLICATIONS FOR CHOLESTEROL HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; FATTY-ACID SYNTHASE; OXYSTEROL RECEPTOR; HUMAN MACROPHAGES; GENE-EXPRESSION; REGULATED GENE; MESSENGER-RNA; ALPHA GENE; LXR-ALPHA; ACTIVATION	High cholesterol levels are associated with prostate cancer development. Androgens promote cholesterol accumulation by activating the sterol-regulatory element-binding protein isoform 2 (SREBP-2) transcription factor. However, SREBP-2 is in balance with the liver X receptor (LXR; NR1H2/NR1H3), a transcription factor that prevents cholesterol accumulation. Here, we show that LXR activity is down-regulated by the androgen receptor (AR; NR3C4). In turn, this reduces LXR target gene expression. This antagonism on LXR is also exerted by other steroid hormone receptors, including the estrogen, glucocorticoid, and progesterone receptors. This suggests a generalizable mechanism, but the AR does not affect LXR mRNA levels, protein degradation, or DNA binding. We also found that the AR does not require protein synthesis to influence LXR, suggesting a direct antagonism. However, the AR does not directly bind LXR. The AR N-terminal domain (involved in transactivation), but not its DNA-binding domain, is required to suppress LXR activity, suggesting coactivator competition. Overall, this androgen-mediated antagonism of LXR complements SREBP-2 activation, providing a more complete picture as to how androgens increase cellular cholesterol levels in a prostate cancer setting. Given the cross-talk between other steroid hormone receptors and LXR, hormonal regulation of cholesterol via LXR may occur in a variety of cellular contexts.	[Krycer, James Robert; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270	Petre Foundation; Prostate Cancer Foundation of Australia [PG2710]	Petre Foundation; Prostate Cancer Foundation of Australia	Recipient of the Petre Foundation Scholarship.; Supported by Prostate Cancer Foundation of Australia Grant PG2710.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bruggenwirth HT, 1998, ENDOCRINOLOGY, V139, P103, DOI 10.1210/en.139.1.103; Chaturvedi NK, 2010, MOL CELL BIOCHEM, V345, P291, DOI 10.1007/s11010-010-0583-6; Chuang KH, 2005, MOL ENDOCRINOL, V19, P1200, DOI 10.1210/me.2004-0181; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Costet P, 2000, J BIOL CHEM, V275, P28240; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; KAIGHN ME, 1979, INVEST UROL, V17, P16; Khor VK, 2008, ENDOCRINOLOGY, V149, P5440, DOI 10.1210/en.2008-0271; Kielar D, 2001, CLIN CHEM, V47, P2089; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kramer PR, 2002, J STEROID BIOCHEM, V81, P203, DOI 10.1016/S0960-0760(02)00065-1; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lee JH, 2008, ENDOCRINOLOGY, V149, P3778, DOI 10.1210/en.2007-1605; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Lundholm L, 2004, J MOL ENDOCRINOL, V32, P879, DOI 10.1677/jme.0.0320879; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rossi S, 2003, MOL CANCER RES, V1, P707; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V312, P716, DOI 10.1016/j.bbrc.2003.10.174; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Swyer GIM, 1942, CANCER RES, V2, P372; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Trasino SE, 2009, MOL CANCER THER, V8, P1934, DOI 10.1158/1535-7163.MCT-09-0020; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Wang JH, 2008, GENE REGUL SYST BIO, V2, P97; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	64	55	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20637	20647		10.1074/jbc.M111.227082	http://dx.doi.org/10.1074/jbc.M111.227082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489984	Green Published, hybrid			2022-12-27	WOS:000291267600050
J	Mannangatti, P; Arapulisamy, O; Shippenberg, TS; Ramamoorthy, S; Jayanthi, LD				Mannangatti, Padmanabhan; Arapulisamy, Obulakshmi; Shippenberg, Toni S.; Ramamoorthy, Sammanda; Jayanthi, Lankupalle D.			Cocaine Up-regulation of the Norepinephrine Transporter Requires Threonine 30 Phosphorylation by p38 Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; EXTRACELLULAR DOPAMINE; SURFACE EXPRESSION; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SEROTONIN TRANSPORTERS; STRIA TERMINALIS; PHOSPHATASE 2A; BED NUCLEUS; TRAFFICKING	The norepinephrine (NE) transporter (NET) regulates NE signaling by rapidly clearing synaptic NE. Cocaine binds NET and modulates NE transport. These actions contribute to rewarding effects and abuse liability of cocaine. Activation of mitogen-activated protein kinase (MAPK) cascades is implicated in cocaine-induced neuroadaptations. However, the role of MAPK and the mechanisms involved in cocaine modulation of NET are not clear. Acute intra-peritoneal injections of cocaine (20 mg/kg body weight) to rats resulted in increased NE uptake by prefrontal cortex (PFC) synaptosomes with a parallel increase in the surface expression of endogenous NET. Cocaine also enhanced the immunoreactivity of phospho-p38 MAPK in the PFC synaptosomes without affecting the total p38 MAPK. In vitro cocaine (30-50 mu M) treatment of rat PFC synaptosomes increased native NET function, surface expression, and phosphorylation in a manner sensitive to p38 MAPK inhibition by PD169316. We next examined cocaine-elicited effects on wild-type human NET (hNET) expressed heterologously in human placental trophoblast cells to gain more insights into the mechanisms involved. Cocaine treatment of hNET expressing human placental trophoblast cells up-regulated the function, surface expression, and phosphorylation of hNET in a PD169316-sensitive manner. In addition, cocaine inhibited constitutive endocytosis of hNET. Mutational analysis of serine and threonine residues revealed that substitution of threonine 30, located at the amino terminus of hNET with alanine (T30A-hNET), abolished cocaine-induced up-regulation of NET function, surface expression, and phosphorylation. Furthermore, cocaine did not alter T30A-hNET endocytosis. These studies identify a novel molecular mechanism that cocaine-activated p38 MAPK-mediated phosphorylation of NET-T30 dictates surface NET availability, and hence, NE transport.	[Mannangatti, Padmanabhan; Arapulisamy, Obulakshmi; Ramamoorthy, Sammanda; Jayanthi, Lankupalle D.] Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA; [Shippenberg, Toni S.] NIDA, Integrat Neurosci Sect, Intramural Res Program, US Dept HHS, Baltimore, MD 21224 USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Jayanthi, LD (corresponding author), Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA.	jayanthi@musc.edu			National Institutes of Health [RO1-GM081054]; NIGMS, National Institute of Mental Health [RO1-MH62612]; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of General Medical Sciences (NIGMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-GM081054 (to L.D.J.) from the NIGMS, National Institute of Mental Health Grant RO1-MH62612 (to S.R.), and the National Institute on Drug Abuse Intramural Research Program (to T.S.S.).	Ahmed BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004730; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Apparsundaram S, 2001, J PHARMACOL EXP THER, V299, P666; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brooks AC, 2007, INFLAMM RES, V56, P154, DOI 10.1007/s00011-006-6151-6; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; Ganapathy Vadivel, 2005, Toxicol Appl Pharmacol, V207, P381, DOI 10.1016/j.taap.2005.02.023; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; JAYANTHI LD, 1993, BIOCHEMISTRY-US, V32, P12178, DOI 10.1021/bi00096a030; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Li GH, 2005, J PHARMACOL EXP THER, V312, P112, DOI 10.1124/jpet.104.073494; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Macey DJ, 2003, J NEUROSCI, V23, P12; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; Mash DC, 2005, J NEUROSCI METH, V143, P79, DOI 10.1016/j.jneumeth.2004.09.013; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Miner LH, 2006, J NEUROSCI, V26, P1571, DOI 10.1523/JNEUROSCI.4450-05.2006; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Moron JA, 2003, J NEUROSCI, V23, P8480; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Platt DM, 2007, J PHARMACOL EXP THER, V322, P894, DOI 10.1124/jpet.107.121806; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; SCHOMIG E, 1989, N-S ARCH PHARMACOL, V340, P502; Shearman LP, 1999, EUR J PHARMACOL, V386, P1, DOI 10.1016/S0014-2999(99)00624-X; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; TRENDELENBURG U, 1991, TRENDS PHARMACOL SCI, V12, P334; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; Valentini V, 2004, J NEUROCHEM, V88, P917, DOI 10.1046/j.1471-4159.2003.02238.x; Valjent E, 2005, M S-MED SCI, V21, P453, DOI 10.1051/medsci/2005215453; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	57	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20239	20250		10.1074/jbc.M111.226811	http://dx.doi.org/10.1074/jbc.M111.226811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498515	Green Published, hybrid			2022-12-27	WOS:000291267600011
J	Osawa, S; Jo, R; Xiong, YB; Reidel, B; Tserentsoodol, N; Arshavsky, VY; Iuvone, PM; Weiss, ER				Osawa, Shoji; Jo, Rebecca; Xiong, Yubin; Reidel, Boris; Tserentsoodol, Nomingerel; Arshavsky, Vadim Y.; Iuvone, P. Michael; Weiss, Ellen R.			Phosphorylation of G Protein-coupled Receptor Kinase 1 (GRK1) Is Regulated by Light but Independent of Phototransduction in Rod Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; N-TERMINAL REGION; RHODOPSIN KINASE; ADENYLYL-CYCLASE; CYCLIC-AMP; PHOTOEXCITED RHODOPSIN; DRIVEN TRANSLOCATION; OGUCHI-DISEASE; RETINAL RODS; CELLS	Phosphorylation of rhodopsin by G protein-coupled receptor kinase 1 (GRK1, or rhodopsin kinase) is critical for the deactivation of the phototransduction cascade in vertebrate photoreceptors. Based on our previous studies in vitro, we predicted that Ser(21) in GRK1 would be phosphorylated by cAMP-dependent protein kinase (PKA) in vivo. Here, we report that dark-adapted, wild-type mice demonstrate significantly elevated levels of phosphorylated GRK1 compared with light-adapted animals. Based on comparatively slow half-times for phosphorylation and dephosphorylation, phosphorylation of GRK1 by PKA is likely to be involved in light and dark adaptation. In mice missing the gene for adenylyl cyclase type 1, levels of phosphorylated GRK1 were low in retinas from both dark-and light-adapted animals. These data are consistent with reports that cAMP levels are high in the dark and low in the light and also indicate that cAMP generated by adenylyl cyclase type 1 is required for phosphorylation of GRK1 on Ser(21). Surprisingly, dephosphorylation was induced by light in mice missing the rod transducin alpha-subunit. This result indicates that phototransduction does not play a direct role in the light-dependent dephosphorylation of GRK1.	[Osawa, Shoji; Jo, Rebecca; Xiong, Yubin; Weiss, Ellen R.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Weiss, Ellen R.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Reidel, Boris; Tserentsoodol, Nomingerel; Arshavsky, Vadim Y.] Duke Univ, Albert Eye Res Inst, Durham, NC 27710 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Emory University; Emory University	Weiss, ER (corresponding author), CB 7090,108 Taylor Hall, Chapel Hill, NC 27599 USA.	erweiss@med.unc.edu	Reidel, Boris/AAG-2714-2020; Weiss, Ellen/AAK-9868-2020		National Institutes of Health Grants [EY072224, EY10336, R01EY004864, EY5722, EY006360]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY005722, R01EY004864, P30EY006360, R01EY010336] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY072224 (to E. R. W.), EY10336 (to V. Y. A.), and R01EY004864 (to P. M. I.) and National Institutes of Health Core Grants for Vision Research EY5722 (to V. Y. A. and E. R. W.) and EY006360 (to P. M. I.) This work was also supported by Research to Prevent Blindness (to P. M. I.).	BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Cideciyan AV, 2003, INVEST OPHTH VIS SCI, V44, P1268, DOI 10.1167/iovs.02-0494; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; COHEN AI, 1990, VISUAL NEUROSCI, V4, P43, DOI 10.1017/S0952523800002753; DICKERSON CD, 1995, EXP CELL RES, V216, P46, DOI 10.1006/excr.1995.1006; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; FARBER DB, 1981, INVEST OPHTH VIS SCI, V20, P24; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; FUTUYAMA DJ, 1998, EVOLUTIONARY BIOL, P130; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; LEE RH, 1990, J BIOL CHEM, V265, P15860; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Pozdeyev N, 2006, J NEUROSCI, V26, P9153, DOI 10.1523/JNEUROSCI.1384-06.2006; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; Traverso V, 2002, INVEST OPHTH VIS SCI, V43, P1655; WEISS ER, 1990, J MOL ENDOCRINOL, V4, P71, DOI 10.1677/jme.0.0040071; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	53	11	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20923	20929		10.1074/jbc.M111.230904	http://dx.doi.org/10.1074/jbc.M111.230904			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504899	hybrid, Green Published			2022-12-27	WOS:000291267600076
J	van Eijk, M; Bruinsma, L; Hartshorn, KL; White, MR; Rynkiewicz, MJ; Seaton, BA; Hemrika, W; Romijn, RA; van Balkom, BW; Haagsman, HP				van Eijk, Martin; Bruinsma, Laurie; Hartshorn, Kevan L.; White, Mitchell R.; Rynkiewicz, Michael J.; Seaton, Barbara A.; Hemrika, Wieger; Romijn, Roland A.; van Balkom, Bas W.; Haagsman, Henk P.			Introduction of N-Linked Glycans in the Lectin Domain of Surfactant Protein D IMPACT ON INTERACTIONS WITH INFLUENZA A VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; INNATE IMMUNE PROTEINS; PULMONARY COLLECTINS; EXPRESSION; BINDING; LUNG; GLYCOSYLATION; MECHANISMS; MODULATE; OPSONIN	Porcine surfactant protein D (pSP-D) displays distinctively strong, broad-range inhibitory activity against influenza A virus (IAV). N-Linked glycosylation of the carbohydrate recognition domain (CRD) of pSP-D contributes to the high affinity of this collectin for IAV. To investigate the role of the N-linked glycan further, HEK293E protein expression was used to produce recombinant pSP-D (RpSP-D) that has similar structural and antiviral properties as NpSP-D. We introduced an additional N-linked glycan in the CRD of RpSP-D but this modification did not alter the antiviral activity. Human SP-D is unglycosylated in its CRD and less active against IAV compared with pSP-D. In an attempt to modify its antiviral properties, several recombinant human SP-D (RhSP-D) mutants were constructed with N-linked glycans introduced at various locations within its CRD. To retain lectin activity, necessary for the primary interactions between SP-D and IAV, N-linked glycosylation of RhSP-D was shown to be restricted to the corresponding position in the CRD of either pSP-D or surfactant protein A (SP-A). These N-glycosylated RhSP-D mutants, however, did not show increased neutralization activity against IAV. By developing RhSP-D mutants that also have the pSP-D-specific Ser-Gly-Ala loop inserted in the CRD, we could demonstrate that the N-linked glycan-mediated interactions between pSP-D and IAV involves additional structural prerequisites of the pSP-D CRD. Ultimately, these studies will help to develop highly effective SP-D-based therapeutic and prophylactic drugs against IAV.	[van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Hartshorn, Kevan L.; White, Mitchell R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [Hemrika, Wieger; Romijn, Roland A.] U Prot Express BV, Sci Pk Utrecht, NL-3584 CH Utrecht, Netherlands; [van Balkom, Bas W.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CH Utrecht, Netherlands	Utrecht University; Boston University; Boston University; Utrecht University; Utrecht University Medical Center	van Eijk, M (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	m.vaneijk@uu.nl	Haagsman, Henk P/F-8919-2010	Hartshorn, Kevan/0000-0002-7196-7433; Rynkiewicz, Michael/0000-0002-4717-5700; Seaton, Barbara/0000-0003-4654-7709	European Union [LSHM-CT-2004-512093]	European Union(European Commission)	This work was supported by European Union FP6 Specific Targeted Research Project Grant LSHM-CT-2004-512093.	Aye TT, 2010, MOL BIOSYST, V6, P1917, DOI 10.1039/c004495d; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Herias MV, 2007, MOL IMMUNOL, V44, P3324, DOI 10.1016/j.molimm.2007.02.025; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Khoshnoodi J, 2007, J MASS SPECTROM, V42, P370, DOI 10.1002/jms.1170; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikerov AN, 2008, MED MICROBIOL IMMUN, V197, P9, DOI 10.1007/s00430-007-0051-4; Morlot C, 2007, ACTA CRYSTALLOGR F, V63, P689, DOI 10.1107/S1744309107033027; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Reading PC, 2007, ADV EXP MED BIOL, V598, P279; SCHOLTISSEK C, 1994, EUR J EPIDEMIOL, V10, P455, DOI 10.1007/BF01719674; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; Vogels MW, 2011, PROTEOMICS, V11, P64, DOI 10.1002/pmic.201000309; White MR, 2008, EXPERT REV CLIN IMMU, V4, P497, DOI 10.1586/1744666X.4.4.497; White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	45	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20137	20151		10.1074/jbc.M111.224469	http://dx.doi.org/10.1074/jbc.M111.224469			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489996	Green Published, hybrid			2022-12-27	WOS:000291267600003
J	Luderer, HF; Gori, F; Demay, MB				Luderer, Hilary F.; Gori, Francesca; Demay, Marie B.			Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; STEM-CELL DIFFERENTIATION; 2 DISTINCT COACTIVATORS; BETA-CATENIN; KERATINOCYTE DIFFERENTIATION; SONIC HEDGEHOG; KNOCKOUT MICE; ANIMAL-MODEL; D-DEFICIENCY; GENE	Ligand-independent actions of the vitamin D receptor (VDR) are required for normal post-morphogenic hair cycles; however, the molecular mechanisms by which the VDR exerts these actions are not clear. Previous studies demonstrated impaired regulation of the canonical Wnt signaling pathway in primary keratinocytes lacking the VDR. To identify the key effector of canonical Wnt signaling that interacts with the VDR, GST pull-down studies were performed. A novel interaction between the VDR and LEF1 (lymphoid enhancer-binding factor-1) that is independent of beta-catenin was identified. This interaction is dependent upon sequences within the N-terminal region of the VDR, a domain required for VDR-DNA interactions and normal hair cycling in mice. Mutation of specific residues within the N-terminal region of the VDR not only abrogated interactions between the VDR and LEF1 but also impaired the ability of the VDR to enhance Wnt signaling in vdr(-/-) primary keratinocytes. Thus, this study demonstrates a novel interaction between the VDR and LEF1 that is mediated by the DNA-binding domain of the VDR and that is required for normal canonical Wnt signaling in keratinocytes.	[Demay, Marie B.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Demay, MB (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Thier 1101,50 Blossom St, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu	Gori, Francesca/S-9422-2019		National Institutes of Health from NIAMS [F32 AR056933-01A1, T32 DK007028]; National Institutes of Health from NIDDK [DK 46974]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR056933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028, R01DK046974] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AR056933-01A1 and T32 DK007028 from NIAMS and DK 46974 from NIDDK.	Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2010, J STEROID BIOCHEM, V121, P308, DOI 10.1016/j.jsbmb.2010.03.027; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Cui CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010009; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; DEMAY MB, 1992, MOL ENDOCRINOL, V6, P557, DOI 10.1210/me.6.4.557; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GLORIEUX FH, 1995, J CLIN ENDOCR METAB, V80, P2255, DOI 10.1210/jc.80.7.2255; Haussler MR, 2010, J STEROID BIOCHEM, V121, P88, DOI 10.1016/j.jsbmb.2010.03.019; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hsieh JC, 1999, BIOCHEMISTRY-US, V38, P16347, DOI 10.1021/bi9916574; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Li M, 2001, DEVELOPMENT, V128, P675; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Niemann C, 2002, DEVELOPMENT, V129, P95; Nothen MM, 1998, AM J HUM GENET, V62, P386, DOI 10.1086/301717; Oda Y, 2004, J STEROID BIOCHEM, V89-90, P273, DOI 10.1016/j.jsbmb.2004.03.106; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Sprecher E, 1998, AM J MED GENET, V80, P546, DOI 10.1002/(SICI)1096-8628(19981228)80:5<546::AID-AJMG28>3.0.CO;2-I; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Teichert A, 2010, J CELL PHYSIOL, V225, P482, DOI 10.1002/jcp.22227; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303	46	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18444	18451		10.1074/jbc.M110.188219	http://dx.doi.org/10.1074/jbc.M110.188219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471213	Green Published, hybrid			2022-12-27	WOS:000290785700017
J	Nishitsuji, K; Hosono, T; Nakamura, T; Bu, GJ; Michikawa, M				Nishitsuji, Kazuchika; Hosono, Takashi; Nakamura, Toshiyuki; Bu, Guojun; Michikawa, Makoto			Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-RELATED PROTEIN; ALZHEIMERS-DISEASE; A-BETA; LIPOPROTEIN RECEPTORS; PLAQUE-FORMATION; LDL-RECEPTOR; MOUSE MODEL; CHOLESTEROL-METABOLISM; ENDOTHELIAL-CELLS	Apolipoprotein E (apoE) is a major apolipoprotein in the brain. The epsilon 4 allele of apoE is a major risk factor for Alzheimer disease, and apoE deficiency in mice leads to blood-brain barrier (BBB) leakage. However, the effect of apoE isoforms on BBB properties are as yet unknown. Here, using an in vitro BBB model consisting of brain endothelial cells and pericytes prepared from wild-type (WT) mice, and primary astrocytes prepared from human apoE3- and apoE4-knock- in mice, we show that the barrier function of tight junctions (TJs) was impaired when the BBB was reconstituted with primary astrocytes from apoE4-knock- in mice (apoE4-BBB model). The phosphorylation of occludin at Thr residues and the activation of protein kinase C (PKC)eta in mBECs were attenuated in the apoE4-BBB model compared with those in the apoE3- BBB model. The differential effects of apoE isoforms on the activation of PKC eta, the phosphorylation of occludin at Thr residues, and TJ integrity were abolished following the treatment with an anti-low density lipoprotein receptor-related protein 1 (LRP1) antibody or a LRP1 antagonist receptor-associated protein. Consistent with the results of in vitro studies, BBB permeability was higher in apoE4-knock- in mice than in apoE3- knock-in mice. Our studies provide evidence that TJ integrity in BBB is regulated by apoE in an isoform-dependent manner.	[Nishitsuji, Kazuchika; Hosono, Takashi; Nakamura, Toshiyuki; Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Alzheimers Dis Res, Aichi 4748522, Japan; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	National Center for Geriatrics & Gerontology; Mayo Clinic	Michikawa, M (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, 35 Gengo, Aichi 4748511, Japan.	michi@ncgg.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19300138, 21300145]; Ministry of Health, Labor, and Welfare of Japan [H20-007]; National Center for Geriatrics and Gerontology, Japan [21-11]; National Institutes of Health [R01AG027924, R01AG035355]; Alzheimer Association; NATIONAL INSTITUTE ON AGING [R01AG035355, P01AG030128, R01AG027924] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21300145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Geriatrics and Gerontology, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by Grants-in-aid for Scientific Research (B) 19300138 and 21300145 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. M.), a grant from the Ministry of Health, Labor, and Welfare of Japan (Research on Dementia, Health and Labor Sciences Research Grant H20-007) (to M. M.), Research Funding for Longevity Sciences Grant 21-11 from the National Center for Geriatrics and Gerontology, Japan (to M. M.), National Institutes of Health Grants R01AG027924 and R01AG035355 (to G. B.), and a Zenith Fellows award from the Alzheimer Association (to G. B.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Minagawa H, 2010, J BIOL CHEM, V285, P38382, DOI 10.1074/jbc.M110.146258; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Nagababu E, 2009, J ALZHEIMERS DIS, V17, P845, DOI 10.3233/JAD-2009-1104; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	165	173	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17536	17542		10.1074/jbc.M111.225532	http://dx.doi.org/10.1074/jbc.M111.225532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21471207	Green Published, hybrid			2022-12-27	WOS:000290585200016
J	Nady, N; Lemak, A; Walker, JR; Avvakumov, GV; Kareta, MS; Achour, M; Xue, S; Duan, SL; Allali-Hassani, A; Zuo, XB; Wang, YX; Bronner, C; Chedin, F; Arrowsmith, CH; Dhe-Paganon, S				Nady, Nataliya; Lemak, Alexander; Walker, John R.; Avvakumov, George V.; Kareta, Michael S.; Achour, Mayada; Xue, Sheng; Duan, Shili; Allali-Hassani, Abdellah; Zuo, Xiaobing; Wang, Yun-Xing; Bronner, Christian; Chedin, Frederic; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano			Recognition of Multivalent Histone States Associated with Heterochromatin by UHRF1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; BINDING-PROTEIN; DIPOLAR COUPLINGS; STRUCTURAL BASIS; MULTIDOMAIN PROTEIN; LYSINE METHYLATION; TUDOR DOMAIN; NP95; H3; REPLICATION	Histone modifications and DNA methylation represent two layers of heritable epigenetic information that regulate eukaryotic chromatin structure and gene activity. UHRF1 is a unique factor that bridges these two layers; it is required for maintenance DNA methylation at hemimethylated CpG sites, which are specifically recognized through its SRA domain and also interacts with histone H3 trimethylated on lysine 9 (H3K9me3) in an unspecified manner. Here we show that UHRF1 contains a tandem Tudor domain (TTD) that recognizes H3 tail peptides with the heterochromatin-associated modification state of trimethylated lysine 9 and unmodified lysine 4 (H3K4me0/K9me3). Solution NMR and crystallographic data reveal the TTD simultaneously recognizes H3K9me3 through a conserved aromatic cage in the first Tudor subdomain and unmodified H3K4 within a groove between the tandem subdomains. The subdomains undergo a conformational adjustment upon peptide binding, distinct from previously reported mechanisms for dual histone mark recognition. Mutant UHRF1 protein deficient for H3K4me0/K9me3 binding shows altered localization to heterochromatic chromocenters and fails to reduce expression of a target gene, p16(INK4A), when overexpressed. Our results demonstrate a novel recognition mechanism for the combinatorial readout of histone modification states associated with gene silencing and add to the growing evidence for coordination of, and cross-talk between, the modification states of H3K4 and H3K9 in regulation of gene expression.	[Nady, Nataliya; Lemak, Alexander; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Nady, Nataliya; Lemak, Alexander; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Walker, John R.; Avvakumov, George V.; Xue, Sheng; Allali-Hassani, Abdellah; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Kareta, Michael S.; Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Achour, Mayada; Bronner, Christian] Fac Pharm, CNRS UMR7213, Lab Biophoton & Pharmacol, F-67401 Illkirch Graffenstaden, France; [Zuo, Xiaobing; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto	Arrowsmith, CH (corresponding author), 101 Coll St,Ste 700, Toronto, ON M5G 1L7, Canada.	carrow@uhnres.utoronto.ca; sirano.dhepaganon@utoronto.ca	Zuo, Xiaobing/F-1469-2010; Bronner, Christian/R-8488-2016	Bronner, Christian/0000-0002-3101-9279; Kareta, Michael/0000-0002-6980-9065; Zuo, Xiaobing/0000-0002-0134-4804; Arrowsmith, Cheryl/0000-0002-4971-3250; /0000-0002-5255-895X; Chedin, Frederic/0000-0002-1306-5335	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886, DE-AC02-06CH11357]; Canadian Institutes for Health Research (CIHR) [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; MerckCo., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Ontario Ministry of Health and Long Term Care; Cancer Research Coordinating Committee; California Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE [ZIABC010379] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(Genome CanadaCanada Foundation for InnovationGlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); MerckCo., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Cancer Research Coordinating Committee; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Use of the National Synchrotron Light Source, Brookhaven National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-98CH10886. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck&Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was supported in part by the Ontario Ministry of Health and Long Term Care (to C. H. A.), the Cancer Research Coordinating Committee (to F. C.), a Stem Cell training grant from the California Institute of Regenerative Medicine (to M. S. K.). a Frederick Banting and Charles Best Canada Doctoral Research Award from the CIHR (to N. N.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Binda O, 2010, EPIGENETICS-US, V5, P767, DOI 10.4161/epi.5.8.13278; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chen WY, 2000, P NATL ACAD SCI USA, V97, P377, DOI 10.1073/pnas.97.1.377; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DHAYALAN A, 2011, HUM MOL GEN IN PRESS; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; GODDARD TD, 2006, SPARKY 3 V 3 113; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hopfner R, 2000, CANCER RES, V60, P121; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krauss V, 2008, GENETICA, V133, P93, DOI 10.1007/s10709-007-9184-z; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Mittermaier A, 2001, J AM CHEM SOC, V123, P6892, DOI 10.1021/ja010595d; Miura M, 2001, EXP CELL RES, V263, P202, DOI 10.1006/excr.2000.5115; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Papait R, 2007, MOL BIOL CELL, V18; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	72	140	147	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24300	24311		10.1074/jbc.M111.234104	http://dx.doi.org/10.1074/jbc.M111.234104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21489993	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000292294900071
J	Leshchyns'ka, I; Tanaka, MM; Schachner, M; Sytnyk, V				Leshchyns'ka, Iryna; Tanaka, Mark M.; Schachner, Melitta; Sytnyk, Vladimir			Immobilized Pool of NCAM180 in the Postsynaptic Membrane Is Homeostatically Replenished by the Flux of NCAM180 from Extrasynaptic Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; MEDIATED NEURITE OUTGROWTH; DENDRITIC SPINE STABILITY; NMDA RECEPTOR ACTIVATION; NULL MUTANT MICE; SYNAPTIC PLASTICITY; POLYSIALIC ACID; N-CAM; EXCITATORY SYNAPSE	Homeostatic mechanisms maintaining high levels of adhesion molecules in synapses over prolonged periods of time remain incompletely understood. We used fluorescence recovery after photobleaching experiments to analyze the steady state turnover of the immobile pool of green fluorescent protein-labeled NCAM180, the largest postsynaptically accumulating isoform of the neural cell adhesion molecule (NCAM). We show that there is a continuous flux of NCAM180 to the postsynaptic membrane from nonsynaptic regions of dendrites by diffusion. In the postsynaptic membrane, the newly delivered NCAM180 slowly intermixes with the immobilized pool of NCAM180. Preferential immobilization and accumulation of NCAM180 in the postsynaptic membrane is reduced after disruption of the association of NCAM180 with the spectrin cytoskeleton and in the absence of the homophilic interactions of NCAM180 in synapses. Our observations indicate that the homophilic interactions and binding to the cytoskeleton promote immobilization of NCAM180 and its accumulation in the postsynaptic membrane. Flux of NCAM180 from extrasynaptic regions and its slow intermixture with the immobile pool of NCAM180 in the postsynaptic membrane may be important for the continuous homeostatic replenishment of NCAM180 protein at synaptic contacts without compromising the long term synaptic contact stability.	[Leshchyns'ka, Iryna; Tanaka, Mark M.; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Leshchyns'ka, Iryna; Schachner, Melitta; Sytnyk, Vladimir] Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of New South Wales Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sytnyk, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	v.sytnyk@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010	Leshchyns'ka, Iryna/0000-0002-2025-5831; Sytnyk, Vladimir/0000-0003-1927-2199	Deutsche Forschungsgemeinschaft; National Health and Medical Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from the Deutsche Forschungsgemeinschaft (to M. S., I. L., and V. S.) and the National Health and Medical Research Council (to V. S.).	Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Aonurm-Helm A, 2010, BRAIN RES, V1309, P1, DOI 10.1016/j.brainres.2009.11.003; Aonurm-Helm A, 2008, BRAIN RES, V1243, P104, DOI 10.1016/j.brainres.2008.08.091; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Fux CM, 2003, MOL CELL NEUROSCI, V24, P939, DOI 10.1016/j.mcn.2003.07.001; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Jacobson KA, 1997, BBA-BIOMEMBRANES, V1330, P138, DOI 10.1016/S0005-2736(97)00128-4; KEANE RW, 1988, J CELL BIOL, V106, P1307, DOI 10.1083/jcb.106.4.1307; Kielland A, 2009, NEURON, V62, P84, DOI 10.1016/j.neuron.2009.03.001; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Park TU, 1997, BIOCHEM BIOPH RES CO, V234, P686, DOI 10.1006/bbrc.1997.6700; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	62	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23397	23406		10.1074/jbc.M111.252098	http://dx.doi.org/10.1074/jbc.M111.252098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550975	hybrid, Green Published			2022-12-27	WOS:000292025000071
J	Patterson, KR; Remmers, C; Fu, YF; Brooker, S; Kanaan, NM; Vana, L; Ward, S; Reyes, JF; Philibert, K; Glucksman, MJ; Binder, LI				Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Kanaan, Nicholas M.; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Philibert, Keith; Glucksman, Marc J.; Binder, Lester I.			Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; A-BETA; CONFORMATIONAL-CHANGES; CASPASE CLEAVAGE; INDUCED DEFECTS; NEURONAL LOSS	Neurofibrillary tangles, composed of insoluble aggregates of the microtubule-associated protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. However, recent evidence indicates that neuronal dysfunction precedes the formation of these insoluble fibrillar deposits, suggesting that earlier prefibrillar Tau aggregates may be neurotoxic. To determine the composition of these aggregates, we have employed a photochemical cross-linking technique to examine intermolecular interactions of full-length Tau in vitro. Using this method, we demonstrate that dimerization is an early event in the Tau aggregation process and that these dimers self-associate to form larger oligomeric aggregates. Moreover, using these stabilized Tau aggregates as immunogens, we generated a monoclonal antibody that selectively recognizes Tau dimers and higher order oligomeric aggregates but shows little reactivity to Tau filaments in vitro. Immunostaining indicates that these dimers/oligomers are markedly elevated in AD, appearing in early pathological inclusions such as neuropil threads and pre-tangle neurons as well as colocalizing with other early markers of Tau pathogenesis. Taken as a whole, the work presented herein demonstrates the existence of alternative Tau aggregates that precede formation of fibrillar Tau pathologies and raises the possibility that these hierarchical oligomeric forms of Tau may contribute to neurodegeneration.	[Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Binder, Lester I.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Kanaan, Nicholas M.] Michigan State Univ, Div Translat Sci & Mol Med, Grand Rapids, MI 49503 USA; [Philibert, Keith; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, Chicago, IL 60064 USA; [Philibert, Keith; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Midwest Proteome Ctr, Chicago Med Sch, Chicago, IL 60064 USA	Northwestern University; Feinberg School of Medicine; Michigan State University; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Patterson, KR (corresponding author), 300 E Super St,Tarry 8-754, Chicago, IL 60611 USA.	k-patterson@md.northwestern.edu	Brooker, Sarah/AAO-6122-2020; Kanaan, Nicholas M./J-3428-2016	Brooker, Sarah/0000-0002-5674-3124; Kanaan, Nicholas M./0000-0002-4362-2593	National Institutes of Health [T32 AF020506, AG09466]; National Center for Research Resources [S10 RR19325]; Health Resources and Services Administration [C76 HF03610-01-00]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, P01AG009466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AF020506 (to K. R. P.), AG09466 (to L. I. B.), National Center for Research Resources S10 RR19325 (to M. J. G.), and Health Resources and Services Administration C76 HF03610-01-00 (to M. J. G.).	Abraha A, 2000, J CELL SCI, V113, P3737; Allen B, 2002, J NEUROSCI, V22, P9340; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Appelt DM, 1997, BRAIN RES, V745, P21, DOI 10.1016/S0006-8993(96)01121-3; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Balin BJ, 2000, METH MOLEC MED, V32, P395, DOI 10.1385/1-59259-195-7:395; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Berry RW, 2004, J NEUROCYTOL, V33, P287, DOI 10.1023/B:NEUR.0000044190.96426.b9; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P2252, DOI 10.1021/bi0272510; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; GUTTMANN RP, 1995, J NEUROCHEM, V64, P1209; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kanaan N. M., 2011, J NEUROSCI IN PRESS; Kanaan NM, 2007, J COMP NEUROL, V502, P683, DOI 10.1002/cne.21333; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Mondragon-Rodriguez S, 2008, INT J EXP PATHOL, V89, P81, DOI 10.1111/j.1365-2613.2007.00568.x; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Novak M, 1989, Prog Clin Biol Res, V317, P755; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oosawa F., 1975, THERMODYNAMICS POLYM; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Reyes JF, 2008, NEUROBIOL DIS, V31, P198, DOI 10.1016/j.nbd.2008.04.005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Singer SM, 2002, NEUROCHEM INT, V40, P17, DOI 10.1016/S0197-0186(01)00061-4; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Tanemura K, 2001, NEUROBIOL DIS, V8, P1036, DOI 10.1006/nbdi.2001.0439; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	86	230	240	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23063	23076		10.1074/jbc.M111.237974	http://dx.doi.org/10.1074/jbc.M111.237974			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550980	hybrid, Green Published			2022-12-27	WOS:000292025000041
J	Zhou, XX; Sun, X; Cooper, KL; Wang, F; Liu, KJ; Hudson, LG				Zhou, Xixi; Sun, Xi; Cooper, Karen L.; Wang, Feng; Liu, Ke Jian; Hudson, Laurie G.			Arsenite Interacts Selectively with Zinc Finger Proteins Containing C3H1 or C4 Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; HUMAN KERATINOCYTES; SYNTHETIC PEPTIDES; MAMMALIAN-CELLS; PARP-1 ACTIVITY; DRINKING-WATER; BINDING; DAMAGE; POLY(ADP-RIBOSE); TOXICITY	Arsenic inhibits DNA repair and enhances the genotoxicity of DNA-damaging agents such as benzo[a] pyrene and ultraviolet radiation. Arsenic interaction with DNA repair proteins containing functional zinc finger motifs is one proposed mechanism to account for these observations. Here, we report that arsenite binds to both CCHC DNA-binding zinc fingers of the DNA repair protein PARP-1 (poly(ADP-ribose) polymerase-1). Furthermore, trivalent arsenite coordinated with all three cysteine residues as demonstrated by MS/MS. MALDI-TOF-MS analysis of peptides harboring site-directed substitutions of cysteine with histidine residues within the PARP-1 zinc finger revealed that arsenite bound to peptides containing three or four cysteine residues, but not to peptides with two cysteines, demonstrating arsenite binding selectivity. This finding was not unique to PARP-1; arsenite did not bind to a peptide representing the CCHH zinc finger of the DNA repair protein aprataxin, but did bind to an aprataxin peptide mutated to a CCHC zinc finger. To investigate the impact of arsenite on PARP-1 zinc finger function, we measured the zinc content and DNA-binding capacity of PARP-1 immunoprecipitated from arsenite-exposed cells. PARP-1 zinc content and DNA binding were decreased by 76 and 80%, respectively, compared with protein isolated from untreated cells. We observed comparable decreases in zinc content for XPA (xeroderma pigmentosum group A) protein (CCCC zinc finger), but not SP-1 (specificity protein-1) or aprataxin (CCHH zinc finger). These findings demonstrate that PARP-1 is a direct molecular target of arsenite and that arsenite interacts selectively with zinc finger motifs containing three or more cysteine residues.	[Zhou, Xixi; Sun, Xi; Cooper, Karen L.; Wang, Feng; Liu, Ke Jian; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Liu, KJ (corresponding author), 1 Univ New Mexico, Coll Pharm, MSC09 5360, Albuquerque, NM 87131 USA.	kliu@salud.unm.edu; lhudson@salud.unm.edu	Zhou, Xixi/F-6474-2013; Zhou, Xixi/F-1760-2011	Zhou, Xixi/0000-0003-4202-8821	National Institutes of Health [R01 ES15826, R01 ES15826-03S1]; University of New Mexico Cancer Research and Treatment Center [NIH P30 CA118100]; University of New Mexico Proteomics/Mass Spectrometry Facility; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Cancer Research and Treatment Center; University of New Mexico Proteomics/Mass Spectrometry Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES15826 and R01 ES15826-03S1. This work was also supported by University of New Mexico Cancer Research and Treatment Center Grant NIH P30 CA118100 and the University of New Mexico Proteomics/Mass Spectrometry Facility.	Agency for Toxic Substances and Disease Registry U. S. Department of Health and Human Services. Syracuse Research Corporation, 2007, TOX PROF ARS; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Germolec DR, 1998, AM J PATHOL, V153, P1775, DOI 10.1016/S0002-9440(10)65692-1; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Hu Y, 1998, MUTAT RES-DNA REPAIR, V408, P203, DOI 10.1016/S0921-8777(98)00035-4; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Kitchin KT, 2006, J BIOCHEM MOL TOXIC, V20, P48, DOI 10.1002/jbt.20108; Kitchin KT, 2006, J BIOCHEM MOL TOXIC, V20, P35, DOI 10.1002/jbt.20112; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lynn S, 1997, MUTAGENESIS, V12, P353, DOI 10.1093/mutage/12.5.353; Maier A, 2002, MUTAT RES-GEN TOX EN, V517, P101, DOI 10.1016/S1383-5718(02)00057-8; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Payne JC, 2003, BIOCHEMISTRY-US, V42, P14214, DOI 10.1021/bi035002l; Piatek K, 2008, CHEM RES TOXICOL, V21, P600, DOI 10.1021/tx7003135; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Ramadan D, 2009, BIOCHEMISTRY-US, V48, P424, DOI 10.1021/bi801988x; Rossman TG, 2004, TOXICOL APPL PHARM, V198, P394, DOI 10.1016/j.taap.2003.10.016; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Schoen A, 2004, TOXICOL APPL PHARM, V198, P253, DOI 10.1016/j.taap.2003.10.011; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuhmacher-Wolz U, 2009, CRIT REV TOXICOL, V39, P271, DOI 10.1080/10408440802291505; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Snow Elizabeth T, 2005, Toxicol Appl Pharmacol, V207, P557, DOI 10.1016/j.taap.2005.01.048; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; YAMAMOTO S, 1995, CANCER RES, V55, P1271; Yoshida T, 2004, TOXICOL APPL PHARM, V198, P243, DOI 10.1016/j.taap.2003.10.022; Yu HS, 2006, J BIOMED SCI, V13, P657, DOI 10.1007/s11373-006-9092-8	43	130	130	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22855	22863		10.1074/jbc.M111.232926	http://dx.doi.org/10.1074/jbc.M111.232926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550982	hybrid, Green Published			2022-12-27	WOS:000292025000020
J	Gong, ZH; Chen, JJ				Gong, Zihua; Chen, Junjie			E3 Ligase RFWD3 Participates in Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; PROTEIN-A RPA; PHYSICAL INTERACTION; BINDING-PROTEIN; DAMAGE; ATR; RECOMBINATION; RECRUITMENT; REGULATOR; COMPLEXES	RFWD3 has E3 ligase activity in vitro, but its in vivo function remains unknown. In this study we identified RFWD3 as a novel replication protein A (RPA)-associated protein. Using purified proteins, we observed a direct interaction between RPA2 and RFWD3. Further analysis showed that RFWD3 is recruited to stalled replication forks and co-localizes with RPA2 in response to replication stress. Moreover, RFWD3 is important for ATR-dependent Chk1 activation in response to replication stress. Upon replication stress, deletion of RPA2 binding region on RFWD3 impairs its localization to stalled replication forks and decreases Chk1 activation. Taken together, our results suggest that RFWD3 and RPA2 functionally interact and participate in replication checkpoint control.	[Gong, Zihua; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org			National Institutes of Health [CA089239, CA092312, CA100109]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA100109, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. E-mail: jchen8@mdanderson.org.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fu XY, 2010, P NATL ACAD SCI USA, V107, P4579, DOI 10.1073/pnas.0912094107; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Perrault R, 2001, INT J RADIAT BIOL, V77, P593, DOI 10.1080/09553000110036773; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	25	37	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22308	22313		10.1074/jbc.M111.222869	http://dx.doi.org/10.1074/jbc.M111.222869			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504906	Green Published, hybrid			2022-12-27	WOS:000291719900039
J	Jaafar, R; Zeiller, C; Pirola, L; Di Grazia, A; Naro, F; Vidal, H; Lefai, E; Nemoz, G				Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Di Grazia, Antonio; Naro, Fabio; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges			Phospholipase D Regulates Myogenic Differentiation through the Activation of Both mTORC1 and mTORC2 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SKELETAL-MUSCLE REGENERATION; MAMMALIAN TARGET; PHOSPHATIDIC-ACID; MYOBLAST DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; PROTEIN-SYNTHESIS; RAPAMYCIN; VASOPRESSIN; HYPERTROPHY	How phospholipase D (PLD) is involved in myogenesis remains unclear. At the onset of myogenic differentiation of L6 cells induced by the PLD agonist vasopressin in the absence of serum, mTORC1 complex was rapidly activated, as reflected by phosphorylation of S6 kinase1 (S6K1). Both the long (p85) and short (p70) S6K1 isoforms were phosphorylated in a PLD1-dependent way. Short rapamycin treatment specifically inhibiting mTORC1 suppressed p70 but not p85 phosphorylation, suggesting that p85 might be directly activated by phosphatidic acid. Vasopressin stimulation also induced phosphorylation of Akt on Ser-473 through PLD1-dependent activation of mTORC2 complex. In this model of myogenesis, mTORC2 had a positive role mostly unrelated to Akt activation, whereas mTORC1 had a negative role, associated with S6K1-induced Rictor phosphorylation. The PLD requirement for differentiation can thus be attributed to its ability to trigger via mTORC2 activation the phosphorylation of an effector that could be PKC alpha. Moreover, PLD is involved in a counter-regulation loop expected to limit the response. This study thus brings new insights in the intricate way PLD and mTOR cooperate to control myogenesis.	[Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] Lyon Univ, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] INSERM, U1060, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] CarMeN Lab, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] Univ Lyon 1, UMR1235, F-69600 Oullins, France; [Vidal, Hubert; Lefai, Etienne] INRA, UMR1235, F-69600 Oullins, France; [Di Grazia, Antonio; Naro, Fabio] Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, I-00161 Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Sapienza University Rome	Nemoz, G (corresponding author), INSERM, U1060, F-69921 Oullins, France.	georges.nemoz@insa-lyon.fr	Lefai, Etienne/E-9615-2019; Jaafar, Rami/K-1027-2019; Vidal, Hubert/M-6674-2017; Lefai, Etienne/L-7961-2019; Pirola, Luciano/I-5250-2018	Lefai, Etienne/0000-0002-3042-7801; Jaafar, Rami/0000-0002-1649-4792; Vidal, Hubert/0000-0002-9467-0317; Lefai, Etienne/0000-0002-3042-7801; Pirola, Luciano/0000-0001-6539-5435	Association Francaise contre les Myopathies [MNM2 2007]; Association pour la Recherche sur le Cancer	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work has been supported by a grant from the Association Francaise contre les Myopathies (MNM2 2007) and a fellowship from the Association pour la Recherche sur le Cancer (to R. J.).	Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Breton C, 2002, J CLIN ENDOCR METAB, V87, P1415, DOI 10.1210/jc.87.3.1415; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; CONVERTINO VA, 1983, J APPL PHYSIOL, V54, P508, DOI 10.1152/jappl.1983.54.2.508; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hu TH, 2003, J BIOL CHEM, V278, P2348, DOI 10.1074/jbc.M210093200; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Komati H, 2004, FEBS LETT, V577, P409, DOI 10.1016/j.febslet.2004.10.036; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Laser M, 1998, J BIOL CHEM, V273, P24610, DOI 10.1074/jbc.273.38.24610; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Mebarek S, 2007, J CELL SCI, V120, P407, DOI 10.1242/jcs.03331; Minotti S, 1998, CELL GROWTH DIFFER, V9, P155; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Moresi V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005570; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; SMITH A, 1992, EARLY HUM DEV, V28, P215, DOI 10.1016/0378-3782(92)90168-G; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Thibonnier M, 1996, GENOMICS, V31, P327, DOI 10.1006/geno.1996.0055; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001	62	22	23	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22609	22621		10.1074/jbc.M110.203885	http://dx.doi.org/10.1074/jbc.M110.203885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525000	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000291719900068
J	Singh, AK; Swarnalatha, M; Kumar, V				Singh, Anup Kumar; Swarnalatha, Manickavinayaham; Kumar, Vijay			c-ETS1 Facilitates G(1)/S-phase Transition by Up-regulating Cyclin E and CDK2 Genes and Cooperates with Hepatitis B Virus X Protein for Their Deregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; EXPRESSION; PROMOTER; ACTIVATION; BINDING; ETS-1; CHROMATIN	Recent studies on the molecular mechanisms responsible for cell cycle deregulation in cancer have puzzled out the role of oncogenes in mediating unscheduled cellular proliferation. This is reminiscence of their activity as proto-oncogenes that drives scheduled cell cycle progression under physiological conditions. Working on the cell cycle regulatory activity of protooncogene, we observed that c-ETS1 transcriptionally up-regulated both cyclin E and CDK2 genes, the master regulators of G(1)/S-phase transition. The process was mediated by kinetic coherence of c-ETS1 expression and its recruitment to both promoters during G(1)/S-phase transition. Furthermore, enforced expression of c-ETS1 helped G(0)-arrested cells to progress into G(1)/S-phases apparently due to the activation of cyclin E/CDK2 genes. Physiological induction of c-ETS1 by EGF showed the remodeling of mononucleosomes bound to the c-ETS1 binding site on both promoters during their activation. The exchange of HDAC1 with histone acetyltransferase-p300 was contemporaneous to the chromatin remodeling with consequent increase in histone H3K9 acetylation. Furthermore, the ATP-dependent chromatin remodeler hBRM1 recruitment was also associated with nucleosome remodeling and promoter occupancy of phos-pho-Ser5 RNA polymerase II. Intriguingly, the activity of the HBx viral oncoprotein was dependent on c-ETS1 in a hepatotropic manner, which led to the activation of cyclin E/CDK2 genes. Thus, cyclin E and CDK2 genes are key physiological effectors of the c-ETS1 proto-oncogene. Furthermore, c-ETS1 is indispensable for the hepatotropic action of HBx in cell cycle deregulation.	[Singh, Anup Kumar; Swarnalatha, Manickavinayaham; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in			International Centre for Genetic Engineering and Biotechnology, New Delhi; Council of Scientific and Industrial Research (New Delhi); Indian Council of Medical Research (New Delhi)	International Centre for Genetic Engineering and Biotechnology, New Delhi; Council of Scientific and Industrial Research (New Delhi)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (New Delhi)(Indian Council of Medical Research (ICMR))	This work was supported by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi.; Recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research (New Delhi).; Recipient of a Senior Research Fellowship from the Indian Council of Medical Research (New Delhi).	AVANTAGGIATI ML, 1993, ONCOGENE, V8, P1567; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Botz J, 1996, MOL CELL BIOL, V16, P3401; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Davie JR, 1999, J CELL BIOCHEM, P141; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Geng Y, 1996, ONCOGENE, V12, P1173; Gilles F, 1996, EXP CELL RES, V222, P370, DOI 10.1006/excr.1996.0046; Glass CK, 2000, GENE DEV, V14, P121; Goodman RH, 2000, GENE DEV, V14, P1553; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Janbandhu VC, 2010, J BIOL CHEM, V285, P17453, DOI 10.1074/jbc.M109.058974; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Kumar V, 1998, HYBRIDOMA, V17, P157, DOI 10.1089/hyb.1998.17.157; KUMAR V, 2008, PLEIOTROPIC FUNCTION, P221; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; McGowan Clare H, 2003, Prog Cell Cycle Res, V5, P1; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Sugimoto H, 2003, J BIOL CHEM, V278, P19716, DOI 10.1074/jbc.M301590200; Takai N, 2002, INT J MOL MED, V9, P287; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; TOPOL LZ, 1992, CANCER LETT, V67, P71, DOI 10.1016/0304-3835(92)90010-S; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yoo YD, 1996, J CLIN INVEST, V97, P388, DOI 10.1172/JCI118427	56	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21961	21970		10.1074/jbc.M111.238238	http://dx.doi.org/10.1074/jbc.M111.238238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515670	hybrid, Green Published			2022-12-27	WOS:000291719900003
J	Wang, J; Zhou, JY; Wu, GS				Wang, Juan; Zhou, Jun-Ying; Wu, Gen Sheng			Bim Protein Degradation Contributes to Cisplatin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; KINASE PHOSPHATASE-1; BH3-ONLY PROTEIN; BCL-2 FAMILY; PHOSPHORYLATION; APOPTOSIS; CHEMOTHERAPY; PROMOTES; BIM(EL); DEATH	Cisplatin is the first-line chemotherapy for the treatment of several cancers. However, the development of cisplatin resistance represents a major clinical problem, and the mechanisms of acquired resistance are not fully understood. Here we show that degradation of the Bcl-2 homology 3-only proapoptotic protein Bim plays an important role in cisplatin resistance in ovarian cancer. Specifically, we show that treatment of ovarian cancer cells with cisplatin caused Bim phosphorylation and subsequent degradation and that its degradation is associated with cisplatin resistance. We also show that cisplatin treatment caused the activation of ERK, which correlated with Bim phosphorylation and degradation. By inhibiting ERK phosphorylation with the MEK inhibitor and knocking down ERK expression with siRNA, we show that Bim phosphorylation and degradation were blocked, which suggests that Bim is phosphorylated by ERK and that such phosphorylation is responsible for cisplatin-induced Bim degradation. We show that ERK was activated in cisplatin-resistant OV433 cells as compared with their counterpart parental OV433 cells. We also show that Bim was phosphorylated and degraded in cisplatin-resistant OV433 cells but not in the parental OV433 cells. Importantly, we show that inhibition of Bim degradation by the proteasome inhibitor MG132 sensitized resistant OV433 cells to cisplatin-induced death. Taken together, our data indicate that degradation of Bim via ERK-mediated phosphorylation can lead to cisplatin resistance. Therefore, these findings suggest that cisplatin resistance can be overcome by the combination of cisplatin and the proteasome inhibitors in ovarian cancer cells.	[Wu, Gen Sheng] Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Oncol, Detroit, MI 48201 USA; [Wu, Gen Sheng] Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Wu, GS (corresponding author), Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Oncol, Detroit, MI 48201 USA.	wug@karmanos.org			Gail Purtan Ovarian Cancer Research Fund	Gail Purtan Ovarian Cancer Research Fund	This work was supported by the Gail Purtan Ovarian Cancer Research Fund.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Beale PJ, 2000, BRIT J CANCER, V82, P436; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cullen KJ, 2003, CANCER RES, V63, P8097; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson SW, 1996, EXP CELL RES, V226, P133, DOI 10.1006/excr.1996.0211; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Perego P, 1996, CANCER RES, V56, P556; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Turchi JJ, 2006, P NATL ACAD SCI USA, V103, P4337, DOI 10.1073/pnas.0601001103; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Weinberg LE, 2010, J SURG ONCOL, V101, P334, DOI 10.1002/jso.21482; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229	35	49	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22384	22392		10.1074/jbc.M111.239566	http://dx.doi.org/10.1074/jbc.M111.239566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21561860	Green Published, hybrid			2022-12-27	WOS:000291719900048
J	Nikiforov, A; Dolle, C; Niere, M; Ziegler, M				Nikiforov, Andrey; Dolle, Christian; Niere, Marc; Ziegler, Mathias			Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells FROM ENTRY OF EXTRACELLULAR PRECURSORS TO MITOCHONDRIAL NAD GENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE RIBOSIDE; MAMMALIAN-CELLS; WALLERIAN DEGENERATION; METABOLISM; PHOSPHORIBOSYLTRANSFERASE; POLY(ADP-RIBOSE); NUCLEOTIDE; SIRTUINS; ENZYME; LIFE	NAD is a vital redox carrier, and its degradation is a key element of important regulatory pathways. NAD-mediated functions are compartmentalized and have to be fueled by specific biosynthetic routes. However, little is known about the different pathways, their subcellular distribution, and regulation in human cells. In particular, the route(s) to generate mitochondrial NAD, the largest subcellular pool, is still unknown. To visualize organellar NAD changes in cells, we targeted poly( ADP-ribose) polymerase activity into the mitochondrial matrix. This activity synthesized immunodetectable poly(ADPribose) depending on mitochondrial NAD availability. Based on this novel detector system, detailed subcellular enzyme localizations, and pharmacological inhibitors, we identified extracellular NAD precursors, their cytosolic conversions, and the pathway of mitochondrial NAD generation. Our results demonstrate that, besides nicotinamide and nicotinic acid, only the corresponding nucleosides readily enter the cells. Nucleotides (e. g. NAD and NMN) undergo extracellular degradation resulting in the formation of permeable precursors. These precursors can all be converted to cytosolic and mitochondrial NAD. For mitochondrial NAD synthesis, precursors are converted to NMN in the cytosol. When taken up into the organelles, NMN (together with ATP) serves as substrate of NMNAT3 to form NAD. NMNAT3 was conclusively localized to the mitochondrial matrix and is the only known enzyme of NAD synthesis residing within these organelles. We thus present a comprehensive dissection of mammalian NAD biosynthesis, the groundwork to understand regulation of NAD-mediated processes, and the organismal homeostasis of this fundamental molecule.	[Nikiforov, Andrey; Dolle, Christian; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway	University of Bergen	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, PB 7803, N-5020 Bergen, Norway.	Mathias.Ziegler@mbi.uib.no	Nikiforov, Andrey A/B-6643-2012	Nikiforov, Andrey A/0000-0002-5009-6130; Ziegler, Mathias/0000-0001-6961-2396	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council.	Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Aleo MF, 2001, J CELL BIOCHEM, V80, P360, DOI 10.1002/1097-4644(20010301)80:3<360::AID-JCB90>3.0.CO;2-X; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Bruzzone S, 2001, FASEB J, V15, P10; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Dolle C, 2009, ANAL BIOCHEM, V385, P377, DOI 10.1016/j.ab.2008.10.033; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Grobben B, 1999, J NEUROCHEM, V72, P826, DOI 10.1046/j.1471-4159.1999.0720826.x; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; HENDERSON LM, 1947, J BIOL CHEM, V170, P261; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; PREISS J, 1958, J BIOL CHEM, V233, P493; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; TYLER D, 1992, MITOCHONDRION HLTH D; Vollmayer P, 2003, EUR J BIOCHEM, V270, P2971, DOI 10.1046/j.1432-1033.2003.03674.x; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang QH, 2002, SCIENCE, V295, P1895; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	52	224	231	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21767	21778		10.1074/jbc.M110.213298	http://dx.doi.org/10.1074/jbc.M110.213298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504897	Green Published, hybrid			2022-12-27	WOS:000291464700072
J	Radulescu, AE; Mukherjee, S; Shields, D				Radulescu, Andreea E.; Mukherjee, Shaeri; Shields, Dennis			The Golgi Protein p115 Associates with gamma-Tubulin and Plays a Role in Golgi Structure and Mitosis Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-GOLGI; TETHERING PROTEIN; MEMBRANE-PROTEIN; CLEAVAGE FURROW; MATRIX PROTEIN; APPARATUS; GM130; CYTOKINESIS; DROSOPHILA; TRANSPORT	The Golgi apparatus is a network of polarized cisternae localized to the perinuclear region in mammalian cells. It undergoes extensive vesiculation at the onset of mitosis and its reassembly requires factors that are in part segregated via the mitotic spindle. Here we show that unlike typical Golgi markers, the Golgi-protein p115 partitioned with the spindle poles throughout mitosis. An armadillo-fold in its N terminus mediated a novel interaction between p115 and gamma-tubulin and functioned in its centrosomal targeting. Both the N- and C-terminal regions of p115 were required to maintain Golgi structure. Strikingly, p115 was essential for mitotic spindle function and the resolution of the cytokinetic bridge because its depletion resulted in spindle collapse, chromosome missegregation, and failed cytokinesis. We demonstrate that p115 plays a critical role in mitosis progression, implicating it as the only known golgin to regulate both mitosis and apoptosis.	[Radulescu, Andreea E.; Mukherjee, Shaeri; Shields, Dennis] Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Radulescu, AE (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	aradulescu@ucsd.edu; shaeri.mukherjee@yale.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021860, R01DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.).	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Barr FA, 2005, J CELL BIOL, V168, P993, DOI 10.1083/jcb.200501088; Barr FA, 2004, J CELL BIOL, V164, P955, DOI 10.1083/jcb.200402011; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; Litvak V, 2002, MOL CELL BIOL, V22, P5064, DOI 10.1128/MCB.22.14.5064-5075.2002; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Mukherjee S, 2009, J BIOL CHEM, V284, P1709, DOI 10.1074/jbc.M807263200; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Puri S, 2004, J CELL SCI, V117, P451, DOI 10.1242/jcs.00863; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830	55	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21915	21926		10.1074/jbc.M110.209460	http://dx.doi.org/10.1074/jbc.M110.209460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536679	Green Published, hybrid			2022-12-27	WOS:000291464700086
J	Canul-Tec, JC; Riano-Umbarila, L; Rudino-Pinera, E; Becerril, B; Possani, LD; Torres-Larios, A				Carlos Canul-Tec, Juan; Riano-Umbarila, Lidia; Rudino-Pinera, Enrique; Becerril, Baltazar; Possani, Lourival D.; Torres-Larios, Alfredo			Structural Basis of Neutralization of the Major Toxic Component from the Scorpion Centruroides noxius Hoffmann by a Human-derived Single-chain Antibody Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; CRYSTAL-STRUCTURE; VOLTAGE SENSOR; ENHANCED ACTIVATION; RECEPTOR-SITES; BETA-TOXIN; STABILIZATION; SPECIFICITY; RESIDUES; SEQUENCE	It has previously been reported that several single-chain antibody fragments of human origin (scFv) neutralize the effects of two different scorpion venoms through interactions with the primary toxins of Centruroides noxius Hoffmann (Cn2) and Centruroides suffusus suffusus (Css2). Here we present the crystal structure of the complex formed between one scFv (9004G) and the Cn2 toxin, determined in two crystal forms at 2.5 and 1.9 angstrom resolution. A 15-residue span of the toxin is recognized by the antibody through a cleft formed by residues from five of the complementarity-determining regions of the scFv. Analysis of the interface of the complex reveals three features. First, the epitope of toxin Cn2 overlaps with essential residues for the binding of beta-toxins to its Na+ channel receptor site. Second, the putative recognition of Css2 involves mainly residues that are present in both Cn2 and Css2 toxins. Finally, the effect on the increase of affinity of previously reported key residues during the maturation process of different scFvs can be inferred from the structure. Taken together, these results provide the structural basis that explain the mechanism of the 9004G neutralizing activity and give insight into the process of directed evolution that gave rise to this family of neutralizing scFvs.	[Carlos Canul-Tec, Juan; Riano-Umbarila, Lidia; Rudino-Pinera, Enrique; Becerril, Baltazar; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Possani, LD (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	possani@ibt.unam.mx; torres@ifc.unam.mx	Possani, Lourival D/J-2397-2013	Rudino-Pinera, Enrique/0000-0001-8170-6379; Torres-Larios, Alfredo/0000-0002-0702-350X; Canul Tec, Juan Carlos/0000-0003-0513-545X; Riano-Umbarila, Lidia/0000-0002-2531-9232	Instituto Bioclon [P-156]; Consejo Nacional de Ciencia y Tecnologia [60127-Q, 45248]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) [IN202910, IN204110]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-279]	Instituto Bioclon; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal	This work was supported by Grant P-156 from Instituto Bioclon (to L. D. P.), Consejo Nacional de Ciencia y Tecnologia Grant 60127-Q (to A. T.-L.), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) Grants IN202910 (to A. T.-L.) and IN204110 (to L. D. P.), and Instituto de Ciencia y Tecnologia del Distrito Federal Grant PIFUTP09-279 (to A. T.-L.).; Recipient of Consejo Nacional de Ciencia y Tecnologia Scholarship 45248.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Estrada G, 2007, BBA-GEN SUBJECTS, V1770, P1161, DOI 10.1016/j.bbagen.2007.04.006; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; Gordon D, 1998, J TOXICOL-TOXIN REV, V17, P131, DOI 10.3109/15569549809009247; Hernandez-Salgado K, 2009, IMMUNOL LETT, V125, P93, DOI 10.1016/j.imlet.2009.06.001; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann M, 2002, J MOL BIOL, V318, P135, DOI 10.1016/S0022-2836(02)00038-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leysath CE, 2009, J MOL BIOL, V387, P680, DOI 10.1016/j.jmb.2009.02.003; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Praveen S, 2008, J APPL CRYSTALLOGR, V41, P952, DOI 10.1107/S0021889808022073; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yun YS, 2005, FEBS J, V272, P1999, DOI 10.1111/j.1742-4658.2005.04627.x; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20892	20900		10.1074/jbc.M111.238410	http://dx.doi.org/10.1074/jbc.M111.238410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489992	Green Published, hybrid			2022-12-27	WOS:000291267600073
J	Zhang, J; Zhao, FB; Zhao, Y; Wang, J; Pei, L; Sun, N; Shi, J				Zhang, Jing; Zhao, Fengbo; Zhao, Yin; Wang, Jing; Pei, Lei; Sun, Ning; Shi, Jing			Hypoxia Induces an Increase in Intracellular Magnesium via Transient Receptor Potential Melastatin 7 (TRPM7) Channels in Rat Hippocampal Neurons in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FUNCTIONAL-CHARACTERIZATION; GLOBAL-ISCHEMIA; ION CHANNELS; MG2+; CALCIUM; CA2+; HOMEOSTASIS; PROTEIN; STROKE	TRPM7, a divalent cation channel, plays an important role in neurons damaged from cerebral ischemia due to permitting intracellular calcium overload. This study aimed to explore whether magnesium was transported via a TRPM7 channel into the intracellular space of rat hippocampal neurons after 1 h of oxygen-glucose deprivation (OGD) and acute chemical ischemia (CI) by using methods of the Mg2+ fluorescent probe Mag-Fura-2 to detect intracellular magnesium concentration ([Mg2+](i)) and flame atomic absorption spectrometry to measure extracellular magnesium concentration ([Mg2+](o)). The results showed that the neuronal [Mg2+](i) was 1.51-fold higher after 1 h of OGD at a basal level, and the increase of neuronal [Mg2+](i) reached a peak after 1 h of OGD and was kept for 60 min with re-oxygenation. Meanwhile, the [Mg2+](o) decreased after 1 h of OGD and recovered to the pre-ischemic level within 15 min after re-oxygenation. In the case of CI, the [Mg2+](i) peak immediately appeared in hippocampal neurons. This increase of [Mg2+](i) declined by removing extracellular magnesium in OGD or CI. Furthermore, by using Gd3+ or 2-aminoethoxydiphenyl borate to inhibit TRPM7 channels, the [Mg2+](i) increase, which was induced by OGD or CI, was attenuated without altering the basal level of [Mg2+](i). By silencing TRPM7 with shRNA in hippocampal neurons, it was found that not only was the increase of [Mg2+](i) induced by OGD or CI but also the basal levels of [Mg2+](i) were attenuated. In contrast, overexpression of TRPM7 in HEK293 cells exaggerated both the basal levels and increased [Mg2+](i) after 1 h of OGD/CI. These results suggest that anoxia induced the increase of [Mg2+](i) via TRPM7 channels in rat hippocampal neurons.	[Shi, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis Hubei Prov, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	sj@mails.tjmu.edu.cn	Zhao, Yin/AAA-5891-2019		National Natural Science Foundation of China [30870793]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 30870793.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299; Altura B M, 1991, Magnes Trace Elem, V10, P182; BEYENBACH KW, 1990, MAGNESIUM TRACE ELEM, V9, P233; BLAIR JL, 1989, STROKE, V20, P507, DOI 10.1161/01.STR.20.4.507; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; CHOI DW, 1987, J NEUROSCI, V7, P369; CROMPTON M, 1976, BIOCHEM J, V154, P735, DOI 10.1042/bj1540735; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gabriel TE, 2007, ARCH BIOCHEM BIOPHYS, V458, P3, DOI 10.1016/j.abb.2006.07.007; GASBARRINI A, 1992, J BIOL CHEM, V267, P6654; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gotoh H, 1999, BRAIN RES, V828, P163, DOI 10.1016/S0006-8993(99)01298-6; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; GRUBBS RD, 1987, MAGNESIUM, V6, P113; HAUGLAND RP, 1996, HDB FLUORESCENT PROB, P507; He Y, 2005, CIRC RES, V96, P207, DOI 10.1161/01.RES.0000152967.88472.3e; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kato H, 1998, BRAIN RES, V779, P329, DOI 10.1016/S0006-8993(97)01232-8; Kennedy HJ, 1998, EXP PHYSIOL, V83, P449, DOI 10.1113/expphysiol.1998.sp004128; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Lee EJ, 1999, J NEUROSCI RES, V58, P442, DOI 10.1002/(SICI)1097-4547(19991101)58:3<442::AID-JNR10>3.0.CO;2-4; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lin MC, 2004, J AM COLL NUTR, V23, p561S, DOI 10.1080/07315724.2004.10719404; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; LONDON RE, 1991, ANNU REV PHYSIOL, V53, P241, DOI 10.1146/annurev.physiol.53.1.241; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakamura T, 1999, NEUROSCIENCE, V88, P57, DOI 10.1016/S0306-4522(98)00207-3; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93; Pisani A, 2000, J CEREBR BLOOD F MET, V20, P839, DOI 10.1097/00004647-200005000-00011; Planells-Cases R, 2006, CURR PHARM DESIGN, V12, P3583, DOI 10.2174/138161206778522092; QUAMME GA, 1990, BIOCHEM BIOPH RES CO, V167, P1406, DOI 10.1016/0006-291X(90)90679-H; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; RHIAN M, 2008, AM J PHYSIOL-HEART C, V294, pH1103; ROMANI A, 1993, CIRC RES, V72, P1139, DOI 10.1161/01.RES.72.6.1139; Romani AMP, 2007, FRONT BIOSCI-LANDMRK, V12, P308, DOI 10.2741/2066; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sato Yoshiaki, 2004, Clin Calcium, V14, P50; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SCHWARTZ PH, 1992, STROKE, V23, P539, DOI 10.1161/01.STR.23.4.539; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; SUGIYAMA T, 1995, AM J PHYSIOL-CELL PH, V269, pC698, DOI 10.1152/ajpcell.1995.269.3.C698; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Tian SL, 2007, NEUROSCI LETT, V419, P93, DOI 10.1016/j.neulet.2007.04.020; Wang M, 2007, ARCH BIOCHEM BIOPHYS, V458, P65, DOI 10.1016/j.abb.2006.10.022; WHITE RJ, 1995, J NEUROSCI, V15, P1318; WOLF FI, 1994, BIOCHEM BIOPH RES CO, V202, P1209, DOI 10.1006/bbrc.1994.2059; Zhang J, 2007, AM J PHYSIOL-HEART C, V292, pH415, DOI 10.1152/ajpheart.01214.2005; Zhao L, 2007, LIFE SCI, V81, P1211, DOI 10.1016/j.lfs.2007.08.034; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zhu DH, 2004, NEUROSCI RES, V49, P347, DOI 10.1016/j.neures.2004.04.001	64	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20194	20207		10.1074/jbc.M110.148494	http://dx.doi.org/10.1074/jbc.M110.148494			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487014	Green Published, hybrid			2022-12-27	WOS:000291267600007
J	Coppotelli, G; Mughal, N; Marescotti, D; Masucci, MG				Coppotelli, Giuseppe; Mughal, Nouman; Marescotti, Diego; Masucci, Maria G.			High Avidity Binding to DNA Protects Ubiquitylated Substrates from Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; GLY-ALA REPEAT; NUCLEAR ANTIGEN 1; HISTONE H1; IN-VIVO; PROTEINS; INHIBITION; CHROMATIN; PATHWAY; SYSTEM	Protein domains that act as degradation and stabilization signals regulate the rate of turnover of proteasomal substrates. Here we report that the bipartite Gly-Arg repeat of the Epstein-Barr virus (EBV) nuclear antigen (EBNA)-1 acts as a stabilization signal that inhibits proteasomal degradation in the nucleus by promoting binding to cellular DNA. Protection can be transferred by grafting the domain to unrelated proteasomal substrates and does not involve changes of ubiquitylation. Protection is also afforded by other protein domains that, similar to the Gly-Arg repeat, mediate high avidity binding to DNA, as exemplified by resistance to detergent extraction. Our findings identify high avidity binding to DNA as a portable inhibitory signal that counteracts proteasomal degradation.	[Coppotelli, Giuseppe; Mughal, Nouman; Marescotti, Diego; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; Marescotti, Diego/0000-0003-1007-8074	Swedish Cancer Society; Swedish Medical Research Council; European Community [LSG-CT-2006-037874, LSG-CT-2005-018683]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Community(European Commission)	This work was supported by grants awarded by the Swedish Cancer Society and Swedish Medical Research Council and by the European Community Contracts LSG-CT-2006-037874 and LSG-CT-2005-018683.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Apcher S, 2009, J VIROL, V83, P1289, DOI 10.1128/JVI.01369-08; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cohen S, 2001, J BIOL CHEM, V276, P26769, DOI 10.1074/jbc.M102448200; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Harrer M, 2004, J CELL SCI, V117, P3459, DOI 10.1242/jcs.01160; Heessen S, 2002, P NATL ACAD SCI USA, V99, P1532, DOI 10.1073/pnas.022306499; Hill DA, 1997, NUCLEIC ACIDS RES, V25, P3523, DOI 10.1093/nar/25.17.3523; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; Kapoor P, 2003, J VIROL, V77, P6946, DOI 10.1128/JVI.77.12.6946-6956.2003; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Lu F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-262; Ossevoort M, 2006, CANCER GENE THER, V13, P584, DOI 10.1038/sj.cgt.7700925; Ossevoort M, 2003, GENE THER, V10, P2020, DOI 10.1038/sj.gt.3302098; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; ROBERTSON E, 1995, J VIROL, V69, P983, DOI 10.1128/JVI.69.2.983-993.1995; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; Sompallae R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012052; Souza PP, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-41; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	45	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19565	19575		10.1074/jbc.M111.224782	http://dx.doi.org/10.1074/jbc.M111.224782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471195	hybrid, Green Published			2022-12-27	WOS:000291027700040
J	de la Pena, P; Alonso-Ron, C; Machin, A; Fernandez-Trillo, J; Carretero, L; Dominguez, P; Barros, F				de la Pena, Pilar; Alonso-Ron, Carlos; Machin, Angeles; Fernandez-Trillo, Jorge; Carretero, Luis; Dominguez, Pedro; Barros, Francisco			Demonstration of Physical Proximity between the N Terminus and the S4-S5 Linker of the Human ether-a-go-go-related Gene (hERG) Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; HUMAN INWARD RECTIFIER; TORSADE-DE-POINTES; K+ CHANNELS; VOLTAGE SENSOR; INTERVAL PROLONGATION; PAS DOMAIN; ACTIVATION; DEACTIVATION; INACTIVATION	Potassium channels encoded by the human ether-a-go-go-related gene (hERG) contribute to cardiac repolarization as a result of their characteristic gating properties. The hERG channel N terminus acts as a crucial determinant in gating. It is also known that the S4-S5 linker couples the voltage-sensing machinery to the channel gate. Moreover, this linker has been repeatedly proposed as an interaction site for the distal portion of the N terminus controlling channel gating, but direct evidence for such an interaction is still lacking. In this study, we used disulfide bond formation between pairs of engineered cysteines to demonstrate the close proximity between the beginning of the N terminus and the S4-S5 linker. Currents from channels with introduced cysteines were rapidly and strongly attenuated by an oxidizing agent, this effect being maximal for cysteine pairs located around amino acids 3 and 542 of the hERG sequence. The state-dependent modification of the double-mutant channels, but not the single-cysteine mutants, and the ability to readily reverse modification with the reducing agent dithiothreitol indicate that a disulfide bond is formed under oxidizing conditions, locking the channels in a non-conducting state. We conclude that physical interactions between the N-terminal-most segment of the N terminus and the S4-S5 linker constitute an essential component of the hERG gating machinery, thus providing a molecular basis for previous data and indicating an important contribution of these cytoplasmic domains in controlling its unusual gating and hence determining its physiological role in setting the electrical behavior of cardiac and other cell types.	[de la Pena, Pilar; Alonso-Ron, Carlos; Machin, Angeles; Fernandez-Trillo, Jorge; Carretero, Luis; Dominguez, Pedro; Barros, Francisco] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	de la Pena, P (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Ed Santiago Gascon, E-33006 Oviedo, Spain.	pdelapena@uniovi.es	Dominguez, Pedro/A-8266-2012; De-la-Pena-Cortines, Pilar/B-1453-2012; Barros, Francisco/O-6647-2019; Barros, Francisco/H-3297-2015	Dominguez, Pedro/0000-0003-4788-1071; De-la-Pena-Cortines, Pilar/0000-0002-3915-730X; Barros, Francisco/0000-0001-9040-1948; Barros, Francisco/0000-0001-9040-1948; Carretero, Luis/0000-0001-7850-7440; Fernandez-Trillo, Jorge/0000-0002-2086-1727	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2009-11262]; Spanish Ion Channel Initiative (SICI) Consolider-Ingenio [CSD2008-00005]; Spanish Ion Channel Initiative Consolider; Ministerio de Educacion y Ciencia (MEC); Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative (SICI) Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative Consolider; Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFU2009-11262 and Spanish Ion Channel Initiative (SICI) Consolider-Ingenio Project CSD2008-00005.; Supported by a postdoctoral contract from Spanish Ion Channel Initiative Consolider 2008.; Supported by predoctoral fellowships from the Ministerio de Educacion y Ciencia (MEC) and the Fondo de Investigacion Cientifica y Tecnica (FICYT) of Spain.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Alonso-Ron C, 2009, PFLUG ARCH EUR J PHY, V457, P1237, DOI 10.1007/s00424-008-0599-x; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Bell DC, 2009, PFLUG ARCH EUR J PHY, V458, P259, DOI 10.1007/s00424-008-0613-3; Brown S, 2008, CELL PHYSIOL BIOCHEM, V22, P601, DOI 10.1159/000185544; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Gomez-Varela D, 2003, FEBS LETT, V535, P125, DOI 10.1016/S0014-5793(02)03888-7; Gomez-Varela D, 2002, J MEMBRANE BIOL, V187, P117, DOI 10.1007/s00232-001-0156-4; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Miranda P, 2008, BBA-MOL CELL RES, V1783, P1681, DOI 10.1016/j.bbamcr.2008.06.009; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schwartz PJ, 2005, NAT CLIN PRACT CARD, V2, P346, DOI 10.1038/ncpcardio0239; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Thomas D, 2003, CARDIOVASC RES, V59, P14, DOI 10.1016/S0008-6363(03)00386-9; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119	50	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19065	19075		10.1074/jbc.M111.238899	http://dx.doi.org/10.1074/jbc.M111.238899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21474444	Green Published, hybrid			2022-12-27	WOS:000290785700076
J	Aran, M; Ferrero, D; Wolosiuk, A; Mora-Garcia, S; Wolosiuk, RA				Aran, Martin; Ferrero, Diego; Wolosiuk, Alejandro; Mora-Garcia, Santiago; Wolosiuk, Ricardo A.			ATP and Mg2+ Promote the Reversible Oligomerization and Aggregation of Chloroplast 2-Cys Peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPAREDOXIN PEROXIDASE; ANTIOXIDANT PROTEIN; CRYSTAL-STRUCTURE; MOLTEN GLOBULE; MODULATION; PHOSPHORYLATION; MECHANISM; 2,2,2-TRIFLUOROETHANOL; REDUCTASE; TOXICITY	2-Cys peroxiredoxins (2-Cys Prxs) are ubiquitous peroxidases with important roles in cellular antioxidant defense and hydrogen peroxide-mediated signaling. Post-translational modifications of conserved cysteines cause the transition from low to high molecular weight oligomers, triggering the functional change from peroxidase to molecular chaperone. However, it remains unclear how non-covalent interactions of 2-Cys Prx with metabolites modulate the quaternary structure. Here, we disclose that ATP and Mg2+ (ATP/Mg) promote the self-polymerization of chloroplast 2-Cys Prx (polypeptide 23.5 kDa) into soluble higher order assemblies (> 2 MDa) that proceed to insoluble aggregates beyond 5mM ATP. Remarkably, the withdrawal of ATP or Mg2+ brings soluble oligomers and insoluble aggregates back to the native conformation without compromising the associated functions. As confirmed by transmission electron microscopy, ATP/Mg drive the toroid-like decamers (diameter 13 nm) to the formation of large sphere-like particles (diameter similar to 30 nm). Circular dichroism studies on ATP-labeled 2-Cys Prx reveal that ATP/Mg enhance the proportion of beta-sheets with the concurrent decrease in the content of alpha-helices. In line with this observation, the formation of insoluble aggregates is strongly prevented by 2,2,2-trifluoroethanol, a cosolvent employed to induce alpha-helical conformations. We further find that the response of self-polymerization to ATP/Mg departs abruptly from that of the associated peroxidase and chaperone activities when two highly conserved residues, Arg(129) and Arg(152), are mutated. Collectively, our data uncover that non-covalent interactions of ATP/Mg with 2-Cys Prx modulate dynamically the quaternary structure, thereby coupling the non-redox chemistry of cell energy with redox transformations at cysteine residues.	[Aran, Martin; Ferrero, Diego; Mora-Garcia, Santiago; Wolosiuk, Ricardo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Invest Bioquim Buenos Aires, Consejo Nacl Invest Cient & Tecn,Inst Leloir,Dept, RA-1053 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Wolosiuk, RA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Invest Bioquim Buenos Aires, Consejo Nacl Invest Cient & Tecn,Inst Leloir,Dept, Patricias Argentinas 435,C1405BWE Buenos Aires, RA-1053 Buenos Aires, DF, Argentina.	rwolosiuk@leloir.org.ar	Ferrero, Diego Sebastian/ABI-6041-2020; Aran, Martin/N-2095-2019	Ferrero, Diego Sebastian/0000-0001-6848-9939; Wolosiuk, Alejandro/0000-0003-0854-9949	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Universidad de Buenos Aires	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Universidad de Buenos Aires.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x; Caporaletti D, 2007, BIOCHEM BIOPH RES CO, V355, P722, DOI 10.1016/j.bbrc.2007.02.013; Carulla N, 2010, ACCOUNTS CHEM RES, V43, P1072, DOI 10.1021/ar9002784; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chauhan R, 2001, BIOCHEM J, V354, P209, DOI 10.1042/0264-6021:3540209; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Dietz KJ, 2010, NEW PHYTOL, V188, P919, DOI 10.1111/j.1469-8137.2010.03502.x; Duek PD, 2001, BBA-PROTEIN STRUCT M, V1546, P299, DOI 10.1016/S0167-4838(01)00150-9; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Flohe L, 2002, ARCH BIOCHEM BIOPHYS, V397, P324, DOI 10.1006/abbi.2001.2688; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harris JR, 2001, BBA-PROTEIN STRUCT M, V1547, P221, DOI 10.1016/S0167-4838(01)00184-4; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jayaraman G, 1996, BIOCHEM BIOPH RES CO, V222, P33, DOI 10.1006/bbrc.1996.0693; KAUR P, 1993, J BACTERIOL, V175, P351, DOI 10.1128/JB.175.2.351-357.1993; KIERDASZUK B, 1988, BIOCHEMISTRY-US, V27, P4952, DOI 10.1021/bi00413a054; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Mora-Garcia S., 2005, CONTROL PRIMARY META, V22, P150; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muthuramalingam M, 2009, MOL PLANT, V2, P1273, DOI 10.1093/mp/ssp089; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Noguera-Mazon V, 2006, PHOTOSYNTH RES, V89, P277, DOI 10.1007/s11120-006-9106-4; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Poole Leslie B., 2007, V44, P61; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Scheibel T., 2005, PROTEIN FOLDING HD 2, P197; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Schuck P., 1999, CURR PROTOC PROTEIN, V3, P2021; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Sota H, 1998, ANAL CHEM, V70, P2019, DOI 10.1021/ac9713666; Starzyk A, 2005, BIOCHEMISTRY-US, V44, P369, DOI 10.1021/bi0481444; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Winzor DJ, 2003, ANAL BIOCHEM, V318, P1, DOI 10.1016/S0003-2697(03)00133-7; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	67	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23441	23451		10.1074/jbc.M111.239434	http://dx.doi.org/10.1074/jbc.M111.239434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525006	Green Published, hybrid			2022-12-27	WOS:000292025000075
J	Momcilovic, M; Carlson, M				Momcilovic, Milica; Carlson, Marian			Alterations at Dispersed Sites Cause Phosphorylation and Activation of SNF1 Protein Kinase during Growth on High Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPK HOMOLOG SNF1; UBIQUITIN-ASSOCIATED DOMAINS; GLYCOGEN-BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; YEAST SNF1; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; UPSTREAM KINASES; STRUCTURAL BASIS	The SNF1/AMP-activated protein kinases are central energy regulators in eukaryotes. SNF1 of Saccharomyces cerevisiae is inhibited during growth on high levels of glucose and is activated in response to glucose depletion and other stresses. Activation entails phosphorylation of Thr(210) on the activation loop of the catalytic subunit Snf1 by Snf1-activating kinases. We have used mutational analysis to identify Snf1 residues that are important for regulation. Alteration of Tyr(106) in the alpha C helix or Leu(198) adjacent to the Asp-Phe-Gly motif on the activation loop relieved glucose inhibition of phosphorylation, resulting in phosphorylation of Thr(210) during growth on high levels of glucose. Substitution of Arg for Gly(53), at the N terminus of the kinase domain, increased activation on both high and low glucose. Alteration of the ubiquitin-associated domain revealed a modest autoinhibitory effect. Previous studies identified alterations of the Gal83 (beta) and Snf4 (gamma) subunits that relieve glucose inhibition, and we have here identified a distinct set of Gal83 residues that are required. Together, these results indicate that alterations at dispersed sites within each subunit of SNF1 cause phosphorylation of the kinase during growth on high levels of glucose. These findings suggest that the conformation of the SNF1 complex is crucial to maintenance of the inactive state during growth on high glucose and that the default state for SNF1 is one in which Thr(210) is phosphorylated and the kinase is active.	[Momcilovic, Milica] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Carlson, Marian] Columbia Univ, Dept Genet & Dev & Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University	Carlson, M (corresponding author), 701 W 168th St,HSC1216, New York, NY 10032 USA.	mbc1@columbia.edu			National Institutes of Health [GM34095]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034095, R37GM034095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34095 (to M. C.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Amodeo GA, 2010, BIOCHEM BIOPH RES CO, V397, P197, DOI 10.1016/j.bbrc.2010.05.083; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; ESTRUCH F, 1992, GENETICS, V132, P639; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Momcilovic M, 2008, J BIOL CHEM, V283, P19521, DOI 10.1074/jbc.M803624200; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; NEIGEBORN L, 1987, GENETICS, V115, P247; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2010, ACTA CRYSTALLOGR F, V66, P999, DOI 10.1107/S1744309110028265; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vincent O, 1999, EMBO J, V18, P6672, DOI 10.1093/emboj/18.23.6672; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23544	23551		10.1074/jbc.M111.244111	http://dx.doi.org/10.1074/jbc.M111.244111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561858	Green Published, hybrid			2022-12-27	WOS:000292025000084
J	Zhang, LH; Malik, S; Kelley, GG; Kapiloff, MS; Smrcka, AV				Zhang, Lianghui; Malik, Sundeep; Kelley, Grant G.; Kapiloff, Michael S.; Smrcka, Alan V.			Phospholipase C epsilon Scaffolds to Muscle-specific A Kinase Anchoring Protein (mAKAP beta) and Integrates Multiple Hypertrophic Stimuli in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-CELL HYPERTROPHY; RYANODINE RECEPTOR; SIGNALING COMPLEX; NUCLEAR-ENVELOPE; GAMMA-SUBUNITS; HEART-FAILURE; CA2+ RELEASE; RAS; ACTIVATION; INDUCTION	To define a role for phospholipase C epsilon (PLC epsilon) signaling in cardiac myocyte hypertrophic growth, PLC epsilon protein was depleted from neonatal rat ventricular myocytes (NRVMs) using siRNA. NRVMs with PLC epsilon depletion were stimulated with endothelin (ET-1), norepinephrine, insulin-like growth factor-1 (IGF-1), or isoproterenol and assessed for development of hypertrophy. PLC epsilon depletion dramatically reduced hypertrophic growth and gene expression induced by all agonists tested. PLC epsilon catalytic activity was required for hypertrophy development, yet PLC epsilon depletion did not reduce global agonist-stimulated inositol phosphate production, suggesting a requirement for localized PLC activity. PLC epsilon was found to be scaffolded to a muscle-specific A kinase anchoring protein (mAKAP beta) in heart and NRVMs, and mAKAP beta localizes to the nuclear envelope in NRVMs. PLC epsilon-mAKAP interaction domains were defined and overexpressed to disrupt endogenous mAKAP beta-PLC epsilon complexes in NRVMs, resulting in significantly reduced ET-1-dependent NRVM hypertrophy. We propose that PLC epsilon integrates multiple upstream signaling pathways to generate local signals at the nucleus that regulate hypertrophy.	[Zhang, Lianghui; Malik, Sundeep; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Sci, Rochester, NY 14642 USA; [Kelley, Grant G.] St Josephs Hosp, Ctr Hlth, Dept Hosp Med, Syracuse, NY 13203 USA; [Kapiloff, Michael S.] Univ Miami, Dept Med, Interdisciplinary Stem Cell Inst, Miller Sch Med, Miami, FL 33101 USA; [Kapiloff, Michael S.] Univ Miami, Dept Pediat, Interdisciplinary Stem Cell Inst, Miller Sch Med, Miami, FL 33101 USA	University of Rochester; University of Rochester; University of Miami; University of Miami	Smrcka, AV (corresponding author), Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	Alan_Smrcka@urmc.rochester.edu		Kapiloff, Michael/0000-0002-7005-6953	National Institutes of Health [GM R01 053536, HL075398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM R01 053536 (to A. V. S.) and HL075398 (to M. S. K.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Barki-Harrington L, 2004, CARDIOVASC RES, V63, P391, DOI 10.1016/j.cardiores.2004.03.011; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Duale H, 2005, EXP PHYSIOL, V90, P71, DOI 10.1113/expphysiol.2004.029173; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Scott JD, 2010, CIRCULATION, V121, P1264, DOI 10.1161/CIRCULATIONAHA.109.896357; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	41	73	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23012	23021		10.1074/jbc.M111.231993	http://dx.doi.org/10.1074/jbc.M111.231993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550986	hybrid, Green Published			2022-12-27	WOS:000292025000036
J	Gianulis, EC; Trudeau, MC				Gianulis, Elena C.; Trudeau, Matthew C.			Rescue of Aberrant Gating by a Genetically Encoded PAS (Per-Arnt-Sim) Domain in Several Long QT Syndrome Mutant Human Ether-a-go-go-related Gene Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE PROTEIN TRAFFICKING; AMINO-TERMINAL DOMAIN; CARDIAC-ARRHYTHMIA; HERG; MUTATION; DEACTIVATION; MECHANISM; TEMPERATURE; EXPRESSION; FAMILY	Congenital long QT syndrome 2 (LQT2) is caused by loss-of-function mutations in the human ether-a-go-go-related gene (hERG) voltage-gated potassium (K+) channel. hERG channels have slow deactivation kinetics that are regulated by an N-terminal Per-Arnt-Sim (PAS) domain. Only a small percentage of hERG channels containing PAS domain LQT2 mutations (hERG PAS-LQT2) have been characterized in mammalian cells, so the functional effect of these mutations is unclear. We investigated 11 hERG PAS-LQT2 channels in HEK293 cells and report a diversity of functional defects. Most hERG PAS-LQT2 channels formed functional channels at the plasma membrane, as measured by whole cell patch clamp recordings and cell surface biotinylation. Mutations located on one face of the PAS domain (K28E, F29L, N33T, R56Q, and M124R) caused defective channel gating, including faster deactivation kinetics and less steady state inactivation. Conversely, the other mutations caused no measurable differences in channel gating (G53R, H70R, and A78P) or no measurable currents (Y43C, C66G, and L86R). We used a genetically encoded hERG PAS domain (NPAS) to examine whether channel dysfunction could be corrected. We found that NPAS fully restored wild-type-like deactivation kinetics and steady-state inactivation to the hERG PAS-LQT2 channels. Additionally, NPAS rescued aberrant currents in hERG R56Q channels during a dynamic ramp voltage clamp. Thus, our results reveal a putative "gating face" in the PAS domain where mutations within this region form functional channels with altered gating properties, and we show that NPAS is a general means for rescuing aberrant gating in hERG LQT2 mutant channels and may be a potential biological therapeutic.	[Gianulis, Elena C.] Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA; [Gianulis, Elena C.; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), 660 W Redwood St,HH502, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu			National Institutes of Health [HL-083121, T32-GM 008181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-083121 (to M. C. T.) and T32-GM 008181 (to E. C. G.) and a gift from the Helen Pumphrey Denit Trust.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grilo LS, 2010, HEART RHYTHM, V7, P260, DOI 10.1016/j.hrthm.2009.09.026; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Rossenbacker T, 2005, CIRCULATION, V111, P961, DOI 10.1161/01.CIR.0000156327.35255.D8; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shushi L, 2005, ANN NONINVAS ELECTRO, V10, P334, DOI 10.1111/j.1542-474X.2005.00643.x; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	31	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22160	22169		10.1074/jbc.M110.205948	http://dx.doi.org/10.1074/jbc.M110.205948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536673	Green Published, hybrid			2022-12-27	WOS:000291719900022
J	Zhang, QH; Wang, D; Singh, NK; Kundumani-Sridharan, V; Gadiparthi, L; Rao, CM; Rao, GN				Zhang, Qiuhua; Wang, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Gadiparthi, Laxmisilpa; Rao, Ch. Mohan; Rao, Gadiparthi N.			Activation of Cytosolic Phospholipase A(2) Downstream of the Src-Phospholipase D1 (PLD1)-Protein Kinase C gamma (PKC gamma) Signaling Axis Is Required for Hypoxia-induced Pathological Retinal Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACID-INDUCED ANGIOGENESIS; CELL-MIGRATION; VASCULAR-PERMEABILITY; INDUCED RETINOPATHY; TUMOR ANGIOGENESIS; VEGF EXPRESSION; TYROSINE KINASE; FATTY-ACIDS; NEOVASCULARIZATION	In view of understanding the mechanisms of retinal neovascularization, we had reported previously that vascular endothelial growth factor (VEGF)-induced pathological retinal angiogenesis requires the activation of Src-PLD1-PKC gamma signaling. In the present work, we have identified cytosolic phospholipase A(2) (cPLA(2)) as an effector molecule of Src-PLD1-PKC gamma signaling in the mediation of VEGF-induced pathological retinal angiogenesis based on the following observations. VEGF induced cPLA(2) phosphorylation in a time-dependent manner in human retinal microvascular endothelial cells (HRMVECs). VEGF also induced arachidonic acid (AA) release in a dose-, time-, and cPLA(2)-dependent manner. Depletion of cPLA(2) levels inhibited VEGF-induced HRMVEC DNA synthesis, migration, and tube formation. In addition, the exogenous addition of AA rescued VEGF-induced HRMVEC DNA synthesis, migration, and tube formation from inhibition by down-regulation of cPLA(2). Inhibition of Src, PLD1, or PKC gamma attenuated VEGF-induced cPLA(2) phosphorylation and AA release. Consistent with these findings, hypoxia induced cPLA(2) phosphorylation and activity in VEGF-Src-PLD1-PKC gamma-dependent manner in a mouse model of oxygen-induced retinopathy. In addition, siRNA-mediated down-regulation of cPLA(2) levels in the retina abrogated hypoxia-induced retinal endothelial cell proliferation and neovascularization. These observations suggest that cPLA(2)-dependent AA release is required for VEGF-induced Src-PLD1-PKC gamma-mediated pathological retinal angiogenesis.	[Zhang, Qiuhua; Wang, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Gadiparthi, Laxmisilpa; Rao, Gadiparthi N.] Univ Tennessee Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Rao, Ch. Mohan] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	University of Tennessee System; University of Tennessee Health Science Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, GN (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016; zhang, qiuhua/C-4939-2013	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health, NEI [EY014856]; NATIONAL EYE INSTITUTE [R01EY014856] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014856 from NEI (to G. N. R.).	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Barnett JM, 2010, INVEST OPHTH VIS SCI, V51, P1136, DOI 10.1167/iovs.09-3691; Cao RH, 2010, P NATL ACAD SCI USA, V107, P856, DOI 10.1073/pnas.0911661107; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kou RQ, 2005, BIOCHEMISTRY-US, V44, P15064, DOI 10.1021/bi0509898; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5; Michaelis UR, 2008, INVEST OPHTH VIS SCI, V49, P1242, DOI 10.1167/iovs.07-1087; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Pechan P, 2009, GENE THER, V16, P10, DOI 10.1038/gt.2008.115; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wouters MM, 2009, J BIOL CHEM, V284, P21177, DOI 10.1074/jbc.M109.015859; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zhang QH, 2010, BLOOD, V116, P1377, DOI 10.1182/blood-2010-02-271478; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200	51	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22489	22498		10.1074/jbc.M110.217786	http://dx.doi.org/10.1074/jbc.M110.217786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536681	hybrid, Green Published			2022-12-27	WOS:000291719900057
J	Fujiwara, Y; Fujiwara, K; Goda, N; Iwaya, N; Tenno, T; Shirakawa, M; Hiroaki, H				Fujiwara, Yoshie; Fujiwara, Ken-ichiro; Goda, Natsuko; Iwaya, Naoko; Tenno, Takeshi; Shirakawa, Masahiro; Hiroaki, Hidekazu			Structure and Function of the N-terminal Nucleolin Binding Domain of Nuclear Valosin-containing Protein-like 2 (NVL2) Harboring a Nucleolar Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE; MEMBRANE-FUSION; PEROXISOME BIOGENESIS; RNA-BINDING; CRYSTAL-STRUCTURE; ALPHA-HELIX; TAR RNA; RECOGNITION; CELL; NSF	The N-terminal regions of AAA-ATPases (ATPase associated with various cellular activities) often contain a domain that defines the distinct functions of the enzymes, such as substrate specificity and subcellular localization. As described herein, we have determined the solution structure of an N-terminal unique domain isolated from nuclear valosin-containing protein (VCP)-like protein 2 (NVL2(UD)). NVL2(UD) contains three alpha-helices with an organization resembling that of a winged helix motif, whereas a pair of beta-strands is missing. The structure is unique and distinct from those of other known type II AAA-ATPases, such as VCP. Consequently, we identified nucleolin from a HeLa cell extract as a binding partner of this domain. Nucleolin contains a long (similar to 300 amino acids) intrinsically unstructured region, followed by the four tandem RNA recognition motifs and the C-terminal glycine/arginine-rich domain. Binding analyses revealed that NVL2(UD) potentially binds to any of the combinations of two successive RNA binding domains in the presence of RNA. Furthermore, NVL2(UD) has a characteristic loop, in which the key basic residues RRKR are exposed to the solvent at the edge of the molecule. The mutation study showed that these residues are necessary and sufficient for nucleolin-RNA complex binding as well as nucleolar localization. Based on the observations presented above, we propose that NVL2 serves as an unfoldase for the nucleolin-RNA complex. As inferred from its RNA dependence and its ATPase activity, NVL2 might facilitate the dissociation and recycling of nucleolin, thereby promoting efficient ribosome biogenesis.	[Fujiwara, Yoshie; Goda, Natsuko; Iwaya, Naoko; Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Div Struct Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujiwara, Yoshie; Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Global Ctr Excellence Program Integrat Membrane B, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujiwara, Yoshie; Goda, Natsuko; Iwaya, Naoko; Hiroaki, Hidekazu] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Kawaguchi, Saitama 3320012, Japan; [Fujiwara, Ken-ichiro] Yokohama City Univ, Field Supramol Biol, Int Grad Sch Arts & Sci, Tsurumi Ku, Kanagawa 2300045, Japan; [Fujiwara, Ken-ichiro] Shionogi & Co Ltd, Shionogi Res Labs, Fukushima Ku, Osaka 5530002, Japan; [Iwaya, Naoko; Shirakawa, Masahiro] Kyoto Univ, Dept Mol Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST); Yokohama City University; Shionogi & Company Limited; Kyoto University	Hiroaki, H (corresponding author), Kobe Univ, Div Struct Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	hiroakih@med.kobe-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; HIROAKI, HIDEKAZU/N-1658-2019	HIROAKI, HIDEKAZU/0000-0003-1621-5893	Japan Science and Technology Agency Institute for Bioinformatics Research and Development; Japanese Ministry of Education, Culture, Sports, Science, and Technology [22570118]	Japan Science and Technology Agency Institute for Bioinformatics Research and Development; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Japan Science and Technology Agency Institute for Bioinformatics Research and Development and by a grant-in-aid for scientific research on Innovative Areas. This work was also supported by Grant-in-aid for Scientific Research (c) 22570118 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to H. H.).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Arumugam S, 2010, J BIOMOL NMR, V47, P79, DOI 10.1007/s10858-010-9412-1; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Chen HY, 2002, J VIROL, V76, P5233, DOI 10.1128/JVI.76.10.5233-5250.2002; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DAVID MJ, 2008, CELL CYCLE, V7, P17; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fujiki Y, 2000, CELL BIOCHEM BIOPHYS, V32, P155, DOI 10.1385/CBB:32:1-3:155; Fujiki Y, 2008, BIOCHEM SOC T, V36, P109, DOI 10.1042/BST0360109; Gadal O, 2001, EMBO J, V20, P3695, DOI 10.1093/emboj/20.14.3695; GermainLee EL, 1997, GENOMICS, V44, P22, DOI 10.1006/geno.1997.4856; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Goda N, 2004, PROTEIN SCI, V13, P652, DOI 10.1110/ps.03439004; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Higurashi M, 2008, PROTEIN SCI, V17, P72, DOI 10.1110/ps.073196308; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwaya N, 2007, J BIOMOL NMR, V37, P53, DOI 10.1007/s10858-006-9103-0; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Long AR, 1998, GENE, V208, P191, DOI 10.1016/S0378-1119(97)00652-5; Long AR, 1998, MECH DEVELOP, V76, P33, DOI 10.1016/S0925-4773(98)00110-5; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Matthews DA, 2006, EMBO REP, V7, P870, DOI 10.1038/sj.embor.7400786; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nagahama M, 2004, MOL BIOL CELL, V15, P5712, DOI 10.1091/mbc.E04-08-0692; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; Shiozawa K, 2006, FEBS J, V273, P4959, DOI 10.1111/j.1742-4658.2006.05494.x; SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8; Stark LA, 2009, EMBO REP, V10, P35, DOI 10.1038/embor.2008.230; Storck S, 2009, BIOL CELL, V101, P153, DOI 10.1042/BC20080054; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; Tenno T, 2004, PROTEIN ENG DES SEL, V17, P305, DOI 10.1093/protein/gzh044; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WHITEHEART SW, 1995, TRENDS CELL BIOL, V5, P64, DOI 10.1016/S0962-8924(00)88948-5; Wu DY, 1999, DEVELOPMENT, V126, P2021; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	71	11	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21732	21741		10.1074/jbc.M110.174680	http://dx.doi.org/10.1074/jbc.M110.174680			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21474449	Green Published, hybrid			2022-12-27	WOS:000291464700069
J	Li, GF; Xu, YD; Guan, DY; Liu, ZS; Liu, DX				Li, Guangfu; Xu, Yidi; Guan, Dongyin; Liu, Zhengshan; Liu, David X.			HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; HEAT-SHOCK-PROTEIN-70 HSP70; CHAPERONE ACTIVITY; INDUCED APOPTOSIS; MESSENGER-RNA; STRESS; EXPRESSION; BINDING; GLIOBLASTOMA	Although both the heat shock protein 70 (HSP70) and the activating transcription factor 5 (ATF5) have been shown to promote cell survival of transformed cells but not survival of non-transformed cells, the relationship of the two molecules is unknown. Here we show that HSP70 and ATF5 are concomitantly up-regulated upon transient but down-regulated over prolonged cellular stress and apoptotic stimulation in the rat C6 glioma and human U87 glioma cells. HSP70 interacts strongly with the N-terminal activation domain of ATF5, which is expected to be rigid and uniquely structured under physiological conditions because of extraordinary high concentration (over 25%) of proline residues. Binding of HSP70 to ATF5 is an ATP-driven process and requires functional ATPase on the nucleotide binding domain of the HSP70 molecule. Overexpression of HSP70 dramatically stabilizes the ATF5 protein, which is otherwise subject to rapid degradation, facilitated by both proteasome-dependent and caspase-dependent processes, whereas HSP70 depletion leads to acceleration of ATF5 degradation and transcription repression of Bcl-2 and Egr-1, which are down-stream targets of ATF5 in C6 and U87 glioma cells. Our data reveal an essential role for HSP70 in maintaining high levels of ATF5 expression in glioma cells and support the conclusion that ATF5 is an important substrate protein of HSP70 that mediates HSP70-promoted cell survival in glioma cells.	[Li, Guangfu; Xu, Yidi; Guan, Dongyin; Liu, Zhengshan; Liu, David X.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Liu, David X.] Penn State Univ, Penn State Canc Inst, Coll Med, Hershey, PA 17033 USA; [Liu, David X.] Penn State Univ, Penn State Hershey Neurosci Inst, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, DX (corresponding author), C3710,500 Univ Dr, Hershey, PA 17033 USA.	dliu@psu.edu		Li, Guangfu/0000-0002-9817-568X	American Cancer Society; United States Department of Defense	American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported by grants from the American Cancer Society and the United States Department of Defense (to D.X.L.).	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chuang HC, 2008, AM J PATHOL, V173, P1397, DOI 10.2353/ajpath.2008.080440; Ciaccio NA, 2009, MOL PHARMACEUT, V6, P1205, DOI 10.1021/mp900058t; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jiang BM, 2010, FEBS J, V277, P642, DOI 10.1111/j.1742-4658.2009.07510.x; Jung JH, 2010, J CELL PHYSIOL, V223, P408, DOI 10.1002/jcp.22049; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mao HP, 2003, J BIOL CHEM, V278, P18214, DOI 10.1074/jbc.M300126200; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pati D, 1999, MOL CELL BIOL, V19, P5001; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Robins H Ian, 2007, Curr Oncol Rep, V9, P66, DOI 10.1007/BF02951428; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Seo JS, 1996, BIOCHEM BIOPH RES CO, V218, P582, DOI 10.1006/bbrc.1996.0103; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Uekusa H, 2009, BIOCHEM BIOPH RES CO, V380, P673, DOI 10.1016/j.bbrc.2009.01.158; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Wei YY, 2008, J BIOL CHEM, V283, P18773, DOI 10.1074/jbc.M707879200; Wei YY, 2010, J BIOCHEM, V148, P171, DOI 10.1093/jb/mvq047; Xanthoudakis S, 2000, NAT CELL BIOL, V2, pE163, DOI 10.1038/35023643; Yang JW, 2009, FEBS LETT, V583, P1409, DOI 10.1016/j.febslet.2009.04.011; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	49	44	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20251	20259		10.1074/jbc.M110.211771	http://dx.doi.org/10.1074/jbc.M110.211771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21521685	Green Published, hybrid			2022-12-27	WOS:000291267600012
J	Balasubramanian, S; Fan, MY; Messmer-Blust, AF; Yang, CH; Trendel, JA; Jeyaratnam, JA; Pfeffer, LM; Vestal, DJ				Balasubramanian, Sujata; Fan, Meiyun; Messmer-Blust, Angela F.; Yang, Chuan H.; Trendel, Jill A.; Jeyaratnam, Jonathan A.; Pfeffer, Lawrence M.; Vestal, Deborah J.			The Interferon-gamma-induced GTPase, mGBP-2, Inhibits Tumor Necrosis Factor alpha(TNF-alpha) Induction of Matrix Metalloproteinase-9 (MMP-9) by Inhibiting NF-kappa B and Rac Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR-I; FACTOR-ALPHA; MATRIX METALLOPROTEINASES; IFN-GAMMA; TNF-ALPHA; GELATINASE-B; ENDOTHELIAL-CELLS; EXPRESSION; ACTIVATION; BINDING	Matrix metalloproteinase-9 (MMP-9) is important in numerous normal and pathological processes, including the angiogenic switch during tumor development and tumor metastasis. Whereas TNF-alpha and other cytokines up-regulate MMP-9 expression, interferons (IFNs) inhibit MMP-9 expression. We found that IFN-gamma treatment or forced expression of the IFN-induced GTPase, mGBP-2, inhibit TNF-alpha-induced MMP-9 expression in NIH 3T3 fibroblasts, by inhibiting MMP-9 transcription. The NF-kappa B transcription factor is required for full induction of MMP-9 by TNF-alpha. Both IFN-gamma and mGBP-2 inhibit the transcription of a NF-kappa B-dependent reporter construct, suggesting that mGBP-2 inhibits MMP-9 induction via inhibition of NF-kappa B-mediated transcription. Interestingly, mGBP-2 does not inhibit TNF-alpha-induced degradation of I kappa B alpha or p65/RelA translocation into the nucleus. However, mGBP-2 inhibits p65 binding to a kappa B oligonucleotide probe in gel shift assays and to the MMP-9 promoter in chromatin immunoprecipitation assays. In addition, TNF-alpha activation of NF-kappa B in NIH 3T3 cells is dependent on Rac activation, as evidenced by the inhibition of TNF-alpha induction of NF-kappa B-mediated transcription by a dominant inhibitory form of Rac1. A role for Rac in the inhibitory action of mGBP-2 on NF-kappa B is further shown by the findings that mGBP-2 inhibits TNF-alpha activation of endogenous Rac and constitutively activate Rac can restore NF-kappa B transcription in the presence of mGBP-2. This is a novel mechanism by which IFNs can inhibit the cytokine induction of MMP-9 expression.	[Balasubramanian, Sujata; Messmer-Blust, Angela F.; Trendel, Jill A.; Jeyaratnam, Jonathan A.; Vestal, Deborah J.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Fan, Meiyun; Yang, Chuan H.; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN 38163 USA	University System of Ohio; University of Toledo; University of Tennessee System; University of Tennessee Health Science Center	Vestal, DJ (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Deborah.Vestal@utoledo.edu		Pfeffer, Lawrence/0000-0003-2809-1234; Messmer-Blust, Angela/0000-0001-9582-5301	American Cancer Society [RPM-CIM-88031]; National Institutes of Health [CA73753]; Muirhead Chair Endowment; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA140346, R01CA073753] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muirhead Chair Endowment; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the American Cancer Society (RPM-CIM-88031) (to D. J. V.), National Institutes of Health Grant CA73753, and funds from the Muirhead Chair Endowment and the University of Tennessee Health Science Center (to L. M. P.).	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; AUSUBEL FM, 1989, PREPARATION ANAL DNA; Bachmeier BE, 2001, ANTICANCER RES, V21, P3821; Balasubramanian S, 2006, CELL MOL BIOL, V52, P43, DOI 10.1170/T696; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Boyer L, 2004, MOL BIOL CELL, V15, P1124, DOI 10.1091/mbc.E03-05-0301; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Karabudak R, 2004, J NEUROL, V251, P279, DOI 10.1007/s00415-004-0285-7; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim BC, 1999, J BIOL CHEM, V274, P24372, DOI 10.1074/jbc.274.34.24372; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; Kupferman ME, 2000, AM J PATHOL, V157, P1777, DOI 10.1016/S0002-9440(10)64815-8; Leber TM, 1998, BRIT J CANCER, V78, P724, DOI 10.1038/bjc.1998.568; Liao JH, 2003, J BIOL CHEM, V278, P31871, DOI 10.1074/jbc.M301931200; MA Z, 2005, J LEUKOCYTE BIOL, V78, P512; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Migita K, 2006, LIFE SCI, V78, P2510, DOI 10.1016/j.lfs.2005.10.003; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nelissen I, 2002, J LEUKOCYTE BIOL, V71, P89; Nguyen J, 2005, FEBS LETT, V579, P5487, DOI 10.1016/j.febslet.2005.09.012; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Tensen CP, 1999, BBA-GENE STRUCT EXPR, V1446, P167, DOI 10.1016/S0167-4781(99)00084-6; Tsuruda T, 2004, HEART FAIL REV, V9, P53, DOI 10.1023/B:HREV.0000011394.34355.bb; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vestal DJ, 1998, J INTERF CYTOK RES, V18, P977, DOI 10.1089/jir.1998.18.977; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vestal DJ, 2005, J INTERF CYTOK RES, V25, P435, DOI 10.1089/jir.2005.25.435; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang TN, 2002, SURGERY, V132, P220, DOI 10.1067/msy.2002.125353; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Wu AJ, 1997, J CELL PHYSIOL, V171, P117, DOI 10.1002/(SICI)1097-4652(199705)171:2<117::AID-JCP1>3.0.CO;2-R; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Yim JH, 2003, J INTERF CYTOK RES, V23, P501, DOI 10.1089/10799900360708623; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Yushchenko M, 2003, J NEUROL, V250, P1224, DOI 10.1007/s00415-003-0191-4; Zhou M, 2003, J BIOL CHEM, V278, P45406, DOI 10.1074/jbc.M309075200	70	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20054	20064		10.1074/jbc.M111.249326	http://dx.doi.org/10.1074/jbc.M111.249326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502320	hybrid, Green Published			2022-12-27	WOS:000291027700082
J	Gorelik, M; Stanger, K; Davidson, AR				Gorelik, Maryna; Stanger, Karen; Davidson, Alan R.			A Conserved Residue in the Yeast Bem1p SH3 Domain Maintains the High Level of Binding Specificity Required for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; RECOGNITION MODULES; SYMMETRY-BREAKING; PEPTIDE; AFFINITY; COMPLEX; CDC42P; MOTIF; PHOSPHORYLATION	The yeast Bem1p SH3b and Nbp2p SH3 domains are unusual because they bind to peptides containing the same consensus sequence, yet they perform different functions and display low sequence similarity. In this work, by analyzing the interactions of these domains with six biologically relevant peptides containing the consensus sequence, they are shown to possess finely tuned and distinct binding specificities. We also identify a residue in the Bem1p SH3b domain that inhibits binding, yet is highly conserved for the purpose of preventing nonspecific interactions. Substitution of this residue results in a marked reduction of in vivo function that is caused by titration of the domain away from its proper targets through nonspecific interactions with other proteins. This work provides a clear illustration of the importance of intrinsic binding specificity for the function of protein-protein interaction modules, and the key role of "negative" interactions in determining the specificity of a domain.	[Gorelik, Maryna; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Stanger, Karen; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca			Canadian Institutes of Health Research [MOP-13609]; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-13609 and by a Natural Sciences and Engineering Research Council PGS-D scholarship (to M. G.).	Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FELLER SM, 1995, ONCOGENE, V10, P1465; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Hiipakka M, 2007, FEBS LETT, V581, P1735, DOI 10.1016/j.febslet.2007.03.044; Hoelz A, 2006, J MOL BIOL, V358, P509, DOI 10.1016/j.jmb.2006.02.027; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mayer BJ, 2001, J CELL SCI, V114, P1253; Ohkuni K, 2003, GENETICS, V165, P517; Panni S, 2002, J BIOL CHEM, V277, P21666, DOI 10.1074/jbc.M109788200; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Takaku T, 2010, J BIOL CHEM, V285, P19346, DOI 10.1074/jbc.M110.116749; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	42	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19470	19477		10.1074/jbc.M111.229294	http://dx.doi.org/10.1074/jbc.M111.229294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489982	Green Published, hybrid			2022-12-27	WOS:000291027700030
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Characterization of Restriction Endonucleases: the Work of Hamilton Smith	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item														Kresge, Nicole/0000-0003-1551-6627				SMITH HO, PUBLICATION LIST	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3							e2					2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	21491685				2022-12-27	WOS:000273429100001
J	Baumer, N; Tickenbrock, L; Tschanter, P; Lohmeyer, L; Diederichs, S; Baumer, S; Skryabin, BV; Zhang, F; Agrawal-Singh, S; Kohler, G; Berdel, WE; Serve, H; Koschmieder, S; Muller-Tidow, C				Baeumer, Nicole; Tickenbrock, Lara; Tschanter, Petra; Lohmeyer, Lisa; Diederichs, Sven; Baeumer, Sebastian; Skryabin, Boris V.; Zhang, Feng; Agrawal-Singh, Shuchi; Koehler, Gabriele; Berdel, Wolfgang E.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten			Inhibitor of Cyclin-dependent Kinase (CDK) Interacting with Cyclin A1 (INCA1) Regulates Proliferation and Is Repressed by Oncogenic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-CYCLE; POTENTIAL MEDIATOR; TUMOR SUPPRESSION; A1-CDK2 COMPLEX; MICE; P27(KIP1); CANCER; FLT3; TUMORIGENESIS	The cell cycle is driven by the kinase activity of cyclin.cyclin-dependent kinase (CDK) complexes, which is negatively regulated by CDK inhibitor proteins. Recently, we identified INCA1 as an interaction partner and a substrate of cyclin A1 in complex with CDK2. On a functional level, we identified a novel cyclin-binding site in the INCA1 protein. INCA1 inhibited CDK2 activity and cell proliferation. The inhibitory effects depended on the cyclin-interacting domain. Mitogenic and oncogenic signals suppressed INCA1 expression, whereas it was induced by cell cycle arrest. We established a deletional mouse model that showed increased CDK2 activity in spleen with altered spleen architecture in Inca1(-/-) mice. Inca1(-/-) embryonic fibroblasts showed an increase in the fraction of S-phase cells. Furthermore, blasts from acute lymphoid leukemia and acute myeloid leukemia patients expressed significantly reduced INCA1 levels highlighting its relevance for growth control in vivo. Taken together, this study identifies a novel CDK inhibitor with reduced expression in acute myeloid and lymphoid leukemia. The molecular events that control the cell cycle occur in a sequential process to ensure a tight regulation, which is important for the survival of a cell and includes the detection and repair of genetic damage and the prevention of uncontrolled cell division.	[Baeumer, Nicole; Tickenbrock, Lara; Tschanter, Petra; Lohmeyer, Lisa; Diederichs, Sven; Baeumer, Sebastian; Zhang, Feng; Agrawal-Singh, Shuchi; Berdel, Wolfgang E.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten] Univ Munster, Dept Med, D-48129 Munster, Germany; [Baeumer, Nicole; Tschanter, Petra; Lohmeyer, Lisa; Skryabin, Boris V.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48129 Munster, Germany; [Diederichs, Sven] Helmholtz Univ, Res Grp Mol RNA Biol & Canc, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Diederichs, Sven] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany; [Skryabin, Boris V.] Univ Munster, Inst Expt Pathol, D-48129 Munster, Germany; [Skryabin, Boris V.] Univ Munster, Ctr Mol Biol Inflammat ZMBE, D-48129 Munster, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48129 Munster, Germany; [Serve, Hubert] Klinikum Johann Wolfgang Goethe Univ, Med Klin 2, D-60596 Frankfurt, Germany	University of Munster; University of Munster; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Munster; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Baumer, N (corresponding author), Univ Munster, Dept Med, Domagkstr 3, D-48129 Munster, Germany.	nbaeumer@uni-muenster.de; muellerc@uni-muenster.de	Baeumer, Sebastian/GYU-0544-2022; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; Skryabin, Boris/AAL-3100-2020; Diederichs, Sven/J-6237-2012	Müller-Tidow, Carsten/0000-0002-7166-5232; Skryabin, Boris/0000-0002-4392-185X; Koschmieder, Steffen/0000-0002-1011-8171; Diederichs, Sven/0000-0001-7901-4752; Serve, Hubert/0000-0001-8472-5516	Interdisciplinary Center for Clinical Research (IZKF) at University of Munster; Deutsche Forschungsgemeinschaft [Mu1328/6-1]	Interdisciplinary Center for Clinical Research (IZKF) at University of Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at University of Munster and Deutsche Forschungsgemeinschaft Grants Mu1328/6-1.	Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Baumer N, 2002, DEVELOPMENT, V129, P4535; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mufti GJ, 1996, ATLAS MALIGNANT HAEM, P389; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Teller S, 2002, LEUKEMIA, V16, P1528, DOI 10.1038/sj.leu.2402630; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zindy F, 2003, CANCER RES, V63, P5420; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	50	12	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28210	28222		10.1074/jbc.M110.203471	http://dx.doi.org/10.1074/jbc.M110.203471			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21540187	Green Published, hybrid			2022-12-27	WOS:000293557800039
J	Lutz, S; Tubert-Brohman, I; Yang, YG; Meuwly, M				Lutz, Stephan; Tubert-Brohman, Ivan; Yang, Yonggang; Meuwly, Markus			Water-assisted Proton Transfer in Ferredoxin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MOLECULAR-DYNAMICS SIMULATION; AB-INITIO; INTERNAL WATER; THEORETICAL INVESTIGATIONS; CARBONIC-ANHYDRASE; ELECTRON-TRANSFER; 3FE-4S CLUSTER; FORCE-FIELDS; PROTEIN	The role of water molecules in assisting proton transfer (PT) is investigated for the proton-pumping protein ferredoxin I (FdI) from Azotobacter vinelandii. It was shown previously that individual water molecules can stabilize between Asp(15) and the buried [3Fe-4S](0) cluster and thus can potentially act as a proton relay in transferring H+ from the protein to the mu(2) sulfur atom. Here, we generalize molecular mechanics with proton transfer to studying proton transfer reactions in the condensed phase. Both umbrella sampling simulations and electronic structure calculations suggest that the PT Asp(15)-COOH + H2O + [3Fe-4S](0) -> Asp(15)-COO- + H2O + [3Fe-4S](0) H+ is concerted, and no stable intermediate hydronium ion (H3O+) is expected. The free energy difference of 11.7 kcal/mol for the forward reaction is in good agreement with the experimental value (13.3 kcal/mol). For the reverse reaction (Asp(15)-COO- + H2O + [3Fe-4S]H-0(+) -> Asp(15)-COOH + H2O + [3Fe-4S](0)), a larger barrier than for the forward reaction is correctly predicted, but it is quantitatively overestimated (23.1 kcal/mol from simulations versus 14.1 from experiment). Possible reasons for this discrepancy are discussed. Compared with the water-assisted process (Delta E approximate to 10 kcal/mol), water-unassisted proton transfer yields a considerably higher barrier of Delta E approximate to 35 kcal/mol.	[Lutz, Stephan; Tubert-Brohman, Ivan; Yang, Yonggang; Meuwly, Markus] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Meuwly, M (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	m.meuwly@unibas.ch	Yang, Yonggang/A-9863-2012	Yang, Yonggang/0000-0003-3711-2842	Schweizerischer National Fonds [200021-117810]; National Center of Competence in Research - Molecular Ultrafast Science and Technology; European Commission [MIF1-CT2006-039088]	Schweizerischer National Fonds(Swiss National Science Foundation (SNSF)); National Center of Competence in Research - Molecular Ultrafast Science and Technology; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Schweizerischer National Fonds through Projects 200021-117810 and the National Center of Competence in Research - Molecular Ultrafast Science and Technology (to M.M.).; Supported by a Marie Curie Fellowship (MIF1-CT2006-039088) from the European Commission.	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Bala P, 1996, J PHYS CHEM-US, V100, P2535, DOI 10.1021/jp952642s; Banushkina P, 2005, J PHYS CHEM B, V109, P16911, DOI 10.1021/jp051938n; BASH PA, 1987, J AM CHEM SOC, V109, P8092, DOI 10.1021/ja00260a028; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERG JM, 2002, BIOCHEMISTRY-US, P96; Bolhuis PG, 2005, BIOPHYS J, V88, P50, DOI 10.1529/biophysj.104.048744; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; Camba R, 2003, BIOCHEMISTRY-US, V42, P10589, DOI 10.1021/bi035021v; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; CHANDRASEKHAR I, 1992, J MOL BIOL, V226, P239, DOI 10.1016/0022-2836(92)90136-8; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Cheng HP, 1996, J CHEM PHYS, V105, P6844, DOI 10.1063/1.471979; Cherepanov DA, 2001, BBA-BIOENERGETICS, V1505, P179, DOI 10.1016/S0005-2728(01)00162-1; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P5671, DOI 10.1021/bi00476a004; Cui Q, 2003, J PHYS CHEM B, V107, P1071, DOI 10.1021/jp021931v; Dai J, 2003, J CHEM PHYS, V119, P6571, DOI 10.1063/1.1603220; Day TJF, 2000, J AM CHEM SOC, V122, P12027, DOI 10.1021/ja002506n; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DU M, 1993, BIOPHYS CHEM, V48, P101, DOI 10.1016/0301-4622(93)85002-Y; ERNST JA, 1995, SCIENCE, V267, P1813, DOI 10.1126/science.7892604; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; Friedman R, 2007, J PHYS CHEM B, V111, P6059, DOI 10.1021/jp070781r; Frisch M.J., 2016, GAUSSIAN16 REV B01; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Geissler PL, 2000, CHEM PHYS LETT, V321, P225, DOI 10.1016/S0009-2614(00)00381-X; Gennis RB, 1998, P NATL ACAD SCI USA, V95, P12747, DOI 10.1073/pnas.95.22.12747; Gottschalk M, 2001, J MOL BIOL, V311, P605, DOI 10.1006/jmbi.2001.4895; Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c; Im S, 1998, EUR J BIOCHEM, V258, P465, DOI 10.1046/j.1432-1327.1998.2580465.x; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; Kaledin M, 2006, J PHYS CHEM A, V110, P2933, DOI 10.1021/jp054374w; Kim YC, 2009, P NATL ACAD SCI USA, V106, P13707, DOI 10.1073/pnas.0903938106; KOTTALAM J, 1988, J AM CHEM SOC, V110, P7690, DOI 10.1021/ja00231a018; KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104; LAIDLER KJ, 1969, THEORIES CHEM REACTI, P41; Lammers S, 2004, AUST J CHEM, V57, P1223, DOI 10.1071/CH04164; Lammers S, 2008, J COMPUT CHEM, V29, P1048, DOI 10.1002/jcc.20864; Lammers S, 2007, J PHYS CHEM A, V111, P1638, DOI 10.1021/jp065323h; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Liu Y, 2001, J PHYS CHEM B, V105, P6598, DOI 10.1021/jp010008a; Loerting T, 2001, J PHYS CHEM A, V105, P5137, DOI 10.1021/jp0038862; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; Mei HS, 1998, J PHYS CHEM B, V102, P10446, DOI 10.1021/jp982623t; Meuwly M, 2004, BIOPHYS J, V86, P1987, DOI 10.1016/S0006-3495(04)74261-7; Meuwly M, 2002, J CHEM PHYS, V116, P2572, DOI 10.1063/1.1431285; Meuwly M, 2003, FARADAY DISCUSS, V124, P297, DOI 10.1039/b211407k; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Papoian GA, 2003, J AM CHEM SOC, V125, P9170, DOI 10.1021/ja034729u; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pomes R, 1996, J PHYS CHEM-US, V100, P2519, DOI 10.1021/jp9525752; Sagnella DE, 1998, J CHEM PHYS, V108, P2073, DOI 10.1063/1.475586; Schipke CG, 1999, BIOCHEMISTRY-US, V38, P8228, DOI 10.1021/bi983008i; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; SHEN BH, 1993, J BIOL CHEM, V268, P25928; Siwick BJ, 2007, J AM CHEM SOC, V129, P13412, DOI 10.1021/ja069265p; Smedarchina Z, 2003, J AM CHEM SOC, V125, P243, DOI 10.1021/ja0210594; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Walter NG, 2007, MOL CELL, V28, P923, DOI 10.1016/j.molcel.2007.12.001; WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Wei DQ, 1997, J CHEM PHYS, V106, P6086, DOI 10.1063/1.473607; WILLIAMS RJP, 1988, ANNU REV BIOPHYS BIO, V17, P71; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104; Zheng C, 1996, J AM CHEM SOC, V118, P2818, DOI 10.1021/ja9523092	74	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23679	23687		10.1074/jbc.M111.230003	http://dx.doi.org/10.1074/jbc.M111.230003			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531725	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000292294900009
J	Faralli, H; Martin, E; Core, N; Liu, QC; Filippi, P; Dilworth, FJ; Caubit, X; Fasano, L				Faralli, Herve; Martin, Elise; Core, Nathalie; Liu, Qi-Cai; Filippi, Pierre; Dilworth, F. Jeffrey; Caubit, Xavier; Fasano, Laurent			Teashirt-3, a Novel Regulator of Muscle Differentiation, Associates with BRG1-associated Factor 57 (BAF57) to Inhibit Myogenin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; ADULT SKELETAL-MUSCLE; STEM-CELL FUNCTION; SATELLITE CELLS; SELF-RENEWAL; FUNCTIONAL-ANALYSIS; SWI/SNF COMPLEXES; SOMITIC ORIGIN; PROXIMAL LEG; MYOD	In adult muscles and under normal physiological conditions, satellite cells are found in a quiescent state but can be induced to enter the cell cycle by signals resulting from exercise, injury-induced muscle regeneration, or specific disease states. Once activated, satellite cells proliferate, self-renew, and differentiate to form myofibers. In the present study, we found that the zinc finger-containing factor Teashirt-3 (TSHZ3) was expressed in quiescent satellite cells of adult mouse skeletal muscles. We showed that following treatment with cardiotoxin TSHZ3 was strongly expressed in satellite cells of regenerating muscles. Moreover, immunohistochemical analysis indicated that TSHZ3 was expressed in both quiescent and activated satellite cells on intact myofibers in culture. TSHZ3 expression was maintained in myoblasts but disappeared with myotube formation. In C2C12 myoblasts, we showed that overexpression of Tshz3 impaired myogenic differentiation and promoted the down-regulation of myogenin (Myog) and up-regulation of paired-box factor 7 (Pax7). Moreover, knockdown experiments revealed a selective effect of Tshz3 on Myog regulation, and transcriptional reporter experiments indicated that TSHZ3 repressed Myog promoter. We identified the BRG1-associated factor 57 (BAF57), a subunit of the SWI/SNF complex, as a partner of TSHZ3. We showed that TSHZ3 cooperated with BAF57 to repress MYOD-dependent Myog expression. These results suggest a novel mechanism for transcriptional repression by TSHZ3 in which TSHZ3 and BAF57 cooperate to modulate MyoD activity on the Myog promoter to regulate skeletal muscle differentiation.	[Faralli, Herve; Martin, Elise; Core, Nathalie; Filippi, Pierre; Caubit, Xavier; Fasano, Laurent] Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, F-13288 Marseille 09, France; [Faralli, Herve; Liu, Qi-Cai; Dilworth, F. Jeffrey] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Ottawa; Ottawa Hospital Research Institute	Fasano, L (corresponding author), Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	laurent.fasano@univmed.fr	Fasano, Laurent/AFL-9580-2022; Fasano, Laurent/AAH-1688-2022	Fasano, Laurent/0000-0003-2307-8428; Fasano, Laurent/0000-0003-2307-8428; Dilworth, F. Jeffrey/0000-0002-6265-8102	Association Francaise contre les Myopathies (AFM) [12545, 13013]; Canadian Institutes of Health Research [MOP-93777]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Association Francaise contre les Myopathies (AFM) Grants 12545 and 13013 (to F. L.) and Canadian Institutes of Health Research Grant MOP-93777 (to F. J. D.).	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Anderson JE, 1998, BIOCHEM CELL BIOL, V76, P13, DOI 10.1139/bcb-76-1-13; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brown JK, 2004, J HISTOCHEM CYTOCHEM, V52, P1219, DOI 10.1369/jhc.3A6200.2004; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cooper RN, 1999, J CELL SCI, V112, P2895; Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Delfini MC, 2004, DEVELOPMENT, V131, P713, DOI 10.1242/dev.00967; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Erkner A, 1999, DEV BIOL, V215, P221, DOI 10.1006/dbio.1999.9452; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gallet A, 2000, DEVELOPMENT, V127, P5509; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lu QL, 1998, J HISTOCHEM CYTOCHEM, V46, P977, DOI 10.1177/002215549804600813; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Onai T, 2007, EMBO J, V26, P2350, DOI 10.1038/sj.emboj.7601684; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171; RODER L, 1992, DEVELOPMENT, V115, P1017; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad.230002; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soanes KH, 2001, MECH DEVELOP, V105, P145, DOI 10.1016/S0925-4773(01)00397-5; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Watanabe S, 2007, J CELL SCI, V120, P4178, DOI 10.1242/jcs.011668; Wu J, 2000, MECH DEVELOP, V94, P47, DOI 10.1016/S0925-4773(00)00311-7; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	82	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23498	23510		10.1074/jbc.M110.206003	http://dx.doi.org/10.1074/jbc.M110.206003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543328	hybrid, Green Published			2022-12-27	WOS:000292025000080
J	Kaulfurst-Soboll, H; Rips, S; Koiwa, H; Kajiura, H; Fujiyama, K; von Schaewen, A				Kaulfuerst-Soboll, Heidi; Rips, Stephan; Koiwa, Hisashi; Kajiura, Hiroyuki; Fujiyama, Kazuhito; von Schaewen, Antje			Reduced Immunogenicity of Arabidopsis hgl1 Mutant N-Glycans Caused by Altered Accessibility of Xylose and core Fucose Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; ASPARAGINE-LINKED GLYCANS; INSECT GLYCOPROTEIN; CARBOHYDRATE MOIETY; MAJOR GLYCOPROTEIN; PLANT; GLYCOSYLATION; THALIANA; OLIGOSACCHARIDES; PEROXIDASE	Arabidopsis N-glycosylation mutants with enhanced salt sensitivity show reduced immunoreactivity of complex N-glycans. Among them, hybrid glycosylation 1 (hgl1) alleles lacking Golgi alpha-mannosidase II are unique, because their glycoprotein N-glycans are hardly labeled by anti-complex glycan antibodies, even though they carry beta 1,2-xylose and alpha 1,3-fucose epitopes. To dissect the contribution of xylose and core fucose residues to plant stress responses and immunogenic potential, we prepared Arabidopsis hgl1 xylT double and hgl1 fucTa fucTb triple mutants by crossing previously established T-DNA insertion lines and verified them by mass spectrometry analyses. Root growth assays revealed that hgl1 fucTa fucTb but not hgl1 xylT plants are more salt-sensitive than hgl1, hinting at the importance of core fucose modification and masking of xylose residues. Detailed immunoblot analyses with anti-beta 1,2-xylose and anti-alpha 1,3-fucose rabbit immunoglobulin G antibodies as well as cross-reactive carbohydrate determinant-specific human immunoglobulin E antibodies ( present in sera of allergy patients) showed that xylose-specific reactivity of hgl1 N-glycans is indeed reduced. Based on three-dimensional modeling of plant N-glycans, we propose that xylose residues are tilted by 30 degrees because of untrimmed mannoses in hgl1 mutants. Glycosidase treatments of protein extracts restored immunoreactivity of hgl1 N-glycans supporting these models. Furthermore, among allergy patient sera, untrimmed mannoses persisting on the alpha 1,6-arm of hgl1 N-glycans were inhibitory to immunoreaction with core fucoses to various degrees. In summary, incompletely trimmed glycoprotein N-glycans conformationally prevent xylose and, to lesser extent, core fucose accessibility. Thus, in addition to N-acetylglucosaminyltransferase I, Golgi alpha-mannosidase II emerges as a so far unrecognized target for lowering the immunogenic potential of plant-derived glycoproteins.	[Kaulfuerst-Soboll, Heidi; Rips, Stephan; von Schaewen, Antje] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Koiwa, Hisashi] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, Dept Hort Sci, College Stn, TX 77843 USA; [Koiwa, Hisashi] Texas A&M Univ, Mol & Environm Plant Sci Program, College Stn, TX 77843 USA; [Kajiura, Hiroyuki; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan	University of Munster; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Osaka University	von Schaewen, A (corresponding author), Schlossgarten 3, D-48149 Munster, Germany.	Schaewen@uni-muenster.de	Koiwa, Hisashi/AAA-8182-2019; Koiwa, Hisashi/AAO-6512-2020	Koiwa, Hisashi/0000-0002-7421-340X; Kajiura, Hiroyuki/0000-0001-5811-1625	Deutsche Forschungsgemeinschaft [SCHA 541/9, SCHA 541/11]; U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES) [2008-34402-19195, 2009-34402-19831, 2010-34402-20875]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SCHA 541/9 and 11 (to A. v. S.) and by U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES) Designing Food for Health Grants 2008-34402-19195, 2009-34402-19831, and 2010-34402-20875 (to H.K.).	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Bencurova M, 2004, GLYCOBIOLOGY, V14, P457, DOI 10.1093/glycob/cwh058; BREWER CF, 1986, J BIOL CHEM, V261, P7306; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Ebo DG, 2004, CLIN EXP ALLERGY, V34, P137, DOI 10.1111/j.1365-2222.2004.01837.x; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; FAYE L, 1988, GLYCOCONJUGATE J, V5, P245, DOI 10.1007/BF01049085; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; Hossain MA, 2009, BIOSCI BIOTECH BIOCH, V73, P140, DOI 10.1271/bbb.80561; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; Jin CS, 2006, GLYCOBIOLOGY, V16, P349, DOI 10.1093/glycob/cwj071; Kajiura H, 2010, GLYCOBIOLOGY, V20, P736, DOI 10.1093/glycob/cwq028; KALADAS PM, 1983, MOL IMMUNOL, V20, P727, DOI 10.1016/0161-5890(83)90050-0; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kaulfurst-Soboll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017800; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; LAURIERE M, 1989, PLANT PHYSIOL, V90, P1182, DOI 10.1104/pp.90.3.1182; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Lommerse JPM, 2002, CARBOHYD RES, V337, P2279, DOI 10.1016/S0008-6215(02)00212-4; LOMMERSE JPM, 1995, J BIOMOL NMR, V6, P79, DOI 10.1007/BF00417494; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; RAMIREZSOTO D, 1991, CARBOHYD RES, V213, P27, DOI 10.1016/S0008-6215(00)90595-0; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; SONNEWALD U, 1989, PLANTA, V178, P176, DOI 10.1007/BF00393192; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; STURM A, 1990, PLANT CELL, V2, P1107, DOI 10.1105/tpc.2.11.1107; STURM A, 1986, PLANT PHYSIOL, V81, P320, DOI 10.1104/pp.81.1.320; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wuhrer M, 2005, BBA-GEN SUBJECTS, V1723, P229, DOI 10.1016/j.bbagen.2005.02.013	50	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22955	22964		10.1074/jbc.M110.196097	http://dx.doi.org/10.1074/jbc.M110.196097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21478158	Green Published, hybrid			2022-12-27	WOS:000292025000030
J	Smith, AM; Qualls, JE; O'Brien, K; Balouzian, L; Johnson, PF; Schultz-Cherry, S; Smale, ST; Murray, PJ				Smith, Amber M.; Qualls, Joseph E.; O'Brien, Kevin; Balouzian, Liza; Johnson, Peter F.; Schultz-Cherry, Stacey; Smale, Stephen T.; Murray, Peter J.			A Distal Enhancer in Il12b Is the Target of Transcriptional Repression by the STAT3 Pathway and Requires the Basic Leucine Zipper (B-ZIP) Protein NFIL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE SUSCEPTIBILITY LOCI; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; T-HELPER-CELLS; ANTIINFLAMMATORY RESPONSE; INTESTINAL INFLAMMATION; CHRONIC ENTEROCOLITIS; PRIMARY MACROPHAGES; SIGNALING PATHWAY; CROHNS-DISEASE	Deregulated IL-12 and IL-23 production from activated myeloid lineage cells is a key driver of numerous T cell-dependent autoimmune and inflammatory diseases. IL-12 and IL-23 share a common p40 subunit encoded by Il12b, which is negatively regulated at the transcriptional level by the STAT3(signal transducer and activator of transcription 3)-activating anti-inflammatory cytokine IL-10. We found that IL-10 targets an enhancer 10 kb upstream of the Il12b transcriptional start site. Within the enhancer, a single 10-bp site is required for the inhibitory effects of IL-10 and is bound by NFIL3 (nuclear factor, interleukin 3-regulated), a B-ZIP transcription factor. Myeloid cells lacking NFIL3 produce excessive IL-12p40 and increased IL-12p70. Thus, the STAT3-dependent expression of NFIL3 is a key component of a negative feedback pathway in myeloid cells that suppresses proinflammatory responses.	[Smith, Amber M.; Qualls, Joseph E.; O'Brien, Kevin; Balouzian, Liza; Schultz-Cherry, Stacey; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Smith, Amber M.; Qualls, Joseph E.; Balouzian, Liza; Murray, Peter J.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Johnson, Peter F.] NCI, Lab Canc Prevent, Ctr Canc Res, Ft Detrick, MD 21702 USA; [Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles	Murray, PJ (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA.	peter.murray@stjude.org	Schultz-Cherry, Stacey/N-2506-2018; Murray, Peter J/K-4725-2018; Johnson, Peter/A-1940-2012	Murray, Peter J/0000-0001-6329-9802; Qualls, Joseph/0000-0002-0113-2166; Johnson, Peter/0000-0002-4145-4725	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institutes of Health [F32 CA138064]; Hartwell Foundation; CORE grant [P30 CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, F32CA138064] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; CORE grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research (to P. F. J.). This work was also supported by National Institutes of Health Grant F32 CA138064 (to J. E. Q.), The Hartwell Foundation (to P. J. M.), CORE grant P30 CA21765, and the American Lebanese Syrian Associated Charities.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Craver MPJ, 2010, MOL BIOCHEM PARASIT, V169, P120, DOI 10.1016/j.molbiopara.2009.10.006; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Elliott M, 2009, ANN NY ACAD SCI, V1182, P97, DOI 10.1111/j.1749-6632.2009.05070.x; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hou B., 2010, NATL ACAD SCI US, V108, P278; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mizoguchi A, 2007, J CLIN INVEST, V117, P605, DOI 10.1172/JCI30150; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Olleros ML, 2007, IMMUNOLOGY, V122, P350, DOI 10.1111/j.1365-2567.2007.02646.x; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Teng MWL, 2011, CANCER RES, V71, P2077, DOI 10.1158/0008-5472.CAN-10-3994; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zwiers A, 2011, J IMMUNOL, V186, P3572, DOI 10.4049/jimmunol.1001330	58	49	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23582	23590		10.1074/jbc.M111.249235	http://dx.doi.org/10.1074/jbc.M111.249235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566115	Green Published, hybrid			2022-12-27	WOS:000292025000088
J	Yue, M; Singh, A; Wang, Z; Xu, YJ				Yue, Ming; Singh, Amanpreet; Wang, Zhuo; Xu, Yong-jie			The Phosphorylation Network for Efficient Activation of the DNA Replication Checkpoint in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; DAMAGE CHECKPOINT; S-PHASE; KINASE CDS1; IN-VITRO; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX; CLAMP; RAD9	Protein phosphorylation is the hallmark of checkpoint activation. Hundreds of targets of checkpoint kinases have been identified recently by genome-wide investigations. However, the complete picture of a phosphorylation network required for activation of a checkpoint pathway has not been available. The DNA replication checkpoint in Schizosaccharomyces pombe contains two major protein kinases, the sensor kinase Rad3 and the effector kinase Cds1, with the latter mediating most of the checkpoint functions. We show here that when DNA replication is arrested, efficient activation of Cds1 requires five phosphorylations that cooperate in a parallel or a sequential manner. Phosphorylation of a threonine residue (Thr(11)) in Cds1 by Rad3 occurs at a basal level in the absence of three other parallel Rad3-dependent phosphorylations on the mediator Mrc1 and Rad9 in the checkpoint clamp complex. However, the three parallel Rad3-dependent phosphorylations are all required for efficient phosphorylation of Thr11 in Cds1 by Rad3. Phosphorylation of Thr11 has been shown previously to promote autophosphorylation of Thr(328) in the kinase domain of Cds1, which directly activates the enzyme, leading to full activation of the checkpoint pathway. Interestingly, phosphorylation of Mrc1 by Rad3 does not require the phosphorylation of Rad9, suggesting that activation of the sensor kinase Rad3 in the replication checkpoint of fission yeast may involve a different mechanism.	[Yue, Ming; Singh, Amanpreet; Wang, Zhuo; Xu, Yong-jie] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 148 Diggs,3640 Col Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu	Wang, Zhuo/F-1759-2017	Wang, Zhuo/0000-0002-8218-6819	Ohio Cancer Research Associates, Inc.	Ohio Cancer Research Associates, Inc.	This work was supported in part by a grant from Ohio Cancer Research Associates, Inc.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Kai M, 2007, NAT CELL BIOL, V9, P691, DOI 10.1038/ncb1600; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2002, GENETICS, V161, P1437; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2010, P NATL ACAD SCI USA, V107, P13561, DOI 10.1073/pnas.1008909107; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003	60	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22864	22874		10.1074/jbc.M111.236687	http://dx.doi.org/10.1074/jbc.M111.236687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561865	hybrid, Green Published			2022-12-27	WOS:000292025000021
J	Borisova, SA; Christman, HD; Metcalf, MEM; Zulkepli, NA; Zhang, JK; van der Donk, WA; Metcalf, WW				Borisova, Svetlana A.; Christman, Harry D.; Metcalf, M. E. Mourey; Zulkepli, Nurul A.; Zhang, Jun Kai; van der Donk, Wilfred A.; Metcalf, William W.			Genetic and Biochemical Characterization of a Pathway for the Degradation of 2-Aminoethylphosphonate in Sinorhizobium meliloti 1021	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-FLUORESCENS 23F; BOND-CLEAVAGE ENZYME; ALDEHYDE DEHYDROGENASE; PHOSPHONOPYRUVATE HYDROLASE; SP PAL2; SUPERFAMILY; MUTAGENESIS; BACTERIA; SEQUENCE; BIODEGRADATION	A variety of microorganisms have the ability to use phosphonic acids as sole sources of phosphorus. Here, a novel pathway for degradation of 2-aminoethylphosphonate in the bacterium Sinorhizobium meliloti 1021 is proposed based on the analysis of the genome sequence. Gene deletion experiments confirmed the involvement of the locus containing phnW, phnA, and phnY genes in the conversion of 2-aminoethylphosphonate to inorganic phosphate. Biochemical studies of the recombinant PhnY and PhnA proteins verified their roles as phosphonoacetaldehyde dehydrogenase and phosphonoacetate hydrolase, respectively. This pathway is likely not limited to S. meliloti as suggested by the presence of homologous gene clusters in other bacterial genomes.	[Borisova, Svetlana A.; van der Donk, Wilfred A.; Metcalf, William W.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Christman, Harry D.; Metcalf, M. E. Mourey; Zhang, Jun Kai; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Zulkepli, Nurul A.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Borisova, Svetlana A.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	metcalf@uiuc.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071	National Institutes of Health [GM P01 GM077596]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM P01 GM077596 from the National Institutes of Health and the Howard Hughes Medical Institute.	BALDOMA L, 1987, J BIOL CHEM, V262, P13991; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Borisova SA, 2010, CHEM BIOL, V17, P28, DOI 10.1016/j.chembiol.2009.11.017; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Chen CCH, 2006, BIOCHEMISTRY-US, V45, P11491, DOI 10.1021/bi061208l; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; Kulakova AN, 2003, J BIOL CHEM, V278, P23426, DOI 10.1074/jbc.M301871200; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; LEE KS, 1992, J BACTERIOL, V174, P2501, DOI 10.1128/jb.174.8.2501-2510.1992; Marchal S, 1999, BIOCHEMISTRY-US, V38, P12950, DOI 10.1021/bi990453k; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; MCGRATH JW, 1995, EUR J BIOCHEM, V234, P225, DOI 10.1111/j.1432-1033.1995.225_c.x; MCMULLAN G, 1994, J BACTERIOL, V176, P320, DOI 10.1128/JB.176.2.320-324.1994; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Morais MC, 2004, J BIOL CHEM, V279, P9353, DOI 10.1074/jbc.M312345200; NAG DK, 1988, GENE, V64, P135, DOI 10.1016/0378-1119(88)90487-8; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Parker GF, 1999, J BACTERIOL, V181, P389, DOI 10.1128/JB.181.2.389-395.1999; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Ternan NG, 1998, SYST APPL MICROBIOL, V21, P346, DOI 10.1016/S0723-2020(98)80043-X; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	36	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22283	22290		10.1074/jbc.M111.237735	http://dx.doi.org/10.1074/jbc.M111.237735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543322	Green Published, hybrid			2022-12-27	WOS:000291719900036
J	Estrada, DF; De Guzman, RN				Estrada, D. Fernando; De Guzman, Roberto N.			Structural Characterization of the Crimean-Congo Hemorrhagic Fever Virus Gn Tail Provides Insight into Virus Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; CYTOPLASMIC TAIL; NMR; PROTEIN; GLYCOPROTEINS; SYSTEM; DOMAIN; SPECTROSCOPY; ASSIGNMENT	The RNA virus that causes the Crimean Congo Hemorrhagic Fever (CCHF) is a tick-borne pathogen of the Nairovirus genus, family Bunyaviridae. Unlike many zoonotic viruses that are only passed between animals and humans, the CCHF virus can also be transmitted from human to human with an overall mortality rate approaching 30%. Currently, there are no atomic structures for any CCHF virus proteins or for any Nairovirus proteins. A critical component of the virus is the envelope Gn glycoprotein, which contains a C-terminal cytoplasmic tail. In other Bunyaviridae viruses, the Gn tail has been implicated in host-pathogen interaction and viral assembly. Here we report the NMR structure of the CCHF virus Gn cytoplasmic tail, residues 729-805. The structure contains a pair of tightly arranged dual beta beta alpha zinc fingers similar to those found in the Hantavirus genus, with which it shares about 12% sequence identity. Unlike Hantavirus zinc fingers, however, the CCHF virus zinc fingers bind viral RNA and contain contiguous clusters of conserved surface electrostatics. Our results provide insight into a likely role of the CCHF virus Gn zinc fingers in Nairovirus assembly.	[Estrada, D. Fernando; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu			AHA [0755724Z]; K-INBRE; NIH [P20 RR016475]; Madison and Lila Self Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR017708] Funding Source: NIH RePORTER	AHA(American Heart Association); K-INBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Madison and Lila Self Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by AHA 0755724Z, K-INBRE, and NIH P20 RR016475 (to R. N. D.) and the Madison and Lila Self Graduate Fellowship (to D. F. E.).	Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; CASE DA, 2002, AMBER7; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; ELLIOTT RM, 2000, VIRUS TAXONOMY CLASS; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Flick R, 2003, J VIROL, V77, P5997, DOI 10.1128/JVI.77.10.5997-6006.2003; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hepojoki J, 2010, J GEN VIROL, V91, P2341, DOI 10.1099/vir.0.021006-0; HOFFMAN RC, 1993, J MAGN RESON SER B, V102, P61, DOI 10.1006/jmrb.1993.1062; JANERT PK, 2009, GNUPLOT ACTION UNDER; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; PELTON JG, 1993, PROTEIN SCI, V2, P543; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; SCHMALJOHN CAH, 2001, BUNYAVIRIDAE VIRUSES; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21678	21686		10.1074/jbc.M110.216515	http://dx.doi.org/10.1074/jbc.M110.216515			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507948	Green Published, hybrid			2022-12-27	WOS:000291464700064
J	Hisaoka, K; Tsuchioka, M; Yano, R; Maeda, N; Kajitani, N; Morioka, N; Nakata, Y; Takebayashi, M				Hisaoka, Kazue; Tsuchioka, Mami; Yano, Ryoya; Maeda, Natsuko; Kajitani, Naoto; Morioka, Norimitsu; Nakata, Yoshihiro; Takebayashi, Minoru			Tricyclic Antidepressant Amitriptyline Activates Fibroblast Growth Factor Receptor Signaling in Glial Cells INVOLVEMENT IN GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOBLASTOMA CELLS; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; GLIOMA-CELLS; FACTOR GDNF; MAJOR DEPRESSION; GENE-EXPRESSION; BIPOLAR DISORDER; ASTROCYTES; TRANSACTIVATION	Recently, both clinical and animal studies demonstrated neuronal and glial plasticity to be important for the therapeutic action of antidepressants. Antidepressants increase glial cell line-derived neurotrophic factor (GDNF) production through monoamine-independent protein-tyrosine kinase, extracellular signal-regulated kinase (ERK), and cAMP responsive element-binding protein (CREB) activation in glial cells (Hisaoka, K., Takebayashi, M., Tsuchioka, M., Maeda, N., Nakata, Y., and Yamawaki, S. (2007) J. Pharmacol. Exp. Ther. 321, 148-157; Hisaoka, K., Maeda, N., Tsuchioka, M., and Takebayashi, M. (2008) Brain Res. 1196, 53-58). This study clarifies the type of tyrosine kinase and mechanism of antidepressant-induced GDNF production in C6 glioma cells and normal human astrocytes. The amitriptyline (a tricyclic antidepressant)-induced ERK activation was specifically and completely inhibited by fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors and siRNA for FGFR1 and -2. Treatment with amitriptyline or several different classes of antidepressants, but not non-antidepressants, acutely increased the phosphorylation of FGFRs and FGFR substrate 2 alpha (FRS2 alpha). Amitriptyline-induced CREB phosphorylation and GDNF production were blocked by FGFR-tyrosine kinase inhibitors. Therefore, antidepressants activate the FGFR/FRS2 alpha/ERK/CREB signaling cascade, thus resulting in GDNF production. Furthermore, we attempted to elucidate how antidepressants activate FGFR signaling. The effect of amitriptyline was inhibited by heparin, non-permeant FGF-2 neutralizing antibodies, and matrix metalloproteinase (MMP) inhibitors. Serotonin (5-HT) also increased GDNF production through FGFR2 (Tsuchioka, M., Takebayashi, M., Hisaoka, K., Maeda, N., and Nakata, Y. (2008) J. Neurochem. 106, 244-257); however, the effect of 5-HT was not inhibited by heparin and MMP inhibitors. These results suggest that amitriptyline-induced FGFR activation might occur through an extracellular pathway, in contrast to that of 5-HT. The current data show that amitriptyline-induced FGFR activation might occur by the MMP-dependent shedding of FGFR ligands, such as FGF-2, thus resulting in GDNF production.	[Takebayashi, Minoru] NHO Kure Med Ctr, Dept Psychiat, Kure 7370023, Japan; [Takebayashi, Minoru] NHO Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure 7370023, Japan; Chugoku Canc Ctr, Kure 7370023, Japan; [Hisaoka, Kazue; Yano, Ryoya; Kajitani, Naoto; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Takebayashi, M (corresponding author), NHO Kure Med Ctr, Dept Psychiat, 3-1 Aoyama, Kure 7370023, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Kajitani, Naoto/0000-0001-7245-9206	Ministry of Health, Labor, and Welfare of Japan; Pharmacological Research Foundation, Tokyo	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo)	This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan and by the Pharmacological Research Foundation, Tokyo.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Ko HG, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-16; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lazar J, 2004, LIFE SCI, V75, P153, DOI 10.1016/j.lfs.2003.11.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsunaga H, 2006, NEUROCHEM INT, V49, P294, DOI 10.1016/j.neuint.2006.01.017; Mercier G, 2004, J MOL NEUROSCI, V24, P207, DOI 10.1385/JMN:24:2:207; Michel TM, 2008, EUR PSYCHIAT, V23, P413, DOI 10.1016/j.eurpsy.2008.06.001; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamua S, 1999, GLIA, V28, P53, DOI 10.1002/(SICI)1098-1136(199910)28:1<53::AID-GLIA7>3.0.CO;2-V; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; OKUMURA N, 1989, J BIOCHEM-TOKYO, V106, P904, DOI 10.1093/oxfordjournals.jbchem.a122950; Otsuki K, 2008, J PSYCHIATR RES, V42, P1145, DOI 10.1016/j.jpsychires.2008.01.010; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Rosa AR, 2006, NEUROSCI LETT, V407, P146, DOI 10.1016/j.neulet.2006.08.026; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shibata SB, 2007, BRAIN RES, V1144, P74, DOI 10.1016/j.brainres.2007.01.090; Shin SY, 2009, J BIOL CHEM, V284, P30583, DOI 10.1074/jbc.M109.010678; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; Takebayashi M, 2009, RECENT DEV DEPRESSIO, P125; Takebayashi M, 2006, INT J NEUROPSYCHOPH, V9, P607, DOI 10.1017/S1461145705006085; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Verity AN, 1998, J NEUROCHEM, V70, P531; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Yamada T, 2008, BIOMATERIALS, V29, P3503, DOI 10.1016/j.biomaterials.2008.03.044; Yan Y, 2007, FASEB J, V21, P1994, DOI 10.1096/fj.06-7772com; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhang XB, 2009, PSYCHIAT RES, V170, P273, DOI 10.1016/j.psychres.2009.01.011; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	55	42	44	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21118	21128		10.1074/jbc.M111.224683	http://dx.doi.org/10.1074/jbc.M111.224683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515689	Green Published, hybrid			2022-12-27	WOS:000291464700011
J	Li, Z; Xu, XL; Bai, L; Chen, WS; Lin, Y				Li, Zi; Xu, Xiuling; Bai, Lang; Chen, Wenshu; Lin, Yong			Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED CYTOTOXICITY; CHOLANGIOCARCINOMA CELLS; DRUG-RESISTANCE; OVARIAN-CANCER; ACTIVATION; PATHWAY; MECHANISMS; INVASION; SENSITIZATION; THERAPEUTICS	Acquired chemoresistance not only blunts anticancer therapy but may also promote cancer cell migration and metastasis. Our previous studies have revealed that acquired tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance in lung cancer cells is associated with Akt-mediated stabilization of cellular caspase 8 and Fas-associated death domain (FADD)-like apoptosis regulator-like inhibitory protein (c-FLIP) and myeloid cell leukemia 1 (Mcl-1). In this report, we show that cells with acquired TRAIL resistance have significantly increased capacities in migration and invasion. By gene expression screening, tissue transglutaminase (TGM2) was identified as one of the genes with the highest expression increase in TRAIL-resistant cells. Suppressing TGM2 dramatically alleviated TRAIL resistance and cell migration, suggesting that TGM2 contributes to these two phenotypes in TRAIL-resistant cells. TGM2-mediated TRAIL resistance is likely through c-FLIP because TGM2 suppression significantly reduced c-FLIP but not Mcl-1 expression. The expression of matrix metalloproteinase 9 (MMP-9) was suppressed when TGM2 was inhibited, suggesting that TGM2 potentiates cell migration through up-regulating MMP-9 expression. We found that EGF receptor (EGFR) was highly active in the TRAIL-resistant cells, and suppression of EGFR dramatically reduced TGM2 expression. We further determined JNK and ERK, but not Akt and NF-kappa B, are responsible for EGFR-mediated TGM2 expression. These results identify a novel pathway that involves EGFR, MAPK (JNK and ERK), and TGM2 for acquired TRAIL resistance and cell migration in lung cancer cells. Because TGM2 couples TRAIL resistance and cell migration, it could be a molecular target for circumventing acquired chemoresistance and metastasis in lung cancer.	[Li, Zi; Xu, Xiuling; Bai, Lang; Chen, Wenshu; Lin, Yong] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM 87108 USA; [Li, Zi] Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Guangzhou 510182, Guangdong, Peoples R China	Lovelace Respiratory Research Institute; Guangzhou Medical University	Lin, Y (corresponding author), Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	ylin@lrri.org			National Institutes of Health NIEHS [R01ES017328]; Department of Energy [DE-SC0001173]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017328] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health NIEHS Grant R01ES017328 and Department of Energy Low Dose Radiation Research Program DE-SC0001173.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Fingas CD, 2010, HEPATOLOGY, V52, P550, DOI 10.1002/hep.23729; Frese-Schaper M, 2010, FEBS LETT, V584, P2867, DOI 10.1016/j.febslet.2010.04.072; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ho C, 2009, EXPERT OPIN INV DRUG, V18, P1133, DOI 10.1517/13543780903066772; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Jang JH, 2010, CANCER LETT, V287, P224, DOI 10.1016/j.canlet.2009.06.013; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Lane D, 2006, MOL CANCER THER, V5, P509, DOI 10.1158/1535-7163.MCT-05-0362; Leong S, 2009, J CLIN ONCOL, V27, P4413, DOI 10.1200/JCO.2008.21.7422; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Park KS, 2010, J CANCER RES CLIN, V136, P493, DOI 10.1007/s00432-009-0681-6; Roche H, 2011, ANN ONCOL, V22, P1000, DOI 10.1093/annonc/mdq429; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Stegehuis JH, 2010, DRUG RESIST UPDATE, V13, P2, DOI 10.1016/j.drup.2009.11.001; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wajant H, 2005, CYTOKINE GROWTH F R, V16, P55, DOI 10.1016/j.cytogfr.2004.12.001; Wajant H, 2004, VITAM HORM, V67, P101; Wang XD, 2001, GENE DEV, V15, P2922; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wenger T, 2006, CELL DEATH DIFFER, V13, P1740, DOI 10.1038/sj.cdd.4401867; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	40	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21164	21172		10.1074/jbc.M110.207571	http://dx.doi.org/10.1074/jbc.M110.207571			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525012	hybrid, Green Published			2022-12-27	WOS:000291464700016
J	Porcher, C; Hatchett, C; Longbottom, RE; McAinch, K; Sihra, TS; Moss, SJ; Thomson, AM; Jovanovic, JN				Porcher, Christophe; Hatchett, Caroline; Longbottom, Rebecca E.; McAinch, Kristina; Sihra, Talvinder S.; Moss, Stephen J.; Thomson, Alex M.; Jovanovic, Jasmina N.			Positive Feedback Regulation between gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Signaling and Brain-derived Neurotrophic Factor (BDNF) Release in Developing Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TRAFFICKING; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; GABAERGIC SYNAPSES; CORTICAL-NEURONS; FACTOR PROMOTES; AMPA RECEPTORS; BETA 3; MATURATION; CELLS	During the early development of the nervous system, gamma-aminobutyric acid (GABA) type A receptor (GABA(A)R)-mediated signaling parallels the neurotrophin/tropomyosin-related kinase (Trk)-dependent signaling in controlling a number of processes from cell proliferation and migration, via dendritic and axonal outgrowth, to synapse formation and plasticity. Here we present the first evidence that these two signaling systems regulate each other through a complex positive feedback mechanism. We first demonstrate that GABA(A)R activation leads to an increase in the cell surface expression of these receptors in cultured embryonic cerebrocortical neurons, specifically at the stage when this activity causes depolarization of the plasma membrane and Ca2+ influx through L-type voltage-gated Ca2+ channels. We further demonstrate that GABA(A)R activity triggers release of the brain-derived neurotrophic factor (BDNF), which, in turn by activating TrkB receptors, mediates the observed increase in cell surface expression of GABA(A)Rs. This BDNF/TrkB-dependent increase in surface levels of GABA(A)Rs requires the activity of phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) and does not involve the extracellular signal-regulated kinase (ERK) 1/2 activity. The increase in GABA(A)R surface levels occurs due to an inhibition of the receptor endocytosis by BDNF, whereas the receptor reinsertion into the plasma membrane remains unaltered. Thus, GABA(A)R activity is a potent regulator of the BDNF release during neuronal development, and at the same time, it is strongly enhanced by the activity of the BDNF/TrkB/PI3K/PKC signaling pathway.	[Hatchett, Caroline; Thomson, Alex M.; Jovanovic, Jasmina N.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Porcher, Christophe] INSERM, Inst Neurobiol Mediterranee, U901, F-13273 Marseille 09, France; [Porcher, Christophe] Univ Mediterranee, F-13273 Marseille 09, France; [Longbottom, Rebecca E.; McAinch, Kristina; Sihra, Talvinder S.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA	University of London; University College London; University of London School of Pharmacy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; Tufts University	Jovanovic, JN (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	jasmina.jovanovic@pharmacy.ac.uk	Sihra, Talvinder S/A-4581-2009; Porcher, Christophe/C-3758-2009	Porcher, Christophe/0000-0002-6026-6367	Biotechnology and Biological Sciences Research Council UK [BB/C507237/1]; Medical Research Council [G0800498]; INSERM and Agence Nationale pour la Recherche; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, R01NS051195, R21NS080064] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C507237/1] Funding Source: researchfish; Medical Research Council [G0401248] Funding Source: researchfish; MRC [G0401248, G0800498] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); INSERM and Agence Nationale pour la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council UK New Investigator Grant BB/C507237/1 (to J. N. J.), Medical Research Council Grant G0800498 (to J. N. J. and A. M. T.), and INSERM and Agence Nationale pour la Recherche (to C. P.).	Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Arancibia-Carcamo IL, 2009, PHARMACOL THERAPEUT, V123, P17, DOI 10.1016/j.pharmthera.2009.03.012; Balslev Y, 1996, ACTA ANAT, V156, P2; Bao SW, 1999, LEARN MEMORY, V6, P276; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Behar TN, 1996, J NEUROSCI, V16, P1808; Belhage B, 1998, PERSPECT DEV NEUROBI, V5, P235; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Boxall AR, 2000, J PHYSIOL-LONDON, V524, P677, DOI 10.1111/j.1469-7793.2000.00677.x; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cheng Q, 2003, J PHYSIOL-LONDON, V548, P711, DOI 10.1113/jphysiol.2002.037846; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Davies P, 1998, PROG NEUROBIOL, V55, P651, DOI 10.1016/S0301-0082(98)00024-0; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fiorentino H, 2009, J NEUROSCI, V29, P11650, DOI 10.1523/JNEUROSCI.3587-09.2009; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Fujii M, 2007, NEUROSCIENCE, V146, P1044, DOI 10.1016/j.neuroscience.2007.02.050; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goffin D, 2010, J NEUROSCI, V30, P2935, DOI 10.1523/JNEUROSCI.4411-09.2010; Goslin K., 1998, CULTURING NERVE CELL, P339; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Haubensak W, 1998, J CELL SCI, V111, P1483; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hewitt SA, 2006, J NEUROPHYSIOL, V95, P2193, DOI 10.1152/jn.01135.2005; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hutcheon B, 2000, J PHYSIOL-LONDON, V522, P3, DOI 10.1111/j.1469-7793.2000.t01-5-00003.xm; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kuczewski N, 2008, J NEUROSCI, V28, P7013, DOI 10.1523/JNEUROSCI.1673-08.2008; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu B, 2009, CURR OPIN NEUROBIOL, V19, P162, DOI 10.1016/j.conb.2009.04.004; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MA W, 1995, J NEUROSCI, V15, P2547, DOI 10.1523/JNEUROSCI.15-03-02547.1995; Mammen AL, 1997, J NEUROSCI, V17, P7351; Maric D, 1997, EUR J NEUROSCI, V9, P507, DOI 10.1111/j.1460-9568.1997.tb01628.x; Marty S, 2000, J NEUROSCI, V20, P8087; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mizoguchi Y, 2003, J BIOL CHEM, V278, P44097, DOI 10.1074/jbc.M305872200; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; MUELLER AL, 1984, J NEUROSCI, V4, P860; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 1999, J NEUROPHYSIOL, V82, P570, DOI 10.1152/jn.1999.82.2.570; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Serafini R, 1998, EUR J NEUROSCI, V10, P1771, DOI 10.1046/j.1460-9568.1998.00187.x; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Tanaka T, 1997, J NEUROSCI, V17, P2959; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wardle RA, 2003, J NEUROSCI, V23, P8722; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; Yamada MK, 2002, J NEUROSCI, V22, P7580; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	90	63	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21667	21677		10.1074/jbc.M110.201582	http://dx.doi.org/10.1074/jbc.M110.201582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21474450	hybrid, Green Published			2022-12-27	WOS:000291464700063
J	French, JB; Yates, PA; Soysa, DR; Boitz, JM; Carter, NS; Chang, BL; Ullman, B; Ealick, SE				French, Jarrod B.; Yates, Phillip A.; Soysa, D. Radika; Boitz, Jan M.; Carter, Nicola S.; Chang, Bailey; Ullman, Buddy; Ealick, Steven E.			The Leishmania donovani UMP Synthase Is Essential for Promastigote Viability and Has an Unusual Tetrameric Structure That Exhibits Substrate-controlled Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; NOVO PYRIMIDINE BIOSYNTHESIS; PROTEIN SECONDARY STRUCTURE; MOLECULAR-WEIGHT FORMS; DE-NOVO; OROTATE PHOSPHORIBOSYLTRANSFERASE; PROFICIENT ENZYME; PURINE METABOLISM; CRYSTAL-STRUCTURE; MECHANISM	The final two steps of de novo uridine 5'-monophosphate (UMP) biosynthesis are catalyzed by orotate phosphoribosyltransferase (OPRT) and orotidine 5'-monophosphate decarboxylase (OMPDC). In most prokaryotes and simple eukaryotes these two enzymes are encoded by separate genes, whereas in mammals they are expressed as a bifunctional gene product called UMP synthase (UMPS), with OPRT at the N terminus and OMPDC at the C terminus. Leishmania and some closely related organisms also express a bifunctional enzyme for these two steps, but the domain order is reversed relative to mammalian UMPS. In this work we demonstrate that L. donovani UMPS (LdUMPS) is an essential enzyme in promastigotes and that it is sequestered in the parasite glycosome. We also present the crystal structure of the LdUMPS in complex with its product, UMP. This structure reveals an unusual tetramer with two head to head and two tail to tail interactions, resulting in two dimeric OMPDC and two dimeric OPRT functional domains. In addition, we provide structural and biochemical evidence that oligomerization of LdUMPS is controlled by product binding at the OPRT active site. We propose a model for the assembly of the catalytically relevant LdUMPS tetramer and discuss the implications for the structure of mammalian UMPS.	[French, Jarrod B.; Chang, Bailey; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Yates, Phillip A.; Soysa, D. Radika; Boitz, Jan M.; Carter, Nicola S.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Cornell University; Oregon Health & Science University	Ealick, SE (corresponding author), Cornell Univ, Baker Lab 120, Ithaca, NY 14853 USA.	see3@cornell.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	National Institutes of Health [GM073220, AI023682]; Tri-institutional Training Program in Chemical Biology; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-institutional Training Program in Chemical Biology; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073220 (to S. E. E.) and AI023682 (to B. U.).; Supported by the Tri-institutional Training Program in Chemical Biology.; We thank the staff at the Northeastern Collaborative Access Team (NE-CAT) beamlines for advice with data collection and processing. Data collected at the NE-CAT beamlines of the Advanced Photon Source are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, contract number DE-AC02-06CH11357. We acknowledge Cynthia Kinsland of the Protein Production Facility in the Department of Chemistry and Chemical Biology for help with molecular biology and Leslie Kinsland for help with manuscript preparation.	Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; ARDALAN B, 1981, CANCER TREAT REV, V8, P157, DOI 10.1016/S0305-7372(81)80014-X; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bello AM, 2009, J MED CHEM, V52, P1648, DOI 10.1021/jm801224t; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN GK, 1975, J BIOL CHEM, V250, P7352; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Datta AK, 2008, ADV EXP MED BIOL, V625, P116, DOI 10.1007/978-0-387-77570-8_10; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; Gonzalez-Segura L, 2007, BIOCHEMISTRY-US, V46, P14075, DOI 10.1021/bi701023z; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HAMMOND DJ, 1981, FEBS LETT, V128, P27, DOI 10.1016/0014-5793(81)81070-8; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; Henriksen A, 1996, BIOCHEMISTRY-US, V35, P3803, DOI 10.1021/bi952226y; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones M E, 1978, Methods Enzymol, V51, P155; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; KUNJARA S, 1991, BIOCHEM MED METAB B, V46, P215, DOI 10.1016/0885-4505(91)90069-W; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; McClard RW, 2006, BIOCHEMISTRY-US, V45, P5330, DOI 10.1021/bi051650o; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sanders S, 2002, AM J MED SCI, V323, P190, DOI 10.1097/00000441-200204000-00004; SCAPIN G, 1994, BIOCHEMISTRY-US, V33, P1287, DOI 10.1021/bi00172a001; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Smith JL, 1999, NAT STRUCT BIOL, V6, P502, DOI 10.1038/9266; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; TRAUT TW, 1977, J BIOL CHEM, V252, P8374; TRAUT TW, 1979, J BIOL CHEM, V254, P1143; UMEZU K, 1971, J BIOCHEM, V70, P249, DOI 10.1093/oxfordjournals.jbchem.a129637; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang GP, 1999, BIOCHEMISTRY-US, V38, P275, DOI 10.1021/bi9820560; Wang GP, 1999, BIOCHEMISTRY-US, V38, P284, DOI 10.1021/bi982057s; Weber G, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1164, DOI 10.1023/A:1012493232344; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704	60	29	29	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20930	20941		10.1074/jbc.M111.228213	http://dx.doi.org/10.1074/jbc.M111.228213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507942	Green Published, hybrid			2022-12-27	WOS:000291267600077
J	Huang, XY; Kocabas, E; Hernick, M				Huang, Xinyi; Kocabas, Evren; Hernick, Marcy			The Activity and Cofactor Preferences of N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside Deacetylase (MshB) Change Depending on Environmental Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONONUCLEAR IRON PROTEIN; CARBONIC-ANHYDRASE-II; S-CONJUGATE AMIDASE; SITE METAL-ION; MYCOBACTERIUM-TUBERCULOSIS; PEPTIDE DEFORMYLASE; ESCHERICHIA-COLI; D-PENICILLAMINE; MYCOTHIOL; ENZYME	Actinomycetes, such as Mycobacterium species, are Gram-positive bacteria that utilize the small molecule mycothiol (MSH) as their primary reducing agent. Consequently, the enzymes involved in MSH biosynthesis are targets for drug development. The metal-dependent enzyme N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) catalyzes the hydrolysis of N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside to form 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside and acetate, the fourth overall step in MSH biosynthesis. Inhibitors of metalloenzymes typically contain a group that binds to the active site metal ion; thus, a comprehensive understanding of the native cofactor(s) of metalloenzymes is critical for the development of biologically effective inhibitors. Herein, we examined the effect of metal ions on the overall activity of MshB and probed the identity of the native cofactor. We found that the activity of MshB follows the trend Fe2+ > Co2+ > Zn2+ > Mn2+ and Ni2+. Additionally, our results show that the identity of the cofactor bound to purified MshB is highly dependent on the purification conditions used (aerobic versus anaerobic), as well as the metal ion content of the medium during protein expression. MshB prefers Fe2+ under anaerobic conditions regardless of the metal ion content of the medium and switches between Fe2+ and Zn2+ under aerobic conditions as the metal content of the medium is altered. These results indicate that the cofactor bound to MshB under biological conditions is dependent on environmental conditions, suggesting that MshB may be a cambialistic metallohydrolase that contains a dynamic cofactor. Consequently, biologically effective inhibitors will likely need to dually target Fe2+-MshB and Zn2+-MshB.	[Huang, Xinyi; Kocabas, Evren; Hernick, Marcy] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hernick, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	hernickm@vt.edu		Hernick, Marcy/0000-0002-2839-5767	Jeffress Memorial Trust [J960]	Jeffress Memorial Trust	This work was supported by Jeffress Memorial Trust Grant J960 (to M.H.)	ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Chong CR, 2000, BIOCHEMISTRY-US, V39, P7580, DOI 10.1021/bi000101+; Chong CR, 2007, J MED CHEM, V50, P5524, DOI 10.1021/jm070803y; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018; Gammon DW, 2010, BIOORGAN MED CHEM, V18, P2501, DOI 10.1016/j.bmc.2010.02.049; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gattis SG, 2010, J BIOL CHEM, V285, P33788, DOI 10.1074/jbc.M110.147173; Groche D, 1998, BIOCHEM BIOPH RES CO, V246, P342, DOI 10.1006/bbrc.1998.8616; Gutierrez-Lugo MT, 2008, J MED CHEM, V51, P2606, DOI 10.1021/jm070719i; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Hernick M, 2010, BIOCHEMISTRY-US, V49, P2246, DOI 10.1021/bi902066t; Huang CC, 1996, BIOCHEMISTRY-US, V35, P3439, DOI 10.1021/bi9526692; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; Li NG, 2009, CURR MED CHEM, V16, P3805, DOI 10.2174/092986709789178037; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; Metaferia BB, 2007, J MED CHEM, V50, P6326, DOI 10.1021/jm070669h; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P2641, DOI 10.1016/S0968-0896(03)00154-8; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Ragusa S, 1998, J MOL BIOL, V280, P515, DOI 10.1006/jmbi.1998.1883; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Sobrado P, 2008, PROTEIN EXPRES PURIF, V58, P229, DOI 10.1016/j.pep.2007.11.018; Steffek M, 2003, BIOCHEMISTRY-US, V42, P12067, DOI 10.1021/bi030080u; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	38	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20275	20282		10.1074/jbc.M111.234229	http://dx.doi.org/10.1074/jbc.M111.234229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507949	hybrid, Green Published			2022-12-27	WOS:000291267600015
J	Reifert, J; Hartung-Cranston, D; Feinstein, SC				Reifert, Jack; Hartung-Cranston, DeeAnn; Feinstein, Stuart C.			Amyloid beta-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; INDUCED NEUROTOXICITY; MICROTUBULE DYNAMICS; CALPAIN ACTIVATION; PROTEIN OLIGOMERS; CASPASE CLEAVAGE; PATHOGENESIS; EXPRESSION; MECHANISM	A variety of genetic and biochemical evidence suggests that amyloid beta (A beta) oligomers promote downstream errors in Tau action, in turn inducing neuronal dysfunction and cell death in Alzheimer and related dementias. To better understand molecular mechanisms involved in A beta-mediated neuronal cell death, we have treated primary rat hippocampal cultures with A beta oligomers and examined the resulting cellular changes occurring before and during the induction of cell death with a focus on altered Tau biochemistry. The most rapid neuronal responses upon A beta administration are activation of caspase 3/7 and calpain proteases. A beta also appears to reduce Akt and Erk1/2 kinase activities while increasing GSK3 beta and Cdk5 activities. Shortly thereafter, substantial Tau degradation begins, generating relatively stable Tau fragments. Only a very small fraction of full-length Tau remains intact after 4 h of A beta treatment. In conflict with expectations based on suggested increases of GSK3 beta and Cdk5 activities, A beta does not cause any major increases in phosphorylation of full-length Tau as assayed by immunoblotting one-dimensional gels with 11 independent site-and phosphospecific anti-Tau antibodies as well as by immunoblotting two-dimensional gels probed with a pan-Tau antibody. There are, however, subtle and transient increases in Tau phosphorylation at 3-4 specific sites before its degradation. Taken together, these data are consistent with the notion that A beta-mediated neuronal cell death involves the loss of full-length Tau and/or the generation of toxic fragments but does not involve or require hyperphosphorylation of full-length Tau.	[Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu			National Institutes of Health [NS-35010]; California Department of Health Services [07-65802]; Santa Barbara Cottage Hospital Research Committee; University of California Santa Barbara Academic Senate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Department of Health Services; Santa Barbara Cottage Hospital Research Committee; University of California Santa Barbara Academic Senate(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-35010. This work was also supported by the California Department of Health Services (Alzheimer's Disease Program Grant 07-65802) and the Santa Barbara Cottage Hospital Research Committee and the University of California Santa Barbara Academic Senate.	Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BEYREUTHER K, 1991, ANN NY ACAD SCI, V640, P129; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bloom GS, 2005, BBA-MOL BASIS DIS, V1739, P116, DOI 10.1016/j.bbadis.2004.08.008; Buee L, 1999, BRAIN PATHOL, V9, P681; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; FEDOROFF S, 2001, PROTOCOLS NEURAL CEL, P255; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janke C, 1996, FEBS LETT, V379, P222, DOI 10.1016/0014-5793(95)01522-1; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LAI RYK, 1995, NEUROBIOL AGING, V16, P433, DOI 10.1016/0197-4580(95)00041-C; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Mi Kaihong, 2006, Current Alzheimer Research, V3, P449, DOI 10.2174/156720506779025279; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sergeant N, 1997, J NEUROCHEM, V69, P834; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	60	66	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20797	20811		10.1074/jbc.M111.234674	http://dx.doi.org/10.1074/jbc.M111.234674			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21482827	Green Published, hybrid			2022-12-27	WOS:000291267600065
J	Spears, JL; Rubio, MAT; Gaston, KW; Wywial, E; Strikoudis, A; Bujnicki, JM; Papavasiliou, FN; Alfonzo, JD				Spears, Jessica L.; Rubio, Mary Anne T.; Gaston, Kirk W.; Wywial, Ewa; Strikoudis, Alexandros; Bujnicki, Janusz M.; Papavasiliou, F. Nina; Alfonzo, Juan D.			A Single Zinc Ion Is Sufficient for an Active Trypanosoma brucei tRNA Editing Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; CRYSTAL-STRUCTURE; CYTIDINE DEAMINASE; ESCHERICHIA-COLI; WOBBLE POSITION; INOSINE; ENZYME; TADA; IDENTIFICATION	Editing of adenosine (A) to inosine (I) at the first anticodon position in tRNA is catalyzed by adenosine deaminases acting on tRNA (ADATs). This essential reaction in bacteria and eukarya permits a single tRNA to decode multiple codons. Bacterial ADATa is a homodimer with two bound essential Zn2+. The ADATa crystal structure revealed residues important for substrate binding and catalysis; however, such high resolution structural information is not available for eukaryotic tRNA deaminases. Despite significant sequence similarity among deaminases, we continue to uncover unexpected functional differences between Trypanosoma brucei ADAT2/3 (TbADAT2/3) and its bacterial counterpart. Previously, we demonstrated that TbADAT2/3 is unique in catalyzing two different deamination reactions. Here we show by kinetic analyses and inductively coupled plasma emission spectrometry that wild type TbADAT2/3 coordinates two Zn2+ per heterodimer, but unlike any other tRNA deaminase, mutation of one of the key Zn2+-coordinating cysteines in TbADAT2 yields a functional enzyme with a single-bound zinc. These data suggest that, at least, TbADAT3 may play a role in catalysis via direct coordination of the catalytic Zn2+. These observations raise the possibility of an unusual Zn2+ coordination interface with important implications for the function and evolution of editing deaminases.	[Spears, Jessica L.; Rubio, Mary Anne T.; Gaston, Kirk W.; Alfonzo, Juan D.] Ohio State Univ, Ohio State Ctr RNA Biol, Dept Microbiol, Columbus, OH 43210 USA; [Alfonzo, Juan D.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Wywial, Ewa; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Strikoudis, Alexandros; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Bujnicki, Janusz M.] Adam Mickiewicz Univ Poznan, Fac Biol, Inst Mol Biol & Biotechnol, PL-02109 Poznan, Poland	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Rockefeller University; Adam Mickiewicz University	Alfonzo, JD (corresponding author), 484 W 12th Ave,376 Biosci Bldg, Columbus, OH 43210 USA.	alfonzo.1@osu.edu			National Institutes of Health [GM084065]; Polish Ministry of Science and Higher Education [POIG.02.03.00-00-003/09]; European Research Council [RNA+p = 123D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084065 (to J.D.A.).; Supported by Polish Ministry of Science and Higher Education Grant POIG.02.03.00-00-003/09.; Supported by European Research Council StG Grant RNA+p = 123D.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Elias Y, 2005, BIOCHEMISTRY-US, V44, P12057, DOI 10.1021/bi050499f; FASSEL VA, 1978, SCIENCE, V202, P183, DOI 10.1126/science.202.4364.183; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; GRAY MW, 1976, NUCLEIC ACIDS RES, V3, P977, DOI 10.1093/nar/3.4.977; Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9; Habig JW, 2007, MOL CELL, V25, P792, DOI 10.1016/j.molcel.2007.03.010; Hurst SR, 1995, RNA, V1, P1051; Karcher D, 2009, RNA, V15, P1251, DOI 10.1261/rna.1600609; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim J, 2006, BIOCHEMISTRY-US, V45, P6407, DOI 10.1021/bi0522394; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; ROGONE FL, 2011, RNA IN PRESS; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	35	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20366	20374		10.1074/jbc.M111.243568	http://dx.doi.org/10.1074/jbc.M111.243568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507956	hybrid, Green Published			2022-12-27	WOS:000291267600024
J	Vecchio, AJ; Malkowski, MG				Vecchio, Alex J.; Malkowski, Michael G.			The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; AMINO-ACID DETERMINANTS; MOLECULAR-GRAPHICS; GLYCEROL ESTERS; PROSTAGLANDIN; 2-ARACHIDONYLGLYCEROL; CRYSTALLOGRAPHY; METABOLISM; INHIBITION; ANANDAMIDE	The cyclooxygenases (COX-1 and COX-2) oxygenate arachidonic acid (AA) in the committed step of prostaglandin biogenesis. Substitutions of I434V, H513R, and I523V constitute the only differences in residues lining the cyclooxygenase channel between COX-1 and COX-2. These changes create a hydrophobic pocket in COX-2, with Arg-513 located at the base of the pocket, which has been exploited in the design of COX-2-selective inhibitors. Previous studies have shown that COX-2, but not COX-1, can oxygenate endocannabinoid substrates, including 2-arachidonoyl glycerol (2-AG). To investigate the isoform-specific structural basis of endocannabinoid binding to COX-2, we determined the crystal structure of the 2-AG isomer 1-arachidonoyl glycerol (1-AG) in complex with wild type and R513H murine (mu) COX-2 to 2.2 and 2.35 angstrom, respectively, and R513H muCOX-2 in complex with AA to 2.45 angstrom resolution. The 2,3-dihydroxypropyl moiety of 1-AG binds near the opening of the cyclooxygenase channel in the space vacated by the movement of the Leu-531 side chain, validating our previous hypothesis implicating the flexibility of the Leu-531 side chain as a determinant for the ability of COX-2 to oxygenate endocannabinoid substrates. Functional analyses carried out to compliment our structural findings indicated that Y355F and R513H muCOX-2 constructs had no effect on the oxygenation of 1-AG and 2-AG, whereas substitutions that resulted in a shortened side chain for Leu-531 had only modest effects. Both AA and 1-AG bind to R513H muCOX-2 in conformations similar to those observed in the co-crystal structures of these substrates with wild type enzyme.	[Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463; Vecchio, Alex/0000-0002-4222-7874	National Institutes of Health [R01 GM077176]; Arthritis Foundation, Segal Osteoarthritis Initiative; National Science Foundation [DMR-0225180]; National Institutes of Health through the National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation, Segal Osteoarthritis Initiative; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077176. This work was also supported by an Arthritis Investigator Award from the Arthritis Foundation as part of the Segal Osteoarthritis Initiative. This work is also based upon research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation under Award DMR-0225180, using the macromolecular diffraction facility at the Cornell High Energy Synchrotron Source, which is supported by Award RR-01646 from the National Institutes of Health through the National Center for Research Resources.	Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2003, BIOCHEMISTRY-US, V42, P9041, DOI 10.1021/bi034471k; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2002, BIOCHEM BIOPH RES CO, V296, P612, DOI 10.1016/S0006-291X(02)00915-4; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	45	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20736	20745		10.1074/jbc.M111.230367	http://dx.doi.org/10.1074/jbc.M111.230367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489986	Green Published, hybrid			2022-12-27	WOS:000291267600059
J	Wenstrup, RJ; Smith, SM; Florer, JB; Zhang, GY; Beason, DP; Seegmiller, RE; Soslowsky, LJ; Birk, DE				Wenstrup, Richard J.; Smith, Simone M.; Florer, Jane B.; Zhang, Guiyun; Beason, David P.; Seegmiller, Robert E.; Soslowsky, Louis J.; Birk, David E.			Regulation of Collagen Fibril Nucleation and Initial Fibril Assembly Involves Coordinate Interactions with Collagens V and XI in Developing Tendon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; FIBRILLOGENESIS IN-SITU; COL5A1 GENE; DIFFERENTIAL EXPRESSION; LATERAL GROWTH; GRAVIS FORM; TENASCIN-X; MUTATION; MATRIX; MICE	Collagens V and XI comprise a single regulatory type of fibril-forming collagen with multiple isoforms. Both co-assemble with collagen I or II to form heterotypic fibrils and have been implicated in regulation of fibril assembly. The objective of this study was to determine the roles of collagens V and XI in the regulation of tendon fibrillogenesis. Flexor digitorum longus tendons from a haplo-insufficient collagen V mouse model of classic Ehlers Danlos syndrome (EDS) had decreased biomechanical stiffness compared with controls consistent with joint laxity in EDS patients. However, fibril structure was relatively normal, an unexpected finding given the altered fibrils observed in dermis and cornea from this model. This suggested roles for other related molecules, i.e. collagen XI, and compound Col5a1(+/-), Col11a1(+/-) tendons had altered fibril structures, supporting a role for collagen XI. To further evaluate this, transcript expression was analyzed in wild type tendons. During development (E18-P10) both collagen V and XI were comparably expressed; however, collagen V predominated in mature (P30) tendons. The collagens had a similar expression pattern. Tendons with altered collagen V and/or XI expression (Col5a1(+/-); Col11a1(+/-); Col5a1(+/-), Col11a1(+/-); Col11a1(-/-); Col5a1(+/-), Col11a1(-/-)) were analyzed at E18. All genotypes demonstrated a reduced fibril number and altered structure. This phenotype was more severe with a reduction in collagen XI. However, the absence of collagen XI with a reduction in collagen V was associated with the most severe fibril phenotype. The data demonstrate coordinate roles for collagens V and XI in the regulation of fibril nucleation and assembly during tendon development.	[Smith, Simone M.; Birk, David E.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Wenstrup, Richard J.] Myriad Genet Labs Inc, Salt Lake City, UT 84108 USA; [Florer, Jane B.] Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Zhang, Guiyun] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Beason, David P.; Soslowsky, Louis J.] Univ Pennsylvania, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Seegmiller, Robert E.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	State University System of Florida; University of South Florida; Myriad Genetics, Inc; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Jefferson University; University of Pennsylvania; Brigham Young University	Birk, DE (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC11, Tampa, FL 33612 USA.	dbirk@health.usf.edu	Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088	National Institutes of Health (NIAMS) [AR044745, AR050950]; National Research Service Award Post Doctoral Fellowship [AR056937]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950, R01AR044745, F32AR056937] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Research Service Award Post Doctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR044745 (NIAMS; to D. E. B.) and AR050950 (NIAMS, supporting the Penn Center for Musculoskeletal Disorders (to L. J. S.)). This work was also supported by National Research Service Award Post Doctoral Fellowship AR056937 (to S. M. S.).	Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; BEIGHTON P, 1992, MCKUSICKS HERITABLE, P189; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; BIRK DE, 1994, J ANAT, V184, P457; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; Birk DE, 1997, DEV DYNAM, V208, P291; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1994, EXTRACELLULAR MATRIX; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Bouma P, 2001, J BIOL CHEM, V276, P13356, DOI 10.1074/jbc.M011742200; Bristow J, 2005, AM J MED GENET C, V139C, P24, DOI 10.1002/ajmg.c.30071; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; Burrows NP, 1997, CLIN EXP DERMATOL, V22, P174, DOI 10.1046/j.1365-2230.1997.2290654.x; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Christner PJ, 2006, J INVEST DERMATOL, V126, P595, DOI 10.1038/sj.jid.5700100; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; DePaepe A, 1997, AM J HUM GENET, V60, P547; DERWIN KA, 1994, J BIOMECH, V27, P1277, DOI 10.1016/0021-9290(94)90281-X; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Hoffman GG, 2010, MATRIX BIOL, V29, P261, DOI 10.1016/j.matbio.2010.01.006; HULMES DJS, 1989, J MOL BIOL, V210, P337, DOI 10.1016/0022-2836(89)90335-5; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lin TW, 2005, J BIOMECH, V38, P99, DOI 10.1016/j.jbiomech.2004.03.008; Lincoln J, 2006, DEV DYNAM, V235, P3295, DOI 10.1002/dvdy.20980; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; MAYNE R, 1993, J BIOL CHEM, V268, P9381; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; OXFORD JT, 1994, EXP CELL RES, V213, P28, DOI 10.1006/excr.1994.1169; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771; Smith SM, 2012, EXP EYE RES, V98, P105, DOI 10.1016/j.exer.2010.08.003; SOKOLOV BP, 1991, HUM GENET, V88, P125; Starborg T, 2009, SCAND J MED SCI SPOR, V19, P547, DOI 10.1111/j.1600-0838.2009.00907.x; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Symoens S, 2011, BIOCHEM J, V433, P371, DOI 10.1042/BJ20101061; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VOGEL A, 1979, LAB INVEST, V40, P201; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P173; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	67	94	94	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20455	20465		10.1074/jbc.M111.223693	http://dx.doi.org/10.1074/jbc.M111.223693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21467034	Green Published, hybrid			2022-12-27	WOS:000291267600033
J	Gagan, J; Dey, BK; Layer, R; Yan, Z; Dutta, A				Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Yan, Zhen; Dutta, Anindya			MicroRNA-378 Targets the Myogenic Repressor MyoR during Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTOR; MUSCLE-SPECIFIC MICRORNA; SKELETAL-MUSCLE; MAMMALIAN-CELLS; DOWN-REGULATION; EXPRESSION; MIR-206; PROLIFERATION; REGENERATION; FIBROBLASTS	MicroRNAs play important roles in many cell processes, including the differentiation process in several different lineages. For example, microRNAs can promote differentiation by repressing negative regulators of transcriptional activity. These regulated transcription factors can further up-regulate levels of the microRNA in a feed-forward mechanism. Here we show that MyoDup-regulates miR-378 during myogenic differentiation in C2C12 cells. ChIP and high throughput sequencing analysis shows that MyoD binds in close proximity to the miR-378 gene and causes both transactivation and chromatin remodeling. Overexpression of miR-378 increases the transcriptional activity of MyoD, in part by repressing an antagonist, MyoR. The 3' untranslated region of MyoR contains a direct binding site for miR-378. The presence of this binding site significantly reduces the ability of MyoR to prevent the MyoD-driven transdifferentiation of fibroblasts. MyoR and miR-378 were anticorrelated during cardiotoxin-induced adult muscle regeneration in mice. Taken together, this shows a feed-forward loop where MyoD indirectly down-regulates MyoR via miR-378.	[Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Layer, Ryan] Univ Virginia, Sch Med, Dept Comp Sci, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Yan, Zhen/0000-0002-4826-9813; Dey, Bijan/0000-0001-9386-2475; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 AR053948]; Heart and Stroke Foundation of Canada; Cell and Molecular Biology Training Grant [T32 GM008136]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053948, R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Cell and Molecular Biology Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR053948 (to A. D.). This work was also supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada (to B. K. D.) and by Cell and Molecular Biology Training Grant T32 GM008136 (to J. G.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Gao XM, 2001, J CELL BIOL, V154, P1161, DOI 10.1083/jcb.200104058; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KURABAYASHI M, 1994, J BIOL CHEM, V269, P6031; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	34	120	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19431	19438		10.1074/jbc.M111.219006	http://dx.doi.org/10.1074/jbc.M111.219006			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471220	Green Published, hybrid			2022-12-27	WOS:000291027700026
J	Tanneberger, K; Pfister, AS; Kriz, V; Bryja, V; Schambony, A; Behrens, J				Tanneberger, Kristina; Pfister, Astrid S.; Kriz, Vitezslav; Bryja, Vitezslav; Schambony, Alexandra; Behrens, Juergen			Structural and Functional Characterization of the Wnt Inhibitor APC Membrane Recruitment 1 (Amer1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; SIGNALING PATHWAY; AXIN; PHOSPHORYLATION; LRP6; WTX; ACTIVATION; MECHANISM; CADHERIN; COMPLEX	Amer1/WTX binds to the tumor suppressor adenomatous polyposis coli and acts as an inhibitor of Wnt signaling by inducing beta-catenin degradation. We show here that Amer1 directly interacts with the armadillo repeats of beta-catenin via a domain consisting of repeated arginine-glutamic acid-alanine (REA) motifs, and that Amer1 assembles the beta-catenin destruction complex at the plasma membrane by recruiting beta-catenin, adenomatous polyposis coli, and Axin/Conductin. Deletion or specific mutations of the membrane binding domain of Amer1 abolish its membrane localization and abrogate negative control of Wnt signaling, which can be restored by artificial targeting of Amer1 to the plasma membrane. In line, a natural splice variant of Amer1 lacking the plasma membrane localization domain is deficient for Wnt inhibition. Knockdown of Amer1 leads to the activation of Wnt target genes, preferentially in dense compared with sparse cell cultures, suggesting that Amer1 function is regulated by cell contacts. Amer1 stabilizes Axin and counteracts Wnt-induced degradation of Axin, which requires membrane localization of Amer1. The data suggest that Amer1 exerts its negative regulatory role in Wnt signaling by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the plasma membrane.	[Tanneberger, Kristina; Pfister, Astrid S.; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dev Biol Unit, Dept Biol, D-91054 Erlangen, Germany; [Kriz, Vitezslav; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Kriz, Vitezslav; Bryja, Vitezslav] Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, Brno 61137, Czech Republic	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de	Bryja, Vítězslav/P-4217-2019; Bryja, Vít?zslav/H-1925-2014; Kriz, Vitezslav/G-6353-2014	Bryja, Vítězslav/0000-0002-9136-5085; Bryja, Vít?zslav/0000-0002-9136-5085; Schambony, Alexandra/0000-0001-8771-5487	DFG [BE 1550/6-1, SCHA965/6-1]; Czech Science Foundation [204/09/J030]	DFG(German Research Foundation (DFG)); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by DFG Research Grants BE 1550/6-1 (to J. B.) and SCHA965/6-1 (to A. S.). This work was also supported by Czech Science Foundation Grant 204/09/J030 (to V. B.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Nieukoop P. D., 1994, NORMAL TABLE XENOPUS; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	39	35	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19204	19214		10.1074/jbc.M111.224881	http://dx.doi.org/10.1074/jbc.M111.224881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498506	hybrid, Green Published			2022-12-27	WOS:000291027700003
J	Diefenbacher, M; Thorsteinsdottir, H; Spang, A				Diefenbacher, Melanie; Thorsteinsdottir, Holmfridur; Spang, Anne			The Dsl1 Tethering Complex Actively Participates in Soluble NSF (N-Ethylmaleimide-sensitive Factor) Attachment Protein Receptor (SNARE) Complex Assembly at the Endoplasmic Reticulum in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE TRANSPORT; MEMBRANE-FUSION; COPII VESICLES; GOLGI; YEAST; ER; RETRIEVAL; COAT; INTERACTS; COMPONENT	Intracellular transport is largely dependent on vesicles that bud off from one compartment and fuse with the target compartment. The first contact of an incoming vesicle with the target membrane is mediated by tethering factors. The tethering factor responsible for recruiting Golgi-derived vesicles to the ER is the Dsl1 tethering complex, which is comprised of the essential proteins Dsl1p, Dsl3p, and Tip20p. We investigated the role of the Tip20p subunit at the ER by analyzing two mutants, tip20-5 and tip20-8. Both mutants contained multiple mutations that were scattered throughout the TIP20 sequence. Individual mutations could not reproduce the temperature-sensitive phenotype of tip20-5 and tip20-8, indicating that the overall structure of Tip20p might be altered in the mutants. Using molecular dynamics simulations comparing Tip20p and Tip20-8p revealed that some regions, particularly the N-terminal domain and parts of the stalk region, were more flexible in the mutant protein, consistent with its increased susceptibility to proteolysis. Both Tip20-5p and Tip20-8p mutants prevented proper ER trans-SNARE complex assembly in vitro. Moreover, Tip20p mutant proteins disturbed the interaction between Dsl1p and the coatomer coat complex, indicating that the Dsl1p-coatomer interaction could be stabilized or regulated by Tip20p. We provide evidence for a direct role of the Dsl1 complex, in particular Tip20p, in the formation and stabilization of ER SNARE complexes.	[Diefenbacher, Melanie; Thorsteinsdottir, Holmfridur; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203	Swiss National Science Foundation; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by the Swiss National Science Foundation and the University of Basel.	Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BRZOVIC PS, 1992, J BIOL CHEM, V267, P13028; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Cosson P, 1997, EUR J CELL BIOL, V73, P93; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gotte M, 1997, FEBS LETT, V411, P48, DOI 10.1016/S0014-5793(97)00575-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Tsui MMK, 2000, J CELL SCI, V113, P145; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	64	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25027	25038		10.1074/jbc.M110.215657	http://dx.doi.org/10.1074/jbc.M110.215657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21482823	Green Published, hybrid			2022-12-27	WOS:000292547900051
J	Clark, EA; Walker, N; Ford, DC; Cooper, IA; Oyston, PCF; Acharya, KR				Clark, Elizabeth A.; Walker, Nicola; Ford, Donna C.; Cooper, Ian A.; Oyston, Petra C. F.; Acharya, K. Ravi			Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; POTENT INHIBITOR; BACTERIA; GENES; ENTEROCOLITICA; RESISTANCE; SYSTEM	Resistance to antibiotics is a problem not only in terms of healthcare but also biodefense. Engineering of resistance into a human pathogen could create an untreatable biothreat pathogen. One such pathogen is Yersinia pestis, the causative agent of plague. Previously, we have used a bioinformatic approach to identify proteins that may be suitable targets for antimicrobial therapy and in particular for the treatment of plague. The serine protease inhibitor ecotin was identified as one such target. We have carried out mutational analyses in the closely related Yersinia pseudotuberculosis, validating that the ecotin gene is a virulence-associated gene in this bacterium. Y. pestis ecotin inhibits chymotrypsin. Here, we present the structure of ecotin in complex with chymotrypsin to 2.74 angstrom resolution. The structure features a biologically relevant tetramer whereby an ecotin dimer binds to two chymotrypsin molecules, similar to what was observed in related serine protease inhibitor structures. However, the vast majority of the interactions in the present structure are distinctive, indicating that the broad specificity of the inhibitor for these proteases is based largely on its capacity to recognize features unique to each of them. These findings will have implications for the development of small ecotin inhibitors for therapeutic use.	[Clark, Elizabeth A.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Walker, Nicola; Ford, Donna C.; Cooper, Ian A.; Oyston, Petra C. F.] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England	University of Bath; Defence Science & Technology Laboratory	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	k.r.acharya@bath.ac.uk	Cooper, Ian/F-8015-2016	Acharya, K. Ravi/0000-0002-3009-4058	Ministry of Defence; Wellcome Trust [088464]; Royal Society (U.K.)	Ministry of Defence; Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society (U.K.)(Royal Society of London)	This work was supported by the Ministry of Defence, Wellcome Trust (U. K.) Equipment Grant 088464 and by a Royal Society (U.K.) industry fellowship (to K. R. A.).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Laws TR, 2010, MICROBES INFECT, V12, P331, DOI 10.1016/j.micinf.2010.01.007; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; RILEY G, 1989, J CLIN MICROBIOL, V27, P213, DOI 10.1128/JCM.27.1.213-214.1989; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Stubben CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-501; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; WIRNT R, 1974, METHODS ENZYMATIC AN	34	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24015	24022		10.1074/jbc.M111.225730	http://dx.doi.org/10.1074/jbc.M111.225730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531711	Green Published, hybrid			2022-12-27	WOS:000292294900044
J	Zheng, YX; Yin, HY; Boeglin, WE; Elias, PM; Crumrine, D; Beier, DR; Brash, AR				Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Elias, Peter M.; Crumrine, Debra; Beier, David R.; Brash, Alan R.			Lipoxygenases Mediate the Effect of Essential Fatty Acid in Skin Barrier Formation A PROPOSED ROLE IN RELEASING OMEGA-HYDROXYCERAMIDE FOR CONSTRUCTION OF THE CORNEOCYTE LIPID ENVELOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL PERMEABILITY BARRIER; STRATUM-CORNEUM; LINOLEIC-ACID; MAMMALIAN EPIDERMIS; LIPID ENVELOPE; PIG EPIDERMIS; 12R-LIPOXYGENASE; DEFICIENCY; METABOLISM; CERAMIDES	A barrier to water loss is vital to maintaining life on dry land. Formation of the mammalian skin barrier requires both the essential fatty acid linoleate and the two lipoxygenases 12R-lipoxygenase (12R-LOX) and epidermal lipoxygenase-3 (eLOX3), although their roles are poorly understood. Linoleate occurs in O-linoleoyl-omega-hydroxyceramide, which, after hydrolysis of the linoleate moiety, is covalently attached to protein via the free omega-hydroxyl of the ceramide, forming the corneocyte lipid envelope, a scaffold between lipid and protein that helps seal the barrier. Here we show using HPLC-UV, LC-MS, GC-MS, and H-1 NMR that O-linoleoyl-omega-hydroxyceramide is oxygenated in a regio- and stereospecific fashion by the consecutive actions of 12R-LOX and eLOX3 and that these products occur naturally in pig and mouse epidermis. 12R-LOX forms 9R-hydroperoxy-linoleoyl-omega-hydroxyceramide, further converted by eLOX3 to specific epoxyalcohol (9R, 10R-trans-epoxy-11E-13R-hydroxy) and 9-keto-10E, 12Z esters of the ceramide; an epoxy-ketone derivative (9R, 10R-trans-epoxy-11E-13-keto) is the most prominent oxidized ceramide in mouse skin. These products are absent in 12R-LOX-deficient mice, which crucially display a near total absence of protein-bound omega-hydroxyceramides and of the corneocyte lipid envelope and die shortly after birth from transepidermal water loss. We conclude that oxygenation of O-linoleoyl-omega-hydroxyceramide is required to facilitate the ester hydrolysis and allow bonding of the omega-hydroxyceramide to protein, providing a coherent explanation for the roles of multiple components in epidermal barrier function. Our study uncovers a hitherto unknown biochemical pathway in which the enzymic oxygenation of ceramides is involved in building a crucial structure of the epidermal barrier.	[Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA; [Elias, Peter M.; Crumrine, Debra] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94122 USA; [Beier, David R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu		yin, hui yong/0000-0001-7049-1560	National Institutes of Health [AR051968, AR019098, HD36404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968, R01AR019098, R01AR061106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR051968 (to A. R. B.), AR019098 (to P. M. E.), and HD36404 (to D. R. B.).	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Behne M, 2000, J INVEST DERMATOL, V114, P185, DOI 10.1046/j.1523-1747.2000.00846.x; Belkner J, 2000, BIOCHEM J, V352, P125, DOI 10.1042/0264-6021:3520125; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Bouwstra JA, 2002, J INVEST DERMATOL, V118, P606, DOI 10.1046/j.1523-1747.2002.01706.x; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Burr GO, 1929, J BIOL CHEM, V82, P345; Butovich IA, 2001, BBA-PROTEIN STRUCT M, V1546, P379, DOI 10.1016/S0167-4838(01)00162-5; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; DOWNING DT, 1992, J LIPID RES, V33, P301; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Farwanah H, 2005, ANAL BIOANAL CHEM, V383, P632, DOI 10.1007/s00216-005-0044-3; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; GALLIARD T, 1971, BIOCHEM J, V124, P431, DOI 10.1042/bj1240431; Groen D, 2010, LANGMUIR, V26, P4168, DOI 10.1021/la9047038; HAMANAKA S, 1989, J BIOCHEM-TOKYO, V105, P684, DOI 10.1093/oxfordjournals.jbchem.a122727; HEDBERG CL, 1988, J INVEST DERMATOL, V91, P169, DOI 10.1111/1523-1747.ep12464438; HOUTSMULLER U M T, 1981, Progress in Lipid Research, V20, P219, DOI 10.1016/0163-7827(81)90041-2; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816; Krieg P, 2010, EXP DERMATOL, V19, P941; Lin D, 2007, J ORG CHEM, V72, P9471, DOI 10.1021/jo701373f; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; NUGTEREN DH, 1985, BIOCHIM BIOPHYS ACTA, V834, P429, DOI 10.1016/0005-2760(85)90017-7; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Schneider C, 1997, CHIRALITY, V9, P563, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<563::AID-CHIR25>3.0.CO;2-L; SEVANIAN A, 1985, Journal of Free Radicals in Biology and Medicine, V1, P263, DOI 10.1016/0748-5514(85)90130-8; Siebert M, 2001, BIOCHEM J, V355, P97, DOI 10.1042/0264-6021:3550097; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; WERTZ PW, 1983, J LIPID RES, V24, P753; WERTZ PW, 1982, SCIENCE, V217, P1261, DOI 10.1126/science.7112128; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, BIOCHIM BIOPHYS ACTA, V753, P350, DOI 10.1016/0005-2760(83)90058-9; WERTZ PW, 1990, J LIPID RES, V31, P1839; WOOLLARD PM, 1986, BIOCHEM BIOPH RES CO, V136, P169, DOI 10.1016/0006-291X(86)90891-0; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P13427, DOI 10.1074/jbc.M109.084632	50	105	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24046	24056		10.1074/jbc.M111.251496	http://dx.doi.org/10.1074/jbc.M111.251496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558561	hybrid, Green Published			2022-12-27	WOS:000292294900047
J	Tsybovsky, Y; Krupenko, SA				Tsybovsky, Yaroslav; Krupenko, Sergey A.			Conserved Catalytic Residues of the ALDH1L1 Aldehyde Dehydrogenase Domain Control Binding and Discharging of the Coenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; CARBOXYL-TERMINAL DOMAIN; STREPTOCOCCUS-MUTANS; CRYSTAL-STRUCTURE; MECHANISTIC IMPLICATIONS; RETINAL SPECIFICITY; ANGSTROM RESOLUTION; ASIAN VARIANT; ACTIVE-SITE; ROLES	The C-terminal domain (C-t-FDH) of 10-formyltetrahydrofolate dehydrogenase (FDH, ALDH1L1) is an NADP(+)-dependent oxidoreductase and a structural and functional homolog of aldehyde dehydrogenases. Here we report the crystal structures of several C-t-FDH mutants in which two essential catalytic residues adjacent to the nicotinamide ring of bound NADP(+), Cys-707 and Glu-673, were replaced separately or simultaneously. The replacement of the glutamate with an alanine causes irreversible binding of the coenzyme without any noticeable conformational changes in the vicinity of the nicotinamide ring. Additional replacement of cysteine 707 with an alanine (E673A/C707A double mutant) did not affect this irreversible binding indicating that the lack of the glutamate is solely responsible for the enhanced interaction between the enzyme and the coenzyme. The substitution of the cysteine with an alanine did not affect binding of NADP(+) but resulted in the enzyme lacking the ability to differentiate between the oxidized and reduced coenzyme: unlike the wild-type C-t-FDH/NADPH complex, in the C707A mutant the position of NADPH is identical to the position of NADP(+) with the nicotinamide ring well ordered within the catalytic center. Thus, whereas the glutamate restricts the affinity for the coenzyme, the cysteine is the sensor of the coenzyme redox state. These conclusions were confirmed by coenzyme binding experiments. Our study further suggests that the binding of the coenzyme is additionally controlled by a long-range communication between the catalytic center and the coenzyme-binding domain and points toward an alpha-helix involved in the adenine moiety binding as a participant of this communication.	[Tsybovsky, Yaroslav; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu			National Institutes of Health [DK54388]; Medical University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388 (to S. A. K.).; We thank Dr. Christopher Davies for helpful discussions. The x-ray crystallography facility used for this work is supported by the Medical University of South Carolina's Research Resource Facilities program. Data were also collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory.	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRES J, 1994, J BIOL CHEM, V269, P13854; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Hempel J., 2007, ENZYMOLOGY MOL BIOL, P9; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Marchal S, 2001, CHEM-BIOL INTERACT, V130, P15, DOI 10.1016/S0009-2797(00)00218-0; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Sheikh S, 1997, J BIOL CHEM, V272, P18817, DOI 10.1074/jbc.272.30.18817; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; TAKAHASHI K, 1980, ARCH BIOCHEM BIOPHYS, V205, P571, DOI 10.1016/0003-9861(80)90140-X; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valenzuela-Soto EM, 2003, CHEM-BIOL INTERACT, V143, P139, DOI 10.1016/S0009-2797(02)00198-9; Wang MF, 2009, CHEM-BIOL INTERACT, V178, P36, DOI 10.1016/j.cbi.2008.10.002; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Wymore T, 2004, PROTEINS, V57, P758, DOI 10.1002/prot.20256; Wymore T, 2007, BIOCHEMISTRY-US, V46, P9495, DOI 10.1021/bi700555g; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	44	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23357	23367		10.1074/jbc.M111.221069	http://dx.doi.org/10.1074/jbc.M111.221069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540484	hybrid, Green Published			2022-12-27	WOS:000292025000067
J	Chim, SM; Qin, A; Tickner, J; Pavlos, N; Davey, T; Wang, H; Guo, YJ; Zheng, MH; Xu, JK				Chim, Shek Man; Qin, An; Tickner, Jennifer; Pavlos, Nathan; Davey, Tamara; Wang, Hao; Guo, Yajun; Zheng, Ming Hao; Xu, Jiake			EGFL6 Promotes Endothelial Cell Migration and Angiogenesis through the Activation of Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; PROTEIN NEPHRONECTIN; RECEPTOR ACTIVATOR; BONE REPAIR; DIFFERENTIATION; EXPRESSION; DOMAIN; GENE; IDENTIFICATION	Angiogenesis is required for bone development, growth, and repair. It is influenced by the local bone environment that involves cross-talks between endothelial cells and adjacent bone cells. However, data regarding factors that directly contribute to angiogenesis by bone cells remain poorly understood. Here, we report that EGFL6, a member of the epidermal growth factor (EGF) repeat superfamily proteins, induces angiogenesis by a paracrine mechanism in which EGFL6 is expressed in osteoblastic- like cells but promotes migration and angiogenesis of endothelial cells. Co-immunoprecipitation assays revealed that EGFL6 is secreted in culture medium as a homodimer protein. Using scratch wound healing and transwell assays, we found that conditioned medium containing EGFL6 potentiates SVEC (a simian virus 40-transformed mouse microvascular endothelial cell line) endothelial cell migration. In addition, EGFL6 promotes the endothelial cell tube-like structure formation in Matrigel assays and angiogenesis in a chick embryo chorioallantoic membrane. Furthermore, we show that EGFL6 recombinant protein induces phosphorylation of ERK in SVEC endothelial cells. Inhibition of ERK impaired EGFL6-induced ERK activation and endothelial cell migration. Together, these results demonstrate, for the first time, that osteoblastic-like cells express EGFL6 that is capable of promoting endothelial cell migration and angiogenesis via ERK activation. Thus, the EGLF6 mediates a paracrine mechanism of cross-talk between vascular endothelial cells and osteoblasts and might offer an important new target for the potential treatment of bone diseases, including osteonecrosis, osteoporosis, and fracture healing.	[Chim, Shek Man; Tickner, Jennifer; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Qin, An; Pavlos, Nathan; Davey, Tamara; Zheng, Ming Hao] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia; [Qin, An] Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200011, Peoples R China; [Wang, Hao; Guo, Yajun] Second Mil Med Univ, Gen Hosp Canc Ctr 301, Shanghai 200433, Peoples R China; [Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China	University of Western Australia; University of Western Australia; Shanghai Jiao Tong University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, JK (corresponding author), Univ Western Australia M508, Sch Pathol & Lab Med, 35 Stirling Hwy, Crawley, WA 6009, Australia.	jiake.xu@uwa.edu.au	Chim, Shek Man/AAK-6809-2020; Tickner, Jennifer/H-5965-2014	Chim, Shek Man/0000-0002-5116-8394; Tickner, Jennifer/0000-0002-5020-0671; Zheng, Minghao/0000-0003-1185-4768; Xu, Jiake/0000-0003-2021-8309; Pavlos, Nathan/0000-0001-7003-188X	National Health and Medical Research Council of Australia; Sir Charles Gairdner Hospital	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sir Charles Gairdner Hospital	This work was supported in part by the National Health and Medical Research Council of Australia and the Sir Charles Gairdner Hospital Research Fund.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Buchner G, 2000, MECH DEVELOP, V98, P179, DOI 10.1016/S0925-4773(00)00462-7; Buchner G, 2000, GENOMICS, V65, P16, DOI 10.1006/geno.2000.6146; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Carlevaro MF, 2000, J CELL SCI, V113, P59; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee S, 2003, FASEB J, V17, pA326, DOI 10.1096/fj.02-0570fje; Leker RR, 2009, NEUROSCIENCE, V163, P233, DOI 10.1016/j.neuroscience.2009.05.050; Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; SCHNEIDER MR, 2009, J BONE MINER RES; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Yeung G, 1999, GENOMICS, V62, P304, DOI 10.1006/geno.1999.6011; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	46	79	93	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22035	22046		10.1074/jbc.M110.187633	http://dx.doi.org/10.1074/jbc.M110.187633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531721	Green Published, hybrid			2022-12-27	WOS:000291719900010
J	Sy, SMH; Jiang, J; Dong, SS; Lok, GTM; Wu, J; Cai, H; Yeung, ESL; Huang, J; Chen, JJ; Deng, YQ; Huen, MSY				Sy, Shirley M. -H.; Jiang, Jun; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Wu, Jun; Cai, Hua; Yeung, Enoch S. L.; Huang, Jun; Chen, Junjie; Deng, Yiqun; Huen, Michael S. Y.			Critical Roles of Ring Finger Protein RNF8 in Replication Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; REPAIR; CHROMATIN; PHOSPHORYLATION; UBIQUITINATION; HISTONES; CASCADE; RNF168; DOMAIN; H2A	Histone ubiquitylation is emerging as an important protective component in cellular responses to DNA damage. The ubiquitin ligases RNF8 and RNF168 assemble ubiquitin chains onto histone molecules surrounding DNA breaks and facilitate retention of DNA repair proteins. Although RNF8 and RNF168 play important roles in repair of DNA double strand breaks, their requirement for cell protection from replication stress is largely unknown. In this study, we uncovered RNF168-independent roles of RNF8 in repair of replication inhibition-induced DNA damage. We showed that RNF8 depletion, but not RNF168 depletion, hyper-sensitized cells to hydroxyurea and aphidicolin treatment. Consistently, hydroxyurea induced persistent single strand DNA lesions and sustained CHK1 activation in RNF8-depleted cells. In line with strict requirement for RAD51-dependent repair of hydroxyurea-stalled replication forks, RNF8depletion compromised RAD51 accumulation onto single strand DNA lesions, suggesting that impaired replication fork repair may underlie the enhanced cellular sensitivity to replication arrest observed in RNF8-depleted cells. In total, our study highlights the differential requirement for the ubiquitin ligase RNF8 in facilitating repair of replication stress-associated DNA damage.	[Jiang, Jun; Wu, Jun; Cai, Hua; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Yeung, Enoch S. L.; Huen, Michael S. Y.] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Yeung, Enoch S. L.; Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	South China Agricultural University; University of Hong Kong; University of Hong Kong; University of Hong Kong; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn; huen.michael@hku.hk	Deng, Yiqun/K-7709-2013	Deng, Yiqun/0000-0002-6838-3779; Sy, Ming Hui/0000-0002-2731-6692; Huen, Michael Shing-Yan/0000-0003-1774-2425	Faculty Development Fund and Seed Funding Programme for Applied Research [201007160001]; National Basic Research Program of China (973 Program) [2009CB118802]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE [R01CA092312] Funding Source: NIH RePORTER	Faculty Development Fund and Seed Funding Programme for Applied Research; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Faculty Development Fund and Seed Funding Programme for Applied Research (Project Code 201007160001, to M. S. Y. H.), by grants from the National Basic Research Program of China (973 Program, Grant 2009CB118802, to M. S. Y. H. and Y. D.), and by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2009, to Y. D.).	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424	26	29	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22355	22361		10.1074/jbc.M111.232041	http://dx.doi.org/10.1074/jbc.M111.232041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21558560	Green Published, hybrid			2022-12-27	WOS:000291719900045
J	Taylor, M; Banerjee, T; Ray, S; Tatulian, SA; Teter, K				Taylor, Michael; Banerjee, Tuhina; Ray, Supriyo; Tatulian, Suren A.; Teter, Ken			Protein-disulfide Isomerase Displaces the Cholera Toxin A1 Subunit from the Holotoxin without Unfolding the A1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSFORM INFRARED-SPECTROSCOPY; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; THERMAL-STABILITY; FTIR SPECTROSCOPY; MAMMALIAN-CELLS; RICIN; CYTOSOL	Protein-disulfide isomerase (PDI) has been proposed to exhibit an "unfoldase" activity against the catalytic A1 subunit of cholera toxin (CT). Unfolding of the CTA1 subunit is thought to displace it from the CT holotoxin and to prepare it for translocation to the cytosol. To date, the unfoldase activity of PDI has not been demonstrated for any substrate other than CTA1. An alternative explanation for the putative unfoldase activity of PDI has been suggested by recent structural studies demonstrating that CTA1 will unfold spontaneously upon its separation from the holotoxin at physiological temperature. Thus, PDI may simply dislodge CTA1 from the CT holotoxin without unfolding the CTA1 subunit. To evaluate the role of PDI in CT disassembly and CTA1 unfolding, we utilized a real-time assay to monitor the PDI-mediated separation of CTA1 from the CT holotoxin and directly examined the impact of PDI binding on CTA1 structure by isotope-edited Fourier transform infrared spectroscopy. Our collective data demonstrate that PDI is required for disassembly of the CT holotoxin but does not unfold the CTA1 subunit, thus uncovering a new mechanism for CTA1 dissociation from its holotoxin.	[Ray, Supriyo; Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Taylor, Michael; Banerjee, Tuhina; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), Biomol Res Annex, 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073783 (to K. T.).	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HOLMES RK, 1983, INFECT IMMUN, V42, P914, DOI 10.1128/IAI.42.3.914-923.1983; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Moore P, 2010, MOL BIOL CELL, V21, P1305, DOI 10.1091/mbc.E09-09-0826; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Pande AH, 2006, BIOCHEMISTRY-US, V45, P13734, DOI 10.1021/bi061175+; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Tatulian SA, 2003, BIOCHEMISTRY-US, V42, P11898, DOI 10.1021/bi034235+; Tatulian SA, 1998, FEBS LETT, V423, P205, DOI 10.1016/S0014-5793(98)00091-X; Tatulian SA, 2010, SPECTROSC-INT J, V24, P37, DOI 10.1155/2010/634831; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	56	36	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22090	22100		10.1074/jbc.M111.237966	http://dx.doi.org/10.1074/jbc.M111.237966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543321	hybrid, Green Published			2022-12-27	WOS:000291719900015
J	Hamatake, M; Miyazaki, N; Sudo, K; Matsuda, M; Sadakata, T; Furuya, A; Ichisaka, S; Hata, Y; Nakagawa, C; Nagata, K; Furuichi, T; Katoh-Semba, R				Hamatake, Michiko; Miyazaki, Noriko; Sudo, Kaori; Matsuda, Motoko; Sadakata, Tetsushi; Furuya, Asako; Ichisaka, Satoshi; Hata, Yoshio; Nakagawa, Chiaki; Nagata, Koh-ichi; Furuichi, Teiichi; Katoh-Semba, Ritsuko			Phase Advance of the Light-Dark Cycle Perturbs Diurnal Rhythms of Brain-derived Neurotrophic Factor and Neurotrophin-3 Protein Levels, Which Reduces Synaptophysin-positive Presynaptic Terminals in the Cortex of Juvenile Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL DENDRITIC GROWTH; BDNF MESSENGER-RNA; CIRCADIAN-RHYTHM; IN-VIVO; HIPPOCAMPUS; EXPRESSION; SLEEP; NEURONS; ACTIVATION; RECEPTOR	In adult rat brains, brain-derived neurotrophic factor (BDNF) rhythmically oscillates according to the light-dark cycle and exhibits unique functions in particular brain regions. However, little is known of this subject in juvenile rats. Here, we examined diurnal variation in BDNF and neurotrophin-3 (NT-3) levels in 14-day-old rats. BDNF levels were high in the dark phase and low in the light phase in a majority of brain regions. In contrast, NT-3 levels demonstrated an inverse phase relationship that was limited to the cerebral neocortex, including the visual cortex, and was most prominent on postnatal day 14. An 8-h phase advance of the light-dark cycle and sleep deprivation induced an increase in BDNF levels and a decrease in NT-3 levels in the neocortex, and the former treatment reduced synaptophysin expression and the numbers of synaptophysin-positive presynaptic terminals in cortical layer IV and caused abnormal BDNF and NT-3 rhythms 1 week after treatment. A similar reduction of synaptophysin expression was observed in the cortices of Bdnf gene-deficient mice and Ca2+-dependent activator protein for secretion 2 gene-deficient mice with abnormal free-running rhythm and autistic-like phenotypes. In the latter mice, no diurnal variation in BDNF levels was observed. These results indicate that regular rhythms of BDNF and NT-3 are essential for correct cortical network formation in juvenile rodents.	[Sadakata, Tetsushi; Furuya, Asako; Furuichi, Teiichi; Katoh-Semba, Ritsuko] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Hamatake, Michiko; Miyazaki, Noriko; Sudo, Kaori; Matsuda, Motoko; Nakagawa, Chiaki; Nagata, Koh-ichi; Katoh-Semba, Ritsuko] Aichi Human Serv Ctr, Inst Dev Res, Aichi 4800392, Japan; [Ichisaka, Satoshi] Tottori Univ, Fac Med, Sch Life Sci, Div Neurobiol, Tottori 6838503, Japan; [Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Div Integrat Biosci, Tottori 6838503, Japan; [Sadakata, Tetsushi; Furuichi, Teiichi; Katoh-Semba, Ritsuko] Japan Sci & Technol, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; Tottori University; Tottori University; Japan Science & Technology Agency (JST)	Katoh-Semba, R (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	katohsemba@brain.riken.jp	Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888				Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bova R, 1998, MOL BRAIN RES, V57, P321, DOI 10.1016/S0169-328X(98)00092-8; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Conner JM, 1997, J NEUROSCI, V17, P2295; Croll SD, 1998, BRAIN RES, V812, P200, DOI 10.1016/S0006-8993(98)00993-7; Dolci C, 2003, BRAIN RES, V994, P67, DOI 10.1016/j.brainres.2003.09.018; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Fawcett JP, 1998, J NEUROSCI, V18, P2808; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Gonzalez MMC, 2008, P NATL ACAD SCI USA, V105, P4898, DOI 10.1073/pnas.0703615105; Gorski JA, 2003, J NEUROSCI, V23, P6856; Hairston IS, 2004, J NEUROPHYSIOL, V91, P1586, DOI 10.1152/jn.00894.2003; He J, 2005, CELL PHYSIOL BIOCHEM, V16, P69, DOI 10.1159/000087733; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; IBUKA N, 1975, BRAIN RES, V96, P76, DOI 10.1016/0006-8993(75)90574-0; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; KAISHO Y, 1994, BRAIN RES, V666, P143, DOI 10.1016/0006-8993(94)90297-6; Katoh-Semba R, 2009, NEUROSCIENCE, V163, P352, DOI 10.1016/j.neuroscience.2009.06.011; Katoh-Semba R, 1999, NEUROSCI RES, V35, P19, DOI 10.1016/S0168-0102(99)00059-0; Katoh-Semba R, 2001, J NEUROCHEM, V77, P71, DOI 10.1046/j.1471-4159.2001.00138.x; Katoh-Semba R, 2008, J NEUROCHEM, V106, P2131, DOI 10.1111/j.1471-4159.2008.05565.x; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kushikata T, 1999, AM J PHYSIOL-REG I, V276, pR1334, DOI 10.1152/ajpregu.1999.276.5.R1334; Liang FQ, 2000, J NEUROSCI, V20, P2978; LINDSAY RM, 1993, NEUROTROPHIC FACTORS, P257; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Perez-Cruz C, 2009, BEHAV BRAIN RES, V205, P406, DOI 10.1016/j.bbr.2009.07.021; Pollock GS, 2001, J NEUROSCI, V21, P3923, DOI 10.1523/JNEUROSCI.21-11-03923.2001; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Schaaf MJM, 2000, MOL BRAIN RES, V75, P342, DOI 10.1016/S0169-328X(99)00314-9; Sei H, 2003, LIFE SCI, V73, P53, DOI 10.1016/S0024-3205(03)00251-0; Shinoda Y, 2005, BRAIN RES, V1042, P99, DOI 10.1016/j.brainres.2005.02.028; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xiong H, 2002, NEUROPHARMACOLOGY, V42, P903, DOI 10.1016/S0028-3908(02)00043-6; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21478	21487		10.1074/jbc.M110.195859	http://dx.doi.org/10.1074/jbc.M110.195859			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527636	Green Published, hybrid			2022-12-27	WOS:000291464700046
J	Rengstl, B; Oster, U; Stengel, A; Nickelsen, J				Rengstl, Birgit; Oster, Ulrike; Stengel, Anna; Nickelsen, Joerg			An Intermediate Membrane Subfraction in Cyanobacteria Is Involved in an Assembly Network for Photosystem II Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL PROCESSING PROTEASE; CHLOROPHYLL BIOSYNTHESIS; MANGANESE CLUSTER; MUTANT STRAIN; REPAIR; HOMOLOG; PLASMA; PSB27	Early steps in the biogenesis of Photosystem II (PSII) in the cyanobacterium Synechocystis sp. PCC 6803 are thought to occur in a specialized membrane fraction that is characterized by the specific accumulation of the PSII assembly factor PratA and its interaction partner pD1, the precursor of the D1 protein of PSII. Here, we report the molecular characterization of this membrane fraction, called the PratA-defined membrane (PDM), with regard to its lipid and pigment composition and its association with PSII assembly factors, including YCF48, Slr1471, Sll0933, and Pitt. We demonstrate that YCF48 and Slr1471 are present and that the chlorophyll precursor chlorophyllide a accumulates in the PDM. Analysis of PDMs from various mutant lines suggests a central role for PratA in the spatial organization of PSII biogenesis. Moreover, quantitative immunoblot analyses revealed a network of interdependences between several PSII assembly factors and chlorophyll synthesis. In addition, formation of complexes containing both YCF48 and Sll0933 was substantiated by co-immunoprecipitation experiments. The findings are integrated into a refined model for PSII biogenesis in Synechocystis 6803.	[Rengstl, Birgit; Oster, Ulrike; Stengel, Anna; Nickelsen, Joerg] Univ Munich, Biozentrum, D-82152 Planegg Martinsried, Germany	University of Munich	Nickelsen, J (corresponding author), Univ Munich, Biozentrum, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	joerg.nickelsen@lrz.uni-muenchen.de	Nickelsen, Jörg/J-8896-2014	Nickelsen, Joerg/0000-0003-4184-4560	Deutsche Forschungsgemeinschaft [SFB TR1 TPC10]; Ludwig-Maximilians-Universitat Munchen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig-Maximilians-Universitat Munchen	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB TR1 TPC10 (to J. N.) and a Bayerische Gleichstellungsforderung (BGF) scholarship from the Ludwig-Maximilians-Universitat Munchen (to A. S.).	ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; Armstrong GA, 1998, J PHOTOCH PHOTOBIO B, V43, P87, DOI 10.1016/S1011-1344(98)00063-3; Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Eaton-Rye JJ, 2004, METH MOL B, V274, P309; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HINTERSTOISSER B, 1993, J PLANT PHYSIOL, V142, P407, DOI 10.1016/S0176-1617(11)81245-9; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Nickelsen J, 2011, FEMS MICROBIOL LETT, V315, P1, DOI 10.1111/j.1574-6968.2010.02096.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; SHESTAKOV SV, 1994, J BIOL CHEM, V269, P19354; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Vermaas W. F. J., 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0001670, DOI 10.1038/NPG.ELS.0001670]; Yaronskaya E, 2003, PLANT J, V35, P512, DOI 10.1046/j.1365-313X.2003.01825.x; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	30	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21944	21951		10.1074/jbc.M111.237867	http://dx.doi.org/10.1074/jbc.M111.237867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531723	Green Published, hybrid			2022-12-27	WOS:000291464700089
J	Sroubek, J; McDonald, TV				Sroubek, Jakub; McDonald, Thomas V.			Protein Kinase A Activity at the Endoplasmic Reticulum Surface Is Responsible for Augmentation of Human ether-a-go-go-related Gene Product (HERG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; CARDIAC SARCOPLASMIC-RETICULUM; CHRONIC HEART-FAILURE; POTASSIUM CHANNEL; CYCLIC-AMP; BETA(2)-ADRENERGIC RECEPTOR; ANCHORING PROTEINS; K+ CHANNEL; IN-VIVO; CAMP	Human ether-a-go-go-related gene product (HERG) is a cardiac potassium channel commonly implicated in the pathogenesis of the long QT syndrome, type 2 (LQT2). LQT2 mutations typically have incomplete penetrance and affect individuals at various stages of their lives; this may mirror variations in intracellular signaling and HERG regulation. Previous work showed that sustained protein kinase A (PKA) activity augments HERG protein abundance by a mechanism that includes enhanced protein translation. To investigate the subcellular site of this regulation, we generated site-specific probes to the cytoplasmic surface of the endoplasmic reticulum (ER), the presumed locale of channel synthesis. Real-time FRET-based indicators demonstrated both cAMP and PKA activity at the ER. A PKA inhibitor targeted to the ER surface (termed p4PKIg) completely abolished PKA-mediated augmentation of HERG in HEK293 cells as well as rat neonatal cardiomyocytes. Immunofluorescence colocalization, targeted FRET-based PKA biosensors, phosphospecific antibodies, and in vivo phosphorylation experiments confirmed that p4PKIg is preferentially active at the ER surface rather than the plasma membrane. Rerouting this inhibitor to the outer mitochondrial membrane diminishes its ability to block cAMP-dependent HERG induction. Our results support a model where PKA-dependent regulation of HERG synthesis occurs at the ER surface. Furthermore, reagents generated for this study provide novel experimental tools to probe compartmentalized cAMP/PKA signaling within cells.	[Sroubek, Jakub; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), 1300 Morris Pk Ave,F-G35, Bronx, NY 10461 USA.	tom.mcdonald@einstein.yu.edu			National Institutes of Health/NHLBI [HL077326]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NHLBI Grant HL077326 (to T. V. M.).	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; AHN KS, 1993, J BIOL CHEM, V268, P18726; ALBERTS B, 2004, MOL BIOL CELL, P659; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Chen JA, 2010, MOL PHARMACOL, V78, P186, DOI 10.1124/mol.109.062216; Chen J, 2009, AM J PHYSIOL-HEART C, V296, pH1244, DOI 10.1152/ajpheart.01252.2008; Choe CU, 2006, HUM MOL GENET, V15, P2888, DOI 10.1093/hmg/ddl230; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Eckardt L, 2000, J CARDIOVASC ELECTR, V11, P106, DOI 10.1111/j.1540-8167.2000.tb00746.x; Farkas AS, 2010, DRUGS, V70, P573, DOI 10.2165/11535230-000000000-00000; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hjalmarson A, 1999, LANCET, V353, P2001; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Hovland R, 1999, BIOCHEM J, V342, P369, DOI 10.1042/0264-6021:3420369; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; KIMURA Y, 1994, J MOL CELL CARDIOL, V26, P1145, DOI 10.1006/jmcc.1994.1133; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2008, J MEMBRANE BIOL, V223, P107, DOI 10.1007/s00232-008-9118-4; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Ma YL, 2002, J BIOL CHEM, V277, P27328, DOI 10.1074/jbc.M201421200; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Modell SM, 2006, GENET MED, V8, P143, DOI 10.1097/01.gim.0000204468.85308.86; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Rockman HA, 1996, J CLIN INVEST, V97, P1618, DOI 10.1172/JCI118587; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1991, CIRC RES, V68, P77, DOI 10.1161/01.RES.68.1.77; Satwani S, 2004, J CARDIOVASC PHARM T, V9, P243, DOI 10.1177/107424840400900404; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; STEINBERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P910, DOI 10.1073/pnas.77.2.910; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; TADA M, 1975, J BIOL CHEM, V250, P2640; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	62	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21927	21936		10.1074/jbc.M110.201699	http://dx.doi.org/10.1074/jbc.M110.201699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536683	hybrid, Green Published			2022-12-27	WOS:000291464700087
J	Veeraraghavan, J; Natarajan, M; Aravindan, S; Herman, TS; Aravindan, N				Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Sheeja; Herman, Terence S.; Aravindan, Natarajan			Radiation-triggered Tumor Necrosis Factor (TNF) alpha-NF kappa B Cross-signaling Favors Survival Advantage in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSE IONIZING-RADIATION; INDUCED APOPTOSIS; THERAPEUTIC TARGET; LUNG-CANCER; ACTIVATION; SENSITIZATION; CARCINOMA; TRANSCRIPTION; INVOLVEMENT; IRRADIATION	Induced radioresistance in the surviving cancer cells after radiotherapy could be associated with clonal selection leading to tumor regrowth at the treatment site. Previously we reported that post-translational modification of I kappa B alpha activates NF kappa B in response to ionizing radiation (IR) and plays a key role in regulating apoptotic signaling. Herein, we investigated the orchestration of NF kappa B after IR in human neuroblastoma. Both in vitro (SH-SY5Y, SK-N-MC, and IMR-32) and in vivo (xenograft) studies showed that IR persistently induced NF kappa B DNA binding activity and NF kappa B-dependent TNF alpha transactivation and secretion. Approaches including silencing NF kappa B transcription, blocking post-translational NF kappa B nuclear import, muting TNF receptor, overexpression, and physiological induction of either NF kappa B or TNF alpha precisely demonstrated the initiation and occurrence of NF kappa B -> TNF alpha -> NF kappa B positive feedback cycle after IR that leads to and sustains NF kappa B activation. Selective TNF-dependent NF kappa B regulation was confirmed with futile inhibition of AP-1 and SP-1 in TNF receptor muted cells. Moreover, IR increased both transactivation and translation of Birc1, Birc2, and Birc5 and induced metabolic activity and clonal expansion. This pathway was further defined to show that IR-induced functional p65 transcription (not NF kappa B1, NF kappa B2, or c-Rel) is necessary for activation of these survival molecules and associated survival advantage. Together, these results demonstrate for the first time the functional orchestration of NF kappa B in response to IR and further imply that p65-dependent survival advantage and initiation of clonal expansion may correlate with an unfavorable prognosis of human neuroblastoma.	[Veeraraghavan, Jamunarani; Herman, Terence S.; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73104 USA; [Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Aravindan, Sheeja] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Natarajan] Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Health San Antonio	Aravindan, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, OUPB 1430,825 NE 10th St, Oklahoma City, OK 73104 USA.	naravind@ouhsc.edu	Aravindan, Natarajan/M-3203-2013	Aravindan, Natarajan/0000-0001-9150-3911; Aravindan, Sheeja/0000-0002-4810-789X; Veeraraghavan, Jamunarani/0000-0002-9524-9487	National Institutes of Health [R01 CA112175]; University of Oklahoma; American Cancer Society [IRG-05-066-01]; Presbyterian Health Foundation [C5046201]; Office of Science (Biological and Environmental Research); United States Department of Energy [DE-FG03-02ER63449]; NATIONAL CANCER INSTITUTE [R01CA112175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma; American Cancer Society(American Cancer Society); Presbyterian Health Foundation; Office of Science (Biological and Environmental Research)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112175 (to M. N.). This work was also supported by University of Oklahoma Health Sciences Center Department of Radiation Oncology research development funds, American Cancer Society Grant IRG-05-066-01, Presbyterian Health Foundation Grant C5046201 (to N. A.), funds from the Office of Science (Biological and Environmental Research), and United States Department of Energy Grant NO.DE-FG03-02ER63449.	Abal M, 2006, HISTOL HISTOPATHOL, V21, P197, DOI 10.14670/HH-21.197; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Aravindan N, 2009, J CELL BIOCHEM, V106, P999, DOI 10.1002/jcb.22079; Armstrong MB, 2006, NEOPLASIA, V8, P967, DOI 10.1593/neo.06574; Baeuerle P. A., 1991, MOL ASPECTS CELLULAR, P409; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Blonska M, 2004, MOL CELL BIOL, V24, P10757, DOI 10.1128/MCB.24.24.10757-10765.2004; Bradbury CM, 2001, CANCER RES, V61, P7689; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Carlson DL, 2003, AM J PHYSIOL-HEART C, V284, pH804, DOI 10.1152/ajpheart.00394.2001; CASTLEBERRY RP, 1991, J CLIN ONCOL, V9, P789, DOI 10.1200/JCO.1991.9.5.789; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; Haase MG, 2003, INT J RADIAT BIOL, V79, P863, DOI 10.1080/09553000310001632903; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Madhusoodhanan R, 2009, J RADIAT RES, V50, P311, DOI 10.1269/jrr.08110; MCGINN CJ, 1992, SEMIN ONCOL, V19, P21; MOHAN N, 1994, RADIAT RES, V140, P97, DOI 10.2307/3578574; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Natarajan M, 2002, RADIAT ENVIRON BIOPH, V41, P139, DOI 10.1007/s00411-002-0143-x; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Parisi MT, 1999, RADIOGRAPHICS, V19, P283, DOI 10.1148/radiographics.19.2.g99mr05283; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; PRASAD AV, 1994, RADIAT RES, V138, P367, DOI 10.2307/3578685; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; SCHULTZ RM, 1990, J INTERFERON RES, V10, P229, DOI 10.1089/jir.1990.10.229; STAAB HJ, 1982, BRIT J CANCER, V46, P841, DOI 10.1038/bjc.1982.293; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Vazquez E, 2003, RADIOGRAPHICS, V23, P1155, DOI 10.1148/rg.235035040; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049	48	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21588	21600		10.1074/jbc.M110.193755	http://dx.doi.org/10.1074/jbc.M110.193755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527635	Green Published, hybrid			2022-12-27	WOS:000291464700056
J	Whitaker, RD; Pember, S; Wallace, BC; Brodley, CE; Walt, DR				Whitaker, Ragnhild D.; Pember, Steven; Wallace, Byron C.; Brodley, Carla E.; Walt, David R.			Single Cell Time-resolved Quorum Responses Reveal Dependence on Cell Density and Configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACYLHOMOSERINE LACTONES; GENE-EXPRESSION; SENSING INHIBITORS; BACTERIA; DIFFUSION; SIGNALS; SYSTEMS	Bacterial communication via quorum sensing has been extensively investigated in recent years. Bacteria communicate in a complex manner through the production, release, and reception of diffusible low molecular weight chemical signaling molecules. Much work has focused on understanding the basic mechanisms of quorum sensing. As more and more bacteria grow resistant to conventional antibiotics, the development of drugs that do not kill bacteria but instead interrupt their communication is of increasing interest. This study presents a method for analyzing bacterial communication by investigating single cell responses. Most conventional analysis methods for bacterial communication are based on the averaged response from many bacteria, masking how individual cells respond to their immediate environment. We applied a fiber-optic microarray to record cellular communication from single cells. Single cell quorum sensing systems have previously been employed, but the highly ordered array reported here is an improvement because it allows us to simultaneously investigate cellular communication in many different environments with known cellular densities and configurations. We employed this method to detect how genes under quorum regulation are induced or repressed over time on the single cell level and to determine whether cellular density and configuration are indicative of the single cell temporal patterns of gene expression.	[Whitaker, Ragnhild D.; Walt, David R.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Pember, Steven; Wallace, Byron C.; Brodley, Carla E.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA	Tufts University; Tufts University	Walt, DR (corresponding author), 62 Talbot Ave, Medford, MA 02155 USA.	david.walt@tufts.edu						Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Barnard Anne M. L., 2004, ComPlexUs, V2, P87, DOI 10.1159/000089986; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Burmolle M, 2005, MICROB ECOL, V50, P221, DOI 10.1007/s00248-004-0113-8; CRAWSHAW J, 1999, CONCISE COURSE ADV L; Fekete A, 2007, ANAL BIOANAL CHEM, V387, P455, DOI 10.1007/s00216-006-0970-8; Frommberger M, 2005, ELECTROPHORESIS, V26, P1523, DOI 10.1002/elps.200410365; Gotz C, 2007, ANAL BIOANAL CHEM, V389, P1447, DOI 10.1007/s00216-007-1579-2; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hentzer M, 2003, J CLIN INVEST, V112, P1300, DOI [10.1172/JCI20074, 10.1172/JCI200320074]; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Khmel IA, 2006, MICROBIOLOGY+, V75, P390, DOI 10.1134/S0026261706040047; Kuang Y, 2004, ANAL CHEM, V76, P2902, DOI 10.1021/ac0354589; Kuang Y, 2004, ANAL CHEM, V76, P6282, DOI 10.1021/ac049053f; Kumari A, 2006, ANAL CHEM, V78, P7603, DOI 10.1021/ac061421n; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Obst U, 2007, ANAL BIOANAL CHEM, V387, P369, DOI 10.1007/s00216-006-0965-5; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Shah IM, 2009, CURR BIOL, V19, pR689, DOI 10.1016/j.cub.2009.07.010; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Whitaker RD, 2007, ANAL BIOCHEM, V360, P63, DOI 10.1016/j.ab.2006.10.013; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Winans SC, 2006, ACS CHEM BIOL, V1, P429, DOI 10.1021/cb6003417	32	9	9	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21623	21632		10.1074/jbc.M111.239897	http://dx.doi.org/10.1074/jbc.M111.239897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527637	Green Published, hybrid			2022-12-27	WOS:000291464700059
J	Bishop, KA; Coy, HM; Nerenz, RD; Meyer, MB; Pike, JW				Bishop, Kathleen A.; Coy, Heidi M.; Nerenz, Robert D.; Meyer, Mark B.; Pike, J. Wesley			Mouse Rankl Expression Is Regulated in T Cells by c-Fos through a Cluster of Distal Regulatory Enhancers Designated the T Cell Control Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-LIGAND; TUMOR-NECROSIS-FACTOR; BONE-MINERAL DENSITY; OSTEOCLAST DIFFERENTIATION FACTOR; TNF FAMILY-MEMBER; RECEPTOR ACTIVATOR; HUMAN GENOME; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; DNA-BINDING	Receptor activator of NF-kappa B ligand (Rankl) is a TNF-like factor that induces the formation of osteoclasts responsible for bone resorption. Although T cell activation up-regulates this gene, the molecular mechanism of its transcriptional control remains unknown. We used ChIP-chip analysis in mouse primary T cells and a T cell hybridoma to define the regulatory enhancers responsible for this up-regulation and to characterize their properties. Elevated H3/H4 acetylation and increased RNA polymerase II density were evident at mRL-D5, a known enhancer located 76 kb upstream of the TSS, as well as at a cluster of regulatory sites located even further upstream between -123 to -156 kb, termed the T cell control region (TCCR). Based upon the ability of calcium signaling and MAPK inhibitors to block Rankl expression, we conducted further ChIP-chip analysis of the transcriptional mediators c-Fos, NF-kappa B, and Nfat. T cell activation induced c-Fos binding at the mRL-D5 enhancer and within the TCCR. The interaction of NF-kappa B was observed at the transcriptional start site and at mRL-D5. Both mRL-D5 and segments of the TCCR exhibited robust transcriptional activity in reporter assays, and site-specific mutagenesis of c-Fos and Nfat elements abrogated reporter activity, suggesting a role for both factors in the control of enhancer-mediated Rankl transcription. Finally, chromosome conformation capture analysis confirmed that mRL-D5 and segments of the TCCR were located in proximity to the Rankl gene promoter and thus potentially able to influence directly Rankl gene promoter activity. We conclude that both mRL-D5 and the TCCR represent control segments that play an integral role in Rankl expression in T cells.	[Bishop, Kathleen A.; Coy, Heidi M.; Nerenz, Robert D.; Meyer, Mark B.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-74993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-74993 (to J. W. P.).	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Burkiewicz JS, 2009, ANN PHARMACOTHER, V43, P1445, DOI 10.1345/aph.1M102; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fionda C, 2007, J IMMUNOL, V178, P4039, DOI 10.4049/jimmunol.178.7.4039; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Josien R, 1999, J IMMUNOL, V162, P2562; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2007, MOL ENDOCRINOL, V21, P197, DOI 10.1210/me.2006-0315; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MARTOWICZ ML, 2011, J CELL BIOC IN PRESS; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakashima T, 2003, CURR OPIN RHEUMATOL, V15, P280, DOI 10.1097/00002281-200305000-00016; Nerenz RD, 2008, MOL ENDOCRINOL, V22, P1044, DOI 10.1210/me.2007-0380; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Silverman Stuart L, 2009, Curr Osteoporos Rep, V7, P91; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsubaki M, 2007, MOL CELL BIOCHEM, V304, P53, DOI 10.1007/s11010-007-9485-7; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang RX, 2002, EUR J IMMUNOL, V32, P1090, DOI 10.1002/1521-4141(200204)32:4<1090::AID-IMMU1090>3.0.CO;2-P; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	53	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20880	20891		10.1074/jbc.M111.231548	http://dx.doi.org/10.1074/jbc.M111.231548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487009	hybrid, Green Published			2022-12-27	WOS:000291267600072
J	Kumazawa, T; Nishimura, K; Kuroda, T; Ono, W; Yamaguchi, C; Katagiri, N; Tsuchiya, M; Masumoto, H; Nakajima, Y; Murayama, A; Kimura, K; Yanagisawa, J				Kumazawa, Takuya; Nishimura, Kazuho; Kuroda, Takao; Ono, Wakana; Yamaguchi, Chie; Katagiri, Naohiro; Tsuchiya, Mai; Masumoto, Hiroshi; Nakajima, Yuka; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn			Novel Nucleolar Pathway Connecting Intracellular Energy Status with p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SYNTHESIS; FACTOR TIF-IA; CELL-PROLIFERATION; DNA-BINDING; 18 S; PROTEIN; STRESS; KINASE; ACETYLATION; APOPTOSIS	In response to a shortage of intracellular energy, mammalian cells reduce energy consumption and induce cell cycle arrest, both of which contribute to cell survival. Here we report that a novel nucleolar pathway involving the energy-dependent nucleolar silencing complex (eNoSC) and Myb-binding protein 1a (MYBBP1A) is implicated in these processes. Namely, in response to glucose starvation, eNoSC suppresses rRNA transcription, which results in a reduction in nucleolar RNA content. As a consequence, MYBBP1A, which is anchored to the nucleolus via RNA, translocates from the nucleolus to the nucleoplasm. The translocated MYBBP1A induces acetylation and accumulation of p53 by enhancing the interaction between p300 and p53, which eventually leads to the cell cycle arrest (or apoptosis). Taken together, our results indicate that the nucleolus works as a sensor that transduces the intracellular energy status into the cell cycle machinery.	[Kumazawa, Takuya; Nishimura, Kazuho; Ono, Wakana; Yamaguchi, Chie; Katagiri, Naohiro; Tsuchiya, Mai; Masumoto, Hiroshi; Nakajima, Yuka; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kuroda, Takao; Nakajima, Yuka; Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Murayama, Akiko] JST, PREST, Saitama, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan.	junny@agbi.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Prives C, 1999, J PATHOL, V187, P112; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023	27	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20861	20869		10.1074/jbc.M110.209916	http://dx.doi.org/10.1074/jbc.M110.209916			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471221	hybrid, Green Published			2022-12-27	WOS:000291267600070
J	Torres, MP; Clement, ST; Cappell, SD; Dohlman, HG				Torres, Matthew P.; Clement, Sarah T.; Cappell, Steven D.; Dohlman, Henrik G.			Cell Cycle-dependent Phosphorylation and Ubiquitination of a G Protein alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DNA-REPLICATION; ANALYSIS REVEALS; KINASE; YEAST; DEGRADATION; ELM1; FAR1; SCF; ACTIVATION	A diverse array of external stimuli, including most hormones and neurotransmitters, bind to cell surface receptors that activate G proteins. Mating pheromones in yeast Saccharomyces cerevisiae activate G protein-coupled receptors and initiate events leading to cell cycle arrest in G(1) phase. Here, we show that the G alpha subunit (Gpa1) is phosphorylated and ubiquitinated in response to changes in the cell cycle. We systematically screened 109 gene deletion strains representing the non-essential yeast kinome and identified a single kinase gene, ELM1, as necessary and sufficient for Gpa1 phosphorylation. Elm1 is expressed in a cell cycle-dependent manner, primarily at S and G(2)/M. Accordingly, phosphorylation of Gpa1 in G(2)/M phase leads to poly-ubiquitination in G(1) phase. These findings demonstrate that Gpa1 is dynamically regulated. More broadly, they reveal how G proteins can simultaneously regulate, and become regulated by, progression through the cell cycle.	[Torres, Matthew P.; Clement, Sarah T.; Cappell, Steven D.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,120 Mason Farm Rd,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Torres, Matthew/0000-0001-7296-4536; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R01 GM059167, R01 GM080739, R01 GM080739-S1, K99 GM094533-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059167, R01GM080739, K99GM094533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM059167 and R01 GM080739 (to H.G.D.) and R01 GM080739-S1 and K99 GM094533-01 (to M.P.T.).	Asano S, 2006, J BIOL CHEM, V281, P27090, DOI 10.1074/jbc.M601483200; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Bouquin N, 2000, J CELL SCI, V113, P1435; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Caydasi AK, 2010, J CELL BIOL, V190, P975, DOI 10.1083/jcb.201006151; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Crutchley J, 2009, MOL BIOL CELL, V20, P1926, DOI 10.1091/mbc.E08-08-0848; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hepler JR, 2003, MOL PHARMACOL, V64, P547, DOI 10.1124/mol.64.3.547; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Koehler CM, 1997, FEBS LETT, V408, P109, DOI 10.1016/S0014-5793(97)00401-8; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; Manderson EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001500; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; NEIMAN AM, 1990, CELL REGUL, V1, P391, DOI 10.1091/mbc.1.5.391; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Palecek SP, 2000, GENETICS, V156, P1005; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suchkov DV, 2010, MOL BIOL CELL, V21, P1737, DOI 10.1091/mbc.E09-08-0706; Szkotnicki L, 2008, MOL BIOL CELL, V19, P4675, DOI 10.1091/mbc.E08-06-0663; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Wittenberg C, 2003, BIOESSAYS, V25, P856, DOI 10.1002/bies.10327	57	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20208	20216		10.1074/jbc.M111.239343	http://dx.doi.org/10.1074/jbc.M111.239343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21521692	Green Published, hybrid			2022-12-27	WOS:000291267600008
J	Anderson, ER; Xue, X; Shah, YM				Anderson, Erik R.; Xue, Xiang; Shah, Yatrik M.			Intestinal Hypoxia-inducible Factor-2 alpha(HIF-2 alpha) Is Critical for Efficient Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-ABSORPTION; EPITHELIAL-CELLS; HEPCIDIN; ANEMIA; MICE; TRANSPORTER; METABOLISM; EXPRESSION; FERROPORTIN; HOMEOSTASIS	Erythropoiesis is a coordinated process by which RBCs are produced. Erythropoietin, a kidney-derived hormone, and iron are critical for the production of oxygen-carrying mature RBCs. To meet the high demands of iron during erythropoiesis, small intestinal iron absorption is increased through an undefined mechanism. In this study, erythropoietic induction of iron absorption was further investigated. Hypoxia-inducible factor-2 alpha (HIF-2 alpha) signaling was activated in the small intestine during erythropoiesis. Genetic disruption of HIF-2 alpha in the intestine abolished the increase in iron absorption genes as assessed by quantitative real-time reverse transcription-PCR and Western blot analyses. Moreover, the increase in serum iron following induction of erythropoiesis was entirely dependent on intestinal HIF-2 alpha expression. Complete blood count analysis demonstrated that disruption of intestinal HIF-2 alpha inhibited efficient erythropoiesis; mice disrupted for HIF-2 alpha demonstrated lower hematocrit, RBCs, and Hb compared with wildtype mice. These data further cement the essential role of HIF-2 alpha in regulating iron absorption and also demonstrate that hypoxia sensing in the intestine, as well as in the kidney, is essential for regulation of erythropoiesis by HIF-2 alpha.	[Anderson, Erik R.; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48108 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shah, YM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 1301 E Catherine St, Ann Arbor, MI 48108 USA.	shahy@umich.edu	Xue, Xiang/P-9071-2014	Xue, Xiang/0000-0003-4704-1814	National Institutes of Health [CA148828]; University of Michigan Gastrointestinal Peptide Center; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Gastrointestinal Peptide Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA148828 (to Y. M. S.). This work was also supported by a grant from the University of Michigan Gastrointestinal Peptide Center (to Y. M. S.).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; Bittorf T, 1997, CELL SIGNAL, V9, P85, DOI 10.1016/S0898-6568(96)00121-0; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; CONRAD ME, 1965, BLOOD-J HEMATOL, V25, P990, DOI 10.1182/blood.V25.6.990.990; Corwin HL, 2006, TRANSFUS MED REV, V20, P27, DOI 10.1016/j.tmrv.2005.08.002; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hodgkiss RJ, 1998, ANTI-CANCER DRUG DES, V13, P687; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; Kong WN, 2008, J GASTROENTEROL, V43, P136, DOI 10.1007/s00535-007-2138-5; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Latunde-Dada GO, 2008, J NUTR, V138, P991, DOI 10.1093/jn/138.6.991; Latunde-Dada GO, 2004, BBA-MOL BASIS DIS, V1690, P169, DOI 10.1016/j.bbadis.2004.06.011; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mena NP, 2008, AM J PHYSIOL-GASTR L, V294, pG192, DOI 10.1152/ajpgi.00122.2007; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Schmid Holger, 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P164; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Tanno T., 2010, ADV HEMATOL, V2010; TAYLOR M, 2011, GASTROENTEROLOG 0318, DOI DOI 10.1053/J.GASTRO.2011.03.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3	46	49	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19533	19540		10.1074/jbc.M111.238667	http://dx.doi.org/10.1074/jbc.M111.238667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498508	Green Published, hybrid			2022-12-27	WOS:000291027700036
J	Lucki, NC; Sewer, MB				Lucki, Natasha C.; Sewer, Marion B.			Genistein Stimulates MCF-7 Breast Cancer Cell Growth by Inducing Acid Ceramidase (ASAH1) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SOY PHYTOESTROGEN GENISTEIN; ESTROGEN-RECEPTOR; PROSTATE-CANCER; SPHINGOLIPID METABOLISM; SPHINGOSINE KINASE; IN-VIVO; SIGNALING PATHWAYS; UP-REGULATION; TUMOR-GROWTH	Sphingolipid metabolites, such as ceramide (Cer), sphingosine (SPH), and sphingosine 1-phosphate (S1P), contribute to multiple aspects of carcinogenesis including cell proliferation, migration, angiogenesis, and tumor resistance. The cellular balance between Cer and S1P levels, for example, is an important determinant of cell fate, with the former inducing apoptosis and the later mitogenesis. Acid ceramidase (ASAH1) plays a pivotal role in regulating the intracellular concentration of these two metabolites by hydrolyzing Cer into SPH, which is rapidly phosphorylated to form S1P. Genistein is a phytoestrogen isoflavone that exerts agonist and antagonist effects on the proliferation of estrogen-dependent MCF-7 cells in a dose-dependent manner, primarily as a ligand for estrogen receptors. Genistein can also activate signaling through GPR30, a G-protein-coupled cell surface receptor. Based on the relationship between bioactive sphingolipids and tumorigenesis, we sought to determine the effect of genistein on ASAH1 transcription in MCF-7 breast cancer cells. We show herein that nanomolar concentrations of genistein induce ASAH1 transcription through a GPR30-dependent, pertussis toxin-sensitive pathway that requires the activation of c-Src and extracellular signal regulated kinase 1/2 (ERK1/2). Activation of this pathway promotes histone acetylation and recruitment of phospho-estrogen receptor alpha and specificity protein-1 to the ASAH1 promoter, ultimately culminating in increased ceramidase activity. Finally, we show that genistein stimulates cyclin B2 expression and cell proliferation in an ASAH1-dependent manner. Collectively, these data identify a mechanism through which genistein promotes sphingolipid metabolism and support a role for ASAH1 in breast cancer cell growth.	[Lucki, Natasha C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sewer, Marion B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego	Sewer, MB (corresponding author), 9500 Gilman Dr,MC 0704, La Jolla, CA 92093 USA.	msewer@ucsd.edu			National Institutes of Health [DK08417]; American Heart Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK08417 (to M. B. S.) and an American Heart Association Predoctoral Fellowship (to N. C. L.).	Albanito L, 2008, ENVIRON HEALTH PERSP, V116, P1648, DOI 10.1289/ehp.11297; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Allred CD, 2001, CANCER RES, V61, P5045; Allred CD, 2001, CARCINOGENESIS, V22, P1667, DOI 10.1093/carcin/22.10.1667; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bai AP, 2009, BIOORGAN MED CHEM, V17, P1840, DOI 10.1016/j.bmc.2009.01.057; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Brown NM, 2000, CELL GROWTH DIFFER, V11, P255; Buteau-Lozano H, 2008, J ENDOCRINOL, V196, P399, DOI 10.1677/JOE-07-0198; Cotroneo MS, 2002, CARCINOGENESIS, V23, P1467, DOI 10.1093/carcin/23.9.1467; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; El Touny LH, 2009, CANCER RES, V69, P3695, DOI 10.1158/0008-5472.CAN-08-2958; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Fan YJ, 2009, CANCER LETT, V284, P189, DOI 10.1016/j.canlet.2009.04.024; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; French KJ, 2003, CANCER RES, V63, P5962; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Gikas PD, 2005, INT J FERTIL WOMEN M, V50, P250; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gupta S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-26; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hsieh CY, 1998, CANCER RES, V58, P3833; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; Ju YH, 2002, CANCER RES, V62, P2474; Ju YH, 2001, J NUTR, V131, P2957, DOI 10.1093/jn/131.11.2957; Kanda N, 2004, J INVEST DERMATOL, V123, P319, DOI 10.1111/j.0022-202X.2004.12645.x; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lamartiniere CA, 2000, AM J CLIN NUTR, V71, p1705S, DOI 10.1093/ajcn/71.6.1705S; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lavieu Gregory, 2008, V445, P159, DOI 10.1007/978-1-59745-157-4_11; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li CM, 1999, GENOMICS, V62, P223, DOI 10.1006/geno.1999.5940; Li CM, 1998, GENOMICS, V50, P267, DOI 10.1006/geno.1998.5334; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Liu B, 2005, CANCER RES, V65, P879, DOI 10.1158/0008-5472.CAN-04-3714; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Lucki Natasha C., 2008, V49, P387, DOI 10.1007/978-1-4020-8831-5_15; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2001, MOL PHARMACOL, V60, P595; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Messina M, 2006, JNCI-J NATL CANCER I, V98, P1275, DOI 10.1093/jnci/djj356; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Moller FJ, 2010, TOXICOL LETT, V196, P142, DOI 10.1016/j.toxlet.2010.03.1117; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Park JH, 2005, BBA-GENE STRUCT EXPR, V1732, P82, DOI 10.1016/j.bbaexp.2006.01.002; Peeters PHM, 2003, BREAST CANCER RES TR, V77, P171, DOI 10.1023/A:1021381101632; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ruckhaberle E, 2009, CLIMACTERIC, V12, P502, DOI 10.3109/13697130902939913; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Selzner M, 2001, CANCER RES, V61, P1233; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; Yang XH, 2003, CANCER RES, V63, P2425	86	61	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19399	19409		10.1074/jbc.M110.195826	http://dx.doi.org/10.1074/jbc.M110.195826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21493710	hybrid, Green Published			2022-12-27	WOS:000291027700022
J	Ruffell, B; Poon, GFT; Lee, SSM; Brown, KL; Tjew, SL; Cooper, J; Johnson, P				Ruffell, Brian; Poon, Grace F. T.; Lee, Sally S. M.; Brown, Kelly L.; Tjew, Sie-Lung; Cooper, Jessie; Johnson, Pauline			Differential Use of Chondroitin Sulfate to Regulate Hyaluronan Binding by Receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD MONOCYTES; CELL-SURFACE RECEPTOR; SMOOTH-MUSCLE-CELLS; TNF-ALPHA; TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; T-CELLS; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; PROTEOGLYCAN	CD44 is a cell surface receptor for the extracellular matrix glycosaminoglycan hyaluronan and is involved in processes ranging from leukocyte recruitment to wound healing. In the immune system, the binding of hyaluronan to CD44 is tightly regulated, and exposure of human peripheral blood monocytes to inflammatory stimuli increases CD44 expression and induces hyaluronan binding. Here we sought to understand how mouse macrophages regulate hyaluronan binding upon inflammatory and anti-inflammatory stimuli. Mouse bone marrow-derived macrophages stimulated with tumor necrosis factor alpha or lipopolysaccharide and interferon-gamma (LPS/IFN gamma) induced hyaluronan binding by up-regulating CD44 and down-regulating chondroitin sulfation on CD44. Hyaluronan binding was induced to a lesser extent in interleukin-4 (IL-4)-activated macrophages despite increased CD44 expression, and this was attributable to increased chondroitin sulfation on CD44, as treatment with beta-D-xyloside to prevent chondroitin sulfate addition significantly enhanced hyaluronan binding. These changes in the chondroitin sulfation of CD44 were associated with changes in mRNA expression of two chondroitin sulfotransferases, CHST3 and CHST7, which were decreased in LPS/IFN gamma-stimulated macrophages and increased in IL-4-stimulated macrophages. Thus, inflammatory and anti-inflammatory stimuli differentially regulate the chondroitin sulfation of CD44, which is a dynamic physiological regulator of hyaluronan binding by CD44 in mouse macrophages.	[Ruffell, Brian; Poon, Grace F. T.; Lee, Sally S. M.; Brown, Kelly L.; Tjew, Sie-Lung; Cooper, Jessie; Johnson, Pauline] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Johnson, P (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	pauline@mail.ubc.ca	Johnson, Pauline/G-9659-2019	Johnson, Pauline/0000-0001-7367-4653; Ruffell, Brian/0000-0002-3846-6872; Brown, Kelly/0000-0001-5385-3582	Canadian Institutes of Health Research [81314]; Heart and Stroke Foundation of British Columbia and Yukon, Canada; Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon, Canada; Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grant 81314 (to P. J.) and a grant from the Heart and Stroke Foundation of British Columbia and Yukon, Canada.; Supported by a fellowship from the Heart and Stroke Foundation of British Columbia and Yukon.; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.	Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CULTY M, 1994, J LEUKOCYTE BIOL, V56, P605, DOI 10.1002/jlb.56.5.605; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Ehnis T, 1996, EXP CELL RES, V229, P388, DOI 10.1006/excr.1996.0384; English NM, 1998, CANCER RES, V58, P3736; FAASSEN AE, 1993, J CELL SCI, V105, P501; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hayes GM, 2002, J BIOL CHEM, V277, P50529, DOI 10.1074/jbc.M206719200; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kawana H, 2008, J IMMUNOL, V180, P4235, DOI 10.4049/jimmunol.180.6.4235; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knutson JR, 1996, MOL BIOL CELL, V7, P383, DOI 10.1091/mbc.7.3.383; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; Li RH, 2001, J BIOL CHEM, V276, P28767, DOI 10.1074/jbc.M100158200; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Maeshima N, 2011, EUR J IMMUNOL, V41, P1108, DOI 10.1002/eji.201040870; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; OHMORI K, 1993, BLOOD, V82, P2797; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; ROMARIS M, 1995, BIOCHEM J, V310, P73, DOI 10.1042/bj3100073; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Ruffell B., 2009, GLYCOFORUM SCI HYALU, V33, P1; Ruffell B, 2008, J IMMUNOL, V181, P7044, DOI 10.4049/jimmunol.181.10.7044; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; ZHOU DFH, 1989, J IMMUNOL, V143, P3390	66	46	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19179	19190		10.1074/jbc.M110.200790	http://dx.doi.org/10.1074/jbc.M110.200790			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471214	Green Published, hybrid			2022-12-27	WOS:000291027700001
J	Gong, C; Yao, YD; Wang, Y; Liu, BD; Wu, W; Chen, JN; Su, FX; Yao, HR; Song, EW				Gong, Chang; Yao, Yandan; Wang, Ying; Liu, Bodu; Wu, Wei; Chen, Jianing; Su, Fengxi; Yao, Herui; Song, Erwei			Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; MICRORNA-21 TARGETS; DOWN-REGULATION; EXPRESSION; PTEN; CELLS; GROWTH; INVASION; PROMOTES; OVEREXPRESSION	Trastuzumab resistance emerges to be a major issue in anti-human epidermal growth factor receptor 2 (HER2) therapy for breast cancers. Here, we demonstrated that miR-21 expression was up-regulated and its function was elevated in HER2(+) BT474, SKBR3, and MDA-MB-453 breast cancer cells that are induced to acquire trastuzumab resistance by long-term exposure to the antibody, whereas protein expression of the PTEN gene, a miR-21 target, was reduced. Blocking the action of miR-21 with antisense oligonucleotides re-sensitized the resistant cells to the therapeutic activities of trastuzumab by inducing growth arrest, proliferation inhibition, and G(1)-S cell cycle checking in the presence of the antibody. Ectopic expression of miR-21 in HER2(+) breast cancer cells confers resistance to trastuzumab. Rescuing PTEN expression with a p3XFLAG-PTEN-mut construct with deleted miR-21 targeting sequence at its 3' UTR restored the growth inhibition of trastuzumab in the resistant cells by inducing PTEN activation and AKT inhibition. In vivo, administering miR-21 antisense oligonucleotides restored trastuzumab sensitivity in the resistant breast cancer xenografts by inducing PTEN expression, whereas injection of miR-21 mimics conferred trastuzumab resistant in the sensitive breast tumors via PTEN silence. Up-regulatin of miR-21 in tumor biopsies obtained from patients receiving pre-operative trastuzumab therapy was associated with poor trastuzumab response. Therefore, miR-21 overexpression contributes to trastuzumab resistance in HER2(+) breast cancers and antagonizing miR-21 demonstrates therapeutic potential by sensitizing the malignancy to anti-HER2 treatment.	[Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510120, Peoples R China; [Gong, Chang; Yao, Yandan; Wang, Ying; Liu, Bodu; Wu, Wei; Chen, Jianing; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yao, HR (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510120, Peoples R China.	yaoherui@163.com; songerwei02@yahoo.com.cn	Liu, Bodu/AAR-9402-2021; Liu, Bodu/G-5222-2016	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Yao, Herui/0000-0001-5520-6469	National Natural Science Foundation of China [30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505, 30945201]; Sun-Yat-Sen Excellent Medicine Youth Project, 973 [2010CB912800, 2009CB521706, 2005CB724605]; Ministry of Science and Technology of China Science Foundation of Guangdong Province [8251008901000011, 2009B030801005]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]; Guangdong Higher Education Institutes, Sun-Yat-sen University [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun-Yat-Sen Excellent Medicine Youth Project, 973; Ministry of Science and Technology of China Science Foundation of Guangdong Province; Foundation of Guangzhou Science and Technology Bureau; Guangdong Higher Education Institutes, Sun-Yat-sen University	This work was supported by National Natural Science Foundation of China Grants 30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505, and 30945201, the Sun-Yat-Sen Excellent Medicine Youth Project, 973 Grants 2010CB912800, 2009CB521706, and 2005CB724605, Projects from Ministry of Science and Technology of China Science Foundation of Guangdong Province Grants 8251008901000011 and 2009B030801005, Foundation of Guangzhou Science and Technology Bureau Grant 2009Y-C011-1, and the Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun-Yat-sen University, Grant KLB09001.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Connolly EC, 2010, MOL CANCER RES, V8, P691, DOI 10.1158/1541-7786.MCR-09-0465; Cooke T, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1011159723172; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mei M, 2010, TECHNOL CANCER RES T, V9, P77, DOI 10.1177/153303461000900109; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pezzolesi MG, 2008, AM J HUM GENET, V82, P1141, DOI 10.1016/j.ajhg.2008.04.005; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shi GH, 2010, ACTA PHARMACOL SIN, V31, P867, DOI 10.1038/aps.2010.48; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	237	252	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19127	19137		10.1074/jbc.M110.216887	http://dx.doi.org/10.1074/jbc.M110.216887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471222	Green Published, hybrid			2022-12-27	WOS:000290785700082
J	Rogov, VV; Rogova, NY; Bernhard, F; Lohr, F; Dotsch, V				Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker			A Disulfide Bridge Network within the Soluble Periplasmic Domain Determines Structure and Function of the Outer Membrane Protein RCSF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; PHOSPHORELAY SIGNALING PATHWAY; TORSION ANGLE DYNAMICS; ESCHERICHIA-COLI K-12; CELL NMR-SPECTROSCOPY; ERWINIA-AMYLOVORA; EXOPOLYSACCHARIDE BIOSYNTHESIS; HISTIDINE KINASES; CHEMICAL-SHIFT; SENSOR KINASE	RcsF, a proposed auxiliary regulator of the regulation of capsule synthesis (rcs) phosphorelay system, is a key element for understanding the RcsC-D-A/B signaling cascade, which is responsible for the regulation of more than 100 genes and is involved in cell division, motility, biofilm formation, and virulence. The RcsC-D-A/B system is one of the most complex bacterial signal transduction pathways, consisting of several membrane-bound and soluble proteins. RcsF is a lipoprotein attached to the outer membrane and plays an important role in activating the RcsC-D-A/B pathway. The exact mechanism of activation of the rcs phosphorelay by RcsF, however, remains unknown. We have analyzed the sequence of RcsF and identified three structural elements: 1) an N-terminal membrane-anchored helix (residues 3-13), 2) a loop (residues 14-48), and 3) a C-terminal folded domain (residues 49-134). We have determined the structure of this C-terminal domain and started to investigate its interaction with potential partners. Important features of its structure are two disulfide bridges between Cys-74 and Cys-118 and between Cys-109 and Cys-124. To evaluate the importance of this RcsF disulfide bridge network in vivo, we have examined the ability of the full-length protein and of specific Cys mutants to initiate the rcs signaling cascade. The results indicate that the Cys-74/Cys-118 and the Cys-109/Cys-124 residues correlate pairwise with the activity of RcsF. Interaction studies showed a weak interaction with an RNA hairpin. However, no interaction could be detected with reagents that are believed to activate the rcs phosphorelay, such as lysozyme, glucose, or Zn2+ ions.	[Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Rogov, Vladimir V.; Rogova, Natalia Yu.; Bernhard, Frank; Loehr, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Rogov, Vladimir V.] Inst Prot Res, Pushchino 142290, Russia	Goethe University Frankfurt; Goethe University Frankfurt	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Doetsch, Volker/D-5697-2011	Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783	Deutsche Forschungsgemeinschaft [BE 1911/4-1]; Center for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt Macromolecular Complexes (CEF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt Macromolecular Complexes (CEF)	This work was supported by Deutsche Forschungsgemeinschaft Grant BE 1911/4-1, the Center for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt Macromolecular Complexes (CEF).	Andresen L, 2007, FEMS MICROBIOL LETT, V273, P229, DOI 10.1111/j.1574-6968.2007.00794.x; BERNHARD F, 1990, MOL PLANT MICROBE IN, V3, P429, DOI 10.1094/MPMI-3-429; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callewaert L, 2009, J BACTERIOL, V191, P1979, DOI 10.1128/JB.01549-08; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Chen MH, 2001, BIOSCI BIOTECH BIOCH, V65, P2364, DOI 10.1271/bbb.65.2364; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Clarke DJ, 2002, J BACTERIOL, V184, P1204, DOI 10.1128/jb.184.4.1204-1208.2002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farris C, 2010, J BACTERIOL, V192, P4894, DOI 10.1128/JB.00505-10; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; GERVAIS FG, 1992, J BACTERIOL, V174, P3964, DOI 10.1128/jb.174.12.3964-3971.1992; Goddard T. D., SPARKY 3; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Rogov VV, 2007, J BIOMOL NMR, V38, P165, DOI 10.1007/s10858-006-9059-0; Rogov VV, 2006, J MOL BIOL, V364, P68, DOI 10.1016/j.jmb.2006.07.052; Rogov VV, 2004, J MOL BIOL, V343, P1035, DOI 10.1016/j.jmb.2004.08.096; Sambrock J, 1989, MOL CLONING LAB MANU; Schmoe K, 2011, STRUCTURE, V19, P577, DOI 10.1016/j.str.2011.01.012; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Singh P, 2008, ANAL CHEM, V80, P8799, DOI 10.1021/ac801646f; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhang WW, 2005, MICROBIOL-SGM, V151, P2159, DOI 10.1099/mic.0.27987-0	43	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18775	18783		10.1074/jbc.M111.230185	http://dx.doi.org/10.1074/jbc.M111.230185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471196	Green Published, hybrid			2022-12-27	WOS:000290785700050
J	Satapathy, AK; Richardson, CC				Satapathy, Ajit K.; Richardson, Charles C.			The Glutamate Switch of Bacteriophage T7 DNA Helicase ROLE IN COUPLING NUCLEOTIDE TRIPHOSPHATE (NTP) AND DNA BINDING TO NTP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HEXAMERIC HELICASES; CRYSTAL-STRUCTURE; GENE-4 HELICASE; PROTEINS; PRIMASE; PRIMASE/HELICASE; MECHANISM; DOMAIN; DTTP	The DNA helicase encoded by gene 4 of bacteriophage T7 forms a hexameric ring in the presence of dTTP, allowing it to bind DNA in its central core. The oligomerization also creates nucleotide-binding sites located at the interfaces of the subunits. DNA binding stimulates the hydrolysis of dTTP but the mechanism for this two-step control is not clear. We have identified a glutamate switch, analogous to the glutamate switch found in AAA + enzymes that couples dTTP hydrolysis to DNA binding. A crystal structure of T7 helicase shows that a glutamate residue (Glu-343), located at the subunit interface, is positioned to catalyze a nucleophilic attack on the gamma-phosphate of a bound nucleoside 5'-triphosphate. However, in the absence of a nucleotide, Glu-343 changes orientation, interacting with Arg-493 on the adjacent subunit. This interaction interrupts the interaction of Arg-493 with Asn-468 of the central beta-hairpin, which in turn disrupts DNA binding. When Glu-343 is replaced with glutamine the altered helicase, unlike the wild-type helicase, binds DNA in the presence of dTDP. When both Arg-493 and Asn-468 are replaced with alanine, dTTP hydrolysis is no longer stimulated in the presence of DNA. Taken together, these results suggest that the orientation of Glu-343 plays a key role in coupling nucleotide hydrolysis to the binding of DNA.	[Satapathy, Ajit K.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; Mogni ME, 2009, BIOCHEMISTRY-US, V48, P8774, DOI 10.1021/bi9012512; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	24	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23113	23120		10.1074/jbc.M111.218651	http://dx.doi.org/10.1074/jbc.M111.218651			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566126	Green Published, hybrid			2022-12-27	WOS:000292025000045
J	Lasagna-Reeves, CA; Glabe, CG; Kayed, R				Lasagna-Reeves, Cristian A.; Glabe, Charles G.; Kayed, Rakez			Amyloid-beta Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; PROTEIN AGGREGATION; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASE; OLIGOMERS IMPLIES; COMMON MECHANISM; PEPTIDE; PATHOGENESIS; MEMBRANES; TOXINS	Annular protofibrils (APFs) represent a new and distinct class of amyloid structures formed by disease-associated proteins. In vitro, these pore-like structures have been implicated in membrane permeabilization and ion homeostasis via pore formation. Still, evidence for their formation and relevance in vivo is lacking. Herein, we report that APFs are in a distinct pathway from fibril formation in vitro and in vivo. In human Alzheimer disease brain samples, amyloid-beta APFs were associated with diffuse plaques, but not compact plaques; moreover, we show the formation of intracellular APFs. Our results together with previous studies suggest that the prevention of amyloid-beta annular protofibril formation could be a relevant target for the prevention of amyloid-beta toxicity in Alzheimer disease.	[Lasagna-Reeves, Cristian A.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, George P & Cynthia Woods Mitchell Ctr Neurodegene, Galveston, TX 77555 USA; [Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Irvine	Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurol, George P & Cynthia Woods Mitchell Ctr Neurodegene, 301 Univ Blvd,Med Res Bldg,Rm 10-138C, Galveston, TX 77555 USA.	rakayed@utmb.edu	Lasagna-Reeves, Cristian/ABE-2001-2021		Alzheimer's Association; Mitchell Center for Neurodegenerative Diseases; Cullen Trust	Alzheimer's Association(Alzheimer's Association); Mitchell Center for Neurodegenerative Diseases; Cullen Trust	This work was supported by grants from the Alzheimer's Association, the Mitchell Center for Neurodegenerative Diseases, and the Cullen Trust.	ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hafner JH, 2001, PROG BIOPHYS MOL BIO, V77, P73, DOI 10.1016/S0079-6107(01)00011-6; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kokubo H, 2009, INT J ALZHEIMERS DIS; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yamaguchi H, 2000, J NEUROPATH EXP NEUR, V59, P723, DOI 10.1093/jnen/59.8.723; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	40	104	105	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22122	22130		10.1074/jbc.M111.236257	http://dx.doi.org/10.1074/jbc.M111.236257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21507938	hybrid, Green Published			2022-12-27	WOS:000291719900018
J	McLean, JE; Wudzinska, A; Datan, E; Quaglino, D; Zakeri, Z				McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Quaglino, Daniela; Zakeri, Zahra			Flavivirus NS4A-induced Autophagy Protects Cells against Death and Enhances Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; MODOC VIRAL-INFECTIONS; DENGUE VIRUS; NONSTRUCTURAL PROTEINS; NEUROBLASTOMA-CELLS; GOLDEN-HAMSTER; NS4A; NS3; LOCALIZATION	Flaviviruses include the most prevalent and medically challenging viruses. Persistent infection with flaviviruses of epithelial cells and hepatocytes that do not undergo cell death is common. Here, we report that, in epithelial cells, up-regulation of autophagy following flavivirus infection markedly enhances virus replication and that one flavivirus gene, NS4A, uniquely determines the up-regulation of autophagy. Dengue-2 and Modoc (a murine flavivirus) kill primary murine macrophages but protect epithelial cells and fibroblasts against death provoked by several insults. The flavivirus-induced protection derives from the up-regulation of autophagy, as up-regulation of autophagy by starvation or inactivation of mammalian target of rapamycin also protects the cells against insult, whereas inhibition of autophagy via inactivation of PI3K nullifies the protection conferred by flavivirus. Inhibition of autophagy also limits replication of both Dengue-2 and Modoc virus in epithelial cells. Expression of flavivirus NS4A is sufficient to induce PI3K-dependent autophagy and to protect cells against death; expression of other viral genes, including NS2A and NS4B, fails to protect cells against several stressors. Flavivirus NS4A protein induces autophagy in epithelial cells and thus protects them from death during infection. As autophagy is vital to flavivirus replication in these cells, NS4A is therefore also identified as a critical determinant of flavivirus replication.	[McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Zakeri, Zahra] CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA; [McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Zakeri, Zahra] CUNY, Grad Ctr, Flushing, NY 11367 USA; [Quaglino, Daniela] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Patol Gen, I-41100 Modena, Italy	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Universita di Modena e Reggio Emilia	Zakeri, Z (corresponding author), CUNY, Queens Coll, Dept Biol, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	zahra_zakeri@hotmail.com	Quaglino, Daniela/A-9381-2010; Datan, Emmanuel/T-8987-2019	Quaglino, Daniela/0000-0002-4302-5078; Datan, Emmanuel/0000-0001-9820-3233	National Institutes of Health [2T34GM070387-03]; City University of New York (CUNY); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM070387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York (CUNY); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health MARC U-STAR Grant 2T34GM070387-03 (to Z. Z.). This work was also supported by Professional Staff Congress-City University of New York (PSC-CUNY) award (to Z. Z.).	BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; CARDIFF RD, 1973, INFECT IMMUN, V7, P809, DOI 10.1128/IAI.7.5.809-816.1973; DAVIS JW, 1974, INFECT IMMUN, V10, P328, DOI 10.1128/IAI.10.2.328-334.1974; DAVIS JW, 1973, APPL MICROBIOL, V26, P344, DOI 10.1128/AEM.26.3.344-348.1973; DAVIS JW, 1974, INFECT IMMUN, V10, P1362, DOI 10.1128/IAI.10.6.1362-1369.1974; Despres P, 1998, J VIROL, V72, P823; Despres P, 1996, J VIROL, V70, P4090; Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; GULATI L, 1982, BRIT J EXP PATHOL, V63, P194; HALSTEAD SB, 1989, REV INFECT DIS, V11, P830; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Leyssen P, 2001, VIROLOGY, V279, P27, DOI 10.1006/viro.2000.0723; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lin L, 2006, CELL DEATH DIFFER, V13, P141, DOI 10.1038/sj.cdd.4401717; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Morens DM, 2009, PEDIATR INFECT DIS J, V28, P635, DOI 10.1097/INF.0b013e3181afcd5b; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; POGODINA VV, 1981, ACTA VIROL, V25, P337; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Siirin MT, 2007, AM J TROP MED HYG, V76, P299, DOI 10.4269/ajtmh.2007.76.299; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	43	179	193	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22147	22159		10.1074/jbc.M110.192500	http://dx.doi.org/10.1074/jbc.M110.192500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21511946	Green Published, hybrid			2022-12-27	WOS:000291719900021
J	Than, TA; Lou, H; Ji, C; Win, S; Kaplowitz, N				Than, Tin Aung; Lou, Huan; Ji, Cheng; Win, Sanda; Kaplowitz, Neil			Role of cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 3 (CRTC3) in the Initiation of Mitochondrial Biogenesis and Stress Response in Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LONG TERMINAL REPEAT; SKELETAL-MUSCLE; KEY REGULATOR; HEPG2 CELLS; PGC-1-ALPHA; ROTENONE; ACTIVATION; MECHANISMS; GLUCOSE	Peroxisome proliferator-activated receptor alpha, coactivator 1 alpha (PGC-1 alpha) is the master regulator of mitochondrial biogenesis. PGC-1 alpha expression is under the control of the transcription factor, cAMP-responsive element-binding protein (CREB). In searching for candidate transcription factors that mediate mitochondrial stress-initiated mitochondria-to-nucleus signaling in the regulation of mitochondrial biogenesis, we assessed the effect of silencing CREB-regulated transcription co-activators (CRTC). CRTC isoforms are co-activators of CREB-regulated transcription by a CREB phosphorylation-independent pathway. Using cultured HepG2 cells and primary mouse hepatocytes, we determined that mitochondrial stress imposed by the complex I inhibitor rotenone elicited mitochondrial biogenesis, which was dependent on an induction of PGC-1 alpha, which was inhibited by silencing PGC-1 alpha. PGC-1 alpha induction in response to rotenone was inhibited by silencing the expression of CRTC3, which blocked downstream mitochondria biogenesis. In contrast, silencing CRTC2 did not affect the induction of this pathway in response to rotenone. Thus, CRTC3 plays a selective role in mitochondrial biogenesis in response to rotenone.	Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, So Calif Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [R21 AA017746, R01 DK067215, R01 AA014428]; National Institutes of Health Training [T32 AA07578]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014428, R21AA017746, R01AA018612, R01AA018846, T32AA007578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AA017746, R01 DK067215, and R01 AA014428 ( to N. K.) and National Institutes of Health Training Grant T32 AA07578.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cederbaum A, 2009, EXPERT OPIN DRUG MET, V5, P1223, DOI 10.1517/17425250903143769; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Gill MB, 2009, J NEUROSCI RES, V87, P2047, DOI 10.1002/jnr.22019; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Ji C, 2008, J GASTROEN HEPATOL, V23, pS16, DOI 10.1111/j.1440-1746.2007.05276.x; Ji C, 2007, HEPATOLOGY, V46, P1586, DOI 10.1002/hep.21854; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KUO SC, 1974, BIOCHEM BIOPH RES CO, V58, P287, DOI 10.1016/0006-291X(74)90925-5; Kyriakakis E, 2010, CELL SIGNAL, V22, P1308, DOI 10.1016/j.cellsig.2010.04.008; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Lund KC, 2007, ANTIMICROB AGENTS CH, V51, P2531, DOI 10.1128/AAC.00039-07; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Plock J, 2007, J HEPATOL, V47, P538, DOI 10.1016/j.jhep.2007.04.016; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SINGER TP, 1994, BBA-BIOENERGETICS, V1187, P198, DOI 10.1016/0005-2728(94)90110-4; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	55	49	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22047	22054		10.1074/jbc.M111.240481	http://dx.doi.org/10.1074/jbc.M111.240481			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536665	Green Published, hybrid			2022-12-27	WOS:000291719900011
J	Moessinger, C; Kuerschner, L; Spandl, J; Shevchenko, A; Thiele, C				Moessinger, Christine; Kuerschner, Lars; Spandl, Johanna; Shevchenko, Andrej; Thiele, Christoph			Human Lysophosphatidylcholine Acyltransferases 1 and 2 Are Located in Lipid Droplets Where They Catalyze the Formation of Phosphatidylcholine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; ACID-BINDING PROTEIN; ACYL-COA; POSSIBLE INVOLVEMENT; MAMMALIAN-CELLS; II CELLS; MEMBRANE; IDENTIFICATION; BIOSYNTHESIS; CLONING	Phosphatidylcholine (PC) is synthesized by two different pathways, the Lands cycle and the Kennedy pathway. The recently identified key enzymes of the Lands cycle, lysophosphatidylcholine acyltransferase 1 and 2 (LPCAT1 and -2), were reported to localize to the endoplasmic reticulum and to function in lung surfactant production and in inflammation response. Here, we show in various mammalian cell lines that both enzymes additionally localize to lipid droplets (LDs), which consist of a core of neutral lipids surrounded by a monolayer of phospholipid, mainly PC. This dual localization is enabled by the monotopic topology of these enzymes demonstrated in this study. Furthermore, we show that LDs have the ability to locally synthesize PC and that this activity correlates with the LPCAT1 and -2 expression level. This suggests that LPCAT1 and -2 have, in addition to their known function in specialized cells, a ubiquitous role in LD-associated lipid metabolism.	[Moessinger, Christine; Kuerschner, Lars; Spandl, Johanna; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Moessinger, Christine; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Bonn; Max Planck Society	Thiele, C (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	cthiele@uni-bonn.de			Deutsche Forschungsgemeinschaft [TR83]; European Union; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German National Academic Foundation	This work was supported by Deutsche Forschungsgemeinschaft (Transregio TR83), the European Union Framework 7 Project "LipidomicNet," and the German National Academic Foundation.	Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ohashi M, 2003, J BIOL CHEM, V278, P36819, DOI 10.1074/jbc.M301408200; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VANCURA A, 1992, J BIOL CHEM, V267, P14353; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	68	107	111	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21330	21339		10.1074/jbc.M110.202424	http://dx.doi.org/10.1074/jbc.M110.202424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498505	Green Published, hybrid			2022-12-27	WOS:000291464700032
J	Javaherian, AD; Yusifov, T; Pantazis, A; Franklin, S; Gandhi, CS; Olcese, R				Javaherian, Anoosh D.; Yusifov, Taleh; Pantazis, Antonios; Franklin, Sarah; Gandhi, Chris S.; Olcese, Riccardo			Metal-driven Operation of the Human Large-conductance Voltage- and Ca2+-dependent Potassium Channel (BK) Gating Ring Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; BINDING-SITES; RCK1 DOMAIN; CA2+ SENSITIVITY; LIPID-MEMBRANE; ION-CHANNEL; N-TERMINUS; CALCIUM; ACTIVATION; SENSOR	Large-conductance voltage-and Ca2+-dependent K+ (BK, also known as MaxiK) channels are homo-tetrameric proteins with a broad expression pattern that potently regulate cellular excitability and Ca2+ homeostasis. Their activation results from the complex synergy between the transmembrane voltage sensors and a large (>300 kDa) C-terminal, cytoplasmic complex (the "gating ring"), which confers sensitivity to intracellular Ca2+ and other ligands. However, the molecular and biophysical operation of the gating ring remains unclear. We have used spectroscopic and particle-scale optical approaches to probe the metal-sensing properties of the human BK gating ring under physiologically relevant conditions. This functional molecular sensor undergoes Ca2+- and Mg2+-dependent conformational changes at physiologically relevant concentrations, detected by time-resolved and steady-state fluorescence spectroscopy. The lack of detectable Ba2+-evoked structural changes defined the metal selectivity of the gating ring. Neutralization of a high-affinity Ca2+-binding site (the "calcium bowl") reduced the Ca2+ and abolished the Mg2+ dependence of structural rearrangements. In congruence with electrophysiological investigations, these findings provide biochemical evidence that the gating ring possesses an additional high-affinity Ca2+-binding site and that Mg2+ can bind to the calcium bowl with less affinity than Ca2+. Dynamic light scattering analysis revealed a reversible Ca2+-dependent decrease of the hydrodynamic radius of the gating ring, consistent with a more compact overall shape. These structural changes, resolved under physiologically relevant conditions, likely represent the molecular transitions that initiate the ligand-induced activation of the human BK channel.	[Javaherian, Anoosh D.; Yusifov, Taleh; Pantazis, Antonios; Franklin, Sarah; Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Olcese, Riccardo] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Gandhi, Chris S.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Olcese, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, BH-570 CHS, Los Angeles, CA 90095 USA.	rolcese@ucla.edu	Pantazis, Antonios/AAB-3846-2019	Pantazis, Antonios/0000-0002-6467-1327	National Institutes of Health Research [NIGMS R01GM082289]; Laubisch Foundation; American Heart Association [09POST2250648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082289] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant NIGMS R01GM082289 and the Laubisch Foundation (to R. O.).; Recipient of American Heart Association (Western States Affiliate) Postdoctoral Fellowship 09POST2250648.	Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P539; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Chakrapani S, 2007, NAT STRUCT MOL BIOL, V14, P180, DOI 10.1038/nsmb0307-180; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Cui JM, 2010, J PHYSIOL-LONDON, V588, P4651, DOI 10.1113/jphysiol.2010.194514; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Horrigan FT, 2008, NAT STRUCT MOL BIOL, V15, P1130, DOI 10.1038/nsmb1108-1130; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu L, 2006, J GEN PHYSIOL, V127, P35, DOI 10.1085/jgp.200509317; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Lakowicz JR., 2006, PRINCIPLES FLUORESCE, P97, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_4]; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lingle CJ, 2007, J GEN PHYSIOL, V129, P101, DOI 10.1085/jgp.200709739; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Pantazis A, 2010, P NATL ACAD SCI USA, V107, P4459, DOI 10.1073/pnas.0911959107; Proteau Ariane, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1710s61; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Vergara C, 1999, J GEN PHYSIOL, V114, P365, DOI 10.1085/jgp.114.3.365; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	64	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20701	20709		10.1074/jbc.M111.235234	http://dx.doi.org/10.1074/jbc.M111.235234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471215	Green Published, hybrid			2022-12-27	WOS:000291267600056
J	Auweter, SD; Bhavsar, AP; de Hoog, CL; Li, YL; Chan, YA; van der Heijden, J; Lowden, MJ; Coombes, BK; Rogers, LD; Stoynov, N; Foster, LJ; Finlay, BB				Auweter, Sigrid D.; Bhavsar, Amit P.; de Hoog, Carmen L.; Li, Yuling; Chan, Y. Alina; van der Heijden, Joris; Lowden, Michael J.; Coombes, Brian K.; Rogers, Lindsay D.; Stoynov, Nikolay; Foster, Leonard J.; Finlay, B. Brett			Quantitative Mass Spectrometry Catalogues Salmonella Pathogenicity Island-2 Effectors and Identifies Their Cognate Host Binding Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; UBIQUITIN LIGASE COMPLEX; NF-KAPPA-B; ESCHERICHIA-COLI; PROTEIN FAMILY; 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; IMMUNE-RESPONSES	Gram-negative bacterial pathogens have developed specialized secretion systems to transfer bacterial proteins directly into host cells. These bacterial effectors are central to virulence and reprogram host cell processes to favor bacterial survival, colonization, and proliferation. Knowing the complete set of effectors encoded by a particular pathogen is the key to understanding bacterial disease. In addition, the identification of the molecular assemblies that these effectors engage once inside the host cell is critical to determining the mechanism of action of each effector. In this work we used stable isotope labeling of amino acids in cell culture (SILAC), a powerful quantitative proteomics technique, to identify the proteins secreted by the Salmonella pathogenicity island-2 type three secretion system (SPI-2 T3SS) and to characterize the host interaction partners of SPI-2 effectors. We confirmed many of the known SPI-2 effectors and were able to identify several novel substrate candidates of this secretion system. We verified previously published host protein-effector binding pairs and obtained 11 novel interactions, three of which were investigated further and confirmed by reciprocal co-immunoprecipitation. The host cell interaction partners identified here suggest that Salmonella SPI-2 effectors target, in a concerted fashion, cellular processes such as cell attachment and cell cycle control that are underappreciated in the context of infection. The technology outlined in this study is specific and sensitive and serves as a robust tool for the identification of effectors and their host targets that is readily amenable to the study of other bacterial pathogens.	[Rogers, Lindsay D.; Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Auweter, Sigrid D.; Bhavsar, Amit P.; de Hoog, Carmen L.; Li, Yuling; Chan, Y. Alina; van der Heijden, Joris; Lowden, Michael J.; Coombes, Brian K.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Rogers, Lindsay D.; Foster, Leonard J.; Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Foster, LJ (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada.	ljfoster@interchange.ubc.ca; bfinlay@interchange.ubc.ca	Rogers, Lindsay/AAO-1985-2021; Coombes, Brian K/A-1727-2009	Chan, Yujia Alina/0000-0002-0731-637X; Bhavsar, Amit/0000-0003-3336-9288; Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health Research; Genome Canada/Genome British Columbia; VGH & UBC Hospital Foundation; Michael Smith Foundation for Health Research; British Columbia Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome British Columbia(Genome Canada); VGH & UBC Hospital Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Knowledge Development Fund	This work was supported by grants from the Canadian Institutes of Health Research (to L. J. F. and B. B. F.) and from Genome Canada/Genome British Columbia through the PRoteomics for Emerging PAthogen REsponse (PREPARE) project and the VGH & UBC Hospital Foundation.; Supported by fellowships from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.; We thank the members of our group for discussions and valuable advice. Mass spectrometry infrastructure used in this work was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and the BC Proteomics Network.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bhavsar AP, 2010, FUTURE MICROBIOL, V5, P253, DOI 10.2217/FMB.09.114; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Carver LA, 1997, J BIOL CHEM, V272, P11452; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; DASILVACORREIA J, 2007, P NATL ACAD SCI USA, V104, P6764; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Dittrich S, 2008, MOL MICROBIOL, V67, P609, DOI 10.1111/j.1365-2958.2007.06073.x; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; FINLAY BB, 1991, J CELL SCI, V99, P283; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; HEILAND I, 1979, BIOCHEMISTRY-US, V18, P4605, DOI 10.1021/bi00588a022; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stokes DL, 2007, CURR OPIN CELL BIOL, V19, P565, DOI 10.1016/j.ceb.2007.09.003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Woo HJ, 2002, FEBS LETT, V523, P234, DOI 10.1016/S0014-5793(02)02997-6; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	67	45	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24023	24035		10.1074/jbc.M111.224600	http://dx.doi.org/10.1074/jbc.M111.224600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566117	Green Published, hybrid			2022-12-27	WOS:000292294900045
J	Gao, ZG; Zhang, J; Kheterpal, I; Kennedy, N; Davis, RJ; Ye, JP				Gao, Zhanguo; Zhang, Jin; Kheterpal, Indu; Kennedy, Norm; Davis, Roger J.; Ye, Jianping			Sirtuin 1 (SIRT1) Protein Degradation in Response to Persistent c-Jun N-terminal Kinase 1 (JNK1) Activation Contributes to Hepatic Steatosis in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MULTIPLE SERINE KINASES; CALORIE RESTRICTION; GLUCOSE-HOMEOSTASIS; MAMMALIAN SIRTUIN-1; FATTY LIVER; RESISTANCE; PROMOTES; MICE; PHOSPHORYLATION	SIRT1 is involved in the pathogenesis of obesity, diabetes, and aging. However, it is not clear how SIRT1 activity is regulated by intracellular kinases in cells. In this study, we investigated SIRT1 phosphorylation and protein degradation in response to JNK1 activation in obese mice. Mouse SIRT1 is phosphorylated by JNK1 at Ser-46 (Ser-47 in human SIRT1), which is one of the four potential residues targeted by JNK1. The phosphorylation induces a brief activation of SIRT1 function and degradation of SIRT1 thereafter by the proteasome. Ubiquitination occurs in SIRT1 protein after the phosphorylation. Mutation of Ser-46 to alanine prevents the phosphorylation, ubiquitination, and degradation. In vivo, SIRT1 undergoes an extensive degradation in hepatocytes in obesity as a consequence of persistent activation of JNK1. The degradation leads to inhibition of SIRT1 function, which contributes to development of hepatic steatosis. The degradation disappears in obesity when JNK1 is inactivated in mice. JNK2 exhibits an opposite activity in the regulation of SIRT1 degradation. The JNK1-SIRT1 pathway provides a new molecular mechanism for the pathogenesis of hepatic steatosis in obesity.	[Gao, Zhanguo; Zhang, Jin; Kheterpal, Indu; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA; [Kennedy, Norm; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Davis, Roger/0000-0002-0130-1652	National Institutes of Health [DK068036, DK085495]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085495, R01DK068036, P30DK072476, R56DK068036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068036 and DK085495 (to J. Y.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497	45	141	145	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22227	22234		10.1074/jbc.M111.228874	http://dx.doi.org/10.1074/jbc.M111.228874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540183	hybrid, Green Published			2022-12-27	WOS:000291719900030
J	Kukimoto-Niino, M; Yoshikawa, S; Takagi, T; Ohsawa, N; Tomabechi, Y; Terada, T; Shirouzu, M; Suzuki, A; Lee, S; Yamauchi, T; Okada-Iwabu, M; Iwabu, M; Kadowaki, T; Minokoshi, Y; Yokoyama, S				Kukimoto-Niino, Mutsuko; Yoshikawa, Seiko; Takagi, Tetsuo; Ohsawa, Noboru; Tomabechi, Yuri; Terada, Takaho; Shirouzu, Mikako; Suzuki, Atsushi; Lee, Suni; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Iwabu, Masato; Kadowaki, Takashi; Minokoshi, Yasuhiko; Yokoyama, Shigeyuki			Crystal Structure of the Ca2+/Calmodulin-dependent Protein Kinase Kinase in Complex with the Inhibitor STO-609	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; REGULATORY MECHANISM; CALMODULIN; ACTIVATION; CALCIUM; DOMAIN; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; SEQUENCE	Ca2+/calmodulin (CaM)-dependent protein kinase (CaMK) kinase (CaMKK) is a member of the CaMK cascade that mediates the response to intracellular Ca2+ elevation. CaMKK phosphorylates and activates CaMKI and CaMKIV, which directly activate transcription factors. In this study, we determined the 2.4 angstrom crystal structure of the catalytic kinase domain of the human CaMKK beta isoform complexed with its selective inhibitor, STO-609. The structure revealed that CaMKK beta lacks the alpha D helix and that the equivalent region displays a hydrophobic molecular surface, which may reflect its unique substrate recognition and autoinhibition. Although CaMKK beta lacks the activation loop phosphorylation site, the activation loop is folded in an active-state conformation, which is stabilized by a number of interactions between amino acid residues conserved among the CaMKK isoforms. An in vitro analysis of the kinase activity confirmed the intrinsic activity of the CaMKK beta kinase domain. Structure and sequence analyses of the STO-609-binding site revealed amino acid replacements that may affect the inhibitor binding. Indeed, mutagenesis demonstrated that the CaMKK beta residue Pro(274), which replaces the conserved acidic residue of other protein kinases, is an important determinant for the selective inhibition by STO-609. Therefore, the present structure provides a molecular basis for clarifying the known biochemical properties of CaMKK beta and for designing novel inhibitors targeting CaMKK beta and the related protein kinases.	[Minokoshi, Yasuhiko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Kukimoto-Niino, Mutsuko; Yoshikawa, Seiko; Takagi, Tetsuo; Ohsawa, Noboru; Tomabechi, Yuri; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamauchi, Toshimasa; Okada-Iwabu, Miki; Iwabu, Masato; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN; University of Tokyo; University of Tokyo	Minokoshi, Y (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	minokosh@nips.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Kukimoto-Niino, Mutsuko/C-6704-2017; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Minokoshi, Yasuhiko/0000-0002-7119-4805	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the RIKEN Structural Genomics/Proteomics Initiative (RSGI), the National Project on Protein Structural and Functional Analyses, and the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kigawa T., 2007, CELL FREE PROTEIN SY, P83; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okuno S, 2000, J BIOCHEM-TOKYO, V127, P965, DOI 10.1093/oxfordjournals.jbchem.a022712; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 1999, J BIOL CHEM, V274, P15803, DOI 10.1074/jbc.274.22.15803; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22570	22579		10.1074/jbc.M111.251710	http://dx.doi.org/10.1074/jbc.M111.251710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504895	Green Published, hybrid			2022-12-27	WOS:000291719900064
J	Compton, S; Kim, C; Griner, NB; Potluri, P; Scheffler, IE; Sen, S; Jerry, DJ; Schneider, S; Yadava, N				Compton, Shannon; Kim, Chul; Griner, Nicholas B.; Potluri, Prasanth; Scheffler, Immo E.; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie; Yadava, Nagendra			Mitochondrial Dysfunction Impairs Tumor Suppressor p53 Expression/Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; SPARE RESPIRATORY CAPACITY; CHINESE-HAMSTER CELLS; COMPLEX-I DEFICIENCY; DNA-BINDING ACTIVITY; WILD-TYPE P53; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; MOLECULAR-GENETICS	Recently, mitochondria have been suggested to act in tumor suppression. However, the underlying mechanisms by which mitochondria suppress tumorigenesis are far from being clear. In this study, we have investigated the link between mitochondrial dysfunction and the tumor suppressor protein p53 using a set of respiration-deficient (Res(-)) mammalian cell mutants with impaired assembly of the oxidative phosphorylation machinery. Our data suggest that normal mitochondrial function is required for gamma-irradiation (gamma IR)-induced cell death, which is mainly a p53-dependent process. The Res(-) cells are protected against gamma IR-induced cell death due to impaired p53 expression/function. We find that the loss of complex I biogenesis in the absence of the MWFE subunit reduces the steady-state level of the p53 protein, although there is no effect on the p53 protein level in the absence of the ESSS subunit that is also essential for complex I assembly. The p53 protein level was also reduced to undetectable levels in Res(-) cells with severely impaired mitochondrial protein synthesis. This suggests that p53 protein expression is differentially regulated depending upon the type of electron transport chain/respiratory chain deficiency. Moreover, irrespective of the differences in the p53 protein expression profile, gamma IR-induced p53 activity is compromised in all Res(-) cells. Using two different conditional systems for complex I assembly, we also show that the effect of mitochondrial dysfunction on p53 expression/function is a reversible phenomenon. We believe that these findings will have major implications in the understanding of cancer development and therapy.	[Compton, Shannon; Kim, Chul; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie; Yadava, Nagendra] Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Sen, Sabyasachi; Yadava, Nagendra] Tufts Univ, Sch Med, Baystate Med Ctr, Div Endocrinol Diabet & Metab, Springfield, MA 01199 USA; [Yadava, Nagendra] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Griner, Nicholas B.; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Potluri, Prasanth; Scheffler, Immo E.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California San Diego	Yadava, N (corresponding author), Pioneer Valley Life Sci Inst, 3601 Main St, Springfield, MA 01107 USA.	Nagendra.Yadava@baystatehealth.org		Compton, Shannon/0000-0001-9372-1891	National Institutes of Health [R21NS057224, R01-CA105452, R01-ES015739]; Baystate Health Foundation; Center of Excellence in Apoptosis Research; NATIONAL CANCER INSTITUTE [R01CA105452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baystate Health Foundation; Center of Excellence in Apoptosis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21NS057224 (to N.Y.) and R01-CA105452, R01-ES015739 (to D.J.J.). This work was also supported in part by funds from a Rays of Hope grant from the Baystate Health Foundation and start-up funds from Center of Excellence in Apoptosis Research.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Au HC, 1999, P NATL ACAD SCI USA, V96, P4354, DOI 10.1073/pnas.96.8.4354; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Cuezva JM, 2007, J BIOENERG BIOMEMBR, V39, P259, DOI 10.1007/s10863-007-9087-9; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Czarnecka AM, 2010, ONCOL REP, V23, P531, DOI 10.3892/or_00000666; Czarnecka AM, 2010, BREAST CANCER RES TR, V121, P511, DOI 10.1007/s10549-009-0358-5; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; DEFRANCESCO L, 1975, J CELL PHYSIOL, V85, P293, DOI 10.1002/jcp.1040850216; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; DITTA G, 1976, SOMAT CELL GENET, V2, P331, DOI 10.1007/BF01538838; DITTA G, 1977, NATURE, V268, P64, DOI 10.1038/268064a0; DONNELLY M, 1976, J CELL PHYSIOL, V89, P39, DOI 10.1002/jcp.1040890105; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu Shaolei, 2008, Endocrinology, V149, P4809, DOI 10.1210/en.2008-0035; Mamelak AJ, 2005, EXP DERMATOL, V14, P336, DOI 10.1111/j.0906-6705.2005.00278.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Nicholls DG, 2010, ESSAYS BIOCHEM, V47, P25, DOI [10.1042/bse0470025, 10.1042/BSE0470025]; Norris PS, 1997, ONCOGENE, V15, P2241, DOI 10.1038/sj.onc.1201406; Okorokov AL, 1999, MOL CELL BIOL, V19, P7501; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566; Potluri P, 2004, EUR J BIOCHEM, V271, P3265, DOI 10.1111/j.1432-1033.2004.04260.x; Ray AM, 2009, PROSTATE, V69, P956, DOI 10.1002/pros.20943; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Scheffler IE, 2004, BBA-BIOENERGETICS, V1659, P160, DOI 10.1016/j.bbabio.2004.08.002; Scheffler IE, 2001, J BIOENERG BIOMEMBR, V33, P243, DOI 10.1023/A:1010739120891; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Theodoratou E, 2010, CARCINOGENESIS, V31, P296, DOI 10.1093/carcin/bgp237; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Verhaegh GW, 1997, MOL CELL BIOL, V17, P5699, DOI 10.1128/MCB.17.10.5699; Verhaegh GW, 1998, MOL CARCINOGEN, V21, P205, DOI 10.1002/(SICI)1098-2744(199803)21:3<205::AID-MC8>3.0.CO;2-K; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013459; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yadava N, 2008, INT J BIOCHEM CELL B, V40, P447, DOI 10.1016/j.biocel.2007.08.015; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	101	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20297	20312		10.1074/jbc.M110.163063	http://dx.doi.org/10.1074/jbc.M110.163063			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502317	hybrid, Green Published			2022-12-27	WOS:000291267600018
J	Huang, WC; Chen, YJ; Li, LY; Wei, YL; Hsu, SC; Tsai, SL; Chiu, PC; Huang, WP; Wang, YN; Chen, CH; Chang, WC; Chang, WC; Chen, AJE; Tsai, CH; Hung, MC				Huang, Wei-Chien; Chen, Yun-Ju; Li, Long-Yuan; Wei, Ya-Ling; Hsu, Sheng-Chieh; Tsai, Shing-Ling; Chiu, Pei-Chun; Huang, Wei-Pang; Wang, Ying-Nai; Chen, Chung-Hsuan; Chang, Wei-Chao; Chang, Wen-Chang; Chen, Andy Jer-En; Tsai, Chang-Hai; Hung, Mien-Chie			Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; LUNG-CANCER; ACQUIRED-RESISTANCE; EGF RECEPTOR; MULTIDRUG-RESISTANCE; GENE-MUTATIONS; ZD1839 IRESSA; ACTIVATION; BINDING; LOCALIZATION	Epidermal growth factor receptor (EGFR), an aberrantly over-expressed or activated receptor-tyrosine kinase in many cancers, plays a pivotal role in cancer progression and has been an attractive target for cancer therapy. Gefitinib and erlotinib, two EGFR-tyrosine kinase inhibitors, have been approved for non-small cell lung cancer. However, durable clinical efficacy of these EGFR inhibitors is severely limited by the emergence of acquired resistance. For example, the expression of breast cancer-resistant protein (BCRP/ABCG2) has been shown to confer acquired resistance of wild-type EGFR (wtEGFR)-expressing cancer cells to gefitinib. However, the underlying molecular mechanisms still remain unclear. Here, we show that wtEGFR expression is elevated in the nucleus of acquired gefitinib-resistant cancer cells. Moreover, nuclear translocation of EGFR requires phosphorylation at Ser-229 by Akt. In the nucleus, EGFR then targets the proximal promoter of BCRP/ABCG2 and thereby enhances its gene transcription. The nuclear EGFR-mediated BCRP/ABCG2 expression may contribute at least in part to the acquired resistance of wtEGFR-expressing cancer cells to gefitinib. Our findings shed light on the role of nuclear EGFR in the sensitivity of wtEGFR-expressing cancer cells to EGFR tyro-sine kinase inhibitors and also deciphered a putative molecular mechanism contributing to gefitinib resistance through BCRP/ABCG2 expression.	[Huang, Wei-Chien; Chen, Yun-Ju; Li, Long-Yuan; Wei, Ya-Ling; Hsu, Sheng-Chieh; Chiu, Pei-Chun; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan; Tsai, Shing-Ling; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan] China Med Univ, Ph D Program Canc Biol & Drug Discovery, Taichung 404, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung 413, Taiwan; [Chen, Yun-Ju; Wang, Ying-Nai; Chen, Andy Jer-En; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Huang, Wei-Pang] Natl Taiwan Univ, Inst Zool, Taipei 106, Taiwan; [Huang, Wei-Pang] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Chen, Yun-Ju; Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 701, Taiwan; [Chen, Yun-Ju; Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Chung-Hsuan; Chang, Wei-Chao] Acad Sinica, Inst Phys, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chung-Hsuan; Chang, Wei-Chao] Acad Sinica, Inst Atom & Mol Sci, Taipei 115, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, WC (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Huang, Wei-Chien/D-1740-2012; Chen, Chung-Hsuan/F-7940-2012; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/H-3126-2019	Huang, Wei-Chien/0000-0001-6467-8716; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; HUANG, WEI-PANG/0000-0001-8410-6555; Wang, Ying-Nai/0000-0002-5275-6729; Li, Long-Yuan/0000-0001-7472-8318	National Institutes of Health (NIH) [PO1 CA099031, RO1 CA109311]; National Breast Cancer Foundation, Inc.; Cancer Center Research of Excellence [DOH-99-TDC-111-05, NSC-2632-B-039-001-MY3, NSC-3111-B-039-002, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002, NSC-96-2917-I-006-004, NHRI-EX-98-9812BC, NHRI-EX98-9603BC, DOH97-TD-G-111-027]; University of Texas M. D. Anderson-China Medical University and Hospital; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Cancer Center Research of Excellence; University of Texas M. D. Anderson-China Medical University and Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA099031 and RO1 CA109311. This work was supported by the following grants: National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Cancer Center Research of Excellence DOH-99-TDC-111-05 (to M.-C. H.), NSC-2632-B-039-001-MY3 (to M.-C. H.), NSC-3111-B-039-002 (to M.-C. H. and L.-Y. L.), NSC-97-2320-B-039-033-MY3 (to W.-C. H.), NSC-98-3112-B-039-002 (to W.-C. H.), NSC-99-3112-B-039-002 (to W.-C. H.), NSC-96-2917-I-006-004 (to Y.-J. C.), NHRI-EX-98-9812BC (to W.-C. H.), NHRI-EX98-9603BC (to L.-Y. L.), DOH97-TD-G-111-027 (to M.-C. H.), and The University of Texas M. D. Anderson-China Medical University and Hospital Sister Institution Fund.	Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chou CK, 2009, MOL CARCINOGEN, V48, P1048, DOI 10.1002/mc.20557; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2008, RADIOTHER ONCOL, V86, P375, DOI 10.1016/j.radonc.2008.01.007; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Moasser MM, 2001, CANCER RES, V61, P7184; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	62	125	133	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20558	20568		10.1074/jbc.M111.240796	http://dx.doi.org/10.1074/jbc.M111.240796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487020	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000291267600042
J	Kisic, M; Matamoros, T; Nevot, M; Mendieta, J; Martinez-Picado, J; Martinez, MA; Menendez-Arias, L				Kisic, Monica; Matamoros, Tania; Nevot, Maria; Mendieta, Jesus; Martinez-Picado, Javier; Martinez, Miguel A.; Menendez-Arias, Luis			Thymidine Analogue Excision and Discrimination Modulated by Mutational Complexes Including Single Amino Acid Deletions of Asp-67 or Thr-69 in HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; DRUG-RESISTANCE; REPLICATION CAPACITY; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING; VIRAL REPLICATION; CATALYTIC COMPLEX; CODING REGION; ZIDOVUDINE	Single amino acid deletions in the beta 3-beta 4 hairpin loop of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have been identified in heavily treated patients. The deletion of Asp-67 together with mutations T69G and K70R (Delta 67 complex) are usually associated with thymidine analog resistance mutations (TAMs) (e. g. M41L, T215Y, etc.) while the deletion of Thr-69 (Delta 69) is rarely found in isolates containing TAMs. Here, we show that the complex Delta 67/T69G/K70R enhances ATP-dependent phosphorolytic activity on primers terminated with 3'-azido-3'-deoxythymidine (AZT) or 2',3'-didehydro-2',3terminated with 3'-azido-3'-deoxythymidine (AZT) or 2',3'-didehydro-2',3'-dideoxythymidine (d4T) both in the presence or absence of TAMs (i.e. M41L/T215Y), while Delta 69 (or the complex S68G/Delta 69/K70G) antagonize the effects of TAMs in ATP-mediated excision. These effects are consistent with AZT susceptibility data obtained with recombinant HIV-1 bearing the relevant RTs. Molecular dynamics studies based on models of wild-type HIV-1 RT and mutant Delta 69, Delta 67/T69G/K70R, and D67N/K70R RTs support a relevant role for Lys/Arg-70 in the excision reaction. In Delta 69 RT, the side chain of Lys-70 locates away from the putative pyrophosphate binding site. Therefore, its participation in interactions required for the excision reaction is unlikely. Our theoretical studies also suggest a role for Lys-219 in thymidine analog excision/discrimination. However, pre-steady-state kinetics revealed only minor differences in selectivity of AZT-triphosphate versus dTTP between deletion-containing RTs and their homologous enzymes having the K219E mutation. K219E reduced both ATP- and pyrophosphate-mediated excision of primers terminated with thymidine analogues, only when introduced in RTs bearing Delta 69 or S68G/Delta 69/K70G, providing further biochemical evidence that explains the lack of association of Delta 69 and TAMs in HIV-1 isolates.	[Kisic, Monica; Matamoros, Tania; Mendieta, Jesus; Menendez-Arias, Luis] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Kisic, Monica; Matamoros, Tania; Mendieta, Jesus; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Nevot, Maria; Martinez-Picado, Javier; Martinez, Miguel A.] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Lab Retrovirol, Barcelona 08916, Spain; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera,1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.uam.es	Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Matamoros, Tania/F-2580-2016; Martinez, Miguel Angel/K-6435-2014; Nevot, Maria/AAC-7839-2022; Martinez-Picado, Javier/G-5507-2012; Mendieta, Jesús/P-4802-2016; Nevot, Maria/E-6187-2016	Arias, Luis Menendez/0000-0002-1251-6640; Matamoros, Tania/0000-0001-9268-0696; Martinez, Miguel Angel/0000-0002-6681-4950; Nevot, Maria/0000-0003-4947-4648; Martinez-Picado, Javier/0000-0002-4916-2129; Mendieta, Jesús/0000-0002-5498-0871; Nevot, Maria/0000-0003-4947-4648; Mendieta, Jesus/0000-0001-9286-2166	Ministry of Science and Innovation of Spain [BIO2010/15542]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36771/08]; Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA") [RD06/006]; Fundacion Ramon Areces; Spanish Ministry of Science and Innovation [BFU2010-15194]; European Community; ICREA Funding Source: Custom	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA")(Instituto de Salud Carlos III); Fundacion Ramon Areces; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); ICREA(ICREA)	This work was supported by grants of the Ministry of Science and Innovation of Spain (BIO2010/15542), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) (Grant 36771/08), Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA" RD06/006), and an institutional grant from the Fundacion Ramon Areces. Work at Fundacio irsiCaixa was supported by Spanish Ministry of Science and Innovation Grant BFU2010-15194 (to M. A. M.), and by the European Community's Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)."	Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2004, J VIROL, V78, P9987, DOI 10.1128/JVI.78.18.9987-9997.2004; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Eggink D, 2007, ANTIVIR RES, V75, P93, DOI 10.1016/j.antiviral.2007.03.001; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Harrigan PR, 1996, J VIROL, V70, P5930, DOI 10.1128/JVI.70.9.5930-5934.1996; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Hooker DJ, 1996, J VIROL, V70, P8010, DOI 10.1128/JVI.70.11.8010-8018.1996; Hu ZX, 2007, JAIDS-J ACQ IMM DEF, V45, P494, DOI 10.1097/QAI.0b013e31806ada48; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Imamichi T, 2000, J VIROL, V74, P1023, DOI 10.1128/JVI.74.2.1023-1028.2000; Imamichi T, 2001, J VIROL, V75, P3988, DOI 10.1128/JVI.75.8.3988-3992.2001; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; LACEY SF, 1994, J VIROL, V68, P3421, DOI 10.1128/JVI.68.5.3421-3424.1994; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; MartinHernandez AM, 1997, NUCLEIC ACIDS RES, V25, P1383, DOI 10.1093/nar/25.7.1383; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Masquelier B, 2001, ANTIMICROB AGENTS CH, V45, P1836, DOI 10.1128/AAC.45.6.1836-1842.2001; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2009, J BIOL CHEM, V284, P32792, DOI 10.1074/jbc.M109.038885; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2006, CURR PHARM DESIGN, V12, P1811, DOI 10.2174/138161206776873608; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Naeger LK, 2001, ANTIVIR THER, V6, P115; Ross L, 2000, J HUMAN VIROL, V3, P144; Ross L, 2004, AIDS, V18, P1691, DOI 10.1097/01.aids.0000131355.44834.e4; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; Villena C, 2007, J VIROL, V81, P4713, DOI 10.1128/JVI.02135-06; Winters MA, 2000, J VIROL, V74, P10707, DOI 10.1128/JVI.74.22.10707-10713.2000; Yahi N, 1999, J CLIN MICROBIOL, V37, P4099, DOI 10.1128/JCM.37.12.4099-4106.1999	47	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20615	20624		10.1074/jbc.M111.226100	http://dx.doi.org/10.1074/jbc.M111.226100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504903	hybrid, Green Published			2022-12-27	WOS:000291267600048
J	Remacle, AG; Shiryaev, SA; Radichev, IA; Rozanov, DV; Stec, B; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Radichev, Ilian A.; Rozanov, Dmitri V.; Stec, Boguslaw; Strongin, Alex Y.			Dynamic Interdomain Interactions Contribute to the Inhibition of Matrix Metalloproteinases by Tissue Inhibitors of Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; X-RAY-STRUCTURE; COMPLEX-FORMATION; IV COLLAGENASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GELATINASE-A; FULL-LENGTH; 1-MATRIX METALLOPROTEINASE; INTEGRIN ALPHA-V-BETA-3	Because of their important function, matrix metalloproteinases (MMPs) are promising drug targets in multiple diseases, including malignancies. The structure of MMPs includes a catalytic domain, a hinge, and a hemopexin domain (PEX), which are followed by a transmembrane and cytoplasmic tail domains or by a glycosylphosphatidylinositol linker in membrane-type MMPs (MT-MMPs). TIMPs-1, -2, -3, and -4 are potent natural regulators of the MMP activity. These are the inhibitory N-terminal and the non-inhibitory C-terminal structural domains in TIMPs. Based on our structural modeling, we hypothesized that steric clashes exist between the non-inhibitory C-terminal domain of TIMPs and the PEX of MMPs. Conversely, a certain mobility of the PEX relative to the catalytic domain is required to avoid these obstacles. Because of its exceedingly poor association constant and, in contrast with TIMP-2, TIMP-1 is inefficient against MT1-MMP. We specifically selected an MT1-MMP . TIMP-1 pair to test our hypothesis, because any improvement of the inhibitory potency would be readily recorded. We characterized the domain-swapped MT1-MMP chimeras in which the PEX of MMP-2 (that forms a complex with TIMP-2) and of MMP-9 (that forms a complex with TIMP-1) replaced the original PEX in the MT1-MMP structure. In contrast with the wild-type MT1-MMP, the diverse proteolytic activities of the swapped-PEX chimeras were then inhibited by both TIMP-1 and TIMP-2. Overall, our studies suggest that the structural parameters of both domains of TIMPs have to be taken into account for their re-engineering to harness the therapeutic in vivo potential of the novel TIMP-based MMP antagonists with constrained selectivity.	[Remacle, Albert G.; Shiryaev, Sergey A.; Radichev, Ilian A.; Rozanov, Dmitri V.; Stec, Boguslaw; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [CA77470, CA83017]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77470 and CA83017 (to A. Y. S.).	Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Choi WS, 2008, J THROMB HAEMOST, V6, P517, DOI 10.1111/j.1538-7836.2007.02871.x; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Edwards DR, 1996, INT J OBESITY, V20, pS9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hutton M, 1998, BIOCHEMISTRY-US, V37, P10094, DOI 10.1021/bi980616p; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Lang R, 2004, J MOL BIOL, V336, P213, DOI 10.1016/j.jmb.2003.12.022; Lee MH, 2010, CANCER LETT, V290, P114, DOI 10.1016/j.canlet.2009.08.029; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase Hideaki, 2008, P787, DOI 10.1007/978-0-387-69057-5_37; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Rapti M, 2008, BIOCHEM J, V411, P433, DOI 10.1042/BJ20071430; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	65	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					21002	21012		10.1074/jbc.M110.200139	http://dx.doi.org/10.1074/jbc.M110.200139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518756	Green Published, hybrid			2022-12-27	WOS:000291267600084
J	Vila-Brau, A; De Sousa-Coelho, AL; Mayordomo, C; Haro, D; Marrero, PF				Vila-Brau, Anna; Luisa De Sousa-Coelho, Ana; Mayordomo, Cristina; Haro, Diego; Marrero, Pedro F.			Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; COA SYNTHASE GENE; 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; PPAR-ALPHA; RESPONSIVE ELEMENT; ADAPTIVE RESPONSE; KETONE-BODY; ENZYME; METABOLISM; KETOGENESIS	HMGCS2 (hydroxymethylglutaryl CoA synthase 2), the gene that regulates ketone body production, is barely expressed in cultured cell lines. In this study, we restored HMGCS2 expression and activity in HepG2 cells, thus showing that the wild type enzyme can induce fatty acid beta-oxidation (FAO) and ketogenesis, whereas a catalytically inactive mutant C166A did not generate either process. Peroxisome proliferator-activated receptor (PPAR) alpha expression also induces fatty acid beta-oxidation and endogenous HMGCS2 expression. Interestingly, PPAR alpha-mediated induction was abolished when HMGCS2 expression was down-regulated by RNAi. These results indicate that HMGCS2 expression is both sufficient and necessary to the control of fatty acid oxidation in these cells. Next, we examined the expression pattern of several PPAR alpha target genes in this now "ketogenic" HepG2 cell line. FGF21 (fibroblast growth factor 21) expression was specifically induced by HMGCS2 activity or by the inclusion of the oxidized form of ketone bodies (acetoacetate) in the culture medium. This effect was blunted by SirT1 (sirtuin 1) RNAi, so we propose a SirT1-dependent mechanism for FGF21 induction by acetoacetate. These data suggest a novel feed-forward mechanism by which HMGCS2 could regulate adaptive metabolic responses during fasting. This mechanism could be physiologically relevant, because fasting-mediated induction of liver FGF21 was dependent on SirT1 activity in vivo.	[Marrero, Pedro F.] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Sch Pharm, E-08028 Barcelona, Spain; Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Marrero, PF (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Sch Pharm, Joan XXIII S-N, E-08028 Barcelona, Spain.	pedromarrero@ub.edu	De Sousa Coelho, Ana Luísa/K-1651-2019; Haro, Diego/I-4623-2015; De Sousa-Coelho, Ana Luísa/V-1529-2019; Marrero, Pedro F/I-1919-2015	Haro, Diego/0000-0001-9147-0486; De Sousa-Coelho, Ana Luísa/0000-0002-8451-4302; Mayordomo Tella, Maria Cristina/0000-0003-3245-0818	Spanish Ministerio de Educacion y Ciencia [BFU2007-67322/BMC, SAF2010-15217]; Catalan government (Ajut de Suport als Grups de Recerca de Catalunya) [2005SGR00857, 2009SGR163]; Catalan government; Fundacao para a Ciencia e a Tecnologia through the Portuguese government;  [RCMNC03/08]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Catalan government (Ajut de Suport als Grups de Recerca de Catalunya); Catalan government; Fundacao para a Ciencia e a Tecnologia through the Portuguese government; 	This work was supported by Grants BFU2007-67322/BMC (to P. F. M.) and SAF2010-15217 (to D. H.) from the Spanish Ministerio de Educacion y Ciencia and RCMNC03/08 (to D. H.) and also by funding from the Catalan government (Ajut de Suport als Grups de Recerca de Catalunya Grants 2005SGR00857 and 2009SGR163).; Supported by Scholarship from Catalan government (Ajut al Personal Investigador, FI 2007-2011).; Supported by the Fundacao para a Ciencia e a Tecnologia through the Portuguese government.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barrero MJ, 2003, BIOCHEM J, V369, P721, DOI 10.1042/BJ20020851; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; KOUNDAKJIAN PP, 1970, BIOCHEM J, V119, P49, DOI 10.1042/bj1190049; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; MISRA I, 1993, J BIOL CHEM, V268, P12129; Napal L, 2005, J MOL BIOL, V354, P751, DOI 10.1016/j.jmb.2005.09.097; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ortiz JA, 1999, BIOCHEM J, V337, P329, DOI 10.1042/0264-6021:3370329; PRIPBUUS C, 1992, EUR J BIOCHEM, V209, P291, DOI 10.1111/j.1432-1033.1992.tb17288.x; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Quant Patti A., 1994, V28, P13; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; ROKOSZ LL, 1994, ARCH BIOCHEM BIOPHYS, V312, P1, DOI 10.1006/abbi.1994.1273; VALERA A, 1994, J BIOL CHEM, V269, P6267; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	34	89	92	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20423	20430		10.1074/jbc.M111.235044	http://dx.doi.org/10.1074/jbc.M111.235044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502324	hybrid, Green Published			2022-12-27	WOS:000291267600030
J	Chan, P; Gabay, M; Wright, FA; Tall, GG				Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Tall, Gregory G.			Ric-8B Is a GTP-dependent G Protein alpha(s) Guanine Nucleotide Exchange Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; HETEROTRIMERIC G-PROTEINS; FUNCTIONAL EXPRESSION; PLASMA-MEMBRANE; CORTICAL LOCALIZATION; MOLECULAR CHAPERONE; DROSOPHILA RIC-8; GAMMA-SUBUNITS; SF9 CELLS; PURIFICATION	ric-8 (resistance to inhibitors of cholinesterase 8) genes have positive roles in variegated G protein signaling pathways, including G alpha(q) and G alpha(s) regulation of neurotransmission, G alpha(i)-dependent mitotic spindle positioning during (asymmetric) cell division, and G alpha(olf)-dependent odorant receptor signaling. Mammalian Ric-8 activities are partitioned between two genes, ric-8A and ric-8B. Ric-8A is a guanine nucleotide exchange factor (GEF) for G alpha(i)/alpha(q)/alpha(12/13) subunits. Ric-8B potentiated G(s) signaling presumably as a G alpha(s)-class GEF activator, but no demonstration has shown Ric-8B GEF activity. Here, two Ric-8B isoforms were purified and found to be G alpha subunit GDP release factor/GEFs. In HeLa cells, full-length Ric-8B (Ric-8BFL) bound endogenously expressed G alpha s and lesser amounts of G alpha(q) and G alpha(13). Ric-8BFL stimulated guanosine 5 '-3-O-(thio) triphosphate (GTP gamma S) binding to these subunits andG alpha(olf), whereas the Ric-8B Delta 9 isoform stimulated G alpha(s) (short) GTP gamma S binding only. Michaelis-Menten experiments showed that Ric-8BFL elevated the V-max of G alpha(s) steady stateGTPhydrolysis and the apparent K-m values of GTP binding to G alpha(s) from similar to 385 nM to an estimated value of similar to 42 mu M. Directionality of the Ric-8BFL-catalyzed G alpha s exchange reaction was GTP-dependent. At sub-K-m GTP, Ric-BFL was inhibitory to exchange despite being a rapid GDP release accelerator. Ric-8BFL binds nucleotide-free G alpha s tightly, and near-K-m GTP levels were required to dissociate the Ric-8B.G alpha nucleotide-free intermediate to release free Ric-8B and G alpha-GTP. Ric-8BFL-catalyzed nucleotide exchange probably proceeds in the forward direction to produce G alpha-GTP in cells.	[Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Tall, GG (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	gregory_tall@urmc.rochester.edu		Chan, PuiYee/0000-0002-9133-9506	National Institutes of Health [GM088242]; New York State Stem Cell Science (NYSTEM) [C024307]; National Institute on Drug Abuse (NIDA) [T32 DA07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant GM088242 (to G. G. T.). This work was also supported by New York State Stem Cell Science (NYSTEM) Grant C024307 (to G. G. T.) and National Institute on Drug Abuse (NIDA) Grant T32 DA07232 (to P. C.).	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; ITOH H, 1991, J BIOL CHEM, V266, P16226; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KOZASA T, 1999, CRC METH SIG TRANS, P23; LEE E, 1994, METHOD ENZYMOL, V237, P146; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Malnic B, 2009, ANN NY ACAD SCI, V1170, P150, DOI 10.1111/j.1749-6632.2009.03874.x; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nagai Y, 2010, J BIOL CHEM, V285, P11114, DOI 10.1074/jbc.M109.063313; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; PANG IH, 1990, J BIOL CHEM, V265, P18707; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ross EM, 2002, METHOD ENZYMOL, V344, P601; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; SINGER WD, 1994, J BIOL CHEM, V269, P19796; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tall GG, 2004, METHOD ENZYMOL, V390, P377; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	50	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19932	19942		10.1074/jbc.M110.163675	http://dx.doi.org/10.1074/jbc.M110.163675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21467038	hybrid, Green Published			2022-12-27	WOS:000291027700072
J	Cho, SJ; Kim, YJ; Surh, YJ; Kim, BM; Lee, SK				Cho, Seung-Ju; Kim, Young-Jong; Surh, Young-Joon; Kim, B. Moon; Lee, Seung-Ki			Ibulocydine Is a Novel Prodrug Cdk Inhibitor That Effectively Induces Apoptosis in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; RNA-POLYMERASE-II; MULTIPLE-MYELOMA CELLS; RETINOBLASTOMA PROTEIN; DOWN-REGULATION; CYCLE; PHOSPHORYLATION; SURVIVAL; MCL-1; DEATH	Hepatocellular carcinoma (HCC) is frequently associated with abnormalities in cell cycle regulation, leading to increased activity of cyclin-dependent kinases (Cdks) due to the loss, or low expression of, Cdk inhibitors. In this study, we showed that ibulocydine (an isobutyrate prodrug of the specific Cdk inhibitor, BMK-Y101) is a candidate anti-cancer drug for HCC. Ibulocydine has high activity against Cdk7/cyclin H/Mat1 and Cdk9/cyclin T. Ibulocydine inhibited the growth of HCC cells more effectively than other Cdk inhibitors, including olomoucine and roscovitine, whereas ibulocydine as well as the other Cdk inhibitors and BMK-Y101 minimally influenced the growth of normal hepatocyte cells. Ibulocydine induced apoptosis in HCC cells, most likely by inhibiting Cdk7 and Cdk9. In vitro treatment of HCC cells with ibulocydine rapidly blocked phosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II, a process mediated by Cdk7/9. Anti-apoptotic gene products such as Mcl-1, survivin, and X-linked IAP (XIAP) are crucial for the survival of many cell types, including HCC. Following the inhibition of RNA polymerase II phosphorylation, ibulocydine caused rapid down-regulation of Mcl-1, survivin, and XIAP, thus inducing apoptosis. Furthermore, ibulocydine effectively induced apoptosis in HCC xenografts with no toxic side effects. These results suggest that ibulocydine is a strong candidate anti-cancer drug for the treatment of HCC.	[Cho, Seung-Ju; Surh, Young-Joon; Lee, Seung-Ki] Seoul Natl Univ, Div Pharmaceut Biosci, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Cho, Seung-Ju; Kim, Young-Jong; Kim, B. Moon] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BM (corresponding author), Seoul Natl Univ, Dept Chem, 599 Gwanakro, Seoul 151747, South Korea.	kimbm@snu.ac.kr; sklcrs@snu.ac.kr			Korea Science and Engineering Foundation [M108KB010025-08K0201-02510]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Fund for Functional Analysis of the Human Genome Grant M108KB010025-08K0201-02510, managed by The Center for Functional Analysis of Human Genome, from the 21st Century Frontier Research and Development program of the National Research and Development programs of the Korea Science and Engineering Foundation.	Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bregman DB, 2000, FRONT BIOSCI, V5, pD244, DOI 10.2741/Bregman; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen R, 2009, BLOOD, V113, P4637, DOI 10.1182/blood-2008-12-190256; Cho SJ, 2010, CANCER LETT, V287, P196, DOI 10.1016/j.canlet.2009.06.011; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Gomez-Bougie P, 2004, EUR J IMMUNOL, V34, P3156, DOI 10.1002/eji.200424981; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hirose Y, 2000, GENE DEV, V14, P1415; HUANG CC, 1992, J NATL CANCER I, V84, P262, DOI 10.1093/jnci/84.4.262; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lam LT, 2001, GENOME BIOL, V2; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Senderowicz AM, 2004, CURR OPIN CELL BIOL, V16, P670, DOI 10.1016/j.ceb.2004.09.014; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Silverman R.B, 2004, ORGANIC CHEM DRUG DE, P497; Sinhababu AK, 1996, ADV DRUG DELIVER REV, V19, P241, DOI 10.1016/0169-409X(95)00109-K; Svendsen A, 2000, BBA-PROTEIN STRUCT M, V1543, P223, DOI 10.1016/S0167-4838(00)00239-9; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Wu KM, 2009, PHARMACEUTICALS, V2, P77, DOI 10.3390/ph2030077; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	39	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19662	19671		10.1074/jbc.M110.209551	http://dx.doi.org/10.1074/jbc.M110.209551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478145	Green Published, hybrid			2022-12-27	WOS:000291027700049
J	Naimy, H; Buczek-Thomas, JA; Nugent, MA; Leymarie, N; Zaia, J				Naimy, Hicham; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Leymarie, Nancy; Zaia, Joseph			Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MASS-SPECTROMETRY; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; FGF; SPECIFICITY; OLIGOSACCHARIDES; PROTEIN	Human fibroblast growth factor-2 (FGF2) regulates cellular processes including proliferation, adhesion, motility, and angiogenesis. FGF2 exerts its biological function by binding and dimerizing its receptor (FGFR), which activates signal transduction cascades. Effective binding of FGF2 to its receptor requires the presence of heparan sulfate (HS), a linear polysaccharide with N-sulfated domains (NS) localized at the cell surface and extracellular matrix. HS acts as a platform facilitating the formation of a functional FGF-FGFR-HS ternary complex. Crystal structures of the signaling ternary complex revealed two conflicting architectures. In the asymmetrical model, two FGFs and two FGFRs bind a single HS chain. In contrast, the symmetrical model postulates that one FGF and one FGFR bind to the free end of the HS chain and dimerization require these ends to join, bringing the two half-complexes together. In this study, we screened a hexasaccharide HS library for compositions that are able to bind FGF2. The library was composed primarily of NS domains internal to the HS chain with minor presence of non-reducing end (NRE) NS. The binders were categorized into low versus high affinity binders. The low affinity fraction contained primarily hexasaccharides with low degree of sulfation that were internal to the HS chains. In contrast, the high affinity bound fraction was enriched in NRE oligosaccharides that were considerably more sulfated and had the ability to promote FGFR-mediated cell proliferation. The results suggest a role of the NRE of HS in FGF2 signaling and favor the formation of the symmetrical architecture on short NS domains.	[Naimy, Hicham; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Buczek-Thomas, JoAnn/0000-0003-2784-9453; Nugent, Matthew/0000-0002-8630-4712	National Institutes of Health [P41RR10888, R01HL098950, R01HL088572, S10RR020946]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL098950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR10888, R01HL098950, R01HL088572, and S10RR020946 for funding.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1986, NATURE, V322, P215, DOI 10.1038/322215b0; Conrad H. E., 1998, HEPARIN BINDING PROT; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KLAGSBRUN M, 1987, P NATL ACAD SCI USA, V84, P1839, DOI 10.1073/pnas.84.7.1839; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LEE JC, 1982, J IMMUNOL, V128, P2393; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2010, BIOCHEMISTRY-US, V49, P3743, DOI 10.1021/bi100135d; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yu YH, 2006, J AM SOC MASS SPECTR, V17, P524, DOI 10.1016/j.jasms.2005.12.008; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556; Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013	65	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19311	19319		10.1074/jbc.M110.204693	http://dx.doi.org/10.1074/jbc.M110.204693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21471211	Green Published, hybrid			2022-12-27	WOS:000291027700013
J	Shinkyo, R; Guengerich, FP				Shinkyo, Raku; Guengerich, F. Peter			Inhibition of Human Cytochrome P450 3A4 by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN CYTOCHROME-P450; DRUG-DRUG INTERACTIONS; HUMAN-LIVER-MICROSOMES; LIGAND-BINDING; ACTIVE-SITE; P450 REDUCTASE; OXIDATION; COOPERATIVITY; METABOLISM; 4-BETA-HYDROXYCHOLESTEROL	Cholesterol has been shown to be hydroxylated at the 4 beta-position by cytochrome P450 3A4, and the reaction occurs in vivo (Bodin, K., Andersson, U., Rystedt, E., Ellis, E., Norlin, M., Pikuleva, I., Eggertsen, G., Bjorkhem, I., and Diczfalusy, U. (2002) J. Biol. Chem. 277, 31534-31540). If cholesterol is a substrate of P450 3A4, then it follows that it should also be an inhibitor, particularly in light of the high concentrations found in liver. Heme perturbation spectra indicated a K-d value of 8 mu M for the P450 3A4-cholesterol complex. Cholesterol inhibited the P450 3A4-catalyzed oxidations of nifedipine and quinidine, two prototypic substrates, in liver microsomes and a reconstituted enzyme system with K-i similar to 10 mu M in an apparently non-competitive manner. The concentration of cholesterol could be elevated 4-6-fold in cultured human hepatocytes by incubation with cholesterol; the level of P450 3A4 and cell viability were not altered under the conditions used. Nifedipine oxidation was inhibited when the cholesterol level was increased. We conclude that cholesterol is both a substrate and an inhibitor of P450 3A4, and a model is presented to explain the kinetic behavior. We propose that the endogenous cholesterol in hepatocytes should be considered in models of prediction of metabolism of drugs and steroids, even in the absence of changes in the concentrations of free cholesterol.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Shinkyo, Raku/HIK-2997-2022		National Institutes of Health [R37 CA090426, P30 ES000267]; Eisai Co., Ltd.; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eisai Co., Ltd.(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and P30 ES000267 (to F. P. G.). This work was also supported by Eisai Co., Ltd. (to R. S.).	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; BOCKER RH, 1986, J MED CHEM, V29, P1596; Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x; Dixon M., 1964, ENZYMES, V2nd; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; GUENGERICH FP, 2009, INHIBITION DRUG META, P203; GUENGERICH FP, 1994, P 8 INT C CYT P450 B, P97; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HE YA, 2006, P 16 INT S MICR DRUG; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; Ohno Y, 2007, CLIN PHARMACOKINET, V46, P681, DOI 10.2165/00003088-200746080-00005; ONEIL MJ, 2001, MERCK INDEX, P2223; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SEGEL IH, 1975, ENZYME KINETICS, P109; Segel IH, 1975, ENZYME KINETICS BEHA; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; SHIMADA T, 1989, P NATL ACAD SCI USA, V86, P462, DOI 10.1073/pnas.86.2.462; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Sligar SG, 2007, DRUG METAB REV, V39, P567, DOI 10.1080/03602530701498521; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Soucek P, 1995, BIOCHEMISTRY-US, V34, P16013, DOI 10.1021/bi00049a015; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; UENG YF, 1995, CHEM RES TOXICOL, V8, P218, DOI 10.1021/tx00044a006; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	45	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18426	18433		10.1074/jbc.M111.240457	http://dx.doi.org/10.1074/jbc.M111.240457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21471209	Green Published, hybrid			2022-12-27	WOS:000290785700015
J	Kitamura, R; Fukatsu, R; Kakusho, N; Cho, YS; Taniyama, C; Yamazaki, S; Toh, G; Yanagi, K; Arai, N; Chang, HJ; Masai, H				Kitamura, Ryo; Fukatsu, Rino; Kakusho, Naoko; Cho, Yong-Soon; Taniyama, Chika; Yamazaki, Satoshi; Toh, Gaik-theng; Yanagi, Kazuo; Arai, Naoko; Chang, Ho-Jin; Masai, Hisao			Molecular Mechanism of Activation of Human Cdc7 Kinase BIPARTITE INTERACTION WITH Dbf4/ACTIVATOR OF S PHASE KINASE (ASK) ACTIVATION SUBUNIT STIMULATES ATP BINDING AND SUBSTRATE RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; DNA-REPLICATION; PROTEIN-KINASE; S-PHASE; CELL-CYCLE; HSK1 KINASE; REGULATORY SUBUNIT; MCM PROTEINS	Cdc7 is a serine/threonine kinase conserved from yeasts to human and is known to play a key role in the regulation of initiation at each replication origin. Its catalytic function is activated via association with the activation subunit Dbf4/activator of S phase kinase (ASK). It is known that two conserved motifs of Dbf4/ASK are involved in binding to Cdc7, and both are required for maximum activation of Cdc7 kinase. Cdc7 kinases possess unique kinase insert sequences (kinase insert I-III) that are inserted at defined locations among the conserved kinase domains. However, precise mechanisms of Cdc7 kinase activation are largely unknown. We have identified two segments on Cdc7, DAM-1 (Dbf4/ASK interacting motif-1; amino acids 448-457 near the N terminus of kinase insert III) and DAM-2 (C-terminal 10-amino acid segment), that interact with motif-M and motif-C of ASK, respectively, and are essential for kinase activation by ASK. The C-terminal 143-amino acid polypeptide (432-574) containing DAM-1 and DAM-2 can interact with Dbf4/ASK. Characterization of the purified ASK-free Cdc7 and Cdc7-ASK complex shows that ATP binding of the Cdc7 catalytic subunit requires Dbf4/ASK. However, the "minimum" Cdc7, lacking the entire kinase insert II and half of kinase insert III, binds to ATP and shows autophosphorylation activity in the absence of ASK. However, ASK is still required for phosphorylation of exogenous substrates by the minimum Cdc7. These results indicate bipartite interaction between Cdc7 and Dbf4/ASK subunits facilitates ATP binding and substrate recognition by the Cdc7 kinase.	[Kitamura, Ryo; Fukatsu, Rino; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Toh, Gaik-theng; Yanagi, Kazuo; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan; [Cho, Yong-Soon; Chang, Ho-Jin] CrystalGenomics Inc, Seoul 138736, South Korea; [Taniyama, Chika; Arai, Naoko] SBI Biotech Co Ltd, Minato Ku, Tokyo 1080071, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [23657081] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for basic scientific research (A) and a grant-in-aid for scientific research on priority area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Takeda Science Foundation, and by Astellas Foundation for Research on Metabolic Disorders (to H. M.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kim BJ, 2007, J BIOL CHEM, V282, P30029, DOI 10.1074/jbc.M703705200; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lei M, 2001, J CELL SCI, V114, P1447; MARCOTE MJ, 1993, MOL CELL BIOL, V13, P5122, DOI 10.1128/MCB.13.8.5122; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H., 1999, FRONT BIOSCI, V4, pD834; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Ogino K, 2006, P NATL ACAD SCI USA, V103, P8131, DOI 10.1073/pnas.0602498103; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sawa Masaaki, 2009, Drug Des Devel Ther, V2, P255; SCLAFANI RA, 1994, MOL MICROBIOL, V11, P805, DOI 10.1111/j.1365-2958.1994.tb00358.x; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Uno S., 2011, GENES CELLS IN PRESS; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	56	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23031	23043		10.1074/jbc.M111.243311	http://dx.doi.org/10.1074/jbc.M111.243311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536671	Green Published, hybrid			2022-12-27	WOS:000292025000038
J	Lopez-Santiago, LF; Brackenbury, WJ; Chen, CL; Isom, LL				Lopez-Santiago, Luis F.; Brackenbury, William J.; Chen, Chunling; Isom, Lori L.			Na+ Channel Scn1b Gene Regulates Dorsal Root Ganglion Nociceptor Excitability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNEL; SENSORY NEURONS; BETA-SUBUNITS; FUNCTIONAL EXPRESSION; RAT; CURRENTS; NA(V)1.8; CELLS; PAIN; AUTOTOMY	Nociceptive dorsal root ganglion (DRG) neurons express tetrodotoxin-sensitive (TTX-S) and -resistant (TTX-R) Na+ current (I-Na) mediated by voltage-gated Na+ channels (VGSCs). In nociceptive DRG neurons, VGSC beta 2 subunits, encoded by Scn2b, selectively regulate TTX-S alpha subunit mRNA and protein expression, ultimately resulting in changes in pain sensitivity. We hypothesized that VGSCs in nociceptive DRG neurons may also be regulated by beta 1 subunits, encoded by Scn1b. Scn1b null mice are models of Dravet Syndrome, a severe pediatric encephalopathy. Many physiological effects of Scn1b deletion on CNS neurons have been described. In contrast, little is known about the role of Scn1b in peripheral neurons in vivo. Here we demonstrate that Scn1b null DRG neurons exhibit a depolarizing shift in the voltage dependence of TTX-S INa inactivation, reduced persistent TTX-RINa, a prolonged rate of recovery of TTX-RINa from inactivation, and reduced cell surface expression of Na(v)1.9 compared with their WT littermates. Investigation of action potential firing shows that Scn1b null DRG neurons are hyperexcitable compared with WT. Consistent with this, transient outward K+ current (I-to) is significantly reduced in null DRG neurons. We conclude that Scn1b regulates the electrical excitability of nociceptive DRG neurons in vivo by modulating both I-Na and I-K.	[Lopez-Santiago, Luis F.; Brackenbury, William J.; Chen, Chunling; Isom, Lori L.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, 1301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	lisom@umich.edu	Brackenbury, William/AAD-1759-2019; Brackenbury, William/D-8029-2014	Brackenbury, William/0000-0001-6882-3351; Brackenbury, William/0000-0001-6882-3351; Isom, Lori/0000-0002-9479-6729	National Institutes of Health [R01MH059980]; University of Michigan Gastrointestinal Peptide Research Center [2P30DK34933]; University of Michigan Center for Organogenesis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059980] Funding Source: NIH RePORTER; Medical Research Council [G1000508] Funding Source: researchfish; MRC [G1000508] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Gastrointestinal Peptide Research Center(University of Michigan System); University of Michigan Center for Organogenesis(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH059980 (to L. L. I.) and 2P30DK34933 (from the University of Michigan Gastrointestinal Peptide Research Center to L. F. L.-S.). This work was also supported by a University of Michigan Center for Organogenesis Non-traditional Postdoctoral Fellowship (to W.J.B.).	Abdulla FA, 2002, J NEUROPHYSIOL, V88, P2518, DOI 10.1152/jn.00913.2001; Abdulla FA, 2001, J NEUROPHYSIOL, V85, P644, DOI 10.1152/jn.2001.85.2.644; Akopian A. N., 1999, NATURE, V402, P541; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Blackburn-Munro G, 1999, NEUROSCIENCE, V90, P153, DOI 10.1016/S0306-4522(98)00415-1; Blair NT, 2002, J NEUROSCI, V22, P10277; Brackenbury WJ, 2008, EXPERT OPIN THER TAR, V12, P1191, DOI 10.1517/14728222.12.9.1191 ; Brackenbury WJ, 2006, J PHYSIOL-LONDON, V573, P343, DOI 10.1113/jphysiol.2006.106906; Brackenbury WJ, 2008, NEUROSCIENTIST, V14, P571, DOI 10.1177/1073858408320293; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Cummins TR, 1997, J NEUROSCI, V17, P3503; Dang K, 2004, AM J PHYSIOL-GASTR L, V286, pG573, DOI 10.1152/ajpgi.00258.2003; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Safronov BV, 1996, J PHYSIOL-LONDON, V493, P393, DOI 10.1113/jphysiol.1996.sp021391; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Vijayaragavan K, 2004, BIOCHEM BIOPH RES CO, V319, P531, DOI 10.1016/j.bbrc.2004.05.026; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xu GY, 2006, AM J PHYSIOL-GASTR L, V291, pG424, DOI 10.1152/ajpgi.00560.2005	36	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22913	22923		10.1074/jbc.M111.242370	http://dx.doi.org/10.1074/jbc.M111.242370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555511	hybrid, Green Published			2022-12-27	WOS:000292025000026
J	Pefani, DE; Dimaki, M; Spella, M; Karantzelis, N; Mitsiki, E; Kyrousi, C; Symeonidou, IE; Perrakis, A; Taraviras, S; Lygerou, Z				Pefani, Dafni-Eleutheria; Dimaki, Maria; Spella, Magda; Karantzelis, Nickolas; Mitsiki, Eirini; Kyrousi, Christina; Symeonidou, Ioanna-Eleni; Perrakis, Anastassis; Taraviras, Stavros; Lygerou, Zoi			Idas, a Novel Phylogenetically Conserved Geminin-related Protein, Binds to Geminin and Is Required for Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CEREBRAL-CORTEX; EMBRYONIC-DEVELOPMENT; G(2)/M CHECKPOINT; LICENSING FACTOR; CHROMOSOMAL DNA; RE-REPLICATION; NEURAL PLATE; CDT1; INHIBITION	Development and homeostasis of multicellular organisms relies on an intricate balance between cell proliferation and differentiation. Geminin regulates the cell cycle by directly binding and inhibiting the DNA replication licensing factor Cdt1. Geminin also interacts with transcriptional regulators of differentiation and chromatin remodelling factors, and its balanced interactions are implicated in proliferation-differentiation decisions during development. Here, we describe Idas (Idas being a cousin of the Gemini in Ancient Greek Mythology), a previously uncharacterised coiled-coil protein related to Geminin. We show that human Idas localizes to the nucleus, forms a complex with Geminin both in cells and in vitro through coiled-coil mediated interactions, and can change Geminin subcellular localization. Idas does not associate with Cdt1 and prevents Geminin from binding to Cdt1 in vitro. Idas depletion from cells affects cell cycle progression; cells accumulate in S phase and are unable to efficiently progress to mitosis. Idas protein levels decrease in anaphase, whereas its overexpression causes mitotic defects. During development, we show that Idas exhibits high level expression in the choroid plexus and the cortical hem of the mouse telencephalon. Our data highlight Idas as a novel Geminin binding partner, implicated in cell cycle progression, and a putative regulator of proliferation-differentiation decisions during development.	[Pefani, Dafni-Eleutheria; Dimaki, Maria; Symeonidou, Ioanna-Eleni; Lygerou, Zoi] Univ Patras, Sch Med, Biol Lab, Patras 26505, Greece; [Spella, Magda; Karantzelis, Nickolas; Kyrousi, Christina; Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26505, Greece; [Mitsiki, Eirini; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	University of Patras; University of Patras; Netherlands Cancer Institute	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Biol Lab, Patras 26505, Greece.	lygerou@med.upatras.gr	Perrakis, Anastassis/E-8704-2013; Taraviras, Stavros/AAJ-4690-2020	Perrakis, Anastassis/0000-0002-1151-6227; Taraviras, Stavros/0000-0002-7455-647X; Kyrousi, Christina/0000-0002-6234-8382; Karantzelis, Nikolaos/0000-0002-6582-6757	Association for International Cancer Research; European Grants; Erasmus and FEBS Summer Fellowships	Association for International Cancer Research; European Grants; Erasmus and FEBS Summer Fellowships	This work was supported by the Association for International Cancer Research, European Grants HYGEIA and 3D-Repertoire, and Erasmus and FEBS Summer Fellowships (to D. P. and N. K.).	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Boos A, 2006, BIOL CELL, V98, P363, DOI 10.1042/BC20060007; Cara E, 2007, TRENDS CELL BIOL, V17, P580, DOI 10.1016/j.tcb.2007.09.008; Caro E, 2007, NATURE, V447, P213, DOI 10.1038/nature05763; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gemund C, 2001, NUCLEIC ACIDS RES, V29, P1272, DOI 10.1093/nar/29.6.1272; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lygerou Z, 2000, SCIENCE, V290, P2271; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Thepaut M, 2004, J MOL BIOL, V342, P275, DOI 10.1016/j.jmb.2004.06.065; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	52	36	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23234	23246		10.1074/jbc.M110.207688	http://dx.doi.org/10.1074/jbc.M110.207688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543332	Green Published, hybrid			2022-12-27	WOS:000292025000057
J	Tavoosi, N; Davis-Harrison, RL; Pogorelov, TV; Ohkubo, YZ; Arcario, MJ; Clay, MC; Rienstra, CM; Tajkhorshid, E; Morrissey, JH				Tavoosi, Narjes; Davis-Harrison, Rebecca L.; Pogorelov, Taras V.; Ohkubo, Y. Zenmei; Arcario, Mark J.; Clay, Mary C.; Rienstra, Chad M.; Tajkhorshid, Emad; Morrissey, James H.			Molecular Determinants of Phospholipid Synergy in Blood Clotting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; MEMBRANE-BINDING; FACTOR VIIA; DYNAMICS; PHOSPHATIDYLSERINE; PROTEIN; COAGULATION; VESICLES; EXPOSURE; SYSTEMS	Many regulatory processes in biology involve reversible association of proteins with membranes. Clotting proteins bind to phosphatidylserine (PS) on cell surfaces, but a clear picture of this interaction has yet to emerge. We present a novel explanation for membrane binding by GLA domains of clotting proteins, supported by biochemical studies, solid-state NMR analyses, and molecular dynamics simulations. The model invokes a single "phospho-L-serine-specific" interaction and multiple "phosphate-specific" interactions. In the latter, the phosphates in phospholipids interact with tightly bound Ca2+ in GLA domains. We show that phospholipids with any headgroup other than choline strongly synergize with PS to enhance factor X activation. We propose that phosphatidylcholine and sphingomyelin (the major external phospholipids of healthy cells) are anticoagulant primarily because their bulky choline headgroups sterically hinder access to their phosphates. Following cell damage or activation, exposed PS and phosphatidylethanolamine collaborate to bind GLA domains by providing phospho-L-serine-specific and phosphate-specific interactions, respectively.	[Morrissey, James H.] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA; [Clay, Mary C.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Pogorelov, Taras V.; Ohkubo, Y. Zenmei; Arcario, Mark J.; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Arcario, Mark J.; Rienstra, Chad M.; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Morrissey, JH (corresponding author), Univ Illinois, Dept Biochem, Coll Med, 417 Med Sci Bldg,MC 714,506 S Mathews Ave, Urbana, IL 61801 USA.	jhmorris@illinois.edu	Morrissey, James H/H-4933-2011; Pogorelov, Taras/AAH-8587-2020; Tajkhorshid, Emad/AAN-8323-2021; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; Pogorelov, Taras/0000-0001-5851-7721; Arcario, Mark/0000-0001-5017-1519; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [R01 HL47014, R01 HL103999, R01 GM086749, R01 GM067887, R01 GM075937, P41 RR05969]; American Heart Association [0920045G];  [MCA06N060]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103999, R01HL047014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075937, R01GM067887, R01GM086749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL47014, R01 HL103999, R01 GM086749, R01 GM067887, R01 GM075937, and P41 RR05969. This work was also supported by American Heart Association Postdoctoral Fellowship 0920045G to R. L. D.-H. All simulations were performed using computer time on TeraGrid resources (Grant MCA06N060).	Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Boettcher JM, 2011, BIOCHEMISTRY-US, V50, P2264, DOI 10.1021/bi1013694; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mann K G, 1976, Methods Enzymol, V45, P123; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Morrissey JH, 2004, INT J HEMATOL, V79, P103, DOI 10.1532/IJH97.03167; Murzyn K, 2006, BIOINTERPHASES, V1, P98, DOI 10.1116/1.2354573; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Ohkubo YZ, 2008, STRUCTURE, V16, P72, DOI 10.1016/j.str.2007.10.021; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SCHROIT AJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P313, DOI 10.1016/0304-4157(91)90019-S; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Smeets EF, 1996, THROMB RES, V81, P419, DOI 10.1016/0049-3848(96)00014-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; VANGEET AL, 1968, ANAL CHEM, V40, P2227, DOI 10.1021/ac50158a064; Waters EK, 2006, BIOCHEMISTRY-US, V45, P3769, DOI 10.1021/bi052600m; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	32	78	82	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23247	23253		10.1074/jbc.M111.251769	http://dx.doi.org/10.1074/jbc.M111.251769			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561861	Green Published, hybrid			2022-12-27	WOS:000292025000058
J	Karpowicz, SJ; Prochnik, SE; Grossman, AR; Merchant, SS				Karpowicz, Steven J.; Prochnik, Simon E.; Grossman, Arthur R.; Merchant, Sabeeha S.			The GreenCut2 Resource, a Phylogenomically Derived Inventory of Proteins Specific to the Plant Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS GENOME REVEALS; I SIGNAL PEPTIDASE; PLASTID EVOLUTION; PROTEOME DATABASE; GENE-EXPRESSION; BZIP PROTEIN; ARABIDOPSIS; CHLOROPLAST; LOCALIZATION; REINHARDTII	The plastid is a defining structure of photosynthetic eukaryotes and houses many plant-specific processes, including the light reactions, carbon fixation, pigment synthesis, and other primary metabolic processes. Identifying proteins associated with catalytic, structural, and regulatory functions that are unique to plastid-containing organisms is necessary to fully define the scope of plant biochemistry. Here, we performed phylogenomics on 20 genomes to compile a new inventory of 597 nucleus-encoded proteins conserved in plants and green algae but not in non-photosynthetic organisms. 286 of these proteins are of known function, whereas 311 are not characterized. This inventory was validated as applicable and relevant to diverse photosynthetic eukaryotes using an additional eight genomes from distantly related plants (including Micromonas, Selaginella, and soybean). Manual curation of the known proteins in the inventory established its importance to plastid biochemistry. To predict functions for the 52% of proteins of unknown function, we used sequence motifs, subcellular localization, co-expression analysis, and RNA abundance data. We demonstrate that 18% of the proteins in the inventory have functions outside the plastid and/or beyond green tissues. Although 32% of proteins in the inventory have homologs in all cyanobacteria, unexpectedly, 30% are eukaryote-specific. Finally, 8% of the proteins of unknown function share no similarity to any characterized protein and are plant lineage-specific. We present this annotated inventory of 597 proteins as a resource for functional analyses of plant-specific biochemistry.	[Karpowicz, Steven J.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Prochnik, Simon E.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Carnegie Institution for Science	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu			National Institutes of Health [GM07185]; Ruth L. Kirschstein National Research Service Award; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; departmental Majeti-Alapati Fellowship; National Science Foundation [MCB-095 1094]; United States Department of Energy [DE-FG02-07ER64427, DE-FC02-02ER63421]; Div Of Molecular and Cellular Bioscience [0951094] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); departmental Majeti-Alapati Fellowship; National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07185, a Ruth L. Kirschstein National Research Service Award (to S.J.K.). This work was also supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231 (to S.E.P.).; Supported in part by a departmental Majeti-Alapati Fellowship.; Supported by National Science Foundation Grant MCB-095 1094 and United States Department of Energy Grant DE-FG02-07ER64427.; Supported by United States Department of Energy Cooperative Agreement DE-FC02-02ER63421 (to David Eisenberg). To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, UCLA, 607 Charles E. Young Dr. E., Los Angeles, CA 90095-1569. Tel.: 310-825-8300; Fax: 310-206-1035; E-mail: sabeeha@chem.ucla.edu.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P5029, DOI 10.1093/nar/gkh833; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Belhaj K, 2009, PLANT J, V58, P287, DOI 10.1111/j.1365-313X.2008.03779.x; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bonsegna S, 2005, ARCH BIOCHEM BIOPHYS, V443, P74, DOI 10.1016/j.abb.2005.09.003; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; CASTRUITA M, 2011, PLANT CELL, DOI DOI 10.1105/TCP.111.084400; Chang CW, 2005, PLANT PHYSIOL, V138, P319, DOI 10.1104/pp.105.059550; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Comas I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S7; Conte MG, 2008, NUCLEIC ACIDS RES, V36, pD991, DOI 10.1093/nar/gkm934; Corami F, 2005, J ENVIRON MONITOR, V7, P1256, DOI 10.1039/b507323p; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Galland N, 2010, EUR J CELL BIOL, V89, P621, DOI 10.1016/j.ejcb.2010.04.001; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; Jancek S, 2008, MOL BIOL EVOL, V25, P2293, DOI 10.1093/molbev/msn168; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kleffmann T, 2006, PLANT CELL PHYSIOL, V47, P432, DOI 10.1093/pcp/pcj005; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Murata N, 2006, J EXP BOT, V57, P235, DOI 10.1093/jxb/erj005; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sasaki NV, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap025; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaistij FE, 2000, P NATL ACAD SCI USA, V97, P14813, DOI 10.1073/pnas.97.26.14813; van Wijk KJ, 2004, PLANT PHYSIOL BIOCH, V42, P963, DOI 10.1016/j.plaphy.2004.10.015; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhu JH, 2007, MOL CELL BIOL, V27, P5214, DOI 10.1128/MCB.01989-06	90	80	81	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21427	21439		10.1074/jbc.M111.233734	http://dx.doi.org/10.1074/jbc.M111.233734			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515685	Green Published, hybrid			2022-12-27	WOS:000291464700041
J	Ticu, C; Murataliev, M; Nechifor, R; Wilson, KS				Ticu, Cristina; Murataliev, Marat; Nechifor, Roxana; Wilson, Kevin S.			A Central Interdomain Protein Joint in Elongation Factor G Regulates Antibiotic Sensitivity, GTP Hydrolysis, and Ribosome Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSIDIC ACID RESISTANCE; TRANSFER-RNA TRANSLOCATION; FACTOR EF-G; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; FACTOR TU; THERMUS-THERMOPHILUS; DOMAIN-III; BINDING; SWITCH	The antibiotic fusidic acid potently inhibits bacterial translation (and cellular growth) by lodging between domains I and III of elongation factor G (EF-G) and preventing release of EF-G from the ribosome. We examined the functions of key amino acid residues near the active site of EF-G that interact with fusidic acid and regulate hydrolysis of GTP. Alanine mutants of these residues spontaneously hydrolyzed GTP in solution, bypassing the normal activating role of the ribosome. A conserved phenylalanine in the switch II element of EF-G was important for suppressing GTP hydrolysis in solution and critical for catalyzing translocation of the ribosome along mRNA. These experimental results reveal the multipurpose roles of an interdomain joint in the heart of an essential translation factor that can both promote and inhibit bacterial translation.	[Wilson, Kevin S.] Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr 246, Stillwater, OK 74078 USA; [Ticu, Cristina; Murataliev, Marat; Nechifor, Roxana; Wilson, Kevin S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Oklahoma State University System; Oklahoma State University - Stillwater; University of Alberta	Wilson, KS (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr 246, Stillwater, OK 74078 USA.	kevin.s.wilson@okstate.edu			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Castanheira M, 2010, ANTIMICROB AGENTS CH, V54, P3614, DOI 10.1128/AAC.01390-09; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johanson U, 1996, J MOL BIOL, V258, P420, DOI 10.1006/jmbi.1996.0259; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Macvanin M, 2000, MOL MICROBIOL, V37, P98, DOI 10.1046/j.1365-2958.2000.01967.x; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; Nguyen B, 2010, J MOL BIOL, V397, P1245, DOI 10.1016/j.jmb.2010.02.039; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Turnidge J, 1999, INT J ANTIMICROB AG, V12, pS23, DOI 10.1016/S0924-8579(98)00071-5; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910	40	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21697	21705		10.1074/jbc.M110.214056	http://dx.doi.org/10.1074/jbc.M110.214056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531717	hybrid, Green Published			2022-12-27	WOS:000291464700066
J	Zhou, W; Brush, MH; Choy, MS; Shenolikar, S				Zhou, Wei; Brush, Matthew H.; Choy, Meng S.; Shenolikar, Shirish			Association with Endoplasmic Reticulum Promotes Proteasomal Degradation of GADD34 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 2; MESSENGER-RNA TRANSLATION; DNA-DAMAGE; GROWTH ARREST; ALPHA-SUBUNIT; ER STRESS; APOPTOSIS; CELLS; DEPHOSPHORYLATION; ACTIVATION	Stress-induced endogenous and ectopically expressed GADD34 proteins were present both in the cytoplasm and in membranes, with their membrane association showing similar biochemical properties. Deletion of N-terminal sequences in GADD34-GFP proteins highlighted an amphipathic helix, whose hydrophobic surface, specifically valine 25 and leucine 29, mediated endoplasmic reticulum (ER) localization. Substitution of leucines for three arginines on the polar surface indicated that the same helix also mediated the association of GADD34 with mitochondria. Fluorescence protease protection and chemical modification of cysteines substituted in the membrane-binding domain pointed to a monotopic insertion of GADD34 into the outer layer of the ER membrane. Fluorescence recovery after photobleaching showed that ER association retards the mobility of GADD34 in living cells. Both WT GADD34 and the mutant, V25R, effectively scaffolded the alpha-isoform of protein phosphatase-1 (PP1 alpha) and enabled eIF2 alpha dephosphorylation. However, the largely cytosolic V25R protein displayed a reduced rate of proteasomal degradation, and unlike WT GADD34, whose ectopic expression resulted in a dilated or distended ER, V25R did not modify ER morphology. These studies suggested that the association of with ER modulates intracellular trafficking and proteasomal degradation of GADD34, and in turn, its ability to modify ER morphology.	[Zhou, Wei; Choy, Meng S.; Shenolikar, Shirish] Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Zhou, Wei; Choy, Meng S.; Shenolikar, Shirish] Duke NUS Grad Med Sch, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Brush, Matthew H.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Shenolikar, S (corresponding author), Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	Shirish.Shenolikar@duke-nus.edu.sg		Choy, Meng Shyan/0000-0002-7590-3031	Duke-NUS Graduate Medical School; National Medical Research Council [IRG09nov003]	Duke-NUS Graduate Medical School; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by research funds provided by Duke-NUS Graduate Medical School and an individual research grant (IRG09nov003) from the National Medical Research Council (to S. S.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Garrido JL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-231; Gill MB, 2009, J NEUROSCI RES, V87, P2047, DOI 10.1002/jnr.22019; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Imai H, 2002, EUR J NEUROSCI, V15, P1929, DOI 10.1046/j.1460-9568.2002.02025.x; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LORD KA, 1990, CELL GROWTH DIFFER, V1, P637; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shnyrova A, 2008, CURR BIOL, V18, pR474, DOI 10.1016/j.cub.2008.04.031; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Yamamoto A, 1996, J CELL SCI, V109, P1727; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	40	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21687	21696		10.1074/jbc.M110.212787	http://dx.doi.org/10.1074/jbc.M110.212787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518769	hybrid, Green Published			2022-12-27	WOS:000291464700065
J	Hagglund, MGA; Sreedharan, S; Nilsson, VCO; Shaik, JHA; Almkvist, IM; Backlin, S; Wrange, O; Fredriksson, R				Hagglund, Maria G. A.; Sreedharan, Smitha; Nilsson, Victor C. O.; Shaik, Jafar H. A.; Almkvist, Ingrid M.; Backlin, Sofi; Wrange, Orjan; Fredriksson, Robert			Identification of SLC38A7 (SNAT7) Protein as a Glutamine Transporter Expressed in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; SYSTEM N; NITROGEN-METABOLISM; GLIAL-CELLS; CLONING; LIVER; LOCALIZATION; SUBTYPE; DISTRIBUTIONS; ORGANIZATION	The SLC38 family of transporters has in total 11 members in humans and they encode amino acid transporters called sodium-coupled amino acid transporters (SNAT). To date, five SNATs have been characterized and functionally subdivided into systems A (SLC38A1, SLC38A2, and SLC38A4) and N (SLC38A3 and SLC38A5) showing the highest transport for glutamine and alanine. Here we present identification of a novel glutamine transporter encoded by the Slc38a7 gene, which we propose should be named SNAT7. This transporter has L-glutamine as the preferred substrate but also transports other amino acids with polar side chains, as well as L-histidine and L-alanine. The expression pattern and substrate profile for SLC38A7 shows highest similarity to the known system N transporters. Therefore, we propose that SLC38A7 is a novel member of this system. We used in situ hybridization and immunohistochemistry with a custom-made antibody to show that SLC38A7 is expressed in all neurons, but not in astrocytes, in the mouse brain. SLC38A7 is unique in being the first system N transporter expressed in GABAergic and also other neurons. The preferred substrate and axonal localization of SLC38A7 close to the synaptic cleft indicates that SLC38A7 could have an important function for the reuptake and recycling of glutamate.	[Hagglund, Maria G. A.; Sreedharan, Smitha; Nilsson, Victor C. O.; Shaik, Jafar H. A.; Almkvist, Ingrid M.; Backlin, Sofi; Fredriksson, Robert] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden; [Wrange, Orjan] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Uppsala University; Karolinska Institutet	Fredriksson, R (corresponding author), Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden.	Robert.Fredriksson@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019	Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council [VR-NT 2008-3228, VR-M 2008-66X]; Ahlens Foundation; Novo Nordisk Foundation; Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Swedish Cancer Foundation [09-0786]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Swedish Cancer Foundation	This work was supported in part by Swedish Research Council Grant VR-NT 2008-3228 (to R. F.), Ahlens Foundation, The Novo Nordisk Foundation, The Goran Gustafsson Foundation, Engkvist Foundation, and the Magnus Bergvall Foundation.; Supported by Swedish Research Council Grant VR-M 2008-66X and Swedish Cancer Foundation Grant 09-0786.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Armano S, 2002, J BIOL CHEM, V277, P10467, DOI 10.1074/jbc.M110942200; BARKER GA, 1990, EXP PHYSIOL, V75, P3, DOI 10.1113/expphysiol.1990.sp003382; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHRISTENSEN HN, 1985, J MEMBRANE BIOL, V84, P97, DOI 10.1007/BF01872207; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gelius B, 2001, EXP CELL RES, V265, P319, DOI 10.1006/excr.2001.5184; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; He Lei, 2009, Human Genomics, V3, P195; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HUBER G, 1984, J NEUROSCI, V4, P151; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37; LAAKE JH, 1995, J NEUROCHEM, V65, P871; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; PENG L, 1993, DEV NEUROSCI-BASEL, V15, P367, DOI 10.1159/000111357; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Tamarappoo BK, 1997, J NEUROCHEM, V68, P954; Tanaka K, 2005, NEUROSCI LETT, V378, P70, DOI 10.1016/j.neulet.2004.12.030; Umapathy NS, 2008, INVEST OPHTH VIS SCI, V49, P5151, DOI 10.1167/iovs.08-2245; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Watford M, 2000, J NUTR, V130, p983S, DOI 10.1093/jn/130.4.983S; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776	59	85	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20500	20511		10.1074/jbc.M110.162404	http://dx.doi.org/10.1074/jbc.M110.162404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21511949	Green Published, hybrid			2022-12-27	WOS:000291267600037
J	Loveless, BC; Mason, JW; Sakurai, T; Inoue, N; Razavi, M; Pearson, TW; Boulanger, MJ				Loveless, Bianca C.; Mason, Jeremy W.; Sakurai, Tatsuya; Inoue, Noboru; Razavi, Morteza; Pearson, Terry W.; Boulanger, Martin J.			Structural Characterization and Epitope Mapping of the Glutamic Acid/Alanine-rich Protein from Trypanosoma congolense DEFINING ASSEMBLY ON THE PARASITE CELL SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFRICAN TRYPANOSOMES; PROCYCLIN COAT; GLYCOPROTEIN; IDENTIFICATION; EXPRESSION; FORMS	Trypanosoma congolense is an African trypanosome that causes serious disease in cattle in Sub-Saharan Africa. The four major life cycle stages of T. congolense can be grown in vitro, which has led to the identification of several cell-surface molecules expressed on the parasite during its transit through the tsetse vector. One of these, glutamic acid/alanine-rich protein (GARP), is the first expressed on procyclic forms in the tsetse midgut and is of particular interest because it replaces the major surface coat molecule of bloodstream forms, the variant surface glycoprotein (VSG) that protects the parasite membrane, and is involved in antigenic variation. Unlike VSG, however, the function of GARP is not known, which necessarily limits our understanding of parasite survival in the tsetse. Toward establishing the function of GARP, we report its three-dimensional structure solved by iodide phasing to a resolution of 1.65A. An extended helical bundle structure displays an unexpected and significant degree of homology to the core structure of VSG, the only other major surface molecule of trypanosomes to be structurally characterized. Immunofluorescence microscopy and immunoaffinity-tandem mass spectrometry were used in conjunction with monoclonal antibodies to map both non-surface-disposed and surface epitopes. Collectively, these studies enabled us to derive a model describing the orientation and assembly of GARP on the surface of trypanosomes. The data presented here suggest the possible structure-function relationships involved in replacement of the bloodstream form VSG by GARP as trypanosomes differentiate in the tsetse vector after a blood meal.	[Loveless, Bianca C.; Mason, Jeremy W.; Razavi, Morteza; Pearson, Terry W.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Sakurai, Tatsuya; Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	University of Victoria; Obihiro University of Agriculture & Veterinary Medicine	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Natural Sciences and Engineering Research Council of Canada; University of Victoria	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Victoria	This work was supported in part by separate Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (to M.J.B. and T.W.P.).; Supported in part by a University of Victoria graduate award.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYNE RAL, 1993, MOL BIOCHEM PARASIT, V61, P295, DOI 10.1016/0166-6851(93)90075-9; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; Butikofer P, 2002, MOL BIOCHEM PARASIT, V119, P7, DOI 10.1016/S0166-6851(01)00382-6; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FISH WR, 1989, BIOCHEMISTRY-US, V28, P5415, DOI 10.1021/bi00439a015; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; Haines LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000793; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pearson TW, 2000, MOL BIOCHEM PARASIT, V111, P333, DOI 10.1016/S0166-6851(00)00327-3; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; RODITI I, 1990, PARASITOL TODAY, V6, P79, DOI 10.1016/0169-4758(90)90216-Q; Sakurai T, 2008, MOL BIOCHEM PARASIT, V161, P1, DOI 10.1016/j.molbiopara.2008.05.003; STEBECK CR, 1994, EXP PARASITOL, V78, P432, DOI 10.1006/expr.1994.1050; Swallow B.M, 2000, PAAT TECHNICAL SCI S, V2; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; TOLSON DL, 1990, INFECT IMMUN, V58, P3500, DOI 10.1128/IAI.58.11.3500-3507.1990; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; VICKERMAN K, 1969, J CELL SCI, V5, P163; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; ZWEYGARTH E, 1987, PARASITOL RES, V73, P479, DOI 10.1007/BF00538209	28	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20658	20665		10.1074/jbc.M111.218941	http://dx.doi.org/10.1074/jbc.M111.218941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21471223	Green Published, hybrid			2022-12-27	WOS:000291267600052
J	Pinto, JR; Yang, SW; Hitz, MP; Parvatiyar, MS; Jones, MA; Liang, JS; Kokta, V; Talajic, M; Tremblay, N; Jaeggi, M; Andelfinger, G; Potter, JD				Pinto, Jose Renato; Yang, Shi Wei; Hitz, Marc-Phillip; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Kokta, Victor; Talajic, Mario; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor; Potter, James D.			Fetal Cardiac Troponin Isoforms Rescue the Increased Ca2+ Sensitivity Produced by a Novel Double Deletion in Cardiac Troponin T Linked to Restrictive Cardiomyopathy A CLINICAL, GENETIC, AND FUNCTIONAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MUSCLE-CONTRACTION; FORCE DEVELOPMENT; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; HEART-FAILURE; FAILING HEART; MOUSE MODEL; MUTATIONS	A novel double deletion in cardiac troponin T (cTnT) of two highly conserved amino acids (Asn-100 and Glu-101) was found in a restrictive cardiomyopathic (RCM) pediatric patient. Clinical evaluation revealed the presence of left atrial enlargement and marked left ventricle diastolic dysfunction. The explanted heart examined by electron microscopy revealed myofibrillar disarray and mild fibrosis. Pedigree analysis established that this mutation arose de novo. The patient tested negative for six other sarcomeric genes. The single and double recombinant cTnT mutants were generated, and their functional consequences were analyzed in porcine skinned cardiac muscle. In the adult Tn environment (cTnT3 + cardiac troponin I), the single cTnT3-Delta N100 and cTnT3-Delta E101 mutations had opposing effects on the Ca2+ sensitivity of force development compared with WT, whereas the double deletion cTnT3-Delta N100/Delta E101 increased the Ca2+ sensitivity + 0.19 pCa units. In addition, cTnT3-Delta N100/Delta E101 decreased the cooperativity of force development, suggesting alterations in intrafilament protein-protein interactions. In the fetal Tn environment, (cTnT1 + slow skeletal troponin I), the single (cTnT1-Delta N110) and double (cTnT1-Delta N110/Delta E111) deletions did not change the Ca2+ sensitivity compared with control. To recreate the patient's heterozygous genotype, we performed a reconstituted ATPase activity assay. Thin filaments containing 50:50 cTnT3-Delta N100/Delta E101:cTnT3-WT also increased the myofilament Ca2+ sensitivity compared with WT. Co-sedimentation of thin filament proteins indicated that no significant changes occurred in the binding of Tn containing the RCM cTnT mutation to actin-Tm. This report reveals the protective role of Tn fetal isoforms as they rescue the increased Ca2+ sensitivity produced by a cTnT-RCM mutation and may account for the lack of lethality during gestation.	[Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Yang, Shi Wei; Hitz, Marc-Phillip; Kokta, Victor; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Yang, Shi Wei; Hitz, Marc-Phillip; Kokta, Victor; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor] Univ Montreal, CHU St Justine, Dept Biochem, Montreal, PQ H3T 1C5, Canada; [Talajic, Mario] Univ Montreal, Dept Med, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	University of Miami; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Room 6083,R-189,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	Tremblay, Nicolas/O-7927-2019; Hitz, Marc/ABD-9495-2021; parvatiyar, michelle/ABH-7542-2020; Hitz, Marc-Phillip/Q-5571-2018; Yang, Wei/HIA-0360-2022; Pinto, Jose Renato/H-2631-2017	Tremblay, Nicolas/0000-0003-4246-7189; Hitz, Marc-Phillip/0000-0001-9894-6897; Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069; Talajic, Mario/0000-0001-8469-4748	National Institutes of Health [HL-042325]; JE King Grant [1KN13-34001]; Sainte Justine Hospital Foundation; American Heart Association; Nussia and Andre Aisenstadt Foundation; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042325, R01HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JE King Grant; Sainte Justine Hospital Foundation; American Heart Association(American Heart Association); Nussia and Andre Aisenstadt Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-042325 (to J. D. P.).; Supported by J&E King Grant 1KN13-34001.; Supported by a grant from the Sainte Justine Hospital Foundation.; Supported by a postdoctoral fellowship from the American Heart Association.; Supported by a Clinician-Scientist Award of the Canadian Institutes of Health Research and the Nussia and Andre Aisenstadt Foundation. To whom correspondence may be addressed: Genetique Cardiovasculaire, CHU Sainte Justine, University of Montreal, 3175, Cote Sainte Catherine, Montreal, Quebec H3T 1C5, Canada. E-mail: gregor.andelfinger@recherche-ste-justine.qc.ca.	Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Ammash NM, 2000, CIRCULATION, V101, P2490, DOI 10.1161/01.CIR.101.21.2490; ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Chen SC, 2001, J HEART LUNG TRANSPL, V20, P90, DOI 10.1016/S1053-2498(00)00162-5; Chimenti C, 2008, AM J PATHOL, V172, P1482, DOI 10.2353/ajpath.2008.070576; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Dipchand AI, 2009, J HEART LUNG TRANSPL, V28, P1312, DOI 10.1016/j.healun.2009.05.019; Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P212, DOI 10.1016/j.echo.2003.12.005; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Huang XP, 1999, CIRC RES, V84, P1; Karam Simon, 2008, Congenit Heart Dis, V3, P138, DOI 10.1111/j.1747-0803.2008.00165.x; Kaski JP, 2008, HEART, V94, P1478, DOI 10.1136/hrt.2007.134684; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kostareva A, 2009, INT J CARDIOL, V131, P410, DOI 10.1016/j.ijcard.2007.07.108; Kranias E. G., 2007, V45, P523; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Menon SC, 2008, CLIN GENET, V74, P445, DOI 10.1111/j.1399-0004.2008.01062.x; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ommen SR, 2000, CIRCULATION, V102, P1788; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Parvatiyar MS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/350706; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Pena JR, 2010, J MOL CELL CARDIOL, V49, P993, DOI 10.1016/j.yjmcc.2010.09.010; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; Soldin SJ, 2006, CLIN CHIM ACTA, V366, P304, DOI 10.1016/j.cca.2005.11.005; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; Urboniene D, 2005, CIRC RES, V97, P70, DOI 10.1161/01.RES.0000173849.68636.1e; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Ware SM, 2008, CLIN GENET, V73, P165, DOI 10.1111/j.1399-0004.2007.00939.x; Weller RJ, 2002, AM J CARDIOL, V90, P501, DOI 10.1016/S0002-9149(02)02522-5; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zangwill SD, 2009, J HEART LUNG TRANSPL, V28, P1335, DOI 10.1016/j.healun.2009.06.028	60	12	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20901	20912		10.1074/jbc.M111.234336	http://dx.doi.org/10.1074/jbc.M111.234336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502316	Green Published, hybrid			2022-12-27	WOS:000291267600074
